PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, S; Lee, E; Jung, J; Lee, JW; Kim, HJ; Kim, J; Yoo, HJ; Lee, HJ; Chae, SY; Jeon, SM; Son, BH; Gong, G; Sharan, SK; Chang, S				Kim, Sinae; Lee, Eunji; Jung, Jaeyun; Lee, Jong Won; Kim, Hee Jung; Kim, Jisun; Yoo, Hyun ju; Lee, Hee Jin; Chae, Sun Young; Jeon, Sang Min; Son, Byung Ho; Gong, Gyungyup; Sharan, Shyam K.; Chang, Suhwan			microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer	ONCOGENE			English	Article							GENE-EXPRESSION; MIR-155; REVEALS; CELLS; TARGETS; GROWTH; FOXO3A; BRCA1; MYC	MicroRNA is an endogenous, small RNA controlling multiple target genes and playing roles in various biological processes including tumorigenesis. Here, we addressed the function of miR-155 using LC-MS/MS-based metabolic profiling of miR-155 deficient breast cancer cells. Our results revealed the loss of miR-155 hampers glucose uptake and glycolysis, via the down-regulation of glucose transporters and metabolic enzymes including HK2, PKM2, and LDHA. We showed this is due to the down-regulation of cMYC, controlled through phosphoinositide-3-kinase regulatory subunit alpha (PIK3R1)-PDK1/AKT-FOXO3a pathway. UTR analysis of the PIK3R1 and FOXO3a indicated miR-155 directly represses these genes. A stable expression of miR-155 in patient-derived cells (PDCs) showed activated glucose metabolism whereas a stable inhibition of miR-155 reduced in vivo tumor growth with retarded glucose metabolism. Furthermore, analysis of 50 triple-negative breast cancer (TNBC) specimens and specific uptake value (SUV) of PET images revealed a positive correlation between miR-155 level and glucose usage in human breast tumors via PIK3R1-PDK/AKT-FOXO3a-cMYC axis. Collectively, these data demonstrate the miR-155 is a key regulator of glucose metabolism in breast cancer.	[Kim, Sinae; Lee, Eunji; Jung, Jaeyun; Chang, Suhwan] Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul 05505, South Korea; [Lee, Jong Won; Kim, Hee Jung; Kim, Jisun; Son, Byung Ho] Asan Med Ctr, Dept Surg, Seoul 05505, South Korea; [Yoo, Hyun ju] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul 05505, South Korea; [Lee, Hee Jin; Gong, Gyungyup] Asan Med Ctr, Dept Pathol, Seoul 05505, South Korea; [Chae, Sun Young] Asan Med Ctr, Dept Nucl Med, Seoul 05505, South Korea; [Jeon, Sang Min] Ajou Univ, Coll Pharm, Suwon 16499, South Korea; [Jeon, Sang Min] Ajou Univ, Inst Pharmaceut Sci & Technol, Suwon 16499, South Korea; [Sharan, Shyam K.] Frederick Natl Lab, Mouse Canc Genet Program, Frederick, MD 21702 USA	University of Ulsan; University of Ulsan; Ajou University; Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chang, S (corresponding author), Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul 05505, South Korea.	suhwan.chang@amc.seoul.kr	Jeon, Sang-Min/I-7917-2018	Jeon, Sang-Min/0000-0002-0132-925X; Lee, Hee Jin/0000-0002-4963-6603; Chang, Suhwan/0000-0002-0282-0120; KIM, JISUN/0000-0002-4884-6107	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1538]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1320140]; NATIONAL CANCER INSTITUTE [ZIABC011311] Funding Source: NIH RePORTER	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank to Dr. Ahn, Sung Gwe (Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine) for valuable suggestions. The biospecimen and data used in this study was provided by Asan Bio-Resource Center, Korea Biobank Network (2014-3(72)). This work is supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare (Grant number: HI13C1538) and by the National R&D Program for Cancer Control, Ministry of Health & Welfare (No. 1320140), Republic of Korea.	Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dang CV., 2007, E SCHERING FDN S P, V4, P35; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Geltz NR, 1998, BLOOD, V91, P930, DOI 10.1182/blood.V91.3.930.930_930_939; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Huang X, 2012, AM J PATHOL, V181, P26, DOI 10.1016/j.ajpath.2012.03.013; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Kim S, 2016, ONCOTARGET, V7, P11094, DOI 10.18632/oncotarget.7150; Kim S, 2015, CANCER LETT, V357, P488, DOI 10.1016/j.canlet.2014.11.058; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006308; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lv X, 2016, MOL MED REP, V14, P1332, DOI 10.3892/mmr.2016.5394; Mattiske S, 2012, CANCER EPIDEM BIOMAR, V21, P1236, DOI 10.1158/1055-9965.EPI-12-0173; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang J, 2012, FRONT BIOSCI-LANDMRK, V17, P2350, DOI 10.2741/4056; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	33	71	73	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2982	2991		10.1038/s41388-018-0124-4	http://dx.doi.org/10.1038/s41388-018-0124-4			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29527004	Green Published, hybrid			2022-12-26	WOS:000433936300006
J	Delporte, C; Boudjeltia, KZ; Furtmuller, PG; Maki, RA; Dieu, M; Noyon, C; Soudi, M; Dufour, D; Coremans, C; Nuyens, V; Reye, F; Rousseau, A; Raes, M; Moguilevsky, N; Vanhaeverbeek, M; Ducobu, J; Neve, J; Robaye, B; Vanhamme, L; Reynolds, WF; Obinger, C; Van Antwerpen, P				Delporte, Cedric; Boudjeltia, Karim Zouaoui; Furtmueller, Paul G.; Maki, Richard A.; Dieu, Marc; Noyon, Caroline; Soudi, Monika; Dufour, Damien; Coremans, Catherine; Nuyens, Vincent; Reye, Florence; Rousseau, Alexandre; Raes, Martine; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Ducobu, Jean; Neve, Jean; Robaye, Bernard; Vanhamme, Luc; Reynolds, Wanda F.; Obinger, Christian; Van Antwerpen, Pierre			Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cardiovascular disease; lipoprotein; myeloperoxidase; post-translational modification (PTM); cyanide; cyanate	LOW-DENSITY-LIPOPROTEIN; PEROXIDASE COMPOUND-I; HYDROGEN-CYANIDE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; HYPOCHLOROUS ACID; AIR-POLLUTION; THIOCYANATE; BINDING; EMISSIONS	Protein carbamylation by cyanate is a post-translational modification associated with several (patho)physiological conditions, including cardiovascular disorders. However, the biochemical pathways leading to protein carbamylation are incompletely characterized. This work demonstrates that the heme protein myeloperoxidase (MPO), which is secreted at high concentrations at inflammatory sites from stimulated neutrophils and monocytes, is able to catalyze the two-electron oxidation of cyanide to cyanate and promote the carbamylation of taurine, lysine, and low-density lipoproteins. We probed the role of cyanide as both electron donor and low-spin ligand by pre-steady-state and steady-state kinetic analyses and analyzed reaction products by MS. Moreover, we present two further pathways of carbamylation that involve reaction products of MPO, namely oxidation of cyanide by hypochlorous acid and reaction of thiocyanate with chloramines. Finally, using an in vivo approach with mice on a high-fat diet and carrying the human MPO gene, we found that during chronic exposure to cyanide, mimicking exposure to pollution and smoking, MPO promotes protein-bound accumulation of carbamyllysine (homocitrulline) in atheroma plaque, demonstrating a link between cyanide exposure and atheroma. In summary, our findings indicate that cyanide is a substrate for MPO and suggest an additional pathway for in vivo cyanate formation and protein carbamylation that involves MPO either directly or via its reaction products hypochlorous acid or chloramines. They also suggest that chronic cyanide exposure could promote the accumulation of carbamylated proteins in atherosclerotic plaques.	[Delporte, Cedric; Noyon, Caroline; Dufour, Damien; Coremans, Catherine; Reye, Florence; Neve, Jean; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Delporte, Cedric; Dufour, Damien; Coremans, Catherine; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Analyt Platform, B-1050 Brussels, Belgium; [Boudjeltia, Karim Zouaoui; Nuyens, Vincent; Rousseau, Alexandre; Vanhaeverbeek, Michel; Ducobu, Jean] Univ Libre Bruxelles, A Vesale Hosp, Lab Expt Med, CHU Charleroi, B-6110 Montignies le Tilleul, Belgium; [Furtmueller, Paul G.; Soudi, Monika; Obinger, Christian] Univ Nat Resources & Life Sci BOKU, Div Biochem, Dept Chem, A-1180 Vienna, Austria; [Maki, Richard A.] Torrey Pines Pharmaceut, Del Mar, CA 92014 USA; [Maki, Richard A.; Reynolds, Wanda F.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Dieu, Marc; Raes, Martine] Univ Namur, Lab Cellular Biol, B-5000 Namur, Belgium; [Moguilevsky, Nicole] Univ Namur, Technol Transfer Off, B-5000 Namur, Belgium; [Robaye, Bernard] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Inst Interdisciplinary Res, Fac Sci, B-6041 Gosselies, Belgium; [Vanhamme, Luc] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Lab Mol Parasitol, Fac Sci, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Natural Resources & Life Sciences, Vienna; Sanford Burnham Prebys Medical Discovery Institute; University of Namur; University of Namur; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Van Antwerpen, P (corresponding author), Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem Analyt Platform, Brussels, Belgium.	pvantwer@ulb.ac.be	Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Delporte, Cedric/C-2228-2013	Furtmüller, Paul G./0000-0002-1199-2469; Obinger, Christian/0000-0002-7133-3430; Delporte, Cedric/0000-0001-7453-7028; Dieu, Marc/0000-0002-3902-542X; Maki, Richard/0000-0002-9593-0723; Van Antwerpen, Pierre/0000-0002-4934-8863	Belgian Fund for Scientific Research (FRS-FNRS); Austrian Science Funds [FWF P 20664]; doctoral program BioToP Grant [W1224]; Belgian National Fund for Scientific Research (FRS) [3.4553.08, T.0136.13 PDR]; Universite Libre de Bruxelles Grant [FER-207]; Department of International Relationships of the Universite Libre de Bruxelles Grant [BRIC SJ/AL/BRIC/130]; National Institutes of Health [RO1-NS074303, R43 AG040935]; Institute of Pathology and Genetics (IRSPG, Loverval, Belgium); CHU of Charleroi; Sanford Burnham Prebys Medical Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG040935] Funding Source: NIH RePORTER	Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Austrian Science Funds(Austrian Science Fund (FWF)); doctoral program BioToP Grant; Belgian National Fund for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles Grant; Department of International Relationships of the Universite Libre de Bruxelles Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Pathology and Genetics (IRSPG, Loverval, Belgium); CHU of Charleroi; Sanford Burnham Prebys Medical Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Austrian Science Funds Grant FWF P 20664 (to P. G. F.) and doctoral program BioToP Grant W1224 (to M. S.), Belgian National Fund for Scientific Research (FRS) Grants 3.4553.08 and T.0136.13 PDR, Universite Libre de Bruxelles Grant FER-207, and Department of International Relationships of the Universite Libre de Bruxelles Grant BRIC SJ/AL/BRIC/130. This study was also supported in part by National Institutes of Health Grants RO1-NS074303 (to W. F. R.) and R43 AG040935 (to R. A. M.). This work was also supported by the Institute of Pathology and Genetics (IRSPG, Loverval, Belgium) and the "CHU of Charleroi." Additional funds to support this work were provided by Sanford Burnham Prebys Medical Discovery Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Postdoctoral researcher supported by the Belgian Fund for Scientific Research (FRS-FNRS).	Abraham K, 2016, ARCH TOXICOL, V90, P559, DOI 10.1007/s00204-015-1479-8; Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Ansell M, 1970, J Forensic Med, V17, P148; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; Baum MM, 2007, ENVIRON SCI TECHNOL, V41, P857, DOI 10.1021/es061402v; BERDNIKO.VM, 1970, RUSS J PHYS CH USSR, V44, P395; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; BOXER GE, 1952, ARCH BIOCHEM BIOPHYS, V39, P7, DOI 10.1016/0003-9861(52)90256-7; CAILLEUX A, 1988, J MED, V19, P345; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; CHANCE B, 1949, J BIOL CHEM, V179, P1299; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Delporte C, 2012, TALANTA, V99, P603, DOI 10.1016/j.talanta.2012.06.044; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Franchini M, 2012, J THROMB HAEMOST, V10, P2438, DOI 10.1111/jth.12006; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Furtmuller PG, 2001, BBA-PROTEIN STRUCT M, V1548, P121, DOI 10.1016/S0167-4838(01)00230-8; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; IKEDASAITO M, 1987, BIOCHEMISTRY-US, V26, P4344, DOI 10.1021/bi00388a024; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jantschko W, 2003, BIOCHEM BIOPH RES CO, V312, P292, DOI 10.1016/j.bbrc.2003.10.117; Kraus LM, 1998, J LAB CLIN MED, V131, P425, DOI 10.1016/S0022-2143(98)90143-3; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Lemma K, 2009, CHEM RES TOXICOL, V22, P1622, DOI 10.1021/tx900212r; Lucking AJ, 2011, CIRCULATION, V123, P1721, DOI 10.1161/CIRCULATIONAHA.110.987263; LUNDQUIST P, 1987, CLIN CHEM, V33, P1228; Mahernia S, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0211-1; Malle E, 2006, BBA-MOL CELL BIOL L, V1761, P392, DOI 10.1016/j.bbalip.2006.03.024; Maricq MM, 2007, J AEROSOL SCI, V38, P1079, DOI 10.1016/j.jaerosci.2007.08.001; MARQUEZ LA, 1989, BIOCHEM CELL BIOL, V67, P187, DOI 10.1139/o89-029; Miller MR, 2012, FUTUR CARDIOL, V8, P577, DOI [10.2217/fca.12.43, 10.2217/FCA.12.43]; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Moussa SG, 2016, ATMOS ENVIRON, V131, P185, DOI 10.1016/j.atmosenv.2016.01.050; National Research Council of the National Academy of Sciences, 2011, GUIDE CARE USE LAB A; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; PALCIC MM, 1981, ARCH BIOCHEM BIOPHYS, V211, P245, DOI 10.1016/0003-9861(81)90451-3; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; ZENG J, 1991, METHOD ENZYMOL, V205, P433; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	56	27	28	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6374	6386		10.1074/jbc.M117.801076	http://dx.doi.org/10.1074/jbc.M117.801076			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496995	hybrid, Green Published			2022-12-26	WOS:000431108600013
J	Okada, H; Yamada, M; Kamimoto, K; Kok, CYY; Kaneko, K; Ema, M; Miyajima, A; Itoh, T				Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota; Ema, Masatsugu; Miyajima, Atsushi; Itoh, Tohru			The transcription factor Klf5 is essential for intrahepatic biliary epithelial tissue remodeling after cholestatic liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; P-GLYCOPROTEIN GENE; STEM-CELLS; PROGENITOR-CELL; HOMOZYGOUS DISRUPTION; ANIMAL-MODEL; BILE; DAMAGE; REPAIR; RAT	Under various conditions of liver injury, the intrahepatic biliary epithelium undergoes dynamic tissue expansion and remodeling, a process known as ductular reaction. Mouse models defective in inducing such a tissue-remodeling process are more susceptible to liver injury, suggesting a crucial role of this process in liver regeneration. However, the molecular mechanisms regulating the biliary epithelial cell (BEC) dynamics in the ductular reaction remain largely unclear. Here, we demonstrate that the transcription factor Kruppel-like factor 5 (Klf5) is highly enriched in mouse liver BECs and plays a key role in regulating the ductular reaction, specifically under cholestatic injury conditions. Although mice lacking Klf5 in the entire liver epithelium, including both hepatocytes and BECs (Klf5-LKO (liver epithelial-specific knockout) mice), did not exhibit any apparent phenotype in the hepatobiliary system under normal conditions, they exhibited significant defects in biliary epithelial tissue remodeling upon 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholangitis, concomitantly with exacerbated cholestasis and reduced survival rate. In contrast, mice lacking Klf5 solely in hepatocytes did not exhibit any such phenotypes, confirming Klf5's specific role in BECs. RNA-sequencing analyses of BECs isolated from the Klf5-LKO mouse livers revealed that the Klf5 deficiency primarily affected expression of cell cycle-related genes. Moreover, immunostaining analysis with the proliferation marker Ki67 disclosed that the Klf5-LKO mice had significantly reduced BEC proliferation levels upon injury. These results indicate that Klf5 plays a critical role in the ductular reaction and biliary epithelial tissue expansion and remodeling by inducing BEC proliferation and thereby contributing to liver regeneration.	[Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota; Miyajima, Atsushi; Itoh, Tohru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan; [Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota] Japan Soc Promot Sci, Tokyo, Japan; [Kamimoto, Kenji] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Kok, Cindy Yuet-Yin] Westmead Inst Med Res, Ctr Heart Res, Westmead, NSW 2145, Australia; [Kaneko, Kota] Univ Calif San Diego, Sch Med, Dept Pathol, Div Biol Sci, La Jolla, CA 92093 USA	University of Tokyo; Shiga University of Medical Science; Japan Society for the Promotion of Science; Washington University (WUSTL); University of Sydney; Westmead Institute for Medical Research; University of California System; University of California San Diego	Itoh, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp	Itoh, Tohru/GYQ-8698-2022	Itoh, Tohru/0000-0002-6579-1638; Kok, Cindy/0000-0003-3086-7097; Okada, Hajime/0000-0002-3204-3633; Ema, Masatsugu/0000-0003-0645-6183; Yamada, Minami/0000-0002-2622-3195; Kamimoto, Kenji/0000-0003-3541-4353	Japan Society for the Promotion of Science KAKENHI Grants [22118006, 24112507, 24590342, 26112704, 26253023, 15H01369, 15J08420, 17H05497]; CREST from the Japan Science and Technology Agency [15652259]; Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi Sankyo Foundation of Life Science	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants 22118006 (to A. M.), 24112507 (to T. I.), 24590342 (to T. I.), 26112704 (to T. I.), 26253023 (to A. M.), 15H01369 (to T. I.), 15J08420 (to H. O.), and 17H05497 (to T. I.); CREST from the Japan Science and Technology Agency Grant 15652259 (to A. M.); a research grant from the Takeda Science Foundation (to T. I.); and a research grant from the Daiichi Sankyo Foundation of Life Science (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Azami T, 2017, DEVELOPMENT, V144, P3706, DOI 10.1242/dev.150755; Bell K. A., 2016, THESIS; Bialkowska AB, 2017, DEVELOPMENT, V144, P737, DOI 10.1242/dev.145441; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Hayashi S, 2016, ELIFE, V5, DOI 10.7554/eLife.17462; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kamimoto K, 2016, ELIFE, V5, DOI 10.7554/eLife.15034; Kaneko K, 2015, HEPATOLOGY, V61, P2056, DOI 10.1002/hep.27685; Kiritsi D, 2013, CELL ADHES MIGR, V7, P135, DOI 10.4161/cam.22418; Kok CY, 2013, MOL THER, V21, P1823, DOI 10.1038/mt.2013.139; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Lesage G, 2001, AM J PHYSIOL-GASTR L, V281, pG182, DOI 10.1152/ajpgi.2001.281.1.G182; LeSage GD, 1999, HEPATOLOGY, V29, P307, DOI 10.1002/hep.510290242; Li M, 2015, INT J BIOL SCI, V11, P1458, DOI [10.7150/ijbs.13444, 10.7150/ijbs.10809]; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; Maehara O, 2015, CANCER BIOL THER, V16, P1453, DOI 10.1080/15384047.2015.1070992; MAUAD TH, 1994, AM J PATHOL, V145, P1237; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Nandan MO, 2014, DEV BIOL, V387, P191, DOI 10.1016/j.ydbio.2014.01.002; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okabe H, 2016, HEPATOLOGY, V64, P1652, DOI 10.1002/hep.28774; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Passman AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5702873; Shinoda Y, 2008, J BIOL CHEM, V283, P24682, DOI 10.1074/jbc.M709857200; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tanimizu N, 2012, J BIOL CHEM, V287, P28586, DOI 10.1074/jbc.M112.350488; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	63	10	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6214	6229		10.1074/jbc.RA118.002372	http://dx.doi.org/10.1074/jbc.RA118.002372			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523685	hybrid, Green Published			2022-12-26	WOS:000431108600001
J	Nakamizo, T; Yamamoto, M; Johkura, K				Nakamizo, Tomoki; Yamamoto, Masahiro; Johkura, Ken			Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor	PLOS ONE			English	Article							WARFARIN; THROMBOEMBOLISM; STRATIFICATION; EPIDEMIOLOGY; METAANALYSIS; EFFICACY; BENEFIT; BURDEN	The risk of atrial fibrillation (AF)-related stroke is usually assessed by calculating the CHA(2)DS(2)-VASc score, the components of which are various risk factors, including prior stroke. Although prior stroke is considered the strongest risk factor, the associated risk is actually inferred. Nevertheless, it implies a "freedom-from-event effect" (FEE)-the longer a patient is stroke-free, the lower the stroke risk. Although dynamic prognostication has been applied to cancer, the FEE has been ignored in AF, probably because of methodological difficulties. We conducted a simulation study to evaluate the FEE in the risk of AF-related stroke. We modeled various populations of AF patients and simulated the development of stroke assuming a nonhomogeneous Poisson process, where the hazard depends on age, comorbidities, and individual variability. Parameters were set so that the model respects the CHA(2)DS(2)-VASc scoring scheme and reproduces the 1-year CHA(2)DS(2)-VASc score-wise stroke risk and relative risk conferred by real-world risk factors. We tracked stroke risk over 0 to 15 years of freedom-from-stroke time (FST), both prospective FST (pFST), which begins at the time of diagnosis and continues to the future, and retrospective FST (rFST), which begins at the present and looks backward to the time of diagnosis. The pFST counterbalanced the increase in stroke risk conferred by aging; in patients with a CHA(2)DS(2)-VASc score of 1, the pFST offset 62% of the age-conferred risk increase. The rFST reduced the stroke risk; in patients with a CHA(2)DS(2)-VASc score of 2 and without prior stroke, an rFST of 6.8 years reduced the stroke risk to the midpoint between CHA(2)DS(2)-VASc scores 1 and 2. The study results suggest that the FEE should be considered in evaluating stroke risk in patients with AF. The FEE may be important in other recurrent diseases for which a prior event is a risk factor for a future event.	[Nakamizo, Tomoki; Yamamoto, Masahiro; Johkura, Ken] Yokohama Brain & Spine Ctr, Dept Neurol, Yokohama, Kanagawa, Japan		Nakamizo, T (corresponding author), Yokohama Brain & Spine Ctr, Dept Neurol, Yokohama, Kanagawa, Japan.	nakamizo@kuhp.kyoto-u.ac.jp	Nakamizo, Tomoki/AAM-8615-2021	Nakamizo, Tomoki/0000-0002-8377-1235				Camm AJ, 2012, EUR HEART J, V33; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Friberg L, 2015, J AM COLL CARDIOL, V65, P225, DOI 10.1016/j.jacc.2014.10.052; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hieke S, 2015, CLIN CANCER RES, V21, P1530, DOI 10.1158/1078-0432.CCR-14-2154; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Johnsen SP, 2014, STROKE, V45, P168, DOI 10.1161/STROKEAHA.113.001792; Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lubitz SA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000126; Nakamizo T, 2009, ASIAN BIOMED, V3, P445; Olesen JB, 2015, THROMB HAEMOSTASIS, V113, P1165, DOI 10.1160/TH15-02-0154; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Ottosen TP, 2014, DAN MED J, V61; Pasupathy R., 2011, WILEY ENCY OPERATION; Pisters R, 2012, CIRC J, V76, P2289, DOI 10.1253/circj.CJ-12-1036; Poli D, 2015, INT J WOMENS HEALTH, V7, P605, DOI 10.2147/IJWH.S45925; Psaty BM, 1997, CIRCULATION, V96, P2455; R Core Team, 2021, R LANGUAGE ENV STAT; Roskell NS, 2013, EUROPACE, V15, P787, DOI 10.1093/europace/eut001; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Shen AYJ, 2008, STROKE, V39, P2736, DOI 10.1161/STROKEAHA.107.508580; Sussman M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000479; Wagstaff AJ, 2014, QJM-INT J MED, V107, P955, DOI 10.1093/qjmed/hcu054; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Yiin GSC, 2014, CIRCULATION, V130, P1236, DOI 10.1161/CIRCULATIONAHA.114.010942	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194307	10.1371/journal.pone.0194307	http://dx.doi.org/10.1371/journal.pone.0194307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529057	Green Submitted, Green Published, gold			2022-12-26	WOS:000427189300051
J	Li, HJ; Qiu, TS; Luan, SY; Song, HY; Wu, LX				Li, Houjie; Qiu, Tianshuang; Luan, Shengyang; Song, Haiyu; Wu, Linxiu			Deblurring traffic sign images based on exemplars	PLOS ONE			English	Article							REGISTRATION; MAXIMIZATION; ALGORITHMS	Motion blur appearing in traffic sign images may lead to poor recognition results, and therefore it is of great significance to study how to deblur the images. In this paper, a novel method for deblurring traffic sign is proposed based on exemplars and several related approaches are also made. First, an exemplar dataset construction method is proposed based on multiple-size partition strategy to lower calculation cost of exemplar matching. Second, a matching criterion based on gradient information and entropy correlation coefficient is also proposed to enhance the matching accuracy. Third, L-0.5-norm is introduced as the regularization item to maintain the sparsity of blur kernel. Experiments verify the superiority of the proposed approaches and extensive evaluations against state-of-the-art methods demonstrate the effectiveness of the proposed algorithm.	[Li, Houjie; Qiu, Tianshuang] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China; [Li, Houjie; Wu, Linxiu] Dalian Minzu Univ, Coll Informat & Commun Engn, Dalian, Liaoning, Peoples R China; [Luan, Shengyang] Jiangsu Normal Univ, Sch Elect Engn & Automat, Xuzhou, Jiangsu, Peoples R China; [Song, Haiyu] Dalian Minzu Univ, Sch Comp Sci & Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian Minzu University; Jiangsu Normal University; Dalian Minzu University	Qiu, TS (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China.	qiutsh@dlut.edu.cn	Song, haiyu/ABB-3879-2020; luan, shengyang/AAZ-3507-2021	luan, shengyang/0000-0002-3252-6854	National Natural Science Foundation of China [61172108]; General Scientific Research Foundation of Liaoning Educational Committee [L2014540]; Fundamental Research Funds for the Central Universities [DC201502060405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Scientific Research Foundation of Liaoning Educational Committee; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by National Natural Science Foundation of China 61172108 to TQ, General Scientific Research Foundation of Liaoning Educational Committee L2014540 to HL, and Fundamental Research Funds for the Central Universities DC201502060405 to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is financially supported by National Natural Science Foundation of China (61172108), General Scientific Research Foundation of Liaoning Educational Committee (L2014540), Fundamental Research Funds for the Central Universities(DC201502060405). The authors are indebted to Dr. Jinshan Pan and Dr. Daniel Zoran for their assistance.	Cho S, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618491; Fleyeln Masan, 2005, J VET MED, V52, P278; Fu MY, 2010, INT C WAVEL ANAL PAT, P119, DOI 10.1109/ICWAPR.2010.5576425; Gomez-Moreno H, 2010, IEEE T INTELL TRANSP, V11, P917, DOI 10.1109/TITS.2010.2054084; HaCohen Y, 2013, IEEE I CONF COMP VIS, P2384, DOI 10.1109/ICCV.2013.296; He KM, 2010, LECT NOTES COMPUT SC, V6311, P1; Jia J., 2014, MATH MODELS PRACTICA; Jia J., 2007, IEEE C COMP VIS PATT, P1; Joshi N., 2008, CVPR, P1; Khyati C., 2011, S JPSET, V2, P27; Krishnan D., 2011, CVPR, P2657; Lee S, 2013, SIGGRAPH AS 2013 COU; Levin A., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2657, DOI 10.1109/CVPR.2011.5995308; Levin A, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239521; Levin A, 2009, PROC CVPR IEEE, P1964, DOI 10.1109/CVPRW.2009.5206815; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Michaeli T, 2014, LECT NOTES COMPUT SC, V8691, P783, DOI 10.1007/978-3-319-10578-9_51; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pan JS, 2017, IEEE T PATTERN ANAL, V39, P342, DOI 10.1109/TPAMI.2016.2551244; Pan JS, 2016, PROC CVPR IEEE, P1628, DOI 10.1109/CVPR.2016.180; Pan JS, 2013, SIGNAL PROCESS-IMAGE, V28, P1156, DOI 10.1016/j.image.2013.05.001; Pluim JPW, 2000, IEEE T MED IMAGING, V19, P809, DOI 10.1109/42.876307; Shan Q, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360672; Stallkamp J, 2012, NEURAL NETWORKS, V32, P323, DOI 10.1016/j.neunet.2012.02.016; Xu L, 2013, PROC CVPR IEEE, P1107, DOI 10.1109/CVPR.2013.147; Xu L, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2024156.2024208; Xu L, 2010, LECT NOTES COMPUT SC, V6311, P157	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191367	10.1371/journal.pone.0191367	http://dx.doi.org/10.1371/journal.pone.0191367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513677	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800005
J	Ruark, CL; Gardner, M; Mitchum, MG; Davis, EL; Sit, TL				Ruark, Casey L.; Gardner, Michael; Mitchum, Melissa G.; Davis, Eric L.; Sit, Tim L.			Novel RNA viruses within plant parasitic cyst nematodes	PLOS ONE			English	Article							SEQUENCE; GENOME; POLYPROTEINS; DISCOVERY; FAMILY; ORDER	The study of invertebrate- and particularly nematode-viruses is emerging with the advancement of transcriptome sequencing. Five single-stranded RNA viruses have now been confirmed within the economically important soybean cyst nematode (SCN; Heterodera glycines). From previous research, we know these viruses to be widespread in greenhouse and field populations of SCN. Several of the SCN viruses were also confirmed within clover (H. trifolii) and beet (H. schachtii) cyst nematodes. In the presented study, we sequenced the transcriptomes of several inbred SCN populations and identified two previously undiscovered viral-like genomes. Both of these proposed viruses are negative-sense RNA viruses and have been named SCN nyami-like virus (NLV) and SCN bunya-like virus (BLV). Finally, we analyzed publicly available transcriptome data of two potato cyst nematode (PCN) species, Globodera pallida and G. rostochiensis. From these data, a third potential virus was discovered and called PCN picorna-like virus (PLV). PCN PLV is a positive-sense RNA virus, and to the best of our knowledge, is the first virus described within PCN. The presence of these novel viruses was confirmed via qRT-PCR, endpoint PCR, and Sanger sequencing with the exception of PCN PLV due to quarantine restrictions on the nematode host. While much work needs to be done to understand the biological and evolutionary significance of these viruses, they offer insight into nematode ecology and the possibility of novel nematode management strategies.	[Ruark, Casey L.; Davis, Eric L.; Sit, Tim L.] North Carolina State Univ, Dept Entomol & Plant Pathol, Thomas Hall, Raleigh, NC 27695 USA; [Gardner, Michael; Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, 371H Bond Life Sci Ctr, Columbia, MO USA; [Gardner, Michael; Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, 371H Bond Life Sci Ctr, Columbia, MO USA	University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sit, TL (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Thomas Hall, Raleigh, NC 27695 USA.	tim@ncsu.edu		Sit, Tim/0000-0001-7302-823X	National Science Foundation [DGE-1252376]; NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service	National Science Foundation(National Science Foundation (NSF)); NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service	This work was supported by the National Science Foundation, DGE-1252376 (www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the NC State University Genomic Sciences Laboratory for RNA sequencing as well as Ioannis Tzanetakis at the University of Arkansas for granting access to VirFind (http://virfind.org). Gratitude is extended towards Xiaohong Wang and Shiyan Chen of Cornell University for their contribution of G. rostochiensis total RNA. We thank the NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service for providing their facilities and support in this work. Lastly, we would like to thank the researchers from which we utilized public transcriptome data.	Bekal S, 2014, J GEN VIROL, V95, P1272, DOI 10.1099/vir.0.060889-0; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; BROWN DJF, 1995, ANNU REV PHYTOPATHOL, V33, P223, DOI 10.1146/annurev.py.33.090195.001255; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Cotton JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep39749; de Boer JM, 1999, MOL PLANT MICROBE IN, V12, P663, DOI 10.1094/MPMI.1999.12.8.663; Donaire L, 2016, VIROLOGY, V499, P212, DOI 10.1016/j.virol.2016.09.017; Dong K, 1997, GENETICS, V146, P1311; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fosu-Nyarko J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147511; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Gardner M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20536-5; Gardner M, 2017, G3-GENES GENOM GENET, V7, P835, DOI 10.1534/g3.116.035964; Geng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092107; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Longdon B, 2012, P ROY SOC B-BIOL SCI, V279, P3889, DOI 10.1098/rspb.2012.1208; Mann KS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00745; Mihindukulasuriya KA, 2009, J VIROL, V83, P5109, DOI 10.1128/JVI.02667-08; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rogers MB, 2014, AM J TROP MED HYG, V91, P159, DOI 10.4269/ajtmh.14-0076; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Ruark CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171514; Shean RC, 2017, GENOME ANNOUNC, V5; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Skantar AM, 2012, J NEMATOL, V44, P58; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Yinda CK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3632-7; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193881	10.1371/journal.pone.0193881	http://dx.doi.org/10.1371/journal.pone.0193881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509804	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200037
J	Sorensen, DM; Holemans, T; van Veen, S; Martin, S; Arslan, T; Haagendahl, IW; Holen, HW; Hamouda, NN; Eggermont, J; Palmgren, M; Vangheluwe, P				Sorensen, Danny Mollerup; Holemans, Tine; van Veen, Sarah; Martin, Shaun; Arslan, Tugce; Haagendahl, Ida Winther; Holen, Henrik Weida; Hamouda, Norin Nabil; Eggermont, Jan; Palmgren, Michael; Vangheluwe, Peter			Parkinson disease related ATP13A2 evolved early in animal evolution	PLOS ONE			English	Article							P-TYPE ATPASE; SECRETORY PATHWAY; ALPHA-SYNUCLEIN; LYSOSOMAL DYSFUNCTION; PHYLOGENETIC ANALYSIS; TRANSPORT ATPASES; HOMEOSTASIS; MUTATIONS; PARK9; CA2+	Several human P5-type transport ATPases are implicated in neurological disorders, but little is known about their physiological function and properties. Here, we investigated the relationship between the five mammalian P5 isoforms ATP13A1-5 in a comparative study. We demonstrated that ATP13A1-4 isoforms undergo autophosphorylation, which is a hallmark P-type ATPase property that is required for substrate transport. A phylogenetic analysis of P5 sequences revealed that ATP13A1 represents Glade P5A, which is highly conserved between fungi and animals with one member in each investigated species. The ATP13A2-5 isoforms belong to Glade P5B and diversified from one isoform in fungi and primitive animals to a maximum of four in mammals by successive gene duplication events in vertebrate evolution. We revealed that ATP13A1 localizes in the endoplasmic reticulum (ER) and experimentally demonstrate that ATP13A1 likely contains 12 transmembrane helices. Conversely, ATP13A2-5 isoforms reside in overlapping compartments of the endosomal system and likely contain 10 transmembrane helices, similar to what was demonstrated earlier for ATP13A2. ATP13A1 complemented a deletion of the yeast P5A ATPase SPF1, while none of ATP13A2-5 could complement either the loss of SPF1 or that of the single P5B ATPase YPK9 in yeast. Thus, ATP13A1 carries out a basic ER function similar to its yeast counterpart Spf1p that plays a role in ER related processes like protein folding and processing. ATP13A2-5 isoforms diversified in mammals and are expressed in the endosomal system where they may have evolved novel complementary or partially redundant functions. While most P5-type ATPases are widely expressed, some P5B-type ATPases (ATP13A4 and ATP13A5) display a more limited tissue distribution in the brain and epithelial glandular cells, where they may exert specialized functions. At least some P5B isoforms are of vital importance for the nervous system, since ATP13A2 and ATP13A4 are linked to respectively Parkinson disease and autism spectrum disorders.	[Sorensen, Danny Mollerup; Holemans, Tine; van Veen, Sarah; Martin, Shaun; Arslan, Tugce; Hamouda, Norin Nabil; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium; [Sorensen, Danny Mollerup; Haagendahl, Ida Winther; Holen, Henrik Weida; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark	KU Leuven; University of Copenhagen	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium.	peter.vangheluwe@kuleuven.be	van Veen, Sarah/AAG-9847-2021; Palmgren, Michael/A-9808-2013; Vangheluwe, Peter/P-5476-2017; Sorensen, Danny Mollerup/C-2166-2015	Palmgren, Michael/0000-0002-9982-6114; Eggermont, Jan/0000-0002-8497-1159; Vangheluwe, Peter/0000-0002-7822-2944; Sorensen, Danny Mollerup/0000-0002-5254-6780; van Veen, Sarah/0000-0002-7639-7847	Interuniversity Poles of Attraction of the Belgian Science Policy Office [P7/13]; KU Leuven [0T/13/091, C16/15/073]; FWO [1503117N, SBO Neuro-TRAFFIC 5006617N]; Queen Elisabeth Medical Foundation; Danish National Research Foundation	Interuniversity Poles of Attraction of the Belgian Science Policy Office; KU Leuven(KU Leuven); FWO(FWO); Queen Elisabeth Medical Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded by the Interuniversity Poles of Attraction of the Belgian Science Policy Office (P7/13 to P.V.; http:/www.belspo.be/IAP/), the KU Leuven (0T/13/091 and C16/15/073 to P.V.; https://www.kuleuven.be/), FWO (1503117N and SBO Neuro-TRAFFIC 5006617N to P.V.; http://www.fwo.be), the Queen Elisabeth Medical Foundation (to P.V.; http://www.fmre-gske.be/index.html) and the Danish National Research Foundation (to M.P.; http://dg.dk/en/). T. H. and S.v.V. are research fellows of the Flanders Research Foundation FWO (http://www.fwo.be/). D.S.M. is paid from the Danish Natural Science Research Council (OrphanPumps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ando A, 2005, MOL GENET GENOMICS, V273, P497, DOI 10.1007/s00438-005-1153-6; Baron S, 2010, BBA-BIOMEMBRANES, V1798, P1512, DOI 10.1016/j.bbamem.2010.03.023; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covy JP, 2012, J NEUROSCI RES, V90, P2306, DOI 10.1002/jnr.23112; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Crosiers D, 2011, PARKINSONISM RELAT D, V17, P135, DOI 10.1016/j.parkreldis.2010.10.011; Pinto FD, 2012, NEUROCHEM INT, V60, P243, DOI 10.1016/j.neuint.2012.01.002; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estrada-Cuzcano A MS, 2016, BRAIN; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009; FELSENSTEIN D, 1985, J INFECT DIS, V152, P198, DOI 10.1093/infdis/152.1.198; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grunewald A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.035; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Krumpe K, 2012, MOL BIOL CELL, V23, P3927, DOI 10.1091/mbc.E11-12-0994; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lambie EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077202; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lesca G, 2012, EPILEPSIA, V53, P1526, DOI 10.1111/j.1528-1167.2012.03559.x; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Martin S, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9531917; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; POST RL, 1973, J BIOL CHEM, V248, P6993; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Rinaldi DE, 2015, BBA-BIOMEMBRANES, V1848, P1646, DOI 10.1016/j.bbamem.2015.04.008; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santoro L, 2011, NEUROGENETICS, V12, P33, DOI 10.1007/s10048-010-0259-0; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schultheis PJ, 2013, HUM MOL GENET, V22, P2067, DOI 10.1093/hmg/ddt057; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2012, J BIOL CHEM, V287, P28336, DOI 10.1074/jbc.M112.387191; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Usenovic M, 2012, AUTOPHAGY, V8, P987, DOI 10.4161/auto.20256; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Weingarten LS, 2012, CELL MOL BIOL LETT, V17, P153, DOI 10.2478/s11658-011-0039-3; Wohlke A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002304; Worthey EA, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-29	76	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193228	10.1371/journal.pone.0193228	http://dx.doi.org/10.1371/journal.pone.0193228			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505581	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000426548200008
J	Drozdova, P; Lipaeva, P; Rogoza, T; Zhouravleva, G; Bondarev, S				Drozdova, Polina; Lipaeva, Polina; Rogoza, Tatyana; Zhouravleva, Galina; Bondarev, Stanislav			Overproduction of Sch9 leads to its aggregation and cell elongation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MULTIPLE-MYELOMA; PROTEIN-KINASES; SHUTTLE VECTORS; YEAST; GROWTH; PRIONS; STRESS; GENE; TOR; LOCALIZATION	The Sch9 kinase of Saccharomyces cerevisiae is one of the major TOR pathway effectors and regulates diverse processes in the cell. Sch9 belongs to the AGC kinase family. In human, amplification of AGC kinase genes is connected with cancer. However, not much is known about the effects of Sch9 overproduction in yeast cells. To fill this gap, we developed a model system to monitor subcellular location and aggregation state of overproduced Sch9 or its regions fused to a fluorescent protein. With this system, we showed that Sch9-YFP forms detergent-resistant aggregates, and multiple protein regions are responsible for this. This finding corroborated the fact that Sch9-YFP is visualized as various fluorescent foci. In addition, we found that Sch9 overproduction caused cell elongation, and this effect was determined by its C-terminal region containing kinase domains. The constructs we present can be exploited to create superior yeast-based model systems to study processes behind kinase overproduction in cancers.	[Drozdova, Polina; Lipaeva, Polina; Rogoza, Tatyana; Zhouravleva, Galina; Bondarev, Stanislav] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Rogoza, Tatyana] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg Branch, St Petersburg, Russia; [Zhouravleva, Galina; Bondarev, Stanislav] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg, Russia; [Drozdova, Polina] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Lipaeva, Polina] LLC Innova Plus, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University; Irkutsk State University	Drozdova, P; Bondarev, S (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia.; Bondarev, S (corresponding author), St Petersburg State Univ, Lab Amyloid Biol, St Petersburg, Russia.; Drozdova, P (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk, Russia.	drozdovapb@gmail.com; stanislavspbgu@gmail.com	Bondarev, Stanislav/AAD-5124-2022; Drozdova, Polina/H-9490-2013; Rogoza, Tatiana/N-4437-2013	Bondarev, Stanislav/0000-0003-3137-944X; Drozdova, Polina/0000-0003-3955-6105; Rogoza, Tatiana/0000-0003-2981-0421	research resource center "Molecular and cell technologies" of the St. Petersburg State University; Russian Science Foundation [17-74-10159]; RFBR [16-04-00202]	research resource center "Molecular and cell technologies" of the St. Petersburg State University; Russian Science Foundation(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR))	The authors are grateful for Maria Cordenaz-Corona and Joanne Kingsbury for their generous gift of anti-732-743-Sch9 and anti-phospho-Thr737-Sch9 antibodies, Simon Alberti for the pAG415GPD-Hsp42-mCherry plasmid, Tobias Wilms for the JW 03 038 strain, Jorg Urban for the pJU675 plasmid and Aleksandr Rubel for the FM4-64 dye. We would like to thank Andrew Matveenko for useful advice and help with plasmid construction. The research was supported by the research resource center "Molecular and cell technologies" of the St. Petersburg State University.; The investigation of Sch9 aggregation and corresponding bioinformatic analysis was supported by Russian Science Foundation (rscf.ru) grant 17-74-10159, while the study of effects of Sch9 overproduction on cell morphology was supported by RFBR (rfbr.ru) grant 16-04-00202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Amen T, 2015, CELL MOL LIFE SCI, V72, P401, DOI 10.1007/s00018-014-1740-y; [Anonymous], 2021, LANG ENV STAT COMP; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Arul N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00201; Bondarev SA, 2015, PRION, V9, P190, DOI 10.1080/19336896.2015.1044186; Brachmann CB, 1998, YEAST, V14, P115; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chee MK, 2012, G3-GENES GENOM GENET, V2, P515, DOI 10.1534/g3.111.001917; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Couch FJ, 1999, CANCER RES, V59, P1408; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Halfmann R, 2008, JOVE-J VIS EXP, p20 ; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hoang B, 2016, MOL CANCER RES, V14, P397, DOI 10.1158/1541-7786.MCR-15-0422; Hollebecque A, 2014, EUR J CANCER, V50, P876, DOI 10.1016/j.ejca.2013.12.006; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kadnar ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000824; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaiser C., 1994, METHODS YEAST GENETI; Kingsbury JM, 2014, GENETICS, V196, P1077, DOI 10.1534/genetics.114.161646; Koh JLY, 2015, G3-GENES GENOM GENET, V5, P1223, DOI 10.1534/g3.115.017830; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu YJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006409; Madhunapantula SV, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/327923; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nizhnikov AA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1127, DOI 10.1134/S0006297915090047; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Roche DB, 2017, PROTEIN SCI, V26, P1864, DOI 10.1002/pro.3225; Ryzhova TA, 2017, CURRENT GENETICS, p1 ; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segatto I, 2016, AGING-US, V8, P958, DOI 10.18632/aging.100954; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Swinnen E, 2014, MOL BIOL CELL, V25, P196, DOI 10.1091/mbc.E13-06-0340; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Tong Z., 2011, BIOPROTOCOL BIO, V101, pe18; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; WEINBERGER M, 2007, PLOONE PUBLIC LIB, V2, DOI DOI 10.1371/JOURNAL.PONE.0000748; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMSON DH, 1965, J CELL BIOL, V25, P517, DOI 10.1083/jcb.25.3.517; Wilms T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006835; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	71	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193726	10.1371/journal.pone.0193726	http://dx.doi.org/10.1371/journal.pone.0193726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494682	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200090
J	Ramezanpour, M; Lee, J; Taneva, SG; Tieleman, DP; Cornell, RB				Ramezanpour, Mohsen; Lee, Jaeyong; Taneva, Svetla G.; Tieleman, D. Peter; Cornell, Rosemary B.			An auto-inhibitory helix in CTP:phosphocholine cytidylyltransferase hijacks the catalytic residue and constrains a pliable, domain-bridging helix pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein dynamic; molecular dynamics; allosteric regulation; lipid-protein interaction; protein cross-linking; CTP:phosphocholine cytidylyltransferase; regulation of catalysis; membrane activation; auto-inhibition; protein-membrane interaction; nucleotide transferase	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; MEMBRANE-BINDING DOMAIN; CAUSE SPONDYLOMETAPHYSEAL DYSPLASIA; CULTURED GLIOMA-CELLS; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; AMPHIPATHIC HELIX; ENZYME	The activity of CTP:phosphocholine cytidylyltransferase (CCT), a key enzyme in phosphatidylcholine synthesis, is regulated by reversible interactions of a lipid-inducible amphipathic helix (domain M) with membrane phospholipids. When dissociated from membranes, a portion of the M domain functions as an auto-inhibitory (AI) element to suppress catalysis. The AI helix from each subunit binds to a pair of helices (E) that extend from the base of the catalytic dimer to create a four-helix bundle. The bound AI helices make intimate contact with loop L2, housing a key catalytic residue, Lys(122). The impacts of the AI helix on active-site dynamics and positioning of Lys(122) are unknown. Extensive MD simulations with and without the AI helix revealed that backbone carbonyl oxygens at the point of contact between the AI helix and loop L2 can entrap the Lys(122) side chain, effectively competing with the substrate, CTP. In silico, removal of the AI helices dramatically increased E dynamics at a predicted break in the middle of these helices, enabling them to splay apart and forge new contacts with loop L2. In vitro cross-linking confirmed the reorganization of the E element upon membrane binding of the AI helix. Moreover, when E bending was prevented by disulfide engineering, CCT activation by membrane binding was thwarted. These findings suggest a novel two-part auto-inhibitory mechanism for CCT involving capture of Lys(122) and restraint of the pliable E helices. We propose that membrane binding enables bending of the E helices, bringing the active site closer to the membrane surface.	[Ramezanpour, Mohsen; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Lee, Jaeyong; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Calgary; Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.; Tieleman, DP (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Tieleman, DP (corresponding author), Univ Calgary, Ctr Mol Simulat, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	tieleman@ucalgary.ca; cornell@sfu.ca			Canadian Institutes of Health Research; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research (to R. B. C. and D. P. T.) and supported in part by the Canada Research Chairs program. The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; Brock JS, 2016, P NATL ACAD SCI USA, V113, P972, DOI 10.1073/pnas.1522891113; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demir O, 2012, J CHEM INF MODEL, V52, P1308, DOI 10.1021/ci3001327; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; EFTINK M, 1983, BIOPHYS J, V43, P323, DOI 10.1016/S0006-3495(83)84356-2; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; GEORGE TP, 1989, BIOCHIM BIOPHYS ACTA, V1004, P283, DOI 10.1016/0005-2760(89)90075-1; GEORGE TP, 1991, J BIOL CHEM, V266, P12419; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoover-Fong J, 2014, AM J HUM GENET, V94, P105, DOI 10.1016/j.ajhg.2013.11.018; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; McMaster CR, 2018, FEBS LETT, V592, P1256, DOI 10.1002/1873-3468.12919; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Testa F, 2017, EUR J HUM GENET, V25, P651, DOI 10.1038/ejhg.2017.23; Trenker R, 2016, CURR OPIN STRUC BIOL, V39, P115, DOI 10.1016/j.sbi.2016.07.001; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamamoto GL, 2014, AM J HUM GENET, V94, P113, DOI 10.1016/j.ajhg.2013.11.022; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	61	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7070	7084		10.1074/jbc.RA118.002053	http://dx.doi.org/10.1074/jbc.RA118.002053			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29519816	Green Published, hybrid			2022-12-26	WOS:000431487300039
J	Dubuisson, L; Lormieres, F; Fochi, S; Turpin, J; Pasquier, A; Douceron, E; Oliva, A; Bazarbachi, A; Lallemand-Breitenbach, V; De The, H; Journo, C; Mahieux, R				Dubuisson, Louise; Lormieres, Florence; Fochi, Stefania; Turpin, Jocelyn; Pasquier, Amandine; Douceron, Estelle; Oliva, Anais; Bazarbachi, Ali; Lallemand-Breitenbach, Valerie; De The, Hugues; Journo, Chloe; Mahieux, Renaud			Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner	ONCOGENE			English	Article							T-CELL LEUKEMIA; KAPPA-B ACTIVATION; VIRUS TYPE-1; IN-VIVO; HBZ; TRANSFORMATION; TRANSCRIPTION; CONJUGATION; PATHWAYS; THERAPY	Since the identification of the antisense protein of HTLV-2 (APH-2) and the demonstration that APH-2 mRNA is expressed in vivo in most HTLV-2 carriers, much effort has been dedicated to the elucidation of similarities and/or differences between APH-2 and HBZ, the antisense protein of HTLV-1. Similar to HBZ, APH-2 negatively regulates HTLV-2 transcription. However, it does not promote cell proliferation. In contrast to HBZ, APH-2 half-life is very short. Here, we show that APH-2 is addressed to PML nuclear bodies in T-cells, as well as in different cell types. Covalent SUMOylation of APH-2 is readily detected, indicating that APH-2 might be addressed to the PML nuclear bodies in a SUMO-dependent manner. We further show that silencing of PML increases expression of APH-2, while expression of HBZ is unaffected. On the other hand, SUMO-1 overexpression leads to a specific loss of APH-2 expression that is restored upon proteasome inhibition. Furthermore, the carboxy-terminal LAGLL motif of APH-2 is responsible for both the targeting of the protein to PML nuclear bodies and its short half-life. Taken together, these observations indicate that natural APH-2 targeting to PML nuclear bodies induces proteasomal degradation of the viral protein in a SUMO-dependent manner. Hence, this study deciphers the molecular and cellular bases of APH-2 short half-life in comparison to HBZ and highlights key differences in the post-translational mechanisms that control the expression of both proteins.	[Dubuisson, Louise; Lormieres, Florence; Turpin, Jocelyn; Pasquier, Amandine; Douceron, Estelle; Oliva, Anais; Journo, Chloe; Mahieux, Renaud] Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Int Ctr Res Infectiol,Univ Lyon, Retroviral Oncogenesis Lab,INSERM U1111,CNRS,UMR5, F-69007 Lyon, France; [Dubuisson, Louise; Lormieres, Florence; Turpin, Jocelyn; Pasquier, Amandine; Douceron, Estelle; Oliva, Anais; Journo, Chloe; Mahieux, Renaud] Equipe Labellisee Ligue Natl Canc, Lyon, France; [Fochi, Stefania] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Bazarbachi, Ali] Amer Univ Beirut, Dept Internal Med, Fac Med, Beirut, Lebanon; [Bazarbachi, Ali] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Lallemand-Breitenbach, Valerie; De The, Hugues] Univ Paris Diderot, Coll France, Paris Sorbonne, Inserm U944,CNRS 7212, Lettre 11 Pl Marcelin Berthelot, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Verona; American University of Beirut; American University of Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite	Journo, C; Mahieux, R (corresponding author), Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Int Ctr Res Infectiol,Univ Lyon, Retroviral Oncogenesis Lab,INSERM U1111,CNRS,UMR5, F-69007 Lyon, France.; Journo, C; Mahieux, R (corresponding author), Equipe Labellisee Ligue Natl Canc, Lyon, France.	chloe.journo@ens-lyon.fr; renaud.mahieux@ens-lyon.fr		Lallemand, Valerie/0000-0001-9852-204X; Bazarbachi, Ali/0000-0002-7171-4997; Journo, Chloe/0000-0002-0973-0777; mahieux, renaud/0000-0002-5129-6804; Turpin, Jocelyn/0000-0001-5177-2471; Lormieres, Florence/0000-0002-7603-1394	ENS Lyon; ANR; Fondation ARC pour la Recherche sur le Cancer; Ministere de la Recherche; ARC; La Ligue Contre le Cancer "programme Equipe Labellisee"; INSERM	ENS Lyon; ANR(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council); La Ligue Contre le Cancer "programme Equipe Labellisee"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank the microscopy facility team of the Lyon SFR Biosciences. R.M., C.J., and F.L. are supported by ENS Lyon. L.D. is supported by ANR. J.T. was supported by the Fondation ARC pour la Recherche sur le Cancer. E.D. was supported by the Ministere de la Recherche. This work was supported by ARC and La Ligue Contre le Cancer "programme Equipe Labellisee" and INSERM.	Bruhn RMR, 2017, CLIN VIROLOGY, P771; Cachat A, 2013, J VIROL, V87, P13386, DOI 10.1128/JVI.02758-13; Ciminale V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00398; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Dassouki Z, 2015, BLOOD, V125, P474, DOI 10.1182/blood-2014-04-572750; Douceron E, 2012, J INFECT DIS, V205, P82, DOI 10.1093/infdis/jir708; El Hajj H, 2010, J EXP MED, V207, P2785, DOI 10.1084/jem.20101095; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Giam CZ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060161; Halin M, 2009, BLOOD, V114, P2427, DOI 10.1182/blood-2008-09-179879; Hivin P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-14; Ivanschitz L, 2015, P NATL ACAD SCI USA, V112, P14278, DOI 10.1073/pnas.1507540112; Jean M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040067; Journo C, 2013, J VIROL, V87, P1123, DOI 10.1128/JVI.01792-12; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI 10.2217/FMB.09.13; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kfoury Y, 2012, ADV CANCER RES, V113, P85, DOI 10.1016/B978-0-12-394280-7.00003-8; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Komatsu T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100290; Lowrey AJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0183-0; Mesnard JM, 2015, VIRUSES-BASEL, V7, P6490, DOI 10.3390/v7122952; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Nicot Christophe, 2015, J Cancer Sci, V2, DOI 10.13188/2377-9292.1000009; Panfil AR, 2016, J VIROL, V90, P3760, DOI 10.1128/JVI.03113-15; Pene S, 2014, J VIROL, V88, P10655, DOI 10.1128/JVI.01827-14; Regad T, 2001, EMBO J, V20, P3495, DOI 10.1093/emboj/20.13.3495; Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Shirinian M, 2015, J VIROL, V89, P8092, DOI 10.1128/JVI.00918-15; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Wang TG, 2000, AIDS RES HUM RETROV, V16, P1661, DOI 10.1089/08892220050193119; Watanabe T, 2017, BLOOD, V129, P1071, DOI 10.1182/blood-2016-09-692574; Xie L, 2005, J VIROL, V79, P14536, DOI 10.1128/JVI.79.23.14536-14545.2005; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Yin H, 2012, J VIROL, V86, P8412, DOI 10.1128/JVI.00717-12; Zhao TJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00247	38	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2806	2816		10.1038/s41388-018-0163-x	http://dx.doi.org/10.1038/s41388-018-0163-x			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29507418				2022-12-26	WOS:000432929800004
J	Cheng, M; Niu, YQ; Fan, JJ; Chi, XJ; Liu, XY; Yang, W				Cheng, Min; Niu, Yuqiang; Fan, Jingjing; Chi, Xiaojing; Liu, Xiuying; Yang, Wei			Interferon down-regulation of miR-1225-3p as an antiviral mechanism through modulating Grb2-associated binding protein 3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; NONCODING RNA; I IFN; MICRORNA; GENES; LONG; IDENTIFICATION; RECOGNITION; RECEPTORS; PROFILES	Induction of interferons (IFNs) is a central event of antiviral innate immunity. As crucial posttranscriptional regulators, microRNAs (miRNAs) are important for IFN-mediated host defense. Although screening has indicated a substantial number of miRNAs to be differentially expressed after IFN stimulation, the detailed mechanisms of these miRNAs in the antiviral response are underexplored and of great significance. Here, we show that hsa-miR-1225-3p is specifically down-regulated by type I IFN through the IFN/JAK/STAT signaling pathway. Silencing endogenous miR-1225-3p inhibited infection by multiple IFN-susceptible viruses, including hepatitis C virus, Sendai virus, and Newcastle disease virus. In contrast, overexpression of miR-1225-3p impaired the antiviral effect of IFNs and facilitated viral infection. Regarding the mechanism, we identified growth factor receptor-bound protein 2-associated binding protein 3 (GAB3) as a direct target of miR-1225-3p. GAB3 expression was up-regulated by IFN, and overexpression of GAB3 demonstrated potent antiviral effects through enhancing IFN response and virus-triggered innate immune activation. Taken together, our findings reveal the biological function of miR-1225-3p for the first time and propose a novel antiviral regulation pathway in which miRNA and GAB3 participate. This study contributes to the understanding of host miRN A participation in antiviral processes of IFN.	Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100176, Peoples R China; [Yang, Wei] Peking Union Med Coll, Beijing 100176, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, W (corresponding author), Peking Union Med Coll, Beijing 100176, Peoples R China.; Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100176, Peoples R China.	wyang@ipb.pumc.edu.cn			National Natural Science Foundation of China [81401674, 81672030, 81471954]; National Basic Research Program of China [2015CB554301]; CAMS Initiative for Innovative Medicine [2016-I2M-3-020]; National Science and Technology Major Project [2017ZX10304402-001-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); CAMS Initiative for Innovative Medicine; National Science and Technology Major Project	This work was supported by National Natural Science Foundation of China Grants 81401674, 81672030, and 81471954; National Basic Research Program of China Grant 2015CB554301; CAMS Initiative for Innovative Medicine Grant 2016-I2M-3-020; and National Science and Technology Major Project 2017ZX10304402-001-013. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Cheng M, 2012, J ANTIMICROB CHEMOTH, V67, P1080, DOI 10.1093/jac/dks015; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ferdousi M, 2016, J BIOCHEM, V160, P325, DOI 10.1093/jb/mvw042; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; Hotho DM, 2013, J VIRAL HEPATITIS, V20, pe78, DOI 10.1111/jvh.12012; Lee HM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00178; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Na YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S17; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Petersen J, 2016, J HEPATOL, V65, P835, DOI 10.1016/j.jhep.2016.05.043; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Su CH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-354; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Vaughan TY, 2011, AM J BLOOD RES, V1, P130; Wang P, 2012, MOL BIOSYST, V8, P2924, DOI 10.1039/c2mb25228g; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Yang CH, 2015, PHARMACEUTICALS, V8, P836, DOI 10.3390/ph8040836; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zhang Y, 2016, BIOCHEM BIOPH RES CO, V478, P1436, DOI 10.1016/j.bbrc.2016.08.142; Zheng QL, 2016, J IMMUNOL, V196, P1317, DOI 10.4049/jimmunol.1502134; Zheng YJ, 2010, J IMMUNOL, V184, P6447, DOI 10.4049/jimmunol.0901750	35	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5975	5986		10.1074/jbc.RA117.000738	http://dx.doi.org/10.1074/jbc.RA117.000738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496996	Green Published, hybrid			2022-12-26	WOS:000430497300018
J	Cairns, L; Tran, T; Fowl, BH; Patterson, A; Kim, YJ; Bothner, B; Kavran, JM				Cairns, Leah; Thao Tran; Fowl, Brendan H.; Patterson, Angela; Kim, Yoo Jin; Bothner, Brian; Kavran, Jennifer M.			Salvador has an extended SARAH domain that mediates binding to Hippo kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NDR-PROTEIN-KINASE; CELL-CYCLE EXIT; TUMOR-SUPPRESSOR; HELIX GEOMETRY; WW DOMAIN; PROLIFERATION ARREST; PROMOTES APOPTOSIS; STRUCTURAL BASIS; MST1 KINASE; DROSOPHILA	The Hippo pathway controls cell proliferation and differentiation through the precisely tuned activity of a core kinase cassette. The activity of Hippo kinase is modulated by interactions between its C-terminal coiled-coil, termed the SARAH domain, and the SARAH domains of either dRassF or Salvador. Here, we wanted to understand the molecular basis of SARAH domain-mediated interactions and their influence on Hippo kinase activity. We focused on Salvador, a positive effector of Hippo activity and the least well-characterized SARAH domain-containing protein. We determined the crystal structure of a complex between Salvador and Hippo SARAH domains from Drosophila. This structure provided insight into the organization of the Salvador SARAH domain including a folded N-terminal extension that expands the binding interface with Hippo SARAH domain. We also found that this extension improves the solubility of the Salvador SARAH domain, enhances binding to Hippo, and is unique to Salvador. We therefore suggest expanding the definition of the Salvador SARAH domain to include this extended region. The heterodimeric assembly observed in the crystal was confirmed by cross-linked MS and provided a structural basis for the mutually exclusive interactions of Hippo with either dRassF or Salvador. Of note, Salvador influenced the kinase activity of Mst2, the mammalian Hippo homolog. In co-transfected HEK293T cells, human Salvador increased the levels of Mst2 autophosphorylation and Mst2-mediated phosphorylation of select substrates, whereas Salvador SARAH domain inhibited Mst2 autophosphorylation in vitro. These results suggest Salvador enhances the effects of Hippo kinase activity at multiple points in the Hippo pathway.	[Cairns, Leah; Thao Tran; Fowl, Brendan H.; Kim, Yoo Jin; Kavran, Jennifer M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 20215 USA; [Patterson, Angela; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 20215 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 20215 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Montana State University System; Montana State University Bozeman; Johns Hopkins University; Johns Hopkins University	Kavran, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	jkavran@jhu.edu		Kim, Yoo Jin/0000-0002-3499-3990; Cairns, Leah/0000-0002-3907-001X	Murdock Charitable Trust; National Institutes of Health of the IDEA program [P20GM103474]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474, T32GM007445] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the IDEA program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Montana State University Proteomics, Metabolomics, and Mass Spectrometry Facility is supported in part by funding from the Murdock Charitable Trust and National Institutes of Health Grant P20GM103474 of the IDEA program. Plasmids encoding Renilla and firefly luciferase and Gal4DBD-Yki used in the reporter assay were provided by K. Irvine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bitra A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45020; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Hwang E, 2014, ACTA CRYSTALLOGR D, V70, P1944, DOI 10.1107/S139900471400947X; John MAS, 1999, NAT GENET, V21, P182, DOI DOI 10.1038/5965; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Liu GG, 2014, J STRUCT BIOL, V185, P366, DOI 10.1016/j.jsb.2014.01.008; Makbul C, 2013, BIOCHEMISTRY-US, V52, P1045, DOI 10.1021/bi3014642; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song J, 2015, J BIOCHEM, V158, P181, DOI 10.1093/jb/mvv031; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053	59	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5532	5543		10.1074/jbc.RA117.000923	http://dx.doi.org/10.1074/jbc.RA117.000923			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29519817	Green Published, hybrid			2022-12-26	WOS:000430044100016
J	Bai, J; Liu, X; Laetitia, L; Gilles, G; Arnaud, F; Jacques, BJ; Phillipe, D; Loic, F; Towledahong, L				Bai, Jie; Liu, Xin; Laetitia, Le Goff; Gilles, Gargala; Arnaud, Francois; Jacques, Ballet Jean; Phillipe, Ducrotte; Loic, Favennec; Towledahong, Liqianhai			Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; MICE; INFECTION; MODEL; HYPERSENSITIVITY; IMMUNOREACTIVITY; INTERNALIZATION; ANALOGS; CELLS; ILEUM	Somatostatins are proteins that are involved in gastrointestinal function. However, little is known with regard to somatostatin receptor subtype (SSTR) expression changes that occur in the jejunum during low-grade inflammation and during subsequent octreotide treatment. The aim of the present study was to investigate the expression of SSTRs in the jejunums of Cryptosporidium parvum (C. parvum)-infected rats by immunohistochemisty, reverse transcription (RT) PCR and quantitative real-time RT-PCR assays. Five-day-old suckling Sprague-Dawley rats (n = 15 for each group) were orally gavaged with 10(5) Nouzilly isolate (NoI) oocysts. Rats then received 50 mu g/kg/day of octreotide by intraperitoneal injection from day 10 to day 17 post-infection. Animals were sacrificed on days 7 and 14 post-infection for immunohistochemical analysis and on days 14, 35 and 50 for mRNA expression analysis of SSTR subtypes. Histological analysis of jejunum tissues demonstrated infection of C. parvum along the villus brush border on day 7 post-infection and infection clearance by day 14 post-infection. Real-time PCR analysis indicated that in the inflamed jejunum, a significant increase in SSTR1 and SSTR2 expression was observed on day 14 post-infection. Octreotide therapy down-regulated the expression of SSTR2 on day 37 post-infection but significantly increased expression of SSTR1, SSTR2 and SSTR3 on day 50 post-infection. The results indicate that specific SSTRs may regulate the inflammatory pathway in the rat intestinal inflammation model.	[Bai, Jie; Liu, Xin; Towledahong, Liqianhai] XinJiang Med Univ, Dept Pharmacol, Urumqi, Xinjiang, Peoples R China; [Laetitia, Le Goff; Gilles, Gargala; Loic, Favennec] Univ Rouen, Parasitol Dept, Rouen Univ Hosp, Rouen, France; [Laetitia, Le Goff; Gilles, Gargala; Phillipe, Ducrotte; Loic, Favennec] Univ Rouen, EA 4311, IFRMP 23, Inst Biomed Res, Rouen, France; [Arnaud, Francois] CHU Charles Nicolle, Dept Histopathol, Rouen, France; [Jacques, Ballet Jean] Univ Caen, Immunol Dept, Caen Univ Hosp, Caen, France; [Jacques, Ballet Jean] Univ Caen, UPRES, EA 2128, Caen, France; [Phillipe, Ducrotte] Univ Rouen, Rouen Univ Hosp, Gastroenterol Unit, Rouen, France	Xinjiang Medical University; CHU de Rouen; Universite de Rouen Normandie; Universite de Rouen Normandie; CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; CHU de Rouen; Universite de Rouen Normandie	Towledahong, L (corresponding author), XinJiang Med Univ, Dept Pharmacol, Urumqi, Xinjiang, Peoples R China.	hailiqian2471@sina.com			Programme Seine-Aval; Direction Regionale de l' Action Sanitaire et Sociale de Haute Normandie (Rouen, France); National Natural Science Foundation of China [81360071]	Programme Seine-Aval; Direction Regionale de l' Action Sanitaire et Sociale de Haute Normandie (Rouen, France); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Programme Seine-Aval and the Direction Regionale de l' Action Sanitaire et Sociale de Haute Normandie (Rouen, France) and the National Natural Science Foundation of China (No. 81360071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RL, 2005, BRIT J CANCER, V92, P1493, DOI 10.1038/sj.bjc.6602503; Baishanbo A, 2006, J ANTIMICROB CHEMOTH, V57, P353, DOI 10.1093/jac/dki456; Ben-Shlomo A, 2010, METHOD ENZYMOL, V484, P149, DOI [10.1016/B978-0-12-381298-8.00008-3, 10.1016/S0076-6879(10)84008-X]; Corleto VD, 2010, CURR OPIN ENDOCRINOL, V17, P63, DOI 10.1097/MED.0b013e32833463ed; Den Bosch JVO, 2008, NEUROGASTROENT MOTIL, V20, P798, DOI 10.1111/j.1365-2982.2008.01088.x; Den Bosch JVO, 2007, NEUROGASTROENT MOTIL, V19, P596, DOI 10.1111/j.1365-2982.2007.00931.x; den bosch JVP, 2009, AM J PHYSIOL-GASTR L, V297, pG406, DOI 10.1152/ajpgi.00059.2009; Gatto F, 2013, ENDOCRINOLOGY, V154, P4715, DOI 10.1210/en.2013-1672; Guesdon W, 2015, J INFECT DIS, V212, P1332, DOI 10.1093/infdis/jiv206; Horvath K, 2014, NEUROPEPTIDES, V48, P371, DOI 10.1016/j.npep.2014.10.001; Hukovic N, 1998, J BIOL CHEM, V273, P21416, DOI 10.1074/jbc.273.33.21416; Hukovic N, 1996, ENDOCRINOLOGY, V137, P4046, DOI 10.1210/en.137.9.4046; Imhof AK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3372; Imhof AK, 2011, ARTHRITIS RHEUM-US, V63, P2352, DOI 10.1002/art.30410; Khaldi S, 2009, INFECT IMMUN, V77, P5163, DOI 10.1128/IAI.00220-09; Kwak SE, 2008, NEUROPEPTIDES, V42, P569, DOI 10.1016/j.npep.2008.09.002; Li X, 2016, AM J PHYSIOL-GASTR L, V311, pG954, DOI 10.1152/ajpgi.00239.2016; Marion R, 2006, INFECT IMMUN, V74, P4387, DOI 10.1128/IAI.02055-05; Miranda J, 2015, NEUROSCIENCE, V286, P37, DOI 10.1016/j.neuroscience.2014.10.049; Mori M, 1996, ONCOL REP, V3, P249; Mulak A, 2015, PEPTIDES, V63, P71, DOI 10.1016/j.peptides.2014.10.013; Petho G, 2017, NEUROPEPTIDES, V62, P1, DOI 10.1016/j.npep.2017.02.079; Reynaert H, 2001, GASTROENTEROLOGY, V121, P915, DOI 10.1053/gast.2001.27971; Robinson BG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04728-z; Ruhl A, 2005, NEUROGASTROENT MOTIL, V17, P777, DOI 10.1111/j.1365-2982.2005.00687.x; Schafer J, 1999, NEUROPEPTIDES, V33, P457, DOI 10.1054/npep.1999.0762; Topouchian A, 2005, PARASITOL RES, V96, P326, DOI 10.1007/s00436-005-1369-8; van der Hoek J, 2005, CURR PHARM DESIGN, V11, P1573; Xiao LH, 2009, EUKARYOT CELL, V8, P429, DOI 10.1128/EC.00295-08; Yuan DM, 2014, CELL MOL NEUROBIOL, V34, P951, DOI 10.1007/s10571-014-0081-6	30	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194058	10.1371/journal.pone.0194058	http://dx.doi.org/10.1371/journal.pone.0194058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522573	Green Submitted, gold, Green Published			2022-12-26	WOS:000427030800038
J	Prieto-Torres, DA; Cuervo, AM; Bonaccorso, E				Prieto-Torres, David A.; Cuervo, Andres M.; Bonaccorso, Elisa			On geographic barriers and Pleistocene glaciations: Tracing the diversification of the Russet-crowned Warbler (Myiothlypis coronata) along the Andes	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; SPECIATION; DIVERGENCE; BIOGEOGRAPHY; TOPOGRAPHY; UPLIFT; BIRDS	We studied the phylogeography and plumage variation of the Russet-crowned Warbler (Myiothlypis coronata), from Venezuela to Bolivia, with focus on populations from Ecuador and northern Peru. We analyzed sequences of mitochondrial and nuclear genes, geographic distributions, as well as photographs of specimens deposited at museum collections. Phylogenetic analyses identified three major lineages formed by populations from: Venezuela and Colombia (M. c. regulus), Ecuador and northern Peru (M. elata, M. castaneiceps, M. orientalis, M. c. chapman!), and central Peru and Bolivia (M. c. coronata). We found further population structure within M. c. regulus and M. c. coronata, and population structure and complexity of plumage variation within the Ecuador-northern Peru lineage. Time-calibrated trees estimated that most intraspecific variation originated during the Pleistocene; however, this pattern may not be attributed to an increase in diversification rate during that period. We discuss these results in the context of the importance of geographic ecological barriers in promoting lineage diversification along the Andes and put forward a preliminary taxonomic proposal for major lineages identified in this study.	[Prieto-Torres, David A.] Univ Int Menendez Pelayo, Master Oficial Biodiversidad Areas Trop & Conserv, Madrid, Spain; [Prieto-Torres, David A.] Univ Zulia, LUZ, CMC, Sect Grado Oro,Fac Expt Ciencias,Eje BioCienci, Calle 65 Con Av Univ, Maracaibo, Estado Zulia, Venezuela; [Cuervo, Andres M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Cuervo, Andres M.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Bonaccorso, Elisa] Univ San Francisco Quito, Inst BIOSFERA, Via Interocean & Diego Robles, Quito, Ecuador; [Bonaccorso, Elisa] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Via Interocean & Diego Robles, Quito, Ecuador; [Bonaccorso, Elisa] Univ Tecnol Indoamer Machala & Sabanilla, Ctr Invest Biodiversidad & Cambio Climat, Quito, Ecuador	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Bonaccorso, E (corresponding author), Univ San Francisco Quito, Inst BIOSFERA, Via Interocean & Diego Robles, Quito, Ecuador.; Bonaccorso, E (corresponding author), Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Via Interocean & Diego Robles, Quito, Ecuador.; Bonaccorso, E (corresponding author), Univ Tecnol Indoamer Machala & Sabanilla, Ctr Invest Biodiversidad & Cambio Climat, Quito, Ecuador.	elisabonaccorso@gmail.com	Prieto-Torres, David A./N-1157-2017; Cuervo, Andrés M./M-8732-2019	Prieto-Torres, David A./0000-0002-0493-5941; Cuervo, Andrés M./0000-0002-4949-0288; Bonaccorso, Elisa/0000-0002-7262-9356	Universidad Tecnologica Indoamerica (Convocatoria a proyectos); Universidad San Francisco de Quito (HUBI) [5447]; National Science Foundation [DDIG DEB-0910285]; Universidad Internacional Menedez Pelayo (Spain); Consejo Superior de Investigaciones Cientificas (Spain)	Universidad Tecnologica Indoamerica (Convocatoria a proyectos); Universidad San Francisco de Quito (HUBI); National Science Foundation(National Science Foundation (NSF)); Universidad Internacional Menedez Pelayo (Spain); Consejo Superior de Investigaciones Cientificas (Spain)	This study was financed by Universidad Tecnologica Indoamerica (Convocatoria a proyectos 2012) to EB, Universidad San Francisco de Quito (HUBI ID 5447) to EB, the National Science Foundation (DDIG DEB-0910285; to AMC), and a master's fellowship from the Universidad Internacional Menedez Pelayo and Consejo Superior de Investigaciones Cientificas (both from Spain) to DAP-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beckman EJ, 2015, MOL PHYLOGENET EVOL, V87, P28, DOI 10.1016/j.ympev.2015.03.005; Benham PM, 2015, J BIOGEOGR, V42, P763, DOI 10.1111/jbi.12452; Benham PM, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0595-2; Bonaccorso E, 2009, MOL PHYLOGENET EVOL, V50, P618, DOI 10.1016/j.ympev.2008.12.012; Cadena CD, 2011, J EVOLUTION BIOL, V24, P402, DOI 10.1111/j.1420-9101.2010.02175.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Curson J, HDB BIRDS WORLD ALIV; dos Anjos L., 2017, HDB BIRDS WORLD ALIV; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duellman WE, 1979, S AM HERPETOFAUNA IT, P1; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koscinski D, 2008, MOL ECOL, V17, P2012, DOI 10.1111/j.1365-294X.2008.03733.x; Krabbe NK, 2017, HDB BIRDS WORLD ALIV; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Lutz HL, 2013, MOL PHYLOGENET EVOL, V69, P873, DOI 10.1016/j.ympev.2013.06.017; Maddison WP., 2019, CHROMASEQ MESQUITE P; Ministerio del Medio Ambiente, 2012, POL NAC GEST INT BIO; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Munoz-Ortiz A, 2015, J BIOGEOGR, V42, P193, DOI 10.1111/jbi.12409; Nielsen R, 2001, GENETICS, V158, P885; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Parker T.A., 1985, ORNITHOL MONOGR, V36, P169, DOI DOI 10.2307/40168282; Price T, 2008, SPECIATION BIRDS; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rambaut A, 2007, TRACER V 1 4; REMSEN JV, 1984, SCIENCE, V224, P171, DOI 10.1126/science.224.4645.171; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ridgely RS, 2001, THE BIRDS OF ECUADOR, VI; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Short L. L., 2017, HDB BIRDS WORLD ALIV; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sorenson MD, 2004, SYST BIOL, V53, P140, DOI 10.1080/10635150490265021; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Valderrama E, 2014, J BIOGEOGR, V41, P1533, DOI 10.1111/jbi.12317; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2009, ANN MO BOT GARD, V96, P410, DOI 10.3417/2008011; Winger BM, 2017, EVOLUTION, V71, P1815, DOI 10.1111/evo.13251; Winger BM, 2015, EVOLUTION, V69, P772, DOI 10.1111/evo.12607; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zwickl D. J, 2006, GENETIC ALGORITHM AP	52	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0191598	10.1371/journal.pone.0191598	http://dx.doi.org/10.1371/journal.pone.0191598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522515	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800004
J	Atsawasuwan, P; Lazari, P; Chen, YH; Zhou, XF; Viana, G; Evans, CA				Atsawasuwan, Phimon; Lazari, Paul; Chen, Yinghua; Zhou, Xiaofeng; Viana, Grace; Evans, Carla A.			Secretory microRNA-29 expression in gingival crevicular fluid during orthodontic tooth movement	PLOS ONE			English	Article							MEMBRANE-VESICLES; EXOSOMES; MICROVESICLES; ALPHA; RANKL; CELLS	Secretory microRNAs (miRNAs) have been used increasingly as biomarkers for cancers, autoimmune diseases and inflammatory diseases. They are reported as being freely circulated or encapsulated in microvesicles such as exosomes. This study was performed to elucidate the presence of miRNAs with exosomes in human gingival crevicular fluid (GCF), and the expression profile of miRNA-29 during orthodontic tooth movement. Four healthy volunteer and fifteen orthodontic patients were enrolled in the study. Secretory miRNA in GCF was collected and analyzed using a bioanalyzer, realtime PCR and Western blot analysis. The expression profile of secretory miR-29 family in GCF was analyzed during the course of canine retraction for 6 weeks. The results demonstrated the presence of miRNAs in the GCF. After series of ultracentrifugation and RT-PCR array, exosome-depleted fractions and pellets were isolated and we found that secretory miRNAs were detected in both the exosome-associated fraction and the exosome-depleted supernatant fraction; however, the concentration of miRNAs was higher in the exosome-associated fraction than in the exosome-depleted fraction suggesting a close association between the secretory miRNAs and exosomes in GCF. We also demonstrated the increased expression profiles of miR-29 family during six weeks of orthodontic tooth movement in humans. Secretory miRNAs are present in GCF and secretory miRNA-29 family expression profiles increase during the tooth movement in humans. Secretory miRNA-29 in GCF could serve as potential biomarkers for periodontal remodeling.	[Atsawasuwan, Phimon; Lazari, Paul; Chen, Yinghua; Viana, Grace] Univ Illinois, Dept Orthodont, Chicago, IL 60607 USA; [Zhou, Xiaofeng] Univ Illinois, Dept Periodont, Chicago, IL USA; [Evans, Carla A.] Boston Univ, Dept Orthodont, Boston, MA 02215 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Boston University	Atsawasuwan, P (corresponding author), Univ Illinois, Dept Orthodont, Chicago, IL 60607 USA.	patsawas@uic.edu	chen, ying/HHS-8254-2022	Evans, Carla/0000-0002-0473-383X; Atsawasuwan, Phimon/0000-0002-2576-060X	National Institute of Dental and Craniofacial research [DE024531]; American Association of Orthodontists Foundation: biomedical research award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024531] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Association of Orthodontists Foundation: biomedical research award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial research: DE024531 to PA and the American Association of Orthodontists Foundation: biomedical research award to PA. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	ALFANO MC, 1974, J THEOR BIOL, V47, P127, DOI 10.1016/0022-5193(74)90103-9; Alhashimi N, 2001, AM J ORTHOD DENTOFAC, V119, P307, DOI 10.1067/mod.2001.110809; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Chen YH, 2015, GENE, V566, P13, DOI 10.1016/j.gene.2015.03.055; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Franceschetti T, 2013, J BIOL CHEM, V288, P33347, DOI 10.1074/jbc.M113.484568; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; George A, 2009, ORTHOD CRANIOFAC RES, V12, P229, DOI 10.1111/j.1601-6343.2009.01457.x; Grant M, 2013, EUR J ORTHODONT, V35, P644, DOI 10.1093/ejo/cjs057; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huang H, 2014, AM J ORTHOD DENTOFAC, V146, P620, DOI 10.1016/j.ajodo.2014.07.007; Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017; Kapoor P, 2014, PROG ORTHOD, V15, DOI 10.1186/s40510-014-0065-6; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; LAMSTER IB, 1985, J PERIODONTOL, V56, P139, DOI 10.1902/jop.1985.56.11s.13; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; Lehmann U, 2010, METHODS MOL BIOL, V667, P113, DOI 10.1007/978-1-60761-811-9_8; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishijima Y, 2006, Orthod Craniofac Res, V9, P63, DOI 10.1111/j.1601-6343.2006.00340.x; Pi CX, 2015, FRONT BIOSCI-LANDMRK, V20, P119, DOI 10.2741/4301; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Saito A, 2017, FEBS OPEN BIO, V7, P981, DOI 10.1002/2211-5463.12238; Sanders R, 2014, ANAL BIOANAL CHEM, V406, P6471, DOI 10.1007/s00216-014-7857-x; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Taba Mario Jr, 2005, Dent Clin North Am, V49, P551, DOI 10.1016/j.cden.2005.03.009; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Toyono T, 2016, CORNEA, V35, P1466, DOI 10.1097/ICO.0000000000000954; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang YF, 2014, BIOCHEM BIOPH RES CO, V446, P940, DOI 10.1016/j.bbrc.2014.03.037	34	16	20	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194238	10.1371/journal.pone.0194238	http://dx.doi.org/10.1371/journal.pone.0194238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518149	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900077
J	Huang, W; Zhang, K; Zhu, YJ; Wang, Z; Li, ZJ; Zhang, J				Huang, Wei; Zhang, Kun; Zhu, Yangjun; Wang, Zhan; Li, Zijun; Zhang, Jun			Genetic polymorphisms of NOS2 and predisposition to fracture non-union: A case control study based on Han Chinese population	PLOS ONE			English	Article							SCHIZOPHRENIA SUSCEPTIBILITY; COMMON VARIANTS; ASSOCIATION; RISK	A non-union, especially atrophic non-unions, is a permanent failure of healing following a fracture and can be difficult to treat. Approximately 5-10% of fractures will result in a nonunion during the healing process. non-unions can be classified into two types: atrophic nonunion which is often due to impaired bone healing with a potential biological mechanism, and hypertrophic non-union which is due to inadequate fixation after fracture. Genetic variations also play an important role in the fracture healing response. Previous studies based on animal models have indicated that NOS2 might be greatly involved in the bone fracture healing process. In this case-control study, 346 nonunion patients were compared to 883 patients with normal fracture healing to investigate the potential genetic association between NOS2 and the fracture healing process using study subjects of Chinese Han ancestry. Twenty-seven single nucleotide polymorphisms (SNPs) covering NOS2were genotyped in our study subjects and analyzed. In addition to the single marker-based analysis, we performed a gene-by-environment analysis to examine the potential interactions between genetic polymorphisms and some environmental factors. SNP rs2297514 showed significant association with the fracture healing process after adjusting for age and gender (OR = 1.38, P= 0.0005). Our results indicated that the T allele of rs2297514 significantly increased the risk of a non-union during the fracture healing process by 38% compared to the C allele. Further stratification analyses conducted for this SNP using data from subgroups classified by different sites of fracture indicated that significance could only be observed in the tibial diaphysis subgroup (N = 428, OR = 1.77, P= 0.0007) but not other groups including femur diaphysis, humeral shaft, ulnar shaft, and femur neck. Gene-by-environment interaction analyses of the three environmental factors showed no significant results. In this study, rs2297514 was significantly associated with the non-union status of fracture healing using a large Chinese population-based study sample. Our findings replicated those of a previous preliminary study and offered strong evidence linking NOS2 and fracture healing.	[Huang, Wei; Zhang, Kun; Zhu, Yangjun; Wang, Zhan; Li, Zijun; Zhang, Jun] Xi An Jiao Tong Univ, Honghui Hosp, Hlth Sci Ctr, Dept Trauma Surg, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Zhang, J (corresponding author), Xi An Jiao Tong Univ, Honghui Hosp, Hlth Sci Ctr, Dept Trauma Surg, Xian, Shaanxi, Peoples R China.	osteojzhang@163.com	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022					Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen G, 2015, J HUM GENET, V60, P479, DOI 10.1038/jhg.2015.66; Cho SH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061255; Copuroglu C, 2013, INJURY, V44, P1379, DOI 10.1016/j.injury.2013.08.003; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Dimitriou R, 2013, INJURY, V44, pS50, DOI 10.1016/S0020-1383(13)70012-3; Emara KM, 2015, WORLD J ORTHOP, V6, P623, DOI 10.5312/wjo.v6.i8.623; Giannoudis PV, 2000, J BONE JOINT SURG BR, V82B, P655, DOI 10.1302/0301-620X.82B5.9899; Guan FL, 2016, SCHIZOPHR RES, V176, P125, DOI 10.1016/j.schres.2016.07.004; Guan FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29586; Guan FL, 2014, SCHIZOPHR RES, V152, P97, DOI 10.1016/j.schres.2013.11.004; Guan FL, 2013, J PSYCHIATR RES, V47, P712, DOI 10.1016/j.jpsychires.2013.01.025; Guan FL, 2012, HUM GENET, V131, P1047, DOI 10.1007/s00439-011-1120-8; Guan FL, 2012, SCHIZOPHR RES, V138, P63, DOI 10.1016/j.schres.2012.03.030; Guan FL, 2016, SCI REPORTS, P6; Guan FL, 2015, SCI REPORTS, P5; Jia XD, 2016, AM J MED GENET B, V171, P1105, DOI 10.1002/ajmg.b.32491; Matsumoto S, 2017, BIOORG MED CHEM LETT, V27, P3391, DOI 10.1016/j.bmcl.2017.06.006; Mitchell EJ, 2010, J ORTHOP TRAUMA, V24, P530, DOI 10.1097/BOT.0b013e3181ed147b; Panteli M, 2015, J CELL MOL MED, V19, P685, DOI 10.1111/jcmm.12532; Papakostidis C, 2011, INJURY, V42, P1353, DOI 10.1016/j.injury.2011.06.024; Santolini E, 2015, INJURY, V46, pS8, DOI 10.1016/S0020-1383(15)30049-8; Sathyendra V, 2014, J BONE JOINT SURG AM, V96A, P1242, DOI 10.2106/JBJS.M.00453; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tavitian JD, 2002, INJURY, V33, P135, DOI 10.1016/S0020-1383(01)00069-9; Weiss S, 2009, ARCH ORTHOP TRAUM SU, V129, P989, DOI 10.1007/s00402-008-0777-5; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Yang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069129; Zhang B, 2015, SCHIZOPHR RES, V169, P128, DOI 10.1016/j.schres.2015.10.012; Zhen XK, 2017, SCI REPORTS, P7; Zhu W, 2001, J BONE MINER RES, V16, P535, DOI 10.1359/jbmr.2001.16.3.535	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193673	10.1371/journal.pone.0193673	http://dx.doi.org/10.1371/journal.pone.0193673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518099	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900033
J	Nair-Shalliker, V; Egger, S; Chrzanowska, A; Mason, R; Waite, L; Le Couteur, D; Seibel, MJ; Handelsman, DJ; Cumming, R; Smith, DP; Armstrong, BK				Nair-Shalliker, Visalini; Egger, Sam; Chrzanowska, Agata; Mason, Rebecca; Waite, Louise; Le Couteur, David; Seibel, Markus J.; Handelsman, David J.; Cumming, Robert; Smith, David P.; Armstrong, Bruce K.			Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels	PLOS ONE			English	Article							NEW-SOUTH-WALES; VITAMIN-D; ULTRAVIOLET-RADIATION; MALIGNANT-MELANOMA; CANCER RISK; SKIN-CANCER; LIFE-STYLE; EXPOSURE; VARIANTS; SLC45A2	Background Melanoma and prostate cancer may share risk factors. This study examined the association between serum PSA levels, which is a risk factor for prostate cancer, and variants in some melanoma-associated pigmentary genes. Methods We studied participants, all aged 70+ years, in the Concord Health and Ageing in Men Project who had no history of prostatitis or received treatment for prostate disease (n = 1033). We genotyped variants in MC1R (rs1805007, rs1805008), ASIP (rs4911414, rs1015362), SLC45A2 (rs28777, rs16891982), IRF4 (rs12203592), TYRP1 (rs1408799), TYR (rs1126809, rs1042602), SLC24A2 (rs12896399), and OCA2 (rs7495174). Generalised linear dominant models with Poisson distribution, log link functions and robust variance estimators estimated adjusted percentage differences (%PSA) in mean serum PSA levels (ng/mL) between variant and wildtype (0%PSA = reference) genotypes, adjusting for age, body mass index, serum 250HD levels and birth regions (Australia or New Zealand (ANZ), Europe or elsewhere). Results Serum PSA levels were strongly associated with advancing age and birth regions: mean PSA levels were lower in Europe-born (-29/%) and elsewhere-born (-11.7%) men than ANZ-born men (reference). Lower %PSA was observed in men with variants in SLC45A2: rs28777 (-19.6;95%Cl: -33.5, -21), rs16891982 (-17.3;95%Cl:-30.4,-1.7) than in wildtype men (reference). There were significant interactions between birth regions and PSA levels in men with variants in MC1R (rs1805007; p-interaction = 0.0001) and ASIP (rs4911414; p-interaction. 0.007). For these genes %PSA was greater in ANZ-born men and lower in Europe-and elsewhere-born men with the variant than it was in wildtype men. In a post hoc analysis, serum testosterone levels were increased in men with MC1R rs1 805007 and serum dihydrotestosterone in men with ASIP rs1015362. Conclusion Men with SNPs in SLC45A2, who have less sun sensitive skin, have lower PSA levels. Men with SNPs in MC1R and ASIP, who have more sun sensitive skin, and were born in ANZ, have higher PSA levels. Androgens may modify these apparent associations of pigmentary genes and sun exposure with PSA levels.	[Nair-Shalliker, Visalini; Egger, Sam; Smith, David P.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Nair-Shalliker, Visalini; Chrzanowska, Agata; Cumming, Robert; Smith, David P.; Armstrong, Bruce K.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Nair-Shalliker, Visalini] Macquarie Univ, Dept Clin Med, Sydney, NSW, Australia; [Mason, Rebecca] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Waite, Louise; Le Couteur, David; Seibel, Markus J.; Handelsman, David J.; Cumming, Robert] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Waite, Louise; Le Couteur, David; Seibel, Markus J.; Handelsman, David J.; Cumming, Robert] Univ Sydney, Sydney, NSW, Australia; [Cumming, Robert] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia; [Smith, David P.] Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia; [Armstrong, Bruce K.] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia	Cancer Council New South Wales; University of Sydney; Macquarie University; University of Sydney; Concord Repatriation General Hospital; University of Sydney; University of Sydney; ANZAC Research Institute; Griffith University; University of Western Australia	Nair-Shalliker, V (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.; Nair-Shalliker, V (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Nair-Shalliker, V (corresponding author), Macquarie Univ, Dept Clin Med, Sydney, NSW, Australia.	visalinin@nswcc.org.au	Mason, Rebecca/AHB-5478-2022; Handelsman, David/AAR-9580-2021; Research Institute, ANZAC/CAE-9030-2022; Armstrong, Bruce/K-9464-2015	Waite, Louise/0000-0001-9056-6996; Egger, Sam/0000-0003-1808-6909; Armstrong, Bruce/0000-0001-8940-7525; NAIR-SHALLIKER, VISALINI/0000-0001-6277-5125; Smith, David/0000-0002-1474-3214; Chrzanowska, Agata/0000-0002-1811-7851; Mason, Rebecca/0000-0003-1534-9697; Handelsman, David/0000-0002-4200-7476	Cancer Council New South Wales project grant [512513]; National Health and Medical Research Council (NHMRC) [301916]; Cancer Institute NSW [15/CDF/1-10]	Cancer Council New South Wales project grant(Cancer Council New South Wales); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This project was funded by the Cancer Council New South Wales project grant (512513 awarded to Prof Armstrong) and the National Health and Medical Research Council (NHMRC) project grant (301916 awarded to Prof Cumming). A/Prof D Smith was supported by a grant from Cancer Institute NSW (#15/CDF/1-10).	ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Australian Institute of Health and Welfare (AIHW), 2017, CANC AUSTR 2017 CANC; Binstock M, 2014, BRIT J DERMATOL, V171, P713, DOI 10.1111/bjd.13283; Bonilla C, 2013, CANCER EPIDEM BIOMAR, V22, P597, DOI 10.1158/1055-9965.EPI-12-1248; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Chia SE, 2012, ASIAN PAC J CANCER P, V13, P3179, DOI 10.7314/APJCP.2012.13.7.3179; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Cust AE, 2012, INT J CANCER, V131, pE269, DOI 10.1002/ijc.27357; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Gibbs DC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw004; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; HOLMAN CDJ, 1984, JNCI-J NATL CANCER I, V72, P257; Hsu B, 2016, J CLIN ENDOCR METAB, V101, P1836, DOI 10.1210/jc.2015-3810; Ibarrola-Villava M, 2012, EUR J CANCER, V48, P2183, DOI 10.1016/j.ejca.2012.03.006; Lee SE, 2000, UROLOGY, V56, P1007, DOI 10.1016/S0090-4295(00)00837-2; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Luscombe CJ, 2001, BRIT J CANCER, V85, P1504, DOI 10.1054/bjoc.2001.2097; Luscombe CJ, 2001, LANCET, V358, P641, DOI 10.1016/S0140-6736(01)05788-9; Maccioni L, 2013, INT J CANCER, V132, P42, DOI 10.1002/ijc.27648; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Mitchell DL, 2014, PIGM CELL MELANOMA R, V27, P408, DOI 10.1111/pcmr.12213; Mitkov M, 2015, MOL CELL ENDOCRINOL, V417, P94, DOI 10.1016/j.mce.2015.09.020; Muller RL, 2012, EUR UROL, V62, P757, DOI 10.1016/j.eururo.2012.05.025; Nair-Shalliker V, 2017, INT J CANCER, V140, P565, DOI 10.1002/ijc.30471; Nair-Shalliker V, 2014, WORLD J UROL, V32, P1251, DOI 10.1007/s00345-013-1201-5; Nair-Shalliker V, 2012, INT J CANCER, V131, pE726, DOI 10.1002/ijc.27400; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Napolitano A, 2014, PIGM CELL MELANOMA R, V27, P721, DOI 10.1111/pcmr.12262; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polascik TJ, 1999, J UROLOGY, V162, P293, DOI 10.1016/S0022-5347(05)68543-6; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; RAMPEN FHJ, 1980, LANCET, V1, P562; Robsahm TE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-210; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Scott MC, 2002, J CELL SCI, V115, P2349; Scott MC, 2002, PIGM CELL RES, V15, P433, DOI 10.1034/j.1600-0749.2002.02051.x; Supramaniam R, 2006, CANC INCIDENCE NEW S; Swerdloff RS, 2017, ENDOCR REV; Thomas LN, 2009, PROSTATE, V69, P595, DOI 10.1002/pros.20911; Tuohimaa P, 2007, EUR J CANCER, V43, P1701, DOI 10.1016/j.ejca.2007.04.018; Weinstein SJ, 2013, BRIT J CANCER, V109, P747, DOI 10.1038/bjc.2013.385; WU AH, 1995, CANCER EPIDEM BIOMAR, V4, P735	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193893	10.1371/journal.pone.0193893	http://dx.doi.org/10.1371/journal.pone.0193893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518100	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900044
J	Balbas-Martinez, V; Ruiz-Cerda, L; Irurzun-Arana, I; Gonzalez-Garcia, I; Vermeulen, A; Gomez-Mantilla, JD; Troconiz, IF				Balbas-Martinez, Violeta; Ruiz-Cerda, Leire; Irurzun-Arana, Itziar; Gonzalez-Garcia, Ignacio; Vermeulen, An; Gomez-Mantilla, Jose David; Troconiz, Inaki F.			A systems pharmacology model for inflammatory bowel disease	PLOS ONE			English	Article							ANTIINTERFERON-GAMMA ANTIBODY; CROHNS-DISEASE; SIGNAL-TRANSDUCTION; ULCERATIVE-COLITIS; MONOCYTE APHERESIS; MONOCLONAL-ANTIBODY; NATURAL-HISTORY; CLINICAL-COURSE; DOUBLE-BLIND; EFFICACY	Motivation The literature on complex diseases is abundant but not always quantitative. This is particularly so for Inflammatory Bowel Disease (IBD), where many molecular pathways are qualitatively well described but this information cannot be used in traditional quantitative mathematical models employed in drug development. We propose the elaboration and validation of a logic network for IBD able to capture the information available in the literature that will facilitate the identification/validation of therapeutic targets. Results In this article, we propose a logic model for Inflammatory Bowel Disease (IBD) which consists of 43 nodes and 298 qualitative interactions. The model presented is able to describe the pathogenic mechanisms of the disorder and qualitatively describes the characteristic chronic inflammation. A perturbation analysis performed on the IBD network indicates that the model is robust. Also, as described in clinical trials, a simulation of anti-TNF alpha, anti-IL2 and Granulocyte and Monocyte Apheresis showed a decrease in the Metalloproteinases node (MMPs), which means a decrease in tissue damage. In contrast, as clinical trials have demonstrated, a simulation of anti-IL17 and anti-IFN gamma or IL10 overexpression therapy did not show any major change in MMPs expression, as corresponds to a failed therapy. The model proved to be a promising in silico tool for the evaluation of potential therapeutic targets, the identification of new IBD biomarkers, the integration of IBD polymorphisms to anticipate responders and non-responders and can be reduced and transformed in quantitative model/s.	[Balbas-Martinez, Violeta; Ruiz-Cerda, Leire; Irurzun-Arana, Itziar; Gonzalez-Garcia, Ignacio; Gomez-Mantilla, Jose David; Troconiz, Inaki F.] Univ Navarra, Sch Pharm & Nutr, Dept Pharm & Pharmaceut Technol, Pharmacometr & Syst Pharmacol, Pamplona, Spain; [Balbas-Martinez, Violeta; Ruiz-Cerda, Leire; Irurzun-Arana, Itziar; Troconiz, Inaki F.] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Vermeulen, An] Janssen Res & Dev, Beerse, Belgium; [Vermeulen, An] Fac Pharmaceut Sci, Lab Med Biochem & Clin Anal, Ghent, Belgium; [Gonzalez-Garcia, Ignacio] PharmaMar, Madrid, Spain; [Gomez-Mantilla, Jose David] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany	University of Navarra; Johnson & Johnson; Janssen Pharmaceuticals; Ghent University; PharmaMar; Boehringer Ingelheim	Troconiz, IF (corresponding author), Univ Navarra, Sch Pharm & Nutr, Dept Pharm & Pharmaceut Technol, Pharmacometr & Syst Pharmacol, Pamplona, Spain.; Troconiz, IF (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.	itraconiz@unav.es	Troconiz, Iñaki/ABA-2543-2020; Arana, Itziar Irurzun/B-1976-2017; Martínez, Violeta/T-3321-2019; Gonzalez-Garcia, Ignacio/K-9695-2014	Troconiz, Iñaki/0000-0003-3700-8658; Arana, Itziar Irurzun/0000-0001-6084-4481; Gonzalez-Garcia, Ignacio/0000-0003-3663-3259	Navarra Government [61.965]; Janssen Research and Development; Navarra Government [61.965]; Janssen Research and Development	Navarra Government; Janssen Research and Development; Navarra Government; Janssen Research and Development	Development of the computational model was supported by a fellowship grant from the Navarra Government to Violeta Balbas-Martinez of 61.965 Euros (http://www.navarra.es/home_es/Actualidad/BON/Boletines/2017/18/Anuncio-5/) and Janssen Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janssen Research and Development provided support in the form of salaries for author AV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abou-Jaoude W, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00094; Balbas-Martinez Violeta, INT C SYST BIOL 2016; Bamba S, 2003, J GASTROENTEROL, V38, P548, DOI 10.1007/s00535-002-1101-8; Bassaganya-Riera J, 2015, COMPUTATIONAL IMMUNO; Ben-Horin S, 2016, CLIN GASTROENTEROL H, V14, P1685, DOI 10.1016/j.cgh.2016.05.023; Biancheri P, 2013, CELL TISSUE RES, V351, P269, DOI 10.1007/s00441-012-1390-z; Boldhaus G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021916; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Butto L. F., 2016, INT J MED MICROBIOL; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Chen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24245; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Coskun M., 2016, TRENDS PHARM SCI; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Danese S, 2017, J CROHNS COLITIS; de Lange KM, 2015, J AUTOIMMUN, V64, P91, DOI 10.1016/j.jaut.2015.07.013; Di Girolamo M, 2016, THER APHER DIAL, V20, P668, DOI 10.1111/1744-9987.12453; Dipasquale V, 2017, VACCINE, V35, P6070, DOI 10.1016/j.vaccine.2017.09.031; Dwivedi G, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2013.64; El Menyawi M, 2014, EGYPT RHEUMATOL, V36, P139, DOI 10.1016/j.ejr.2014.01.004; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fischer S, 2017, CLIN PHARMACOL THER, V102, P623, DOI 10.1002/cpt.793; Fox RF, 1993, BIOPHYS J, V65, P2698; Furfaro F, 2017, EXPERT REV CLIN IMMU, P1; Gasparetto M, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/829040; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1; Grevenitis P, 2015, SURG CLIN N AM, V95, P1159, DOI 10.1016/j.suc.2015.08.004; Hamedani R, 1997, ALIMENT PHARM THER, V11, P98; Harvey I, 1997, FROM ANIM ANIMAT, P67; Helikar T, 2013, CLIN PHARMACOL THER, V93, P393, DOI 10.1038/clpt.2013.41; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Henriksen M, 2006, INFLAMM BOWEL DIS, V12, P543, DOI 10.1097/01.MIB.0000225339.91484.fc; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Hopfensitz M, 2013, COMPUTATION STAT, V28, P19, DOI 10.1007/s00180-012-0324-2; HORST HJ, 1987, CLIN EXP IMMUNOL, V68, P156; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Irurzun-Arana I, 2017, BIOINFORMATICS; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Laffin M, 2017, CLIN PHARMACOL THER, V102, P588, DOI 10.1002/cpt.747; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Lawrance IC., 2015, J CROHNS COLITIS; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liu ZF, 2016, EUR J INTERN MED, V36, pE26, DOI 10.1016/j.ejim.2016.08.028; Loftus EV, 2002, ALIMENT PHARM THERAP, V16, P51, DOI 10.1046/j.1365-2036.2002.01140.x; Matricon J, 2010, SELF NONSELF, V1, P299, DOI DOI 10.4161/SELF.1.4.13560; McManus R, 2003, J ENDOCRINOL, V178, P1, DOI 10.1677/joe.0.1780001; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Monteleone G, 2006, GUT, V55, P1774, DOI 10.1136/gut.2006.093187; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naija Narjess, 2011, Tunis Med, V89, P517; Naldi A, 2015, BIOINFORMATICS, V31, P1154, DOI 10.1093/bioinformatics/btv013; O'Sullivan S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/964131; PALIOGIANNI F, 1993, J IMMUNOL, V151, P4081; Palsson S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-95; Pender SL, 2004, CURR OPIN PHARMACOL, V4, P546, DOI 10.1016/j.coph.2004.06.005; Peters LA, 2017, NAT GENET, V49, P1437, DOI 10.1038/ng.3947; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Raine T, 2014, UNITED EUR GASTROENT, V2, P333, DOI 10.1177/2050640614550672; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P321, DOI 10.1007/0-387-25465-X_15; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Ruiz-Cerda ML, 2016, EUR J PHARM SCI; Ryll A, 2011, MOL BIOSYST, V7, P3253, DOI 10.1039/c1mb05261f; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Sands BE, 2012, GASTROENTEROLOGY, V143, P356, DOI 10.1053/j.gastro.2012.04.043; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Shelton E, 2015, INFLAMM BOWEL DIS, V21, P2879, DOI 10.1097/MIB.0000000000000561; Shi M, 2015, MOL MED REP, V11, P121, DOI 10.3892/mmr.2014.2681; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Solberg IC, 2009, SCAND J GASTROENTERO, V44, P431, DOI 10.1080/00365520802600961; Tan Y, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2405291; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Thomas DW, 2016, BIO IND ANAL; Van Assche G, 2006, GUT, V55, P1568, DOI 10.1136/gut.2005.089854; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wasilewska A, 2016, POSTEP DERM ALERGOL, V33, P247, DOI 10.5114/ada.2016.61599; Wehkamp J, 2016, J MOL MED; Wehkamp J, 2016, DTSCH ARZTEBL INT, V113, P72, DOI 10.3238/arztebl.2016.0072; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Willadsen K., 2008, ARTIF LIFE, P694; Wynn ML, 2012, INTEGR BIOL-UK, V4, P1323, DOI 10.1039/c2ib20193c; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yi FM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/710915; Yoshimura N, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0390-3; Zhou W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020246	96	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192949	10.1371/journal.pone.0192949	http://dx.doi.org/10.1371/journal.pone.0192949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513758	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800026
J	Lim, S; Roseman, G; Peshenko, I; Manchala, G; Cudia, D; Dizhoor, AM; Millhauser, G; Ames, JB				Lim, Sunghyuk; Roseman, Graham; Peshenko, Igor; Manchala, Grace; Cudia, Diana; Dizhoor, Alexander M.; Millhauser, Glenn; Ames, James B.			Retinal guanylyl cyclase activating protein 1 forms a functional dimer	PLOS ONE			English	Article							DOMINANT CONE DYSTROPHY; NITROXIDE SPIN LABELS; VERTEBRATE PHOTOTRANSDUCTION; MAPPING SITES; WEB SERVER; CALCIUM; GCAP1; DEGENERATION; MUTATION; TARGET	Retinal guanylyl cyclases (RetGCs) in vertebrate photoreceptors are regulated by the guanylyl cyclase activator proteins (GCAP1 and GCAP2). Here, we report EPR double electron-electron resonance (DEER) studies on the most ubiquitous GCAP isoform, GCAP1 and site-directed mutagenesis analysis to determine an atomic resolution structural model of a GCAP1 dimer. Nitroxide spin-label probes were introduced at individual GCAP1 residues: T29C, E57C, E133C, and E154C. The intermolecular distance of each spin-label probe (measured by DEER) defined restraints for calculating the GCAP1 dimeric structure by molecular docking. The DEER-derived structural model of the GCAP1 dimer was similar within the experimental error for both the Mg2+-bound activator and Ca2+-bound inhibitor states (RMSD < 2.0 angstrom). The GCAP1 dimer possesses intermolecular hydrophobic contacts involving the side chain atoms of H19, Y22, F73 and V77. The structural model of the dimer was validated by GCAP1 mutations (H19R, Y22D, F73E, and V77E) at the dimer interface that each abolished protein dimerization. Previous studies have shown that each of these mutants either diminished or completely suppressed the ability of GCAP1 to activate the cyclase. These results suggest that GCAP1 dimerization may affect compartmentalization of GCAP1 in the photoreceptors and/or affect regulation of the cyclase activity.	[Lim, Sunghyuk; Manchala, Grace; Cudia, Diana; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Roseman, Graham; Millhauser, Glenn] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Peshenko, Igor; Dizhoor, Alexander M.] Salus Univ, Penns Coll Optometry, Elkins Pk, PA USA	University of California System; University of California Davis; University of California System; University of California Santa Cruz	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbames@ucdavis.edu		Ames, James/0000-0003-0934-2595; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health, National Eye Institute [EY012347, EY011522]; NATIONAL EYE INSTITUTE [R01EY011522, R01EY012347] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health, National Eye Institute, award number EY012347 (JBA); National Institutes of Health, National Eye Institute, award number EY011522 (AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Behnen P, 2010, BIOL CHEM, V391, P631, DOI 10.1515/BC.2010.063; Bolin KA, 1998, J MAGN RESON, V131, P248, DOI 10.1006/jmre.1998.1365; Chen X, 2017, GENET MED, V19, P945, DOI 10.1038/gim.2016.217; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; HORTON RM, 1991, DIRECTED MUTAGENESIS; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; Jiang L, 2010, ADV EXP MED BIOL, V664, P273, DOI 10.1007/978-1-4419-1399-9_31; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Koch KW, 2013, ACS CHEM NEUROSCI, V4, P909, DOI 10.1021/cn400027z; Koch KW, 2002, MOL CELL BIOCHEM, V230, P97, DOI 10.1023/A:1014209711793; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Lim S, 2017, BIOCHEMISTRY-US, V56, P6652, DOI 10.1021/acs.biochem.7b01029; Lim S, 2016, J BIOL CHEM, V291, P4429, DOI 10.1074/jbc.M115.696161; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081822; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Marino V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34277; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Myers WK, 2013, BIOCHEMISTRY-US, V52, P5800, DOI 10.1021/bi400538w; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Schrem A, 1999, J BIOL CHEM, V274, P6244, DOI 10.1074/jbc.274.10.6244; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193947	10.1371/journal.pone.0193947	http://dx.doi.org/10.1371/journal.pone.0193947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513743	gold, Green Published			2022-12-26	WOS:000426896800092
J	Mitchell, EP; Prozesky, L; Lawrence, J				Mitchell, Emily P.; Prozesky, Leon; Lawrence, John			A new perspective on the pathogenesis of chronic renal disease in captive cheetahs (Acinonyx jubatus)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYSTEMIC AA-AMYLOIDOSIS; INFLAMMATORY-BOWEL-DISEASE; SOUTH-AFRICA; MOLECULAR-MECHANISMS; BLOOD VALUES; CATS; PATHOLOGY; STRESS; MORPHOLOGY	The sustainability of captive cheetah populations is limited by high mortality due to chronic renal disease. This necropsy study, conducted on 243 captive cheetahs from one institution, investigated the relationships between focal palatine erosions, gastritis, enterocolitis, glomerulosclerosis, chronic renal infarcts, renal cortical and medullary fibrosis, and renal medullary amyloidosis at death. Associations between the individual renal lesions and death due to chronic renal disease and comparisons of lesion prevalence between captive bred and wild born and between normal and king coated cheetahs were also assessed. All lesions were significantly positively correlated with age at death. Renal medullary fibrosis was the only lesion associated with the likelihood of death being due to chronic renal disease, and cheetahs with this lesion were younger, on average, than cheetahs with other renal lesions. Alimentary tract lesions were not associated with amyloidosis. All lesions, except for palatine erosions, were more common in wild born than in captive bred cheetahs; the former were older at death than the latter. Having a king coat had no clear effect on disease prevalence. These results suggest that age and renal medullary fibrosis are the primary factors influencing the pathogenesis of chronic renal disease in captive cheetahs. Apart from amyloidosis, these findings are analogous to those described in chronic renal disease in domestic cats, which is postulated to result primarily from repetitive hypoxic injury of renal tubules, mediated by age and stress. Cheetahs may be particularly susceptible to acute renal tubular injury due to their propensity for stress and their extended life span in captivity, as well as their adaptation for fecundity (rather than longevity) and adrenaline-mediated high speed prey chases. The presence of chronic renal disease in subadult cheetahs suggests that prevention, identification and mitigation of stress are critical to the successful prevention of chronic renal disease in captive cheetahs.	[Mitchell, Emily P.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [Mitchell, Emily P.; Prozesky, Leon; Lawrence, John] Univ Pretoria, Dept Paraclin Sci, Fac Vet Sci, Onderstepoort, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria	Mitchell, EP (corresponding author), Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa.; Mitchell, EP (corresponding author), Univ Pretoria, Dept Paraclin Sci, Fac Vet Sci, Onderstepoort, South Africa.	emily.mitchell@up.ac.za		Lane, Emily/0000-0003-0379-3790	Ann van Dyk Cheetah Centre (AvDCC); National Zoological Gardens of South Africa	Ann van Dyk Cheetah Centre (AvDCC); National Zoological Gardens of South Africa(National Research Foundation - South Africa)	This work was funded jointly by the Ann van Dyk Cheetah Centre (AvDCC) and annual core operational funds from the National Zoological Gardens of South Africa, a facility of the National Research Foundation. The funders had no role in the study design, analysis or preparation of the manuscript. Ms Ann van Dyk and the staff of the AvDCC participated in sample and data collection and the decision to publish.	Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Augustus P, 2006, ZOO BIOL, V25, P383, DOI 10.1002/zoo.20097; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Bechert U, 2002, J ZOO WILDLIFE MED, V33, P16, DOI 10.1638/1042-7260(2002)033[0016:DCABVO]2.0.CO;2; Bergstrom J, 2006, AMYLOID, V13, P93, DOI 10.1080/13506120600722621; BERTANI T, 1989, LAB INVEST, V60, P196; BLANCHARD PC, 1991, J NUTR, V121, pS77, DOI 10.1093/jn/121.suppl_11.S77; Bolton LA, 1999, VET PATHOL, V36, P14, DOI 10.1354/vp.36-1-14; Brodsky SV, 2010, HISTOL HISTOPATHOL, V25, P1379, DOI 10.14670/HH-25.1379; Brown CA, 2016, VET PATHOL, V53, P309, DOI 10.1177/0300985815622975; Buffington CAT, 2001, J UROLOGY, V165, P2051, DOI 10.1016/S0022-5347(05)66292-1; Burnham K, 2002, MODEL SELECTION MULT, P111; Chakrabarti S, 2013, VET PATHOL, V50, P147, DOI 10.1177/0300985812453176; Chakrabarti S, 2012, J VET INTERN MED, V26, P275, DOI 10.1111/j.1939-1676.2011.00874.x; Chen L, 2012, J HERED, V103, P115, DOI 10.1093/jhered/esr105; Chida Y, 2005, LIFE SCI, V76, P1707, DOI 10.1016/j.lfs.2004.08.032; Cianciolo RE, 2016, JUBB KENNEDY PALMERS, P425; Cianciolo RE, 2015, VET PATHOL, V53, P1; Cowgill LD, 2016, VET CLIN N AM-SMALL, V46, P995, DOI 10.1016/j.cvsm.2016.06.001; Crawford J, 1999, ROBBINS PATHOLOGIC B, P911; Delaney MA, 2016, VET PATHOL, V53, P493, DOI 10.1177/0300985815612557; Dember LM, 2006, J AM SOC NEPHROL, V17, P3458, DOI 10.1681/ASN.2006050460; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; Depauw S, 2012, ZOO BIOL, V31, P629, DOI 10.1002/zoo.20427; DIBARTOLA SP, 1986, J COMP PATHOL, V96, P387, DOI 10.1016/0021-9975(86)90034-4; DIBARTOLA SP, 1993, J AM VET MED ASSOC, V202, P744; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; EATON KA, 1993, VET PATHOL, V30, P55, DOI 10.1177/030098589303000107; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fitch H.M., 1982, Zoo Biology, V1, P295, DOI 10.1002/zoo.1430010403; Franklin AD, 2016, J HERED, V107, P115, DOI 10.1093/jhered/esv089; Gaffney PM, 2016, VET PATHOL, V53, P637, DOI 10.1177/0300985815604725; Gamble M., 2008, THEORY PRACT HISTOL, V6th ed, P121, DOI DOI 10.1016/B978-0-443-10279-0.50037-3; Garner MM, 2007, J ZOO WILDLIFE MED, V38, P32, DOI 10.1638/06-023.1; Gillis-Germitsch N, 2017, ZOO BIOL, V36, P40, DOI 10.1002/zoo.21341; GOSSELIN SJ, 1988, VET PATHOL, V25, P48, DOI 10.1177/030098588802500107; Hudson-Lamb GC, 2016, J S AFR VET ASSOC, V87, DOI 10.4102/jsava.v87i1.1316; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Jepson RE, 2016, VET CLIN N AM-SMALL, V46, P1015, DOI 10.1016/j.cvsm.2016.06.002; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Koster LS, 2007, J S AFR VET ASSOC, V78, P133; Lane EP, 2012, ZOO BIOL, V31, P669, DOI 10.1002/zoo.20431; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Ludlage E, 2005, VET PATHOL, V42, P117, DOI 10.1354/vp.42-2-117; Magy N, 2003, ARTHRITIS RHEUM, V48, P1430, DOI 10.1002/art.10964; Marker L, 2014, INT CHEETAH ACINONY, pA9; Marker LL, 2004, J MAMMAL, V85, P19, DOI 10.1644/1545-1542(2004)085<0019:DAAIOP>2.0.CO;2; McLeland SM, 2015, VET PATHOL, V52, P524, DOI 10.1177/0300985814561095; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Meuwese CL, 2013, ARCH MED RES, V44, P591, DOI 10.1016/j.arcmed.2013.10.009; Mitani S, 2013, J VET MED SCI, V75, P127, DOI 10.1292/jvms.12-0314; Mitchell E, 2017, VET PATHOL; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; Murakami T, 2014, VET PATHOL, V51, P363, DOI 10.1177/0300985813511128; Newkirk KM, 2011, VET PATHOL, V48, P698, DOI 10.1177/0300985810382089; Papendick RE, 1997, VET PATHOL, V34, P549, DOI 10.1177/030098589703400602; Phillips J. A., 1993, Madoqua, V18, P79; Schmiedt CW, 2016, VET PATHOL, V53, P87, DOI 10.1177/0300985815600500; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Steffens A.B., 1999, P108; Terio KA, 2008, VET PATHOL, V45, P393, DOI 10.1354/vp.45-3-393; Terio KA, 2012, VET PATHOL, V49, P824, DOI 10.1177/0300985811412620; Terio KA, 2000, GASTROENTEROLOGY, V118, pA746, DOI 10.1016/S0016-5085(00)85123-9; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Terio KA, 2014, AM ASS ZOO VET ANN C, P107; Tidiere M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36361; Url A, 2016, J ZOO WILDLIFE MED, V47, P797; vanderLindeSipman JS, 1997, VET IMMUNOL IMMUNOP, V56, P1, DOI 10.1016/S0165-2427(96)05717-0; Weiss DJ, 1996, J AM VET MED ASSOC, V209, P1114; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Whitehouse-Tedd KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120903; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; Zordan M, 2012, ZOO BIOL, V31, P181, DOI 10.1002/zoo.20392; ZSCHIESCHE W, 1989, PHARMACOL THERAPEUT, V41, P49, DOI 10.1016/0163-7258(89)90102-2	81	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194114	10.1371/journal.pone.0194114	http://dx.doi.org/10.1371/journal.pone.0194114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513736	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800103
J	Wang, X; Pinto-Duarte, A; Behrens, MM; Zhou, XJ; Sejnowski, TJ				Wang, Xin; Pinto-Duarte, Antonio; Behrens, M. Margarita; Zhou, Xianjin; Sejnowski, Terrence J.			Ketamine independently modulated power and phase-coupling of theta oscillations in Sp4 hypomorphic mice	PLOS ONE			English	Article							NMDA-RECEPTOR ENCEPHALITIS; TRANSCRIPTION FACTOR SP4; PSYCHIATRIC-DISORDERS; PREFRONTAL SYNCHRONY; BIPOLAR DISORDER; SCHIZOPHRENIA; MEMORY; EEG; MODEL; EXPRESSION	Reduced expression of Sp4, the murine homolog of human SP4, a risk gene of multiple psychiatric disorders, led to N-methyl-D-aspartate ( NMDA) hypofunction in mice, producing behavioral phenotypes reminiscent of schizophrenia, including hypersensitivity to ketamine. As accumulating evidence on molecular mechanisms and behavioral phenotypes established Sp4 hypomorphism as a promising animal model, systems-level neural circuit mechanisms of Sp4 hypomorphism, especially network dynamics underlying cognitive functions, remain poorly understood. We attempted to close this gap in knowledge in the present study by recording multi-channel epidural electroencephalogram ( EEG) from awake behaving wildtype and Sp4 hypomorphic mice. We characterized cortical theta-band power and phase-coupling phenotypes, a known neural circuit substrate underlying cognitive functions, and further studied the effects of a subanesthetic dosage of ketamine on theta abnormalities unique to Sp4 hypomorphism. Sp4 hypomorphic mice had markedly elevated theta power localized frontally and parietally, a more pronounced theta phase progression along the neuraxis, and a stronger frontal-parietal theta coupling. Acute subanesthetic ketamine did not affect theta power in wildtype animals but significantly reduced it in Sp4 hypomorphic mice, nearly completely neutralizing their excessive frontal/parietal theta power. Ketamine did not significantly alter cortical theta phase progression in either wildtype or Sp4 hypomorphic animals, but significantly strengthened cortical theta phase-coupling in wildtype, but not in Sp4 hypomorphic animals. Our results suggested that the resting-state phenotypes of cortical theta oscillations unique to Sp4 hypomorphic mice closely mimicked a schizophrenic endophenotype. Further, ketamine independently modulated Sp4 hypomorphic anomalies in theta power and phase-coupling, suggesting separate underlying neural circuit mechanisms.	[Wang, Xin; Pinto-Duarte, Antonio; Behrens, M. Margarita; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, X (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	xinw@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Pinto-Duarte, Antonio/B-6392-2008	Pinto-Duarte, Antonio/0000-0002-2215-7653; Wang, Xin/0000-0003-3270-3782	Life Sciences Research Foundation (US); Fundacao Calouste Gulbenkian; Brain and Behavior Research Foundation [YI19582]; National Institute of Mental Health [MH091407, MH073991]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091407] Funding Source: NIH RePORTER	Life Sciences Research Foundation (US); Fundacao Calouste Gulbenkian(European Commission); Brain and Behavior Research Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by Life Sciences Research Foundation (US) to XW, Fundacao Calouste Gulbenkian to APD, Brain and Behavior Research Foundation (YI19582 to XW), National Institute of Mental Health (MH091407) to MMB, National Institute of Mental Health (MH073991) to XZ, Howard Hughes Medical Institute to TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou C, 2015, SCHIZOPHR RES, V161, P299, DOI 10.1016/j.schres.2014.12.018; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Choi JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148272; Cousijn H, 2015, HUM BRAIN MAPP, V36, P2387, DOI 10.1002/hbm.22778; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Di Lorenzo G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00234; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Garakh Z, 2015, CLIN NEUROPHYSIOL, V126, P2090, DOI 10.1016/j.clinph.2014.12.031; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hanslmayr S, 2013, HUM BRAIN MAPP, V34, P2266, DOI 10.1002/hbm.22064; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Higa K.K., 2015, INT J NEUROPSYCHOPH, P1; Holcomb HH, 2005, NEUROPSYCHOPHARMACOL, V30, P2275, DOI 10.1038/sj.npp.1300824; Hong LE, 2008, ARCH GEN PSYCHIAT, V65, P1008, DOI 10.1001/archpsyc.65.9.1008; Horvath G, 2016, BEHAV BRAIN RES, V307, P65, DOI 10.1016/j.bbr.2016.03.051; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Ji B, 2013, PLOS ONE, V8; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kim JW, 2015, NEUROSCI LETT, V589, P126, DOI 10.1016/j.neulet.2014.12.064; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Lanre-Amos T, 2010, FRONT PSYCHIATRY, V1, P1; Law A.J., 2001, NEUROCHEM NEUROREP, V12, P959; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Martin-Sanchez A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00197; Mathes B, 2015, INT FEDERATION CLIN, V127, P419; Narayanan B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.76; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Popov T, 2015, PSYCHOPHYSIOLOGY, V52, P648, DOI 10.1111/psyp.12393; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; SPONHEIM SR, 1994, PSYCHOPHYSIOLOGY, V31, P37, DOI 10.1111/j.1469-8986.1994.tb01023.x; Sun X, 2014, DEV NEUROBIOL, V2; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tomimatsu Y, 2015, SCHIZOPHR RES, V166, P171, DOI 10.1016/j.schres.2015.05.002; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Wang X, 2010, NEURO PHYSIOL COMPUT, P1195; Wang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14964; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Young AMJ, 2015, NEUROSCIENCE, V287, P157, DOI 10.1016/j.neuroscience.2014.12.014; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193446	10.1371/journal.pone.0193446	http://dx.doi.org/10.1371/journal.pone.0193446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513708	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800061
J	Keyhani, S; Vali, M; Cohen, B; Woodbridge, A; Arenson, M; Eilkhani, E; Aivadyan, C; Hasin, D				Keyhani, Salomeh; Vali, Marzieh; Cohen, Beth; Woodbridge, Alexandra; Arenson, Melanie; Eilkhani, Elnaz; Aivadyan, Christina; Hasin, Deborah			A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record	PLOS ONE			English	Article							ALCOHOL-USE DISORDER; PULMONARY-FUNCTION; CANNABIS USE; TOBACCO; PATIENT; RISK; PREVALENCE; SYMPTOMS; ADULTS; SMOKE	Background The harmful effects of marijuana on health and in particular cardiovascular health are understudied. To develop such knowledge, an efficient method of developing an informative cohort of marijuana users and non-users is needed. Methods We identified patients with a diagnosis of coronary artery disease using ICD-9 codes who were seen in the San Francisco VA in 2015. We imported these patients' medical record notes into an informatics platform that facilitated text searches. We categorized patients into those with evidence of marijuana use in the past 12 months and patients with no such evidence, using the following text strings: "marijuana", "mjx", and "cannabis". We randomly selected 51 users and 51 non-users based on this preliminary classification, and sent a recruitment letter to 97 of these patients who had contact information available. Patients were interviewed on marijuana use and domains related to cardiovascular health. Data on marijuana use collected from the medical record was compared to data collected as part of the interview. Results The interview completion rate was 71%. Among the 35 patients identified by text strings as having used marijuana in the previous year, 15 had used marijuana in the past 30 days (positive predictive value = 42.9%). The probability of use in the past month increased from 8.8% to 42.9% in people who have these keywords in their medical record compared to those who did not have these terms in their medical record. Conclusion Methods that combine text search strategies for participant recruitment with health interviews provide an efficient approach to developing prospective cohorts that can be used to study the health effects of marijuana.	[Keyhani, Salomeh; Vali, Marzieh; Cohen, Beth] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Keyhani, Salomeh; Cohen, Beth; Eilkhani, Elnaz] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Woodbridge, Alexandra] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Arenson, Melanie] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Aivadyan, Christina; Hasin, Deborah] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hasin, Deborah] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Tulane University; University System of Maryland; University of Maryland College Park; New York State Psychiatry Institute; Columbia University	Keyhani, S (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Keyhani, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Salomeh.keyhani@ucsf.edu	Arenson, Melanie/K-9378-2019	Arenson, Melanie/0000-0001-6334-1548	NIH [RO1HL116522-01A1, RO1HL114563-01A1]; VAHSRD [1IP1HX001994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VAHSRD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was not directly supported by any research funds. Dr. Keyhani is funded by grants from the NIH grants(RO1HL116522-01A1, RO1HL114563-01A1) and VAHSR&D (1IP1HX001994)	[Anonymous], 1999, MARIJUANA MED ASSESS; Bostwick JM, 2012, MAYO CLIN PROC, V87, P172, DOI 10.1016/j.mayocp.2011.10.003; Compton WM, 2016, LANCET PSYCHIAT, V3, P954, DOI 10.1016/S2215-0366(16)30208-5; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Godin G, 1997, MED SCI SPORTS EXERC, V29, P36, DOI DOI 10.1097/00005768-199706001-00009; Gustman AL, 2001, SOC SECUR BULL, V64, P66; Hammash MH, 2013, EUR J CARDIOVASC NUR, V12, P446, DOI 10.1177/1474515112468068; Hashibe M, 2005, ALCOHOL, V35, P265, DOI 10.1016/j.alcohol.2005.04.008; Hasin DS, 2016, AM J PSYCHIAT, V173, P588, DOI 10.1176/appi.ajp.2015.15070907; Hasin DS, 2016, JAMA PSYCHIAT, V73, P532, DOI 10.1001/jamapsychiatry.2015.3158; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hasin DS, 2015, DRUG ALCOHOL DEPEN, V148, P40, DOI 10.1016/j.drugalcdep.2014.12.011; Hickman DE, 2003, ANN PHARMACOTHER, V37, P187; HIGGINS M, 1991, CHEST, V99, P315, DOI 10.1378/chest.99.2.315; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Patton GC, 2005, ADDICTION, V100, P1518, DOI 10.1111/j.1360-0443.2005.01220.x; Pletcher MJ, 2012, JAMA-J AM MED ASSOC, V307, P173, DOI 10.1001/jama.2011.1961; Ramo DE, 2013, J STUD ALCOHOL DRUGS, V74, P301, DOI 10.15288/jsad.2013.74.301; Rodondi N, 2006, AM J CARDIOL, V98, P478, DOI 10.1016/j.amjcard.2006.03.024; Rubinsky AD, 2013, ALCOHOL CLIN EXP RES, V37, P1380, DOI 10.1111/acer.12092; Sarafian TA, 1999, AM J RESP CELL MOL, V20, P1286, DOI 10.1165/ajrcmb.20.6.3424; Spoont MR, 2015, JAMA-J AM MED ASSOC, V314, P501, DOI 10.1001/jama.2015.7877; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; Thombs BD, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-124; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Welsh GH, 1999, CRIT CARE MED, V27, P1466, DOI 10.1097/00003246-199908000-00011; WU TC, 1988, NEW ENGL J MED, V318, P347, DOI 10.1056/NEJM198802113180603; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071	29	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193706	10.1371/journal.pone.0193706	http://dx.doi.org/10.1371/journal.pone.0193706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509775	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200025
J	You, YQ; Song, L; Nonyane, BAS; Price, LB; Silbergeld, EK				You, Yaqi; Song, Li; Nonyane, Bareng A. S.; Price, Lance B.; Silbergeld, Ellen K.			Genomic differences between nasal Staphylococcus aureus from hog slaughterhouse workers and their communities	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; ANTIMICROBIAL RESISTANCE; PATHOGENICITY ISLANDS; ENTEROTOXIN GENE; HIGHLY PREVALENT; IMMUNE EVASION; S. AUREUS; METHICILLIN; SEQUENCE; TRANSMISSION	New human pathogens can emerge from the livestock-human interface and spread into human populations through many pathways including livestock products. Occupational contact with livestock is a risk factor for exposure to those pathogens and may cause further spreading of those pathogens in the community. The current study used whole genome sequencing to explore nasal Staphylococcus aureus obtained from hog slaughterhouse workers and their community members, all of whom resided in a livestock-dense region in rural North Carolina. Sequence data were analyzed for lineage distribution, pathogenicity-related genomic features, and mobile genetic elements. We observed evidence of nasal S. aureus differences between hog workers and non-workers. Nasal S. aureus from hog workers showed a greater lineage diversity than nasal S. aureus from community residents. Hog worker isolates were less likely to carry the phi Sa3 prophage and human-specific immune evasion cluster genes than community resident isolates (phi Sa3 prophage: 54.5% vs. 91.7%, Benjamini-Hochberg (BH) corrected p = 0.035; immune evasion cluster genes: 66.7% vs. 100%, BH p = 0.021). Hog worker isolates had a lower prevalence and diversity of enterotoxins than community resident isolates, particularly lacking the enterotoxin gene cluster (39.4% vs. 70.8%, BH p = 0.125). Moreover, hog worker isolates harbored more diverse antibiotic resistance genes, with a higher prevalence of carriage of multiple resistance genes, than community resident isolates (75.8% vs. 29.2%, BH p = 0.021). Phylogenetic analysis of all ST5 isolates, the most abundant lineage in the collection, further supported separation of isolates from hog workers and non-workers. Together, our observations suggest impact of occupational contact with livestock on nasal S. aureus colonization and highlight the need for further research on the complex epidemiology of S. aureus at the livestock-human interface.	[You, Yaqi; Silbergeld, Ellen K.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA; [Song, Li] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Song, Li] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Computat Biol, Baltimore, MD USA; [Nonyane, Bareng A. S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Price, Lance B.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Environm & Occupat Hlth, Washington, DC USA; [Price, Lance B.] Translat Genom Res Inst, Div Pathogen Genom, Flagstaff, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Translational Genomics Research Institute	Silbergeld, EK (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA.	esilber2@jhu.edu	Nonyane, Bareng A.S./AAC-8118-2020	Nonyane, Bareng A.S./0000-0001-5633-7487	National Institute for Occupational Safety and Health [5R210H009829]; Heinz Endowments (Pittsburgh, Pennsylvania); National Science Foundation award [IOS-1339134]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI101371-02]; Merck; Applegate Farms LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Heinz Endowments (Pittsburgh, Pennsylvania); National Science Foundation award(National Science Foundation (NSF)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck(Merck & Company); Applegate Farms LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Occupational Safety and Health (grant 5R210H009829) and by the Heinz Endowments (Pittsburgh, Pennsylvania) to E.K.S. L.S. was supported by a National Science Foundation award (IOS-1339134). L.B.P. was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (5R01AI101371-02) and received research support from Merck and general operating funds from Applegate Farms LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3717-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Driebe EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130955; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hau SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142832; Hau SJ, 2017, APPL ENV MICROBIOL; Hiramatsu K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/ic.2013.45.2.117; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Khokhlova OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128017; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McCarthy AJ, 2014, GENOME BIOL EVOL, V6, P2697, DOI 10.1093/gbe/evu214; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nashev D, 2007, LETT APPL MICROBIOL, V45, P681, DOI 10.1111/j.1472-765X.2007.02254.x; Neyra RC, 2014, ENVIRON HEALTH PERSP, V122, P471, DOI 10.1289/ehp.1306741; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Nowrouzian FL, 2015, EUR J CLIN MICROBIOL, V34, P1443, DOI 10.1007/s10096-015-2371-4; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Peter C, 2016, J AM STAT ASSOC, V89, P1012; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; Sun JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143670; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Suzuki Y, 2015, J APPL MICROBIOL, V118, P1507, DOI 10.1111/jam.12786; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Ye XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19184; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	68	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193820	10.1371/journal.pone.0193820	http://dx.doi.org/10.1371/journal.pone.0193820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509797	Green Submitted, gold, Green Published			2022-12-26	WOS:000426813200033
J	Aumailley, L; Roux-Dalvai, F; Kelly, I; Droit, A; Lebel, M				Aumailley, Lucie; Roux-Dalvai, Florence; Kelly, Isabelle; Droit, Arnaud; Lebel, Michel			Vitamin C alters the amount of specific endoplasmic reticulum associated proteins involved in lipid metabolism in the liver of mice synthesizing a nonfunctional Werner syndrome (Wrn) mutant protein	PLOS ONE			English	Article							SYNDROME HELICASE; TPD52 EXPRESSION; CULTURED-CELLS; SYNDROME GENE; MOUSE MODEL; DNA; IDENTIFICATION; RECOMBINATION; TRANSCRIPTION; INFLAMMATION	Werner syndrome (WS) is a premature aging disorder caused by mutations in a protein containing both a DNA exonuclease and DNA helicase domain. Mice lacking the helicase domain of the Wrn protein orthologue exhibit transcriptomic and metabolic alterations, some of which are reversed by vitamin C. Recent studies on these animals indicated that the mutant protein is associated with enriched endoplasmic reticulum (ER) fractions of tissues resulting in an ER stress response. In this study, we identified proteins that exhibit actual level differences in the ER enriched fraction between the liver of wild type and Wrn mutant mice using quantitative proteomic profiling with label-free Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Multiple Reaction Monitoring (MRM) and immunoblotting were performed to validate findings in a secondary independent cohort of wild type and Wrn mutant mice. DAVID 6.7 (NIH) was used for functional annotation analysis and indicated that the identified proteins exhibiting level changes between untreated wild type, Wrn mutant, and vitamin C treated Wrn mutant mice (ANOVA P-value < 0.05) were involved in fatty acid and steroid metabolism pathways (Bonferroni P-value = 0.0137). Finally, when we compared the transcriptomic and the proteomic data of our mouse cohorts only similar to 7% of the altered mRNA profiles encoding for ER gene products were consistent with their corresponding protein profiles measured by the label-free quantification methods. These results suggest that a great number of ER gene products are regulated at the post-transcriptional level in the liver of Wrn mutant mice exhibiting an ER stress response.	[Aumailley, Lucie; Lebel, Michel] Univ Laval, CHU Quebec, Fac Med, Ctr Rech, Quebec City, PQ, Canada; [Roux-Dalvai, Florence; Kelly, Isabelle; Droit, Arnaud] Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Proteom Platform Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Lebel, M (corresponding author), Univ Laval, CHU Quebec, Fac Med, Ctr Rech, Quebec City, PQ, Canada.	michel.lebel@crchudequebec.ulaval.ca	Roux-Dalvai, Florence/AAY-4134-2020; ROUX-DALVAI, Florence/ABD-4524-2020; Droit, Arnaud/AGZ-6283-2022	ROUX-DALVAI, Florence/0000-0002-9961-8964; Droit, Arnaud/0000-0001-7922-790X	Canadian Institutes of Health Research (Institute of Aging) [MOP-257669]; Canadian Institutes of Health Research [MOP-257669]	Canadian Institutes of Health Research (Institute of Aging)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to Eric Paquet (Laval University) for help with the microarray analyses. This work was supported by the Canadian Institutes of Health Research (Institute of Aging) to M.L (grant # MOP-257669). L.A. is a scholar from the Fondation du CHU de Quebec.; This work was supported by the Canadian Institutes of Health Research (grant # MOP-257669) to M L. LA is a scholar from the Fondation du CHU de Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley L, 2015, EXP GERONTOL, V72, P192, DOI 10.1016/j.exger.2015.10.012; Aumailley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140292; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169; Cooper MP, 2000, GENE DEV, V14, P907; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deracinois B, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030180; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Head GA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00493; HOEFLER G, 1994, GENOMICS, V19, P60, DOI 10.1006/geno.1994.1013; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Ipsen DH, 2014, NUTRIENTS, V6, P5473, DOI 10.3390/nu6125473; Ivanova AA, 2015, DOKL BIOCHEM BIOPHYS, V463, P213, DOI 10.1134/S1607672915040043; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Johnston CS, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-35; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamili A, 2015, J CELL SCI, V128, P3223, DOI 10.1242/jcs.167692; Labbe A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2001, CANCER RES, V61, P1816; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; Nicolas-Frances V, 2014, BIOCHIMIE, V98, P86, DOI 10.1016/j.biochi.2013.11.014; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Trapeaux J, 2013, BRIT J PHARM; Turaga RVN, 2007, AGING CELL, V6, P471, DOI 10.1111/j.1474-9726.2007.00301.x; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2016, ONCOTARGET, V7, P6323, DOI 10.18632/oncotarget.6319; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193170	10.1371/journal.pone.0193170	http://dx.doi.org/10.1371/journal.pone.0193170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494634	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200027
J	Gerasimou, P; Nicolaidou, V; Skordis, N; Picolos, M; Monos, D; Costeas, PA				Gerasimou, Petroula; Nicolaidou, Vicky; Skordis, Nicos; Picolos, Michalis; Monos, Demetrios; Costeas, Paul A.			Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis	PLOS ONE			English	Article							HLA CLASS-I; GENETICS CONSORTIUM; RISING INCIDENCE; SUSCEPTIBILITY; MELLITUS; DQ; LOCI; ASSOCIATIONS; CHILDREN; ALLELES	The contribution of specific HLA Class II alleles in type 1 diabetes is determined by polymorphic amino acid epitopes that direct antigen binding therefore, along with conventional allele frequency analysis, epitope analysis can provide important insights into disease susceptibility. We analyzed the highly heterogeneous Cypriot population for the HLA class II loci of T1DM patients and controls and we report for the first time their allele frequencies. Within our patient cohort we identified a subgroup that did not carry the DRB1*03: 01-DQA1*05: 01-DQB1*02:01 and DRB1*04: xx-DQA1*03:01-DQB1*03:02 risk haplotypes but a novel recombinant one, DRB1*04: XX-DQA1*03:01-DQB1*02: 01 designated DR4-DQ2.3. Through epitope analysis we identified established susceptibility (DQB1 A(57), DRB1 H-13) and resistance (DQB1 D-57) residues as well as other novel susceptibility residues DRB1 Q(70), DQB1 L-26 and resistance residues DRB1 D-70, R-70 and DQB1 Y-47. Prevalence of susceptibility epitopes was higher in patients and was not exclusively a result of linkage disequilibrium. Residues DRB1 Q(70), DQB1 L-26 and A(57) and a 10 amino acid epitope of DQA1 were the most significant in discriminating risk alleles. An extended haplotype containing these epitopes was carried by 92% of our patient cohort. Sharing of susceptibility epitopes could also explain the absence of risk haplotypes in patients. Finally, many significantly associated epitopes were non-pocket residues suggesting that critical immune functions may exist spanning further from the binding pockets.	[Gerasimou, Petroula; Costeas, Paul A.] Karaiskakio Fdn, Nicosia, Cyprus; [Gerasimou, Petroula] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Nicolaidou, Vicky] Univ Nicosia, Sch Sci & Engn, Dept Life & Hlth Sci, Nicosia, Cyprus; [Skordis, Nicos] Paedi Ctr Specialized Paediat, Div Paediat Endocrinol, Nicosia, Cyprus; [Picolos, Michalis] Alithia Endocrinol Ctr, Nicosia, Cyprus; [Monos, Demetrios] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Cyprus; University of Nicosia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Costeas, PA (corresponding author), Karaiskakio Fdn, Nicosia, Cyprus.	paul.costeas@karaiskakio.org.cy	Nicolaidou, Vicky/AAX-4756-2021	Costeas, Paul/0000-0002-7257-4746; nicolaidou, vicky/0000-0003-1017-2677				Bahillo MP, 2007, PEDIATR DIABETES, V8, P369, DOI 10.1111/j.1399-5448.2007.00255.x; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Castelli EC, 2017, MOL IMMUNOL, V83, P115, DOI 10.1016/j.molimm.2017.01.020; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Cereb N, 2015, HUM IMMUNOL, V76, P923, DOI 10.1016/j.humimm.2015.09.015; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Eike MC, 2009, GENES IMMUN, V10, P56, DOI 10.1038/gene.2008.74; Eisenbarth GS, 2010, DIABETES, p759 ; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Ettinger RA, 2006, J IMMUNOL, V176, P1988, DOI 10.4049/jimmunol.176.3.1988; Freed BM, 2011, ARTHRITIS RHEUM-US, V63, P3733, DOI 10.1002/art.30636; Gerasimou P, 2016, INT J IMMUNOGENET, V43, P135, DOI 10.1111/iji.12259; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Kanterakis S, 2008, HUM IMMUNOL, V69, P522, DOI 10.1016/j.humimm.2008.05.011; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; KOVATS S, 1995, J CLIN INVEST, V96, P217, DOI 10.1172/JCI118023; Nakayama M, 2015, P NATL ACAD SCI USA, V112, P4429, DOI 10.1073/pnas.1502967112; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Roark CL, 2014, DIABETES, V63, P323, DOI 10.2337/db13-1153; Sato AK, 1999, HUM IMMUNOL, V60, P1227, DOI 10.1016/S0198-8859(99)00120-2; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; Silva HPV, 2016, GENES IMMUN, V17, P13, DOI 10.1038/gene.2015.45; Skordis Nicos, 2002, Pediatr Diabetes, V3, P200, DOI 10.1034/j.1399-5448.2002.30406.x; Skordis N, 2012, HORM-INT J ENDOCRINO, V11, P86, DOI 10.1007/BF03401541; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Tait BD, 2003, TISSUE ANTIGENS, V61, P146, DOI 10.1034/j.1399-0039.2003.00013.x; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; Toumba M, 2007, PEDIATR DIABETES, V8, P374, DOI 10.1111/j.1399-5448.2007.00262.x; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Zerva L, 1996, J EXP MED, V183, P829, DOI 10.1084/jem.183.3.829	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193684	10.1371/journal.pone.0193684	http://dx.doi.org/10.1371/journal.pone.0193684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494662	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200082
J	Hou, SY; Dai, JR				Hou, Shunyu; Dai, Jianrong			Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer	PLOS ONE			English	Article							RESISTANCE	Taxol is a widely used chemotherapy drug used clinically for ovarian cancer, although the response to Taxol among individuals varies due to the heterogeneity among ovarian cancer patients. In this work, we analyzed differences in the prognostic effect of gene expression and Taxol usage in the Cancer Genome Atlas (TCGA) dataset and identified specific genes associated with the Taxol effect. Using the Cox regression model, a risk model (Taxol score) was developed to assess the outcome of ovarian cancer patients who underwent chemotherapy with Taxol. According to the results, survival was significantly associated with the Taxol score. Moreover, the patients in the high and low Taxol score group had different responses to Taxol. This result was further validated in another two independent datasets. The correlation between clinicopathological indicators was also analyzed, and we determined that the Taxol score is not associated with age, pathological stage, or Taxol treatment, while there was significant correlation with tumor size and grade. Gene Set Enrichment Analysis (GSEA) showed that various signaling pathways including ECM receptor, drug metabolism and ascorbate metabolism pathways were significantly enriched in the high Taxol score group. Collectively, these results indicate that the model is robust for predicting the effectiveness of Taxol by reflecting the various cell statuses of serous ovarian carcinoma.	[Hou, Shunyu; Dai, Jianrong] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China	Nanjing Medical University	Dai, JR (corresponding author), Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China.	daijianrong2018@163.com			Special Funds for Industrial Technology Innovation of Suzhou [SYS201567]; Clinical Medical Centers of Suzhou [SZZX201505]; Introduce Project of Clinical Medicine Experts of Suzhou [SZYJTD201707]	Special Funds for Industrial Technology Innovation of Suzhou; Clinical Medical Centers of Suzhou; Introduce Project of Clinical Medicine Experts of Suzhou	This work was supported by the Special Funds for Industrial Technology Innovation of Suzhou SYS201567 to Jianrong Dai, Clinical Medical Centers of Suzhou SZZX201505 to Jianrong Dai, Introduce Project of Clinical Medicine Experts of Suzhou SZYJTD201707 to Jianrong Dai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Gao Y, 2015, ONCOTARGET, V6, P9313, DOI 10.18632/oncotarget.3220; Kim SK, 2014, MOL ONCOL, V8, P1653, DOI 10.1016/j.molonc.2014.06.016; Kim YW, 2014, DRUG DES DEV THER, V8, P293, DOI 10.2147/DDDT.S51969; Lisowska KM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00006; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Samra EB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/423174; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh YA, 2015, INT J ONCOL, V46, P1405, DOI 10.3892/ijo.2014.2808; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196	13	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192812	10.1371/journal.pone.0192812	http://dx.doi.org/10.1371/journal.pone.0192812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494610	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200014
J	Vilaca-Alves, J; Muller, F; Rosa, C; Payan-Carreira, R; Lund, R; Matos, F; Garrido, N; Saavedra, FJ; Reis, VM				Vilaca-Alves, Jose; Muller, Fernanda; Rosa, Claudio; Payan-Carreira, Rita; Lund, Rafael; Matos, Filipe; Garrido, Nuno; Saavedra, Francisco Jose; Reis, Victor Machado			Cardiorespiratory, enzymatic and hormonal responses during and after walking while fasting	PLOS ONE			English	Article							EXERCISE; TESTOSTERONE; CARBOHYDRATE; OXIDATION; INGESTION; CORTISOL; RATIO; DIET	The aim of the present study was to observe whether performing a low intensity endurance exercise following an overnight fasted (FAST) or fed (FED) condition promotes different cardiorespiratory, enzymatic and hormonal responses. Nine male physical active subjects, (age 21.89 +/- 2.52 years old, height 175.89 +/- 5.16 cm, weight 72.10 +/- 4.31 kg, estimated body fat 7.25 +/- 2.11%), randomly performed two sessions of 45 minutes' low intensity exercise (individual ventilator threshold) interspersed by seven days, differentiated only in whether they were provided with a standardized meal or not. The oxygen consumption (VO2) and heart rate (HR) were measured continuously at the 30-min rest, the 45-min during and the 30-min post-exercise. The testosterone (T) and cortisol (C) hormones were measured at rest, immediately post-exercise and 15-min post-exercise. The Glucose (GLU), Free fatty acids (FFA) and enzyme lipase activity (ELP) were measured at rest, 15-min and 30-min exercise, immediately, 15-min and 30-min post-exercise. Significantly lower values were observed in FED compared to FAST with: C (nmol/L) from pre (428.87 +/- 120.41; 454.62 +/- 148.33, respectively) to immediately post-exercise (285.10 +/- 85.86; 465.66 +/- 137.70, respectively) and 15-min post-exercise (248.00 +/- 87.88; 454.31 +/- 112.72, respectively) (p<0.05); and GLU at all times, with an exception at 15-min post-exercise. The testosterone/cortisol ratio (T/C) was significantly higher in the FED compared with FAST from pre (0.05 +/- 0.02, 0.05 +/- 0.01, respectively) to 15-min post-exercise (0.08 +/- 0.03, 0.05 +/- 0.02, respectively). No other significant differences were observed between conditions. We conclude that fasting prior to low intensity endurance exercise does not seem be advantageous, when it comes to fat loss, compared with the same exercise performed after a meal.	[Vilaca-Alves, Jose; Muller, Fernanda; Rosa, Claudio; Lund, Rafael; Saavedra, Francisco Jose; Reis, Victor Machado] Univ Tras os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal; [Vilaca-Alves, Jose; Matos, Filipe; Garrido, Nuno; Saavedra, Francisco Jose; Reis, Victor Machado] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Payan-Carreira, Rita] Univ Tras os Montes & Alto Douro, CECAV, Anim & Vet Res Ctr, Vila Real, Portugal	University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro	Vilaca-Alves, J (corresponding author), Univ Tras os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal.; Vilaca-Alves, J (corresponding author), CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal.	josevilaca@utad.pt	Carreira, Rita Payan/D-2757-2012; Barbosa, Tiago M./ABE-6789-2020; Lund, Rafael Guerra/B-5364-2017; Garrido, Nuno Domingos/K-6842-2014; Vilaca-Alves, Jose/I-3965-2012	Carreira, Rita Payan/0000-0001-5225-4510; Barbosa, Tiago M./0000-0001-7071-2116; Lund, Rafael Guerra/0000-0003-1006-3809; Garrido, Nuno Domingos/0000-0002-8105-7580; Saavedra, Francisco/0000-0002-0439-5420; Matos, Filipe/0000-0002-0162-8735; Vilaca-Alves, Jose/0000-0001-5399-7797	Research Center for Sports, Health and Human Development (CIDESD) [UID/DTP/04045/2013]	Research Center for Sports, Health and Human Development (CIDESD)	This work was supported by the Research Center for Sports, Health and Human Development (CIDESD) - project reference UID/DTP/04045/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; American College of Sports Medicine [ACSM], 2013, ACSMS GUIDELINES EXE; Antinozzi C, 2017, J ENDOCRINOL INVEST, V40, P1133, DOI 10.1007/s40618-017-0686-y; Brownlee KK, 2005, J SPORT SCI MED, V4, P76; Cohen J.E., 1988, STAT POWER ANAL BEHA; DAVIS JM, 1992, ADDICT BEHAV, V17, P185, DOI 10.1016/0306-4603(92)90023-O; Derave W, 2007, OBESITY, V15, P704, DOI 10.1038/oby.2007.548; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P1532, DOI 10.1249/MSS.0b013e3181ae46a1; Drummond MJ, 2005, J STRENGTH COND RES, V19, P332; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fogelholm M, 2005, DIS MANAG HEALTH OUT, V13, P9, DOI 10.2165/00115677-200513010-00002; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GARDNER LB, 1982, P SOC EXP BIOL MED, V169, P36, DOI 10.3181/00379727-169-41303; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Goben W, 1990, EXERCISE INTENSITY T; Guyton C, GUYTON HALL TXB MED; Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE828, DOI 10.1152/ajpendo.1999.276.5.E828; HOWLETT TA, 1987, CLIN ENDOCRINOL, V26, P723, DOI 10.1111/j.1365-2265.1987.tb00832.x; Jeukendrup AE, 2003, BIOCHEM SOC T, V31, P1270, DOI 10.1042/BST0311270; Karkoulias K, 2008, EUR J INTERN MED, V19, P598, DOI 10.1016/j.ejim.2007.06.032; Kim TW, 2015, J PHYS THER SCI, V27, P1929, DOI 10.1589/jpts.27.1929; Kirwan JP, 2001, METABOLISM, V50, P849, DOI 10.1053/meta.2001.24191; Lee YS, 1999, J SPORT MED PHYS FIT, V39, P341; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; McArdle D, SPORTS EXERCISE NUTR; Nelson L.D., 2017, LEHNINGER PRINCIPLES, V7th; Paoli A, 2011, INT J SPORT NUTR EXE, V21, P48, DOI 10.1123/ijsnem.21.1.48; Rahimi R, 2011, APUNTS-MED ESPORT, V46, P145, DOI 10.1016/j.apunts.2011.03.002; Sapata KB, 2006, REV BRAS MED ESPORTE, V12, P189, DOI DOI 10.1590/S1517-86922006000400005; Schoenfeld B, 2011, STRENGTH COND J, V33, P23, DOI 10.1519/SSC.0b013e31820396ec; Schoenfeld BJ, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0054-7; Stiegler P, 2006, SPORTS MED, V36, P239, DOI 10.2165/00007256-200636030-00005; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; Uchida Marco Carlos, 2004, Rev Bras Med Esporte, V10, P165, DOI 10.1590/S1517-86922004000300005; Utter AC, 1999, EUR J APPL PHYSIOL O, V80, P92, DOI 10.1007/s004210050563; VANCE ML, 1989, J CLIN ENDOCR METAB, V68, P1013, DOI 10.1210/jcem-68-6-1013; Vesely Jennifer M, 2014, FP Essent, V425, P11; Vuorimaa T, 2008, SCAND J MED SCI SPOR, V18, P565, DOI 10.1111/j.1600-0838.2007.00733.x; Xu F, 1999, SPORTS MED, V27, P313, DOI 10.2165/00007256-199927050-00003	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193702	10.1371/journal.pone.0193702	http://dx.doi.org/10.1371/journal.pone.0193702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494664	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200087
J	Tajpara, P; Schuster, C; Schon, E; Kienzl, P; Vierhapper, M; Mildner, M; Elbe-Burger, A				Tajpara, Pooja; Schuster, Christopher; Schoen, Elisabeth; Kienzl, Philip; Vierhapper, Martin; Mildner, Michael; Elbe-Buerger, Adelheid			Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells	FASEB JOURNAL			English	Article						therapeutic vaccination; skin; tape stripping; downstream signaling; nuclear translocation	DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; DERMAL DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; HUMAN KERATINOCYTES; SKIN MODEL; CONTACT HYPERSENSITIVITY; EPIDERMAL-KERATINOCYTES	Together with keratinocytes (KCs) and the dense network of Langerhans cells (LCs), the epidermis is an ideal portal for vaccine delivery. Pattern recognition receptor agonists, in particular polyinosinic-polycytidylic acid [p(I:C)], are promising adjuvant candidates for therapeutic vaccination to generate protective T-cell immunity. Here we established an ex vivo skin explant model to study the expression and activation of double-stranded RNA (dsRNA)-sensing pattern recognition receptors in LCs and KCs in human skin. Whereas KCs expressed all known dsRNA sensing receptors at a constitutive and inducible level, LCs exclusively expressed melanoma differentiation-associated protein 5 (MDA5) in untreated skin and freshly isolated cells. Comparative assessments of downstream signaling pathways induced by p(I:C) revealed distinct mitochondrial antiviral-signaling protein, IFN-regulatory factor 3, and NF-B activation in LCs and KCs. Consequently, p(I:C) treatment of LCs significantly induced IFN- and IFN- mRNA expression, while in KCs an up-regulation of IFN- and TNF- mRNA was detectable. Stimulation of LCs with specific ligands revealed that not the TLR3- but only the MDA5-specific ligand induced IFN-2, IFN-, and TNF- cytokines, but no IL-6 and -8. In KCs, both ligands induced production of high IL-6 and IL-8 levels, and low IFN-2 and IFN- levels, indicating that different dsRNA-sensing receptors and/or downstream signaling pathways are activated in both cell types. Our data suggest that MDA5 may be an attractive adjuvant target for epicutaneous delivery of therapeutic vaccines with the goal to target LCs.Tajpara, P., Schuster, C., Schon, E., Kienzl, P., Vierhapper, M., Mildner, M., Elbe-Burger, A. Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells.	[Tajpara, Pooja; Schuster, Christopher; Schoen, Elisabeth; Kienzl, Philip; Elbe-Buerger, Adelheid] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Lab Cellular & Mol Immunobiol Skin, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Vierhapper, Martin] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Elbe-Burger, A (corresponding author), Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Lab Cellular & Mol Immunobiol Skin, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.; Mildner, M (corresponding author), Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	michael.mildner@meduniwien.ac.at; adelheid.elbe-buerger@meduniwien.ac.at		Kienzl, Philip/0000-0002-0114-6904	Austrian Science Fund (FWF) [DK W1248-B30]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) DK W1248-B30. The authors thank W. Bauer, B. Reininger, J. Strobl and M. Buchberger (Department of Dermatology, Medical University of Vienna) for excellent help with the sorting and analysis of epidermal cells. The authors are grateful for helpful discussions with J. Stockl (Institute of Immunology, Medical University of Vienna) and R. de Martin (Department of Vascular Biology and Thrombosis Research, Medical University of Vienna). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Furio L, 2009, J INVEST DERMATOL, V129, P1963, DOI 10.1038/jid.2009.21; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; Heaton SM, 2016, J EXP MED, V213, P1, DOI 10.1084/jem.20151531; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iram N, 2012, DEVELOPMENT, V139, P4210, DOI 10.1242/dev.083477; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Miller LS, 2007, SEMIN IMMUNOPATHOL, V29, P15, DOI 10.1007/s00281-007-0061-8; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oosterhoff D, 2013, J IMMUNOL, V190, P3338, DOI 10.4049/jimmunol.1200598; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Renn CN, 2006, J IMMUNOL, V177, P298, DOI 10.4049/jimmunol.177.1.298; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Schlupp P, 2014, Results Pharma Sci, V4, P26, DOI 10.1016/j.rinphs.2014.09.002; Seneschal J, 2014, J INVEST DERMATOL, V134, P686, DOI 10.1038/jid.2013.418; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strittmatter GE, 2016, J INVEST DERMATOL, V136, P610, DOI 10.1016/j.jid.2015.12.022; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Wang XY, 2013, PHOTODERMATOL PHOTO, V29, P41, DOI 10.1111/phpp.12011; Wellmann S, 2001, CLIN CHEM, V47, P654; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105	61	9	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4132	4144		10.1096/fj.201701090R	http://dx.doi.org/10.1096/fj.201701090R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509510	hybrid, Green Published			2022-12-26	WOS:000439325400007
J	Perron, A; Nishikawa, Y; Iwata, J; Shimojo, H; Takaya, J; Kobayashi, K; Imayoshi, I; Mbenza, NM; Takenoya, M; Kageyama, R; Kodama, Y; Uesugi, M				Perron, Amelie; Nishikawa, Yoshihiro; Iwata, Jun; Shimojo, Hiromi; Takaya, Junichiro; Kobayashi, Kumiko; Imayoshi, Itaru; Mbenza, Naasson M.; Takenoya, Mihoko; Kageyama, Ryoichiro; Kodama, Yuzo; Uesugi, Motonari			Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; small molecule; Notch pathway; basic helix-loop-helix transcription factor; cell proliferation; chaperone; pancreatic cancer; Prohibitin 2	GAMMA-SECRETASE INHIBITORS; CELL-PROLIFERATION; NUCLEAR EXPORT; NOTCH; IDENTIFICATION; LOCALIZATION; ACTIVATION; PROHIBITIN; EXPRESSION; DOMAIN	The transcription factor Hes family basic helix-loop-helix transcription factor 1 (Hes1) is a downstream effector of Notch signaling and plays a crucial role in orchestrating developmental processes during the embryonic stage. However, its aberrant signaling in adulthood is linked to the pathogenesis of cancer. In the present study, we report the discovery of small organic molecules (JI051 and JI130) that impair the ability of Hes1 to repress transcription. Hes1 interacts with the transcriptional corepressor transducing-like enhancer of split 1 (TLE1) via an interaction domain comprising two tryptophan residues, prompting us to search a chemical library of 1,800 small molecules enriched for indole-like -electron-rich pharmacophores for a compound that blocks Hes1-mediated transcriptional repression. This screening identified a lead compound whose extensive chemical modification to improve potency yielded JI051, which inhibited HEK293 cell proliferation with an EC50 of 0.3 m. Unexpectedly, using immunomagnetic isolation and nanoscale LC-MS/MS, we found that JI051 does not bind TLE1 but instead interacts with prohibitin 2 (PHB2), a cancer-associated protein chaperone. We also found that JI051 stabilizes PHB2's interaction with Hes1 outside the nucleus, inducing G(2)/M cell-cycle arrest. Of note, JI051 dose-dependently reduced cell growth of the human pancreatic cancer cell line MIA PaCa-2, and JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model. These results suggest a previously unrecognized role for PHB2 in the regulation of Hes1 and may inform potential strategies for managing pancreatic cancer.	[Perron, Amelie; Takaya, Junichiro; Mbenza, Naasson M.; Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Perron, Amelie; Shimojo, Hiromi; Takenoya, Mihoko; Kageyama, Ryoichiro; Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Uji, Kyoto 6110011, Japan; [Nishikawa, Yoshihiro; Kodama, Yuzo] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Shimojo, Hiromi; Kobayashi, Kumiko; Imayoshi, Itaru; Kageyama, Ryoichiro] Kyoto Univ, Grad Sch Med, Inst Frontier Life & Med Sci, Kyoto 6068507, Japan; [Imayoshi, Itaru] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Uesugi, M (corresponding author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.; Uesugi, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Uji, Kyoto 6110011, Japan.; Kodama, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan.	kodamayu@kuhp.kyoto-u.ac.jp; uesugi@scl.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020	Shimojo, Hiromi/0000-0001-5455-4218; Nishikawa, Yoshihiro/0000-0002-1113-6937	Kyoto University; AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT); MEXT (JSPS) KAKENHI [25870365, 26220206]; Grants-in-Aid for Scientific Research [17H06408] Funding Source: KAKEN	Kyoto University; AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT); MEXT (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a start-up grant from Kyoto University (to A.P.), AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT), and MEXT (JSPS) KAKENHI Grants-in-aid for Scientific Research 25870365 (to A.P.) and 26220206 (to M.U.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai MA, 2016, CHEM SCI, V7, P1514, DOI 10.1039/c5sc03540f; Arai MA, 2009, BIOORG MED CHEM LETT, V19, P5778, DOI 10.1016/j.bmcl.2009.07.146; ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cao Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0346-7; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Husberg C, 2003, BBA-MOL CELL RES, V1640, P143, DOI 10.1016/S0167-4889(03)00041-7; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kageyama R, 2015, CELL TISSUE RES, V359, P125, DOI 10.1007/s00441-014-1888-7; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kita M, 2013, J AM CHEM SOC, V135, P18089, DOI 10.1021/ja406580w; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-38; Mc Gee MM, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/146282; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Sail V, 2013, CHEM BIOL DRUG DES, V81, P334, DOI 10.1111/cbdd.12059; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	56	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8285	8294		10.1074/jbc.RA118.002316	http://dx.doi.org/10.1074/jbc.RA118.002316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29523683	Green Published, hybrid			2022-12-26	WOS:000433224600032
J	Jiang, YQ; Xu, ES; Zhang, J; Chen, MY; Flores, E; Chen, XB				Jiang, Yuqian; Xu, Enshun; Zhang, Jin; Chen, Mingyi; Flores, Elsa; Chen, Xinbin			The Rbm38-p63 feedback loop is critical for tumor suppression and longevity	ONCOGENE			English	Article							RNA-BINDING PROTEIN; P53 FAMILY; CELLULAR SENESCENCE; TARGET GENES; P63; CELLS; STABILITY; RNPC1; TAP63; MICE	The RNA-binding protein Rbm38 is a target of p63 tumor suppressor and can in-turn repress p63 expression via mRNA stability. Thus, Rbm38 and p63 form a negative feedback loop. To investigate the biological significance of the Rbm38-p63 loop in vivo, a cohort of WT, Rbm38(-/-), TAp63(+/-), and Rbm38(-/-); TAp63(+/-) mice were generated and monitored throughout their lifespan. While mice deficient in Rbm38 or TAp63 alone died mostly from spontaneous tumors, compound Rbm38(-/-); TAp63(+/-) mice had an extended lifespan along with reduced tumor incidence. We also found that loss-of-Rbm38 markedly decreased the percentage of liver steatosis in TAp63(+/)- mice. Moreover, we found that Rbm38 deficiency extends the lifespan of tumor-free TAp63(+/-) mice along with reduced expression of senescence-associated biomarkers. Consistent with this, Rbm38(-/-); TAp63(+/-) MEFs were resistant, whereas Rbm38(-/-) or TAp63(+/-) MEFs were prone, to cellular senescence. Importantly, we showed that the levels of inflammatory cytokines (IL17D and Tnfsf15) were significantly reduced by Rbm38 deficiency in senescence-resistant Rbm38(-/-); TAp63(+/-) mouse livers and MEFs. Together, our data suggest that Rbm38 and p63 function as intergenic suppressors in aging and tumorigenesis and that the Rbm38-p63 loop may be explored for enhancing longevity and cancer management.	[Jiang, Yuqian; Xu, Enshun; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA; [Chen, Mingyi] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Flores, Elsa] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA	University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas; H Lee Moffitt Cancer Center & Research Institute	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu	jiang, yu/HGU-0029-2022	chen, xinbin/0000-0002-4582-6506	National Institutes of Health [CA195828]; NATIONAL CANCER INSTITUTE [R01CA195828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health (CA195828 to X.C.).	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2000, IN VIVO, V14, P183; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen XB, 2003, CANCER BIOL THER, V2, P55; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Hall BM, 2016, AGING-US, V8, P1294, DOI 10.18632/aging.100991; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Porteiro B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15111; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang J, 2006, CELL DEATH DIFFER, V13, P2118, DOI 10.1038/sj.cdd.4401972; Zhang J, 2014, P NATL ACAD SCI USA, V111, P18637, DOI 10.1073/pnas.1415607112; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	35	12	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2863	2872		10.1038/s41388-018-0176-5	http://dx.doi.org/10.1038/s41388-018-0176-5			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29520104	Green Accepted, Green Submitted			2022-12-26	WOS:000432929800008
J	Meder, L; Konig, K; Dietlein, F; Macheleidt, I; Florin, A; Ercanoglu, MS; Rommerscheidt-Fuss, U; Koker, M; Schon, G; Odenthal, M; Klein, F; Buttner, R; Schulte, JH; Heukamp, LC; Ullrich, RT				Meder, Lydia; Koenig, Katharina; Dietlein, Felix; Macheleidt, Iris; Florin, Alexandra; Ercanoglu, Meryem S.; Rommerscheidt-Fuss, Ursula; Koker, Mirjam; Schoen, Gisela; Odenthal, Margarete; Klein, Florian; Buettner, Reinhard; Schulte, Johannes H.; Heukamp, Lukas C.; Ullrich, Roland T.			LIN28B enhanced tumorigenesis in an autochthonous KRAS(G12V)-driven lung carcinoma mouse model	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER PATIENTS; K-RAS; MULTIPLE MECHANISMS; CELL-PROLIFERATION; PANCREATIC-CANCER; DOWN-REGULATION; KRAS MUTATIONS; BREAST-CANCER; SELF-RENEWAL	LIN28B is a RNA-binding protein regulating predominantly let-7 microRNAs with essential functions in inflammation, wound healing, embryonic stem cells, and cancer. LIN28B expression is associated with tumor initiation, progression, resistance, and poor outcome in several solid cancers, including lung cancer. However, the functional role of LIN28B, especially in non-small cell lung adenocarcinomas, remains elusive. Here, we investigated the effects of LIN28B expression on lung tumorigenesis using LIN28B transgenic overexpression in an autochthonous KRAS(G12V)-driven mouse model. We found that LIN28B overexpression significantly increased the number of CD44+/CD326+ tumor cells, upregulated VEGF-A and miR-21 and promoted tumor angiogenesis and epithelial-to-mesenchymal transition (EMT) accompanied by enhanced AKT phosphorylation and nuclear translocation of c-MYC. Moreover, LIN28B accelerated tumor initiation and enhanced proliferation which led to a shortened overall survival. In addition, we analyzed lung adenocarcinomas of the Cancer Genome Atlas (TCGA) and found LIN28B expression in 24% of KRAS-mutated cases, which underscore the relevance of our model.	[Meder, Lydia; Koker, Mirjam; Schoen, Gisela; Ullrich, Roland T.] Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany; [Meder, Lydia; Koker, Mirjam; Schoen, Gisela; Odenthal, Margarete; Buettner, Reinhard; Ullrich, Roland T.] Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany; [Koenig, Katharina] Lab Dr Quade & Kollegen GmbH, Aachener Str 338, D-50933 Cologne, Germany; [Dietlein, Felix] Dana Faber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Dietlein, Felix] Broad Inst MIT & Havard, Canc Program, Cambridge, MA 02142 USA; [Macheleidt, Iris; Florin, Alexandra; Rommerscheidt-Fuss, Ursula; Odenthal, Margarete; Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Kerpener Str 62, D-50937 Cologne, Germany; [Ercanoglu, Meryem S.; Klein, Florian] Univ Cologne, Lab Expt Immunol, Inst Virol, Robert Koch Str 21, D-50931 Cologne, Germany; [Buettner, Reinhard] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Kerpener Str 62, D-50937 Cologne, Germany; [Schulte, Johannes H.] Charite Univ Med Berlin, Dept Pediat Oncol Hematol, Augustenburger Pl 1, D-13353 Berlin, Germany; [Schulte, Johannes H.] German Canc Consortium DKTK Berlin, Berlin, Germany; [Schulte, Johannes H.] BIH, Berlin, Germany; [Schulte, Johannes H.] Deutsch Krebsforschungszentrum Heidelberg DKFZ, Heidelberg, Germany; [Heukamp, Lukas C.] New Oncol, Gottfried Hagen Str 20, D-51105 Cologne, Germany; [Heukamp, Lukas C.] Inst Hematopathol Hamburg, Fangdieckstr 75a, Hamburg, Germany	University of Cologne; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cologne; University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Helmholtz Association; German Cancer Research Center (DKFZ)	Meder, L (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.; Meder, L (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany.	lydia.meder@uk-koeln.de	Schulte, Johannes H./V-2474-2018; Heukamp, Lukas/G-9967-2012	Meder, Lydia/0000-0002-9547-5812; Heukamp, Lukas/0000-0002-3388-3482; Schulte, Johannes Hubertus/0000-0003-0671-1201	Deutsche Forschungsgemeinschaft (DFG) [UL379/1-1]; German Research Foundation [SFB832]; Thyssen foundation [10.16.1.028MN]; Nachwuchsforschungsgruppen-NRW [1411ng005]; German ministry of science and education (BMBF) as part of the e:Med initiative [01ZX11307E, 017X1303B]; Center for Molecular Medicine Cologne (CMMC)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Thyssen foundation; Nachwuchsforschungsgruppen-NRW; German ministry of science and education (BMBF) as part of the e:Med initiative; Center for Molecular Medicine Cologne (CMMC)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (Grant No.: UL379/1-1 to RTU), by the German Research Foundation (SFB832, Z2 and TP6 to RTU; Z1 and TP5 to LCH and RB), by the Thyssen foundation (Grant No.: 10.16.1.028MN to RTU), by the Nachwuchsforschungsgruppen-NRW (Grant No.: 1411ng005 to RTU), by the German ministry of science and education (BMBF) as part of the e:Med initiative (Grant No.: 01ZX11307E and 017X1303B to JHS) and by the Center for Molecular Medicine Cologne (CMMC) (to RB and MO).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alam M, 2015, MOL CANCER RES, V13, P449, DOI 10.1158/1541-7786.MCR-14-0363; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao J, 2016, MOL MED REP, V13, P75, DOI 10.3892/mmr.2015.4568; Chien CS, 2015, CANCER RES, V75, P2553, DOI 10.1158/0008-5472.CAN-14-2215; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cufii S, 2013, SCI REP-UK, V3, P1, DOI 10.1038/srep02459; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Fennell DA, 2016, CANCER TREAT REV, V44, P42, DOI 10.1016/j.ctrv.2016.01.003; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hu HB, 2016, LUNG CANCER, V97, P87, DOI 10.1016/j.lungcan.2016.04.017; Hu Q, 2014, INT J CLIN EXP PATHO, V7, P5083; Kasinski AL, 2012, CANCER RES, V72, P5576, DOI 10.1158/0008-5472.CAN-12-2001; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Konig K, 2015, J THORAC ONCOL, V10, P1049, DOI 10.1097/JTO.0000000000000570; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Lee YS, 2016, ONCOGENE, V35, P827, DOI 10.1038/onc.2015.153; Li C, 2016, ONCOTARGET, V7, P66989, DOI 10.18632/oncotarget.11888; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Li Y, 2014, CANCER LETT, V355, P130, DOI 10.1016/j.canlet.2014.09.007; Liu CH, 2017, INT J ONCOL, V50, P1109, DOI 10.3892/ijo.2017.3876; Manier S, 2017, LEUKEMIA, V31, P853, DOI 10.1038/leu.2016.296; Mellema WW, 2013, J THORAC ONCOL, V8, P1190, DOI 10.1097/JTO.0b013e318298764e; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Morizane R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04578; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Powers JT, 2016, NATURE, V535, P246, DOI 10.1038/nature18632; Qiu JL, 2012, CHIN J CANCER, V31, P223, DOI 10.5732/cjc.011.10426; Qu X, 2014, J INVEST DERMATOL, V134, P159, DOI 10.1038/jid.2013.281; Ragusa M, 2014, AM J CLIN ONCOL-CANC, V37, P343, DOI 10.1097/COC.0b013e31827a7e7a; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40847; Shao YB, 2015, AM J CANCER RES, V5, P2643; Sonobe M, 2012, ANN SURG ONCOL, V19, pS347, DOI 10.1245/s10434-011-1799-8; Stahlhut C, 2015, CELL CYCLE, V14, P2171, DOI 10.1080/15384101.2014.1003008; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Wefers AK, 2017, CEREBELLUM, V16, P122, DOI 10.1007/s12311-016-0774-0; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wu TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083869; Wu ZH, 2016, TUMOR BIOL, V37, P7245, DOI 10.1007/s13277-015-4604-7; Yu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0372-7; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhang Z, 2017, CANCER GENE THER, V24, P83, DOI 10.1038/cgt.2017.1; Zhou JB, 2017, MOL CANCER RES, V15, P294, DOI 10.1158/1541-7786.MCR-16-0275-T; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	60	14	14	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2746	2756		10.1038/s41388-018-0158-7	http://dx.doi.org/10.1038/s41388-018-0158-7			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29503447				2022-12-26	WOS:000432545100010
J	Cao, K; Li, N; Wang, HC; Cao, X; He, JJ; Zhang, B; He, QY; Zhang, G; Sun, XS				Cao, Kun; Li, Nan; Wang, Hongcui; Cao, Xin; He, Jiaojiao; Zhang, Bing; He, Qing-Yu; Zhang, Gong; Sun, Xuesong			Two zinc-binding domains in the transporter AdcA from Streptococcus pyogenes facilitate high-affinity binding and fast transport of zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYLOGENETIC INFORMATION; FUNCTIONAL REGIONS; PROTEIN; IDENTIFICATION; CONSURF; PATHOGENESIS; SIMULATIONS; PNEUMONIAE; DEFICIENCY; MECHANISMS	Zinc is an essential metal in bacteria. One important bacterial zinc transporter is AdcA, and most bacteria possess AdcA homologs that are single-domain small proteins due to better efficiency of protein biogenesis. However, a double-domain AdcA with two zinc-binding sites is significantly overrepresented in Streptococcus species, many of which are major human pathogens. Using molecular simulation and experimental validations of AdcA from Streptococcus pyogenes, we found here that the two AdcA domains sequentially stabilize the structure upon zinc binding, indicating an organization required for both increased zinc affinity and transfer speed. This structural organization appears to endow Streptococcus species with distinct advantages in zinc-depleted environments, which would not be achieved by each single AdcA domain alone. This enhanced zinc transport mechanism sheds light on the significance of the evolution of the AdcA domain fusion, provides new insights into double-domain transporter proteins with two binding sites for the same ion, and indicates a potential target of antimicrobial drugs against pathogenic Streptococcus species.	[Cao, Kun; Li, Nan; Wang, Hongcui; Cao, Xin; He, Jiaojiao; Zhang, Bing; He, Qing-Yu; Zhang, Gong; Sun, Xuesong] Jinan Univ, Key Lab Funct Prot Res Guangdong Higher Educ Inst, Inst Life & Hlth Engn, Coll Life Sci & Technol, 601 Huang Pu Ave West, Guangzhou 510632, Guangdong, Peoples R China	Jinan University	He, QY; Zhang, G; Sun, XS (corresponding author), Jinan Univ, Key Lab Funct Prot Res Guangdong Higher Educ Inst, Inst Life & Hlth Engn, Coll Life Sci & Technol, 601 Huang Pu Ave West, Guangzhou 510632, Guangdong, Peoples R China.	tqyhe@email.jnu.edu.cn; zhanggong@qq.com; tsunxs@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Zhang, Gong/Q-7419-2017	He, Qing-Yu/0000-0003-0503-9492; Zhang, Gong/0000-0003-0418-3433	National Natural Science Foundation of China [21571082, 21271086]; National High-Tech Research and Development Program (863) of China [2014AA020504]; Guangdong Natural Science Research Grants [2015A030313334, 32213027/32215077]; Guangzhou Science and Technology Grant [201607010228]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020504] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Guangdong Natural Science Research Grants; Guangzhou Science and Technology Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Natural Science Foundation of China Grants 21571082 (to X.S.) and 21271086 (to Q.-Y.H.), National High-Tech Research and Development Program (863) of China Grant 2014AA020504 (to G.Z.), Guangdong Natural Science Research Grants 2015A030313334 (to X.S.) and 32213027/32215077 (to Q.-Y.H.), and Guangzhou Science and Technology Grant 201607010228 (to X.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anil B, 2004, J AM CHEM SOC, V126, P13194, DOI 10.1021/ja047119i; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blindauer CA, 2015, CHEM COMMUN, V51, P4544, DOI 10.1039/c4cc10174j; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Capdevila DA, 2016, J BIOL CHEM, V291, P20858, DOI 10.1074/jbc.R116.742023; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Czub J, 2017, J AM CHEM SOC, V139, P4025, DOI 10.1021/jacs.6b11708; Ding BB, 2017, J BIOL CHEM, V292, P8531, DOI 10.1074/jbc.H116.762948; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Georgoulas G, 2015, MECH SYST SIGNAL PR, V60-61, P229, DOI 10.1016/j.ymssp.2015.01.033; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Graen T, 2016, J AM CHEM SOC, V138, P16620, DOI 10.1021/jacs.6b05609; Guo JM, 2015, MOL BIOSYST, V11, P370, DOI 10.1039/c4mb00462k; He Y, 2017, P NATL ACAD SCI USA, V114, P1578, DOI 10.1073/pnas.1621344114; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Jacob E, 2013, CELL REP, V3, P1051, DOI 10.1016/j.celrep.2013.03.032; Junejo IN, 2012, J VIS COMMUN IMAGE R, V23, P853, DOI 10.1016/j.jvcir.2012.05.001; Keogh E, 2005, KNOWL INF SYST, V8, P154, DOI 10.1007/s10115-004-0172-7; Kumar A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003318; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Li BJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15544; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065682; Li Junhua, 2014, Biomed Res Int, V2014, P708364, DOI 10.1155/2014/708364; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma L, 2015, METALLOMICS, V7, P1541, DOI 10.1039/c5mt00170f; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Manzetti S, 2003, J COMPUT AID MOL DES, V17, P551, DOI 10.1023/B:JCAM.0000005765.13637.38; Mayer LS, 2014, METALLOMICS, V6, P1288, DOI 10.1039/c4mt00051j; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Monecke T, 2013, P NATL ACAD SCI USA, V110, P960, DOI 10.1073/pnas.1215214110; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Pereira AR, 2016, MBIO, V7, DOI 10.1128/mBio.00908-16; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Rose AS, 2014, J AM CHEM SOC, V136, P11244, DOI 10.1021/ja5055109; Shafeeq S, 2013, MOL MICROBIOL, V88, P1047, DOI 10.1111/mmi.12256; Skjaerven L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002004; Sun XQ, 2014, J PHYS CHEM B, V118, P14737, DOI 10.1021/jp506579a; Tedde V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152835; Timmins A, 2017, J AM CHEM SOC, V139, P9855, DOI 10.1021/jacs.7b02839; Unissa AN, 2011, BIOINFORMATION, V7, P107; Valleriani A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042903; Van Gunsteren F., 1996, BIOMOLECULAR SIMULAT, P397; Van Gunsteren WF, 2002, ENCY COMPUTATIONAL C, V2, P1211; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Zalewski PD, 2005, PHARMACOL THERAPEUT, V105, P127, DOI 10.1016/j.pharmthera.2004.09.004; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang L, 2017, J INORG BIOCHEM, V167, P150, DOI 10.1016/j.jinorgbio.2016.08.015; Zhou XX, 2015, J BIOL CHEM, V290, P18361, DOI 10.1074/jbc.M115.663906	62	21	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6075	6089		10.1074/jbc.M117.818997	http://dx.doi.org/10.1074/jbc.M117.818997			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491141	Green Published, hybrid			2022-12-26	WOS:000430497300026
J	Skeie, JM; Aldrich, BT; Goldstein, AS; Schmidt, GA; Reed, CR; Greiner, MA				Skeie, Jessica M.; Aldrich, Benjamin T.; Goldstein, Andrew S.; Schmidt, Gregory A.; Reed, Cynthia R.; Greiner, Mark A.			Proteomic analysis of corneal endothelial cell-descemet membrane tissues reveals influence of insulin dependence and disease severity in type 2 diabetes mellitus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HUMAN EYE PROTEOME; SKELETAL-MUSCLE; MITOCHONDRIAL DYSFUNCTION; MASS-SPECTROMETRY; THICKNESS; DONOR; IDENTIFICATION; KERATOPLASTY; METABOLISM	The objective of this study was to characterize the proteome of the corneal endothelial cell layer and its basement membrane (Descemet membrane) in humans with various severities of type II diabetes mellitus compared to controls, and identify differentially expressed proteins across a range of diabetic disease severities that may influence corneal endothelial cell health. Endothelium-Descemet membrane complex tissues were peeled from transplant suitable donor corneas. Protein fractions were isolated from each sample and subjected to multidimensional liquid chromatography and tandem mass spectrometry. Peptide spectra were matched to the human proteome, assigned gene ontology, and grouped into protein signaling pathways unique to each of the disease states. We identified an average of 12,472 unique proteins in each of the endothelium-Descemet membrane complex tissue samples. There were 2,409 differentially expressed protein isoforms that included previously known risk factors for type II diabetes mellitus related to metabolic processes, oxidative stress, and inflammation. Gene ontology analysis demonstrated that diabetes progression has many protein footprints related to metabolic processes, binding, and catalysis. The most represented pathways involved in diabetes progression included mitochondrial dysfunction, cell-cell junction structure, and protein synthesis regulation. This proteomic dataset identifies novel corneal endothelial cell and Descemet membrane protein expression in various stages of diabetic disease. These findings give insight into the mechanisms involved in diabetes progression relevant to the corneal endothelium and its basement membrane, prioritize new pathways for therapeutic targeting, and provide insight into potential biomarkers for determining the health of this tissue.	[Skeie, Jessica M.; Aldrich, Benjamin T.; Goldstein, Andrew S.; Greiner, Mark A.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Skeie, Jessica M.; Aldrich, Benjamin T.; Goldstein, Andrew S.; Schmidt, Gregory A.; Reed, Cynthia R.; Greiner, Mark A.] Iowa Lions Eye Bank, Coralville, IA 52241 USA; [Skeie, Jessica M.; Aldrich, Benjamin T.; Schmidt, Gregory A.; Reed, Cynthia R.; Greiner, Mark A.] Univ Iowa, Cornea Res Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Greiner, MA (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA.; Greiner, MA (corresponding author), Iowa Lions Eye Bank, Coralville, IA 52241 USA.; Greiner, MA (corresponding author), Univ Iowa, Cornea Res Ctr, Iowa City, IA 52242 USA.	mark-greiner@uiowa.edu		Greiner, Mark/0000-0002-7170-6655	M.D. Wagoner & M.A. Greiner Cornea Excellence Fund; Beulah and Florence Usher Chair in Cornea/External Disease and Refractive Surgery; UIHC Cornea Research Fund	M.D. Wagoner & M.A. Greiner Cornea Excellence Fund; Beulah and Florence Usher Chair in Cornea/External Disease and Refractive Surgery; UIHC Cornea Research Fund	This study was supported in part by the M.D. Wagoner & M.A. Greiner Cornea Excellence Fund, the Beulah and Florence Usher Chair in Cornea/External Disease and Refractive Surgery, the UIHC Cornea Research Fund, Mr. and Mrs. Lloyd and Betty Schermer, and Mr. and Mrs. Robert and Joell Brightfelt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aldrich BT, 2017, INVEST OPHTH VIS SCI, V58, P2130, DOI 10.1167/iovs.16-21094; Briggs S, 2015, J BIOMED RES, V30; BUSTED N, 1981, BRIT J OPHTHALMOL, V65, P687, DOI 10.1136/bjo.65.10.687; Calvo-Maroto AM, 2014, EYE, V28, P1271, DOI 10.1038/eye.2014.176; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Cnop M, 2017, MOL METAB, V6, P1024, DOI 10.1016/j.molmet.2017.06.001; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Decanini A, 2008, DIABETOLOGIA, V51, P1051, DOI 10.1007/s00125-008-0991-2; Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k; El-Agamy A, 2017, CLIN OPHTHALMOL, V11, P481, DOI 10.2147/OPTH.S126217; FOULKS GN, 1979, ARCH OPHTHALMOL-CHIC, V97, P1076; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x; Greiner MA, 2014, CORNEA, V33, P1129, DOI 10.1097/ICO.0000000000000262; He X, 2017, CORNEA, V36, P948, DOI 10.1097/ICO.0000000000001245; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Hugod M, 2011, CORNEA, V30, P749, DOI 10.1097/ICO.0b013e31820142d9; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Johnson DT, 2009, AM J PHYSIOL-ENDOC M, V296, pE422, DOI 10.1152/ajpendo.90352.2008; Kaji Y, 2001, CURR EYE RES, V23, P469, DOI 10.1076/ceyr.23.6.469.6968; Kaji Y, 2000, INVEST OPHTH VIS SCI, V41, P362; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kim J, 2011, GRAEF ARCH CLIN EXP, V249, P529, DOI 10.1007/s00417-010-1573-9; Lauwen S, 2017, INVEST OPHTH VIS SCI, V58, pBIO88, DOI 10.1167/iovs.17-21809; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Leem HS, 2011, YONSEI MED J, V52, P322, DOI 10.3349/ymj.2011.52.2.322; Liaboe CA, 2017, CORNEA, V36, P561, DOI 10.1097/ICO.0000000000001174; Liu RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092810; Ljubimov AV, 2017, VISION RES, V139, P138, DOI 10.1016/j.visres.2017.03.002; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MANDELCORN MS, 1976, AM J OPHTHALMOL, V81, P561, DOI 10.1016/0002-9394(76)90117-3; Mathew PT, 2011, CORNEA, V30, P424, DOI 10.1097/ICO.0b013e3181eadb4b; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mullen E, 2010, INT J MOL MED, V25, P445, DOI 10.3892/ijmm_00000364; Ohlendieck K, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/893876; Omenn GS, 2013, PROTEOMICS, V13, P2375, DOI 10.1002/pmic.201300255; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; PIERRO L, 1993, ACTA OPHTHALMOL, V71, P169; Price MO, 2017, CORNEA, V36, P1184, DOI 10.1097/ICO.0000000000001305; Putti R, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00426; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Saini JS, 1996, ARCH OPHTHALMOL-CHIC, V114, P649, DOI 10.1001/archopht.1996.01100130641001; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sato E, 2001, DIABETES CARE, V24, P479, DOI 10.2337/diacare.24.3.479; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schwarz C, 2016, EXP EYE RES, V153, P152, DOI 10.1016/j.exer.2016.10.015; Semba RD, 2013, PROTEOMICS, V13, P2500, DOI 10.1002/pmic.201300075; Shenoy R, 2009, EUR J OPHTHALMOL, V19, P369, DOI 10.1177/112067210901900307; Shih KC, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.4; SHIMAZAKI J, 1995, CORNEA, V14, P196; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; SKAFF A, 1995, OPHTHAL PHYSL OPT, V15, P287, DOI 10.1016/0275-5408(95)00005-X; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Szalai E, 2016, INVEST OPHTH VIS SCI, V57, P853, DOI 10.1167/iovs.15-18735; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Varemo L, 2015, CELL REP, V11, P921, DOI 10.1016/j.celrep.2015.04.010; Warfel JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep37941; Wengrod JC, 2015, CELL CYCLE, V14, P2571, DOI 10.1080/15384101.2015.1056947; WESTON BC, 1995, INVEST OPHTH VIS SCI, V36, P586; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoon MS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111176; Zabielski P, 2016, DIABETES, V65, P561, DOI 10.2337/db15-0823; Ziadi M, 2002, CORNEA, V21, P453, DOI 10.1097/00003226-200207000-00004	69	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0192287	10.1371/journal.pone.0192287	http://dx.doi.org/10.1371/journal.pone.0192287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529022	gold, Green Submitted, Green Published			2022-12-26	WOS:000427189300003
J	Ujino-Ihara, T; Ueno, S; Uchiyama, K; Futamura, N				Ujino-Ihara, Tokuko; Ueno, Saneyoshi; Uchiyama, Kentaro; Futamura, Norihiro			Comprehensive analysis of small RNAs expressed in developing male strobili of Cryptomeria japonica	PLOS ONE			English	Article							LTR RETROTRANSPOSONS; ARABIDOPSIS; MIRNAS; PLANTS; MICRORNA; FAMILIES; PROGRAM; RICE; IDENTIFICATION; TRANSPOSONS	Deep sequencing of small RNAs (sRNAs) in developing male strobili of second-generation offspring originating from a nuclear genic male sterile tree of Cryptomeria japonica were performed to characterize sRNA populations in the male strobili at early pollen developmental stages. Comparing to sequences of microRNA (miRNA) families of plant species and sRNAs expressed in the reproductive organs of representative vascular plants, 37 conserved miRNA families were detected, of which eight were ubiquitously expressed in the reproductive organs of land plant species. In contrast, miR1083 was common in male reproductive organs of gymnosperm species but absent in angiosperm species. In addition to conserved miRNAs, 199 novel miRNAs candidates were predicted. The expression patterns of the obtained sRNAs were further investigated to detect the differentially expressed (DE) sRNAs between genic male sterile and fertile individuals. A total of 969 DE sRNAs were obtained and only three known miRNA families were included among them. These results suggest that both conserved and species-specific sRNAs contribute to the development of male strobili in C. japonica.	[Ujino-Ihara, Tokuko; Ueno, Saneyoshi; Uchiyama, Kentaro; Futamura, Norihiro] Forest Res & Management Org, Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan	Ujino-Ihara, T (corresponding author), Forest Res & Management Org, Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan.	udino@ffpri.affrc.go.jp			Forestry and Forest Products Research Institute [201123]; Genome-support grant, National Institute of Agrobiological Sciences; FFPRI Encouragement Model in Support of Researchers with Family Responsibilities of the Forestry and Forest Products Research Institute	Forestry and Forest Products Research Institute(Forestry & Forest Products Research Institute - Japan); Genome-support grant, National Institute of Agrobiological Sciences; FFPRI Encouragement Model in Support of Researchers with Family Responsibilities of the Forestry and Forest Products Research Institute	This work was supported by the Forestry and Forest Products Research Institute, Research grant #201123 (https://www.ffpri.affrc.go.jp/ffpri/en/index.html) to TUI; Genome-support grant, National Institute of Agrobiological Sciences (http://www.naro.affrc.go.jp/archive/nias/index_e.html) to KU and this research also supported by the FFPRI Encouragement Model in Support of Researchers with Family Responsibilities of the Forestry and Forest Products Research Institute to TUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accerbi M, 2010, METHODS MOL BIOL, V592, P31, DOI 10.1007/978-1-60327-005-2_3; Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Creasey KM, 2014, NATURE, V508, P411, DOI 10.1038/nature13069; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Futamura N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-383; Goto S, 2016, PLANT J, V86, P493, DOI 10.1111/tpj.13184; Grant-Downton R, 2009, MOL PLANT, V2, P500, DOI 10.1093/mp/ssp003; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Ito H, 2013, GENES GENET SYST, V88, P3, DOI 10.1266/ggs.88.3; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kogawara S, 2010, P 124 ANN M JAP FOR, pP2; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WL, 2016, PLANT PHYSIOL, V173, P167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miura S., 2011, Journal of the Japanese Forest Society, V93, P1, DOI 10.4005/jjfs.93.1; Moriguchi Y, 2014, TREE GENET GENOMES, V10, P1069, DOI 10.1007/s11295-014-0743-z; Moriguchi Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-95; Niu SH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1885-6; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6; Omidvar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2077-0; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Saito M, 1998, J FOR RES, V3, P167, DOI DOI 10.1007/BF02762139; Shen Y, 2011, FUNCT INTEGR GENOMIC, V11, P179, DOI 10.1007/s10142-010-0202-3; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Surbanovski N, 2016, PLANT J, V85, P70, DOI 10.1111/tpj.13090; Taira H., 1993, Journal of the Japanese Forestry Society, V75, P377; Taira H, 1999, J RES, V4, P271, DOI DOI 10.1007/BF02762782; Tamura M, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0859-9; Tsubomura M, 2016, TREE PHYSIOL, V36, P653, DOI 10.1093/treephys/tpw001; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia R, 2015, MOL BIOL EVOL, V32, P2905, DOI 10.1093/molbev/msv164; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan JJ, 2015, PLANTA, V241, P109, DOI 10.1007/s00425-014-2167-2; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4; Zhou H, 2012, CELL RES, V22, P649, DOI 10.1038/cr.2012.28; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193665	10.1371/journal.pone.0193665	http://dx.doi.org/10.1371/journal.pone.0193665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529051	Green Submitted, Green Published, gold			2022-12-26	WOS:000427189300027
J	Winkler, TW; Brandl, C; Grassmann, F; Gorski, M; Stark, K; Loss, J; Weber, BHF; Heid, IM				Winkler, Thomas W.; Brandl, Caroline; Grassmann, Felix; Gorski, Mathias; Stark, Klaus; Loss, Julika; Weber, Bernhard H. F.; Heid, Iris M.		Int Agerelated Macular Degeneratio	Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci	PLOS ONE			English	Article							RETINALDEHYDE-BINDING PROTEIN; RETINITIS PUNCTATA ALBESCENS; GENOME-WIDE ASSOCIATION; BEAVER DAM EYE; MACULAR DEGENERATION; ENVIRONMENT INTERACTION; BOTHNIA DYSTROPHY; RISK-FACTORS; RLBP1 GENE; CFH GENE	Late-stage age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly with a complex etiology.The most important non-modifiable risk factors for onset and progression of late AMD are age and genetic risk factors, however, little is known about the interplay between genetics and age or sex. Here, we conducted a large-scale age-and sex-stratified genome-wide association study (GWAS) using 1000 Genomes imputed genome-wide and ExomeChip data (>12 million variants). The data were established by the International Age-related Macular Degeneration Genomics Consortium (IAMDGC) from 16,144 late AMD cases and 17,832 controls. Our systematic search for interaction effects yielded significantly stronger effects among younger individuals at two known AMD loci (near CFH and ARMS2/HTRA1). Accounting for age and gene-age interaction using a joint test identified two additional AMD loci compared to the previous main effect scan. One of these two is a novel AMD GWAS locus, near the retinal clusterin-like protein (CLUL1) gene, and the other, near the retinaldehyde binding protein 1 (RLBP1), was recently identified in a joint analysis of nuclear and mitochondrial variants. Despite considerable power in our data, neither sex-dependent effects nor effects with opposite directions between younger and older individuals were observed. This is the first genome-wide interaction study to incorporate age, sex and their interaction with genetic effects for late AMD. Results diminish the potential for a role of sex in the etiology of late AMD yet highlight the importance and existence of age-dependent genetic effects.	[Winkler, Thomas W.; Brandl, Caroline; Gorski, Mathias; Stark, Klaus; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Brandl, Caroline; Grassmann, Felix; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Loss, Julika] Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.	iris.heid@klinik.uni-regensburg.de	Stark, Klaus/L-7367-2013	Stark, Klaus/0000-0002-7832-1942; Winkler, Thomas/0000-0003-0292-5421; Grassmann, Felix/0000-0003-1390-7528; Brandl, Caroline/0000-0001-8223-6137	German Federal Ministry of Education and Research [BMBF 01ER1206, BMBF 01ER1507, BMBF 01GP1308]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors gratefully acknowledge the excellent International Age-related Macular Degeneration Genomics Consortium (IAMDGC), (http://amdgeneticsorg/). This analyses are supported by grants from the German Federal Ministry of Education and Research (BMBF 01ER1206, BMBF 01ER1507 to IMH, and BMBF 01GP1308) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2016, COLD SPRING HARBOR L; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aschard H, 2010, HUM HERED, V70, P292, DOI 10.1159/000323318; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Brandl C, 2015, J CLIN MED, V4, P282, DOI 10.3390/jcm4020282; Buitendijk GHS, 2013, OPHTHALMOLOGY, V120, P2644, DOI 10.1016/j.ophtha.2013.07.053; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; Cruickshanks KJ, 2017, JAMA OPHTHALMOL, V135, P1417, DOI 10.1001/jamaophthalmol.2017.5001; Daiger S, 1998, INVEST OPHTHALMOLVIS, V39, P295; Eichers ER, 2002, AM J HUM GENET, V70, P955, DOI 10.1086/339688; Fraser-Bell S, 2005, AM J OPHTHALMOL, V139, P30, DOI 10.1016/j.ajo.2004.08.029; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grassmann F, 2017, GENETICS, V205, P919, DOI 10.1534/genetics.116.195966; Grassmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037979; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hipp S, 2015, ACTA OPHTHALMOL, V93, pE281, DOI 10.1111/aos.12573; Katsanis N, 2001, CLIN GENET, V59, P424, DOI 10.1034/j.1399-0004.2001.590607.x; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; Naj AC, 2013, ANN HUM GENET, V77, P215, DOI 10.1111/ahg.12011; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Persad PJ, 2017, INVEST OPHTH VIS SCI, V58, P4027, DOI 10.1167/iovs.17-21734; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sturgill GM, 2006, OPHTHALMIC GENET, V27, P151, DOI 10.1080/13816810600976871; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sung YJ, 2016, GENET EPIDEMIOL, V40, P404, DOI 10.1002/gepi.21978; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Winkler TW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181038; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yonekawa Y, 2015, J CLIN MED, V4, P343, DOI 10.3390/jcm4020343; Zhang Q, 2003, INVEST OPHTH VIS SCI, V44, P4542, DOI 10.1167/iovs.02-1202; Zhang Q, 2000, GENE, V243, P151, DOI 10.1016/S0378-1119(99)00542-9	46	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194321	10.1371/journal.pone.0194321	http://dx.doi.org/10.1371/journal.pone.0194321			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529059	Green Published, Green Submitted, gold			2022-12-26	WOS:000427189300053
J	Dvirnas, A; Pichler, C; Stewart, CL; Quaderi, S; Nyberg, LK; Muller, V; Bikkarolla, SK; Kristiansson, E; Sandegren, L; Westerlund, F; Ambjornsson, T				Dvirnas, Albertas; Pichler, Christoffer; Stewart, Callum L.; Quaderi, Saair; Nyberg, Lena K.; Muller, Vilhelm; Bikkarolla, Santosh Kumar; Kristiansson, Erik; Sandegren, Linus; Westerlund, Fredrik; Ambjornsson, Tobias			Facilitated sequence assembly using densely labeled optical DNA barcodes: A combinatorial auction approach	PLOS ONE			English	Article							RESISTANCE PLASMIDS; MOLECULE; ALIGNMENT	The output from whole genome sequencing is a set of contigs, i.e. short non-overlapping DNA sequences (sizes 1-100 kilobasepairs). Piecing the contigs together is an especially difficult task for previously unsequenced DNA, and may not be feasible due to factors such as the lack of sufficient coverage or larger repetitive regions which generate gaps in the final sequence. Here we propose a new method for scaffolding such contigs. The proposed method uses densely labeled optical DNA barcodes from competitive binding experiments as scaffolds. On these scaffolds we position theoretical barcodes which are calculated from the contig sequences. This allows us to construct longer DNA sequences from the contig sequences. This proof-of-principle study extends previous studies which use sparsely labeled DNA barcodes for scaffolding purposes. Our method applies a probabilistic approach that allows us to discard "foreign" contigs from mixed samples with contigs from different types of DNA. We satisfy the contig non-overlap constraint by formulating the contig placement challenge as a combinatorial auction problem. Our exact algorithm for solving this problem reduces computational costs compared to previous methods in the combinatorial auction field. We demonstrate the usefulness of the proposed scaffolding method both for synthetic contigs and for contigs obtained using Illumina sequencing for a mixed sample with plasmid and chromosomal DNA.	[Dvirnas, Albertas; Pichler, Christoffer; Stewart, Callum L.; Quaderi, Saair; Ambjornsson, Tobias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden; [Quaderi, Saair; Nyberg, Lena K.; Muller, Vilhelm; Bikkarolla, Santosh Kumar] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Kristiansson, Erik] Univ Gothenburg, Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Sandegren, Linus] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Lund University; Chalmers University of Technology; Chalmers University of Technology; University of Gothenburg; Uppsala University	Ambjornsson, T (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	tobias.ambjornsson@thep.lu.se		Muller, Vilhelm/0000-0002-4554-2124; Stewart, Callum/0000-0001-9947-8677	Swedish Research Council [2014-4305]; Ake Wibergs Stiftelse; European Union; EuroNanoMedII Grant: "Nanofluidics for ultrafast diagnosis of bacterial infections - NanoDiaBac"; Knut and Alice Wallenberg Foundation; Swedish Research Council - Medicine and Health [K2013-99X-22208-01-5]; Erling-Persson Family Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wibergs Stiftelse; European Union(European Commission); EuroNanoMedII Grant: "Nanofluidics for ultrafast diagnosis of bacterial infections - NanoDiaBac"; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council - Medicine and Health(Swedish Research Council); Erling-Persson Family Foundation	TA was supported by the Swedish Research Council, 2014-4305. FW was supported by Ake Wibergs Stiftelse, "Novel Molecular Tools for Antibiotic Resistance Epidemiology." FW and TA were supported by European Union Horizon 2020: "Genomic Diagnostics Beyond the Sequence - BeyondSeq." FW was supported by EuroNanoMedII Grant: "Nanofluidics for ultrafast diagnosis of bacterial infections - NanoDiaBac." EK was supported by The Knut and Alice Wallenberg Foundation. LS was supported by Swedish Research Council - Medicine and Health, grant K2013-99X-22208-01-5. FW, TA, EK and LS were supported by The Erling-Persson Family Foundation.	[Anonymous], 1932, STAT METHODS RES WOR; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Chen YM, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S7; Chen YM, 2013, BMC SYSTEMS BIOL, V7, P1; El-Metwally S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003345; Genomics B, 2016, BIONANOGENOMMICS IRY; Grada A, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2013.248; Grunwald A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv563; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Leung AKY, 2017, BIOINFORMATICS, V33, P311, DOI 10.1093/bioinformatics/btw620; Leung BO, 2011, APPL SPECTROSC, V65, P967, DOI 10.1366/11-06398; Luo J, 2014, BIOINFORMATICS; Marie R, 2013, P NATL ACAD SCI USA, V110, P4893, DOI 10.1073/pnas.1214570110; McCaffrey J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv878; McCarthy A, 2010, CHEM BIOL, V17, P675, DOI 10.1016/j.chembiol.2010.07.004; Mendelowitz L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-33; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Muggli MD, 2014, LECT N BIOINFORMAT, V8701, P68, DOI 10.1007/978-3-662-44753-6_6; Muller V, 2016, SCI REPORTS, V6, P37938; Muller V, 2017, LAB CHIP, V17, P579, DOI 10.1039/c6lc01439a; Muller V, 2016, ACS INFECT DIS, V2, P322, DOI 10.1021/acsinfecdis.6b00017; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Nilsson AN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku556; Nyberg LK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30410; Nyberg LK, 2012, BIOCHEM BIOPH RES CO, V417, P404, DOI 10.1016/j.bbrc.2011.11.128; OpGen, 2016, OPGEN ARG; Orlek A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00182; Reisner W, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106601; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; Rothkopf MH, 1998, MANAGE SCI, V44, P1131, DOI 10.1287/mnsc.44.8.1131; Sarkar D, 2012, J COMPUT BIOL, V19, P478, DOI 10.1089/cmb.2011.0221; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Shelton JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1911-8; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tang HB, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0044-y; Valouev A, 2006, J COMPUT BIOL, V13, P442, DOI 10.1089/cmb.2006.13.442; van Hoesel S., 2001, Netnomics, V3, P23, DOI 10.1023/A:1009940607600	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193900	10.1371/journal.pone.0193900	http://dx.doi.org/10.1371/journal.pone.0193900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522539	gold, Green Published, Green Submitted			2022-12-26	WOS:000427030800026
J	Ghosh, M; Thangada, S; Dasgupta, O; Khanna, KM; Yamase, HT; Kashgarian, M; Hla, T; Shapiro, LH; Ferrer, FA				Ghosh, Mallika; Thangada, Shobha; Dasgupta, Oisharya; Khanna, Kamal M.; Yamase, Harold T.; Kashgarian, Michael; Hla, Timothy; Shapiro, Linda H.; Ferrer, Fernando A.			Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction	PLOS ONE			English	Article							KIDNEY INJURY; TUBULOINTERSTITIAL FIBROSIS; M2 MACROPHAGES; MOUSE MODEL; 1 RECEPTOR; ACTIVATION; PHENOTYPE; INHIBITION; TISSUE; ROLES	Sphingosine Kinase-2 (Sphk2) is responsible for the production of the bioactive lipid Sphingosine-1 Phosphate, a key regulator of tissue repair. Here we address the in vivo significance of Sphingosine Kinase -2 in renal inflammation/fibrosis in response to unilateral ureteral obstruction using both genetic and pharmacological strategies. Obstructed kidneys of Sphk2(-/-) mice showed reduced renal damage and diminished levels of the renal injury markers TGF beta(1) and alpha SMA when compared to wild type controls. We found a consistently significant increase in anti-inflammatory (M2) macrophages in obstructed Sphk2(-/-) kidneys by flow cytometry and a decrease in mRNA levels of the inflammatory cytokines, MCP1, TNF alpha, CXCL1 and IL beta(1), suggesting an anti-inflammatory bias in the absence of Sphk2. Indeed, metabolic profiling showed that the pro-inflammatory glycolytic pathway is largely inactive in Sphk2(-/-) bone marrow-derived macrophages. Furthermore, treatment with the M2-promoting cytokines IL-4 or IL-13 demonstrated that macrophages lacking Sphk2 polarized more efficiently to the M2 phenotype than wild type cells. Bone marrow transplant studies indicated that expression of Sphk2(-/-) on either the hematopoietic or parenchymal cells did not fully rescue the pro-healing phenotype, confirming that both infiltrating M2-macrophages and the kidney microenvironment contribute to the damaging Sphk2 effects. Importantly, obstructed kidneys from mice treated with an Sphk2 inhibitor recapitulated findings in the genetic model. These results demonstrate that reducing Sphk2 activity by genetic or pharmacological manipulation markedly decreases inflammatory and fibrotic responses to obstruction, resulting in diminished renal injury and supporting Sphk2 as a novel driver of the pro-inflammatory macrophage phenotype.	[Ghosh, Mallika; Thangada, Shobha; Dasgupta, Oisharya; Shapiro, Linda H.; Ferrer, Fernando A.] Univ Connecticut, Sch Med, Ctr Vasc Biol, Farmington, CT 06030 USA; [Ghosh, Mallika; Thangada, Shobha; Dasgupta, Oisharya; Shapiro, Linda H.; Ferrer, Fernando A.] Univ Connecticut, Sch Med, Dept Cell Biol, Farmington, CT 06030 USA; [Khanna, Kamal M.] Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT USA; [Yamase, Harold T.] Univ Connecticut, Sch Med, Dept Pathol, Farmington, CT 06032 USA; [Kashgarian, Michael] Yale Univ, Canc Res Ctr, Dept Pathol, New Haven, CT USA; [Hla, Timothy] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Ferrer, Fernando A.] Univ Nebraska, Sch Med, Dept Surg, Sect Pediat Urol,Childrens Hosp Omaha, Omaha, NE 68198 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Yale University; Harvard University; Boston Children's Hospital; University of Nebraska System	Shapiro, LH; Ferrer, FA (corresponding author), Univ Connecticut, Sch Med, Ctr Vasc Biol, Farmington, CT 06030 USA.; Shapiro, LH; Ferrer, FA (corresponding author), Univ Connecticut, Sch Med, Dept Cell Biol, Farmington, CT 06030 USA.; Ferrer, FA (corresponding author), Univ Nebraska, Sch Med, Dept Surg, Sect Pediat Urol,Childrens Hosp Omaha, Omaha, NE 68198 USA.	lshapiro@uchc.edu; fferrer@childrensomaha.org	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065; Shapiro, Linda H./0000-0003-4590-4671; Dasgupta, Oisharya/0000-0002-0329-4871	National Institute of Health [R01HL127449, R01HL125186, R01CA1689, HL67330, HL089934, HL70694]; Scientific Research Grant, Connecticut Children's Medical Center, Hartford, Connecticut; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127449] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Research Grant, Connecticut Children's Medical Center, Hartford, Connecticut; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by multi-investigator grants from National Institute of Health R01HL127449 and R01HL125186 (LHS), R01CA1689 (FF), HL67330, HL089934 and HL70694 (TH) and Scientific Research Grant, Connecticut Children's Medical Center, Hartford, Connecticut (FF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa A, 2016, J AM SOC NEPHROL; Bajwa A, 2010, J AM SOC NEPHROL, V21, P955, DOI 10.1681/ASN.2009060662; Bartels K, 2014, KIDNEY INT, V85, P733, DOI 10.1038/ki.2013.435; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cao Q, 2011, J AM SOC NEPHROL, V22, P1229, DOI 10.1681/ASN.2010070693; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Dunscombe P, 2015, PRACT RADIAT ONCOL, V5, P127, DOI 10.1016/j.prro.2014.10.012; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Fitzpatrick Leo R., 2011, Inflammopharmacology, V19, P75, DOI 10.1007/s10787-010-0060-6; Fitzpatrick LR, 2011, PHARMACOLOGY, V87, P135, DOI 10.1159/000323911; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Geissmann F, 2015, SEMIN IMMUNOL, V27, P353, DOI 10.1016/j.smim.2016.03.016; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Ghosh M, 2015, J IMMUNOL, V194, P4466, DOI 10.4049/jimmunol.1403133; Gill SE, 2013, AM J RESP CELL MOL, V49, P768, DOI 10.1165/rcmb.2012-0377OC; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Gross MLP, 2006, LAB INVEST, V86, P262, DOI 10.1038/labinvest.3700383; Guiteras R, 2016, CLIN KIDNEY J, V9, P765, DOI 10.1093/ckj/sfw096; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Jang HS, 2013, BBA-MOL BASIS DIS, V1832, P817, DOI 10.1016/j.bbadis.2013.02.016; Jo SK, 2009, KIDNEY INT, V75, P167, DOI 10.1038/ki.2008.400; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kharel Y, 2015, J PHARMACOL EXP THER, V355, P23, DOI 10.1124/jpet.115.225862; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kim D, 2014, NEPHROL DIAL TRANSPL, V29, P2043, DOI 10.1093/ndt/gfu240; Kushiyama T, 2011, NEPHROLOGY, V16, P522, DOI 10.1111/j.1440-1797.2010.01439.x; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lan RP, 2016, J AM SOC NEPHROL, V27, P3356, DOI 10.1681/ASN.2015020177; Lech M, 2014, J AM SOC NEPHROL, V25, P292, DOI 10.1681/ASN.2013020152; Li C, 2015, CELL PHYSIOL BIOCHEM, V36, P358, DOI 10.1159/000430106; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lo TH, 2014, KIDNEY INT, V86, P1174, DOI 10.1038/ki.2014.205; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Maines Lynn W., 2010, Inflammopharmacology, V18, P73, DOI 10.1007/s10787-010-0032-x; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Masaki T, 2003, KIDNEY INT, V63, P1256, DOI 10.1046/j.1523-1755.2003.00874.x; Meng XM, 2015, KIDNEY DIS-BASEL, V1, P138, DOI 10.1159/000431214; Mills EL, 2016, EUR J IMMUNOL, V46, P13, DOI 10.1002/eji.201445427; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2016, CIRC RES, V119, P414, DOI 10.1161/CIRCRESAHA.116.309194; Natoli TA, 2012, HUM MOL GENET, V21, P3397, DOI 10.1093/hmg/dds172; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Obinata H, 2012, CHEM BIOL, V19, P1080, DOI 10.1016/j.chembiol.2012.09.002; Pan BX, 2015, CELL PHYSIOL BIOCHEM, V35, P1062, DOI 10.1159/000373932; Park SW, 2012, KIDNEY INT, V82, P878, DOI 10.1038/ki.2012.224; Park SJ, 2014, CELL SIGNAL, V26, P2249, DOI 10.1016/j.cellsig.2014.07.009; Patwardhan NN, 2015, J MED CHEM, V58, P1879, DOI 10.1021/jm501760d; Qin T, 2016, FREE RADICAL BIO MED, V92, P90, DOI 10.1016/j.freeradbiomed.2016.01.011; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Schwalm S, 2017, AM J PATHOL, V187, P2413, DOI 10.1016/j.ajpath.2017.06.017; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Shivshankar P, 2014, J MOL CELL CARDIOL, V76, P84, DOI 10.1016/j.yjmcc.2014.07.020; Susnik N, 2014, KIDNEY INT, V85, P1357, DOI 10.1038/ki.2013.525; Swaminathan S, 2008, KIDNEY INT, V74, P1509, DOI 10.1038/ki.2008.555; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thangada S, 2014, J UROLOGY, V191, P1508, DOI 10.1016/j.juro.2013.10.072; Tian SJ, 2015, AM J PHYSIOL-RENAL, V308, pF69, DOI 10.1152/ajprenal.00484.2014; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Wang YQ, 2015, J SURG RES, V197, P145, DOI 10.1016/j.jss.2015.03.034; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Yang N, 2016, CARDIOVASC THER, V34, P234, DOI 10.1111/1755-5922.12193; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhao LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108678; Zhou LS, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0053-8	77	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194053	10.1371/journal.pone.0194053	http://dx.doi.org/10.1371/journal.pone.0194053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518138	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900063
J	Horie, Y; Makihara, H; Horikawa, K; Takeshige, F; Ibuki, A; Satake, T; Yasumura, K; Maegawa, J; Mitsui, H; Ohashi, K; Akase, T				Horie, Yoshiko; Makihara, Hiroko; Horikawa, Kazumasa; Takeshige, Fumika; Ibuki, Al; Satake, Toshihiko; Yasumura, Kazunori; Maegawa, Jiro; Mitsui, Hideaki; Ohashi, Kenichi; Akase, Tomoko			Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes	PLOS ONE			English	Article							BODY-MASS INDEX; BARRIER FUNCTION; PERMEABILITY BARRIER; EPIDERMAL HYPERPLASIA; CHOLESTEROL-SYNTHESIS; CERAMIDE SYNTHESIS; CUTANEOUS BARRIER; ATOPIC-DERMATITIS; LOWEST MORBIDITY; WATER-LOSS	Skin barrier function is often deficient in obese individuals, but the underlying molecular mechanisms remain unclear. This study investigated how skin structure and lipid metabolism, factors strongly associated with barrier function, differed among 50 Japanese women of greatly varying body mass index (BMI). Subjects receiving breast reconstruction surgery were chosen for analysis to obtain skin samples from the same site. The subjects were classified into two groups, control (BMI < 25 kg/m(2)) and obese (25 kg/m(2) < BMI < 35 kg/m(2)), according to standards in Japan. Hematoxylin and eosin staining was used to assess skin thickness, Ki-67 immunostaining to examine keratinocyte proliferation, and real-time polymerase chain reaction to measure skin expression levels of genes associated with lipid metabolism. Total lipids, cholesterol, and fatty acids were also measured from these same skin samples. In the obese group, structural changes included epidermal thickening and an increase in the number of Ki-67-positive (proliferating) cells. Both skin cholesterol and fatty acid levels exhibited an "inverted-U" relationship with BMI, suggesting that there is an optimal BMI for peak lipid content and barrier function. Decreased lipid levels at higher BMI were accompanied by downregulated expression of PPAR delta and other genes related to lipid metabolism, including those encoding acetyl-CoA carboxylase and HMG-CoA reductase, the rate-limiting enzymes for fatty acid and cholesterol synthesis, respectively. Thus, elevated BMI may lead to deficient skin barrier function by suppressing local lipid synthesis.	[Horie, Yoshiko; Makihara, Hiroko; Horikawa, Kazumasa; Takeshige, Fumika; Ibuki, Al; Akase, Tomoko] Yokohama City Univ, Grad Sch Med, Dept Biol Sci & Nursing, Yokohama, Kanagawa, Japan; [Satake, Toshihiko] Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa, Japan; [Yasumura, Kazunori] Kanagawa Childrens Med Ctr, Plast & Reconstruct Surg, Yokohama, Kanagawa, Japan; [Maegawa, Jiro] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa, Japan; [Mitsui, Hideaki; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University	Akase, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Biol Sci & Nursing, Yokohama, Kanagawa, Japan.	akase@yokohama-cu.ac.jp			Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24593252]	Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (24593252).	Ajani G, 2007, EXP CELL RES, V313, P3005, DOI 10.1016/j.yexcr.2007.04.021; Ananthapadmanabhan KP, 2013, INT J COSMETIC SCI, V35, P337, DOI 10.1111/ics.12042; Cho Y, 2004, J KOREAN MED SCI, V19, P859, DOI 10.3346/jkms.2004.19.6.859; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Denda M, 1996, ARCH DERMATOL RES, V288, P230, DOI 10.1007/BF02530090; Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27; Feingold K, 2014, BBA-MOL CELL BIOL L, V1841, P279, DOI 10.1016/j.bbalip.2013.12.004; FEINGOLD KR, 1991, J INVEST DERMATOL, V96, P201, DOI 10.1111/1523-1747.ep12461153; FEINGOLD KR, 1990, J CLIN INVEST, V86, P1738, DOI 10.1172/JCI114899; Foss YJ, 2009, MED HYPOTHESES, V72, P314, DOI 10.1016/j.mehy.2008.10.005; Garcia-Hidalgo L, 1999, OBES RES, V7, P299, DOI 10.1002/j.1550-8528.1999.tb00410.x; GERDES J, 1984, J IMMUNOL, V133, P1710; Guida B, 2010, J EUR ACAD DERMATOL, V24, P191, DOI 10.1111/j.1468-3083.2009.03503.x; Ishikawa J, 2013, ARCH DERMATOL RES, V305, P151, DOI 10.1007/s00403-012-1286-5; Kang D, 2015, BREAST CANCER RES TR, V152, P675, DOI 10.1007/s10549-015-3502-4; Loffler H, 2002, SKIN RES TECHNOL, V8, P19; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; MAOQIANG M, 1993, J CLIN INVEST, V92, P791, DOI 10.1172/JCI116652; MATSUZAWA Y, 1990, DIABETES RES CLIN PR, V10, pS159, DOI 10.1016/0168-8227(90)90157-O; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Salama RHM, 2013, DIS MARKERS, V34, P33, DOI [10.1155/2013/659864, 10.3233/DMA-2012-120945]; Shipman AR, 2011, BRIT J DERMATOL, V165, P743, DOI 10.1111/j.1365-2133.2011.10393.x; Takahashi H, 2014, J DERMATOL, V41, P144, DOI 10.1111/1346-8138.12393; TOKUNAGA K, 1991, INT J OBESITY, V15, P1; Ueda O, 2009, DRUG METAB PHARMACOK, V24, P180, DOI 10.2133/dmpk.24.180; Vanlint S, 2013, NUTRIENTS, V5, P949, DOI 10.3390/nu5030949; World Health Organization, 2000, WHO TECHN REP SER, V894; WUPONG S, 1994, J INVEST DERMATOL, V102, P799, DOI 10.1111/1523-1747.ep12378556; Yamane T, 2011, MOL NUTR FOOD RES, V55, pS186, DOI 10.1002/mnfr.201100144; Zhang A, 2015, J AM ACAD DERMATOL, V72, P606, DOI 10.1016/j.jaad.2014.12.013	32	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193830	10.1371/journal.pone.0193830	http://dx.doi.org/10.1371/journal.pone.0193830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518109	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900040
J	Godlewska, M; Krasuska, W; Czarnocka, B				Godlewska, Marlene; Krasuska, Wanda; Czarnocka, Barbara			Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines	PLOS ONE			English	Article							HUMAN THYROPEROXIDASE; CONFORMATIONAL EPITOPES; IMMUNODOMINANT REGION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; MESSENGER-RNA; LACTOPEROXIDASE; AUTOIMMUNITY; ANTIBODIES; AUTOANTIBODIES	Thyroid peroxidase (TPO) is an enzyme and autoantigen expressed in thyroid and breast tissues. Thyroid TPO undergoes a complex maturation process however, nothing is known about post-translational modifications of breast-expressed TPO. In this study, we have investigated the biochemical properties of TPO expressed in normal and cancerous human breast tissues, and the maturation process and antigenicity of TPO present in a panel of human breast tissue-derived cell lines. We found that the molecular weight of breast TPO was slightly lower than that of thyroid TPO due to decreased glycosylation and as suggest results of Western blot also shorter amino acid chain. Breast TPO exhibit enzymatic activity and isoelectric point comparable to that of thyroid TPO. The biochemical properties of TPO expressed in mammary cell lines and normal thyrocytes are similar regarding glycan content, molecular weight and isoelectric point. However, no peroxidase activity and dimer formation was detected in any of these cell lines since the majority of TPO protein was localized in the cytoplasmic compartment, and the TPO expression at the cell surface was too low to detect its enzymatic activity. Lactoperoxidase, a protein highly homologous to TPO expressed also in breast tissues, does not influence the obtained data. TPO expressed in the cell lines was recognized by a broad panel of TPO-specific antibodies. Although some differences in biochemical properties between thyroid and breast TPO were observed, they do not seem to be critical for the overall three-dimensional structure. This conclusion is supported by the fact that TPO expressed in breast tissues and cell lines reacts well with conformation-sensitive antibodies. Taking into account a close resemblance between both proteins, especially high antigenicity, future studies should investigate the potential immunotherapies directed against breast-expressed TPO and its specific epitopes.	[Godlewska, Marlene; Krasuska, Wanda; Czarnocka, Barbara] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland	Czarnocka, B (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	bczarnocka@cmkp.edu.pl	Czarnocka, Barbara/V-1048-2019; Krasuska, Wanda/U-8820-2019; Godlewska, Marlena/J-9540-2019	Czarnocka, Barbara/0000-0001-7701-760X; Krasuska, Wanda/0000-0002-4807-4864; Godlewska, Marlena/0000-0003-2337-6724	Center of Postgraduate Medical Education [501-1-25-01-16]	Center of Postgraduate Medical Education	This work was supported by the Center of Postgraduate Medical Education (grant number 501-1-25-01-16). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano B, 2007, THYROID, V17, P851, DOI 10.1089/thy.2007.0122; Arroyo-Helguera O, 2008, ENDOCR-RELAT CANCER, V15, P1003, DOI 10.1677/ERC-08-0125; Brandt J, 2016, BRIT J SURG, V103, P1649, DOI 10.1002/bjs.10284; Brandt J, 2015, CANCER CAUSE CONTROL, V26, P1093, DOI 10.1007/s10552-015-0602-8; CHAZENBALK GD, 1993, J CLIN INVEST, V92, P62, DOI 10.1172/JCI116600; Czarnocka B, 1997, J CLIN ENDOCR METAB, V82, P2639, DOI 10.1210/jc.82.8.2639; CZARNOCKA B, 1985, FEBS LETT, V190, P147, DOI 10.1016/0014-5793(85)80446-4; Czarnocka B, 2014, AUTOANTIBODIES, P365; Di Cristotaro J, 2006, ENDOCR-RELAT CANCER, V13, P485, DOI 10.1677/erc.1.01164; EWINS DL, 1992, AUTOIMMUNITY, V11, P141, DOI 10.3109/08916939209035148; Farahati J, 2012, CLIN CHEM LAB MED, V50, P709, DOI 10.1515/CCLM.2011.819; Fayadat L, 1998, ENDOCRINOLOGY, V139, P4277, DOI 10.1210/en.139.10.4277; Fayadat L, 2000, ENDOCRINOLOGY, V141, P959, DOI 10.1210/en.141.3.959; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Ferrand M, 2003, J BIOL CHEM, V278, P3793, DOI 10.1074/jbc.M209513200; Fiore E, 2007, J ENDOCRINOL INVEST, V30, P734, DOI 10.1007/BF03350810; Fragoso MA, 2009, ARCH BIOCHEM BIOPHYS, V482, P52, DOI 10.1016/j.abb.2008.11.015; Gardas A, 2000, REDOX REP, V5, P237, DOI 10.1179/135100000101535681; GIRAUD A, 1992, J ENDOCRINOL, V132, P317, DOI 10.1677/joe.0.1320317; Giustarini E, 2006, EUR J ENDOCRINOL, V154, P645, DOI 10.1530/eje.1.02108; Godlewska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179066; Godlewska M, 2014, THYROID, V24, P371, DOI 10.1089/thy.2013.0127; Godlewska M, 2012, AUTOIMMUNITY, V45, P476, DOI 10.3109/08916934.2012.682667; Gora M, 2004, CLIN EXP IMMUNOL, V136, P137, DOI 10.1111/j.1365-2249.2004.02422.x; Gorlewska-Roberts KM, 2004, CHEM RES TOXICOL, V17, P1659, DOI 10.1021/tx049787n; Hobby P, 2000, ENDOCRINOLOGY, V141, P2018, DOI 10.1210/en.141.6.2018; Jiskra J, 2007, ONCOL REP, V18, P1603; Jomaa B, 2015, ALTEX-ALTERN ANIM EX, V32, P191, DOI 10.14573/altex.1412201; KISO Y, 1992, AUTOIMMUNITY, V12, P259, DOI 10.3109/08916939209148468; Kopp P., 2012, WERNER INGBARS THYRO, V10th ed., P48; Le Fourn V, 2005, J BIOL CHEM, V280, P4568, DOI 10.1074/jbc.M408042200; Le Fourn V, 2004, BBA-MOL BASIS DIS, V1689, P134, DOI 10.1016/j.bbadis.2004.03.001; Le Fourn V, 2006, BIOCHEMISTRY-US, V45, P7380, DOI 10.1021/bi060415i; Le SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142615; McLachlan SM, 2007, THYROID, V17, P939, DOI 10.1089/thy.2007.0169; Mondal S, 2016, ANGEW CHEM INT EDIT, V55, P7606, DOI 10.1002/anie.201601116; Muller I, 2014, INT J CANCER, V134, P1706, DOI 10.1002/ijc.28493; Muller I, 2017, EUR THYROID J, V6, P197, DOI 10.1159/000460246; Orgiazzi J, 2012, PRESSE MED, V41, pE611, DOI 10.1016/j.lpm.2012.10.002; RUF J, 1989, ENDOCRINOLOGY, V125, P1211, DOI 10.1210/endo-125-3-1211; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shin K, 2000, J NUTR BIOCHEM, V11, P94, DOI 10.1016/S0955-2863(99)00082-0; SIPE HJ, 1994, CARCINOGENESIS, V15, P2637, DOI 10.1093/carcin/15.11.2637; Smyth PPA, 1998, J CLIN ENDOCR METAB, V83, P2711, DOI 10.1210/jc.83.8.2711; Soriano O, 2011, ENDOCR-RELAT CANCER, V18, P529, DOI 10.1530/ERC-11-0065; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609	46	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193624	10.1371/journal.pone.0193624	http://dx.doi.org/10.1371/journal.pone.0193624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513734	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800065
J	Monma, H; Iida, Y; Moritani, T; Okimoto, T; Tanino, R; Tajima, Y; Harada, M				Monma, Hiroyuki; Iida, Yuichi; Moritani, Tamami; Okimoto, Tamio; Tanino, Ryosuke; Tajima, Yoshitsugu; Harada, Mamoru			Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells	PLOS ONE			English	Article							TUMOR-CELLS; C-FLIPL; AUTOPHAGY INHIBITION; RADIATION LETHALITY; MEDIATED APOPTOSIS; MILD HYPERTHERMIA; CARCINOMA CELLS; LUNG-CANCER; THERAPY; DEATH	Autophagy contributes to the treatment-resistance of many types of cancers, and chloroquine (CQ) inhibits autophagy. The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) kills cancer cells but is minimally cytotoxic to normal cells. However, because the therapeutic efficacy of TRAIL is limited, it is necessary to augment TRAIL-induced anti-tumor effects. In this study, we explored the anti-tumor effects of a combination of CQ and TRAIL on two human pancreatic cancer cell lines: TRAIL-sensitive MiaPaCa-2 cells and Panc-1 cells that are less sensitive to TRAIL. Although both CQ and TRAIL reduced cancer cell viability in a dose-dependent manner, the combination acted synergistically. CQ increased the expression level of type-II LC3B without decreasing the expression of p62, an autophagic substrate, thus indicating inhibition of autophagy. CQ did not increase the levels of death receptors on cancer cells but reduced the expression of anti-apoptotic proteins. A combination of CQ and TRAIL significantly increased cancer cell apoptosis. CQ induced cell-cycle arrest in the G2/M phase. Also, CQ increased the p21 level but reduced that of cyclin B1. A combination of CQ and TRAIL reduced the colony-forming abilities of cancer cells to extents greater than either material alone. In xenograft models, combination CQ and TRAIL therapy significantly suppressed the growth of subcutaneously established MiaPaCa-2 and Panc-1 cells, compared with the untreated or monotherapy groups. Together, the results indicate that CQ in combination with TRAIL may be useful to treat human pancreatic cancer.	[Monma, Hiroyuki; Tajima, Yoshitsugu] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Matsue, Shimane, Japan; [Monma, Hiroyuki] Hygo Prefectural Kakogawa Med Ctr, Dept Surg, Kakogawa, Hyogo, Japan; [Iida, Yuichi; Moritani, Tamami; Harada, Mamoru] Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan; [Okimoto, Tamio; Tanino, Ryosuke] Shimane Univ, Fac Med, Dept Internal Med, Div Med Oncol & Resp Med, Matsue, Shimane, Japan	Shimane University; Shimane University; Shimane University	Harada, M (corresponding author), Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan.	haramamo@med.shimane-u.ac.jp	Tanino, Ryosuke/X-2564-2019	Tanino, Ryosuke/0000-0002-5148-9526; Iida, Yuichi/0000-0002-0579-4626	Japan Society for the Promotion of Science KAKENHI Grant [17K07217]; Shimane University "SUIGANN" Project	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Shimane University "SUIGANN" Project	This study was supported in part by Japan Society for the Promotion of Science KAKENHI Grant (no. 17K07217 to M. Harada) and from the Shimane University "SUIGANN" Project to M. Harada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Balic A, 2014, MOL CANCER THER, V13, P1758, DOI 10.1158/1535-7163.MCT-13-0948; Boone BA, 2015, ANN SURG ONCOL, V22, P4402, DOI 10.1245/s10434-015-4566-4; Carnero A, 2016, CANCER TREAT REV, V49, P25, DOI 10.1016/j.ctrv.2016.07.001; DJORDEVIC B, 1992, MELANOMA RES, V2, P321, DOI 10.1097/00008390-199212000-00005; DJORDJEVIC B, 1992, RADIAT RES, V130, P267, DOI 10.2307/3578284; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Gewirtz DA, 2009, AUTOPHAGY, V5, P1232, DOI 10.4161/auto.5.8.9896; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Haag C, 2011, GUT, V60, P225, DOI 10.1136/gut.2009.202325; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Harashima N, 2012, CANCER IMMUNOL IMMUN, V61, P667, DOI 10.1007/s00262-011-1132-1; Hari Y, 2015, ONCOTARGET, V6, P41902, DOI 10.18632/oncotarget.5881; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KIM SH, 1973, CANCER, V32, P536, DOI 10.1002/1097-0142(197309)32:3<536::AID-CNCR2820320304>3.0.CO;2-E; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Moon JH, 2015, ONCOL REP, V34, P375, DOI 10.3892/or.2015.3991; Moon JH, 2015, ONCOL REP, V33, P1171, DOI 10.3892/or.2014.3676; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Nagappan A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174591; Nazim UMD, 2016, ONCOTARGET, V7, P23468, DOI 10.18632/oncotarget.8048; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22921; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Sun WJ, 2017, BIOCHEM PHARMACOL, V127, P90, DOI 10.1016/j.bcp.2016.12.008; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Wang G, 2014, ONCOL REP, V32, P2789, DOI 10.3892/or.2014.3525; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Xu JN, 2016, J CELL BIOCHEM, V117, P1136, DOI 10.1002/jcb.25397; Yang MC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0449-3; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu XH, 2017, ONCOTARGET, V8, P6691, DOI 10.18632/oncotarget.14262; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	43	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193990	10.1371/journal.pone.0193990	http://dx.doi.org/10.1371/journal.pone.0193990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513749	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800096
J	Rahimi-Levene, N; Ziv-Baran, T; Peer, V; Golik, A; Kornberg, A; Zeidenstein, R; Koren-Michowitz, M				Rahimi-Levene, Naomi; Ziv-Baran, Tomer; Peer, Victoria; Golik, Ahuva; Kornberg, Abraham; Zeidenstein, Ronit; Koren-Michowitz, Maya			Hemoglobin transfusion trigger in an internal medicine department - A "real world" six year experience	PLOS ONE			English	Article							BLOOD-CELL TRANSFUSION; REQUIREMENTS; SURGERY; TRENDS; TRIAL	Background Transfusion guidelines advocate restrictive rather than liberal use of red blood cells (RBC) and are based mostly on randomized trials in intensive care and surgical departments. We aimed to study RBC transfusion practice in the medical patients' population. Methods The data in this study were collected from patients over the age of 18 years admitted to an Internal Medicine department between 2009 and 2014 who received at least one unit of packed red blood cells (RBC). In addition, data on demographics, patients' diagnoses, laboratory tests and number of transfused RBC units were extracted from the electronic health records. Results One thousand three hundred and twenty eight patients were included, having mean age of 75 +/- 14 years. The median hemoglobin (Hb) trigger for RBC transfusion was 8.0 g/dl (IQR 7.3-8.7g/dl), and most patients received either one (43.4%) or two (33.4%) RBC units. There was no significant difference in Hb trigger between males and females (Hb 8.0 g/dl and 7.9 g/dl, respectively, p = 0.098), and a weak correlation with age (r = 0.108 p = 0.001). Patients with cardiovascular and lung diseases had a statistically significant higher Hb trigger compared to patients without those diagnoses, however the median difference between them was 0.5 g/dl or less. Conclusions These "real world" data we collected show a Hb trigger compliant with the upper limit of published guidelines and influenced by medical patients' common diagnoses. Prospective trials addressing patients hospitalized in internal medicine departments could further contribute to transfusion decision algorithms.	[Rahimi-Levene, Naomi; Peer, Victoria] Assaf Harofeh Med Ctr, Blood Bank, Zerifin, Israel; [Rahimi-Levene, Naomi; Kornberg, Abraham; Koren-Michowitz, Maya] Assaf Harofeh Med Ctr, Hematol Inst, Zerifin, Israel; [Rahimi-Levene, Naomi; Golik, Ahuva; Kornberg, Abraham; Zeidenstein, Ronit; Koren-Michowitz, Maya] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ziv-Baran, Tomer] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel; [Golik, Ahuva; Zeidenstein, Ronit] Assaf Harofeh Med Ctr, Internal Med Dept A, Zerifin, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University	Rahimi-Levene, N (corresponding author), Assaf Harofeh Med Ctr, Blood Bank, Zerifin, Israel.; Rahimi-Levene, N; Koren-Michowitz, M (corresponding author), Assaf Harofeh Med Ctr, Hematol Inst, Zerifin, Israel.; Rahimi-Levene, N; Koren-Michowitz, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	nrlevene@asaf.health.gov.il; korenm@asaf.health.gov.il	Ziv-Baran, Tomer/AAA-8408-2022	Koren-Michowitz, Maya/0000-0002-7223-328X				Avdic A, 2016, TRANSFUSION, V56, P2346, DOI 10.1111/trf.13708; Callum JL, 2014, TRANSFUSION, V54, P2344, DOI 10.1111/trf.12802; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461; Frank SM, 2013, TRANSFUSION, V53, P3052, DOI 10.1111/trf.12227; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; James P, 2011, GETTING STARTED PATI; Kass GV, 1980, J R STAT SOC C-APPL, P119; Roubinian NH, 2014, TRANSFUSION, V54, P2678, DOI 10.1111/trf.12825; Salpeter SR, 2014, AM J MED, V127, P124, DOI 10.1016/j.amjmed.2013.09.017; Shehata N, 2014, TRANSFUSION, V54, P2631, DOI 10.1111/trf.12644; Surial B, 2015, SWISS MED WEEKLY, P1; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193873	10.1371/journal.pone.0193873	http://dx.doi.org/10.1371/journal.pone.0193873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513750	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800085
J	Wilson, B; Jones, B; McGreevy, P				Wilson, Bethany; Jones, Bidda; McGreevy, Paul			Longitudinal trends in the frequency of medium and fast race winning times in Australian harness racing: Relationships with rules moderating whip use	PLOS ONE			English	Article								The use of whips in racing is subject to current debate, not least because the prospect that fatigued horses cannot respond renders the practice futile and inhumane. The racing industries maintain whip use is a form of encouragement and that the rules of racing that govern whip use safeguard horse welfare. The current study examined longitudinal trends in the frequency of medium and fast race winning times in Australian harness racing between September 2007 and August 2016 to explore relationships with a series of changes that moderated whip use. The first change, introduced January 2010, moderated whip action so that horses were struck with less force. Subsequent amendments reversed this change for the final 200m of the race except in one racing jurisdiction. However, those amendments were eventually reversed, restoring the first rule change in all geographic locations. Despite whip use being regulated from January 2010, a long-term trend of increased frequency of both fast and medium winning times over 1609m (similar to 1 mile) was noted. Even after adjusting for this trend, all whip handling codes were associated with greater odds of winning times being less than 1: 55 minutes compared with the pre-2010 period. A similar finding for times less than 2: 00 minutes did not reach statistical significance. Additionally, the periods immediately before and after introducing the most stringent regulations were compared. This revealed that, when introduced in 2010, these regulations were associated with faster winning times. Their re-introduction in 2016, was associated with no significant differences. Despite concerns that tightening of whip regulations might reduce performance, none of our analyses revealed any significant reduction in either fast or medium winning times in races following the tightening of regulations governing the use of the whip. These findings question the putative need for whips to improve racing performance.	[Wilson, Bethany; Jones, Bidda; McGreevy, Paul] Univ Sydney, Sch Vet Sci, Sydney, NSW, Australia; [Jones, Bidda] RSPCA Australia, Deakin West, ACT, Australia	University of Sydney	Wilson, B (corresponding author), Univ Sydney, Sch Vet Sci, Sydney, NSW, Australia.	bethany@cafallstats.com.au		McGreevy, Paul/0000-0001-7220-8378	RSPCA Australia	RSPCA Australia	RSPCA Australia provided the funds for this study and the costs of open access publishing. They facilitated acquisition of the raw data from Harness Racing Australia, but played no role in the study design, analysis, or decision to publish.; This work was a collaboration between the University of Sydney and RSPCA Australia. This study and the costs of publishing in open access were funded by RSPCA Australia. The authors thank Harness Racing Australia for making the data we have analysed publicly available. They also thank the reviewers of this article for their valuable comments on an earlier draft of the manuscript.	[Anonymous], 2015, AUSTRALIAN; [Anonymous], 2012, GREENS BACK RSPCA CA; Australia HR, 2017, IND NOT WHIPS; Australia HR, 2017, NAT STAK STAT STARTS; Bergmann I, 2015, PFERDEHEILKUNDE, V31, P490, DOI 10.21836/PEM20150509; British Horseracing Authority, 2011, RESP REG REV US WHIP; DEUEL NR, 1988, J EQUINE VET SCI, V8, P240, DOI 10.1016/S0737-0806(88)80016-9; Evans D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015622; Francome John, 2015, BAN WHIP US WOULD BE; Graham R, 2016, ANIMALS, V6, DOI 10.3390/ani6050032; Harness Racing Australia, 2016, TROTS HARN WHIP FREE; Harness Racing Australia, 2016, WHIP ITS YOUR DVD RE; Harness Racing Australia, 2016, WHIP RUL EFF; Harness Racing Australia, 2017, CHAIRM UPD; Harness Racing Australia, 2017, AUSTR HARN RAC RUL 9; Harness Racing Australia, 2009, WHIP RUL AM FREQ ASK; Harness Racing Victoria, 2011, HRV BOARD REV NAT WH; Harness Racing Victoria, 2010, MEMO VICT LOC RUL; Heleski CR, 2012, J VET BEHAV, V7, P169, DOI 10.1016/j.jveb.2011.08.003; Hood J, 2017, ANIMALS, V7, DOI 10.3390/ani7010004; Jones B, 2015, ANIMALS, V5, P138, DOI 10.3390/ani5010138; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; McGreevy PD, 2013, J VET BEHAV, V8, P395, DOI 10.1016/j.jveb.2013.03.003; McGreevy PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033398; McGreevy PD, 2011, J VET BEHAV, V6, P287, DOI 10.1016/j.jveb.2011.02.010; McLean AN, 2010, J VET BEHAV, V5, P203, DOI 10.1016/j.jveb.2010.04.003; RSPCA, 2016, RSPCA POL C05 HORS R; Taylor PM, 2016, VET ANAESTH ANALG, V43, P99, DOI 10.1111/vaa.12274; Victoria HR, 2017, 2017 HRV ANN REP 201	30	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0184091	10.1371/journal.pone.0184091	http://dx.doi.org/10.1371/journal.pone.0184091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513660	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800001
J	Cathasaigh, MO; Read, MR; Atilla, A; Schiller, T; Kwong, GPS				Cathasaigh, Micheal O.; Read, Matt R.; Atilla, Aylin; Schiller, Teresa; Kwong, Grace P. S.			Blood concentration of bupivacaine and duration of sensory and motor block following ultrasound-guided femoral and sciatic nerve blocks in dogs	PLOS ONE			English	Article							PLATEAU-LEVELING-OSTEOTOMY; PELVIC LIMB; SUPRAINGUINAL APPROACH; ORTHOPEDIC-SURGERY; PSOAS COMPARTMENT; ILIOPSOAS MUSCLE; ROPIVACAINE; LIDOCAINE; TOXICITY; PLEXUS	Peripheral nerve blocks are becoming increasingly popular for perioperative use as anesthetics and analgesics in small animals. This prospective study was performed to investigate the duration of motor and sensory blockade following use of bupivacaine for ultrasoundguided femoral and sciatic nerve blocks in dogs and to measure the plasma concentrations of bupivacaine that result from these procedures. Six dogs were anesthetized twice using a randomized cross-over design. At the first anesthetic, dogs were assigned to receive either an ultrasound-guided femoral nerve block or sciatic nerve block with 0.15 mL kg(-1) of bupivacaine 0.5%. Two months later, the other nerve block was performed during a second anesthetic. At 5, 10, 15, 20, 30 and 60 minutes after injection, arterial blood samples were collected for laboratory measurement of bupivacaine. After 60 minutes, dogs were recovered from anesthesia. Starting at two hours post-injection, video-recordings of the dogs were made every two hours for 24 hours. The videos were randomized and the degree of motor and sensory blockade was evaluated using a three-point scoring system (0 = no effect, 1 = mild effect, 2 = complete blockade) by two blinded assessors. The median (range) times to full recovery from motor blockade were 11 (6 +/- 14) hours (femoral) and 12 (4 +/- 18) hours (sciatic), and 15 (10 +/- 18) hours (femoral) and 10 (4 +/- 12) hours (sciatic) for sensory blockade. There were no differences in the median times to functional recovery for the two techniques. Plasma concentrations of bupivacaine were no different following the blocks and were less than 0.78 mu g mL(-1) at all times. These results suggest that these ultrasoundguided nerve blocks do not result in potentially toxic systemic levels of local anesthetic and that their duration of action is useful for providing anesthesia and analgesia for pelvic limb procedures.	[Cathasaigh, Micheal O.; Read, Matt R.; Atilla, Aylin; Schiller, Teresa; Kwong, Grace P. S.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Cathasaigh, Micheal O.] Univ Cambridge, Queens Vet Sch Hosp, Cambridge, England	University of Calgary; University of Cambridge	Read, MR (corresponding author), Univ Calgary, Fac Vet Med, Calgary, AB, Canada.	mattread@ucalgary.ca		O Cathasaigh, Micheal/0000-0003-0105-6965	University of Calgary Faculty of Veterinary Medicine	University of Calgary Faculty of Veterinary Medicine	This study was funded by the Intern Research Fund (2014) of the University of Calgary Faculty of Veterinary Medicine. The funding was secured by Micheal O Cathasaigh and Matt Read. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel AKG, 2016, VET ANAESTH ANALG, V43, P435, DOI 10.1111/vaa.12318; Benigni L, 2007, VET RADIOL ULTRASOUN, V48, P428, DOI 10.1111/j.1740-8261.2007.00273.x; Boscan P, 2016, J AM ANIM HOSP ASSOC, V52, P102, DOI 10.5326/JAAHA-MS-6278; Campoy L, 2012, VET ANAESTH ANALG, V39, P436, DOI 10.1111/j.1467-2995.2012.00712.x; Campoy L, 2012, VET ANAESTH ANALG, V39, P91, DOI 10.1111/j.1467-2995.2011.00673.x; Campoy L, 2010, VET ANAESTH ANALG, V37, P144, DOI 10.1111/j.1467-2995.2009.00518.x; Costa-Farre C, 2011, VET J, V187, P221, DOI 10.1016/j.tvjl.2009.10.016; Echeverry DF, 2012, VET ANAESTH ANALG, V39, P611, DOI 10.1111/j.1467-2995.2012.00750.x; Echeverry DF, 2012, VET J, V192, P333, DOI 10.1016/j.tvjl.2011.06.043; Echeverry DF, 2010, VET J, V186, P210, DOI 10.1016/j.tvjl.2009.08.005; FELDMAN HS, 1989, ANESTH ANALG, V69, P794; Graff SM, 2015, VET ANAESTH ANALG, V42, P394, DOI 10.1111/vaa.12224; Groban L, 2001, ANESTH ANALG, V92, P37; LIU P, 1982, ANESTH ANALG, V61, P317; LIU PL, 1983, ANESTH ANALG, V62, P375; Mahler SP, 2012, VET ANAESTH ANALG, V39, P550, DOI 10.1111/j.1467-2995.2012.00731.x; McCally RE, 2015, VET SURG, V44, P983, DOI 10.1111/vsu.12406; Mogicato G, 2015, VET ANAESTH ANALG, V42, P425, DOI 10.1111/vaa.12240; OCONNOR BL, 1982, J ANAT, V134, P563; Portela DA, 2013, VET ANAESTH ANALG, V40, P194, DOI 10.1111/j.1467-2995.2012.00765.x; Shilo Y, 2010, VET ANAESTH ANALG, V37, P460, DOI 10.1111/j.1467-2995.2010.00560.x; Shimada S, 2017, VET ANAESTH ANALG, V44, P1208, DOI 10.1016/j.vaa.2017.03.002; Tayari H, 2017, VET ANAESTH ANALG, V44, P1216, DOI 10.1016/j.vaa.2016.12.062; Trein TA, 2017, VET ANAESTH ANALG, V44, P144, DOI 10.1111/vaa.12399; Vettorato E, 2013, J SMALL ANIM PRACT, V54, P630, DOI 10.1111/jsap.12146; Vettorato E, 2012, VET COMP ORTHOPAED, V25, P314, DOI 10.3415/VCOT-11-08-0111	26	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193400	10.1371/journal.pone.0193400	http://dx.doi.org/10.1371/journal.pone.0193400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505566	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200014
J	Kim, DH; Cho, S; Jo, K; Shin, E; Hong, CS; Han, Y; Suh, TS; Lim, DH; Choi, DH				Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Shin, EunHyuk; Hong, Chae-Seon; Han, Youngyih; Suh, Tae-Suk; Lim, Do Hoon; Choi, Doo Ho			Proton range verification in inhomogeneous tissue: Treatment planning system vs. measurement vs. Monte Carlo simulation	PLOS ONE			English	Article							PENCIL BEAM ALGORITHM; RADIATION-THERAPY; DOSE CALCULATION; STOPPING POWER; BRAGG PEAK; UNCERTAINTIES; GEANT4; NOZZLE	In particle radiotherapy, range uncertainty is an important issue that needs to be overcome. Because high-dose conformality can be achieved using a particle beam, a small uncertainty can affect tumor control or cause normal-tissue complications. From this perspective, the treatment planning system (TPS) must be accurate. However, there is a well-known inaccuracy regarding dose computation in heterogeneous media. This means that verifying the uncertainty level is one of the prerequisites for TPS commissioning. We evaluated the range accuracy of the dose computation algorithm implemented in a commercial TPS, and Monte Carlo (MC) simulation against measurement using a CT calibration phantom. A treatment plan was produced for eight different materials plugged into a phantom, and two-dimensional doses were measured using a chamber array. The measurement setup and beam delivery were simulated by MC code. For an infinite solid water phantom, the gamma passing rate between the measurement and TPS was 97.7%, and that between the measurement and MC was 96.5%. However, gamma passing rates between the measurement and TPS were 49.4% for the lung and 67.8% for bone, and between the measurement and MC were 85.6% for the lung and 100.0% for bone tissue. For adipose, breast, brain, liver, and bone mineral, the gamma passing rates computed by TPS were 91.7%, 90.6%, 81.7%, 85.6%, and 85.6%, respectively. The gamma passing rates for MC for adipose, breast, brain, liver, and bone mineral were 100.0%, 97.2%, 95.0%, 98.9%, and 97.8%, respectively. In conclusion, the described procedure successfully evaluated the allowable range uncertainty for TPS commissioning. The TPS dose calculation is inefficient in heterogeneous media with large differences in density, such as lung or bone tissue. Therefore, the limitations of TPS in heterogeneous media should be understood and applied in clinical practice.	[Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Shin, EunHyuk; Hong, Chae-Seon; Han, Youngyih; Lim, Do Hoon; Choi, Doo Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Dae-Hyun; Suh, Tae-Suk] Catholic Univ Korea, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Dae-Hyun; Suh, Tae-Suk] Catholic Univ Korea, Res Inst Biomed Engn, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea	Han, Y (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea.; Suh, TS (corresponding author), Catholic Univ Korea, Dept Biomed Engn, Coll Med, Seoul, South Korea.; Suh, TS (corresponding author), Catholic Univ Korea, Res Inst Biomed Engn, Coll Med, Seoul, South Korea.	youngyih@skku.edu; suhsanta@catholic.ac.kr		Hong, Chae-Seon/0000-0001-9120-6132	National Research Foundation - Ministry of Science, ICT and Future Planning, Republic of Korea [2013M2A2A7043507, 2012M3A9B6055201, 2016R1C1B2009258]	National Research Foundation - Ministry of Science, ICT and Future Planning, Republic of Korea	This study was supported by a grant (2013M2A2A7043507, 2012M3A9B6055201, 2016R1C1B2009258) of the National Research Foundation funded by the Ministry of Science, ICT and Future Planning, Republic of Korea.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Andreo P, 2009, PHYS MED BIOL, V54, pN205, DOI 10.1088/0031-9155/54/11/N01; Besemer A, 2013, PHYS MED BIOL, V58, P887, DOI 10.1088/0031-9155/58/4/887; Brada M, 2007, J CLIN ONCOL, V25, P965, DOI 10.1200/JCO.2006.10.0131; Carlsson AK, 1997, PHYS MED BIOL, V42, P1033, DOI 10.1088/0031-9155/42/6/004; Chung K, 2015, RADIAT ONCOL J, V33, P337, DOI 10.3857/roj.2015.33.4.337; Egashira Y, 2013, PHYS MED BIOL, V58, P1169, DOI 10.1088/0031-9155/58/4/1169; Fippel M, 2004, MED PHYS, V31, P2263, DOI 10.1118/1.1769631; GOITEIN M, 1978, RADIAT RES, V74, P217, DOI 10.2307/3574883; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Hong L, 1996, PHYS MED BIOL, V41, P1305, DOI 10.1088/0031-9155/41/8/005; ICRU, 46 ICRU; ICRU, 1993, 49 ICRU; International Commission on Radiation Units and Measurements (ICRU), 44 ICRU; Jiang H, 2004, MED PHYS, V31, P2811, DOI 10.1118/1.1796952; Kim DH, 2012, J KOREAN PHYS SOC, V61, P1125, DOI 10.3938/jkps.61.1125; Kimura A, 2004, IEEE NUCL SCI CONF R, P2124; Low DA, 2003, MED PHYS, V30, P2455, DOI 10.1118/1.1598711; Paganetti H, 2004, MED PHYS, V31, P2107, DOI 10.1118/1.1762792; Paganetti H, 2008, PHYS MED BIOL, V53, P4825, DOI 10.1088/0031-9155/53/17/023; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; PETTI PL, 1992, MED PHYS, V19, P137, DOI 10.1118/1.596887; Sawakuchi GO, 2008, PHYS MED BIOL, V53, P4605, DOI 10.1088/0031-9155/53/17/010; Schneider U, 2005, MED PHYS, V32, P195, DOI 10.1118/1.1833041; Schuemann J, 2014, PHYS MED BIOL, V59, P4007, DOI 10.1088/0031-9155/59/15/4007; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Stankovskiy A, 2009, PHYS MED BIOL, V54, P2377, DOI 10.1088/0031-9155/54/8/008; Szymanowski H, 2002, PHYS MED BIOL, V47, P3313, DOI 10.1088/0031-9155/47/18/304; Szymanowski H, 2001, MED PHYS, V28, P975, DOI 10.1118/1.1376445; URIE M, 1986, PHYS MED BIOL, V31, P1, DOI 10.1088/0031-9155/31/1/001; Warren DR, 2015, PHYS MED BIOL, V60, P4243, DOI 10.1088/0031-9155/60/11/4243; Yamashita T, 2012, PHYS MED BIOL, V57, P7673, DOI 10.1088/0031-9155/57/22/7673	32	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193904	10.1371/journal.pone.0193904	http://dx.doi.org/10.1371/journal.pone.0193904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505589	Green Submitted, Green Published, gold			2022-12-26	WOS:000426548200041
J	Margiotta, DPE; Basta, F; Dolcini, G; Batani, V; Lo Vullo, M; Vernuccio, A; Navarini, L; Afeltra, A				Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Lo Vullo, Marina; Vernuccio, Alessia; Navarini, Luca; Afeltra, Antonella			Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK; VALIDATION; HEALTH; MORTALITY; LEPTIN; WOMEN; INDEX; TIME	Introduction The aim of this study was to evaluate the proportion of patients with Systemic Lupus Erythematosus (SLE) who did not met the WHO recommendations for physical activity and to evaluate the amount of time spent in sedentary behavior. Methods SLE patients were consecutively enrolled in a cross sectional study. The type and the time spent in physical activity and sedentary behavior were evaluated using the IPAQ short form questionnaire. The adequate physical activity was defined according to the 2010 WHO recommendations for health and the sedentary behavior according to the 2017 SBRN consensus. We also assessed quality of life using SF-36, mood disorders using BDI and HAM-H, fatigue using Facit-Fatigue and sleep disorders using PSQI scores. Results Physical activity was not sufficient to meet WHO recommendations in 56 of 93 SLE patients (60%). SLE patients spent a median (95% range) of 180 (0 +/- 600) minutes everyday in sedentary activities. The length of daily sedentary time was more than 6 hours in 25% of SLE patients. In multivariable analysis, the factors associated to the probability of not meeting WHO criteria was only the time of exposure to antimalarials (OR 0.88, p 0.03) and the factors related to the probability of being in the upper tertile of sedentary time (more than 270 minutes) were age (OR 1.04, p 0.02), disease activity expressed by SELENA-SLEDAI score (OR 1.2, p 0.01) and Facit-fatigue score (OR 0.94, p 0.04). Conclusion A relevant proportion of SLE patients were inadequately physically active. It is essential to improve the awareness of the importance of increase physical activity and reduce sedentary time. A better control of disease activity and fatigue and a prolonged use of antimalarials could help to reach this notable goal.	[Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Lo Vullo, Marina; Vernuccio, Alessia; Navarini, Luca; Afeltra, Antonella] Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Rome, Italy	University Campus Bio-Medico - Rome Italy	Navarini, L (corresponding author), Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Rome, Italy.	l.navarini@unicampus.it	Navarini, Luca/AAC-6635-2022; Margiotta, Domenico Paolo Emanuele/G-5769-2018; Navarini, Luca LN/A-7987-2011	Navarini, Luca/0000-0001-8537-1510; Margiotta, Domenico Paolo Emanuele/0000-0002-3597-8645; 				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Ayan C, 2007, LUPUS, V16, P5, DOI 10.1177/0961203306074795; Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Boggi R PA, 2017, ATTIVITA FISICA NEI; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; Eriksson K, 2012, SCAND J RHEUMATOL, V41, P290, DOI 10.3109/03009742.2011.624117; Fasano S, 2017, LUPUS, V26, P1463, DOI 10.1177/0961203317722847; Giacomelli R, 2017, AUTOIMMUN REV, V16, P911, DOI 10.1016/j.autrev.2017.07.012; Gibbs BB, 2015, MED SCI SPORT EXER, V47, P1295, DOI 10.1249/MSS.0000000000000517; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Jolly M, 2016, LUPUS, V25, P735, DOI 10.1177/0961203315627200; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Legge A, 2017, OPEN ACCESS RHEUMATO, V9, P191, DOI 10.2147/OARRR.S148376; Mancuso CA, 2011, LUPUS, V20, P231, DOI 10.1177/0961203310383737; Margiotta D, 2016, EUR REV MED PHARMACO, V20, P636; Margiotta DPE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187645; O'Dwyer T, 2017, SEMIN ARTHRITIS RHEU, V47, P204, DOI 10.1016/j.semarthrit.2017.04.003; Paley MA, 2017, CURR OPIN RHEUMATOL, V29, P178, DOI 10.1097/BOR.0000000000000369; Pancheri P, 2002, J AFFECT DISORDERS, V68, P41, DOI 10.1016/S0165-0327(00)00328-1; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pinto AJ, 2016, ARTHRIT CARE RES, V68, P1780, DOI 10.1002/acr.22905; Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Ruiz-Arruza I, 2014, RHEUMATOLOGY, V53, P1470, DOI 10.1093/rheumatology/keu148; Sacco R, 2016, EUR J NEUROL, V23, P744, DOI 10.1111/ene.12932; Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050; Sharif K, 2017, AUTOIMMUN REV; Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753; SYMMONS DPM, 1988, Q J MED, V69, P927; Tang C, 2012, INTERN MED J, V42, P968, DOI 10.1111/j.1445-5994.2012.02886.x; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Urushidani S, 2015, ANN INTERN MED, V162, P875, DOI 10.7326/L15-0180; Vadacca M, 2013, INTERN EMERG MED, V8, P705, DOI 10.1007/s11739-011-0726-0; Vadacca M, 2011, CELL MOL IMMUNOL, V8, P203, DOI 10.1038/cmi.2010.75; Vadacca M, 2009, J RHEUMATOL, V36, P295, DOI 10.3899/jrheum.080503; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; Volkmann ER, 2010, ARTHRIT CARE RES, V62, P258, DOI 10.1002/acr.20076; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	52	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193728	10.1371/journal.pone.0193728	http://dx.doi.org/10.1371/journal.pone.0193728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505598	gold, Green Submitted, Green Published			2022-12-26	WOS:000426548200027
J	Srihirun, S; Piknova, B; Sibmooh, N; Schechter, AN				Srihirun, Sirada; Piknova, Barbora; Sibmooh, Nathawut; Schechter, Alan N.			Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELL; OXIDE SYNTHASE; IN-VITRO; ENDOTHELIAL-CELLS; NO RELEASE; INHIBITION; BIOACTIVATION; HEMOGLOBIN; AGGREGATION; MECHANISMS	Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline PVASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 mu M) increased P-VASP(Ser239) in platelets about 31% at 10 +/- 20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20 +/- 40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions.	[Srihirun, Sirada; Piknova, Barbora; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Srihirun, Sirada] Mahidol Univ, Dept Pharmacol, Fac Dent, Bangkok, Thailand; [Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mahidol University; Mahidol University	Schechter, AN (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	AlanS@intra.niddk.nih.gov		Srihirun, Sirada/0000-0003-1616-9487	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Intramural Research Program to Alan N. Schechter.	Akrawinthawong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092435; Anfossi G, 2001, THROMB RES, V102, P319, DOI 10.1016/S0049-3848(01)00240-7; Apostoli GL, 2014, J THROMB HAEMOST, V12, P1880, DOI 10.1111/jth.12711; Benz PM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0144-z; Bohmer A, 2015, PLATELETS, V26, P583, DOI 10.3109/09537104.2014.974024; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dautov RF, 2014, NITRIC OXIDE-BIOL CH, V40, P36, DOI 10.1016/j.niox.2014.05.005; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Fens MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101626; Gambaryan S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0139-9; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grossi L, 2005, J MED CHEM, V48, P2622, DOI 10.1021/jm049857n; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Liu C, 2015, J BIOL CHEM, V290, P1281, DOI 10.1074/jbc.M114.609222; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; Megson IL, 2000, BRIT J PHARMACOL, V131, P1391, DOI 10.1038/sj.bjp.0703731; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Parakaw T, 2017, NITRIC OXIDE-BIOL CH, V66, P10, DOI 10.1016/j.niox.2017.02.008; Park JW, 2014, NITRIC OXIDE-BIOL CH, V40, P45, DOI 10.1016/j.niox.2014.05.006; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Porro B, 2014, BIOCHEM SOC T, V42, P996, DOI 10.1042/BST20140122; ROCHELLE LG, 1994, TOXICOL APPL PHARM, V128, P123, DOI 10.1006/taap.1994.1189; Salgado MT, 2015, BIOCHEMISTRY-US, V54, P6712, DOI 10.1021/acs.biochem.5b00643; Shah A, 2011, CARDIOVASC RES, V91, P625, DOI 10.1093/cvr/cvr115; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Wajih N, 2017, REDOX BIOL, V12, P1026, DOI 10.1016/j.redox.2017.05.006; Wajih N, 2016, REDOX BIOL, V8, P415, DOI 10.1016/j.redox.2016.04.004; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; WENNMALM A, 1992, BRIT J PHARMACOL, V106, P507, DOI 10.1111/j.1476-5381.1992.tb14365.x	39	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193747	10.1371/journal.pone.0193747	http://dx.doi.org/10.1371/journal.pone.0193747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505609	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200028
J	Tekalegn, Y; Addissie, A; Kebede, T; Ayele, W				Tekalegn, Yohannes; Addissie, Adamu; Kebede, Tedla; Ayele, Wondimu			Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							CARE; COMPLICATIONS; INITIATION; THERAPY; ADULTS	Background Diabetes is increasing at an alarming rate throughout the world and about 80% of diabetic cases live in low and middle income countries. Glycemic control is the most important predictor for diabetic related complications and deaths. Identifying factors associated with glycemic control help health care providers and patients to work in the areas that reduce risks of diabetic related complications and deaths. Objectives The aim of this study is to assess the magnitude and factors associated with glycemic control among type 2 diabetic patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Methods Hospital-based cross sectional study was conducted on 412 type 2 diabetic patients who were attending in diabetic clinics at Tikur Anbessa Specialized Hospital. Data were collected through structured interview questionnaire, and data abstraction format to collect information from each patient's medical records from March to April, 2015. Data were entered and analyzed using SPSS version 20 statistical software. Both descriptive and inferential statistics were used to determine magnitude of glycemic control and factors associated with poor glycemic control. Result Median age of participants was 52 years old (IQR = 40 +/- 60 years old). From the study participants, 51.7% were females. Median duration of living with diabetes since diagnosis was 10 years (IQR: 5 +/- 16 years). About 80% of the respondents had uncontrolled fasting blood glucose level. The factors which are significantly associated with poor glycemic control were longer duration of diabetes (AOR = 2.72 95% CI: 1.16 +/- 6.32), and being on insulin therapy (AOR = 3.01 95% CI: 1.5 +/- 5.9). Conclusion A high proportion of patients had poor glycemic control. Longer duration of the disease, and being on drug regimen of insulin were associated with poor glycemic control. Appropriate attention should be given to patients with longer duration of disease and those who are on insulin therapy.	[Tekalegn, Yohannes] Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia; [Addissie, Adamu; Ayele, Wondimu] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Kebede, Tedla] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Addis Ababa University	Tekalegn, Y (corresponding author), Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia.	yohannesefa@gmail.com	TEKALEGN, YOHANNES/AAG-9451-2020	TEKALEGN, YOHANNES/0000-0001-6628-8180; Ayele, Wondimu/0000-0001-5899-347X				Abebe SM, 2015, DIABET METAB SYND OB, V8, P65, DOI 10.2147/DMSO.S75467; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Angamo MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061759; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; center of disease prevention and control, 2005, NAT DIAB FACT SHEET; Cho N., 2013, INT DIABETES FEDERAT; Craig ME, 2009, PEDIATR DIABETES, V10, P3, DOI 10.1111/j.1399-5448.2009.00568.x; Feleke Y, 2005, ETHIOP J HEALTH DEV, V19, P204; Gudina EK, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-19; Hailu E, 2012, AFR J PRIM HEALTH CA, V4, DOI 10.4102/phcfm.v4i1.311; Juarez DT, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120065; Karter AJ, 2005, AM J MANAG CARE, V11, P262; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Mullugeta Y, 2012, INDIAN J CLIN BIOCHE, V27, P363, DOI 10.1007/s12291-012-0225-8; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sekhar TVDS, 2013, J CLIN DIAGN RES, V7, P857, DOI 10.7860/JCDR/2013/5726.2958; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1998, LANCET, V352, P1557; Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369; Woldu M, 2014, ENDOCRINOL METAB SYN, V3, DOI DOI 10.4172/2161-1017.1000143	26	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193442	10.1371/journal.pone.0193442	http://dx.doi.org/10.1371/journal.pone.0193442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505602	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200016
J	Faralli, JA; Dimeo, KD; Trane, RM; Peters, D				Faralli, Jennifer A.; Dimeo, Kaylee D.; Trane, Ralph M.; Peters, Donna			Absence of a secondary glucocorticoid response in C57BL/6J mice treated with topical dexamethasone	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; INDUCED OCULAR HYPERTENSION; LINKED ACTIN NETWORKS; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; RECEPTOR-BETA; FLUID-DYNAMICS; HTM CELLS; EXPRESSION; CORTICOSTEROIDS	Glucocorticoids such as dexamethasone can cause an increase in intraocular pressure (IOP) in some of the population, but not all. In this paper we used a mouse model of glucocorticoid induced ocular hypertension to examine the changes in the anterior segment of the eye in mice that failed to respond to glucocorticoid treatment with a sustained increase in IOP. C57BL/6J mice were treated with either 0.1% dexamethasone sodium phosphate ophthalmic solution or sterile PBS 3 times daily for up to 5 weeks. IOP was measured weekly at approximately the same time of the day. After 3-5 weeks of treatment, eyes were enucleated and evaluated for changes associated with steroid induced glaucoma. These studies showed that IOP was significantly elevated in dexamethasone (DEX) treated mice compared to PBS treated mice after 3 weeks of treatment, but IOP in DEX treated mice returned to baseline levels after 5 weeks of treatment. All the mice demonstrated a response to the glucocorticoid treatments and showed an elevation in FKBP5 expression after both 3 and 5 weeks of DEX treatment (primary glucocorticoid response protein) and a weight loss. Western blot analysis of anterior segments from treated mice, however, did not show an increase in secondary glucocorticoid response proteins such as beta 3 integrin or myocilin. Fibronectin levels were also not statistically different. The data suggest that in mice, which do not exhibit a prolonged increase in IOP in response to the DEX treatment, there is a compensatory mechanism that can prevent or turn off the secondary glucocorticoid response.	[Faralli, Jennifer A.; Dimeo, Kaylee D.; Peters, Donna] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Trane, Ralph M.; Peters, Donna] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peters, D (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Peters, D (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	dmpeter2@wisc.edu		Peters, Donna/0000-0002-1303-7027	National Institutes of Health [EY026009, EY017006]; Core grant to the Department of Ophthalmology and Visual Sciences grant [P30 EY016665]; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core grant to the Department of Ophthalmology and Visual Sciences grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health grants EY026009 (DP), EY017006 (DP), and a Core grant to the Department of Ophthalmology and Visual Sciences grant P30 EY016665 (DP), (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049532; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Barathi VA, 2009, VISION RES, V49, P383, DOI 10.1016/j.visres.2008.11.005; BECKER B, 1963, ARCH OPHTHALMOL-CHIC, V70, P500; Bermudez JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169671; Clark A F, 1995, J Glaucoma, V4, P354; Clark A F, 1995, J Glaucoma, V4, P183; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Derijk RH, 2001, J RHEUMATOL, V28, P2383; Dibas A, 2016, EUR J PHARMACOL, V787, P57, DOI 10.1016/j.ejphar.2016.06.018; DUNHAM CN, 1994, BRIT J OPHTHALMOL, V78, P38, DOI 10.1136/bjo.78.1.38; ESPILDORA J, 1981, J FR OPHTALMOL, V4, P503; Faralli JA, 2015, EXP EYE RES, V130, P9, DOI 10.1016/j.exer.2014.11.009; Faralli JA, 2013, BBA-MOL CELL RES, V1833, P3306, DOI 10.1016/j.bbamcr.2013.09.020; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Filla MS, 2017, EXP EYE RES, V165, P7, DOI 10.1016/j.exer.2017.08.017; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2010, MOL VIS, V16, P596; FRANCOIS J, 1977, ANN OPHTHALMOL, V9, P1075; Gagen D, 2013, INVEST OPHTH VIS SCI, V54, P5000, DOI 10.1167/iovs.13-12084; Hamid QA, 1999, AM J RESP CRIT CARE, V159, P1600, DOI 10.1164/ajrccm.159.5.9804131; Hamilos DL, 2001, J ALLERGY CLIN IMMUN, V108, P59; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Kersey JP, 2006, EYE, V20, P407, DOI 10.1038/sj.eye.6701895; Kumar S, 2013, INVEST OPHTH VIS SCI, V54, P1280, DOI 10.1167/iovs.12-11223; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Longui CA, 2000, HORM METAB RES, V32, P401, DOI 10.1055/s-2007-978661; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Park JM, 2013, BMB REP, V46, P454, DOI 10.5483/BMBRep.2013.46.9.234; Peotter JL, 2016, EXP CELL RES, V347, P301, DOI 10.1016/j.yexcr.2016.08.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piltz J, 2000, AM J OPHTHALMOL, V130, P441, DOI 10.1016/S0002-9394(00)00527-4; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Qiu YG, 2014, CURR EYE RES, V39, P365, DOI 10.3109/02713683.2013.845224; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rybkin I, 2017, EXP EYE RES, V158, P51, DOI 10.1016/j.exer.2016.07.013; Savinova OV, 2001, BMC GENET, V2; Shen L, 2013, CHINESE MED J-PEKING, V126, P78, DOI 10.3760/cma.j.issn.0366-6999.20120782; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; STEELY HT, 1992, INVEST OPHTH VIS SCI, V33, P2242; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188302; Whitlock NA, 2010, INVEST OPHTH VIS SCI, V51, P6496, DOI 10.1167/iovs.10-5430; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192665	10.1371/journal.pone.0192665	http://dx.doi.org/10.1371/journal.pone.0192665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499052	Green Submitted, Green Published, gold			2022-12-26	WOS:000426472300003
J	Garcia, GR; Bugel, SM; Truong, L; Spagnoli, S; Tanguay, RL				Garcia, Gloria R.; Bugel, Sean M.; Truong, Lisa; Spagnoli, Sean; Tanguay, Robert L.			AHR2 required for normal behavioral responses and proper development of the skeletal and reproductive systems in zebrafish	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DENDRITIC GROWTH; TOXICITY; EXPRESSION; EXPOSURE; GENE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MUTAGENESIS; DISRUPTION; ACTIVATION	The aryl hydrocarbon receptor ( AHR) is a conserved ligand-activated transcription factor required for proper vertebrate development and homeostasis. The inappropriate activation of AHR by ubiquitous pollutants can lead to adverse effects on wildlife and human health. The zebrafish is a powerful model system that provides a vertebrate data stream that anchors hypothesis at the genetic and cellular levels to observations at the morphological and behavioral level, in a high-throughput format. In order to investigate the endogenous functions of AHR, we generated an AHR2 ( homolog of human AHR)-null zebrafish line ( ahr2(osu1)) using the clustered, regulatory interspaced, short palindromic repeats ( CRISPR)-Cas9 precision genome editing method. In zebrafish, 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) mediated toxicity requires AHR2. The AHR2-null line was resistant to TCDD-induced toxicity, indicating the line can be used to investigate the biological and toxicological functions of AHR2. The AHR2-null zebrafish exhibited decreased survival and fecundity compared to the wild type line. At 36 weeks, histological evaluations of the AHR2-null ovaries revealed a reduction of mature follicles when compared to wild type ovaries, suggesting AHR2 regulates follicle growth in zebrafish. AHR2-null adults had malformed cranial skeletal bones and severely damaged fins. Our data suggests AHR2 regulates some aspect( s) of neuromuscular and/or sensory system development, with impaired behavioral responses observed in larval and adult AHR2-null zebrafish. This study increases our understanding of the endogenous functions of AHR, which may help foster a better understanding of the target organs and molecular mechanisms involved in AHR-mediated toxicities.	[Garcia, Gloria R.; Bugel, Sean M.; Truong, Lisa; Tanguay, Robert L.] Oregon State Univ, Sinnhuber Aquat Res Lab, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Spagnoli, Sean] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Tanguay, RL (corresponding author), Oregon State Univ, Sinnhuber Aquat Res Lab, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu		Truong, Lisa/0000-0003-1751-4617; Tanguay, Robyn/0000-0001-6190-3682	National Institutes of Health [P42 ES016465, R21 ES025421, T32 ES07060, F31 ES026518, K99 ES025280]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060, F31ES026518, R21ES025421, K99ES025280, P42ES016465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants: [P42 ES016465 to RLT, R21 ES025421 to RLT, T32 ES07060 to RLT, F31 ES026518 to GRG, K99 ES025280 to SMB]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Benedict JC, 2000, TOXICOL SCI, V56, P382, DOI 10.1093/toxsci/56.2.382; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Crews ST, 2006, GENE DEV, V20, P2773, DOI 10.1101/gad.1487706; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garcia GR, 2016, PHARMACOL THERAPEUT, V161, P11, DOI 10.1016/j.pharmthera.2016.03.009; Garcia GR, 2017, MOL PHARM; Gonzalez FJ, 1995, TOXICOL LETT, V82-3, P117, DOI 10.1016/0378-4274(95)03548-6; Goodale BC, 2015, TOXICOL SCI, V147, P397, DOI 10.1093/toxsci/kfv139; Goodale BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029346; Hahn Mark E., 2017, Current Opinion in Toxicology, V2, P58, DOI 10.1016/j.cotox.2017.02.003; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Heiden TK, 2006, TOXICOL SCI, V90, P490, DOI 10.1093/toxsci/kfj085; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hernandez-Ochoa I, 2010, BIOL REPROD, V83, P698, DOI 10.1095/biolreprod.110.087015; Hernandez-Ochoa I, 2009, BIOCHEM PHARMACOL, V77, P547, DOI 10.1016/j.bcp.2008.09.037; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08022; Johnston RJ, 2014, SCIENCE, V343, P661, DOI 10.1126/science.1243039; Karchner SI, 2005, BIOCH J; Kimura E., 2017, PLOS ONE, V12; Kimura E, 2015, NEUROTOXICOL TERATOL, V52, P42, DOI 10.1016/j.ntt.2015.10.005; Knecht AL, 2017, TOXICOL APPL PHARM, V329, P148, DOI 10.1016/j.taap.2017.05.033; Knecht AL, 2017, NEUROTOXICOL TERATOL, V59, P27, DOI 10.1016/j.ntt.2016.10.006; Latchney SE, 2013, J NEUROCHEM, V125, P430, DOI 10.1111/jnc.12130; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; POLAND A, 1976, FED PROC, V35, P2404; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Schneider AJ, 2014, INT J MOL SCI, V15, P17852, DOI 10.3390/ijms151017852; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shi ZQ, 2007, BIOL REPROD, V76, P198, DOI 10.1095/biolreprod.106.053991; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; Tseng HP, 2005, TOXICOL APPL PHARM, V205, P247, DOI 10.1016/j.taap.2004.10.019; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Vezina CM, 2009, BIOCHEM PHARMACOL, V77, P566, DOI 10.1016/j.bcp.2008.09.039; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Watabe Y, 2010, BIOL PHARM BULL, V33, P389, DOI 10.1248/bpb.33.389; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	61	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193484	10.1371/journal.pone.0193484	http://dx.doi.org/10.1371/journal.pone.0193484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494622	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200054
J	Kim, YH; Yoo, H; Hong, AR; Kwon, M; Kang, SW; Kim, K; Song, Y				Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo; Kang, Sang-Wook; Kim, Kyunggon; Song, Youngsup			NEDD4L limits cAMP signaling through ubiquitination of CREB-regulated transcription coactivator 3	FASEB JOURNAL			English	Article						CRTC3; NEDD4-2; feedback regulation; adipose tissues	EPITHELIAL NA+ CHANNEL; CYCLIC-AMP; LIDDLES-SYNDROME; SODIUM-CHANNEL; WW DOMAINS; CELL-SURFACE; BETA-SUBUNIT; PHOSPHORYLATION; HYPERTENSION; EXPRESSION	The transcription factor cAMP-responsive element-binding protein (CREB) is involved in a variety of physiologic processes. Although its activity appears to be largely correlated with its phosphorylation status, cAMP-mediated dephosphorylation and the subsequent nuclear migration of the CREB-regulated transcription factors (CRTCs) are required to stimulate CREB transcriptional activity. Among the 3 identified mammalian homologs of CRTCs, CRTC3 has been shown to be expressed predominantly in adipose tissues in response to catecholamine signals that regulate lipid metabolism. Here, we show that prolonged cAMP signaling down-regulates CRTC3 in a proteasome-dependent manner and that neural precursor cell-expressed developmentally down-regulated gene 4-like (NEDD4L), a specific ubiquitin ligase for CRTC3, is responsible for this process. By recognizing the PY motif of CRTC3, NEDD4L interacts with CRTC3 and promotes its polyubiquitination. Interaction between NEDD4L and CRTC3 is further boosted by cAMP signaling, and this enhanced interaction appears to be dependent on the cAMP-mediated phosphorylation of NEDD4L at the Ser448 site. Furthermore, we show that food withdrawal stimulates NEDD4L phosphorylation in mice, which then show a decrease of adipose tissue CRTC3 protein levels. Together, these results suggest that NEDD4L plays a key role in the feedback regulation of cAMP signaling by limiting CRTC3 protein levels.Kim, Y.-H., Yoo, H., Hong, A.-R., Kwon, M., Kang, S.-W., Kim, K., Song, Y. NEDD4L limits cAMP signaling through ubiquitination of CREB-regulated transcription coactivator 3.	[Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo; Kang, Sang-Wook; Song, Youngsup] Univ Ulsan, Convergence Med Res Ctr, Biomed Res Ctr,Coll Med, Dept Biomed Sci,Asan Med Ctr,Asan Inst Life Sci, Seoul, South Korea; [Kim, Yo-Han; Yoo, Hanju; Hong, A-Reum; Kwon, Minseo] Univ Ulsan, Convergence Med Res Ctr, Biomed Res Ctr,Coll Med, Dept Convergence Med,Asan Med Ctr,Asan Inst Life, Seoul, South Korea; [Kim, Kyunggon] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Song, Y (corresponding author), Univ Ulsan, Coll Med, Dept Biomed Sci, Olymp Ro 43 Gil 88, Seoul 05505, South Korea.	ysong@amc.seoul.kr		Yoo, Hanju/0000-0002-0332-6423	National Research Foundation of Korea [2017R1A2B2002691]; Asan Institute for Life Sciences [2017-611]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences	The authors thank Dr. Wesley Sundquist (University of Utah, Salt Lake City, UT, USA) for providing NEDD4L and its variants, Donghwan Kim (Department of Biomedical Sciences, University of Ulsan College of Medicine) for mouse experiments, and the Clinical proteomics core facility at the ConveRgence mEDicine research cenTer (CREDIT), Asan Medical Center for supporting and instrumentation for mass spectrometry. The authors thank Ryan at Enago for the English language review. This work was supported by a National Research Foundation of Korea (2017R1A2B2002691) and by the Asan Institute for Life Sciences and Basic Science Program (2017-611). The authors declare no conflicts of interest.	ALBERTS AS, 1994, J BIOL CHEM, V269, P7623; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Fu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078522; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Minegishi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27137; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Ou ZJ, 2014, MOL BIOL REP, V41, P125, DOI 10.1007/s11033-013-2844-4; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Weng L, 2015, CELL PHYSIOL BIOCHEM, V36, P1911, DOI 10.1159/000430160	36	12	12	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4053	4062		10.1096/fj.201701406R	http://dx.doi.org/10.1096/fj.201701406R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29505301				2022-12-26	WOS:000435104500048
J	Li, XM; Ruan, XH; Zhang, PT; Yu, Y; Gao, M; Yuan, SK; Zhao, ZW; Yang, J; Zhao, L				Li, Xiaomeng; Ruan, Xianhui; Zhang, Peitao; Yu, Yang; Gao, Ming; Yuan, Shukai; Zhao, Zewei; Yang, Jie; Zhao, Li			TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57(KIP2) repression	ONCOGENE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; BOX TRANSCRIPTION FACTORS; ULNAR-MAMMARY SYNDROME; BREAST-CANCER; DOWNSTREAM TARGET; CYCLE REGULATORS; E-CADHERIN; C-MYC; EXPRESSION; GENE	The T-box transcription factor TBX3 has been implicated in the patterning and differentiation of a number of tissues during embryonic development, and is overexpressed in a variety of cancers; however, the precise function of TBX3 in papillary thyroid carcinoma (PTC) development remains to be determined. In the current study, we report downregulation of TBX3 in PTC cells delays the G1/S-phase transition, decreases cell growth in vitro, and inhibits tumor formation in vivo. We identified p57(KIP2) as a novel downstream target that serves as the key mediator of TBX3's control over PTC cell proliferation. Reduced expression of TBX3 resulted in increased p57(KIP2) level, while knockdown of p57(KIP2) rescues the cell-cycle arrest phenotype. In clinical PTC specimens, the expression of TBX3 is markedly upregulated and significantly correlated with advanced tumor grade, but negatively correlated with the expression of p57(KIP2). Mechanism investigation revealed that TBX3 directly binds to the CDKN1C gene promoter region, the coding gene of p57(KIP2), and represses its transcription. Furthermore, recruitment of main components of the PRC2 complex as well as class I histone deacetylases, HDAC1 and HDAC2, is required for TBX3 to fulfill the transcriptional repression function. Our findings illustrate the previously unknown function and mechanism in cell proliferation regulation by the TBX3-p57(KIP2) axis and provide evidence for the contribution of the PRC2 complex and HDAC1/2. Targeting of this pathway may present a novel and molecular defined strategy against PTC development.	[Li, Xiaomeng; Zhang, Peitao; Yuan, Shukai; Zhao, Zewei; Yang, Jie; Zhao, Li] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Ruan, Xianhui; Yu, Yang; Gao, Ming] Tianjin Med Univ Canc Inst & Hosp, Dept Thyroid & Neck Tumor, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yang, J; Zhao, L (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China.	yangj@tijmu.edu.cn; shzhaoli@tijmu.edu.cn		Yuan, Shukai/0000-0003-0354-5113	National Natural Science Foundation of China [31371329, 81702710, 81472580]; Innovation Team Development Plan of the Ministry of Education [IRT13085]; Tianjin Municipal Science and Technology Commission [13JCYBJC37200, 17JCQNJC11200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development Plan of the Ministry of Education; Tianjin Municipal Science and Technology Commission	This research work was supported by the grants from the National Natural Science Foundation of China (31371329 to L.Z., 81702710 to S.Y., 81472580 to M.G.). Innovation Team Development Plan of the Ministry of Education (IRT13085), The Tianjin Municipal Science and Technology Commission (13JCYBJC37200 to L,Z., 17JCQNJC11200 to S.Y.).	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Borriello A, 2011, MOL CANCER RES, V9, P1269, DOI 10.1158/1541-7786.MCR-11-0220; Boyd SC, 2013, J INVEST DERMATOL, V133, P1269, DOI 10.1038/jid.2012.421; Burgucu D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-481; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Fagman H, 2011, DEV BIOL, V359, P163, DOI 10.1016/j.ydbio.2011.08.015; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Higashimoto K, 2006, CYTOGENET GENOME RES, V113, P306, DOI 10.1159/000090846; Ito Y, 2004, PATHOBIOLOGY, V71, P164, DOI 10.1159/000076472; Ito Y, 2002, INT J MOL MED, V9, P373; Kikuchi T, 2002, ONCOGENE, V21, P2741, DOI 10.1038/sj.onc.1205376; Kobatake T, 2004, ONCOL REP, V12, P1087; Lai SL, 2000, CLIN CANCER RES, V6, P3172; Li J, 2013, MOL BIOL CELL, V24, P3569, DOI 10.1091/mbc.E13-05-0273; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lloyd RV, 2011, HEAD NECK PATHOL, V5, P51, DOI 10.1007/s12105-010-0236-9; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Melck A, 2007, ANN SURG ONCOL, V14, P3403, DOI 10.1245/s10434-007-9572-8; Mesbah K, 2012, HUM MOL GENET, V21, P1217, DOI 10.1093/hmg/ddr553; Perkhofer L, 2016, STEM CELL RES, V17, P367, DOI 10.1016/j.scr.2016.08.007; Platonova N, 2007, CELL TISSUE RES, V328, P301, DOI 10.1007/s00441-006-0364-4; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Shan ZZ, 2015, AM J CANCER RES, V5, P344; Sun CC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.94; Trowe MO, 2013, DEVELOPMENT, V140, P2299, DOI 10.1242/dev.094524; Wansleben S, 2014, BBA-REV CANCER, V1846, P380, DOI 10.1016/j.bbcan.2014.08.004; Willmer T, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0019-0; Willmer T, 2015, CELL CYCLE, V14, P3173, DOI 10.1080/15384101.2015.1080398; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhao L, 2012, DEV CELL, V22, P585, DOI 10.1016/j.devcel.2011.12.023	38	15	15	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2773	2792		10.1038/s41388-017-0090-2	http://dx.doi.org/10.1038/s41388-017-0090-2			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511350				2022-12-26	WOS:000432929800002
J	Liu, YY; Chen, MB; Cheng, L; Zhang, ZQ; Yu, ZQ; Jiang, Q; Chen, G; Cao, C				Liu, Yuan-yuan; Chen, Min-Bin; Cheng, Long; Zhang, Zhi-qing; Yu, Zheng-quan; Jiang, Qin; Chen, Gang; Cao, Cong			microRNA-200a downregulation in human glioma leads to G alpha i1 over-expression, Akt activation, and cell proliferation	ONCOGENE			English	Article							CANCER STATISTICS; TUMOR-SUPPRESSOR; COMPLEX; GENE; RESISTANCE; SURVIVAL; THERAPY; KINASE	We previously identified a pivotal role for G protein alpha inhibitory subunit 1 (G alpha i1) in mediating PI3K-Akt signaling by receptor tyrosine kinases (RTKs). Here, we examined the expression and biological function of G alpha i1 in human glioma. G alpha i1 mRNA and protein expression were significantly upregulated in human glioma tissues, which correlated with downregulation of an anti-G alpha i1 miRNA: microRNA-200a ("miR-200a"). Forced-expression of miR-200a in established (A172/U251MG lines) and primary (patient-derived) human glioma cells resulted in G alpha i1 downregulation, Akt inactivation and proliferation inhibition. Reduction of G alpha i1 expression by shRNA, dominant negative mutant interference, or complete G alpha i1 depletion inhibited Akt activation and cell proliferation. Notably, miR-200a was unable to inhibit glioma cell proliferation when G alpha i1 was silenced or mutated. Co-immunoprecipitation studies, in human glioma cells and tissues, show that G alpha i1 forms a complex with multiple RTKs (EGFR, PDGFR alpha, and FGFR) and the adapter protein Gab1. In vivo, the growth of subcutaneous and orthotopic glioma xenografts in nude mice was largely inhibited by expression of G alpha i1 shRNA or miRNA-200a. Collectively, miR-200a downregulation in human glioma leads to G alpha i1 over-expression, Akt activation and glioma cell proliferation.	[Liu, Yuan-yuan] Jiangsu Univ, Kunshan Peoples Hosp 1, Clin Res & Lab Ctr, Kunshan, Peoples R China; [Liu, Yuan-yuan; Cheng, Long; Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Liu, Yuan-yuan; Cheng, Long; Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China; [Chen, Min-Bin] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Radiotherapy & Oncol, Kunshan, Peoples R China; [Cheng, Long] Soochow Univ, Affiliated Hosp 2, Dept Intervent Radiol, Suzhou, Peoples R China; [Yu, Zheng-quan; Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Jiang, Qin; Cao, Cong] Nanjing Med Univ, Affiliated Eye Hosp, Nanjing, Jiangsu, Peoples R China; [Cao, Cong] Municipal Hosp Suzhou, Suzhou, Peoples R China	Jiangsu University; Soochow University - China; Soochow University - China; Jiangsu University; Soochow University - China; Soochow University - China; Nanjing Medical University	Cao, C (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China.; Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Peoples R China.; Chen, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China.; Jiang, Q; Cao, C (corresponding author), Nanjing Med Univ, Affiliated Eye Hosp, Nanjing, Jiangsu, Peoples R China.; Cao, C (corresponding author), Municipal Hosp Suzhou, Suzhou, Peoples R China.	Jqin710@vip.sina.com; nju_neurosurgery@163.com; caocong@suda.edu.cn	liu, yuanyuan/GWZ-5838-2022		National Natural Science Foundation of China [81771457, 81371055, 81570859, 81302195, 31371139, 81502162, 81571282, 81472786, 81773192]; Natural Science Foundation of Jiangsu Province [BK20130301, BK20170060, BK20171248]; Clinical Special Project of Suzhou [LCZX201601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Clinical Special Project of Suzhou	This study was supported in part by grants from the National Natural Science Foundation of China (81502162, 81771457, 81371055, and 81570859, 81302195, 31371139 and 81502162, 81571282, 81472786, and 81773192); Grants from Natural Science Foundation of Jiangsu Province (BK20130301, BK20170060, and BK20171248), and by Clinical Special Project of Suzhou (LCZX201601). We thank Dr. John Marshall for English edits and proof-reading of the manuscript.	Agnihotri S, 2012, J CLIN INVEST, V122, P253, DOI 10.1172/JCI59334; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Bostrom J, 1998, CANCER RES, V58, P29; Cai S, 2017, ONCOTARGET, V8, P35061, DOI 10.18632/oncotarget.17043; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Faivre S, 2001, MOL PHARMACOL, V60, P363, DOI 10.1124/mol.60.2.363; Fan JB, 2016, ONCOTARGET, V7, P70613, DOI 10.18632/oncotarget.12138; FURMAN MA, 1977, J NEUROSURG, V46, P477, DOI 10.3171/jns.1977.46.4.0477; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Li KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25525; Li XJ, 2015, P NATL ACAD SCI USA, V112, P4731, DOI 10.1073/pnas.1503779112; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; Li Z, 2016, ONCOTARGET; Liu M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150092; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Pollack IF, 2010, NAT REV NEUROL, V6, P533, DOI 10.1038/nrneurol.2010.144; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Wang ZW, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-10; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Zhang D, 2016, TUMOR BIOL, V37, P1327, DOI 10.1007/s13277-015-3922-0; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang YM, 2015, J INVEST DERMATOL, V135, P181, DOI 10.1038/jid.2014.326	39	62	63	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2890	2902		10.1038/s41388-018-0184-5	http://dx.doi.org/10.1038/s41388-018-0184-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29520106				2022-12-26	WOS:000432929800010
J	Smith, DL; Kerns, JP; Walker, NR; Payne, AF; Horvath, B; Inguagiato, JC; Kaminski, JE; Tomaso-Peterson, M; Koch, PL				Smith, D. L.; Kerns, J. P.; Walker, N. R.; Payne, A. F.; Horvath, B.; Inguagiato, J. C.; Kaminski, J. E.; Tomaso-Peterson, M.; Koch, P. L.			Development and validation of a weather-based warning system to advise fungicide applications to control dollar spot on turfgrass	PLOS ONE			English	Article							HEAD BLIGHT EPIDEMICS; CREEPING BENTGRASS; SCLEROTINIA-HOMOEOCARPA; FIELD VALIDATION; PLANT PATHOLOGY; METAANALYSIS; DISEASE; MODEL; CULTIVARS; BIOLOGY	Dollar spot is one of the most common diseases of golf course turfgrass and numerous fungicide applications are often required to provide adequate control. Weather-based disease warning systems have been developed to more accurately time fungicide applications; however, they tend to be ineffective and are not currently in widespread use. The primary objective of this research was to develop a new weather-based disease warning system to more accurately advise fungicide applications to control dollar spot activity across a broad geographic and climactic range. The new dollar spot warning system was developed from data collected at field sites in Madison, WI and Stillwater, OK in 2008 and warning system validation sites were established in Madison, WI, Stillwater, OK, Knoxville, TN, State College, PA, Starkville, MS, and Storrs, CT between 2011 and 2016. A meta-analysis of all site-years was conducted and the most effective warning system for dollar spot development consisted of a five-day moving average of relative humidity and average daily temperature. Using this model the highest effective probability that provided dollar spot control similar to that of a calendar-based program across the numerous sites and years was 20%. Additional analysis found that the 20% spray threshold provided comparable control to the calendar-based program while reducing fungicide usage by up to 30%, though further refinement may be needed as practitioners implement this warning system in a range of environments not tested here. The weather-based dollar spot warning system presented here will likely become an important tool for implementing precision disease management strategies for future turfgrass managers, especially as financial and regulatory pressures increase the need to reduce pesticide usage on golf course turfgrass.	[Smith, D. L.; Koch, P. L.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Kerns, J. P.] North Carolina State Univ, Dept Plant Pathol & Entomol, Raleigh, NC USA; [Walker, N. R.; Payne, A. F.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK USA; [Horvath, B.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Inguagiato, J. C.] Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT USA; [Kaminski, J. E.] Penn State Univ, Dept Plant Sci, State Coll, PA USA; [Tomaso-Peterson, M.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Connecticut; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Mississippi State University	Koch, PL (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	plkoch@wisc.edu	Kerns, James/AAC-3208-2020	Kerns, James/0000-0002-1980-0126	United States Golf Association; Wisconsin Turfgrass Association; Oklahoma Turfgrass Research Foundation	United States Golf Association; Wisconsin Turfgrass Association; Oklahoma Turfgrass Research Foundation	Funding for this work was provided by the United States Golf Association (www.usga.org) to D. Smith, the Wisconsin Turfgrass Association (www.wisconsinturfgrassasseciation.org) to J. Kerns, and the Oklahoma Turfgrass Research Foundation (www.otrf.org) to D. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, P249, DOI [10.1016/B978-0-08-047378-9.50013-0, DOI 10.1016/B978-0-08-047378-9.50013-0]; Allison P. D., 1999, LOGISTIC REGRESSION; Bennett FT, 1937, ANN APPL BIOL, V24, P236, DOI 10.1111/j.1744-7348.1937.tb05032.x; BURPEE L, 1992, PLANT DIS, V76, P112, DOI 10.1094/PD-76-0112; BURPEE LL, 1986, CAN J PLANT SCI, V66, P345, DOI 10.4141/cjps86-049; Cordova LG, 2017, PLANT DIS, V101, P1910, DOI 10.1094/PDIS-04-17-0477-RE; De Wolf ED, 2003, PHYTOPATHOLOGY, V93, P428, DOI 10.1094/PHYTO.2003.93.4.428; DeVries RE, 2008, PLANT DIS, V92, P83, DOI 10.1094/PDIS-92-1-0083; Fidanza MA, 1996, PHYTOPATHOLOGY, V86, P385, DOI 10.1094/Phyto-86-385; Golf Course Superintendents Association of America, 2007, GOLF COURS ENV PROF, V1; GOODMAN DM, 1991, PHYTOPATHOLOGY, V81, P1438, DOI 10.1094/Phyto-81-1438; HALL R, 1984, CAN J PLANT SCI, V64, P167, DOI 10.4141/cjps84-021; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaminski JE, 2007, PLANT DIS, V91, P565, DOI 10.1094/PDIS-91-5-0565; Kovach J, 1992, N Y FOOD LIFE SCI B, V139; Langston DB, 2002, PLANT DIS, V86, P118, DOI 10.1094/PDIS.2002.86.2.118; Madden LV, 2011, PHYTOPATHOLOGY, V101, P16, DOI 10.1094/PHYTO-03-10-0069; Maqbool F, 2016, LIFE SCI, V145, P265, DOI 10.1016/j.lfs.2015.10.022; Miller GL, 2002, PLANT DIS, V86, P1240, DOI 10.1094/PDIS.2002.86.11.1240; Mills S. G., 1982, GREENMASTER, V18, P14; Paul PA, 2011, PHYTOPATHOLOGY, V101, P1122, DOI 10.1094/PHYTO-03-11-0091; Rogers PM, 2006, PLANT DIS, V90, P358, DOI 10.1094/PD-90-0358; Ryan CP, 2012, HORTSCIENCE, V47, P422, DOI 10.21273/HORTSCI.47.3.422; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Scherm H, 2014, ANNU REV PHYTOPATHOL, V52, P453, DOI 10.1146/annurev-phyto-102313-050214; Shah DA, 2013, PHYTOPATHOLOGY, V103, P906, DOI 10.1094/PHYTO-11-12-0304-R; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Smiley RW., 2005, COMPENDIUM TURFGRASS, DOI DOI 10.1094/9780890546154; Smith DL, 2007, PLANT DIS, V91, P1436, DOI 10.1094/PDIS-91-11-1436; Smith DL, 2011, PHYTOPATHOLOGY, V101, pS268; Sullivan MJ, 2003, PLANT DIS, V87, P923, DOI 10.1094/PDIS.2003.87.8.923; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; Wilbur JF, 2017, PLANT DIS, P101; Wilson CJ, 2011, THESIS; World Golf Foundation, 2012, GOLF 20 20 2011 GOLF	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194216	10.1371/journal.pone.0194216	http://dx.doi.org/10.1371/journal.pone.0194216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522560	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800046
J	Ann, SJ; Kim, KK; Cheon, EJ; Noh, HM; Hwang, I; Yu, JW; Park, S; Kang, SM; Manabe, I; Miller, YI; Kim, S; Lee, SH				Ann, Soo-jin; Kim, Ka-Kyung; Cheon, Eun Jeong; Noh, Hye-Min; Hwang, Inhwa; Yu, Je-Wook; Park, Sungha; Kang, Seek-Min; Manabe, Ichiro; Miller, Yury I.; Kim, Sangwoo; Lee, Sang-Hak			Palmitate and minimally-modified low-density lipoprotein cooperatively promote inflammatory responses in macrophages	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; TOLL-LIKE RECEPTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; INNATE IMMUNITY; RECOGNITION; BINDS; CYCLOOXYGENASE-2; ATHEROSCLEROSIS; CHOLESTEROL	Increased consumption of Western-type diets and environmental insults lead to wide-spread increases in the plasma levels of saturated fatty acids and lipoprotein oxidation. The aim of this study is to examine whether palmitate and minimally modified low-density lipoprotein (mmLDL) exert an additive effect on macrophage activation. We found that CXCL2 and TNF-alpha secretion as well as ERK and p38 phosphorylation were additively increased by co-treatment of J774 macrophages with palmitate and mmLDL in the presence of lipopolysaccharide (LPS). Furthermore, the analysis of differentially expressed genes using the KEGG database revealed that several pathways, including cytokine-cytokine receptor interaction, and genes were significantly altered. These results were validated with real-time PCR, showing upregulation of 11-6, Csf3, XI-1P, and Clec4d. The present study demonstrated that palmitate and mmLDL additively potentiate the LPS-induced activation of macrophages. These results suggest the existence of synergistic mechanisms by which saturated fatty acids and oxidized lipoproteins activate immune cells.	[Ann, Soo-jin; Cheon, Eun Jeong; Noh, Hye-Min; Park, Sungha; Kang, Seek-Min; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Ann, Soo-jin; Cheon, Eun Jeong; Noh, Hye-Min; Park, Sungha; Kang, Seek-Min; Lee, Sang-Hak] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Kim, Ka-Kyung; Kim, Sangwoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Hwang, Inhwa; Yu, Je-Wook] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Manabe, Ichiro] Chiba Univ, Grad Sch Med, Dept Dis Biol & Mol Med, Chiba, Japan; [Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chiba University; University of California System; University of California San Diego	Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.; Kim, S (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	swkim@yuhs.ac; shl1106@yuhs.ac	Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021	Kang, Seok-Min/0000-0001-9856-9227; Hwang, Inhwa/0000-0001-5235-3519; Kim, Sangwoo/0000-0001-5356-0827; Park, Sungha/0000-0001-5362-478X; Yu, Je-Wook/0000-0001-5943-4071	Yonsei University College of Medicine [6-2011-0162, 6-2016-0081]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A4A1029061, 2014R1A1A2056104]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) [CAP-12-2-KBSI]; US National Institute of Health [HL135737]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135737] Funding Source: NIH RePORTER	Yonsei University College of Medicine(General Electric); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was financially supported by a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0162) (SH Lee), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104) (SH Lee), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138) (SH Lee), the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI) (SH Lee), a faculty research grant of Yonsei University College of Medicine (6-2016-0081) (S Kim), and a grant HL135737 from the US National Institute of Health (Y.I.Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Choi SH, 2017, BBA-MOL CELL BIOL L, V1862, P393, DOI 10.1016/j.bbalip.2016.06.020; Choi SH, 2016, BIOCHEM BIOPH RES CO, V470, P877, DOI 10.1016/j.bbrc.2016.01.126; Choi SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083145; Choi SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032378; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eguchi K, 2014, J ATHEROSCLER THROMB, V21, P629, DOI 10.5551/jat.22533; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Ichioka M, 2011, DIABETES, V60, P819, DOI 10.2337/db10-0864; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Karagiannis GS, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-4; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2017, TRENDS ENDOCRIN MET, V28, P143, DOI 10.1016/j.tem.2016.11.002; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004	35	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193649	10.1371/journal.pone.0193649	http://dx.doi.org/10.1371/journal.pone.0193649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518116	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900031
J	Bongiorno, T; Gura, J; Talwar, P; Chambers, D; Young, KM; Arafat, D; Wang, GH; Jackson-Holmes, EL; Qiu, P; McDevitt, TC; Sulchek, T				Bongiorno, Tom; Gura, Jeremy; Talwar, Priyanka; Chambers, Dwight; Young, Katherine M.; Arafat, Delia; Wang, Gonghao; Jackson-Holmes, Emily L.; Qiu, Peng; McDevitt, Todd C.; Sulchek, Todd			Biophysical subsets of embryonic stem cells display distinct phenotypic and morphological signatures	PLOS ONE			English	Article							SELF-RENEWAL; VISCOELASTIC PROPERTIES; PRECURSOR CELLS; PCR EFFICIENCY; LAMIN A/C; IN-VITRO; DIFFERENTIATION; MOUSE; EXPRESSION; MECHANICS	The highly proliferative and pluripotent characteristics of embryonic stem cells engender great promise for tissue engineering and regenerative medicine, but the rapid identification and isolation of target cell phenotypes remains challenging. Therefore, the objectives of this study were to characterize cell mechanics as a function of differentiation and to employ differences in cell stiffness to select population subsets with distinct mechanical, morphological, and biological properties. Biomechanical analysis with atomic force microscopy revealed that embryonic stem cells stiffened within one day of differentiation induced by leukemia inhibitory factor removal, with a lagging but pronounced change from spherical to spindle-shaped cell morphology. A microfluidic device was then employed to sort a differentially labeled mixture of pluripotent and differentiating cells based on stiffness, resulting in pluripotent cell enrichment in the soft device outlet. Furthermore, sorting an unlabeled population of partially differentiated cells produced a subset of "soft" cells that was enriched for the pluripotent phenotype, as assessed by post-sort characterization of cell mechanics, morphology, and gene expression. The results of this study indicate that intrinsic cell mechanical properties might serve as a basis for efficient, high-throughput, and label-free isolation of pluripotent stem cells, which will facilitate a greater biological understanding of pluripotency and advance the potential of pluripotent stem cell differentiated progeny as cell sources for tissue engineering and regenerative medicine.	[Bongiorno, Tom; Wang, Gonghao; Sulchek, Todd] Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Gura, Jeremy; Talwar, Priyanka; Chambers, Dwight; Young, Katherine M.; Qiu, Peng; Sulchek, Todd] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gura, Jeremy; Talwar, Priyanka; Chambers, Dwight; Young, Katherine M.; Qiu, Peng; Sulchek, Todd] Emory Univ, Atlanta, GA 30322 USA; [Arafat, Delia] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Jackson-Holmes, Emily L.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [McDevitt, Todd C.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [McDevitt, Todd C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sulchek, Todd] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University System of Georgia; Georgia Institute of Technology	Sulchek, T (corresponding author), Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Sulchek, T (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Sulchek, T (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Sulchek, T (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	todd.sulchek@me.gatech.edu	Bongiorno, Tom/B-6837-2014	Bongiorno, Tom/0000-0003-1768-2207; Gura, Jeremy/0000-0002-5377-7134; Young, Katherine/0000-0001-6567-3335; Chambers, Dwight/0000-0003-0814-9136	National Institute of General Medical Sciences Biotechnology Training Grant on Cell and Tissue Engineering [T32 GM008433]; National Science Foundation Stem Cell Biomanufacturing Integrative Graduate Education and Research Traineeship [DGE 0965945]; National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation [1538161]; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems [CBET1538161]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, T32GM008433] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Biotechnology Training Grant on Cell and Tissue Engineering; National Science Foundation Stem Cell Biomanufacturing Integrative Graduate Education and Research Traineeship; National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation(National Science Foundation (NSF)); National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institute of General Medical Sciences Biotechnology Training Grant on Cell and Tissue Engineering (T32 GM008433, https://researchtraining.nih.gov/programs/training-grants/T32) and the National Science Foundation Stem Cell Biomanufacturing Integrative Graduate Education and Research Traineeship (DGE 0965945, http://www.igert.org/public/about) to TB as well as the National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation (1538161, https://www.nsf.gov/div/index.jsp?div=CMMI) and the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET1538161, https://www.nsf.gov/div/index.jsp?div=CBET) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059928; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bongiorno T, 2016, BIOPHYS J, V111, P1761, DOI 10.1016/j.bpj.2016.09.005; Bongiorno T, 2014, J BIOMECH, V47, P2197, DOI 10.1016/j.jbiomech.2013.11.017; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Diogo MM, 2012, BIOTECHNOL BIOENG, V109, P2699, DOI 10.1002/bit.24706; Eckersley-Maslin MA, 2013, NUCLEUS-PHILA, V4, P53, DOI 10.4161/nucl.23384; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Esue O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004411; Golpanian S, 2016, STEM CELL TRANSL MED, V5, P186, DOI 10.5966/sctm.2015-0101; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; HENTZE H, 2009, STEM CELL RES; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; KARLEN Y, 2007, BIOMED CENTRAL, V8, DOI DOI 10.1186/1471-2105-8-131; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kinney MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04290; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kropp EM, 2014, PROTEOM CLIN APPL, V8, P603, DOI 10.1002/prca.201400021; Kwak DH, 2006, EXP MOL MED, V38, P668, DOI 10.1038/emm.2006.79; Labriola NR, 2015, J BIOMECH, V48, P1058, DOI 10.1016/j.jbiomech.2015.01.033; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lulevich V, 2009, J PHYS CHEM B, V113, P6511, DOI 10.1021/jp8103358; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murray P, 2013, INT J BIOCHEM CELL B, V45, P2698, DOI 10.1016/j.biocel.2013.07.001; Neuringer IP, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-6; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pillarisetti A, 2011, CELL REPROGRAM, V13, P371, DOI 10.1089/cell.2011.0028; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/nmeth.2437, 10.1038/NMETH.2437]; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wachsstock DH, 1993, BIOPHYS J; Wang GH, 2015, MICROFLUID NANOFLUID, V19, P987, DOI 10.1007/s10404-015-1608-y; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075901; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Willoughby NA, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4939946; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang JL, 2011, AGING DIS, V2, P18	61	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192631	10.1371/journal.pone.0192631	http://dx.doi.org/10.1371/journal.pone.0192631			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518080	gold, Green Published, Green Submitted			2022-12-26	WOS:000426902900009
J	Maliszewska, J; Marcinkowska, S; Nowakowska, A; Kletkiewicz, H; Rogalska, J				Maliszewska, Justyna; Marcinkowska, Sonia; Nowakowska, Anna; Kletkiewicz, Hanna; Rogalska, Justyna			Altered heat nociception in cockroach Periplaneta americana L. exposed to capsaicin	PLOS ONE			English	Article							OXIDATIVE STRESS; RECEPTOR ANTAGONIST; VANILLOID RECEPTORS; LIPID-PEROXIDATION; TRP CHANNELS; CAPSAZEPINE; THERMOREGULATION; INFLAMMATION; NEURONS; RAT	Some natural alkaloids, e.g. capsaicin and camphor, are known to induce a desensitization state, causing insensitivity to pain or noxious temperatures in mammals by acting on TRP receptors. Our research, for the first time, demonstrated that a phenomenon of pharmacological blockade of heat sensitivity may operate in American cockroach, Periplaneta americana (L.). We studied the escape reaction time from 50 degrees C for American cockroaches exposed to multiple doses of different drugs affecting thermo-TRP. Capsaicin, capsazepine, and camphor induced significant changes in time spent at noxious ambient temperatures. Moreover, we showed that behavioral thermoregulation in normal temperature ranges (10-40 degrees C) is altered in treated cockroaches, which displayed a preference for warmer regions compared to non-treated insects. We also measured the levels of malondialdehyde (MDA) and catalase activity to exclude the secondary effects of the drugs on these processes. Our results demonstrated that increase in time spent at 50 degrees C (five versus one trial at a heat plate) induced oxidative stress, but only in control and vehicle-treated groups. In capsaicin, capsazepine, menthol, camphor and AITC-treated cockroaches the number of exposures to heat had no effect on the levels of MDA. Additionally, none of the tested compounds affected catalase activity. Our results demonstrate suppression of the heat sensitivity by repeated capsazepine, camphor and capsaicin administration in the American cockroach.	[Maliszewska, Justyna; Marcinkowska, Sonia; Nowakowska, Anna; Kletkiewicz, Hanna; Rogalska, Justyna] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Anim Physiol, Torun, Poland	Nicolaus Copernicus University	Maliszewska, J (corresponding author), Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Anim Physiol, Torun, Poland.	ojustyna@umk.pl	Nowakowska, Anna/P-9769-2019; Rogalska, Justyna/G-6693-2014; Rogalska, Justyna/AAN-6701-2020; Maliszewska, Justyna/G-5172-2014	Nowakowska, Anna/0000-0003-4016-1522; Rogalska, Justyna/0000-0002-7819-7814; Rogalska, Justyna/0000-0002-7819-7814; Maliszewska, Justyna/0000-0002-0089-3123	National Science Centre, Poland [2016/23/D/NZ4/01394]	National Science Centre, Poland(National Science Centre, Poland)	This study was funded by the grant from the National Science Centre, Poland ( grant no. 2016/23/D/NZ4/01394). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the grant from the National Science Centre, Poland ( grant no. 2016/23/D/NZ4/01394). The authors would like to thank the Reviewers for valuable comments that greatly improved this manuscript.	Abdelgaleil SAM, 2009, J CHEM ECOL, V35, P518, DOI 10.1007/s10886-009-9635-3; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Aldrich BT, 2010, J NEUROGENET, V24, P33, DOI 10.3109/01677060903419751; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Alpizar YA, 2014, PFLUG ARCH EUR J PHY, V466, P507, DOI 10.1007/s00424-013-1334-9; Ambudkar I. S., 2007, V179, P541; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; BALL HAROLD J., 1965, J INSECT PHYSIOL, V11, P1311, DOI 10.1016/0022-1910(65)90166-6; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Chen WY, 2013, MOLECULES, V18, P5434, DOI 10.3390/molecules18055434; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Crouzin N, 2010, MOL NUTR FOOD RES, V54, P496, DOI 10.1002/mnfr.200900188; Diplock A.T., 1991, TECHNIQUES FREE RADI; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; DONNERER J, 1983, BRIT J PHARMACOL, V79, P719, DOI 10.1111/j.1476-5381.1983.tb10009.x; French AS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00207; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009267; Jakab B, 2005, EUR J PHARMACOL, V517, P35, DOI 10.1016/j.ejphar.2005.05.002; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; KELLY KM, 1990, J INSECT PHYSIOL, V36, P287, DOI 10.1016/0022-1910(90)90113-T; Kistner K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28621; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Kuenzi FM, 1996, BRIT J PHARMACOL, V119, P81, DOI 10.1111/j.1476-5381.1996.tb15680.x; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; Liu ZG, 2015, FOOD CHEM TOXICOL, V82, P12, DOI 10.1016/j.fct.2015.04.025; Luqman S, 2006, PHYTOTHER RES, V20, P303, DOI 10.1002/ptr.1861; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Maliszewska J, 2016, EUR J ENTOMOL, V113, P315, DOI 10.14411/eje.2016.040; Maruyama T, 2007, INT ARCH ALLERGY IMM, V143, P144, DOI 10.1159/000099081; Masamoto Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1021, DOI 10.1271/bbb.80796; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Olszewska J, 2011, J COMP PHYSIOL A, V197, P1021, DOI 10.1007/s00359-011-0657-2; Orta-Zavalza E., 2014, MOL MICROBIOL, V4, P1072, DOI [10.21769/bioprotoc.1072, DOI 10.21769/BIOPROTOC.1072]; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Schwartz ES, 2008, PAIN, V138, P514, DOI 10.1016/j.pain.2008.01.029; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Spurr E.B., 2003, Science for Conservation (Wellington), V232, P1; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; SZALLASI A, 1990, BRAIN RES, V524, P106, DOI 10.1016/0006-8993(90)90498-Z; Szallasi A, 2002, AM J CLIN PATHOL, V118, P110; Szallasi A, 1999, PHARMACOL REV, V51, P159; SZIKSZAY M, 1982, N-S ARCH PHARMACOL, V320, P97, DOI 10.1007/BF00506307; Tominaga M, 2000, JPN J PHARMACOL, V83, P20, DOI 10.1254/jjp.83.20; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; VERHAERT P, 1985, HISTOCHEMISTRY, V83, P501, DOI 10.1007/BF00492451; Wang Y, 2001, FREE RADICAL BIO MED, V30, P1254, DOI 10.1016/S0891-5849(01)00520-2; Wei JJ, 2015, INSECT MOL BIOL, V24, P412, DOI 10.1111/imb.12168; Wetsel WC, 2011, INT J HYPERTHER, V27, P388, DOI 10.3109/02656736.2011.554337; Wicher D, 2006, J BIOL CHEM, V281, P3227, DOI 10.1074/jbc.M511741200; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yeom HJ, 2015, J AGR FOOD CHEM, V63, P2241, DOI 10.1021/jf505927n; Yu YM, 2016, J FOOD DRUG ANAL, V24, P556, DOI 10.1016/j.jfda.2016.02.004; ZABALA NA, 1991, PHARMACOL BIOCHEM BE, V40, P887, DOI 10.1016/0091-3057(91)90102-8; Zermoglio PF, 2015, J INSECT PHYSIOL, V81, P145, DOI 10.1016/j.jinsphys.2015.07.014; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	65	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194109	10.1371/journal.pone.0194109	http://dx.doi.org/10.1371/journal.pone.0194109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518142	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900068
J	Li, XH; Yang, R; Chen, HM				Li, Xiaohui; Yang, Rui; Chen, Haimin			The Arabidopsis thaliana Mediator subunit MED8 regulates plant immunity to Botrytis Cinerea through interacting with the basic helix-loop-helix (bHLH) transcription factor FAMA	PLOS ONE			English	Article							NECROTROPHIC FUNGAL PATHOGENS; SYSTEMIC ACQUIRED-RESISTANCE; STOMATAL DEVELOPMENT; GENE-EXPRESSION; ABSCISIC-ACID; GUARD-CELLS; COMPLEX SUBUNIT16; JASMONATE; DIFFERENTIATION; DEFENSE	The Mediator complex is at the core of transcriptional regulation and plays a central role in plant immunity. The MEDIATOR25 (MED25) subunit of Arabidopsis thaliana regulates jasmonate-dependent resistance to Botrytis cinerea through interacting with the basic helixloop-helix (bHLH) transcription factor of jasmonate signaling, MYC2. Another Mediator subunit, MED8, acts independently or together with MED25 in plant immunity. However, unlike MED25, the underlying action mechanisms of MED8 in regulating B. cinerea resistance are still unknown. Here, we demonstrated that MED8 regulated plant immunity to B. cinerea through interacting with another bHLH transcription factor, FAMA, which was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed plants displayed enhanced resistance to B. cinerea infection and increased expression levels of defensin genes following B. cinerea treatment. Genetic analysis of MED8 and FAMA suggested that FAMA-regulated pathogen resistance was dependent on MED8. In addition, MED8 and FAMA were both associated with the G-box region in the promoter of ORA59. Our findings indicate that the MED8 subunit of the A. thaliana Mediator regulates plant immunity to B. cinerea through interacting with the transcription factor FAMA, which was discovered to be a key component in B. cinerea resistance.	[Li, Xiaohui; Yang, Rui; Chen, Haimin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China	Ningbo University	Li, XH (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China.	lixiaohui@nbu.edu.cn			National Natural Science Foundation of China [31600986]; Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China(Ministry of Education, China - 111 Project); K. C. Wong Magna Fund in Ningbo University	This work was supported by the National Natural Science Foundation of China (31600986); Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; and partly sponsored by K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Birkenbihl RP, 2016, PLANT CELL; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen L, 2016, DEVELOPMENT, V143, P1600, DOI 10.1242/dev.129098; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Chhun T, 2016, PLANT CELL PHYSIOL, V57, P1689, DOI 10.1093/pcp/pcw095; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Hachez C, 2011, PLANT PHYSIOL, V155, P1458, DOI 10.1104/pp.110.167718; Hahlbrock K, 2003, P NATL ACAD SCI USA, V100, P14569, DOI 10.1073/pnas.0831246100; Hemsley PA, 2014, PLANT CELL, V20, P9812; Hsieh TF, 2001, EUR J PLANT PATHOL, V107, P571, DOI 10.1023/A:1017947328718; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laluk K., 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Lee E, 2014, PLANT J, V78, P566, DOI 10.1111/tpj.12516; Li B, 2016, CELL HOST MICROBE, V19, P641, DOI 10.1016/j.chom.2016.04.011; Li M, 2014, PLANT CELL, V26, P4053, DOI 10.1105/tpc.114.129726; Li WQ, 2015, PLANT J, V81, P282, DOI 10.1111/tpj.12725; Liao CJ, 2016, PLANT CELL, V28, P1662, DOI 10.1105/tpc.16.00105; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Matos JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03271; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Seguela-Arnaud M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0592-4; Serna L, 2009, PLANT PHYSIOL, V149, P1625, DOI 10.1104/pp.108.133090; Shirakawa M, 2014, PLANT CELL, V26, P4039, DOI 10.1105/tpc.114.129874; Song SS, 2014, PLANT CELL, V26, P263, DOI 10.1105/tpc.113.120394; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Torii KU, 2007, PLANT SIGNAL BEHAV, V2, P311, DOI 10.4161/psb.2.4.4072; Tricker PJ, 2012, J EXP BOT, V63, P3799, DOI 10.1093/jxb/ers076; Wang CG, 2015, PLANT PHYSIOL, V169, P856, DOI 10.1104/pp.15.00351; Wang FQ, 2011, PLANT CELL REP, V30, P2117, DOI 10.1007/s00299-011-1118-7; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Xu R, 2012, PLANT SIGNAL BEHAV, V7, P182, DOI 10.4161/psb.18803; Zhai QZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003422; Zhang XD, 2013, PLANT J, V75, P484, DOI 10.1111/tpj.12216; Zhang XD, 2012, PLANT CELL, V24, P4294, DOI 10.1105/tpc.112.103317; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu JY, 2011, METHODS MOL BIOL MET, V876; Zhu YF, 2014, PLANT CELL, V26, P4149, DOI 10.1105/tpc.114.128611; Zou JJ, 2015, PLANT CELL, V27, P1445, DOI 10.1105/tpc.15.00144	65	16	17	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193458	10.1371/journal.pone.0193458	http://dx.doi.org/10.1371/journal.pone.0193458			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513733	Green Published, gold			2022-12-26	WOS:000426896800062
J	Liu, PD; You, XL				Liu, Peide; You, Xinli			Some linguistic neutrosophic Hamy mean operators and their application to multi-attribute group decision making	PLOS ONE			English	Article							AGGREGATION OPERATORS; SYMMETRIC FUNCTION; ENTROPY; MODEL	Linguistic neutrosophic numbers (LNNs) can easily describe the incomplete and indeterminate information by the truth, indeterminacy, and falsity linguistic variables (LVs), and the Hamy mean (HM) operator is a good tool to deal with multiple attribute group decision making (MAGDM) problems because it can capture the interrelationship among the multi-input arguments. Motivated by these ideas, we develop linguistic neutrosophic HM (LNHM) operator and weighted linguistic neutrosophic HM (WLNHM) operator. Some desirable properties and special cases of two operators are discussed in detail. Furthermore, considering the situation in which the decision makers (DMs) can't give the suitable weight of each attribute directly from various reasons, we propose the concept of entropy for linguistic neutrosophic set (LNS) to obtain the attribute weight vector objectively, and then the method for MAGDM problems with LNNs is proposed, and some examples are used to illustrate the effectiveness and superiority of the proposed method by comparing with the existing methods.	[Liu, Peide; You, Xinli] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China	Shandong University of Finance & Economics	Liu, PD (corresponding author), Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China.	Peide.liu@gmail.com	Liu, Peide/D-3392-2013	Liu, Peide/0000-0001-5048-8145	National Natural Science Foundation of China [71771140, 71471172]; Special Funds of Taishan Scholars Project of Shandong Province [ts201511045]; Shandong Province Higher Educational Science and Technology Program [J16LN25, J17KA189]; National Natural Science Foundation of China [71771140, 71471172]; Special Funds of Taishan Scholars Project of Shandong Province [ts201511045]; Shandong Province Higher Educational Science and Technology Program [J16LN25, J17KA189]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds of Taishan Scholars Project of Shandong Province; Shandong Province Higher Educational Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds of Taishan Scholars Project of Shandong Province; Shandong Province Higher Educational Science and Technology Program	This work is supported by the National Natural Science Foundation of China (Nos. 71771140 and 71471172), the Special Funds of Taishan Scholars Project of Shandong Province (No. ts201511045) and a Project of Shandong Province Higher Educational Science and Technology Program (Nos. J16LN25 and J17KA189).	[Anonymous], 1977, IEEE T SYST MAN CYB, V7, P495, DOI [DOI 10.1109/TSMC.1977.4309751, 10.1109/TSMC.1977.4309751]; Atanassov K., 1986, OMEGA, V20, P87; Celik E, 2014, J INTELL FUZZY SYST, V27, P2847, DOI 10.3233/IFS-141246; Chen ZC, 2015, INT J COMPUT INT SYS, V8, P747, DOI 10.1080/18756891.2015.1061394; Chu YM, 2012, J MULTIVARIATE ANAL, V105, P412, DOI 10.1016/j.jmva.2011.08.004; DELUCA A, 1972, INFORM CONTROL, V20, P301, DOI 10.1016/S0019-9958(72)90199-4; Fan CX, 2017, INFORMATION, V8, DOI 10.3390/info8030107; Fang ZB, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9070111; Guan KZ, 2006, MATH INEQUAL APPL, V9, P797, DOI 10.7153/mia-09-70; Guan KZ, 2011, J MATH ANAL APPL, V376, P494, DOI 10.1016/j.jmaa.2010.10.014; Gurbuz T, 2014, APPL SOFT COMPUT, V21, P365, DOI 10.1016/j.asoc.2014.03.025; Hara Y, 1998, J INEQUAL APPL, V2, P387; Hashemkhani Zolfani S, 2015, J BUS ECON MANAG, V16, P290, DOI 10.3846/16111699.2014.967715; Herrera F, 1996, FUZZY SET SYST, V78, P73, DOI 10.1016/0165-0114(95)00107-7; Herrera F, 2000, FUZZY SET SYST, V115, P67, DOI 10.1016/S0165-0114(99)00024-X; Jiang W. D., 2007, J MATH INEQUAL, V1, P117, DOI DOI 10.7153/JMI-01-121131.260092347710; KOSKO B, 1986, INFORM SCIENCES, V40, P165, DOI 10.1016/0020-0255(86)90006-X; Liang RX, 2018, NEURAL COMPUT APPL, V30, P3383, DOI 10.1007/s00521-017-2925-8; Liang WZ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9080149; Liu PD, 2017, INT J INF TECH DECIS, V16, P817, DOI 10.1142/S0219622017500110; Majumdar P, 2012, ANN FUZZY MATH INFOR; Peng HG, 2018, INT J MACH LEARN CYB, V9, P1053, DOI 10.1007/s13042-016-0630-z; Peng JJ, 2017, INT J UNCERTAIN QUAN, V7, P355, DOI 10.1615/Int.J.UncertaintyQuantification.2017020126; Qin JD, 2017, GRANULAR COMPUT, V2, P249, DOI 10.1007/s41066-017-0041-x; Qin JD, 2015, J INTELL FUZZY SYST, V29, P171, DOI 10.3233/IFS-151584; Qin JD, 2015, INFORM SCIENCES, V297, P293, DOI 10.1016/j.ins.2014.11.022; Qin JD, 2014, J INTELL FUZZY SYST, V27, P2177, DOI 10.3233/IFS-141182; Rabbani A, 2014, EXPERT SYST APPL, V41, P7316, DOI 10.1016/j.eswa.2014.05.023; Shi LL, 2017, INFORMATION, V8, DOI 10.3390/info8040117; Szmidt E, 2001, FUZZY SET SYST, V118, P467, DOI 10.1016/S0165-0114(98)00402-3; Tian ZP, 2018, J INTELL FUZZY SYST, V34, P177, DOI 10.3233/JIFS-171055; Tian ZP, 2018, INT J MACH LEARN CYB, V9, P523, DOI 10.1007/s13042-016-0552-9; Wang JQ, 2018, NEURAL COMPUT APPL, V30, P1529, DOI 10.1007/s00521-016-2747-0; Wang JQ, 2018, J INTELL FUZZY SYST, V34, P381, DOI 10.3233/JIFS-171421; Wang L, 2018, INT J FUZZY SYST, V20, P13, DOI 10.1007/s40815-017-0373-3; Xu ZS, 2006, GROUP DECIS NEGOT, V15, P593, DOI 10.1007/s10726-005-9008-4; Xu ZS, 2011, IEEE T SYST MAN CY B, V41, P568, DOI 10.1109/TSMCB.2010.2072918; Xu ZS, 2004, INFORM SCIENCES, V168, P171, DOI 10.1016/j.ins.2004.02.003; Xu ZS, 2002, INT J INTELL SYST, V17, P709, DOI 10.1002/int.10045; Yager RR, 2001, IEEE T SYST MAN CY A, V31, P724, DOI 10.1109/3468.983429; YAGER RR, 1979, INT J MAN MACH STUD, V11, P189, DOI 10.1016/S0020-7373(79)80016-4; Ye J, 2017, INFORMATION, V8, DOI 10.3390/info8030110; Yu SM, 2018, INT J INTELL SYST, V33, P953, DOI 10.1002/int.21907; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; Zadeh LA, 1965, INT J GEN SYST, P129	45	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193027	10.1371/journal.pone.0193027	http://dx.doi.org/10.1371/journal.pone.0193027			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513697	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800030
J	Margulies, DH				Margulies, David H.			How MHC molecules grab citrullinated peptides to foster rheumatoid arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The molecular immunologist's dream is to elucidate a fundamental biochemical process that explains the basis of an affliction that affects millions of people, and that, precisely understood, might yield a rational approach to diagnosis, prevention, or therapy. In this issue of JBC, Ting et al. report proteomic, biochemical, and structural analyses that better explain how the antigen-presenting HLA-DR4 molecules bind citrullinated peptides to provoke rheumatoid arthritis (RA), a chronic autoimmune disease that affects 0.5-1% of the population.	[Margulies, David H.] NIAID, Lab Immune Syst Biol, NIH, Bldg 10,Rm 11D12,10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Lab Immune Syst Biol, NIH, Bldg 10,Rm 11D12,10 Ctr Dr, Bethesda, MD 20892 USA.	dhm@nih.gov	Margulies, David/W-2889-2019		NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000394, ZIAAI000622] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the NIAID, National Institutes of Health.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; PIKE RM, 1949, J IMMUNOL, V63, P447; Scally SW, 2017, ANN RHEUM DIS, V76, P1915, DOI 10.1136/annrheumdis-2017-211300; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Ting YT, 2018, J BIOL CHEM, V293, P3236, DOI 10.1074/jbc.RA117.001013	8	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3252	3253		10.1074/jbc.H118.001829	http://dx.doi.org/10.1074/jbc.H118.001829			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29500270	hybrid, Green Published			2022-12-26	WOS:000426562800018
J	Park, J; Kim, JH; Park, Y; Park, SJ; Cheon, JH; Kim, WH; Park, JS; Jeon, JY; Kim, TI				Park, Jihye; Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Park, Ji Soo; Jeon, Justin Y.; Kim, Tae Il			Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence	PLOS ONE			English	Article							PERCENTAGE BODY-FAT; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; CANCER RESECTION; BETA-BLOCKER; COLON-CANCER; RISK-FACTORS; FOLLOW-UP; SURVEILLANCE; HEALTH	Background and aim High heart rate is an independent predictor of total cancer incidence and all-cause mortality in patients with cancer. We aimed to evaluate the impact of resting heart rate on the recurrence of colorectal polyp, using long-term surveillance follow-up data of colorectal cancer survivors. Methods Three hundred patients were selected from the colorectal cancer survivor cohort of Severance Hospital, Seoul, Korea. Resting heart rate, physical activity, and body composition analysis at the time of 5-year survival, and clinical data including colonoscopy surveillance results were collected for mean follow-up duration of 8 years. Results Patients with a high resting heart rate showed a significantly higher recurrence rate of advanced adenoma than those with a low resting heart rate (quartile 1, 45-66 beats per minute (b.p.m.); quartile 2, 67-73 b.p.m.; quartile 3, 74-80 b.p.m.; quartile 4, 81-120 b.p.m.; 3.8% vs. 7.9% vs. 10.0% vs. 14.7%, p for trend = 0.018). After adjustment for various risk factors, patients in the highest quartile of resting heart rate (<= 81 b.p.m.) had a significantly higher risk of advanced adenoma recurrence (hazard ratio [HR]: 6.183, 95% confidence interval [CI]: 1.181-32.373, p = 0.031), compared to those in the lowest quartile (<= 66 b.p.m.). In subgroup analysis, the association of resting heart rate with advanced adenoma recurrence appeared to be stronger among patients who had more than normal body fat mass or sedentary life style. Conclusions Elevated resting heart rate was independently associated with a higher rate of advanced adenoma recurrence in colorectal cancer survivors.	[Park, Jihye; Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Kim, Tae Il] Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul, South Korea; [Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Kim, Tae Il] Yonsei Univ, Coll Med, Inst Gastroenterol, 50 Yonsei Ro, Seoul, South Korea; [Park, Ji Soo; Jeon, Justin Y.; Kim, Tae Il] Yonsei Univ, Canc Prevent Ctr, Coll Med, 50 Yonsei Ro, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, TI (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul, South Korea.; Kim, TI (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, 50 Yonsei Ro, Seoul, South Korea.; Jeon, JY; Kim, TI (corresponding author), Yonsei Univ, Canc Prevent Ctr, Coll Med, 50 Yonsei Ro, Seoul, South Korea.	jjeon@yonsei.ac.kr; taeilkim@yuhs.ac	Park, Yehyun/AAC-8861-2022; Cheon, Jae Hee/B-4523-2015; Park, Jihye/AAC-1333-2022	Park, Yehyun/0000-0001-8811-0631; Cheon, Jae Hee/0000-0002-2282-8904; Park, Jihye/0000-0002-5836-8735; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; Park, Ji Soo/0000-0002-0023-7740; Jeon, Justin/0000-0001-7978-4271	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1631020]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1631020).	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Anker MS, 2016, EUR J HEART FAIL, V18, P1524, DOI 10.1002/ejhf.670; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Aune D, 2017, NUTR METAB CARDIOVAS, V27, P504, DOI 10.1016/j.numecd.2017.04.004; Bauman AE, 2006, AM J PREV MED, V31, pS57, DOI 10.1016/j.amepre.2006.06.026; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Bohm M, 2017, EUR J HEART FAIL, V19, P250, DOI 10.1002/ejhf.689; Boyle T, 2014, CANCER CAUSE CONTROL, V25, P1659, DOI 10.1007/s10552-014-0470-7; Choi CH, 2014, J CANCER RES CLIN, V140, P1179, DOI 10.1007/s00432-014-1658-7; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Custodis F, 2010, J AM COLL CARDIOL, V56, P1973, DOI 10.1016/j.jacc.2010.09.014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Francois F, 2006, AM J GASTROENTEROL, V101, P823, DOI 10.1111/j.1572-0241.2006.00433.x; Gibson AL, 2008, AM J CLIN NUTR, V87, P332, DOI 10.1093/ajcn/87.2.332; Hassan C, 2006, DIGEST LIVER DIS, V38, P45, DOI 10.1016/j.dld.2005.09.005; Jang Hye-In, 2017, Obstet Gynecol Sci, V60, P170, DOI 10.5468/ogs.2017.60.2.170; Lee DH, 2016, BREAST CANCER RES TR, V159, P375, DOI 10.1007/s10549-016-3938-1; Lee SY, 2014, J DIGEST DIS, V15, P367, DOI 10.1111/1751-2980.12154; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Masur K, 2001, CANCER RES, V61, P2866; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Oh DJ, 2016, J EXERC REHABIL, V12, P42, DOI 10.12965/jer.150258; Paik JH, 2015, ANN COLOPROCTOL, V31, P182, DOI 10.3393/ac.2015.31.5.182; Park J, 2017, CANCER PREV RES, V10, P478, DOI 10.1158/1940-6207.CAPR-17-0065; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; Rosenberg L, 2006, CANCER EPIDEM BIOMAR, V15, P1438, DOI 10.1158/1055-9965.EPI-06-0079; Shin A, 2012, CANCER RES TREAT, V44, P219, DOI 10.4143/crt.2012.44.4.219; Vallance JK, 2015, J CANCER SURVIV, V9, P404, DOI 10.1007/s11764-014-0409-8; van Kruijsdijk RCM, 2014, CANCER EPIDEMIOL, V38, P715, DOI 10.1016/j.canep.2014.09.004; Verrier RL, 2009, HEART RHYTHM, V6, pS68, DOI 10.1016/j.hrthm.2009.07.017; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Yang HI, 2016, CLIN CHIM ACTA, V455, P195, DOI 10.1016/j.cca.2016.01.006; Yoon M, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015038	36	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193753	10.1371/journal.pone.0193753	http://dx.doi.org/10.1371/journal.pone.0193753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499053	Green Published, Green Submitted, gold			2022-12-26	WOS:000426472300020
J	Xu, Y; Wang, SJ; Bai, XY; Shu, DC; Tian, YC				Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Shu, Dongcai; Tian, Yichao			Runoff response to climate change and human activities in a typical karst watershed, SW China	PLOS ONE			English	Article							LAND-USE CHANGE; YELLOW-RIVER BASIN; SEDIMENT LOAD; LOESS PLATEAU; HYDROLOGICAL RESPONSE; YANGTZE-RIVER; CATCHMENT; IMPACTS; VARIABILITY; STREAMFLOW	This study aims to reveal the runoff variation characteristics of long time series in a karst region, analyse comprehensively its different driving factors, and estimate quantitatively the contribution rates of climate change and human activities to net runoff variation. Liudong river basin, a typical karst watershed in southwest China, is the study site. Statistical methods, such as linear fitting, the Morlet wavelet analysis, normalized curve and double mass curve, are applied to analyse the runoff of the watershed. Results show that the runoff in the karst watershed during the research period exhibits a three-stage change and the abrupt change points are the years 1981 and 2007: (1) 1968 +/- 1980, the runoff initially exhibited a trend of sustained decreasing and then an abrupt fluctuation. The runoff was obviously destroyed through precipitation-producing processes. Improper land utilisation and serious forest and grass destruction intensified the fluctuation variation amplitude of the runoff. (2) 1981 +/- 2006, the changing processes of runoff and precipitation exhibited good synchronism. Precipitation significantly affected runoff variation and human activities had a slight interference degree. (3) 2007 +/- 2013, the fluctuation range of runoff was considerably smaller than that of precipitation. The significant growth of forest and grassland areas and the increase in water consumption mitigated runoff fluctuation and greatly diminished runoff variation amplitude. According to calculation, the relative contribution rates of precipitation and human activities to net runoff variation with 1981 +/- 2007 as the reference period were -81% and 181% in average, respectively, during 1968 +/- 1980, and -117% and 217% in average, respectively, during 2007 +/- 2013. In general, the analysis of runoff variation trend and of the contribution rate of its main influencing factors in the typical karst watershed for nearly half a century may be significant to solve the drought problem in the karst region and for the sustainable development of the drainage basin.	[Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Tian, Yichao] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Guizhou, Peoples R China; [Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Tian, Yichao] Chinese Acad Sci, Puding Karst Ecosyst Res Stn, Puding, Guizhou, Peoples R China; [Xu, Yan; Tian, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shu, Dongcai] Guizhou Prov Bur Hydrol & Water Resources, Guiyang, Guizhou, Peoples R China	Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, XY (corresponding author), Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Guizhou, Peoples R China.; Bai, XY (corresponding author), Chinese Acad Sci, Puding Karst Ecosyst Res Stn, Puding, Guizhou, Peoples R China.	994656336@qq.com	Bai, Xiaoyong/L-6885-2019	Bai, Xiaoyong/0000-0001-9705-5574	National Key Research Program of China [2016YFC0502300, 2016YFC0502102, 2013CB956700, 2014BAB03B02]; International cooperation research projects of the national natural science fund committee [41571130074, 41571130042]; Science and Technology Plan of Guizhou Province of China [2012-6015]; Agricultural Science and Technology Key Project of Guizhou Province of China [2014-3039]; Science and technology cooperation projects [2014-3]; Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China [2012-205]	National Key Research Program of China; International cooperation research projects of the national natural science fund committee; Science and Technology Plan of Guizhou Province of China; Agricultural Science and Technology Key Project of Guizhou Province of China; Science and technology cooperation projects; Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China	This research work was supported jointly by National Key Research Program of China (No. 2016YFC0502300, 2016YFC0502102, 2013CB956700 & 2014BAB03B02), International cooperation research projects of the national natural science fund committee (No. 41571130074 & 41571130042), Science and Technology Plan of Guizhou Province of China (No. 2012-6015), Agricultural Science and Technology Key Project of Guizhou Province of China (No. 2014-3039), Science and technology cooperation projects (No. 2014-3), Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China (No. 2012-205).	Bai XY, 2013, LAND DEGRAD DEV, V24, P47, DOI 10.1002/ldr.1102; Breuer L, 2009, ADV WATER RESOUR, V32, P129, DOI 10.1016/j.advwatres.2008.10.003; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Bureau of Water Conservancy Management of GuiZhou, 2005, PROCL SOIL WAT LOSS; Chang JX, 2015, QUATERN INT, V380, P169, DOI 10.1016/j.quaint.2014.03.048; [陈宏峰 Chen Hongfeng], 2005, [中国岩溶, Carsologica Sinica], V24, P300; Claessens L, 2009, AGR ECOSYST ENVIRON, V129, P157, DOI 10.1016/j.agee.2008.08.008; [戴明宏 Dai Minghong], 2015, [生态科学, Ecologic Science], V34, P189; Gao GY, 2016, SCI TOTAL ENVIRON, V557, P331, DOI 10.1016/j.scitotenv.2016.03.019; Gao Y, 2014, AGR FOREST METEOROL, V195, P32, DOI 10.1016/j.agrformet.2014.04.010; Gosling R, 2014, HYDROL RES, V45, P806, DOI 10.2166/nh.2014.148; [胡奕 Hu Yi], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P46; [黄承标 Huang Chengbiao], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P34; Kim J, 2013, SCI TOTAL ENVIRON, V452, P181, DOI 10.1016/j.scitotenv.2013.02.005; Kong DX, 2016, ECOL ENG, V91, P566, DOI 10.1016/j.ecoleng.2016.02.023; Kong L., 2007, CARSOLOGICA SINICA, P341; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Lee KS, 2007, HYDROL PROCESS, V21, P3046, DOI 10.1002/hyp.6513; Legesse D, 2003, J HYDROL, V275, P67, DOI 10.1016/S0022-1694(03)00019-2; [李丽娟 Li Lijuan], 2010, [地理研究, Geographical Research], V29, P1233; [李瑞 Li Rui], 2012, [水土保持通报, Bulletin of Soil and Water Conservation], V32, P132; Li S, 2014, CATENA, V116, P157, DOI 10.1016/j.catena.2013.12.013; Li SM, 2009, J FUNCT FOODS, V1, P2, DOI 10.1016/j.jff.2008.09.003; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; Liang H., 1994, Chinese Vegetables, P1; Liang W, 2015, WATER RESOUR RES, V51, P6500, DOI 10.1002/2014WR016589; Liu F, 2011, J GEOGR SCI, V21, P1047, DOI 10.1007/s11442-011-0899-5; Lorup JK, 1998, J HYDROL, V205, P147, DOI 10.1016/S0168-1176(97)00311-9; Luo GJ, 2016, SOLID EARTH, V7, P457, DOI 10.5194/se-7-457-2016; Marshall E, 2008, CLIMATIC CHANGE, V89, P263, DOI 10.1007/s10584-007-9389-2; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; Minville M, 2008, J HYDROL, V358, P70, DOI 10.1016/j.jhydrol.2008.05.033; [彭韬 PENG Tao], 2008, [地球与环境, Earth and Environment], V36, P125; [秦罗义 Qin Luoyi], 2015, [山地学报, Mountain Research], V33, P619; Qin LY, 2015, AGR WATER MANAGE, V159, P55, DOI 10.1016/j.agwat.2015.05.024; Shi HY, 2015, HYDROL PROCESS, V29, P3236, DOI 10.1002/hyp.10439; Shi P, 2010, J HYDROL ENG, V15, P370, DOI 10.1061/(ASCE)HE.1943-5584.0000206; Su X. L., 2005, EARTH ENV, P24; Tian YC, 2016, SCI TOTAL ENVIRON, V566, P1297, DOI 10.1016/j.scitotenv.2016.05.190; Viney NR, 2009, ADV WATER RESOUR, V32, P147, DOI 10.1016/j.advwatres.2008.05.006; Wang DB, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010283; Wang F., J HYDROLOGY, V527, P884; Wang SF, 2008, HYDROL PROCESS, V22, P2502, DOI 10.1002/hyp.6846; [王随继 Wang Suiji], 2012, [地理学报, Acta Geographica Sinica], V67, P388; Wang WG, 2016, J HYDROL, V541, P1042, DOI 10.1016/j.jhydrol.2016.08.014; [熊亚兰 Xiong Yalan], 2010, [水土保持研究, Research of Soil and Water Conservation], V17, P30; Xu JX, 2011, QUATERN INT, V244, P230, DOI 10.1016/j.quaint.2010.09.014; Xu XY, 2014, J HYDROL, V510, P530, DOI 10.1016/j.jhydrol.2013.12.052; Yang SL, 2002, J HYDROL, V263, P56, DOI 10.1016/S0022-1694(02)00028-8; [杨涛 YANG Tao], 2009, [地球与环境, Earth and Environment], V37, P207; Yang XL, 2012, HYDROL RES, V43, P23, DOI 10.2166/nh.2011.120; Ye XC, 2013, J HYDROL, V494, P83, DOI 10.1016/j.jhydrol.2013.04.036; Yu PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132395; ZHAN CS, 2014, HYDROL EARTH SYST SC, V11, P2149, DOI DOI 10.5194/hessd-11-2149-2014; Zhang CQ, 2014, HYDROL PROCESS, V28, P43, DOI 10.1002/hyp.9539; [穆兴民 MU Xingmin], 2007, [泥沙研究, Journal of Sediment Research], P36; Zhang X, 2007, J TROPICAL SUBTROPIC, V15, P527; Zhao YF, 2015, SCI TOTAL ENVIRON, V536, P803, DOI 10.1016/j.scitotenv.2015.07.119; Zhou YC, 2013, AGR FOREST METEOROL, V182, P332, DOI 10.1016/j.agrformet.2013.04.018; [朱颖洁 Zhu Yingjie], 2010, [水文, Hydrology], V30, P50; Zuo DP, 2016, SCI TOTAL ENVIRON, V544, P238, DOI 10.1016/j.scitotenv.2015.11.060	62	25	27	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193073	10.1371/journal.pone.0193073	http://dx.doi.org/10.1371/journal.pone.0193073			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494602	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200021
J	Nakano, T; Seino, K; Wakabayashi, I; Stafforini, DM; Topham, MK; Goto, K				Nakano, Tomoyuki; Seino, Keiko; Wakabayashi, Ichiro; Stafforini, Diana M.; Topham, Matthew K.; Goto, Kaoru			Deletion of diacylglycerol kinase epsilon confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes	FASEB JOURNAL			English	Article						adipose triglyceride lipase; hormone-sensitive lipase; lipid droplet; PKC; type 2 diabetes	HIGH-FAT-DIET; HEPATIC INSULIN-RESISTANCE; TRANSCRIPTION FACTOR FOXO1; ADIPOSE-TISSUE; LIPID-METABOLISM; ACYLTRANSFERASE-2 DGAT2; ENDOPLASMIC-RETICULUM; ENERGY-METABOLISM; MICE; LOCALIZATION	Lipid metabolism is closely involved with signal transduction and energy homeostasis. Excess calorie intake causes abnormal lipid metabolism, promoting obesity and insulin resistance. Diacylglycerol (DG) represents not only a lipidic second messenger but also an intermediate metabolite for triglyceride metabolism in the endoplasmic reticulum (ER). However, it remains undetermined how the roles of DG in signaling and energy homeostasis is regulated within the cell. Of DG kinases (DGKs), which are enzymes that phosphorylate DG, DGK epsilon resides in the ER. This study examined how DGK epsilon is implicated in signal transduction and lipid homeostasis. DGK epsilon-deficient mice were fed a high-fat diet (HFD) for 40 d. We observed that DGK epsilon deficiency promotes fat accumulation in adipocytes and subsequently promotes insulin resistance in mice fed an HFD. This abnormal fat metabolism is mediated by down-regulation of lipolytic activities, such as adipose triglyceride lipase and hormone-sensitive lipase. In addition, activation of DG-sensitive PKC leads to insulin resistance in adipose tissue, which may be caused by delayed metabolism of DG. Our data suggest that DGK epsilon links the second messenger signaling system to energy homeostasis in adipocytes and that its deficiency results in abnormal lipid metabolism such as obesity and insulin resistance.Nakano, T., Seino, K., Wakabayashi, I., Stafforini, D. M., Topham, M. K., Goto, K. Deletion of diacylglycerol kinase epsilon confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes.	[Nakano, Tomoyuki; Seino, Keiko; Goto, Kaoru] Yamagata Univ, Dept Anat & Cell Biol, Sch Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Wakabayashi, Ichiro] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo, Japan; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Yamagata University; Hyogo College of Medicine; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Nakano, T; Goto, K (corresponding author), Yamagata Univ, Dept Anat & Cell Biol, Sch Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	t-nakano@med.id.yamagata-u.ac.jp; kgoto@med.id.yamagata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26460265, 17H04012]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid 26460265 (to T.N.) and 17H04012 (to K.G.). The authors declare no conflicts of interest.	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Benoit B, 2013, NUTR RES, V33, P952, DOI 10.1016/j.nutres.2013.07.017; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Dolley G, 2009, MOL GENET METAB, V97, P149, DOI 10.1016/j.ymgme.2009.02.011; Fan NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088299; Goto K, 2007, INT REV CYTOL, V264, P25, DOI 10.1016/S0074-7696(07)64002-9; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang LQ, 2016, AM J PHYSIOL-ENDOC M, V310, pE51, DOI 10.1152/ajpendo.00209.2015; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kobayashi N, 2007, EUR J CELL BIOL, V86, P433, DOI 10.1016/j.ejcb.2007.05.002; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Li SY, 2005, DIABETES OBES METAB, V7, P448, DOI 10.1111/j.1463-1326.2004.00387.x; Lowe CE, 2013, OBESITY, V21, P1823, DOI 10.1002/oby.20297; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Manneras-Holm L, 2017, J LIPID RES, V58, P907, DOI [10.1194/jlr.m074443, 10.1194/jlr.M074443]; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsui H, 2014, BBA-MOL CELL BIOL L, V1841, P1440, DOI 10.1016/j.bbalip.2014.07.007; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	50	9	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4121	4131		10.1096/fj.201701050R	http://dx.doi.org/10.1096/fj.201701050R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509511				2022-12-26	WOS:000439325400006
J	Guan, RB; Li, HC; Fan, YJ; Hu, SR; Christiaens, O; Smagghe, G; Miao, XX				Guan, Ruo-Bing; Li, Hai-Chao; Fan, Yu-Jie; Hu, Shao-Ru; Christiaens, Olivier; Smagghe, Guy; Miao, Xue-Xia			A nuclease specific to lepidopteran insects suppresses RNAi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; SCHISTOCERCA-GREGARIA; DESERT LOCUST; BOMBYX-MORI; PIN DOMAINS; INTERFERENCE; GENE; EXPRESSION; INJECTION	More than 70% of all agricultural pests are insects in the order Lepidoptera, which, unlike other related insect orders, are not very sensitive to RNAi, limiting genetic studies of this insect group. However, the reason for this distinct lepidopteran characteristic is unknown. Previously, using transcriptome analysis of the Asian corn borer Ostrinia furnacalis, we identified a gene, termed up56, that is up-regulated in response to dsRNA. Here we report that this Lepidoptera-specific gene encodes a nuclease that contributes to RNAi insensitivity in this insect order. Its identity was experimentally validated, and sequence analysis indicated that up56 encodes a previously uncharacterized protein with homologous sequences in seven other lepidopteran species. Its computationally predicted three-dimensional structure revealed a high structural similarity to human exonuclease I. Exposure to dsRNA in O. furnacalis strongly up-regulated this gene's expression, and the protein could digest single-stranded RNA (ssRNA), dsRNA, and dsDNA both in vitro and in vivo. Of note, we found that this up-regulation of up56 expression is faster than that of the gene encoding the key RNAi-associated nuclease Dicer. up56 knockdown in O. furnacalis significantly enhanced RNAi efficiency. Moreover, up56 overexpression in Drosophila melanogaster suppressed RNAi efficiency. Finally, up56 knockdown significantly increased the amount and diversity of small RNAs. Therefore, we renamed this protein RNAi efficiency-related nuclease (REase). In conclusion, we propose that REase may explain why lepidopterans are refractory to RNAi and that it represents a target for further research of RNAi efficiency in this insect order.	[Guan, Ruo-Bing; Li, Hai-Chao; Fan, Yu-Jie; Hu, Shao-Ru; Miao, Xue-Xia] Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Hu, Shao-Ru] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Christiaens, Olivier; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ghent University	Miao, XX (corresponding author), Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.; Smagghe, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be; xxm@sibs.ac.cn	Li, Haichao/AGY-6004-2022; Smagghe, Guy/AAE-8914-2019; Christiaens, Olivier/AAB-3634-2019	Li, Haichao/0000-0002-1359-4640; Smagghe, Guy/0000-0001-8334-3313; Christiaens, Olivier/0000-0001-5850-340X	National Basic Research Program of China [2015CB755703]; National Key R&D Program of China [2017YFD0200900]; National Transgenic Great Subject from the Ministry of Agriculture of China [2016ZX08009003-001-002]; National Natural Science Foundation of China [31672354, 31702057]	National Basic Research Program of China(National Basic Research Program of China); National Key R&D Program of China; National Transgenic Great Subject from the Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2015CB755703), the National Key R&D Program of China (2017YFD0200900), the National Transgenic Great Subject from the Ministry of Agriculture of China (2016ZX08009003-001-002), and the National Natural Science Foundation of China (31672354 and 31702057). The authors declare that they have no conflicts of interest with the contents of this article.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arimatsu Y, 2007, INSECT BIOCHEM MOLEC, V37, P176, DOI 10.1016/j.ibmb.2006.11.004; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christiaens O, 2016, SCI REP-UK, V6, DOI 10.1038/srep38836; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Dowling D, 2016, GENOME BIOL EVOL, V8, P3784, DOI 10.1093/gbe/evw281; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garbutt JS, 2013, J INSECT PHYSIOL, V59, P171, DOI 10.1016/j.jinsphys.2012.05.013; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Guan RB, 2018, INSECT SCI, V25, P356, DOI 10.1111/1744-7917.12437; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ivashuta S, 2015, RNA, V21, P840, DOI 10.1261/rna.048116.114; Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553; Kennedy S., 2004, C ELEGANS NATURE, V427, P640; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Liu JH, 2012, J INSECT PHYSIOL, V58, P1166, DOI 10.1016/j.jinsphys.2012.05.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luo Y, 2013, INSECT MOL BIOL, V22, P574, DOI 10.1111/imb.12046; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meiss G, 1999, J MOL BIOL, V288, P377, DOI 10.1006/jmbi.1999.2694; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Page MF, 1999, MOL CELL BIOL, V19, P5943; Prentice K, 2017, PEST MANAG SCI, V73, P44, DOI 10.1002/ps.4337; Santos D, 2014, CURR OPIN INSECT SCI, V6, P9, DOI 10.1016/j.cois.2014.09.013; Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Spit J, 2017, INSECT BIOCHEM MOLEC, V81, P103, DOI 10.1016/j.ibmb.2017.01.004; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Weinheimer I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004711; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	41	85	94	5	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6011	6021		10.1074/jbc.RA117.001553	http://dx.doi.org/10.1074/jbc.RA117.001553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29500196	hybrid, Green Published			2022-12-26	WOS:000430497300021
J	McCullough, LL; Connell, Z; Xin, H; Studitsky, VM; Feofanov, AV; Valieva, ME; Formosa, T				McCullough, Laura L.; Connell, Zaily; Xin, Hua; Studitsky, Vasily M.; Feofanov, Alexey V.; Valieva, Maria E.; Formosa, Tim			Functional roles of the DNA-binding HMGB domain in the histone chaperone FACT in nucleosome reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP BOX; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; PROTEIN NHP6A; TRANSCRIPTION; REPLICATION; REVEALS; POB3; H2A-H2B; COMPLEX	The essential histone chaperone FACT (facilitates chromatin transcription) promotes both nucleosome assembly and disassembly. FACT is a heterodimer of Spt16 with either SSRP1 or Pob3, differing primarily by the presence of a high-mobility group B (HMGB) DNA-binding domain furnished only by SSRP1. Yeast FACT lacks the intrinsic HMGB domain found in SSRP1-based homologs such as human FACT, but yeast FACT activity is supported by Nhp6, which is a freestanding, single HMGB-domain protein. The importance of histone binding by FACT domains has been established, but the roles of DNA-binding activity remain poorly understood. Here, we examined these roles by fusing single or multiple HMGB modules to Pob3 to mimic SSRP1 or to test the effects of extended DNA-binding capacity. Human FACT and a yeast mimic both required Nhp6 to support nucleosome reorganization in vitro, indicating that a single intrinsic DNA-binding HMGB module is insufficient for full FACT activity. Three fused HMGB modules supported activity without Nhp6 assistance, but this FACT variant did not efficiently release from nucleosomes and was toxic in vivo. Notably, intrinsic DNA-binding HMGB modules reduced the DNA accessibility and histone H2A-H2B dimer loss normally associated with nucleosome reorganization. We propose that DNA bending by HMGB domains promotes nucleosome destabilization and reorganization by exposing FACT's histone-binding sites, but DNA bending also produces DNA curvature needed to accommodate nucleosome assembly. Intrinsic DNA-bending activity therefore favors nucleosome assembly by FACT over nucleosome reorganization, but excessive activity impairs FACT release, suggesting a quality control checkpoint during nucleosome assembly.	[McCullough, Laura L.; Connell, Zaily; Xin, Hua; Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; [Studitsky, Vasily M.; Feofanov, Alexey V.; Valieva, Maria E.] Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1, Moscow 119992, Russia; [Feofanov, Alexey V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Studitsky, Vasily M.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Utah System of Higher Education; University of Utah; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Fox Chase Cancer Center	Formosa, T (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr East,Rm 4100, Salt Lake City, UT 84112 USA.	tim@biochem.utah.edu	Valieva, Maria/AAP-1168-2021; Feofanov, Alexey V/K-3082-2012	Valieva, Maria/0000-0002-4419-2839; Feofanov, Alexey V/0000-0002-1596-9506	National Institutes of Health Grants [R01 GM064649, R01 GM119398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119398, R01GM064649] Funding Source: NIH RePORTER; Russian Science Foundation [17-24-00007] Funding Source: Russian Science Foundation	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by National Institutes of Health Grants R01 GM064649 (to T.F.) and R01 GM119398 (to V.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Evans DRH, 1998, GENETICS, V150, P1393; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hoffmann C, 2015, ACS CHEM BIOL, V10, P2753, DOI 10.1021/acschembio.5b00493; Hondele M, 2013, NUCLEUS-AUSTIN, V4, P443, DOI 10.4161/nucl.27235; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Khuong MT, 2015, COLD SH Q B, V80, P65, DOI 10.1101/sqb.2015.80.027300; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Kruppa M, 2001, MOL CELL, V7, P309, DOI 10.1016/S1097-2765(01)00179-4; Kurat CF, 2017, MOL CELL, V65, P117, DOI 10.1016/j.molcel.2016.11.016; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCullough L, 2015, GENETICS, V201, P1031, DOI 10.1534/genetics.115.180794; McCullough L, 2013, GENETICS, V195, P101, DOI 10.1534/genetics.113.153080; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Prendergast L, 2016, GENE DEV, V30, P1313, DOI 10.1101/gad.275073.115; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Singer RA, 2004, BIOCHEM CELL BIOL, V82, P419, DOI 10.1139/O04-050; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; Valieva M. E., 2017, CANCERS, V9, pE3; Valieva ME, 2016, NAT STRUCT MOL BIOL, V23, P1111, DOI 10.1038/nsmb.3321; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yang JY, 2016, CELL REP, V14, P1128, DOI 10.1016/j.celrep.2015.12.096; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Yen YM, 1998, J BIOL CHEM, V273, P4424, DOI 10.1074/jbc.273.8.4424; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791	55	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6121	6133		10.1074/jbc.RA117.000199	http://dx.doi.org/10.1074/jbc.RA117.000199			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29514976	hybrid, Green Published			2022-12-26	WOS:000430497300029
J	Shommu, NS; Jenne, CN; Blackwood, J; Joffe, AR; Martin, DA; Thompson, GC; Vogel, HJ				Shommu, Nusrat S.; Jenne, Craig N.; Blackwood, Jaime; Joffe, Ari R.; Martin, Dori-Ann; Thompson, Graham C.; Vogel, Hans J.			Metabolomic and inflammatory mediator based biomarker profiling as a potential novel method to aid pediatric appendicitis identification	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; PERFORATED APPENDICITIS; APPENDECTOMY RATE; SEPTIC SHOCK; DIAGNOSIS; CHILDREN; CHEMOMETRICS; SPECTROSCOPY; INFORMATION	Various limitations hinder the timely and accurate diagnosis of appendicitis in pediatric patients. The present study aims to investigate the potential of metabolomics and cytokine profiling for improving the diagnosis of pediatric appendicitis. Serum and plasma samples were collected from pediatric patients for metabolic and inflammatory mediator analyses respectively. Targeted metabolic profiling was performed using Proton Nuclear Magnetic Resonance Spectroscopy and Flow Injection Analysis Mass Spectrometry/Mass Spectrometry and targeted cytokine/chemokine profiling was completed using a multiplex platform to compare children with and without appendicitis. Twenty-three children with appendicitis and 35 control children without appendicitis from the Alberta Sepsis Network pediatric cohorts were included. Metabolomic profiling revealed clear separation between the two groups with very good sensitivity (80%), specificity (97%), and AUROC (0.93 +/- 0.05) values. Inflammatory mediator analysis also distinguished the two groups with high sensitivity (82%), specificity (100%), and AUROC (0.97 +/- 0.02) values. A biopattern comprised of 9 metabolites and 7 inflammatory compounds was detected to be significant for the separation between appendicitis and control groups. Integration of these 16 significant compounds resulted in a combined metabolic and cytokine profile that also demonstrated strong separation between the two groups with 81% sensitivity, 100% specificity and AUROC value of 0.96 +/- 0.03. The study demonstrated that metabolomics and cytokine mediator profiling is capable of distinguishing children with appendicitis from those without. These results suggest a potential new approach for improving the identification of appendicitis in children.	[Shommu, Nusrat S.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Bio NMR Ctr, Calgary, AB, Canada; [Jenne, Craig N.] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Blackwood, Jaime] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Joffe, Ari R.] Univ Alberta, Div Pediat Crit Care Med, Dept Pediat, Edmonton, AB, Canada; [Martin, Dori-Ann; Thompson, Graham C.] Univ Calgary, Dept Pediat & Emergency Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Bio NMR Ctr, Calgary, AB, Canada.	vogel@ucalgary.ca	Jenne, Craig/HCH-3413-2022; Thompson, Graham/Y-4180-2019	Thompson, Graham/0000-0002-6781-4186	Alberta Sepsis Network from Alberta Innovates Health Solutions (AIHS) Team Grant	Alberta Sepsis Network from Alberta Innovates Health Solutions (AIHS) Team Grant	This study was supported by the Alberta Sepsis Network, which in turn received financial support from Alberta Innovates Health Solutions (AIHS) Team Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas MH, 2014, SURG LAPARO ENDO PER, V24, P488, DOI 10.1097/SLE.0000000000000067; Allister L, 2011, J SURG RES, V168, P70, DOI 10.1016/j.jss.2009.10.029; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersson M, 2008, WORLD J SURG, V32, P1843, DOI 10.1007/s00268-008-9649-y; Beltran MA, 2007, J PEDIATR SURG, V42, P1208, DOI 10.1016/j.jpedsurg.2007.02.010; Blomqvist PG, 2001, ANN SURG, V233, P455, DOI 10.1097/00000658-200104000-00001; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Bundy DG, 2007, JAMA-J AM MED ASSOC, V298, P438, DOI 10.1001/jama.298.4.438; Eriksson L, 2006, MULTI MEGAVARIATE 1, P425; Eriksson L JE, 2006, MULTI MEGAVARIATE 1, P307; Euser SM, 2015, J PEDIAT SURG; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; Hartwich JE, 2013, J SURG RES, V180, P222, DOI 10.1016/j.jss.2012.04.043; Hennelly KE, 2011, CURR OPIN PEDIATR, V23, P281, DOI 10.1097/MOP.0b013e32834604da; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasper D.L., 2012, HARRISONS PRINCIPLES; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mickiewicz B., 2014, PEDIAT CRIT CARE MED, V15, P146, DOI [10.1097/01.pcc.0000449371.98387.91, DOI 10.1097/01.PCC.0000449371.98387.91]; Mickiewicz B, 2014, METABOLOMIC PROFILIN, P146; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1026-2; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0729-0; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; MIKAELSSON C, 1984, ANN CHIR GYNAECOL FE, V73, P281; Milne WK, 2016, ACAD EMERG MED; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Oyetunji TA, 2012, J SURG RES, V173, P16, DOI 10.1016/j.jss.2011.04.046; Paajanen H, 2002, SCAND J CLIN LAB INV, V62, P579, DOI 10.1080/003655102764654312; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; PIEPER R, 1982, ACTA CHIR SCAND, V148, P63; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Roberts DJ, 2013, J NEUROTRAUM, V30, P1717, DOI 10.1089/neu.2012.2841; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Ross MJ, 2014, ACAD EMERG MED, V21, P538, DOI 10.1111/acem.12377; Rothrock SG, 2000, ANN EMERG MED, V36, P39, DOI 10.1067/mem.2000.105658; Samuel M, 2002, J PEDIATR SURG, V37, P877, DOI 10.1053/jpsu.2002.32893; Sit M, 2014, Clin Ter, V165, pe148, DOI [10.7471/CT.2014.1669, 10.7471/CT.2014.1688, 10.7471/CT.2014.1699]; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Thompson GC, 2015, ACAD EMERG MED, V22, P811, DOI 10.1111/acem.12709; Tintinalli JE, 2011, EMERGENCY MED COMPRE; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VELANOVICH V, 1992, AM SURGEON, V58, P264; Vissers RJ, 2010, EMERG MED CLIN N AM, V28, P103, DOI 10.1016/j.emc.2009.09.003; Wangensteen OH, 1937, ARCH SURG-CHICAGO, V34, P496, DOI 10.1001/archsurg.1937.01190090121006; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; ZWEIG MH, 1993, CLIN CHEM, V39, P561	50	11	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193563	10.1371/journal.pone.0193563	http://dx.doi.org/10.1371/journal.pone.0193563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529041	Green Published, Green Submitted, gold			2022-12-26	WOS:000427189300025
J	Hajjej, A; Almawi, WY; Arnaiz-Villena, A; Hattab, L; Hmida, S				Hajjej, Abdelhafidh; Almawi, Wassim Y.; Arnaiz-Villena, Antonio; Hattab, Lasmar; Hmida, Slama			The genetic heterogeneity of Arab populations as inferred from HLA genes	PLOS ONE			English	Article							CLASS-II POLYMORPHISMS; TYPE-1 DIABETES-MELLITUS; NEIGHBOR-JOINING METHOD; HAPLOTYPE FREQUENCIES; EVOLUTIONARY HISTORY; PHYLOGENETIC TREES; ALLELE FREQUENCIES; MOROCCAN POPULATION; LEBANESE POPULATION; MOLECULAR ANALYSIS	This is the first genetic anthropology study on Arabs in MENA (Middle East and North Africa) region. The present meta-analysis included 100 populations from 36 Arab and non-Arab communities, comprising 16,006 individuals, and evaluates the genetic profile of Arabs using HLA class I (A, B) and class II (DRB1, DQB1) genes. A total of 56 Arab populations comprising 10,283 individuals were selected from several databases, and were compared with 44 Mediterranean, Asian, and sub-Saharan populations. The most frequent alleles in Arabs are A*01, A*02, B*35, B*51, DRB1*03:01, DRB1*07:01, DQB1*02:01, and DQB1*03:01, while DRB1*03:01-DQB1*02:01 and DRB1*07:01-DQB1*0202 are the most frequent class II haplotypes. Dendrograms, correspondence analyses, genetic distances, and haplotype analysis indicate that Arabs could be stratified into four groups. The first consists of North Africans (Algerians, Tunisians, Moroccans, and Libyans), and the first Arabian Peninsula cluster (Saudis, Kuwaitis, and Yemenis), who appear to be related to Western Mediterraneans, including Iberians; this might be explained for a massive migration into these areas when Sahara underwent a relatively rapid desiccation, starting about 10,000 years BC. The second includes Levantine Arabs (Palestinians, Jordanians, Lebanese, and Syrians), along with Iraqi and Egyptians, who are related to Eastern Mediterraneans. The third comprises Sudanese and Comorians, who tend to cluster with Sub-Saharans. The fourth comprises the second Arabian Peninsula cluster, made up of Omanis, Emiratis, and Bahrainis. It is noteworthy that the two large minorities (Berbers and Kurds) are indigenous (autochthonous), and are not genetically different from "host" and neighboring populations. In conclusion, this study confirmed high genetic heterogeneity among present-day Arabs, and especially those of the Arabian Peninsula.	[Hajjej, Abdelhafidh; Hmida, Slama] Natl Blood Transfus Ctr, Dept Immunogenet, Tunis, Tunisia; [Almawi, Wassim Y.] Harvard Med Sch, Dept Med, Boston, MA USA; [Arnaiz-Villena, Antonio] Univ Complutense, Sch Med, Madrid Reg Blood Ctr, Dept Immunol, Madrid, Spain; [Hattab, Lasmar] Hosp Gabes Ghannouch, Dept Med Anal, Gabes, Tunisia; [Almawi, Wassim Y.] Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon	Universite de Tunis-El-Manar; Centre National de Transfusion Sanguine; Harvard University; Harvard Medical School; Complutense University of Madrid; Lebanese American University	Hajjej, A (corresponding author), Natl Blood Transfus Ctr, Dept Immunogenet, Tunis, Tunisia.	abdelhafidhhajjej@gmail.com	Almawi, Wassim/FGW-0821-2022					Agrawal S, 2008, TISSUE ANTIGENS, V72, P120, DOI 10.1111/j.1399-0039.2008.01083.x; Al-Tonbary Y, 2004, Hematology, V9, P139, DOI 10.1080/1024533042000205487; Albalushi KR, 2014, ANTHROPOLOGIST, V18, P205, DOI 10.1080/09720073.2014.11891537; Albalushi KR, 2014, J TRANSPLANTATION TE, V4, P134; Almawi WY, 2004, CLIN DIAGN LAB IMMUN, V11, P770, DOI 10.1128/CDLI.11.4.770-774.2004; Amar A, 1999, HUM IMMUNOL, V60, P723, DOI 10.1016/S0198-8859(99)00043-9; [Anonymous], 2001, NOBIE HIST LEVANT AN; Arnaiz-Villena A, 1999, TISSUE ANTIGENS, V53, P213, DOI 10.1034/j.1399-0039.1999.530301.x; Arnaiz-Villena A, 2002, TISSUE ANTIGENS, V60, P111, DOI 10.1034/j.1399-0039.2002.600201.x; Arnaiz-Villena A, 2001, HUM IMMUNOL, V62, P1051, DOI 10.1016/S0198-8859(01)00300-7; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P308, DOI 10.1034/j.1399-0039.2001.057004308.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P118, DOI 10.1034/j.1399-0039.2001.057002118.x; Arnaiz-Villena A, 2001, HUM IMMUNOL, V62, P869, DOI 10.1016/S0198-8859(01)00285-3; Arnaiz-Villena A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169929; ArnaizVillena A, 1997, IMMUNOGENETICS, V47, P37, DOI 10.1007/s002510050324; ARNAIZVILLENA A, 1995, HUM IMMUNOL, V43, P259, DOI 10.1016/0198-8859(95)00024-X; ArnaizVillena A., 2015, INT J MOD ANTHR, V1, P67; Ayed K, 2004, TISSUE ANTIGENS, V64, P520, DOI 10.1111/j.1399-0039.2004.00313.x; Bengio O, MINORITIES STATE ARA, P1999; Brick C, 2006, TRANSFUS CLIN BIOL, V13, P346, DOI 10.1016/j.tracli.2006.12.003; Canossi A, 2010, TISSUE ANTIGENS, V76, P177, DOI 10.1111/j.1399-0039.2010.01498.x; Carter R, 2006, ANTIQUITY, V80, P52, DOI 10.1017/S0003598X0009325X; Clayton J, 1997, GENETIC DIVERSITY HL, P665; Comas D, 1998, TISSUE ANTIGENS, V51, P30, DOI 10.1111/j.1399-0039.1998.tb02944.x; Djidjik R, 2014, INT J RHEUMATIC DIS; Elbjeirami WM, 2013, BIOL BLOOD MARROW TR, V19, P221, DOI 10.1016/j.bbmt.2012.09.009; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farjadian S, 2007, INT J IMMUNOGENET, V34, P457, DOI 10.1111/j.1744-313X.2007.00723.x; Farjadian Shirin, 2007, Iran J Immunol, V4, P85; Galgani A, 2013, HUM IMMUNOL, V74, P52, DOI 10.1016/j.humimm.2012.10.001; Gibert M, 2006, ANN HUM BIOL, V33, P265, DOI 10.1080/03014460600578599; Gomez-Casado E, 2000, TISSUE ANTIGENS, V55, P239, DOI 10.1034/j.1399-0039.2000.550307.x; Grimaldi MC, 2001, TISSUE ANTIGENS, V58, P281, DOI 10.1034/j.1399-0039.2001.580501.x; Guenounou BA, 2006, INT J IMMUNOGENET, V33, P93, DOI 10.1111/j.1744-313X.2006.00577.x; Hachid M., 2003, PUBLICATION I ROYAL; Haider MZ, 2000, AM J MED GENET, V96, P870, DOI 10.1002/1096-8628(20001204)96:6<870::AID-AJMG36>3.0.CO;2-L; Haider MZ, 1999, CLIN GENET, V56, P450, DOI 10.1034/j.1399-0004.1999.560608.x; Hajeer AH, 2013, TISSUE ANTIGENS, V82, P252, DOI 10.1111/tan.12200; Hajeer AH, 2009, INT J IMMUNOGENET, V36, P169, DOI 10.1111/j.1744-313X.2009.00843.x; Hajjej A, 2006, TISSUE ANTIGENS, V68, P153, DOI 10.1111/j.1399-0039.2006.00622.x; Hajjej A, 2006, EUR J MED GENET, V49, P43, DOI 10.1016/j.ejmg.2005.01.001; Hajjej A, 2011, INT J IMMUNOGENET, V38, P191, DOI 10.1111/j.1744-313X.2011.01003.x; Hajjej A, 2011, ANN HUM BIOL, V38, P156, DOI 10.3109/03014460.2010.504195; Hajjej A, 2017, J HUM GENET, V62, P419, DOI 10.1038/jhg.2016.146; Hajjej A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136909; Hamdi NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111403; Hitti PK., 2004, HIST SYRIA INCLUDING, P26; HMIDA S, 1995, TISSUE ANTIGENS, V45, P63, DOI 10.1111/j.1399-0039.1995.tb02416.x; Hourani A., 2002, HIST ARAB PEOPLES, P15; Hoyland R., 2001, ARABIA ARABS BRONZE, P51; HUDSON RR, 2001, HDB STAT GENETICS, P309; Imanish T, 1992, HLA 1991, V1, P1065; Izaabel H, 1998, TISSUE ANTIGENS, V51, P106, DOI 10.1111/j.1399-0039.1998.tb02954.x; Jazairi B, 2016, IMMUNOL INVEST, V45, P172, DOI 10.3109/08820139.2015.1131293; Khansa S, 2012, GENE, V506, P396, DOI 10.1016/j.gene.2012.06.063; Kollaee A, 2012, INT J IMMUNOGENET, V39, P414, DOI 10.1111/j.1744-313X.2012.01104.x; Korotayev A., 1995, ANCIENT YEMEN; Korotayev A., 1996, PREISLAMIC YEMEN; Kuhrt A, 2001, ANCIENT NEAR E 3000, VII; Mahfoudh N, 2013, ANN HUM BIOL, V40, P41, DOI 10.3109/03014460.2012.734334; Malika H., 2000, 1 BEREBERS ENTRE BER; MARTINEZLASO J, 1995, TISSUE ANTIGENS, V45, P237, DOI 10.1111/j.1399-0039.1995.tb02446.x; Matevosyan L, 2011, TISSUE ANTIGENS, V78, P21, DOI 10.1111/j.1399-0039.2011.01668.x; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Migot-Nabias F, 1999, TISSUE ANTIGENS, V53, P580, DOI 10.1034/j.1399-0039.1999.530610.x; Mira-Guardiola MA, 2000, CARTAGO CONTRA ROMA; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Mohyuddin A, 2002, TISSUE ANTIGENS, V59, P492, DOI 10.1034/j.1399-0039.2002.590606.x; Mourad J, 2013, REV BRAS REUMATOL, V53, P47, DOI 10.1016/S2255-5021(13)70005-1; Munro-Hay S., 1991, AKSUM AFRICAN CIVILI; Muro M, 2001, HUM IMMUNOL, V62, P910, DOI 10.1016/S0198-8859(01)00290-7; Nassar Mogahid Y, 2015, Sultan Qaboos Univ Med J, V15, pe241; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M, 1996, ANNU REV GENET, V30, P371, DOI 10.1146/annurev.genet.30.1.371; Oumhani K, 2002, HUM IMMUNOL, V63, P129, DOI 10.1016/S0198-8859(01)00370-6; Rani R, 2004, TISSUE ANTIGENS, V64, P145, DOI 10.1111/j.1399-0039.2004.00246.x; Reil A, 1997, TISSUE ANTIGENS, V50, P501, DOI 10.1111/j.1399-0039.1997.tb02906.x; Renquin J, 2001, TISSUE ANTIGENS, V58, P211, DOI 10.1034/j.1399-0039.2001.580401.x; Robin Christian Julien, 2012, OXFORD HDB LATE ANTI, P247; ROITBERGTAMBUR A, 1995, TISSUE ANTIGENS, V46, P104, DOI 10.1111/j.1399-0039.1995.tb02485.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samaha H, 2003, MOL IMMUNOL, V39, P1079, DOI 10.1016/S0161-5890(03)00073-7; Sanchez-Velasco P, 2001, HUM IMMUNOL, V62, P901, DOI 10.1016/S0198-8859(01)00289-0; Sanchez-Velasco P, 2003, TISSUE ANTIGENS, V61, P384, DOI 10.1034/j.1399-0039.2003.00041.x; Sayad A, 2012, INT J IMMUNOGENET, V39, P429, DOI 10.1111/j.1744-313X.2012.01116.x; Sellier J., 1993, ATLAS PEUPLES ORIENT; Stearns PN, 2001, ENCY WORLD HIST ANCI, V2017, P129; Sulcebe G, 2009, INT J IMMUNOGENET, V36, P337, DOI 10.1111/j.1744-313X.2009.00868.x; Takezaki N, 2008, GENETICS, V178, P385, DOI 10.1534/genetics.107.081505; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Young FW, 1996, STAT COMPUTING ENV S, ps207; 2017, DATABASE ALLELE FREQ	95	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0192269	10.1371/journal.pone.0192269	http://dx.doi.org/10.1371/journal.pone.0192269			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522542	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800010
J	Kolling, Y; Salva, S; Villena, J; Alvarez, S				Kolling, Yanina; Salva, Susana; Villena, Julio; Alvarez, Susana			Are the immunomodulatory properties of Lactobacillus rhamnosus CRL1505 peptidoglycan common for all Lactobacilli during respiratory infection in malnourished mice?	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; ALVEOLAR MACROPHAGES; HOST-DEFENSE; MICROBIOTA; RESPONSES; RECOVERY; IMMUNITY; PROTEIN; SEPSIS; ADULTS	Previously, we reported that Lactobacillus rhamnosus CRL1505 peptidoglycan (PG05) improves the innate immune response in immunocompromised-malnourished mice after Streptococcus pneumoniae infection. This study extends those previous findings by demonstrating that the dietary recovery of malnourished mice with nasal administration of PG05 improves not only the innate immune response but the respiratory and systemic adaptive humoral response as well. PG05 enhanced the Th2 response, the recovery of B cells, and the concentration and opsonophagocytic activity of anti-pneumococcal antibodies. In addition, by performing comparative studies with the peptidoglycans from lactobacilli of the same species (L. rhamnosus CRL534) or with similar immunomodulatory properties (L. plantarum CRL1506), we demonstrated here that PG05 has unique immunomodulatory properties that cannot be extended to peptidoglycans from other probiotic strains. However, the knowledge of the molecular characteristics of PG05 is indispensable to understand immunomodulatory abilities of L. rhamnosus CRL1505.	[Kolling, Yanina; Salva, Susana; Villena, Julio; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Tucuman, Argentina; [Alvarez, Susana] Tucuman Univ, Inst Appl Biochem, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Alvarez, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Tucuman, Argentina.; Alvarez, S (corresponding author), Tucuman Univ, Inst Appl Biochem, San Miguel De Tucuman, Tucuman, Argentina.	salvarez@cerela.org.ar		Salva, Susana/0000-0001-9571-1259	CIUNT [26D/403]; PICT [1381, 3209]	CIUNT; PICT(ANPCyT)	This work was supported by grants from CIUNT 26D/403, PICT 2010 no. 1381 and PICT 2013 no. 3209. The authors declare no conflict of interest.; This work was supported by grants from CIUNT 26D/403, PICT 2010 no. 1381 and PICT 2013 no. 3209. The authors declare no conflict of interest.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Aktas B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156374; Aslam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025367; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Barbieri N, 2017, BENEF MICROBES; Barbieri N, 2013, J NUTR, V143, P227, DOI 10.3945/jn.112.165811; Blok DC, 2014, J INNATE IMMUN, V6, P542, DOI 10.1159/000358239; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Dalpke AH, 2002, IMMUNOBIOLOGY, V206, P392, DOI 10.1078/0171-2985-00189; Das R, 2014, J IMMUNOL, V193, P764, DOI 10.4049/jimmunol.1400133; Findlay EG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/140937; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Herrera M, 2014, PLOS ONE, V9; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jensen H, 2015, PROBIOTICS ANTIMICRO, V7, P14, DOI 10.1007/s12602-014-9174-2; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Kirby AC, 2009, AM J PATHOL, V175, P1107, DOI 10.2353/ajpath.2009.090258; Kitazawa H, 2008, ANIM SCI J, V79, P11, DOI [10.1111/j.1740-0929.2007.00492.x, 10.1111/j.1740-0929.2007.00491.x-i1]; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kolling Y, 2015, INT IMMUNOPHARMACOL, V25, P474, DOI 10.1016/j.intimp.2015.02.006; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Levine AP, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0018-2015; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Markowicz C, 2016, CAN J MICROBIOL, V62, P72, DOI 10.1139/cjm-2015-0249; Marranzino G, 2012, MICROBIOL IMMUNOL, V56, P771, DOI 10.1111/j.1348-0421.2012.00495.x; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Passera M, 2016, J HOSP INFECT, V94, P361, DOI 10.1016/j.jhin.2016.09.018; Penaloza HF, 2015, IMMUNOLOGY, V146, P100, DOI 10.1111/imm.12486; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Rodriguez AV, 2001, FEMS MICROBIOL LETT, V204, P33, DOI 10.1111/j.1574-6968.2001.tb10858.x; Salva S, 2008, FOOD AGR IMMUNOL, V19, P195, DOI 10.1080/09540100802247243; Salva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031171; Salva S, 2011, J SCI FOOD AGR, V91, P2355, DOI 10.1002/jsfa.4467; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Savino W, 2010, P NUTR SOC, V69, P636, DOI 10.1017/S0029665110002545; Sharma SK, 2013, VACCINE, V31, P3090, DOI 10.1016/j.vaccine.2013.03.060; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Shimosato T, 2011, J AGR FOOD CHEM, V59, P2646, DOI 10.1021/jf104240d; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J., 2012, International Journal of Biotechnology for Wellness Industries, V1, P189; Villena J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00563; Villena J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-53; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; Zelaya H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00633	49	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194034	10.1371/journal.pone.0194034	http://dx.doi.org/10.1371/journal.pone.0194034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518131	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900062
J	Mertens, UK; Voss, A; Radev, S				Mertens, Ulf Kai; Voss, Andreas; Radev, Stefan			ABrox A-user-friendly Python module for approximate Bayesian computation with a focus on model comparison	PLOS ONE			English	Article							FACILITATION; PREJUDICE	We give an overview of the basic principles of approximate Bayesian computation (ABC), a class of stochastic methods that enable flexible and likelihood-free model comparison and parameter estimation. Our new open-source software called ABrox is used to illustrate ABC for model comparison on two prominent statistical tests, the two-sample t-test and the Leverie-Test. We further highlight the flexibility of ABC compared to classical Bayesian hypothesis testing by computing an approximate Bayes factor for two multinomial processing tree models. Last but not least, throughout the paper, we introduce ABrox using the accompanied graphical user interface.	[Mertens, Ulf Kai; Voss, Andreas; Radev, Stefan] Heidelberg Univ, Dept Psychol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mertens, UK (corresponding author), Heidelberg Univ, Dept Psychol, Heidelberg, Germany.	uff.mertens@psychologie.uni-heidelberg.de	Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitit Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitit Heidelberg	We acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitit Heidelberg within the funding programme Open Access Publishing (UKM).	Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2009, BIOMETRIKA, V96, P983, DOI 10.1093/biomet/asp052; Berger JO, 1988, LECT NOTES MONOGRAPH, V6, P19, DOI DOI 10.1214/LNMS/1215466214; Bishara AJ, 2009, J EXP SOC PSYCHOL, V45, P524, DOI 10.1016/j.jesp.2008.11.002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conrey FR, 2005, J PERS SOC PSYCHOL, V89, P469, DOI 10.1037/0022-3514.89.4.469; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Csillery K, 2012, METHODS ECOLOGY EVOL; Didelot X, 2011, BAYESIAN ANAL, V6, P49, DOI 10.1214/11-BA602; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Grelaud A, 2009, BAYESIAN ANAL, V4, P317, DOI 10.1214/09-BA412; Gronau QF, 2017, SIMPLE METHOD UNPUB; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JASP Team T, 2017, JASP VERS 0 8 0 1 CO; Lambert AJ, 2003, J PERS SOC PSYCHOL, V84, P277, DOI 10.1037/0022-3514.84.2.277; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; Morey RD, 2015, PACKAGE BAYESFACTOR; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037/0022-3514.81.2.181; Pudlo P, 2015, BIOINFORMATICS, V32; RIEFER DM, 1988, PSYCHOL REV, V95, P318, DOI 10.1037/0033-295X.95.3.318; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Statisticat LLC, 2016, LAPLACESDEMON TUT; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; van der Walt S., 2011, CORR; Vandekerckhove J., 2014, OXFORD HDB COMPUTATI; Wagenmakers EJ, PSYCHONOMIC IN PRESS; Wagenmakers EJ, NEED BAYESI IN PRESS; Wagenmakers EJ, 2016, BAYESIAN STA UNPUB 2; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3								10.1371/journal.pone.0193981	http://dx.doi.org/10.1371/journal.pone.0193981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5UV	29518130	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900055
J	Rallon, N; Garcia, M; Garcia-Sarnaniego, J; Cabello, A; Alvarez, B; Restrepo, C; Nistal, S; Gorgolas, M; Benito, JM				Rallon, Norma; Garcia, Marcial; Garcia-Sarnaniego, Javier; Cabello, Alfonso; Alvarez, Beatriz; Restrepo, Clara; Nistal, Sara; Gorgolas, Miguel; Benito, Jose M.			Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection	PLOS ONE			English	Article							PROGRAMMED DEATH-1; IMMUNE ACTIVATION; FREQUENCIES; LYMPHOCYTES; SUBSETS	Introduction T-cell exhaustion has been involved in the pathogenesis of HIV infection. We have longitudinally analyzed PD1 and Tim3 surrogate markers of T-cells exhaustion, in parallel with other markers of HIV progression, and its potential association with CD4 changes in treated and untreated infection. Patients and methods 96 HIV patients, 49 of them followed in the absence of cART (cART-naYve group) and 47 after initiation of cART (cART group) were included and followed for a median of 43 [IQR: 31-60] months. PD1 and Tim3 expression, CD8 T-cells activation, recent thymic emigrants, activation/apoptosis and turnover of CD4 cells were assessed at baseline and during follow up. Univariate and multivariate associations with CD4 evolution were explored. Results Parameters significantly associated with CD4 depletion in cART-naYve group were: baseline level (p = 0.02) and variation (p = 0.002) of PD1 and Tim3 co-expression on CD8, and variation of CD95 expression on CD4 (p = 0.007). Parameters significantly associated with CD4 restoration in cART group were: baseline level of CD38+ HLADR-subset of CD8 (p = 0.01), variation of PD1 expression on CD8 (p = 0.036), variation of Tim3 expression on CD4 (p = 0.039) and variation of CD95 expression on CD4 (p = 0.035). Conclusions Our results suggest that PD1 and Tim3 markers of exhaustion have a pivotal role in CD4 dynamics in HIV patients and its down-regulation would be a desirable effect of immunotherapies aimed to restore CD4 T-cell pool during progression of HIV infection.	[Rallon, Norma; Garcia, Marcial; Restrepo, Clara; Benito, Jose M.] Univ Autonoma Madrid, IIS FJD, Madrid, Spain; [Rallon, Norma; Garcia, Marcial; Restrepo, Clara; Nistal, Sara; Benito, Jose M.] Hosp Univ Rey Juan Carlos, Mostoles, Spain; [Garcia-Sarnaniego, Javier] Hosp Univ Carlos III La Paz, Madrid, Spain; [Garcia-Sarnaniego, Javier] CIBERehd, Madrid, Spain; [Cabello, Alfonso; Alvarez, Beatriz; Gorgolas, Miguel] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Rallon, N (corresponding author), Univ Autonoma Madrid, IIS FJD, Madrid, Spain.; Rallon, N (corresponding author), Hosp Univ Rey Juan Carlos, Mostoles, Spain.	normaibon@yahoo.com	Benito, Jose/AAC-4554-2020; Cabello, Alfonso/ABH-3203-2021	Garcia-Samaniego, Javier/0000-0002-9974-0855; Cabello-Ubeda, Alfonso/0000-0001-8429-8358; Garcia, Marcial/0000-0001-7462-1836; Benito, Jose/0000-0002-7172-049X; Rallon, Norma/0000-0002-4643-247X	Health Research and Development Strategy [RD12/0017/0031, RD16/0025/0013, PI14/00518]; State Plan for Scientific and Technical Research and Innovation; Institute of Health Carlos III; ISCIII Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF); ISCIII [CP14/00198]; IIS-FJD	Health Research and Development Strategy; State Plan for Scientific and Technical Research and Innovation; Institute of Health Carlos III(Instituto de Salud Carlos III); ISCIII Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); ISCIII(Instituto de Salud Carlos III); IIS-FJD	This study has been funded by the RD12/0017/0031, RD16/0025/0013 and PI14/00518 projects as part of the Health Research and Development Strategy, State Plan for Scientific and Technical Research and Innovation (2008-2011; 2013-2016) and cofinanced by Institute of Health Carlos III, ISCIII Sub-Directorate General for Research Assessment and Promotion and European Regional Development Fund (ERDF). Norma Rallon is a Miguel Servet investigator from the ISCIII (CP14/00198), Madrid, Spain. M Garcia is a predoctoral student co-funded by CP14/00198 project and Intramural Research Scholarship from IIS-FJD, and Clara Restrepo was funded by project RD12/0017/0031 and is currently funded by project RD16/0025/0013. There was no additional external funding received for this study.	Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Grabmeier-Pfistershammer Katharina, 2011, J Acquir Immune Defic Syndr, V56, P118, DOI 10.1097/QAI.0b013e3181fbab9f; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Legat A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00455; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Poonia B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-91; Rallon N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173943; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Savarino A, 2000, AIDS, V14, P1079, DOI 10.1097/00002030-200006160-00004; Shive CL, 2016, JAIDS-J ACQ IMM DEF, V71, P483, DOI 10.1097/QAI.0000000000000913; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Valiathan R, 2016, IMMUNOBIOLOGY, V221, P670, DOI 10.1016/j.imbio.2016.01.002; Vigano A, 2000, CHEM IMMUNOL, V75, P207; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZHANG Z, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1155/2015/825136	32	24	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193829	10.1371/journal.pone.0193829	http://dx.doi.org/10.1371/journal.pone.0193829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518102	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900039
J	Bod'ova, K; Mitchell, GJ; Harpaz, R; Schneidman, E; Tkacik, G				Bod'ova, Katarina; Mitchell, Gabriel J.; Harpaz, Roy; Schneidman, Elad; Tkacik, Gasper			Probabilistic models of individual and collective animal behavior	PLOS ONE			English	Article							SOCIAL INFORMATION; DECISION-MAKING; FISH; SIMULATION; MOVEMENT; SYSTEMS; RULES	Recent developments in automated tracking allow uninterrupted, high-resolution recording of animal trajectories, sometimes coupled with the identification of stereotyped changes of body pose or other behaviors of interest. Analysis and interpretation of such data represents a challenge: the timing of animal behaviors may be stochastic and modulated by kinematic variables, by the interaction with the environment or with the conspecifics within the animal group, and dependent on internal cognitive or behavioral state of the individual. Existing models for collective motion typically fail to incorporate the discrete, stochastic, and internal-state- dependent aspects of behavior, while models focusing on individual animal behavior typically ignore the spatial aspects of the problem. Here we propose a probabilistic modeling framework to address this gap. Each animal can switch stochastically between different behavioral states, with each state resulting in a possibly different law of motion through space. Switching rates for behavioral transitions can depend in a very general way, which we seek to identify from data, on the effects of the environment as well as the interaction between the animals. We represent the switching dynamics as a Generalized Linear Model and show that: (i) forward simulation of multiple interacting animals is possible using a variant of the Gillespie's Stochastic Simulation Algorithm; (ii) formulated properly, the maximum likelihood inference of switching rate functions is tractably solvable by gradient descent; (iii) model selection can be used to identify factors that modulate behavioral state switching and to appropriately adjust model complexity to data. To illustrate our framework, we apply it to two synthetic models of animal motion and to real zebrafish tracking data.	[Bod'ova, Katarina; Mitchell, Gabriel J.; Tkacik, Gasper] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Bod'ova, Katarina] Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia; [Harpaz, Roy; Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Institute of Science & Technology - Austria; Comenius University Bratislava; Weizmann Institute of Science	Bod'ova, K (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.; Bod'ova, K (corresponding author), Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia.	kbodova@ist.ac.at	Bodova, Katarina/AAX-4565-2021	Bodova, Katarina/0000-0002-7214-0171; Tkacik, Gasper/0000-0002-6699-1455; schneidman, elad/0000-0001-8653-9848; Harpaz, Roy/0000-0001-9587-3389	Human Frontier Science Program [RGP0065/2012]; Human Frontier Science Program (HFSP)	Human Frontier Science Program(Human Frontier Science Program); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the Human Frontier Science Program RGP0065/2012 (GT, ES).; This work was supported by the Human Frontier Science Program (HFSP) grant to GT and ES.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davis MH, 1993, MARKOV PROCESSES OPT, V7, P7; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Ghosh MK, 1997, SIAM J CONTROL OPTIM, V35, P1952, DOI 10.1137/S0363012996299302; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girdhar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128668; GOLDSTEIN S, 1951, Q J MECH APPL MATH, V4, P129, DOI 10.1093/qjmam/4.2.129; Harpaz R, 2017, P NATL ACAD SCI USA, V114, P10149, DOI 10.1073/pnas.1703817114; Hu JH, 2000, LECT NOTES COMPUT SC, V1790, P160; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Kac Marc, 1974, ROCKY MOUNTAIN J MAT, V4; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kennedy MJ, 2017, PHYS BIOL, V14; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; McCullagh P, 1989, LOG LINEAR MODELS GE, P193; Nagy M, 2010, ARXIV10105394; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nelder J. A., 1972, GEN LINEAR MODELS; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pola G., 2003, P IFAC C AN DES HYBR, P45, DOI DOI 10.3182/20050703-6-CZ-1902.00396; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	38	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193049	10.1371/journal.pone.0193049	http://dx.doi.org/10.1371/journal.pone.0193049			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513700	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800032
J	Borjkhani, M; Bahrami, F; Janahmadi, M				Borjkhani, Mehdi; Bahrami, Fariba; Janahmadi, Mahyar			Computational modeling of opioid-induced synaptic plasticity in hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MATHEMATICAL-MODEL; SIGNALING PATHWAY; CALCIUM-CHANNELS; NMDA RECEPTORS; RELEASE; TRANSMISSION; STIMULATION; DEPENDS; AREA	According to a broad range of research, opioids consumption can lead to pathological memory formation. Experimental observations suggested that hippocampal glutamatergic synapses play an indispensable role in forming such a pathological memory. It has been suggested that memory formation at the synaptic level is developed through LTP induction. Here, we attempt to computationally indicate how morphine induces pathological LTP at hippocampal CA3-CA1 synapses. Then, based on simulations, we will suggest how one can prevent this type of pathological LTP. To this purpose, a detailed computational model is presented, which consists of one pyramidal neuron and one interneuron both from CA3, one CA1 pyramidal neuron, and one astrocyte. Based on experimental findings morphine affects the hippocampal neurons in three primary ways: 1) disinhibitory mechanism of interneurons in CA3, 2) enhancement of NMDARs current by mu Opioid Receptor (mu OR) activation and 3) by attenuation of astrocytic glutamate reuptake ability. By utilizing these effects, simulations were implemented. Our results indicate that morphine can induce LTP by all aforementioned possible mechanisms. Based on our simulation results, attenuation of pathologic LTP achieved mainly by stimulation of astrocytic glutamate transporters, down-regulation of the astrocytic metabotropic glutamate receptors (mGlurs) or by applying NMDAR's antagonist. Based on our observations, we suggest that astrocyte has a dominant role in forming addiction- related memories. This finding may help researchers in exploring drug actions for preventing relapse.	[Borjkhani, Mehdi; Bahrami, Fariba] Univ Tehran, Coll Engn, CIPCE, Sch ECE,Motor Control & Computat Neurosci Lab, Tehran, Iran; [Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Sch Med, Neurosci Res Ctr, Tehran, Iran; [Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran	University of Tehran; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Bahrami, F (corresponding author), Univ Tehran, Coll Engn, CIPCE, Sch ECE,Motor Control & Computat Neurosci Lab, Tehran, Iran.	fbahrami@ut.ac.ir	Janahmadi, Mahyar/AAU-6425-2021	Borjkhani, Mehdi/0000-0003-0469-0902				Akaishi T, 2000, NEUROSCI RES, V38, P357, DOI 10.1016/S0168-0102(00)00177-2; Bertram R, 2003, J NEUROPHYSIOL, V90, P1643, DOI 10.1152/jn.00190.2003; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; Castellani GC, 2005, LEARN MEMORY, V12, P423, DOI 10.1101/lm.80705; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; CAUDLE RM, 1990, J PHARMACOL EXP THER, V252, P1361; Chartoff EH, 2014, FRONT PHARMACOL, P5; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen L, 1992, PROTEIN KINASE C RED; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; GAHWILER BH, 1980, BRAIN RES, V194, P193, DOI 10.1016/0006-8993(80)91328-1; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Heidari MH, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/290414; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Herman B.H., 2003, GLUTAMATE ADDICTION; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosseinmardi N, 2011, EUR J PHARMACOL, V670, P487, DOI 10.1016/j.ejphar.2011.09.008; Hosseinmardi N, 2009, BRAIN RES, V1296, P1, DOI 10.1016/j.brainres.2009.08.020; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kow LM, 2002, BRAIN RES, V935, P87, DOI 10.1016/S0006-8993(02)02532-5; Li YJ, 2015, ADDICTION BIOL; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Luscher C, 2013, J NEUROSCI, V33, P17641, DOI 10.1523/JNEUROSCI.3406-13.2013; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mao JR, 1999, BRAIN RES REV, V30, P289, DOI 10.1016/S0165-0173(99)00020-X; Martin G, 1999, J NEUROSCI, V19, P9081, DOI 10.1523/JNEUROSCI.19-20-09081.1999; Min R, 2012, FRONT COMPUT NEUROSC, P6; Moradi K, 2013, J COMPUT NEUROSCI, V34, P521, DOI 10.1007/s10827-012-0434-4; Nadkarni S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000088; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler Eric J, 2013, Dialogues Clin Neurosci, V15, P431; Peters J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012088; Przewlocki R, 1999, J NEUROSCI, V19, P9705; RHIM H, 1994, J NEUROSCI, V14, P7608; Scofield MD, 2014, NEUROSCIENTIST; Shen F, 2016, NEUROPHARMACOLOGY, V102, P216, DOI 10.1016/j.neuropharm.2015.11.008; Shen F, 2012, NEUROBIOL LEARN MEM, V98, P130, DOI 10.1016/j.nlm.2012.07.005; Shen HW, 2014, J NEUROSCI, V34, P5649, DOI 10.1523/JNEUROSCI.4564-13.2014; Siahposht-Khachaki A, 2016, BASIC CLIN NEUROSCI, V7, P341, DOI 10.15412/J.BCN.03070407; Sweeney AM, 2017, SCI REPORTS, P7; Taepavarapruk P, 2003, PSYCHOPHARMACOLOGY, V168, P99, DOI 10.1007/s00213-002-1337-2; Tewari S, 2013, FRONTIERS COMPUTATIO, P7; Tewari S, 2012, J COMPUT NEUROSCI, V33, P341, DOI 10.1007/s10827-012-0389-5; Tewari SG, 2012, J BIOL PHYS, V38, P465, DOI 10.1007/s10867-012-9267-7; Trujillo KA, 2002, NEUROTOX RES, V4, P373, DOI 10.1080/10298420290023954; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; van Huijstee AN, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00466; Vengeliene V, 2015, J NEUROCHEM, V135, P1080, DOI 10.1111/jnc.13350; Wade JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029445; Wang HF, 2018, J X-RAY SCI TECHNOL, V26, P171, DOI 10.3233/XST-17302; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; Zachariou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058926; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	59	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193410	10.1371/journal.pone.0193410	http://dx.doi.org/10.1371/journal.pone.0193410			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513763	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800058
J	Chen, CY; Strobaugh, TP; Nguyen, LHT; Abley, M; Lindsey, RL; Jackson, CR				Chen, Chin-Yi; Strobaugh, Terence P., Jr.; Nguyen, Ly-Huong T.; Abley, Melanie; Lindsey, Rebecca L.; Jackson, Charlene R.			Isolation and characterization of two novel groups of kanamycin-resistance ColE1-like plasmids in Salmonella enterica serotypes from food animals	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; UNITED-STATES; ANTIMICROBIAL RESISTANCE; FOODBORNE ILLNESS; SEQUENCE; STRAINS; GENE; PROGRAMS; SEROVARS; HEALTH	While antimicrobial resistance in Salmonella enterica is mainly attributed to large plasmids, small plasmids may also harbor antimicrobial resistance genes. Previously, three major groups of ColE1-like plasmids conferring kanamycin-resistance (Kan(R)) in various S. enterica serotypes from diagnostic samples of human or animals were reported. In this study, over 200 Kan(R) S. enterica isolates from slaughter samples, collected in 2010 and 2011 as a part of the animal arm of the National Antimicrobial Resistance Monitoring System, were screened for the presence of ColE1-like plasmids. Twenty-three Kan(R) ColE1-like plasmids were successfully isolated. Restriction fragment mapping revealed five major plasmid groups with subgroups, including two new groups, X (n = 3) and Y/Y2/Y3 (n = 4), in addition to the previously identified groups A (n = 7), B (n = 6), and C/C3 (n = 3). Nearly 75% of the plasmid-carrying isolates were from turkey and included all the isolates carrying X and Y plasmids. All group X plasmids were from serotype Hadar. Serotype Senftenberg carried all the group Y plasmids and one group B plasmid. All Typhimurium isolates (n = 4) carried group A plasmids, while Newport isolates (n = 3) each carried a different plasmid group (A, B, or C). The presence of the selection bias in the NARMS strain collection prevents interpretation of findings at the population level. However, this study demonstrated that Kan(R) ColE1-like plasmids are widely distributed among different S. enterica serotypes in the NARMS isolates and may play a role in dissemination of antimicrobial resistance genes.	[Chen, Chin-Yi; Strobaugh, Terence P., Jr.; Nguyen, Ly-Huong T.] USDA ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; [Abley, Melanie; Lindsey, Rebecca L.; Jackson, Charlene R.] USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, Richard B Russell Agr Res Ctr, Athens, GA 30605 USA; [Abley, Melanie] USDA, Food Safety Inspect Serv, Washington, DC 20250 USA; [Lindsey, Rebecca L.] Ctr Dis Control & Prevent, Atlanta, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	Chen, CY (corresponding author), USDA ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.	chin-yi.chen@ars.usda.gov		Chen, Chin-Yi/0000-0001-5058-0347; Lindsey, Rebecca/0000-0002-2149-7971	United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety	United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety	This research was funded by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00988-13; Briggs CE, 1999, ANTIMICROB AGENTS CH, V43, P846, DOI 10.1128/AAC.43.4.846; CANNON PM, 1992, PLASMID, V27, P220, DOI 10.1016/0147-619X(92)90024-5; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, VET RES, V32, P243, DOI 10.1051/vetres:2001122; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; *CDC, 2004, ON DAY 24 28 H STAND; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Chen CY, 2011, PLASMID, V65, P246, DOI 10.1016/j.plasmid.2011.02.001; Chen CY, 2010, APPL ENVIRON MICROB, V76, P6707, DOI 10.1128/AEM.00692-10; Chen CY, 2010, PLASMID, V63, P150, DOI 10.1016/j.plasmid.2009.12.005; Clinical and Laboratory Standards Institute, 2006, 16 INF SUPPL CLSI WA; Crarey E, 2015, ANTIMICROBIAL RESIST, P259; FDA, 2013, 2011 EX REP; Fedorka-Cray PJ, 2002, ANIM BIOTECHNOL, V13, P43, DOI 10.1081/ABIO-120005769; FINNEGAN J, 1982, MOL GEN GENET, V185, P344, DOI 10.1007/BF00330810; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gregorova D, 2004, CAN J MICROBIOL, V50, P107, DOI 10.1139/W03-113; Gregorova D, 2002, FEMS MICROBIOL LETT, V214, P195, DOI 10.1111/j.1574-6968.2002.tb11346.x; Hofinger C, 1998, J CLIN MICROBIOL, V36, P24, DOI 10.1128/JCM.36.1.24-29.1998; Jackson CR, 2007, FOODBORNE PATHOG DIS, V4, P241, DOI 10.1089/fpd.2006.0067; Klumper U, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00730; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; NCCLS, 2004, PERFORMANCE STANDARD; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Rychlik I, 2001, J BACTERIOL, V183, P2852, DOI 10.1128/JB.183.9.2852-2858.2001; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2015, J FOOD PROTECT, V78, P1064, DOI 10.4315/0362-028X.JFP-14-505; Tollefson L, 1999, ACTA VET SCAND, P67; Tollefson L, 1998, VET CLIN N AM-FOOD A, V14, P141, DOI 10.1016/S0749-0720(15)30285-1; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; USDA, 2012, 2010 NARMS AN ARM AN; USDA, NAT ANT RES MON SYST; USDA, 2014, 2011 NARMS AN ARM AN; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wu JJ, 2008, J ANTIMICROB CHEMOTH, V62, P1269, DOI 10.1093/jac/dkn426; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zioga A, 2009, ANTIMICROB AGENTS CH, V53, P1256, DOI 10.1128/AAC.01284-08	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193435	10.1371/journal.pone.0193435	http://dx.doi.org/10.1371/journal.pone.0193435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513730	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800059
J	Barbet-Massin, M; Rome, Q; Villemant, C; Courchamp, F				Barbet-Massin, Morgane; Rome, Quentin; Villemant, Claire; Courchamp, Franck			Can species distribution models really predict the expansion of invasive species?	PLOS ONE			English	Article							VESPA-VELUTINA LEPELETIER; CLIMATIC NICHE SHIFTS; BIOLOGICAL INVASIONS; LAND-USE; FUTURE; RISK; EUROPE; CONSERVATISM; EQUILIBRIUM; NIGRITHORAX	Predictive studies are of paramount importance for biological invasions, one of the biggest threats for biodiversity. To help and better prioritize management strategies, species distribution models (SDMs) are often used to predict the potential invasive range of introduced species. Yet, SDMs have been regularly criticized, due to several strong limitations, such as violating the equilibrium assumption during the invasion process. Unfortunately, validation studies-with independent data-are too scarce to assess the predictive accuracy of SDMs in invasion biology. Yet, biological invasions allow to test SDMs usefulness, by retrospectively assessing whether they would have accurately predicted the latest ranges of invasion. Here, we assess the predictive accuracy of SDMs in predicting the expansion of invasive species. We used temporal occurrence data for the Asian hornet Vespa velutina nigrithorax, a species native to China that is invading Europe with a very fast rate. Specifically, we compared occurrence data from the last stage of invasion (independent validation points) to the climate suitability distribution predicted from models calibrated with data from the early stage of invasion. Despite the invasive species not being at equilibrium yet, the predicted climate suitability of validation points was high. SDMs can thus adequately predict the spread of V. v. nigrithorax, which appears to be-at least partially-climatically driven. In the case of V. v. nigrithorax, SDMs predictive accuracy was slightly but significantly better when models were calibrated with invasive data only, excluding native data. Although more validation studies for other invasion cases are needed to generalize our results, our findings are an important step towards validating the use of SDMs in invasion biology.	[Barbet-Massin, Morgane; Courchamp, Franck] Univ Paris Saclay, Univ Paris Sud, CNRS, AgroParisTech,Ecol Syst & Evolut, Orsay, France; [Rome, Quentin; Villemant, Claire] Sorbonne Univ, CNRS, UPMC, EPHE,ISYEB,MNHN,UMR 7205, Paris, France; [Rome, Quentin] Museum Natl Hist Nat, CNRS, AFB, UMS Patrimoine Nat 2006, Paris, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Barbet-Massin, M (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, AgroParisTech,Ecol Syst & Evolut, Orsay, France.	morganebm@gmail.com	Rome, Quentin/AAD-1870-2019; Courchamp, Franck/ABE-7204-2020	Rome, Quentin/0000-0002-7055-8064; Courchamp, Franck/0000-0001-7605-4548	INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture); MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie); MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture)(French National Research Agency (ANR)); MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie); MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	This work was supported by the INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture, 2008-2011 and 2013-2016), the MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie) and the MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret).; This work was supported by the INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture, 2008-2011 and 2013-2016), the MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie) and the MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret). We are most thankful all persons and organizations that provided records of hornet nests in France and in Europe (their list is available on the INPN website).	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Areias-Guerreiro J, 2016, HYSTRIX, V27, DOI 10.4404/hystrix-27.1-11867; Barbet-Massin M, 2015, GLOBAL CHANGE BIOL, V21, P2917, DOI 10.1111/gcb.12905; Barbet-Massin M, 2014, DIVERS DISTRIB, V20, P1285, DOI 10.1111/ddi.12229; Barbet-Massin M, 2013, BIOL CONSERV, V157, P4, DOI 10.1016/j.biocon.2012.09.015; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bertolino S, 2016, APPL ENTOMOL ZOOL, P1; Bessa AS, 2016, INSECT CONSERV DIVER, V9, P27, DOI 10.1111/icad.12140; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Crall AW, 2013, ECOL APPL, V23, P60, DOI 10.1890/12-0465.1; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Giljohann KM, 2011, J APPL ECOL, V48, P1286, DOI 10.1111/j.1365-2664.2011.02016.x; Goldarazena A., 2015, Bulletin OEPP, V45, P133, DOI 10.1111/epp.12185; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hattab T, 2017, DIVERS DISTRIB, V23, P806, DOI 10.1111/ddi.12566; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Jarnevich CS, 2010, INVAS PLANT SCI MANA, V3, P365, DOI 10.1614/IPSM-08-073.1; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jones CC, 2012, FOREST ECOL MANAG, V284, P69, DOI 10.1016/j.foreco.2012.07.024; Keeling MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06212-0; Kramer AM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1883; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Lecocq T, 2016, CONSERV LETT, V9, P281, DOI 10.1111/conl.12215; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Lopez S., 2011, Bulletin OEPP, V41, P439, DOI 10.1111/j.1365-2338.2011.02513.x; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Milanesio D, 2017, ECOL EVOL, V7, P4599, DOI 10.1002/ece3.3053; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Mouquet N, 2015, J APPL ECOL, V52, P1293, DOI 10.1111/1365-2664.12482; Parravicini V, 2015, ECOL LETT, V18, P246, DOI 10.1111/ele.12401; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Porporato M, 2014, REDIA, V97, P189; R Core Team, 2013, R LANG ENV STAT COMP; Robinet C., 2016, J APPL ECOL; Rodrigues JFM, 2016, FRESHWATER BIOL, V61, P1119, DOI 10.1111/fwb.12772; Rodriguez-Rey M, 2013, ECOL MODEL, V256, P1, DOI 10.1016/j.ecolmodel.2013.01.024; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Rome Quentin, 2013, Bulletin de la Societe Entomologique de France, V118, P21; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Sheppard CS, 2014, GLOBAL CHANGE BIOL, V20, P2800, DOI 10.1111/gcb.12531; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Thuiller W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4118; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tingley R, 2017, ECOGRAPHY; Tulloch AIT, 2014, CONSERV BIOL, V28, P1462, DOI 10.1111/cobi.12403; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Witt R, 2015, AMPULEX, V7, P42	74	95	97	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193085	10.1371/journal.pone.0193085	http://dx.doi.org/10.1371/journal.pone.0193085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509789	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200009
J	Choi, SS; Uehara, H; Wu, YY; Das, S; Zhang, XH; Archer, B; Carroll, L; Ambati, BK				Choi, Susie; Uehara, Hironori; Wu, Yuanyuan; Das, Subrata; Zhang, Xiaohui; Archer, Bonnie; Carroll, Lara; Ambati, Balamurali Krishna			RNA activating-double stranded RNA targeting flt-1 promoter inhibits endothelial cell proliferation through soluble FLT-1 upregulation	PLOS ONE			English	Article							RECEPTOR 1 SFLT1; GENE-EXPRESSION; MACULAR DEGENERATION; ARGONAUTE PROTEINS; CANCER; VEGF; ANGIOGENESIS; METHYLATION; THERAPY; NEOVASCULARIZATION	Short-activating RNA (saRNA), which targets gene promoters, has been shown to increase the target gene expression. In this study, we describe the use of an saRNA (Flt a-1) to target the flt-1 promoter, leading to upregulation of the soluble isoform of Flt-1 and inhibition of angiogenesis. We demonstrate that Flt a-1 increased sFlt-1 mRNA and protein levels, while reducing VEGF expression. This was associated with suppression of human umbilical vascular endothelial cell (HUVEC) proliferation and cell cycle arrest at the G(0)/G(1) phase. HUVEC migration and tube formation were also suppressed by Flt a-1. An siRNA targeting Flt-1 blocked the effects of Flt a-1. Flt a-1 effects were not mediated via argonaute proteins. However, trichostatin A and 5'-deoxy-5'-(methylthio) adenosine inhibited Flt a-1 effects, indicating that histone acetylation and methylation are mechanistically involved in RNA activation of Flt-1. In conclusion, RNA activation of sFlt-1 can be used to inhibit angiogenesis.	[Choi, Susie; Uehara, Hironori; Wu, Yuanyuan; Zhang, Xiaohui; Archer, Bonnie; Carroll, Lara; Ambati, Balamurali Krishna] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Das, Subrata] Patanjali Res Inst, Haridwar, India	Utah System of Higher Education; University of Utah	Uehara, H (corresponding author), Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.	hironori.uehara@hsc.utah.edu		zhang, xiaohui/0000-0001-7216-4256; DAS, SUBRATA/0000-0001-8608-3270	National Institutes of Health/NEI [R01EY17950]; Research to Prevent Blindness, New York, NY [RPB 2017]	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB))	This work was supported by the National Institutes of Health/NEI (R01EY17950) and unrestricted grant (RPB 2017) from Research to Prevent Blindness, New York, NY to the Department of Ophthalmology & Visual Sciences, University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carpentier G., 2012, IMAGEJ NEWS; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cho YK, 2012, INVEST OPHTH VIS SCI, V53, P685, DOI 10.1167/iovs.11-8391; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Constable IJ, 2016, EBIOMEDICINE, V14, P168, DOI 10.1016/j.ebiom.2016.11.016; Heier JS, 2017, LANCET, V390, P50, DOI 10.1016/S0140-6736(17)30979-0; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jiao AL, 2014, EPIGENETICS-US, V9, P27, DOI 10.4161/epi.26942; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Ling H, 2016, ADV EXP MED BIOL, V937, P229, DOI 10.1007/978-3-319-42059-2_12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyake T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24853; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Moserle L, 2013, J INTERN MED, V273, P128, DOI 10.1111/joim.12018; Owen LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033576; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Timar Jozsef, 2001, Pathology and Oncology Research, V7, P85; Uehara H, 2015, AM J OPHTHALMOL, V159, P92, DOI 10.1016/j.ajo.2014.09.036; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Verrax J, 2011, MOL PHARMACEUT, V8, P701, DOI 10.1021/mp100268t; Wang JY, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.PPAT.1005243; Wang XL, 2012, BIOCHEM J, V443, P821, DOI 10.1042/BJ20111491; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Yue XA, 2010, NAT CHEM BIOL, V6, P621, DOI [10.1038/NCHEMBIO.400, 10.1038/nchembio.400]; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193590	10.1371/journal.pone.0193590	http://dx.doi.org/10.1371/journal.pone.0193590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509796	Green Submitted, gold, Green Published			2022-12-26	WOS:000426813200017
J	Wang, GS; Mathew, AV; Yu, HY; Li, L; He, LY; Gao, W; Liu, XD; Guo, YH; Byun, J; Zhang, JF; Chen, YE; Pennathur, S				Wang, Guisong; Mathew, Anna Vachaparampil; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei; Liu, Xiaodan; Guo, Yanhong; Byun, Jaeman; Zhang, Jifeng; Chen, Y. Eugene; Pennathur, Subramaniam			Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX CAPACITY; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; RISK-FACTOR; POPULATION; SEVERITY; SMOKING	High density lipoprotein (HDL) cholesterol levels and cholesterol efflux capacity (CEC) are inversely correlated with coronary artery disease (CAD) risk. Myeloperoxidase (MPO) derived oxidants and HDL proteome changes are implicated in HDL dysfunction in subjects with CAD in the United States; however, the effect of MPO on HDL function and HDL proteome in ethnic Chinese population is unknown. We recruited four matched ethnic Chinese groups (20 patients each): subjects with 1) low HDL levels (HDL levels in men < 40mg/dL and women < 50mg/dL) and non-CAD (identified by coronary angiography or cardiac CT angiography); 2) low HDL and CAD; 3) high HDL (men > 50mg/dL; women > 60mg/dL) with no CAD; and 4) high HDL with CAD. Serum cytokines, serum MPO levels, serum CEC, MPO-oxidized HDL tyrosine moieties, and HDL proteome were assessed by mass spectrometry individually in the four groups. The cytokines, MPO levels, and HDL proteome profiles were not significantly different between the four groups. As expected, CEC was depressed in the entire CAD group but more specifically in the CAD low-HDL group. HDL of CAD subjects had significantly higher 3-nitrotyrosine than non-CAD subjects, but the MPO-specific 3-chlorotyrosine was unchanged; CEC in the CAD low-HDL group did not correlate with either HDL 3-chlorotyrosine or 3-nitrotyrosine levels. Neither 3-chlorotyrosine, which is MPO-specific, nor 3-nitrotyrosine generated from MPO or other reactive nitrogen species was associated with CEC. MPO mediated oxidative stress and HDL proteome composition changes are not the primary cause HDL dysfunction in Chinese subjects with CAD. These studies highlight ethnic differences in HDL dysfunction between United States and Chinese cohorts raising possibility of unique pathways of HDL dysfunction in this cohort.	[Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Mathew, Anna Vachaparampil; Guo, Yanhong; Byun, Jaeman; Zhang, Jifeng; Chen, Y. Eugene; Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Liu, Xiaodan] China Med Univ, Affiliated Hosp 1, Dept Med, Nephrol, Shenyang, Liaoning, Peoples R China	Peking University; Peking University; University of Michigan System; University of Michigan; China Medical University	Pennathur, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	spennath@umich.edu	Mathew, Anna V/V-2511-2018; Guo, Yanhong/D-9764-2012	Mathew, Anna/0000-0002-7043-4221; Gao, Wei/0000-0003-3541-9568	University of Michigan-Peking University Joint Institute for Translational and Clinical Research; National Institutes of Health NIDDK [P30DK081943]; NHLBI [K08HL130944]; National Institutes of Health [P30DK081943, K08HL130944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL130944] Funding Source: NIH RePORTER	University of Michigan-Peking University Joint Institute for Translational and Clinical Research; National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Michigan-Peking University Joint Institute for Translational and Clinical Research (http://puuma.org/research-programs/cardiovascular-disease/dysfunctional-hdi-and-cardiovascular-disease) to to SP, EC, GW and WG; National Institutes of Health NIDDK (P30DK081943) to S.P;, and NHLBI (K08HL130944)to AVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported in part by grants from the University of Michigan-Peking University Joint Institute for Translational and Clinical Research and National Institutes of Health (P30DK081943 and K08HL130944).	Agarwala AP, 2015, ARTERIOSCL THROM VAS, V35, P1515, DOI 10.1161/ATVBAHA.115.305504; Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Feng H, 2009, CURR OPIN ENDOCRINOL, V16, P156, DOI 10.1097/MED.0b013e32832922fc; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Gui LX, 2014, ATHEROSCLEROSIS, V237, P480, DOI 10.1016/j.atherosclerosis.2014.09.032; Jin ZM, 2006, ACTA CARDIOL, V61, P603, DOI 10.2143/AC.61.6.2017958; Kashiwagi M, 2009, CIRC J, V73, P1291, DOI 10.1253/circj.CJ-08-0968; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Ko DT, 2016, J AM COLL CARDIOL, V68, P2073, DOI 10.1016/j.jacc.2016.08.038; Krishnan S, 2015, J PROTEOME RES, V14, P5109, DOI 10.1021/acs.jproteome.5b00730; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Li YP, 2016, J AM COLL CARDIOL, V68, P818, DOI 10.1016/j.jacc.2016.06.011; Lin CC, 2014, ATHEROSCLEROSIS, V235, P488, DOI 10.1016/j.atherosclerosis.2014.05.939; Liu CQ, 2016, ATHEROSCLEROSIS, V249, P116, DOI 10.1016/j.atherosclerosis.2015.10.111; Liu HH, 2017, ATHEROSCLEROSIS, V263, P104, DOI 10.1016/j.atherosclerosis.2017.06.013; Lu NH, 2015, CLIN CHIM ACTA, V441, P163, DOI 10.1016/j.cca.2014.12.014; Martiniuk ALC, 2006, TOB CONTROL, V15, P181, DOI 10.1136/tc.2005.013284; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Min X, 2017, BIOMED RES INT, V2017, P9; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Monette JS, 2016, CIRC RES, V119, P83, DOI 10.1161/CIRCRESAHA.116.308357; Noori M, 2009, J CLIN LIPIDOL, V3, P39, DOI 10.1016/j.jacl.2008.11.010; Okamura DM, 2015, REDOX BIOL, V6, P495, DOI 10.1016/j.redox.2015.09.039; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; Riwanto M, ALTERED ACTIVATION E; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Siddiqi HK, 2015, CURR OPIN CARDIOL, V30, P536, DOI 10.1097/HCO.0000000000000211; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Song P, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/761939; Su CS, 2015, ACTA CARDIOL SIN, V31, P528, DOI 10.6515/ACS20150421A; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tong XL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-27; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086332; Yan LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098368; Yang XL, 2016, CIRCULATION, V134, P1430, DOI 10.1161/CIRCULATIONAHA.116.022367; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; YU JJ, 1990, JAMA-J AM MED ASSOC, V264, P1575, DOI 10.1001/jama.264.12.1575; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zhao L, 2017, ONCOTARGET, V8, P66438, DOI 10.18632/oncotarget.20090; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193782	10.1371/journal.pone.0193782	http://dx.doi.org/10.1371/journal.pone.0193782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505607	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200031
J	Bukabau, JB; Sumaili, EK; Cavalier, E; Pottel, H; Kifakiou, B; Nkodila, A; Makulo, JRR; Mokoli, VM; Zinga, CV; Longo, AL; Engole, YM; Nlandu, YM; Lepira, FB; Nseka, NM; Krzesinski, JM; Delanaye, P				Bukabau, Justine B.; Sumaili, Ernest K.; Cavalier, Etienne; Pottel, Hans; Kifakiou, Bejos; Nkodila, Aliocha; Makulo, Jean Robert R.; Mokoli, Vieux M.; Zinga, Chantal V.; Longo, Augustin L.; Engole, Yannick M.; Nlandu, Yannick M.; Lepira, Francois B.; Nseka, Nazaire M.; Krzesinski, Jean Marie; Delanaye, Pierre			Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The inopportunity of the ethnic correction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; IMPROVING GLOBAL OUTCOMES; BLACK SOUTH-AFRICANS; SERUM CREATININE; CYSTATIN C; CLINICAL-PRACTICE; RENAL-FUNCTION; POSITION STATEMENT; PLASMA-CLEARANCE; PUBLIC-HEALTH	Context and objective In the estimation of glomerular filtration rate (GFR), ethnicity is an important determinant. However, all existing equations have been built solely from Caucasian and Afro-American populations and they are potentially inaccurate for estimating GFR in African populations. We therefore evaluated the performance of different estimated GFR (eGFR) equations in predicting measured GFR (mGFR). Methods In a cross-sectional study, 93 healthy adults were randomly selected in the general population of Kinshasa, Democratic Republic of the Congo, between June 2015 and April 2016. We compared mGFR by plasma clearance of iohexol with eGFR obtained with the Modified Diet in Renal Disease (MDRD) equation with and without ethnic factor, the Chronic Kidney Disease Epidemiology (CKD-EPI) serum creatinine (SCr)-based equation, with and without ethnic factor, the cystatin C-based CKD-EPI equation (CKD-EPI SCys) and with the combined equation (CKD-EPI SCrCys) with and without ethnic factor. The performance of the equations was studied by calculating bias, precision and accuracy within 30% (P30) of mGFR. Results There were 48 women and 45 men. Their mean age was 45.0 +/- 15.7 years and the average body surface area was 1.68 +/- 0.16m(2). Mean mGFR was 92.0 +/- 17.2 mL/min/1.73m(2) (range of 57 to 141 mL/min/1.73m(2)). Mean eGFRs with the different equations were 105.5 +/- 30.1 and 87.2 +/- 24.8 mL/min/1.73m(2) for MDRD with and without ethnic factor, respectively; 108.8 +/- 24.1 and 94.3x20.9 mL/min/1.73m(2) for CKD-EPI SCr with and without ethnic factor, respectively, 93.5 +/- 18.6 mL/min/1.73m(2) for CKD-EPI SCys; 93.5 +/- 18.0 and 101 +/- 19.6 mL/min/1.73m(2) for CKD-EPI SCrCys with and without ethnic factor, respectively. All equations slightly overestimated mGFR except MDRD without ethnic factor which underestimated by -3.8 +/- 23.0 mL/min /1.73m(2). Both CKD-EPI SCr and MDRD with ethnic factors highly overestimated mGFR with a bias of 17.9 +/- 19.2 and 14.5 +/- 27.1 mL/min/1.73m(2), respectively. There was a trend for better P30 for MDRD and CKD-EPI SCr without than with the ethnic factor [86.0% versus 79.6% for MDRD (p = 0.21) and 81.7% versus 73.1% for the CKD-EPI SCr equations (p = 0.057)]. CKD-EPI SCrCys and CKD-EPI SCys were more effective than creatinine-based equations. Conclusion In the Congolese healthy population, MDRD and CKD-EPI equations without ethnic factors had better performance than the same equations with ethnic factor. The equations using Cys C (alone or combined with SCr) performed better than the creatinine-based equations.	[Bukabau, Justine B.; Sumaili, Ernest K.; Kifakiou, Bejos; Nkodila, Aliocha; Makulo, Jean Robert R.; Mokoli, Vieux M.; Zinga, Chantal V.; Longo, Augustin L.; Engole, Yannick M.; Nlandu, Yannick M.; Lepira, Francois B.; Nseka, Nazaire M.] Univ Kinshasa, Kinshasa Univ Hosp, Dept Internal Med, Renal Unit, Kinshasa, DEM REP CONGO; [Cavalier, Etienne] Univ Liege, CHU Sart Tilman ULg CHU, Div Clin Chem, Liege, Belgium; [Pottel, Hans] Katholieke Univ Leuven, Div Publ Hlth & Primary Care, Campus Kulak Kortrijk, Kortrijk, Belgium; [Krzesinski, Jean Marie; Delanaye, Pierre] Univ Liege, CHU Sart Tilman ULg CHU, Div Nephrol Dialysis Transplantat, Liege, Belgium	Universite de Kinshasa; University of Liege; KU Leuven; University of Liege	Bukabau, JB (corresponding author), Univ Kinshasa, Kinshasa Univ Hosp, Dept Internal Med, Renal Unit, Kinshasa, DEM REP CONGO.	justinebuk@yahoo.fr	Cavalier, Etienne/E-8661-2011; Pottel, Hans/AAD-9444-2019; Delanaye, Pierre/T-4225-2019; Nlandu, Yannick/W-7583-2019	Cavalier, Etienne/0000-0003-0947-2226; Pottel, Hans/0000-0003-0074-8919; Delanaye, Pierre/0000-0002-1480-5761; 	University of Liege	University of Liege(University of Liege)	This study was supported by JBB and in part by funding from University of Liege particularly iohexol and serum creatinine, cystatin C dosages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; Delanaye P, 2016, CLIN KIDNEY J, V9, P700, DOI 10.1093/ckj/sfw071; Delanaye P, 2016, CLIN KIDNEY J, V9, P682, DOI 10.1093/ckj/sfw070; Delanaye P, 2013, NEPHROL DIAL TRANSPL, V28, P1396, DOI 10.1093/ndt/gft006; Delanaye P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-57; Delanaye P, 2011, CLIN J AM SOC NEPHRO, V6, P906, DOI 10.2215/CJN.10931210; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Ebert N, 2016, CLIN CHIM ACTA, V456, P115, DOI 10.1016/j.cca.2016.03.002; Fan L, 2014, NEPHROL DIAL TRANSPL, V29, P1195, DOI 10.1093/ndt/gft509; Flamant M, 2013, AM J KIDNEY DIS, V62, P182, DOI 10.1053/j.ajkd.2013.03.015; Froissart M, 2008, ANN BIOL CLIN-PARIS, V66, P269, DOI 10.1684/abc.2008.0228; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Goldwasser P, 1997, AM J KIDNEY DIS, V30, P16, DOI 10.1016/S0272-6386(97)90559-X; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Katz IJ, 2010, CLIN NEPHROL, V74, pS113; Kramer H, 2008, CLIN J AM SOC NEPHRO, V3, P1391, DOI 10.2215/CJN.04160907; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; Madala ND, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-61; Matsha TE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-75; Nyssen L, 2016, CLIN CHIM ACTA, V463, P96, DOI 10.1016/j.cca.2016.10.021; Perico N, 2015, CLIN NEPHROL, V83, pS42, DOI 10.5414/CNP83S042; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pottel H., 2015, INT J NEPHROLOGY KID, V1; Pottel H, 2017, NEPHROL DIAL TRANSPL, V32, P497, DOI 10.1093/ndt/gfw425; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sterner G, 2008, SCAND J UROL NEPHROL, V42, P278, DOI 10.1080/00365590701701806; Sumaili EK, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-18; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; van Deventer HE, 2011, NEPHROL DIAL TRANSPL, V26, P1553, DOI 10.1093/ndt/gfq621; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601; Yayo ES, 2016, NEPHROL THER, V12, P454, DOI 10.1016/j.nephro.2016.03.006	41	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193384	10.1371/journal.pone.0193384	http://dx.doi.org/10.1371/journal.pone.0193384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499039	gold, Green Submitted, Green Published			2022-12-26	WOS:000426472300012
J	Reza, SH; Delhomme, N; Street, NR; Ramachandran, P; Dalman, K; Nilsson, O; Minina, EA; Bozhkov, PV				Reza, Salim H.; Delhomme, Nicolas; Street, Nathaniel R.; Ramachandran, Prashanth; Dalman, Kerstin; Nilsson, Ove; Minina, Elena A.; Bozhkov, Peter V.			Transcriptome analysis of embryonic domains in Norway spruce reveals potential regulators of suspensor cell death	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; BAX INHIBITOR-1; CATHEPSIN-B; AUXIN TRANSPORT; STRESS; EXPRESSION; FLAVONOIDS; GENES; BIOSYNTHESIS; ACCUMULATION	The terminal differentiation and elimination of the embryo-suspensor is the earliest manifestation of programmed cell death (PCD) during plant ontogenesis. Molecular regulation of suspensor PCD remains poorly understood. Norway spruce (Picea abies) embryos provide a powerful model for studying embryo development because of their large size, sequenced genome, and the possibility to obtain a large number of embryos at a specific developmental stage through somatic embryogenesis. Here, we have carried out global gene expression analysis of the Norway spruce embryo-suspensor versus embryonal mass (a gymnosperm analogue of embryo proper) using RNA sequencing. We have identified that suspensors have enhanced expression of the NAC domain-containing transcription factors, XND1 and ANAC075, previously shown to be involved in the initiation of developmental PCD in Arabidiopsis. The analysis has also revealed enhanced expression of Norway spruce homologues of the known executioners of both developmental and stress-induced cell deaths, such as metacaspase 9 (MC9), cysteine endopeptidase-1 (CEP1) and ribonuclease 3 (RNS3). Interestingly, a spruce homologue of bax inhibitor-1 (PaBI-1, for Picea abies BI-1), an evolutionarily conserved cell death suppressor, was likewise up-regulated in the embryosuspensor. Since Arabidopsis BI-1 so far has been implicated only in the endoplasmic reticulum (ER)-stress induced cell death, we investigated its role in embryogenesis and suspensor PCD using RNA interference (RNAi). We have found that PaBI-1-deficient lines formed a large number of abnormal embryos with suppressed suspensor elongation and disturbed polarity. Cytochemical staining of suspensor cells has revealed that PaBI-1 deficiency suppresses vacuolar cell death and induces necrotic type of cell death previously shown to compromise embryo development. This study demonstrates that a large number of cell-death components are conserved between angiosperms and gymnosperms and establishes a new role for BI-1 in the progression of vacuolar cell death.	[Reza, Salim H.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden; [Reza, Salim H.; Dalman, Kerstin; Minina, Elena A.; Bozhkov, Peter V.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Mol Sci, Uppsala, Sweden; [Delhomme, Nicolas; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Street, Nathaniel R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Ramachandran, Prashanth] Uppsala Univ, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Organismal Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University; Umea University; Swedish University of Agricultural Sciences; Uppsala University	Reza, SH (corresponding author), Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden.; Reza, SH; Minina, EA; Bozhkov, PV (corresponding author), Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Mol Sci, Uppsala, Sweden.	salim.hossain.reza@slu.se; alena.minina@slu.se; peter.bozhkov@slu.se	Street, Nathaniel Robert/B-3920-2008; Delhomme, Nicolas/B-9187-2015; Bozhkov, Peter/K-3387-2012; Minina, Elena/C-9888-2017	Street, Nathaniel Robert/0000-0001-6031-005X; Delhomme, Nicolas/0000-0002-3053-0796; Minina, Elena/0000-0002-2619-1859; Bozhkov, Peter/0000-0002-8819-3884; Reza, Salim Hossain/0000-0002-3646-3440	Pehrssons Fund; Knut and Alice Wallenberg Foundation	Pehrssons Fund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from Pehrssons Fund and Knut and Alice Wallenberg Foundation to P.V.B.r This work was supported by grants from Pehrssons Fund and Knut and Alice Wallenberg Foundation to P.V.B. Computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at UPPMAX.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Bertolini A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0917-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bollhoner B, 2013, NEW PHYTOL, V200, P498, DOI 10.1111/nph.12387; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Bozhkov PV, 2011, CELL DEATH DIFFER, V18, P1239, DOI 10.1038/cdd.2011.86; Bozhkov PV, 2005, CURR TOP DEV BIOL, V67, P135, DOI 10.1016/S0070-2153(05)67004-4; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Businge E, 2013, PHYSIOL PLANTARUM, V149, P273, DOI 10.1111/ppl.12039; Ciavatta VT, 2002, PLANTA, V215, P694, DOI 10.1007/s00425-002-0822-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Denay G, 2014, DEVELOPMENT, V141, P1222, DOI 10.1242/dev.103531; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubos C, 2003, TREE PHYSIOL, V23, P169, DOI 10.1093/treephys/23.3.169; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Endo H, 2015, PLANT CELL PHYSIOL, V56, P242, DOI 10.1093/pcp/pcu134; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Ge Y, 2016, CELL DEATH DIFFER, V23, P1493, DOI 10.1038/cdd.2016.34; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Godiard L, 1998, FEBS LETT, V438, P245, DOI 10.1016/S0014-5793(98)01309-X; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Han Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39155; Hogberg KA, 1998, CAN J FOREST RES, V28, P1536, DOI 10.1139/cjfr-28-10-1536; Huysmans M, 2017, CURR OPIN PLANT BIOL, V35, P37, DOI 10.1016/j.pbi.2016.11.005; Ishikawa T, 2011, CELL DEATH DIFFER, V18, P1271, DOI 10.1038/cdd.2011.59; Jin J, 2017, NUCLEIC ACIDS RES, V45; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Larsson E, 2008, PLANT SIGNAL BEHAV, V3, P469, DOI 10.4161/psb.3.7.5676; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; Lee DW, 2016, MOL PLANT, V9, P1428, DOI 10.1016/j.molp.2016.06.005; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Liu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-84; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Maruyama Y, 2013, PLANT SCI, V213, P79, DOI 10.1016/j.plantsci.2013.08.008; Mathieu M, 2006, PLANT MOL BIOL, V61, P615, DOI 10.1007/s11103-006-0036-5; McLellan H, 2009, NEW PHYTOL, V183, P408, DOI 10.1111/j.1469-8137.2009.02865.x; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Moschou PN, 2016, NEW PHYTOL, V212, P232, DOI 10.1111/nph.14012; Nitschke S, 2016, PLANT CELL, V28, P1616, DOI 10.1105/tpc.16.00016; Olvera-Carrillo Y, 2015, PLANT PHYSIOL, V169, P2684, DOI 10.1104/pp.15.00769; Payasi Anurag, 2009, Physiology and Molecular Biology of Plants, V15, P103, DOI 10.1007/s12298-009-0012-z; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Peer WA, 2013, J EXP BOT, V64, P2629, DOI 10.1093/jxb/ert152; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Sundell D, 2015, NEW PHYTOL, V208, P1149, DOI 10.1111/nph.13557; Takasaki H, 2015, PLANT J, V84, P1114, DOI 10.1111/tpj.13067; Takuji Wada NH, 2015, PLANT SIGNAL BEHAV, V10; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Tesniere C, 2006, J EXP BOT, V57, P91, DOI 10.1093/jxb/erj007; Trontin JF, 2016, METHODS MOL BIOL, V1359, P167, DOI 10.1007/978-1-4939-3061-6_8; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Van Durme M, 2016, CURR OPIN PLANT BIOL, V29, P29, DOI 10.1016/j.pbi.2015.10.013; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Venkatesh J, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-38; Wang FB, 2016, MOL GENET GENOMICS, V291, P1545, DOI 10.1007/s00438-016-1203-2; Wang Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.539; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Xu G, 2017, AUTOPHAGY; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282	78	9	9	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192945	10.1371/journal.pone.0192945	http://dx.doi.org/10.1371/journal.pone.0192945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499063	Green Submitted, Green Published, gold			2022-12-26	WOS:000426472300004
J	Jansson, DS; Brojer, C; Neimanis, A; Morner, T; Murphy, CL; Otman, F; Westermark, P				Jansson, Desiree S.; Brojer, Caroline; Neimanis, Aleksija; Morner, Torsten; Murphy, Charles L.; Otman, Faruk; Westermark, Per			Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus)	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PROTEIN-A; FIBRIL PROTEIN; TRANSMISSION; BIRDS	Since the late 1990s, high mortality and declining populations have been reported among sea birds including Herring gulls ( Larus argentatus) from the Baltic Sea area in Northern Europe. Repeated BoNT type C/D botulism outbreaks have occurred, but it remains unclear whether this is the sole and primary cause of mortality. Thiamine deficiency has also been suggested as a causal or contributing factor. With this study, we aimed to investigate gross and microscopic pathology in Herring gulls from affected breeding sites in Sweden in search of contributing diseases. Herring gulls from Iceland served as controls. Necropsies and histopathology were performed on 75 birds, of which 12 showed signs of disease at the time of necropsy. Parasites of various classes and tissues were commonly observed independent of host age, e.g. oesophageal capillariosis and nematode infection in the proventriculus and gizzard with severe inflammation, air sac larid pentastomes and bursal trematodiasis in pre-fledglings. Gross and microscopic findings are described. Notably, amyloidosis was diagnosed in 93 and 33% of the adult birds from Sweden and Iceland, respectively ( p<0.001), with more pronounced deposits in Swedish birds ( p<0.001). Gastrointestinal deposits were observed in the walls of arteries or arterioles, and occasionally in villi near the mucosal surface. Amyloid was identified within the intestinal lumen in one severely affected gull suggesting the possibility of oral seeding and the existence of a primed state as previously described in some mammals and chickens. This could speculatively explain the high occurrence and previously reported rapid onset of amyloidosis upon inflammation or captivity in Herring gulls. Amyloid-induced malabsorbtion is also a possibility. The Herring gull SAA/AA protein sequence was shown to be highly conserved but differed at the N-terminus from other avian species.	[Jansson, Desiree S.; Otman, Faruk] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Brojer, Caroline; Neimanis, Aleksija] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Morner, Torsten] Natl Vet Inst SVA, Dept Dis Control & Epidemiol, Uppsala, Sweden; [Murphy, Charles L.] Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN USA; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	National Veterinary Institute SVA; National Veterinary Institute SVA; National Veterinary Institute SVA; University of Tennessee System; University of Tennessee Health Science Center; Uppsala University	Jansson, DS (corresponding author), Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden.	desiree.jansson@sva.se	Jansson, Desiree/AAO-6266-2021; Neimanis, Aleksija/E-4168-2016	Jansson, Desiree/0000-0003-1887-6054; Neimanis, Aleksija/0000-0001-7747-2290				Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Bosch M, 2000, CAN J ZOOL, V78, P777, DOI 10.1139/cjz-78-5-777; BRASSARD A, 1965, CAN J COMP MED VET S, V29, P253; Bustnes JO, 2006, P ROY SOC B-BIOL SCI, V273, P3117, DOI 10.1098/rspb.2006.3687; COWAN DF, 1968, PATHOL VET, V5, P59, DOI 10.1177/030098586800500107; CROWELL WA, 1975, VET PATHOL, V12, P178, DOI 10.1177/030098587501200303; ERICSSON LH, 1987, FEBS LETT, V218, P11, DOI 10.1016/0014-5793(87)81008-6; FITZMAURICE M, 1993, MAR POLLUT BULL, V26, P64, DOI 10.1016/0025-326X(93)90092-X; Fox GA, 2007, J TOXICOL ENV HEAL A, V70, P1471, DOI 10.1080/15287390701384536; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Green M., 2017, MONITORING POPULATIO; Hampel MR, 2009, AMYLOID, V16, P122, DOI 10.1080/13506120903090759; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HELCOM, 2013, BALT SEA ENV P; HOFFMAN AM, 1985, J AM VET MED ASSOC, V187, P1125; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; KENNEDY CR, 1989, PARASITOLOGY, V98, P439, DOI 10.1017/S0031182000061527; Kennel SJ, 2014, AMYLOID, V21, P45, DOI 10.3109/13506129.2013.876400; Kovacs BM, 2005, AMYLOID, V12, P109, DOI 10.1080/13506120500106941; Landman WJM, 1998, AVIAN PATHOL, V27, P437, DOI 10.1080/03079459808419367; Landman WJM, 1996, SCAND J IMMUNOL, V43, P210, DOI 10.1046/j.1365-3083.1996.d01-31.x; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Lundmark K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079104; Morner T, 2005, SVENSK VETERINARTIDN, V8-9, P11; Mullarney K, 1999, EUROPAS MEDELHAVSOMR; Murakami T, 2013, AMYLOID, V20, P80, DOI 10.3109/13506129.2013.783474; Neimanis A, 2007, J WILDLIFE DIS, V43, P327, DOI 10.7589/0090-3558-43.3.327; Nystrom SN, 2012, AMYLOID, V19, P138, DOI 10.3109/13506129.2012.711391; Osterblom H, 2004, IBIS, V146, P531, DOI 10.1111/j.1474-919X.2004.00266.x; ROSSEVATN K, 1992, SCAND J IMMUNOL, V35, P217, DOI 10.1111/j.1365-3083.1992.tb02853.x; Siebert U, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-43; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Skarin H, 2010, AVIAN PATHOL, V39, P511, DOI 10.1080/03079457.2010.526923; Sletten K, 2003, AMYLOID, V10, P144, DOI 10.3109/13506120308998995; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; THRELFALL W, 1967, PARASITOLOGY, V57, P431, DOI 10.1017/S0031182000072334; WAALEN K, 1980, EUR J BIOCHEM, V104, P407, DOI 10.1111/j.1432-1033.1980.tb04441.x; Westermark GT, 2017, COLD SPRING IN PRESS; Westermark GT, 2015, ANNU REV PATHOL-MECH, V10, P321, DOI 10.1146/annurev-pathol-020712-163913; Westermark Gunilla T., 2004, V299, P243; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; ZSCHIESCHE W, 1989, PHARMACOL THERAPEUT, V41, P49, DOI 10.1016/0163-7258(89)90102-2; ZSCHIESCHE W, 1989, ACTA HISTOCHEM, V86, P45, DOI 10.1016/S0065-1281(89)80046-7	45	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193265	10.1371/journal.pone.0193265	http://dx.doi.org/10.1371/journal.pone.0193265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494674	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200035
J	Merk, B; Litskevich, D; Gregg, R; Mount, AR				Merk, B.; Litskevich, D.; Gregg, R.; Mount, A. R.			Demand driven salt clean-up in a molten salt fast reactor - Defining a priority list	PLOS ONE			English	Article								The PUREX technology based on aqueous processes is currently the leading reprocessing technology in nuclear energy systems. It seems to be the most developed and established process for light water reactor fuel and the use of solid fuel. However, demand driven development of the nuclear system opens the way to liquid fuelled reactors, and disruptive technology development through the application of an integrated fuel cycle with a direct link to reactor operation. The possibilities of this new concept for innovative reprocessing technology development are analysed, the boundary conditions are discussed, and the economic as well as the neutron physical optimization parameters of the process are elucidated. Reactor physical knowledge of the influence of different elements on the neutron economy of the reactor is required. Using an innovative study approach, an element priority list for the salt clean-up is developed, which indicates that separation of Neodymium and Caesium is desirable, as they contribute almost 50% to the loss of criticality. Separating Zirconium and Samarium in addition from the fuel salt would remove nearly 80% of the loss of criticality due to fission products. The theoretical study is followed by a qualitative discussion of the different, demand driven optimization strategies which could satisfy the conflicting interests of sustainable reactor operation, efficient chemical processing for the salt clean-up, and the related economic as well as chemical engineering consequences. A new, innovative approach of balancing the throughput through salt processing based on a low number of separation process steps is developed. Next steps for the development of an economically viable salt clean-up process are identified.	[Merk, B.; Litskevich, D.] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Merk, B.; Gregg, R.] Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England; [Mount, A. R.] Univ Edinburgh, EaStCHEM, Sch Chem, Edinburgh, Midlothian, Scotland	University of Liverpool; University of Edinburgh	Merk, B (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.; Merk, B (corresponding author), Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England.	b.merk@liverpool.ac.uk		Litskevich, Dzianis/0000-0002-3207-3058	Royal Academy of Engineering; National Nuclear Laboratory of the United Kingdom	Royal Academy of Engineering(Royal Academy of Engineering - UK); National Nuclear Laboratory of the United Kingdom	The leading author wants to thank the Royal Academy of Engineering and the National Nuclear Laboratory of the United Kingdom for sponsoring the NNL/RAEng research chair position which creates space and time to develop highly innovative thinking for the future success of nuclear systems.	acatech, 2014, OPPORTUNITIES RISKS; [Anonymous], 2014, TECHNOLOGY ROADMAP U; [Anonymous], 2012, SPENT NUCL FUEL REPR; Burstall R. F., 1979, NDRD328R; Dekusar V., 2017, INT C FAST REACT REL; Gill M., 2016, THESIS; Haubenreich PN, 1970, NUCL APPL TECHNOLOGY, V8; Merk B., PLOS ONE; Merk B., ENERGIES, V8, P12557; Merk B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180703; Merk B, 2015, APPL ENERG, V147, P104, DOI 10.1016/j.apenergy.2015.02.023; Merk B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092776; Nash KL, 2015, SOLVENT EXTR ION EXC, V33, P1, DOI 10.1080/07366299.2014.985912; Nash KL, 2015, WOODHEAD PUBLISHING, V79; Romano PK, 2015, ANN NUCL ENERGY, V82, P90, DOI 10.1016/j.anucene.2014.07.048	15	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192020	10.1371/journal.pone.0192020	http://dx.doi.org/10.1371/journal.pone.0192020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494604	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200009
J	O'Brien, PP; Webber, QMR; Vander Wal, E				O'Brien, Paul P.; Webber, Quinn M. R.; Vander Wal, Eric			Consistent individual differences and population plasticity in network-derived sociality: An experimental manipulation of density in a gregarious ungulate	PLOS ONE			English	Article							NORTH-AMERICAN ELK; REACTION NORMS; BEHAVIORAL PLASTICITY; PHENOTYPIC PLASTICITY; SEXUAL SEGREGATION; PREDATION RISK; GREAT TITS; GROUP-SIZE; PERSONALITY; HABITAT	In many taxa, individual social traits appear to be consistent across time and context, thus meeting the criteria for animal personality. How these differences are maintained in response to changes in population density is unknown, particularly in large mammals, such as ungulates. Using a behavioral reaction norm ( BRN) framework, we examined how among- and within-individual variation in social connectedness, measured using social network analyses, change as a function of population density. We studied a captive herd of elk ( Cervus canadensis) separated into a group of male elk and a group of female elk. Males and females were exposed to three different density treatments and we recorded social associations between individuals with proximity-detecting radio-collars fitted to elk. We constructed social networks using dyadic association data and calculated three social network metrics reflective of social connectedness: eigenvector centrality, graph strength, and degree. Elk exhibited consistent individual differences in social connectedness across densities; however, they showed little individual variation in their response to changes in density, i.e., individuals oftentimes responded plastically, but in the same manner to changes in density. Female elk had highest connectedness at an intermediate density. In contrast, male elk increased connectedness with increasing density. Whereas this may suggest that the benefits of social connectedness outweigh the costs of increased competition at higher density for males, females appear to exhibit a threshold in social benefits ( e.g. predator detection and forage information). Our study illustrates the importance of viewing social connectedness as a density-dependent trait, particularly in the context of plasticity. Moreover, we highlight the need to revisit our understanding of density dependence as a population-level phenomenon by accounting for consistent individual differences not only in social connectedness, but likely in other ecological processes ( e.g., predator-prey dynamics, mate choice, disease transfer).	[O'Brien, Paul P.; Vander Wal, Eric] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Webber, Quinn M. R.; Vander Wal, Eric] Mem Univ Newfoundland, Cognit & Behav Ecol Interdisciplinary Program, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Webber, QMR (corresponding author), Mem Univ Newfoundland, Cognit & Behav Ecol Interdisciplinary Program, St John, NF, Canada.	webber.quinn@gmail.com			National Sciences and Engineering Research Council (NSERC); Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC); Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC)	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC); Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided to EVW by National Sciences and Engineering Research Council (NSERC). http://www.nserc-crsng.gc.ca/index_eng.asp, Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC) to QMRW and Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC) to PPO.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aplin LM, 2015, ANIM BEHAV, V108, P117, DOI 10.1016/j.anbehav.2015.07.016; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Araya-Ajoy YG, 2017, J ANIM ECOL, V86, P227, DOI 10.1111/1365-2656.12621; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Benton TG, 2012, PHILOS T R SOC B, V367, P200, DOI 10.1098/rstb.2011.0168; Bode NWF, 2011, BEHAV ECOL SOCIOBIOL, V65, P117, DOI 10.1007/s00265-010-1111-0; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Boyland NK, 2013, BEHAV ECOL SOCIOBIOL, V67, P1877, DOI 10.1007/s00265-013-1622-6; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; Brennan A, 2015, J APPL ECOL, V52, P1656, DOI 10.1111/1365-2664.12514; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Casalini M, 2010, BEHAVIOUR, V147, P1035, DOI 10.1163/000579510X504879; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Coleing Amelia, 2009, Bioscience Horizons, V2, P32; Conner MM, 2008, ANN NY ACAD SCI, V1134, P146, DOI 10.1196/annals.1439.005; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Cross PC, 2013, ECOLOGY, V94, P2076, DOI 10.1890/12-2086.1; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dingemanse NJ, 2012, J EVOLUTION BIOL, V25, P485, DOI 10.1111/j.1420-9101.2011.02439.x; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Formica V, 2016, BEHAV ECOLOGY; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hirsch BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075830; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jacoby DMP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1995, DOI 10.1007/s00265-014-1805-9; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Krause S, 2017, BEHAV ECOL, V28, P429, DOI 10.1093/beheco/arw177; Le Galliard JF, 2015, J EVOLUTION BIOL, V28, P1144, DOI 10.1111/jeb.12641; Lea AJ, 2010, P NATL ACAD SCI USA, V107, P21587, DOI 10.1073/pnas.1009882107; Long RA, 2009, J MAMMAL, V90, P423, DOI 10.1644/08-MAMM-A-181.1; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; Mathot KJ, 2011, ECOL LETT, V14, P1254, DOI 10.1111/j.1461-0248.2011.01698.x; MERESZCZAK IM, 1981, J RANGE MANAGE, V34, P184, DOI 10.2307/3898037; Moyle K, 2009, J WORLD AQUACULT SOC, V40, P255, DOI 10.1111/j.1749-7345.2009.00248.x; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nicolaus M, 2013, J EVOLUTION BIOL, V26, P2031, DOI 10.1111/jeb.12210; Nicolaus M, 2016, ECOL LETT, V19, P478, DOI 10.1111/ele.12584; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Rutschmann A, 2016, J ANIM ECOL, V85, P457, DOI 10.1111/1365-2656.12473; Shizuka D, 2012, ANIM BEHAV, V83, P925, DOI 10.1016/j.anbehav.2012.01.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Stewart KM, 2015, ECOL EVOL, V5, P709, DOI 10.1002/ece3.1397; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Toweill D.E., 2002, N AM ELK ECOLOGY MAN; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; Vander Wal E, 2015, ECOLOGY, V96, P631, DOI 10.1890/14-1320.1; Vander Wal E, 2013, CAN J ZOOL, V91, P601, DOI 10.1139/cjz-2012-0237; Vander Wal E, 2012, ECOLOGY, V93, P206, DOI 10.1890/11-0020.1; Vander Wal E, 2016, BEHAV ECOL, V27, P560, DOI 10.1093/beheco/arv193; Vander Wal E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053777; Webber QMR, 2018, J ANIM ECOL, V87, P113, DOI 10.1111/1365-2656.12773; Webber QMR, 2016, BEHAV ECOL SOCIOBIOL, V70, P701, DOI 10.1007/s00265-016-2093-3; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Wilson ADM, 2015, BEHAV ECOL SOCIOBIOL, V69, P1617, DOI 10.1007/s00265-015-1973-2; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wilson ADM, 2013, BEHAV ECOL SOCIOBIOL, V67, P163, DOI 10.1007/s00265-012-1428-y; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	78	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193425	10.1371/journal.pone.0193425	http://dx.doi.org/10.1371/journal.pone.0193425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494640	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200048
J	Pluschke, AM; Williams, BA; Zhang, DG; Anderson, ST; Roura, E; Gidley, MJ				Pluschke, Anton M.; Williams, Barbara A.; Zhang, Dagong; Anderson, Stephen T.; Roura, Eugeni; Gidley, Michael J.			Male grower pigs fed cereal soluble dietary fibres display biphasic glucose response and delayed glycaemic response after an oral glucose tolerance test	PLOS ONE			English	Article							BETA-CELL FUNCTION; GLUCAGON-SECRETION; GASTRIC BYPASS; INSULIN SENSITIVITY; ARABINOXYLAN FIBER; METABOLIC SYNDROME; GHRELIN LEVELS; GIP; PLASMA; HUMANS	Acute and sustained soluble dietary fibre (SDF) consumption are both associated with improved glucose tolerance in humans and animal models (e.g. porcine). However, the effects on glucose tolerance in grower pigs, adapted to diets with a combination of SDF have not been studied previously. In this experiment, cereal SDF wheat arabinoxylan (AX) and oat beta-glucan (BG) were fed individually and in combination to determine the effect on glucose tolerance in jugular vein catheterized grower pigs. Five groups of Large White male grower pigs were fed highly digestible diets containing either 10% AX, 10% BG, 5% AX with 5% BG, a model cereal whole wheat flour (WWF), or a control wheat starch diet (WS) with no SDF. Blood was collected via jugular vein catheters over 240 minutes following a feed challenge and an oral glucose tolerance test (OGTT) on two separate days. Postprandial blood samples were used to determine plasma glucose, insulin, non-esterified fatty acids (NEFA), glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY), ghrelin, glucagon and cortisol concentrations. No dietary effects on glycaemic response were observed following the feed challenge or the OGTT as determined by the area under the curve (AUC). A biphasic glucose and insulin response was detected for all pigs following the OGTT. The current study showed male grower pigs have tight glycaemic control and glucose tolerance regardless of diet. In addition, pigs fed the combined SDF had a reduced GIP response and delayed insulin peak following the feed challenge. Incretin (GLP-1 and GIP) secretion appeared asynchronous reflecting their different enteroendocrine cell locations and response to nutrient absorption.	[Pluschke, Anton M.; Williams, Barbara A.; Zhang, Dagong; Roura, Eugeni; Gidley, Michael J.] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Anderson, Stephen T.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Pluschke, AM; Gidley, MJ (corresponding author), Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.	a.pluschke@uq.edu.au; m.gidley@uq.edu.au	Gidley, Mike/AAT-9543-2021; Williams, Barbara/A-9268-2011; Anderson, Stephen T/F-5281-2013; Roura, Eugeni/A-7101-2011	Williams, Barbara/0000-0002-3635-5554; Anderson, Stephen T/0000-0002-1176-4394; Roura, Eugeni/0000-0002-9073-9946	Australian Research Council Centre of Excellence in Plant Cell Walls [CE110001007]	Australian Research Council Centre of Excellence in Plant Cell Walls(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence in Plant Cell Walls (CE110001007), http://www.plantcellwalls.org.au/. MJG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadi T, 2013, PSYCHOPHYSIOLOGY, V50, P821, DOI 10.1111/psyp.12069; Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Beck EJ, 2010, BRIT J NUTR, V103, P1212, DOI 10.1017/S0007114509992856; Bervoets L, 2015, HORM METAB RES, V47, P445, DOI 10.1055/s-0034-1395551; Bodinham CL, 2013, BRIT J NUTR, V110, P1429, DOI 10.1017/S0007114513000731; Breneman CB, 2013, BRIT J NUTR, V110, P375, DOI 10.1017/S0007114512004953; Christensen KL, 2013, J AGR FOOD CHEM, V61, P7760, DOI 10.1021/jf400965j; de Leeuw JA, 2008, P NUTR SOC, V67, P334, DOI 10.1017/S002966510800863X; Delzenne NM, 2005, CURR OPIN CLIN NUTR, V8, P636, DOI 10.1097/01.mco.0000171124.06408.71; Garcia AL, 2007, EUR J CLIN NUTR, V61, P334, DOI 10.1038/sj.ejcn.1602525; Grundy MML, 2016, BRIT J NUTR, V116, P816, DOI 10.1017/S0007114516002610; Haenen D., 2014, ANIMAL, V8, P1; Hooda S, 2010, J NUTR, V140, P1564, DOI 10.3945/jn.110.122721; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Ito T, 2006, J ENDOCRINOL, V191, P113, DOI 10.1677/joe.1.06855; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Jenkins AL, 2014, J AM COLL NUTR, P1; JENKINS DJA, 1986, AM J CLIN NUTR, V43, P516, DOI 10.1093/ajcn/43.4.516; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; KNAPPER JME, 1995, HORM METAB RES, V27, P485, DOI 10.1055/s-2007-980008; Lindqvist A, 2017, PEPTIDES, V90, P78, DOI 10.1016/j.peptides.2017.02.009; Lu ZX, 2004, EUR J CLIN NUTR, V58, P621, DOI 10.1038/sj.ejcn.1601857; Lu ZX, 2000, AM J CLIN NUTR, V71, P1123; Manell E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148896; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Meier JJ, 2006, DIABETES, V55, P1051, DOI 10.2337/diabetes.55.04.06.db05-1449; Meier JJ, 2003, DIABETOLOGIA, V46, P798, DOI 10.1007/s00125-003-1103-y; Mohling M, 2005, HORM METAB RES, V37, P303, DOI 10.1055/s-861474; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Osaki N, 2016, EUROPEAN J NUTR, P1; PARRILLA R, 1974, DIABETES, V23, P725, DOI 10.2337/diab.23.9.725; Pluschke AM, 2017, LAB ANIM-UK, V51, P397, DOI 10.1177/0023677216682772; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; Roura E, 2016, NUTR RES REV, P1; Shelat KJ, 2010, CARBOHYD POLYM, V82, P46, DOI 10.1016/j.carbpol.2010.04.019; SOCORRO M, 1989, STARCH-STARKE, V41, P69, DOI 10.1002/star.19890410208; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; UNGER RH, 1976, PHYSIOL REV, V56, P778, DOI 10.1152/physrev.1976.56.4.778; Weickert MO, 2006, BRIT J NUTR, V96, P795, DOI 10.1017/BJN20061902; Wierup N, 2015, OBES SURG, V25, P180, DOI 10.1007/s11695-014-1459-8; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu K, 2014, ASIA PAC J CLIN NUTR, V23, P210, DOI 10.6133/apjcn.2014.23.2.01; Zijlstra RT, 2012, J ANIM SCI, V90, P49, DOI 10.2527/jas.53718	47	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193137	10.1371/journal.pone.0193137	http://dx.doi.org/10.1371/journal.pone.0193137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494594	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200025
J	Wenzlaff, F; Briken, P; Dekker, A				Wenzlaff, Frederike; Briken, Peer; Dekker, Arne			If there's a penis, it's most likely a man: Investigating the social construction of gender using eye tracking	PLOS ONE			English	Article							SEX CATEGORIZATION; SIGNAL-DETECTION; RECOGNITION; PSYCHOLOGY; MOVEMENTS; ATTENTION; PEOPLE; CHOICE; FEMALE; FACES	In their foundational work on the social construction of gender, Kessler and McKenna (1978) investigated the relationship between gender attribution and genital attribution. We used digital reproductions of the original stimuli to replicate their findings in the current social context. To further investigate the underlying decision processes we applied eye tracking. The stimuli shown varied in the composition of gender cues: from those more commonly associated with maleness to associated with femaleness. Applying the ethnomethodological approach originally used, participants were asked to decide for each stimulus whether they saw a man or a woman and to indicate subjective confidence with the decision. In line with the original results we found that the genital attribution contributed immensely to the gender attribution. Also, male gender was ascribed more often when the penis was present than was female gender when the vulva was shown. Eye tracking revealed that overall most dwell time as a proxy for important information was dedicated to the head, chest and genital areas of all the stimuli. Total dwell time depended on whether the gender attribution was made in line with the depicted genital, if the genital was a penis. Attributing female gender when a penis was present was associated with longer total dwell time, unlike attributing male gender with a vulva shown. This is indicative of higher cognitive effort and more difficulty ignoring the penis as opposed to the vulva. We interpret this finding in context of the persistent male dominance as well as to the socio-cultural understanding of the vulva as a concealed and therefore seemingly absent organ. In summary, we were able to show that the gender attribution is still closely linked to genital attribution when having a binary forced choice task and that the penis is a special cue in this attribution process.	[Wenzlaff, Frederike; Briken, Peer; Dekker, Arne] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Wenzlaff, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany.	f.wenzlaff@uke.de			Federal Ministry of Education and Research (BMBF)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The positions of the first and last author are funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The positions of the first and last author are funded by the Federal Ministry of Education and Research (BMBF).	Armstrong T, 2010, BEHAV RES THER, V48, P402, DOI 10.1016/j.brat.2010.01.002; Bekhouche Y.H.R., 2015, GLOBAL GENDER GAP RE; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Blond A, 2008, BODY IMAGE, V5, P244, DOI 10.1016/j.bodyim.2008.02.003; Borji A, 2014, J VISION, V14, DOI 10.1167/14.3.29; Boroughs M, 2005, SEX ROLES, V52, P637, DOI 10.1007/s11199-005-3731-9; Braun V, 2001, J REPROD INFANT PSYC, V19, P17, DOI 10.1080/02646830020032374; Braun V, 2013, PSYCHOL WOMEN QUART, V37, P478, DOI 10.1177/0361684313492950; Brickell C, 2006, SOCIOL REV, V54, P87, DOI 10.1111/j.1467-954X.2006.00603.x; Brielmann AA, 2015, ADV COGN PSYCHOL, V11, P84, DOI 10.5709/acp-0174-y; Bruce V., 1998, EYE BEHOLDER SCI FAC; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Carothers BJ, 2013, J PERS SOC PSYCHOL, V104, P385, DOI 10.1037/a0030437; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connell RW, 2005, SIGNS, V30, P1801, DOI 10.1086/427525; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; Crawford M, 2000, FEM PSYCHOL, V10, P7, DOI 10.1177/0959353500010001002; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; Dixson BJ, 2010, HUM NATURE-INT BIOS, V21, P355, DOI 10.1007/s12110-010-9100-6; Eagly AH, 2013, PERSPECT PSYCHOL SCI, V8, P340, DOI 10.1177/1745691613484767; Eagly AH, 2012, AM PSYCHOL, V67, P211, DOI 10.1037/a0027260; Fausto-Sterling A, 2000, SCIENCES, V40, P18, DOI 10.1002/j.2326-1951.2000.tb03504.x; FAUSTOSTERLING A, 1993, SCIENCES, V33, P20, DOI 10.1002/j.2326-1951.1993.tb03081.x; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Fiske ST, 2010, PERSPECT PSYCHOL SCI, V5, P688, DOI 10.1177/1745691610388768; Gaetano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148623; Gaetano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091032; Garfinkel Harold, 1967, STUDIES ETHNOMETHODO; Gerson J, 2005, SOCIOL FORUM, V20, P179, DOI 10.1007/s11206-005-1904-5; Hall C, 2011, J SEX RES, V48, P461, DOI 10.1080/00224499.2010.521899; Hall CL, 2014, J SEX RES, V51, P184, DOI 10.1080/00224499.2012.716872; Hammarstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034193; Harrison Wendy Cealy, 2002, SEX GENDER; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Herdt G., 1994, 3 SEX 3 GENDER SEXUA; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; Hess U, 2009, J VISION, V9, DOI 10.1167/9.12.19; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Johnson KL, 2010, CHILD DEV, V81, P1346, DOI 10.1111/j.1467-8624.2010.01476.x; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Kessler S.J., 1985, GENDER ETHNOMETHODOL; Kohnen M., 2015, QUEER REPRESENTATION; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; McKenna W, 2000, FEM PSYCHOL, V10, P66, DOI 10.1177/0959353500010001010; MERRITT RD, 1995, SEX ROLES, V33, P145, DOI 10.1007/BF01544608; Mikkola M., 2016, STANFORD ENCY PHILOS; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Orquin JL, 2016, J BEHAV DECIS MAKING, V29, P103, DOI 10.1002/bdm.1867; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Pega F, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/473451; Petersen JL, 2011, J SEX RES, V48, P149, DOI 10.1080/00224499.2011.551851; Petersen JL, 2010, PSYCHOL BULL, V136, P21, DOI 10.1037/a0017504; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Saunders DR, 2010, J VISION, V10, DOI 10.1167/10.11.9; Schutz A., 1964, PHENOMENOLOGY SOCIAL; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Stryker Susan, 2006, TRANSGENDER STUDIES, P253; Suschinsky K. D., 2007, EVOL PSYCHOL-US, V5, DOI DOI 10.1177/147470490700500214; Tiggemann M, 2004, PSYCHOL WOMEN Q, V28, P419; Tiggemann M, 2008, SEX ROLES, V59, P889, DOI 10.1007/s11199-008-9494-3; Wenzlaff F, 2016, J SEX RES, V53, P1008, DOI 10.1080/00224499.2015.1107524; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	69	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193616	10.1371/journal.pone.0193616	http://dx.doi.org/10.1371/journal.pone.0193616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494689	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200076
J	Inoue, H; Shirakawa, J; Togashi, Y; Tajima, K; Okuyama, T; Kyohara, M; Tanaka, Y; Orime, K; Saisho, Y; Yamada, T; Shibue, K; Kulkarni, RN; Terauchi, Y				Inoue, Hideaki; Shirakawa, Jun; Togashi, Yu; Tajima, Kazuki; Okuyama, Tomoko; Kyohara, Mayu; Tanaka, Yui; Orime, Kazuki; Saisho, Yoshifumi; Yamada, Taketo; Shibue, Kimitaka; Kulkarni, Rohit N.; Terauchi, Yasuo			Signaling between pancreatic beta cells and macrophages via S100 calcium-binding protein A8 exacerbates beta-cell apoptosis and islet inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GLUCOKINASE ACTIVATION; GLYCEMIC CONTROL; EXPRESSION; STRESS; CHEMOATTRACTANTS; PROLIFERATION; IL-1-BETA; INHIBITOR; MONOCYTES	Chronic low-grade inflammation in the pancreatic islets is observed in individuals with type 2 diabetes, and macrophage levels are elevated in the islets of these individuals. However, the molecular mechanisms underlying the interactions between the pancreatic beta cells and macrophages and their involvement in inflammation are not fully understood. Here, we investigated the role of S100 calcium-binding protein A8 (S100A8), a member of the damage-associated molecular pattern molecules (DAMPs), in beta-cell inflammation. Co-cultivation of pancreatic islets with unstimulated peritoneal macrophages in the presence of palmitate (to induce lipotoxicity) and high glucose (to induce glucotoxicity) synergistically increased the expression and release of islet-produced S100A8 in a Toll-like receptor 4 (TLR4)-independent manner. Consistently, a significant increase in the expression of the S100a8 gene was observed in the islets of diabetic db/db mice. Furthermore, the islet-derived S100A8 induced TLR4-mediated inflammatory cytokine production by migrating macrophages. When human islet cells were co-cultured with U937 human monocyte cells, the palmitate treatment up-regulated S100A8 expression. This S100A8-mediated interaction between islets and macrophages evoked beta-cell apoptosis, which was ameliorated by TLR4 inhibition in the macrophages or S100A8 neutralization in the pancreatic islets. Of note, both glucotoxicity and lipotoxicity triggered S100A8 secretion from the pancreatic islets, which in turn promoted macrophage infiltration of the islets. Taken together, a positive feedback loop between islet-derived S100A8 and macrophages drives beta-cell apoptosis and pancreatic islet inflammation. We conclude that developing therapeutic approaches to inhibit S100A8 may serve to prevent beta-cellloss in patients with diabetes.	[Inoue, Hideaki; Shirakawa, Jun; Togashi, Yu; Tajima, Kazuki; Okuyama, Tomoko; Kyohara, Mayu; Tanaka, Yui; Orime, Kazuki; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan; [Saisho, Yoshifumi] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1088345, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 1088345, Japan; [Orime, Kazuki; Shibue, Kimitaka; Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Brigham & Womens Hosp,Dept Med, Sect Islet Cell & Regenerat Biol,Joslin Diabet Ct, Boston, MA 02138 USA	Yokohama City University; Keio University; Keio University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Shirakawa, J; Terauchi, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	jshira-tky@umin.ac.jp; terauchi-tky@umin.ac.jp	Terauchi, Yasuo/AAO-4347-2020; Saisho, Yoshifumi/H-2925-2019	Saisho, Yoshifumi/0000-0002-6071-4393; Shirakawa, Jun/0000-0002-0822-8750	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [16H05329]; Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd.(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant-in-Aid for Scientific Research (B) 16H05329 (to Y. Terauchi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a grant-in-aid from the Japan Foundation for Applied Enzymology (to J. S.), and a Junior Scientist Development Grant supported by Novo Nordisk Pharma Ltd. (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Basso D, 2011, J CELL PHYSIOL, V226, P456, DOI 10.1002/jcp.22355; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Bouma G, 2004, DIABETES, V53, P1979, DOI 10.2337/diabetes.53.8.1979; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burkhardt K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-10; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ikemoto M, 2007, ANN CLIN BIOCHEM, V44, P570, DOI 10.1258/000456307782268156; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Oh YS, 2014, EUR J PHARM SCI, V51, P137, DOI 10.1016/j.ejps.2013.09.005; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Roma LP, 2015, AM J PHYSIOL-ENDOC M, V309, pE632, DOI 10.1152/ajpendo.00154.2015; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Shirakawa J, 2017, CELL METAB, V25, P868, DOI 10.1016/j.cmet.2017.02.004; Shirakawa J, 2014, ENDOCRINOLOGY, V155, P2102, DOI 10.1210/en.2013-2032; Shirakawa J, 2013, DIABETES, V62, P3448, DOI 10.2337/db13-0052; Shirakawa J, 2011, J BIOL CHEM, V286, P25467, DOI 10.1074/jbc.M110.217216; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu YX, 2011, BIOCHEM BIOPH RES CO, V404, P159, DOI 10.1016/j.bbrc.2010.11.085	46	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5934	5946		10.1074/jbc.M117.809228	http://dx.doi.org/10.1074/jbc.M117.809228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496993	hybrid, Green Published			2022-12-26	WOS:000430497300015
J	Hoang, S; Georget, A; Asselineau, J; Venier, AG; Leroyer, C; Rogues, AM; Thiebaut, R				Hoang, S.; Georget, A.; Asselineau, J.; Venier, A-G.; Leroyer, C.; Rogues, A. M.; Thiebaut, R.			Risk factors for colonization and infection by Pseudomonas aeruginosa in patients hospitalized in intensive care units in France	PLOS ONE			English	Article							ACQUISITION; MORTALITY; CARRIAGE; ROUTES; COSTS	Pseudomonas aeruginosa (P. aeruginosa) remains a prominent nosocomial pathogen responsible for high morbi-mortality in intensive care units (ICUs). P. aeruginosa transmission is known to be partly endogenous and exogenous. Main factors have been highlighted but the precise role of environment in regard to antibiotics use remained unclear. Objective To assess the role of environment, medical care and individual risks factors for P. aeruginosa colonization and infection. Study design and setting A French multicentric prospective study involved ten ICUs for a five months period. Every adult patient newly hospitalized in ICUs with no P. aeruginosa carriage up to 48 hours after admission was included and weekly screened before discharge or death. Screening swabs were either rectal, sputum or oropharyngeal samples. Hydric environment was also sampled each week. Data on patient clinical features, environmental and device exposures, and antibiotics supports were regularly collected. Multivariate analysis was performed with a multistate model. Results The overall prevalence of P. aeruginosa carriage was 15.3% (201/1314). Risk factors associated with patient colonization were: use of inactive antibiotics against P. aeruginosa (HR = 1.60 [1.15-2.21] p< 0.01), tap water contamination at the entry in the room (HR = 1.66 [1.01-2.27] p<0.05) and mechanical invasive ventilation (HR = 4.70 [2.66-8.31] p<0.0001). Active antibiotics prevented from colonization (HR = 0.67 [0.48-0.93] p = 0.02) and from infection (HR = 0.64 [0.41-1.01] p = 0.05). Interaction between hydric environment antibiotics support was not statistically associated with patient colonization. Conclusion Hydric contamination and antibiotics pressure seem to remain key independent risk factors in P. aeruginosa colonization. These results advocate the need to carry on preventive and targeted interventions toward healthcare associated infections.	[Hoang, S.; Venier, A-G.; Leroyer, C.; Rogues, A. M.; Thiebaut, R.] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR 1219,Inria SISTM,ISPED, Bordeaux, France; [Hoang, S.] Ctr Hosp Univ Sud Reunion, Ile De La Reunion, France; [Hoang, S.; Georget, A.; Asselineau, J.; Thiebaut, R.] CHU Bordeaux, Pole Sante Publ, Serv Informat Med, Unite Soutien Methodol Rech Clin & Epiderniol, Bordeaux, France; [Venier, A-G.; Leroyer, C.; Rogues, A. M.] Grp Hosp Pellegrin, Serv Hyg Hosp, Bordeaux, France; [Venier, A-G.] CHU Pellegrin, Ctr Coordinat Comites Lutte Infect Nosocomiales S, Bordeaux, France; [Hoang, S.] Ctr Hosp Andree Rosemon, Ctr Invest Clin Antilles Guyane, Cayenne, Guyane Francais, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Reunion; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thiebaut, R (corresponding author), Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR 1219,Inria SISTM,ISPED, Bordeaux, France.; Thiebaut, R (corresponding author), CHU Bordeaux, Pole Sante Publ, Serv Informat Med, Unite Soutien Methodol Rech Clin & Epiderniol, Bordeaux, France.	Rodolphe.thiebaut@u-bordeaux.fr	Thiebaut, Rodolphe/T-6803-2019	Thiebaut, Rodolphe/0000-0002-5235-3962; leroyer, christophe/0000-0002-7601-1692				Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; [Anonymous], 2014, SURV INF NOS REAN AD; [Anonymous], [No title captured]; Bergmans DCJJ, 1998, THORAX, V53, P1053, DOI 10.1136/thx.53.12.1053; Bernard Grynfogel, 2009, HYGIENE; Berthelot P, 2001, INTENS CARE MED, V27, P503, DOI 10.1007/s001340100870; Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; Cobos-Trigueros N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0916-7; Cohen R, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-016-0167-7; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Gomez-Zorrilla S, 2015, ANTIMICROB AGENTS CH, V59, P5213, DOI 10.1128/AAC.04636-14; Halwani M, 2006, J HOSP INFECT, V63, P39, DOI 10.1016/j.jhin.2005.10.012; Jackson CH, 2011, J STAT SOFTW, V38, P1; Laupland KB, 2006, J HOSP INFECT, V63, P124, DOI 10.1016/j.jhin.2005.12.016; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; Martinez J, 2009, INTENS CARE MED, V35, P439, DOI 10.1007/s00134-008-1326-y; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Obadia T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004170; Ortona L, 1985, Eur J Epidemiol, V1, P94, DOI 10.1007/BF00141799; Petignat C, 2006, INFECT CONT HOSP EP, V27, P953, DOI 10.1086/506409; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rogues AM, 2007, J HOSP INFECT, V67, P72, DOI 10.1016/j.jhin.2007.06.019; Sanchez-Velazquez LD, 2006, ARCH MED RES, V37, P370, DOI 10.1016/j.arcmed.2005.07.004; Slekovec C, 2010, ANN FR ANESTH, V29, P279, DOI 10.1016/j.annfar.2009.12.023; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Talon D, 1998, AM J RESP CRIT CARE, V157, P978, DOI 10.1164/ajrccm.157.3.9702096; Thuong M, 2003, J HOSP INFECT, V53, P274, DOI 10.1053/jhin.2002.1370; Venier AG, 2014, J HOSP INFECT, V88, P103, DOI 10.1016/j.jhin.2014.06.018; Zhou ZY, 2016, J INFECT CHEMOTHER, V22, P450, DOI 10.1016/j.jiac.2016.03.016	30	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193300	10.1371/journal.pone.0193300	http://dx.doi.org/10.1371/journal.pone.0193300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522559	Green Published, Green Submitted, gold			2022-12-26	WOS:000427030800016
J	Sorice, MG; Donlan, CJ; Boyle, KJ; Xu, WB; Gelcich, S				Sorice, Michael G.; Josh Donlan, C.; Boyle, Kevin J.; Xu, Weibin; Gelcich, Stefan			Scaling participation in payments for ecosystem services programs	PLOS ONE			English	Article							TERRITORIAL USER RIGHTS; BIODIVERSITY CONSERVATION; SOCIAL NORMS; MARINE; SCIENCE; CHALLENGES; COUNTRIES; FISHERIES; PROTECT; CONTEXT	Payments for ecosystem services programs have become common tools but most have failed to achieve wide-ranging conservation outcomes. The capacity for scale and impact increases when PES programs are designed through the lens of the potential participants, yet this has received little attention in research or practice. Our work with small-scale marine fisheries integrates the social science of PES programs and provides a framework for designing programs that focus a priori on scaling. In addition to payments, desirable non monetary program attributes and ecological feedbacks attract a wider range of potential participants into PES programs, including those who have more negative attitudes and lower trust. Designing programs that draw individuals into participating in PES programs is likely the most strategic path to reaching scale. Research should engage in new models of participatory research to understand these dynamics and to design programs that explicitly integrate a broad range of needs, values, and modes of implementation.	[Sorice, Michael G.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA 24061 USA; [Josh Donlan, C.; Gelcich, Stefan] Adv Conservat Strategies, Cordoba, Spain; [Josh Donlan, C.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Boyle, Kevin J.; Xu, Weibin] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Study Multiple Drivers Marine Socioecol Syst, Santiago, Chile; [Gelcich, Stefan] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	Virginia Polytechnic Institute & State University; Cornell University; Virginia Polytechnic Institute & State University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of California System; University of California Santa Barbara	Sorice, MG (corresponding author), Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA 24061 USA.; Donlan, CJ; Gelcich, S (corresponding author), Adv Conservat Strategies, Cordoba, Spain.; Donlan, CJ (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.; Gelcich, S (corresponding author), Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile.; Gelcich, S (corresponding author), Pontificia Univ Catolica Chile, Ctr Study Multiple Drivers Marine Socioecol Syst, Santiago, Chile.; Gelcich, S (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	msorice@vt.edu; jdonlan@advancedconservation.org; sgelcich@bio.puc.cl		Sorice, Michael/0000-0001-9865-0965	David & Lucile Packard Foundation; Walton Family Foundation; Pew Marine Fellows Program; Nucleo Milenio Musels; Project Basal [0002]; Conicyt Basal [0002]; Nucleo-Milenio Initiatives [P10-033, NC-120086]; Fondecyt [1160145]; Pew Marine Conservation Fellowship Program; USDA National Institute of Food and Agriculture McIntire-Stennis Program project [1007271]	David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Walton Family Foundation; Pew Marine Fellows Program; Nucleo Milenio Musels; Project Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Conicyt Basal; Nucleo-Milenio Initiatives; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Pew Marine Conservation Fellowship Program; USDA National Institute of Food and Agriculture McIntire-Stennis Program project	This research was funded by Conicyt Basal 0002, Nucleo-Milenio Initiatives P10-033 and NC-120086, Fondecyt 1160145, The Pew Marine Conservation Fellowship Program, The Walton Family Foundation, The David & Lucile Packard Foundation, and supported by the Virginia Agricultural Experiment Station and the USDA National Institute of Food and Agriculture McIntire-Stennis Program project 1007271.; G. M. Luque, V. Ortiz, M. Herrera and J. C. Castilla assisted with fieldwork and provided insights on earlier drafts. We thank the David & Lucile Packard Foundation, Walton Family Foundation, Pew Marine Fellows Program, Nucleo Milenio Musels and Project Basal (#0002) for supporting this work.	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Arriagada RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131544; Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064; Banerjee S, 2013, FRONT ECOL ENVIRON, V11, P297, DOI 10.1890/120044; Baylis K, 2016, CONSERV LETT, V9, P58, DOI 10.1111/conl.12180; Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Borger T, 2014, MAR POLICY, V46, P161, DOI 10.1016/j.marpol.2014.01.019; Brooks JS, 2012, P NATL ACAD SCI USA, V109, P21265, DOI 10.1073/pnas.1207141110; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Chen BW, 2015, MOTIV EMOTION, V39, P216, DOI 10.1007/s11031-014-9450-1; Davis K, 2015, CONSERV BIOL, V29, P226, DOI 10.1111/cobi.12358; De Cremer D, 1999, EUR J SOC PSYCHOL, V29, P871, DOI 10.1002/(SICI)1099-0992(199911)29:7<871::AID-EJSP962>3.0.CO;2-I; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gelcich S, 2007, ECOL ECON, V61, P246, DOI 10.1016/j.ecolecon.2006.02.017; Gelcich S, 2015, MARIT STUD, V14, DOI 10.1186/s40152-015-0022-0; Gelcich S, 2015, CONSERV BIOL, V29, P1076, DOI 10.1111/cobi.12477; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Kinzig AP, 2013, BIOSCIENCE, V63, P164, DOI 10.1525/bio.2013.63.3.5; Le Velly G, 2017, LAND ECON, V93, P230, DOI 10.3368/le.93.2.230; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Manriquez PH, 2011, MAR ECOL PROG SER, V430, P207, DOI 10.3354/meps09153; Marin A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04562-170113; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; Marshall N, 2013, ECOSYSTEMS, V16, P797, DOI 10.1007/s10021-013-9651-6; Milne S, 2009, ORYX, V43, P530, DOI 10.1017/S0030605309990330; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Naeem S, 2015, SCIENCE, V347, P1206, DOI 10.1126/science.aaa1403; Nyborg K, 2016, SCIENCE, V354, P42, DOI 10.1126/science.aaf8317; Paluck EL, 2016, P NATL ACAD SCI USA, V113, P566, DOI 10.1073/pnas.1514483113; Pattanayak S.K., 2010, REV ENV ECON POLICY; Pierce JL, 2004, J MANAGE, V30, P591, DOI 10.1016/j.jm.2003.10.001; Siegrist M, 2000, RISK ANAL, V20, P353, DOI 10.1111/0272-4332.203034; Somerfield PJ, 2013, J EXP MAR BIOL ECOL, V449, P261, DOI 10.1016/j.jembe.2013.10.002; Sorice MG, 2015, AMBIO, V44, P788, DOI 10.1007/s13280-015-0650-z; Sorice MG, 2013, ECOL APPL, V23, P1146, DOI 10.1890/12-1878.1; Sorice MG, 2011, CONSERV BIOL, V25, P587, DOI 10.1111/j.1523-1739.2011.01673.x; Stern MJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07248-200214; Stuart D, 2013, LAND USE POLICY, V31, P223, DOI 10.1016/j.landusepol.2012.07.003; Van Vugt M, 2009, CURR DIR PSYCHOL SCI, V18, P169, DOI 10.1111/j.1467-8721.2009.01630.x; Vincent JR, 2014, P NATL ACAD SCI USA, V111, P10113, DOI 10.1073/pnas.1312246111; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Yoeli E, 2013, P NATL ACAD SCI USA, V110, P10424, DOI 10.1073/pnas.1301210110	49	11	11	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0192211	10.1371/journal.pone.0192211	http://dx.doi.org/10.1371/journal.pone.0192211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY7GW	29522554	gold, Green Submitted, Green Published			2022-12-26	WOS:000427030800009
J	Lancelotti, C				Lancelotti, Carla			'Not all that burns is wood'. A social perspective on fuel exploitation and use during the Indus urban period (2600-1900 BC)	PLOS ONE			English	Article							CHARCOAL MACRO-REMAINS; NORTHWEST INDIA; ARCHAEOLOGICAL CONTEXTS; VARIABLE ENVIRONMENTS; GEO-ETHNOARCHAEOLOGY; WOODLAND VEGETATION; FECAL SPHERULITES; OPAL PHYTOLITHS; SOUTH-ASIA; DUNG	Ancient civilisations depended heavily on natural fuel resources for a wide array of activities, and this had an impact on such resources that can be traced in the archaeological record. At its urban apex, the populations of the Indus Civilisation (2600 +/- 1900 BC) produced a wide range of objects and crafts, several of which involved highly specialised pyrotechnology. In the wake of increasing aridity and a period of weakened monsoon rainfall that affected South Asia from 2100 BC, these activities potentially put pressure on the natural resource base that may have had to be counterbalanced by differentiation in fuel use. The combined analysis of archaeobotanical and geoarchaeological remains from four Indus urban phase archaeological sites, has enable an assessment of the mechanisms through which people exploited wood, and diversified their fuel resources to adapt to the arid to semi-arid environments in which they lived. The combined use of local wood species with alternative fuels, such as dung and crop-processing leftovers, are evidence for resilient socio-ecological practices during the 700 years of Indus urbanism and perhaps beyond.	[Lancelotti, Carla] Univ Pompeu Fabra, Dept Humanities, CaSEs Res Grp, Barcelona, Spain	Pompeu Fabra University	Lancelotti, C (corresponding author), Univ Pompeu Fabra, Dept Humanities, CaSEs Res Grp, Barcelona, Spain.	carlalancelotti@upf.edu	Lancelotti, Carla/L-2655-2014	Lancelotti, Carla/0000-0003-1099-7329	AHRC Doctoral grant [2007/131224]; St John's College; Cambridge European Trust [300469695]; University of Cambridge (Isbel-Fletcher Garden Fund); University of Cambridge (Smuts Memorial Fund) [S2007/E2007]; University of Cambridge (Anthony Wilkin Fund)	AHRC Doctoral grant(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); St John's College; Cambridge European Trust; University of Cambridge (Isbel-Fletcher Garden Fund); University of Cambridge (Smuts Memorial Fund); University of Cambridge (Anthony Wilkin Fund)	The results presented in this paper are part of the author's PhD degree obtained at the University of Cambridge, Department of Archaeology in 2010. The research was funded by AHRC Doctoral grant (2007/131224), St John's College [no grant number], Cambridge European Trust (300469695) and The University of Cambridge (Isbel-Fletcher Garden Fund [no grant number], Smuts Memorial Fund [S2007/E2007], and Anthony Wilkin Fund [no grant number]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 1999, HOLOCENE, V9, P175, DOI 10.1191/095968399666631581; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Amundson Ronald, 1991, HARAPPA EXCAVATIONS, V3, P13; Anderson S., 1998, ENVIRON ARCHAEOL, V1, P99, DOI [10.1179/env.1996.1.1.99, DOI 10.1179/env.1996.1.1.99]; [Anonymous], LINGUISTICS ARCHAEOL; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2013, MAN ENV; Asouti E, 2003, J ARCHAEOL SCI, V30, P1185, DOI 10.1016/S0305-4403(03)00015-3; Asouti E, 2005, ENVIRON ARCHAEOL, V10, P1, DOI 10.1179/env.2005.10.1.1; Bangles Parpola A., 1990, S ASIAN ARCHAEOLOGY, P263; Bates J, 2017, VEG HIST ARCHAEOBOT, V26, P25, DOI 10.1007/s00334-016-0576-9; Belcher W.B., 1998, FISH EXPLOITATION BA; Bhan KK, 2007, EXCAVATIONS SHIKARPU; Bhatnagar IML, 1965, TREE SYMBOLS WORKSHI, P89; Braadbaart F, 2008, J ARCHAEOL SCI, V35, P2434, DOI 10.1016/j.jas.2008.03.016; Bull ID, 1999, ANTIQUITY, V73, P86, DOI 10.1017/S0003598X0008786X; BullIan D.M.E., 2005, INHABITING CATALHOYU, V38, P415, DOI [10.18866/j.ctt1pk874x, DOI 10.18866/J.CTT1PK874X]; Canti MG, 2003, CATENA, V54, P339, DOI 10.1016/S0341-8162(03)00127-9; Canti MG, 1999, J ARCHAEOL SCI, V26, P251, DOI 10.1006/jasc.1998.0322; Canti MG, 1998, J ARCHAEOL SCI, V25, P435, DOI 10.1006/jasc.1997.0210; Chabal L., 1992, B SOC BOT FR, V2, P213; Chabal L., 1997, FORETS SOC LANGUEDOC; Chakrabarti Dilip K., 1999, INDIA ARCHAEOLOGICAL; Champion HG, FOREST TYPES INDIA; Charles M., 1998, ENVIRON ARCHAEOL, V1, P111, DOI [DOI 10.1179/ENV.1996.1.1.111, 10.1179/env.1996.1.1.111]; de Lernia S, 2001, J ANTHROPOL ARCHAEOL, V20, P408, DOI 10.1006/jaar.2001.0384; Delhon C, 2008, J ARCHAEOL SCI, V35, P2937, DOI 10.1016/j.jas.2008.06.007; Desai BL, 1965, TREE SYMBOL WORSHIP, P54; Dixit Y, 2014, GEOLOGY, V42, P339, DOI 10.1130/G35236.1; Eksambekar SP, FORMATION PROCESSES; Evans JA, 2006, IAWA J, P5; Evershed RP, 1997, J ARCHAEOL SCI, V24, P485, DOI 10.1006/jasc.1996.0132; Evershed RP, 1996, ACS SYM SER, V625, P157, DOI 10.1021/bk-1996-0625.ch013; FAO, 2010, GLOBAL FOREST RESOUR; FAO, 2010, TECHNICAL REPORT; Friesem DE, 2016, J ARCHAEOL SCI, V70, P145, DOI 10.1016/j.jas.2016.05.004; Gamble J. S., 1902, MANUAL INDIAN TIMBER; Ghosh A, 1959, INDIAN ARCHAEOLOGY R, P50; Gur-Arieh S, 2014, J ARCHAEOL SCI, V46, P50, DOI 10.1016/j.jas.2014.03.011; Hastorf Christine A., 1998, Journal of Ethnobiology, V18, P211; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Holliday VT, 2007, J ARCHAEOL SCI, V34, P301, DOI 10.1016/j.jas.2006.05.004; Joglekar P.P., 2017, INDIAN J ARCHAEOLOGY, V2, P25; Joglekar PP, 2016, BHARATI, V39, P1; JONES AKG, 1988, ANTIQUITY, V62, P275, DOI 10.1017/S0003598X00074007; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Kenoyer JK, 1991, S ASIAN ARCHAEOLOGY, P165; Kenoyer JM, 1998, LAHORE MUEUM B, V9, P1; Kharakwal J.S., 2007, LINGUISTICS ARCHAEOL, P21; Lal Braj Basi, 1984, FRONTIERS INDUS CIVI, P511; Lancelotti C, 2010, THESIS; Lancelotti C, 2012, J ARCHAEOL SCI, V39, P953, DOI 10.1016/j.jas.2011.11.007; Law RW, 2011, CURRENT STUDIES INDU, V8; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Madella M, 2011, QUATERN INT, V275, P76; Madella M., 2003, INDUS ETHNOBIOLOGY N, P201; Madella M, 2006, QUATERNARY SCI REV, V25, P1283, DOI 10.1016/j.quascirev.2005.10.012; Marinova E, 2013, ENVIRON ARCHAEOL, V18, P1, DOI 10.1179/1461410313Z.00000000023; Meadow R.H., 2002, INDIAN ARCHAEOLOGY R, V2, P391; Meadow RH, ORIGINS SPREAD AGR P; Meadow RH, 2003, INDUS ETHNOBIOLOGY N, P65; Miller HML, 2013, CONNECTIONS AND COMPLEXITY: NEW APPROACHES TO THE ARCHAEOLOGY OF SOUTH ASIA, P161; Miller N.F., 1984, J ETHNOBIOL, V4, P15; Miller NF, 1996, CURR ANTHROPOL, V37, P521, DOI 10.1086/204514; Miller NF., 1988, CURRENT PALEOETHNOBO, P72; Miller NF., 1984, PALEORIENT, V10, P71; Neumann K., 2001, WOODS SAHARA SAHEL A; Orwa C, 2009, AGROFORESTRY TREE DA; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Parpola Asko, 1992, S ASIAN ARCHAEOLOGY, P227; Patel Ajita K., 2009, Anthropozoologica, V44, P173, DOI 10.5252/az2009n1a8; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pendall E, 1990, GEOARCHAEOLOGY, V5, P301; Petrie CA, 2017, J WORLD PREHIST, V30, P81, DOI 10.1007/s10963-017-9101-z; Petrie CA, 2017, CURR ANTHROPOL, V58, P1, DOI 10.1086/690112; Picornell Gelabert L, ANTHR ARCHAEO, V30, P375; Piperno D, 2006, PHYTOLITHS COMPREHEN; Portillo M, 2017, QUATERN INT, V431, P131, DOI 10.1016/j.quaint.2015.12.040; Possehl Gregory L., 2002, INDUS CIVILIZATION C; POWERS AH, 1989, J ARCHAEOL SCI, V16, P27, DOI 10.1016/0305-4403(89)90054-X; Rajaguru S.N., 2008, OCCASIONAL PAPER, P1; Reddy S. N., 1999, PALEORIENT, V24, P61; Reddy SN, 1997, J ANTHROPOL ARCHAEOL, V16, P162, DOI 10.1006/jaar.1997.0308; Rice P., 1987, POTTERY ANAL SOURCEB; SCHELVIS J, 1992, J ARCHAEOL SCI, V19, P677, DOI 10.1016/0305-4403(92)90037-4; Schuldenrein J, 2004, J ARCHAEOL SCI, V31, P777, DOI 10.1016/j.jas.2003.10.015; Shahack-Gross R, 2003, J ARCHAEOL SCI, V30, P439, DOI 10.1006/jasc.2002.0853; Shahack-Gross R, 2008, J ARCHAEOL SCI, V35, P965, DOI 10.1016/j.jas.2007.06.019; Shahack-Gross R, 2011, J ARCHAEOL SCI, V38, P205, DOI 10.1016/j.jas.2010.09.019; Sillar B, 2000, ARCHAEOMETRY, V42, P43, DOI 10.1111/j.1475-4754.2000.tb00865.x; Simpson IA, 1998, J ARCHAEOL SCI, V25, P729, DOI 10.1006/jasc.1997.0216; Valamoti SM, 2005, VEG HIST ARCHAEOBOT, V14, P528, DOI 10.1007/s00334-005-0090-y; VANDERVEEN M, 1982, J ARCHAEOL SCI, V9, P287, DOI 10.1016/0305-4403(82)90024-3; Weber S, 1999, ANTIQUITY, V73, P813, DOI 10.1017/S0003598X00065558; Weber S.A., 1991, PLANTS HARAPPAN SUBS; Weber SA, 2001, HARAPPA ARCHAEOLOGIC; WEBER SA, 2010, MAN ENV, V35, P62; Weber SA., 2003, INDUS ETHNOBIOLOGY N, P175; Wright R.P, 2010, ANCIENT INDUS URBANI; Zapata Pena L., 2003, AFRICA PRAEHISTORICA, P163; Zomer RJ, 2007, 122 IWMI; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014; Zurro D., THESIS; Zurro D., 2017, ARCHAEOL ANTHR SCI; [No title captured]	105	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192364	10.1371/journal.pone.0192364	http://dx.doi.org/10.1371/journal.pone.0192364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513672	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800012
J	Ma, CB; Zhang, WY; Wu, QW; Liu, Y; Wang, C; Lao, GY; Yang, LT; Liu, P				Ma, Chengbin; Zhang, Wenying; Wu, Qiongwei; Liu, Yu; Wang, Chao; Lao, Guoying; Yang, Longtao; Liu, Ping			Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE REGULATORY FACTOR; RADICAL HYSTERECTOMY; MICROVESSEL DENSITY; FACTOR EXPRESSION; CIRCADIAN GENES; CANCER; ADENOCARCINOMA; IMPACT; PROGRESSION	Background The aim of this study is to find the potential miRNA expression signature capable of predicting survival time for cervical squamous cell carcinoma (CSCC) patients. Methods The expression of 332 miRNAs was measured in 131 (Training cohort) and 130 (Validation cohort) patients with CSCC in the Cancer Genome Atlas (TCGA) data portal. The miRNA expression signature was identified by Cox Proportion Hazard regression model to the Training data set, and subsequently validated in an independent Validation set. Kaplan-Meier curves and the receiver operating characteristic analyses of 5 years were used to access the overall survival of miRNA signature. MiRNA signature-gene target analysis was performed, followed by the construction of the regulatory network. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis were used to explore the function of target genes of miRNA signature. Results A 2-miRNA expression signature of hsa-mir-642a and hsa-mir-378c associated with survivability was identified in CSCC. Both of them had a significant diagnostic and prognostic value of patients with CSCC. A total of 345 miRNA signature-target pairs were obtained in the miRNA signature-gene target regulatory network, in which 316 genes were targets of has-mir-378c and has-mir-642a. Functional analysis of target genes showed that MAPK signaling pathway, VEGF signaling pathway and endocytosis were the significantly enriched signal pathways that covered most genes. Conclusions The 2-miRNA signature adds to the prognostic value of CSCC. In-depth interrogation of the 2-miRNAs will provide important biological insights that finding and developing novel molecularly prediction to improve prognosis for CSCC patients.	[Ma, Chengbin; Zhang, Wenying; Wu, Qiongwei; Liu, Yu; Wang, Chao; Lao, Guoying; Yang, Longtao; Liu, Ping] Changning Matern & Infant Hlth Hosp, Dept Gynecol, Shanghai, Peoples R China		Liu, P (corresponding author), Changning Matern & Infant Hlth Hosp, Dept Gynecol, Shanghai, Peoples R China.	lupingshai@163.com						Bachtiary B, 2002, CANCER LETT, V179, P197, DOI 10.1016/S0304-3835(01)00872-2; Bibi F, 2015, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3090-7; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Braoudaki M, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0096-y; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Chen YX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-88; Dai HJ, 2011, BREAST CANCER RES TR, V127, P531, DOI 10.1007/s10549-010-1231-2; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fujiwaki R, 2000, ANTICANCER RES, V20, P1317; Gao LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-118; Gao LJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-384; Guo P, 2015, ONCOTARGETS THER, V8, P73, DOI 10.2147/OTT.S72832; Han Y, 2017, TRANSL ONCOL, V10, P378, DOI 10.1016/j.tranon.2017.03.005; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hosaka M, 2011, INT J CLIN ONCOL, V16, P33, DOI 10.1007/s10147-010-0123-0; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Intaraphet S, 2013, ASIAN PAC J CANCER P, V14, P5355, DOI 10.7314/APJCP.2013.14.9.5355; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kasamatsu T, 2009, BRIT J CANCER, V100, P1400, DOI 10.1038/sj.bjc.6605048; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Li Z, 2017, J CELL MOL MED, V21, P177, DOI 10.1111/jcmm.12951; Liu B, 2001, BRIT J CANCER, V85, P303, DOI 10.1054/bjoc.2001.1910; Liu B, 2016, ONCOTARGET, V7, P56690, DOI 10.18632/oncotarget.10678; Liu DQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11955; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Ma D, 2013, CHINESE J CANCER RES, V25, P656, DOI 10.3978/j.issn.1000-9604.2013.11.04; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Obermair A, 1997, J NATL CANCER I, V89, P1212, DOI 10.1093/jnci/89.16.1212; Olivares AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00788-3; Patel S, 2009, CURR OPIN OBSTET GYN, V21, P54, DOI 10.1097/GCO.0b013e32831a9890; Qin XB, 2017, INT J NANOMED, V12, P3721, DOI 10.2147/IJN.S131516; Quwaider D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0461-8; Rana Sobia, 2010, J Circadian Rhythms, V8, P3, DOI 10.1186/1740-3391-8-3; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Shih MC, 2006, MOL CARCINOGEN, V45, P732, DOI 10.1002/mc.20198; Suprasert P, 2005, INT J GYNECOL CANCER, V15, P995, DOI 10.1111/j.1525-1438.2005.00259.x; Tang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.518; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Tjalma W, 2000, EUR J OBSTET GYN R B, V92, P251, DOI 10.1016/S0301-2115(99)00295-X; Trattner M, 2001, GYNECOL ONCOL, V82, P11, DOI 10.1006/gyno.2001.6252; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04386-1; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Weng QJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01732-1; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Xu L, 2011, ACTA OBSTET GYN SCAN, V90, P1200, DOI 10.1111/j.1600-0412.2011.01231.x; Yeh SA, 1999, GYNECOL ONCOL, V72, P10, DOI 10.1006/gyno.1998.5217; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Zhang LY, 2013, PROG MOL BIOL TRANSL, V119, P51, DOI 10.1016/B978-0-12-396971-2.00003-8; Zhang WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167449; Zhao HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083571; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	59	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193625	10.1371/journal.pone.0193625	http://dx.doi.org/10.1371/journal.pone.0193625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513728	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800066
J	Ollivier, QR; Hammill, E; Booth, DJ; Madin, EMP; Hinchliffe, C; Harborne, AR; Lovelock, CE; Macreadie, PI; Atwood, TB				Ollivier, Quinn R.; Hammill, Edward; Booth, David J.; Madin, Elizabeth M. P.; Hinchliffe, Charles; Harborne, Alastair R.; Lovelock, Catherine E.; Macreadie, Peter I.; Atwood, Trisha B.			Benthic meiofaunal community response to the cascading effects of herbivory within an algal halo system of the Great Barrier Reef	PLOS ONE			English	Article							PARTICLE-SIZE; MARINE ECOSYSTEMS; TROPHIC CASCADES; PATCH REEFS; SEDIMENT; INVERTEBRATES; BIODIVERSITY; ASSEMBLAGES; QUALITY; DISTRIBUTIONS	Benthic fauna play a crucial role in organic matter decomposition and nutrient cycling at the sediment-water boundary in aquatic ecosystems. In terrestrial systems, grazing herbivores have been shown to influence below-ground communities through alterations to plant distribution and composition, however whether similar cascading effects occur in aquatic systems is unknown. Here, we assess the relationship between benthic invertebrates and above-ground fish grazing across the 'grazing halos' of Heron Island lagoon, Australia. Grazing halos, which occur around patch reefs globally, are caused by removal of seagrass or benthic macroalgae by herbivorous fish that results in distinct bands of unvegetated sediments surrounding patch reefs. We found that benthic algal canopy height significantly increased with distance from patch reef, and that algal canopy height was positively correlated with the abundances of only one invertebrate taxon (Nematoda). Both sediment carbon to nitrogen ratios (C: N) and mean sediment particle size (mu m) demonstrated a positive correlation with Nematoda and Arthropoda (predominantly copepod) abundances, respectively. These positive correlations indicate that environmental conditions are a major contributor to benthic invertebrate community distribution, acting on benthic communities in conjunction with the cascading effects of above-ground algal grazing. These results suggest that benthic communities, and the ecosystem functions they perform in this system, may be less responsive to changes in above-ground herbivorous processes than those previously studied in terrestrial systems. Understanding how above-ground organisms, and processes, affect their benthic invertebrate counterparts can shed light on how changes in aquatic communities may affect ecosystem function in previously unknown ways.	[Ollivier, Quinn R.; Macreadie, Peter I.] Deakin Univ, Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Ollivier, Quinn R.; Hammill, Edward; Booth, David J.; Hinchliffe, Charles] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Hammill, Edward; Atwood, Trisha B.] Utah State Univ, Dept Watershed Sci & Ecol Ctr, Logan, UT 84322 USA; [Madin, Elizabeth M. P.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Madin, Elizabeth M. P.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Hinchliffe, Charles] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Ctr Excellence Coral Reef Studies, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Ctr Excellence Coral Reef Studies, Australian Res Council, Brisbane, Qld, Australia; [Harborne, Alastair R.] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [Lovelock, Catherine E.; Atwood, Trisha B.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Deakin University; University of Technology Sydney; Utah System of Higher Education; Utah State University; Macquarie University; University of Hawaii System; University of New South Wales Sydney; University of Queensland; University of Queensland; State University System of Florida; Florida International University; University of Queensland; University of Queensland	Ollivier, QR (corresponding author), Deakin Univ, Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia.; Ollivier, QR (corresponding author), Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia.	Q.Oilivier@deakin.edu.au	Lovelock, Catherine E./AAF-7294-2020; Lovelock, Catherine E/G-7370-2012; Harborne, Alastair R/F-6155-2013	Lovelock, Catherine E./0000-0002-2219-6855; Lovelock, Catherine E/0000-0002-2219-6855; Harborne, Alastair R/0000-0002-6818-8615; Booth, David/0000-0002-8256-1412	Global Change Institute Seed Grant; Australian Research Council DECRA Fellowships [DE120102614, DE120102459, DE130101084]; World Wildlife Fund Kathryn S. Fuller Science for Nature Fund; US National Science Foundation International Postdoctoral Fellowship; Marine and Coastal Carbon Biogeochemistry Cluster	Global Change Institute Seed Grant; Australian Research Council DECRA Fellowships(Australian Research Council); World Wildlife Fund Kathryn S. Fuller Science for Nature Fund; US National Science Foundation International Postdoctoral Fellowship; Marine and Coastal Carbon Biogeochemistry Cluster	This research was funded by a Global Change Institute Seed Grant to T.B.A, C.E.L., and A.R.H., Australian Research Council DECRA Fellowships to E.M.P.M. (DE120102614), A.R.H. (DE120102459), and P.I.M. (DE130101084), a World Wildlife Fund Kathryn S. Fuller Science for Nature Fund awarded to E.M.P.M., a US National Science Foundation International Postdoctoral Fellowship awarded to E.M.P.M, and The Marine and Coastal Carbon Biogeochemistry Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLER RC, 1983, J MAR RES, V41, P299, DOI 10.1357/002224083788520225; Alougi D.M., 1980, Belle W. Baruch Library in Marine Science, V11, P151; Anderson M.J., 2004, PERMDISP FORTRAN COM, P24; Anderson M. J, 2004, DISTLM V 5 FORTRAN C, P10; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; [Anonymous], 2014, R LANG ENV STAT COMP; Armitage AR, 2006, J EXP MAR BIOL ECOL, V339, P65, DOI 10.1016/j.jembe.2006.07.013; Atwood TB, 2015, NAT CLIM CHANGE, V5, P1038, DOI 10.1038/NCLIMATE2763; Australian Bureau of Meteorology BOM, 2015, STAT CLIM 2014; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; COULL BC, 1990, T AM MICROSC SOC, V109, P233, DOI 10.2307/3226794; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Downie RA, 2013, MAR ECOL PROG SER, V482, P217, DOI 10.3354/meps10250; Duplisea DE, 1999, MAR ECOL PROG SER, V177, P73, DOI 10.3354/meps177073; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; GBRMPA, 2011, GREAT BARR REEF MANN; Giere O., 2008, MEIOBENTHOLOGY MICRO; Glynn P., 2015, BIOEROSION CORAL REE, P67, DOI DOI 10.1007/978-94-017-7249-5_4; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Hinchliffe C, 2017, MAR FRESHWATER RES, V68, P1867, DOI 10.1071/MF16301; HOGUE EW, 1981, J EXP MAR BIOL ECOL, V53, P181, DOI 10.1016/0022-0981(81)90018-6; Holdredge C, 2010, MAR ECOL PROG SER, V399, P253, DOI 10.3354/meps08331; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; JANSSON BO, 1967, OIKOS, V18, P311, DOI 10.2307/3565107; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Leduc D, 2012, DEEP-SEA RES PT I, V63, P164, DOI 10.1016/j.dsr.2011.10.009; LEE JJ, 1977, HELGOLAND WISS MEER, V30, P272, DOI 10.1007/BF02207841; Lewis LS, 2012, ECOLOGY, V93, P2746, DOI 10.1890/12-0038.1; Madin EMP, 2016, GLOBAL CHANGE BIOL, V22, P44, DOI 10.1111/gcb.13083; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Madin EMP, 2010, AM NAT, V176, P785, DOI 10.1086/657039; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Molles M., 1999, ECOLOGY CONCEPTS APP; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; NICOTRI ME, 1980, J EXP MAR BIOL ECOL, V42, P13, DOI 10.1016/0022-0981(80)90163-X; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; OGDEN J C, 1976, Aquatic Botany, V2, P103, DOI 10.1016/0304-3770(76)90013-9; OGDEN JC, 1973, SCIENCE, V182, P715, DOI 10.1126/science.182.4113.715; Olafsson E, 2003, VIE MILIEU, V53, P249; Pinheiro J, 2015, NLME LINEAR NONLINEA; RANDALL JE, 1965, ECOLOGY, V46, P255, DOI 10.2307/1936328; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Ruiz-Reynes D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603262; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Snelgrove P V R, 1995, OCEANOGRAPHIC LIT RE, V42, P668; STATZNER B, 1986, FRESHWATER BIOL, V16, P127, DOI 10.1111/j.1365-2427.1986.tb00954.x; Stoddart D.R., 1977, P59; SWEATMAN H, 1994, MAR ECOL PROG SER, V111, P1, DOI 10.3354/meps111001; TAGHON GL, 1982, OECOLOGIA, V52, P295, DOI 10.1007/BF00367951; Ullberg J, 2003, MAR ECOL PROG SER, V260, P141, DOI 10.3354/meps260141; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Vdovic N, 2010, EUR J SOIL SCI, V61, P854, DOI 10.1111/j.1365-2389.2010.01298.x; Von Bertrab MG, 2013, ECOL INDIC, V24, P589, DOI 10.1016/j.ecolind.2012.08.001; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle David A., 2010, P203; WILLIAMS R, 1972, J ANIM ECOL, V41, P623, DOI 10.2307/3199; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	68	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193932	10.1371/journal.pone.0193932	http://dx.doi.org/10.1371/journal.pone.0193932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513746	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800091
J	Saetre, CL; Johnsen, A; Stensrud, E; Cramer, ERA				Saetre, Camilla Lo Cascio; Johnsen, Arild; Stensrud, Even; Cramer, Emily R. A.			Sperm morphology, sperm motility and paternity success in the bluethroat (Luscinia svecica)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; AGE-RELATED VARIATION; FERTILIZATION SUCCESS; SEXUAL SELECTION; EVOLUTIONARY CONSEQUENCES; COMPETITION; PASSERINE; QUALITY; STORAGE; FERTILITY	Postcopulatory sexual selection may select for male primary sexual characteristics like sperm morphology and sperm motility, through sperm competition or cryptic female choice. However, how such characteristics influence male fertilization success remains poorly understood. In this study, we investigate possible correlations between sperm characteristics and paternity success in the socially monogamous bluethroat (Luscinia svecica svecica), predicting that sperm length and sperm swimming speed is positively correlated with paternity success. In total, 25% (15/61) of broods contained extra-pair offspring and 10% (33/315) of the offspring were sired by extra-pair males. Paternity success did not correlate significantly with sperm morphology or any aspects of sperm motility. Furthermore, sperm morphology and sperm motility did not correlate significantly with male morphological characters that previously have been shown to be associated with paternity success. Thus, the sperm characteristics investigated here do not appear to be strong predictors of paternity success in bluethroats.	[Saetre, Camilla Lo Cascio; Johnsen, Arild; Stensrud, Even; Cramer, Emily R. A.] Univ Oslo, Nat Hist Museum, Oslo, Norway	University of Oslo	Saetre, CL (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	c.l.c.satre@ibv.uio.no		Johnsen, Arild/0000-0003-4864-6284	Research Council of Norway [213592]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway, grant number 213592. URL: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; ALLEN T. E., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P788, DOI 10.1071/AR9570788; Bakst M. R., 1994, Poultry Science Reviews, V5, P117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennison C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1897; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1992, SPERM COMPETITION BI; Bitton PP, 2007, ANIM BEHAV, V74, P1777, DOI 10.1016/j.anbehav.2007.03.018; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; Bouwman KM, 2007, ANIM BEHAV, V73, P15, DOI 10.1016/j.anbehav.2006.01.031; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Briskie JV, 1996, FUNCT ECOL, V10, P375, DOI 10.2307/2390286; BRISKIE JV, 1993, CONDOR, V95, P442, DOI 10.2307/1369366; Calhim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028809; Casselman SJ, 2006, CAN J FISH AQUAT SCI, V63, P2119, DOI 10.1139/F06-108; Cramer ERA, 2016, ECOL EVOL, V6, P1363, DOI 10.1002/ece3.1977; Cramer ERA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1845, DOI 10.1007/s00265-013-1594-6; Cramer ERA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059208; Cramer ERA, 2013, J ORNITHOL, V154, P129, DOI 10.1007/s10336-012-0878-3; CROW JF, 1958, AM ANTHROPOL, V60, P1; Delmore KE, 2008, BEHAV ECOL, V19, P1243, DOI 10.1093/beheco/arn081; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Dobbe K., 2014, THESIS; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edme A, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2242-8; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Fossoy F, 2008, EVOLUTION, V62, P145, DOI 10.1111/j.1558-5646.2007.00284.x; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Froman D, 2003, BIOL REPROD, V69, P248, DOI 10.1095/biolreprod.102.013482; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Gasparini C, 2010, J EVOLUTION BIOL, V23, P124, DOI 10.1111/j.1420-9101.2009.01889.x; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hasson O, 2009, BIOL REV, V84, P225, DOI 10.1111/j.1469-185X.2008.00068.x; Helfenstein F, 2010, BEHAV ECOL SOCIOBIOL, V64, P557, DOI 10.1007/s00265-009-0871-x; Hogner S, 2013, BEHAV ECOL SOCIOBIOL, V67, P1205, DOI 10.1007/s00265-013-1548-z; Humphries S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-319; Immler S, 2007, J EVOLUTION BIOL, V20, P1008, DOI 10.1111/j.1420-9101.2007.01302.x; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Johnsen A, 2003, ETHOLOGY, V109, P147, DOI 10.1046/j.1439-0310.2003.00861.x; Johnsen A, 2001, BEHAVIOUR, V138, P1371, DOI 10.1163/156853901317367645; Johnsen A, 2012, BEHAV ECOL SOCIOBIOL, V66, P181, DOI 10.1007/s00265-011-1265-4; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Krakauer AH, 2011, J EVOLUTION BIOL, V24, P2064, DOI 10.1111/j.1420-9101.2011.02317.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2007, ORNIS FENNICA, V84, P131; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Mossman J, 2009, EVOLUTION, V63, P2730, DOI 10.1111/j.1558-5646.2009.00753.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Powell M. J. D, 2009, 2009NA06 DAMTP U CAM; Rosengrave P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0001; Rowe M, 2013, EMU, V113, P218, DOI 10.1071/MU12084; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Svensson L., 1992, IDENTIFICATION GUIDE; Webster MS, 1995, EVOLUTION, V49, P1147, DOI [10.2307/2410439, 10.1111/j.1558-5646.1995.tb04441.x]; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Wolfson A., 1952, Bird-Banding, V23, P159; Yeates SE, 2013, EVOLUTION, V67, P3523, DOI 10.1111/evo.12208	75	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192644	10.1371/journal.pone.0192644	http://dx.doi.org/10.1371/journal.pone.0192644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509773	Green Published, gold			2022-12-26	WOS:000426813200006
J	Syed, S; Iqbal, NT; Sadiq, K; Ma, JNZ; Akhund, T; Xin, WJ; Moore, SR; Liu, EJ; Qureshi, S; Gosselin, K; Gewirtz, A; Duggan, CP; Ali, SA				Syed, Sana; Iqbal, Najeeha T.; Sadiq, Kamran; Ma, Jennie Z.; Akhund, Tauseef; Xin, Wenjun; Moore, Sean R.; Liu, Enju; Qureshi, Shahida; Gosselin, Kerri; Gewirtz, Andrew; Duggan, Christopher P.; Ali, S. Asad			Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction	PLOS ONE			English	Article							PROINFLAMMATORY RESPONSE; BACTERIAL FLAGELLIN; ENTEROPATHY; PERMEABILITY; INFLAMMATION; INFECTIONS; INNATE; INDUCE	Background Environmental Enteric Dysfunction (EED) in children from low-income countries has been linked to linear growth declines. There is a critical need to identify sensitive and early EED biomarkers. Objective Determine whether levels of antibodies against bacterial components flagellin (flic) and lipopolysaccharide (LPS) predict poor growth. Design/Methods In a prospective birth cohort of 380 children in rural Pakistan blood and stool samples were obtained at ages 6 and 9 months. Linear mixed effects models were used to examine longitudinal associations between quartiles of anti-flic and anti-LPS antibodies and changes in LAZ, WAZ and WLZ scores. Spearman's correlations were measured between anti-flic and anti-LPS immunoglobulins with measures of systemic/enteric inflammation and intestinal regeneration. Results Anti-LPS IgA correlated significantly with CRP, AGP and Reg1 serum at 6mo and with MPO at 9mo. In multivariate analysis at 6mo of age, higher anti-LPS IgA levels predicted greater declines in LAZ scores over subsequent 18mo (comparing highest to lowest quartile, beta (SE) change in LAZ score/year = -0.313 (0.125), p-value = 0.013). Anti-flic Ig A in the two highest quartiles measured at 9mo of age had declines in LAZ of -0.269 (0.126), p = 0.033; and -0.306 (0.129), p = 0.018 respectively, during the subsequent 18mo of life, compared to those in the lowest quartile of anti-flic IgA. Conclusions and relevance Elevated anti-flic IgA and anti-LPS IgA antibodies at 6 and 9mo, predict declines in linear growth. Systemic and enteric inflammation correlated with anti-LPS IgA provides mechanistic considerations for potential future interventions.	[Syed, Sana; Moore, Sean R.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Syed, Sana; Iqbal, Najeeha T.; Sadiq, Kamran; Akhund, Tauseef; Qureshi, Shahida; Ali, S. Asad] Aga Khan Univ, Dept Pediat, Karachi, Pakistan; [Syed, Sana; Liu, Enju; Gosselin, Kerri; Duggan, Christopher P.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Ma, Jennie Z.; Xin, Wenjun] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Gewirtz, Andrew] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Populat, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Nutr, Boston, MA USA	University of Virginia; Aga Khan University; Harvard University; Boston Children's Hospital; University of Virginia; University System of Georgia; Georgia State University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ali, SA (corresponding author), Aga Khan Univ, Dept Pediat, Karachi, Pakistan.	asad.ali@aku.edu		Moore, Sean/0000-0003-1150-6632; Syed, Sana/0000-0003-0954-0583; Ali, Syed Asad/0000-0001-5274-7665	Bill and Melinda Gates Foundation [OPP1066200, OPP1066203]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK034854] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Bill and Melinda Gates Foundation Grant OPP1066200 to AA and OPP1066203 to CPD. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Ali A, 2016, CURR OPIN GASTROEN, V32, P12, DOI 10.1097/MOG.0000000000000226; BARROW PA, 1994, INT J FOOD MICROBIOL, V21, P55, DOI 10.1016/0168-1605(94)90200-3; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2006, CURR OPIN GASTROEN, V22, P8, DOI 10.1097/01.mog.0000194791.59337.28; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Goto R, 2009, BRIT J NUTR, V101, P1509, DOI 10.1017/S0007114508083554; Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal N, 2018, SCI REPORTS; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kosek MN, 2017, EBIOMEDICINE, V18, P109, DOI 10.1016/j.ebiom.2017.02.024; KRUIS W, 1987, HEPATO-GASTROENTEROL, V34, P123; Lampl M, 2001, ANN HUM BIOL, V28, P403, DOI 10.1080/03014460010016662; McDonald CM, 2016, AM J CLIN NUTR; Petri WA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0187-1; Reed KA, 2002, J BIOL CHEM, V277, P13346, DOI 10.1074/jbc.M200149200; Syed S., 2016, J PEDIAT GASTROENTER; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; WHO, WHO CHILD GROWTH STA; world health organization, DIARRH DIS FACT SHEE; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193768	10.1371/journal.pone.0193768	http://dx.doi.org/10.1371/journal.pone.0193768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509790	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200029
J	Lee, M; Baek, H; Park, JS; Kim, S; Kyung, C; Baik, SJ; Lee, BK; Kim, JH; Ahn, CW; Kim, KR; Kang, S				Lee, Minyoung; Baek, Haeri; Park, Jong Suk; Kim, Sohee; Kyung, Chanhee; Baik, Su Jung; Lee, Byoung Kwon; Kim, Jie-Hyun; Ahn, Chul Woo; Kim, Kyung Rae; Kang, Shinae			Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study	PLOS ONE			English	Article							ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; ERADICATION THERAPY; STRAINS; SEROPOSITIVITY; INFLAMMATION	Helicobacter pylori is a gastrointestinal pathogen known to be associated with cardiovascular disease (CVD). However, most analyses about the effect of H. pylori infection have been done in patients with a history of CVD but not in healthy subjects. We evaluated the association between H. pylori infection and subclinical atherosclerosis by using cardiac multidetector computed tomography (MDCT) in healthy subjects without previous CVD. From December 2007 to February 2014, 463 subjects who underwent the rapid urease test (CLO test), pulse-wave velocity (PWV) measurement, and MDCT for a self-referred health checkup were enrolled to this study. Helicobacter pylori infection was defined on the basis of CLO test positivity on endoscopic gastric biopsy. Significant coronary artery stenosis was defined as >= 50% stenosis in any of the major epicardial coronary vessel on MDCT. The CLO-positive subjects had a lower high-density lipoprotein-cholesterol (HDL-cholesterol) level compared to the CLO-negative subjects. The incidence of significant coronary stenosis was higher in the CLO-positive group (7.6% vs. 2.9%, P = 0.01). Furthermore, the number of subjects with coronary artery calcium score > 0 and log{(number of segments with plaque)+ 1} were also significantly higher in the CLO-positive group. However, there was no statistical difference in the number of subjects with coronary artery calcium score > 100, the prevalence of any plaque nor the plaque characteristics (calcified, mixed, or soft). Pulse-wave velocity (PWV) was neither associated with CLO test positivity. The CLO-positive group was 3-fold more likely to have significant coronary artery stenosis even after adjusting for confounding factors (adjusted odds ratio 2.813, 95% confidence interval 1.051-7.528, P = 0.04). In a healthy population, current H. pylori infection was associated with subclinical but significant coronary artery stenosis. The causal relationship between H. pylori infection and subclinical atherosclerosis in a "healthy" population remains to be investigated in the future.	[Lee, Minyoung; Baek, Haeri; Park, Jong Suk; Kyung, Chanhee; Ahn, Chul Woo; Kim, Kyung Rae; Kang, Shinae] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Endocrinol,Dept Internal Med, Seoul, South Korea; [Baek, Haeri] HPlus Yangji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Park, Jong Suk; Ahn, Chul Woo; Kang, Shinae] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Kim, Sohee] Aswell Convalescent Hosp, Gwangju, South Korea; [Kyung, Chanhee] Rhin Hosp, Gyeonggi Do, South Korea; [Baik, Su Jung] Gangnam Severance Hosp, Hlth Promot Ctr, Healthcare Res Team, Seoul, South Korea; [Lee, Byoung Kwon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Endocrinol,Dept Internal Med, Seoul, South Korea.; Kang, S (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea.	shinae95@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Lee, Minyoung/0000-0002-9333-7512; Kang, Shinae/0000-0002-9719-4774; Park, Jong Suk/0000-0002-5385-1373; Lee, Byoung Kwon/0000-0001-9259-2776; Baik, Su Jung/0000-0002-3790-7701; Ahn, Chul Woo/0000-0003-3733-7486	National Research Foundation of Korea (NRF) - Korea government Ministry of Science (MSIP) [2014R1A1A3051221]	National Research Foundation of Korea (NRF) - Korea government Ministry of Science (MSIP)	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr) grant funded by the Korea government Ministry of Science (MSIP) (No. 2014R1A1A3051221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, J GASTROEN HEPATOL, V18, P771, DOI 10.1046/j.1440-1746.2003.03059.x; Adiloglu AK, 2005, ACTA CARDIOL, V60, P599, DOI 10.2143/AC.60.6.2004930; Al-Nozha MM, 2003, SAUDI MED J, V24, P1370; Atkinson NSS, 2016, DIGEST DIS SCI, V61, P19, DOI 10.1007/s10620-015-3877-4; Ayada K, 2007, ANN NY ACAD SCI, V1108, P594, DOI 10.1196/annals.1422.062; Blankenberg S, 2001, HERZ, V26, P9; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; Budzynski J, 2016, INT J ANGIOL, V25, P3, DOI 10.1055/s-0035-1547385; Chen LW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003616; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Chmiela M, 2003, FEMS IMMUNOL MED MIC, V36, P187, DOI 10.1016/S0928-8244(03)00030-0; Chmiela M, 2015, WORLD J CARDIOL, V7, P187, DOI 10.4330/wjc.v7.i4.187; Chon Seung Joo, 2016, J Menopausal Med, V22, P146, DOI 10.6118/jmm.2016.22.3.146; Coskun S, 2008, PEDIATR INT, V50, P150, DOI 10.1111/j.1442-200X.2008.02542.x; Crabtree JE, 1999, J CLIN PATHOL, V52, P653, DOI 10.1136/jcp.52.9.653; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; Diomedi M, 2008, HELICOBACTER, V13, P525, DOI 10.1111/j.1523-5378.2008.00627.x; Duntas LH, 2007, THYROID, V17, P1075, DOI 10.1089/thy.2007.0116; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Farsak B, 2000, J CLIN MICROBIOL, V38, P4408, DOI 10.1128/JCM.38.12.4408-4411.2000; Franceschi F, 2009, ATHEROSCLEROSIS, V202, P535, DOI 10.1016/j.atherosclerosis.2008.04.051; Haberl R, 2001, J AM COLL CARDIOL, V37, P451, DOI 10.1016/S0735-1097(00)01119-0; Huang BS, 2011, DIGEST DIS SCI, V56, P109, DOI 10.1007/s10620-010-1274-6; Ikeda A, 2013, ATHEROSCLEROSIS, V230, P67, DOI 10.1016/j.atherosclerosis.2013.06.013; Jin Seung-Won, 2007, Korean Journal of Internal Medicine, V22, P152; Kanbay M, 2005, DIGEST DIS SCI, V50, P2071, DOI 10.1007/s10620-005-3009-7; Kim DW, 2014, ORAL DIS, V20, P551, DOI 10.1111/odi.12168; Kim SK, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/2052-4374-26-1; Kountouras J, 2017, INT J CARDIOL, V229, P17, DOI 10.1016/j.ijcard.2016.11.265; Kowalski M, 2002, DIGEST LIVER DIS, V34, P398, DOI 10.1016/S1590-8658(02)80036-6; Kowalski M, 2001, DIGEST LIVER DIS, V33, P222, DOI 10.1016/S1590-8658(01)80711-8; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Kuller LH, 2006, ARCH INTERN MED, V166, P71, DOI 10.1001/archinte.166.1.71; Laurila A, 1999, ATHEROSCLEROSIS, V142, P207, DOI 10.1016/S0021-9150(98)00194-4; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu M, 2014, EUR REV MED PHARMACO, V18, P2918; Makoveichuk E, 2017, BBA-MOL CELL BIOL L, V1862, P533, DOI 10.1016/j.bbalip.2017.02.005; Manolakis A, 2007, HELICOBACTER, V12, P287, DOI 10.1111/j.1523-5378.2007.00511.x; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Mayr M, 2003, STROKE, V34, P610, DOI 10.1161/01.STR.0000058481.82639.EF; MENDALL MA, 1994, BRIT HEART J, V71, P437; Mentis A, 2015, HELICOBACTER, V20, P1, DOI 10.1111/hel.12250; Mete R, 2013, EUR REV MED PHARMACO, V17, P2884; Nakagawa H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/142358; Nazligul Y, 2011, CLIN BIOCHEM, V44, P647, DOI 10.1016/j.clinbiochem.2011.03.001; Niemela S, 1996, HEART, V75, P573, DOI 10.1136/hrt.75.6.573; Ohnishi M, 2008, METABOLISM, V57, P1760, DOI 10.1016/j.metabol.2008.08.001; Okada T, 2007, J AUTOIMMUN, V29, P106, DOI 10.1016/j.jaut.2007.05.004; Park MJ, 2011, GUT LIVER, V5, P321, DOI 10.5009/gnl.2011.5.3.321; Pohjanen VM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009987; Qu BG, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43059; Quinn MJ, 1999, AM J CARDIOL, V83, P1664, DOI 10.1016/S0002-9149(99)00175-7; Rezaee-Zavareh MS, 2016, ARYA ATHEROSCLER, V12, P41; Rogha M, 2012, ARYA ATHEROSCLER, V8, P5; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Sheu WHH, 2000, CLIN EXP HYPERTENS, V22, P595, DOI 10.1081/CEH-100100094; Silverman MG, 2014, JACC-CARDIOVASC IMAG, V7, P476, DOI 10.1016/j.jcmg.2014.03.005; Sun J, 2016, HELICOBACTER, V21, P11, DOI 10.1111/hel.12234; Tabata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166240; Tobin NP, 2008, AM J PHYSIOL-HEART C, V295, pH1403, DOI 10.1152/ajpheart.00240.2008; Tsai CJ, 2000, DIGEST DIS SCI, V45, P1227, DOI 10.1023/A:1005522624004; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yu XJ, 2017, EXP THER MED, V13, P787, DOI 10.3892/etm.2017.4028; Zuin M, 2016, INT J CARDIOL, V223, P711, DOI 10.1016/j.ijcard.2016.08.320	65	34	42	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193646	10.1371/journal.pone.0193646	http://dx.doi.org/10.1371/journal.pone.0193646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499055	Green Submitted, Green Published, gold			2022-12-26	WOS:000426472300018
J	Nieto-Vera, R; Kahuam-Lopez, N; Meneses, A; Cruz-Martinez, Y; Anaya-Jimenez, RM; Liy-Salmeron, G; Carvajal, HG; Ponce-Lopez, MT; Ibarra, A				Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Meneses, Alfredo; Cruz-Martinez, Yolanda; Maria Anaya-Jimenez, Rosa; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio			Copolymer-1 enhances cognitive performance in young adult rats	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LONG-TERM-MEMORY; GLATIRAMER ACETATE; NEUROTROPHIC FACTOR; BDNF; HIPPOCAMPUS; IMMUNITY; MICE; NEUROGENESIS; IMPAIRMENT	Cognitive impairment is a dysfunction observed as a sequel of various neurodegenerative diseases, as well as a concomitant element in the elderly stages of life. In clinical settings, this malfunction is identified as mild cognitive impairment. Previous studies have suggested that cognitive impairment could be the result of a reduction in the expression of brain-derived neurotrophic factor (BDNF) and/or immune dysfunction. Copolymer-1 (Cop-1) is an FDA-approved synthetic peptide capable of inducing the activation of Th2/3 cells, which are able to release BDNF, as well as to migrate and accumulate in the brain. In this study, we evaluated the effect of Cop-1 immunization on improvement of cognition in adult rats. For this purpose, we performed four experiments. We evaluated the effect of Cop-1 immunization on learning/memory using the Morris water maze for spatial memory and autoshaping for associative memory in 3- or 6-month-old rats. BDNF concentrations at the hippocampus were determined by ELISA. Cop-1 immunization induced a significant improvement of spatial memory and associative memory in 6-month-old rats. Likewise, Cop-1 improved spatial memory and associative memory when animals were immunized at 3 months and evaluated at 6 months old. Additionally, Cop-1 induced a significant increase in BDNF levels at the hippocampus. To our knowledge, the present investigation reports the first instance of Cop-1 treatment enhancing cognitive function in normal young adult rats, suggesting that Cop-1 may be a practical therapeutic strategy potentially useful for age-or disease-related cognitive impairment.	[Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Cruz-Martinez, Yolanda; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio] Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte, Huixquilucan, Estado De Mexic, Mexico; [Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Cruz-Martinez, Yolanda; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio] Av Univ Anahuac 46, Huixquilucan, Estado De Mexic, Mexico; [Meneses, Alfredo; Maria Anaya-Jimenez, Rosa] IPN, CINVESTAV, Dept Farmacobiol, Mexico City, DF, Mexico	Universidad Anahuac; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Ibarra, A (corresponding author), Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte, Huixquilucan, Estado De Mexic, Mexico.; Ibarra, A (corresponding author), Av Univ Anahuac 46, Huixquilucan, Estado De Mexic, Mexico.	jose.ibarra@anahuac.mx	Cruz, Yolanda/GPT-1412-2022; Kahuam-López, Nicolás/G-1158-2018	Kahuam-López, Nicolás/0000-0003-3887-0629; Anaya-Jimenez, Rosa/0000-0003-0383-4580; Carvajal, Horacio/0000-0003-1424-8472; Cruz, Yolanda/0000-0001-5559-2339; Ponce-Lopez, Teresa/0000-0003-4789-661X	Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico [CSNBIAIIAJ12070412]; Consejo Nacional de Ciencia y Tecnologia [178544]	Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico (CSNBIAIIAJ12070412), and the Consejo Nacional de Ciencia y Tecnologia (178544). Al is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Aparicio-Nava L., 2018, BEHAV BRAIN RES; Arya A, 2016, INT J NANOMED, V11, P1159, DOI 10.2147/IJN.S102096; Azoulay D, 2005, J NEUROIMMUNOL, V167, P215, DOI 10.1016/j.jneuroim.2005.07.001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Chander RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12755-z; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14308; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Cruz Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121854; Di Benedetto S, 2017, NEUROSCI BIOBEHAV R, V75, P114, DOI 10.1016/j.neubiorev.2017.01.044; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Gonzalez R, 2013, BEHAV BRAIN RES, V252, P246, DOI 10.1016/j.bbr.2013.05.051; Halai AD, 2018, NEUROIMAGE-CLIN, V17, P465, DOI 10.1016/j.nicl.2017.10.037; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Meneses A, 2015, PSYCHOPHARMACOLOGY, V232, P595, DOI 10.1007/s00213-014-3693-0; Meneses A, 2003, LEARN MEMORY, V10, P363, DOI 10.1101/lm.60503; Meneses A, 2017, REV NEUROSCIENCE, V28, P455, DOI 10.1515/revneuro-2016-0079; Nandrajog P, 2016, ASIAN J NEUROSURG; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Prat A, 2005, J AUTOIMMUN, V24, P119, DOI 10.1016/j.jaut.2005.01.004; Qian SH, 2013, CLIN EXP OPHTHALMOL, V41, P881, DOI 10.1111/ceo.12110; Ritchie K, 1996, BRIT J PSYCHIAT, V168, P470, DOI 10.1192/bjp.168.4.470; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Roberts R, 2013, CLIN GERIATR MED, V29, P753, DOI 10.1016/j.cger.2013.07.003; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Shang YC, 2016, NEUROBIOL LEARN MEM, V134, P369, DOI 10.1016/j.nlm.2016.08.016; Srey CS, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00054; Urbach A, 2017, J CEREBR BLOOD F MET, V37, P1776, DOI 10.1177/0271678X16643736; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192885	10.1371/journal.pone.0192885	http://dx.doi.org/10.1371/journal.pone.0192885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494605	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200016
J	Ren, XF; Schmidt, W; Huang, YY; Lu, HS; Liu, WJ; Bu, WM; Eckenhoff, R; Cammarato, A; Gao, WD				Ren, Xianfeng; Schmidt, William; Huang, Yiyuan; Lu, Haisong; Liu, Wenjie; Bu, Weiming; Eckenhoff, Roderic; Cammarato, Anthony; Gao, Wei Dong			Fropofol decreases force development in cardiac muscle	FASEB JOURNAL			English	Article						excitation contraction coupling; myofilament protein; intracellular calcium; fropofol; in vitro motility	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; VITRO MOTILITY ASSAY; DILATED CARDIOMYOPATHY; HEART-FAILURE; CLINICAL-MANIFESTATIONS; MYOCARDIAL-CONTRACTION; VENTRICULAR-MUSCLE; INDUCED DEPRESSION; CA2+ SENSITIVITY; STRONG BINDING	Supranormal contractile properties are frequently associated with cardiac diseases. Anesthetic agents, including propofol, can depress myocardial contraction. We tested the hypothesis that fropofol, a propofol derivative, reduces force development in cardiac muscles via inhibition of cross-bridge cycling and may therefore have therapeutic potential. Force and intracellular Ca2+ concentration ([Ca2+](i)) transients of rat trabecular muscles were determined. Myofilament ATPase, actin-activated myosin ATPase, and velocity of actin filaments propelled by myosin were also measured. Fropofol dose dependently decreased force without altering [Ca2+](i) in normal and pressure-induced hypertrophied-hypercontractile muscles. Similarly, fropofol depressed maximum Ca2+-activated force (F-max) and increased the [Ca2+](i) required for 50% of F-max (Ca-50) at steady state without affecting the Hill coefficient in both intact and skinned cardiac fibers. The drug also depressed cardiac myofibrillar and actin-activated myosin ATPase activity. In vitro actin sliding velocity was significantly reduced when fropofol was introduced during rigor binding of cross-bridges. The data suggest that the depressing effects of fropofol on cardiac contractility are likely to be related to direct targeting of actomyosin interactions. From a clinical standpoint, these findings are particularly significant, given that fropofol is a nonanesthetic small molecule that decreases myocardial contractility specifically and thus may be useful in the treatment of hypercontractile cardiac disorders.Ren, X., Schmidt, W., Huang, Y., Lu, H., Liu, W., Bu, W., Eckenhoff, R., Cammarato, A., Gao, W. D. Fropofol decreases force development in cardiac muscle.	[Ren, Xianfeng] China Japan Friendship Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Schmidt, William; Cammarato, Anthony] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Ross 1050,720 Rutland Ave, Baltimore, MD 21205 USA; [Huang, Yiyuan; Gao, Wei Dong] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA; [Lu, Haisong] Fuwai Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Liu, Wenjie] South China Univ, Dept Anesthesiol, Sch Med, Hengyang, Peoples R China; [Bu, Weiming; Eckenhoff, Roderic] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA	China-Japan Friendship Hospital; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Pennsylvania; Pennsylvania Medicine	Schmidt, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Ross 1050,720 Rutland Ave, Baltimore, MD 21205 USA.; Gao, WD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA.	wschmid6@jhmi.edu; wgao3@jhmi.edu	Gao, Wei/GXH-0380-2022; Huang, Yi-yuan/AAG-7324-2020	Huang, Yi-yuan/0000-0002-0698-2784	Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine); American Heart Association-Global Innovation Award (AHA-GIA) [17GRNT33670387]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM055867, GM008076]; NIH National Institute of Neurological Disease and Stroke Grant [NS080519]; NIH National Heart, Lung, and Blood Institute Grant [T32HL007227-38, R01HL124091]; AHA Grant [17POST33630159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227, R01HL124091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076, R01GM055867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine); American Heart Association-Global Innovation Award (AHA-GIA); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Neurological Disease and Stroke Grant; NIH National Heart, Lung, and Blood Institute Grant; AHA Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in part, by a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StARR) Award from the Department of Anesthesiology and Critical Care Medicine (Johns Hopkins University School of Medicine; to W.D.G.); American Heart Association-Global Innovation Award (AHA-GIA) (17GRNT33670387; to W.D.G.); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants GM055867 and GM008076, and NIH National Institute of Neurological Disease and Stroke Grant NS080519 (to R.E.); NIH National Heart, Lung, and Blood Institute Grant T32HL007227-38 (to W.S.) and R01HL124091 (to A.C.); and AHA Grant 17POST33630159 (to W.S.). The authors declare no conflicts of interest.	Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Chang AN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00460; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dai TY, 2007, J PHYSIOL-LONDON, V580, P951, DOI 10.1113/jphysiol.2007.129254; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Ding WG, 2011, J PHARMACOL EXP THER, V339, P825, DOI 10.1124/jpet.111.185272; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; GAO WD, 1994, CIRC RES, V74, P408, DOI 10.1161/01.RES.74.3.408; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; Gao WD, 2012, CIRC RES, V111, P1002, DOI 10.1161/CIRCRESAHA.112.270827; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008; Hanley PJ, 2004, ANESTHESIOLOGY, V101, P999, DOI 10.1097/00000542-200410000-00027; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Ly S, 2012, BIOCHEMISTRY-US, V51, P6413, DOI 10.1021/bi3006835; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Meng T, 2016, FASEB J, V30, P2915, DOI 10.1096/fj.201600290RR; Orzechowski M, 2014, ARCH BIOCHEM BIOPHYS, V545, P63, DOI 10.1016/j.abb.2014.01.001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Ryan JJ, 2014, CIRC RES, V115, P176, DOI 10.1161/CIRCRESAHA.113.301129; Schiattarella GG, 2015, CIRCULATION, V131, P1435, DOI 10.1161/CIRCULATIONAHA.115.013894; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Tardiff JC, 2015, CARDIOVASC RES, V105, P457, DOI 10.1093/cvr/cvv023; UCHIDA K, 1977, J BIOCHEM, V82, P469; Viswanathan MC, 2017, CELL REP, V20, P2612, DOI 10.1016/j.celrep.2017.08.070; Woll KA, 2015, ACS CHEM NEUROSCI, V6, P927, DOI 10.1021/acschemneuro.5b00078; Yip GW, 2009, J HUM HYPERTENS, V23, P295, DOI 10.1038/jhh.2008.141; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	45	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4203	4213		10.1096/fj.201701442R	http://dx.doi.org/10.1096/fj.201701442R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522375	Green Published			2022-12-26	WOS:000439325400012
J	Bao, LL; You, B; Shi, S; Shan, Y; Zhang, QC; Yue, HJ; Zhang, J; Zhang, W; Shi, YW; Liu, YF; Wang, X; Liu, D; You, YW				Bao, Lili; You, Bo; Shi, Si; Shan, Ying; Zhang, Qicheng; Yue, Huijun; Zhang, Jie; Zhang, Wei; Shi, Yunwei; Liu, Yifei; Wang, Xin; Liu, Dong; You, Yiwen			Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10	ONCOGENE			English	Article							TUMOR ANGIOGENESIS; EXPRESSION; CANCER; MICRORNAS; CHEMOTHERAPY; OVEREXPRESSION; RADIOTHERAPY; METAANALYSIS; VESICLES; GROWTH	Benefiting from more precise imaging and radiotherapy, patients with locoregionally nasopharyngeal carcinoma (NPC) have a significantly higher survival rate. Nonetheless, distant metastasis is still the predominant mode of failure. Advances in cancer research have highlighted that pathological angiogenesis is necessary for tumor metastasis by offering oxygen, nutrients, or cell metastatic conduits. MicroRNAs (miRNAs), a class of small noncoding RNAs, are increasingly implicated in modulation of angiogenesis in physiological and pathological conditions. Currently, we detected that miR-23a was highly enriched in NPC tissues at the metastatic or premetastatic stage, and its levels in NPC were associated with microvessel density. Subsequently, we proved that alteration of miR-23a expression modulated the growth, migration, and tube formation of HUVECs in vitro and affected the blood vessel outgrowth in the zebrafish model. Considering the possibility that extracellular miR-23a was horizontally transferred from CNE2 cells to HUVECs, we analyzed miR-23a encapsulated in exosomes, showing that overexpression of exosomal miR-23a in NPC promoted angiogenesis both in vitro and in vivo. Moreover, we provided evidences that miR-23a regulated angiogenesis by directly targeting testis-specific gene antigen (TSGA10). Taken together, our findings revealed that metastasis-associated miR-23a from NPC-derived exosomes plays an important role in mediating angiogenesis by targeting TSGA10.	[Bao, Lili; You, Bo; Shi, Si; Shan, Ying; Zhang, Qicheng; Yue, Huijun; Zhang, Jie; Zhang, Wei; You, Yiwen] Nantong Univ, Dept Otorhinolaryngol Head & Neck Surg, Affiliated Hosp, Xisi Rd 20, Nantong 226001, Peoples R China; [Shi, Yunwei; Wang, Xin; Liu, Dong] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Qixiu Rd 19, Nantong 226001, Peoples R China; [Liu, Yifei] Nantong Univ, Dept Pathol, Affiliated Hosp, Xisi Rd 20, Nantong 226001, Peoples R China	Nantong University; Nantong University; Nantong University	You, YW (corresponding author), Nantong Univ, Dept Otorhinolaryngol Head & Neck Surg, Affiliated Hosp, Xisi Rd 20, Nantong 226001, Peoples R China.; Liu, D (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Qixiu Rd 19, Nantong 226001, Peoples R China.	liudongtom@gmail.com; docyouyiwen@163.com	Liu, Dong/O-1271-2013	Liu, Dong/0000-0002-2764-6544	National Natural Science Foundation of China [81672682, 81602385]; Provincial Natural Science Foundation of Jiangsu, China [SBK2015022581]; innovative research project for postgraduate students of Jiangsu province [SJLX15_0645]; innovative research project for Nantong University postgraduate students [YKC15093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Jiangsu, China(National Natural Science Foundation of China (NSFC)); innovative research project for postgraduate students of Jiangsu province; innovative research project for Nantong University postgraduate students	This work was supported by grants from the National Natural Science Foundation of China (No. 81672682 to YY, and No. 81602385 to BY), the Provincial Natural Science Foundation of Jiangsu, China (No. SBK2015022581 to YY), the innovative research project for postgraduate students of Jiangsu province (No. SJLX15_0645 to LB), and the innovative research project for Nantong University postgraduate students (No. YKC15093 to LB).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bao LL, 2016, TUMOR BIOL, V37, P15043, DOI 10.1007/s13277-016-5400-8; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Demircioglu F, 2016, CURR OPIN CELL BIOL, V42, P121, DOI 10.1016/j.ceb.2016.07.008; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hatzl S, 2016, CANCER RES, V76, P3644, DOI 10.1158/0008-5472.CAN-15-3049; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1044712; Lin JC, 2003, BRIT J CANCER, V88, P187, DOI 10.1038/sj.bjc.6600716; Liu YF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027472; Mansouri K, 2016, HUM MOL GENET, V25, P233, DOI 10.1093/hmg/ddv461; NIELSEN NH, 1977, ACTA PATH MICRO IM A, V85, P850; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Shi S, 2015, J CANCER, V6, P1245, DOI 10.7150/jca.12825; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Suzuki HI, 2015, ONCOGENE, V34, P3085, DOI 10.1038/onc.2014.254; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Wang X, 2016, CARDIOVASC RES, V110, P140, DOI 10.1093/cvr/cvw023; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang Z, 2016, BRIT J CANCER, V115, P731, DOI 10.1038/bjc.2016.244; You B, 2016, ONCOTARGET, V7, P12505, DOI 10.18632/oncotarget.7274; Yuan X, 2013, INT J CLIN EXP PATHO, V6, P2651; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zheng LS, 2017, CANCER RES, V77, P579, DOI 10.1158/0008-5472.CAN-16-1281; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhuo XL, 2015, INT J CLIN EXP MED, V8, P1265	52	115	122	3	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2873	2889		10.1038/s41388-018-0183-6	http://dx.doi.org/10.1038/s41388-018-0183-6			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29520105	Green Published, hybrid			2022-12-26	WOS:000432929800009
J	Li, ZH; Takenobu, H; Setyawati, AN; Akita, N; Haruta, M; Satoh, S; Shinno, Y; Chikaraishi, K; Mukae, K; Akter, J; Sugino, RP; Nakazawa, A; Nakagawara, A; Aburatani, H; Ohira, M; Kamijo, T				Li, Zhenghao; Takenobu, Hisanori; Setyawati, Amallia Nuggetsiana; Akita, Nobuhiro; Haruta, Masayuki; Satoh, Shunpei; Shinno, Yoshitaka; Chikaraishi, Koji; Mukae, Kyosuke; Akter, Jesmin; Sugino, Ryuichi P.; Nakazawa, Atsuko; Nakagawara, Akira; Aburatani, Hiroyuki; Ohira, Miki; Kamijo, Takehiko			EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications	ONCOGENE			English	Article							NERVE GROWTH-FACTOR; ISLAND METHYLATOR PHENOTYPE; HIGH-RISK NEUROBLASTOMA; PROGNOSTIC-SIGNIFICANCE; FAVORABLE PROGNOSIS; TRK PROTOONCOGENE; H3K27 METHYLATION; PROSTATE-CANCER; FACTOR RECEPTOR; TARGET GENE	The polycomb repressor complex 2 molecule EZH2 is now known to play a role in essential cellular processes, namely, cell fate decisions, cell cycle regulation, senescence, cell differentiation, and cancer development/progression. EZH2 inhibitors have recently been developed; however, their effectiveness and underlying molecular mechanisms in many malignancies have not yet been elucidated in detail. Although the functional role of EZH2 in tumorigenesis in neuroblastoma (NB) has been investigated, mutations of EZH2 have not been reported. A Kaplan-Meier analysis on the event free survival and overall survival of NB patients indicated that the high expression of EZH2 correlated with an unfavorable prognosis. In order to elucidate the functional roles of EZH2 in NB tumorigenesis and its aggressiveness, we knocked down EZH2 in NB cell lines using lentivirus systems. The knockdown of EZH2 significantly induced NB cell differentiation, e.g., neurite extension, and the neuronal differentiation markers, NF68 and GAP43. EZH2 inhibitors also induced NB cell differentiation. We performed a comprehensive transcriptome analysis using Human Gene Expression Microarrays and found that NTRK1 (TrkA) is one of the EZH2-related suppression targets. The depletion of NTRK1 canceled EZH2 knockdown-induced NB cell differentiation. Our integrative methylome, transcriptome, and chromatin immunoprecipitation assays using NB cell lines and clinical samples clarified that the NTRK1 P1 and P2 promoter regions were regulated differently by DNA methylation and EZH2-related histone modifications. The NTRK1 transcript variants 1/2, which were regulated by EZH2-related H3K27me3 modifications at the P1 promoter region, were strongly expressed in favorable, but not unfavorable NB. The depletion and inhibition of EZH2 successfully induced NTRK1 transcripts and functional proteins. Collectively, these results indicate that EZH2 plays important roles in preventing the differentiation of NB cells and also that EZH2-related NTRK1 transcriptional regulation may be the key pathway for NB cell differentiation.	[Li, Zhenghao; Takenobu, Hisanori; Haruta, Masayuki; Satoh, Shunpei; Shinno, Yoshitaka; Chikaraishi, Koji; Mukae, Kyosuke; Akter, Jesmin; Sugino, Ryuichi P.; Ohira, Miki; Kamijo, Takehiko] Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama, Japan; [Li, Zhenghao; Kamijo, Takehiko] Saitama Univ, Lab Tumor Mol Biol, Dept Grad Sch Sci & Engn, Saitama, Saitama, Japan; [Setyawati, Amallia Nuggetsiana; Akita, Nobuhiro] Chiba Canc Ctr, Res Inst, Chiba, Chiba, Japan; [Setyawati, Amallia Nuggetsiana] Diponegoro Univ, Dept Biochem, Fac Med, Kota Semarang, Jawa Tengah, Indonesia; [Akita, Nobuhiro] Nagoya Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Chikaraishi, Koji] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Nakazawa, Atsuko] Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Saitama, Japan; [Nakagawara, Akira] Saga Med Ctr KOSEIKAN, Life Sci Res Inst, Saga, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Div Genome Sci, Res Ctr Adv Sci & Technol, Tokyo, Japan	Saitama University; Chiba Cancer Center; Diponegoro University; Nagoya Medical Center; Chiba University; Saitama Children's Medical Center; University of Tokyo	Kamijo, T (corresponding author), Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama, Japan.; Kamijo, T (corresponding author), Saitama Univ, Lab Tumor Mol Biol, Dept Grad Sch Sci & Engn, Saitama, Saitama, Japan.	tkamijo@cancer-c.pref.saitama.jp	Mukae, Kyosuke/K-5181-2019	Mukae, Kyosuke/0000-0001-6411-2990; Akter, Jesmin/0000-0002-4573-1603	Practical Research for Innovative Cancer Control [16ck0106011j0003, 17ck0106332h0001]; Tailor-made Medical Treatment Program from the Japan Agency for Medical Research and Development, AMED [15km0305013h0101]; JSPS KAKENHI [17K19623]; Grants-in-Aid for Scientific Research [16K10051, 17K10131] Funding Source: KAKEN	Practical Research for Innovative Cancer Control; Tailor-made Medical Treatment Program from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ms. K Sakurai and Ms. N Kawanabe for their technical assistance and Mr. Daniel Mrozek (Medical English Service, Kyoto) for his English editorial assistance. This work was supported in part by Practical Research for Innovative Cancer Control (No. 16ck0106011j0003; No. 17ck0106332h0001) and the Tailor-made Medical Treatment Program (No. 15km0305013h0101) from the Japan Agency for Medical Research and Development, AMED, and JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (17K19623).	Abe M, 2005, CANCER RES, V65, P828; Abe M, 2007, CANCER LETT, V247, P253, DOI 10.1016/j.canlet.2006.05.001; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Bate-Eya LT, 2017, EUR J CANCER, V75, P63, DOI 10.1016/j.ejca.2016.12.019; Chang BB, 1998, J BIOL CHEM, V273, P39, DOI 10.1074/jbc.273.1.39; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Dardenne E, 2016, CANCER CELL, V30, P563, DOI 10.1016/j.ccell.2016.09.005; Frumm SM, 2013, CHEM BIOL, V20, P713, DOI 10.1016/j.chembiol.2013.03.020; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Haruta M, 2014, CANCER LETT, V348, P167, DOI 10.1016/j.canlet.2014.03.022; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Henrich KO, 2016, CANCER RES, V76, P5523, DOI 10.1158/0008-5472.CAN-15-2507; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Indo Y, 1997, JPN J HUM GENET, V42, P343, DOI 10.1007/BF02766957; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kamijo T, 2012, INT J CLIN ONCOL, V17, P190, DOI 10.1007/s10147-012-0415-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; KOGNER P, 1993, CANCER RES, V53, P2044; Kurata K, 2008, ONCOGENE, V27, P741, DOI 10.1038/sj.onc.1210672; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Lau DT, 2012, CLIN CANCER RES, V18, P5690, DOI 10.1158/1078-0432.CCR-12-0294; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Niizuma H, 2006, ONCOGENE, V25, P5046, DOI 10.1038/sj.onc.1209515; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Satoh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32682; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Scaruffi P, 1999, INT J ONCOL, V14, P935; Schramm A, 2015, NAT GENET, V47, P872, DOI 10.1038/ng.3349; Sugawara W, 2007, PEDIATR BLOOD CANCER, V49, P240, DOI 10.1002/pbc.21031; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; de Souza DRV, 2011, PEDIATR BLOOD CANCER, V56, P749, DOI 10.1002/pbc.22823; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604	49	43	44	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2714	2727		10.1038/s41388-018-0133-3	http://dx.doi.org/10.1038/s41388-018-0133-3			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29507419	hybrid, Green Published			2022-12-26	WOS:000432545100008
J	Dayeh, DM; Kruithoff, BC; Nakanishi, K				Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro			Structural and functional analyses reveal the contributions of the C- and N-lobes of Argonaute protein to selectivity of RNA target cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; Argonaute; X-ray crystallography; ribonuclear protein (RNP); structural biology	CRYSTAL-STRUCTURE; GUIDE RNA; RECOGNITION; RISC; DNA; INSIGHTS; COMPLEX; DOMAIN; INTERFERENCE; SUPERFAMILY	Some gene transcripts have cellular functions as regulatory noncoding RNAs. For example, similar to 23-nucleotide (nt)-long siRNAs are loaded into Argonaute proteins. The resultant ribonucleoprotein assembly, the RNA-induced silencing complex (RISC), cleaves RNAs that are extensively base-paired with the loaded siRNA. To date, base complementarity is recognized as the major determinant of specific target cleavage (or slicing), but little is known about how Argonaute inspects base pairing before cleavage. A hallmark of Argonaute proteins is their bilobal structure, but despite the significance of this structure for curtailing slicing activity against mismatched targets, the molecular mechanism remains elusive. Here, our structural and functional studies of a bilobed yeast Argonaute protein and its isolated catalytic C-terminal lobe (C-lobe) revealed that the C-lobe alone retains almost all properties of bilobed Argonaute: siRNA-duplex loading, passenger cleavage/ejection, and siRNA-dependent RNA cleavage. A 2.1 angstrom-resolution crystal structure revealed that the catalytic C-lobe mirrors the bilobed Argonaute in terms of guide-RNA recognition and that all requirements for transitioning to the catalytically active conformation reside in the C-lobe. Nevertheless, we found that in the absence of the N-terminal lobe (N-lobe), target RNAs are scanned for complementarity only at positions 5-14 on a 23-nt guide RNA before endonucleolytic cleavage, thereby allowing for some off-target cleavage. Of note, acquisition of an N-lobe expanded the range of the guide RNA strand used for inspecting target complementarity to positions 2-23. These findings offer clues to the evolution of the bilobal structure of catalytically active Argonaute proteins.	[Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Dayeh, Daniel M.; Nakanishi, Kotaro] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Nakanishi, K (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.; Nakanishi, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Nakanishi, K (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.	nakanishi.9@osu.edu		Nakanishi, Kotaro/0000-0002-9857-6010	NIGMS, National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10OD021527]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM124320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023582, S10OD021527] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health, Grant P41 GM103403. The Eiger 16M detector on 24-ID-E beam line is funded by National Institutes of Health-ORIP HEI Grant S10OD021527. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We thank V. Gopalan, M. Ibba, J. Jackman, K. Mohler, and A. Singh for help and discussion as well as the NE-CAT beamline staff at the Advanced Photon Source.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Hirose T, 2014, EMBO REP, V15, P489, DOI 10.1002/embr.201338390; Hur JK, 2013, J BIOL CHEM, V288, P7829, DOI 10.1074/jbc.M112.441030; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Matsumoto N, 2016, CELL, V167, P484, DOI 10.1016/j.cell.2016.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; Nakanishi K, 2016, WIRES RNA, V7, P637, DOI 10.1002/wrna.1356; Nakanishi K, 2013, CELL REP, V3, P1893, DOI 10.1016/j.celrep.2013.06.010; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park MS, 2017, NUCLEIC ACIDS RES, V45, P11867, DOI 10.1093/nar/gkx916; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schroedinger LLC, 2015, AXPYMOL MOL GRAPH PL; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yao CY, 2015, MOL CELL, V59, P125, DOI 10.1016/j.molcel.2015.05.015; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	67	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6308	6325		10.1074/jbc.RA117.001051	http://dx.doi.org/10.1074/jbc.RA117.001051			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29519815	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000431108600008
J	Matsumura, T; Hida, S; Kitazawa, M; Fujii, C; Kobayashi, A; Takeoka, M; Taniguchi, S; Miyagawa, S				Matsumura, Tomio; Hida, Shigeaki; Kitazawa, Masato; Fujii, Chifumi; Kobayashi, Akira; Takeoka, Michiko; Taniguchi, Shun-ichiro; Miyagawa, Shin-ichi			Fascin1 suppresses RIG-I-like receptor signaling and interferon-beta production by associating with I kappa B kinase epsilon (IKK epsilon) in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; interferon regulatory factor (IRF); invasion; RIG-I-like receptor (RLR); signal transducers and activators of transcription 1 (STAT1); IB Kinase E fascin1; poly(I.C)	CELL-PROLIFERATION; VIRUS-INFECTION; PROTEIN TANK; IFN-BETA; ACTIVATION; EXPRESSION; STAT1; METASTASIS; TARGET; DOMAIN	Fascin1 is an actin-bundling protein involved in cancer cell migration and has recently been shown also to have roles in virus-mediated immune cell responses. Because viral infection has been shown to activate immune cells and to induce interferon-beta expression in human cancer cells, we evaluated the effects of fascin1 on virus-dependent signaling via the membrane- and actin-associated protein RIG-I (retinoic acid-inducible gene I) in colon cancer cells. We knocked down fascin1 expression with shRNA retrovirally transduced into a DLD-1 colon cancer and L929 fibroblast-like cell lines and used luciferase reporter assays and co-immunoprecipitation to identify fascin1 targets. We found that intracellular poly(I.C) transfection to mimic viral infection enhances the RIG-I/MDA5 (melanoma differentiation-associated gene 5)-mediated dimerization of interferon regulatory factor 3 (IRF-3). The transfection also significantly increased the expression levels of IRF-7, interferon-beta, and interferon-inducible cytokine IP-10 in fascin1-deleted cells compared with controls while significantly suppressing cell growth, migration, and invasion. We also found that fascin1 constitutively interacts with I kappa B kinase epsilon (IKK epsilon) in the RIG-I signaling pathway. In summary, we have identified fascin1 as a suppressor of the RIG-I signaling pathway associating with I kappa B kinase epsilon in DLD-1 colon cancer cells to suppress immune responses to viral infection.	[Matsumura, Tomio; Fujii, Chifumi; Taniguchi, Shun-ichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 3908621, Japan; [Matsumura, Tomio] Shinshu Univ, Grad Sch Med, Dept Aging Biol, Matsumoto, Nagano 3908621, Japan; [Matsumura, Tomio; Kitazawa, Masato; Kobayashi, Akira; Takeoka, Michiko; Miyagawa, Shin-ichi] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan; [Fujii, Chifumi] Shinshu Univ, Inst Biomed Sci, Dept Adv Med Hlth Promot, Matsumoto, Nagano 3908621, Japan; [Hida, Shigeaki] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi 4678603, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University; Nagoya University	Miyagawa, S (corresponding author), Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan.; Hida, S (corresponding author), Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi 4678603, Japan.	hida@phar.nagoya-cu.ac.jp; shinichi@shinshu-u.ac.jp		Fujii, Chifumi/0000-0001-8735-5274	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP20012020, JP26293300]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by General Scientific Research Grants JP20012020 and JP26293300 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Booy S, 2015, AM J CANCER RES, V5, P2035; Chen JJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0656-0; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Duewell P, 2014, CELL DEATH DIFFER, V21, P1825, DOI 10.1038/cdd.2014.96; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Harashima N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-217; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Huang FK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8465; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Kim JK, 2011, J IMMUNOL, V187, P6327, DOI 10.4049/jimmunol.1100612; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma YF, 2015, MELANOMA RES, V25, P169, DOI 10.1097/CMR.0000000000000135; Morosky SA, 2011, J BIOL CHEM, V286, P28574, DOI 10.1074/jbc.M111.227942; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Snyder M, 2014, J BIOL CHEM, V289, P30082, DOI 10.1074/jbc.M114.591719; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516; Verhelst K, 2013, BIOCHEM PHARMACOL, V85, P873, DOI 10.1016/j.bcp.2013.01.007; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 2009, CELL MOTIL CYTOSKEL, V66, P524, DOI 10.1002/cm.20356; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang JJ, 2016, CELL REP, V16, P405, DOI 10.1016/j.celrep.2016.05.083; Zhao HX, 2009, VIROLOGY, V392, P186, DOI 10.1016/j.virol.2009.07.006	46	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6326	6336		10.1074/jbc.M117.819201	http://dx.doi.org/10.1074/jbc.M117.819201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496994	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000431108600009
J	Li, HR; Chiang, WC; Chou, PC; Wang, WJ; Huang, JR				Li, Hao-Ru; Chiang, Wan-Chin; Chou, Po-Chun; Wang, Won-Jing; Huang, Jie-Rong			TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-FIBRIL FORMATION; IN-VIVO; MEMBRANELESS ORGANELLES; GLOBULAR-PROTEINS; NMR-SPECTROSCOPY; SELF-ASSOCIATION; AGGREGATION; SEQUENCE	Eukaryotic cells contain distinct organelles, but not all of these compartments are enclosed by membranes. Some intrinsically disordered proteins mediate membraneless organelle formation through liquid-liquid phase separation (LLPS). LLPS facilitates many biological functions such as regulating RNA stability and ribonucleoprotein assembly, and disruption of LLPS pathways has been implicated in several diseases. Proteins exhibiting LLPS typically have low sequence complexity and specific repeat motifs. These motifs promote multivalent connections with other molecules and the formation of higher-order oligomers, and their removal usually prevents LLPS. The intrinsically disordered C-terminal domain of TAR DNA-binding protein 43 (TDP-43), a protein involved in motor neuron disease and dementia lacks a dominant LLPS motif, however, and how this domain forms condensates is unclear. Using extensive mutagenesis of TDP-43, we demonstrate here that three tryptophan residues and, to a lesser extent, four other aromatic residues are most important for TDP-43 to undergo LLPS. Our results also suggested that only a few residues may be required for TDP-43 LLPS because the alpha-helical segment (spanning similar to 20 residues) in the middle part of the C-terminal domain tends to self-assemble, reducing the number of motifs required for forming a multivalent connection. Our results indicating that a self-associating alpha-helical element with a few key residues regulates condensate formation highlight a different type of LLPS involving intrinsically disordered regions. The C-terminal domain of TDP-43 contains similar to 50 disease-related mutations, with no clear physicochemical link between them. We propose that they may disrupt LLPS indirectly by interfering with the key residues identified here.	[Li, Hao-Ru; Chiang, Wan-Chin; Chou, Po-Chun; Wang, Won-Jing; Huang, Jie-Rong] Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan; [Huang, Jie-Rong] Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.; Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.	jierongh@ym.edu.tw	Huang, Jie-rong/O-3661-2019	Huang, Jie-rong/0000-0003-3674-2228; Wang, Won-Jing/0000-0001-9733-0839	Ministry of Science and Technology of Taiwan Grants [106-2113-M-010-005-MY2, 106-2633-B-009-001, 105-2628-B-010-004-MY3]	Ministry of Science and Technology of Taiwan Grants	This work was supported by the Ministry of Science and Technology of Taiwan Grants 106-2113-M-010-005-MY2 (to J.R.H.), 106-2633-B-009-001, and 105-2628-B-010-004-MY3 (to W.J.W.). The authors declare that they have no conflicts of interest with the contents of this article. Downloaded from http://www.jbc.org/at ISI, Thomson Scientific on April 23, 2018	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chen TC, 2016, PROTEIN PEPTIDE LETT, V23, P967, DOI 10.2174/0929866523666160920100045; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guo L, 2015, MOL CELL, V60, P189, DOI 10.1016/j.molcel.2015.10.006; He RY, 2015, CHEM COMMUN, V51, P8652, DOI 10.1039/c5cc00513b; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li HR, 2018, BBA-PROTEINS PROTEOM, V1866, P214, DOI 10.1016/j.bbapap.2017.10.001; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin YH, 2017, J BIOL CHEM, V292, P17845, DOI 10.1074/jbc.M117.802793; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2015, J PHYS CHEM LETT, V6, P2608, DOI 10.1021/acs.jpclett.5b00918; Mompean M, 2014, ARCH BIOCHEM BIOPHYS, V545, P53, DOI 10.1016/j.abb.2014.01.007; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Polling S, 2015, NAT STRUCT MOL BIOL, V22, P1008, DOI 10.1038/nsmb.3127; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Wilkins MR, 1999, METH MOL B, V112, P531; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	65	110	110	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6090	6098		10.1074/jbc.AC117.001037	http://dx.doi.org/10.1074/jbc.AC117.001037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29511089	Green Published, hybrid			2022-12-26	WOS:000430497300027
J	Hamilton-Brehm, SD; Hristova, LT; Edwards, SR; Wedding, JR; Snow, M; Kruger, BR; Moser, DP				Hamilton-Brehm, Scott D.; Hristova, Lidia T.; Edwards, Susan R.; Wedding, Jeffrey R.; Snow, Meradeth; Kruger, Brittany R.; Moser, Duane P.			Ancient human mitochondrial DNA and radiocarbon analysis of archived quids from the Mule Spring Rockshelter, Nevada, USA	PLOS ONE			English	Article							HUMAN MICROBIOMES; GREAT-BASIN; MTDNA; AMERICA; DELETIONS; SITES; POPULATIONS; MITOGENOMES; HAPLOGROUPS; EXTRACTION	Chewed and expectorated quids, indigestible stringy fibers from the roasted inner pulp of agave or yucca root, have proven resilient over long periods of time in dry cave environments and correspondingly, although little studied, are common in archaeological archives. In the late 1960s, thousands of quids were recovered from Mule Spring Rockshelter (Nevada, USA) deposits and stored without consideration to DNA preservation in a museum collection, remaining unstudied for over fifty years. To assess the utility of these materials as repositories for genetic information about past inhabitants of the region and their movements, twentyone quids were selected from arbitrary excavation depths for detailed analysis. Human mitochondrial DNA sequences from the quids were amplified by PCR and screened for diagnostic single nucleotide polymorphisms. Most detected single nucleotide polymorphisms were consistent with recognized Native American haplogroup subclades B2a5, B2i1, C1, C1c, C1c2, and D1; with the majority of the sample set consistent with subclades C1, C1c, and C1c2. In parallel with the DNA analysis, each quid was radiocarbon dated, revealing a time-resolved pattern of occupancy from 347 to 977 calibrated years before present. In particular, this dataset reveals strong evidence for the presence of haplogroup C1/C1c at the Southwestern edge of the US Great Basin from similar to 670 to 980 cal YBP, which may temporally correspond with the beginnings of the so-called Numic Spread into the region. The research described here demonstrates an approach which combines targeted DNA analysis with radiocarbon age dating; thus enabling the genetic analysis of archaeological materials of uncertain stratigraphic context. Here we present a survey of the maternal genetic profiles from people who used the Mule Spring Rockshelter and the historic timing of their utilization of a key natural resource.	[Hamilton-Brehm, Scott D.; Hristova, Lidia T.; Edwards, Susan R.; Wedding, Jeffrey R.; Kruger, Brittany R.; Moser, Duane P.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89119 USA; [Hamilton-Brehm, Scott D.] Southern Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Hristova, Lidia T.] Univ Nevada, Dept Anthropol, Las Vegas, NV USA; [Snow, Meradeth] Univ Montana, Dept Anthropol, Missoula, MT USA; [Kruger, Brittany R.; Moser, Duane P.] Desert Res Inst, Div Hydrol Sci, Las Vegas, NV 89119 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Southern Illinois University System; Southern Illinois University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Montana System; University of Montana; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Hamilton-Brehm, SD; Moser, DP (corresponding author), Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89119 USA.; Hamilton-Brehm, SD (corresponding author), Southern Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.; Moser, DP (corresponding author), Desert Res Inst, Div Hydrol Sci, Las Vegas, NV 89119 USA.	Scott.Hamilton-Brehm@siu.edu; Duane.Moser@dri.edu			Frederick Lander Family Foundation; Desert Research Institute; Southern Illinois University Carbondale	Frederick Lander Family Foundation; Desert Research Institute; Southern Illinois University Carbondale	This work received support from Frederick Lander Family Foundation, SE SH LH DM JW; Desert Research Institute salary support for DM, SH, and LH; and Southern Illinois University Carbondale, support for SH and MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Balter M, 2013, SCIENCE, V342, P409, DOI 10.1126/science.342.6157.409; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; BETTINGER RL, 1982, AM ANTIQUITY, V47, P485, DOI 10.2307/280231; Bettinger RL, W HUMAN POPULATION M; Bradley WG, 1965, BIOTIC COMMUNITIES S; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CANN RL, 1984, GENETICS, V106, P479; Cano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106833; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Cooper A, 2000, SCIENCE, V289, P1139; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; FOX JC, 1991, J VIROL METHODS, V33, P375, DOI 10.1016/0166-0934(91)90037-Z; Fridez F, 1996, FORENSIC SCI INT, V78, P103, DOI 10.1016/0379-0738(95)01872-7; Gefrides LA, 2010, FORENSIC SCI INT-GEN, V4, P89, DOI 10.1016/j.fsigen.2009.06.008; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; HOCHMEISTER MN, 1991, INT J LEGAL MED, V104, P229, DOI 10.1007/BF01369812; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2006, J ARCHAEOL SCI, V33, P1680, DOI 10.1016/j.jas.2006.02.015; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; LAMB SM, 1958, INT J AM LINGUIST, V24, P95, DOI 10.1086/464442; LeBlanc SA, 2007, J FIELD ARCHAEOL, V32, P161, DOI 10.1179/009346907791071610; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Lyons EA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-881; Morales-Arce AY, 2017, AM J PHYS ANTHEROPOL; Nevada ICo, 1976, NUW SO PAIUT HIST SA; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Raff JA, 2011, AM J PHYS ANTHROPOL, V146, P503, DOI 10.1002/ajpa.21594; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sambrook J., 2006, MOL CLONING LAB MANU, V3rd; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Simms EM., 2008, ANCIENT PEOPLES GREA, V10, P445; Snow M, 2017, J ARCHAEOL SCI-REP, V13, P229, DOI 10.1016/j.jasrep.2017.03.042; Snow MH, 2010, J ARCHAEOL SCI, V37, P1635, DOI 10.1016/j.jas.2010.01.024; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Sutton M. Q., 1993, J CALIFORNIA GREAT B, V15, P111; Sutton MQ, 1994, ACROSS THE WEST, P6; Sweet D, 1999, INT J LEGAL MED, V112, P201, DOI 10.1007/s004140050234; Tackney JC, 2015, P NATL ACAD SCI USA, V112, P13833, DOI 10.1073/pnas.1511903112; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; TORRONI A, 1992, GENETICS, V130, P153; Turner T., 1978, THESIS; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2009, HUM BIOL, V81, P509, DOI 10.3378/027.081.0602; Warinner C, 2015, J HUM EVOL, V79, P125, DOI 10.1016/j.jhevol.2014.10.016; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906	61	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194223	10.1371/journal.pone.0194223	http://dx.doi.org/10.1371/journal.pone.0194223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY7GW	29522562	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800047
J	Jung, WJ; Lee, SY; Choi, SI; Kim, BK; Lee, EJ; In, KH; Lee, MG				Jung, Won Jai; Lee, Sang Yeub; Choi, Sue In; Kim, Byung-Keun; Lee, Eun Joo; In, Kwang Ho; Lee, Min-Goo			Toll-like receptor expression in pulmonary sensory neurons in the bleomycin-induced fibrosis model	PLOS ONE			English	Article							INDUCED LUNG FIBROSIS; CHRONIC COUGH; VAGAL; PAIN; PATHOGENESIS; RECOGNITION; ACTIVATION; CHANNELS; AIRWAYS; NERVES	Airway sensory nerves are known to express several receptors and channels that are activated by exogenous and endogenous mediators that cause coughing. Toll-like receptor (TLR) s are expressed in nociceptive neurons and play an important role in neuroinflammation. However, there have been very few studies of TLR expression in lung-derived sensory neurons or their relevance to respiratory symptoms such as cough. We used the bleomycin-induced pulmonary fibrosis model to investigate the change in TLR expression in pulmonary neurons and the association of TLRs with transient receptor potential (TRP) channels in pulmonary neurons. After 2 weeks of bleomycin or saline administration, pulmonary fibrosis changes were confirmed using tissue staining and the SIRCOL collagen assay. TLRs (TLR 1-9) and TRP channel expression was analyzed using single cell reverse transcription polymerase chain reaction (RT-PCR) in isolated sensory neurons from the nodose/jugular ganglion and the dorsal root ganglion (DRG). Pulmonary sensory neurons expressed TLR2 and TLR5. In the bleomycin- induced pulmonary fibrosis model, TLR2 expression was detected in 29.5% (18/61) and 26.9% (21/78) of pulmonary nodose/jugular neurons and DRG neurons, respectively. TLR5 was also detected in 55.7% (34/61) and 42.3% (33/78) of pulmonary nodose/jugular neurons and DRG neurons, respectively, in the bleomycin-induced pulmonary fibrosis model. TLR5 was expressed in 63.4% of TRPV1 positive cells and 43.4% of TRPM8 positive cells. In conclusion, TLR2 and TLR5 expression is enhanced, especially in vagal neurons, in the bleomycin-induced fibrosis model group when compared to the saline treated control group. Co-expression of TLR5 and TRP channels in pulmonary sensory neurons was also observed. This work sheds new light on the role of TLRs in the control and manifestation of clinical symptoms, such as cough. To understand the role of TLRs in pulmonary sensory nerves, further study will be required.	[Jung, Won Jai; Lee, Sang Yeub; Choi, Sue In; Kim, Byung-Keun; Lee, Eun Joo; In, Kwang Ho] Korea Univ, Coll Med, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Seoul, South Korea; [Lee, Min-Goo] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, SY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Seoul, South Korea.	pulsy@korea.ac.kr		Kim, Byung-Keun/0000-0001-5147-6306	Korea University [K1507811]; Samjin Pharmaceutical Co [Q1526261]	Korea University; Samjin Pharmaceutical Co	This study was supported by grants from Korea University (No. K1507811 to SYL) and Samjin Pharmaceutical Co (No. Q1526261 to SYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bonvini SJ, 2015, N-S ARCH PHARMACOL, V388, P401, DOI 10.1007/s00210-014-1082-1; Chaudhuri N, 2005, CLIN SCI, V109, P125, DOI 10.1042/CS20050044; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Geppetti P, 2010, LUNG, V188, pS63, DOI 10.1007/s00408-009-9201-3; Gu QH, 2008, RESP PHYSIOL NEUROBI, V161, P87, DOI 10.1016/j.resp.2007.11.006; Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012; Iraz M, 2006, PHARMACOL RES, V53, P310, DOI 10.1016/j.phrs.2005.12.009; Ji RR, 2015, PULM PHARMACOL THER, V35, P81, DOI 10.1016/j.pupt.2015.09.001; Jia YL, 2005, DRUG NEWS PERSPECT, V18, P165, DOI 10.1358/dnp.2005.18.3.892761; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kwong K, 2002, J APPL PHYSIOL, V93, P1419, DOI 10.1152/japplphysiol.00382.2002; Li YA, 2014, J INEQUAL APPL, DOI 10.1186/1029-242X-2014-456; Lieu TM, 2012, AM J PHYSIOL-LUNG C, V302, pL941, DOI 10.1152/ajplung.00366.2011; Liu T, 2013, PFLUG ARCH EUR J PHY, V465, P1671, DOI 10.1007/s00424-013-1284-2; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; McGarvey LP, 2014, J ALLERGY CLIN IMMUN, V133, P704, DOI 10.1016/j.jaci.2013.09.016; Millqvist E, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030045; Min H, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0059-9; Molina-Molina M, 2006, THORAX, V61, P604, DOI 10.1136/thx.2005.051946; Morice AH, 2004, THORAX, V59, P257, DOI 10.1136/thx.2003.013482; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Patberg KW, 2011, AM J RESP CRIT CARE, V184, P382, DOI 10.1164/ajrccm.184.3.382; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shikhagaie MM, 2014, CLIN EXP ALLERGY, V44, P184, DOI 10.1111/cea.12176; Song WJ, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0069-4; SPRINGALL DR, 1987, J AUTONOM NERV SYST, V20, P155, DOI 10.1016/0165-1838(87)90113-5; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Udalov S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-26; Walters Dianne M, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0546s40; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003	45	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e193117	10.1371/journal.pone.0193117	http://dx.doi.org/10.1371/journal.pone.0193117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518161	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900014
J	Chacon-Madrigal, E; Wanek, W; Hietz, P; Dullinger, S				Chacon-Madrigal, Eduardo; Wanek, Wolfgang; Hietz, Peter; Dullinger, Stefan			Is local trait variation related to total range size of tropical trees?	PLOS ONE			English	Article							INTRASPECIFIC VARIABILITY; NICHE BREADTH; LEAF TRAITS; SEED SIZE; EVOLUTION; CONSTRAINTS; WIDESPREAD; ECOLOGY; CLIMATE; DIVERSIFICATION	The reasons why the range size of closely related species often varies significantly have intrigued scientists for many years. Among other hypotheses, species with high trait variation were suggested to occupy more diverse environments, have more continuity in their distributions, and consequently have larger range sizes. Here, using 34 tree species of lowlands tropical rainforest in southern Costa Rica, we explored whether inherent trait variability expressed at the local scale in functional traits is related to the species' total geographical range size. We formed 17 congeneric pairs of one narrow endemic and one widespread species, sampled 335 individuals and measured eight functional traits: leaf area, leaf thickness, leaf dry matter content, specific leaf area, leaf nitrogen content, leaf phosphorus content, leaf nitrogen to phosphorus ratio, and wood specific gravity. We tested whether there are significant differences in the locally expressed variation of individual traits or in multidimensional trait variance between the species in congeneric pairs and whether species' range size could hence be predicted from local trait variability. However, we could not find such differences between widely distributed and narrow range species. We discuss the possible reasons for these findings including the fact that higher trait variability of widespread species may result from successive local adaptations during range expansion and may hence often be an effect rather than the cause of larger ranges.	[Chacon-Madrigal, Eduardo] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Chacon-Madrigal, Eduardo] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Wanek, Wolfgang] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Hietz, Peter] Univ Nat Resources & Life Sci, Inst Bot, Vienna, Austria	University of Vienna; Universidad Costa Rica; University of Vienna; University of Natural Resources & Life Sciences, Vienna	Chacon-Madrigal, E (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria.; Chacon-Madrigal, E (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	edchacon@gmail.com	Chacón-Madrigal, Eduardo/AAK-1048-2021; Wanek, Wolfgang/E-7001-2012	Chacón-Madrigal, Eduardo/0000-0002-8328-5456; Wanek, Wolfgang/0000-0003-2178-8258	Rufford Small Grants Foundation [15981-1]; CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica) [FI-183-13]; CONICIT [FI-183-13]; University of Costa Rica [OAICE-CAB-175-2014]	Rufford Small Grants Foundation; CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica); CONICIT; University of Costa Rica	The first author (EC) received funding for fieldwork and laboratory analysis with the fellowship 15981-1 of The Rufford Small Grants Foundation. Fieldwork was also supported by the scholarship FI-183-13 by the CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica) (EC). Part of the costs for laboratory analysis was covered by the Centro de Investigaciones Agronomicas (CIA) of the University of Costa Rica. The first author (EC) also was supported by the scholarships FI-183-13 by CONICIT and OAICE-CAB-175-2014 by the University of Costa Rica.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Alvarado A., 2015, COSTA RICAN ECOSYSTE, P64; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Bechtold WA, 2003, NORTH J APPL FOR, V20, P154, DOI 10.1093/njaf/20.4.154; Benavides C, 2008, EFECTO AMBIENTE DIST; Boulangeat I, 2012, J BIOGEOGR, V39, P204, DOI 10.1111/j.1365-2699.2011.02581.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Cadotte M, 2013, ECOL LETT, V16, P1234, DOI 10.1111/ele.12161; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Climate Coen E., 1983, COSTA RICAN NATURAL, P35; Cornejo X, 2012, BRITTONIA, V64, P76, DOI 10.1007/s12228-011-9194-0; de Souza FC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1587; Erkens RHJ, 2007, MOL PHYLOGENET EVOL, V44, P399, DOI 10.1016/j.ympev.2007.02.017; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Fine PVA, 2014, EVOLUTION, V68, P1988, DOI 10.1111/evo.12414; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Gorman CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111190; Grime J. P., 2001, PLANT STRATEGIES VEG; Grossenbacher D, 2015, ECOL LETT, V18, P706, DOI 10.1111/ele.12449; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Huber W, 2008, COSTA RICA STAPFIA, V88, P97; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Laliberte E., 2014, PACKAGE FD MEASURING; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lasky JR, 2013, J ECOL, V101, P722, DOI 10.1111/1365-2745.12065; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Li R, 2013, SYST BOT, V38, P536, DOI 10.1600/036364413X666606; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Meng H, 2017, PLANT BIOLOGY, V19, P552, DOI 10.1111/plb.12564; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mitchell RM, 2017, OIKOS, V126, P988, DOI 10.1111/oik.04001; Mitchell RM, 2017, OECOLOGIA; Morin X, 2011, ECOGRAPHY, V34, P738, DOI 10.1111/j.1600-0587.2010.06854.x; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; Murray BR, 2004, AUSTRAL ECOL, V29, P287, DOI 10.1111/j.1442-9993.2004.01365.x; O'Brien MJ, 2017, J APPL ECOL, V54, P1669, DOI 10.1111/1365-2664.12874; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Pinheiro J, R PACKAGE VERSION; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Quesada F.J., 1997, ARBOLES PENINSULA OS; RCore Team, 2020, R LANG ENV STAT COMP; Read QD, 2014, FUNCT ECOL, V28, P37, DOI 10.1111/1365-2435.12162; Reich PB, 1996, FUNCT ECOL, V10, P768, DOI 10.2307/2390512; Sexton JP, 2017, ANNU REV ECOL EVOL S, V48, P183, DOI 10.1146/annurev-ecolsys-110316-023003; Sexton JP, 2016, AM J BOT, V103, P129, DOI 10.3732/ajb.1500224; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sides CB, 2014, AM J BOT, V101, P56, DOI 10.3732/ajb.1300284; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Soolanayakanahally RY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00528; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2014, ECOGRAPHY, V37, P1198, DOI 10.1111/j.1600-0587.2013.00574.x; Turcotte MM, 2016, TRENDS ECOL EVOL, V31, P803, DOI 10.1016/j.tree.2016.07.013; Uriarte M, 2016, FUNCT ECOL, V30, P157, DOI 10.1111/1365-2435.12576; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; VANDERWERF A, 1993, OECOLOGIA, V94, P434, DOI 10.1007/BF00317120; Walck JL, 2001, J BIOGEOGR, V28, P1221, DOI 10.1046/j.1365-2699.2001.00620.x; Wallace AR, 1867, GEOGRAPHICAL DISTRIB; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Witkowski ETF, 1997, J BIOGEOGR, V24, P469, DOI 10.1111/j.1365-2699.1997.00131.x; Wright IJ, 2017, SCIENCE, V357, P917, DOI 10.1126/science.aal4760; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zadworny M, 2016, NEW PHYTOL, V212, P389, DOI 10.1111/nph.14048	84	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193268	10.1371/journal.pone.0193268	http://dx.doi.org/10.1371/journal.pone.0193268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513689	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800049
J	Kim, SK; Kim, JH; Jeon, SS; Hong, SM				Kim, Sung Kyun; Kim, Ji Hoon; Jeon, Seung Sik; Hong, Seok Min			Relationship between sleep quality and dizziness	PLOS ONE			English	Article							INDEX PSQI; MIGRAINE; VERSION; STIMULATION; RELIABILITY; INSOMNIA; VALIDITY; APNEA; ASSOCIATION; DYSFUNCTION	Objective Poor sleep quality has a number of significant negative effects on daytime function. However, few studies have examined sleep quality in patients with dizziness. Here, we investigated the potential association between sleep quality and various types of dizziness. Subjects and methods We examined dizziness and sleep disturbance in 237 patients experiencing dizziness using Korean versions of the Pittsburgh Sleep Quality Index (PSQI), the Insomnia Severity Index (ISI), and Dizziness Handicap Inventory (DHI). All participants were classified as having benign paroxysmal positional vertigo (BPPV), Me A niere's disease (MD), vestibular neuritis (VN), vestibular migraine (VM), psychogenic dizziness (PD), or Other. Results The mean PSQI and ISI scores were highest in the PD group. The rate of sleep disturbance was highest in the Other group when the cut-off score for each questionnaire was set differently, except ISI >= 15. The correlation between DHI and sleep disturbance indices was highest in the VM group. Multivariate regression showed that PSQI score and DHI-E score were significantly related to the PD and Other groups, while the Other group was significantly related to the ISI score. Conclusion The findings of this study strongly suggest that there are associations between sleep quality and some disease subtypes associated with dizziness. Therefore, it is important to consider sleep disturbance in patients with psychogenic dizziness, such as phobic postural vertigo and chronic subjective dizziness, or nonspecific dizziness.	[Kim, Sung Kyun; Kim, Ji Hoon; Jeon, Seung Sik; Hong, Seok Min] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Hwaseong, South Korea	Hallym University	Hong, SM (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Hwaseong, South Korea.	thece1120@gmail.com						Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Joao KAD, 2017, PSYCHIAT RES, V247, P225, DOI 10.1016/j.psychres.2016.11.042; Della Marca G, 2006, CEPHALALGIA, V26, P857, DOI 10.1111/j.1468-2982.2006.01122.x; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gallina S, 2010, ACTA OTORHINOLARYNGO, V30, P281; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Haponik EF, 1996, J GEN INTERN MED, V11, P759, DOI 10.1007/BF02598994; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kayabasi S, 2015, LARYNGOSCOPE, V125, P1244, DOI 10.1002/lary.25021; Konomi U., 2014, EQUILIBRIUM RES, V73, P502, DOI DOI 10.3757/jser.73.502; Li Y, 2015, HYPERTENSION, V65, P644, DOI 10.1161/HYPERTENSIONAHA.114.04604; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Martin T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155067; Nakayama M, 2010, J CLIN SLEEP MED, V6, P445; Nayak C, 2016, SLEEP BREATH, V20, P263, DOI 10.1007/s11325-015-1207-x; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Park SY, 2015, KOREAN J FAM MED, V35, P294, DOI 10.4082/kjfm.2015.36.6.294; Sitasuwan Tullaya, 2014, Journal of the Medical Association of Thailand, V97, pS57; Soffer-Dudek N, 2009, CONSCIOUS COGN, V18, P891, DOI 10.1016/j.concog.2008.07.007; Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9; Son CN, 2015, KOREAN J INTERN MED, V30, P384, DOI 10.3904/kjim.2015.30.3.384; Sowerby LJ, 2010, LARYNGOSCOPE, V120, P1274, DOI 10.1002/lary.20899; Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f; Sugaya N, 2017, ACTA OTO-LARYNGOL, V137, P47, DOI 10.1080/00016489.2016.1213418; Takacs J, 2016, SLEEP BREATH, V20, P1045, DOI 10.1007/s11325-016-1347-7; Vass Z, 2001, NEUROSCIENCE, V103, P189, DOI 10.1016/S0306-4522(00)00521-2; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Weidt S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-317	32	32	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192705	10.1371/journal.pone.0192705	http://dx.doi.org/10.1371/journal.pone.0192705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513688	Green Submitted, gold, Green Published			2022-12-26	WOS:000426896800020
J	Mondini, V; Mangia, AL; Cappello, A				Mondini, Valeria; Mangia, Anna Lisa; Cappello, Angelo			Single-session tDCS over the dominant hemisphere affects contralateral spectral EEG power, but does not enhance neurofeedbackguided event-related desynchronization of the non-dominant hemisphere's sensorimotor rhythm	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; BRAIN-COMPUTER INTERFACE; HUMAN MOTOR CORTEX; TRANSCRANIAL DIRECT; INTERHEMISPHERIC INHIBITION; CORTICAL SYNCHRONIZATION; STROKE RECOVERY; IMAGERY; EXCITABILITY; REHABILITATION	Background and objective Transcranial direct current stimulation (tDCS) and neurofeedback-guided motor imagery (MI) have attracted considerable interest in neurorehabilitation, given their ability to influence neuroplasticity. As tDCS has been shown to modulate event-related desynchronization (ERD), the neural signature of motor imagery detected for neurofeedback, a combination of the techniques was recently proposed. One limitation of this approach is that the area targeted for stimulation is the same from which the signal for neurofeedback is acquired. As tDCS may interfere with proximal electroencephalographic (EEG) electrodes, in this study our aim was to test whether contralateral tDCS could have interhemispheric effects on the spectral power of the unstimulated hemisphere, possibly mediated by transcallosal connection, and whether such effects could be used to enhance ERD magnitudes. A contralateral stimulation approach would indeed facilitate co-registration, as the stimulation electrode would be far from the recording sites. Methods Twenty right-handed healthy volunteers (aged 21 to 32) participated in the study: ten assigned to cathodal, ten to anodal versus sham stimulation. We applied stimulation over the dominant (left) hemisphere, and assessed ERD and spectral power over the non-dominant (right) hemisphere. The effect of tDCS was evaluated over time. Spectral power was assessed in theta, alpha and beta bands, under both rest and MI conditions, while ERD was evaluated in alpha and beta bands. Results Two main findings emerged: (1) contralateral alpha-ERD was reduced after anodal (p = 0.0147), but not enhanced after cathodal tDCS; (2) both stimulations had remote effects on the spectral power of the contralateral hemisphere, particularly in theta and alpha ( significant differences in the topographical t-value maps). Conclusion The absence of contralateral cathodal ERD enhancement suggests that the protocol is not applicable in the context of MI training. Nevertheless, ERD results of anodal and spectral power results of both stimulations complement recent findings on the distant tDCS effects between functionally related areas.	[Mondini, Valeria; Mangia, Anna Lisa; Cappello, Angelo] Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy	University of Bologna	Mondini, V (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy.	valeria.mondini3@unibo.it	Coish, Elizabeth/AAU-1245-2020	Mondini, Valeria/0000-0001-7680-6199				Ang KK, 2015, ARCH PHYS MED REHAB, V96, pS79, DOI 10.1016/j.apmr.2014.08.008; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Baxter BS, 2016, BRAIN STIMUL, V9, P834, DOI 10.1016/j.brs.2016.07.003; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cincotti F, 2008, J NEUROSCI METH, V167, P31, DOI 10.1016/j.jneumeth.2007.06.031; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2012, J NEURAL TRANSM, V119, P1499, DOI 10.1007/s00702-012-0845-4; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hatem SM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00442; Hochberg Y, 1987, MULTIPLE COMP PROCED, pi; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Kasashima-Shindo Y, 2015, J REHABIL MED, V47, P318, DOI 10.2340/16501977-1925; Kasuga S, 2015, LATERALITY, V20, P453, DOI 10.1080/1357650X.2014.998679; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lapenta OM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00256; Ludemann-Podubecka J, 2014, NEUROSCI BIOBEHAV R, V47, P245, DOI 10.1016/j.neubiorev.2014.07.022; Mancini M, 2016, NEUROIMAGE, V140, P57, DOI 10.1016/j.neuroimage.2016.06.003; Mancini M, 2015, IEEE ENG MED BIO, P2729, DOI 10.1109/EMBC.2015.7318956; Mangia AL, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00057; Mangia AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00601; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Morone G, 2015, ARCH PHYS MED REHAB, V96, pS71, DOI 10.1016/j.apmr.2014.05.026; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pichiorri F, 2015, ANN NEUROL, V77, P851, DOI 10.1002/ana.24390; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Roy A, 2014, IEEE T BIO-MED ENG, V61, P1967, DOI 10.1109/TBME.2014.2311071; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Sharbrough FW, 1991, RESEARCHGATE, V8, P200; Soekadar SR, 1991, ENHANCING HEBBIAN LE; Soekadar SR, 2015, NEUROBIOL DIS, V83, P172, DOI 10.1016/j.nbd.2014.11.025; Soekadar SR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00093; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Tazoe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114244; Tohyama Takamichi, 2011, Keio Journal of Medicine, V60, P114; Ursino M, 2010, NEUROIMAGE, V52, P1080, DOI 10.1016/j.neuroimage.2009.12.084; van Dokkum LEH, 2015, ANN PHYS REHABIL MED, V58, P3, DOI 10.1016/j.rehab.2014.09.016; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Wei PF, 2013, IEEE T NEUR SYS REH, V21, P404, DOI 10.1109/TNSRE.2013.2249111; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	62	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193004	10.1371/journal.pone.0193004	http://dx.doi.org/10.1371/journal.pone.0193004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513682	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800029
J	Gadar, L; Abonyl, J				Gadar, Laszlo; Abonyl, Janos			Graph configuration model based evaluation of the education-occupation match	PLOS ONE			English	Article							LABOR-MARKET; MULTIRESOLUTION METHODS; STATISTICAL-MECHANICS; OVEREDUCATION; RESOLUTION; MISMATCH	To study education-occupation matchings we developed a bipartite network model of education to work transition and a graph configuration model based metric. We studied the career paths of 15 thousand Hungarian students based on the integrated database of the National Tax Administration, the National Health Insurance Fund, and the higher education information system of the Hungarian Government. A brief analysis of gender pay gap and the spatial distribution of over-education is presented to demonstrate the background of the research and the resulted open dataset. We highlighted the hierarchical and clustered structure of the career paths based on the multi-resolution analysis of the graph modularity. The results of the cluster analysis can support policymakers to fine-tune the fragmented program structure of higher education.	[Gadar, Laszlo] Innopod Solut Ltd, Budapest, Hungary; [Gadar, Laszlo] Univ Pannonia, MTA PE Budapest Ranking Res Grp, Veszprem, Hungary; [Abonyl, Janos] Univ Pannonia, MTA PE Lendulet Complex Syst Monitoring Res Grp, Veszprem, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Pannonia; University of Pannonia	Abonyl, J (corresponding author), Univ Pannonia, MTA PE Lendulet Complex Syst Monitoring Res Grp, Veszprem, Hungary.	janos@abonyilab.com	Abonyi, Janos/O-2832-2013; Gadár, László/AAU-6881-2020	Abonyi, Janos/0000-0001-8593-1493; Gadár, László/0000-0003-2581-7917	National Research, Development and Innovation Office - NKFIH [OTKA - 116674]; National Research, Development and Innovation Office-NKFIH [OTKA-116674]	National Research, Development and Innovation Office - NKFIH; National Research, Development and Innovation Office-NKFIH	The research has been supported by the National Research, Development and Innovation Office - NKFIH, through the project OTKA - 116674 (Process mining and deep learning in the natural sciences and process development). The employing company of Laszlo Gadar was not involved in the research. The "Innopod Solutions Ltd, Budapest, Hungary" did not have any role in the design of the study, the collection of the data, preparation of the manuscript, decision to publish. The company does not claim any right to the results. The data used in the publication is public and freely available without any restriction. The specific roles of these authors are articulated in the author contributions section. The funder provided support in the form of salary for the author Laszlo Gadar, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific the authors are articulated in the 'author contributions' section.; The research has been supported by the National Research, Development and Innovation Office-NKFIH, through the project OTKA-116674 (Process mining and deep learning in the natural sciences and process development)	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi A. L., 2014, NETWORK SCI GRAPH TH; BarabuYsi A.-L., 2015, NETW SCI; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Berggren C, 2010, EUR EDUC, V42, P61, DOI 10.2753/EUE1056-4934420103; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cremonini L, 2008, HIGH EDUC, V55, P373, DOI 10.1007/s10734-007-9062-8; Cunha JM, 2014, ECON EDUC REV, V42, P64, DOI 10.1016/j.econedurev.2014.06.001; Duncan GJ., 1981, EC ED REV, V1, P75, DOI [10.1016/0272-7757(81)90028-5, DOI 10.1016/0272-7757(81)90028-5]; ENQA, 2015, STAND GUID QUAL ASS, P32; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gal A., 2013, ALLAMIGAZGATASI ADAT, P5; Garam I., 2005, FINNISH EMPLOYERS VI; Garcia-Aracil A, 2015, HIGH EDUC, V69, P735, DOI 10.1007/s10734-014-9803-4; Gillespie CS, 2015, J STAT SOFTW, V64; Groot W, 2000, ECON EDUC REV, V19, P149, DOI 10.1016/S0272-7757(99)00057-6; Hartog J, 2000, ECON EDUC REV, V19, P131, DOI 10.1016/S0272-7757(99)00050-3; Hung CY, 2008, J ASIAN ECON, V19, P125, DOI 10.1016/j.asieco.2008.02.001; Iriondo I, 2016, J POLICY MODEL, V38, P304, DOI 10.1016/j.jpolmod.2015.12.008; Kler P, 2005, EDUC ECON, V13, P47, DOI 10.1080/0964529042000325207; Kumpula JM, 2007, PROC SPIE, V6601, DOI 10.1117/12.725560; McGuinness S, 2011, ECON EDUC REV, V30, P130, DOI 10.1016/j.econedurev.2010.07.006; Morris S, 2005, PHYS0503061 ARXIV; Murillo IP, 2012, J POLICY MODEL, V34, P646, DOI 10.1016/j.jpolmod.2011.07.012; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nyusti S, 2013, DIPLOMAS PALYAKOVETE; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Saar E, 2008, INT J COMP SOCIOL, V49, P31, DOI 10.1177/0020715207088586; Sojkin B, 2012, HIGH EDUC, V63, P565, DOI 10.1007/s10734-011-9459-2; VERDUGO RR, 1989, J HUM RESOUR, V24, P629, DOI 10.2307/145998; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wallgren A., 2011, JOINT STAT M SECT SU, P357; Xiang J, 2012, PHYSICA A, V391, P4995, DOI 10.1016/j.physa.2012.05.006; Young D, 2010, AM J PUBLIC HEALTH, V100, P1208, DOI 10.2105/AJPH.2009.184705	35	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192427	10.1371/journal.pone.0192427	http://dx.doi.org/10.1371/journal.pone.0192427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509783	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000426813200003
J	Andrade-Silva, LE; Ferreira-Paim, K; Ferreira, TB; Vilas-Boas, A; Mora, DJ; Manzato, VM; Fonseca, FM; Buosi, K; Andrade-Silva, J; Prudente, BD; Araujo, NE; Sales-Campos, H; da Silva, MV; Rodrigues, V; Meyer, W; Silva-Vergara, ML				Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Vilas-Boas, Anderson; Mora, Delio Jose; Manzato, Veronica Morais; Fonseca, Fernanda Machado; Buosi, Kelli; Andrade-Silva, Juliana; Prudente, Bruno da Silva; Araujo, Natalia Evelyn; Sales-Campos, Helioswilton; da Silva, Marcus Vinicius; Rodrigues Junior, Virmondes; Meyer, Wieland; Silva-Vergara, Mario Leon			Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors	PLOS ONE			English	Article							HIV-ASSOCIATED CRYPTOCOCCOSIS; VAR. GRUBII; MOLECULAR EPIDEMIOLOGY; PHOSPHOLIPASE-ACTIVITY; VIRULENCE FACTORS; MATING-TYPE; SEROTYPE-A; GATTII; POPULATION; STRAINS	Cryptococcal infections are mainly caused by members of the Cryptococcus neoformans species complex (molecular types VNI, VNII, VNB, VNIV and the AD hybrid VNIII). PCR of the mating type loci and MLST typing using the ISHAM-MLST consensus scheme were used to evaluate the genetic relationship of 102 (63 clinical and 39 environmental) C. neoformans isolates from Uberaba, Brazil and to correlate the obtained genotypes with clinical, antifungal susceptibility and virulence factor data. All isolates were mating type alpha. MLST identified 12 known and five new sequence types (ST). Fourteen STs were identified within the VNI isolates, with ST93 (57/102, 56%) and ST77 (19/102, 19%) being the most prevalent. From the nine VNII isolates previously identify by URA5-RFLP only four (ST40) were confirmed by MLST. The remaining five grouped within the VNB Glade in the phylogenetic analysis corresponding to the sequence type ST504. Other two environmental isolates also grouped within VNB Glade with the new sequence type ST527. The four VNII/ST40 isolates were isolated from CSF. The two VNIV sequence types (ST11 and ST160) were isolated from blood cultures. Two of six patients evaluated with more than one isolates had mixed infections. Amongst the VNI isolates 4 populations were identified, which showed differences in their susceptibility profiles, clinical outcome and virulence factors. These results reinforce that ST93 is the most prevalent ST in HIV-infected patients in the Southeastern region of Brazil. The finding of the VNB molecular type amongst environmental Brazilian isolates highlights that this genotype is not restricted to the African continent.	[Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Vilas-Boas, Anderson; Mora, Delio Jose; Manzato, Veronica Morais; Buosi, Kelli; Andrade-Silva, Juliana; Prudente, Bruno da Silva; Araujo, Natalia Evelyn; Silva-Vergara, Mario Leon] Triangulo Mineiro Fed Univ, Infect Dis Dept, Uberaba, Brazil; [Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio] Triangulo Mineiro Fed Univ, Clin Pathol Dept, Uberaba, Brazil; [Ferreira-Paim, Kennio; Meyer, Wieland] Univ Sydney, Marie Bashir Inst Emerging Infect Dis & Biosecur, Ctr Infect Dis & Microbiol,Sydney Med Sch,Westmea, Westmead Inst Med Res,Mol Mycol Res Lab,Westmead, Sydney, NSW, Australia; [Fonseca, Fernanda Machado] Univ Fed Piaui, Biomed Dept, Parnaiba, Brazil; [Sales-Campos, Helioswilton; da Silva, Marcus Vinicius; Rodrigues Junior, Virmondes] Triangulo Mineiro Fed Univ, Lab Immunol, Uberaba, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; University of Sydney; Westmead Institute for Medical Research; Universidade Federal do Piaui; Universidade Federal do Triangulo Mineiro	Andrade-Silva, LE (corresponding author), Triangulo Mineiro Fed Univ, Infect Dis Dept, Uberaba, Brazil.; Andrade-Silva, LE (corresponding author), Triangulo Mineiro Fed Univ, Clin Pathol Dept, Uberaba, Brazil.	leonardoeuripedes@gmail.com	Ferreira-Paim, Kennio/A-8194-2013; andrade-silva, leonardo/AAA-4356-2020; Fonseca, Fernanda Machado/AAV-2433-2021; Fonseca, Fernanda/E-8285-2018; Fonseca, Fernanda Machado/AAV-8930-2021; Silva, Marcos Vinicius/AAY-1986-2020; Mora, Delio José/G-1614-2012; Sales-Campos, Helioswilton/O-5367-2017; FONSECA, FERNANDA/HDN-9451-2022	Ferreira-Paim, Kennio/0000-0002-6035-8392; andrade-silva, leonardo/0000-0002-0485-229X; Fonseca, Fernanda Machado/0000-0002-5326-0776; Fonseca, Fernanda/0000-0002-5326-0776; Silva, Marcos Vinicius/0000-0002-2966-7621; Sales-Campos, Helioswilton/0000-0003-3252-2834; FONSECA, FERNANDA/0000-0002-0315-6479; Rodrigues Jr, Virmondes/0000-0001-8706-4223	Grant Support Foundation of Minas Gerais (FAPEMIG) [APQ71035 / 2010]; NH MRC grant [APP1031943]	Grant Support Foundation of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NH MRC grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant Support Foundation of Minas Gerais (FAPEMIG) Grant: #APQ71035 / 2010 to MLSV, and an NH & MRC grant #APP1031943 to WM. The funders analysis, decision to publish, or preparation of the manuscript.	Andrade-Silva L, 2010, FUNGAL BIOL-UK, V114, P438, DOI 10.1016/j.funbio.2010.03.005; AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Arsenijevic VA, 2014, MYCOSES, V57, P380, DOI 10.1111/myc.12171; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beale MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003847; Bertout S, 2013, CLIN MICROBIOL INFEC, V19, P763, DOI 10.1111/1469-0691.12019; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866; Casali AK, 2003, FEMS YEAST RES, V3, P405, DOI 10.1016/S1567-1356(03)00038-2; Cattana ME, 2013, REV ARGENT MICROBIOL, V45, P89, DOI 10.1016/S0325-7541(13)70005-1; Chang YC, 2000, J EXP MED, V191, P871, DOI 10.1084/jem.191.5.871; Chaturvedi S, 2000, J CLIN MICROBIOL, V38, P2007, DOI 10.1128/JCM.38.5.2007-2009.2000; Chen Y, 2015, MOL ECOL; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2012, REF METH BROTH DIL A; Cogliati M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/675213; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; da Silva EG, 2006, J MED MICROBIOL, V55, P139, DOI 10.1099/jmm.0.46206-0; de Oliveira MTB, 2004, J CLIN MICROBIOL, V42, P1356, DOI 10.1128/JCM.42.3.1356-1359.2004; Desalermos A, 2012, EXPERT OPIN PHARMACO, V13, P783, DOI 10.1517/14656566.2012.658773; Desnos-Ollivier M, 2015, MBIO, V6, DOI 10.1128/mBio.00311-15; Desnos-Ollivier M, 2010, MBIO, V1, DOI 10.1128/mBio.00091-10; Dou HT, 2015, EUR J CLIN MICROBIOL, V34, P753, DOI 10.1007/s10096-014-2289-2; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira-Paim K, 2010, GENOTYPING CRYPTOCOC; Ferreira-Paim K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005223; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kanemitsu K, 2001, J MICROBIOL METH, V47, P11, DOI 10.1016/S0167-7012(01)00283-4; Kaocharoen S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002297; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002495; Litvintseva AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019688; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Luo G, 2001, J CLIN MICROBIOL, V39, P2971, DOI 10.1128/JCM.39.8.2971-2974.2001; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Miglia KJ, 2011, J CLIN MICROBIOL, V49, P307, DOI 10.1128/JCM.01277-10; Mihara T, 2013, MED MYCOL, V51, P252, DOI 10.3109/13693786.2012.708883; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Pappalardo MCSM, 2007, AIDS, V21, P1971, DOI 10.1097/01.aids.0000287549.79368.33; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pedroso RS, 2010, MEM I OSWALDO CRUZ, V105, P993, DOI 10.1590/S0074-02762010000800008; PRICE MF, 1982, SABOURAUDIA, V20, P7; Pritchard JK, 2000, GENETICS, V155, P945; Rhodes J, 2017, GENETICS, V207, P327, DOI 10.1534/genetics.117.203836; Rhodes J, 2017, G3-GENES GENOM GENET, V7, P1165, DOI 10.1534/g3.116.037499; Ribeiro AM, 2006, MED MYCOL, V44, P707, DOI 10.1080/13693780600917209; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sanchez A, 2008, REV IBEROAM MICOL, V25, P145, DOI 10.1016/S1130-1406(08)70034-2; Sanchini A, 2014, MED MICROBIOL IMMUN, V203, P333, DOI 10.1007/s00430-014-0341-6; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Sun S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004849; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Rodriguez JM, 2008, REV IBEROAM MICOL, V25, P27, DOI 10.1016/S1130-1406(08)70007-X; Tortorano AM, 1997, MYCOSES, V40, P297, DOI 10.1111/j.1439-0507.1997.tb00235.x; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Umeyama T, 2013, JPN J INFECT DIS, V66, P51, DOI 10.7883/yoken.66.51; Van Wyk M, 2014, J CLIN MICROBIOL, V52, P1921, DOI 10.1128/JCM.03177-13; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wiesner DL, 2012, MBIO, V3, DOI 10.1128/mBio.00196-12; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	74	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193237	10.1371/journal.pone.0193237	http://dx.doi.org/10.1371/journal.pone.0193237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505557	gold, Green Published, Green Submitted			2022-12-26	WOS:000426548200009
J	Andre, EM; Daviaud, N; Sindji, L; Cayon, J; Perrot, R; Montero-Menei, CN				Andre, E. M.; Daviaud, N.; Sindji, L.; Cayon, J.; Perrot, R.; Montero-Menei, C. N.			A novel ex vivo Huntington's disease model for studying GABAergic neurons and cell grafts by laser microdissection	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; REAL-TIME PCR; ORGANOTYPIC BRAIN-SLICES; R6/2 MOUSE MODEL; CAPTURE MICRODISSECTION; NEUROTROPHIC FACTOR; ANIMAL-MODELS; GENE-EXPRESSION; CULTURE MODEL; BEHAVIORAL DEFICITS	Organotypic brain slice cultures have been recently used to study neurodegenerative disorders such as Parkinson's disease and Huntington's disease (HD). They preserve brain three-dimensional architecture, synaptic connectivity and brain cells microenvironment. Here, we developed an innovative model of Huntington's disease from coronal rat brain slices, that include all the areas involved in the pathology. HD-like neurodegeneration was obtained in only one week, in a single step, during organotypic slice preparation, without the use of neurotoxins. HD-like histopathology was analysed and after one week, a reduction of 40% of medium spiny neurons was observed. To analyse new therapeutic approaches in this innovative HD model, we developed a novel protocol of laser microdissection to isolate and analyse by RT-qPCR, grafted cells as well as surrounding tissue of fresh organotypic slices. We determined that laser microdissection could be performed on a 400 mu m organotypic slice after alcohol dehydration protocol, allowing the analysis of mRNA expression in the rat tissue as well as in grafted cells. In conclusion, we developed a new approach for modeling Huntington's disease ex vivo, and provided a useful innovative method for screening new potential therapies for neurodegenerative diseases especially when associated with laser microdissection.	[Andre, E. M.; Daviaud, N.; Sindji, L.; Montero-Menei, C. N.] Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France; [Daviaud, N.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Daviaud, N.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Cayon, J.] Angers Univ, PACEM, Angers, France; [Perrot, R.] Angers Univ, SCIAM, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universite d'Angers; Universite d'Angers	Montero-Menei, CN (corresponding author), Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France.	claudia.montero-menei@univ-angers.tr	Daviaud, Nicolas/GRF-5681-2022; Daviaud, Nicolas/O-1727-2019	Daviaud, Nicolas/0000-0001-8105-9124; Montero-Menei, Claudia/0000-0002-1373-6987; SINDJI, Laurence/0000-0001-5449-4817	Education Audiovisual; cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program; Angers Loire Metropole; Fondation de l'Avenir; "Inserm", France; "Region des Pays de La Loire through the "Paris Scientifiques" grant	Education Audiovisual; cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program; Angers Loire Metropole(Region Pays de la Loire); Fondation de l'Avenir; "Inserm", France(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Region des Pays de La Loire through the "Paris Scientifiques" grant	This project is supported by the "Education Audiovisual" and the cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program, by Angers Loire Metropole and by the "Fondation de l'Avenir" & "Inserm", France.; This project is supported by the "Education Audiovisual" and the executive cultural agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program, by Angers Loire Metropole, by "Region des Pays de La Loire through the "Paris Scientifiques" grant and by the "Fondation de l'Avenir" & "Inserm", France	Andre EM, 2016, BIOMATERIALS, V83, P347, DOI 10.1016/j.biomaterials.2015.12.008; Le AVP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12859; Arsenault Jason, 2013, BMC Res Notes, V6, P544, DOI 10.1186/1756-0500-6-544; Bullock MD, 2014, JOVE-J VIS EXP, DOI 10.3791/51475; Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Daviaud N, 2014, NEUROSCIENCE, V256, P10, DOI 10.1016/j.neuroscience.2013.10.021; Daviaud N, 2015, STEM CELL TRANSL MED, V4, P670, DOI 10.5966/sctm.2014-0139; Daviaud N, 2013, EXP NEUROL, V248, P429, DOI 10.1016/j.expneurol.2013.07.012; Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fink KD, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt341; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Jaderstad LM, 2010, REGEN MED, V5, P901, DOI 10.2217/RME.10.80; Jiang W, 2009, J NEUROSCI METH, V179, P219, DOI 10.1016/j.jneumeth.2009.01.033; Jin X, 2003, J NEUROSCI, V23, P5662; Johnson MA, 2006, J NEUROCHEM, V97, P737, DOI 10.1111/j.1471-4159.2006.03762.x; Kaiser A, 2014, BRAIN RES, V1566, P12, DOI 10.1016/j.brainres.2014.04.006; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kerkis I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0248-1; Kerman IA, 2006, J NEUROSCI METH, V153, P71, DOI 10.1016/j.jneumeth.2005.10.010; Kim H, 2013, PROG NEURO-PSYCHOPH, V41, P36, DOI 10.1016/j.pnpbp.2012.11.004; Kumamaru H, 2012, NAT COMMUN, P3; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Liu Angen, 2010, J Biomol Tech, V21, P120; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; McLeod MC, 2013, CELL TRANSPLANT, V22, P2237, DOI 10.3727/096368912X658809; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Milcheva R, 2013, ACTA HISTOCHEM, V115, P279, DOI 10.1016/j.acthis.2012.08.002; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Murphy RC, 2001, MOL THER, V3, P113, DOI 10.1006/mthe.2000.0235; Navarro-Galve B, 2005, J GENE MED, V7, P18, DOI 10.1002/jgm.639; Nopoulos PC, 2016, DIALOGUES CLIN NEURO, V18, P91; Ortiz AN, 2011, NEUROSCI LETT, V492, P11, DOI 10.1016/j.neulet.2011.01.036; Ostergaard K, 1996, EXP NEUROL, V142, P340, DOI 10.1006/exnr.1996.0203; Ou Y, 2010, EXP PHYSIOL, V95, P938, DOI 10.1113/expphysiol.2009.051300; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Philips T, 2014, MOVEMENT DISORD, V29, P1391, DOI 10.1002/mds.26010; Precious SV, 2017, NEUROCHEM INT, V106, P114, DOI 10.1016/j.neuint.2017.01.016; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Rasmussen A, 2000, NEUROPEDIATRICS, V31, P190, DOI 10.1055/s-2000-7461; Reinhart PH, 2011, NEUROBIOL DIS, V43, P248, DOI 10.1016/j.nbd.2011.03.017; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rossignol J, 2011, BEHAV BRAIN RES, V217, P369, DOI 10.1016/j.bbr.2010.11.006; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Shannon KM, 2015, MOVEMENT DISORD, V30, P1539, DOI 10.1002/mds.26331; Shear DA, 1998, PROG NEURO-PSYCHOPH, V22, P1217, DOI 10.1016/S0278-5846(98)00070-0; Squitieri F, 2015, CLIN GENET; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Tanvig M, 2009, BRAIN RES, V1295, P1, DOI 10.1016/j.brainres.2009.07.075; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Vandewoestyne M, 2013, ANAL BIOCHEM, V439, P88, DOI 10.1016/j.ab.2013.04.023; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Wang LH, 2006, ACTA PHARMACOL SIN, V27, P1287, DOI 10.1111/j.1745-7254.2006.00410.x; Yhnell E, 2016, J HUNTINGTONS DIS, V5, P149, DOI 10.3233/JHD-160191; Yokota K, 2015, STEM CELL REP, V5, P264, DOI 10.1016/j.stemcr.2015.06.004; Zach S, 2007, CELL MOL NEUROBIOL, V27, P505, DOI 10.1007/s10571-007-9141-5	72	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193409	10.1371/journal.pone.0193409	http://dx.doi.org/10.1371/journal.pone.0193409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505597	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200015
J	Trombetta, BA; Carlyle, BC; Koenig, AM; Shaw, LM; Trojanowski, JQ; Wolk, DA; Locascio, JJ; Arnold, SE				Trombetta, Bianca A.; Carlyle, Becky C.; Koenig, Aaron M.; Shaw, Leslie M.; Trojanowski, John Q.; Wolk, David A.; Locascio, Joseph J.; Arnold, Steven E.			The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease	PLOS ONE			English	Article							ACID-BINDING PROTEIN; BRAIN INSULIN-RESISTANCE; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; TAU; PATHOLOGY; DEMENTIA; MARKERS; CSF; INFLAMMATION	Objective Alzheimer's disease (AD) is a complex neurodegenerative disease driven by multiple interacting pathophysiological processes that ultimately results in synaptic loss, neuronal death, and dementia. We implemented a fit-for-purpose modeled approach to qualify a broad selection of commercially available immunoassays and evaluate the biotemporal stability of analytes across five pathophysiological domains of interest in AD, including core amyloid-beta (A beta) and tau AD biomarkers, neurodegeneration, inflammation/immune modulation, neurovascular injury, and metabolism/oxidative stress. Methods Paired baseline and eight-week CSFs from twenty participants in a clinical drug trial for mild cognitive impairment (MCI) or mild dementia due to AD were used to evaluate sensitivity, intra-assay precision, inter-assay replicability, and eight-week biotemporal stability for sixty unique analytes measured with commercially available single-and multi-plex ELISA assays. Coefficients of variation (CV) were calculated, and intraclass correlation and Wilcoxon signed rank tests were applied. Results We identified 32 biomarker candidates with good to excellent performance characteristics according to assay technical performance and CSF analyte biotemporal stability cut-off criteria. These included: 1) the core AD biomarkers A beta 1 +/- 42, A beta 1 +/- 40, A beta 1 +/- 38, and total tau; 2) non-A beta, non-tau neurodegeneration markers NfL and FABP3; 3) inflammation/immune modulation markers IL-6, IL-7, IL-8, IL-12/23p40, IL-15, IL-16, MCP-1, MDC, MIP-1 beta, and YKL-40; 4) neurovascular markers Flt-1, ICAM-1, MMP-1, MMP-2, MMP-3, MMP-10, PlGF, VCAM-1, VEGF, VEGF-C, and VEGF-D; and 5) metabolism/oxidative stress markers 24OHC, adiponectin, leptin, soluble insulin receptor, and 8-OHdG. Conclusions Assays for these CSF analytes demonstrate consistent sensitivity, reliability, and biotemporally stability for use in a multiple pathophysiological CSF biomarker panel to profile AD. Their qualification enables further investigation for use in AD diagnosis, staging and progression, disease mechanism profiling, and clinical trials.	[Trombetta, Bianca A.; Carlyle, Becky C.; Koenig, Aaron M.; Locascio, Joseph J.; Arnold, Steven E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MGH Inst Neurodegenerat Dis, Charlestown, MA USA; [Shaw, Leslie M.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wolk, David A.] Univ Penn, Perelman Sch Med, Dept Neurol, Penn Memory Ctr, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Arnold, SE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MGH Inst Neurodegenerat Dis, Charlestown, MA USA.	searnold@mgh.harvard.edu	Carlyle, Becky/HGD-4177-2022	Carlyle, Becky/0000-0003-1491-3217; Trombetta, Bianca/0000-0001-7501-0666	BrightFocus Foundation [AHAF_A2012116]; National Institute on Aging [AG039478, AG005134, AG10124]; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	BrightFocus Foundation(BrightFocus Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the BrightFocus Foundation (www.brightfocus.org < http://www.brightfocus.org/>) AHAF_A2012116 to SEA, National Institute on Aging grants AG039478 to SEA, AG005134 to SEA and AG10124 to JQT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldacci F, 2017, EXPERT REV PROTEOMIC, V14, P285, DOI 10.1080/14789450.2017.1304217; Beach TG, 2017, NEUROL THER, V6, pS5, DOI 10.1007/s40120-017-0072-x; Bettcher Brianne M, 2016, Alzheimers Dement (Amst), V3, P91, DOI 10.1016/j.dadm.2016.05.004; Boehm J, 2013, EUR J NEUROSCI, V37, P1925, DOI 10.1111/ejn.12251; Briggs CA, 2017, BIOCHEM BIOPH RES CO, V483, P988, DOI 10.1016/j.bbrc.2016.09.088; BUCHHAVE P, 2009, PLOONE PUBLIC LIB, V4; Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Cha E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167819; Chiasserini D, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0276-4; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cox K.L., 2004, ASSAY GUIDANCE MANUA; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Cummings J, 2014, CLIN PHARMACOL THER, V95, P67, DOI 10.1038/clpt.2013.205; Desikan RS, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-39; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourier A, 2015, CLIN CHIM ACTA, V449, P9, DOI 10.1016/j.cca.2015.05.024; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gmitterova K, 2009, NEURODEGENER DIS, V6, P263, DOI 10.1159/000237221; Hachinski V, 2012, ARCH NEUROL-CHICAGO, V69, P169, DOI 10.1001/archneurol.2011.1698; Hall JR, 2013, J ALZHEIMERS DIS, V35, P363, DOI 10.3233/JAD-122359; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hofmann JN, 2011, CYTOKINE, V56, P145, DOI 10.1016/j.cyto.2011.06.012; Huang CW, 2015, THROMB HAEMOSTASIS, V114, P1230, DOI 10.1160/TH14-11-0938; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jani D, 2016, AAPS J, V18, P1, DOI 10.1208/s12248-015-9820-y; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Koenig AM, 2017, ALZ DIS ASSOC DIS, V31, P107, DOI 10.1097/WAD.0000000000000202; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P807, DOI 10.3233/JAD-2012-110029; Lewczuk P, 2018, WORLD J BIOL PSYCHIA, V19, P244, DOI 10.1080/15622975.2017.1375556; Li Q, 2017, CELL MOL NEUROBIOL, V37, P377, DOI 10.1007/s10571-016-0386-8; Lista S, 2017, NEUROCHEM INT, V108, P355, DOI 10.1016/j.neuint.2017.05.010; Llorens F, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0226-4; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattsson N, 2016, EMBO MOL MED, V8, P1184, DOI 10.15252/emmm.201606540; Mattsson Niklas, 2015, Alzheimers Dement (Amst), V1, P412, DOI 10.1016/j.dadm.2015.09.001; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mollenhauer B, 2007, NEURODEGENER DIS, V4, P366, DOI 10.1159/000105157; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Muszynski P, 2017, CURR NEUROPHARMACOL, V15, P906, DOI 10.2174/1570159X15666170208124324; Neth BJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00345; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Olsson B, 2013, J ALZHEIMERS DIS, V34, P673, DOI 10.3233/JAD-121384; Pan C, 2015, J ALZHEIMERS DIS, V45, P709, DOI 10.3233/JAD-143099; Popp J, 2017, BRAIN BEHAV IMMUN, V62, P203, DOI 10.1016/j.bbi.2017.01.020; Portney L, 2000, STAT MEASURES RELIAB; R Core Team, 2016, R LANG ENV STAT COMP; Ribe EM, 2016, J INTERN MED, V280, P430, DOI 10.1111/joim.12534; Ritter A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00186; Rozga M, 2017, CLIN CHEM LAB MED, V55, P1545, DOI 10.1515/cclm-2016-1061; RStudio Team, 2016, RSTUDIO INT DEV R; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Stomrud Erik, 2015, Alzheimers Dement (Amst), V1, P403, DOI 10.1016/j.dadm.2015.09.002; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Testa G, 2016, REDOX BIOL, V10, P24, DOI 10.1016/j.redox.2016.09.001; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Wennstrom M, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0145-y; Wennstrom M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135458; Wu AHB, 2015, AM HEART J, V169, P674, DOI 10.1016/j.ahj.2015.01.016; Wu DL, 2017, AM J PATHOL, V187, P2620, DOI 10.1016/j.ajpath.2017.08.007; Yarchoan M, 2014, DIABETES, V63, P2253, DOI 10.2337/db14-0287; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zarrouk A, 2018, CURR ALZHEIMER RES, V15, P303, DOI DOI 10.2174/1567205014666170505101426; Zetterberg H, 2017, AM J PHYSIOL-CELL PH, V313, pC3, DOI 10.1152/ajpcell.00007.2017; Zetterberg H, 2015, CURR OPIN PSYCHIATR, V28, P402, DOI 10.1097/YCO.0000000000000179	77	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193707	10.1371/journal.pone.0193707	http://dx.doi.org/10.1371/journal.pone.0193707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505610	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200026
J	Wilson, AM; van der Nest, MA; Wilken, PM; Wingfield, MJ; Wingfield, BD				Wilson, Andi M.; van der Nest, Magriet A.; Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.			Pheromone expression reveals putative mechanism of unisexuality in a saprobic ascomycete fungus	PLOS ONE			English	Article							MATING-TYPE GENES; RNA-SEQ; PODOSPORA-ANSERINA; CANDIDA-ALBICANS; PRECURSOR GENES; IDENTIFICATION; REPRODUCTION; MICROARRAY; INDUCTION; SEQUENCES	Homothallism (self-fertility) describes a wide variety of sexual strategies that enable a fungus to reproduce in the absence of a mating partner. Unisexual reproduction, a form of homothallism, is a process whereby a fungus can progress through sexual reproduction in the absence of mating genes previously considered essential for self-fertility. In this study, we consider the molecular mechanisms that allow for this unique sexual behaviour in the saprotrophic ascomycete; Huntiella moniliformis. These molecular mechanisms are also compared to the underlying mechanisms that control sex in Huntiella omanensis, a closely related, but self-sterile, species. The main finding was that H. omanensis displayed mating type dependent expression of the a- and alpha-pheromones. This was in contrast to H. moniliformis where both pheromones were co-expressed during vegetative growth and sexual development. Furthermore, H. moniliformis also expressed the receptors of both pheromones. Consequently, this fungus is likely able to recognize and respond to the endogenously produced pheromones, allowing for self-fertility in the absence of other key mating genes. Overall, these results are concomitant with those reported for other unisexual species, but represent the first detailed study considering the unisexual behaviour of a filamentous fungus.	[Wilson, Andi M.; van der Nest, Magriet A.; Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, Pretoria, South Africa	University of Pretoria	Wilson, AM (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, Pretoria, South Africa.	Andi.wilson@fabi.up.ac.za	Wilson, Andi/AAT-5036-2020; Wilken, Markus/B-2049-2010; Wingfield, Brenda/B-1376-2008	Wilken, Markus/0000-0003-0827-6098; van der Nest, Magriet/0000-0001-6914-8343; Wilson, Andrea/0000-0002-3239-0045; Wingfield, Brenda/0000-0002-6189-1519	University of Pretoria; Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB); National Research Foundation of South Africa [UID 83924]; Brenda Wingfield's SARCHi grant; NRF	University of Pretoria; Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India)); National Research Foundation of South Africa(National Research Foundation - South Africa); Brenda Wingfield's SARCHi grant; NRF	This project was financed by the University of Pretoria and the Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB). This work is based on the research supported in part by a number of grants from the National Research Foundation of South Africa (including Grant specific unique reference number, UID 83924). This research was also funded in part by Prof Brenda Wingfield's SARCHi grant. The grant holders acknowledge that opinions, findings, conclusions and/or recommendations expressed in any publication generated by the NRF supported research are that of the author(s), and that the NRF accepts no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Arnaise S, 2001, GENETICS, V159, P545; Aylward J, 2016, FUNGAL GENET BIOL, V96, P47, DOI 10.1016/j.fgb.2016.10.002; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; GLASS NL, 1994, MOL GEN GENET, V244, P401, DOI 10.1007/BF00286692; Gyawali R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006772; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; HUANG W, 2010, BMC GENOMICS, V11; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; LEONARD TJ, 1968, P NATL ACAD SCI USA, V59, P745, DOI 10.1073/pnas.59.3.745; LEONARD TJ, 1973, MYCOLOGIA, V65, P809, DOI 10.2307/3758520; LESLIE JF, 1979, MOL GEN GENET, V171, P257, DOI 10.1007/BF00267580; Lin Xiaorong, 2007, P35; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poeggeler S, 2000, CURRENTGENETICS GOTE, V37, P403; Poggeler S, 2001, GENE, V280, P9, DOI 10.1016/S0378-1119(01)00786-7; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; RAPER JR, 1958, MYCOLOGIA, V50, P707, DOI 10.2307/3756180; Roach KC, 2014, ADV GENET, V85, P255, DOI 10.1016/B978-0-12-800271-1.00005-6; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schuerg T., 2017, CURRENT BIOTECHNOLOG, V6, P89, DOI 10.2174/2211550105666160520123504; Shen WC, 1999, FUNGAL GENET BIOL, V27, P253, DOI 10.1006/fgbi.1999.1151; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Van der Nest MA, 2014, FUNGAL GENET BIOL, V73, P104, DOI 10.1016/j.fgb.2014.10.008; van der Nest MA, 2014, IMA FUNGUS, V5, P473, DOI 10.5598/imafungus.2014.05.02.11; van der Nest MA, 2014, IMA FUNGUS, V5, P135, DOI 10.5598/imafungus.2014.05.01.13; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wilson AM, 2015, FUNGAL GENET BIOL, V80, P1, DOI 10.1016/j.fgb.2015.04.008; Wilson AM, 2015, IMA FUNGUS, V6, P207, DOI 10.5598/imafungus.2015.06.01.13	57	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0192517	10.1371/journal.pone.0192517	http://dx.doi.org/10.1371/journal.pone.0192517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505565	Green Submitted, Green Published, gold			2022-12-26	WOS:000426548200002
J	Draborg, AH; Rasmussen, NS; Larsen, JL; Jorgensen, CS; Sandhu, N; Skogstrand, K; Jacobsen, S; Houen, G				Draborg, Anette Holck; Rasmussen, Niclas Stefan; Larsen, Janni Lisander; Jorgensen, Charlotte Svmrke; Sandhu, Noreen; Skogstrand, Kristin; Jacobsen, Soren; Houen, Gunnar			Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN-HERPESVIRUS 6; DNA-POLYMERASE; INFECTION; EBV; IMMUNOASSAY; EXPRESSION; REACTIVATION; MECHANISMS; BLOCKADE	We investigated immune responses to a lytic cytomegalovirus antigen (CMVpp52), and to a lytic human herpes virus (HHV) 6 antigen (HHV6p41), in systemic lupus erythematosus (SLE) patients and healthy controls (HCs), in order to clarify if the previously established impaired responses to Epstein-Barr virus (EBV) in SLE patients is a general defect in their responses against (all) HHVs. Multiplex Luminex technology results showed a normal induction of five quantified cytokines (interferon., interleukin(IL) 12, IL17, IL10, and tumor necrosis factor a) in SLE patients compared to HCs upon stimulation with CMVpp52 and HHV6p41. However, flow cytometric results showed a reduced upregulation of the activation marker CD69 on T-cells from SLE patients (n = 17) compared to HCs (n = 17) upon stimulation with CMVpp52, indicating limited or defective CMVpp52-specific T-cells and/or poor antigen-presentation in SLE patients, and thereby possibly decreased control of the CMV infection. In conclusion, the dysfunctional immune response against EBV previously established in SLE patients does not seem to apply to the same degree regarding the immune responses against CMV or HHV6. Results designate that the main contributing HHV agent in development or exacerbation of SLE (in genetically predisposed individuals) is the previously determined uncontrolled EBV infection, and to a lesser extent CMV infection, and probably with no involvement of HHV6 infection.	[Draborg, Anette Holck; Rasmussen, Niclas Stefan; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, Copenhagen, Denmark; [Rasmussen, Niclas Stefan; Larsen, Janni Lisander; Jacobsen, Soren] Copenhagen Univ Hosp, Copenhagen Lupus & Vasculitis Clin, Ctr Rheumatol & Spine Dis, Rigshosp, Blegdamsvej 9, Copenhagen, Denmark; [Jorgensen, Charlotte Svmrke] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Artillerivej 5, Copenhagen, Denmark; [Sandhu, Noreen; Skogstrand, Kristin] Statens Serum Inst, Dept Congenital Disorders, Ctr Neonatal Screening, Artillerivej 5, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Statens Serum Institut	Houen, G (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, Copenhagen, Denmark.	gh@ssi.dk	Jacobsen, Søren/T-2491-2019; Larsen, Janni Lisander/S-7789-2019	Jacobsen, Søren/0000-0002-5654-4993; Larsen, Janni Lisander/0000-0002-0165-6461				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Azevedo PC, 2014, METHODS MOL BIOL, V1134, P1, DOI 10.1007/978-1-4939-0326-9_1; Berkun Y, 2009, LUPUS, V18, P1129, DOI 10.1177/0961203309345729; Blake N, 2000, J IMMUNOL, V165, P7078, DOI 10.4049/jimmunol.165.12.7078; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Braun DK, 1997, CLIN MICROBIOL REV, V10, P521, DOI 10.1128/CMR.10.3.521; Broccolo F, 2013, J MED VIROL, V85, P1925, DOI 10.1002/jmv.23670; BROZEK CM, 1988, CLIN IMMUNOL IMMUNOP, V46, P299, DOI 10.1016/0090-1229(88)90192-4; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Chen J, 2015, CLIN RHEUMATOL, V34, P691, DOI 10.1007/s10067-015-2868-3; Doaty S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0561-4; Draborg A, 2016, CURR OPIN RHEUMATOL, V28, P398, DOI 10.1097/BOR.0000000000000289; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Draborg AH, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6473204; Draborg AH, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000015; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hrycek A, 2005, AUTOIMMUNITY, V38, P487, DOI 10.1080/08916930500285667; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Krueger G R, 1991, In Vivo, V5, P217; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Mohamed AE, 2015, INT J RHEUM DIS, V18, P452, DOI 10.1111/1756-185X.12261; Namjou B, 2007, AUTOIMMUNITY, V40, P602, DOI 10.1080/08916930701510962; NIELSEN CM, 1987, J VIROL METHODS, V16, P195, DOI 10.1016/0166-0934(87)90004-8; NIELSEN CM, 1987, J MED VIROL, V22, P67, DOI 10.1002/jmv.1890220109; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Oster B, 2002, J VIROL, V76, P7578, DOI 10.1128/JVI.76.15.7578-7586.2002; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rasmussen NS, 2015, SCAND J RHEUMATOL, V44, P143, DOI 10.3109/03009742.2014.973061; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Rigante D, 2015, INT J MOL SCI, V16, P17331, DOI 10.3390/ijms160817331; Sarzi-Puttini P, 2005, AUTOIMMUNITY, V38, P465, DOI 10.1080/08916930500285394; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Su BYJ, 2007, MED MICROBIOL IMMUN, V196, P165, DOI 10.1007/s00430-007-0040-7; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Taylor GH, 2003, AM FAM PHYSICIAN, V67, P519; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tsokos GC, 1996, ARTHRITIS RHEUM, V39, P600, DOI 10.1002/art.1780390409; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Zhang Q, 1997, VIROLOGY, V230, P22, DOI 10.1006/viro.1997.8470	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193244	10.1371/journal.pone.0193244	http://dx.doi.org/10.1371/journal.pone.0193244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499037	Green Published, gold, Green Submitted			2022-12-26	WOS:000426472300008
J	Kondratick, CM; Litman, JM; Shaffer, KV; Washington, MT; Dieckman, LM				Kondratick, Christine M.; Litman, Jacob M.; Shaffer, Kurt V.; Washington, M. Todd; Dieckman, Lynne M.			Crystal structures of PCNA mutant proteins defective in gene silencing suggest a novel interaction site on the front face of the PCNA ring	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; ASSEMBLY FACTOR-I; TRANSLESION DNA-SYNTHESIS; MISMATCH REPAIR; CHROMATIN; REPLICATION; YEAST; CAF-1; INHERITANCE; POLYMERASE	Proliferating cell nuclear antigen (PCNA), a homotrimeric protein, is the eukaryotic sliding clamp that functions as a processivity factor for polymerases during DNA replication. Chromatin association factor 1 (CAF-1) is a heterotrimeric histone chaperone protein that is required for coupling chromatin assembly with DNA replication in eukaryotes. CAF-1 association with replicating DNA, and the targeting of newly synthesized histones to sites of DNA replication and repair requires its interaction with PCNA. Genetic studies have identified three mutant forms of PCNA in yeast that cause defects in gene silencing and exhibit altered association of CAF-1 to chromatin in vivo, as well as inhibit binding to CAF-1 in vitro. Three of these mutant forms of PCNA, encoded by the pol30-6, pol30-8, and the pol30-79 alleles, direct the synthesis of PCNA proteins with the amino acid substitutions D41A/D42A, R61A/D63A, and L126A/I128A, respectively. Interestingly, these double alanine substitutions are located far away from each other within the PCNA protein. To understand the structural basis of the interaction between PCNA and CAF-1 and how disruption of this interaction leads to reduced gene silencing, we determined the X-ray crystal structures of each of these mutant PCNA proteins. All three of the substitutions caused disruptions of a surface cavity on the front face of the PCNA ring, which is formed in part by three loops comprised of residues 21-24, 41-44, and 118-134. We suggest that this cavity is a novel binding pocket required for the interaction between PCNA and CAF-1, and that this region in PCNA also represents a potential binding site for other PCNA-binding proteins.	[Kondratick, Christine M.; Litman, Jacob M.; Washington, M. Todd] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Shaffer, Kurt V.; Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA	University of Iowa; Creighton University	Dieckman, LM (corresponding author), Creighton Univ, Dept Chem, Omaha, NE 68178 USA.	lynnedieckman@creighton.edu		Litman, Jacob/0000-0002-3256-8747; Washington, Todd/0000-0001-8680-2992	National Institute of General Medical Science of the National Institutes of Health [R01GM081433, P20-GM103427]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081433] Funding Source: NIH RePORTER	National Institute of General Medical Science of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Award Number R01GM081433 from the National Institute of General Medical Science of the National Institutes of Health to M.T.W. and Award Number P20-GM103427 from the National Institute of General Medical Science of the National Institutes of Health to L.M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project described was supported by Award Number R01GM081433 from the National Institute of General Medical Science of the National Institutes of Health to M.T.W. and by Award Number P20-GM103427 from the National Institute of General Medical Science of the National Institutes of Health to L.M.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We would like to acknowledge use of resources at the Carver College of Medicine's Protein Crystallography Facility at the University of Iowa. We would also like to acknowledge Lokesh Gakhar for providing technical assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanko ER, 2016, J BIOL CHEM, V291, P9203, DOI 10.1074/jbc.M115.713271; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brachet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125965; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; Dieckman LM, 2013, BIOCHEMISTRY-US, V52, P5611, DOI 10.1021/bi400378e; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2010, BIOPHYS J, V98, P2984, DOI 10.1016/j.bpj.2010.02.057; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; GRUSS C, 1993, EMBO J, V12, P4533, DOI 10.1002/j.1460-2075.1993.tb06142.x; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Klapholz B, 2009, CHROMOSOMA, V118, P235, DOI 10.1007/s00412-008-0192-2; Kondratick CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Li X, 2016, ELIFE, V5, DOI 10.7554/eLife.15129; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mello JA, 2001, CURR OPIN GENET DEV, V11, P136, DOI 10.1016/S0959-437X(00)00170-2; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schnieders MJ, 2011, J CHEM THEORY COMPUT, V7, P1141, DOI 10.1021/ct100506d; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tsurimoto Toshiki, 1999, Frontiers in Bioscience, V4, pd849, DOI 10.2741/Tsurimoto; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018	52	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193333	10.1371/journal.pone.0193333	http://dx.doi.org/10.1371/journal.pone.0193333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499038	Green Submitted, gold, Green Published			2022-12-26	WOS:000426472300011
J	Walling, LL				Walling, Linda L.			Extreme resistance: The GLK-Rx1 alliance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RECEPTOR RX1	Plant immune surveillance systems depend on nucleotide-binding leucine-rich repeat receptors (NLRs). A subset of NLRs are nuclear-localized, including Rx1, which confers an extreme immunity against potato virus X (PVX). As with many NLRs, the downstream signaling partners of Rx1 are unknown. Townsend et al. identify a Golden-like transcription factor that interacts with Rx1 and mediates antiviral immunity, providing the first insights into the specificity factors that enable the nonspecific DNA-binding Rx1 to confer extreme resistance to PVX.	[Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	lwalling@ucr.edu			National Science Foundation [IOS EAGER-1450331]; Bill AMP; Melinda Gates Foundation (National Research Institute (NRI), University of Greenwich, UK) [B0426_5]	National Science Foundation(National Science Foundation (NSF)); Bill AMP; Melinda Gates Foundation (National Research Institute (NRI), University of Greenwich, UK)	This work was supported by a grant from the National Science Foundation (IOS EAGER-1450331) and a grant from the Bill & Melinda Gates Foundation (via subcontractB0426_5 from the National Research Institute (NRI), University of Greenwich, UK). The author declares that she has no conflicts of interests with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official view of the National Science Foundation, the NRI, or the Bill & Melinda Gates Foundation.	Baggs E, 2017, CURR OPIN PLANT BIOL, V38, P59, DOI 10.1016/j.pbi.2017.04.012; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Birkenbihl RP, 2017, CURR OPIN PLANT BIOL, V38, P1, DOI 10.1016/j.pbi.2017.04.004; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sukarta OCA, 2016, SEMIN CELL DEV BIOL, V56, P134, DOI 10.1016/j.semcdb.2016.05.012; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Townsend PD, 2018, J BIOL CHEM, V293, P3218, DOI 10.1074/jbc.RA117.000485	10	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3234	3235		10.1074/jbc.H118.001456	http://dx.doi.org/10.1074/jbc.H118.001456			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29500269	Green Published, hybrid			2022-12-26	WOS:000426562800016
J	Hu, PL; Yuan, YH; Yue, TL; Guo, CF				Hu, Peng-Li; Yuan, Ya-Hong; Yue, Tian-Li; Guo, Chun-Feng			Bile acid patterns in commercially available oxgall powders used for the evaluation of the bile tolerance ability of potential probiotics	PLOS ONE			English	Article							LACTOBACILLUS; BACTERIA; STRAINS	This study aimed to analyze the bile acid patterns in commercially available oxgall powders used for evaluation of the bile tolerance ability of probiotic bacteria. Qxgall powders purchased from Sigma-Aldrich, Oxoid and BD Difco were dissolved in distilled water, and analyzed. Conjugated bile acids were profiled by ion-pair high-performance liquid chromatography (HPLC), free bile acids were detected as their p-bromophenacyl ester derivatives using reversed-phase HPLC after extraction with acetic ether, and total bile acids were analyzed by enzymatic-colorimetric assay. The results showed that 9 individual bile acids (i.e., taurocholic acid, glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, taurochenodeoxycholic acid, glycochenodeoxycholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid) were present in each of the oxgall powders tested. The content of total bile acid among the three oxgall powders was similar; however, the relative contents of the individual bile acids among these oxgall powders were significantly different (P < 0.001). The oxgall powder from Sigma-Aldrich was closer to human bile in the ratios of glycine-conjugated bile acids to taurine-conjugated bile acids, dihydroxy bile acids to trihydroxy bile acids, and free bile acids to conjugated bile acids than the other powders were. It was concluded that the oxgall powder from Sigma-Aldrich should be used instead of those from Oxoid and BD Difco to evaluate the bile tolerance ability of probiotic bacteria as human bile model.	[Hu, Peng-Li; Yuan, Ya-Hong; Yue, Tian-Li; Guo, Chun-Feng] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China	Northwest A&F University - China	Guo, CF (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China.	gcf@nwafu.edu.cn	yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	National Natural Science Foundation of China [31301444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (No. 31301444) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Beckingham IJ, 2001, BRIT MED J, V322, P91, DOI 10.1136/bmj.322.7278.91; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Charnchai P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157958; Dahiya DK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00563; Damodharan K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00768; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; DESMET I, 1995, J APPL BACTERIOL, V79, P292; Enhsen A, 1998, DRUG DISCOV TODAY, V3, P409, DOI 10.1016/S1359-6446(96)10046-5; Fijalkowski K, 2016, LWT-FOOD SCI TECHNOL, V68, P322, DOI 10.1016/j.lwt.2015.12.038; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Guo CF, 2016, J FUNCT FOODS, V26, P691, DOI 10.1016/j.jff.2016.08.035; Guo CF, 2015, J FUNCT FOODS, V12, P294, DOI 10.1016/j.jff.2014.11.029; HEUMAN DM, 1989, J LIPID RES, V30, P719; Huang Y, 2013, J DAIRY SCI, V96, P2816, DOI 10.3168/jds.2012-6371; Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lee NK, 2014, LWT-FOOD SCI TECHNOL, V58, P130, DOI 10.1016/j.lwt.2014.02.028; Liu WJ, 2013, J DAIRY SCI, V96, P6807, DOI 10.3168/jds.2013-6582; MINGRONE G, 1980, J CHROMATOGR, V183, P277, DOI 10.1016/S0378-4347(00)81707-7; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; Oh YJ, 2015, LWT-FOOD SCI TECHNOL, V63, P437, DOI 10.1016/j.lwt.2015.03.005; Plessas S, 2017, FOOD CHEM, V226, P102, DOI 10.1016/j.foodchem.2017.01.052; Portincasa P, 2009, CURR MED CHEM, V16, P1531, DOI 10.2174/092986709787909631; Rouhi M, 2013, CRIT REV FOOD SCI, V53, P331, DOI 10.1080/10408398.2010.531407; SCALIA S, 1994, ANAL LETT, V27, P1789, DOI 10.1080/00032719408007436; Silva BC, 2013, BENEF MICROBES, V4, P267, DOI 10.3920/BM2012.0048; STAGGERS JE, 1990, BIOCHEMISTRY-US, V29, P2028, DOI 10.1021/bi00460a011; SWOBODNIK W, 1985, J CHROMATOGR, V339, P263, DOI 10.1016/S0378-4347(00)84653-8; Tremblay S, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00942-16; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116; Yadav R, 2017, CRIT REV FOOD SCI, V57, P3233, DOI 10.1080/10408398.2015.1108957; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	33	19	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192964	10.1371/journal.pone.0192964	http://dx.doi.org/10.1371/journal.pone.0192964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494656	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200018
J	Huang, J; Gao, N; Wang, SZ; Milewicz, DM; Kamm, KE; Stull, JT				Huang, Jian; Gao, Ning; Wang, Shanzhi; Milewicz, Dianna M.; Kamm, Kristine E.; Stull, James T.			Genetic approaches to identify pathological limitations in aortic smooth muscle contraction	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; PHOSPHATASE TARGETING SUBUNIT-1; SALT-INDUCED HYPERTENSION; NONMUSCLE MYOSIN; SIGNAL-TRANSDUCTION; FORCE GENERATION; DISSECTIONS; ANEURYSMS; PHOSPHORYLATION; MUTATIONS	Aortic smooth muscle contains limiting amounts of myosin light chain kinase (MLCK) for myosin regulatory light chain (RLC) phosphorylation and contraction that predisposes to thoracic aortic disease in humans containing heterozygous loss-of-function mutations in MYLK. We tested the hypothesis that thoracic aortic smooth muscle contraction may also be susceptible to variations in the smooth muscle-specific isoform of the motor protein myosin where inactivation of one Myh11 allele or the presence of one Myh11 missense variant associated with an increased risk of human aortic disease may result in a reduced force development response. Additionally, other kinds of smooth muscles may be less sensitive to the effects of mutations in one smooth muscle myosin allele, similar to results obtained with Mylk. Force development responses were reduced in aortic tissue from a conditional knockout of smooth muscle myosin heavy chain in adult mice (Myh11(+/-) or Myh11(-/-)) with a greater reduction with homozygous vs heterozygous tissues. Similar reductions in force responses were obtained with tissues containing either a heterozygous or homozygous knockin mutation in smooth muscle myosin heavy chain (Myh11(+/ R247C) or Myh11(R247C/R247C) mutations that cause human aortic disease) with no significant changes in RLC phosphorylation. Agonist-dependent force responses were not reduced significantly in urinary bladder, ileal, or tracheal tissues from Myh11(+/-) mice while only ileal tissue showed a reduced force response in Myh11(R247C/R247C) mice. Thus, heterozygous mutations in Myh11 associated with reduced myosin function result in compromised contractile function primarily in aortic smooth muscle.	[Huang, Jian; Gao, Ning; Kamm, Kristine E.; Stull, James T.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wang, Shanzhi; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston	Stull, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [R01 HL112778, P01 HL110869]; Moss Heart Fund at the University of Texas Southwestern Medical Center; Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109942, P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund at the University of Texas Southwestern Medical Center; Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health R01 HL112778 and P01 HL110869 (https://www.nih.gov/); Moss Heart Fund at the University of Texas Southwestern Medical Center (http://www.utsouthwestern.edu/); and Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center (http://www.utsouthwestern.edu/).	Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; GABELLA G, 1984, PHYSIOL REV, V64, P455, DOI 10.1152/physrev.1984.64.2.455; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Gao YZ, 2014, AM J PHYSIOL-HEART C, V307, pH1252, DOI 10.1152/ajpheart.00392.2014; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Humphrey JD, 2015, CIRC RES, V116, P1448, DOI 10.1161/CIRCRESAHA.114.304936; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Karimi A, 2016, CAN J CARDIOL, V32, P26, DOI 10.1016/j.cjca.2015.11.004; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kuang SQ, 2012, CIRC RES, V110, P1411, DOI 10.1161/CIRCRESAHA.111.261743; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Sehgel NL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00335; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	39	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193769	10.1371/journal.pone.0193769	http://dx.doi.org/10.1371/journal.pone.0193769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494672	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200096
J	Taverner, D; Vallve, JC; Ferre, R; Paredes, S; Masana, L; Castro, A				Taverner, Delia; Vallve, Joan-Carles; Ferre, Raimon; Paredes, Silvia; Masana, Lluis; Castro, Antoni			Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; B-MODE ULTRASOUND; CARDIOVASCULAR-DISEASE; CAROTID PLAQUE; RISK-FACTORS; METAANALYSIS; ANTIBODIES	Objective To advance the study of variables associated with subclinical atherosclerosis in rheumatoid arthritis (RA) with special consideration for the degree of disease activity, age and gender. Methods The carotid intima-media thickness (cIMT) and the presence of carotid atherosclerotic plaques along with clinical and biochemical characteristics were determined in 214 RA patients. Results Adjusted analysis reveals that men had a 0.059 mm significantly increased cIMT compared with women (p = 0.001; R-2 = 3.8%) and that age was associated with cIMT (beta = 0.0048 mm; p = 0.0001; R-2 = 16%). Interestingly, we observed a significant interaction between gender and age. Thus, the effect of age on cIMT was significantly increased (12%) in men compared with women (p-value for interaction term = 0.041). Moreover, adjusted multivariable linear regression analysis revealed that disease activity score (DAS28) was significantly associated with cIMT in women (beta = 0.021; p = 0.018: R-2 = 0.03) but not men. In particular, women with high disease activity had a 0.079 mm increased cIMT compared with women in remission (p = 0.026). In addition, men in remission had a 0.134 mm increased cIMT compared with women in remission (p = 0.003; R-2 = 8.7%). Active patients did not exhibit differences in cIMT values. Furthermore, 43% of patients presented carotid plaques. The variables independently associated with carotid plaques were age, smoking, health assessment questionnaire, erythrocyte sedimentation rate and rheumatoid factor (p<0.0001; R-2 = 46%). Conclusion In our cohort of patients with RA, DAS28 and age are differentially associated with cIMT in men and women. Our findings could explain the contradictory results that have previously been published in the literature.	[Taverner, Delia; Paredes, Silvia] Hosp Univ Sant Joan, Inst Invest Sanitaria Pere Virgili Reus, Serv Med Interna, Seccio Reumatol, Catalonia, Spain; [Vallve, Joan-Carles] Univ Rovira & Virgili, Fac Med, CIBER Diabet & Enfermedades Metab Asociadas, Inst Invest Sanitaria Pere Virgili Reus, Catalonia, Spain; [Ferre, Raimon; Masana, Lluis; Castro, Antoni] Univ Rovira & Virgili, Hosp Univ Sant Joan,Serv Med Interna, Fac Med,Inst Invest Sanitaria Pere Virgili Reus, CIBER Diabet & Enfermedades Meta Asociadas, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Universitat Rovira i Virgili	Vallve, JC (corresponding author), Univ Rovira & Virgili, Fac Med, CIBER Diabet & Enfermedades Metab Asociadas, Inst Invest Sanitaria Pere Virgili Reus, Catalonia, Spain.	jc.vallve@urv.cat	MASANA, LUIS/M-7002-2019; Castro, Antoni/AAI-4431-2021; Vallvé, Joan-Carles/T-6742-2019	MASANA, LUIS/0000-0002-0789-4954; Castro, Antoni/0000-0001-5441-6333; Vallvé, Joan-Carles/0000-0001-8711-9618	Instituto de Salud Carlos III (ISCIII) [PI 10/02547, PI030786]; Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM); Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Reumatologia	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Reumatologia	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) (PI 10/02547, PI030786), Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM), Fondo Europeo de Desarrollo Regional (FEDER), and Sociedad Espanola de Reumatologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Ahmed HMMS, 2010, CLIN RHEUMATOL, V29, P1237, DOI 10.1007/s10067-010-1436-0; Ajeganova S, 2012, J RHEUMATOL, V39, P1146, DOI 10.3899/jrheum.111334; Akrout R, 2012, ANN CARDIOL ANGEIOL, V61, P267, DOI 10.1016/j.ancard.2012.04.009; Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Ballantyne C, 2002, AM J CARDIOL, V89, p15B; Barbarroja N, 2014, ARTERIOSCL THROM VAS, V34, P2706, DOI 10.1161/ATVBAHA.114.304475; Carotti M, 2007, REUMATISMO, V59, P38, DOI 10.4081/reumatismo.2007.38; Castaneda S, 2015, SEMIN ARTHRITIS RHEU, V44, P618, DOI 10.1016/j.semarthrit.2014.12.002; Corrales A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0576-7; Cuomo G, REUMATISMO, V56, P242; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; El-Barbary AM, 2011, J RHEUMATOL, V38, P828, DOI 10.3899/jrheum.101143; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; Diaz JDG, 2008, MED CLIN-BARCELONA, V130, P210; Gerli R, 2008, ANN RHEUM DIS, V67, P724, DOI 10.1136/ard.2007.073718; Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1219; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hannawi S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2323; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; Im CH, 2015, RHEUMATOLOGY, V54, P808, DOI 10.1093/rheumatology/keu376; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Liao L-J, 2017, CLIN OTOLARYNGOL; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Mohan A, 2014, INDIAN J MED RES, V140, P379; Pereira IA, ACTA REUM PORT, V34, P58; Pope Janet E, 2016, Open Rheumatol J, V10, P49; Ristic GG, 2010, RHEUMATOLOGY, V49, P1076, DOI 10.1093/rheumatology/kep456; Ruscitti P, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008180; Ruscitti P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170108; Sandoo A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4396; Scarno A, 2014, WORLD J ORTHOP, V5, P328, DOI 10.5312/wjo.v5.i3.328; Spence JD, 2002, AM J CARDIOL, V89, p10B; Stevens Robert J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009154; Sung JH, 2014, J CARDIOVASC MED, V15, P371, DOI 10.2459/JCM.0b013e32836411d6; Tanasescu C, 2009, EUR J INTERN MED, V20, P348, DOI 10.1016/j.ejim.2008.09.005; Targonska-Stepniak B, 2011, JCR-J CLIN RHEUMATOL, V17, P249, DOI 10.1097/RHU.0b013e3182290dbf; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tutoglu A, 2014, J PHYS THER SCI, V26, P1093, DOI 10.1589/jpts.26.1093; van Breukelen-van der Stoep DF, 2015, PLOS ONE, V10; van den Oever IAM, 2013, THER ADV MUSCULOSKEL, V5, P166, DOI 10.1177/1759720X13491025; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; Vazquez-Del Mercado M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/342649; Zampeli E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3757	53	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193690	10.1371/journal.pone.0193690	http://dx.doi.org/10.1371/journal.pone.0193690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494666	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200084
J	Zhao, SW; Yang, Q; Yu, ZX; Lv, Y; Zhi, JM; Gustin, P; Zhang, WH				Zhao, Shiwei; Yang, Qi; Yu, Zhixi; Lv, You; Zhi, Jianming; Gustin, Pascal; Zhang, Wenhui			Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; INHALED CORTICOSTEROIDS; ACUTE EXACERBATIONS; SHORT-TERM; INHIBITION; BROMIDE; COPD; EXPRESSION; RELEASE	As a potent bronchodilator, the anti-inflammatory effects of tiotropium and its interaction with budesonide against cadmium-induced acute pulmonary inflammation were investigated. Compared to values obtained in rats exposed to cadmium, cytological analysis indicated a significant decrease of total cell and neutrophil counts and protein concentration in bronchoalveolar lavage fluid (BALF) in rats pretreated with tiotropium (70 mu g/15ml or 350 mu g/15ml). Zymographic tests showed a decrease of MMP-2 activity in BALF in rats pretreated only with high concentration of tiotropium. Histological examination revealed a significant decrease of the severity and extent of inflammatory lung injuries in rats pretreated with both tested concentrations of tiotropium. Though tiotropium (70 mu g/15ml) or budesonide (250 mu g/15ml) could not reduce cadmium-induced bronchial hyper-responsiveness, their combination significantly decreased bronchial contractile response to methacholine. These two drugs separately decreased the neutrophil number and protein concentration in BALF but no significant interaction was observed when both drugs were combined. Although no inhibitory effects on MMP-2 and MMP-9 was observed in rats pretreated with budesonide alone, the combination with the ineffective dose of tiotropium induced a significant reduction on these parameters. The inhibitory effect of tiotropium on lung injuries was not influenced by budesonide which alone induced a limited action on the severity and extent of inflammatory sites. Our findings show that tiotropium exerts anti-inflammatory effects on cadmium-induced acute neutrophilic pulmonary inflammation. The combination of tiotropium with budesonide inhibits cadmium-induced inflammatory injuries with a synergistic interaction on MMP-2 and MMP-9 activity and airway hyper-responsiveness.	[Zhao, Shiwei; Yang, Qi; Yu, Zhixi; Lv, You] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Zhi, Jianming; Zhang, Wenhui] Shanghai Jiao Tong Univ, Sch Med, Dept Anat & Physiol, Shanghai, Peoples R China; [Gustin, Pascal] Univ Liege, Fac Vet Med, Dept Funct Sci, Liege, Belgium	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Liege	Zhang, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anat & Physiol, Shanghai, Peoples R China.	i_zhangwenhui@163.com			National Natural Science Foundation of China [81373468]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 81373468) to WZ.	Arai N, 2010, EUR RESPIR J, V35, P1164, DOI 10.1183/09031936.00040709; Asano Kazuhito, 2010, Int J Chron Obstruct Pulmon Dis, V5, P277; Asano Kazuhito, 2008, Int J Chron Obstruct Pulmon Dis, V3, P781; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Blum JL, 2014, INHAL TOXICOL, V26, P48, DOI 10.3109/08958378.2013.851746; Bolognin M, 2009, VET J, V179, P443, DOI 10.1016/j.tvjl.2007.10.004; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Bucher H, 2016, J PHARMACOL EXP THER, V357, P606, DOI 10.1124/jpet.116.232009; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Criner GJ, 2015, CHEST, V147, P894, DOI 10.1378/chest.14-1676; Cui Y, 2010, EUR RESPIR J, V35, P1370, DOI 10.1183/09031936.00139909; Evans DJW, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011437.pub2, 10.1002/14651858.CD011397.pub2]; Fievez L, 2009, EUR J PHARMACOL, V606, P210, DOI 10.1016/j.ejphar.2009.01.020; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gushima Y, 2001, EUR RESPIR J, V18, P827, DOI 10.1183/09031936.01.00049201; Kataranovski M, 2009, ENVIRON TOXICOL PHAR, V28, P225, DOI 10.1016/j.etap.2009.04.008; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Konrad FM, 2014, AM J PHYSIOL-LUNG C, V307, pL707, DOI 10.1152/ajplung.00145.2014; Kwak MS, 2015, INT J CHRONIC OBSTR, V10, P2365, DOI 10.2147/COPD.S93191; Matsuse H, 2015, EXPERT OPIN PHARMACO, V16, P1403, DOI 10.1517/14656566.2015.1045877; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Olszowski T, 2012, ACTA BIOCHIM POL, V59, P475; Pasternak Y, 2016, AM J EMERG MED, V34, P1977, DOI 10.1016/j.ajem.2016.07.003; Perng DW, 2009, EUR RESPIR J, V33, P778, DOI 10.1183/09031936.00115308; Pirrone F, 2009, VET RES COMMUN, V33, pS121, DOI 10.1007/s11259-009-9255-y; Salpeter Shelley R, 2007, Int J Chron Obstruct Pulmon Dis, V2, P11, DOI 10.2147/copd.2007.2.1.11; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Shen LL, 2014, INT IMMUNOPHARMACOL, V18, P358, DOI 10.1016/j.intimp.2013.12.021; Silva PL, 2009, EUR RESPIR J, V33, P634, DOI 10.1183/09031936.00052408; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Suzaki I, 2011, INT J CHRONIC OBSTR, V6, P439, DOI 10.2147/COPD.S23695; Turner DL, 2012, BRIT J PHARMACOL, V167, P515, DOI 10.1111/j.1476-5381.2012.02016.x; Vacca G, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-24; Vogelmeier CF, 2017, ARCH BRONCONEUMOL, V53, P128, DOI 10.1016/j.arbres.2017.02.001; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094701; Welte T, 2009, INT J CLIN PRACT, V63, P1136, DOI 10.1111/j.1742-1241.2009.02139.x; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Zhang WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109136; Zhang WH, 2010, EUR J PHARMACOL, V628, P171, DOI 10.1016/j.ejphar.2009.11.015; Zhang Y, 2014, INFLAMMATION, V37, P1654, DOI 10.1007/s10753-014-9893-2	44	8	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193610	10.1371/journal.pone.0193610	http://dx.doi.org/10.1371/journal.pone.0193610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489916	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000095
J	Rehrauer, H; Wu, LC; Blum, W; Pecze, L; Henzi, T; Serre-Beinier, V; Aquino, C; Vrugt, B; de Perrot, M; Schwaller, B; Felley-Bosco, E				Rehrauer, Hubert; Wu, Licun; Blum, Walter; Pecze, Lazslo; Henzi, Thomas; Serre-Beinier, Veronique; Aquino, Catherine; Vrugt, Bart; de Perrot, Marc; Schwaller, Beat; Felley-Bosco, Emanuela			How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations	ONCOGENE			English	Article							T-CELLS; MOUSE MODEL; GENE; CANCER; MURINE; IDENTIFICATION; EXPRESSION; NF2; REPOPULATION; CHEMOTHERAPY	Chronic exposure to intraperitoneal asbestos triggered a marked response in the mesothelium well before tumor development. Macrophages, mesothelial precursor cells, cytokines, and growth factors accumulated in the peritoneal lavage. Transcriptome profiling revealed YAP/TAZ activation in inflamed mesothelium with further activation in tumors, paralleled by increased levels of cells with nuclear YAP/TAZ. Arg1 was one of the highest upregulated genes in inflamed tissue and tumor. Inflamed tissue showed increased levels of single-nucleotide variations, with an RNA-editing signature, which were even higher in the tumor samples. Subcutaneous injection of asbestos-treated, but tumor-free mice with syngeneic mesothelioma tumor cells resulted in a significantly higher incidence of tumor growth when compared to naive mice supporting the role of the environment in tumor progression.	[Rehrauer, Hubert; Aquino, Catherine] Swiss Fed Inst Technol, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Rehrauer, Hubert; Aquino, Catherine] Univ Zurich, CH-8057 Zurich, Switzerland; [Wu, Licun; de Perrot, Marc] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Latner Thorac Surg Res Labs,Div Thorac Surg, Toronto, ON, Canada; [Blum, Walter; Pecze, Lazslo; Henzi, Thomas; Schwaller, Beat] Univ Fribourg, Dept Med, Unit Anat, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland; [Serre-Beinier, Veronique] Univ Hosp Geneva, Dept Thorac Surg, Geneva, Switzerland; [Vrugt, Bart] Univ Hosp Zurich, Inst Surg Pathol, Zurich, Switzerland; [Felley-Bosco, Emanuela] Univ Hosp Zurich, Lab Mol Oncol, Lungen & Thoraxonkol Zentrum, Sternwartstr 14, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Fribourg; University of Geneva; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Felley-Bosco, E (corresponding author), Univ Hosp Zurich, Lab Mol Oncol, Lungen & Thoraxonkol Zentrum, Sternwartstr 14, CH-8091 Zurich, Switzerland.	emanuela.felley-bosco@usz.ch	Serre-Beinier, Véronique/T-8064-2019; Wu, Licun/AAL-9596-2021; Felley-Bosco, Emanuela/E-7484-2017	Serre-Beinier, Véronique/0000-0002-6016-1645; Wu, Licun/0000-0003-4803-9361; Felley-Bosco, Emanuela/0000-0002-3408-0294; de Perrot, Marc/0000-0003-2000-9427; Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation Sinergia Grant CRSII3 [147697]	Swiss National Science Foundation Sinergia Grant CRSII3(Swiss National Science Foundation (SNSF))	The project is financed by the Swiss National Science Foundation Sinergia Grant CRSII3 #147697.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Blum W, 2015, IN VITRO CELL DEV-AN, V51, P714, DOI 10.1007/s11626-015-9885-z; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Broad Institute TCGA Genome Data Analysis Center, 2014, PARADIGM PATHW AN MR; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Carmona R, 2011, J CELL MOL MED, V15, P1200, DOI 10.1111/j.1582-4934.2010.01087.x; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; CHERIE AL, 2016, J THORAC ONCOL, V11, P1765, DOI DOI 10.1016/J.JTHO.2016.06.022; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Chow MT, 2012, IMMUNOL CELL BIOL, V90, P983, DOI 10.1038/icb.2012.46; Cornelissen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106742; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Echeverry N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.124; Fleury-Feith J, 2003, ONCOGENE, V22, P3799, DOI 10.1038/sj.onc.1206593; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Frei C, 2011, CARCINOGENESIS, V32, P1324, DOI 10.1093/carcin/bgr127; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; GORMLEY IP, 1980, CARCINOGENESIS, V1, P219, DOI 10.1093/carcin/1.3.219; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Huaux F, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0158-0; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Jiang QF, 2017, NAT REV CANCER, V17, P381, DOI 10.1038/nrc.2017.23; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Jongsma J, 2008, CANCER CELL, V13, P261, DOI 10.1016/j.ccr.2008.01.030; Kadariya Y, 2016, CANCER PREV RES, V9, P406, DOI 10.1158/1940-6207.CAPR-15-0347; Khanna S, 2016, J THORAC ONCOL, V11, P1993, DOI 10.1016/j.jtho.2016.07.033; Kitayama J, 2014, CELL IMMUNOL, V288, P8, DOI 10.1016/j.cellimm.2014.01.008; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lievense LA, 2016, J THORAC ONCOL, V11, P1755, DOI 10.1016/j.jtho.2016.06.021; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; MOALLI PA, 1987, AM J PATHOL, V128, P426; Moore DA, 2013, J MOL DIAGN, V15, P687, DOI 10.1016/j.jmoldx.2013.04.008; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Musah S, 2014, P NATL ACAD SCI USA, V111, P13805, DOI 10.1073/pnas.1415330111; Napolitano A, 2016, ONCOGENE, V35, P1996, DOI 10.1038/onc.2015.243; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Parrotta R, 2017, J THORAC ONCOL, V12, P1309, DOI 10.1016/j.jtho.2017.03.023; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Ren YZR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193458; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Robinson C, 2011, EUR J CANCER, V47, P151, DOI 10.1016/j.ejca.2010.08.015; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; SEKIDO Y, 1995, CANCER RES, V55, P1227; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suraokar MB, 2014, ANN ONCOL, V25, P1184, DOI 10.1093/annonc/mdu127; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamminen JA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.29; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; WAGNER JC, 1962, NATURE, V196, P180, DOI 10.1038/196180a0; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wu LC, 2017, CLIN CANCER RES, V23, P1060, DOI 10.1158/1078-0432.CCR-16-0844; Wu LC, 2012, MOL CANCER THER, V11, P1809, DOI 10.1158/1535-7163.MCT-11-1014; Wu LC, 2011, J THORAC ONCOL, V6, P1578, DOI 10.1097/JTO.0b013e3182208ee0; Zervos E, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0314-2; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	76	35	35	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2645	2659		10.1038/s41388-018-0153-z	http://dx.doi.org/10.1038/s41388-018-0153-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29507420	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-26	WOS:000432545100003
J	Galassi, VV; Villarreal, MA; Montich, GG				Galassi, Vanesa V.; Villarreal, Marcos A.; Montich, Guillermo G.			Relevance of the protein macrodipole in the membrane-binding process. Interactions of fatty-acid binding proteins with cationic lipid membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NERVE NA+/CA2+ EXCHANGER; L-BABP; PREDICTION; BILAYER; SYSTEMS; ELECTROSTATICS; REP1-NCXSQ; EFFICIENCY; KINETICS	The fatty acid-binding proteins L-BABP and Rep1-NCXSQ bind to anionic lipid membranes by electrostatic interactions. According to Molecular Dynamics (MD) simulations, the interaction of the protein macrodipole with the membrane electric field is a driving force for protein binding and orientation in the interface. To further explore this hypothesis, we studied the interactions of these proteins with cationic lipid membranes. As in the case of anionic lipid membranes, we found that both proteins, carrying a negative as well as a positive net charge, were bound to the positively charged membrane. Their major axis, those connecting the bottom of the beta-barrel with the alpha-helix portal domain, were rotated about 180 degrees as compared with their orientations in the anionic lipid membranes. Fourier transform infrared (FTIR) spectroscopy of the proteins showed that the positively charged membranes were also able to induce conformational changes with a reduction of the beta-strand proportion and an increase in alpha-helix secondary structure. Fatty acid-binding proteins (FABPs) are involved in several cell processes, such as maintaining lipid homeostasis in cells. They transport hydrophobic molecules in aqueous medium and deliver them into lipid membranes. Therefore, the interfacial orientation and conformation, both shown herein to be electrostatically determined, have a strong correlation with the specific mechanism by which each particular FABP exerts its biological function.	[Galassi, Vanesa V.; Montich, Guillermo G.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina; [Galassi, Vanesa V.; Montich, Guillermo G.] Univ Nacl Cordoba, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, Cordoba, Argentina; [Villarreal, Marcos A.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Teor & Computac, Cordoba, Argentina; [Villarreal, Marcos A.] Univ Nacl Cordoba, CONICET, Inst Invest Fis Quim Cordoba INFIQC, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Montich, GG (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina.; Montich, GG (corresponding author), Univ Nacl Cordoba, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, Cordoba, Argentina.	gmontich@fcc.unc.edu.ar		Galassi, Vanesa/0000-0002-6642-7555	Consejo Nacional de Investigaciones Cientificas y Tecnicas (AR) [PIP 2013-2015]; Fondo para la Investigacion Cientifica y Tecnologica [PICT 2015-1612]; Secretaria de Ciencia y Tecnica UNC; CONICET; FONCyT; SECyT UNC	Consejo Nacional de Investigaciones Cientificas y Tecnicas (AR); Fondo para la Investigacion Cientifica y Tecnologica; Secretaria de Ciencia y Tecnica UNC; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT); SECyT UNC(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (AR), PIP 2013-2015; Fondo para la Investigacion Cientifica y Tecnologica, PICT 2015-1612; and Secretaria de Ciencia y Tecnica UNC.; This work was supported by grants from CONICET, FONCyT and SECyT UNC.	Aberle AM, 1998, BIOCHEMISTRY-US, V37, P6533, DOI 10.1021/bi9801154; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berberian G, 2009, BBA-BIOMEMBRANES, V1788, P1255, DOI 10.1016/j.bbamem.2008.12.016; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cousido-Siah A, 2012, ACTA CRYSTALLOGR D, V68, P1098, DOI 10.1107/S090744491202094X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Decca MB, 2010, J PHYS CHEM B, V114, P15141, DOI 10.1021/jp104035z; Decca MB, 2007, BBA-BIOMEMBRANES, V1768, P1583, DOI 10.1016/j.bbamem.2007.03.018; Farago O, 2007, BIOPHYS J, V92, P3228, DOI 10.1529/biophysj.106.096990; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Galassi V, 2009, BIOCHEM BIOPH RES CO, V382, P771, DOI 10.1016/j.bbrc.2009.03.103; Galassi VV, 2014, BBA-BIOMEMBRANES, V1838, P910, DOI 10.1016/j.bbamem.2013.11.008; Gurtovenko AA, 2005, J PHYS CHEM B, V109, P21126, DOI 10.1021/jp053667m; Gurtovenko AA, 2004, BIOPHYS J, V86, P3461, DOI 10.1529/biophysj.103.038760; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; He K, 2017, CHEM BIOL INTERACT; Heimburg T, 1999, BIOPHYS J, V76, P2575, DOI 10.1016/S0006-3495(99)77410-2; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; MacDonald RC, 1999, BIOPHYS J, V77, P2612, DOI 10.1016/S0006-3495(99)77095-5; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Miettinen MS, 2009, J PHYS CHEM B, V113, P9226, DOI 10.1021/jp810233q; Mihajlovic M, 2006, J PHYS CHEM B, V110, P3375, DOI 10.1021/jp055906b; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nichesola D, 2004, BIOCHEMISTRY-US, V43, P14072, DOI 10.1021/bi0489661; Nolan V, 2005, BIOCHEMISTRY-US, V44, P8486, DOI 10.1021/bi050129r; Nolan V, 2003, BBA-BIOMEMBRANES, V1611, P98, DOI 10.1016/S0005-2736(03)00030-0; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pokorna S, 2013, FARADAY DISCUSS, V160, P341, DOI 10.1039/c2fd20098h; Porschke D, 1997, BIOPHYS CHEM, V66, P241, DOI 10.1016/S0301-4622(97)00060-4; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Scott AM, 2013, J BIOL CHEM, V288, P16905, DOI 10.1074/jbc.M113.467456; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Tandia BM, 2003, MOL THER, V8, P264, DOI 10.1016/S1525-0016(03)00150-3; Tzlil S, 2008, BIOPHYS J, V95, P1745, DOI 10.1529/biophysj.108.132522; Vallejo DF, 2009, BBA-BIOMEMBRANES, V1788, P696, DOI 10.1016/j.bbamem.2008.12.007; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Villarreal MA, 2008, BBA-BIOMEMBRANES, V1778, P1390, DOI 10.1016/j.bbamem.2008.02.015; Wee CL, 2008, BIOPHYS J, V95, P1649, DOI 10.1529/biophysj.107.123190; Xue HY, 2015, CURR PHARM DESIGN, V21, P3140, DOI 10.2174/1381612821666150531164540; Zamarreno F, 2012, BBA-BIOMEMBRANES, V1818, P1691, DOI 10.1016/j.bbamem.2012.03.003; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194154	10.1371/journal.pone.0194154	http://dx.doi.org/10.1371/journal.pone.0194154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518146	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900071
J	Gray, MA; Chao, CY; Staudacher, HM; Kolosky, NA; Talley, NJ; Holtmann, G				Gray, Marcus A.; Chao, Che-yung; Staudacher, Heidi M.; Kolosky, Natasha A.; Talley, Nicholas J.; Holtmann, Gerald			Anti-TNF alpha therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; CROHNS-DISEASE; FECAL CALPROTECTIN; ANXIETY; COMORBIDITY; INFLIXIMAB; SYMPTOMS; IMPROVES	Background In inflammatory bowel disease (IBD), immune activation with increased circulating TNF-alpha is linked to the intensity of gastrointestinal symptoms and depression or anxiety. A central feature of depression is cognitive biases linked to negative attributions about self, the world and the future. We aimed to assess the effects of anti-TNF alpha therapy on the central processing of self-attribution biases and visceral afferent information in patients with Crohn's disease. Methods We examined 9 patients with Crohn's disease (age 26.1 +/- 10.6. yrs, 5 female, 5 ileocolonic, 2 colonic and 2 ileal disease) during chronic anti-TNF alpha therapy (5 adalimumab, 4 infliximab). Patients were studied twice in randomized order before and after anti-TNF alpha administration. On each occasion patients underwent functional magnetic resonance imaging (fMRI) of the brain during a test of implicit attribution biases regarding sickness/health and undertook a standardized nutrient challenge. Results Following anti-TNFa treatment, ratings of 'fullness' following nutrient challenge reduced compared to pre-treatment ratings (p<0.05). Reaction times revealed improved processing of self-related and positive health words, consistent with improved implicit sense of wellbeing that correlated with improvements in sensory function after treatment (r = 0.67, p<0.05). Treatment-associated improvements in implicit processing were mirrored by alterations of prefrontal, amygdala, posterior cingulate and visual regions. Between patients, the degree of functional amygdala change was additionally explained by individual differences in attention regulation and body awareness rankings. Conclusion In patients with Crohn's disease, anti-TNF alpha administration reduces visceral sensitivity and improves implicit cognitive-affective biases linked to alterations in limbic (amygdala) function.	[Gray, Marcus A.; Chao, Che-yung; Staudacher, Heidi M.; Kolosky, Natasha A.; Holtmann, Gerald] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia; [Gray, Marcus A.; Staudacher, Heidi M.; Kolosky, Natasha A.; Holtmann, Gerald] Translat Res Inst, Brisbane, Qld, Australia; [Gray, Marcus A.; Holtmann, Gerald] Univ Queensland, Fac Hlth & Behav Sci, Brisbane, Qld, Australia; [Kolosky, Natasha A.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Kolosky, Natasha A.; Talley, Nicholas J.] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia	University of Queensland; University of Queensland; University of Newcastle	Gray, MA (corresponding author), Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia.; Gray, MA (corresponding author), Translat Res Inst, Brisbane, Qld, Australia.; Gray, MA (corresponding author), Univ Queensland, Fac Hlth & Behav Sci, Brisbane, Qld, Australia.	marcus.gray@tri.edu.au	Staudacher, Heidi/AAC-8193-2022; Holtmann, Gerald/S-4065-2019; Holtmann, Gerald/I-5341-2014	Staudacher, Heidi/0000-0001-6704-2131; Holtmann, Gerald/0000-0002-0206-2358				af Bjorkesten CG, 2012, SCAND J GASTROENTERO, V47, P528, DOI 10.3109/00365521.2012.660542; Bastin C, 2015, BIOL PSYCHIAT, V77; BECK AT, 1964, ARCH GEN PSYCHIAT, V10, P561; BECK AT, 1963, ARCH GEN PSYCHIAT, V9, P324; Beck AT, 1972, DEPRESSION CAUSES TR, pxiv; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099293; Bernstein CN, 2016, DIGEST DIS, V34, P58, DOI 10.1159/000442929; Bojic D, 2016, J CROHNS COLITIS; Bortolato B, 2015, CURR NEUROPHARMACOL, V13, P558, DOI 10.2174/1570159X13666150630171433; Bortolato B, 2014, CNS NEUROL DISORD-DR, V13, P1804; Cadahia V, 2004, REV ESP ENFERM DIG, V96, P369; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; D'Haens G, 2012, INFLAMM BOWEL DIS, V18, P2218, DOI 10.1002/ibd.22917; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Evertsz FB, 2012, J CROHNS COLITIS, V6, P68, DOI 10.1016/j.crohns.2011.07.006; Farraye FA, 2017, AM J GASTROENTEROL; Feldman SR, 2008, BRIT J DERMATOL, V159, P704, DOI 10.1111/j.1365-2133.2008.08727.x; Frackowiak RSJ, 2004, HUMAN BRAIN FUNCTION, pxvi; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Haag S, 2007, ALIMENT PHARM THER, V25, P973, DOI 10.1111/j.1365-2036.2007.03277.x; Haag S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01415.x; Haag S, 2004, GUT, V53, P1445, DOI 10.1136/gut.2003.030049; Harrison NA, 2009, BIOL PSYCHIAT, V66, P415, DOI 10.1016/j.biopsych.2009.03.007; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Healy GF, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00605; Hess A, 2015, GASTROENTEROLOGY, V149, P864, DOI 10.1053/j.gastro.2015.05.063; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Holtmann GT, 1996, GASTROENTEROLOGY, V110, pA680; Horst S, 2015, DIGEST DIS SCI, V60, P465, DOI 10.1007/s10620-014-3375-0; Hughes PA, 2014, BRAIN BEHAV IMMUN, V42, P191, DOI 10.1016/j.bbi.2014.07.001; Hughes PA, 2013, GUT, V62, P1456, DOI 10.1136/gutjnl-2011-301856; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Manabe Noriaki, 2013, Nihon Naika Gakkai Zasshi, V102, P32; Martin-Subero M, 2016, CNS SPECTRUMS, V21, P184, DOI 10.1017/S1092852915000449; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Mikocka-Walus A, 2008, J GASTROEN HEPATOL, V23, P1137, DOI 10.1111/j.1440-1746.2007.05245.x; Mikocka-Walus A, 2016, INFLAMM BOWEL DIS, V22, P752, DOI 10.1097/MIB.0000000000000620; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miwa Y, 2014, EUR J RHEUMATOL, V1, P147, DOI 10.5152/eurjrheumatol.2014.140074; Molander P, 2013, J CROHNS COLITIS, V7, P730, DOI 10.1016/j.crohns.2012.10.018; Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004; Neuendorf R, 2016, J PSYCHOSOM RES, V87, P70, DOI 10.1016/j.jpsychores.2016.06.001; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Porges, 1993, BODY PERCEPTION QUES; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Schoepfer AM, 2010, AM J GASTROENTEROL, V105, P162, DOI 10.1038/ajg.2009.545; Shestyuk AY, 2010, AM J PSYCHIAT, V167, P536, DOI 10.1176/appi.ajp.2009.06091444; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Williet N, 2014, CLIN GASTROENTEROL H, V12, P1246, DOI 10.1016/j.cgh.2014.02.016; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193542	10.1371/journal.pone.0193542	http://dx.doi.org/10.1371/journal.pone.0193542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5UV	29518097	gold, Green Submitted, Green Published			2022-12-26	WOS:000426902900023
J	Sharma, S; Tobin, V; Vas, PRJ; Malik, RA; Rayman, G				Sharma, Sanjeev; Tobin, Victoria; Vas, Prashanth R. J.; Malik, Rayaz A.; Rayman, Gerry			The influence of age, anthropometric and metabolic variables on LDIFLARE and corneal confocal microscopy in healthy individuals	PLOS ONE			English	Article							NERVE-FIBER DENSITY; DIABETIC PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY; GLYCEMIC CONTROL; INSULIN; PLEXUS; COMPLICATIONS; SENSITIVITY; DIAGNOSIS; SEVERITY	Introduction The laser Doppler imaging (LDI)(FLARE) and corneal confocal microscopy (CCM) are reliable markers of small fibre function (SFF) and structure (SFS), respectively, but the impact of potential confounding variables needs to be defined. The objective of this study was to determine the influence of age, anthropometric and biochemical variables on LDI and CCM. Methods 80 healthy volunteers (43 males) (age: 39.7 +/- 15.2 yrs.) underwent LDIFLARE and CCM assessment and the effect of age, anthropometric and biochemical variables was determined using multivariate analysis. Results There was an age-related decline in LDIFLARE (0.07cm(2)/yr; R-2 = 0.669; p = < 0.0001) and CCM parameters (CNFD: 0.05 fibres/mm(2)/yr; R-2 = 0.590; p = < 0.0001, CNBD: 0.06 branches/mm(2)/yr; R-2 = 0.549; p = 0.001 and CNFL 0.07 mm/mm(2)/yr; R-2 = 0.369; p = 0.009). BMI did not influence SFF (p = 0.08) but had a significant independent association with CNFD (p = 0.01). Fasting triglycerides (TG) independently influenced the LDIFLARE (beta(c):-0.204; p = 0.008) and all CCM indices (beta(c):-0.191 to -0.243; p = < 0.05). HbA(1c) was significantly associated with CNFD only (p = 0.001) but not with LDIFLARE, CNBD or CNFL (p = >= 0.05). Blood pressure and total cholesterol were not associated with LDIFLARE or any CCM parameters. There was a significant correlation between LDIFLARE and all CCM parameters (p = < 0.01). Conclusions This study shows that in healthy controls, both SFF measured by LDIFLARE and SFS assessed by CCM showed a significant inverse correlation with age and triglycerides, perhaps suggesting the use of age-specific normative values when interpreting these outcomes. Furthermore, this study shows that in healthy controls, despite measuring different neural parameters, both methods correlated significantly with each other.	[Sharma, Sanjeev; Tobin, Victoria; Rayman, Gerry] Ipswich Hosp NHS Trust, Diabet Res Unit, Ipswich, Suffolk, England; [Vas, Prashanth R. J.] Kings Coll NHS Fdn Trust, Dept Diabet, London, England; [Malik, Rayaz A.] Weill Cornell Med Qatar, Doha, Qatar; [Malik, Rayaz A.] Univ Manchester, Inst Cardiovasc Med, Manchester, Lancs, England	Ipswich Hospital NHS Trust; Ipswich Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Manchester	Rayman, G (corresponding author), Ipswich Hosp NHS Trust, Diabet Res Unit, Ipswich, Suffolk, England.	gerry.rayman@ipswichhospital.nhs.uk		Vas, Prashanth/0000-0001-7448-2995				Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Balakumar M, 2013, INDIAN J EXP BIOL, V51, P56; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Breiner A, 2014, DIABETES CARE; Cho YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083204; Dabbah MA, 2011, MED IMAGE ANAL, V15, P738, DOI 10.1016/j.media.2011.05.016; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; Dehghani C, 2014, CORNEA, V33, P696, DOI 10.1097/ICO.0000000000000152; Divisova S, 2012, J PERIPHER NERV SYST, V17, P341, DOI 10.1111/j.1529-8027.2012.00420.x; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; DYCK PJ, 1986, ANN NEUROL, V19, P425, DOI 10.1002/ana.410190503; Erie JC, 2005, CORNEA, V24, P705, DOI 10.1097/01.ico.0000154387.51355.39; Gibbons Christopher H, 2014, Continuum (Minneap Minn), V20, P1398, DOI 10.1212/01.CON.0000455874.68556.02; Goransson LG, 2004, NEUROLOGY, V62, P774, DOI 10.1212/01.WNL.0000113732.41127.8F; Graz H, 2018, DIABETES RES CLIN PR, V135, P158, DOI 10.1016/j.diabres.2017.10.030; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Grupcheva CN, 2002, CLIN EXP OPHTHALMOL, V30, P187, DOI 10.1046/j.1442-9071.2002.00507.x; Hafner J, 2015, J CLIN NEUROSCI, V22, P588, DOI 10.1016/j.jocn.2014.09.017; Krishnan STM, 2009, DIABETES CARE, V32, P451, DOI 10.2337/dc08-1453; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; Liu YD, 2014, NEUROL RES, V36, P911, DOI 10.1179/1743132814Y.0000000377; Lovblom LE, 2015, CAN J DIABETES, V39, P390, DOI 10.1016/j.jcjd.2015.02.006; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; MILLODOT M, 1977, INVEST OPHTH VIS SCI, V16, P240; Niederer RL, 2007, BRIT J OPHTHALMOL, V91, P1165, DOI 10.1136/bjo.2006.112656; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; Patel DV, 2009, CORNEA, V28, P735, DOI 10.1097/ICO.0b013e318193e0e3; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Pop-Busui R, 2010, CURR DIABETES REP, V10, P276, DOI 10.1007/s11892-010-0120-8; Pritchard N, 2015, DIABETES CARE, V38, P671, DOI 10.2337/dc14-2114; Rajamani K, 2009, LANCET, V373, P1780, DOI 10.1016/S0140-6736(09)60698-X; Roszkowska Anna M., 2004, International Ophthalmology, V25, P163, DOI 10.1007/s10792-004-1957-0; Shimada H, 2001, AUTON NEUROSCI-BASIC, V92, P72, DOI 10.1016/S1566-0702(01)00287-9; Smith AG, 2013, J DIABETES COMPLICAT, V27, P436, DOI 10.1016/j.jdiacomp.2013.04.003; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tesfaye S, 2009, CURR DIABETES REP, V9, P432, DOI 10.1007/s11892-009-0070-1; Uceyler N, 2013, AKTUEL NEUROL, V40, P96, DOI 10.1055/s-0033-1333767; Vas PRJ, 2012, DIABETOLOGIA, V55, P795, DOI 10.1007/s00125-011-2417-9; Vas PR, 2014, MUSCLE NERVE; Vas PRJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069920; Vas PRJ, 2013, MUSCLE NERVE, V47, P351, DOI 10.1002/mus.23532; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Wright EM, 1997, J R STAT SOC A STAT, V160, P47, DOI 10.1111/1467-985X.00045; Wu T, 2012, DIABETIC MED, V29, pE297, DOI 10.1111/j.1464-5491.2012.03678.x; Xiong Q, 2017, DIABETES RES CLIN PR	54	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193452	10.1371/journal.pone.0193452	http://dx.doi.org/10.1371/journal.pone.0193452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518115	gold, Green Published, Green Submitted			2022-12-26	WOS:000426902900021
J	Tisato, V; Zuliani, G; Vigliano, M; Longo, G; Franchini, E; Secchiero, P; Zauli, G; Paraboschi, EM; Singh, AV; Serino, ML; Ortolani, B; Zurlo, A; Bosi, C; Greco, A; Seripa, D; Asselta, R; Gemmati, D				Tisato, Veronica; Zuliani, Giovanni; Vigliano, Marco; Longo, Giovanna; Franchini, Eugenia; Secchiero, Paola; Zauli, Giorgio; Paraboschi, Elvezia Maria; Singh, Ajay Vikram; Serino, Maria Luisa; Ortolani, Beatrice; Zurlo, Amedeo; Bosi, Cristina; Greco, Antonio; Seripa, Davide; Asselta, Rosanna; Gemmati, Donato			Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ONSET ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; HEMOCHROMATOSIS GENE; OXIDATIVE STRESS; VASCULAR DEMENTIA; VENOUS DISEASE; OLDER SUBJECTS; BASAL GANGLIA; HFE MUTATIONS	Cognitive impairments of different aetiology share alterations in iron and lipid homeostasis with mutual relationships. Since iron and cholesterol accumulation impact on neurodegener-ative disease, the associated gene variants are appealing candidate targets for risk and disease progression assessment. In this light, we explored the role of common single nucleotide polymorphisms (SNPs) in the main iron homeostasis genes and in the main lipoprotein transporter gene (APOE) in a cohort of 765 patients with dementia of different origin: Alzheimer's disease (AD) n = 276; vascular dementia (VaD), n = 255; mild cognitive impairment (MCI), n = 234; and in normal controls (n = 1086). In details, four genes of iron homeostasis (Hemochromatosis (HFE: 0282Y, H63D), Ferroportin (FPN1: -8CG), Hepcidin (HAMP. -582AG), Transferrin (TF: P570S)), and the three major alleles of APOE (APOE2, APOE3, APOE4) were analyzed to explore causative interactions and synergies. In single analysis, HFE282Y allele yielded a 3-fold risk reduction in the whole cohort of patients (P<0.0001), confirmed in AD and VaD, reaching a 5-fold risk reduction in MCI (P = 0.0019). The other iron SNPs slightly associated with risk reduction whereas APOE4 allele resulted in increased risk, reaching more than 7-fold increased risk in AD homozygotes (P = 0.001), confirmed to a lower extent in VaD and MCI (P = 0.038 and P = 0.013 respectively) as well as in the whole group (P<0.0001). Comparisons of Mini Mental State Examination (MMSE) among AD showed appreciable lowering in APOE4 carriers (P = 0.038), confirmed in the whole cohort of patients (P = 0.018). In interaction analysis, the HFE282Y allele completely extinguished the APOE4 allele associated risk. Conversely, the coexistence in patients of a	[Tisato, Veronica; Zuliani, Giovanni; Secchiero, Paola; Zauli, Giorgio; Ortolani, Beatrice; Bosi, Cristina] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Tisato, Veronica; Secchiero, Paola; Zauli, Giorgio] Univ Ferrara, LTTA Ctr, Ferrara, Italy; [Zuliani, Giovanni; Ortolani, Beatrice; Bosi, Cristina] Univ Ferrara, Azienda Osped, Sect Internal & Cardioresp Med, Ferrara, Italy; [Vigliano, Marco; Longo, Giovanna; Franchini, Eugenia; Gemmati, Donato] Univ Ferrara, Dept Biomed & Specialty Surg Sci, Ferrara, Italy; [Vigliano, Marco; Longo, Giovanna; Franchini, Eugenia; Gemmati, Donato] Univ Ferrara, Sect Med Biochem Mol Biol & Genet, Ferrara, Italy; [Vigliano, Marco; Longo, Giovanna; Franchini, Eugenia; Serino, Maria Luisa; Gemmati, Donato] Univ Ferrara, Ctr Thrombosis & Hemostasis, Ferrara, Italy; [Paraboschi, Elvezia Maria; Asselta, Rosanna] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Paraboschi, Elvezia Maria; Asselta, Rosanna] Humanitas Clin & Res Ctr, Milan, Italy; [Singh, Ajay Vikram] Max Planck Inst, Dept Phys Intelligence, Stuttgart, Germany; [Serino, Maria Luisa] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Zurlo, Amedeo] Univ S Anna, Azienda Osped, Operat Unit Geriatr, Ferrara, Italy; [Greco, Antonio; Seripa, Davide] IRCCS, Casa Sollievo Sofferenza, Dept Med Sci, Complex Struct Geriatr Res Lab, Foggia, Italy	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara; University of Ferrara; Humanitas University; Max Planck Society; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; IRCCS Casa Sollievo Della Sofferenza	Gemmati, D (corresponding author), Univ Ferrara, Dept Biomed & Specialty Surg Sci, Ferrara, Italy.; Gemmati, D (corresponding author), Univ Ferrara, Sect Med Biochem Mol Biol & Genet, Ferrara, Italy.; Gemmati, D (corresponding author), Univ Ferrara, Ctr Thrombosis & Hemostasis, Ferrara, Italy.	d.gemmati@unife.it	Asselta, Rosanna/AAC-2367-2019; Tisato, Veronica/K-4525-2016; Serino, Maria Luisa/AAC-7368-2022; Zauli, Giorgio/ABE-8001-2020; Seripa, Davide/AAK-1342-2021; Singh, Ajay Vikram/AAM-3665-2020; Greco, Antonio/C-1100-2017; Singh, Ajay/AAF-4414-2020; Paraboschi, Elvezia Maria/K-6799-2016; Seripa, Davide/B-9408-2017	Asselta, Rosanna/0000-0001-5351-0619; Greco, Antonio/0000-0001-6674-5468; Paraboschi, Elvezia Maria/0000-0002-7935-798X; Tisato, Veronica/0000-0001-8448-066X; Bosi, Cristina/0000-0002-9443-1447; Seripa, Davide/0000-0001-7331-0470; Zuliani, Giovanni/0000-0003-0969-3184; Gemmati, Donato/0000-0001-6213-6120				Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Ali-Rahmani F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00165; Altes A, 2009, ANN HEMATOL, V88, P341, DOI 10.1007/s00277-008-0590-9; Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Ayton S, 2017, JAMA NEUROL, V74, P122, DOI 10.1001/jamaneurol.2016.4406; Ayton S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7760; Bandyopadhyay S, 2014, BIOCHEM PHARMACOL, V88, P486, DOI 10.1016/j.bcp.2014.01.032; Berg D, 2000, NEURORADIOLOGY, V42, P9, DOI 10.1007/s002340050002; Buchanan DD, 2002, NEUROSCI LETT, V327, P91, DOI 10.1016/S0304-3940(02)00398-1; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Casado A, 2008, NEUROCHEM RES, V33, P450, DOI 10.1007/s11064-007-9453-3; Chico L, 2013, FREE RADICAL RES, V47, P569, DOI 10.3109/10715762.2013.804622; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Combarros O, 2003, DEMENT GERIATR COGN, V15, P151, DOI 10.1159/000068480; Connor JR, 2006, J ALZHEIMERS DIS, V10, P267; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Correia AP, 2009, NEUROSCI LETT, V457, P129, DOI 10.1016/j.neulet.2009.03.088; Crespo AC, 2014, NEUROBIOL AGING, V35, P777, DOI 10.1016/j.neurobiolaging.2013.10.078; De Mattei M, 2008, DERMATOL SURG, V34, P347, DOI 10.1111/j.1524-4725.2007.34068.x; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025324; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fujioka M, 2003, ANN NEUROL, V54, P732, DOI 10.1002/ana.10751; Gazzina S, 2016, NEURODEGENER DIS, V16, P172, DOI 10.1159/000440843; Gebril OH, 2011, J NEUROGENET, V25, P7, DOI 10.3109/01677063.2011.556206; Gemmati D, 2004, WOUND REPAIR REGEN, V12, P512, DOI 10.1111/j.1067-1927.2004.012503.x; Gemmati D, 2006, J VASC SURG, V44, P554, DOI 10.1016/j.jvs.2006.05.011; Gemmati D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162084; Gemmati D, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-70; Gemmati D, 2009, J VASC SURG, V50, P1444, DOI 10.1016/j.jvs.2009.07.103; Giambattistelli F, 2012, NEUROBIOL AGING, V33, P1633, DOI 10.1016/j.neurobiolaging.2011.03.005; Gozzelino R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010130; Guzior N, 2015, CURR MED CHEM, V22, P373; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Heidari M, 2016, RARE DIS, V4, DOI 10.1080/21675511.2016.1198458; HIXSON JE, 1990, J LIPID RES, V31, P545; Hofer T, 2016, J TRACE ELEM MED BIO, V38, P1, DOI 10.1016/j.jtemb.2016.06.005; Huang YA, 2017, CELL, V168; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Kauwe JSK, 2010, AM J MED GENET B, V153B, P955, DOI 10.1002/ajmg.b.31053; Khalil RB, 2016, WORLD J PSYCHIATR, V6, P208, DOI 10.5498/wjp.v6.i2.208; Komori N, 1997, MOL BRAIN RES, V49, P103, DOI 10.1016/S0169-328X(97)00133-2; Lambracht-Washington D, 2013, J NEUROIMMUNOL, V254, P63, DOI 10.1016/j.jneuroim.2012.09.008; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; Leong WI, 2004, J NUTR, V134, P1; Li XP, 2011, J NEURAL TRANSM, V118, P473, DOI 10.1007/s00702-010-0518-0; Lim YY, 2017, J ALZHEIMERS DIS, V58, P1293, DOI 10.3233/JAD-170072; Lin M, 2012, MOL BIOL REP, V39, P3089, DOI 10.1007/s11033-011-1072-z; Lucotte G, 2003, BLOOD CELL MOL DIS, V31, P262, DOI 10.1016/S1079-9796(03)00133-5; Lupton MK, 2017, J ALZHEIMERS DIS, V59, P85, DOI 10.3233/JAD-170027; Matias-Guiu JA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00053; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Mutter J, 2004, NEUROENDOCRINOL LETT, V25, P331; Myhre O, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/726954; NIELSEN JE, 1995, J NEUROL NEUROSUR PS, V59, P318, DOI 10.1136/jnnp.59.3.318; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Peters DG, 2015, NEUROBIOL DIS, V81, P49, DOI 10.1016/j.nbd.2015.08.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pirpamer L, 2016, NEUROBIOL AGING, V43, P149, DOI 10.1016/j.neurobiolaging.2016.04.002; Potter Huntington, 2012, Int J Alzheimers Dis, V2012, P489428, DOI 10.1155/2012/489428; Puertas MC, 2012, EXP GERONTOL, V47, P625, DOI 10.1016/j.exger.2012.05.019; Pulliam JF, 2003, AM J MED GENET B, V119B, P48, DOI 10.1002/ajmg.b.10069; Ramagopalan SV, 2008, J NEUROIMMUNOL, V203, P104, DOI 10.1016/j.jneuroim.2008.06.036; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ristic S, 2005, NEUROSCI LETT, V383, P301, DOI 10.1016/j.neulet.2005.04.045; Rogers JT, 2016, J NEUROCHEM, V138, P479, DOI 10.1111/jnc.13671; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rottkamp CA, 2001, FREE RADICAL BIO MED, V30, P447, DOI 10.1016/S0891-5849(00)00494-9; Rubio JP, 2004, HUM GENET, V114, P573, DOI 10.1007/s00439-004-1095-9; Sampietro M, 2001, NEUROBIOL AGING, V22, P563, DOI 10.1016/S0197-4580(01)00219-6; Sheykhansari S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0379-2; Singh AV, 2010, INT J LOW EXTR WOUND, V9, P166, DOI 10.1177/1534734610384653; Singh AV, 2012, J NEUROSCI RURAL PRA, V3, P301, DOI 10.4103/0976-3147.102611; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; Stankiewicz JM, 2009, CURR OPIN CLIN NUTR, V12, P22, DOI 10.1097/MCO.0b013e32831ba07c; Sullivan JL, 2004, J LAB CLIN MED, V144, P280, DOI 10.1016/j.lab.2004.10.006; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tisato V, 2016, DEMENT GERIATR COGN, V41, P273, DOI 10.1159/000446275; Tognazzo S, 2006, J VASC SURG, V44, P815, DOI 10.1016/j.jvs.2006.06.006; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Bergen JMG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35514; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wang Y, 2013, CAN J NEUROL SCI, V40, P691, DOI 10.1017/S0317167100014931; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; WONG CT, 1986, ACTA HAEMATOL-BASEL, V75, P215, DOI 10.1159/000206128; Zambenedetti P, 2003, J ALZHEIMERS DIS, V5, P423, DOI 10.3233/JAD-2003-5601; Zamboni P, 2005, J VASC SURG, V42, P309, DOI 10.1016/j.jvs.2005.04.003; Zamboni P, 2005, DERMATOL SURG, V31, P644, DOI 10.1097/00042728-200506000-00005; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589; Zamboni P, 2006, FREE RADICAL BIO MED, V40, P1869, DOI 10.1016/j.freeradbiomed.2006.01.026; Zamboni Paolo, 2004, Vasc Endovascular Surg, V38, P431, DOI 10.1177/153857440403800506; Zhang P, 2003, NEUROSCI LETT, V349, P209, DOI 10.1016/S0304-3940(03)00837-1; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008	101	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193867	10.1371/journal.pone.0193867	http://dx.doi.org/10.1371/journal.pone.0193867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518107	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900041
J	Wang, LL; Minchin, RF; Butcher, NJ				Wang, LiLi; Minchin, Rodney F.; Butcher, Neville J.			Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability	PLOS ONE			English	Article							N-ACETYLTRANSFERASE-1; CELLS; NAT1	Human arylamine N-acetyltransferase 1 (NAT1) has been associated with cancer cell growth and invasion, but the underlying molecular mechanisms remain unknown. NAT1 is located on the short arm of chromosome 8 (8p2l), a region that is commonly deleted in colon cancer. Previously, it was reported that HT-29 colon cancer cells, which have a large deletion at 8p2l-22, show marked morphological changes, increased E-cadherin expression and altered cell-cell contact inhibition following down-regulation of NAT1 with shRNA. By contrast, no effects on growth were observed in HeLa cells. In the present study, cellular changes following knockout of NAT1 with CRISPR/Cas9 in HT-29 and HeLa cells were compared in the presence and absence of glucose. Cell growth decreased in both cell- lines during glucose starvation, but it was enhanced in HT-29 cells following NAT1 deletion. This was due to an increase in ROS production that induced cell apoptosis. Both ROS production and cell death were prevented by the glutathione precursor N-acetylcysteine. NAT1 knockout also resulted in a loss of the gain-of-function p53 protein in HT-29 cells. When p53 expression was inhibited with siRNA in parental HT-29 cells, ROS production and apoptosis increased to levels seen in the NAT1 knockout cells. The loss of p53 may explain the decreased colony formation and increased contact inhibition previously reported following NAT1 down-regulation in these cells. In conclusion, NAT1 is important in maintaining intracellular ROS, especially during glucose starvation, by stabilizing gain-of-function p53 in HT-29 cells. These results suggest that NAT1 may be a novel target to decrease intracellular gain-of-function p53.	[Wang, LiLi; Minchin, Rodney F.; Butcher, Neville J.] Univ Queensland, Sch Biomed Sci, Lab Mol & Cellular Pharmacol, Brisbane, Qld, Australia	University of Queensland	Minchin, RF (corresponding author), Univ Queensland, Sch Biomed Sci, Lab Mol & Cellular Pharmacol, Brisbane, Qld, Australia.	r.minchin@uq.edu.au		Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589; WANG, lili/0000-0001-9804-886X	Australian National Health and Medical Research Council [1083036]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council, Grant #1083036 (https://www.nhmrc.gov.au/ to RFM, NJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, MOL CANCER RES, V1, P826; Ajay AK, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-2; Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Butcher NJ, 1998, PHARMACOGENETICS, V8, P67, DOI 10.1097/00008571-199802000-00009; Butcher NJ, 2000, MOL PHARMACOL, V57, P468, DOI 10.1124/mol.57.3.468; Carlisle SM, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1056-z; Dairou J, 2005, MOL PHARMACOL, V67, P1299, DOI 10.1124/mol.104.009738; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Laurieri N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096370; Lee JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12642; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Payton MA, 1998, BIOCHEM PHARMACOL, V55, P361, DOI 10.1016/S0006-2952(97)00478-4; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; Savci-Heijink CD, 2016, BREAST CANCER RES TR, V156, P249, DOI 10.1007/s10549-016-3741-z; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Stepp MW, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3221-9; Stepp Marcus W, 2015, Biochem Biophys Rep, V3, P45; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Tiang JM, 2015, CANCER MED-US, V4, P565, DOI 10.1002/cam4.415; Tiang JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017031; Tiang JM, 2010, BIOCHEM BIOPH RES CO, V393, P95, DOI 10.1016/j.bbrc.2010.01.087; Witham KL, 2017, BIOCHEM PHARMACOL, V125, P93, DOI 10.1016/j.bcp.2016.11.015; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76	28	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193560	10.1371/journal.pone.0193560	http://dx.doi.org/10.1371/journal.pone.0193560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518119	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900024
J	Massawe, A; Kidanto, HL; Moshiro, R; Majaliwa, E; Chacha, F; Shayo, A; Mdoe, P; Ringia, P; Azayo, M; Msemo, G; Mduma, E; Ersdal, HL; Perlman, JM				Massawe, Augustine; Kidanto, Hussein L.; Moshiro, Robert; Majaliwa, Edna; Chacha, Flora; Shayo, Aisa; Mdoe, Paschal; Ringia, Prisca; Azayo, Mary; Msemo, Georgina; Mduma, Estomih; Ersdal, Hege L.; Perlman, Jeffrey M.			A care bundle including antenatal corticosteroids reduces preterm infant mortality in Tanzania a low resource country	PLOS ONE			English	Article								Background Preterm neonatal mortality (NM) has remained high and unchanged for many years in Tanzania, a resource-limited country. Major causes of mortality include birth asphyxia, respiratory insufficiency and infections. Antenatal corticosteroids (ACS) have been shown to significantly reduce mortality in developed countries. There is inconsistent use of ACS in Tanzania. Objective To determine whether implementation of a care bundle that includes ACS, maternal antibiotics (MA), neonatal antibiotics (NA) and avoidance of moderate hypothermia (temperature < 36 degrees C) targeting infants of estimated gestational age (EGA) 28 to 34 6/7 weeks would reduce NM (<7 days) by 35%. Methods A Pre (September 2014 to May 2015) and Post (June 2015 to June 2017) Implementation strategy was used and introduced at three University-affiliated and one District Hospital. Dexamethasone, as the ACS, was added to the national formulary in May 2015, facilitating its free use down to the district level. Findings NM was reduced 26% from 166 to 122/1000 livebirths (P = 0.005) and fresh stillbirths (FSB) 33% from 162/1000 to 111/1000 (p = 0.0002) Pre versus Post Implementation. Medications including combinations increased significantly at all sites (p<0.0001). By logistic regression, combinations of ACS, maternal and NA (odds ratio (OR) 0.33), ACS and NA (OR 0.30) versus no treatment were significantly associated with reduced NM. NM significantly decreased per 250g birthweight increase (OR 0.59), and per one week increase in EGA (OR 0.87). Moderate hypothermia declined pre versus post implementation (p<0.0001) and was two-fold more common in infants who died versus survivors. Interpretation A low-cost care bundle, similar to$6 per patient, was associated with a significant reduction in NM and FSB rates. The former presumably by reducing respiratory morbidity with ACS and minimizing infections with antibiotics. If these findings can be replicated in other resource-limited settings, the potential for further reduction of <5 year mortality rates becomes enormous.	[Massawe, Augustine; Moshiro, Robert; Majaliwa, Edna] Muhimbili Univ Hlth & Allied Sci, Sch Med, Paediat & Child Hlth, Dar Es Salaam, Tanzania; [Kidanto, Hussein L.] Muhimbili Univ Hlth & Allied Sci, Obstet & Gynecol, Dar Es Salaam, Tanzania; [Chacha, Flora] Catholic Univ Hlth & Allied Sci Bugando, Paediat, Mwanza, Tanzania; [Shayo, Aisa] Kilimanjaro Christian Med Ctr, Dept Paediat, Moshi, Tanzania; [Mdoe, Paschal; Mduma, Estomih] Haydom Lutheran Hosp, Obstet & Gynecol, Haydom, Tanzania; [Ringia, Prisca] Weill Bugando Hosp, Div Obstet Nursing, Mwanza, Tanzania; [Azayo, Mary; Msemo, Georgina] Minist Hlth & Social Serv, Reprod & Child Hlth Serv, Dar Es Salaam, Tanzania; [Ersdal, Hege L.] Stavanger Univ Hosp, Dept Anaesthesiol & Intens Care, Stavanger, Norway; [Perlman, Jeffrey M.] Weill Cornell Med, Dept Pediat, New York, NY 10021 USA	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Kilimanjaro Christian Medical Centre; Stavanger University Hospital; Cornell University	Perlman, JM (corresponding author), Weill Cornell Med, Dept Pediat, New York, NY 10021 USA.	jmp2007@med.cornell.edu			Laerdal Foundation for Acute Medicine	Laerdal Foundation for Acute Medicine	Jeffrey Perlman has received a research travel award from the Laerdal Foundation for Acute Medicine for work in Tanzania but does not have any financial or personal relationships with other people or organizations. The study has been funded in part by Bloomberg Philanthropies. Bloomberg Philanthropies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/789729; Althabe F, 2015, LANCET, V385, P629, DOI 10.1016/S0140-6736(14)61651-2; American Academy of Pediatrics, HELP BAB SURV; [Anonymous], 2011, Obstet Gynecol, V117, P1472, DOI 10.1097/AOG.0b013e3182238c31; [Anonymous], 2013, MAN COMPL PREGN CHIL; Castrodale V, 2014, ADV NEONAT CARE, V14, P9, DOI 10.1097/ANC.0b013e31828d0289; GILSTRAP LC, 1995, AM J OBSTET GYNECOL, V173, P246; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; Liu G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P650, DOI 10.1001/archpediatrics.2010.103; Perlman J, 2015, LANCET, V385, P1944, DOI 10.1016/S0140-6736(15)60954-0; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; UNICEF, LEV TRENDS CHILD MOR; Verani J, 2010, MORBIDITY MORTALITY; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; World Health Organization, 1997, MEAS QUAL LIF, P1; World Health Organization, 2010, MAT NEWB CHILD AD HL; You D, 2014, LEVELS TRENDS CHILD	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193146	10.1371/journal.pone.0193146	http://dx.doi.org/10.1371/journal.pone.0193146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513706	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800040
J	Naik, P; Wang, JP; Sederoff, R; Chiang, V; Williams, C; Ducoste, JJ				Naik, Punith; Wang, Jack P.; Sederoff, Ronald; Chiang, Vincent; Williams, Cranos; Ducoste, Joel J.			Assessing the impact of the 4CL enzyme complex on the robustness of monolignol biosynthesis using metabolic pathway analysis	PLOS ONE			English	Article							POPULUS-TRICHOCARPA; SENSITIVITY-ANALYSIS; LIGNIN BIOSYNTHESIS; SYSTEMS BIOLOGY; TREE GROWTH; LIGASE; 4-COUMARATECOENZYME; PLANTS; LIGNIFICATION; METHODOLOGY	Lignin is a polymer present in the secondary cell walls of all vascular plants. It is a known barrier to pulping and the extraction of high-energy sugars from cellulosic biomass. The challenge faced with predicting outcomes of transgenic plants with reduced lignin is due in part to the presence of unique protein-protein interactions that influence the regulation and metabolic flux in the pathway. Yet, it is unclear why certain plants have evolved to create these protein complexes. In this study, we use mathematical models to investigate the role that the protein complex, formed specifically between Ptr4CL3 and Ptr4CL5 enzymes, have on the monolignol biosynthesis pathway. The role of this Ptr4CL3-Ptr4CL5 enzyme complex on the steady state flux distribution was quantified by performing Monte Carlo simulations. The effect of this complex on the robustness and the homeostatic properties of the pathway were identified by performing sensitivity and stability analyses, respectively. Results from these robustness and stability analyses suggest that the monolignol biosynthetic pathway is resilient to mild perturbations in the presence of the Ptr4CL3-Ptr4CL5 complex. Specifically, the presence of Ptr4CL3-Ptr4CL5 complex increased the stability of the pathway by 22%. The robustness in the pathway is maintained due to the presence of multiple enzyme isoforms as well as the presence of alternative pathways resulting from the presence of the Ptr4CL3-Ptr4CL5 complex.	[Naik, Punith; Ducoste, Joel J.] North Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA; [Wang, Jack P.; Sederoff, Ronald; Chiang, Vincent] North Carolina State Univ, Dept Forestry & Environm Resources, Forest Biotechnol Grp, Raleigh, NC 27695 USA; [Williams, Cranos] North Carolina State Univ, Elect & Comp Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Ducoste, JJ (corresponding author), North Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA.	jducoste@ncsu.edu	Ducoste, Joel/A-1964-2016; Naik, Punith/AAH-1291-2019	Ducoste, Joel/0000-0002-3021-3942; Wang, Jack P./0000-0002-5392-0076	National Science Foundation (USA) Plant Genome Research Program Grant [DBI-0922391]	National Science Foundation (USA) Plant Genome Research Program Grant	This work was supported by the National Science Foundation (USA) Plant Genome Research Program Grant (DBI-0922391) (to V.C.) (URL: https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Chen HC, 2014, PLANT CELL, V26, P876, DOI 10.1105/tpc.113.119685; Chen HC, 2013, PLANT PHYSIOL, V161, P1501, DOI 10.1104/pp.112.210971; Chiang VL, 2002, NAT BIOTECHNOL, V20, P557, DOI 10.1038/nbt0602-557; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Girbig D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034686; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Kajita S, 1996, PLANT CELL PHYSIOL, V37, P957, DOI 10.1093/oxfordjournals.pcp.a029045; Kajita S, 1997, PLANT PHYSIOL, V114, P871, DOI 10.1104/pp.114.3.871; Kelley CT, 2003, SOLVING NONLINEAR EQ, pxiv; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lee Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002047; Lee Y, 2010, MATH BIOSCI, V228, P78, DOI 10.1016/j.mbs.2010.08.009; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marsh JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7394; Matisziw TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039788; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Romani A, 2014, RECENT ADV POLYPHENO; Saltelli A., 2000, WILEY SERIES PROBABI; Sarkanen K.V., 1971, LIGNIN OCCURRENCE FO; Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Steuer R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002218; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Sumner T, 2012, J R SOC INTERFACE, V9, P2156, DOI 10.1098/rsif.2011.0891; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wang JP, 2014, PLANT CELL, V26, P894, DOI 10.1105/tpc.113.120881; Zhou K., 1995, ROBUST OPTIMAL CONTR	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193896	10.1371/journal.pone.0193896	http://dx.doi.org/10.1371/journal.pone.0193896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509777	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200040
J	Turner, M; Mutter, ST; Deeth, RJ; Platts, JA				Turner, Matthew; Mutter, Shaun T.; Deeth, Robert J.; Platts, James A.			Ligand field molecular dynamics simulation of Pt(II)-phenanthroline binding to N-terminal fragment of amyloid-beta peptide	PLOS ONE			English	Article							PLATINUM-BASED INHIBITORS; ALZHEIMERS-DISEASE; METAL-IONS; PROTEIN; COORDINATION; AGGREGATION; COMPLEXES; MECHANICS; OLIGOMERS; MONOMER	We report microsecond timescale molecular dynamics simulation of the complex formed between Pt(II)-phenanthroline and the 16 N-terminal residues of the A beta peptide that is implicated in the onset of Alzheimer's disease, along with equivalent simulations of the metal-free peptide. Simulations from a variety of starting points reach equilibrium within 100 ns, as judged by root mean square deviation and radius of gyration. Platinum-bound peptides deviate rather more from starting points, and adopt structures with larger radius of gyration, than their metal-free counterparts. Residues bound directly to Pt show smaller fluctuation, but others actually move more in the Pt-bound peptide. Hydrogen bonding within the peptide is disrupted by binding of Pt, whereas the presence of salt-bridges are enhanced.	[Turner, Matthew; Mutter, Shaun T.; Platts, James A.] Cardiff Univ, Sch Chem, Pk Pl, Cardiff, S Glam, Wales; [Deeth, Robert J.] Univ Warwick, Dept Chem, Gibbet Hill, Coventry, W Midlands, England	Cardiff University; University of Warwick	Platts, JA (corresponding author), Cardiff Univ, Sch Chem, Pk Pl, Cardiff, S Glam, Wales.	platts@cardiff.ac.uk	Platts, Jamie/A-2310-2011; Deeth, Robert J/B-8641-2009	Platts, Jamie/0000-0002-1008-6595; Deeth, Robert J/0000-0001-7933-4406	EPSRC [EP/N016858/1]; Engineering and Physical Sciences Research Council [EP/N016858/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Work was funded in part by EPSRC (https://www.epsrc.ac.uk/) under grant ref EP/N016858/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Torres J, 2015, AIP ADV, V5, DOI 10.1063/1.4921072; Ali-Torres J, 2011, J AM CHEM SOC, V133, P15008, DOI 10.1021/ja203407v; Anastasi AE, 2009, J CHEM THEORY COMPUT, V5, P2339, DOI 10.1021/ct9001569; Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BURTON VJ, 1995, J AM CHEM SOC, V117, P8407, DOI 10.1021/ja00137a014; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collin F, 2013, CHEM COMMUN, V49, P2130, DOI 10.1039/c3cc38537j; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deeth RJ, 2005, J COMPUT CHEM, V26, P123, DOI 10.1002/jcc.20137; Deeth RJ, 2009, COORDIN CHEM REV, V253, P795, DOI 10.1016/j.ccr.2008.06.018; Dong MY, 2016, ACS CHEM NEUROSCI, V7, P599, DOI 10.1021/acschemneuro.5b00343; Frisch M.J, 2009, GAUSSIAN 09 REVISION; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hureau C, 2014, DALTON T, V43, P4233, DOI 10.1039/c3dt52954a; Kenche VB, 2013, ANGEW CHEM INT EDIT, V52, P3374, DOI 10.1002/anie.201209885; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Ma GL, 2013, METALLOMICS, V5, P879, DOI 10.1039/c3mt20262c; Ma GL, 2011, CHEM-EUR J, V17, P11657, DOI 10.1002/chem.201101859; Molecular Operating Environment (MOE), 2013, MOL OP ENV MOE 2013; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Huy PDQ, 2016, ACS CHEM NEUROSCI, V7, P1348, DOI 10.1021/acschemneuro.6b00109; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; Streltsov VA, 2013, CHEM COMMUN, V49, P11364, DOI 10.1039/c3cc47326k; Tai HC, 2012, INORG CHEM, V51, P6830, DOI 10.1021/ic3005745; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Turner M, 2017, J INORG BIOCHEM, V173, P44, DOI 10.1016/j.jinorgbio.2017.05.003; Turner M, 2016, J CHEM THEORY COMPUT, V12, P1385, DOI 10.1021/acs.jctc.5b01045; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XH, 2012, CHEM SCI, V3, P1304, DOI 10.1039/c2sc01100j; Warmlander S, 2013, CHEMBIOCHEM, V14, P1692, DOI 10.1002/cbic.201300262; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yong CW, 2016, J CHEM INF MODEL, V56, P1405, DOI 10.1021/acs.jcim.6b00323	44	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193668	10.1371/journal.pone.0193668	http://dx.doi.org/10.1371/journal.pone.0193668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509784	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000426813200023
J	Sabeh, M; Duceppe, MO; St-Arnaud, M; Mimee, B				Sabeh, Michael; Duceppe, Marc-Olivier; St-Arnaud, Marc; Mimee, Benjamin			Transcriptome-wide selection of a reliable set of reference genes for gene expression studies in potato cyst nematodes (Globodera spp.)	PLOS ONE			English	Article							RT-PCR NORMALIZATION; ROSTOCHIENSIS; TOOL	Relative gene expression analyses by qRT-PCR (quantitative reverse transcription PCR) require an internal control to normalize the expression data of genes of interest and eliminate the unwanted variation introduced by sample preparation. A perfect reference gene should have a constant expression level under all the experimental conditions. However, the same few housekeeping genes selected from the literature or successfully used in previous unrelated experiments are often routinely used in new conditions without proper validation of their stability across treatments. The advent of RNA-Seq and the availability of public datasets for numerous organisms are opening the way to finding better reference genes for expression studies. Globodera rostochiensis is a plant-parasitic nematode that is particularly yield-limiting for potato. The aim of our study was to identify a reliable set of reference genes to study G. rostochiensis gene expression. Gene expression levels from an RNA-Seq database were used to identify putative reference genes and were validated with qRT-PCR analysis. Three genes, GR, PMP-3, and aaRS, were found to be very stable within the experimental conditions of this study and are proposed as reference genes for future work.	[Sabeh, Michael; Mimee, Benjamin] Agr & Agri Food Canada, St Jean Sur Richelieu Res & Dev Ctr, St Jean, PQ, Canada; [Sabeh, Michael; St-Arnaud, Marc] Univ Montreal & Jardin Bot Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ, Canada; [Duceppe, Marc-Olivier] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada	Agriculture & Agri Food Canada; Universite de Montreal; Canadian Food Inspection Agency	Mimee, B (corresponding author), Agr & Agri Food Canada, St Jean Sur Richelieu Res & Dev Ctr, St Jean, PQ, Canada.	benjamin.mimee@agr.gc.ca	St-Arnaud, Marc/D-1184-2017	St-Arnaud, Marc/0000-0002-7181-9895; Sabeh, Michael/0000-0001-5496-3695	Agriculture and Agri-Food Canada (AAFC); United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato"; National Institute for Food and Agriculture [2015-69004-23634]	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato"; National Institute for Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by Agriculture and Agri-Food Canada (AAFC) and the United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato", supported by award #2015-69004-23634 from the National Institute for Food and Agriculture (https://www.globodera.org/).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anonymous, 2004, Bulletin OEPP, V34, P309, DOI 10.1111/j.1365-2338.2004.00734.x; Belair G, 2005, PHYTOPROTECTION, V86, P65, DOI 10.7202/011717ar; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chauvin L, 2008, CAH AGRIC, V17, P368, DOI 10.1684/agr.2008.0217; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Duceppe MO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03871-x; Espinola SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102228; Eves-van den Akker S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0985-1; FAO, 2016, FAO STAT POCK 2015; Goellner M, 2000, J NEMATOL, V32, P154; Hofmann J, 2007, NEMATOLOGY, V9, P317, DOI 10.1163/156854107781352034; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANNERVIK B, 1987, BIOCHEM SOC T, V15, P717, DOI 10.1042/bst0150717; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Schwekendiek A, 1999, J NEMATOL, V31, P568; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spanier B, 2005, J MOL BIOL, V352, P429, DOI 10.1016/j.jmb.2005.06.063; Taki FA, 2013, PSYCHOPHARMACOLOGY, V230, P77, DOI 10.1007/s00213-013-3139-0; Turner SJ, 1996, ANN APPL BIOL, V129, P315, DOI 10.1111/j.1744-7348.1996.tb05754.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yu Q, 2010, CAN J PLANT PATHOL, V32, P264, DOI 10.1080/07060661003740322; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	38	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193840	10.1371/journal.pone.0193840	http://dx.doi.org/10.1371/journal.pone.0193840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499068	Green Published, Green Submitted, gold			2022-12-26	WOS:000426472300024
J	Pachaiappan, R; Tamboli, E; Acharya, A; Su, CH; Gopinath, SCB; Chen, Y; Velusamy, P				Pachaiappan, Raman; Tamboli, Ekant; Acharya, Aurovind; Su, Chia-Hung; Gopinath, Subash C. B.; Chen, Yeng; Velusamy, Palaniyandi			Separation and identification of bioactive peptides from stem of Tinospora cordifolia (Willd.) Miers	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITIES; ANTIOXIDANT ACTIVITY; PROTEIN HYDROLYSATE; FUNCTIONAL-PROPERTIES; LIPOSOME SYSTEM; POSSIBLE MODE; DIGESTION; CHROMATOGRAPHY; PURIFICATION; MECHANISMS	Enzyme hydrolysates (trypsin, papain, pepsin, a-chymotrypsin, and pepsin-pancreatin) of Tinospora cordifolia stem proteins were analyzed for antioxidant efficacy by measuring (1) 1,1-diphenyl-2-picrylhydrazyl (DPPH center dot) radical scavenging activity, (2) 2,20-azinobis(3-ethyl-benzothiazoline- 6-sulfonic acid) (ABTS(+)) radical scavenging capacity, and (3) Fe2+ chelation. Trypsin hydrolysate showed the strongest DPPH center dot scavenging, while alpha-chymotrypsin hydrolysate exhibited the highest ABTS(+) scavenging and Fe2+ chelation. Undigested protein strongly inhibited the gastrointestinal enzymes, trypsin (50% inhibition at enzyme/substrate ratio = 1: 6.9) and a-chymotrypsin (50% inhibition at enzyme/substrate ratio = 1: 1.82), indicating the prolonged antioxidant effect after ingestion. Furthermore, gel filtration purified peptide fractions of papain hydrolysates exhibited a significantly higher ABTS(+) and superoxide radical scavenging as compared to non-purified digests. Active fraction 9 showing the highest radical scavenging ability was further purified and confirmed by MALDI-TOF MS followed by MS/MS with probable dominant peptide sequences identified are VLYSTPVKM-WEPGR, VITVVATAGSETMR, and HIGININSR. The obtained results revealed that free radical scavenging capacity of papain hydrolysates might be related to its consistently low molecular weight hydrophobic peptides.	[Pachaiappan, Raman; Tamboli, Ekant; Acharya, Aurovind; Velusamy, Palaniyandi] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India; [Su, Chia-Hung] Ming Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn Arau, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn Kangar, Perlis, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Dept Oral & Craniofacial Sci, Kuala Lumpur, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr OCRCC, Kuala Lumpur, Malaysia	SRM Institute of Science & Technology Chennai; Ming Chi University of Technology; Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaya; Universiti Malaya	Pachaiappan, R (corresponding author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India.	pachaiappan.ra@ktr.srmuniv.ac.in	BIOTECH, SRMITE/AAW-8572-2020; Velusamy, Palaniyandi/AAA-6517-2022; Gopinath, Subash/D-2953-2015; Chen, Yeng -/A-6873-2011; Raman, Pachaiappan/O-2968-2019	Velusamy, Palaniyandi/0000-0002-6551-979X; Gopinath, Subash/0000-0002-8347-4687; Chen, Yeng -/0000-0002-0064-7678; Raman, Pachaiappan/0000-0003-2739-4882; Tamboli, Ekant/0000-0002-8649-4931; Su, Chia-Hung/0000-0002-4203-5143	University of Malaya Research grants-"MoE" [UM.C/625/1/HIR/MOE/DENT/09]; University of Malaya Research Grants (UMRG) [RG454-12HTM]	University of Malaya Research grants-"MoE"; University of Malaya Research Grants (UMRG)	Y. Chen thanks the support from University of Malaya Research grants-"MoE Grant UM.C/625/1/HIR/MOE/DENT/09". Dr. Yeng Chen would like to thank University of Malaya Research Grants (UMRG) RG454-12HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANASEV IB, 1989, BIOCHEM PHARMACOL, V38, P1763, DOI 10.1016/0006-2952(89)90410-3; Andrew SM, 2001, CURR PROTOC IMMUNOL, P1; Aranha I, 2012, J ETHNOPHARMACOL, V139, P366, DOI 10.1016/j.jep.2011.11.013; Arunvanan M., 2013, ASIAN J PHARM CLIN R, V6, P46; Bamdad F, 2011, J CEREAL SCI, V54, P20, DOI 10.1016/j.jcs.2011.01.006; Bayram T, 2008, TALANTA, V75, P705, DOI 10.1016/j.talanta.2007.12.007; Benov L, 2001, PROTOPLASMA, V217, P33, DOI 10.1007/BF01289410; Binsan W, 2008, FOOD CHEM, V106, P185, DOI 10.1016/j.foodchem.2007.05.065; Bourdon E, 2001, ANTIOXID REDOX SIGN, V3, P293, DOI 10.1089/152308601300185241; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Camargo ACM, 2012, C SERIES NEUROPEPTID; Chen HM, 1998, J AGR FOOD CHEM, V46, P49, DOI 10.1021/jf970649w; Cheng YH, 2006, J CENT SOUTH UNIV T, V13, P160, DOI 10.1007/s11771-006-0149-7; Cupp-Enyard C., 2008, JOVE, V19, P899, DOI [DOI 10.3791/899, 10.3791/899]; De Noni I., 2009, EFSA SCI REPORT, V231, P1, DOI DOI 10.2903/J.EFSA.2009.231R; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gupta R, 2009, INDIAN J BIOCHEM BIO, V46, P126; Hassan AB, 2007, FOOD CHEM, V102, P257, DOI 10.1016/j.foodchem.2006.04.043; Hattori M, 1998, J AGR FOOD CHEM, V46, P2167, DOI 10.1021/jf970484r; Jagetia GC, 2006, BIOL PHARM BULL, V29, P460, DOI 10.1248/bpb.29.460; Jamdar SN, 2012, J FOOD BIOCHEM, V36, P494, DOI 10.1111/j.1745-4514.2011.00562.x; Jang IC, 2010, J MED PLANTS RES, V4, P155; Jeong HJ, 2003, J AGR FOOD CHEM, V51, P7901, DOI 10.1021/jf034460y; Kangsanant S, 2014, INT J FOOD SCI TECH, V49, P1932, DOI 10.1111/ijfs.12551; Kaur M, 2014, J ADV PHARM TECHNOL, V5, P122, DOI 10.4103/2231-4040.137417; Kavitha B T, 2011, J Basic Clin Pharm, V2, P139; KLEIN IB, 1969, J BIOL CHEM, V244, P5928; Kong BH, 2006, J AGR FOOD CHEM, V54, P6059, DOI 10.1021/jf060632q; Kong BH, 2010, MEAT SCI, V85, P772, DOI 10.1016/j.meatsci.2010.04.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li B, 2007, FOOD CHEM, V102, P1135, DOI 10.1016/j.foodchem.2006.07.002; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Ma YY, 2010, FOOD CHEM, V118, P582, DOI 10.1016/j.foodchem.2009.05.024; Ma YY, 2009, J AGR FOOD CHEM, V57, P4372, DOI 10.1021/jf803670u; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Martos G, 2010, J AGR FOOD CHEM, V58, P5640, DOI 10.1021/jf904538w; Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Moure A, 2006, PROCESS BIOCHEM, V41, P447, DOI 10.1016/j.procbio.2005.07.014; Narkhede AN, 2014, INDIAN J EXP BIOL, V52, P808; Park PJ, 2001, J AM OIL CHEM SOC, V78, P651, DOI 10.1007/s11746-001-0321-0; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pihlanto A, 2006, INT DAIRY J, V16, P1306, DOI 10.1016/j.idairyj.2006.06.005; Rahees, 2013, IRANIAN J PHARM THER, V12, P30; Rajapakse N, 2005, J NUTR BIOCHEM, V16, P562, DOI 10.1016/j.jnutbio.2005.02.005; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Saiga A, 2003, J AGR FOOD CHEM, V51, P3661, DOI 10.1021/jf021156g; Saito K, 2003, J AGR FOOD CHEM, V51, P3668, DOI 10.1021/jf021191n; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Singh S. S., 2003, Indian Journal of Pharmacology, V35, P83; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suetsuna K, 2000, J NUTR BIOCHEM, V11, P128, DOI 10.1016/S0955-2863(99)00083-2; Sun J, 2004, J AGR FOOD CHEM, V52, P6646, DOI 10.1021/jf0495136; Tang XY, 2010, J AGR FOOD CHEM, V58, P587, DOI 10.1021/jf9028656; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; Thompson VF, 2003, BBA-PROTEINS PROTEOM, V1648, P140, DOI 10.1016/S1570-9639(03)00115-8; TURNER M W, 1970, Clinical and Experimental Immunology, V7, P603; Upadhyay Avnish K, 2010, Int J Ayurveda Res, V1, P112, DOI 10.4103/0974-7788.64405; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; Walther B, 2011, INT J VITAM NUTR RES, V81, P181, DOI 10.1024/0300-9831/a000054; Wani IA, 2015, FOOD RES INT, V76, P11, DOI 10.1016/j.foodres.2014.08.027; Wu HC, 2005, J FOOD DRUG ANAL, V13, P176; Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078; Zhu LJ, 2008, J AGR FOOD CHEM, V56, P2714, DOI 10.1021/jf703697e	69	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193717	10.1371/journal.pone.0193717	http://dx.doi.org/10.1371/journal.pone.0193717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494663	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200089
J	Bouzroud, S; Gouiaa, S; Hu, N; Bernadac, A; Mila, I; Bendaou, N; Smouni, A; Bouzayen, M; Zouine, M				Bouzroud, Sarah; Gouiaa, Sandra; Hu, Nan; Bernadac, Anne; Mila, Isabelle; Bendaou, Najib; Smouni, AbdelAziz; Bouzayen, Mondher; Zouine, Mohamed			Auxin Response Factors (ARFs) are potential mediators of auxin action in tomato response to biotic and abiotic stress (Solanum lycopersicum)	PLOS ONE			English	Article							LATERAL ROOT-FORMATION; ABSCISIC-ACID; EXPRESSION ANALYSIS; GENE FAMILY; POSSIBLE INVOLVEMENT; PROFILING REVEALS; ARABIDOPSIS; TRANSCRIPTION; AUX/IAA; LEAF	Survival biomass production and crop yield are heavily constrained by a wide range of environmental stresses. Several phytohormones among which abscisic acid (ABA), ethylene and salicylic acid (SA) are known to mediate plant responses to these stresses. By contrast, the role of the plant hormone auxin in stress responses remains so far poorly studied. Auxin controls many aspects of plant growth and development, and Auxin Response Factors play a key role in the transcriptional activation or repression of auxin-responsive genes through direct binding to their promoters. As a mean to gain more insight on auxin involvement in a set of biotic and abiotic stress responses in tomato, the present study uncovers the expression pattern of SlARF genes in tomato plants subjected to biotic and abiotic stresses. In silico mining of the RNAseq data available through the public TomExpress web platform, identified several SlARFs as responsive to various pathogen infections induced by bacteria and viruses. Accordingly, sequence analysis revealed that 5' regulatory regions of these SlARFs are enriched in biotic and abiotic stress-responsive cis-elements. Moreover, quantitative qPCR expression analysis revealed that many SlARFs were differentially expressed in tomato leaves and roots under salt, drought and flooding stress conditions. Further pointing to the putative role of SlARFs in stress responses, quantitative qPCR expression studies identified some miRNA precursors as potentially involved in the regulation of their SlARF target genes in roots exposed to salt and drought stresses. These data suggest an active regulation of SlARFs at the post-transcriptional level under stress conditions. Based on the substantial change in the transcript accumulation of several SlARF genes, the data presented in this work strongly support the involvement of auxin in stress responses thus enabling to identify a set of candidate SlARFs as potential mediators of biotic and abiotic stress responses.	[Bouzroud, Sarah; Gouiaa, Sandra; Hu, Nan; Bernadac, Anne; Mila, Isabelle; Bouzayen, Mondher; Zouine, Mohamed] Univ Toulouse, GBF, INRA, Castanet Tolosan, France; [Bouzroud, Sarah; Bendaou, Najib; Smouni, AbdelAziz] Univ Mohammed V Rabat, Lab Physiol & Biotechnol Vegetales, Ctr Biotechnol Vegetale & Microbienne Biodivers, Fac Sci, Rabat, Morocco	INRAE; Mohammed V University in Rabat	Zouine, M (corresponding author), Univ Toulouse, GBF, INRA, Castanet Tolosan, France.	mohamed.zouine@ensat.fr	Bouzayen, Mondher/AFQ-0802-2022; Bouzroud, Sarah/HCI-1338-2022; SMOUNI, Abdelaziz/GQZ-1979-2022	Isabelle, Mila/0000-0002-8878-0018; Smouni, Abdelaziz/0000-0003-2456-038X; Bouzroud, Sarah/0000-0001-9430-2242	"Laboratoire d'Excellence" (LABEX) entitled TULIP [ANR-10-LABX-41]; European COST [FA1106]; ANR TomEpiSet [ANR-16-CE20-0014]; TomGEM H2020 project; Hubert-Curien partnership program Volubilis [MA/12/280-27105PL]; CMCU [08G0906]	"Laboratoire d'Excellence" (LABEX) entitled TULIP; European COST(European Cooperation in Science and Technology (COST)); ANR TomEpiSet(French National Research Agency (ANR)); TomGEM H2020 project; Hubert-Curien partnership program Volubilis; CMCU	This research was supported by the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41) and benefited from networking activities within the European COST Action FA1106, from the ANR TomEpiSet (ANR-16-CE20-0014) project, the TomGEM H2020 project, by Hubert-Curien partnership program Volubilis (MA/12/280-27105PL) and CMCU program (08G0906) granted to Dr Habib Khoudi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to L. Lemonnier, D. Saint-Martin and O. Berseille for genetic transformation and culture of tomato plants. This research was supported by the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41) and benefited from networking activities within the European COST Action FA1106, from the ANR TomEpiSet (ANR-16-CE20-0014) project, the TomGEM H2020 project, by Hubert-Curien partnership program Volubilis (MA/12/280-27105PL) and CMCU program (08G0906) granted to Dr Habib Khoudi.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cao YR, 2008, PLANT SIGNAL BEHAV, V3, P761, DOI 10.4161/psb.3.10.5934; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chandler JW, 2016, PLANT CELL ENVIRON, V39, P1014, DOI 10.1111/pce.12662; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Cheng YF, 2007, J INTEGR PLANT BIOL, V49, P99, DOI 10.1111/j.1744-7909.2006.00412.x; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Curaba J, 2014, J EXP BOT, V65, P1425, DOI 10.1093/jxb/eru002; Deb A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137295; Dorantes-Acosta A. E., 2012, Frontiers in Genetics, V3, P256, DOI 10.3389/fgene.2012.00256; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Gharbi I, 2007, PLANT CELL ENVIRON, V30, P508, DOI 10.1111/j.1365-3040.2007.01640.x; Goh T, 2012, PHILOS T R SOC B, V367, P1461, DOI 10.1098/rstb.2011.0232; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hendelman A, 2012, PLANT MOL BIOL, V78, P561, DOI 10.1007/s11103-012-9883-4; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; HU W, 2015, FRONT PLANT SCI, V6; Dang HQ, 2011, PLANT SIGNAL BEHAV, V6, P1006, DOI 10.4161/psb.6.7.15502; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; Kirch HH, 1997, PLANT MOL BIOL, V33, P897, DOI 10.1023/A:1005759925962; Krizek BA, 2011, J EXP BOT, V62, P3311, DOI 10.1093/jxb/err127; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Lopez-Bucio J, 2005, PLANT PHYSIOL, V137, P681, DOI 10.1104/pp.104.049577; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mariani C, 2009, J EXP BOT; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Popko J, 2010, PLANT BIOLOGY, V12, P242, DOI 10.1111/j.1438-8677.2009.00305.x; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Trivedi Dipesh Kumar, 2013, Commun Integr Biol, V6, pe25260, DOI 10.4161/cib.25260; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290; Zouine M, 2017, PLANT J, V92, P727, DOI 10.1111/tpj.13711; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	87	73	77	8	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193517	10.1371/journal.pone.0193517	http://dx.doi.org/10.1371/journal.pone.0193517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489914	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000083
J	Woll, KA; Zhou, XJ; Bhanu, NV; Garcia, BA; Covarrubias, M; Miller, KW; Eckenhoff, RG				Woll, Kellie A.; Zhou, Xiaojuan; Bhanu, Natarajan V.; Garcia, Benjamin A.; Covarrubias, Manuel; Miller, Keith W.; Eckenhoff, Roderic G.			Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors	FASEB JOURNAL			English	Article						photoaffinity labeling; isoflurane; sevoflurane; crosslinking	GAMMA-AMINOBUTYRIC-ACID; GATED ION CHANNELS; GENERAL-ANESTHETICS; SYNAPTIC INHIBITION; SUBUNIT COMPOSITION; LIGAND; ISOFLURANE; PROPOFOL; SUBTYPES; PURIFICATION	Most general anesthetics enhance GABA type A (GABA(A)) receptor activity at clinically relevant concentrations. Sites of action of volatile anesthetics on the GABA(A) receptor remain unknown, whereas sites of action of many intravenous anesthetics have been identified in GABA(A) receptors by using photolabeling. Here, we used photoactivatable analogs of isoflurane (AziISO) and sevoflurane (AziSEVO) to locate their sites on (132L) and (13) GABA(A) receptors. As with isoflurane and sevoflurane, AziISO and AziSEVO enhanced the currents elicited by GABA. AziISO and AziSEVO each labeled 10 residues in (13) receptors and 9 and 8 residues, respectively, in (132L) receptors. Photolabeled residues were concentrated in transmembrane domains and located in either subunit interfaces or in the interface between the extracellular domain and the transmembrane domain. The majority of these transmembrane residues were protected from photolabeling with the addition of excess parent anesthetic, which indicated specificity. Binding sites were primarily located within +/- and +/- subunit interfaces, but residues in the +/- interface were also identified, which provided a basis for differential receptor subtype sensitivity. Isoflurane and sevoflurane did not always share binding sites, which suggests an unexpected degree of selectivity.Woll, K. A., Zhou, X., Bhanu, N. V., Garcia, B. A., Covarrubias, M., Miller, K. W., Eckenhoff, R. G. Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors.	[Woll, Kellie A.; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Zhou, Xiaojuan; Miller, Keith W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Jefferson University; Jefferson University	Eckenhoff, RG (corresponding author), Univ Penn, 311A John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Covarrubias, Manuel/0000-0002-0881-4143	U.S. National Institutes of Health [P01-GM55876, GM107117, GM110174, P01-GM58448, AI118891]; National Science Foundation Graduate Research Fellowship Program [DGE-1321851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, P01GM055876, R01GM107117, R01GM110174] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health Grants P01-GM55876, GM107117, GM110174, P01-GM58448 (National Institute of General Medical Sciences), and AI118891 (Department of Defense); and by the National Science Foundation Graduate Research Fellowship Program (DGE-1321851). The authors declare no conflicts of interest.	Arcario MJ, 2017, J BIOL CHEM, V292, P9480, DOI 10.1074/jbc.M117.780197; Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bayley H, 1983, LAB TECHNIQUES BIOCH, V12; Brickley SG, 1999, J NEUROSCI, V19, P2960; BROWN CL, 1983, NEUROSCI LETT, V35, P37, DOI 10.1016/0304-3940(83)90523-2; BROWN CL, 1984, J NEUROCHEM, V43, P272, DOI 10.1111/j.1471-4159.1984.tb06707.x; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; CURTIS DR, 1971, BRAIN RES, V32, P69, DOI 10.1016/0006-8993(71)90156-9; Dai SP, 2012, ANESTHESIOLOGY, V116, P816, DOI 10.1097/ALN.0b013e31824be0e3; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kinde MN, 2016, ANESTHESIOLOGY, V124, P664, DOI 10.1097/ALN.0000000000001005; Lambert S, 2005, EUR J PHARMACOL, V516, P23, DOI 10.1016/j.ejphar.2005.04.030; Lea WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007150; Lees G, 1998, ANESTHESIOLOGY, V88, P206, DOI 10.1097/00000542-199801000-00029; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Liang QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143363; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; MIHIC SJ, 1994, MOL PHARMACOL, V46, P851; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Ogawa SK, 2011, NEUROPHARMACOLOGY, V60, P701, DOI 10.1016/j.neuropharm.2010.11.016; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen Richard W, 2015, Adv Pharmacol, V73, P167, DOI 10.1016/bs.apha.2014.11.005; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Sanchis-Segura C, 2007, NEUROSCI LETT, V416, P275, DOI 10.1016/j.neulet.2007.02.024; Schrodinger L., 2017, PYMOL MOL GRAPHICS S; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Stewart DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111470; Tretter V, 1997, J NEUROSCI, V17, P2728; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Werner DF, 2011, J PHARMACOL EXP THER, V336, P134, DOI 10.1124/jpet.110.170431; Woll KA, 2017, ACS CHEM BIOL, V12, P1353, DOI 10.1021/acschembio.7b00222; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Woll KA, 2016, J BIOL CHEM, V291, P20473, DOI 10.1074/jbc.M116.736975; Woll KA, 2015, ACS CHEM NEUROSCI, V6, P927, DOI 10.1021/acschemneuro.5b00078; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zhang X, 2015, MOL CELL PROTEOMICS, V14, P724, DOI 10.1074/mcp.M114.042556	60	14	15	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4172	4189		10.1096/fj.201701347R	http://dx.doi.org/10.1096/fj.201701347R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505303	Green Published			2022-12-26	WOS:000439325400010
J	Itoh, H; Kadomatsu, T; Tanoue, H; Yugami, M; Miyata, K; Endo, M; Morinaga, J; Kobayashi, E; Miyamoto, T; Kurahashi, R; Terada, K; Mizuta, H; Oike, Y				Itoh, Hitoshi; Kadomatsu, Tsuyoshi; Tanoue, Hironori; Yugami, Masaki; Miyata, Keishi; Endo, Motoyoshi; Morinaga, Jun; Kobayashi, Eisuke; Miyamoto, Takeshi; Kurahashi, Ryoma; Terada, Kazutoyo; Mizuta, Hiroshi; Oike, Yuichi			TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; INTEGRATIVE ANALYSIS; DNA METHYLATION; STROMAL CELLS; C-MYC; CANCER; EXPRESSION; METABOLISM; GROWTH; STAT3	The tumor microenvironment promotes epigenetic changes in tumor cells associated with tumor aggressiveness. Here we report that in primary tumor cells, increased interleukin-6 (IL-6) expression brought on by DNA demethylation of its promoter by ten-eleven translocation 2 (TET2) promotes lung metastasis in osteosarcoma (OS). Xenograft experiments show increased IL-6 expression and decreased methylation of its promoter in OS cells after implantation relative to before implantation. In addition, changes in IL-6 methylation and expression seen in OS cells at the primary site were maintained at the metastatic site. TET2 knockdown in OS cells suppressed upregulation of IL-6 and demethylation of its promoter in xenograft tumors and decreased tumor metastasis. We also present evidence showing that tumor cell-derived IL-6 facilitates glycolytic metabolism in tumor cells by activating the MEK/ERK1/2/hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha) pathway and increases lung colonization by OS cells by upregulating expression of intercellular adhesion molecule-1 (ICAM-1), enhancing tumor metastasis. Blocking IL-6 signaling with a humanized monoclonal antibody against the IL-6 receptor reduced lung metastasis and prolonged survival of xenografted mice. These findings suggest that TET2-dependent IL-6 induction enables acquisition of aggressive phenotypes in OS cells via the tumor microenvironment and that blocking IL-6 signaling could be serve as a potential therapy to antagonize metastasis.	[Itoh, Hitoshi; Kadomatsu, Tsuyoshi; Tanoue, Hironori; Yugami, Masaki; Miyata, Keishi; Endo, Motoyoshi; Morinaga, Jun; Kurahashi, Ryoma; Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Itoh, Hitoshi; Tanoue, Hironori; Yugami, Masaki; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Morinaga, Jun] Kumamoto Univ, Grad Sch Med Sci, Clin Res Ctr, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Morinaga, Jun] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Kobayashi, Eisuke; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608525, Japan; [Kobayashi, Eisuke] Natl Canc Ctr, Div Muscloskeletal Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Kurahashi, Ryoma] Kumamoto Univ, Grad Sch Med Sci, Dept Urol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Oike, Yuichi] Japan Agcy Med Res & Dev, AMED, CREST, Tokyo, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Keio University; National Cancer Center - Japan; Kumamoto University; Japan Science & Technology Agency (JST)	Kadomatsu, T; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.; Oike, Y (corresponding author), Japan Agcy Med Res & Dev, AMED, CREST, Tokyo, Japan.	tkado@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Endo, Motoyoshi/T-5840-2019; Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26116722, 15K06836, 17K08663]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) [13417915]; CREST program of the Japan Agency for Medical Research and Development (AMED) [17gm0610007h0005]	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); CREST program of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	We thank our colleagues for valuable suggestions and discussion. We also thank K. Tabu, N. Shirai, S. Iwaki, Y. Shogenji, and M. Kamada for technical assistance. This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant 26116722 to YO, grant 15K06836 to TK, grant 17K08663 to ME), and by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (grant 13417915 to YO) and by the CREST program of the Japan Agency for Medical Research and Development (AMED) (grant 17gm0610007h0005 to YO).	Agger K, 2016, GENE DEV, V30, P1278, DOI 10.1101/gad.280495.116; Alfranca A, 2015, CELL MOL LIFE SCI, V72, P3097, DOI 10.1007/s00018-015-1918-y; Avnet S, 2017, INT J CANCER, V140, P1331, DOI 10.1002/ijc.30540; Baglio SR, 2017, CLIN CANCER RES, V23, P3721, DOI 10.1158/1078-0432.CCR-16-2726; Bharti R, 2016, CANCER LETT, V375, P51, DOI 10.1016/j.canlet.2016.02.048; Bian ZY, 2010, CANCER SCI, V101, P2554, DOI 10.1111/j.1349-7006.2010.01731.x; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chen QC, 2015, MOL MED REP, V12, P219, DOI 10.3892/mmr.2015.3375; Cortini M, 2017, CANCER LETT, V405, P90, DOI 10.1016/j.canlet.2017.07.024; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Deng M, 2017, CANCER RES, V77, P6069, DOI 10.1158/0008-5472.CAN-16-2964; Eason K, 2016, CANCER RES, V76, P5195, DOI 10.1158/0008-5472.CAN-16-0141; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Flint TR, 2017, TRENDS MOL MED, V23, P451, DOI 10.1016/j.molmed.2017.03.001; Gianferante DM, 2017, NAT REV ENDOCRINOL, V13, P480, DOI 10.1038/nrendo.2017.16; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Goumas FA, 2015, INT J CANCER, V137, P1035, DOI 10.1002/ijc.29445; Guo X, 2011, NEOPLASMA, V58, P153, DOI 10.4149/neo_2011_02_153; Han J, 2016, ONCOL LETT, V12, P4665, DOI 10.3892/ol.2016.5227; Han XG, 2015, CANCER LETT, V369, P405, DOI 10.1016/j.canlet.2015.09.002; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He XD, 2016, CANCER BIOL THER, V17, P188, DOI 10.1080/15384047.2016.1139228; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Isobe A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118080; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kadomatsu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057921; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Lamora A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5110096; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; Meyer FRL, 2015, VET J, V206, P67, DOI 10.1016/j.tvjl.2015.06.003; Mylonis I, 2017, J CELL SCI, V130, P466, DOI 10.1242/jcs.195339; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Ohba T, 2014, MOL CANCER RES, V12, P1100, DOI 10.1158/1541-7786.MCR-14-0037; Ohba T, 2014, J BONE MINER RES, V29, P1431, DOI 10.1002/jbmr.2182; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Qiu GZ, 2017, TRENDS PHARMACOL SCI, V38, P669, DOI 10.1016/j.tips.2017.05.002; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reimann E, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0020-0; Rokavec M, 2016, CELL MOL LIFE SCI, V73, P23, DOI 10.1007/s00018-015-2045-5; Sechler M, 2017, ONCOGENE, V36, P4150, DOI 10.1038/onc.2017.44; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Smida J, 2017, INT J CANCER, V141, P816, DOI 10.1002/ijc.30778; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Ueda J, 2014, MOL CELL BIOL, V34, P3702, DOI 10.1128/MCB.00099-14; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wilson C, 2017, ONCOGENE, V36, P2565, DOI 10.1038/onc.2016.412; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu MZ, 2015, CANCER RES, V75, P3912, DOI 10.1158/0008-5472.CAN-14-3208; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254	70	33	33	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2903	2920		10.1038/s41388-018-0160-0	http://dx.doi.org/10.1038/s41388-018-0160-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29515232				2022-12-26	WOS:000433936300001
J	Gallo-Ebert, C; Francisco, J; Liu, HY; Draper, R; Modi, K; Hayward, MD; Jones, BK; Buiakova, O; McDonough, V; Nickels, JT				Gallo-Ebert, Christina; Francisco, Jamie; Liu, Hsing-Yin; Draper, Riley; Modi, Kinnari; Hayward, Michael D.; Jones, Beverly K.; Buiakova, Olesia; McDonough, Virginia; Nickels, Joseph T., Jr.			Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; BILE-ACID METABOLISM; FIBROBLAST GROWTH FACTOR-21; CHRONIC VIRAL-HEPATITIS; TRIGLYCERIDE SYNTHESIS; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; LIPID-METABOLISM; PROTECTS MICE	Metabolic syndrome (MetS) is a term used to characterize individuals having at least three of the following diseases: obesity, dyslipidemia, hyperglycemia, insulin resistance, hypertension, and nonalcoholic fatty liver disease (NAFLD). It is widespread, and the number of individuals with MetS is increasing. However, the events leading to the manifestation of MetS are not well-understood. Here, we show that loss of murine ARV1 (mARV1) results in resistance to acquiring diseases associated with MetS. Arv1(-/-) animals fed a high-fat diet were resistant to diet-induced obesity, had lower blood cholesterol and triglyceride levels, and retained glucose tolerance and insulin sensitivity. Livers showed no gross morphological changes, contained lower levels of cholesterol, triglycerides, and fatty acids, and showed fewer signs of NAFLD. Knockout animals had elevated levels of liver farnesol X receptor (FXR) protein and its target, small heterodimer protein (SHP). They also had decreased levels of CYP7 alpha 1, CYP8 beta 1, and mature SREBP1 protein, evidence suggesting that liver FXR signaling was activated. Strengthening this hypothesis was the fact that peroxisome proliferator-activating receptor alpha (PPAR alpha) protein was elevated, along with its target, fibroblast growth factor 21 (FGF21). Arv1(-/-) animals excreted more fecal cholesterol, free fatty acids, and bile acids. Their small intestines had 1) changes in bile acid composition, 2) an increase in the level of the intestinal FXR antagonist, tauromuricholic acid, and 3) showed signs of attenuated FXR signaling. Overall, we believe that ARV1 function is deleterious when consuming a high-fat diet. We further hypothesize that ARV1 is critical for initiating events required for the progression of diseases associated with MetS and NAFLD.	[Gallo-Ebert, Christina; Francisco, Jamie; Liu, Hsing-Yin; Modi, Kinnari; Nickels, Joseph T., Jr.] Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA; [Draper, Riley; McDonough, Virginia] Hope Coll, Holland, MI 49423 USA; [Hayward, Michael D.; Jones, Beverly K.; Buiakova, Olesia] Invivotek, Genesis Biotechnol Grp, Hamilton, NJ 08691 USA; [Nickels, Joseph T., Jr.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Hope College; Rutgers State University New Brunswick	Nickels, JT (corresponding author), Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Draper, Riley/0000-0002-7158-1936; Gallo-Ebert, Christina/0000-0003-0985-3547; Draper, Riley/0000-0002-4968-922X	Genesis Biotechnology Group	Genesis Biotechnology Group	This work was supported by the Genesis Biotechnology Group. The authors declare that they have no conflicts of interest with the contents of this article.	AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Balsan GA, 2015, REV ASSOC MED BRAS, V61, P72, DOI 10.1590/1806-9282.61.01.072; Banh T, 2015, J LIPID RES, V56, P379, DOI 10.1194/jlr.M055228; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee IA, 2010, NUTR RES REV, V23, P146, DOI 10.1017/S0954422410000028; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Crujeiras AB, 2015, LIFE SCI, V140, P57, DOI 10.1016/j.lfs.2015.05.003; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; EDER K, 1993, CLIN CHIM ACTA, V219, P93, DOI 10.1016/0009-8981(93)90200-N; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fazio S, 2001, FRONT BIOSCI-LANDMRK, V6, pD515, DOI 10.2741/Fazio; Feitosa MF, 2005, J LIPID RES, V46, P281, DOI 10.1194/jlr.M400252-JLR200; Ferrell JM, 2016, J LIPID RES, V57, P1144, DOI 10.1194/jlr.M064709; Flak JN, 2016, MOL ENDOCRINOL, V30, P3, DOI 10.1210/me.2015-1232; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Gallo-Ebert C, 2012, FUNGAL GENET BIOL, V49, P101, DOI 10.1016/j.fgb.2011.11.006; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Georgiev AG, 2013, TRAFFIC, V14, P912, DOI 10.1111/tra.12082; Gluchowski NL, 2017, J LIPID RES, V58, P1230, DOI 10.1194/jlr.P075119; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Gonzalez FJ, 2017, DIGEST DIS, V35, P178, DOI 10.1159/000450908; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Imaizumi S, 2011, CIRC J, V75, P1533, DOI 10.1253/circj.CJ-11-0460; Imbriglio JE, 2015, J MED CHEM, V58, P9345, DOI 10.1021/acs.jmedchem.5b01345; Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008; ISHIDA BY, 1991, J LIPID RES, V32, P559; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khan A, 2008, PHYSIOL BEHAV, V93, P588, DOI 10.1016/j.physbeh.2007.10.019; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Lagor WR, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.32; Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; McDonough VM, 2004, ANTON LEEUW INT J G, V86, P349, DOI 10.1007/s10482-004-0515-0; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Ni D., 2017, CURR PROTOC PROTEIN, V88, DOI DOI 10.10.1; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Ohshiro T, 2015, EXPERT OPIN THER PAT, V25, P145, DOI 10.1517/13543776.2014.989833; Padmalayam I, 2013, CURR PHARM DESIGN, V19, P5755, DOI 10.2174/13816128113199990360; PAIGEN B, 1987, BIOCHEM GENET, V25, P881, DOI 10.1007/BF00502607; Palmer EE, 2016, HUM MOL GENET, V25, P3042, DOI 10.1093/hmg/ddw157; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Qi YP, 2015, BBA-MOL CELL BIOL L, V1851, P19, DOI 10.1016/j.bbalip.2014.04.008; ROSSI SS, 1987, J LIPID RES, V28, P589; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Ruggles KV, 2014, J BIOL CHEM, V289, P4417, DOI 10.1074/jbc.M113.515197; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sun RB, 2017, MOL PHARMACOL, V91, P110, DOI 10.1124/mol.116.106617; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; Targher G, 2016, DIABETES METAB, V42, P142, DOI 10.1016/j.diabet.2016.04.002; Than NN, 2015, ATHEROSCLEROSIS, V239, P192, DOI 10.1016/j.atherosclerosis.2015.01.001; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Villasmil ML, 2011, FEMS YEAST RES, V11, P524, DOI 10.1111/j.1567-1364.2011.00737.x; Villasmil ML, 2011, GENETICS, V187, P455, DOI 10.1534/genetics.110.120725; Wall PM, 2000, BEHAV BRAIN RES, V109, P229, DOI 10.1016/S0166-4328(99)00177-1; Wang HY, 2013, FERTIL STERIL, V99, P241, DOI 10.1016/j.fertnstert.2012.08.030; Warita K, 2006, J VET MED SCI, V68, P1257, DOI 10.1292/jvms.68.1257; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Xie C, 2017, DIABETES, V66, P613, DOI 10.2337/db16-0663; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	97	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5956	5974		10.1074/jbc.RA117.000800	http://dx.doi.org/10.1074/jbc.RA117.000800			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491146	hybrid, Green Published			2022-12-26	WOS:000430497300017
J	Wei, FF; Trenson, S; Monney, P; Yang, WY; Pruijm, M; Zhang, ZY; Bouatou, Y; Huang, QF; Ponte, B; Martin, PY; Thijs, L; Kuznetsova, T; Allegaert, K; Janssens, S; Vermeer, C; Verhamme, P; Burnier, M; Bochud, M; Ehret, G; Staessen, JA				Wei, Fang-Fei; Trenson, Sander; Monney, Pierre; Yang, Wen-Yi; Pruijm, Menno; Zhang, Zhen-Yu; Bouatou, Yassine; Huang, Qi-Fang; Ponte, Belen; Martin, Pierre-Yves; Thijs, Lutgarde; Kuznetsova, Tatiana; Allegaert, Karel; Janssens, Stefan; Vermeer, Cees; Verhamme, Peter; Burnier, Michel; Bochud, Murielle; Ehret, Georg; Staessen, Jan A.			Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; PRESERVED EJECTION FRACTION; K-DEPENDENT PROTECTION; VITAMIN-K; HEART-FAILURE; MENAQUINONE-7 SUPPLEMENTATION; ARTERIAL STIFFNESS; POWERFUL PREDICTOR; GENERAL-POPULATION; FILLING PRESSURE	Objectives A novel paradigm of diastolic left ventricular (LV) dysfunction proposes involvement of the cardiac microvasculature. Vitamin K dependent matrix Gla protein (MGP) plays a role in preserving microcirculatory integrity. We hypothesized that LV filling pressure a measure of diastolic LV dysfunction increases with higher plasma level of inactive desphospho-uncar-boxylated MGP (dp-ucMGP). We also studied the distribution of active and inactive MGP in human myocardium. Methods We measured echocardiographic diastolic LV function and plasma dp-ucMGP (ELISA) in 668 Flemish and for replication in 386 Swiss. Results Among Flemish and Swiss, E/e' (6.78 vs. 6.73) and dp-ucMGP (3.94 mu g/L vs. 4.20 mu g/L) were similarly distributed. In multivariable-adjusted models, for each doubling of dp-ucMGP, E/e' increased by 0.26, 0.33 and 0.31 in Flemish, Swiss and both cohorts combined (P <= 0.026); the odds ratios for having E/e' >= 8.5 were 1.99, 3.29 and 2.36, respectively (P <= 0.017). Cardiac biopsies from patients with ischemic or dilated cardiomyopathy and healthy hearts (n = 4 for each) were stained with conformation-specific MGP antibodies. In diseased compared with normal hearts, uncarboxylated inactive MGP was more prevalent (P <= 0.004) in the perivascular matrix and interstitium (204.4 vs. 8.6 mu m2 per field) and phosphorylated active MGP in and around capillaries and interstitial cells (31.3 vs. 6.6 number of positive capillaries and cells per field). Conclusions Our study supports a role of activated MGP in maintaining myocardial integrity and diastolic LV performance and can potentially be translated into new strategies for managing diastolic LV dysfunction and preventing its progression to heart failure.	[Wei, Fang-Fei; Yang, Wen-Yi; Zhang, Zhen-Yu; Huang, Qi-Fang; Thijs, Lutgarde; Kuznetsova, Tatiana; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Trenson, Sander; Janssens, Stefan] Univ Hosp Leuven, Div Cardiol, Leuven, Belgium; [Monney, Pierre] Univ Lausanne, Dept Cardiol, CHU Vaudois, Lausanne, Switzerland; [Pruijm, Menno; Burnier, Michel] Univ Hosp Lausanne, Dept Nephrol, Lausanne, Switzerland; [Bouatou, Yassine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Ponte, Belen; Martin, Pierre-Yves] Univ Hosp Geneva, Dept Nephrol, Geneva, Switzerland; [Allegaert, Karel] Univ Leuven, Dept Dev & Regenerat, Res Unit Organ Syst, Leuven, Belgium; [Allegaert, Karel] Sophia Childrens Univ Hosp, Dept Pediat Surg, Erasmus Med Ctr, Rotterdam, Netherlands; [Vermeer, Cees; Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands; [Verhamme, Peter] Univ Leuven, Dept Cardiovasc Sci, Res Unit Mol & Vasc Biol, Leuven, Belgium; [Bochud, Murielle] Univ Hosp Lausanne, Inst Social & Prevent Med, Div Chron Dis, Lausanne, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland; [Ehret, Georg] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA	KU Leuven; KU Leuven; University Hospital Leuven; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Geneva; KU Leuven; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Maastricht University; KU Leuven; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Johns Hopkins University	Staessen, JA (corresponding author), Univ Leuven, Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium.; Staessen, JA (corresponding author), Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands.	jan.staessen@med.kuleuven.be	EHRET, Georg B/A-9532-2009; allegaert, karel/C-3611-2016; Staessen, Jan A/A-1065-2011; Pruijm, Menno/AAA-4281-2020; Yang, Wenyi/ABA-5526-2021; Zhang, Zhenyu/GZL-8479-2022; Kuznetsova, Tatiana/ABI-5662-2020	EHRET, Georg B/0000-0002-5730-0675; allegaert, karel/0000-0001-9921-5105; Staessen, Jan A/0000-0002-3026-1637; Pruijm, Menno/0000-0003-1027-1851; Zhang, Zhenyu/0000-0002-3785-7417; Kuznetsova, Tatiana/0000-0003-4293-4576; Verhamme, Anne/0000-0002-2201-1865; Thijs, Lutgarde/0000-0002-8108-2356	European Union [HEALTH-F7-305507 HOMAGE]; European Research Council [2011-294713-EPLORE, 713601-uPROPHET]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, 1103416N]; Swiss National Science Foundation [FN 33CM30-140331/1]; Fondation pour Recherches Medicales, Geneva, Switzerland; Maastricht University, The Netherlands	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation pour Recherches Medicales, Geneva, Switzerland; Maastricht University, The Netherlands(Netherlands Government)	The European Union (HEALTH-F7-305507 HOMAGE and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and 1103416N) currently support the Studies Coordinating Centre in Leuven. The Swiss National Science Foundation funded the Swiss Kidney Project on Genes in Hypertension (FN 33CM30-140331/1). G Ehret is supported by the Fondation pour Recherches Medicales, Geneva, Switzerland. The EPLORE grant paid for the plasma dp ucMGP measurement at R&D Group VitaK (Maastricht University, The Netherlands). Jan A. Staessen was a scientific adviser to R&D Group VitaK, but did never receive any monetary or other compensation from VitaK. Cees Vermeer was an employee of and received a salary from R&D Group VitaK, but this did not influence the study design, decision to publish or the preparation of the manuscript. Likewise the funders providing support to the Academic Partners in the form of authors' salaries (FFW, ST, WYY, ZYZ, QFH, LT) did not have any role in the study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Blomstrand P, 2015, EUR HEART J-CARD IMG, V16, P1000, DOI 10.1093/ehjci/jev027; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cagavi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110752; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Dalmeijer GW, 2012, ATHEROSCLEROSIS, V225, P397, DOI 10.1016/j.atherosclerosis.2012.09.019; FRASER JD, 1988, J BIOL CHEM, V263, P11033; Goiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080344; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Han PD, 2016, NATURE, V534, P700, DOI 10.1038/nature18310; Hillis GS, 2004, J AM COLL CARDIOL, V43, P360, DOI 10.1016/j.jacc.2003.07.044; Hu CW, 2014, PFLUG ARCH EUR J PHY, V466, P2049, DOI 10.1007/s00424-014-1459-5; Kloch-Badelek M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-10; Knapen MHJ, 2015, THROMB HAEMOSTASIS, V113, P1135, DOI 10.1160/TH14-08-0675; Kuznetsova T, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002882; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Liu YP, 2015, HYPERTENSION, V65, P463, DOI 10.1161/HYPERTENSIONAHA.114.04494; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Okura H, 2006, HEART, V92, P1248, DOI 10.1136/hrt.2005.082594; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pivin E, 2015, HYPERTENSION, V66, P85, DOI 10.1161/HYPERTENSIONAHA.115.05177; Pruijm MT, 2010, BLOOD PRESS MONIT, V15, P322, DOI 10.1097/MBP.0b013e32833f56a8; Riphagen IJ, 2016, CLIN CHEM LAB MED, V54, P1201, DOI 10.1515/cclm-2015-0864; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Sharp ASP, 2010, EUR HEART J, V31, P747, DOI 10.1093/eurheartj/ehp498; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Venardos N, 2015, J SURG RES, V199, P1, DOI 10.1016/j.jss.2015.04.076; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Wang M, 2005, J HYPERTENS, V23, P183, DOI 10.1097/00004872-200501000-00029; Wei FF, 2018, NEPHROL DIAL TRANSPL, V33, P1122, DOI 10.1093/ndt/gfx258; Wei FF, 2016, PULSE, V4, P85, DOI 10.1159/000448008; Wei FF, 2016, EBIOMEDICINE, V4, P162, DOI 10.1016/j.ebiom.2016.01.011; Wiley DM, 2011, SEMIN CELL DEV BIOL, V22, P1012, DOI 10.1016/j.semcdb.2011.10.005; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193967	10.1371/journal.pone.0193967	http://dx.doi.org/10.1371/journal.pone.0193967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529056	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000427189300037
J	Chen, CY; Huang, EJC; Kuo, CN; Wu, PL; Chen, CL; Wu, PC; Wu, SH; King, YC; Lai, CH				Chen, Chau-Yin; Huang, Evelyn Jou-Chen; Kuo, Chien-Neng; Wu, Pei-Lun; Chen, Ching-Lung; Wu, Pei-Chen; Wu, Shin-Hua; King, Yin-Chi; Lai, Chien-Hsiung			The relationship between age, axial length and retinal nerve fiber layer thickness in the normal elderly population in Taiwan: The Chiayi eye study in Taiwan	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD DEFECTS; MULTIPLE-SCLEROSIS; GLAUCOMA; OCT; DISEASES; MYOPIA	Aims To interpret how the thickness of the peripapillary retinal nerve fiber layer (RNFL) changes with increasing age, axial length, or anterior chamber depth as measured by spectral domain optical coherence tomography (OCT) in the normal elderly population in Taiwan. Methods A total of 82 volunteers (143 eyes) were enrolled. Generalized estimating equations were used to evaluate the correlation. Results The RNFL was significantly thinner in the superonasal (p = 0.004), inferotemporal (p = 0.046), and temporolower (p = 0.009) segments with age. The same trend was also observed in the superotemporal (p = 0.330) segment, although it was not statistically significant. The global RNFL thickness decreased by 4.97 mu m per decade (beta = -0.497; p = 0.021), and thinning was significant in the superonasal (-9.90 mu m per decade, p < 0.001) and temporolower (-6.78 mu m per decade, p < 0.001) segments; the same trend showed borderline significance in the superotemporal (-6.96 mu m per decade, p = 0.073) and inferotemporal (-7.23 mu m per decade, p = 0.059) segments. In eyes with longer axial length, the RNFLs significantly decreased in the non-temporal segments. Global RNFL thickness decreased by 3.086 mu m for each additional millimeter of axial length (beta = -3.086; p < 0.001). Conclusions Changes in RNFL thickness were correlated with age in the superonasal, superotemporal, inferotemporal, and temporolower segments, and were correlated with axial length in the non-temporal segments. Anterior chamber depth was not correlated with RNFL thickness.	[Chen, Chau-Yin; Huang, Evelyn Jou-Chen; Kuo, Chien-Neng; Wu, Pei-Lun; Chen, Ching-Lung; Wu, Pei-Chen; King, Yin-Chi; Lai, Chien-Hsiung] Chang Gung Mem Hosp, Dept Ophthalmol, Chiayi, Taiwan; [Chen, Chau-Yin; Huang, Evelyn Jou-Chen; Kuo, Chien-Neng; Wu, Pei-Lun; Chen, Ching-Lung; Wu, Pei-Chen; King, Yin-Chi; Lai, Chien-Hsiung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Shin-Hua] China Med Univ, Beigang Hosp, Dept Ophthalmol, Yunlin, Taiwan; [Lai, Chien-Hsiung] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; Chang Gung University of Science & Technology	Lai, CH (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Chiayi, Taiwan.; Lai, CH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lai, CH (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan.	oph4557@gmail.com			Chang Gung Memorial Hospital Chiayi Branch [CMRPG6C0221]	Chang Gung Memorial Hospital Chiayi Branch	This study was funded by Chang Gung Memorial Hospital Chiayi Branch (grant number: CMRPG6C0221) to CHL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Chen L, 2013, INVEST OPHTH VIS SCI, V54, P7990, DOI 10.1167/iovs.12-11252; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Dhami A, 2016, J CLIN DIAGN RES, V10, pNC15, DOI 10.7860/JCDR/2016/15038.7672; Feuer WJ, 2011, J GLAUCOMA, V20, P133, DOI 10.1097/IJG.0b013e3181e079b2; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Greenfield DS, 2008, AM J OPHTHALMOL, V145, P598, DOI 10.1016/j.ajo.2007.12.018; Harizman N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1579, DOI 10.1001/archopht.124.11.1579; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang EJC, 2014, EYE, V28, P705, DOI 10.1038/eye.2014.55; Jones-Odeh E, 2015, EYE, V29, P1270, DOI 10.1038/eye.2015.158; Jones-Odeh E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34116; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; Kim MJ, 2010, BRIT J OPHTHALMOL, V94, P115, DOI 10.1136/bjo.2009.162206; Kromer Robert, 2014, Front Psychiatry, V5, P22, DOI 10.3389/fpsyt.2014.00022; Lee Jong Yeon, 2012, Korean J Ophthalmol, V26, P163, DOI 10.3341/kjo.2012.26.3.163; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Mwanza JC, 2011, J GLAUCOMA, V20, P37, DOI 10.1097/IJG.0b013e3181ccb93b; Pakravan Mohammad, 2009, J Ophthalmic Vis Res, V4, P220; Pareja-Esteban J., 2009, Arch Soc Esp Oftalmol, V84, P305; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Rougier MB, 2015, ACTA OPHTHALMOL, V93, P539, DOI 10.1111/aos.12658; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Vemon SA, 2008, BRIT J OPHTHALMOL, V92, P1076, DOI 10.1136/bjo.2007.127571; Wu H, 2015, EYE, V29, P525, DOI 10.1038/eye.2014.317; Yalvac IS, 2009, J GLAUCOMA, V18, P53, DOI 10.1097/IJG.0b013e318179f751	31	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194116	10.1371/journal.pone.0194116	http://dx.doi.org/10.1371/journal.pone.0194116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522558	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800043
J	Lee, HS; Park, T				Lee, Ho-Sun; Park, Taesung			Nuclear receptor and VEGF pathways for gene-blood lead interactions, on bone mineral density, in Korean smokers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPOSURE; CADMIUM; ASSOCIATIONS; ENVIRONMENT; COEXPOSURE; OSTEOBLAST; LEVEL; MASS; WNT	Osteoporosis has a complex etiology and is considered a multifactorial polygenic disease, in which genetic determinants are modulated by hormonal, lifestyle, environmental, and nutritional factors. Therefore, investigating these multiple factors, and the interactions between them, might lead to a better understanding of osteoporosis pathogenesis, and possible therapeutic interventions. The objective of this study was to identify the relationship between three blood metals (Pb, Cd, and Al), in smoking and nonsmoking patients' sera, and prevalence of osteoporosis. In particular, we focused on gene-environment interactions of metal exposure, including a dataset obtained through genome-wide association study (GWAS). Subsequently, we conducted a pathway-based analysis, using a GWAS dataset, to elucidate how metal exposure influences susceptibility to osteoporosis. In this study, we evaluated blood metal exposures for estimating the prevalence of osteoporosis in 443 participants (aged 53.24 +/- 8.29), from the Republic of Korea. Those analyses revealed a negative association between lead blood levels and bone mineral density in current smokers (p trend <0.01). By further using GWAS-based pathway analysis, we found nuclear receptor (FDR<0.05) and VEGF pathways (FDR<0.05) to be significantly upregulated by blood lead burden, with regard to the prevalence of osteoporosis, in current smokers. These findings suggest that the intracellular pathways of angiogenesis and nuclear hormonal signaling can modulate interactions between lead exposure and genetic variation, with regard to susceptibility to diminished bone mineral density. Our findings may provide new leads for understanding the mechanisms underlying the development of osteoporosis, including possible interventions.	[Lee, Ho-Sun; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Gwanak 1 Gwanak Ro, Seoul, South Korea; [Lee, Ho-Sun; Park, Taesung] Seoul Natl Univ, Dept Stat, Gwanak 1 Gwanak Ro, Seoul, South Korea; [Lee, Ho-Sun] Daegu Inst, Natl Forens Serv, Waegwon Eup, Gyeomgsamgbuk D, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Forensic Service	Park, T (corresponding author), Seoul Natl Univ, Interdisciplinary Program Bioinformat, Gwanak 1 Gwanak Ro, Seoul, South Korea.; Park, T (corresponding author), Seoul Natl Univ, Dept Stat, Gwanak 1 Gwanak Ro, Seoul, South Korea.	tspark@stat.snu.ac.kr	Lee, Ho-Sun/AAD-6112-2019	Lee, Ho-Sun/0000-0003-2864-015X	Bio-Synergy Research Project [2013M3A9C4078158]; Ministry of Science, ICT and Future Planning, through the Korean National Research Foundation; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C2165]	Bio-Synergy Research Project; Ministry of Science, ICT and Future Planning, through the Korean National Research Foundation; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by a Bio-Synergy Research Project funding award (2013M3A9C4078158), as bestowed by the Ministry of Science, ICT and Future Planning, through the Korean National Research Foundation and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2165).	AKAIKE H, 1981, CC/ENG TECH APPL SCI, P22; Baek T-H, 2015, BMC PUBLIC HEALTH, V15, P1; Barbeito AG, 2010, NEUROBIOL DIS, V37, P574, DOI 10.1016/j.nbd.2009.11.007; Beier EE, 2016, TOXICOL SCI, V149, P277, DOI 10.1093/toxsci/kfv234; Beier EE, 2014, J ORTHOP RES, V32, P1397, DOI 10.1002/jor.22677; Beier EE, 2013, ENVIRON HEALTH PERSP, V121, P97, DOI 10.1289/ehp.1205374; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Campbell JR, 2007, ENVIRON HEALTH PERSP, P1018; Cao SZ, 2016, CHEMOSPHERE, V147, P404, DOI 10.1016/j.chemosphere.2015.12.134; Carmouche JJ, 2005, ENVIRON HEALTH PERSP, V113, P749, DOI 10.1289/ehp.7596; Chen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37809; Chen X, 2014, BONE, V63, P76, DOI 10.1016/j.bone.2014.02.017; Chowdhury S, 2015, DATABASE-OXFORD, DOI 10.1093/database/bau126; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Ericson B, 2016, ANN GLOBAL HLTH; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Gambelunghe A, 2016, ENVIRON RES, V149, P157, DOI 10.1016/j.envres.2016.05.015; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Gruber HE, 1997, MINER ELECTROL METAB, V23, P65; Hambach R, 2013, TOXICOL LETT, V222, P233, DOI 10.1016/j.toxlet.2013.06.218; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hu Q., 2015, TOBACCO SMOKE EXPOSU; Imai Y, 2013, PHYSIOL REV, V93, P481, DOI 10.1152/physrev.00008.2012; Jin HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135285; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Jin ZX, 2015, MOL ENDOCRINOL, V29, P172, DOI 10.1210/me.2014-1316; Jung SY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008218; Karasik D, 2016, NATURE REV RHEUMATOL; Khalil N, 2014, J AM GERIATR SOC, V62, P141, DOI 10.1111/jgs.12603; Kim Y, 2016, INT J EPIDEMIOL; Kung Annie W. C., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P26; Li C, 2016, J BIOSCI BIOENG, V121, P213, DOI 10.1016/j.jbiosc.2015.05.017; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Marini M, 2015, ACTA HISTOCHEM, V117, P228, DOI 10.1016/j.acthis.2015.02.006; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Mitra P, 2017, CRIT REV CL LAB SCI, V54, P506, DOI 10.1080/10408363.2017.1408562; MONTEAGUDO FSE, 1989, MED TOXICOL ADV DRUG, V4, P1; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Oyen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092882; Pares A, 2001, HEPATOLOGY, V33, P554, DOI 10.1053/jhep.2001.22758; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Pollack AZ, 2011, ENVIRON HEALTH PERSP, V119, P1156, DOI 10.1289/ehp.1003284; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Saghiri MA, 2016, CRIT REV ONCOL HEMAT, V98, P290, DOI 10.1016/j.critrevonc.2015.10.004; Scimeca M, 2016, ENV TOXICOLOGY; Sever R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016709; Tabrez S, 2014, MUTAT RES-GEN TOX EN, V760, P1, DOI 10.1016/j.mrgentox.2013.11.002; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Tsoi MF, 2016, AM J MED, V129, P1213, DOI 10.1016/j.amjmed.2016.05.042; Wallin M, 2015, J BONE MINERAL RES; Wang Y, 2016, MOL VIS, V22; Wevers-de Boer KVC, 2015, ANN RHEUM DIS, V74, P341, DOI 10.1136/annrheumdis-2013-203749; Wong PKK, 2007, CLIN SCI, V113, P233, DOI 10.1042/CS20060173; Zhang H, 2014, J PHOTOCH PHOTOBIO B, V136, P46, DOI 10.1016/j.jphotobiol.2014.04.020; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhao HY, 2015, J VET SCI, V16, P297, DOI 10.4142/jvs.2015.16.3.297; Zhao J, 2016, PREV MED, V85, P1, DOI 10.1016/j.ypmed.2015.12.021; Ziola-Frankowska A, 2015, J INORG BIOCHEM, V152, P167, DOI 10.1016/j.jinorgbio.2015.08.019	59	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193323	10.1371/journal.pone.0193323	http://dx.doi.org/10.1371/journal.pone.0193323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518117	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900019
J	Cazarim, MD; Pereira, LRL				Cazarim, Maurilio de Souza; Leira Pereira, Leonardo Regis			Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; PREVALENCE; OUTCOMES	Introduction Only 20% of patients with systemic arterial hypertension (SAH) have blood pressure within recommended parameters. SAH has been the main risk factor for morbidity and mortality of cardiovascular diseases, which affects the burden of the Public Health System (PHS). Some studies have shown the effectiveness of Pharmaceutical Care (PC) in the care of hypertensive patients. Objective To perform a cost-effectiveness analysis to compare SAH treatment with PC management and conventional treatment for hypertensive patients offered by the PHS. Methods A cost-effectiveness study nested to a quasi-experimental study was conducted, in which 104 hypertensive patients were followed up in a PC program. Blood pressure control was considered as the outcome for the economic analysis and the costs were direct and non-direct medical costs. Results PC was dominant for two years in the post-PC period compared with the pre-PC year. The mean cost effectiveness ratio (CER) for the CERPre-PC, CERPC, and CERPost-PC periods were: US$364.65, US$415.39, and US$231.14 respectively. The incremental cost effectiveness ratio (ICER) analysis presented ICER of US$478.41 in the PC period and US$42.95 in the post PC period. Monte Carlo sensitivity analysis presented mean ICERPC and ICERPost-PC equal to US$605.09 and US$128.03, reaching US$1,725.00 and US$740.00 respectively. Conclusion Even for the highest ICER, the values were below the cost effectiveness threshold, which means that PC was a cost effective strategy for the care of hypertensive patients in the PHS.	[Cazarim, Maurilio de Souza; Leira Pereira, Leonardo Regis] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil; [Leira Pereira, Leonardo Regis] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ctr Pesquisa Assistencia Farmaceut & Farm Clin CP, 23 Blc S,Av Cafe S-N, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cazarim, MD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil.	maurilio.jf@gmail.com	Pereira, Leonardo R L/J-9322-2012	Pereira, Leonardo R L/0000-0002-8609-1390; Cazarim, Maurilio de Souza/0000-0002-2826-5903	Sao Paulo Research Foundation (FAPESP) [2014/02087-9]; FAPESP [2014/02087-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by funding of Sao Paulo Research Foundation (FAPESP). This organization helped with a scholarship for the author Maurilio de Souza Cazarim [grant number 2014/02087-9] from 01/08/2014 to 31/01/2016, URL (http://bvs.fapesp.br/en/pesquisador/673633/maurillo-de-souza-cazarim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP.; We thank the FAPESP funding agency for the scholarship support for the author Maurilio Souza Cazarim [grant number 2014/02087-9] from 01/08/2014 to 31/01/2016, URL (http:// bvs.fapesp.br/en/pesquisador/673633/maurilio-de-souza-cazarim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are the responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP. We thank Estael L.C. Cruz-Cazarim, Pharmacist, employee of the Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Brazil, for the help with the costing of Pharmaceutical Care. We thank John Carpenter, Ribeirao Preto, SP, Brazil, for the English revision.	Aguwa CN, 2008, PHARM WORLD SCI, V30, P107, DOI 10.1007/s11096-007-9151-x; Alvarez JS, 2012, EVALUACION EC MEDICA; Araujo A. L. A., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P87; Borghi C, 2015, EXPERT REV PHARM OUT, V15, P199, DOI 10.1586/14737167.2015.1018894; Brazil Brazilian Central Bank, 2013, CONS EC IND; Brazil Brazilian Central Bank, 2015, COIN CONV; Brazil Ministry of Health, 2015, SYST MAN TABL PROC M; Brazil Ministry of Health. Brazilian Network for Health Technology Assessment (BNHTA), 2009, METH GUID STUD EC A; Brazil Ministry of Health. Brazilian Network for Health Technology Assessment (BNHTA), 2014, METH GUID EC EV GU A; Brazil Ministry of Health. Secretariat of Health Surveillance Secretariat of Health Care, 2008, GUID REC INT CAR CHR; Brazilian Institute of Geography and Statistics-BIGS, 2012, CIT TOWNS RIB PRET S; Brazilian Institute of Geography and Statistics-BIGS, 2015, BRAZ SYNTH GDP PER C; Cazarim MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155204; Chinwong S, 2004, PHARM WORLD SCI, V26, P96, DOI 10.1023/B:PHAR.0000018599.47002.e7; Cipullo JP, 2010, ARQ BRAS CARDIOL, V94, P519, DOI 10.1590/S0066-782X2010005000014; Costa JSDD, 2002, SAO PAULO MED J, V120, P100; Andrade SSD, 2015, EPIDEMIOL SERV SAUDE, V24, P297, DOI 10.5123/S1679-49742015000200012; de Castro MS, 2007, ANN PHARMACOTHER, V41, P1486, DOI 10.1345/aph.1K080; de Lyra DP, 2008, REV BRAS CIENC FARM, V44, P451, DOI 10.1590/S1516-93322008000300015; Borges APD, 2011, ARQ BRAS ENDOCRINOL, V55, P686, DOI 10.1590/S0004-27302011000900003; Dib MW, 2010, REV PANAM SALUD PUBL, V27, P125, DOI 10.1590/S1020-49892010000200006; Drummond MF, 2015, METHODS EC EVALUATIO; Etemad LR, 2003, VALUE HEALTH, V6, P425, DOI 10.1046/j.1524-4733.2003.64255.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Pereira LRL, 2008, REV BRAS CIENC FARM, V44, P601, DOI 10.1590/S1516-93322008000400006; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P599, DOI [10.5123/S1679-49742014000400002, 10.5123/S1679-49742014000400017, 10.5123/S1679-49742014000300002]; Municipal Government of Ribeirao Preto, 2015, ACC 2013; Municipal Government of Ribeirao Preto. Department of Health of Ribeirao Preto, 2015, 2013 MAN REP; Municipal Government of Ribeirao Preto. Department of Health of Ribeirao Preto, 2015, PROGR SERV; Nita ME, 2009, EVALUATION HLTH TECH; Penaforte TR, 2011, THESIS; Piola SF, 2009, HLTH BRAZIL SOME QUE; Polgreen LA, 2015, HYPERTENSION, V66, P1145, DOI 10.1161/HYPERTENSIONAHA.115.06023; Pontes-Neto OM, 2008, STROKE, V39, P292, DOI 10.1161/STROKEAHA.107.493908; Rascati KL, 2014, ESSENTIALS PHARMACOE; Rodrigues FA., 2015, THESIS; Rosário Tânia Maria do, 2009, Arq. Bras. Cardiol., V93, P672, DOI 10.1590/S0066-782X2009001200018; Jardim PCBV, 2007, ARQ BRAS CARDIOL, V88, P452, DOI 10.1590/S0066-782X2007000400015; Vieira LS, 2013, THESIS; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, GLOB STAT REP NONC D; World Health Organisation, 2003, INN CAR CHRON COND B; World Health Organization, 2014, CARD DIS DEATHS PER; World Health Organization (WHO), 2013, CARD DIS CVDS; Zubioli A, 2013, BRAZ J PHARM SCI, V49, P85, DOI 10.1590/S1984-82502013000100010	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193567	10.1371/journal.pone.0193567	http://dx.doi.org/10.1371/journal.pone.0193567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509802	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200016
J	Cozma, S; Ghiciuc, CM; Damian, L; Pasquali, V; Saponaro, A; Lupusoru, EC; Patacchioli, FR; Dima-Cozma, LC				Cozma, Sebastian; Ghiciuc, Cristina Mihaela; Damian, Lisandra; Pasquali, Vittorio; Saponaro, Angelo; Lupusoru, Elena Catalina; Patacchioli, Francesca Romana; Dima-Cozma, Lucia Corina			Distinct activation of the sympathetic adreno-medullar system and hypothalamus pituitary adrenal axis following the caloric vestibular test in healthy subjects	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; OBSTRUCTIVE SLEEP-APNEA; STRESS-INDUCED CHANGES; PSYCHOLOGICAL STRESS; DHEA-S; CORTISOL; STIMULATION; SCALE; DYSREGULATIONS; IMBALANCE		[Cozma, Sebastian] Univ Med & Pharm Grigore T Popa, Rehabil Hosp, Sch Med, Dept Otorhinolaryngol, Iasi, Romania; [Ghiciuc, Cristina Mihaela; Damian, Lisandra; Lupusoru, Elena Catalina] Univ Med & Pharm Grigore T Popa, Sch Med, Dept Pharmacol, Iasi, Romania; [Pasquali, Vittorio] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Saponaro, Angelo; Patacchioli, Francesca Romana] Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Rome, Italy; [Dima-Cozma, Lucia Corina] Univ Med & Pharm Grigore T Popa, Rehabil Hosp, Sch Med, Dept Internal Med, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Sapienza University Rome; Sapienza University Rome; Grigore T Popa University of Medicine & Pharmacy	Patacchioli, FR (corresponding author), Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Rome, Italy.	francesca.patacchioli@uniroma1.it	Ghiciuc, Cristina Mihaela/AAA-3942-2019; Cozma, Sebastian/AAV-2996-2020; Patacchioli, Francesca R/D-3336-2009; Patacchioli, Francesca Romana/AAD-4183-2022	Ghiciuc, Cristina Mihaela/0000-0003-1791-0425; Pasquali, Vittorio/0000-0003-1294-0254; Patacchioli, Francesca Romana/0000-0001-9672-2603	University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania [29234]	University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania	This study was supported by grant no 29234/December 20th, 2013 from the University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RS, 2007, YONSEI MED J, V48, P379, DOI 10.3349/ymj.2007.48.3.379; Aiken L. S., 1991, MULTIPLE REGRESSION; Akizuki K, 2014, J PHYS THER SCI, V26, P1059, DOI 10.1589/jpts.26.1059; Ali N, 2012, PHYSIOL BEHAV, V106, P65, DOI 10.1016/j.physbeh.2011.10.003; Archana R, 2016, BIOMED RES-INDIA, V27, P985; Biaggioni I, 1998, J VESTIBUL RES-EQUIL, V8, P35, DOI 10.1016/S0957-4271(97)00033-5; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; British Society of Audiology (BSA), 2010, REC PROC CAL TEST; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen S, 2008, SOCIAL PSYCHOL HLTH, P31; Cortelli P, 2012, AUTON NEUROSCI-BASIC, V169, P7, DOI 10.1016/j.autneu.2012.02.005; COSTA F, 1995, CLIN AUTON RES, V5, P289, DOI 10.1007/BF01818894; Cozma S, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165577, 10.1590/1414-431x20165577]; Dagilas A, 2005, OTOL NEUROTOL, V26, P476, DOI 10.1097/01.mao.0000169785.15083.28; Damian L, 2016, NEUROENDOCRINOL LETT, V37, P155; Delle Chiaie R, 2013, PSYCHOTHER PSYCHOSOM, V82, P264, DOI 10.1159/000348609; Duracinsky M, 2007, VALUE HEALTH, V10, P273, DOI 10.1111/j.1524-4733.2007.00182.x; Gananca Mauricio Malavasi, 2009, Braz J Otorhinolaryngol, V75, P2; Ghiciuc CM, 2016, BRAZ J OTORHINOLAR, V82, P529, DOI 10.1016/j.bjorl.2015.09.004; Ghiciuc CM, 2013, CHRONOBIOL INT, V30, P1024, DOI 10.3109/07420528.2013.795155; Ghiciuc CM, 2011, NEUROENDOCRINOL LETT, V32, P475; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Hackney AC, 2008, J ATHL TRAINING, V43, P631, DOI 10.4085/1062-6050-43.6.631; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hallgren E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17627; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hammam E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00334; Jauregui-Renaud K, 2000, BRAIN RES BULL, V53, P17, DOI 10.1016/S0361-9230(00)00304-X; Jonsson P, 2010, PSYCHONEUROENDOCRINO, V35, P1397, DOI 10.1016/j.psyneuen.2010.04.003; Kang Y, 2010, NURS HEALTH SCI, V12, P477, DOI 10.1111/j.1442-2018.2010.00562.x; Kasbekar AV, 2010, J LARYNGOL OTOL, V124, P616, DOI 10.1017/S0022215110000472; Katz ED, 2014, CLIN PROCEDURES EMER, P1434; Kerman IA, 2000, AM J PHYSIOL-REG I, V279, pR118, DOI 10.1152/ajpregu.2000.279.1.R118; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KOHN PM, 1992, J BEHAV MED, V15, P221, DOI 10.1007/BF00848327; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2013, PSYCHONEUROENDOCRINO, V38, P3167, DOI 10.1016/j.psyneuen.2013.09.008; Patacchioli FR, 2015, CLIMACTERIC, V18, P528, DOI 10.3109/13697137.2015.1008444; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23, DOI 10.1007/BF03349149; Patacchioli FR, 2014, PEDIATR PULM, V49, P1145, DOI 10.1002/ppul.22972; Patacchioli Francesca Romana, 2006, J Headache Pain, V7, P90, DOI 10.1007/s10194-006-0274-6; Pippi R, 2014, J BIOL REG HOMEOS AG, V28, P147; Saman Y., 2012, FRONT NEUROL, V3, P1; Schumacher S, 2013, PSYCHONEUROENDOCRINO, V38, P729, DOI 10.1016/j.psyneuen.2013.02.003; Simeoni S, 2011, STRESS, V14, P282, DOI 10.3109/10253890.2010.545458; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; YATES BJ, 1994, J NEUROPHYSIOL, V71, P2087, DOI 10.1152/jn.1994.71.6.2087; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	52	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193963	10.1371/journal.pone.0193963	http://dx.doi.org/10.1371/journal.pone.0193963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509800	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200047
J	Kaur, R; Sodhi, M; Sharma, A; Sharma, VL; Verma, P; Swami, SK; Kumari, P; Mukesh, M				Kaur, Ramneek; Sodhi, Monika; Sharma, Ankita; Sharma, Vijay Lakshmi; Verma, Preeti; Swami, Shelesh Kumar; Kumari, Parvesh; Mukesh, Manishi			Selection of suitable reference genes for normalization of quantitative RT-PCR (RT-qPCR) expression data across twelve tissues of riverine buffaloes (Bubalus bubalis)	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; INTERNAL CONTROL GENES; REAL-TIME PCR; HOUSEKEEPING GENES; RIBOSOMAL-RNA; BETA-ACTIN; IDENTIFICATION; VALIDATION; QUANTIFICATION; CELLS	Selection of reference genes has become an integral step in any real time quantitative PCR (RT-qPCR) based expression studies. The importance of this study stems from the fact that riverine buffaloes are major dairy species of Indian sub-continent and the information generated here will be of great interest to the investigators engaged in functional genomic studies of this important livestock species. In this study, an effort was made to evaluate a panel of 10 candidate reference genes (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB), ubiquitously expressed transcript (UXT), ribosomal protein S15 (RPS15), ribosomal protein L-4 (RPL4), ribosomal protein S9 (RPS9), ribosomal protein S23 (RPS23), hydroxymethylbilane synthase (HMBS), beta 2 Microglobulin (beta 2M) and eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) across 12 tissues (mammary gland, kidney, spleen, liver, heart, intestine, ovary, lung, muscle, brain, subcutaneous fat and testis) of riverine buffaloes. In addition to overall analysis, tissue wise evaluation of expression stability of individual RG was also performed. Three different algorithms provided in geN-orm, NormFinder and BestKeeper softwares were used to evaluate the stability of 10 potential reference genes from different functional classes. The M-value given by geNorm ranged from 0.9797 (RPS9 and UXT) to 1.7362 (RPS15). From the most stable to the least stable, genes were ranked as: UXT/ RPS9> RPL4> RPS23> EEF1A1> ACTB> HMBS> GAPDH> B2M> RPS15. While NormFinder analysis ranked the genes as: UXT> RPS23> RPL4> RPS9> EEF1A1> HMBS> ACTB> beta 2M> GAPDH> RPS15. Based on the crossing point SD value and range of fold change expression, BestKeeper analysis ranked the genes as: RPS9> RPS23/UXT> RPL4> GAPDH> EEF1A1> ACTB> HMBS> beta 2M> RPS15. Overall the study has identified RPS23, RPS9, RPL4 and UXT genes to be the most stable and appropriate RGs that could be utilized for normalization of transcriptional data in various tissues of buffaloes. This manuscript thus provide useful information on panel of reference genes that could be helpful for researchers conducting functional genomic studies in riverine buffaloes.	[Kaur, Ramneek; Sodhi, Monika; Sharma, Ankita; Verma, Preeti; Swami, Shelesh Kumar; Kumari, Parvesh; Mukesh, Manishi] Natl Bur Anim Genet Resources, ICAR, Dept Anim Biotechnol, Karnal, Haryana, India; [Kaur, Ramneek; Sharma, Vijay Lakshmi] Panjab Univ, Dept Zool, Chandigarh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Panjab University	Mukesh, M (corresponding author), Natl Bur Anim Genet Resources, ICAR, Dept Anim Biotechnol, Karnal, Haryana, India.	mmukesh_26@hotmail.com		mukesh, manishi/0000-0001-8101-3863; Sodhi, Monika/0000-0003-1356-3999	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi [27(3)/2010-HRD]; ICAR; Department of Science and Technology, Govt. of India; Indian Council of Agriculture Research, New Delhi under National Fellow Scheme	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); ICAR(Indian Council of Agricultural Research (ICAR)); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Indian Council of Agriculture Research, New Delhi under National Fellow Scheme	This work was supported under National Fellow Scheme of Indian Council of Agricultural Research, New Delhi grant number 27(3)/2010-HRD, http://www.icar.org.in/files/edu/Award-of-National-Fellow.pdf. MM, Principal Scientist and National Fellow, received the funding from ICAR. RK has received the inspire fellowship from Department of Science and Technology, Govt. of India.; The work was supported by Indian Council of Agriculture Research, New Delhi under National Fellow Scheme. The fellowship received by Ms Ramneek Kaur from DST-INSPIRE, Govt. of India is duly acknowledged.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2012, LIV CENS; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46494; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jatav P, 2016, ANIM SCI J, V87, P344, DOI 10.1111/asj.12384; Kackar V, 2013, INDIAN J ANIMAL SCI, V83; Kapila N, 2013, ISRN BIOTECHNOLOGY; Kishore A, 2013, MOL CELL PROBE, V27, P140, DOI 10.1016/j.mcp.2013.02.003; Koramutla MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25883; Li QM, 2011, INT J MOL SCI, V12, P1727, DOI 10.3390/ijms12031727; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Sodhi M, 2013, J ANIM BREED GENET, V130, P106, DOI 10.1111/j.1439-0388.2012.01004.x; Spalenza V, 2011, VET J, V189, P278, DOI 10.1016/j.tvjl.2010.11.017; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Terzi V, 2010, ANIMAL, V4, P853, DOI 10.1017/S1751731110000042; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vorachek WR, 2013, INT J MOL SCI, V14, P11484, DOI 10.3390/ijms140611484; Yadav P, 2012, LIVEST SCI, V147, P72, DOI 10.1016/j.livsci.2012.04.004; Yu Zhang, 2013, ASIAN AUSTRALASIAN J, V26	33	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0191558	10.1371/journal.pone.0191558	http://dx.doi.org/10.1371/journal.pone.0191558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509770	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200002
J	Huang, YL; Zhang, SD; Fang, XY; Qin, L; Fan, Y; Ding, DD; Liu, XS; Xie, M				Huang, Yali; Zhang, Shengding; Fang, Xiaoyu; Qin, Lu; Fan, Yu; Ding, Dandan; Liu, Xiansheng; Xie, Min			Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function	PLOS ONE			English	Article							AIRWAY INFLAMMATION; INDUCED SPUTUM; MICRORNAS; IDENTIFICATION; BIOMARKERS; KNOWLEDGE; RNAS	Objective We investigated the relationship between plasma miRNAs levels and inflammatory characteristics in asthmatic patients. Methods Eligible adults with untreated asthma (n = 35) underwent a clinical assessment, sputum induction, and assessment of pulmonary function test and Asthma Control Test (ACT) scores. Asthma phenotypes were defined using the sputum cell count. miR-199a-5p expression was measured using quantitative real-time polymerase chain reaction (qPCR). Lipopolysaccharide (LPS) stimulation was used to detect miR-199a-5p secretion from peripheral blood-derived neutrophil, lymphocyte, macrophage and BEAS-2B cells. The correlation of miR-199a-5p expression with clinical parameters was analyzed using multiple linear regression analysis. In silico analysis predicted the target genes and signaling pathway of miR199a-5p. Transfection of miR-199a-5p mimics in human airway smooth muscle cells (HASMCs) was performed in vitro. Results The miRNA-199a-5p levels in plasma and sputum increased significantly in patients with neutrophilic asthma compared to healthy subjects (ps = 0.014 and 0.006, respectively). Expression of miR-199a-5p in the plasma of asthmatic patients positively correlated with sputum miR-199a-5p expression (r = 0.511, p = 0.021). The miR-199a-5p level was only elevated with LPS stimulation in neutrophils but not macrophages, lymphocytes, or epithelial cells from healthy controls (p < 0.01). miR-199a-5p expression increased in response to LPS (p = 0.005) and LPS combined with IL-4(p = 0.003), but not IL-4 alone. However, peripheral neutrophils from eosinophilic asthma patients did not respond to LPS with increased miR-199a-5p expression (n = 5, p > 0.05) in contrast to the significant response from neutrophilic patients (n = 4, p < 0.0001). miR-199a-5p negatively correlated with FEV1, FVC and PEF (r = -0.377, p = 0.026; r = -0.419, p = 0.012; and r = -0.392, p = 0.024, respectively). Multivariate correlation analysis confirmed that the plasma miR-199a-5p levels negatively correlated with FEV1 in patients with asthma (Adjusted R-2 = 0.164, p = 0.015). In silico analysis suggested that the WNT signaling pathway participates in miR-199a-5p mediation of smooth muscle cell hypertrophy. In vitro experiment, miR-199a-5p mimics inhibited the protein expressions of WNT2 and WNT4, decreased the c-myc expression and dramatically increased the Sm-MHC expression in HASMCs. Conclusion Plasma miR-199a-5p was increased in neutrophilic asthma and negatively correlated with pulmonary function, which suggests that miR-199a-5p actively contributes to disease pathogenesis by modulating the inflammatory process and transferring the signal from inflammatory cells to structure cells.	[Huang, Yali; Zhang, Shengding; Fang, Xiaoyu; Qin, Lu; Fan, Yu; Ding, Dandan; Liu, Xiansheng; Xie, Min] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp & Crit Care Med, Wuhan, Hubei, Peoples R China; [Huang, Yali] Third Peoples Hosp Wuhan, Dept Resp Med, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Xie, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp & Crit Care Med, Wuhan, Hubei, Peoples R China.	xie_m@126.com	Liu, xiansheng/GWQ-6485-2022	xie, min/0000-0003-4052-1647	National Natural Science Foundation of China [81470002, 81670020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81470002 and 81670020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Davies AR, 2013, CURR OPIN PULM MED, V19, P60, DOI 10.1097/MCP.0b013e32835b118e; Davis JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180329; Demarche SF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0615-9; Elbehidy RM, 2016, MOL IMMUNOL, V71, P107, DOI 10.1016/j.molimm.2015.12.015; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; James Anna, 2016, Curr Treat Options Allergy, V3, P439; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZH, 2016, CARDIOVASC RES, V110, P258, DOI 10.1093/cvr/cvw052; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Milger K, 2017, ALLERGY, V72, P1962, DOI 10.1111/all.13205; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Quinlan S, 2017, INT REV CEL MOL BIO, V334, P309, DOI 10.1016/bs.ircmb.2017.04.002; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rupani H, 2016, AM J RESP CRIT CARE, V194, P26, DOI 10.1164/rccm.201502-0280OC; Simpson JL, 2010, RESPIRATION, V79, P147, DOI 10.1159/000245899; Tang FSM, 2016, THORAX, V71, P1039, DOI 10.1136/thoraxjnl-2015-207781; Tarlo SM, 2006, EUR RESPIR J, V27, P607, DOI 10.1183/09031936.06.00062105; Tay HL, 2014, ANN MED, V46, P633, DOI 10.3109/07853890.2014.958196; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169469; Wang SM, 2017, EPIGENETICS-US, V12, P187, DOI 10.1080/15592294.2016.1273308; Wang YH, 2015, CLIN LAB, V61, P467, DOI 10.7754/Clin.Lab.2014.141020; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Zhang SC, 2013, ARCH VIROL, V158, P2443, DOI 10.1007/s00705-013-1744-1; Zhou SR, 2017, MOL CELL BIOL, V37, DOI [10.1128/MCB.00058-17, 10.1128/mcb.00058-17]	43	18	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193502	10.1371/journal.pone.0193502	http://dx.doi.org/10.1371/journal.pone.0193502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505605	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200018
J	Crona, K				Crona, Kristina			Recombination and peak jumping	PLOS ONE			English	Article							EMPIRICAL FITNESS LANDSCAPES; ORDER EPISTASIS; SEX; POPULATIONS; EVOLUTION	We show that genetic recombination can be a powerful mechanism for escaping suboptimal peaks. Recent studies of empirical fitness landscapes reveal complex gene interactions and multiple peaks. However, classical work on recombination largely ignores the effect of complex gene interactions. Briefly, we restrict to fitness landscapes where the global peak is difficult to access. If the optimal genotype can be generated by shuffling genes present in the population, then recombination will produce the genotype. If, in addition, recombination is sufficiently rare, then the proportion of the genotype is expected to increase. Specifically, we consider landscapes where shuffling of suboptimal peak genotypes can produce the global peak genotype. The advantage of recombination we identify has no correspondence for 2-locus systems or for smooth landscapes. The effect of recombination indicated is sometimes extreme, also for rare recombination, in the sense that shutting off recombination could result in the organism failing to adapt. A standard question about recombination is whether the mechanism tends to accelerate or decelerate adaptation. However, we argue that extreme effects may be more important than how the majority falls. In a limited sense, our result can be considered a support for Sewall Wright's view that adaptation sometimes works better in subdivided populations.	[Crona, Kristina] Amer Univ, Washington, DC 20016 USA	American University	Crona, K (corresponding author), Amer Univ, Washington, DC 20016 USA.	kcrona@american.edu						Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301; Crona K, 2013, SPRINGER SERIES EMER, P177; Crona K, 2013, J THEOR BIOL, V317, P1, DOI 10.1016/j.jtbi.2012.09.028; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; Draghi J. A., 2013, EVOLUTION; Galassi M., GNU SCI LIB REFERENC; Greene D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003520; Hartl DL, 2014, CURR OPIN MICROBIOL, V21, P51, DOI 10.1016/j.mib.2014.08.001; Kauffman S. A., 1993, ORIGINS ORDER; Kim Y, 2005, GENETICS, V171, P1377, DOI 10.1534/genetics.105.045252; Kondrashov D. A., 2014, TRENDS GENETICS; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Misevic D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000510; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Moradigaravand D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002735; Nowak S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003836; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Sailer ZR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005541; Sailer ZR, 2017, GENETICS, V205, P1079, DOI 10.1534/genetics.116.195214; Szendro IG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01005; Watson RA, 2011, EVOLUTION, V65, P523, DOI 10.1111/j.1558-5646.2010.01144.x; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2005, EVOLUTION, V59, P1165; Weissman DB, 2010, GENETICS, V186, P1389, DOI 10.1534/genetics.110.123240; Wright S, 1931, GENETICS, V16, P0097	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193123	10.1371/journal.pone.0193123	http://dx.doi.org/10.1371/journal.pone.0193123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494618	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200024
J	Li, QF; Chen, YG; Yue, F; Qian, W; Song, HY				Li, Qinfei; Chen, Yangui; Yue, Fang; Qian, Wei; Song, Hongyuan			Microspore culture reveals high fitness of B. napus-like gametes in an interspecific hybrid between Brassica napus and B. oleracea	PLOS ONE			English	Article							ALLOPOLYPLOID COFFEA-ARABICA; TRIAZINE RESISTANCE; GENOMIC COMPONENTS; GENETIC DIVERSITY; RAPA; INTROGRESSION; HYBRIDIZATION; MECHANISMS; EXPRESSION; EVOLUTION	The strategies of crossing B. napus with parental species play important role in broadening and improving the genetic basis of B. napus by the introgression of genetic resources from parental species. With these strategies, it is easy to select new types of B. napus, but difficult to select new types of B. rapa or B. oleracea by self-pollination. This characteristic may be a consequence of high competition with B. napus gametes. To verify the role of gamete viability in producing new B. napus individuals, the meiotic chromosome behavior of the interspecific hybrid between B. napus ( Zhongshuang 9) and B. oleracea ( 6m08) was studied, and microspore-derived ( MD) individuals were analyzed. The highest fitness of the 9: 19 ( 1.10%) pattern was observed with a 5.49-fold higher than theoretical expectation among the six chromosome segregation patterns in the hybrid. A total of 43 MD lines with more than 14 chromosomes were developed from the hybrid, and 8 ( 18.6%) of them were B. napus-like ( n = 19) type gametes, having the potential to broaden the genetic basis of natural B. napus ( GD = 0.43 +/- 0.04). It is easy to produce B. napus-like gametes with 19 chromosomes, and these gametes showed high fitness and competition in the microspore-derived lines, suggesting it might be easy to select new types of B. napus from the interspecific hybrid between B. napus and B. oleracea.	[Li, Qinfei; Song, Hongyuan] Southwest Univ, Coll Hort & Landscape, Chongqing, Peoples R China; [Li, Qinfei; Chen, Yangui; Yue, Fang; Qian, Wei] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Song, HY (corresponding author), Southwest Univ, Coll Hort & Landscape, Chongqing, Peoples R China.; Qian, W (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	qianwei666@hotmail.com; yuahs@163.com		LI, Qinfei/0000-0002-5353-2137	National Key Research and Development Program of China [2017YFD0101804]; China Postdoctoral Science Foundation [2015M582500]; Fundamental Research Funds for the Central Universities in China [XDJK2016C080]; Chongqing Postdoctoral Science Foundation [Xm2016029]; Science and Technology Innovation Project of Chongqing [cstc2015shms-ztzx80005, cstc2015shms-ztzx80007, cstc2015shms-zta80009]	National Key Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities in China; Chongqing Postdoctoral Science Foundation; Science and Technology Innovation Project of Chongqing	This work was supported by the National Key Research and Development Program of China (2017YFD0101804), Hongyuan Song receive the funding; the China Postdoctoral Science Foundation (2015M582500) and the Fundamental Research Funds for the Central Universities in China (XDJK2016C080), the Chongqing Postdoctoral Science Foundation (Xm2016029), Qinfei Li receive these three funding; the Science and Technology Innovation Project of Chongqing (cstc2015shms-ztzx80005, cstc2015shms-ztzx80007 and cstc2015shms-zta80009), Hongyuan Song receive these fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181784; An DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134534; AYOTTE R, 1988, EUPHYTICA, V38, P137; AYOTTE R, 1988, EUPHYTICA, V37, P189, DOI 10.1007/BF00036857; Bardil A, 2011, NEW PHYTOL, V192, P760, DOI 10.1111/j.1469-8137.2011.03833.x; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Combes MC, 2012, J HERED, V103, P36, DOI 10.1093/jhered/esr120; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Edger PP, 2017, PLANT CELL, V29, P2150, DOI 10.1105/tpc.17.00010; Fakhri Z, 2016, PLANT CELL REP, V35, P1143, DOI 10.1007/s00299-016-1951-9; Friedt W, 2005, BIOTECHNOL AGRIC FOR, V56, P191; Ge XH, 2006, PLANT CELL REP, V25, P1075, DOI 10.1007/s00299-006-0170-1; Geng XX, 2013, PLANT CELL TISS ORG, V113, P501, DOI 10.1007/s11240-013-0292-4; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Li QF, 2014, MOL BREEDING, V34, P1955, DOI 10.1007/s11032-014-0153-9; Li QF, 2013, THEOR APPL GENET, V126, P2073, DOI 10.1007/s00122-013-2119-4; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; LICHTER R, 1981, Z PFLANZENPHYSIOL, V103, P229, DOI 10.1016/S0044-328X(81)80155-9; Liu H, 2000, GENETICS BREEDING OI; Lu CM, 2001, BREEDING SCI, V51, P73, DOI 10.1270/jsbbs.51.73; Malik MR, 2008, J EXP BOT, V59, P2857, DOI 10.1093/jxb/ern149; Mason AS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0555-9; Mason AS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-103; Mei J, 2011, EUPHYTICA, V177, P393, DOI 10.1007/s10681-010-0274-0; Mei J, 2010, GENET RESOUR CROP EV, V57, P687, DOI 10.1007/s10722-009-9504-5; Mei JQ, 2015, THEOR APPL GENET, V128, P639, DOI 10.1007/s00122-015-2459-3; Mirzaghaderi G, 2017, PLANT CELL REP, V36, P1277, DOI 10.1007/s00299-017-2152-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson MN, 2009, THEOR APPL GENET, V119, P497, DOI 10.1007/s00122-009-1056-8; Qian W, 2006, THEOR APPL GENET, V113, P49, DOI 10.1007/s00122-006-0269-3; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; Rahman H, 2015, CAN J PLANT SCI, V95, P29, DOI 10.4141/CJPS-2014-017; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; SAS Institute Inc, 1992, SAS STAT SOFTW CHANG; Schmidt A, 2015, DEVELOPMENT, V142, P229, DOI 10.1242/dev.102103; Shariatpanahi M.E., 2016, PLANT TISSUE CULT, P487, DOI [10.1007/978-981-10-1917-3_21, DOI 10.1007/978-981-10-1917-3, DOI 10.1007/978-981-10-1917-3_21]; Silkova OG, 2011, EUPHYTICA, V178, P415, DOI 10.1007/s10681-010-0325-6; Sora D, 2016, HEREDITY, V117, P440, DOI 10.1038/hdy.2016.69; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; U. N., 1935, Japanese Journal of Botany, V7, P389; Wen J, 2008, EUPHYTICA, V162, P81, DOI 10.1007/s10681-007-9566-4; Wen J, 2010, EUPHYTICA, V173, P99, DOI 10.1007/s10681-010-0129-8; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yang S, 2016, THEOR APPL GENET, V129, P689, DOI 10.1007/s00122-015-2657-z; Younis A, 2014, PLANT CELL REP, V33, P215, DOI 10.1007/s00299-013-1534-y; Zhou Yong-Ming, 1995, Acta Botanica Sinica, V37, P848	48	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193548	10.1371/journal.pone.0193548	http://dx.doi.org/10.1371/journal.pone.0193548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494698	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200065
J	Wedding, LM; Lecky, J; Gove, JM; Walecka, HR; Donovan, MK; Williams, GJ; Jouffray, JB; Crowder, LB; Erickson, A; Falinski, K; Friedlander, AM; Kappel, CV; Kittinger, JN; McCoy, K; Norstrom, A; Nystrom, M; Oleson, KLL; Stamoulis, KA; White, C; Selkoe, KA				Wedding, Lisa M.; Lecky, Joey; Gove, Jamison M.; Walecka, Hilary R.; Donovan, Mary K.; Williams, Gareth J.; Jouffray, Jean-Baptiste; Crowder, Larry B.; Erickson, Ashley; Falinski, Kim; Friedlander, Alan M.; Kappel, Carrie V.; Kittinger, John N.; McCoy, Kaylyn; Norstrom, Albert; Nystrom, Magnus; Oleson, Kirsten L. L.; Stamoulis, Kostantinos A.; White, Crow; Selkoe, Kimberly A.			Advancing the integration of spatial data to map human and natural drivers on coral reefs	PLOS ONE			English	Article							COMMUNITY-BASED MANAGEMENT; MARINE PROTECTED AREAS; CLIMATE-CHANGE; KANEOHE BAY; ECOSYSTEM SERVICES; HAWAIIAN-ISLANDS; FISH ASSEMBLAGES; DECISION-MAKING; RESILIENCE; NORTHWESTERN	A major challenge for coral reef conservation and management is understanding how a wide range of interacting human and natural drivers cumulatively impact and shape these ecosystems. Despite the importance of understanding these interactions, a methodological framework to synthesize spatially explicit data of such drivers is lacking. To fill this gap, we established a transferable data synthesis methodology to integrate spatial data on environmental and anthropogenic drivers of coral reefs, and applied this methodology to a case study location-the Main Hawaiian Islands (MHI). Environmental drivers were derived from time series (2002-2013) of climatological ranges and anomalies of remotely sensed sea surface temperature, chlorophyll-a, irradiance, and wave power. Anthropogenic drivers were characterized using empirically derived and modeled datasets of spatial fisheries catch, sedimentation, nutrient input, new development, habitat modification, and invasive species. Within our case study system, resulting driver maps showed high spatial heterogeneity across the MHI, with anthropogenic drivers generally greatest and most widespread on O'ahu, where 70% of the state's population resides, while sedimentation and nutrients were dominant in less populated islands. Together, the spatial integration of environmental and anthropogenic driver data described here provides a first-ever synthetic approach to visualize how the drivers of coral reef state vary in space and demonstrates a methodological framework for implementation of this approach in other regions of the world. By quantifying and synthesizing spatial drivers of change on coral reefs, we provide an avenue for further research to understand how drivers determine reef diversity and resilience, which can ultimately inform policies to protect coral reefs.	[Wedding, Lisa M.; Walecka, Hilary R.; Crowder, Larry B.; Erickson, Ashley] Stanford Univ, Ctr Ocean Solut, Palo Alto, CA 94304 USA; [Lecky, Joey; Falinski, Kim; Oleson, Kirsten L. L.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Lecky, Joey; Gove, Jamison M.] NOAA, Pacific Islands Fisheries Sci Ctr, Ecosyst Sci Div, Honolulu, HI USA; [Walecka, Hilary R.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Donovan, Mary K.; Friedlander, Alan M.; Stamoulis, Kostantinos A.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Williams, Gareth J.] Bangor Univ, Sch Ocean Sci, Anglesey, Wales; [Jouffray, Jean-Baptiste; Norstrom, Albert; Nystrom, Magnus] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Kappel, Carrie V.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kittinger, John N.] Ctr Oceans, Conservat Int, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Ctr Biodivers Outcomes, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ USA; [Norstrom, Albert; Nystrom, Magnus] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Acad Programme, Stockholm, Sweden; [Stamoulis, Kostantinos A.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia; [White, Crow] Calif Polytech State Univ San Luis Obispo, Biol Sci Dept, San Luis Obispo, CA 93407 USA; [Selkoe, Kimberly A.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA	Stanford University; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Barbara; University of Hawaii System; University of Hawaii Manoa; Bangor University; Stockholm University; National Geographic Society; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Conservation International; Arizona State University; Arizona State University-Tempe; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Curtin University; California State University System; California Polytechnic State University San Luis Obispo; University of Hawaii System; University of Hawaii Manoa	Wedding, LM (corresponding author), Stanford Univ, Ctr Ocean Solut, Palo Alto, CA 94304 USA.	lwedding@stanford.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Wedding, Lisa/GRY-3972-2022; Jouffray, Jean-Baptiste/AAN-1329-2020	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Wedding, Lisa/0000-0002-3782-915X; Jouffray, Jean-Baptiste/0000-0002-4105-6372; Williams, Dr Gareth J./0000-0001-7837-1619; Stamoulis, Kostantinos/0000-0003-2688-4695; Lecky, Joey/0000-0001-9364-4793; Norstrom, Albert/0000-0002-0706-9233	Gordon and Betty Moore Foundation [2897.01]; NOAA Coral Reef Conservation Program [NA13NOS482002, NA14NOS4820089, NA14NOS4820098]; United States Department of Agriculture, National Institute of Food and Agriculture [2014HI433B]; NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary [004496-00002]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary	This study was supported by the Gordon and Betty Moore Foundation (https://www.moore.org/), grant number 2897.01, and authors receiving funding included Lisa M. Wedding, Mary K. Donovan, Hilary R. Walecka, Larry B. Crowder, Ashley Erickson, Carrie V. Kappel, John N. Kittinger, Crow White and Kimberly A. Selkoe; NOAA Coral Reef Conservation Program (http://coralreef.noaa.gov/), grant numbers: NA13NOS482002 and NA14NOS4820089 and NA14NOS4820098, and authors receiving funding included Kirsten Oleson, Kim Falinski, Joey Lecky, and Mary Donovan; United States Department of Agriculture, National Institute of Food and Agriculture (https://nifa.usda.gov/), grant number: 2014HI433B, and authors receiving funding included Kim Falinski, Joey Lecky; and NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary (http://hawaiihumpbackwhale.noaa.gov/), grant number: 004496-00002, and the author receiving funding was Joey Lecky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I.A., 1999, MARINE RED ALGAE HAW; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Armitage D, 2011, GLOBAL ENVIRON CHANG, V21, P995, DOI 10.1016/j.gloenvcha.2011.04.006; Bahr KD, 2015, PEERJ, V3, DOI 10.7717/peerj.950; Bejarano S, 2017, FUNCTIONAL ECOLOGY; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Boss E, 2003, LIMNOL OCEANOGR, V48, P346, DOI 10.4319/lo.2003.48.1_part_2.0346; Bremer LL, 2015, ENVIRON MANAGE, V55, P884, DOI 10.1007/s00267-014-0426-4; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carrier SD, 2012, OCEAN COAST MANAGE, V69, P291, DOI 10.1016/j.ocecoaman.2012.07.028; Cash DW, 2006, SCI TECHNOL HUM VAL, V31, P465, DOI 10.1177/0162243906287547; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; Costa B. M., 2016, 2016035 OCS BOEM; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falinski KA, THESIS; Falinski KA, 2016, OC SCI M 2016; Friedlander A, 2003, CONSERV BIOL, V17, P1769, DOI 10.1111/j.1523-1739.2003.00338.x; Friedlander A, 2008, 73 NOAA NOS NCCOS; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2014, ADV MAR BIOL, V69, P153, DOI 10.1016/B978-0-12-800214-8.00005-0; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2002, J FISH BIOL, V60, P28, DOI 10.1006/jfbi.2001.1808; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedlander AM, 2017, AQUAT CONSERV, P1; Friedlander AM, 2014, MARINE HIST ECOLOGY, V24, P91; Gove JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10581; Gove JM, 2015, MAR ECOL PROG SER, V522, P33, DOI 10.3354/meps11118; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, P6; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Heron SF, 2014, J OPER OCEANOGR, V7, P3, DOI 10.1080/1755876X.2014.11020154; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUNTER CL, 1995, B MAR SCI, V57, P501; Izuka SK, 2010, STREAMFLOW SUSPENDED; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kittinger JN, 2014, FRONT ECOL ENVIRON, V12, P448, DOI 10.1890/130267; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Kleypas JA, 1999, AM ZOOL, V39, P146; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Le Cornu E, 2014, CONSERV BIOL, V28, P902, DOI 10.1111/cobi.12310; Lester SE, 2013, MAR POLICY, V38, P80, DOI 10.1016/j.marpol.2012.05.022; Li N, 2016, OCEAN MODEL, V100, P78, DOI 10.1016/j.ocemod.2016.02.001; Lorenzen K, 2010, B MAR SCI, V86, P169; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; McClanahan TR, 2007, MAR POLLUT BULL, V54, P1947, DOI 10.1016/j.marpolbul.2007.09.023; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McCoy K., 2015, THESIS; Meyer A.L., 2008, THESIS U HAWAII HONO; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Norse Elliott A., 2005, P302; Norse EA, 2010, B MAR SCI, V86, P179; Norstrom AV, 2016, FRONT ECOL ENVIRON, V14, P490, DOI 10.1002/fee.1427; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Oleson KLL, 2017, J ENVIRON MANAGE, V191, P8, DOI 10.1016/j.jenvman.2016.12.067; Olsen E, 2011, J COAST CONSERV, V15, P257, DOI 10.1007/s11852-010-0108-1; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; RANDALL JE, 1987, B MAR SCI, V41, P490; Randall JE, 2007, REEF SHORE FISHES HA; Rassweiler A, 2014, P ROY SOC LOND B BIO, P281; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rooney John J., 2008, V1, P519, DOI 10.1007/978-1-4020-6847-8_13; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shackeroff J. M., 2009, ECOSYSTEM BASED MANA, P33; Sharp R, 2015, VEST 3 2 USERS GUIDE; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Smith Jennifer E., 2004, Pacific Science, V58, P325, DOI 10.1353/psc.2004.0023; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; Smith M. Kimberly, 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P34; Stamoulis KA, MARINE BIOGEOGRAPHIC, P156; Stamoulis KA, 2015, OCEAN COAST MANAGE, V116, P214, DOI 10.1016/j.ocecoaman.2015.07.011; Stamoulis KA, 2013, FISH RES, V144, P2, DOI 10.1016/j.fishres.2012.09.016; Stender Y, 2014, PEERJ, V2, DOI 10.7717/peerj.300; Stimson J, 2001, CORAL REEFS, V19, P343, DOI 10.1007/s003380000123; Storlazzi CD, 2009, MAR GEOL, V264, P140, DOI 10.1016/j.margeo.2009.05.002; Storlazzi CD, 2004, CONT SHELF RES, V24, P1397, DOI 10.1016/j.csr.2004.02.010; Tissot BN, 2009, COAST MANAGE, V37, P255, DOI 10.1080/08920750902851096; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Whittier R.B., 2014, HUMAN HLTH ENV RISK; Whittier RB, 2009, HUMAN ENV RISK RANKI; Wiegner TN, 2009, LIMNOLOGY OCEANOGRAP, P54; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	115	36	37	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0189792	10.1371/journal.pone.0189792	http://dx.doi.org/10.1371/journal.pone.0189792			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494613	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200002
J	Reebye, V; Huang, KW; Lin, V; Jarvis, S; Cutilas, P; Dorman, S; Ciriello, S; Andrikakou, P; Voutila, J; Saetrom, P; Mintz, PJ; Reccia, I; Rossi, JJ; Huber, H; Habib, R; Kostomitsopoulos, N; Blakey, DC; Habib, NA				Reebye, Vikash; Huang, Kai-Wen; Lin, Vivian; Jarvis, Sheba; Cutilas, Pedro; Dorman, Stephanie; Ciriello, Simona; Andrikakou, Pinelopi; Voutila, Jon; Saetrom, Pal; Mintz, Paul J.; Reccia, Isabella; Rossi, John J.; Huber, Hans; Habib, Robert; Kostomitsopoulos, Nikos; Blakey, David C.; Habib, Nagy A.			Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer	ONCOGENE			English	Article							CCAAT/ENHANCER-BINDING-PROTEIN; HUMAN HEPATOCELLULAR-CARCINOMA; C/EBP-ALPHA; TRANSCRIPTION FACTORS; IN-VIVO; PROLIFERATION; EXPRESSION; FIBROSIS; MORTALITY; DISEASE	Liver diseases are a growing epidemic worldwide. If unresolved, liver fibrosis develops and can lead to cirrhosis and clinical decompensation. Around 5% of cirrhotic liver diseased patients develop hepatocellular carcinoma (HCC), which in its advanced stages has limited therapeutic options and negative survival outcomes. CEPBA is a master regulator of hepatic function where its expression is known to be suppressed in many forms of liver disease including HCC. Injection of MTL-CEBPA, a small activating RNA oligonucleotide therapy (CEBPA-51) formulated in liposomal nanoparticles (NOV340- SMARTICLES) upregulates hepatic CEBPA expression. Here we show how MTL-CEBPA therapy promotes disease reversal in rodent models of cirrhosis, fibrosis, hepatosteatosis, and significantly reduces tumor burden in cirrhotic HCC. Restoration of liver function markers were observed in a carbon-tetrachloride-induced rat model of fibrosis following 2 weeks of MTL-CEBPA therapy. At 14 weeks, animals showed reduction in ascites and enhanced survival rates. MTLCEBPA reversed changes associated with hepatosteatosis in non-alcoholic methionine and cholic-deficient diet-induced steaotic liver disease. In diethylnitrosamine induced cirrhotic HCC rats, MTL-CEBPA treatment led to a significant reduction in tumor burden. The data included here and the rapid adoption of MTL-CEBPA into a Phase 1 study may lead to new therapeutic oligonucleotides for undruggable diseases.	[Reebye, Vikash; Dorman, Stephanie; Andrikakou, Pinelopi; Mintz, Paul J.; Reccia, Isabella; Habib, Nagy A.] Imperial Coll London, Dept Surg, London, England; [Huang, Kai-Wen; Lin, Vivian] Natl Taiwan Univ, Dept Surg & Hepatitis Res, Taipei, Taiwan; [Huang, Kai-Wen; Lin, Vivian] Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan; [Jarvis, Sheba] Imperial Coll London, Dept Surg & Canc, London, England; [Cutilas, Pedro] Queen Mary Univ London, Barts Canc Inst, Cell Signalling & Prote Grp, Ctr Haematooncol, London, England; [Ciriello, Simona; Voutila, Jon; Habib, Robert; Blakey, David C.] MiNA Therapeut Ltd, London, England; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, Trondheim, Norway; [Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA USA; [Huber, Hans] BioTD Strategies LLC, Lansdale, PA USA; [Kostomitsopoulos, Nikos] Biomed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Athens, Greece	Imperial College London; National Taiwan University; National Taiwan University; Imperial College London; University of London; Queen Mary University London; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); City of Hope; Beckman Research Institute of City of Hope; Academy of Athens	Reebye, V (corresponding author), Imperial Coll London, Dept Surg, London, England.	v.reebye@ic.ac.uk; nagy.habib@ic.ac.uk	Reccia, Isabella/GXZ-6729-2022; Sætrom, Pål/AAH-1216-2019	Sætrom, Pål/0000-0001-8142-7441; Ciriello, Simona/0000-0002-5547-4778; Rodriguez Cutillas, Pedro/0000-0002-3426-2274; Reccia, Isabella/0000-0003-1194-8828; Voutila, Jon/0000-0001-7193-2110; HUANG, KAI-WEN/0000-0001-6375-8714; Andrikakou, Dr Pinelopi/0000-0002-3955-7995	MiNA Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042552] Funding Source: NIH RePORTER	MiNA Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by MiNA Therapeutics.	Allen AM, 2016, HEPATOLOGY, V64, P2165, DOI 10.1002/hep.28812; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Ee HT, 2005, CANCER RES, V65, P10330; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Ge PS, 2016, NEW ENGL J MED, V375, P767, DOI 10.1056/NEJMra1504367; Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780; Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200; Lu GD, 2010, GASTROENTEROLOGY, V139, P632, DOI 10.1053/j.gastro.2010.03.051; Mei S, 2007, HEPATOL RES, V37, P531, DOI 10.1111/j.1872-034X.2007.00074.x; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Portnoy V, 2016, CELL RES, V26, P320, DOI 10.1038/cr.2016.22; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; Rodrigueza WV, 2014, CANCER CHEMOTH PHARM, V74, P151, DOI 10.1007/s00280-014-2476-y; Shi YC, 2013, DIGEST LIVER DIS, V45, P844, DOI 10.1016/j.dld.2013.03.013; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Tao LL, 2012, APOPTOSIS, V17, P492, DOI 10.1007/s10495-012-0700-y; Tomizawa M, 2003, ANTICANCER RES, V23, P351; Voutila J, 2017, MOL THER, V25, P2705, DOI 10.1016/j.ymthe.2017.07.018; Watkins PJ, 1996, CANCER RES, V56, P1063; Xu L, 2001, CANCER RES, V61, P3176	21	45	48	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 14	2018	37	24					3216	3228		10.1038/s41388-018-0126-2	http://dx.doi.org/10.1038/s41388-018-0126-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GJ6XB	29511346	Green Accepted, Green Submitted, hybrid			2022-12-26	WOS:000435526600003
J	Lee, KM; Kang, SB; Chung, CY; Park, MS; Kang, DW; Chang, CB				Lee, Kyoung Min; Kang, Seung-Baik; Chung, Chin Youb; Park, Moon Seok; Kang, Dong-wan; Chang, Chong Bum			Factors associated with knee pain in 5148 women aged 50 years and older: A population-based study	PLOS ONE			English	Article							OSTEOARTHRITIS; SEVERITY; OBESITY; DEPRESSION; COMMUNITY	Objective This study was performed to investigate the factors associated with the level of knee pain in a nationally representative sample of non institutionalized women aged 50 years or older. Methods Women aged 50 years or older were selected and included in the data analyses from the Korean National Health and Nutrition Examination Surveys (2010-2013). Those having malignant diseases or using osteoarthritis medication were excluded. Significant factors associated with the level of knee pain were analyzed using multivariate regression analysis. Results A total of 5148 women (average age, 62.9 years; standard deviation, 9.3 years) were included. For women without knee osteoarthritis, level of hip pain (p<0.001), presence of back pain (p<0.001), age (p<0.001), and body mass index (BMI) (p<0.001) were found to be significant factors associated with the level of knee pain. For women with knee osteoarthritis, the radiographic grade of knee osteoarthritis (p<0.001), presence of back pain (p<0.001), level of hip pain (p<0.001), presence of depressive symptoms (p<0.001), and BMI (p = 0.026) were the factors significantly associated with the level of knee pain. Conclusions Women without knee osteoarthritis tended to report increasing knee pain with increasing age. BMI is considered a significant controllable factor in knee pain in women regardless of the presence of radiographic knee osteoarthritis. The presence of depressive symptoms may aggravate knee pain in women with knee osteoarthritis. Attention needs to be focused on concomitant musculoskeletal problems such as lumbar spinal and hip diseases in women with knee pain.	[Lee, Kyoung Min; Chung, Chin Youb; Park, Moon Seok; Kang, Dong-wan] Seoul Natl Univ, Dept Orthopaed Surg, Bundang Hosp, Gyeonggi, South Korea; [Kang, Seung-Baik; Chang, Chong Bum] Seoul Natl Univ, Dept Orthopaed Surg, SMG SNU Boramae Med Ctr, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Chang, CB (corresponding author), Seoul Natl Univ, Dept Orthopaed Surg, SMG SNU Boramae Med Ctr, Coll Med, Seoul, South Korea.	ccbknee@gmail.com		Chang, Chong Bum/0000-0002-8597-1054	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [NRF-2017M3A9D8064200]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT	This study has been supported by Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (NRF-2017M3A9D8064200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley EJ, 2015, ARTHRITIS CARE RES; Bastick AN, 2015, CLIN ORTHOP RELAT R, V473, P2969, DOI 10.1007/s11999-015-4349-z; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Chappell AS, 2011, PAIN PRACT, V11, P33, DOI 10.1111/j.1533-2500.2010.00401.x; Chiu N, 2016, J ONCOL PHARM PRACT; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Creamer P, 1999, ARTHRIT CARE RES, V12, P3, DOI 10.1002/1529-0131(199902)12:1<3::AID-ART2>3.0.CO;2-K; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Doherty M, 2011, ANN RHEUM DIS, V70, P1534, DOI 10.1136/ard.2011.154047; Felson DT, 2004, J RHEUMATOL, V31, P2; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Glass N, 2014, OSTEOARTHR CARTILAGE, V22, P1100, DOI 10.1016/j.joca.2014.06.030; Goulston LM, 2011, ARTHRIT CARE RES, V63, P1398, DOI 10.1002/acr.20546; Grant CRK, 2008, BJA EDUC, V8, P56, DOI 10.1093/bjaceaccp/mkn007; Holt Robert J, 2015, Phys Sportsmed, P1; Jordan J, 1997, J RHEUMATOL, V24, P1344; Kim KW, 2011, J BONE JOINT SURG AM, V93A, P556, DOI 10.2106/JBJS.I.01344; McVinnie DS, 2013, BRIT J PAIN, V7, P163, DOI 10.1177/2049463713484296; Nakamura J, 2013, MOD RHEUMATOL, V23, P119, DOI 10.1007/s10165-012-0638-5; Naugle KM, 2014, MED SCI SPORT EXER, V46, P622, DOI 10.1249/MSS.0b013e3182a69cf1; Niravath P, 2013, ANN ONCOL, V24, P1443, DOI 10.1093/annonc/mdt037; Rahbar M, 2015, J PAK MED ASSOC, V65, P626; Rainville J, 2013, SPINE, V38, P1282, DOI 10.1097/BRS.0b013e31828f463e; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Zheng HQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007568	27	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192478	10.1371/journal.pone.0192476	http://dx.doi.org/10.1371/journal.pone.0192476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518078	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900007
J	Onyemaobi, I; Ayalew, H; Liu, H; Siddique, KHM; Yan, GJ				Onyemaobi, Ifeyinwa; Ayalew, Habtamu; Liu, Hui; Siddique, Kadambot H. M.; Yan, Guijun			Identification and validation of a major chromosome region for high grain number per spike under meiotic stage water stress in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; YIELD COMPONENTS; DROUGHT TOLERANCE; GENETIC-ANALYSIS; SPRING WHEAT; QTL ANALYSIS; BREAD WHEAT; MAPPING QTL; WEIGHT; MARKERS	Grain number is a major trait for wheat yield under dryland farming. An International Triticeae Mapping Initiative (ITMI) mapping population comprising 105 recombinant inbred lines (RIL) developed from a cross between a Synthetic hexaploid wheat (Triticum aestivum) 'W7984' and a spring wheat variety 'Opata M85' was used to identify quantitative trait loci (QTL) associated with grain number per spike under two treatment conditions, normal watering and water stress during meiosis. Two major QTL for grain number per spike on the main stem Q. Gnu. uwa-5A-1 and Q. Gnu. uwa-5A-2 with phenotypic variations of 25.71% and 24.93%, respectively, were detected on the long arm of chromosome 5A when plants were exposed to water stress during meiosis. One QTL (Q. Gnu. uwa-2A) with a LOD score of 2.8 was detected on the long arm of chromosome 2A under normal watering condition. The alleles associated with higher grain number per spike under different treatment conditions came from the Synthetic W7984 parent. Two populations developed from crosses Synthetic W7984 x Lang and Synthetic W7984 x Westonia were used to validate the identified QTL under water stress during meiosis. SSR markers Xbarc230 and Xbarc319 linked with the identified QTL on chromosome 5AL were validated in the two F-2:4 segregating populations. These closely linked SSR markers could potentially be utilized in marker-assisted selection to reduce yield loss in regions where water stress during meiosis occurs frequently. The identified QTL can be incorporated into elite lines / cultivars to improve wheat grain yield.	[Yan, Guijun] Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia; Univ Western Australia, UWA Inst Agr, Perth, WA, Australia	University of Western Australia; University of Western Australia	Yan, GJ (corresponding author), Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia.	guijun.yan@uwa.edu.au	Ayalew, Habtamu/AAI-7307-2021; Liu, Hui/ABB-2141-2021; Siddique, Kadambot H.M./B-3462-2011; Yan, Guijun/A-9809-2011	Ayalew, Habtamu/0000-0002-4778-9008; Liu, Hui/0000-0003-1653-5774; Siddique, Kadambot H.M./0000-0001-6097-4235; Yan, Guijun/0000-0001-9628-1211				ABS, 2012, YB AUSTR YB AUSTR 20; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ayalew H, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1914-4; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bezant J, 1997, MOL BREEDING, V3, P29, DOI 10.1023/A:1009648220852; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Castanha ER, 2006, J MICROBIOL METH, V64, P27, DOI 10.1016/j.mimet.2005.04.032; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Doerge RW, 1996, GENETICS, V142, P285; Dolferus R, 2011, PLANT SCI, V181, P331, DOI 10.1016/j.plantsci.2011.05.015; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Elhani S, 2007, FIELD CROP RES, V103, P25, DOI 10.1016/j.fcr.2007.05.008; Fang XW, 2010, J EXP BOT, V61, P335, DOI 10.1093/jxb/erp307; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Food and Agricultural Organization, 2016, SUST AGR BIOD BIOD S; Griffiths S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118847; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo ZF, 2015, J EXP BOT, V66, P5945, DOI 10.1093/jxb/erv303; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Heidari B, 2011, GENOME, V54, P517, DOI [10.1139/g11-017, 10.1139/G11-017]; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Ji XM, 2010, PLANT CELL ENVIRON, V33, P926, DOI 10.1111/j.1365-3040.2010.02130.x; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Kearsey MJ, 1998, GENETICAL ANAL QUANT; Kim DM, 2014, RICE, V7, DOI 10.1186/s12284-014-0014-5; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Monneveux P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00429; Nezhad KZ, 2012, EUPHYTICA, V186, P127, DOI 10.1007/s10681-011-0559-y; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Onyemaobi I, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02071; Passioura JB, 2012, FUNCT PLANT BIOL, V39, P851, DOI 10.1071/FP12079; PASSIOURA JB, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P343; Peltonen-Sainio P, 2007, FIELD CROP RES, V100, P179, DOI 10.1016/j.fcr.2006.07.002; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Powell N, 2012, FUNCT PLANT BIOL, V39, P539, DOI 10.1071/FP12078; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; QUARRIE SA, 1994, THEOR APPL GENET, V89, P794, DOI 10.1007/BF00223721; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Saini HS, 1997, SEX PLANT REPROD, V10, P67, DOI 10.1007/s004970050069; SAINI HS, 1981, ANN BOT-LONDON, V48, P623, DOI 10.1093/oxfordjournals.aob.a086170; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; SIDDIQUE KHM, 1989, FIELD CROP RES, V21, P59, DOI 10.1016/0378-4290(89)90041-5; SNAPE JW, 1985, THEOR APPL GENET, V71, P518, DOI 10.1007/BF00251199; Sohail Q, 2011, BREEDING SCI, V61, P347, DOI 10.1270/jsbbs.61.347; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Torada A, 2006, THEOR APPL GENET, V112, P1042, DOI 10.1007/s00122-006-0206-5; Turner NC, 1979, DROUGHT RESISTANCE A; Varshney RK, 2000, THEOR APPL GENET, V100, P1290, DOI 10.1007/s001220051437; VSN INTERNATIONAL, 2014, GENSTAT WINDOWS; Wang S, 2012, WINDOWS QTL CARTOGRA; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Zhang PF, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0676-y	63	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194075	10.1371/journal.pone.0194075	http://dx.doi.org/10.1371/journal.pone.0194075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518125	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900065
J	Linn, SN; Boeer, M; Scheumann, M				Linn, Sabrina N.; Boeer, Michael; Scheumann, Marina			First insights into the vocal repertoire of infant and juvenile Southern white rhinoceros	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM; GROUP COORDINATION; BEHAVIOR; PRIMATE; AROUSAL; CALLS; VOCALIZATIONS; ACOUSTICS; CONTEXT; CUES	Describing vocal repertoires represents an essential step towards gaining an overview about the complexity of acoustic communication in a given species. The analysis of infant vocalisations is essential for understanding the development and usage of species- specific vocalisations, but is often underrepresented, especially in species with long interbirth intervals such as the white rhinoceros. Thus, this study aimed for the first time to characterise the infant and juvenile vocal repertoire of the Southern white rhinoceros and to relate these findings to the adult vocal repertoire. The behaviour of seven motherreared white rhinoceros calves (two males, five females) and one hand- reared calf (male), ranging from one month to four years, was simultaneously audio and video- taped at three zoos. Normally reared infants and juveniles uttered four discriminable call types (Whine, Snort, Threat, and Pant) that were produced in different behavioural contexts. All call types were also uttered by the hand- reared calf. Call rates of Whines, but not of the other call types, decreased with age. These findings provide the first evidence that infant and juvenile rhinoceros utter specific call types in distinct contexts, even if they grow up with limited social interaction with conspecifics. By comparing our findings with the current literature on vocalisations of adult white rhinoceros and other solitary rhinoceros species, we discuss to which extent differences in the social lifestyle across species affect acoustic communication in mammals.	[Linn, Sabrina N.; Scheumann, Marina] Univ Vet Med Hannover, Inst Zool, Bunteweg 17, Hannover, Germany; [Linn, Sabrina N.] Serengeti Pk Hodenhagen GmbH, Safaripk 1, Hodenhagen, Germany; [Boeer, Michael] Osnabruck Zoo, Klaus Strick Weg 12, Osnabruck, Germany	University of Veterinary Medicine Hannover, Foundation	Linn, SN (corresponding author), Univ Vet Med Hannover, Inst Zool, Bunteweg 17, Hannover, Germany.; Linn, SN (corresponding author), Serengeti Pk Hodenhagen GmbH, Safaripk 1, Hodenhagen, Germany.	sabrina.linn@gmx.de		Scheumann, Marina/0000-0002-4091-9500	Serengeti-Park-Stiftung; Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover	Serengeti-Park-Stiftung; Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover	This study was financially supported by the Serengeti-Park-Stiftung (MS; hftp://www.serengeti-park-stiftung.de/) and the Studienstiftung des Deutschen Volkes (SL; https://www.studienstiftung.de/). Furthermore, this publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amman H, 1986, CONTRIBUTIONS ECOLOG; Baotic A, 2014, BIOACOUSTICS, V23, P15, DOI 10.1080/09524622.2013.798744; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; BENSON BN, 1992, J MAMMAL, V73, P106, DOI 10.2307/1381871; BINZ H, 1989, BEHAVIOUR, V109, P142, DOI 10.1163/156853989X00196; Boeer M, 1996, ZOOL GART, V66, P349; Boersma Paul, 2002, GLOT INT, V5, P341; Braune P, 2005, BEHAV ECOL SOCIOBIOL, V58, P587, DOI 10.1007/s00265-005-0944-4; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; Budde C, 2003, MAMM BIOL, V68, P42, DOI 10.1078/1616-5047-00060; Cao DD, 2016, ANIM BIOL, V66, P145, DOI 10.1163/15707563-00002493; Cinkova I, 2016, ANIM COGN, V19, P375, DOI 10.1007/s10071-015-0940-7; Cinkova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098475; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Esser KH, 2003, SPEECH COMMUN, V41, P179, DOI 10.1016/S0167-6393(02)00102-4; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fischer J, 2002, FOLIA PRIMATOL, V73, P32, DOI 10.1159/000060417; Haccou P, 1994, STAT ANAL BEHAV DATA; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Hazarika B.C., 2010, NeBIO, V1, P62; Herler A, 2012, BEHAVIOUR, V149, P575, DOI 10.1163/156853912X648516; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Knornschild M, 2010, ACTA CHIROPTEROL, V12, P205, DOI 10.3161/150811010X504707; LAURIE A, 1982, J ZOOL, V196, P307; Lea AJ, 2011, ETHOLOGY, V117, P839, DOI 10.1111/j.1439-0310.2011.01947.x; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Muggenthaler E, 2003, J ACOUST SOC AM, V113, P2277; Mumm CAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112562; Owen-Smith N, 1973, BEHAV ECOLOGY WHITE; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith R.N., 1974, IUCN Publs (New Series), VNo. 24, P341; Passilongo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063841; Pfefferle D, 2011, INT J PRIMATOL, V32, P992, DOI 10.1007/s10764-011-9517-8; Pokrovskaya L, 2013, BIOACOUSTICS, V22, P229, DOI 10.1080/09524622.2013.785023; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Ramanankirahina R, 2016, AM J PHYS ANTHROPOL, V159, P466, DOI 10.1002/ajpa.22898; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Roper KM, 2014, AM J PRIMATOL, V76, P192, DOI 10.1002/ajp.22221; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schenkel R., 1969, Acta Tropica, V26, P97; Schenkel R, 1969, HDB ZOOLOGIE, V8, P1; Schenkel R., 1969, ECOLOGY BEHAV BLACK; Scheumann M, 2007, DEV PSYCHOBIOL, V49, P708, DOI 10.1002/dev.20234; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schibler F, 2007, ANIM BEHAV, V74, P1259, DOI 10.1016/j.anbehav.2007.02.026; Schneiderova I, 2012, NATURWISSENSCHAFTEN, V99, P55, DOI 10.1007/s00114-011-0870-4; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Skinner JD, 2006, ONDERSTEPOORT J VET, V73, P237; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; Stoeger AS, 2012, ETHOLOGY, V118, P896, DOI 10.1111/j.1439-0310.2012.02080.x; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Tajuddin binAbdullah M, 1987, J WILDLIFE PARKS MAL, V6, P39; Volodin IA, 2015, ETHOLOGY, V121, P103, DOI 10.1111/eth.12321; Volodin IA, 2014, ANIM COGN, V17, P349, DOI 10.1007/s10071-013-0666-3; von Muggenthaler E, 2003, ACOUST RES LETT ONL, V4, P83, DOI 10.1121/1.1588271; Zahari ZZ, 2005, ANIM REPROD SCI, V85, P327, DOI 10.1016/j.anireprosci.2004.04.041; Zaytseva AS, 2015, BEHAV PROCESS, V118, P130, DOI 10.1016/j.beproc.2015.06.012	62	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192166	10.1371/journal.pone.0192166	http://dx.doi.org/10.1371/journal.pone.0192166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513670	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800011
J	Mamat-Noorhidayah; Yazawa, K; Numata, K; Norma-Rashid, Y				Mamat-Noorhidayah; Yazawa, Kenjiro; Numata, Keiji; Norma-Rashid, Y.			Morphological and mechanical properties of flexible resilin joints on damselfly wings (Rhinocypha spp.)	PLOS ONE			English	Article							RUBBER-LIKE PROTEIN; NANOMECHANICAL PROPERTIES; INSECT; NANOINDENTATION; NANOSTRUCTURE	Resilin functions as an elastic spring that demonstrates extraordinary extensibility and elasticity. Here we use combined techniques, laser scanning confocal microscopy (LSCM) and scanning electron microscopy (SEM) to illuminate the structure and study the function of wing flexibility in damselflies, focusing on the genus Rhinocypha. Morphological studies using LSCM and SEM revealed that resilin patches and cuticular spikes were widespread along the longitudinal veins on both dorsal and ventral wing surfaces. Nanoindentation was performed by using atomic force microscopy (AFM), where the wing samples were divided into three sections (membrane of the wing, mobile and immobile joints). The resulting topographic images revealed the presence of various sizes of nanostructures for all sample sections. The elasticity range values were: membrane (0.04 to 0.16 GPa), mobile joint (1.1 to 2.0 GPa) and immobile joint (1.8 to 6.0 GPa). The elastomeric and glycine-rich biopolymer, resilin was shown to be an important protein responsible for the elasticity and wing flexibility.	[Mamat-Noorhidayah; Norma-Rashid, Y.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yazawa, Kenjiro; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Res Div, Enzyme Res Team, Wako, Saitama, Japan	Universiti Malaya; RIKEN	Mamat-Noorhidayah (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	nhidayahm@siswa.um.edu.my	Norma-Rashid, Y/B-8028-2010; MAMAT, NOORHIDAYAH/AAK-6911-2020; Numata, Keiji/H-9751-2012	Norma-Rashid, Y/0000-0002-1450-1995; MAMAT, NOORHIDAYAH/0000-0001-5353-790X; Numata, Keiji/0000-0003-2199-7420; Yazawa, Kenjiro/0000-0001-7268-5983	International Program Associate (RIKEN, Japan); Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project; University of Malaya [PG065-2015A]	International Program Associate (RIKEN, Japan); Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project; University of Malaya(Universiti Malaya)	The study was supported by the International Program Associate (RIKEN, Japan), by Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project and by the University of Malaya Grant Numbers: PG065-2015A.	Alam P., 2014, NEW DEV POLYM COMPOS, P325; Alsteens D, 2008, PFLUG ARCH EUR J PHY, V456, P117, DOI 10.1007/s00424-007-0386-0; Andersen S. O., 1964, P1; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Appel Esther, 2014, Zoologica (Stuttgart), V159, P1; Appel E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046006; AZUMA A, 1985, J EXP BIOL, V116, P79; BAILEY K, 1961, BIOCHIM BIOPHYS ACTA, V48, P452, DOI 10.1016/0006-3002(61)90043-9; BORROR D. J., 1998, FIELD GUIDE INSECTS, VSecond; Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41; Cabibbo M, 2012, MICRON, V43, P215, DOI 10.1016/j.micron.2011.07.016; Chapman RF, 2013, J CHEM INF MODEL, V5th; Ching-Hsin C, 2009, ADV MATER RES-SWITZ, V79-82, P1325, DOI 10.4028/www.scientific.net/AMR.79-82.1325; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Costa PB, 2009, XIX IMEKO WORLD CONGRESS: FUNDAMENTAL AND APPLIED METROLOGY, PROCEEDINGS, P1028; Dirks JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043411; Donoughe S, 2011, J MORPHOL, V272, P1409, DOI 10.1002/jmor.10992; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Ganguli R, 2010, EXP MECH, V50, P1183, DOI 10.1007/s11340-009-9316-8; Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Hedrick TL, 2015, CAN J ZOOL, V93, P925, DOI 10.1139/cjz-2013-0196; Ho S, 2003, PROG AEROSP SCI, V39, P635, DOI 10.1016/j.paerosci.2003.04.001; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; JPK Instruments, 2017, DET EL MOD BIOL SAMP; Kempf M., 2000, APPL NOTE; Kim JY, 2006, J MATER RES, V21, P2975, DOI 10.1557/JMR.2006.0370; Kim WK, 2009, J THEOR BIOL, V260, P523, DOI 10.1016/j.jtbi.2009.07.015; King RJ., 2010, THESIS; Kreuz P, 2001, ANN BIOMED ENG, V29, P1054, DOI 10.1114/1.1424921; Marrocco J, 2010, ACSESS P; Matzke R, 2001, NAT CELL BIOL, V360, P7; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; Newman DJS., 1982, FUNCTIONAL WING MORP; Orr A.G., 2003, GUIDE DRAGONFLY BORN; Rajabi H, 2017, ACTA BIOMATER, V60, P330, DOI 10.1016/j.actbio.2017.07.034; Rajabi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39039; Rajabi H, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150610; Rajabi H, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056003; Rajendran S, 2012, MICRON, V43, P1299, DOI 10.1016/j.micron.2011.10.017; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; RIEK EF, 1984, CAN J ZOOL, V62, P1150, DOI 10.1139/z84-166; Rockstein M., 1978, BIOCH INSECTS; Shuman DJ, 2007, MATER CHARACT, V58, P380, DOI 10.1016/j.matchar.2006.06.005; Shyy W, 2008, CAMB AERO SER, P1; Shyy W, 2010, PROG AEROSP SCI, V46, P284, DOI 10.1016/j.paerosci.2010.01.001; Song F, 2007, MAT SCI ENG A-STRUCT, V23, P281; Sun JY, 2010, IET NANOBIOTECHNOL, V4, P10, DOI 10.1049/iet-nbt.2009.0009; Sun JY, 2012, RSC ADV, V2, P12606, DOI 10.1039/c2ra21276e; Sun JY, 2007, P SPIE; Tamai M., 2007, THESIS; Tamburro AM, 2010, CHEMBIOCHEM, V11, P83, DOI 10.1002/cbic.200900460; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; van Eldijk MB, 2012, TOP CURR CHEM, V310, P71, DOI 10.1007/128_2011_205; VanLandingham MR, 2003, J RES NATL INST STAN, V108, P249, DOI 10.6028/jres.108.024; Wang Q, 2013, J APPL PHYS, V112; Wang XS, 2008, COMPOS SCI TECHNOL, V68, P186, DOI 10.1016/j.compscitech.2007.05.023; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Wootton R.J., 1991, Advances in Odonatology, V5, P153; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; WOOTTON RJ, 1981, J ZOOL, V193, P447; Wootton RJ, 1998, SCIENCE, V282, P749, DOI 10.1126/science.282.5389.749; Wootton Robin J., 2008, P261; Xiao KW, 2007, ACTA MECH SINICA, V23, P281, DOI 10.1007/s10409-007-0070-9; Zhao HX, 2012, ODONATOLOGICA, V41, P161; Zhao HX, 2010, CHINESE SCI BULL, V55, P1993, DOI 10.1007/s11434-010-3253-x	72	13	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193147	10.1371/journal.pone.0193147	http://dx.doi.org/10.1371/journal.pone.0193147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513694	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800041
J	Selvamani, Y; Singh, P				Selvamani, Y.; Singh, Pushpendra			Socioeconomic patterns of underweight and its association with self-rated health, cognition and quality of life among older adults in India	PLOS ONE			English	Article							BODY-MASS INDEX; CROSS-SECTIONAL ANALYSIS; PUBLIC-HEALTH; GLOBAL BURDEN; ORAL-HEALTH; TOBACCO USE; ALL-CAUSE; POPULATION; OBESITY; DISABILITY	Background Underweight defined as body mass index (BMI) < 18.5 is associated with negative health and quality of life outcomes including mortality. Yet, little is known about the socioeconomic differentials in underweight and its association with health and well-being among older adults in India. This study examined the socioeconomic differentials in underweight among respondents aged >= 50 in India. Consequently, three outcomes of the association of underweight were studied. These are poor self-rated health, cognition and quality of life. Methods Cross-sectional data on 6,372 older adults derived from the first wave of the WHO's Study on global AGEing and adult health (SAGE), a nationally representative survey conducted in six states of India during 2007-8, were used. Bivariate and multivariate regression analyses were applied to fulfil the objectives. Results The overall prevalence of underweight was 38 percent in the study population. Further, socioeconomic status showed a significant and negative association with underweight. The association of underweight with poor self-rated health (OR = 1.60; p <.001), cognition (beta = -0.95; p <.001) and quality of life (beta = -1.90; p <.001) were remained statistically significant after adjusting for age, sex, place of residence, marital status, years of schooling, wealth quintile, sleep problems, chronic diseases, low back pain and state/province. Conclusion The results indicated significant socioeconomic differentials in underweight and its association with poor self-rated health, cognition and quality of life outcomes. Interventions focussing on underweight older adults are important to enhance the overall wellbeing of the growing older population in India.	[Selvamani, Y.] IIPS, Dept Dev Studies, Bombay, Maharashtra, India; [Singh, Pushpendra] Indian Inst Technol Roorkee, Dept Humanities & Social Sci, Roorkee, Uttar Pradesh, India	International Institute for Population Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Selvamani, Y (corresponding author), IIPS, Dept Dev Studies, Bombay, Maharashtra, India.	selvamani@iips.net	Singh, Pushpendra/T-4248-2018	Singh, Pushpendra/0000-0002-7277-115X; Selvamani, Y/0000-0002-1190-9127				Akinyemiju TF, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0474-x; Amarya S, 2015, J CLIN GERONTOL GERI, V6, P78, DOI 10.1016/j.jcgg.2015.05.003; Arnold F, 2005, NAT FAM HLTH SURV NF, V6, P59; Arokiasamy P, 2016, J CROSS-CULT GERONTO, V31, P193, DOI 10.1007/s10823-016-9283-3; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bhan N, 2016, NICOTINE TOB RES, V18, P1711, DOI 10.1093/ntr/ntw092; Bhandary N., 2017, INT J PUBLIC HEALTH, P1; Daly RM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-71; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Deaton A., 2009, Economic and Political Weekly, V44, P42; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Dotchin CL, 2015, J EPIDEMIOL GLOB HEA, V5, P57, DOI 10.1016/j.jegh.2014.09.004; Duraisamy P, 2005, NATL COMMISSION MACR; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Fares D, 2012, REV ASSOC MED BRAS, V58, P434, DOI 10.1590/S0104-42302012000400013; Fernihough A, 2015, ECON HUM BIOL, V16, P30, DOI 10.1016/j.ehb.2013.12.010; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Giezenaar C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010028; Goli S, 2014, J CROSS-CULT GERONTO, V29, P353, DOI 10.1007/s10823-014-9251-8; Griffiths P, 2005, EUR J CLIN NUTR, V59, P1217, DOI 10.1038/sj.ejcn.1602228; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; do Nascimento TLH, 2013, NUTRITION, V29, P152, DOI 10.1016/j.nut.2012.05.011; Hirve S, 2014, SOC INDIC RES, V117, P105, DOI 10.1007/s11205-013-0334-7; Hong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117731; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; IIPS, 2007, ORC MACR NAT FAM HLT; Imai K, 2008, OBESITY, V16, P402, DOI 10.1038/oby.2007.70; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Khongsdier R, 2002, EUR J CLIN NUTR, V56, P484, DOI 10.1038/sj.ejcn.1601281; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Koyanagi A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007313; Kumar K, 2016, J ECON AGEING, V7, P43, DOI 10.1016/j.jeoa.2016.02.002; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Lee J, 2014, J ECON AGEING, V4, P26, DOI 10.1016/j.jeoa.2014.02.002; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Myint PK, 2006, OBESITY, V14, P884, DOI 10.1038/oby.2006.102; Nedo E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-60; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; Neuman M, 2011, AM J CLIN NUTR; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Pednekar MS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-70; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Razak F, 2015, JAMA-J AM MED ASSOC, V314, P2164, DOI 10.1001/jama.2015.15666; Reddy KK, 2004, ASIA PACIFIC J CLIN, V13; Samal S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008608; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Schrock JM, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.23033; Schubert CR, 2002, SLEEP, V25, P889; Selvamani Y, APPL DEMOGRAPHY PUBL, P329; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Sheiham A, 2002, BRIT DENT J, V192, P703, DOI 10.1038/sj.bdj.4801461a; Shukla A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094433; Shukla HC, 2002, J EPIDEMIOL COMMUN H, V56, P876, DOI 10.1136/jech.56.11.876; Siddiqui ST, 2015, INT J PUBLIC HEALTH, V60, P717, DOI 10.1007/s00038-015-0720-9; Singh P, 2016, STUD FUZZ SOFT COMP, V330, P1, DOI [10.1007/978-3-319-26293-2, 10.1155/2016/2796863]; SJOGREN A, 1994, AGE AGEING, V23, P108, DOI 10.1093/ageing/23.2.108; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Vedantam A, 2010, PUBLIC HEALTH NUTR, V13, P1328, DOI 10.1017/S1368980009991674; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wang A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150070; Wang J., 2016, SCI REPORTS, V6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Wu F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166986; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Xiang XL, 2015, ARCH GERONTOL GERIAT, V60, P394, DOI 10.1016/j.archger.2015.02.008; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	86	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193979	10.1371/journal.pone.0193979	http://dx.doi.org/10.1371/journal.pone.0193979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513768	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800095
J	Wood, PL; Tippireddy, S; Feriante, J; Woltjer, RL				Wood, Paul L.; Tippireddy, Soumya; Feriante, Joshua; Woltjer, Randall L.			Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; TARGETED LIPIDOMICS; PHOSPHOLIPASE-D; GLUCOCEREBROSIDASE MUTATIONS; CERAMIDE METABOLISM; GAUCHER-DISEASE; WHITE-MATTER; DEMENTIA; INVOLVEMENT	Background Research from our laboratory, and that of other investigators, has demonstrated augmented levels of diacylglycerols (DAG) in the frontal cortex and plasma of subjects with Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). We have extended these observations to investigate the frontal cortex of subjects with Parkinson's disease (PD) and Lewy Body Disease (LBD), with and without coexisting pathologic features of AD. Methods/Principal findings Utilizing a high-resolution mass spectrometry analytical platform, we clearly demonstrate that DAG levels are significantly increased in the frontal cortex of subjects with PD, LBD with intermediate neocortical AD neuropathology, and in LBD with established neocortical AD neuropathology. In the case of the PD cohort, increases in cortical DAG levels were detected in cases with no neocortical pathology but were greater in subjects with neocortical pathology. These data suggest that DAG changes occur early in the disease processes and are amplified as cortical dysfunction becomes more established. Conclusions These findings suggest that altered DAG synthesis/metabolism is a common feature of neurodegenerative diseases, characterized by proteinopathy, that ultimately result in cognitive deficits. With regard to the mechanism responsible for these biochemical alterations, selective decrements in cortical levels of phosphatidylcholines in LBD and PD suggest that augmented degradation and/or decreased synthesis of these structural glycerophospholipids may contribute to increases in the pool size of free DAGs. The observed augmentation of DAG levels may be phospholipase-driven since neuroinflammation is a consistent feature of all disease cohorts. If this conclusion can be validated it would support utilizing DAG levels as a biomarker of the early disease process and the investigation of early intervention with anti-inflammatory agents.	[Wood, Paul L.] Lincoln Mem Univ, Coll Vet Med, Metabol Unit, Cumberland Gap Pkwy, Harrogate, TN 37752 USA; [Tippireddy, Soumya; Feriante, Joshua] Lincoln Mem Univ, DeBusk Coll Osteopath Med, Cumberland Gap Pkwy, Harrogate, TN USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Woltjer, Randall L.] Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Wood, PL (corresponding author), Lincoln Mem Univ, Coll Vet Med, Metabol Unit, Cumberland Gap Pkwy, Harrogate, TN 37752 USA.	paul.wood@lmunet.edu		Feriante, Joshua/0000-0003-3482-254X	Lincoln Memorial University [AG08017]; NIA [AG08017]; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	Lincoln Memorial University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funding sources had no influence on data collection or interpretation. This work was funded by Lincoln Memorial University and the NIA (AG08017) to RLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2014, MOVEMENT DISORD, V29, P518, DOI 10.1002/mds.25729; Aflaki E, 2017, NEURON, V93, P737, DOI 10.1016/j.neuron.2017.01.018; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Blanc F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127396; Boutin M, 2016, ANAL CHEM, V88, P1856, DOI 10.1021/acs.analchem.5b04227; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Cosgrove J, 2015, POSTGRAD MED J, V91, P212, DOI 10.1136/postgradmedj-2015-133247; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; Downing AE, 1992, LAB METHODS HISTOTEC, P88; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; Evangelisti C, 2006, EUR J HISTOCHEM, V50, P9; Ferrazza R, 2016, BIOCHEM BIOPH RES CO, V478, P1141, DOI 10.1016/j.bbrc.2016.08.082; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Fujishiro H, 2015, GERIATR GERONTOL INT, V15, P817, DOI 10.1111/ggi.12466; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Gonzalez-Dominguez R, 2015, TALANTA, V131, P480, DOI 10.1016/j.talanta.2014.07.075; Goodall EF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00178; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Kim Dana, 2014, Exp Neurobiol, V23, P352, DOI 10.5607/en.2014.23.4.352; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Lam SM, 2014, NEUROBIOL AGING, V35, P2369, DOI 10.1016/j.neurobiolaging.2014.02.025; Lichtenstein MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00142; Liu AKL, 2015, ACTA NEUROPATHOL, V129, P527, DOI 10.1007/s00401-015-1392-5; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mata IF, 2008, ARCH NEUROL-CHICAGO, V65, P379, DOI 10.1001/archneurol.2007.68; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Mrak RE, 2007, J NEUROPATH EXP NEUR, V66, P683, DOI 10.1097/nen.0b013e31812503e1; Mukaetova-Ladinska EB, 2013, J NEUROPATH EXP NEUR, V72, P53, DOI 10.1097/NEN.0b013e31827c5710; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; PERRY EK, 1991, ANN NY ACAD SCI, V640, P197; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Shin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077983; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Streit WJ, 2016, BRAIN BEHAV IMMUN, V55, P191, DOI 10.1016/j.bbi.2015.10.012; STROSZNAJDER J, 1979, BIOCHIM BIOPHYS ACTA, V574, P48, DOI 10.1016/0005-2760(79)90083-3; Tagliafierro L., 2017, ALZHEIMERS DEMENT; Tanabe F, 2014, BIOCHEM BIOPH RES CO, V446, P933, DOI 10.1016/j.bbrc.2014.03.038; Trubiani O, 2016, CELL SIGNAL, V28, P1631, DOI 10.1016/j.cellsig.2016.07.012; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Tsuchiya R, 2015, BBA-MOL CELL RES, V1853, P361, DOI 10.1016/j.bbamcr.2014.11.011; Walker L, 2015, ACTA NEUROPATHOL, V129, P729, DOI 10.1007/s00401-015-1406-3; Wood P., 2014, JSM ALZHEIMERS DIS R, V1, P1001; Wood P. L., 2014, J PARKINSONS DIS ALZ, V1, P4; Wood P, 2017, NEUROMETHODS, V125, P13, DOI 10.1007/978-1-4939-6946-3_2; Wood Paul L., 2003, P3; Wood PL, 2016, BBA CLIN, V5, P25, DOI 10.1016/j.bbacli.2015.11.004; Wood PL, 2015, J ALZHEIMERS DIS, V48, P537, DOI 10.3233/JAD-150336; Wood PL, 2015, ACTA NEUROPSYCHIATR, V27, P270, DOI 10.1017/neu.2015.18; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; Wood PL, 2010, J PSYCHIATR NEUROSCI, V35, P59, DOI 10.1503/jpn.090059; Zhang QS, 2017, TOXICOL LETT, V265, P30, DOI 10.1016/j.toxlet.2016.11.002; Zilberter Y, 2017, J NEUROSCI RES	59	33	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191815	10.1371/journal.pone.0191815	http://dx.doi.org/10.1371/journal.pone.0191815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513680	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800009
J	Stroustrup, A; Bragg, JB; Andra, SS; Curtin, PC; Spear, EA; Sison, DB; Just, AC; Arora, M; Gennings, C				Stroustrup, Annemarie; Bragg, Jennifer B.; Andra, Syam S.; Curtin, Paul C.; Spear, Emily A.; Sison, Denise B.; Just, Allan C.; Arora, Manish; Gennings, Chris			Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance	PLOS ONE			English	Article							MATERNAL LIFE-STYLE; LOW-BIRTH-WEIGHT; PRENATAL EXPOSURE; MEDICAL DEVICES; CHILDREN BORN; HUMAN URINE; MONO(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; METABOLITES; DEHP	Every year in the United States, more than 300,000 infants are admitted to neonatal intensive care units (NICU) where they are exposed to a chemical-intensive hospital environment during a developmentally vulnerable period. The neurodevelopmental impact of environmental exposure to phthalates during the NICU stay is unknown. As phthalate exposure during the third trimester developmental window has been implicated in neurobehavioral deficits in term-born children that are strikingly similar to a phenotype of neurobehavioral morbidity common among children born premature, the role of early-life phthalate exposure on the neurodevelopmental trajectory of premature infants may be clinically important. In this study, premature newborns with birth weight < 1500g were recruited to participate in a prospective environmental health cohort study, NICU-HEALTH (Hospital Exposures and Long-Term Health), part of the DINE (Developmental Impact of NICU Exposures) cohort of the ECHO (Environmental influences on Child Health Outcomes) program. Seventy-six percent of eligible infants enrolled in the study. Sixty-four of 81 infants survived and are included in this analysis. 164 urine specimens were analyzed for phthalate metabolites using highperformance liquid chromatography/tandem mass spectrometry. The NICU Network Neurobehavioral Scale (NNNS) was performed prior to NICU discharge. Linear and weighted quantile sum regression quantified associations between phthalate biomarkers and NNNS performance, and between phthalate biomarkers and intensity of medical intervention. The sum of di(2-ethylhexyl) phthalate metabolites (SDEHP) was associated with improved performance on the Attention and Regulation scales. Specific mixtures of phthalate biomarkers were also associated with improved NNNS performance. More intense medical intervention was associated with higher SDEHP exposure. NICU-based exposure to phthalates mixtures was associated with improved attention and social response. This suggests that the impact of phthalate exposure on neurodevelopment may follow a non-linear trajectory, perhaps accelerating the development of certain neural networks. The long-term neurodevelopmental impact of NICU-based phthalate exposure needs to be evaluated.	[Stroustrup, Annemarie; Bragg, Jennifer B.; Spear, Emily A.; Sison, Denise B.] Icahn Sch Med Mt Sinai, Dept Pediat, Div Newborn Med, New York, NY 10029 USA; [Stroustrup, Annemarie] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Stroustrup, Annemarie; Andra, Syam S.; Curtin, Paul C.; Just, Allan C.; Arora, Manish; Gennings, Chris] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, Div Newborn Med, New York, NY 10029 USA.; Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.; Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.	annemarie.stroustrup@mssm.edu	Stroustrup, Annemarie/ABB-5846-2020; ANDRA, SYAM/B-4693-2011	Stroustrup, Annemarie/0000-0002-5667-6195; ANDRA, SYAM/0000-0003-2839-6417; Just, Allan/0000-0003-4312-5957	National Institutes of Environmental Health Sciences (NIEHS) [K23ES022268]; National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program [UG3OD023320]; Passport Foundation; Mount Sinai Children's Environmental Health Center; NIEHS [P30ES023515]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES022268, P30ES023515, R00ES023450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023320, UH3OD023320] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program; Passport Foundation; Mount Sinai Children's Environmental Health Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Stroustrup is supported by a career development award, K23ES022268, from the National Institutes of Environmental Health Sciences (NIEHS) and a cooperative agreement, UG3OD023320, from the National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program. Additional funding for the investigators and this project came through pilot grants from the Passport Foundation, the Mount Sinai Children's Environmental Health Center, and an NIEHS center grant P30ES023515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Ahlsson F, 2015, EPIDEMIOLOGY, V26, P106, DOI 10.1097/EDE.0000000000000171; Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013; Andrews B, 2012, ACTA PAEDIATR, V101, P574, DOI 10.1111/j.1651-2227.2012.02609.x; [Anonymous], 2009, 4 CDCP; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bernard L, 2014, TALANTA, V129, P39, DOI 10.1016/j.talanta.2014.04.069; Boukydis CFZ, 2004, PEDIATRICS, V113, P679; Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x; Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429; Calafat AM, 2015, ENVIRON HEALTH PERSP, V123, pA166, DOI 10.1289/ehp.1510041; Carrico C, 2014, J AGR BIOL IN PRESS; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Conrad AL, 2010, PEDIATRICS, V125, pE83, DOI 10.1542/peds.2009-0634; de Jong M, 2015, EARLY HUM DEV, V91, P761, DOI 10.1016/j.earlhumdev.2015.08.015; de Jong M, 2012, SEMIN FETAL NEONAT M, V17, P163, DOI 10.1016/j.siny.2012.02.003; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Donauer S, 2015, J PEDIATR-US, V166, P736, DOI 10.1016/j.jpeds.2014.11.021; Downey LC, 2015, J PEDIATR-US, V166, P20, DOI 10.1016/j.jpeds.2014.08.004; Ejaredar M, 2015, ENVIRON RES, V142, P51, DOI 10.1016/j.envres.2015.06.014; Elgen SK, 2015, EUR CHILD ADOLES PSY, V24, P463, DOI 10.1007/s00787-014-0597-9; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001; Factor-Litvak P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114003; Frederiksen H, 2014, ENVIRON HEALTH PERSP, V122, P998, DOI 10.1289/ehp.1307569; Gennings C, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-66; Glover Vivette, 2015, Adv Neurobiol, V10, P269, DOI 10.1007/978-1-4939-1372-5_13; Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/ehp.7932; Grizenko N, 2015, J CAN ACAD CHILD ADO, V24, P92; Guy A, 2015, J PEDIATR-US, V166, P269, DOI 10.1016/j.jpeds.2014.10.053; Harrison W, 2015, JAMA PEDIATR, V169, P855, DOI 10.1001/jamapediatrics.2015.1305; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008; Kraft AD, 2016, NEUROTOXICOL TERATOL, V55, P38, DOI 10.1016/j.ntt.2016.03.005; Latini G, 2010, CURR MED CHEM, V17, P2979, DOI 10.2174/092986710792064992; Latini G, 2009, NEONATOLOGY, V95, P317, DOI 10.1159/000181161; Lejeune F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23329; Lester BM, 2014, JOVE-J VIS EXP, DOI 10.3791/3368; Lester BM, 2004, PEDIATRICS, V113, P641; Lester BM, 2004, PEDIATRICS, V113, P668; Lester BM, 2004, PEDIATRICS, V113, P634; Lester BM, 2002, PEDIATRICS, V110, P1182, DOI 10.1542/peds.110.6.1182; Lester BM, 2004, NICU NETWORK NEUROBE; Lien YJ, 2015, ENVIRON HEALTH PERSP, V123, P95, DOI 10.1289/ehp.1307154; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Liu J, 2010, PEDIATRICS, V125, pE90, DOI 10.1542/peds.2009-0204; Madlinger-Lewis L, 2014, RES DEV DISABIL, V35, P490, DOI 10.1016/j.ridd.2013.11.019; Mallow EB, 2014, J PERINATOL, V34, P892, DOI 10.1038/jp.2014.157; Martin Joyce A, 2015, NCHS Data Brief, P1; Martinez-Arguelles DB, 2016, ANDROLOGY-US, V4, P573, DOI 10.1111/andr.12175; Meredith RM, 2015, NEUROSCI BIOBEHAV R, V50, P180, DOI 10.1016/j.neubiorev.2014.12.001; Monnier M, 2014, ARCH PEDIATRIE, V21, P944, DOI 10.1016/j.arcped.2014.04.032; Montagna A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00080; Montirosso R, 2012, PEDIATRICS, V129, pE1129, DOI 10.1542/peds.2011-0813; Mueller CA, 2015, COMP BIOCHEM PHYS A, V184, P113, DOI 10.1016/j.cbpa.2015.02.013; Mundy WR, 2015, NEUROTOXICOL TERATOL, V52, P25, DOI 10.1016/j.ntt.2015.10.001; Park S, 2014, INT J ENV RES PUB HE, V11, P6743, DOI 10.3390/ijerph110706743; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Philippat C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0024-9; Polanska K, 2014, EARLY HUM DEV, V90, P477, DOI 10.1016/j.earlhumdev.2014.06.006; Posner J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.146; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Scheinost D, 2016, PEDIAT RES; Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023; Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Smith JR, 2014, ADV NEONAT CARE, V14, P187, DOI 10.1097/ANC.0000000000000093; Stroustrup A, 2017, JAMA PEDIATR, V171, P1139, DOI 10.1001/jamapediatrics.2017.3230; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, P461; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Textor J, 2011, GESUNDHEITSWESEN, V73, P897, DOI 10.1055/s-0031-1291197; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Treyvaud K, 2013, J CHILD PSYCHOL PSYC; Tronick E, 2013, J CHILD ADOL PS NURS, V26, P193, DOI 10.1111/jcap.12042; Tronick EZ, 2004, PEDIATRICS, V113, P676; Udagawa Jun, 2016, Nihon Eiseigaku Zasshi, V71, P188; Van Vliet EDS, 2011, J PERINATOL, V31, P551, DOI 10.1038/jp.2010.208; Ventrice P, 2013, ENVIRON TOXICOL PHAR, V36, P88, DOI 10.1016/j.etap.2013.03.014; Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Yolton K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-79; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003	89	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193835	10.1371/journal.pone.0193835	http://dx.doi.org/10.1371/journal.pone.0193835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505594	gold, Green Submitted, Green Published			2022-12-26	WOS:000426548200034
J	Lim, YH; Kwon, DH; Kim, J; Park, WJ; Kook, H; Kim, YK				Lim, Yeong-Hwan; Kwon, Duk-Hwa; Kim, Jaetaek; Park, Woo Jin; Kook, Hyun; Kim, Young-Kook			Identification of long noncoding RNAs involved in muscle differentiation	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CELLS IN-VITRO; STEM-CELLS; PHENOTYPIC MODULATION; RESPONSE FACTOR; HUMAN GENOME; VIVO; PROLIFERATION; HOMEOSTASIS; EXPRESSION	Long noncoding RNAs (lncRNAs) are a large class of regulatory RNAs with diverse roles in cellular processes. Thousands of lncRNAs have been discovered; however, their roles in the regulation of muscle differentiation are unclear because no comprehensive analysis of lncRNAs during this process has been performed. In the present study, by combining diverse RNA sequencing datasets obtained from public database, we discovered lncRNAs that could behave as regulators in the differentiation of smooth or skeletal muscle cells. These analyses confirmed the roles of previously reported lncRNAs in this process. Moreover, we discovered dozens of novel lncRNAs whose expression patterns suggested their possible involvement in the phenotypic switch of vascular smooth muscle cells. The comparison of lncRNA expression change suggested that many lncRNAs have common roles during the differentiation of smooth and skeletal muscles, while some lncRNAs may have opposite roles in this process. The expression change of lncRNAs was highly correlated with that of their neighboring genes, suggesting that they may function as cis-acting lnc RNAs. Furthermore, within the lncRNA sequences, there were binding sites for miRNAs with expression levels inversely correlated with the expression of corresponding lncRNAs during differentiation, suggesting a possible role of these lncRNAs as competing endogenous RNAs. The lncRNAs identified in this study will be a useful resource for future studies of gene regulation during muscle differentiation.	[Lim, Yeong-Hwan; Kwon, Duk-Hwa; Kim, Jaetaek; Park, Woo Jin; Kook, Hyun; Kim, Young-Kook] Chonnam Natl Univ, Med Sch, Basic Res Lab Cardiac Remodeling Res Lab, Jeollanam Do, South Korea; [Lim, Yeong-Hwan; Kim, Young-Kook] Chonnam Natl Univ, Med Sch, Dept Biochem, Jeollanam Do, South Korea; [Lim, Yeong-Hwan; Kook, Hyun; Kim, Young-Kook] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Dept Biomed Sci, Jeollanam Do, South Korea; [Kwon, Duk-Hwa; Kook, Hyun] Chonnam Natl Univ, Med Sch, Dept Pharmacol, Jeollanam Do, South Korea; [Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Woo Jin] GIST, Coll Life Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chung Ang University; Chung Ang University Hospital; Gwangju Institute of Science & Technology (GIST)	Kim, YK (corresponding author), Chonnam Natl Univ, Med Sch, Basic Res Lab Cardiac Remodeling Res Lab, Jeollanam Do, South Korea.; Kim, YK (corresponding author), Chonnam Natl Univ, Med Sch, Dept Biochem, Jeollanam Do, South Korea.; Kim, YK (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Dept Biomed Sci, Jeollanam Do, South Korea.	ykk@jnu.ac.kr	Kim, Jaetaek/AAE-7147-2020; Kim, Young-Kook/AAE-8306-2020; Kook, Hyun/AAR-5405-2021	Kim, Jaetaek/0000-0001-5247-0408; Kim, Young-Kook/0000-0001-6434-2235; Kook, Hyun/0000-0002-0740-1806; Kim, Young Kook/0000-0002-6037-8449; Kwon, Duk-hwa/0000-0001-6424-0300	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015R1C 1A1A02036313, NRF-2016R1A4A1009895]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was financially supported by the grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1C 1A1A02036313, NRF-2016R1A4A1009895 to YKK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brock M, 2017, EXP BIOL MED, V242, P487, DOI 10.1177/1535370216685434; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Coletti D, 2016, EUR J TRANSL MYOL, V26, P87, DOI 10.4081/ejtm.2016.6008; Coll-Bonfill N, 2016, PFLUG ARCH EUR J PHY, V468, P1071, DOI 10.1007/s00424-016-1821-x; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong SH, 2013, MOL MED REP, V8, P407, DOI 10.3892/mmr.2013.1538; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fei J, 2016, CIRC RES, V119, P463, DOI 10.1161/CIRCRESAHA.116.309003; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Hao Y, 2016, NPINTER V3 0 UPGRADE; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hellbach N, 2014, HUM MOL GENET, V23, P6177, DOI 10.1093/hmg/ddu338; Huang Y, 2013, STEM CELLS, V31, P906, DOI 10.1002/stem.1324; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jeong G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3252-7; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Martone J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10488; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Song J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00227; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Wang G, 2012, J BIOL CHEM, V287, P2896, DOI 10.1074/jbc.M111.297028; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang TM, 2017, J CELL MOL MED, V21, P3592, DOI 10.1111/jcmm.13269; Yu X, 2015, CELL DEATH DIFFER, V22, P1170, DOI 10.1038/cdd.2014.206; Zhao JJ, 2017, FASEB J, V31, P2576, DOI 10.1096/fj.201601021R; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026; Zong Y, 2017, CIRC J, V81, P567, DOI 10.1253/circj.CJ-16-0751	45	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193898	10.1371/journal.pone.0193898	http://dx.doi.org/10.1371/journal.pone.0193898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499054	Green Published, Green Submitted, gold			2022-12-26	WOS:000426472300026
J	Yang, M; Feng, YH; Yue, CH; Xu, B; Chen, LJ; Jiang, JT; Lu, BF; Zhu, YB				Yang, Min; Feng, Yuehua; Yue, Cuihua; Xu, Bin; Chen, Lujun; Jiang, Jingting; Lu, Binfeng; Zhu, Yibei			Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CD8(+) T; COLORECTAL-CANCER; MAST-CELLS; NK CELLS; METASTASIS; ACTIVATION; MICROENVIRONMENT; PROMOTE; INNATE	Objective Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the response rate of immunotherapy is still low for lung cancer. Studying the tumor microenvironment (TME) should shed light on improvement of immunotherapy of lung cancer. Interleukin-33 (IL-33), an "alarmin" cytokine, has been implicated in tumor associated immune responses and inflammatory diseases of the lung. The role of IL-33 in lung cancer progression, however, remains elusive. This study is designed to characterize IL-33 expression in lung tumor tissues and establish the clinical significance of IL-33 in non-small cell lung cancer lung cancer (NSCLC). Materials and methods Tumor tissue specimens from patients suffering from NSCLC were analyzed for expression of IL-33 protein by immunohistochemistry and expression of IL-33 and ST2 mRNA by RT-quantitative PCR (RT-QPCR). The expression data were analyzed for their association with clinical and pathological parameters of NSCLC. In addition, the association between expression levels of IL-33 mRNA and patient survival was determined using 5 independent expression profiling datasets of human lung cancer. Results and conclusion The expression levels of IL-33 and ST2 were significantly down-regulated in both adenocarcinoma and squamous cell carcinoma of the lung when compared to adjacent normal lung tissues. In addition, the level of IL-33 protein was inversely correlated with tumor grade and size. Moreover, analysis of TCGA and GEO lung cancer expression datasets revealed that higher expression levels of IL-33 mRNA were correlated with longer overall survival of patients suffering from adenocarcinoma of the lung. These data indicate that the expression levels of IL-33 are inversely associated with lung cancer progression, consistent with the hypothesis that IL-33 is involved in immune surveillance of NSCLC.	[Yang, Min; Yue, Cuihua; Zhu, Yibei] Soochow Univ, Sch Biol & Basic Med Sci, Dept Immunol, Suzhou, Peoples R China; [Yang, Min; Yue, Cuihua; Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Yang, Min; Yue, Cuihua; Xu, Bin; Chen, Lujun; Jiang, Jingting] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China; [Feng, Yuehua] Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China; [Jiang, Jingting; Zhu, Yibei] Soochow Univ, Inst Cell Therapy, Suzhou, Peoples R China; [Zhu, Yibei] Soochow Univ, Jiangsu Key Lab Clin Immunol, Suzhou, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhu, YB (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Dept Immunol, Suzhou, Peoples R China.; Lu, BF (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Zhu, YB (corresponding author), Soochow Univ, Inst Cell Therapy, Suzhou, Peoples R China.; Zhu, YB (corresponding author), Soochow Univ, Jiangsu Key Lab Clin Immunol, Suzhou, Peoples R China.	binfeng@pitt.edu; xlyb99@163.com			National Natural Science Foundation of China [31670916, 81273208, 31729001]; Suzhou industrial technology innovation special fund [SS201664]; NIH [R21CA205727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou industrial technology innovation special fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was mainly supported by the National Natural Science Foundation of China (Grants 31670916, 81273208 to Y.Z., 31729001 to B.L., http://www.nsfc.gov.cn/), Suzhou industrial technology innovation special fund (SS201664 to Y.Z.), and partly supported by NIH R21CA205727 (https://www.nih.gov/) to B.L.	Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dominguez D, 2017, J IMMUNOL, V198, P1365, DOI 10.4049/jimmunol.1501399; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fang M, 2017, CANCER RES, V77, P2735, DOI 10.1158/0008-5472.CAN-16-1602; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Hanna Jennifer M, 2013, J Carcinog, V12, P6, DOI 10.4103/1477-3163.109033; He ZX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05716-z; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; KLEIN G, 1966, ANNU REV MICROBIOL, V20, P223, DOI 10.1146/annurev.mi.20.100166.001255; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Liu J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00141; Lu BF, 2016, J MOL MED, V94, P535, DOI 10.1007/s00109-016-1397-0; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Maywald RL, 2015, P NATL ACAD SCI USA, V112, pE2487, DOI 10.1073/pnas.1422445112; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; O'Donnell C, 2016, BRIT J CANCER, V114, P37, DOI 10.1038/bjc.2015.433; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Rowbotham SP, 2014, P NATL ACAD SCI USA, V111, P4745, DOI 10.1073/pnas.1401955111; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Wang CH, 2016, BIOCHEM BIOPH RES CO, V479, P461, DOI 10.1016/j.bbrc.2016.09.081; Wang KL, 2017, ONCOTARGET, V8, P68571, DOI 10.18632/oncotarget.19786; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Zhang Y, 2017, MOL CARCINOGEN, V56, P272, DOI 10.1002/mc.22491	39	23	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193428	10.1371/journal.pone.0193428	http://dx.doi.org/10.1371/journal.pone.0193428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499051	gold, Green Published, Green Submitted			2022-12-26	WOS:000426472300013
J	Ferrarini, A; Forcato, C; Buson, G; Tononi, P; del Monaco, V; Terracciano, M; Bolognesi, C; Fontana, F; Medoro, G; Neves, R; Mohlendick, B; Rihawi, K; Ardizzoni, A; Sumanasuriya, S; Flohr, P; Lambros, M; de Bono, J; Stoecklein, NH; Manaresi, N				Ferrarini, Alberto; Forcato, Claudio; Buson, Genny; Tononi, Paola; del Monaco, Valentina; Terracciano, Mario; Bolognesi, Chiara; Fontana, Francesca; Medoro, Gianni; Neves, Rui; Moehlendick, Birte; Rihawi, Karim; Ardizzoni, Andrea; Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann; Stoecklein, Nikolas H.; Manaresi, Nicolo			A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; C-MYC ONCOGENE; CENTROSOME DEFECTS; BREAST-TUMORS; CANCER; GENE; DNA; EXPRESSION; RECURRENT; IDENTIFICATION	Chromosomal instability and associated chromosomal aberrations are hallmarks of cancer and play a critical role in disease progression and development of resistance to drugs. Single-cell genome analysis has gained interest in latest years as a source of biomarkers for targeted-therapy selection and drug resistance, and several methods have been developed to amplify the genomic DNA and to produce libraries suitable for Whole Genome Sequencing (WGS). However, most protocols require several enzymatic and cleanup steps, thus increasing the complexity and length of protocols, while robustness and speed are key factors for clinical applications. To tackle this issue, we developed a single-tube, single-step, streamlined protocol, exploiting ligation mediated PCR (LM-PCR) Whole Genome Amplification (WGA) method, for low-pass genome sequencing with the Ion Torrent T platform and copy number alterations (CNAs) calling from single cells. The method was evaluated on single cells isolated from 6 aberrant cell lines of the NCI-H series. In addition, to demonstrate the feasibility of the workflow on clinical samples, we analyzed single circulating tumor cells (CTCs) and white blood cells (WBCs) isolated from the blood of patients affected by prostate cancer or lung adenocarcinoma. The results obtained show that the developed workflow generates data accurately representing whole genome absolute copy number profiles of single cell and allows alterations calling at resolutions down to 100 Kbp with as few as 200,000 reads. The presented data demonstrate the feasibility of the Ampli1 (TM) WGA-based lowpass workflow for detection of CNAs in single tumor cells which would be of particular interest for genome-driven targeted therapy selection and for monitoring of disease progression.	[Ferrarini, Alberto; Forcato, Claudio; Buson, Genny; Tononi, Paola; del Monaco, Valentina; Terracciano, Mario; Bolognesi, Chiara; Fontana, Francesca; Medoro, Gianni; Manaresi, Nicolo] Menarini Silicon Biosyst Spa, Bologna, Italy; [Neves, Rui; Moehlendick, Birte; Stoecklein, Nikolas H.] Heinrich Heine Univ Dusseldorf, Univ Hosp, Med Fac, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Rihawi, Karim; Ardizzoni, Andrea] Policlin St Orsola Malpighi, Unita Operat Oncol Med, Bologna, Italy; [Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann] Inst Canc Res, London, England; [Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann] Royal Marsden NHS Fdn Trust, London, England	Heinrich Heine University Dusseldorf; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Manaresi, N (corresponding author), Menarini Silicon Biosyst Spa, Bologna, Italy.	nmanaresi@siliconbiosystems.com	ardizzoni, andrea/AAC-4337-2021; t, lf/AAJ-4924-2020; Rihawi, Karim/AAC-5431-2021; Neves, Rui/AAF-9626-2021	ardizzoni, andrea/0000-0003-2678-0714; Neves, Rui/0000-0002-4515-739X; de Bono, Johann S/0000-0002-2034-595X; Mohlendick, Birte/0000-0001-9093-8585; rihawi, karim/0000-0002-3915-466X	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU); CANCER-ID [115749]	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU); CANCER-ID	This work was supported by CANCER-ID, a project funded by the Innovative Medicines Joint Undertaking (IMI JU) in conjunction with CANCER-ID [Grant Agreement #115749]. The funder (Menarini Silicon Biosystems S.p.A.) provided support in the form of salaries for authors AF, CF, GB, CB, VDM, PT, MT, FB, FF, GM, NM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Anders S, 2014, BIOINFORMATICS, V2014, P1, DOI 10.1093/bioinformatics/btu638; Arason A, 1998, J MED GENET, V35, P446, DOI 10.1136/jmg.35.6.446; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Carter L, 2016, NAT MED; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Cryz ZT, 2014, PLOS ONE, V9; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Glasspool RM, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS5603; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Huang J, 2007, BIOINFORMATICS, V23, P2463, DOI 10.1093/bioinformatics/btm359; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Hyman E, 2002, CANCER RES, V62, P6240; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jenkins RB, 1997, CANCER RES, V57, P524; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lee YS, 2008, TAIWAN J OBSTET GYNE, V47, P32, DOI 10.1016/S1028-4559(08)60052-2; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2014, BIOINFORMATICS, V30, P2121, DOI 10.1093/bioinformatics/btu174; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Meric-Bernstam F., 2015, JNCI-J NATL CANCER I, V107, P1; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Normand E, 2016, PRENATAL DIAG, V36, P823, DOI 10.1002/pd.4866; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Pompetti F, 1996, J CELL BIOCHEM, V63, P37; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Roh W, 2017, SCI TRANSL MED, V9; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Sato N, 1999, CLIN CANCER RES, V5, P963; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Seo AN, 2014, BRIT J CANCER, V110, P2688, DOI 10.1038/bjc.2014.218; Silverman B., 1986, CHAPMAN HALL, V37, P1, DOI [10.2307/2347507, DOI 10.2307/2347507]; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wong A, 1986, SCIENCE, V233; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	71	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193689	10.1371/journal.pone.0193689	http://dx.doi.org/10.1371/journal.pone.0193689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494651	gold, Green Published			2022-12-26	WOS:000426363200083
J	Lee, WH; Kim, JW; Lim, JS; Kong, IG; Choi, HG				Lee, Woo Hyun; Kim, Jeong-Whun; Lim, Jae-Sung; Kong, Il Gyu; Choi, Hyo Geun			Chronic rhinosinusitis increases the risk of hemorrhagic and ischemic stroke: A longitudinal follow-up study using a national sample cohort	PLOS ONE			English	Article							INTRACRANIAL COMPLICATIONS; CIGARETTE-SMOKING; SINUSITIS; HEART; EPIDEMIOLOGY; ASSOCIATION; INFARCTION; COUNTRIES; DISEASE; HEALTH	Background Several studies have reported that chronic rhinosinusitis (CRS) increases the risk of stroke. The aim of this study is to elucidate the putative association between CRS and stroke (ischemic or hemorrhagic) using large population-based national health insurance data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, CRS patients (n = 22,959) and control participants (n = 91,836) were selected and matched at a rate of 1: 4 (age, sex, income, region, hypertension, diabetes, and dyslipidemia). A Cox-proportional hazard model was used to analyze the hazard ratio (HR) of CRS for hemorrhagic stroke and ischemic stroke. We divided the participants according to age and gender for the subgroup analysis. Results The HR for hemorrhagic and ischemic stroke was significantly increased in the CRS patients compared to that in the controls (adjusted HR = 2.43, 95% confidence interval [CI] = 2.10-2.80 for hemorrhagic stroke; adjusted HR = 1.76, 95% CI = 1.61-1.92 for ischemic stroke) after adjusting for age, sex, income, region of residence, hypertension, diabetes, dyslipidemia, ischemic heart disease, migraine, chronic kidney disease, depression, sleep disorder, and chronic obstructive pulmonary disorder. In the subgroup analysis, the HR of hemorrhagic stroke was significantly increased in the CRS group regardless of age and gender. The HR of ischemic stroke was also significantly increased in all subgroups of the CRS group. Conclusion CRS consistently increased the risk of ischemic and hemorrhagic stroke regardless of age and gender.	[Lee, Woo Hyun] Kangwon Natl Univ Hosp, Dept Otolaryngol, Chunchon, South Korea; [Kim, Jeong-Whun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol, Seongnam, South Korea; [Lim, Jae-Sung] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Anyang, South Korea; [Kong, Il Gyu; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol, Dept Head & Neck Surg, Anyang, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol, Dept Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Lim, Jae-Sung/D-5555-2012; Choi, Hyo Geun/K-4461-2019	Lim, Jae-Sung/0000-0001-6157-2908; Choi, Hyo Geun/0000-0003-1655-9549				Arslan H, 1999, Auris Nasus Larynx, V26, P39, DOI 10.1016/S0385-8146(98)00024-8; Barreto MP, 2000, ANN OTO RHINOL LARYN, V109, P227, DOI 10.1177/000348940010900220; Bayonne E, 2009, RHINOLOGY, V47, P59; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Bhat VM, 2008, STROKE, V39, P2439, DOI 10.1161/STROKEAHA.107.510073; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Giannoni C, 1998, AM J RHINOL, V12, P173, DOI 10.2500/105065898781390127; Giannoni CM, 1997, LARYNGOSCOPE, V107, P863, DOI 10.1097/00005537-199707000-00005; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Hurst RW, 2001, AM J NEURORADIOL, V22, P858; Kang JH, 2013, LARYNGOSCOPE, V123, P835, DOI 10.1002/lary.23829; Kim J, 2013, INT J CHRONIC OBSTR, V8, P561, DOI 10.2147/COPD.S48577; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; Lee WH, 2015, INT FORUM ALLERGY RH, V5, P937, DOI 10.1002/alr.21553; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pleis JR, 2006, VITAL HLTH STAT, V10; Righini Christian Adrien, 2009, Ear Nose Throat J, V88, pE23; Rochat P, 2001, RHINOLOGY, V39, P173; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Salerno SM, 2005, ARCH INTERN MED, V165, P1686, DOI 10.1001/archinte.165.15.1686; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; TOKUSHIGE E, 1994, LARYNGOSCOPE, V104, P1245; Wu CW, 2012, AM J RHINOL ALLERGY, V26, P278, DOI [10.2500/ajra.2012.26.3783, 10.2500/ajra.2012.26.3783a]; Yildirim Yavuz Selim, 2011, Kulak Burun Bogaz Ihtis Derg, V21, P266, DOI 10.5606/kbbihtisas.2011.039; Yoon BW, 2007, NEUROLOGY, V68, P146, DOI 10.1212/01.wnl.0000250351.38999.f2	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193886	10.1371/journal.pone.0193886	http://dx.doi.org/10.1371/journal.pone.0193886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494700	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200099
J	Abdel-Moneim, AS; Mahfouz, ME; Zytouni, DM				Abdel-Moneim, Ahmed S.; Mahfouz, Mohammad E.; Zytouni, Dalia M.			Detection of human bocavirus in Saudi healthy blood donors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PARVOVIRUSES; PLASMA; GENOTYPE-1; PARV4	Human bocavirus is associated with respiratory disease worldwide, mainly in children. There are conflicting results, however, regarding the existence of the HBoV in blood donors. Three hundred whole blood samples from non-immunodeficient healthy blood donors were screened for the presence of HBoV by polymerase chain reaction. The HBoV genotype of positive samples was determined using direct gene sequencing. Twenty-one out of the three hundred blood samples were found to be positive for HBoV. Sequence analysis of the positive samples revealed that all the strains were related to the HBoV-1 type with a low rate of variation among the detected sequences. It was concluded that there is a considerable risk of contracting HBoV from a blood transfusion from normal healthy individuals.	[Abdel-Moneim, Ahmed S.] Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia; [Abdel-Moneim, Ahmed S.] Beni Suef Univ, Fac Vet Med, Virol Dept, Bani Suwayf, Egypt; [Mahfouz, Mohammad E.] Taif Univ, Coll Med, Dept Surg, Al Taif, Saudi Arabia; [Mahfouz, Mohammad E.; Zytouni, Dalia M.] King Faisal Hosp, Al Taif, Saudi Arabia	Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Taif University	Abdel-Moneim, AS (corresponding author), Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia.; Abdel-Moneim, AS (corresponding author), Beni Suef Univ, Fac Vet Med, Virol Dept, Bani Suwayf, Egypt.	asa@tu.edu.sa	Abdel-Moneim, Ahmed S./G-7445-2012; Mahfouz, Mohammad Eid M/T-5874-2018	Abdel-Moneim, Ahmed S./0000-0002-3148-6782; 	Taif University [4912-437-1]	Taif University	This work was supported by the Taif University, Project Number 4912-437-1 to ASA. The funder had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Abdel-Moneim AS, 2017, J MED MICROBIOL, V66, P245, DOI 10.1099/jmm.0.000432; Abdel-Moneim AS, 2016, ARCH VIROL, V161, P2095, DOI 10.1007/s00705-016-2885-9; Abdel-Moneim AS, 2016, J VIROL METHODS, V228, P108, DOI 10.1016/j.jviromet.2015.11.023; Abdel-Moneim AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055500; Adami V, 2004, CLIN MICROBIOL INFEC, V10, P1075, DOI 10.1111/j.1469-0691.2004.01025.x; [Anonymous], 2016, VIRUS TAXONOMY CLASS; Assal A, 2009, TRANSFUSION, V49, P289, DOI 10.1111/j.1537-2995.2008.01965.x; Bonvicini F, 2011, DIAGN MICR INFEC DIS, V71, P460, DOI 10.1016/j.diagmicrobio.2011.08.019; Cassinotti P, 2000, EUR J CLIN MICROBIOL, V19, P886, DOI 10.1007/s100960000384; Costa C, 2009, J CLIN VIROL, V45, P81, DOI 10.1016/j.jcv.2009.02.008; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Eis-Hubinger AM, 2010, TRANSFUSION, V50, P266, DOI 10.1111/j.1537-2995.2009.02433.x; Foglieni B, 2011, TRANSFUSION, V51, P719, DOI 10.1111/j.1537-2995.2010.02942.x; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Lefrere JJ, 1999, J VIROL METHODS, V80, P33, DOI 10.1016/S0166-0934(99)00028-2; Li HX, 2015, TRANSFUSION, V55, P154, DOI 10.1111/trf.12785; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Ma YY, 2012, VOX SANG, V103, P183, DOI 10.1111/j.1423-0410.2012.01605.x; Modrow S, 2011, VOX SANG, V100, P351, DOI 10.1111/j.1423-0410.2010.01445.x; Norja P, 2012, BRIT J HAEMATOL, V159, P385, DOI 10.1111/bjh.12060; Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16; Schenk T, 2007, EMERG INFECT DIS, V13, P1425, DOI 10.3201/eid1309.070318; Shyamala V, 2014, ISBT SCI SERIES, V9, P315, DOI DOI 10.1111/VOXS.12106	27	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193594	10.1371/journal.pone.0193594	http://dx.doi.org/10.1371/journal.pone.0193594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489915	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000093
J	Wei, JX; Dong, S; Yao, KN; Martinez, MFYM; Fleisher, PR; Zhao, YT; Ma, HC; Zhao, J				Wei, Jianxin; Dong, Su; Yao, Kangning; Martinez, Maria Francesca Ysabelle M.; Fleisher, Paine R.; Zhao, Yutong; Ma, Haichun; Zhao, Jing			Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit	FASEB JOURNAL			English	Article						ubiquitination; protein stability; Cdc42 GTPase	DEGRADATION; STABILITY; MIGRATION; COMPLEX; TARGET; SKP2	Ubiquitin E3 ligases mediate ubiquitination and degradation of intracellular proteins. We have shown that a relatively new Skp, Cullin, F-box (SCF) protein E3 ligase, SCF FBXL19, has an anti-inflammatory effect and controls actin cytoskeleton dynamics via targeting cell membrane receptor and small GTPases for their ubiquitination and degradation, but the molecular regulation of its subunit FBXL19 stability remains unclear. Here we show that FBXL19 degradation is controlled by the balance between its ubiquitination and acetylation. FBXL19 is an unstable protein with a half-life of approximate to 3 h. FBXL19 can be polyubiquitinated, and the proteasome inhibitor MG-132 prolongs FBXL19 half-life, suggesting that FBXL19 degradation is mediated in the ubiquitin-proteasome system. FBXL19 can also be acetylated, and enhancing acetylation of FBXL19 by a deacetylase inhibitor reduces FBXL19 ubiquitination levels. Acetylation-mimic FBXL19 mutant exhibits a longer half-life than wild type. An acetyltransferase CBP catalyzes acetylation of FBXL19. Inhibition or down-regulation of CBP reduces FBXL19 stability, whereas it is increased in CBP-overexpressing cells. Taken together, the data indicate that CBP-mediated acetylation reduces ubiquitination and stabilizes FBXL19. Further, we demonstrate that FBXL19 targets small GTPase Cdc42 for its ubiquitination and degradation, whereas this effect is reversed by inhibition of CBP, suggesting that CBP increases the effect of SCF FBXL19 E3 ligase through acetylation and stabilization of FBXL19. Our study reveals a new molecular model for regulation of SCF E3 ligase function by acetylation and stabilization of its subunit F-box protein.Wei, J., Dong, S., Yao, K., Martinez, M. F. Y. M., Fleisher, P. R., Zhao, Y., Ma, H., Zhao, J. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.	[Wei, Jianxin; Dong, Su; Yao, Kangning; Martinez, Maria Francesca Ysabelle M.; Fleisher, Paine R.; Zhao, Yutong; Zhao, Jing] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Dong, Su; Ma, Haichun] Jilin Univ, Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jilin University	Zhao, J (corresponding author), Univ Pittsburgh, Dept Med, 3459 Fifth Ave,NW 628 MUH, Pittsburgh, PA 15213 USA.	zhaoj@upmc.edu			U.S. National Institutes of Health [R01 HL112791, HL136294, HL131665, R01GM115389]; American Lung Association Biomedical Research [RG350146]; American Heart Association [16GRNT30660001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136294, R01HL131665, R01HL112791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Biomedical Research; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary J. Kaltreider (Department of Medicine, University of Pittsburgh) for technical assistance. This study was supported by U.S. National Institutes of Health Grants R01 HL112791, HL136294, and HL131665 (National Heart, Lung, and Blood Institute; to Y.Z.) and R01GM115389 (National Institute of General Medical Sciences; to J.Z.); by American Lung Association Biomedical Research Grant RG350146 (to J.Z.); and by American Heart Association Grant 16GRNT30660001 (to Y.Z.). The authors declare no conflicts of interest.	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; Hu G, 1999, MOL CELL BIOL, V19, P724; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Murali A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.305; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Wei JX, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9660; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; WILKINSON KD, 1987, ANTI-CANCER DRUG DES, V2, P211; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	31	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4284	4292		10.1096/fj.201701069R	http://dx.doi.org/10.1096/fj.201701069R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522376	Bronze, Green Published			2022-12-26	WOS:000439325400019
J	Chiang, N; Riley, IR; Dalli, J; Rodriguez, AR; Spur, BW; Serhan, CN				Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Rodriguez, Ana R.; Spur, Bernd W.; Serhan, Charles N.			New maresin conjugates in tissue regeneration pathway counters leukotriene D-4-stimulated vascular responses	FASEB JOURNAL			English	Article						resolution; inflammation; resolvin; omega-3; leukocyte; lipoxygenase	CIONA-INTESTINALIS; LIPID MEDIATORS; INFLAMMATION; RESOLUTION; BIOSYNTHESIS; SELECTIVITY; RECEPTORS; ENZYMES	Resolution of acute inflammation is governed, in part, by lipid mediator class switching from proinflammatory eicosanoids to specialized proresolving mediators, including a recently identified new pathway of mediators, termed maresin conjugates in tissue regeneration (MCTR), which includes MCTR1, MCTR2, and MCTR3. Here, we addressed whether each MCTR can impact the known vascular actions of cysteinyl leukotrienes. Leukotriene D-4 (LTD4; 1.5 nmol/mouse) initiated vascular leakage in mouse cremaster vessels, which was reduced (>75%) by MCTR1 and MCTR2 (0.15 nmol each). With isolated Ciona intestinalis (sea squirt) primordial hearts, LTD4 (1-100 nM) induced negative inotropic action and lowered heartbeats 20-30%. Each MCTR (1-100 nM) prevented LTD4-reduced heart rates. With human cysteinyl leukotriene receptor-1 (CysLT1) expressed in CHO cells, each MCTR (10-100 nM) significantly reduced LTD4-initiated signaling. To assess the contribution of CysLT1 in the proresolving actions of MCTR, we carried out human macrophage (M phi) phagocytosis. Each MCTR (0.1-10 nM) stimulated human M phi phagocytosis of live Escherichia coli, whereas LTD4 did not stimulate phagocytosis. MCTR-activated phagocytosis was significantly blocked by a pharmacologic receptor antagonist (MK571). With both CHO-CysLT1 and human M phi s, each MCTR competed for specific [H-3]-LTD4 binding with apparent lower affinity than LTD4. Thus, each MCTR functionally interacts with human CysLT1 to pharmacologically counter-regulate vascular responses and stimulate physiologic phagocytosis with M phi s.Chiang, N., Riley, I. R., Dalli, J., Rodriguez, A. R., Spur, B. W., Serhan, C. N. New maresin conjugates in tissue regeneration pathway counters leukotriene D-4-stimulated vascular responses.	[Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Chiang, Nan; Riley, Ian R.; Dalli, Jesmond; Serhan, Charles N.] Harvard Med Sch, Boston, MA USA; [Rodriguez, Ana R.; Spur, Bernd W.] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ USA; [Dalli, Jesmond] John Vane Sci Ctr, William Harvey Res Inst, London, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rowan University; Rowan University School of Osteopathic Medicine; University of London; Queen Mary University London	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Harvard Inst Med, 60 Fenwood Rd,BTM 3-016, Boston, MA 02115 USA.	cserhan@partners.org	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Spur, Bernd/0000-0002-7581-4741; Dalli, Jesmond/0000-0001-6328-3640; Rodriguez Rosich, Ana/0000-0002-4802-2845	U.S. National Institutes of Health, National Institute of General Medical Sciences [P01-GM095467, R01-GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Enis Hrustic (Center for Marine Research, Ruder Boskovic Institute, Rovinj, Croatia) for helpful discussion, and Mary Small (Brigham and Women's Hospital, Boston, MA, USA) for assistance with manuscript preparation. This work was supported, in part, by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants P01-GM095467 and R01-GM38765 (to C.N.S.). The authors declare no conflicts of interest.	Aagaard L, 2014, INT J CLIN PHARM-NET, V36, P243, DOI 10.1007/s11096-014-9924-y; Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Capra V, 2004, BIOCHEM PHARMACOL, V67, P1569, DOI 10.1016/j.bcp.2003.12.027; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; HATTORI Y, 1984, J PHARMACOL EXP THER, V230, P646; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Knight J, 1999, BBA-MOL CELL BIOL L, V1436, P467, DOI 10.1016/S0005-2760(98)00153-2; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; Levi R., 1988, BIOL LEUKOTRIENES; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; Piper P. J., 1981, SRS LEUKOTRIENES; Pope EC, 2002, J EXP BIOL, V205, P1577; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P3936, DOI 10.1016/j.tetlet.2015.04.131; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687	26	28	28	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4043	4052		10.1096/fj.201701493R	http://dx.doi.org/10.1096/fj.201701493R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29490167	Green Published, Bronze			2022-12-26	WOS:000435104500047
J	Shao, YJ; Wang, LR; Guo, NN; Wang, SF; Yang, L; Li, YJ; Wang, MS; Yin, SM; Han, HH; Zeng, L; Zhang, LD; Hui, LJ; Ding, QR; Zhang, JQ; Geng, HQ; Liu, MY; Li, DL				Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Han, Honghui; Zeng, Li; Zhang, Ludi; Hui, Lijian; Ding, Qiurong; Zhang, Jiqin; Geng, Hongquan; Liu, Mingyao; Li, Dali			Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; gene therapy; liver; fibrosis; genetic disease; Cas9 nickase; gene editing; genome editing; hereditary tyrosinemia	IN-VIVO; NTBC TREATMENT; MOUSE MODEL; MICE; VECTORS; REPAIR; PATHOPHYSIOLOGY; TYPE-1	Hereditary tyrosinemia type I (HTI) is a metabolic genetic disorder caused by mutation of fumarylacetoacetate hydrolase (FAH). Because of the accumulation of toxic metabolites, HTI causes severe liver cirrhosis, liver failure, and even hepatocellular carcinoma. HTI is an ideal model for gene therapy, and several strategies have been shown to ameliorate HTI symptoms in animal models. Although CRISPR/Cas9-mediated genome editing is able to correct the Fah mutation in mouse models, WT Cas9 induces numerous undesired mutations that have raised safety concerns for clinical applications. To develop a new method for gene correction with high fidelity, we generated a Fah mutant rat model to investigate whether Cas9 nickase (Cas9n)-mediated genome editing can efficiently correct the Fah. First, we confirmed that Cas9n rarely induces indels in both on-target and off-target sites in cell lines. Using WT Cas9 as a positive control, we delivered Cas9n and the repair donor template/single guide (sg)RNA through adenoviral vectors into HTI rats. Analyses of the initial genome editing efficiency indicated that only WT Cas9 but not Cas9n causes indels at the on-target site in the liver tissue. After receiving either Cas9n or WT Cas9-mediated gene correction therapy, HTI rats gained weight steadily and survived. Fah-expressing hepatocytes occupied over 95% of the liver tissue 9 months after the treatment. Moreover, CRISPR/Cas9-mediated gene therapy prevented the progression of liver cirrhosis, a phenotype that could not be recapitulated in the HTI mouse model. These results strongly suggest that Cas9n-mediated genome editing is a valuable and safe gene therapy strategy for this genetic disease.	[Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Zeng, Li; Zhang, Jiqin; Liu, Mingyao; Li, Dali] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Zeng, Li; Zhang, Jiqin; Liu, Mingyao; Li, Dali] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Han, Honghui; Zeng, Li] Bioray Labs Inc, Shanghai 200241, Peoples R China; [Zhang, Ludi; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Ding, Qiurong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Geng, Hongquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200092, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA	East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY; Li, DL (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Liu, MY; Li, DL (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Liu, MY (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA.	myliu@bio.ecnu.edu.cn; dlli@bio.ecnu.edu.cn	Wang, liren/GQQ-5391-2022	Shao, Yanjiao/0000-0001-7204-3534	National Natural Science Foundation of China [81670470, 81600149]; Shanghai Municipal Commission for Science and Technology [14140901600, 15JC1400201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	This work was supported by National Natural Science Foundation of China Grants 81670470 and 81600149 and Shanghai Municipal Commission for Science and Technology Grants 14140901600 and 15JC1400201. The authors declare that they have no conflicts of interest with the contents of this article.	Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crone J, 2003, ACTA PAEDIATR, V92, P625; de Laet C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-8; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Grompe M, 2001, SEMIN LIVER DIS, V21, P563, DOI 10.1055/s-2001-19035; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Lusky M, 2005, HUM GENE THER, V16, P281, DOI 10.1089/hum.2005.16.281; Malik S, 2015, JIMD REP, V18, P13, DOI 10.1007/8904_2014_337; Masurel-Paulet A, 2008, J INHERIT METAB DIS, V31, P81, DOI 10.1007/s10545-008-0793-1; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nygaard S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8166; Paulk NK, 2012, HUM GENE THER, V23, P658, DOI 10.1089/hum.2012.038; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Wang ZY, 2012, MOL THER, V20, P1902, DOI 10.1038/mt.2012.157; Wold WSM, 2013, CURR GENE THER, V13, P421; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31460	33	33	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6883	6892		10.1074/jbc.RA117.000347	http://dx.doi.org/10.1074/jbc.RA117.000347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29507093	Green Published, hybrid			2022-12-26	WOS:000431487300021
J	Barbosa, CV; Barreto, MM; Andrade, RD; Sodre, F; d'Avila-Levy, CM; Peralta, JM; Igreja, RP; de Macedo, HW; Santos, HLC				Barbosa, Carolina Valenca; Barreto, Magali Muniz; Andrade, Rosemary de Jesus; Sodre, Fernando; d'Avila-Levy, Claudia Masini; Peralta, Jose Mauro; Igreja, Ricardo Pereira; de Macedo, Heloisa Werneck; Carneiro Santos, Helena Lucia			Intestinal parasite infections in a rural community of Rio de Janeiro (Brazil): Prevalence and genetic diversity of Blastocystis subtypes	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; HELMINTH INFECTIONS; DIFFERENT GENOTYPES; ZOO ANIMALS; HOMINIS; PROTOZOA; IDENTIFICATION; HUMANS; EPIDEMIOLOGY; VARIABILITY	Background Intestinal parasitic infections are considered a serious public health problem and widely distributed worldwide, mainly in urban and rural environments of tropical and subtropical countries. Globally, soil-transmitted helminths and protozoa are the most common intestinal parasites. Blastocystis sp. is a highly prevalent suspected pathogenic protozoan, and considered an unusual protist due to its significant genetic diversity and host plasticity. Methodology/main findings A total of 294 stool samples were collected from inhabitants of three rural valleys in Rio de Janeiro, Brazil. The stool samples were evaluated by parasitological methods, fecal culture, nested PCR and PCR/Sequencing. Overall prevalence by parasitological analyses was 64.3% (189 out of 294 cases). Blastocystis sp. (55.8%) was the most prevalent, followed by Endolimax nana (18.7%), Entamoeba histolytica complex (7.1%), hookworm infection (7.1%), Entomoeba coli (5.8%), Giardia intestinalis (4.1%), Iodamoeba butchilii (1.0%), Trichuris trichiura (1.0%), Pentatrichomonas hominis (0.7%), Enterobius vermicularis (0.7%), Ascaris lumbricoides (0.7%) and Strongyloides stercoralis (0.7%). Prevalence of IPIs was significantly different by gender. Phylogenetic analysis of Blastocystis sp. and BLAST search revealed five different subtypes: ST3 (34.0%), ST1 (27.0%), ST2 (27.0%), ST4 (3.5%), ST8 (7.0%) and a non-identified subtype. Conclusions/significance Our findings demonstrate that intestinal parasite infection rates in rural areas of the Sumidouro municipality of Rio de Janeiro, Brazil are still high and remain a challenge to public health. Moreover, our data reveals significant genetic heterogeneity of Blastocystis sp. subtypes and a possible novel subtype, whose confirmation will require additional data. Our study contributes to the understanding of potential routes of transmission, epidemiology, and genetic diversity of Blastocystis sp. in rural areas both at a regional and global scale.	[Barbosa, Carolina Valenca; d'Avila-Levy, Claudia Masini; Carneiro Santos, Helena Lucia] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, Brazil; [Barreto, Magali Muniz] Fiocruz MS, Inst Oswaldo Cruz, Lab Avaliacao & Promocao Saude Ambiental, Rio De Janeiro, Brazil; [Andrade, Rosemary de Jesus] Fiocruz MS, Inst Fernandes Figueira, Dept Ginecol & Obstet, Rio De Janeiro, Brazil; [Sodre, Fernando; de Macedo, Heloisa Werneck] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Patol, Lab Parasitol, Rio De Janeiro, Brazil; [Peralta, Jose Mauro] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio de Janeiro, Brazil; [Igreja, Ricardo Pereira] Univ Fed Rio de Janeiro, Fac Med, Dept Med Prevent, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Santos, HLC (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, Brazil.	helenalucias@gmail.com	santos, Helena/AAA-5514-2020; d'Avila-Levy, Claudia M/O-7192-2014	Valenca-Barbosa, Carolina/0000-0001-9579-8710; Santos, Helena/0000-0002-5240-5662; Pereira Igreja, Ricardo/0000-0003-2541-3840; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Oswaldo Cruz (PAPES-VI/FIOCRUZ) [407768/2012-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (PAPES-VI/FIOCRUZ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Oswaldo Cruz (PAPES-VI/FIOCRUZ) number (407768/2012-2) to HLCS and MMB and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro to CMd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Abe N, 2004, VET PARASITOL, V120, P235, DOI 10.1016/j.vetpar.2004.01.003; Agudelo-Lopez Sonia, 2008, Rev. salud pública, V10, P633, DOI 10.1590/S0124-00642008000400013; Aguiar JIA, 2007, REV SOC BRAS MED TRO, V40, P631, DOI 10.1590/S0037-86822007000600006; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Alum A, 2010, INT J INFECT DIS, V14, pE732, DOI 10.1016/j.ijid.2009.11.036; Balint A, 2014, PARASITOL RES, V113, P1585, DOI 10.1007/s00436-014-3805-0; Bart A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-389; Boonjaraspinyo S, 2013, KOREAN J PARASITOL, V51, P727, DOI 10.3347/kjp.2013.51.6.727; BRASIL, 2010, CONT POP CENS DEM 20; Cabrine-Santos M, 2015, REV INST MED TROP SP, V57, P211, DOI 10.1590/S0036-46652015000300005; Cian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169659; Clark CG, 1997, MOL BIOCHEM PARASIT, V87, P79, DOI 10.1016/S0166-6851(97)00046-7; Damazio SM, 2013, REV I MED TROP SAO P, V55; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Forsell J, 2012, EUR J CLIN MICROBIOL, V31, P1689, DOI 10.1007/s10096-011-1416-6; Gil FF, 2013, PATHOG GLOB HEALTH, V107, P320, DOI 10.1179/2047773213Y.0000000107; Goncalves AQ, 2016, REV SOC BRAS MED TRO, V49, P119, DOI 10.1590/0037-8682-0128-2015; Gonçalves Margareth Maria Lessa, 2005, Cad. Saúde Pública, V21, P92, DOI 10.1590/S0102-311X2005000100011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P32, DOI 10.1007/BF02105802; Helenbrook WD, 2015, PARASITOL RES, V114, P2517, DOI 10.1007/s00436-015-4451-x; Hoffman WA., 1934, PUERTO RICO J PUBLIC, V9, P283; Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003575; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Hussein EM, 2008, PARASITOL RES, V102, P853, DOI 10.1007/s00436-007-0833-z; Iguchi A, 2007, PARASITOL INT, V56, P107, DOI 10.1016/j.parint.2006.12.004; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Khairnar K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-47; Leipe DD TS, EUROPEAN J PROTISTOL, V32, P449; Malheiros AF, 2011, AM J TROP MED HYG, V85, P1050, DOI 10.4269/ajtmh.2011.11-0481; Meloni D, 2011, PARASITOL RES, V109, P613, DOI 10.1007/s00436-011-2294-7; Nasiri V, 2009, KOREAN J PARASITOL, V47, P265, DOI 10.3347/kjp.2009.47.3.265; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Nylander JAA., 2004, BIOINFORMATICS; Ozyurt M, 2008, PARASITOL INT, V57, P300, DOI 10.1016/j.parint.2008.01.004; Pandey PK, 2015, INFECT GENET EVOL, V31, P296, DOI 10.1016/j.meegid.2015.02.012; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Popruk S, 2015, KOREAN J PARASITOL, V53, P13, DOI 10.3347/kjp.2015.53.1.13; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rebolla MF, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658031, 10.1590/S1678-9946201658031]; Rene BA, 2009, AM J TROP MED HYG, V80, P588, DOI 10.4269/ajtmh.2009.80.588; Roberts T, 2013, EUR J CLIN MICROBIOL, V32, P335, DOI 10.1007/s10096-012-1746-z; Robertson LJ, 2013, TRENDS PARASITOL, V29, P101, DOI 10.1016/j.pt.2012.12.004; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Silberman JD, 1996, NATURE, V380, P398, DOI 10.1038/380398a0; Souppart L, 2010, PARASITOL RES, V106, P505, DOI 10.1007/s00436-009-1693-5; Speich B, 2016, LANCET INFECT DIS, V16, P87, DOI 10.1016/S1473-3099(15)00349-7; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2011, AM J TROP MED HYG, V84, P883, DOI 10.4269/ajtmh.2011.11-0005; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034; Dominguez-Marquez MV, 2009, PARASITOL RES, V105, P949, DOI 10.1007/s00436-009-1485-y; WILLIS H. Hastings, 1921, Medical Journal of Australia, V2, P375; Yan Y, 2007, PARASITOL RES, V101, P1527, DOI 10.1007/s00436-007-0672-y; Yan YM, 2006, PARASITOL RES, V99, P597, DOI 10.1007/s00436-006-0186-z; Yoshikawa H, 2004, MICROBIOL-SGM, V150, P1147, DOI 10.1099/mic.0.26899-0; Yoshikawa H, 1998, MOL CELL PROBE, V12, P153, DOI 10.1006/mcpr.1998.0161; Yoshikawa H, 2016, PARASITOL INT, V65, P780, DOI 10.1016/j.parint.2016.03.010; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; Zerpa LR, 2000, REV MEX PATOL CLIN, V47, P17	73	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193860	10.1371/journal.pone.0193860	http://dx.doi.org/10.1371/journal.pone.0193860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522552	gold, Green Submitted, Green Published			2022-12-26	WOS:000427030800025
J	Fletcher, E; Morgan, KT; Qureshi, JA; Leiva, JA; Nkedi-Kizza, P				Fletcher, Evelyn; Morgan, Kelly T.; Qureshi, Jawwad A.; Leiva, Jorge A.; Nkedi-Kizza, Peter			Imidacloprid soil movement under micro-sprinkler irrigation and soil-drench applications to control Asian citrus psyllid (ACP) and citrus leafminer (CLM)	PLOS ONE			English	Article							PHENOL RED METHOD; WATER; BROMIDE; DRIP; RAINFALL; SORPTION	Imidacloprid (IM) is used to control the Asian Citrus Psyllid (ACP) and citrus leafminer (CLM), which are related to the spread of huanglongbing (HLB or citrus greening) and citrus canker diseases, respectively. In Florida citrus, imidacloprid is mainly soil-drenched around the trees for proper root uptake and translocation into plant canopy to impact ACP and CLM. The objective of this study was to determine the effect of imidacloprid rate, and irrigate amount on concentration of imidacloprid in the soil following drench application to citrus trees in three age classes. The plots were established at the Southwest Florida Research and Education Center, lmmokalee, using a randomized complete-block design for three age classes of trees: one-year-old trees (B1), three to five-year-old trees (B2), and eight-year old trees (53). The treatments were a combination of two rates each of imidacloprid (1D, 2D) and micro -sprinkling irrigation (11, 21). Imidacloprid and bromide (Br-) used as tracer were applied simultaneously. Soil moisture and concentrations of imidacloprid and Br were monitored using soil cores from hand held augers. Soil moisture content (theta v) did not differ under two irrigation rates at any given observation day or depth, except following heavy rainfall events. Br was lost from the observation depths (0-45 cm) about two weeks after soil drench. Contrarily, imidacloprid persisted for a much longer time (4-8 weeks) at all soil depths, regardless of treatment combinations. The higher retardation of imidacloprid was related to the predominantly unsaturated conditions of the soil (which in turn reduced soil hydraulic conductivities by orders of magnitude), the imidacloprid sorption on soil organic matter, and the citrus root uptake. Findings of this study are important for citrus growers coping with the citrus greening and citrus canker diseases because they suggest that imidacloprid soil drenches can still be an effective control measure of ACP and CLM, and the potential for imidacloprid leaching to groundwater is minimal.	[Fletcher, Evelyn] UF, IFAS, Putnam Cty Extens Off, East Palatka, FL USA; [Morgan, Kelly T.] UF IFAS Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA; [Qureshi, Jawwad A.] UF IFAS Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Leiva, Jorge A.; Nkedi-Kizza, Peter] UF IFAS Soil & Water Sci Dept, Gainesville, FL USA		Morgan, KT (corresponding author), UF IFAS Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA.	conserv@ufl.edu		Morgan, Kelly/0000-0001-8919-0231	Citrus Research and Development Foundation [425]	Citrus Research and Development Foundation	This study was supported by Citrus Research and Development Foundation (425) to Evelyn Fletcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AK, 1999, IRRIGATION SCI, V18, P109, DOI 10.1007/s002710050051; ANAGNOSTOPOULOU PI, 1986, ANAL CHEM, V58, P322, DOI 10.1021/ac00293a013; BASEL CL, 1982, ANAL CHEM, V54, P2090, DOI 10.1021/ac00249a041; Baskaran S, 1997, J CHROMATOGR A, V787, P271, DOI 10.1016/S0021-9673(97)00652-3; Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bayer CropScience, 2013, ADM PRO SYST PROT; Benton EP, 2016, FOREST ECOL MANAG, V360, P152, DOI 10.1016/j.foreco.2015.10.028; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Bove JM, 2006, J PLANT PATHOL, V88, P7; Choquette AF, 2009, WATER QUALITY EVALUA; Choquette AF, 2014, PESTICIDES NITRATE G; Cowles RS, 2009, FOREST ECOL MANAG, V257, P1026, DOI 10.1016/j.foreco.2008.11.005; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Fossen M, 2006, ENV IMIDACLOPRID; Gervais J.A., 2010, IMIDACLOPRID TECHNIC; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Johnson EG, 2014, PLANT PATHOL, V63, P290, DOI 10.1111/ppa.12109; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P1351, DOI 10.2136/sssaj2014.02.0054; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P645, DOI 10.2136/sssaj2013.07.0319; Kamble ST, 2005, B ENVIRON CONTAM TOX, V75, P1077, DOI 10.1007/s00128-005-0859-9; Leib BG, 2000, T ASAE, V43, P615, DOI 10.13031/2013.2742; Leiva JA, 2014, THESIS; Leiva JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183767; Leiva JA, 2015, J AGR FOOD CHEM, V63, P4915, DOI 10.1021/acs.jafc.5b00532; NIKOLIC SD, 1992, FRESEN J ANAL CHEM, V342, P98, DOI 10.1007/BF00321701; Noling JW, 2016, FLORIDA CITRUS PEST; OBREZA T.A, 2008, NUTR FLORIDA CITRUS; Obreza T.A., 1997, P FLA STATE HORT SOC, V110, P36; Oliver DP, 2005, J AGR FOOD CHEM, V53, P6420, DOI 10.1021/jf050293l; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Samnani P, 2011, B ENVIRON CONTAM TOX, V86, P554, DOI 10.1007/s00128-011-0245-8; Setamou M, 2010, J ECON ENTOMOL, V103, P1711, DOI 10.1603/EC09371; Stansly PA, 2017, ENY734 IFAS EXT; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; UF-IFAS Extension, 2014, FLOR AUT WEATH NETW; University of Florida, 2017, CITR GREEN HIST; *USDA, 1998, SOIL SURV COLL COUNT; Vanderborght J, 2007, VADOSE ZONE J, V6, P29, DOI 10.2136/vzj2006.0096; Weichel L, 2004, PEST MANAG SCI, V60, P440, DOI 10.1002/ps.831	40	9	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192668	10.1371/journal.pone.0192668	http://dx.doi.org/10.1371/journal.pone.0192668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518086	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900010
J	Bergsten, EL; Mathiassen, SE; Larsson, J; Kwak, L				Bergsten, Eva L.; Mathiassen, Svend Erik; Larsson, Johan; Kwak, Lydia			Implementation of an ergonomics intervention in a Swedish flight baggage handling company-A process evaluation	PLOS ONE			English	Article							LEADERSHIP-BEHAVIOR; IMPACT	Objective To conduct a process evaluation of the implementation of an ergonomics training program aimed at increasing the use of loading assist devices in flight baggage handling. Methods Feasibility related to the process items recruitment, reach, context, dose delivered (training time and content); dose received (participants' engagement); satisfaction with training; intermediate outcomes (skills, confidence and behaviors); and barriers and facilitators of the training intervention were assessed by qualitative and quantitative methods. Results Implementation proved successful regarding dose delivered, dose received and satisfaction. Confidence among participants in the training program in using and talking about devices, observed use of devices among colleagues, and internal feedback on work behavior increased significantly (p<0.01). Main facilitators were self-efficacy, motivation, and perceived utility of training among the trainees. Barriers included lack of peer support, opportunities to observe and practice behaviors, and follow-up activities; as well as staff reduction and job insecurity. Conclusions In identifying important barriers and facilitators for a successful outcome, this study can help supporting the effectiveness of future interventions. Our results suggest that barriers caused by organizational changes may likely be alleviated by recruiting motivated trainees and securing strong organizational support for the implementation.	[Bergsten, Eva L.; Mathiassen, Svend Erik; Larsson, Johan] Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Bergsten, Eva L.] Uppsala Univ, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden; [Kwak, Lydia] Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Res, Stockholm, Sweden	University of Gavle; Uppsala University; Karolinska Institutet	Bergsten, EL (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden.; Bergsten, EL (corresponding author), Uppsala Univ, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden.	eva.bergsten@hig.se	Mathiassen, Svend Erik/ABF-3165-2020	Mathiassen, Svend Erik/0000-0003-1443-6211	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2009-1761]	Swedish Research Council for Health, Working Life and Welfare (FORTE)	This work received funding from The Swedish Research Council for Health, Working Life and Welfare (FORTE) Grant number 2009-1761. http://forte.se/en/. Received: SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by grants from the Swedish Research Council for Health, Working Life and Welfare (FORTE Dnr 2009-1761). We gratefully acknowledge the participating baggage handling company and the Vocational Training and Working Environment Council (TYA) for collaboration. The authors would also like to thank Reidar Pettersson, Erik Alphonse, Dan Holmberg and informer baggage handlers for their contributions to the data collection. Finally, we would like to thank all the baggage handlers who participated in this study.	Baldwin TT, 1988, PERS PSYCHOL, V41, P43; Bergsten EL, 2015, BIOMED RES INT, V2015, P11; Blume BD, 2010, J MANAGE, V36, P1065, DOI 10.1177/0149206309352880; Coffeng JK, 2013, J OCCUP ENVIRON MED, V55, P1409, DOI 10.1097/JOM.0b013e3182a50053; Grossman R, 2011, INT J TRAIN DEV, V15, P103, DOI 10.1111/j.1468-2419.2011.00373.x; Kennedy C. A., 2009, J OCCUPATIONAL REHAB, V20, P127, DOI DOI 10.1007/S10926-009-9211-2; Koningsveld EAP, 2005, ERGONOMICS, V48, P559, DOI 10.1080/00140130400029136; Kristensen T S, 2005, Occup Environ Med, V62, P205, DOI 10.1136/oem.2004.016097; Larsson J, 2010, TOTAL QUAL MANAG BUS, V21, P317, DOI 10.1080/14783360903561779; Linnan L., 2002, PROCESS EVALUATION P, P1; Montano D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-135; Murta SG, 2007, AM J HEALTH PROMOT, V21, P248, DOI 10.4278/0890-1171-21.4.248; Nielsen K, 2013, EUR J WORK ORGAN PSY, V22, P601, DOI 10.1080/1359432X.2012.690556; Nielsen K, 2006, WORK STRESS, V20, P272, DOI 10.1080/02678370601022688; Nielsen K, 2010, WORK STRESS, V24, P219, DOI 10.1080/02678373.2010.519176; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, P1; Pehkonen I, 2009, APPL ERGON, V40, P115, DOI 10.1016/j.apergo.2008.01.006; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139; Robroek SJW, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-26; Skakon J, 2010, WORK STRESS, V24, P107, DOI 10.1080/02678373.2010.495262; Taylor PJ, 2005, J APPL PSYCHOL, V90, P692, DOI 10.1037/0021-9010.90.4.692; van Eerd D, 2010, ERGONOMICS, V53, P1153, DOI 10.1080/00140139.2010.513452; Velada R, 2007, INT J TRAIN DEV, V11, P282, DOI 10.1111/j.1468-2419.2007.00286.x; Verbeek JH, 2011, COCHRANE DATABASE SY; Wahlstrom J, 2016, ANN OCCUPATIONAL HYG; Weiler MR, 2012, ERGONOMICS, V55, P1362, DOI 10.1080/00140139.2012.714474; Wells R, 2009, WORK, V34, P117, DOI 10.3233/WOR-2009-0937; Wierenga D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1190; Wijk K, 2011, SCAND J WORK ENV HEA, V37, P363, DOI 10.5271/sjweh.3159; Yukl G, 2012, ACAD MANAGE PERSPECT, V26, P66, DOI 10.5465/amp.2012.0088	30	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191760	10.1371/journal.pone.0191760	http://dx.doi.org/10.1371/journal.pone.0191760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513671	Green Submitted, gold, Green Published			2022-12-26	WOS:000426896800008
J	McDonnell, BM; Buchanan, PJ; Prise, KM; McCloskey, KD				McDonnell, Bronagh M.; Buchanan, Paul J.; Prise, Kevin M.; McCloskey, Karen D.			Acute radiation impacts contractility of guinea-pig bladder strips affecting mucosal-detrusor interactions	PLOS ONE			English	Article							MOUSE URINARY-BLADDER; URINATION FREQUENCY; X-IRRADIATION; SMOOTH-MUSCLE; DAMAGE; CANCER; TRANSMISSION; RADIOTHERAPY; STIMULATION; MODULATION	Radiation-induced bladder toxicity is associated with radiation therapy for pelvic malignancies, arising from unavoidable irradiation of neighbouring normal bladder tissue. This study aimed to investigate the acute impact of ionizing radiation on the contractility of bladder strips and identify the radiation-sensitivity of the mucosa vs the detrusor. Guinea-pig bladder strips (intact or mucosa-free) received ex vivo sham or 20Gy irradiation and were studied with in vitro myography, electrical field stimulation and Ca2+-fluorescence imaging. Frequency-dependent, neurogenic contractions in intact strips were reduced by irradiation across the force-frequency graph. The radiation-difference persisted in atropine (1 mu M); subsequent addition of PPADs (100 mu M) blocked the radiation effect at higher stimulation frequencies and decreased the force-frequency plot. Conversely, neurogenic contractions in mucosa-free strips were radiation-insensitive. Radiation did not affect agonist-evoked contractions (1 mu M carbachol, 5mM ATP) in intact or mucosa-free strips. Interestingly, agonist-evoked contractions were larger in irradiated mucosa-free strips vs irradiated intact strips suggesting that radiation may have unmasked an inhibitory mucosal element. Spontaneous activity was larger in control intact vs mucosa-free preparations; this difference was absent in irradiated strips. Spontaneous Ca2+-transients in smooth muscle cells within tissue preparations were reduced by radiation. Radiation affected neurogenic and agonist-evoked bladder contractions and also reduced Ca2+-signalling events in smooth muscle cells when the mucosal layer was present. Radiation eliminated a positive modulatory effect on spontaneous activity by the mucosa layer. Overall, the findings suggest that radiation impairs contractility via mucosal regulatory mechanisms independent of the development of radiation cystitis.	[McDonnell, Bronagh M.; Buchanan, Paul J.; Prise, Kevin M.; McCloskey, Karen D.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	McCloskey, KD (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	k.mccloskey@qub.ac.uk	Prise, Kevin/N-7872-2015	Prise, Kevin/0000-0001-6134-7946; Buchanan, Paul/0000-0002-9055-2794; McCloskey, Karen/0000-0002-9135-9013	European Union [223234]; Cancer Research UK [CR-UK] [C1513/A7047]; Medical Research Council [MR/M012425/1]; Department of Employment and Learning, Northern Ireland; MRC [MR/M012425/1] Funding Source: UKRI	European Union(European Commission); Cancer Research UK [CR-UK](Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Employment and Learning, Northern Ireland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was received from the European Union, FP7 "INComb" (FP7-HEALTH-2007-B, 223234), Cancer Research UK [CR-UK] (C1513/A7047) and the Medical Research Council (MR/M012425/1). BMcD was supported by a PhD studentship from the Department of Employment and Learning, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino H, 2012, LUTS, V4, P42, DOI 10.1111/j.1757-5672.2011.00117.x; Andersson KE, 2014, NEUROUROL URODYNAM, V33, P9, DOI 10.1002/nau.22465; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; ANTONAKOPOULOS GN, 1984, J PATHOL, V143, P103, DOI 10.1002/path.1711430205; Berveling MJ, 2011, J GYNECOL ONCOL, V22, P152, DOI 10.3802/jgo.2011.22.3.152; Campbell PC, 2017, NEUROUROL URODYNAM, V36, P1052, DOI 10.1002/nau.23082; DORR W, 1992, RADIAT RES, V131, P35, DOI 10.2307/3578313; Gray SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053423; Guan NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103932; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hynds S, 2011, BRIT J RADIOL, V84, P813, DOI 10.1259/bjr/50048151; Imai T, 2002, ACTA PHYSIOL SCAND, V176, P57, DOI 10.1046/j.1365-201X.2002.01009.x; Jaal J, 2006, RADIOTHER ONCOL, V80, P250, DOI 10.1016/j.radonc.2006.07.015; Kennedy C, 2007, J NEUROSCI, V27, P845, DOI 10.1523/JNEUROSCI.3115-06.2007; Longhurst PA, 2000, BRIT J PHARMACOL, V131, P177, DOI 10.1038/sj.bjp.0703551; LUNDBECK F, 1992, J UROLOGY, V148, P179, DOI 10.1016/S0022-5347(17)36548-5; LUNDBECK F, 1989, RADIOTHER ONCOL, V15, P383, DOI 10.1016/0167-8140(89)90085-6; MARKS LB, 1995, INT J RADIAT ONCOL, V31, P1257, DOI 10.1016/0360-3016(94)00431-J; MICHAILOV MC, 1975, RADIAT ENVIRON BIOPH, V11, P289, DOI 10.1007/BF01326751; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Ritchey M, 2009, PEDIATR BLOOD CANCER, V52, P439, DOI 10.1002/pbc.21826; Samper-Ternent R, 2011, GYNECOL ONCOL, V120, P198, DOI 10.1016/j.ygyno.2010.10.017; Smit SG, 2010, NAT REV UROL, V7, P206, DOI 10.1038/nrurol.2010.23; STEWART FA, 1991, INT J RADIAT ONCOL, V21, P1211, DOI 10.1016/0360-3016(91)90278-C; STEWART FA, 1978, RADIAT RES, V75, P649, DOI 10.2307/3574851; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Tward JD, 2016, INT J RADIAT ONCOL, V95, P1443, DOI 10.1016/j.ijrobp.2016.03.047; Uvin P, 2013, EUR UROL, V64, P502, DOI 10.1016/j.eururo.2013.05.031; VALE JA, 1994, UROL RES, V22, P51, DOI 10.1007/BF00431549; Viswanathan AN, 2010, INT J RADIAT ONCOL, V76, pS116, DOI 10.1016/j.ijrobp.2009.02.090; Xin WK, 2012, AM J PHYSIOL-CELL PH, V302, pC1361, DOI 10.1152/ajpcell.00432.2011; Zwaans Bernadette M M, 2016, Adv Radiat Oncol, V1, P333, DOI 10.1016/j.adro.2016.07.004	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193923	10.1371/journal.pone.0193923	http://dx.doi.org/10.1371/journal.pone.0193923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513744	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800089
J	Nishiyama, R				Nishiyama, Ryoji			Separability of active semantic and phonological maintenance in verbal working memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ARTICULATORY SUPPRESSION; SERIAL-RECALL; INFORMATION; SIMILARITY; REHEARSAL; WORDS; COMPREHENSION; CONSTRAINTS; RETENTION	Models of verbal working memory that incorporate active memory maintenance, long-term memory networks, and attention control have been developed. Current studies suggest that semantic representations of words, evoked via long-term memory networks, are actively maintained until they are needed to fulfill a role. In other words, it is possible that some mechanism actively refreshes semantic representations of words, analogous to but independently from articulatory rehearsal which refreshes phonological representations. One valuable piece of evidence is a double dissociation, observed in a dual task paradigm in which manual tapping disrupted a semantic memory task while articulatory suppression disrupted a phonological memory task. However, in that study, the secondary tasks could have competed not only with the maintenance but also with the encoding activities. Additionally, the study items in the phonological memory tasks were words; hence, the discriminability of the memory tasks is doubtful. The present study, therefore, examined a potential double dissociation in situations where the secondary tasks could not compete with encoding, using a modified phonological memory task. Furthermore, this article discusses a potential mechanism for maintaining semantic representations.	[Nishiyama, Ryoji] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	Kyoto University	Nishiyama, R (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	Ryoji.nishiyama@gmail.com						Alloway TP, 2010, EUR J COGN PSYCHOL, V22, P297, DOI 10.1080/09541440902793731; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D, 1986, WORKING MEMORY; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Belleville S, 2003, J MEM LANG, V48, P686, DOI 10.1016/S0749-596X(02)00532-6; BESNER D, 1982, CAN J PSYCHOL, V36, P701, DOI 10.1037/h0080665; Camos V, 2009, J MEM LANG, V61, P457, DOI 10.1016/j.jml.2009.06.002; Camos V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00900; Camos V, 2011, MEM COGNITION, V39, P231, DOI 10.3758/s13421-010-0011-x; Campoy G, 2015, Q J EXP PSYCHOL, V68, P759, DOI 10.1080/17470218.2014.966248; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan N., 2016, PSYCHON B REV; Cowan N., 1999, MODELS WORKING MEMOR, V20, P506, DOI DOI 10.1017/CBO9781139174909.006; ELLIS NR, 1968, J EXP PSYCHOL, V77, P613, DOI 10.1037/h0026064; Friedmann N, 2003, BRAIN LANG, V86, P23, DOI 10.1016/S0093-934X(02)00530-8; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; Guerard K, 2009, EXP PSYCHOL, V56, P367, DOI 10.1027/1618-3169.56.5.367; Haarmann H, 2001, PSYCHON B REV, V8, P568, DOI 10.3758/BF03196193; Haarmann HJ, 2005, INT J PSYCHOPHYSIOL, V57, P115, DOI 10.1016/j.ijpsycho.2005.03.017; Haarmann HJ, 2003, J MEM LANG, V48, P320, DOI 10.1016/S0749-596X(02)00506-5; Howard D, 2005, COGN NEUROPSYCHOL, V22, P42, DOI 10.1080/02643290342000582; Hudjetz A, 2007, MEM COGNITION, V35, P1675, DOI 10.3758/BF03193501; Hutchison KA, 2007, J EXP PSYCHOL LEARN, V33, P645, DOI 10.1037/0278-7393.33.4.645; Innocenti I, 2010, NEUROIMAGE, V53, P325, DOI 10.1016/j.neuroimage.2010.06.011; Iwamoto K., TAKAO KO1841 1916; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; Loaiza VM, J EXP PSYCH IN PRESS; Majerus S, 2004, COGN NEUROPSYCHOL, V21, P491, DOI 10.1080/02643290342000104; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; Martin RC, 2004, BRAIN LANG, V89, P76, DOI 10.1016/S0093-934X(03)00300-6; MCLEOD P, 1984, ATTENTION PERFORM, V10, P55; MIYAKE A, 1994, J MEM LANG, V33, P175, DOI 10.1006/jmla.1994.1009; Morey RD, PACKAGE BAYESFACTOR; Morita A, 2007, Q J EXP PSYCHOL, V60, P581, DOI 10.1080/17470210600682405; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; MURRAY DJ, 1968, J EXP PSYCHOL, V78, P679, DOI 10.1037/h0026641; NAVEHBENJAMIN M, 1984, J EXP PSYCHOL LEARN, V10, P369, DOI 10.1037/0278-7393.10.3.369; Nishiyama R, 2014, PSYCHON B REV, V21, P1583, DOI 10.3758/s13423-014-0618-1; Nishiyama R, 2013, J EXP PSYCHOL LEARN, V39, P642, DOI 10.1037/a0029160; R Development Core Team, 2016, R LANG ENV STAT COMP; Romani C, 2008, Q J EXP PSYCHOL, V61, P292, DOI 10.1080/17470210601147747; Rose NS, 2014, MEM COGNITION, V42, P689, DOI 10.3758/s13421-014-0398-x; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; Saint-Aubin J, 1999, Q J EXP PSYCHOL-A, V52, P367, DOI 10.1080/027249899391115; Saito S, 1997, BRIT J PSYCHOL, V88, P565, DOI 10.1111/j.2044-8295.1997.tb02658.x; SAITO S, 1994, MEM COGNITION, V22, P181; Sakuma N., 2005, NTT DATABASE SERIES, V8; Shivde G, 2004, COGN AFFECT BEHAV NE, V4, P10, DOI 10.3758/CABN.4.1.10; Shivde G, 2011, J EXP PSYCHOL LEARN, V37, P1342, DOI 10.1037/a0024832; SHULMAN HG, 1970, J VERB LEARN VERB BE, V9, P499, DOI 10.1016/S0022-5371(70)80093-7; SHULMAN HG, 1972, J VERB LEARN VERB BE, V11, P221, DOI 10.1016/S0022-5371(72)80080-X; Umemoto T, 1955, JPN J PSYCHOL, V26, P148, DOI 10.4992/jjpsy.26.148; Vergauwe E, 2015, PSYCHON B REV, V22, P1001, DOI 10.3758/s13423-014-0755-6; Walker I, 1999, J EXP PSYCHOL LEARN, V25, P1256, DOI 10.1037/0278-7393.25.5.1256; WATKINS MJ, 1974, J VERB LEARN VERB BE, V13, P430, DOI 10.1016/S0022-5371(74)80021-6	60	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193808	10.1371/journal.pone.0193808	http://dx.doi.org/10.1371/journal.pone.0193808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513731	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800077
J	Qian, J; Mummalaneni, S; Larsen, J; Grider, JR; Spielman, AI; Ozdener, MH; Lyall, V				Qian, Jie; Mummalaneni, Shobha; Larsen, James; Grider, John R.; Spielman, Andrew I.; Ozdener, Mehmet Hakan; Lyall, Vijay			Nicotinic acetylcholine receptor (CHRN) expression and function in cultured human adult fungiform (HBO) taste cells	PLOS ONE			English	Article							UP-REGULATION; ETHANOL INTAKE; NEUROTROPHIC FACTOR; BRAIN; ALCOHOL; RAT; ACTIVATION; ADDICTION; RESPONSES; ALPHA-7	In rodents, CHRNs are involved in bitter taste transduction of nicotine and ethanol. Currently, it is not clear if CHRNs are expressed in human taste cells and if they play a role in transducing the bitter taste of nicotine and ethanol or in the synthesis and release of neurohumoral peptides. Accordingly, we investigated the expression and functional role of CHRNs in HBO cells. Using molecular techniques, we demonstrate that a subset of HBO cells express CHRNs that also co-express TRPM5, T1R3 or T2R38. Exposing HBO cells to nicotine or ethanol acutely or to nicotine chronically induced a differential increase in the expression of CHRN mRNA and protein in a dose- and time-dependent manner. Acutely exposing HBO cells to a mixture containing nicotine plus ethanol induced a smaller increase in CHRN mRNAs relative to nicotine or ethanol treatment alone. A subset of HBO cells responded to nicotine, acetylcholine and ATP with a transient increase in [Ca2+];. Nicotine effects on [Ca2+]; were mecamylamine sensitive. Brain-derived neurotrophic factor (BDNF) protein was detected in HBO cells using ELISA. Acute nicotine exposure decreased BDNF in HBO cells and increased BDNF release in the medium. CHRNs were also detected in HEK293 cells by RT-PCR. Unlike HBO cells, CHRNs were localized in most of HEK293 cells and majority of HEK293 cells responded to nicotine and ethanol stimulation with a transient increase in [Ca2+];. BDNF levels in HEK293 cells were significantly higher than in HBO cells but the nicotine induced release of BDNF in the media was a fraction of the BDNF cellular content. We conclude that CHRNs are expressed in TRPM5 positive HBO cells. CHRN mRNA expression is modulated by exposure to nicotine and ethanol in a dose- and time dependent manner. Nicotine induces the synthesis and release of BDNF in HBO cells.	[Qian, Jie; Mummalaneni, Shobha; Larsen, James; Grider, John R.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Spielman, Andrew I.] NYU Coll Dent, New York, NY USA; [Ozdener, Mehmet Hakan] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Virginia Commonwealth University; New York University; Monell Chemical Senses Center	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA.	vijay.lyall@vcuhelth.org	Spielman, Andrew I./ABG-1150-2021; Ozdener, Mehmet Hakan/I-4097-2019	Spielman, Andrew I./0000-0002-7052-3689; 	National Institute on Deafness and other Communication Disorders (NIDCD) [DC-011569]; Deans Bridge Funds from the VCU School of Medicine; NIH-NINDS Center core grant [5P30NS047463]; NIH-NIDCD Core Grant [P30DC011735];  [DK34153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034153] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Deans Bridge Funds from the VCU School of Medicine; NIH-NINDS Center core grant; NIH-NIDCD Core Grant; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institute on Deafness and other Communication Disorders (NIDCD) grant DC-011569 (VL), Deans Bridge Funds from the VCU School of Medicine (VL), and DK34153 (JRG). Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). Some of the imaging experiments were performed at the Monell Chemical Senses Center "The Histology and Cellular Localization Core", which is supported, in part, by funding from the NIH-NIDCD Core Grant P30DC011735.	Al-Qudah M, 2015, NEUROGASTROENT MOTIL, V27, P1162, DOI 10.1111/nmo.12604; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bell RL, 2009, ALCOHOL, V43, P581, DOI 10.1016/j.alcohol.2009.09.027; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Bierut LJ, 2000, ALCOHOL RES HEALTH, V24, P233; Blomqvist O, 1996, EUR J PHARMACOL, V314, P257, DOI 10.1016/S0014-2999(96)00583-3; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Dani JA, 2015, INT REV NEUROBIOL, V124, P3019; Davis TJ, 2006, ALCOHOL RES HEALTH, V29, P179; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Dehkordi O, 2010, LIFE SCI, V86, P281, DOI 10.1016/j.lfs.2009.12.016; Fox AM, 2015, J BIOL CHEM, V290, P24403, DOI 10.1074/jbc.M115.661827; Fucito LM, 2011, PSYCHOPHARMACOLOGY, V215, P655, DOI 10.1007/s00213-010-2160-9; Gallego X, 2012, ALCOHOL, V46, P205, DOI 10.1016/j.alcohol.2011.11.005; Gees M, 2014, CHEM SENSES, V39, P295, DOI 10.1093/chemse/bjt115; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; Grider JR, 2006, GASTROENTEROLOGY, V130, P771, DOI 10.1053/j.gastro.2005.12.026; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Hochheimer A, 2014, CHEM SENSES, V39, P359, DOI 10.1093/chemse/bju009; Huang T, 2015, DEV BIOL, V405, P225, DOI 10.1016/j.ydbio.2015.07.006; Hurley LL, 2012, NEUROTOX RES, V21, P57, DOI 10.1007/s12640-011-9275-6; Hussmann GP, 2011, J BIOL CHEM, V286, P39726, DOI 10.1074/jbc.M111.289546; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Leslie FM, 2013, MOL PHARMACOL, V83, P753, DOI 10.1124/mol.112.083659; Melroy-Greif WE, 2016, GENES BRAIN BEHAV, V15, P89, DOI 10.1111/gbb.12251; Meng LB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0097-15.2015; Mori Y, 2016, PFLUG ARCH EUR J PHY, V468, P2053, DOI 10.1007/s00424-016-1879-5; Mousavi M, 2003, NEUROSCIENCE, V122, P515, DOI 10.1016/S0306-4522(03)00460-3; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Ozdener H, 2012, JOVE-J VIS EXP, DOI 10.3791/3730; Ozdener MH, 2014, GASTROENTEROLOGY, V146, P995, DOI 10.1053/j.gastro.2014.01.006; Ozdener MH, 2011, CHEM SENSES, V36, P601, DOI 10.1093/chemse/bjr012; Parker SL, 2004, MOL PHARMACOL, V65, P611, DOI 10.1124/mol.65.3.611; Qian J, 2014, ACHEMS ANN M BON SPR; Qian J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190465; Qian J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171335; Qian J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166565; Ren ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127936; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Subramaniam S, 2016, FASEB J, V30, P3489, DOI 10.1096/fj.201600422R; Sun CS, 2015, J NEUROSCI, V35, P409, DOI 10.1523/JNEUROSCI.2381-14.2015; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wang XY, 2015, NEUROL SCI, V36, P289, DOI 10.1007/s10072-014-1934-y; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Xu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07756-x; Yee C, 2005, J COMP NEUROL, V490, P371, DOI 10.1002/cne.20670; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Zhao-Shea R, 2011, NEUROPSYCHOPHARMACOL, V36, P1021, DOI 10.1038/npp.2010.240	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194089	10.1371/journal.pone.0194089	http://dx.doi.org/10.1371/journal.pone.0194089			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513745	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800101
J	Macey, PM; Haris, N; Kumar, R; Thomas, MA; Woo, MA; Harper, RM				Macey, Paul M.; Haris, Natasha; Kumar, Rajesh; Thomas, M. Albert; Woo, Mary A.; Harper, Ronald M.			Obstructive sleep apnea and cortical thickness in females and males	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INSULAR CORTEX; INTERMITTENT HYPOXIA; BRAIN MORPHOLOGY; SEX-DIFFERENCES; DEPRESSIVE SYMPTOMS; STRUCTURAL-CHANGES; MOOD DISORDERS; RESPONSES; INJURY	Introduction Obstructive sleep apnea (OSA) affects approximately 10% of adults, and alters brain gray and white matter. Psychological and physiological symptoms of the disorder are sex-specific, perhaps related to greater injury occurs in female than male patients in white matter. Our objective was to identify influences of OSA separated by sex on cortical gray matter. Methods We assessed cortical thickness in 48 mild-severe OSA patients (mean age +/- std[range] = 46.5 +/- 9.0[30.8-62.7] years; apnea-hypopnea index = 32.6 +/- 21.1[6-102] events/hour; 12 female, 36 male; OSA severity: 5 mild, 18 moderate, 25 severe) and 62 controls (mean age = 47.7 +/- 8.9[30.9-65.8] years; 22 female, 40 male). All OSA patients were recently-diagnosed via polysomnography, and control subjects screened and a subset assessed with sleep studies. We used high-resolution magnetic resonance imaging to identify OSA-related cortical thinning, based on a model with condition and sex as independent variables. OSA and OSA-by-sex interaction effects were assessed (P<0.05, corrected for multiple comparisons). Results Multiple regions of reduced cortical thickness appeared bilaterally in the superior frontal lobe in female OSA vs. all other groups. Significant thinning within the pre- and post-central gyri and the superior temporal gyrus, extending into the insula, appeared between the general OSA populations vs. control subjects. No areas showed increased thickness in OSA vs. controls or positive female OSA interaction effects. Conclusions Reduced cortical thickness likely represents tissue atrophy from long term injury, including death of neurons and supporting glia from repeated intermittent hypoxic exposure in OSA, although disease comordities may also contribute to thinning. Lack of polysomnography in all control subjects means results may be confounded by undiagnosed OSA. The greater cortical injury in cognitive areas of female OSA patients may underlie enhanced symptoms in that group. The thinning associated with OSA in male and females OSA patients may contribute to autonomic dysregulation and impaired upper airway sensori-motor function.	[Macey, Paul M.; Haris, Natasha; Woo, Mary A.] Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90024 USA; [Macey, Paul M.; Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med UCLA, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Kumar, Rajesh; Thomas, M. Albert] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90024 USA.; Macey, PM (corresponding author), Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med UCLA, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Thomas, M. Albert/A-6176-2012; Thomas, M. Albert/J-7210-2019; Macey, Paul M./B-5037-2008	Thomas, M. Albert/0000-0001-9037-2585; Thomas, M. Albert/0000-0001-9037-2585; Macey, Paul M./0000-0003-4093-7458	National Institute of Nursing Research [NR013693]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013693] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Institute of Nursing Research (NR013693).; This research was funded by the National Institute of Nursing Research NR013693. The authors thank Rebecca Harper for assistance with data collection.	Anttalainen U, 2010, ACTA OBSTET GYN SCAN, V89, P605, DOI 10.3109/00016341003681249; Asghari A, 2012, EUR ARCH OTO-RHINO-L, V269, P2549, DOI 10.1007/s00405-012-1942-6; Ball G, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00003; Baronio D, 2013, RESP PHYSIOL NEUROBI, V185, P217, DOI 10.1016/j.resp.2012.10.012; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bonner MF, 2013, J NEUROSCI, V33, P4213, DOI 10.1523/JNEUROSCI.0041-13.2013; Brodmann K, 1909, VERGLEICHENDE LOKALI, Vx; BROUILLETTE RT, 1980, J APPL PHYSIOL, V49, P801, DOI 10.1152/jappl.1980.49.5.801; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Buysse D J, 1989, Psychiatry Res, V28, P193; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEEGAN PC, 1995, EUR RESPIR J, V8, P1161, DOI 10.1183/09031936.95.08071161; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Gozal D, 2002, AM J RESP CRIT CARE, V166, P1305, DOI 10.1164/rccm.2208005; Harper RM, 2009, SLEEP, V32, pA341; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P31, DOI 10.1113/jphysiol.1991.sp018537; Huynh NT, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00058; Joo EY, 2013, SLEEP, V36, P1153, DOI 10.5665/sleep.2876; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Joseph R, 1999, PSYCHIATRY, V62, P138, DOI 10.1080/00332747.1999.11024862; Kilicarslan R, 2014, SCI WORLD J, DOI 10.1155/2014/768415; Kim JS, 2013, PARKINSONISM RELAT D, V19, P970, DOI 10.1016/j.parkreldis.2013.06.012; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kumar R, 2008, NEUROSCI LETT, V438, P330, DOI 10.1016/j.neulet.2008.04.071; Kumar R, 2014, SLEEP, V37, P723, DOI 10.5665/sleep.3578; Kumar R, 2014, NEUROIMAGE-CLIN, V4, P383, DOI 10.1016/j.nicl.2014.01.009; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Littner MR, 2007, J CLIN SLEEP MED, V3, P263; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Macey PM, 2012, SLEEP, V35, P9, DOI 10.5665/sleep.1572; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marques-Iturria I, 2013, PSYCHIAT RES-NEUROIM, V214, P109, DOI 10.1016/j.pscychresns.2013.06.004; Mazzola L, 2012, NEUROIMAGE, V60, P409, DOI 10.1016/j.neuroimage.2011.12.072; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Metman Leo Verhagen, 1993, Brain Topography, V6, P13, DOI 10.1007/BF01234122; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Nijboer CHA, 2007, DEV NEUROSCI-BASEL, V29, P385, DOI 10.1159/000105479; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; ONAL E, 1981, J APPL PHYSIOL, V50, P1052, DOI 10.1152/jappl.1981.50.5.1052; Parpia P, 2011, NEURAL COMPUT, V23, pCP3; Pink A, 2017, J ALZHEIMERS DIS, V58, P1273, DOI 10.3233/JAD-170041; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Sanfilippo-Cohn B, 2006, SLEEP, V29, P152, DOI 10.1093/sleep/29.2.152; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; SHEFER V F, 1973, Neuroscience and Behavioral Physiology, V6, P319, DOI 10.1007/BF01182672; Shepertycky MR, 2005, SLEEP, V28, P309; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Tsumori T, 2006, NEUROSCI RES, V56, P261, DOI 10.1016/j.neures.2006.07.005; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Yadav SK, 2013, NEUROSCI LETT, V555, P159, DOI 10.1016/j.neulet.2013.09.033; Yang QC, 2013, NEUROPSYCH DIS TREAT, V9, P1077, DOI 10.2147/NDT.S49868; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	75	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193854	10.1371/journal.pone.0193854	http://dx.doi.org/10.1371/journal.pone.0193854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509806	Green Published, gold			2022-12-26	WOS:000426813200035
J	Ricotti, R; Genoni, G; Giglione, E; Monzani, A; Nugnes, M; Zanetta, S; Castagno, M; Marolda, A; Bellomo, G; Bona, G; Bellone, S; Prodam, F				Ricotti, Roberta; Genoni, Giulia; Giglione, Enza; Monzani, Alice; Nugnes, Martina; Zanetta, Sara; Castagno, Matteo; Marolda, Agostina; Bellomo, Giorgio; Bona, Gianni; Bellone, Simonetta; Prodam, Flavia			High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; CARDIOMETABOLIC RISK; GENERAL-POPULATION; URIC-ACID; MICROALBUMINURIA; ASSOCIATION; ADOLESCENTS; PREVALENCE; OVERWEIGHT	Background Childhood obesity represents a major health concern worldwide due to its well established detrimental effect on cardiovascular and its potential negative effect on kidney functions. However, biomarkers that can help diagnose early stages of kidney damage in obese children represent an unmet clinical need. Objectives In this study, we asked whether the prevalence of microalbuminuria, estimated glomerular filtration rate (eGFR) or hyperuricemia recorded in a wide cohort of obese children and adolescents would positively correlate with cardiometabolic dysfunction in these subjects. Methods We carried out a cross-sectional study on 360 obese children and adolescents between the ages of 3 +/- 18 years, enrolled in a tertiary care center. Clinical and biochemical evaluations including oral glucose tolerance tests (OGTTs) were performed on all patients. Microalbuminuria was defined as urinary albumin-to-creatinine ratio (u-ACR) of 30 +/- 300 mg/g. All data are expressed as mean +/- standard deviation (SD), absolute values or percentages. Sex age-specific and eGFR SDs were used for statistical analyses. Serum uric acid >= 5.5 mg/dL was considered abnormal. Results The prevalence of microalbuminuria was 6.4%. Except for a lower insulinogenic-index, no correlations between microalbuminuria and cardiometabolic risk factors were detected. eGFR was < -1 SD and > 1 SD in 1.4% and 60.8% of subjects, respectively. Subjects with an eGFR > 1 SD had higher systolic blood pressure, liver enzymes, insulin resistance, glucose and insulin during OGTT, lower insulin sensitivity and a more prevalent microalbuminuria. Hyperuricemia (27.5%) increased the odds of hypertension, HDL <= 10 th percentile and glucose <= 155.0 mg/dL after 60 minutes of OGTT. Conclusions A worse cardiometabolic profile was observed in subjects with an eGFR > 1 SD compared to other subgroups. Therefore, pediatric obese patients with eGFR > 1 SD or hyperuricemia should be closely monitored for microalbuminuria and post-challenge glucose and insulin secretion, all potential indicators of renal dysfunction in these young patients.	[Ricotti, Roberta; Genoni, Giulia; Giglione, Enza; Monzani, Alice; Nugnes, Martina; Zanetta, Sara; Castagno, Matteo; Marolda, Agostina; Bona, Gianni; Bellone, Simonetta; Prodam, Flavia] Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, Novara, Italy; [Bellomo, Giorgio] Univ Piemonte Orientale, Dept Hlth Sci, Clin Chem, Novara, Italy; [Bellone, Simonetta; Prodam, Flavia] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Prodam, Flavia] Univ Piemonte Orientale, Dept Translat Med, Endocrinol, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Prodam, F (corresponding author), Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, Novara, Italy.; Prodam, F (corresponding author), Univ Piemonte Orientale, IRCAD, Novara, Italy.; Prodam, F (corresponding author), Univ Piemonte Orientale, Dept Translat Med, Endocrinol, Novara, Italy.	FLAVIA.PRODAM@MED.UNIUPO.IT	Bellone, Simonetta/K-2196-2016; Monzani, Alice/K-2804-2016	Monzani, Alice/0000-0002-6676-5773; Prodam, Flavia/0000-0001-9660-5335	Fondazione Comunita Novarese Onlus	Fondazione Comunita Novarese Onlus	This study was supported by Fondazione Comunita Novarese Onlus. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgert TS, 2006, INT J OBESITY, V30, P273, DOI 10.1038/sj.ijo.0803136; Cho H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178716; Cindik N, 2005, ACTA PAEDIATR, V94, P1732, DOI 10.1080/08035250500277101; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cruz Martha L, 2004, Curr Diab Rep, V4, P53, DOI 10.1007/s11892-004-0012-x; Csernus K, 2005, EUR J PEDIATR, V164, P44, DOI 10.1007/s00431-004-1546-2; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; DeBoer MD, 2012, METABOLISM, V61, P554, DOI 10.1016/j.metabol.2011.09.003; Di Bonito P, 2014, OBESITY, V22, P585, DOI 10.1002/oby.20497; Di Bonito P, 2010, ATHEROSCLEROSIS, V213, P611, DOI 10.1016/j.atherosclerosis.2010.09.017; Fadrowski JJ, 2011, CLIN J AM SOC NEPHRO, V6, P1427, DOI 10.2215/CJN.06460710; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Fiorentino TV, 2015, J CLIN ENDOCR METAB, V100, P3744, DOI 10.1210/jc.2015-2573; Grubbs V, 2014, AM J KIDNEY DIS, V63, P590, DOI 10.1053/j.ajkd.2013.10.055; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Invitti C, 2006, INT J OBESITY, V30, P627, DOI 10.1038/sj.ijo.0803151; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Khan UI, 2015, CHILD OBES, V11, P289, DOI 10.1089/chi.2014.0112; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lytvyn Y, 2016, DIABETES CARE, V39, P611, DOI 10.2337/dc15-2345; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2012, CLIN J AM SOC NEPHRO, V7, P101, DOI 10.2215/CJN.06450611; Nguyen S, 2008, PEDIATRICS, V121, P37, DOI 10.1542/peds.2007-3594; Prodam F, 2013, J ENDOCRINOL INVEST, V36, P466, DOI 10.3275/8768; Prodam F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087157; Radhakishun NNE, 2013, PEDIATR NEPHROL, V28, P1145, DOI 10.1007/s00467-013-2451-6; Sanad M, 2011, PEDIATR NEPHROL, V26, P2193, DOI 10.1007/s00467-011-1931-9; Savino A, 2011, PEDIATR NEPHROL, V26, P749, DOI 10.1007/s00467-010-1659-y; Savino A, 2010, HORM RES PAEDIAT, V73, P303, DOI 10.1159/000308161; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Storhaug HM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0207-1; Wang X, 2015, HUANG HJSICHUAN DA X, V46, P750	35	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193755	10.1371/journal.pone.0193755	http://dx.doi.org/10.1371/journal.pone.0193755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505614	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200030
J	Rasmussen, TB; Boniotti, MB; Papetti, A; Grasland, B; Frossard, JP; Dastjerdi, A; Hulst, M; Hanke, D; Pohlmann, A; Blome, S; van der Poel, WHM; Steinbach, F; Blanchard, Y; Lavazza, A; Botner, A; Belsham, GJ				Rasmussen, Thomas Bruun; Boniotti, Maria Beatrice; Papetti, Alice; Grasland, Beatrice; Frossard, Jean-Pierre; Dastjerdi, Akbar; Hulst, Marcel; Hanke, Dennis; Pohlmann, Anne; Blome, Sandra; van der Poel, Wim H. M.; Steinbach, Falko; Blanchard, Yannick; Lavazza, Antonio; Botner, Anette; Belsham, Graham J.			Full-length genome sequences of porcine epidemic diarrhoea virus strain CV777; Use of NGS to analyse genomic and sub-genomic RNAs	PLOS ONE			English	Article							UNITED-STATES; CORONAVIRUS; OUTBREAK; INFECTION; VARIANT; TABLET; SWINE; GENE	Porcine epidemic diarrhoea virus, strain CV777, was initially characterized in 1978 as the causative agent of a disease first identified in the UK in 1971. This coronavirus has been widely distributed among laboratories and has been passaged both within pigs and in cell culture. To determine the variability between different stocks of the PEDV strain CV777, sequencing of the full-length genome (ca. 28kb) has been performed in 6 different laboratories, using different protocols. Not surprisingly, each of the different full genome sequences were distinct from each other and from the reference sequence (Accession number AF353511) but they are >99% identical. Unique and shared differences between sequences were identified. The coding region for the surface-exposed spike protein showed the highest proportion of variability including both point mutations and small deletions. The predicted expression of the ORF3 gene product was more dramatically affected in three different variants of this virus through either loss of the initiation codon or gain of a premature termination codon. The genome of one isolate had a substantially rearranged 5'-terminal sequence. This rearrangement was validated through the analysis of sub-genomic mRNAs from infected cells. It is clearly important to know the features of the specific sample of CV777 being used for experimental studies.	[Rasmussen, Thomas Bruun; Botner, Anette; Belsham, Graham J.] Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Boniotti, Maria Beatrice; Papetti, Alice; Lavazza, Antonio] IZSLER Ist Zooprofilatt Sperimentale Lombardia &, Brescia, Italy; [Grasland, Beatrice; Blanchard, Yannick] ANSES, Lab Ploufragan Plouzane, BP 53, Ploufragan, France; [Grasland, Beatrice; Blanchard, Yannick] Univ Bretagne Loire, Rennes, France; [Frossard, Jean-Pierre; Dastjerdi, Akbar; Steinbach, Falko] Anim & Plant Hlth Agcy, Dept Virol, Addlestone, Surrey, England; [Hulst, Marcel; van der Poel, Wim H. M.] Wageningen BioVet Res, Dept Virol, Lelystad, Netherlands; [Hanke, Dennis; Pohlmann, Anne; Blome, Sandra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Greifswald, Germany	Technical University of Denmark; IZS Lombardia e Emilia; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; Animal & Plant Health Agency UK; Wageningen University & Research; Friedrich Loeffler Institute	Belsham, GJ (corresponding author), Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Papetti, Alice/AAG-7829-2019; Belsham, Graham J./H-8589-2019; Frossard, Jean-Pierre/D-8100-2011; Belsham, Graham/J-3132-2019; Steinbach, Falko/V-1682-2019; Boniotti, Maria Beatrice/AAD-1762-2022	Belsham, Graham J./0000-0003-1187-4873; Frossard, Jean-Pierre/0000-0003-1272-8173; Belsham, Graham/0000-0003-1187-4873; Steinbach, Falko/0000-0003-1236-2837; Boniotti, Maria Beatrice/0000-0001-6252-9848; Papetti, Alice/0000-0003-4966-2884	CoVet Lab (a partnership of national veterinary public health institutes from Denmark); CoVet Lab (a partnership of national veterinary public health institutes from France); CoVet Lab (a partnership of national veterinary public health institutes from The Netherlands); CoVet Lab (a partnership of national veterinary public health institutes from Sweden); CoVet Lab (a partnership of national veterinary public health institutes from United Kingdom); EU Horizon program (European Commission Grant) [643476]	CoVet Lab (a partnership of national veterinary public health institutes from Denmark); CoVet Lab (a partnership of national veterinary public health institutes from France); CoVet Lab (a partnership of national veterinary public health institutes from The Netherlands); CoVet Lab (a partnership of national veterinary public health institutes from Sweden); CoVet Lab (a partnership of national veterinary public health institutes from United Kingdom); EU Horizon program (European Commission Grant)	Financial support was received from the CoVet Lab (a partnership of national veterinary public health institutes from Denmark, France, The Netherlands, Sweden and the United Kingdom) to AB, WvdP, FS and YB. The study has also been funded, in part, by the EU Horizon 2020 program (European Commission Grant Agreement No. 643476 "COMPARE") for SB and YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support from the CoVet Lab (a partnership of national veterinary public health institutes from Denmark, France, The Netherlands, Sweden and the United Kingdom). At FLI and ANSES, the study has been funded, in part, by the EU Horizon 2020 program (European Commission Grant Agreement No. 643476 "COMPARE"). In addition, we are grateful for excellent technical assistance from Preben Normann (DTU), Jane Borch (DTU), Marlene D. Dalgaard (DMAC, DTU), Patrick Zitzow (FLI), Julie Peake (APHA), Richard Ellis (APHA) and Frank Harders (WBVR).	Authie E, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3877; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; BRIDGEN A, 1993, J GEN VIROL, V74, P1795, DOI 10.1099/0022-1317-74-9-1795; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Choudhury B, 2016, VIRUS RES, V226, P40, DOI 10.1016/j.virusres.2016.09.003; Dastjerdi A, 2015, EMERG INFECT DIS, V21, P2235, DOI 10.3201/eid2112.150272; Grasland B., 2015, GENOME ANNOUNC, V3; Gurrala R, 2009, VIRUS RES, V144, P202, DOI 10.1016/j.virusres.2009.04.028; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; HAVE P, 1992, VET MICROBIOL, V31, P1, DOI 10.1016/0378-1135(92)90135-G; HIERHOLZER JC, 1978, J CLIN MICROBIOL, V7, P499; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; LIN CM, 2015, VET RES, V46; Lohse L, 2017, TRANSBOUND EMERG DIS, V64, P1380, DOI 10.1111/tbed.12509; Madhugiri R, 2014, VIRUS RES, V194, P76, DOI 10.1016/j.virusres.2014.10.001; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Mesquita JR, 2015, TRANSBOUND EMERG DIS, V62, P586, DOI 10.1111/tbed.12409; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Song DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120310; Steinrigl A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0624-1; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Svitkin YV, 2001, RNA, V7, P1743; TOPLAK I, 2016, GENOME ANNOUNC, V4; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193682	10.1371/journal.pone.0193682	http://dx.doi.org/10.1371/journal.pone.0193682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494671	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200080
J	Wadhwa, S; Gupta, A; Dokania, S; Kanji, R; Bagler, G				Wadhwa, Somin; Gupta, Aishwarya; Dokania, Shubham; Kanji, Rakesh; Bagler, Ganesh			A hierarchical anatomical classification schema for prediction of phenotypic side effects	PLOS ONE			English	Article							DRUGS; DATABASE; PROFILES	Prediction of adverse drug reactions is an important problem in drug discovery endeavors which can be addressed with data-driven strategies. SIDER is one of the most reliable and frequently used datasets for identification of key features as well as building machine learning models for side effects prediction. The inherently unbalanced nature of this data presents with a difficult multi-label multi-class problem towards prediction of drug side effects. We highlight the intrinsic issue with SIDER data and methodological flaws in relying on performance measures such as AUC while attempting to predict side effects. We argue for the use of metrics that are robust to class imbalance for evaluation of classifiers. Importantly, we present a 'hierarchical anatomical classification schema' which aggregates side effects into organs, sub-systems, and systems. With the help of a weighted performance measure, using 5-fold cross-validation we show that this strategy facilitates biologically meaningful side effects prediction at different levels of anatomical hierarchy. By implementing various machine learning classifiers we show that Random Forest model yields best classification accuracy at each level of coarse-graining. The manually curated, hierarchical schema for side effects can also serve as the basis of future studies towards prediction of adverse reactions and identification of key features linked to specific organ systems. Our study provides a strategy for hierarchical classification of side effects rooted in the anatomy and can pave the way for calibrated expert systems for multi-level prediction of side effects.	[Wadhwa, Somin; Gupta, Aishwarya; Dokania, Shubham; Kanji, Rakesh; Bagler, Ganesh] Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi 110020, India; [Wadhwa, Somin] Guru Gobind Singh Indraprastha Univ, Maharaja Agrasen Inst Technol, New Delhi 110086, India; [Gupta, Aishwarya] Indira Gandhi Delhi Tech Univ Women, New Delhi 110006, India; [Dokania, Shubham] Delhi Technol Univ, New Delhi 110042, India; [Kanji, Rakesh] Indian Inst Technol Jodhpur, Dept Biosci & Bioengn, Jodhpur 342011, Rajasthan, India	Indraprastha Institute of Information Technology Delhi; GGS Indraprastha University; Maharaja Agrasen Institute of Technology; Indira Gandhi Delhi Technical University for Women (IGDTUW); Delhi Technological University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi 110020, India.	bagler@iiitd.ac.in	Bagler, Ganesh/A-1102-2009	Bagler, Ganesh/0000-0003-1924-6070	IIIT-Delhi; Ministry of Human Resource Development, Government of India; Indian Institute of Technology Jodhpur; Indraprastha Institute of Information Technology (IIIT-Delhi)	IIIT-Delhi; Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Indian Institute of Technology Jodhpur; Indraprastha Institute of Information Technology (IIIT-Delhi)	G.B. thanks the Indraprastha Institute of Information Technology (IIIT-Delhi) for providing computational facilities and support. S.W., A.G. and S.D. were Summer Research Interns in Dr. Bagler's lab at the Center for Computational Biology, and are thankful to IIIT-Delhi for the support and fellowship. R.K. thanks the Ministry of Human Resource Development, Government of India and Indian Institute of Technology Jodhpur for the senior research fellowship.	Atias N, 2011, J COMPUT BIOL, V18, P207, DOI 10.1089/cmb.2010.0255; Cai MC, 2015, NUCLEIC ACIDS RES, V43, pD907, DOI 10.1093/nar/gku1066; Chen LK, 2013, PAIN RES TREAT, V2013, P7, DOI DOI 10.1155/2013/485034; Cheng FX, 2013, J CHEM INF MODEL, V53, P744, DOI 10.1021/ci4000079; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Huang LC, 2013, PROTEOMICS, V13, P313, DOI 10.1002/pmic.201200337; Huang LC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S11; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kalash R, 2014, IN VIVO, V28, P147; Kanji R, 2015, MOL BIOSYST, V11, P2900, DOI 10.1039/c5mb00312a; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Li R, 2016, CHIN CONTR CONF, P9314, DOI 10.1109/ChiCC.2016.7554838; Liu M, 2012, J AM MED INFORM ASSN, V19, pE28, DOI 10.1136/amiajnl-2011-000699; Mizutani S, 2012, BIOINFORMATICS, V28, pI522, DOI 10.1093/bioinformatics/bts383; Niu SY, 2015, J COMPUT BIOL, V22, P1108, DOI 10.1089/cmb.2015.0129; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Shaked I, 2016, CELL SYST, V2, P209, DOI 10.1016/j.cels.2016.03.001; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Yamanishi Y, 2012, J CHEM INF MODEL, V52, P3284, DOI 10.1021/ci2005548; 황유현, 2016, [Journal of The Korea Society of Computer and Information, 한국컴퓨터정보학회논문지], V21, P115; Zhang W, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0774-y	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193959	10.1371/journal.pone.0193959	http://dx.doi.org/10.1371/journal.pone.0193959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494708	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200103
J	Weaver, CA; Armitage, AR				Weaver, Carolyn A.; Armitage, Anna R.			Nutrient enrichment shifts mangrove height distribution: Implications for coastal woody encroachment	PLOS ONE			English	Article							AVICENNIA-GERMINANS; SALT-MARSH; SPARTINA-ALTERNIFLORA; PHOSPHORUS LIMITATION; PLANT ENCROACHMENT; BLACK MANGROVE; CLIMATE-CHANGE; REGIME SHIFTS; EXPANSION; NITROGEN	Global changes, such as increased temperatures and elevated CO2, are driving shifts in plant species distribution and dominance, like woody plant encroachment into grasslands. Local factors within these ecotones can influence the rate of regime shifts. Woody encroachment is occurring worldwide, though there has been limited research within coastal systems, where mangrove (woody shrub/tree) stands are expanding into salt marsh areas. Because coastal systems are exposed to various degrees of nutrient input, we investigated how nutrient enrichment may locally impact mangrove stand expansion and salt marsh displacement over time. We fertilized naturally co-occurring Avicennia germinans (black mangrove) and Spartina alterniflora (smooth cordgrass) stands in Port Aransas, TX, an area experiencing mangrove encroachment within the Northern Gulf of Mexico mangrove-marsh ecotone. After four growing seasons (2010 +/- 2013) of continuous fertilization, Avicennia was more positively influenced by nutrient enrichment than Spartina. Most notably, fertilized plots had a higher density of taller (> 0.5 m) mangroves and mangrove maximum height was 46% taller than in control plots. Fertilization may promote an increase in mangrove stand expansion within the mangrove-marsh ecotone by shifting Avicennia height distribution. Avicennia individuals, which reach certain species-specific height thresholds, have reduced negative neighbor effects and have higher resilience to freezing temperatures, which may increase mangrove competitive advantage over marsh grass. Therefore, we propose that nutrient enrichment, which augments mangrove height, could act locally as a positive feedback to mangrove encroachment, by reducing mangrove growth suppression factors, thereby accelerating the rates of increased mangrove coverage and subsequent marsh displacement. Areas within the mangrove-marsh ecotone with high anthropogenic nutrient input may be at increased risk of a regime shift from grass to woody dominated ecosystems.	[Weaver, Carolyn A.; Armitage, Anna R.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Armitage, Anna R.] Texas A&M Univ Galveston, Dept Marine Biol, Galveston, TX 77553 USA; [Weaver, Carolyn A.] Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University Corpus Christi	Weaver, CA (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.; Weaver, CA (corresponding author), Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	Carolyn.Weaver@tamucc.edu	Armitage, Anna/X-2773-2019	Armitage, Anna/0000-0003-1563-8026; Weaver, Carolyn/0000-0002-1447-6371	National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA100AR4170099]; Tom Slick Graduate Research Fellowship; Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant; Erma Lee and Luke Mooney Graduate Student Travel Grant; Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant	National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Tom Slick Graduate Research Fellowship; Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant; Erma Lee and Luke Mooney Graduate Student Travel Grant; Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant	This work was supported by a Institutional Grant (NA100AR4170099) to the Texas Sea Grant College Program from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce (http://texassseagrant.orgi/). Additional funding provided by: Tom Slick Graduate Research Fellowship, Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant, Erma Lee and Luke Mooney Graduate Student Travel Grant, and Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2015, CURR CLIM CHANGE REP, V1, P30, DOI 10.1007/s40641-015-0002-x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Armitage AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125404; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; BURESH RJ, 1980, ESTUARIES, V3, P111, DOI 10.2307/1351555; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; Darby FA, 2008, ESTUAR COAST, V31, P223, DOI 10.1007/s12237-007-9014-7; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; FELLER IC, 1995, ECOL MONOGR, V65, P477, DOI 10.2307/2963499; Feller IC, 2007, ECOSYSTEMS, V10, P347, DOI 10.1007/s10021-007-9025-z; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Fox L, 2012, ESTUAR COAST, V35, P445, DOI 10.1007/s12237-012-9479-x; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Giri C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122010; Guo H, 2017, ECOLOGY, V98, P762, DOI 10.1002/ecy.1698; Guo HY, 2013, GLOBAL CHANGE BIOL, V19, P2765, DOI 10.1111/gcb.12221; Kelleway JJ, 2017, GLOBAL CHANGE BIOL; KIRBY CJ, 1976, ECOLOGY, V57, P1052, DOI 10.2307/1941070; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2014, ECOHYDROLOGY, V7, P354, DOI 10.1002/eco.1353; MacTavish RM, 2017, J EXP MAR BIOL ECOL, V488, P52, DOI 10.1016/j.jembe.2016.12.009; MARKLEY JL, 1982, CAN J BOT, V60, P2704, DOI 10.1139/b82-330; Mckee KL, 2008, GLOBAL CHANGE BIOL, V14, P971, DOI 10.1111/j.1365-2486.2008.01547.x; Montagna P.A., 2011, IMPACT GLOBAL WARMIN; Naidoo G, 2009, AQUAT BOT, V90, P184, DOI 10.1016/j.aquabot.2008.10.001; Nielsen-Gammon JW., 2012, TEX WATER J, V3, P59, DOI DOI 10.21423/TWJ.V3I1.6463; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Osland MJ, 2017, ECOL MONOGR, V87, P341, DOI 10.1002/ecm.1248; Osland MJ, 2017, ECOLOGY, V98, P125, DOI 10.1002/ecy.1625; Osland MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00042.1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; PATTERSON CS, 1993, J COASTAL RES, V9, P801; Pennings SC, 2002, ESTUARIES, V25, P1164, DOI 10.1007/BF02692213; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Rogers K, 2005, ESTUARIES, V28, P551, DOI 10.1007/BF02696066; Saintilan N, 2015, NEW PHYTOL, V205, P1062, DOI 10.1111/nph.13147; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SHERROD CL, 1981, CONTRIB MAR SCI, V24, P115; SHERROD CL, 1985, CONTRIB MAR SCI, V28, P129; Simpson LT, 2013, AQUAT BOT, V104, P55, DOI 10.1016/j.aquabot.2012.09.006; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	52	18	18	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193617	10.1371/journal.pone.0193617	http://dx.doi.org/10.1371/journal.pone.0193617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494657	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200077
J	Guo, WH; Zhong, KH; Wei, H; Nie, CL; Yuan, Z				Guo, Wenhao; Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu			Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; COLORECTAL-CANCER; LNCRNA SPRY4-IT1; METASTASIS; EXPRESSION; CARCINOMA	Accumulating evidence has demonstrated that long non-coding RNAs (lncRNAs) play a critical role in the development of human cancers including pancreatic cancer. Long non-coding RNA SPRY4-IT1 (sprouty4-intron transcript 1) has been reported to play an oncogenic role in various types of human carcinomas. However, the role of SPRY4-IT1 in pancreatic cancer is unclear. The objective of this study was to determine the function of SPRY4-IT1 on proliferation and invasion in pancreatic cancer. In the current study, we dissected the function and mechanism of SPRY4-IT1 by multiple approaches including Real-time RT-PCR, Western blotting analysis, MTT assay, Wound healing assay, Transwell assay, and transfection. We found that down-regulation of SPRY4-IT1 inhibited cell growth and induced cell apoptosis in pancreatic cancer cells. Moreover, SPRY4-IT1 knockdown induced cell cycle arrest at G0/G1 phase. Furthermore, inhibition of SPRY4-IT1 retarded cell migration and invasion in pancreatic cancer cells. Overexpression of SPRY4-IT1 enhanced cell growth and invasion, and inhibited cell apoptosis in pancreatic cancer cells. Mechanistically, suppression of SPRY4-IT1 inhibited the expression of Cdc20 in pancreatic cancer cells. Our findings demonstrated that inhibition of SPRY4-IT1 could be a potential therapeutic approach for the treatment of pancreatic cancer.	[Guo, Wenhao] Sichuan Univ, Canc Ctr, Dept Abdominal Oncol, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China; [Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu] Sichuan Univ, West China Hosp, Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Guo, WH (corresponding author), Sichuan Univ, Canc Ctr, Dept Abdominal Oncol, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China.; Guo, WH (corresponding author), Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China.; Yuan, Z (corresponding author), Sichuan Univ, West China Hosp, Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; Yuan, Z (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China.	wenhaoguo2011@163.com; yuanzhu@scu.edu.cn			National Natural Science Foundation of China (NSFC) [81773021]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was support by National Natural Science Foundation of China (NSFC, No. 81773021 to Zhu Yuan).	Aroldi F, 2017, IMMUNOTHERAPY-UK, V9, P607, DOI 10.2217/imt-2016-0142; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Blythe AJ, 2016, BBA-GENE REGUL MECH, V1859, P46, DOI 10.1016/j.bbagrm.2015.08.009; Cao D, 2016, ONCOTARGETS THER, V9, P5417, DOI 10.2147/OTT.S111794; Cui F, 2016, TUMOR BIOL, V37, P10871, DOI 10.1007/s13277-016-4962-9; Gupta R, 2017, J SURG ONCOL, V116, P25, DOI 10.1002/jso.24623; Jing W, 2016, ONCOL REP, V36, P1085, DOI 10.3892/or.2016.4859; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Li H, 2017, J NANOTECHNOL, V2017, P1, DOI DOI 10.1016/J.BI0PHA.2017.01.037; Li J, 2017, TUMOR BIOL, V39, DOI DOI 10.1177/101042831771140628651500; Li S., 2017, CANC GENE THER; Liu D, 2017, CANCER LETT, V388, P281, DOI 10.1016/j.canlet.2016.12.005; Liu HX, 2015, J ZHEJIANG UNIV-SC B, V16, P10, DOI 10.1631/jzus.B1400172; Mazar J, 2014, ONCOTARGET, V5, P8959, DOI 10.18632/oncotarget.1863; Peng W, 2015, TUMOR BIOL, V36, P6751, DOI 10.1007/s13277-015-3376-4; Ramos MC, 2017, EXPERT OPIN THER PAT, V27, P1251, DOI 10.1080/13543776.2017.1349106; Ru N, 2016, DNA CELL BIOL, V35, P290, DOI 10.1089/dna.2016.3226; Shen F, 2017, ONCOTARGET, V8, P14479, DOI 10.18632/oncotarget.10407; Shi YG, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0318-0; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.256; Tan WL, 2017, MED SCI MONITOR, V23, P309, DOI 10.12659/MSM.898369; Wang JJ, 2015, ONCOTARGET, V6, P17192, DOI 10.18632/oncotarget.3780; Wang LX, 2015, PHARMACOL THERAPEUT, V151, P141, DOI 10.1016/j.pharmthera.2015.04.002; Xie HW, 2014, TUMOR BIOL, V35, P7743, DOI 10.1007/s13277-014-2013-y; Xu YJ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711140; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yang J, 2017, ONCOTARGET, V8, P23492, DOI 10.18632/oncotarget.15626; Yu GF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16781-9; Yu J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317709129; Zeng S, 2015, ONCOLOGIST, V20, P898, DOI 10.1634/theoncologist.2014-0475; Zhang CY, 2016, CELL BIOL TOXICOL, V32, P391, DOI 10.1007/s10565-016-9341-1; Zhang HM, 2014, INT J CLIN EXP PATHO, V7, P5801; Zhang X, 2017, ONCOTARGET; Zhao XL, 2015, INT J CLIN EXP PATHO, V8, P1954; Zhong YC, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008583; Zhou M, 2017, BIOMED PHARMACOTHER, V85, P348, DOI 10.1016/j.biopha.2016.11.035; Zhou Y, 2016, EUR REV MED PHARMACO, V20, P3035	38	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193483	10.1371/journal.pone.0193483	http://dx.doi.org/10.1371/journal.pone.0193483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489909	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000081
J	Wang, SY; Shi, XH; Wei, S; Ma, D; Oyinlade, O; Lv, SQ; Ying, MY; Zhang, YA; Claypool, SM; Watkins, P; Xia, SL				Wang, Shuyan; Shi, Xiaohai; Wei, Shuang; Ma, Ding; Oyinlade, Olutobi; Lv, Sheng-Qing; Ying, Mingyao; Zhang, Yu Alex; Claypool, Steven Michael; Watkins, Paul; Xia, Shuli			Kruppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; METABOLIC-REGULATION; DYNAMICS; CANCER; DEATH; PROLIFERATION; REQUIREMENTS; INHIBITION; APOPTOSIS; FISSION	Kruppel-like factor 4 (KLF4) is a zinc finger transcription factor critical for the regulation of many cellular functions in both normal and neoplastic cells. Here, using human glioblastoma cells, we investigated KLF4's effects on cancer cell metabolism. We found that forced KLF4 expression promotes mitochondrial fusion and induces dramatic changes in mitochondrial morphology. To determine the impact of these changes on the cellular functions following, we analyzed how KLF4 alters glioblastoma cell metabolism, including glucose uptake, glycolysis, pentose phosphate pathway, and oxidative phosphorylation. We did not identify significant differences in baseline cellular metabolism between control and KLF4-expressing cells. However, when mitochondrial function was impaired, KLF4 significantly increased spare respiratory capacity and levels of reactive oxygen species in the cells. To identify the biological effects of these changes, we analyzed proliferation and survival of control and KLF4-expressing cells under stress conditions, including serum and nutrition deprivation. We found that following serum starvation, KLF4 altered cell cycle progression by arresting the cells at the G(2)/M phase and that KLF4 protected cells from nutrition deprivation-induced death. Finally, we demonstrated that methylation-dependent KLF4-binding activity mediates mitochondrial fusion. Specifically, the downstream targets of KLF4-mCpG binding, guanine nucleotide exchange factors, serve as the effector of KLF4-induced mitochondrial fusion, cell cycle arrest, and cell protection. Our experimental system provides a robust model for studying the interactions between mitochondrial morphology and function, mitochondrial dynamics and metabolism, and mitochondrial fusion and cell death during tumor initiation and progression.	[Wang, Shuyan; Zhang, Yu Alex] Capital Med Univ, Xuanwu Hosp, Cell Therapy Ctr, Beijing 100053, Peoples R China; [Wang, Shuyan; Shi, Xiaohai; Wei, Shuang; Ma, Ding; Oyinlade, Olutobi; Ying, Mingyao; Watkins, Paul; Xia, Shuli] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Wang, Shuyan; Wei, Shuang; Ma, Ding; Ying, Mingyao; Watkins, Paul; Xia, Shuli] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Claypool, Steven Michael] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Wei, Shuang] Huazhong Univ Sci & Technol, Dept Resp & Crit Care Med, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lv, Sheng-Qing] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing 400037, Peoples R China	Capital Medical University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology; Army Medical University	Xia, SL (corresponding author), Johns Hopkins Sch Med, Hugo W Moser Res Inst Kennedy Krieger, Dept Neurol, 707 N Broadway,Rm 400C, Baltimore, MD 21205 USA.	xia@kennedykrieger.org	Wei, Shuang/AAA-4031-2019	Claypool, Steven/0000-0001-5316-1623	NICHD NIH HHS [U54 HD079123] Funding Source: Medline; NIGMS NIH HHS [T32 GM007445] Funding Source: Medline; NINDS NIH HHS [R01 NS091165, K08 NS063956] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099460, R21NS106407, R01NS091165] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Baarine M, 2015, J NEUROCHEM, V133, P380, DOI 10.1111/jnc.12992; Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VII; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Farrugia MK, 2016, CANCER RES, V76, P1677, DOI 10.1158/0008-5472.CAN-15-1806; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang C, 2015, TRENDS ENDOCRIN MET, V26, P587, DOI 10.1016/j.tem.2015.08.004; JENKINS AB, 1986, INT J BIOCHEM, V18, P311, DOI 10.1016/0020-711X(86)90036-4; Kumar Hari R, 2008, Expert Rev Neurother, V8, P1497, DOI 10.1586/14737175.8.10.1497; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCOMB RB, 1976, CLIN CHEM, V22, P141; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Oanh NTK, 2017, CELL SIGNAL, V38, P67, DOI 10.1016/j.cellsig.2017.06.019; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sanchis-Gomar F, 2014, NEW ENGL J MED, V370, P1073, DOI 10.1056/NEJMc1316254; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Serasinghe MN, 2017, HANDB EXP PHARMACOL, V240, P159, DOI 10.1007/164_2016_38; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suh SW, 2003, J NEUROSCI, V23, P10681; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wan J, 2017, ELIFE, V6, DOI 10.7554/eLife.20068; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xia S, 2007, MOL CANCER RES, V5, P783, DOI 10.1158/1541-7786.MCR-06-0433; Xia SL, 2006, BIOCHEM BIOPH RES CO, V345, P1358, DOI 10.1016/j.bbrc.2006.05.064; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Xia SL, 2005, CANCER RES, V65, P5248, DOI 10.1158/0008-5472.CAN-04-4332; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441	42	17	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6544	6555		10.1074/jbc.RA117.001323	http://dx.doi.org/10.1074/jbc.RA117.001323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29507094	Green Published, hybrid			2022-12-26	WOS:000431108600025
J	Lee, JE; Morrison, W; Hollien, J				Lee, Ji Eun; Morrison, William; Hollien, Julie			Hairy and enhancer of split 1 (HES1) protects cells from endoplasmic reticulum stress-induced apoptosis through repression of GADD34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MAMMALIAN-CELLS; ER STRESS; EXPRESSION; TRANSLATION; SURVIVAL; IRE1; LOOP; ACTIVATION; RESISTANCE	Disruption in endoplasmic reticulum (ER) function, termed ER stress, occurs in many diseases, including neurodegenerative disorders, diabetes, and cancer. Cells respond to ER stress with the unfolded protein response (UPR), which triggers a broad transcriptional program to restore and enhance ER function. Here, we found that ER stress up-regulates the mRNA encoding the developmentally regulated transcriptional repressor hairy and enhancer of split 1 (HES1), in a variety cell types. Depletion of HES1 increased cell death in response to ER stress in mouse and human cells, in a manner that depended on the pro-apoptotic gene growth arrest and DNA damage-inducible protein GADD34 (also known as Protein phosphatase 1 regulatory subunit 15A, or MyD116). Furthermore, HES1 bound to the GADD34 promoter, and its depletion led to an up-regulation of GADD34 expression during ER stress. Our results identify HES1 as a repressor of GADD34 expression, and reveal that HES1 contributes to cell fate determination in response to ER stress.	[Hollien, Julie] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA; [Lee, Ji Eun] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Morrison, William] Recurs Pharmaceut, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Memorial Sloan Kettering Cancer Center	Hollien, J (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	hollien@biology.utah.edu		Hollien, Julie/0000-0003-0649-1261	General Medical Science Institute, National Institutes of Health [R35 GM119540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119540] Funding Source: NIH RePORTER	General Medical Science Institute, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by General Medical Science Institute, National Institutes of Health Grant R35 GM119540. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Gao F, 2014, SCI REP-UK, V4, DOI 10.1038/srep03963; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XY, 2010, J CANCER RES CLIN, V136, P989, DOI 10.1007/s00432-009-0744-8; Weng MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144322; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young SK, 2016, J BIOL CHEM, V291, P13780, DOI 10.1074/jbc.M116.729830; Yuan RX, 2015, CLIN EXP METASTAS, V32, P169, DOI 10.1007/s10585-015-9700-y; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	35	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5947	5955		10.1074/jbc.RA118.002124	http://dx.doi.org/10.1074/jbc.RA118.002124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491143	Green Published, hybrid			2022-12-26	WOS:000430497300016
J	Floreani, M; Enrico, R; Taboga, P; Ganzini, A; Pisot, R; Simunic, B; Biolo, G; Reggiani, C; Passaro, A; Narici, M; Rittweger, J; di Prampero, PE; Lazzer, S				Floreani, Mirco; Rejc, Enrico; Taboga, Paolo; Ganzini, Alessandro; Pisot, Rado; Simunic, Bostjan; Biolo, Gianni; Reggiani, Carlo; Passaro, Angelina; Narici, Marco; Rittweger, Joern; di Prampero, Pietro Enrico; Lazzer, Stefano			Effects of 14 days of bed rest and following physical training on metabolic cost, mechanical work, and efficiency during walking in older and young healthy males	PLOS ONE			English	Article							FUNCTIONAL IMPAIRMENT; HINDLIMB SUSPENSION; LEVEL WALKING; MUSCLE VOLUME; BODY-MASS; ADULTS; GAIT; BALANCE; AGE; MEN	In this study, we investigated: i) the effects of bed rest and a subsequent physical training program on metabolic cost (Cw), mechanical work and efficiency during walking in older and young men; ii) the mechanisms underlying the higher Cw observed in older than young men. Twenty-three healthy male subjects (N = 16 older adults, age 59.6 +/- 3.4 years; N = 7 young, age: 23.1 +/- 2.9 years) participated in this study. The subjects underwent 14 days of bed rest followed by two weeks of physical training (6 sessions). Cw, mechanical work, efficiency, and co-contraction time of proximal muscles (vastus lateralis and biceps femoris) and distal muscles (gastrocnemius medialis and tibialis anterior) were measured during walking at 0.83, 1.11, 1.39, 1.67 m.s(-1) before bed rest (pre-BR), after bed rest (post-BR) and after physical training (post-PT). No effects of bed rest and physical training were observed on the analysed parameters in either group. Older men showed higher Cw and lower efficiency at each speed (average + 25.1 and -20.5%, P<0.001, respectively) compared to young. Co-contraction time of proximal and distal muscles were higher in older than in young men across the different walking speeds (average +30.0 and +110.3%, P<0.05, respectively). The lack of bed rest and physical training effects on the parameters analyzed in this study may be explained by the healthy status of both young and older men, which could have mitigated the effects of these interventions on walking motor function. On the other hand, the fact that older adults showed greater Cw, overall higher co-contraction time of antagonist lower limb muscles, and lower efficiency compared to the young cohort throughout a wide range of walking speed may suggest that older adults sacrificed economy of walking to improve stability.	[Floreani, Mirco; Rejc, Enrico; Taboga, Paolo; Ganzini, Alessandro; di Prampero, Pietro Enrico; Lazzer, Stefano] Univ Udine, Dept Med Area, Udine, Italy; [Floreani, Mirco; Ganzini, Alessandro; di Prampero, Pietro Enrico; Lazzer, Stefano] Univ Udine, Sch Sport Sci, Udine, Italy; [Taboga, Paolo] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Taboga, Paolo] Calif State Univ Sacramento, Dept Kinesiol & Hlth Sci, Sacramento, CA 95819 USA; [Pisot, Rado; Simunic, Bostjan] Sci & Res Ctr Koper, Inst Kinesiol Res, Koper, Slovenia; [Biolo, Gianni] Univ Trieste, Dept Med Surg & Hlth Sci, Div Internal Med, Trieste, Italy; [Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Passaro, Angelina] Univ Ferrara, Sect Internal & Cardioresp Med, Dept Med Sci, Ferrara, Italy; [Narici, Marco] Univ Nottingham, Derby Royal Hosp, MRC ARUK Ctr Musculoskeletal Ageing Res, Derby, England; [Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Rittweger, Joern] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany	University of Udine; University of Udine; University of Louisville; California State University System; California State University Sacramento; University of Trieste; University of Padua; University of Ferrara; University of Nottingham; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne	Lazzer, S (corresponding author), Univ Udine, Dept Med Area, Udine, Italy.; Lazzer, S (corresponding author), Univ Udine, Sch Sport Sci, Udine, Italy.	stefano.lazzer@uniud.it	Rittweger, Jörn/A-4308-2009; Passaro, Angelina/P-3401-2015; Biolo, Gianni/AAB-4983-2022	Rittweger, Jörn/0000-0002-2223-8963; Passaro, Angelina/0000-0001-8462-7000; Floreani, Mirco/0000-0002-4417-9597; TABOGA, PAOLO/0000-0001-6529-8299; Simunic, Bostjan/0000-0003-1565-7833; BIOLO, GIANNI/0000-0002-6397-1598	Cross-border Cooperation Program Slovenia - Italy; European Regional Development Fund [042-417 2/2009-18/052012]	Cross-border Cooperation Program Slovenia - Italy; European Regional Development Fund(European Commission)	The study was conducted in the framework of the project PANGeA: CB147 - Physical Activity and Nutrition for Quality Ageing, supported by the Cross-border Cooperation Program Slovenia - Italy 2007-2013 and co-financed by the European Regional Development Fund (grant no. 042-417 2/2009-18/052012) to RP.	Aboutorabi A, 2016, AGING CLIN EXP RES, V28, P393, DOI 10.1007/s40520-015-0420-6; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bean J, 2002, J AM GERIATR SOC, V50, P663; Bean JF, 2004, J AM GERIATR SOC, V52, P799, DOI 10.1111/j.1532-5415.2004.52222.x; Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; CHEN L, 1994, J BIOMECH, V27, P493, DOI 10.1016/0021-9290(94)90024-8; Coker RH, 2015, J GERONTOL A-BIOL, V70, P91, DOI 10.1093/gerona/glu123; Conley KE, 2000, J PHYSIOL-LONDON, V526, P211, DOI 10.1111/j.1469-7793.2000.00211.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; DEMPSTER WT, 1959, AM J PHYS ANTHROPOL, V17, P289, DOI 10.1002/ajpa.1330170405; ELBLE RJ, 1991, J NEUROL, V238, P1, DOI 10.1007/BF00319700; Enoka RM., 2015, NEUROMECHANICS HUMAN, P285; FERRANDO AA, 1995, AVIAT SPACE ENVIR MD, V66, P976; Finley F R, 1969, Arch Phys Med Rehabil, V50, P140; Frost G, 1997, J ELECTROMYOGR KINES, V7, P179, DOI 10.1016/S1050-6411(97)84626-3; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; GARDETTO PR, 1989, J APPL PHYSIOL, V66, P2739, DOI 10.1152/jappl.1989.66.6.2739; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; HAGEMAN PA, 1986, PHYS THER, V66, P1382, DOI 10.1093/ptj/66.9.1382; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hess JA, 2005, J MANIP PHYSIOL THER, V28, P582, DOI 10.1016/j.jmpt.2005.08.013; Hess JA, 2006, AGING CLIN EXP RES, V18, P107, DOI 10.1007/BF03327425; HOENIG HM, 1991, J AM GERIATR SOC, V39, P220, DOI 10.1111/j.1532-5415.1991.tb01632.x; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hortobagyi T, 2011, J GERONTOL A-BIOL, V66, P541, DOI 10.1093/gerona/glr008; Hortobagyi T, 2009, GAIT POSTURE, V29, P558, DOI 10.1016/j.gaitpost.2008.12.007; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Ko SU, 2009, J BIOMECH, V42, P1834, DOI 10.1016/j.jbiomech.2009.05.037; Kolahi A, 2007, BIOMED SIGNAL PROCES, V2, P59, DOI 10.1016/j.bspc.2007.02.001; Kortebein P, 2008, J GERONTOL A-BIOL, V63, P1076, DOI 10.1093/gerona/63.10.1076; Kubo K, 2004, BRIT J SPORT MED, V38, P324, DOI 10.1136/bjsm.2003.005595; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Marusic U, 2015, PSYCHOL AGING, V30, P334, DOI 10.1037/pag0000021; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; Mulder E, 2014, J MUSCULOSKEL NEURON, V14, P359; Nardello F, 2011, HUM MOVEMENT SCI, V30, P90, DOI 10.1016/j.humov.2010.05.012; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; NIGG BM, 1992, FOOT ANKLE, V13, P336, DOI 10.1177/107110079201300608; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Onambele GL, 2008, J BIOMECH, V41, P3133, DOI 10.1016/j.jbiomech.2008.09.004; Pavei G, 2016, J APPL PHYSIOL, V120, P1223, DOI 10.1152/japplphysiol.00839.2015; Peterka R J, 1990, J Vestib Res, V1, P49; Peterson DS, 2010, GAIT POSTURE, V31, P355, DOI 10.1016/j.gaitpost.2009.12.005; Petrella RJ, 1997, AM J PHYS MED REHAB, V76, P235, DOI 10.1097/00002060-199705000-00015; Pigos G., 2006, SPORT J; Pisot R, 2016, J APPL PHYSIOL, V120, P922, DOI 10.1152/japplphysiol.00858.2015; Rejc E, 2015, EUR J APPL PHYSIOL, V115, P1323, DOI 10.1007/s00421-015-3111-2; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Schuch CP, 2011, BIOL SPORT, V28, P165, DOI 10.5604/959282; SHAPIRO R, 1978, RES QUART, V49, P197, DOI 10.1080/10671315.1978.10615524; Stelmach G E, 1985, Clin Geriatr Med, V1, P679; Sudarsky L, 2001, ADV NEUROL, V87, P111; Taboga P, 2012, EUR J APPL PHYSIOL, V112, P4027, DOI 10.1007/s00421-012-2389-6; Winiarski S., 2003, ACTA BIOENG BIOMECH, V5, P544; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340	71	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194291	10.1371/journal.pone.0194291	http://dx.doi.org/10.1371/journal.pone.0194291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY9MC	29529070	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000427189300048
J	Gruneberg, P; Kadone, H; Kuramoto, N; Ueno, T; Hada, Y; Yamazaki, M; Sankai, Y; Suzuki, K				Gruneberg, Patrick; Kadone, Hideki; Kuramoto, Naomi; Ueno, Tomoyuki; Hada, Yasushi; Yamazaki, Masashi; Sankai, Yoshiyuki; Suzuki, Kenji			Robot-assisted voluntary initiation reduces control-related difficulties of initiating joint movement: A phenomenal questionnaire study on shaping and compensation of forward gait	PLOS ONE			English	Article							COMPARATOR MODEL; MOTOR IMAGERY; REHABILITATION; FEASIBILITY; LOCOMOTION; RECOVERY; LIMB; WILL	Humans employ various control strategies to initiate and maintain bodily movement. In case that the normal gait function is impaired, exoskeleton robots provide motor assistance during therapy. While the robotic control system builds on kinematic gait functions, the patient's voluntary efforts to initiate motion also contribute to the effectiveness of the therapy process. However, it is currently not well understood how voluntary initiation as a subjective capacity affects the physiological level of motor control. In order to understand the functional nexus between voluntary initiation and motor control, we interviewed patients undergoing robotic gait rehabilitation with the HAL exoskeleton robot about their experience and command of voluntarily initiating forward gait while using the HAL system. Their reports provide phenomenal evidence for voluntary initiation as a distinct cognitive act that comes as phenomenal performance. Furthermore, phenomenal evidence about the functional relation of intention and initiation correlates with FIM-M gait scores. Based on the assumption that HAL reduces control-related difficulties of voluntarily initiating joint movement, we identified two cognitive control strategies, shaping and compensation of gait, that imply a heterarchic organization of the human system of action control.	[Gruneberg, Patrick] Kanazawa Univ, Fac Global Stand Educ, Inst Liberal Arts & Sci Fac, Kanazawa, Ishikawa, Japan; [Kadone, Hideki] Univ Tsukuba, Ctr Innovat Med & Engn, Tsukuba, Ibaraki, Japan; [Kuramoto, Naomi] Univ Tsukuba, Grad Sch Empowerment Informat, Tsukuba, Ibaraki, Japan; [Ueno, Tomoyuki; Hada, Yasushi] Univ Tsukuba Hosp, Dept Rehabil Med, Tsukuba, Ibaraki, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Orthopaed Surg, Tsukuba, Ibaraki, Japan; [Sankai, Yoshiyuki; Suzuki, Kenji] Univ Tsukuba, Ctr Cybern Res, Tsukuba, Ibaraki, Japan	Kanazawa University; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Gruneberg, P (corresponding author), Kanazawa Univ, Fac Global Stand Educ, Inst Liberal Arts & Sci Fac, Kanazawa, Ishikawa, Japan.	grueneberg@staff.kanazawa-u.ac.jp	Grüneberg, Patrick/N-8718-2019	Grüneberg, Patrick/0000-0003-1640-3536; Suzuki, Kenji/0000-0003-1736-5404; Hada, Yasushi/0000-0003-0292-3493				Aach M, 2014, SPINE J, V14, P2847, DOI 10.1016/j.spinee.2014.03.042; Ach, 1905, WILLENSTATIGKEIT DEN; Ach N., 1910, ON VOLITION; Ach N, 1935, HDB BIOL ARBEITSMETH, V6, P460; Barthel D, 1965, MD ST MED J, V14, P16; Bayne T, 2008, PHILOS COMPASS, V3, P182, DOI 10.1111/j.1747-9991.2007.00122.x; Belda-Lois JM, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-66; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Chambon V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00320; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Diaz I, 2011, J ROBOT, V2011, DOI 10.1155/2011/759764; Eitam B, 2013, EXP BRAIN RES, V229, P475, DOI 10.1007/s00221-012-3370-7; Fusco A, 2016, RESTOR NEUROL NEUROS, V34, P247, DOI 10.3233/RNN-150573; Gallagher S, 2007, PHILOS COMPASS, V2, P347, DOI 10.1111/j.1747-9991.2007.00067.x; Gotz-Neumann K., 2011, GEHEN VERSTEHEN GANG, V3rd; Gruneberg P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00688; Gruneberg P, 2018, RESULTS INTERVIEW VO; Gunther G, 1971, CYBERNETICSTECHNIQUE, P119; Haggard P, 2013, EXP BRAIN RES, V229, P285, DOI 10.1007/s00221-013-3582-5; Hogan N, 2006, J REHABIL RES DEV, V43, P605, DOI 10.1682/JRRD.2005.06.0103; Horgan T, 2011, J CONSCIOUSNESS STUD, V18, P180; Ivanenko YP, 2006, NEUROSCIENTIST, V12, P339, DOI 10.1177/1073858406287987; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kadone H, 2018, VOLUNTARY INITIATION; Kadone H, 2018, INTERVIEW BASED QUES; Kawamoto H, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-141; Kubota S, 2013, ARCH PHYS MED REHAB, V94, P1080, DOI 10.1016/j.apmr.2012.12.020; Kuhl J., 1985, ACTION CONTROL COGNI; Kuhn S, 2013, CORTEX, V49, P1935, DOI 10.1016/j.cortex.2012.09.002; Latash ML, 2008, SYNERGY; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Lindworsky J., 1921, WILLE SEINE ERSCHEIN; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Maeshima S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-116; McCulloch Warren S., 1945, BULL MATH BIOPHYS, V7, P89, DOI 10.1007/BF02478457; Mele A., 2009, EFFECTIVE INTENTIONS, DOI 10.1093/acprof:oso/9780195384260.001.0001; Metzinger T., 2006, DISORDERS VOLITION; Michotte A, 1910, ARCH PSYCHOL, V38-39, P113; Mulder T, 2007, J NEURAL TRANSM, V114, P1265, DOI 10.1007/s00702-007-0763-z; Nahmias E, 2004, J CONSCIOUSNESS STUD, V11, P162; Nilsson A, 2014, J NEUROENG REHABIL, V11, P1; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; Pacherie E, 2014, TOPOI-INT REV PHILOS, V33, P33, DOI 10.1007/s11245-013-9187-6; Pfander Alexander, 1900, PHANOMENOLOGIE WOLLE; Ribeiro PRD, 2013, ADV HUM-COMPUT INTER, V2013, DOI 10.1155/2013/369425; Sakakima Harutoshi, 2013, Case Rep Orthop, V2013, P621405, DOI 10.1155/2013/621405; Sczesny-Kaiser M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0058-9; Suzuki K, 2007, ADV ROBOTICS, V21, P1441, DOI 10.1163/156855307781746061; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2012, CONSCIOUS COGN, V21, P1, DOI 10.1016/j.concog.2012.01.007; Ueba T, 2013, NEUROL MED-CHIR, V53, P287, DOI 10.2176/nmc.53.287; Wall A, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00048; Watanabe H, 2014, ARCH PHYS MED REHAB, V95, P2006, DOI 10.1016/j.apmr.2014.07.002; Zhu J, 2004, CAN J PHILOS, V34, P175; Zhu J, 2012, CONATIVE MIND VOLITI	56	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194214	10.1371/journal.pone.0194214	http://dx.doi.org/10.1371/journal.pone.0194214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY9MC	29529071	Green Published, Green Submitted, gold			2022-12-26	WOS:000427189300045
J	Rufo, JC; Paciencia, I; Silva, D; Martins, C; Madureira, J; Fernandes, ED; Padrao, P; Moreira, P; Delgado, L; Moreira, A				Rufo, Joao Cavaleiro; Paciencia, Ines; Silva, Diana; Martins, Carla; Madureira, Joana; Fernandes, Eduardo de Oliveira; Padrao, Patricia; Moreira, Pedro; Delgado, Luis; Moreira, Andre			Swimming pool exposure is associated with autonomic changes and increased airway reactivity to a beta-2 agonist in school aged children: A cross-sectional survey	PLOS ONE			English	Article							ELITE SWIMMERS; PARASYMPATHETIC ACTIVITY; RESPIRATORY SYMPTOMS; TRP CHANNELS; ASTHMA; ATTENDANCE; EXERCISE; INFLAMMATION; PREVALENCE; DISEASE	Background Endurance swimming exercises coupled to disinfection by-products exposure has been associated with increased airways dysfunction and neurogenic inflammation in elite swimmers. However, the impact of swimming pool exposure at a recreational level on autonomic activity has never been explored. Therefore, this study aimed to investigate how swimming pool attendance is influencing lung and autonomic function in school-aged children. Methods A total of 858 children enrolled a cross sectional survey. Spirometry and airway reversibility to beta-2 agonist, skin-prick-tests and exhaled nitric oxide measurements were performed. Pupillometry was used to evaluate autonomic nervous function. Children were classified as current swimmers (CS), past swimmers (PS) and non-swimmers (NS), according to the amount of swimming practice. Results Current swimmers group had significantly lower maximum and average pupil constriction velocities when compared to both PS and NS groups (3.8 and 5.1 vs 3.9 and 5.3 vs 4.0 and 5.4 mm/s, p = 0.03 and p = 0.01, respectively). Moreover, affinity to the beta-2 agonist and levels of exhaled nitric oxide were significantly higher in CS when compared to NS (70 vs 60 mL and 12 vs 10 ppb, p< 0.01 and p = 0.03, respectively). A non-significant trend for a higher risk of asthma, atopic eczema and allergic rhinitis was found with more years of swimming practice, particularly in atopic individuals (beta = 1.12, 1.40 and 1.31, respectively). After case-case analysis, it was possible to observe that results were not influenced by the inclusion of individuals with asthma. Conclusions Concluding, swimming pool attendance appears to be associated with autonomic changes and increased baseline airway smooth muscle constriction even in children without asthma.	[Rufo, Joao Cavaleiro; Paciencia, Ines; Silva, Diana; Martins, Carla; Delgado, Luis; Moreira, Andre] Univ Porto, Fac Med, Dept Pathol, Basic & Clin Immunol, Porto, Portugal; [Rufo, Joao Cavaleiro; Paciencia, Ines; Silva, Diana; Martins, Carla; Delgado, Luis; Moreira, Andre] S Joao Hosp Ctr, Immunoalergol Dept, Porto, Portugal; [Rufo, Joao Cavaleiro; Paciencia, Ines; Madureira, Joana; Fernandes, Eduardo de Oliveira] Inst Sci & Innovat Mech & Ind Engn, Energy & Built Environm Grp, Porto, Portugal; [Rufo, Joao Cavaleiro; Paciencia, Ines; Moreira, Andre] Univ Porto, Inst Saude Publ, EPIUnit, Rua Taipas 135, Porto, Portugal; [Padrao, Patricia; Moreira, Pedro; Moreira, Andre] Univ Porto, Fac Nutr & Food Sci, Porto, Portugal	Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Universidade do Porto	Rufo, JC (corresponding author), Univ Porto, Fac Med, Dept Pathol, Basic & Clin Immunol, Porto, Portugal.; Rufo, JC (corresponding author), S Joao Hosp Ctr, Immunoalergol Dept, Porto, Portugal.; Rufo, JC (corresponding author), Inst Sci & Innovat Mech & Ind Engn, Energy & Built Environm Grp, Porto, Portugal.; Rufo, JC (corresponding author), Univ Porto, Inst Saude Publ, EPIUnit, Rua Taipas 135, Porto, Portugal.	jcrufo@gmail.com	Moreira, Pedro/U-2581-2019; Delgado, Luis/L-8035-2013; Moreira, Pedro/K-5456-2012; Moreira, Pedro/U-3034-2019; Moreira, André/AAH-9683-2020; Martins, Carla/M-9714-2019; Silva, Diana/ABC-4233-2021; Padrão, Patrícia/K-8230-2012; Rufo, João Cavaleiro/K-7994-2013; Madureira, Joana/V-1284-2017	Delgado, Luis/0000-0003-2375-9071; Moreira, Pedro/0000-0002-7035-7799; Moreira, Pedro/0000-0002-7035-7799; Moreira, André/0000-0002-7294-9296; Martins, Carla/0000-0002-4643-2285; Silva, Diana/0000-0002-0656-7206; Padrão, Patrícia/0000-0001-6310-4956; Rufo, João Cavaleiro/0000-0003-1175-242X; Paciencia, Ines/0000-0001-5762-7814; Madureira, Joana/0000-0001-5279-877X	Fundacao para a Ciencia e Tecnologia through the ARIA project [PTDC/DTP-SAP/1522/2012, SFRH/BD/108605/2015, SFRH/BD/112269/2015]; Health, Comfort and Energy in the Built Environment (HEBE) [NORTE-01-0145-FEDER-000010]; Programa Operacional Regional do Norte (NORTE), through Fundo Europeu de Desenvolvimento Regional (FEDER)	Fundacao para a Ciencia e Tecnologia through the ARIA project; Health, Comfort and Energy in the Built Environment (HEBE); Programa Operacional Regional do Norte (NORTE), through Fundo Europeu de Desenvolvimento Regional (FEDER)	Authors gratefully acknowledge the funding by Fundacao para a Ciencia e Tecnologia through the ARIA project (PTDC/DTP-SAP/1522/2012), through the scholarships SFRH/BD/108605/2015, awarded to JCR, and SFRH/BD/112269/2015 awarded to IP, and by the Project NORTE-01-0145-FEDER-000010 - Health, Comfort and Energy in the Built Environment (HEBE), cofinanced by Programa Operacional Regional do Norte (NORTE2020), through Fundo Europeu de Desenvolvimento Regional (FEDER).	Akopian AN, 2016, SEMIN IMMUNOPATHOL, V38, P331, DOI 10.1007/s00281-016-0554-4; Anderson SD, 2005, CURR ALLERGY ASTHM R, V5, P116, DOI 10.1007/s11882-005-0084-y; Andersson M, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0023-x; Baja ES, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-81; Banner KH, 2011, PHARMACOL THERAPEUT, V130, P371, DOI 10.1016/j.pharmthera.2011.03.005; Belda J, 2008, BRIT J SPORT MED, V42, P244, DOI 10.1136/bjsm.2007.036335; Belda J, 2008, BRIT J SPORT MED, V42, P244; Bernard A, 2003, OCCUP ENVIRON MED, V60, P385, DOI 10.1136/oem.60.6.385; Bernard A, 2007, PEDIATRICS, V119, P1095, DOI 10.1542/peds.2006-3333; Bernard A, 2015, ENVIRON RES, V140, P119, DOI 10.1016/j.envres.2015.03.034; Bernard A, 2009, PEDIATRICS, V124, P1110, DOI 10.1542/peds.2009-0032; Bougault V, 2009, EUR RESPIR J, V33, P740, DOI 10.1183/09031936.00117708; Burbank AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1, DOI 10.1016/j.jaci.2017.05.010; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; Colsoul B, 2009, CLIN EXP ALLERGY, V39, P1456, DOI 10.1111/j.1365-2222.2009.03315.x; Courteix D, 1997, EUR J APPL PHYSIOL O, V76, P264, DOI 10.1007/s004210050246; Couto M, 2016, EUR ANN ALLERGY CLIN, V48, P36; Couto M, 2015, REV PORT PNEUMOL, V21, P22, DOI 10.1016/j.rppnen.2014.05.004; Couto M, 2013, EUROPEAN RESP J S57, V42; Doherty M, 1997, BRIT J SPORT MED, V31, P337, DOI 10.1136/bjsm.31.4.337; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Font-Ribera L, 2014, RESP MED, V108, P1056, DOI 10.1016/j.rmed.2014.04.018; Font-Ribera L, 2011, AM J RESP CRIT CARE, V183, P582, DOI 10.1164/rccm.201005-0761OC; Geppetti P, 2014, CURR OPIN ALLERGY CL, V14, P77, DOI 10.1097/ACI.0000000000000040; Giacco SRD, 2015, EUROPEAN CLIN RESP J, V2; Global Initiative for Asthma (GINA), GLOB STAT ASTHM MAN; Goodman M, 2008, J ASTHMA, V45, P639, DOI 10.1080/02770900802165980; Hellard P, 2011, MED SCI SPORT EXER, V43, P1063, DOI 10.1249/MSS.0b013e318204de1c; Jacobs JH, 2007, EUR RESPIR J, V29, P690, DOI 10.1183/09031936.00024706; Jacobs JH, 2012, OCCUP ENVIRON MED, V69, P823, DOI 10.1136/oemed-2011-100621; Lazovic-Popovic B, 2016, REV PORT PNEUMOL, V22, P151, DOI 10.1016/j.rppnen.2015.11.003; Lomax M, 2016, OPEN ACCESS J SPORTS, V7, P55, DOI 10.2147/OAJSM.S88339; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mountjoy M, 2015, J ALLERGY CLIN IMMUN, V136, P588, DOI 10.1016/j.jaci.2015.01.041; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Ramalho R, 2014, J SPORT MED PHYS FIT, V54, P252; Sarmento AD, 2017, CLIN INTERV AGING, V12, P1021, DOI 10.2147/CIA.S120876; Schwartz J, 2005, THORAX, V60, P455, DOI 10.1136/thx.2004.024836; Silva D, 2015, EXPERT REV CLIN IMMU, V11, P993, DOI 10.1586/1744666X.2015.1058158; Stang J, 2016, MED SCI SPORT EXER, V48, P2100, DOI 10.1249/MSS.0000000000001008; Stang J, 2016, MED SCI SPORT EXER, V48, P316, DOI 10.1249/MSS.0000000000000769; Uyan ZS, 2009, PEDIATR PULM, V44, P31, DOI 10.1002/ppul.20947; Voisin C, 2010, EUR RESPIR J, V36, P41, DOI 10.1183/09031936.00118009; Voisin C, 2014, INT J HYG ENVIR HEAL, V217, P38, DOI 10.1016/j.ijheh.2013.03.004; Williams AE, 2012, IMMUNOLOGY: MUCOSAL AND BODY SURFACE DEFENCES, P1; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Yoo YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178361	49	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193848	10.1371/journal.pone.0193848	http://dx.doi.org/10.1371/journal.pone.0193848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529048	gold, Green Published, Green Submitted			2022-12-26	WOS:000427189300029
J	Fu, XJ; Xing, SP; Xiong, HW; Min, H; Zhu, XJ; He, JL; Feng, JX; Mu, HL				Fu, Xiaoji; Xing, Shengping; Xiong, Huiwei; Min, Hua; Zhu, Xuejing; He, Jialin; Feng, Jianxiong; Mu, Honglei			Effects of packaging materials on storage quality of peanut kernels	PLOS ONE			English	Article							ROASTED ALMONDS; AUTOXIDATION; GROWTH	In order to obtain optimum packaging materials for peanut kernels, the effects of four types of packaging materials on peanut storage quality (coat color, acid value, germination rate, relative damage, and prevention of aflatoxin contamination) were examined. The results showed that packaging materials had a major influence on peanut storage quality indexes. The color of the peanut seed coat packaged in the polyesterhaluminum/polyarnide/polyethylene (PET/AL/PA/PE) composite film bag did not change significantly during the storage period. Color deterioration was slower with polyamide/polyethylene (PA/PE) packaging materials than with polyethylene (PE) film bags and was slower in PE bags than in the woven bags. The use of PET/AL/PA/PE and PA/PE bags maintained peanut quality and freshness for more than one year and both package types resulted in better germination rates. There were significant differences between the four types of packaging materials in terms of controlling insect pests. The peanuts packaged in the highly permeable woven bags suffered serious invasion from insect pests, while both PET/AL/PA/PE and PA/PE bags effectively prevented insect infection. Peanuts stored in PET/AL/PA/PE and PA/PE bags were also better at preventing and controlling aflatoxin contamination.	[Fu, Xiaoji; Xing, Shengping; Xiong, Huiwei; Min, Hua; Zhu, Xuejing; He, Jialin; Feng, Jianxiong; Mu, Honglei] Jiangxi Acad Agr Sci, Inst Food Sci & Technol, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS	Feng, JX (corresponding author), Jiangxi Acad Agr Sci, Inst Food Sci & Technol, Nanchang, Jiangxi, Peoples R China.	fjx630320@163.com		feng, jianxiong/0000-0002-3176-3997	National Natural Science Foundation of China [31360299, 31571907]; Special Fund for Agro-scientific Research in the Public Interest [201203037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (31360299, http://www.nsfc.gov.cn), the Special Fund for Agro-scientific Research in the Public Interest (201203037, http://www.moa.gov.cn), the National Natural Science Foundation of China (31571907, http://www.nsfc.gov.cn). We declare that all the funding that supported this specific study is listed.	Alonso-Amelot ME, 2011, J STORED PROD RES, V47, P82, DOI 10.1016/j.jspr.2011.01.001; Baoua IB, 2012, J STORED PROD RES, V51, P81, DOI 10.1016/j.jspr.2012.07.003; Barros G, 2003, J SCI FOOD AGR, V83, P1303, DOI 10.1002/jsfa.1539; Boxall R. A., 2002, Integrated Pest Management Reviews, V7, P105, DOI 10.1023/A:1026397115946; Chen Hong, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P269; Deng YX, 2003, GRAIN STORAGE, V1, P5; Devereau A.D., 2002, CROP POSTHARVEST SCI, V1, P62; Diener U. L., 1977, AFLATOXIN FORMATION; Ding XX, 2015, TOXINS, V7, P4157, DOI 10.3390/toxins7104157; Fu XJ, 2012, J PEANUT SCI, V41, P26; Gao X, 2009, CEREALS OILS PROCESS, V5, P47; Garcia-Pascual P, 2003, BIOSYST ENG, V84, P201, DOI 10.1016/S1537-5110(02)00262-3; General Accountability Office Report, 2005, GBT55302005 GEN ADM, P1; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2005, 104112005 GBT GEN AD, P2; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2008, 215292008 GBT GEN AD, P2; Ledbetter CA, 2006, POSTHARVEST BIOL TEC, V40, P295, DOI 10.1016/j.postharvbio.2006.02.001; Ministry of Health P.R. China, 2006, 5009232006GBT MIN PE; Ryan D, 1998, ANALYST, V123, p31R, DOI 10.1039/a708920a; Severini C, 2000, J AGR FOOD CHEM, V48, P4635, DOI 10.1021/jf0000575; Severini C, 2003, J FOOD PROCESS PRES, V27, P321, DOI 10.1111/j.1745-4549.2003.tb00520.x; SHEIKH A-S, 1985, Pakistan Journal of Scientific and Industrial Research, V28, P46; Williams SB, 2017, J STORED PROD RES, V71, P125, DOI 10.1016/j.jspr.2016.12.008; Williams SB, 2014, J STORED PROD RES, V59, P190, DOI 10.1016/j.jspr.2014.08.003; Zhang CS, 2014, APPL MECH MATER, V668-669, P1550, DOI 10.4028/www.scientific.net/AMM.668-669.1550	24	15	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0190377	10.1371/journal.pone.0190377	http://dx.doi.org/10.1371/journal.pone.0190377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518085	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900001
J	Wronska, AK; Bogus, MI; Wloka, E; Kazek, M; Kaczmarek, A; Zalewska, K				Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Wloka, Emilia; Kazek, Micheline; Kaczmarek, Agate; Zalewska, Katarzyna			Cuticular fatty acids of Galleria mellonella (Lepidoptera) inhibit fungal enzymatic activities of pathogenic Conidiobolus coronatus	PLOS ONE			English	Article							INSECT CUTICLE; ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; ALKALINE PROTEASE; LIPIDS; GERMINATION; PROTEINASE; GROWTH; COMPONENTS	The entomopathogenic fungus Conidiobolus coronatus produces enzymes that may hydrolyze the cuticle of Galleria mellonella. Of these enzymes, elastase activity was the highest: this figure being 24 times higher than NAGase activity 553 times higher than chitinase activity and 1844 times higher than lipase activity. The present work examines the differences in the hydrolysis of cuticles taken from larvae, pupae and adults (thorax and wings), by C. coronatus enzymes. The cuticles of the larvae and adult thorax were the most susceptible to digestion by proteases and lipases. Moreover, the maximum concentration of free N-glucosamine was in the hydrolysis of G. mellonella thorax. These differences in the digestion of the various types of cuticle may result from differences in their composition. GC-MS analysis of the cuticular fatty acids isolated from pupae of G. mellonella confirmed the presence of C 8:0, C 9:0, C 12:0, C 14:0, C 15:0, C 16:1, C 16:0, C 17:0, C 18:1, C 18:0, with C 16:0 and C 18:0 being present in the highest concentrations. Additional fatty acids were found in extracts from G. mellonella imagines: C 10:0, C 13:0, C 20:0 and C 20:1, with a considerable dominance of C 16:0 and C 18:1. In larvae, C 16:0 and C 18:1 predominated. Statistically significant differences in concentration (p <= 0.05) were found between the larvae, pupae and imago for each fatty acid. The qualitative and quantitative differences in the fatty acid composition of G. mellonella cuticle occurring throughout normal development might be responsible for the varied efficiency of fungal enzymes in degrading larval, pupal and adult cuticles.	[Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Wloka, Emilia; Kazek, Micheline; Kaczmarek, Agate] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena; Zalewska, Katarzyna] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Wronska, AK (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	a.wronska@twarda.pan.pl	Wrońska, Anna/HHZ-6185-2022; Kaczmarek, Agata/ABG-3202-2020; Kaczmarek, Agata/ABG-3240-2020; Wrońska, Anna/AAN-8684-2020	Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Kaczmarek, Agata/0000-0001-7319-7973; 	Institute of Parasitology PAS in Warsaw; National Centre for Research and Development [POIG.01.04.00-14-019/12]; Biomibo	Institute of Parasitology PAS in Warsaw; National Centre for Research and Development; Biomibo	The main source of financing were statutory funds from the resources of the Institute of Parasitology PAS in Warsaw. This work was partly supported by National Centre for Research and Development grant POIG.01.04.00-14-019/12 to the Biomibo company. There was no additional external funding received for this study. Biomibo provided support in the form of salary to KZ, the purchase of chemicals, and made laboratory equipment available for AKW, MK, and AK. The specific roles of these authors are articulated in the, author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 2004, INSECT BIOCHEM MOLEC, V34, P1079, DOI 10.1016/j.ibmb.2004.06.013; [Anonymous], 1993, INSECT LIPIDS CHEM B; BAKER JE, 1978, INSECT BIOCHEM, V8, P287, DOI 10.1016/0020-1790(78)90039-2; Bania J, 2006, ARCH INSECT BIOCHEM, V62, P186, DOI 10.1002/arch.20134; Barnes SE, 1997, MYCOL RES, V101, P662, DOI 10.1017/S0953756296003152; Bogus MI, 2017, MED VET ENTOMOL, V31, P23, DOI 10.1111/mve.12202; Bogus MI, 2010, EXP PARASITOL, V125, P400, DOI 10.1016/j.exppara.2010.04.001; BOUCIAS DG, 1988, J INVERTEBR PATHOL, V51, P168, DOI 10.1016/0022-2011(88)90077-8; BUCKNER JS, 1994, INSECT BIOCHEM MOLEC, V24, P977, DOI 10.1016/0965-1748(94)90135-X; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Czygier M., 2000, Acta Parasitologica, V45, P247; Duarte RT, 2016, J ECON ENTOMOL, V109, P594, DOI 10.1093/jee/tow008; ELSAYED GN, 1991, MYCOPATHOLOGIA, V113, P95, DOI 10.1007/BF00442417; Farenhorst M, 2011, J MED ENTOMOL, V48, P305, DOI 10.1603/ME10134; Flores A, 1997, CURR GENET, V31, P30, DOI 10.1007/s002940050173; Freimoser FM, 2003, MICROBIOL-SGM, V149, P1893, DOI 10.1099/mic.0.26252-0; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gibbs AG, 1998, AM ZOOL, V38, P471; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Golebiowski M, 2008, INSECT BIOCHEM MOLEC, V38, P619, DOI 10.1016/j.ibmb.2008.03.005; Golebiowski M, 2007, COMP BIOCHEM PHYS B, V147, P288, DOI 10.1016/j.cbpb.2007.01.016; Golebiowski M, 2013, J INSECT PHYSIOL, V59, P416, DOI 10.1016/j.jinsphys.2013.02.001; Hamilton R., 1995, WAXES; Kang SC, 1998, FEMS MICROBIOL LETT, V165, P267, DOI 10.1111/j.1574-6968.1998.tb13156.x; Kaur G, 2009, J BASIC MICROB, V49, P264, DOI 10.1002/jobm.200800156; KOIDSUMI K, 1957, J INSECT PHYSIOL, V1, P40, DOI 10.1016/0022-1910(57)90022-7; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; MORITZ RFA, 1991, NATURWISSENSCHAFTEN, V78, P179, DOI 10.1007/BF01136209; ORAHA VS, 1990, COMP BIOCHEM PHYS B, V95, P603, DOI 10.1016/0305-0491(90)90028-R; Ortiz-Urquiza Almudena, 2013, Insects, V4, P357, DOI 10.3390/insects4030357; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; PHADATARE SU, 1992, EUR J BIOCHEM, V205, P679, DOI 10.1111/j.1432-1033.1992.tb16829.x; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Singer TL, 1998, AM ZOOL, V38, P394; Singh AK, 2012, APPL BIOCHEM BIOTECH, V166, P486, DOI 10.1007/s12010-011-9444-3; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; STLEGER RJ, 1986, J INVERTEBR PATHOL, V48, P85, DOI 10.1016/0022-2011(86)90146-1; STLEGER RJ, 1991, J INVERTEBR PATHOL, V58, P415, DOI 10.1016/0022-2011(91)90188-V; SUTAR II, 1991, BIOTECHNOL LETT, V13, P119, DOI 10.1007/BF01030462; Tanksale AM, 2000, BIOCHEM BIOPH RES CO, V270, P910, DOI 10.1006/bbrc.2000.2494; THOMPSON SN, 1973, COMP BIOCHEM PHYSIOL, V45, P467, DOI 10.1016/0305-0491(73)90078-3; UZIEL A, 1991, J INVERTEBR PATHOL, V58, P118, DOI 10.1016/0022-2011(91)90169-Q; Vilcinskas A, 1999, ADV PARASIT, V43, P267, DOI 10.1016/S0065-308X(08)60244-4; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Wicher D, 2015, PROG MOL BIOL TRANSL, V130, P37, DOI 10.1016/bs.pmbts.2014.11.002; WIELOCH W, 2007, ACTA BIOCHIM POL, V54, P79	47	15	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192715	10.1371/journal.pone.0192715	http://dx.doi.org/10.1371/journal.pone.0192715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518079	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900011
J	Abiri, N; Pang, JL; Ou, JQ; Shi, B; Wang, XH; Zhang, SC; Sun, YX; Yang, DC				Abiri, Naghmeh; Pang, Jianlei; Ou, Jiquan; Shi, Bo; Wang, Xianghong; Zhang, Sucai; Sun, Yunxia; Yang, Daichang			Assessment of the immunogenicity of residual host cell protein impurities of OsrHSA	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; LARGE-SCALE PRODUCTION; HUMAN SERUM-ALBUMIN; RECOMBINANT PROTEINS; RICE ENDOSPERM; EXPRESSION; CULTURE; RISK; IDENTIFICATION; TRIAL	Human serum albumin (HSA) is the most abundant protein in human plasma and is widely used at high doses for treating various diseases. Recombinant HSA is an alternative approach to plasma-derived HSA, providing increased safety and an unlimited supply. However, the safety of the residual host cell proteins (HCPs) co-purified with Oryza sativa HSA (OsrHSA) remains to be determined. An animal system was used to assess the immunogenicity of OsrHSA and its residual HCPs. Low immunogenicity and immunotoxicity of the residual HCPs at a dose of 25 mu g/kg, equivalent to 25 times the clinical dosage of HSA, were observed. An anti-drug-antibody (ADA) analysis revealed that anti-HSA, anti-OsrHSA or anti-HCP antibodies developed with a low frequency in pHSA and OsrHSA treatments, but the titers were as low as 1.0-2.0. Furthermore, the titer and the incidence of the specific antibodies were not significantly different between the pHSA and OsrHSA groups, indicating that OsrHSA presents similar immunogenicity to that of pHSA. More importantly, no cytokines were stimulated after the administration of OsrHSA and the residual HCPs, suggesting that there was no risk of a cytokine storm. These results demonstrated that the residual HCPs from OsrHSA have low immunogenicity, indicating that the rice endosperm is one of the best hosts for plant molecular pharming.	[Abiri, Naghmeh; Pang, Jianlei; Wang, Xianghong; Yang, Daichang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China; [Ou, Jiquan; Shi, Bo] Healthgen Biotechnol Co Ltd, Wuhan, Hubei, Peoples R China; [Zhang, Sucai; Sun, Yunxia] JOINN Labs Inc, Beijing, Peoples R China	Wuhan University	Yang, DC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China.	ciyang@whu.edu.cn		Yang, Daichang/0000-0002-7488-6356; Abiri, Naghmeh/0000-0002-4686-2314	National major project for New Drug development in China [2009ZX09301-014]; National major project for Genetically modified crops in China [2011ZX08001-006]	National major project for New Drug development in China; National major project for Genetically modified crops in China	This study was granted by National major project for New Drug development in China (Grant No. 2009ZX09301-014) and National major project for Genetically modified crops in China (Grant No. 2011ZX08001-006). Those fundings were from Chinese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2016, BASIC IMMUNOLOGY FUN; Aboul-Ata AAE, 2014, ADV VIRUS RES, V89, P1, DOI 10.1016/B978-0-12-800172-1.00001-X; Alderson P., 2004, COCHRANE DB SYST REV, P18, DOI [10.1002/14651858.CD001208.pub2, DOI 10.1002/14651858.CD001208.PUB2]; ALEXANDER MR, 1982, JAMA-J AM MED ASSOC, V247, P831, DOI 10.1001/jama.247.6.831; An N, 2013, INT J MOL SCI, V14, P3556, DOI 10.3390/ijms14023556; Andrews LB, 2005, BIOTECHNOL PROGR, V21, P946, DOI 10.1021/bp049569k; Bracewell DG, 2015, BIOTECHNOL BIOENG, V112, P1727, DOI 10.1002/bit.25628; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Eckardt KU, 2003, NEPHROL DIAL TRANSPL, V18, P865, DOI 10.1093/ndt/gfg182; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; ERSTAD BL, 1991, ARCH INTERN MED, V151, P901, DOI 10.1001/archinte.151.5.901; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Foster JR, 2001, INT J EXP PATHOL, V82, P171, DOI 10.1046/j.1365-2613.2001.00192.x; Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472; Fu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104426; Haile LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125078; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Herzyk DJ, 2008, IMMUNOTOXICOLOGY STR; Huang N, 2008, IN VITRO CELL DEV-AN, V44, P464, DOI 10.1007/s11626-008-9136-7; Jawa V, 2016, AAPS J, V18, P1439, DOI 10.1208/s12248-016-9948-4; Krawitz DC, 2006, PROTEOMICS, V6, P94, DOI 10.1002/pmic.200500225; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Ning TT, 2008, BIOTECHNOL LETT, V30, P1679, DOI 10.1007/s10529-008-9717-2; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Peakman M., 2009, BASIC CLIN IMMUNOLOG; Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Shin YJ, 2011, PLANT BIOTECHNOL J, V9, P1109, DOI 10.1111/j.1467-7652.2011.00636.x; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tekoah Y, 2015, PLANT BIOTECHNOL J, V13, P1199, DOI 10.1111/pbi.12428; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Valente KN, 2015, BIOTECHNOL BIOENG, V112, P1232, DOI 10.1002/bit.25515; Wang X, 2009, BIOTECHNOL BIOENG, V103, P446, DOI 10.1002/bit.22304; Wycoff KL, 2005, CURR PHARM DESIGN, V11, P2429, DOI 10.2174/1381612054367508; Yang DC, 2003, PLANTA, V216, P597, DOI 10.1007/s00425-002-0919-x; Yang DC, 2001, P NATL ACAD SCI USA, V98, P11438, DOI 10.1073/pnas.201411298	38	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193339	10.1371/journal.pone.0193339	http://dx.doi.org/10.1371/journal.pone.0193339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513721	gold, Green Submitted, Green Published			2022-12-26	WOS:000426896800055
J	Dobbie, F; MacKintosh, AM; Clegg, G; Stirzaker, R; Bauld, L				Dobbie, Fiona; MacKintosh, Anne Marie; Clegg, Gareth; Stirzaker, Rebecca; Bauld, Linda			Attitudes towards bystander cardiopulmonary resuscitation: Results from a cross-sectional general population survey	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; SOCIOECONOMIC-STATUS; SCHOOL-STUDENTS; CPR; SURVIVAL; INTERVENTION; KNOWLEDGE	Survival from out-of-hospital cardiac arrest (OHCA) varies across the developed world. Although not all OHCA are recoverable, the survival rate in Scotland is lower than in comparable countries, with higher average survival rates of 7.9% in England and 9% across Europe. The purpose of this paper is to explore the barriers, facilitators and public attitudes to administering bystander cardiopulmonary resuscitation (CPR) which could inform future policy and initiatives to improve the rate of bystander CPR. Data was collected via a cross-sectional general population survey of 1027 adults in Scotland. 52% of respondents had been trained in CPR. Of those who were not trained, two fifths (42%) expressed a willingness to receive CPR training. Fewer than half (49%) felt confident administering CPR, rising to 82% if they were talked through it by a call handler. Multivariate analyses identified that people in social grade C2DE were less likely than those in social grade ABC1 to be CPR trained and less confident to administer CPR if talked through by a call handler. The older a person was, the less likely they were to be CPR trained, show willingness to be CPR trained or be confident to administer bystander CPR with or without instruction from an emergency call handler. These findings are particularly relevant considering that most OHCA happen in the homes of older people. In a developed country such as Scotland with widely available CPR training, only half of the adult population reported feeling confident about administering bystander CPR. Further efforts tailored specifically for people who are older, unemployed and have a lower social grade are required to increase knowledge, confidence and uptake of training in bystander CPR.	[Dobbie, Fiona; MacKintosh, Anne Marie; Bauld, Linda] Univ Stirling, Fac Hlth Sci & Sport, Inst Social Mkt, Stirling, Scotland; [Clegg, Gareth] Univ Edinburgh, Resuscitat Res Grp, Edinburgh, Midlothian, Scotland; [Stirzaker, Rebecca] Heriot Watt Univ, Sch Social Sci, Edinburgh, Midlothian, Scotland	University of Stirling; University of Edinburgh; Heriot Watt University	Dobbie, F (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Inst Social Mkt, Stirling, Scotland.	fiona.dobbie@stir.ac.uk	Stirzaker, Rebecca/AAA-9713-2021; Dobbie, Fiona/L-5858-2016	Clegg, Gareth/0000-0002-4314-611X; Stirzaker, Rebecca/0000-0002-0962-3664; Dobbie, Fiona/0000-0002-8294-8203	Resuscitation Research Group, University of Edinburgh	Resuscitation Research Group, University of Edinburgh	The study was funded by the Resuscitation Research Group, University of Edinburgh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AMR, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-24; Axelsson A, 2000, RESUSCITATION, V47, P71, DOI 10.1016/S0300-9572(00)00209-4; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; Donohoe RT, 2006, RESUSCITATION, V71, P70, DOI 10.1016/j.resuscitation.2006.03.003; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Ghose R, 2010, RESUSCITATION, V81, P1488, DOI 10.1016/j.resuscitation.2010.06.012; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Hawkes C, 2017, RESUSCITATION, V133; Johnston TC, 2003, RESUSCITATION, V56, P67, DOI 10.1016/S0300-9572(02)00277-0; Kanstad BK, 2011, RESUSCITATION, V82, P1053, DOI 10.1016/j.resuscitation.2011.03.033; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; Lynch B, 2010, RESUSCITATION, V81, P568, DOI 10.1016/j.resuscitation.2009.12.022; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Perkins GD, 2012, HEART, V98, P529, DOI 10.1136/heartjnl-2011-300802; Public Health Seattle & King Country Division of Emergency Medical Services, 2013, 2013 ANN REP KING CO; Riegel B, 2006, RESUSCITATION, V70, P98, DOI 10.1016/j.resuscitation.2005.10.029; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stromsoe A, 2015, EUR HEART J, V36, P863, DOI 10.1093/eurheartj/ehu240; Swor R, 2006, ACAD EMERG MED, V13, P596, DOI 10.1197/j.aem.2005.12.021; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012	21	34	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193391	10.1371/journal.pone.0193391	http://dx.doi.org/10.1371/journal.pone.0193391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513722	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800056
J	Vera, DRB; Smith, CC; Bixby, LM; Glatt, DM; Dunn, SS; Saito, R; Kim, WY; Serody, JS; Vincent, BG; Parrott, MC				Vera, Denis R. Beckford; Smith, Christof C.; Bixby, Lisa M.; Glatt, Dylan M.; Dunn, Stuart S.; Saito, Ryoichi; Kim, William Y.; Serody, Jonathan S.; Vincent, Benjamin G.; Parrott, Matthew C.			Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors	PLOS ONE			English	Article							GROWTH-FACTOR DISTINCT; MONOCLONAL-ANTIBODIES; CELL; NIVOLUMAB; ANTIGEN; CANCER; IDENTIFICATION; RESPONSES; SAFETY; ZR-89	The ability to non-invasively monitor tumor-infiltrating T cells in vivo could provide a powerful tool to visualize and quantify tumor immune infiltrates. For non-invasive evaluations in vivo, an anti-CD3 mAb was modified with desferrioxamine (DFO) and radiolabeled with zirconium 89 (Zr-89 or Zr-89). Radiolabeled Zr-89-DFO-anti-CD3 was tested for T cell detection using positron emission tomography (PET) in both healthy mice and mice bearing syngeneic bladder cancer BBN975. In vivo PET/CT and ex vivo biodistribution demonstrated preferential accumulation and visualization of tracer in the spleen, thymus, lymph nodes, and bone marrow. In tumor bearing mice, Zr-89-DFO-anti-CD3 demonstrated an 11.5-fold increase in tumor-to blood signal compared to isotype control. Immunological profiling demonstrated no significant change to total T cell count, but observed CD4(+) T cell depletion and CD8(+) T cell expansion to the central and effector memory. This was very encouraging since a high CD8(+) to CD4(+) T cell ratio has already been associated with better patient prognosis. Ultimately, this anti-CD3 mAb allowed for in vivo imaging of homeostatic T cell distribution, and more specifically tumor-infiltrating T cells. Future applications of this radiolabeled mAb against CD3 could include prediction and monitoring of patient response to immunotherapy.	[Vera, Denis R. Beckford; Dunn, Stuart S.; Parrott, Matthew C.] Univ N Carolina, Dept Radiol, Marsico Hall, Chapel Hill, NC 27599 USA; [Vera, Denis R. Beckford; Dunn, Stuart S.; Parrott, Matthew C.] Univ N Carolina, Biomed Res Imaging Ctr, Marsico Hall, Chapel Hill, NC 27599 USA; [Smith, Christof C.; Serody, Jonathan S.] UNC Sch Med, Dept Microbiol & Immunol, Marsico Hall, Chapel Hill, NC USA; [Bixby, Lisa M.; Saito, Ryoichi; Kim, William Y.; Serody, Jonathan S.; Vincent, Benjamin G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Marsico Hall, Chapel Hill, NC 27599 USA; [Glatt, Dylan M.] UNC Eshelman Sch Pharm, Dept Pharmaceut Sci, Div Mol Pharmaceut, Marsico Hall, Chapel Hill, NC USA; [Kim, William Y.] Univ N Carolina, Sch Med, Dept Genet, Genet Med Bldg, Chapel Hill, NC USA; [Kim, William Y.] Univ N Carolina, Sch Med, Dept Urol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Parrott, MC (corresponding author), Univ N Carolina, Dept Radiol, Marsico Hall, Chapel Hill, NC 27599 USA.; Parrott, MC (corresponding author), Univ N Carolina, Biomed Res Imaging Ctr, Marsico Hall, Chapel Hill, NC 27599 USA.; Vincent, BG (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Marsico Hall, Chapel Hill, NC 27599 USA.	benjamin_vincent@med.unc.edu; parrotmc@email.unc.edu	, Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022; , BRIC Small Animal Imaging Facility/AEV-1023-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Beckford Vera, Denis/0000-0003-3949-1495; Smith, Christof/0000-0001-6517-0439	National Center for Advancing Translational Sciences, National Institutes of Health [1KL2TR001109, 1UL1TR001111]; UNC University Cancer Research Fund; UNC Oncology Clinical Translational Research Training Program [5K12CA120780]; NATIONAL CANCER INSTITUTE [P50CA058223, P30CA016086] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UNC University Cancer Research Fund; UNC Oncology Clinical Translational Research Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (https://ncats.nih.gov/), through Grant 1KL2TR001109 and 1UL1TR001111, as well as the UNC University Cancer Research Fund (https://unclineberger.org/ucrf) and UNC Oncology Clinical Translational Research Training Program (https://www.med.unc.edu/hemonc/fellowship-program/research-resources/funding-and-education-opportunities/clinical-translational-research) (5K12CA120780).	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brien SMO, 2012, NEW ENGL J MED, P1467; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15, DOI [DOI 10.1007/978-3-0346-0136-8_2, 10.1007/978-3-0346-0136-8_2]; BRYAN GT, 1977, CANCER RES, V37, P2813; Chang AJ, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00016; CHIN Y, 1992, ANTICANCER RES, V12, P1463; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; Countouriotis A, 2002, STEM CELLS, V20, P215, DOI 10.1634/stemcells.20-3-215; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; Fischer G, 2013, MOLECULES, V18, P6469, DOI 10.3390/molecules18066469; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Howard M, 2013, J IMMUNOL, V190, P864; KAMINSKI NE, 1986, J IMMUNOPHARMACOL, V8, P15; Kasbollah A, 2013, J NUCL MED TECHNOL, V41, P35, DOI 10.2967/jnmt.112.111377; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Larimer BM, 2016, J NUCL MED, V57, P1607, DOI 10.2967/jnumed.116.173930; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006; Loubaki L, 2013, J IMMUNOL METHODS, V393, P38, DOI 10.1016/j.jim.2013.04.004; McCracken MN, 2016, ADV IMMUNOL, V131, P187, DOI 10.1016/bs.ai.2016.02.004; Mendler CT, 2015, J NUCL MED, V56, P1112, DOI 10.2967/jnumed.114.149690; Nagao M, 1977, MUTAGENICITY N BUTYL, P399; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Price EW, 2014, CHEM SOC REV, V43, P260, DOI 10.1039/c3cs60304k; Rashidian M, 2015, PNAS, V112, P1; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Tavare R, 2015, J NUCL MED, V56, P1258, DOI 10.2967/jnumed.114.153338; Tavare R, 2014, PROTEIN ENG DES SEL, V27, P317, DOI 10.1093/protein/gzu030; Tavare R, 2014, P NATL ACAD SCI USA, V111, P1108, DOI 10.1073/pnas.1316922111; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13; Weinstock M, 2015, THER ADV UROL, V7, P365, DOI 10.1177/1756287215597647; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zeglis BM, 2015, JOVE-J VIS EXP, DOI 10.3791/52521	39	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193832	10.1371/journal.pone.0193832	http://dx.doi.org/10.1371/journal.pone.0193832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513764	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800080
J	Dong, L; Cornaglia, M; Krishnamani, G; Zhang, JW; Mouchiroud, L; Lehnert, T; Auwerx, J; Gijs, MAM				Dong, Li; Cornaglia, Matteo; Krishnamani, Gopalan; Zhang, Jingwei; Mouchiroud, Laurent; Lehnert, Thomas; Auwerx, Johan; Gijs, Martin A. M.			Reversible and long-term immobilization in a hydrogel-microbead matrix for high-resolution imaging of Caenorhabditis elegans and other small organisms	PLOS ONE			English	Article							C-ELEGANS; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYNAMICS; BIOLOGICAL-RESEARCH; PLATFORM; NEURONS; STRESS; TRANSPORT; GENETICS; FISSION	The nematode Caenorhabditis elegans is an important model organism for biomedical research and genetic studies relevant to human biology and disease. Such studies are often based on high-resolution imaging of dynamic biological processes in the worm body tissues, requiring well-immobilized and physiologically active animals in order to avoid movement-related artifacts and to obtain meaningful biological information. However, existing immobilization methods employ the application of either anesthetics or servere physical constraints, by using glue or specific microfluidic on-chip mechanical structures, which in some cases may strongly affect physiological processes of the animals. Here, we immobilize C. elegans nematodes by taking advantage of a biocompatible and temperature-responsive hydrogel-microbead matrix. Our gel-based immobilization technique does not require a specific chip design and enables fast and reversible immobilization, thereby allowing successive imaging of the same single worm or of small worm populations at all development stages for several days. We successfully demonstrated the applicability of this method in challenging worm imaging contexts, in particular by applying it for high-resolution confocal imaging of the mitochondrial morphology in worm body wall muscle cells and for the long-term quantification of number and size of specific protein aggregates in different C. elegans neurodegenerative disease models. Our approach was also suitable for immobilizing other small organisms, such as the larvae of the fruit fly Drosophila melanogaster and the unicellular parasite Trypanosoma brucei. We anticipate that this versatile technique will significantly simplify biological assay-based longitudinal studies and long-term observation of small model organisms.	[Dong, Li; Cornaglia, Matteo; Krishnamani, Gopalan; Zhang, Jingwei; Lehnert, Thomas; Gijs, Martin A. M.] Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland; [Krishnamani, Gopalan; Mouchiroud, Laurent; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat Syst Physiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gijs, MAM (corresponding author), Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland.	martin.gijs@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Dong, Li/0000-0002-3034-888X	 [ERC-2012-AdG-320404]		This work is supported by ERC-2012-AdG-320404 (http://cordis.europa.eu/project/rcn/106969_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun Z. F., 2017, INTRO C ELEGANS ANAT; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Aubry G, 2015, LAB CHIP, V15, P1424, DOI 10.1039/c4lc01384k; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Bakhtina NA, 2014, RSC ADV, V4, P4691, DOI 10.1039/c3ra43758b; Basak R, 2013, LANGMUIR, V29, P4350, DOI 10.1021/la304836e; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Chuang H-S, 2017, SENSORS ACTUATORS B; Cornaglia M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0083-6; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dong L, 2016, LAB CHIP, V16, P574, DOI 10.1039/c5lc01328c; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Gilleland CL, 2010, NAT PROTOC, V5, P1888, DOI 10.1038/nprot.2010.143; Gokce SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113917; Gonzales DL, 2017, NATURE NANOTECHNOLOG; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gupta BP, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7070123; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Hwang H, 2014, LAB CHIP, V14, P3498, DOI 10.1039/c4lc00697f; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Krajniak J, 2013, LAB CHIP, V13, P2963, DOI 10.1039/c3lc50300c; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lee H, 2014, LAB CHIP, V14, P4513, DOI 10.1039/c4lc00789a; LEWIS JA, 1980, GENETICS, V95, P905; Li J, 2013, EXP NEUROL, V250, P94, DOI 10.1016/j.expneurol.2013.09.024; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Sebastian D., 2017, TRENDS MOL MED; Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sivagnanam V, 2013, CHEM REV, V113, P3214, DOI 10.1021/cr200432q; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Wang JJ, 2013, SENSOR ACTUAT B-CHEM, V178, P343, DOI 10.1016/j.snb.2012.12.102; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155	50	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193989	10.1371/journal.pone.0193989	http://dx.doi.org/10.1371/journal.pone.0193989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509812	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200048
J	Tan, BY; MacLellan, B; Mason, E; Bizheva, K				Tan, Bingyao; MacLellan, Benjamin; Mason, Erik; Bizheva, Kostadinka			Structural, functional and blood perfusion changes in the rat retina associated with elevated intraocular pressure, measured simultaneously with a combined OCT plus ERG system	PLOS ONE			English	Article							OPTIC-NERVE HEAD; B-WAVE; A-WAVE; POSTISCHEMIC REPERFUSION; OSCILLATORY POTENTIALS; COHERENCE TOMOGRAPHY; FLOW; DOPAMINE; DEFORMATION; AMPLITUDES	Acute elevation of intraocular pressure (IOP) to ischemic and non-ischemic levels can cause temporary or permanent changes in the retinal morphology, function and blood flow/blood perfusion. Previously, such changes in the retina were assessed separately with different methods in clinical studies and animal models. In this study, we used a combined OCT+ERG system in combination with Doppler OCT and OCT angiography (OCTA) imaging protocols, in order to evaluate simultaneously and correlate changes in the retinal morphology, the retinal functional response to visual stimulation, and the retinal blood flow/blood perfusion, associated with IOP elevation to ischemic and non-ischemic levels in rats. Results from this study suggest that the inner retina responds faster to IOP elevation to levels greater than 30 mmHg with significant reduction of the total retinal blood flow (TRBF), decrease of the capillaries' perfusion and reduction of the ON bipolar cells contribution to the ERG traces. Furthermore, this study showed that ischemic levels of IOP elevation cause an additional significant decrease in the ERG photoreceptor response in the posterior retina. Thirty minutes after IOP normalization, retinal morphology, blood flow and blood perfusion recovered to baseline values, while retinal function did not recover completely.	[Tan, Bingyao; MacLellan, Benjamin; Mason, Erik; Bizheva, Kostadinka] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada; [Bizheva, Kostadinka] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Bizheva, Kostadinka] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada	University of Waterloo; University of Waterloo; University of Waterloo	Bizheva, K (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada.; Bizheva, K (corresponding author), Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada.; Bizheva, K (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada.	kbizheva@uwaterloo.ca			NSERC [312037]; Natural Sciences and Engineering Research Council of Canada [NSERC-DG-312037]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the NSERC Discovery, Grant 312037 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Nancy Gibson and Jean Flanagan for assistance with the animal related procedures, and Harmen Vander Heide for assistance with the design of the custom stereotactic animal holder. This research project was funded by the Natural Sciences and Engineering Research Council of Canada: NSERC-DG-312037.	ASI H, 1992, DOC OPHTHALMOL, V79, P125, DOI 10.1007/BF00156572; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Bui B V., 2013, J OPHTHALMOL, V2013; Choe TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113011; Choh V, 2017, DOC OPHTHALMOL; Choh V, 2016, INVEST OPHTH VIS SCI, V57, P2140, DOI 10.1167/iovs.15-18770; Creel DJ, 2016, WEBVISION ORG RETINA, P1; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fox DA, 2008, ENVIRON HEALTH PERSP, V116, P618, DOI 10.1289/ehp.11268; Guo L, 2005, BRIT J OPHTHALMOL, V89, P1210, DOI 10.1136/bjo.2004.058941; Gurdita A, 2017, DOC OPHTHALMOL, V134, P205, DOI 10.1007/s10633-017-9586-x; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hariri S, 2009, OPT EXPRESS, V17, P24304, DOI 10.1364/OE.17.024304; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; He Z, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.55; He Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031104; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Ishihara M, 2000, JPN J PHYSIOL, V50, P125, DOI 10.2170/jjphysiol.50.125; JAGADEESH JM, 1980, INVEST OPHTH VIS SCI, V19, P1449; Joos KM, 2010, INVEST OPHTH VIS SCI, V51, P6431, DOI 10.1167/iovs.10-5212; Kong YX, 2009, INVEST OPHTH VIS SCI, V50, P5732, DOI 10.1167/iovs.09-3814; Kornfield TE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0005-15.2015; Lavery WJ, 2012, INVEST OPHTH VIS SCI, V53, P560, DOI 10.1167/iovs.11-8429; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Marschall S, 2013, P SOC PHOTO-OPT INS, VXXVII; MATSUI Y, 1994, BRIT J OPHTHALMOL, V78, P191, DOI 10.1136/bjo.78.3.191; Matsumoto CS, 2011, CLIN OPHTHALMOL; Matsuura K, 1998, JPN J PHYSIOL, V48, P9, DOI 10.2170/jjphysiol.48.9; Moayed AA, 2011, OPT LETT, V36, P4575, DOI 10.1364/OL.36.004575; Moayed AA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475489; Nagahara M, 2000, BRIT J OPHTHALMOL, V84, P31, DOI 10.1136/bjo.84.1.31; OGASAWARA H, 1992, BRIT J OPHTHALMOL, V76, P275, DOI 10.1136/bjo.76.5.275; OLIVIER P, 1986, BRAIN RES BULL, V16, P751, DOI 10.1016/0361-9230(86)90148-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PERLMAN I, 1983, BRIT J OPHTHALMOL, V67, P443, DOI 10.1136/bjo.67.7.443; Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421; Pinhas A, 2014, INVEST OPHTH VIS SCI, V55, P8056, DOI 10.1167/iovs.14-15136; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; REGILLO CD, 1993, OPHTHALMOLOGY, V100, P1044; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; RIVA CE, 1992, EXP EYE RES, V55, P499, DOI 10.1016/0014-4835(92)90123-A; Ro F., 1998, MED IMAGE COMPUT COM, V1496, P130; Rothenberg SJ, 2002, INVEST OPHTH VIS SCI, V43, P2036; SCHNEIDER T, 1991, EXP EYE RES, V52, P425, DOI 10.1016/0014-4835(91)90038-G; SKRANDIES W, 1988, EXP BRAIN RES, V71, P231; SPEROS P, 1981, SURV OPHTHALMOL, V25, P237, DOI 10.1016/0039-6257(81)90093-X; Srinivasan VJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076025; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; Sugawara R, 2006, BRIT J OPHTHALMOL, V90, P1363, DOI 10.1136/bjo.2006.097485; Tan BY, 2017, INVEST OPHTH VIS SCI, V58, P1673, DOI 10.1167/iovs.17-21543; Tayyari F, 2014, INVEST OPHTH VIS SCI, V55, P7716, DOI 10.1167/iovs.14-14430; Tsai TI, 2014, INVEST OPHTH VIS SCI, V55, P1067, DOI 10.1167/iovs.13-13003; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P3509, DOI 10.1167/iovs.14-14020; Wang Q, 2011, INVEST OPHTH VIS SCI, V52, P6292, DOI 10.1167/iovs.10-6424; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wong VHY, 2013, INVEST OPHTH VIS SCI, V54, P2133, DOI 10.1167/iovs.13-11595; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; Yang Q, 2011, VET OPHTHALMOL, V14, P353, DOI 10.1111/j.1463-5224.2011.00881.x; Yasuda S, 2011, INVEST OPHTH VIS SCI, V52, P5737, DOI 10.1167/iovs.10-6923; Zhao D, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12507; Zhi Z, 2015, MICROVASC RES, V101, P86, DOI 10.1016/j.mvr.2015.07.001; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	65	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193592	10.1371/journal.pone.0193592	http://dx.doi.org/10.1371/journal.pone.0193592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509807	Green Submitted, gold, Green Published			2022-12-26	WOS:000426813200018
J	White, RL; Eberstein, K; Scott, DM				White, Rachel L.; Eberstein, Katie; Scott, Dawn M.			Birds in the playground: Evaluating the effectiveness of an urban environmental education project in enhancing school children's awareness, knowledge and attitudes towards local wildlife	PLOS ONE			English	Article							CONSERVATION; BENEFITS; ANIMALS; IDENTIFICATION; BIODIVERSITY; EXPERIENCES; CHILDHOOD; PROGRAM; VISITS; EXTINCTION	Children nowadays, particularly in urban areas, are more disconnected from nature than ever before, leading to a large-scale "extinction of experience" with the natural world. Yet there are many potential benefits from children interacting with nature first-hand, including via outdoor learning opportunities. Urban environmental education programmes typically aim to increase awareness and knowledge of local biodiversity and to promote positive attitudes and behaviour towards the environment. However, limited research has been conducted evaluating to what extent these interventions achieve their goals. Here, we explore and assess the influence of a six-week bird-feeding and monitoring project conducted within school grounds ("Bird Buddies") on individual awareness, knowledge and attitudes towards birds by primary school children. This initiative was conducted across eight (sub-) urban primary schools within Brighton and Hove (UK), with 220 participating children (aged 7 to 10). Via pre-and post-project questionnaires, we found evidence for enhanced awareness of local biodiversity, alongside significant gains in both bird identification knowledge and attitudes, which were greatest for children with little prior exposure to nature. Many children expressed a keenness to continue improving the environmental value of their school grounds and to apply elements of the project at home. Student project evaluation scores were consistently positive. Mirroring this, participating teachers endorsed the project as a positive learning experience for their students. One year after the project, several schools were continuing to feed and watch birds. Collectively, the findings from this study highlight the multiple benefits that can be derived from engagement with a relatively short outdoor environmental activity. We therefore believe that such interventions, if repeated locally/ longer term, could enhance children's experience with nature in urban settings with combined positive environmental impact.	[White, Rachel L.; Scott, Dawn M.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Eberstein, Katie] Sussex Wildlife Trust, Brighton & Hove Environm Educ, Brighton, E Sussex, England	University of Brighton	White, RL (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	r.white2@brighton.ac.uk		Scott, Dawn/0000-0002-9570-2739; White, Rachel/0000-0003-0694-7847	Sussex Ornithological Society's (SOS) Avifauna Award; School of Pharmacy and Biomolecular Sciences at the University of Brighton	Sussex Ornithological Society's (SOS) Avifauna Award; School of Pharmacy and Biomolecular Sciences at the University of Brighton	Funding for the project came from the Sussex Ornithological Society's (SOS) Avifauna Award (https://www.sos.org.uk/)[RLW, KE]. Additional financial support was provided by the School of Pharmacy and Biomolecular Sciences at the University of Brighton [RLW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1995, CHILDRENS ENV, V12, P256; [Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Ballouard JM, 2015, INT J SCI EDUC, V37, P469, DOI 10.1080/09500693.2014.993000; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Balmford A, 2002, SCI MAG, V295, P5; Beck AM, 2001, ANTHROZOOS, V14, P19, DOI 10.2752/089279301786999599; Bentsen P, 2017, CHILDREN LEARNING OU; BHCC (Brighton & Hove City Council), 2014, BRIGHT HOV CIT SNAPS; Binngiesser J, 2013, ANTHROZOOS, V26, P325, DOI 10.2752/175303713X13697429463475; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjerke T, 2001, ANTHROZOOS, V14, P86, DOI 10.2752/089279301786999535; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Blair D, 2009, J ENVIRON EDUC, V40, P15, DOI 10.3200/JOEE.40.2.15-38; Blumstein DT, 2007, PLOS BIOL, V5, P973, DOI 10.1371/journal.pbio.0050120; Bogner FX, 1999, INT J SCI EDUC, V21, P1169, DOI 10.1080/095006999290138; Bradley Jennifer CAMPBELL, 1999, J ENVIRON EDUC, V30, P17, DOI [DOI 10.1080/00958969909601873, 10.1080/00958969909601873]; Braun M, 2010, INT J ENV SCI ED, V5, P151; Brewer C, 2002, CONSERV BIOL, V16, P577, DOI 10.1046/j.1523-1739.2002.01633.x; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Brynjegard S., 2001, SCH GARDENS RAISING; Cardak O, 2009, SCI RES ESSAYS, V4, P1518; Chawla L, 2014, HEALTH PLACE, V28, P1, DOI 10.1016/j.healthplace.2014.03.001; Cox DTC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158717; Cox DTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141505; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Department for Education, 2015, NAT CURR ENGL SCI PR; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Eagles P. F. J., 1999, J ENVIRON EDUC, V30, P33, DOI DOI 10.1080/00958969909601882; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Evans S, 2006, SCH SCI REV, V88, P93; Ewert A, 2005, LEISURE SCI, V27, P225, DOI 10.1080/01490400590930853; Fisman L., 2005, J ENVIRON EDUC, V36, P39, DOI [10.3200/JOEE.36.3.39-50, DOI 10.3200/JOEE.36.3.39-50]; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Genovart M, 2013, BIOL CONSERV, V159, P484, DOI 10.1016/j.biocon.2012.10.028; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hinds J, 2008, J ENVIRON PSYCHOL, V28, P109, DOI 10.1016/j.jenvp.2007.11.001; Huxham M, 2006, J BIOL EDUC, V41, P9, DOI 10.1080/00219266.2006.9656050; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kaiser FG, 1999, J ENVIRON PSYCHOL, V19, P1, DOI 10.1006/jevp.1998.0107; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kidd AH, 1996, APPL ANIM BEHAV SCI, V47, P119, DOI 10.1016/0168-1591(95)01015-7; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kubiatko M, 2017, EURASIA J MATH SCI T, V13, P1161, DOI 10.12973/eurasia.2017.00665a; Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Lindemann-Matthies P, 2006, INT J SCI EDUC, V28, P895, DOI 10.1080/10670560500438396; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neuvonen Mario, 2007, Urban Forestry & Urban Greening, V6, P235, DOI 10.1016/j.ufug.2007.05.003; Oerke B, 2013, INT J SCI EDUC, V35, P713, DOI 10.1080/09500693.2011.566897; Patrick P, 2011, J SCI EDUC TECHNOL, V20, P630, DOI 10.1007/s10956-011-9290-7; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Prokop P., 2008, EURASIA J MATH SCI T, V4, P87, DOI [https://doi.org/10.12973/ejmste/75309, DOI 10.12973/EJMSTE/75309, 10.12973/ejmste/75309]; Prokop P., 2009, EURASIA J MATH SCI T, V5, P127, DOI [DOI 10.12973/ejmste/75264, 10.12973/ejmste/, DOI 10.12973/EJMSTE]; Prokop P, 2008, ANTHROZOOS, V21, P221, DOI 10.2752/175303708X332035; Prokop P, 2008, INT J SCI EDUC, V30, P431, DOI 10.1080/09500690701206686; Prokop P, 2007, RES SCI EDUC, V37, P393, DOI 10.1007/s11165-006-9031-8; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Pyle R. M., 1993, THUNDER TREE LESSONS; PYLE RM, 1977, HORTICULTURE, V55, P65; R Development Core Team, 2016, R LANG ENV STAT COMP; Randler C, 2002, J BIOL EDUC, V36, P181, DOI 10.1080/00219266.2002.9655830; Randler C., 2008, EURASIA J MATH SCI T, V4, P223, DOI [DOI 10.12973/ejmste/75344, 10.12973/ejmste/75344, DOI 10.12973/EJMSTE/75344]; Randler C., 2005, J ENVIRON EDUC, V37, P43, DOI [10.3200/JOEE.37.1.43-52, DOI 10.3200/JOEE.37.1.43-52]; Randler C, 2006, J BIOL EDUC, V40, P161, DOI 10.1080/00219266.2006.9656038; Randler C, 2010, J BALT SCI EDUC, V9, P135; Randler C, 2009, J SCI EDUC TECHNOL, V18, P138, DOI 10.1007/s10956-008-9139-x; Randler C, 2008, J BALT SCI EDUC, V7, P48; Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004; Reynolds SJ, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00024; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rickinson M., 2004, REV RES OUTDOOR LEAR; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shwartz A, 2014, BIOL CONSERV, V171, P82, DOI 10.1016/j.biocon.2014.01.009; Shwartz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038642; Skelly S. M., 1998, HORTTECHNOLOGY, V8, P579; Soga M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060529; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Sousa E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154440; Stagg BC, 2013, J BIOL EDUC, V47, P104, DOI 10.1080/00219266.2013.764341; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Thomas M., 2005, BRIGHTON HOVE BIODIV; Thompson CW, 2008, ENVIRON BEHAV, V40, P111, DOI 10.1177/0013916507300119; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; UNESCO, 1978, INT C ENV ED TBIL US; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Yore LB, 1997, AM BIOL TEACH, V59, P558; Zarybnicka M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001132; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011; [No title captured]	102	26	26	8	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193993	10.1371/journal.pone.0193993	http://dx.doi.org/10.1371/journal.pone.0193993			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509809	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000426813200049
J	Serino-Silva, C; Morais-Zani, K; Toyama, MH; Toyama, DD; Gaeta, HH; Rodrigues, CFB; Aguiar, WD; Tashima, AK; Grego, KF; Tanaka-Azevedo, AM				Serino-Silva, Caroline; Morais-Zani, Karen; Toyama, Marcos Hikari; Toyama, Daniela de Oliveira; Gaeta, Henrique Hesse; Bittencourt Rodrigues, Caroline Fabri; Aguiar, Weslei da Silva; Tashima, Alexandre Keiji; Grego, Kathleen Fernandes; Tanaka-Azevedo, Anita Mitico			Purification and characterization of the first gamma-phospholipase inhibitor (gamma PLI) from Bothrops jararaca snake serum	PLOS ONE			English	Article							A(2) MYOTOXIN INHIBITOR; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-CLONING; CROTOXIN-B; VENOM; PLASMA; IDENTIFICATION; VIPERIDAE; PROTEINS	Phospholipases A(2) (PLA(2)) are enzymes acting on the cell membrane phospholipids resulting in fatty acids and lysophospholipids and deconstructing the cell membrane. This protein is commonly found in snake venoms, causing tissue inflammation in the affected area. Evidence indicates that snakes have natural resistance to their own venom due to protective properties in plasma, that inhibit the action of proteins present in their venom. Given that, this study aimed to purify and characterize a gamma PLI from Bothrops jararaca serum, named gamma BjPLI. PLA(2) inhibitor was isolated using two chromatographic steps: an ion exchange column (DEAE), followed by an affinity column (crotoxin coupled to a CNBr-activated Sepharose resin). The purity and biochemical characterization of the isolated protein were analyzed by RP-HPLC, SEC, SDS-PAGE, circular dichroism and mass spectrometry. The ability to inhibit PLA(2) was determined by enzymatic activity, neutralization of paw edema and myonecrosis. The protein purity was confirmed by RP-HPLC and SEC, whilst an apparent molecular mass of 25 kDa and 20 kDa was obtained by SDS-PAGE, under reducing and non-reducing conditions, respectively. According to mass spectrometry analysis, this protein showed 72% and 68% of coverage when aligned to amino acid sequences of two proteins already described as PLIs. Thus, the inhibitory activity of enzymatic, edema and myonecrotic activities by gamma BjPLI suggests a role of this inhibitor for protection of these snakes against self-envenomation.	[Serino-Silva, Caroline; Bittencourt Rodrigues, Caroline Fabri; Aguiar, Weslei da Silva] Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, SP, Brazil; [Serino-Silva, Caroline; Morais-Zani, Karen; Bittencourt Rodrigues, Caroline Fabri; Grego, Kathleen Fernandes; Tanaka-Azevedo, Anita Mitico] Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil; [Toyama, Marcos Hikari; Toyama, Daniela de Oliveira; Gaeta, Henrique Hesse] Univ Estadual Paulista, Inst Biociencias Litoral Paulista, Sao Vicente, SP, Brazil; [Tashima, Alexandre Keiji] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Tanaka-Azevedo, AM (corresponding author), Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil.	amt.azevedo@uol.com.br	Grego, Kathleen/GOV-3529-2022; Grego, Kathleen F/A-6394-2014; Morais-Zani, Karen/B-3821-2014; Tashima, Alexandre Keiji/B-8228-2015; Toyama, Marcos H/P-4673-2017; Azevedo, Anita M Tanaka/B-3429-2014	Grego, Kathleen/0000-0003-4769-5818; Grego, Kathleen F/0000-0003-4769-5818; Morais-Zani, Karen/0000-0001-9900-8384; Tashima, Alexandre Keiji/0000-0002-1332-8895; Toyama, Marcos H/0000-0001-6836-3084; Azevedo, Anita M Tanaka/0000-0002-4694-4475	Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/19321-9, 2016/03839-0, 2013/05357-4, 2014/11108-0, 2017/01890-0, 2017/16908-2, 2013/12826-0]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES	Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES	This work was supported by Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2012/19321-9 and 2016/03839-0 to AKT, 2013/05357-4, 2014/11108-0, 2017/01890-0 to AMTA, 2017/16908-2 to KMZ and 2013/12826-0 to CSS) and Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar W da S, ESTUDO CARACTERIZAC; Brazilian Ministry of Health, AC AN PEC NOT 2016; Calvete JJ, 2007, J MASS SPECTROM, V42, P1405, DOI 10.1002/jms.1242; Calvete JJ, 2010, J PROTEOME RES, V9, P528, DOI 10.1021/pr9008749; Campos PC, 2016, J VENOM ANIM TOXINS, V22, DOI 10.1186/s40409-016-0092-5; Cardoso JLC, 2009, ANIMAIS PECONHENTOS, V2nd; Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662; Gimenes SNC, 2014, TOXICON, V81, P58, DOI 10.1016/j.toxicon.2014.01.012; CURY Y, 1994, TOXICON, V32, P1425, DOI 10.1016/0041-0101(94)90414-6; DEWIT CA, 1987, TOXICON, V25, P315, DOI 10.1016/0041-0101(87)90260-1; Estevo-Costa MI, 2008, TOXICON, V52, P122, DOI 10.1016/j.toxicon.2008.04.167; Fortes-Dias CL, 2003, TOXICON, V41, P909, DOI 10.1016/S0041-0101(03)00073-4; FORTESDIAS CL, 1991, TOXICON, V29, P997, DOI 10.1016/0041-0101(91)90082-3; Gans C, 1968, Adv Oral Biol, V3, P45; Gomes CM, 2017, PEERJ, V5, DOI 10.7717/peerj.3203; Goncalves LRC, 2000, MEDIAT INFLAMM, V9, P101, DOI 10.1080/096293500411569; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 1989, LOCAL TISSUE DAMAGE, P211; Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; Kinkawa K, 2010, BIOCHEM BIOPH RES CO, V395, P377, DOI 10.1016/j.bbrc.2010.04.024; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; KOGAKI H, 1989, J BIOCHEM-TOKYO, V106, P966, DOI 10.1093/oxfordjournals.jbchem.a122983; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leon IR, 2012, PROTEOMICS, V12, P2753, DOI 10.1002/pmic.201200062; Lizano S, 1997, BIOCHEM J, V326, P853, DOI 10.1042/bj3260853; LOMONTE B, 1990, REV BIOL TROP, V38, P325; Lomonte B, 2011, ACTA CHIM SLOV, V58, P647; Luna KPO, 2011, J VENOM ANIM TOXINS, V17, P130, DOI 10.1590/S1678-91992011000200003; Malaque CMS, 2003, VENOMOUS ANIMALS BRA; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; Okumura K, 2002, ARCH BIOCHEM BIOPHYS, V408, P124, DOI 10.1016/S0003-9861(02)00551-9; Okumura K, 1999, BIOCHEM J, V341, P165, DOI 10.1042/0264-6021:3410165; Oliveira CZ, 2008, BIOCHIMIE, V90, P1506, DOI 10.1016/j.biochi.2008.05.009; Oliveira CZ, 2011, CURR TOP MED CHEM, V11, P2509; Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250; Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3; Picelli CG, 2017, INT J BIOL MACROMOL, V103, P525, DOI 10.1016/j.ijbiomac.2017.05.076; Quiros S, 2007, COMP BIOCHEM PHYS B, V146, P60, DOI 10.1016/j.cbpb.2006.09.003; Santoro ML, 2008, TOXICON, V51, P1440, DOI 10.1016/j.toxicon.2008.03.018; Santos NA, 2011, BIOCHIMIE, V93, P583, DOI 10.1016/j.biochi.2010.11.016; Service FT, 2006, BIOR PROT ASS; Shirai R, 2009, TOXICON, V53, P685, DOI 10.1016/j.toxicon.2009.02.001; Soares AM, 2003, BIOCHEM BIOPH RES CO, V302, P193, DOI 10.1016/S0006-291X(03)00155-4; Soares AM, 2001, INT J BIOCHEM CELL B, V33, P877, DOI 10.1016/S1357-2725(01)00065-6; TOMIHARA Y, 1990, TOXICON, V28, P989, DOI 10.1016/0041-0101(90)90028-6; TOMIHARA Y, 1988, TOXICON, V26, P420, DOI 10.1016/0041-0101(88)90013-X; TOMIHARA Y, 1987, TOXICON, V25, P685, DOI 10.1016/0041-0101(87)90117-6; Toyama MH, 2000, BBA-GEN SUBJECTS, V1474, P56, DOI 10.1016/S0304-4165(99)00211-1; VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538; Vieira SM, 2017, PLOS NEGLECT TROP D, V11, P1; WHO, 2007, RAB ENV NEGL PUBL HL; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024; Zelanis A., 2011, PROTEOMICA TRANSCRIP; Zhong LP, 2016, TOXICON, V122, P1, DOI 10.1016/j.toxicon.2016.09.011	60	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193105	10.1371/journal.pone.0193105	http://dx.doi.org/10.1371/journal.pone.0193105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505564	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200004
J	dos Santos, FID; Marini, N; dos Santos, RS; Hoffman, BSF; Alves-Ferreira, M; de Oliveira, AC				de Castro dos Santos, Fabiane Igansi; Marini, Naciele; dos Santos, Railson Schreinert; Fernandes Hoffman, Bianca Silva; Alves-Ferreira, Marcio; de Oliveira, Antonio Costa			Selection and testing of reference genes for accurate RT-qPCR in rice seedlings under iron toxicity	PLOS ONE			English	Article							HOUSEKEEPING GENES; PCR NORMALIZATION; EXPRESSION; IDENTIFICATION	Reverse Transcription quantitative PCR ( RT-qPCR) is a technique for gene expression profiling with high sensibility and reproducibility. However, to obtain accurate results, it depends on data normalization by using endogenous reference genes whose expression is constitutive or invariable. Although the technique is widely used in plant stress analyzes, the stability of reference genes for iron toxicity in rice ( Oryza sativa L.) has not been thoroughly investigated. Here, we tested a set of candidate reference genes for use in rice under this stressful condition. The test was performed using four distinct methods: NormFinder, BestKeeper, geNorm and the comparative Delta Ct. To achieve reproducible and reliable results, Minimum Information for Publication of Quantitative Real-Time PCR Experiments ( MIQE) guidelines were followed. Valid reference genes were found for shoot ( P2, OsGAPDH and OsNABP), root ( OsEF-1a, P8 and OsGAPDH) and root+shoot ( OsNABP, OsGAPDH and P8) enabling us to perform further reliable studies for iron toxicity in both indica and japonica subspecies. The importance of the study of other than the traditional endogenous genes for use as normalizers is also shown here.	[de Castro dos Santos, Fabiane Igansi; dos Santos, Railson Schreinert; Fernandes Hoffman, Bianca Silva; de Oliveira, Antonio Costa] Univ Fed Pelotas, Plant Genom & Breeding Ctr, Capao Do Leao, Brazil; [Marini, Naciele] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	Universidade Federal de Pelotas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Rio de Janeiro	de Oliveira, AC (corresponding author), Univ Fed Pelotas, Plant Genom & Breeding Ctr, Capao Do Leao, Brazil.	acostol@cgfufpel.org	Oliveira, Antonio/K-5923-2019; Costa de Oliveira, Antonio/GWZ-3969-2022; Alves-Ferreira, Marcio/C-5849-2009	Oliveira, Antonio/0000-0001-8835-8071; Alves-Ferreira, Marcio/0000-0002-6107-3700	CNPq; CAPES; FAPERGS	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Grants and fellowships were received from CNPq, CAPES and FAPERGS, all to ACdO.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; da Silveira VC, BRAZILIAN J PLANT PH; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; dos Santos RS, 2017, GENET MOL BIOL, V40, P312, DOI [10.1590/1678-4685-gmb-2016-0036, 10.1590/1678-4685-GMB-2016-0036]; dos Santos RS, 2013, TROP PLANT BIOL, V6, P16, DOI 10.1007/s12042-013-9117-1; Finatto T, 2015, RICE, V8, DOI 10.1186/s12284-015-0045-6; Gomez, 1972, LAB MANUAL PHYSL STU; Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kobayashi T, 2014, RICE, V7, DOI 10.1186/s12284-014-0027-0; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu F, 2016, REV BRAS FARMACOGN, V26, P564, DOI 10.1016/j.bjp.2016.05.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pabuayon IM, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0104-7; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha P, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01071, 10.3389/fpls.2015.01065]; Sperotto RA, 2007, PLANT CELL REP, V26, P1399, DOI 10.1007/s00299-007-0330-y; Storch TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120599; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG D, 2008, BIOMED CENTRAL, V9, DOI DOI 10.1186/1471-2164-9-44; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou L, 2016, J AM SOC HORTIC SCI, V141, P99, DOI 10.21273/JASHS.141.2.99; Zimmermann P, 2008, MOL PLANT, V1, P851, DOI 10.1093/mp/ssn048	39	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193418	10.1371/journal.pone.0193418	http://dx.doi.org/10.1371/journal.pone.0193418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494624	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200046
J	Javeed, S; Alimgeer, KS; Javed, W; Atif, M; Uddin, M				Javeed, Shumaila; Alimgeer, Khurram Saleem; Javed, Wajahat; Atif, M.; Uddin, Mueen			A modified artificial neural network based prediction technique for tropospheric radio refractivity	PLOS ONE			English	Article							INDEX; TEMPERATURE; EXTRACTION; MOISTURE; NIGERIA	Radio refractivity plays a significant role in the development and design of radio systems for attaining the best level of performance. Refractivity in the troposphere is one of the features affecting electromagnetic waves, and hence the communication system interrupts. In this work, a modified artificial neural network (ANN) based model is applied to predict the refractivity. The suggested ANN model comprises three modules: the data preparation module, the feature selection module, and the forecast module. The first module applies pre-processing to make the data compatible for the feature selection module. The second module discards irrelevant and redundant data from the input set. The third module uses ANN for prediction. The ANN model applies a sigmoid activation function and a multi-variate auto regressive model to update the weights during the training process. In this work, the refractivity is predicted and estimated based on ten years (2002-2011) of meteorological data, such as the temperature, pressure, and humidity, obtained from the Pakistan Meteorological Department (PMD), Islamabad. The refractivity is estimated using the method suggested by the International Telecommunication Union (ITU). The refractivity is predicted for the year 2012 using the database of the previous ten years, with the help of ANN. The ANN model is implemented in MATLAB. Next, the estimated and predicted refractivity levels are validated against each other. The predicted and actual values (PMD data) of the atmospheric parameters agree with each other well, and demonstrate the accuracy of the proposed ANN method. It was further found that all parameters have a strong relationship with refractivity, in particular the temperature and humidity. The refractivity values are higher during the rainy season owing to a strong association with the relative humidity. Therefore, it is important to properly cater the signal communication system during hot and humid weather. Based on the results, the proposed ANN method can be used to develop a refractivity database, which is highly important in a radio communication system.	[Javeed, Shumaila] COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan; [Alimgeer, Khurram Saleem; Javed, Wajahat] COMSATS Inst Informat Technol, Dept Elect Engn, Pk Rd, Islamabad, Pakistan; [Atif, M.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh, Saudi Arabia; [Uddin, Mueen] Effat Univ, Fac Engn, Dept Informat Syst, Jeddah, Saudi Arabia	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); King Saud University; Effat University	Alimgeer, KS (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Pk Rd, Islamabad, Pakistan.	saleem.khurram@gmail.com	Saleem, Khurram/N-9547-2019; Alimgeer, Khurram S/AGW-9805-2022; Alimgeer, Khurram S/F-4911-2011; Atif, Muhammad/C-4789-2013; Uddin, Mueen/C-8588-2011; Atif, Muhammad/Z-5682-2019	Alimgeer, Khurram S/0000-0001-5732-2463; Atif, Muhammad/0000-0002-7356-4275; Uddin, Mueen/0000-0003-1919-3407; Atif, Muhammad/0000-0002-7356-4275	King Saud University [RGP-VPP-293]	King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-VPP-293. The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-VPP-293.	Adediji TA, 2008, PROGR ELECTROMAGNE C, V4, P157; Agbo GA, 2012, J BASIC PHYS RES, V3, P24; Ahmad A, 2015, APPL SCI-BASEL, V5, P1756, DOI 10.3390/app5041756; Ali S, 2012, J ATMOS SOL-TERR PHY, V77, P96, DOI 10.1016/j.jastp.2011.12.001; Amjady N, 2009, IEEE T POWER SYST, V24, P306, DOI 10.1109/TPWRS.2008.2006997; Anderson CW, 1998, IEEE T BIO-MED ENG, V45, P277, DOI 10.1109/10.661153; [Anonymous], 2007, COMPUTATIONAL INTELL, DOI DOI 10.1002/9780470512517; Balaji SA, 2013, INT J COMPUTER SCI E, V3; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bogucki J., 2009, J TELECOMMUNICATIONS, P48; Pra ALD, 2015, INT J COMPUT INT SYS, V8, P28, DOI 10.1080/18756891.2015.1129589; Falodun SE, 2006, J ATMOS SOL-TERR PHY, V68, P236, DOI 10.1016/j.jastp.2005.10.002; Famorji J.O., 2013, RES DESK, V2, P334; Freeman R., 2007, RADIO SYSTEM DESIGN; Gao JD, 2008, ADV ATMOS SCI, V25, P1098, DOI 10.1007/s00376-008-1098-x; Grabner M, 2003, RADIOENGINEERING, V12, P5; Guo GJ, 2000, INT J INFRARED MILLI, V21, P1103, DOI 10.1023/A:1026452522574; Ibeh GF, 2012, GLOBAL J SCI FRONTIE, V12, P1; IHARA T, 1994, IEICE T COMMUN, VE77B, P1275; ITU-R, 2003, EFF TEMP VAR REFR RA, P131; Maitham A, 2003, ARAB J SCI ENG, V28, P3; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Minsky M., 1969, CAMB TIASS HIT, V479, P480; Nel J. W., 1988, COMM SIGN PROC P COM; Okoro ON, 2016, GLOBAL J SCI FRONTIE, V12; Palade V, 2001, LECT NOTES COMPUT SC, V2206, P152; Priestley J. T., 1985, Journal of Atmospheric and Oceanic Technology, V2, P233, DOI 10.1175/1520-0426(1985)002<0233:MHFHTA>2.0.CO;2; Smith B.A., 2007, INT J COMPUTATIONAL, V3, P179; Tamo siunaite M, 2015, ELEKTRON ELEKTROTECH, V105, P9; Tom G., 2006, AMSELIETS06015; Valma E, 2015, ELEKTRON ELEKTROTECH, V106, P125; Willoughby AA, 2002, J ATMOS SOL-TERR PHY, V64, P417, DOI 10.1016/S1364-6826(01)00111-0; Zheng J, 2015, ADV ATMOS SCI, V32, P319, DOI 10.1007/s00376-014-3162-z; Zurada J.M., 1992, INTRO ARTIFICIAL NEU	34	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192069	10.1371/journal.pone.0192069	http://dx.doi.org/10.1371/journal.pone.0192069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494609	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200010
J	Tajparast, M; Frigon, D				Tajparast, Mohammad; Frigon, Dominic			Predicting the accumulation of storage compounds by Rhodococcus jostii RHA1 in the feast-famine growth cycles using genome-scale flux balance analysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLIC NETWORKS; SYSTEMS; MODELS; LIPIDS	Feast-famine cycles in biological wastewater resource recovery systems select for bacterial species that accumulate intracellular storage compounds such as poly-beta-hydroxybutyrate (PHB), glycogen, and triacylglycerols (TAG). These species survive better the famine phase and resume rapid substrate uptake at the beginning of the feast phase faster than microorganisms unable to accumulate storage. However, ecophysiological conditions favouring the accumulation of either storage compounds remain to be clarified, and predictive capabilities need to be developed to eventually rationally design reactors producing these compounds. Using a genome-scale metabolic modelling approach, the storage metabolism of Rhodococcus jostii RHA1 was investigated for steady-state feast-famine cycles on glucose and acetate as the sole carbon sources. R. jostii RHA1 is capable of accumulating the three storage compounds (PHB, TAG, and glycogen) simultaneously. According to the experimental observations, when glucose was the substrate, feast phase chemical oxygen demand (COD) accumulation was similar for the three storage compounds; when acetate was the substrate, however, PHB accumulation was 3 times higher than TAG accumulation and essentially no glycogen was accumulated. These results were simulated using the genomescale metabolic model of R. jostii RHA1 (iMT1174) by means of flux balance analysis (FBA) to determine the objective functions capable of predicting these behaviours. Maximization of the growth rate was set as the main objective function, while minimization of total reaction fluxes and minimization of metabolic adjustment (environmental MOMA) were considered as the sub-objective functions. The environmental MOMA sub-objective performed better than the minimization of total reaction fluxes sub-objective function at predicting the mixture of storage compounds accumulated. Additional experiments with C-13-labelled bicarbonate (HCO3-) found that the fluxes through the central metabolism reactions during the feast phases were similar to the ones during the famine phases on acetate due to similarity in the carbon sources in the feast and famine phases (i.e., acetate and poly-beta-hydroxybutyrate, respectively); this suggests that the environmental MOMA sub-objective function could be used to analyze successive environmental conditions such as the feast and famine cycles while the metabolically similar carbon sources are taken up by microorganisms.	[Tajparast, Mohammad; Frigon, Dominic] McGill Univ, Dept Civil Engn & Appl Mech, Microbial Community Engn Lab, Montreal, PQ, Canada	McGill University	Frigon, D (corresponding author), McGill Univ, Dept Civil Engn & Appl Mech, Microbial Community Engn Lab, Montreal, PQ, Canada.	dominic.frigon@mcgill.ca	Frigon, Dominic/P-7898-2018	Frigon, Dominic/0000-0003-1587-8943	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 341393-11]; McGill Engineering Doctoral Award (MEDA); Canada Foundation of Innovation; Dr. John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation (TFF Oncometabolism Team) [116128]; McGill University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill Engineering Doctoral Award (MEDA); Canada Foundation of Innovation(Canada Foundation for Innovation); Dr. John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation (TFF Oncometabolism Team); McGill University	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant awarded to DF (RGPIN 341393-11). MT is grateful to the McGill Engineering Doctoral Award (MEDA) for the financial support of his Ph.D. study. Labelled amino acid measurements were performed at the Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility supported by the Canada Foundation of Innovation, The Dr. John R. and Clara M. Fraser Memorial Trust, the Terry Fox Foundation (TFF Oncometabolism Team Grant 116128), and McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HM, 2000, APPL MICROBIOL BIOT, V54, P218, DOI 10.1007/s002530050012; Alvarez HM, 1997, FETT-LIPID, V99, P239, DOI 10.1002/lipi.19970990704; Atlas RM., 1998, MICROBIAL ECOLOGY FU, V4; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Beun JJ, 2000, BIOTECHNOL BIOENG, V67, P379, DOI 10.1002/(SICI)1097-0290(20000220)67:4<379::AID-BIT1>3.0.CO;2-2; Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Frigon D, 2006, APPL ENVIRON MICROB, V72, P2322, DOI 10.1128/AEM.72.4.2322-2330.2006; Frigon D., 2005, PROPOSED MECH EXPLAI; Goodfellow M, 1998, ANTON LEEUW INT J G, V74, P3, DOI 10.1023/A:1001730725003; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; LAW JH, 1961, J BACTERIOL, V82, P33, DOI 10.1128/JB.82.1.33-36.1961; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Maurer M, 1997, WATER RES, V31, P907, DOI 10.1016/S0043-1354(96)00369-7; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moralejo-Garate H, 2013, BIOTECHNOL BIOENG, V110, P3148, DOI 10.1002/bit.24991; Mori M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004913; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Paganelli FL, 2011, WORLD J MICROB BIOT, V27, P773, DOI 10.1007/s11274-010-0515-3; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Poskar CH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-295; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rhine ED, 1998, SOIL SCI SOC AM J, V62, P473, DOI 10.2136/sssaj1998.03615995006200020026x; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Tajparast M, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0190-y; van Oosterwijk N, 2011, ACTA CRYSTALLOGR F, V67, P1269, DOI 10.1107/S1744309111028727; VANDERHEIJDEN RTJM, 1994, BIOTECHNOL BIOENG, V43, P11, DOI 10.1002/bit.260430104; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957	39	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191835	10.1371/journal.pone.0191835	http://dx.doi.org/10.1371/journal.pone.0191835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494607	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200006
J	Desai, RJ; Franklin, JM; Spoendlin-Allen, J; Solomon, DH; Danaei, G; Kim, SC				Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Danaei, Goodarz; Kim, Seoyoung C.			An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; MEDICARE CLAIMS; NATIONAL-HEALTH; DISEASE; HYPERURICEMIA; PREVALENCE; MANAGEMENT; METAANALYSIS; ALLOPURINOL; INHIBITORS	Objective Gout patients have a high burden of co-morbid conditions including diabetes mellitus (DM), chronic kidney disease (CKD), and cardiovascular disease (CVD). We sought to evaluate the association between changes in serum uric acid (SUA) levels over time and the risk of incident DM, CVD, and renal function decline in gout patients. Methods An observational cohort study was conducted among enrollees of private health insurance programs in the US between 2004 and 2015. Gout patients were included on the index date of a SUA measurement >= 6.8 mg/dl. The exposure of interest was cumulative change in SUA levels from baseline. Hazard ratios (HR) and 95% confidence intervals (CI) for incident DM, incident CVD, and renal function decline (>= 30% reduction in glomerular filtration rate) were derived using marginal structural models with stabilized inverse probability weights accounting for baseline confounders (age, gender, co-morbidities, co-medications) and time-varying confounders (serum creatinine, blood urea nitrogen, glycated hemoglobin). Results Among 26,341 patients with gout, the average age was 62, 75% were men, and the median baseline SUA was 8.6 mg/dl (interquartile range 7.7 to 9.5). The incidence rates/100 person-years (95% CI) were 1.63 (1.51-1.75) for DM, 0.77 (0.70-0.84) for CVD, and 4.32 (4.14-4.49) for renal function decline. The adjusted HR (95% CI) per 3 mg/dl reduction in SUA, corresponding on average to achieving the target level of <6 mg/dl in this population, was 1.04 (0.92-1.17) for DM, 1.07 (0.89-1.29) for CVD, and 0.85 (0.78-0.92) for renal function decline. Conclusions Reduction in SUA in patients with gout may be associated with a reduced risk of renal function decline, but not with DM or CVD.	[Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Kim, Seoyoung C.] Harvard Med Sch, Boston, MA 02115 USA; [Solomon, Daniel H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Danaei, Goodarz] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Desai, RJ (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Desai, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	rdesai@bwh.harvard.edu	Desai, Rishi/AAH-8988-2021; Danaei, Goodarz/B-6085-2008	Kim, Seoyoung/0000-0002-2517-3579; Franklin, Jessica/0000-0002-8941-4116	National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS- R21 AR069271]; Merck; AstraZeneca; Lilly; Pfizer; Bristol-Myers Squibb; Genentech; Amgen; CORRONA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR069271] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Merck(Merck & Company); AstraZeneca(AstraZeneca); Lilly(Eli Lilly); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); Amgen(Amgen); CORRONA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS- R21 AR069271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS- R21 AR069271).; Drs. Desai & Franklin have received unrestricted research grants from Merck. Dr. Kim has received unrestricted research grants from AstraZeneca, Lilly, Pfizer, Bristol-Myers Squibb, and Genentech. Dr. Solomon receives salary support through research support to his hospital from Amgen, Pfizer, AstraZeneca, Genentech, and CORRONA. Other authors declare no conflicts.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Hernan M, 2017, CAUSAL INFE IN PRESS; Hernan MA, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.82; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kim SC, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.013; Kim SC, 2014, ARTHRITIS RHEUMATOL, V66, pS19; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kok VC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-108; Krishnan E, 2013, QJM-INT J MED, V106, P721, DOI 10.1093/qjmed/hct093; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levy GD, 2014, J RHEUMATOL, V41, P955, DOI 10.3899/jrheum.131159; Lottmann K, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-011-0234-2; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robinson P, 2012, INTERN MED J; Roughley MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0610-9; Singh JA, 2015, GOUT GOES HEART DOES; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; Singh JA, 2017, ANN RHEUM DIS, V76, P133, DOI 10.1136/annrheumdis-2015-209046; Singh JA, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1111-1; Singh JA, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0692-2; Trifiro G, 2012, ANN RHEUM DIS; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193622	10.1371/journal.pone.0193622	http://dx.doi.org/10.1371/journal.pone.0193622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489919	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000096
J	Li, MJ; Guttman, M; Atkins, WM				Li, Mavis Jiarong; Guttman, Miklos; Atkins, William M.			Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug transport; conformational change; protein dynamic; protein conformation; ATPase; conformational selection; multidrug resistance	EXCHANGE MASS-SPECTROMETRY; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; ATP HYDROLYSIS; INDUCED FIT; GLUTAMATE RESIDUES; ALTERNATING ACCESS; CATALYTIC CYCLE; MECHANISM; FLEXIBILITY	P-glycoprotein (P-gp) is a highly substrate-promiscuous efflux transporter that plays a critical role in drug disposition. P-gp utilizes ATP hydrolysis by nucleotide-binding domains (NBDs) to drive transitions between inward-facing (IF) conformations that bind drugs and outward-facing (OF) conformations that release them to the extracellular solution. However, the details of the protein dynamics within either macroscopic IF or OF conformation remain uncharacterized, and the functional role of local dynamics has not been determined. In this work we measured the local dynamics of the IF state of P-gp in lipid nanodiscs and in detergent solution by hydrogen-deuterium (H/D) exchange MS. We observed EX1 exchange kinetics, or bimodal kinetics, for several peptides distributed in both NBDs, particularly for P-gp in the lipid nanodiscs. Remarkably, the EX1 kinetics occurred on several time scales, ranging from seconds to hours, suggesting highly complex, and correlated, motions. The results indicate at least three distinct conformational states in the ligand-free P-gp and suggest a rough conformational landscape. Addition of excess ATP and vanadate, to favor the OF conformations, caused a generalized, but modest, decrease in H/D exchange throughout the NBDs and slowed the EX1 kinetic transitions of several peptides. The functional implications of the results are consistent with the possibility that conformational selection provides a source of substrate promiscuity.	[Li, Mavis Jiarong; Guttman, Miklos; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Atkins, WM (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.	winky@uw.edu			NIGMS NIH HHS [R01 GM121603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burkitt W, 2008, RAPID COMMUN MASS SP, V22, P3893, DOI 10.1002/rcm.3794; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Fang J, 2011, INT J MASS SPECTROM, V302, P19, DOI 10.1016/j.ijms.2010.06.039; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Honaker MT, 2013, J BIOL CHEM, V288, P18599, DOI 10.1074/jbc.M112.445767; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li MJ, 2017, BIOCHEMISTRY-US, V56, P2506, DOI 10.1021/acs.biochem.6b01245; Livnat-Levanon N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21696; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Subramanian N, 2016, NEUROCHEM INT, V98, P146, DOI 10.1016/j.neuint.2016.05.005; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Vigano C, 2002, J BIOL CHEM, V277, P5008, DOI 10.1074/jbc.M107928200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Yang ZR, 2017, BBA-BIOMEMBRANES, V1859, P48, DOI 10.1016/j.bbamem.2016.10.009	42	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6297	6307		10.1074/jbc.RA118.002190	http://dx.doi.org/10.1074/jbc.RA118.002190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511086	hybrid, Green Published			2022-12-26	WOS:000431108600007
J	Huyghe, F; Kochzius, M				Huyghe, Filip; Kochzius, Marc			Sea surface currents and geographic isolation shape the genetic population structure of a coral reef fish in the Indian Ocean	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; AVIAN PHYLOGEOGRAPHY; MOZAMBIQUE CHANNEL; CONNECTIVITY; DIVERGENCE; MICROSATELLITE; ANEMONEFISH; SOFTWARE; GROWTH; SIZE	In this contribution, we determine the genetic population structure in the Skunk Clownfish (Amphiprion akallopsisos) across the Indian Ocean, and on a smaller geographic scale in the Western Indian Ocean (WIO). Highly restricted gene flow was discovered between populations on either side of the Indian Ocean using the control region as a mitochondrial marker (mtDNA). We verify this conclusion using 13 microsatellite markers and infer fine scale genetic structuring within the WIO. In total 387 samples from 21 sites were analysed using mtDNA and 13 microsatellite loci. Analysis included estimation of genetic diversity and population differentiation. A haplotype network was inferred using mtDNA. Nuclear markers were used in Bayesian clustering and a principal component analysis. Both markers confirmed strong genetic differentiation between WIO and Eastern Indian Ocean (EIO) populations, and a shallower population structure among Malagasy and East African mainland populations. Limited gene flow across the Mozambique Channel may be explained by its complex oceanography, which could cause local retention of larvae, limiting dispersal between Madagascar and the East African coast. Two other potential current-mediated barriers to larval dispersal suggested in the WIO, the split of the SEC at approximately 10 degrees S and the convergence of the Somali Current with the East African Coast Current at approximately 3 degrees S, were not found to form a barrier to gene flow in this species.	[Huyghe, Filip; Kochzius, Marc] VUB, Marine Biol Ecol & Biodivers, Brussels, Belgium	Vrije Universiteit Brussel	Huyghe, F (corresponding author), VUB, Marine Biol Ecol & Biodivers, Brussels, Belgium.	filip.huyghe@vub.be	Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719	Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS); Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) [1501612N]; German Federal Ministry of Education and Research (BMBF) [03F0390B]	Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS); Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS) provided a travel grant and VLADOC PhD scholarship to F. H.; Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) funded the COCOMA-WIO project (Connectivity of Coral Reefs and Mangroves in the Western Indian Ocean; grant no. 1501612N); German Federal Ministry of Education and Research (BMBF) funded the SPICE project (Science for the Protection of Indonesian Coastal Marine Ecosystems; grant no. 03F0390B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Barrowclough GF, 2009, MOL ECOL, V18, P2934, DOI 10.1111/j.1365-294X.2009.04271.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Dhaneesh K. V., 2012, Journal of King Saud University Science, V24, P201, DOI 10.1016/j.jksus.2011.03.005; DiBattista JD, 2012, J HERED, V103, P617, DOI 10.1093/jhered/ess056; Dohna TA, 2015, ECOL EVOL, V5, P1717, DOI 10.1002/ece3.1455; Dorenbosch M, 2006, HYDROBIOLOGIA, V568, P43, DOI 10.1007/s10750-006-0020-8; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fu YX, 1997, GENETICS, V147, P915; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hancke L, 2014, DEEP-SEA RES PT II, V100, P27, DOI 10.1016/j.dsr2.2013.10.014; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hoarau G, 2004, J SEA RES, V51, P183, DOI 10.1016/j.seares.2003.12.002; Hoareau TB, 2007, J EXP MAR BIOL ECOL, V349, P223, DOI 10.1016/j.jembe.2007.05.015; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Hui M, 2016, J MOLLUS STUD, V82, P403, DOI 10.1093/mollus/eyw001; Huyghe F, 2016, MAR ECOL, V38; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; LEE WJ, 1995, J MOL EVOL, V41, P54; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mulligan CJ, 2006, SCIENCE, V314, DOI 10.1126/science.1132585; Muths D, 2012, CAN J FISH AQUAT SCI, V69, P842, DOI 10.1139/F2012-012; Muths D, 2011, MAR ECOL PROG SER, V443, P167, DOI 10.3354/meps09394; Muths D, 2015, MAR ECOL-EVOL PERSP, V36, P447, DOI 10.1111/maec.12153; Naturaliste, 1992, FIELD GUIDE ANEMONE; O'Donnell JL, 2017, CORAL REEFS, V36, P223, DOI 10.1007/s00338-016-1495-z; Otwoma LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165552; Palsboll PJ, 2010, MOL ECOL RESOUR, V10, P797, DOI 10.1111/j.1755-0998.2010.02887.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Ridgway Tyrone, 2005, Western Indian Ocean Journal of Marine Science, V4, P1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schouten MW, 2003, DEEP-SEA RES PT II, V50, P1987, DOI 10.1016/S0967-0645(03)00042-0; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Silva IC, 2010, BIOL J LINN SOC, V99, P28, DOI 10.1111/j.1095-8312.2009.01338.x; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timm J, 2012, CONSERV GENET, V13, P693, DOI 10.1007/s10592-012-0318-1; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; van der Meer MH, 2012, ECOL EVOL, V2, P1592, DOI 10.1002/ece3.251; van der Meer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049660; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Visram S, 2010, MAR BIOL, V157, P1475, DOI 10.1007/s00227-010-1422-8; Vogler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043499; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	64	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193825	10.1371/journal.pone.0193825	http://dx.doi.org/10.1371/journal.pone.0193825			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522547	Green Submitted, gold, Green Published			2022-12-26	WOS:000427030800024
J	Li, F; Zhang, XM; Gong, JY; Liu, LX; Yi, Y				Li, Fei; Zhang, Ximin; Gong, Jiyi; Liu, Lunxian; Yi, Yin			Specialized core bacteria associate with plants adapted to adverse environment with high calcium contents	PLOS ONE			English	Article							MICROBIOME; COMMUNITIES; RHIZOSPHERE; ENDOPHYTES; SYMBIOSIS	Karst topography is formed from the dissolution of soluble rocks, such as limestone and dolomite. In soils of such a landform, excessive contents of exchangeable calcium seriously limit the growth of vegetations. Researches have proved that rhizosphere microorganisms and endophytes help host plants to adapt to various adverse environments. The adaptive capacity of plants that grow in adverse environment with salt, drought, thermal and heavy metal stresses partially or completely comes from symbiotic microorganisms. By using the high-throughput amplicon sequencing, the bacterial community structures in soil with high calcium contents and roots and leaves of Cochlearia henryi that is commonly seen in karst area were analyzed. The bacteria community structures in these three compartments showed obvious differences. This indicates that C. henryi, which is adaptive to high calcium stress, selectively co-exists with specific bacteria. Although the bacteria community structures in these three compartments differed significantly, there were 73 operational taxonomic units (OTUs) shared by karst soils as well as roots and leaves of C. henryi. The phylogenetic diversity of these 73 OTUs differed significantly from that of overall OTUs detected. There were also obvious differences in KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways and abundance values between the 73 OTUs and overall bacterial communities. A large number of OTUs shared by the karst soils, roots and leaves of C. henryi had close genetic relationship with known stress-resistant bacterial strains. Our results showed that the functional bacteria can be predicted by exploring core bacteria, bacteria shared by soils, adaptable plant roots and leaves. This information will potentially accelerate studies on natural microbial communities which can promote the adaptive capacity of host plants to high calcium stress, and will be valuable for finding microbial strains for field application in karst topography.	[Li, Fei; Zhang, Ximin; Gong, Jiyi; Liu, Lunxian; Yi, Yin] Guizhou Normal Univ, Sch Life Sci, Key Lab Plant Physiol & Dev Regulat, Guiyang, Guizhou, Peoples R China	Guizhou Normal University	Yi, Y (corresponding author), Guizhou Normal Univ, Sch Life Sci, Key Lab Plant Physiol & Dev Regulat, Guiyang, Guizhou, Peoples R China.	yiyin1964@outlook.com			Natural Science Foundation of Guizhou Province [[2016]7212]; Guizhou Normal University Foundation	Natural Science Foundation of Guizhou Province; Guizhou Normal University Foundation	This work was supported by Natural Science Foundation of Guizhou Province; Award Number: [2016]7212 vertical bar http://kjt.gzst.gov.cn/, Guizhou Normal University Foundation for Ph.D Scholars http://www.gznu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00491; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cleary DFR, 2015, MICROB ECOL, V70, P889, DOI 10.1007/s00248-015-0632-5; DREW DP, 1983, J HYDROL, V61, P113, DOI 10.1016/0022-1694(83)90238-X; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Gilbert SF, 2012, Q REV BIOL, V87, P325, DOI 10.1086/668166; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Guttman DS, 2014, NAT REV GENET, V15, P797, DOI 10.1038/nrg3748; Hacquard S, 2015, NEW PHYTOL, V205, P1424, DOI 10.1111/nph.13133; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Lakshmanan V, 2014, PLANT PHYSIOL, V166, P689, DOI 10.1104/pp.114.245811; Lau JA, 2012, P NATL ACAD SCI USA, V109, P14058, DOI 10.1073/pnas.1202319109; Lebeis SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00287; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Martins Teresa Vaz, 2013, Plants-Basel, V2, P541, DOI 10.3390/plants2040541; Nogales A, 2016, BRIEF FUNCT GENOMICS, V15, P288, DOI 10.1093/bfgp/elv030; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pontes FVM, 2009, ANAL CHIM ACTA, V632, P284, DOI 10.1016/j.aca.2008.11.011; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Thomas P, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu002; van der Heijden MGA, 2015, P NATL ACAD SCI USA, V112, P2299, DOI 10.1073/pnas.1500709112; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Wang DD, 2015, GEODERMA, V243, P157, DOI 10.1016/j.geoderma.2014.12.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Yuan ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32467	30	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194080	10.1371/journal.pone.0194080	http://dx.doi.org/10.1371/journal.pone.0194080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518143	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900066
J	Malacrino, A; Campolo, O; Medina, RF; Palmeri, V				Malacrino, Antonino; Campolo, Orlando; Medina, Raul F.; Palmeri, Vincenzo			Instar- and host-associated differentiation of bacterial communities in the Mediterranean fruit fly Ceratitis capitata	PLOS ONE			English	Article							GUT MICROBIOTA; BACTROCERA-CARAMBOLAE; DEVELOPMENTAL-STAGE; DIPTERA TEPHRITIDAE; SYMBIOTIC BACTERIA; MIDGUT MICROBIOTA; LIFE STAGES; PLANT USE; DIVERSITY; POPULATIONS	Microorganisms are acknowledged for their role in shaping insects' evolution, life history and ecology. Previous studies have shown that microbial communities harbored within insects vary through ontogenetic development and among insects feeding on different host-plant species. In this study, we characterized the bacterial microbiota of the highly polyphagous Mediterranean fruit fly, Ceratitis capitata (Diptera: Tephritidae), at different instars and when feeding on different host-plant species. Our results show that the bacterial microbiota hosted within the Mediterranean fruit fly differs among instars and host-plant species. Most of the bacteria harbored by the Mediterranean fruit fly belong to the phylum Proteobacteria, including genera of Alphaproteobacteria such as Acetobacterand Gluconobacter, Betaprotobacteria such as Burkholderia and Gammaproteobacteria such as Pseudomonas.	[Malacrino, Antonino] Linkoping Univ, Dept Phys Chem & Biol IFM, Linkoping, Sweden; [Malacrino, Antonino; Campolo, Orlando; Palmeri, Vincenzo] Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy; [Medina, Raul F.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Linkoping University; Universita Mediterranea di Reggio Calabria; Texas A&M University System; Texas A&M University College Station	Malacrino, A (corresponding author), Linkoping Univ, Dept Phys Chem & Biol IFM, Linkoping, Sweden.; Malacrino, A (corresponding author), Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy.	antonino.malacrino@gmail.com	Campolo, Orlando/B-9760-2014; Campolo, Orlando/AAT-3873-2020; Malacrinò, Antonino/J-3652-2012; Medina, Raul F/S-8294-2016	Campolo, Orlando/0000-0002-1243-8435; Campolo, Orlando/0000-0002-1243-8435; Malacrinò, Antonino/0000-0002-0811-1229; Medina, Raul F/0000-0002-8697-8901	PON SAF@MED [PON a3_00016]; PON RAMP;C - Italian Ministry of Education, University and Research	PON SAF@MED; PON RAMP;C - Italian Ministry of Education, University and Research	Analyses were carried out using instruments acquired with the support of PON SAF@MED (PON a3_00016). "Research infrastructure for sustainable agriculture and food in Mediterranean area" supported by the PON R&C 2007-2013 grant funded by the Italian Ministry of Education, University and Research.	Abdelfattah A, 2018, BIOL CONTROL, V120, P1, DOI 10.1016/j.biocontrol.2017.07.009; Aharon Y, 2013, APPL ENVIRON MICROB, V79, P303, DOI 10.1128/AEM.02761-12; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Augustinos AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136459; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behar A, 2008, ISR J ECOL EVOL, V54, P181, DOI 10.1080/15659801.2008.10639612; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Chen BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29505; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Crotti E, 2012, MICROB BIOTECHNOL, V5, P307, DOI 10.1111/j.1751-7915.2011.00312.x; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; de Souza DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-29; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Gutzwiller F, 2015, ECOL EVOL, V5, P4049, DOI 10.1002/ece3.1580; Hadapad AB, 2016, PEST MANAG SCI, V72, P1222, DOI 10.1002/ps.4102; Hammer TJ, 2015, OECOLOGIA, V179, P1, DOI 10.1007/s00442-015-3327-1; Hammer TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086995; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Johnston PR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005246; Kellner RLL, 2002, INSECT BIOCHEM MOLEC, V32, P389, DOI 10.1016/S0965-1748(01)00115-1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lauzon CR, 2012, J PEST SCI, V85, P217, DOI 10.1007/s10340-011-0410-1; Lawrence AL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv134; Liquido N.J., 1991, MISCELLANEOUS PUBLIC, V77, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mason CJ, 2014, OECOLOGIA, V175, P901, DOI 10.1007/s00442-014-2950-6; McFrederick QS, 2014, FEMS MICROBIOL ECOL, V88, P398, DOI 10.1111/1574-6941.12302; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Medina RF, 2011, J EVOLUTION BIOL, V24, P761, DOI 10.1111/j.1420-9101.2010.02215.x; Morrow JL, 2015, MICROB ECOL, V70, P498, DOI 10.1007/s00248-015-0571-1; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Paramasiva I, 2014, ARCH INSECT BIOCHEM, V87, P201, DOI 10.1002/arch.21190; Parmentier L, 2016, APIDOLOGIE, V47, P237, DOI 10.1007/s13592-015-0393-7; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; R Core Team, 2021, R LANGUAGE ENV STAT; Ruokolainen L, 2016, OECOLOGIA, V181, P895, DOI 10.1007/s00442-016-3603-8; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Sant'Anna MRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042531; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; Strano CP, 2017, MICROB ECOL; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Szyniszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111582; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wagner SM, 2015, FUNCT ECOL, V29, P1402, DOI 10.1111/1365-2435.12459; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Yong HS, 2017, META GENE, V14, P6, DOI 10.1016/j.mgene.2017.07.007; Yong HS, 2017, CURR MICROBIOL, V74, P1076, DOI 10.1007/s00284-017-1287-x; Yong HS, 2017, META GENE, V11, P189, DOI 10.1016/j.mgene.2016.10.009; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zindel R, 2011, J APPL ECOL, V48, P864, DOI 10.1111/j.1365-2664.2011.01984.x	78	45	45	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194131	10.1371/journal.pone.0194131	http://dx.doi.org/10.1371/journal.pone.0194131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518170	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900069
J	Pulido-Valdeolivas, I; Gomez-Andres, D; Martin-Gonzalo, JA; Rodriguez-Andonaegul, I; Lopez-Lopez, J; Pascual-Pascual, SI; Rausell, E				Pulido-Valdeolivas, Irene; Gomez-Andres, David; Andres Martin-Gonzalo, Juan; Rodriguez-Andonaegul, Irene; Lopez-Lopez, Javier; Ignacio Pascual-Pascual, Samuel; Rausell, Estrella			Gait phenotypes in paediatric hereditary spastic paraplegia revealed by dynamic time warping analysis and random forests	PLOS ONE			English	Article							MARIE-TOOTH DISEASE; SINGLE-LIMB STANCE; CEREBRAL-PALSY; CLASSIFICATION; CHILDREN; KNEE; DIPLEGIA; PATHOPHYSIOLOGY; PATTERNS; PARESIS	The Hereditary Spastic Paraplegias (HSP) are a group of heterogeneous disorders with a wide spectrum of underlying neural pathology, and hence HSP patients express a variety of gait abnormalities. Classification of these phenotypes may help in monitoring disease progression and personalizing therapies. This is currently managed by measuring values of some kinematic and spatio-temporal parameters at certain moments during the gait cycle, either in the doctor's surgery room or after very precise measurements produced by instrumental gait analysis (IGA). These methods, however, do not provide information about the whole structure of the gait cycle. Classification of the similarities among time series of IGA measured values of sagittal joint positions throughout the whole gait cycle can be achieved by hierarchical clustering analysis based on multivariate dynamic time warping (DTVV). Random forests can estimate which are the most important isolated parameters to predict the classification revealed by DTW, since clinicians need to refer to them in their daily practice. We acquired time series of pelvic, hip, knee, ankle and forefoot sagittal angular positions from 26 HSP and 33 healthy children with an optokinetic IGA system. DTW revealed six gait patterns with different degrees of impairment of walking speed, cadence and gait cycle distribution and related with patient's age, sex, GMFCS stage, concurrence of polyneuropathy and abnormal visual evoked potentials or corpus callosum. The most important parameters to differentiate patterns were mean pelvic tilt and hip flexion at initial contact. Longer time of support, decreased values of hip extension and increased knee flexion at initial contact can differentiate the mildest, near to normal HSP gait phenotype and the normal healthy one. Increased values of knee flexion at initial contact and delayed peak of knee flexion are important factors to distinguish GMFCS stages I from II-III and concurrence of polyneuropathy.	[Pulido-Valdeolivas, Irene; Gomez-Andres, David; Andres Martin-Gonzalo, Juan; Lopez-Lopez, Javier; Rausell, Estrella] Univ Autonoma Madrid, Dept Anat Histol & Neurosci, TRADESMA IdiPaz, Madrid, Spain; [Pulido-Valdeolivas, Irene] Univ Barcelona, Inst Biomed Res August Pi Sunyer, Hosp Clin Barcelona, Ctr Neuroimmunol, Barcelona, Spain; [Pulido-Valdeolivas, Irene] Univ Barcelona, Inst Biomed Res August Pi Sunyer, Hosp Clin Barcelona, Serv Neurol, Barcelona, Spain; [Gomez-Andres, David] Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, Child Neurol Unit, Barcelona, Spain; [Andres Martin-Gonzalo, Juan; Rodriguez-Andonaegul, Irene] Univ Autonoma Madrid, Sch Physiotherapy ONCE, Madrid, Spain; [Lopez-Lopez, Javier] Hosp Univ Infanta Sofia, Dept Phys Med & Rehabil, Madrid, Spain; [Ignacio Pascual-Pascual, Samuel] Univ Autonoma Madrid, Hosp Univ La Paz, Dept Child Neurol, TRADESMA IdiPaz, Madrid, Spain	Autonomous University of Madrid; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Madrid; Hospital Universitario Infanta Sofia; Autonomous University of Madrid; Hospital Universitario La Paz	Pulido-Valdeolivas, I; Rausell, E (corresponding author), Univ Autonoma Madrid, Dept Anat Histol & Neurosci, TRADESMA IdiPaz, Madrid, Spain.; Pulido-Valdeolivas, I (corresponding author), Univ Barcelona, Inst Biomed Res August Pi Sunyer, Hosp Clin Barcelona, Ctr Neuroimmunol, Barcelona, Spain.; Pulido-Valdeolivas, I (corresponding author), Univ Barcelona, Inst Biomed Res August Pi Sunyer, Hosp Clin Barcelona, Serv Neurol, Barcelona, Spain.	PULEDO@clinic.cat; estrella.rausell@uam.es	Martín Gonzalo, Juan Andrés/HCI-1197-2022; Gómez-Andrés, David/AAO-1847-2020; Rausell, Estrella/L-8781-2014; LOPEZ-LOPEZ, JAVIER/J-3578-2017	Gómez-Andrés, David/0000-0001-5654-7791; Rausell Tamayo, Estrella/0000-0002-1129-7116; LOPEZ-LOPEZ, JAVIER/0000-0002-9315-1048; PULIDO-VALDEOLIVAS, IRENE/0000-0003-0188-2458; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121	Universidad Autonoma de Madrid; Sociedad Espanola de Neurologia Pediatrica (SENEP); EUF-ONCE-UAM; Asociacion Espahola de Paraparesia Espastica Familiar (AEPEF)	Universidad Autonoma de Madrid; Sociedad Espanola de Neurologia Pediatrica (SENEP); EUF-ONCE-UAM; Asociacion Espahola de Paraparesia Espastica Familiar (AEPEF)	Escuela Universitaria de fisioterapia ONCE-UAM (EUF-ONCE-UAM) supports this project through maintenance and accommodation of the gait laboratory. IPV was in receipt of a Doctorate Grant from Universidad Autonoma de Madrid. DGA was in receipt of a grant from Sociedad Espanola de Neurologia Pediatrica (SENEP). Publication fee was supported by EUF-ONCE-UAM and Asociacion Espahola de Paraparesia Espastica Familiar (AEPEF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2022, NLME LINEAR NONLINEA; [Anonymous], 2015, FAM SPIN CORD SYNDR; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cimolin V, 2007, FUNCT NEUROL, V22, P23; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Ferrarin M, 2012, GAIT POSTURE, V35, P131, DOI 10.1016/j.gaitpost.2011.08.023; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; HARDING AE, 1983, LANCET, V1, P1151; Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822; Herring JA, 2008, TEXAS SCOTTISH RITE; Hicks JL, 2008, J BIOMECH, V41, P960, DOI 10.1016/j.jbiomech.2008.01.002; Kennedy RA, 2016, J PERIPHER NERV SYST, V21, P317, DOI 10.1111/jns.12183; Keogh E, PARAMETER FREE DATA; Klebe S, 2004, J NEUROL, V251, P571, DOI 10.1007/s00415-004-0366-7; Lee RW, 2014, NEUROMOL MED, V16, P821, DOI 10.1007/s12017-014-8331-9; Lin CJ, 2000, GAIT POSTURE, V11, P224, DOI 10.1016/S0966-6362(00)00049-7; Nonnekes J, 2013, J NEUROL, V260, P2387, DOI 10.1007/s00415-013-7002-3; Peng Y, 2010, ARTIFICIAL INTELLIGE; Perry J, 2010, GAIT ANAL NORMAL PAT, Vxvi; Piccinini L, 2011, EUR J PAEDIATR NEURO, V15, P138, DOI 10.1016/j.ejpn.2010.07.009; Quinn GP, 2002, EXPT DESIGN DATA ANA, P473, DOI DOI 10.1017/CBO9780511806384.019; Rosenbaum PL, 2008, DEV MED CHILD NEUROL, V50, P249, DOI 10.1111/j.1469-8749.2008.02045.x; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; Schwartz MH, 2014, GAIT POSTURE, V39, P778, DOI 10.1016/j.gaitpost.2013.10.016; Schwartz MH, 2013, GAIT POSTURE, V37, P473, DOI 10.1016/j.gaitpost.2012.08.016; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; SUTHERLAND DH, 1993, CLIN ORTHOP RELAT R, P139; Tesson C, 2015, HUM GENET, V134, P511, DOI 10.1007/s00439-015-1536-7; Whittle M. W., 2007, GAIT ANAL INTRO; Wolf SI, 2011, GAIT POSTURE, V33, P556, DOI 10.1016/j.gaitpost.2011.01.009; Young JL, 2010, ORTHOP CLIN N AM, V41, P561, DOI 10.1016/j.ocl.2010.06.006	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192345	10.1371/journal.pone.0192345	http://dx.doi.org/10.1371/journal.pone.0192345			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518090	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900006
J	Van Os, JMC; Mintline, EM; DeVries, TJ; Tucker, CB				Van Os, Jennifer M. C.; Mintline, Erin M.; DeVries, Trevor J.; Tucker, Cassandra B.			Domestic cattle (Bos taurus taurus) are motivated to obtain forage and demonstrate contrafreeloading	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; FEED-SORTING BEHAVIOR; LACTATING DAIRY-COWS; SHORT-COMMUNICATION; DIET SELECTION; RUMEN FILL; INGESTIVE BEHAVIOR; BEEF-CATTLE; TIME; HEIFERS	Domestic cattle (Bos taurus taurus) are adapted to digest high-roughage diets, but in confinement they are commonly fed low-roughage, high-energy diets. This practice may leave cattle with an unfulfilled need to consume forage. A way to quantify motivation is to require animals to work to access a resource. Using this method, we evaluated cattle motivation to obtain forage when fed high-or low-roughage diets during and 30 d before the study. Individual heifers were fed Sudan grass (Sorghum x drummondii) hay (high roughage, n = 6) or a diet with 12% forage (as fed, low roughage, n = 6) in an open feed trough. In a second trough, 200 g/d of Sudan grass hay were fed behind a push gate, to which additional weight was added daily until heifers no longer pushed. We predicted heifers would push heavier weights, show a shorter latency, and spend more time pushing the gate when fed a low-vs. high-roughage diet. Indeed, heifers fed a low-roughage diet pushed the gate immediately after hay delivery (1.7 min) and much sooner than those fed a high-roughage diet (75.7 min). On the day before they no longer pushed the gate, latency for heifers in the low-roughage treatment remained only 3.2 min after hay delivery. The suddenness with which they ceased pushing the next day suggests they were unable to move heavier weights to express their motivation. This may explain why maximum weight pushed and time spent pushing the gate did not differ between treatments. The gate pushing by heifers with unrestricted hay access is the first demonstration by cattle of contrafreeloading: performing work to obtain a resource that is simultaneously available for free. In conclusion, consuming forage is important to cattle and is affected by both their primary diet and an internal motivation to work to obtain feed.	[Van Os, Jennifer M. C.; Mintline, Erin M.; Tucker, Cassandra B.] Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA; [DeVries, Trevor J.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Van Os, Jennifer M. C.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of California System; University of California Davis; University of Guelph; University of Wisconsin System; University of Wisconsin Madison	Tucker, CB (corresponding author), Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA.	cbtucker@ucelavis.edu	DeVries, Trevor/AAE-5538-2019	Van Os, Jennifer/0000-0002-7107-2867; DeVries, Trevor/0000-0001-9364-2456; Tucker, Cassandra/0000-0002-6014-444X	United States Department of Agriculture (USDA) [NC 1029]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	The study was funded by the United States Department of Agriculture (USDA) Multistate Research Project NC 1029: Applied Animal Behavior and Welfare to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean D, 1999, BEHAVIOUR, V136, P1267, DOI 10.1163/156853999500712; Beauchemin KA, 2008, J DAIRY SCI, V91, P2077, DOI 10.3168/jds.2007-0726; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; Chilibroste P, 1997, GRASS FORAGE SCI, V52, P249, DOI 10.1111/j.1365-2494.1997.tb02355.x; Cooper MD, 2010, J VET BEHAV, V5, P75, DOI 10.1016/j.jveb.2009.09.045; Costa JHC, 2016, J DAIRY SCI, V99, P5635, DOI 10.3168/jds.2015-10052; de Jonge FH, 2008, APPL ANIM BEHAV SCI, V114, P359, DOI 10.1016/j.applanim.2008.03.006; DeVries TJ, 2008, J DAIRY SCI, V91, P3958, DOI 10.3168/jds.2008-1347; DeVries TJ, 2014, ANIM PROD SCI, V54, P1238, DOI 10.1071/AN14227; DeVries TJ, 2014, J ANIM SCI, V92, P1728, DOI 10.2527/jas.2013-7252; DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0; Forkman B, 1996, BEHAVIOUR, V133, P129, DOI 10.1163/156853996X00071; Fraser D., 2011, Animal welfare, P183, DOI 10.1079/9781845936594.0183; Galyean ML, 2003, CAN J ANIM SCI, V83, P13, DOI 10.4141/A02-061; Gonzalez LA, 2009, J ANIM SCI, V87, P2709, DOI 10.2527/jas.2008-1709; Gregorini P, 2009, J DAIRY SCI, V92, P2095, DOI 10.3168/jds.2008-1803; Greter AM, 2015, J DAIRY SCI, V98, P1248, DOI 10.3168/jds.2014-8879; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; Hessle A, 2008, APPL ANIM BEHAV SCI, V111, P108, DOI 10.1016/j.applanim.2007.05.017; Hessle Anna, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P334, DOI 10.1080/21513732.2014.968805; Hollenbeck A., 1978, OBSERVING BEHAVIOR, VII, P79; INGLIS IR, 1986, ANIM BEHAV, V34, P614, DOI 10.1016/S0003-3472(86)80136-1; Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320; James SM, 2002, BRIT J NUTR, V88, P81, DOI 10.1079/BJN2002589; JENSEN GD, 1963, J EXP PSYCHOL, V65, P451, DOI 10.1037/h0049174; Kelly AK, 2010, J ANIM SCI, V88, P109, DOI 10.2527/jas.2009-2196; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Kilgour RJ, 2012, APPL ANIM BEHAV SCI, V138, P1, DOI 10.1016/j.applanim.2011.12.002; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004; Kyriazakis I, 1999, P NUTR SOC, V58, P765, DOI 10.1017/S0029665199001044; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335; Lindstrom T, 2000, APPL ANIM BEHAV SCI, V70, P83, DOI 10.1016/S0168-1591(00)00148-9; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P333, DOI 10.1016/j.cvfa.2007.04.002; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Ogura T, 2011, ANIM COGN, V14, P427, DOI 10.1007/s10071-010-0377-y; Owens FN, 1998, J ANIM SCI, V76, P275; PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8; Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8; REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T; SAS Institute Inc, 2014, SAS STAT 13 2 US GUI; Schutz KE, 2008, APPL ANIM BEHAV SCI, V114, P307, DOI 10.1016/j.applanim.2008.04.001; Schutz K, 2006, APPL ANIM BEHAV SCI, V101, P253, DOI 10.1016/j.applanim.2006.02.008; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; SINGH D, 1970, J COMP PHYSIOL PSYCH, V73, P320, DOI 10.1037/h0030222; Spinka M., 2011, Animal welfare, P27, DOI 10.1079/9781845936594.0027; TARTE RD, 1981, PSYCHOL REP, V49, P859, DOI 10.2466/pr0.1981.49.3.859; Toaff-Rosenstein RL, 2016, APPL ANIM BEHAV SCI, V181, P49, DOI 10.1016/j.applanim.2016.05.016; USDA. Feedlot, 2011, 6260313 USDAAPHIS 1; Van Os JMC, 2017, APPL ANIM BEHAV SCI, V197, P68, DOI 10.1016/j.applanim.2017.09.001; Webb LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088778; Weiss WP, 1998, J DAIRY SCI, V81, P830, DOI 10.3168/jds.S0022-0302(98)75641-3; Wood KM, 2011, ANIM FEED SCI TECH, V165, P23, DOI 10.1016/j.anifeedsci.2011.02.011	58	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193109	10.1371/journal.pone.0193109	http://dx.doi.org/10.1371/journal.pone.0193109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513705	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800038
J	Farhate, CVV; de Souza, ZM; Oliveira, SRD; Tavares, RLM; Carvalho, JLN				Vieira Farhate, Camila Viana; de Souza, Zigomar Menezes; de Medeiros Oliveira, Stanley Robson; Moraes Tavares, Rose Luiza; Nunes Carvalho, Joao Luis			Use of data mining techniques to classify soil CO2 emission induced by crop management in sugarcane field	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; REDUCED TILLAGE; RESPIRATION; TEMPERATURE	Soil CO2 emissions are regarded as one of the largest flows of the global carbon cycle and small changes in their magnitude can have a large effect on the CO2 concentration in the atmosphere. Thus, a better understanding of this attribute would enable the identification of promoters and the development of strategies to mitigate the risks of climate change. Therefore, our study aimed at using data mining techniques to predict the soil CO2 emission induced by crop management in sugarcane areas in Brazil. To do so, we used different variable selection methods (correlation, chi-square, wrapper) and classification (Decision tree, Bayesian models, neural networks, support vector machine, bagging with logistic regression), and finally we tested the efficiency of different approaches through the Receiver Operating Characteristic (ROC) curve. The original dataset consisted of 19 variables (18 independent variables and one dependent (or response) variable). The association between cover crop and minimum tillage are effective strategies to promote the mitigation of soil CO2 emissions, in which the average CO2 emissions are 63 kg ha(-1) day(-1). The variables soil moisture, soil temperature (Ts), rainfall, pH, and organic carbon were most frequently selected for soil CO2 emission classification using different methods for attribute selection. According to the results of the ROC curve, the best approaches for soil CO2 emission classification were the following: (I) the Multilayer Perceptron classifier with attribute selection through the wrapper method, that presented rate of false positive of 13,50%, true positive of 94,20% area under the curve (AUC) of 89,90% (II) the Bagging classifier with logistic regression with attribute selection through the Chi-square method, that presented rate of false positive of 13,50%, true positive of 94,20% AUC of 89,90%. However, the (I) approach stands out in relation to (II) for its higher positive class accuracy (high CO2 emission) and lower computational cost.	[Vieira Farhate, Camila Viana; de Souza, Zigomar Menezes; de Medeiros Oliveira, Stanley Robson] Univ Estadual Campinas, Sch Agr Engn, Campinas, SP, Brazil; [de Medeiros Oliveira, Stanley Robson] Brazilian Agr Res Corp Embrapa Campinas, Agr Informat Computat Intelligence Lab, Sao Paulo, Brazil; [Moraes Tavares, Rose Luiza] Univ Rio Verde, Dept Soil, Rio Verde, Go, Brazil; [Nunes Carvalho, Joao Luis] Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Rio Verde Universidade Fesurv	Farhate, CVV (corresponding author), Univ Estadual Campinas, Sch Agr Engn, Campinas, SP, Brazil.	camila.vieira@feagri.unicamp.br	Farhate, Camila/AAT-3044-2020; Carvalho, João Luís/AAD-5370-2020; Oliveira, Stanley/AAT-5252-2020; Farhate, Camila/H-2151-2018; Tavares, Rose Luiza/AAV-6497-2020	Farhate, Camila/0000-0002-5027-9295; Carvalho, João Luís/0000-0001-5089-9411; Farhate, Camila/0000-0002-5027-9295; Tavares, Rose Luiza/0000-0003-4672-8470; Souza, Zigomar Menezes de/0000-0001-9302-6725				Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Corradi MM, 2013, ENG AGR-JABOTICABAL, V33, P699, DOI 10.1590/S0100-69162013000400009; de Figueiredo EB, 2015, GCB BIOENERGY, V7, P316, DOI 10.1111/gcbb.12151; DEXTER AR, 1985, J AGR ENG RES, V31, P139, DOI 10.1016/0021-8634(85)90066-6; Duda R.O., 2000, PATTERN CLASSIFICATI; Elisabeth M, 2011, MANUAL ANALISE SOLOS; Embrapa, 2013, SISTEMA BRASILEIRO C, V3rd; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freitas LPS, 2016, AN 14 INT C ENG TECH; Fuentes JP, 2006, SOIL TILL RES, V88, P123, DOI 10.1016/j.still.2005.05.001; Fuentes M, 2012, PLANT SOIL, V355, P183, DOI 10.1007/s11104-011-1092-4; Galvao ND, 2009, ACTA PAUL ENFERM, V22, P686, DOI 10.1590/S0103-21002009000500014; Hall M., 1998, THESIS U WAIKATO HAM; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Han J, 2012, MOR KAUF D, P1; Iamaguti JL, 2015, REV BRAS ENG AGR AMB, V19, P497, DOI 10.1590/1807-1929/agriambi.v19n5p497-504; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kemper W.D., 1965, SIZE DISTRIBUTION 1, P499; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; La Scala N, 2000, SOIL BIOL BIOCHEM, V32, P1469, DOI 10.1016/S0038-0717(00)00053-5; La Scala N, 2006, SOIL TILL RES, V91, P244, DOI 10.1016/j.still.2005.11.012; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Lu XL, 2016, SOIL RES, V54, P38, DOI 10.1071/SR14300; Marcelo AV, 2012, REV BRAS CIENC SOLO, V36, P45, DOI 10.1590/S0100-06832012000100005; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Moitinho MR, 2015, SOIL TILL RES, V148, P127, DOI 10.1016/j.still.2014.12.012; Moitinho MR, 2013, REV BRAS CIENC SOLO, V37, P1720, DOI 10.1590/S0100-06832013000600028; Tavares RLM, 2016, SCI AGR, V73, P543, DOI 10.1590/0103-9016-2015-0174; Panosso A. R., 2006, Cientifica (Jaboticabal), V34, P257; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Paustian L, 2016, AN C P 1 NAT C CARB; Prati RC, 2008, IEEE AM LATINA, V6, P1; Quinlan R, 1993, C4 5 PROGRAMS MACHIN; Raij B.V., 2001, B TECNICO; Reuss JODW, 1986, ECOLOGICAL STUDIES; Torres JLR, 2015, REV BRAS CIENC SOLO, V39, P428, DOI 10.1590/01000683rbcs20140597; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Sierra CA, 2015, J ADV MODEL EARTH SY, V7, P335, DOI 10.1002/2014MS000358; Silva-Olaya AM, 2012, ENVIRON RES LETT, V8, P1; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Soil Survey Staff, 2003, KEYS SOIL TAXONOMY, V9; Stolf R, 1991, REV BRAS CIENC SOLO, V15, P229, DOI DOI 10.1590/S0100-06832014000300009; Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140; Teixeira LG, 2010, ENG AGR-JABOTICABAL, V30, P224, DOI 10.1590/S0100-69162010000200004; Teixeira LG, 2013, SCI AGR, V70, P327, DOI 10.1590/S0103-90162013000500007; Tossell JA, 2009, ENVIRON SCI TECHNOL, V43, P2575, DOI 10.1021/es802393s; Ussiri DAN, 2009, SOIL TILL RES, V104, P39, DOI 10.1016/j.still.2008.11.008; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Witten IH, 2011, MOR KAUF D, P3, DOI 10.1016/B978-0-12-374856-0.00001-8; Zanatta J.A., 2014, PROTOCOLO MED FLUXOS	54	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193537	10.1371/journal.pone.0193537	http://dx.doi.org/10.1371/journal.pone.0193537			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513765	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800063
J	Mastop, M; Reinhard, NR; Zuconelli, CR; Terwey, F; Gadella, TWJ; van Unen, J; Adjobo-Hermans, MJW; Goedhart, J				Mastop, Marieke; Reinhard, Nathalie R.; Zuconelli, Cristiane R.; Terwey, Fenna; Gadella, Theodorus W. J., Jr.; van Unen, Jakobus; Adjobo-Hermans, Merel J. W.; Goedhart, Joachim			A FRET-based biosensor for measuring G alpha 13 activation in single cells	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; SUBUNIT DISSOCIATION; SIGNALING PATHWAYS; THROMBIN RECEPTOR; ALPHA; RHO; EXTENSION; FAMILY; ASSAY	Fo E rster Resonance Energy Transfer (FRET) provides a way to directly observe the activation of heterotrimeric G-proteins by G-protein coupled receptors (GPCRs). To this end, FRET based biosensors are made, employing heterotrimeric G-protein subunits tagged with fluorescent proteins. These FRET based biosensors complement existing, indirect, ways to observe GPCR activation. Here we report on the insertion of mTurquoise2 at several sites in the human G alpha 13 subunit, aiming to develop a FRET-based G alpha 13 activation biosensor. Three fluorescently tagged G alpha 13 variants were found to be functional based on i) plasma membrane localization and ii) ability to recruit p115-RhoGEF upon activation of the LPA2 receptor. The tagged G alpha 13 subunits were used as FRET donor and combined with cp173Venus fused to the G gamma 2 subunit, as the acceptor. We constructed G alpha 13 biosensors by generating a single plasmid that produces G alpha 13-mTurquoise2, G ss 1 and cp173Venus-G gamma 2. The G alpha 13 activation biosensors showed a rapid and robust response when used in primary human endothelial cells that were exposed to thrombin, triggering endogenous protease activated receptors (PARs). This response was efficiently inhibited by the RGS domain of p115-RhoGEF and from the biosensor data we inferred that this is due to GAP activity. Finally, we demonstrated that the G alpha 13 sensor can be used to dissect heterotrimeric G-protein coupling efficiency in single living cells. We conclude that the G alpha 13 biosensor is a valuable tool for live-cell measurements that probe spatiotemporal aspects of G alpha 13 activation.	[Mastop, Marieke; Reinhard, Nathalie R.; Terwey, Fenna; Gadella, Theodorus W. J., Jr.; van Unen, Jakobus; Goedhart, Joachim] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Zuconelli, Cristiane R.; Adjobo-Hermans, Merel J. W.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands; [van Unen, Jakobus] Univ Bern, Inst Cell Biol, Dept Biol, Bern, Switzerland	University of Amsterdam; Radboud University Nijmegen; University of Bern	Goedhart, J (corresponding author), Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.goedhart@uva.nl	Zuconelli, Cristiane/G-6213-2016; Zuconelli, Cristiane/Q-4717-2019; Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015	Zuconelli, Cristiane/0000-0002-6316-3937; Zuconelli, Cristiane/0000-0002-6316-3937; Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Gadella, Theodorus/0000-0002-7639-219X; van Unen, Jakobus/0000-0002-7931-0989	NWO Chemical Sciences ECHO [711.013.009]; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) [BEX 13247/13-1]	NWO Chemical Sciences ECHO; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)	JG was supported by a NWO Chemical Sciences ECHO grant (711.013.009). MJWA was supported financially by the Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) (grant: BEX 13247/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bodmann EL, 2017, FASEB J, V31, P3663, DOI 10.1096/fj.201700026R; Clister T, 2015, J BIOL CHEM, V290, P6681, DOI 10.1074/jbc.R114.616391; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Goyet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28231; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Janetopoulos C, 2002, METHODS, V27, P366, DOI 10.1016/S1046-2023(02)00095-6; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mastop M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12212-x; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Reinhard NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25502; Reinhard NR, 2017, MOL BIOL CELL; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Strange PG, 2010, BRIT J PHARMACOL, V161, P1238, DOI 10.1111/j.1476-5381.2010.00963.x; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; van Unen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36825; van Unen J, 2016, MOL PHARMACOL, V90, P162, DOI 10.1124/mol.116.104505; van Unen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146789; van Unen J, 2015, MOL PHARMACOL, V88, P589, DOI 10.1124/mol.115.098897; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193705	10.1371/journal.pone.0193705	http://dx.doi.org/10.1371/journal.pone.0193705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505611	gold, Green Published, Green Submitted			2022-12-26	WOS:000426548200025
J	Zhao, LG; Hang, ZZ; Yang, JZ; Qi, H				Zhao, Longgang; Hang, Zhongzhi; Yang, Jinzhong; Qi, Hua			Single seed precise sowing of maize using computer simulation	PLOS ONE			English	Article								In order to test the feasibility of computer simulation in field maize planting, the selection of the method of single seed precise sowing in maize is studied based on the quadratic function model Y = Ax(D-Dm)(2) + Ym, which depicts the relationship between maize yield and planting density. And the advantages and disadvantages of the two planting methods under the condition of single seed sowing are also compared: Method 1 is optimum density planting, while Method 2 is the ideal seedling emergence number planting. It is found that the yield reduction rate and yield fluctuation of Method 2 are all lower than those of Method 1. The yield of Method 2 increased by at least 0.043 t/hm(2), and showed more advantages over Method 1 with higher yield level. Further study made on the influence of seedling emergence rate on the yield of maize finds that the yields of the two methods are both highly positively correlated with the seedling emergence rate and the standard deviations of their yields are both highly negatively correlated with the seedling emergence rate. For the study of the break-up problem of sparse caused by the method of single seed precise sowing, the definition of seedling missing spots is put forward. The study found that the relationship between number of hundred-dot spot and field seedling emergence rate is as the parabola function y = -189.32x(2) + 309.55x - 118.95 and the relationship between number of spot missing seedling and field seedling emergence rate is as the negative exponent function y = 395.69e(-6.144x). The results may help to guide the maize seeds production and single seed precise sowing to some extent.	[Zhao, Longgang; Qi, Hua] Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China; [Hang, Zhongzhi] Qingdao Agr Univ, Coll Informat Sci & Engn, Qingdao, Peoples R China; [Yang, Jinzhong] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Shenyang Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University	Qi, H (corresponding author), Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China.	qihua09@163.com			National Key Research and Development Program of China [2016YFD0300103]	National Key Research and Development Program of China	The corresponding author, Qi Hua, received the National Key Research and Development Program of China (2016YFD0300103) for this work.	[Anonymous], 2008, 440412008 GB, P12; Bock M, 2010, B MATH BIOL, V72, P1696, DOI 10.1007/s11538-009-9498-3; Butzen Steve, 2014, CROP INSIGHTS CORN S; Chu Jie, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P34; DONG Xue, 2011, J HARBIN U COMMERCE, V27, P867; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; DUNCAN W. G., 1958, Agronomy Journal, V50, P82; Gu W. L., 1985, J SHENYANG AGR COLL, V16, P1; Han ZhongZhi, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P17; Li Dong, 2013, SEED WORLD, V12, P35; [李凤海 LI Fenghai], 2007, [种子, Seed], V26, P77; Li Hui, 2012, INT SOC OPTICS PHOTO; [刘帅 Liu Shuai], 2014, [生态学报, Acta Ecologica Sinica], V34, P1436; [彭云玲 Peng Yunling], 2014, [干旱地区农业研究, Agricultural Research in the Arid Areas], V32, P25; Reem D, 2011, COMPUTATIONAL GEOMETRY (SCG 11), P254; [肖继兵 Xiao Jibing], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1917; Yang JinZhong, 2013, Acta Agronomica Sinica, V39, P515, DOI 10.3724/SP.J.1006.2013.00515; YANG Jinzhong, 2015, J BIOMATHEMATICS, V30, P243; [朱金城 Zhu Jincheng], 2013, [中国农业大学学报, Journal of China Agricultural University], V18, P34	19	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193750	10.1371/journal.pone.0193750	http://dx.doi.org/10.1371/journal.pone.0193750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505619	gold, Green Submitted, Green Published			2022-12-26	WOS:000426548200029
J	Chan, CP; Yuen, CK; Cheung, PHH; Fung, SY; Lui, PY; Chen, H; Kok, KH; Jin, DY				Chan, Chi-Ping; Yuen, Chun-Kit; Cheung, Pak-Hin Hinson; Fung, Sin-Yee; Lui, Pak-Yin; Chen, Honglin; Kok, Kin-Hang; Jin, Dong-Yan			Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase	FASEB JOURNAL			English	Article						RIG-I; antiviral response; PA; PB1; PB2	I INTERFERON-PRODUCTION; INDUCIBLE GENE I; SENSOR RIG-I; INNATE IMMUNITY; INDUCED ACTIVATION; NS1 PROTEIN; INFECTION; INHIBITION; REPLICATION; INDUCTION	PACT is a double-stranded RNA-binding protein that has been implicated in host-influenza A virus (IAV) interaction. PACT facilitates the action of RIG-I in the activation of the type I IFN response, which is suppressed by the viral nonstructural protein NS1. PACT is also known to interact with the IAV RNA polymerase subunit PA. Exactly how PACT exerts its antiviral activity during IAV infection remains to be elucidated. In the current study, we demonstrated the interplay between PACT and IAV polymerase. Induction of IFN- by the IAV RNP complex was most robust when both RIG-I and PACT were expressed. PACT-dependent activation of IFN- production was suppressed by the IAV polymerase subunits, polymerase acidic protein, polymerase basic protein 1 (PB1), and PB2. PACT associated with PA, PB1, and PB2. Compromising PACT in IAV-infected A549 cells resulted in the augmentation of viral RNA (vRNA) transcription and replication and IFN- production. Furthermore, vRNA replication was boosted by knockdown of PACT in both A549 cells and IFN-deficient Vero cells. Thus, the antiviral activity of PACT is mediated primarily via its interaction with and inhibition of IAV polymerase. Taken together, our findings reveal a new facet of the host-IAV interaction in which the interplay between PACT and IAV polymerase affects the outcome of viral infection and antiviral response.Chan, C.-P., Yuen, C.-K., Cheung, P.-H. H., Fung, S.-Y., Lui, P.-Y., Chen, H., Kok, K.-H., Jin, D.-Y. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.	[Chan, Chi-Ping; Cheung, Pak-Hin Hinson; Fung, Sin-Yee; Lui, Pak-Yin; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, 3rd Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Yuen, Chun-Kit; Chen, Honglin; Kok, Kin-Hang] Univ Hong Kong, Dept Microbiol, 5th Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Sch Biomed Sci, 3rd Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Kok, KH; Jin, DY (corresponding author), Univ Hong Kong, Dept Microbiol, 5th Floor,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	khkok@hku.hk; dyjin@hku.hk	Chan, Chi Ping/AAB-9463-2020; Kok, Kin-Hang/C-4184-2009; Jin, Dong-Yan/C-4287-2009	Chan, Chi Ping/0000-0001-6876-0864; Cheung, Pak Hin Hinson/0000-0003-3682-7571; /0000-0003-3426-332X; Jin, Dong-Yan/0000-0002-2778-3530	Hong Kong Research Grants Council [C7011-15R, ECS-27121515]; Hong Kong Health and Medical Research Fund [HKM-15-M01, 15140662]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Health and Medical Research Fund	The authors thank Connie Cepko (Harvard Medical School, Boston, MA, USA), Takashi Fujita (KyotoUniversity, Kyoto, Japan), and Yoshihiro Kawaoka (University of Wisconsin, Madison, WI, USA) for reagents, and Jasper Ho, Edwin Kong, and Sam Yuen (all from The University of Hong Kong) for critical reading of the manuscript. This work was supported by the Hong Kong Research Grants Council (C7011-15R and ECS-27121515) and the Hong Kong Health and Medical Research Fund (HKM-15-M01 and 15140662). The authors declare no conflicts of interest.	Ahmad S, 2015, TRENDS BIOCHEM SCI, V40, P576, DOI 10.1016/j.tibs.2015.08.001; Anchisi S, 2016, J VIROL, V90, P586, DOI 10.1128/JVI.01671-15; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Benitez AA, 2015, CELL REP, V11, P1714, DOI 10.1016/j.celrep.2015.05.032; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung NN, 2017, J GEN VIROL, V98, P946, DOI 10.1099/jgv.0.000758; Coch C, 2017, MOL THER, V25, P2093, DOI 10.1016/j.ymthe.2017.07.003; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Ding Z, 2017, ONCOTARGET, V8, P49655, DOI 10.18632/oncotarget.17912; Eisfeld AJ, 2015, NAT REV MICROBIOL, V13, P28, DOI 10.1038/nrmicro3367; Fitzgerald ME, 2017, NUCLEIC ACIDS RES, V45, P1442, DOI 10.1093/nar/gkw816; Gabriel G, 2014, CURR TOP MICROBIOL, V385, P35, DOI 10.1007/82_2014_386; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15; Hsu SF, 2015, J VIROL, V89, P3671, DOI 10.1128/JVI.03610-14; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kew C, 2013, J VIROL, V87, P13141, DOI 10.1128/JVI.02564-13; Kim JS, 2017, EUR HEART J-CARD PHA, V3, P91, DOI 10.1093/ehjcvp/pvw040; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Kok KH, 2013, CELL HOST MICROBE, V14, P5, DOI 10.1016/j.chom.2013.07.004; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Lai MC, 2016, FEBS J, V283, P88, DOI 10.1111/febs.13553; Lee MK, 2016, NUCLEIC ACIDS RES, V44, P8407, DOI 10.1093/nar/gkw525; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li WZ, 2014, J VIROL, V88, P10432, DOI 10.1128/JVI.01383-14; Liedmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6645; Liu GQ, 2015, J VIROL, V89, P6067, DOI 10.1128/JVI.00232-15; Lui PY, 2017, J IMMUNOL, V199, P1846, DOI 10.4049/jimmunol.1601493; Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33; Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Marc D, 2014, J GEN VIROL, V95, P2594, DOI 10.1099/vir.0.069542-0; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez-Cidoncha M, 2014, J VIROL, V88, P4632, DOI 10.1128/JVI.00014-14; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prantner D, 2017, J BIOL CHEM, V292, P292, DOI 10.1074/jbc.M116.763268; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shin D, 2017, J VIROL, V91, DOI 10.1128/JVI.02260-16; Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13; Song WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6509; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Tawaratsumida K, 2014, J VIROL, V88, P9038, DOI 10.1128/JVI.00830-14; To KKW, 2014, CURR OPIN PULM MED, V20, P225, DOI 10.1097/MCP.0000000000000047; To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005; Weber-Gerlach M, 2016, CURR OPIN IMMUNOL, V42, P71, DOI 10.1016/j.coi.2016.05.016; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yao H, 2015, MOL CELL, V58, P541, DOI 10.1016/j.molcel.2015.03.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Yuen CK, 2016, J VIROL, V90, P3902, DOI 10.1128/JVI.00129-16; Zhang YL, 2016, J IMMUNOL, V197, P824, DOI 10.4049/jimmunol.1501563	68	9	9	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4380	4393		10.1096/fj.201701361R	http://dx.doi.org/10.1096/fj.201701361R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513570				2022-12-26	WOS:000439325400027
J	Manna, I; Iaccino, E; Dattilo, V; Barone, S; Vecchio, E; Mimmi, S; Filippelli, E; Demonte, G; Polidoro, S; Granata, A; Scannapieco, S; Quinto, I; Valentino, P; Quattrone, A				Manna, Ida; Iaccino, Enrico; Dattilo, Vincenzo; Barone, Stefania; Vecchio, Eleonora; Mimmi, Selena; Filippelli, Enrica; Demonte, Giulio; Polidoro, Serena; Granata, Alfredo; Scannapieco, Sara; Quinto, Ileana; Valentino, Paola; Quattrone, Aldo			Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients	FASEB JOURNAL			English	Article						exosomes; biomarkers; response to drugs	CIRCULATING MICRORNAS; INTERFERON-BETA; EXTRACELLULAR VESICLES; BIOMARKERS; MECHANISM; BIOGENESIS; REVEALS; SYSTEM	Multiple sclerosis (MS) is an autoimmune pathology leading to neurodegeneration. Because of the complexity and heterogenic etiology of this disease, diagnosis and treatment for individual patients are challenging. Exosome-associated microRNAs (miRNAs) have recently emerged as a new class of diagnostic biomarkers involved in both autoimmune and neurologic disorders. Interesting new evidence has emerged showing that circulating miRNAs are dysregulated in MS body fluids, including serum, plasma, and cerebrospinal fluid. We hypothesized that exosome-associated miRNAs could present a readily accessible blood-based assay for MS disease. We detected expression of miRNAs by quantitative PCR on a small cohort of MS patients. We analyzed circulating exosome-associated miRNAs of MS patients before and after therapy and found that 14 exosome-associated miRNAs were significantly down-regulated, while 2 exosome-associated miRNAs were significantly up-regulated in IFN--treated relapsing-remitting MS patients with response to therapy compared to those without response. We identified a serum miRNA panel that could be used to monitor the response to IFN- therapy. Overall, these data suggest that circulating exosome-associated miRNA profiling could represent an easily detectable biomarker of disease and treatment response.Manna, I., Iaccino, E., Dattilo, V., Barone, S., Vecchio, E., Mimmi, S., Filippelli, E., Demonte, G., Polidoro, S., Granata, A., Scannapieco, S., Quinto, I., Valentino, P., Quattrone, A. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.	[Manna, Ida; Quattrone, Aldo] CNR, Inst Mol Bioimaging & Physiol IBFM, Catanzaro, Italy; [Quattrone, Aldo] CNR, Neuroimaging Res Unit, Sect Germaneto, Catanzaro, Italy; [Iaccino, Enrico; Dattilo, Vincenzo; Vecchio, Eleonora; Mimmi, Selena; Quinto, Ileana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Barone, Stefania; Filippelli, Enrica; Demonte, Giulio; Polidoro, Serena; Granata, Alfredo; Scannapieco, Sara; Valentino, Paola] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, I-88100 Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Iaccino, E (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.; Valentino, P (corresponding author), Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, I-88100 Catanzaro, Italy.	iaccino@unicz.it; p.vale@unicz.it	VALENTINO, Paola/AAA-4243-2019; Barone, Stefania/AAB-9887-2019; Mimmi, Selena/AAB-9585-2019; vecchio, eleonora/AAT-4287-2020; Dattilo, Vincenzo/AAB-3167-2020; Mimmi, Selena/J-7860-2016	VALENTINO, Paola/0000-0001-7863-9195; Mimmi, Selena/0000-0003-2187-9176; Dattilo, Vincenzo/0000-0001-8493-6188; Mimmi, Selena/0000-0003-2187-9176; vecchio, eleonora/0000-0001-8422-2679; Barone, Stefania/0000-0002-0239-8214; QUINTO, Ileana/0000-0001-8212-8515	Italian National Research Council	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported, in part, by the Italian National Research Council. The authors declare no conflicts of interest.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Angerstein C, 2012, MOL NEUROBIOL, V45, P520, DOI 10.1007/s12035-012-8270-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Ciregia F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00276; Comi G, 2017, LANCET, V389, P1347, DOI 10.1016/S0140-6736(16)32388-1; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; De Felice B, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-26; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Einarson TR, 2017, CURR MED RES OPIN, V33, P579, DOI 10.1080/03007995.2016.1276895; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fenoglio C, 2013, MULT SCLER J, V19, P1938, DOI 10.1177/1352458513485654; Gandhi R, 2015, MULT SCLER J, V21, P1095, DOI 10.1177/1352458515578771; Gandhi R, 2013, ANN NEUROL, V73, P729, DOI 10.1002/ana.23880; Guerau-de-Arellano M, 2012, J NEUROIMMUNOL, V248, P32, DOI 10.1016/j.jneuroim.2011.10.006; Hecker M, 2013, INT J MOL SCI, V14, P16087, DOI 10.3390/ijms140816087; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Iaccino E, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0730-8; Ingwersen J, 2015, ANN CLIN TRANSL NEUR, V2, P43, DOI 10.1002/acn3.152; Jagot F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00129; Junker A, 2011, NAT REV NEUROL, V7, P56, DOI 10.1038/nrneurol.2010.179; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Krishnan SR, 2016, NEOPLASIA, V18, P25, DOI 10.1016/j.neo.2015.11.011; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lin ST, 2009, DIS MODEL MECH, V2, P178, DOI 10.1242/dmm.001065; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mancuso R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0504-2; Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2; Meira M, 2014, MULT SCLER J, V20, P1363, DOI 10.1177/1352458514524998; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paap BK, 2013, J CLIN CELL IMMUNOL, V2013; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Potenza N, 2018, BBA-MOL BASIS DIS, V1864, P317, DOI 10.1016/j.bbadis.2017.09.024; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sarchielli P, 2008, NEUROSCI LETT, V435, P223, DOI 10.1016/j.neulet.2008.02.040; Selmaj I, 2017, ANN NEUROL, V81, P703, DOI 10.1002/ana.24931; Selmaj I, 2017, J NEUROIMMUNOL, V306, P1, DOI 10.1016/j.jneuroim.2017.02.002; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tufekci KU, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/807426; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waschbisch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024604	52	69	72	3	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4241	4246		10.1096/fj.201701533R	http://dx.doi.org/10.1096/fj.201701533R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505299				2022-12-26	WOS:000439325400015
J	Christensen, CU; Glavind, E; Thomsen, KL; Kim, YO; Heeboll, S; Schuppan, D; Hamilton-Dutoit, S; Heegaard, CW; Gronbaek, H				Christensen, Claus Uhrenholt; Glavind, Emilie; Thomsen, Karen Louise; Kim, Yong Ook; Heeboll, Sara; Schuppan, Detlef; Hamilton-Dutoit, Stephen; Heegaard, Christian Wurtz; Gronbaek, Henning			Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease	PLOS ONE			English	Article							ABCA1-DEPENDENT LIPID EFFLUX; CHOLESTEROL ACCUMULATION; SCORING SYSTEM; STEATOHEPATITIS; RESVERATROL; TRANSPORT; STRESS; OBESE; GENE; NPC2	Background and aims Hepatic cholesterol deposition drives inflammation and fibrosis in non-alcoholic steatohepatitis (NASH). The Niemann-Pick type C2 (NPC2) protein plays an important role in regulating intracellular cholesterol trafficking and homeostasis. We hypothesized that intravenous NPC2 supplementation reduces cholesterol accumulation, hepatic inflammation and fibrogenesis in a nutritional NASH rat model. Methods Rats were fed a high-fat, high-cholesterol (HFHC) diet for four weeks resulting in moderately severe NASH. Animals were treated with intravenous NPC2 or placebo twice weekly for either the last two weeks or the entire four weeks. End-points were liver/body- and spleen/body weight ratios, histopathological NASH scores, fibrosis, serum liver enzymes, cholesterol, lipoproteins, cytokines, and quantitative polymerase chain reaction derived hepatic gene expression related to cholesterol metabolism, inflammation, and fibrosis. Results HFHC rats developed hepatomegaly, non-fibrotic NASH histopathology, elevated liver enzymes, serum cholesterol, and pro-inflammatory cytokines. Their sterol regulatory element binding factor 2 (SREBF2) and low-density lipoprotein receptor (LDL-R) mRNAs were down-regulated compared with rats on standard chow. NPC2 did not improve liver weight, histopathology, levels of serum liver enzymes or pro-inflammatory tumor necrosis factor-a (TNF alpha), Interleukin (IL)-6, or IL-1 beta in HFHC rats. Two weeks of NPC2 treatment lowered hepatic TNF alpha and COL1A1 mRNA expression. However, this effect was ultimately reversed following additional two weeks of treatment. Four weeks NPC2 treatment of rats raised ATP-binding cassette A1 (ABCA1) and low-density lipoprotein receptor (LDLR) mRNAs in the liver, concurrent with a strong tendency towards higher serum high-density lipoprotein (HDL). Furthermore, the peroxisome proliferator activated receptor-gamma (PPARG) gene expression was reduced. Conclusions NPC2 proved inefficient at modifying robust hepatic NASH end-points in a HFHC NASH model. Nonetheless, our data suggest that hepatic ABCA1 expression and reverse cholesterol transport were upregulated by NPC2 treatment, thus presenting putative therapeutic effects in diseases associated with deregulated lipid metabolism.	[Christensen, Claus Uhrenholt; Glavind, Emilie; Thomsen, Karen Louise; Heeboll, Sara; Gronbaek, Henning] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Kim, Yong Ook; Schuppan, Detlef] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Mainz, Germany; [Kim, Yong Ook; Schuppan, Detlef] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany; [Schuppan, Detlef] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA USA; [Hamilton-Dutoit, Stephen] Aarhus Univ Hosp, Inst Pathol, Aarhus, Denmark; [Heegaard, Christian Wurtz] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Aarhus University; Aarhus University	Christensen, CU (corresponding author), Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark.	clausuc@gmail.com	Heegaard, Christian W/A-4814-2019; Gronbaek, Henning/AAJ-3202-2020	Gronbaek, Henning/0000-0001-8998-7910; Heeboll, Sara/0000-0002-3474-0379; Glavind, Emilie/0000-0003-4933-8064; Thomsen, Karen Louise/0000-0002-8118-4643; Wurtz Heegaard, Christian/0000-0002-7989-2624; Hamilton-Dutoit, Stephen/0000-0003-2158-3885	Novo Nordisk Foundation [NNF10oc1013267, Nnf14coc0012141]; Arla Foods Ingredients P/S	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arla Foods Ingredients P/S	Funding for this research was provided by The Novo Nordisk Foundation (grant numbers NNF10oc1013267 and Nnf14coc0012141) and Arla Foods Ingredients P/S.	Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Anderson RGW, 2003, TRENDS CELL BIOL, V13, P534, DOI 10.1016/j.tcb.2003.08.007; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Boadu E, 2006, J MOL MED, V84, P266, DOI 10.1007/s00109-005-0001-9; Boadu E, 2012, BBA-MOL CELL BIOL L, V1821, P396, DOI 10.1016/j.bbalip.2011.11.013; Bowden KL, 2011, J BIOL CHEM, V286, P30624, DOI 10.1074/jbc.M111.274381; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Dubland JA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00003; Fang C, 2012, CANCER RES, P72; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; Hannaford J, 2013, OBESITY, V21, P1586, DOI 10.1002/oby.20136; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Heeboll S, 2016, SCAND J GASTROENTERO, V51, P456, DOI 10.3109/00365521.2015.1107620; Heeboll S, 2015, PHARMACOL RES, V95-96, P34, DOI 10.1016/j.phrs.2015.03.005; Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077586; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liao YJ, 2015, INT J CANC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nielsen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027287; Sanchez-Muniz FJ, 2008, EUR J LIPID SCI TECH, V110, P295, DOI 10.1002/ejlt.200700280; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Thomsen KL, 2011, SCAND J CLIN LAB INV, V71, P150, DOI 10.3109/00365513.2010.547213; Thomsen KL, 2014, AM J PHYSIOL-GASTR L, V307, pG295, DOI 10.1152/ajpgi.00036.2014; Tomita K, 2014, HEPATOLOGY, V59, P154, DOI 10.1002/hep.26604; Twu YC, 2016, INT J MOL SCI, P17; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Yamanashi Y, 2012, HEPATOLOGY, V55, P953, DOI 10.1002/hep.24772; Yamanashi Y, 2011, GASTROENTEROLOGY, V140, P1664, DOI 10.1053/j.gastro.2011.01.050; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x	42	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0192728	10.1371/journal.pone.0192728	http://dx.doi.org/10.1371/journal.pone.0192728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522534	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800012
J	Li, MY; Chadda, KR; Matthews, GDK; Marr, CM; Huang, CLH; Jeevaratnam, K				Li, Mengye; Chadda, Karan R.; Matthews, Gareth D. K.; Marr, Celia M.; Huang, Christopher L. -H.; Jeevaratnam, Kamalan			Cardiac electrophysiological adaptations in the equine athlete-Restitution analysis of electrocardiographic features	PLOS ONE			English	Article							INDUCED ATRIAL-FIBRILLATION; PERFUSED MURINE HEARTS; T-WAVE ALTERNANS; LONG QT SYNDROME; VENTRICULAR ARRHYTHMIAS; SUDDEN-DEATH; SINUS NODE; FOLLOW-UP; HORSES; INTERVAL	Exercising horses uniquely accommodate 7-8-fold increases in heart rate (HR). The present experiments for the first time analysed the related adaptations in action potential (AP) restitution properties recorded by in vivo telemetric electrocardiography from Thoroughbred horses. The horses were subjected to a period of acceleration from walk to canter. The QRS durations, and QT and TQ intervals yielded AP conduction velocities, AP durations (APDs) and diastolic intervals respectively. From these, indices of active, lambda = QT/(QRS duration), and resting, lambda(0) = TQ/(QRS duration), AP wavelengths were calculated. Critical values of QT and TQ intervals, and of lambda and lambda(0) at which plots of these respective pairs of functions showed unity slope, were obtained. These were reduced by 38.9 +/- 2.7% and 86.2 +/- 1.8%, and 34.1 +/- 3.3% and 85.9 +/- 1.2%, relative to their resting values respectively. The changes in. were attributable to falls in QT interval rather than QRS duration. These findings both suggested large differences between the corresponding critical (129.1 +/- 10.8 or 117.4 +/- 5.6 bpm respectively) and baseline HRs (32.9 +/- 2.1 (n = 7) bpm). These restitution analyses thus separately identified concordant parameters whose adaptations ensure the wide range of HRs over which electrophysiological activation takes place in an absence of heart block or arrhythmias in equine hearts. Since the horse is amenable to this in vivo electrophysiological analysis and displays a unique wide range of heart rates, it could be a novel cardiac electrophysiology animal model for the study of sudden cardiac death in human athletes.	[Li, Mengye; Chadda, Karan R.; Matthews, Gareth D. K.; Huang, Christopher L. -H.; Jeevaratnam, Kamalan] Univ Cambridge, Physiol Lab, Cambridge, England; [Chadda, Karan R.; Jeevaratnam, Kamalan] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Marr, Celia M.] Rossdales Equine Hosp & Diagnost Ctr, Exning, Suffolk, England; [Huang, Christopher L. -H.] Univ Cambridge, Dept Biochem, Div Cardiovasc Biol, Cambridge, England	University of Cambridge; University of Surrey; University of Cambridge	Jeevaratnam, K (corresponding author), Univ Cambridge, Physiol Lab, Cambridge, England.; Jeevaratnam, K (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England.	drkamalanjeeva@gmail.com	Matthews, Gareth/GZK-6840-2022; Chadda, Karan/GZA-3251-2022	Marr, Celia/0000-0002-5093-5694; Chadda, Karan R/0000-0002-8060-8408; Jeevaratnam, Kamalan/0000-0002-6232-388X; Matthews, Gareth/0000-0001-8353-4806	Physiological Society at the University of Surrey; Wellcome Trust [105727/Z/14/Z]; Medical Research Council [MR/M001288/1]; British Heart Foundation [PG/14/79/31102]; Department of Preclinical Veterinary Sciences, School of Veterinary Medicine, University of Surrey; MRC [MR/M001288/1] Funding Source: UKRI	Physiological Society at the University of Surrey; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Department of Preclinical Veterinary Sciences, School of Veterinary Medicine, University of Surrey; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KRC was funded by the Physiological Society (www.physoc.org/) at the University of Surrey. GDKM was funded by the Wellcome Trust and CLHH is funded by the Medical Research Council (MR/M001288/1) (www.mrc.ac.uk/), Wellcome Trust (105727/Z/14/Z) (wellcome.ac.uk) and British Heart Foundation (PG/14/79/31102) (www.bhf.org.uk/). Department of Preclinical Veterinary Sciences, School of Veterinary Medicine, University of Surrey, provided travel and subsistence funding for KJ to undertake the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Banville I, 2004, J CARDIOVASC ELECTR, V15, P455, DOI 10.1046/j.1540-8167.2004.03330.x; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Birettoni F, 2007, VET RES COMMUN, V31, P273, DOI 10.1007/s11259-007-0045-0; Broux B, 2016, J VET INTERN MED, V30, P1253, DOI 10.1111/jvim.13957; Buhl R, 2013, J EQUINE VET SCI, V33, P590, DOI 10.1016/j.jevs.2012.09.009; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; D'Souza A, 2015, J PHYSIOL-LONDON, V593, P1749, DOI 10.1113/jphysiol.2014.284356; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; De Clercq D, 2008, J VET INTERN MED, V22, P1353, DOI 10.1111/j.1939-1676.2008.0202.x; Drezner JA, 2009, CIRCULATION, V120, P518, DOI 10.1161/CIRCULATIONAHA.109.855890; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Fossa AA, 2006, J PHARMACOL EXP THER, V316, P498, DOI 10.1124/jpet.105.095471; Fossa AA, 2014, ANN NONINVAS ELECTRO, V19, P582, DOI 10.1111/anec.12202; Gaeta SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00157; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Haugaard MM, 2015, J VET INTERN MED, V29, P339, DOI 10.1111/jvim.12496; Hood S, 1999, BRIT J SPORT MED, V33, P239, DOI 10.1136/bjsm.33.4.239; Hothi SS, 2008, PROG BIOPHYS MOL BIO, V98, P267, DOI 10.1016/j.pbiomolbio.2009.01.006; Huang CLH, 2017, J PHYSIOL-LONDON, V595, P2299, DOI 10.1113/JP273815; Janssen PML, 2016, CIRC RES, V119, P418, DOI 10.1161/CIRCRESAHA.116.309126; Kijtawornrat A, 2010, J PHARMACOL TOX MET, V61, P231, DOI 10.1016/j.vascn.2010.02.001; Lyle CH, 2011, EQUINE VET J, V43, P324, DOI 10.1111/j.2042-3306.2010.00164.x; Martin BB, 2000, J AM VET MED ASSOC, V216, P554, DOI 10.2460/javma.2000.216.554; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; Matthews GDK, 2012, J APPL PHYSIOL, V112, P1847, DOI 10.1152/japplphysiol.00039.2012; Noble D., 1979, INITIATION HEARTBEAT, Vxiii; NOBLE DENIS, 1966, ADVAN SCI, V23, P412; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; Ohmura H, 2000, J VET MED SCI, V62, P711, DOI 10.1292/jvms.62.711; Padrini R, 1997, PHARMACOL RES, V35, P409, DOI 10.1006/phrs.1997.0152; Pastore JM, 2006, HEART RHYTHM, V3, P711, DOI 10.1016/j.hrthm.2006.02.1034; Pedersen PJ, 2016, J VET CARDIOL, V18, P255, DOI 10.1016/j.jvc.2016.02.002; Platt SB, 1996, J CARDIOVASC ELECTR, V7, P144, DOI 10.1111/j.1540-8167.1996.tb00509.x; Qu ZL, 2006, J CARDIOVASC ELECTR, V17, P1042, DOI 10.1111/j.1540-8167.2006.00567.x; Rosenbaum DS, 1996, J CARDIOVASC ELECTR, V7, P1095, DOI 10.1111/j.1540-8167.1996.tb00487.x; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Ryan N, 2005, EQUINE VET J, V37, P265, DOI 10.2746/0425164054530713; Sabir IN, 2008, PFLUG ARCH EUR J PHY, V455, P653, DOI 10.1007/s00424-007-0327-y; Sabir IN, 2008, PFLUG ARCH EUR J PHY, V455, P637, DOI 10.1007/s00424-007-0326-z; Sabir IN, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00126; Sabir IN, 2008, PROG BIOPHYS MOL BIO, V98, P208, DOI 10.1016/j.pbiomolbio.2008.10.011; SALERNO JA, 1986, EUR HEART J, V7, P63; Tolkacheva EG, 2012, NONLINEAR DYNAM, V68, P347, DOI 10.1007/s11071-011-0241-x; van Loon G, 2004, EQUINE VET J, V36, P609, DOI 10.2746/0425164044864516; Wasfy Meagan M, 2016, Methodist Debakey Cardiovasc J, V12, P76, DOI 10.14797/mdcj-12-2-76; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Wolff L., 1950, ELECTROCARDIOGRAPHY, Vviii	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194008	10.1371/journal.pone.0194008	http://dx.doi.org/10.1371/journal.pone.0194008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522557	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800030
J	Yeh, CC; Su, FH; Tzeng, CR; Muo, CH; Wang, WC				Yeh, Chih-Ching; Su, Fu-Hsiung; Tzeng, Chii-Ruey; Muo, Chih-Hsin; Wang, Wen-Chang			Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; UTERINE ADENOMYOSIS; ADENOCARCINOMA; NATIONWIDE; DIAGNOSIS; PATHOGENESIS; ASSOCIATION; EXPRESSION; PROGNOSIS; GRIM-19	Objective Both adenomyosis and endometriosis are characterized by the presence of ectopic endometrial glands and stroma and have been suggested to share some characteristics with malignant tumors. Although accumulating evidence indicates that endometriosis is associated with some cancer types, the cancer risks in patients with adenomyosis have been rarely examined. In this study, we investigated the relationship between adenomyosis and risks of common cancers. Methods This study included a cohort of 12,447 women with adenomyosis but not endometriosis, born in 1951-1984, and a cohort of 124,470 adenomyosis-free women matched by birth year. Their medical records (collected between 1996 and 2011) were obtained from the National Health Insurance Research Database of Taiwan. We first compared the distribution of cancer-free survival (CFS) between cohorts with and without adenomyosis. Subsequently, within the adenomyosis cohort, we examined whether time-to-onset of the identified cancer type was correlated with time-to-onset of adenomyosis. The Cox proportional hazards model was used to compare the distribution of CFS between the adenomyosis and adenomyosis-free cohorts and between the early- and late-diagnosed adenomyosis groups. For comparison, we further evaluated the cancer risks for a cohort of 10,962 women with endometriosis but not adenomyosis and a birth-year matched cohort of 109,620 endometriosis-free women. Results Compared with adenomyosis-free women, patients with adenomyosis had higher risks of endometrial and thyroid cancers, with estimated hazard ratios (HRs) (95% confidence interval) of 2.19 (1.51-3.16) and 1.70 (1.29-2.24), respectively. For both cancers, distributions of CFS were not significantly different between the early-and late-diagnosed adenomyosis groups. Furthermore, compared with endometriosis-free women, patients with endometriosis had higher risks of endometrial and ovarian cancers, with HRs of 1.89 (1.07-3.35) and 2.01 (1.27-3.16), respectively. Conclusions Women with adenomyosis are at higher risks of endometrial and thyroid cancers, while women with endometriosis are at higher risks of endometrial and ovarian cancers.	[Yeh, Chih-Ching] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Su, Fu-Hsiung] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan; [Su, Fu-Hsiung] Fu Jen Catholic Univ Hosp, Div Family Med, Dept Community Med & Long Term Care, New Taipei, Taiwan; [Tzeng, Chii-Ruey] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Ctr Reprod Med & Sci, Taipei, Taiwan; [Tzeng, Chii-Ruey] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Wen-Chang] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan	Taipei Medical University; China Medical University Taiwan; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University	Wang, WC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.	wangwc@tmu.edu.tw	Su, Fu-Hsiung/AAO-5468-2021	Wang, Wen-Chang/0000-0003-3124-2136; Su, Fu-Hsiung/0000-0002-9867-7655	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; Taipei Medical University [TMU101-AE1-B67]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank Stroke Biosignature Project; Taipei Medical University	This study was supported by grants from the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), and Taipei Medical University (TMU101-AE1-B67) (WCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Benagiano G, 2014, HUM REPROD UPDATE, V20, P386, DOI 10.1093/humupd/dmt052; Boes AS, 2011, EUR J GYNAECOL ONCOL, V32, P431; Braganza MZ, 2014, CANCER PREV RES, V7, P418, DOI 10.1158/1940-6207.CAPR-13-0367; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Gizzo S, 2016, ONCOL LETT, V11, P1213, DOI 10.3892/ol.2015.4032; Gun I, 2012, MED GLAS, V9, P268; Kitawaki J, 2006, BEST PRACT RES CL OB, V20, P493, DOI 10.1016/j.bpobgyn.2006.01.010; Koike N, 2013, ONCOL REP, V29, P861, DOI 10.3892/or.2012.2184; Kok VC, 2015, INT J GYNECOL CANCER, V25, P968, DOI 10.1097/IGC.0000000000000454; Kvaskoff M, 2015, HUM REPROD UPDATE, V21, P500, DOI 10.1093/humupd/dmv013; Lee AW, 2016, FERTIL STERIL, V105, P35, DOI 10.1016/j.fertnstert.2015.09.023; Lee SM, 2010, CANCER NURS, V33, P310, DOI 10.1097/NCC.0b013e3181cd2844; Lee WL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001633; Li J, 2017, ONCOL LETT, V13, P2731, DOI 10.3892/ol.2017.5762; Lim H, 2017, JAMA-J AM MED ASSOC, V317, P1338, DOI 10.1001/jama.2017.2719; Lu Y, 2015, HUM MOL GENET, V24, P5955, DOI 10.1093/hmg/ddv306; Machida H, 2017, ARCH GYNECOL OBSTET, V295, P1459, DOI 10.1007/s00404-017-4375-z; Matsuo K, 2016, ANN SURG ONCOL, V23, P959, DOI 10.1245/s10434-015-4952-y; Matsuo K, 2014, ANN SURG ONCOL, V21, P4246, DOI 10.1245/s10434-014-3880-6; Melin A, 2007, HUM REPROD, V22, P3021, DOI 10.1093/humrep/dem209; Musa F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.051; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Sasaki T, 2001, PATHOL INT, V51, P308, DOI 10.1046/j.1440-1827.2001.01200.x; Shen GH, 2016, INT J CLIN EXP PATHO, V9, P11781; Taneichi A, 2014, INT J GYNECOL CANCER, V24, P1429, DOI 10.1097/IGC.0000000000000243; Templeman C, 2008, FERTIL STERIL, V90, P415, DOI 10.1016/j.fertnstert.2007.06.027; Vercellini P, 2006, BEST PRACT RES CL OB, V20, P465, DOI 10.1016/j.bpobgyn.2006.01.017; Wang J, 2016, FERTIL STERIL, V105, P1093, DOI 10.1016/j.fertnstert.2015.12.019; Wang KC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-831; Xie XC, 2017, ONCOTARGET, V8, P24882, DOI 10.18632/oncotarget.15079; Yi KW, 2015, FERTIL STERIL, V103; Yu HC, 2015, INT J GYNECOL CANCER, V25, P447, DOI 10.1097/IGC.0000000000000384; Yu TM, 2016, LANCET ONCOL, V17, P1419, DOI 10.1016/S1470-2045(16)30250-9; Zhu XL, 2016, INT J ONCOL, V48, P2321, DOI 10.3892/ijo.2016.3485	37	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194011	10.1371/journal.pone.0194011	http://dx.doi.org/10.1371/journal.pone.0194011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522577	gold, Green Submitted, Green Published			2022-12-26	WOS:000427030800031
J	Bhanjadeo, MM; Rath, K; Gupta, D; Pradhan, N; Biswal, SK; Mishra, BK; Subudhi, U				Bhanjadeo, Madhabi M.; Rath, Kalyani; Gupta, Dhirendra; Pradhan, Nilotpata; Biswal, Surendra K.; Mishra, Barada K.; Subudhi, Umakanta			Differential desulfurization of dibenzothiophene by newly identified MTCC strains: Influence of Operon Array	PLOS ONE			English	Article							DBT DESULFURIZATION; IMMOBILIZED CELLS; KINETIC-MODEL; BIODESULFURIZATION; FUELS; SYSTEM; GENES; OILS	Since the sulfur specific cleavage is vital for the organic sulfur removal from fossil fuel, we explored potential bacterial strains of MTCC (Microbial Type Culture Collection) to desulfurize the Dibenzothiophene (DBT) through C-S bond cleavage (4-S pathway). MTCC strains Rhodococcus rhodochrous (3552), Arthrobacter sulfureus (3332), Gordonia rubro-pertincta (289), and Rhodococcus erythropolis (3951) capable of growing in 0.5 mM DBT were examined for their desulfurization ability. The presence of dsz genes as well as the metabolites was screened by polymerase chain reaction (PCR) and HPLC, respectively. All these strains showed > 99% DBT desulfurization with 10 days of incubation in minimal. salt medium. From the HPLC analysis it was further revealed that these MTCC strains show differences in the end metabolites and desulfurize DBT differently following a variation in the regular 4-S pathway. These findings are also well corroborating with their respective organization of dszABC operons and their relative abundance. The above MTCC strains are capable of desulfurizing DBT efficiently and hence can be explored for biodesulfurization of petrochemicals and coal with an eco-friendly and energy economical process.	[Bhanjadeo, Madhabi M.; Rath, Kalyani; Pradhan, Nilotpata; Biswal, Surendra K.; Mishra, Barada K.; Subudhi, Umakanta] Inst Minerals & Mat Technol, CSIR, Bhubaneswar, Odisha, India; [Bhanjadeo, Madhabi M.; Pradhan, Nilotpata; Biswal, Surendra K.; Subudhi, Umakanta] Acad Sci & Innovat Res, New Delhi, India; [Gupta, Dhirendra] Inst Genom & Integrat Biol, CSIR, New Delhi, India; [Mishra, Barada K.] Indian Inst Technol Goa, Farmagudi, Ponda, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Minerals & Materials Technology (IMMT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) Goa	Subudhi, U (corresponding author), Inst Minerals & Mat Technol, CSIR, Bhubaneswar, Odisha, India.; Subudhi, U (corresponding author), Acad Sci & Innovat Res, New Delhi, India.	usubudhi@immt.res.in			Ministry of Steel, government of India [GAP-220]	Ministry of Steel, government of India	This study was funded by Ministry of Steel, government of India, GAP-220.	Abin-Fuentes A, 2014, BIOTECHNOL BIOENG, V111, P876, DOI 10.1002/bit.25148; Akhtar N, 2015, BIOTECHNOL LETT, V37, P837, DOI 10.1007/s10529-014-1736-6; Akhtar N, 2009, FEMS MICROBIOL LETT, V301, P95, DOI 10.1111/j.1574-6968.2009.01797.x; Alcon A, 2008, BIOCHEM ENG J, V39, P486, DOI 10.1016/j.bej.2007.11.005; Alves L, 2007, ENZYME MICROB TECH, V40, P1598, DOI 10.1016/j.enzmictec.2006.11.008; Alves L, 2015, RSC ADV, V5, P34047, DOI 10.1039/c4ra14216k; Alves L, 2011, BIORESOURCE TECHNOL, V102, P9162, DOI 10.1016/j.biortech.2011.06.070; Bahuguna A, 2011, J ENVIRON SCI-CHINA, V23, P975, DOI 10.1016/S1001-0742(10)60504-9; Bhasarkar JB, 2015, BIORESOURCE TECHNOL, V187, P369, DOI 10.1016/j.biortech.2015.03.102; Bordoloi NK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153547; Buzanello EB, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0257-8; Caro A, 2007, BIOCHEM ENG J, V35, P191, DOI 10.1016/j.bej.2007.01.013; Dai Y, 2014, APPL BIOCHEM BIOTECH, V174, P2236, DOI 10.1007/s12010-014-1184-8; Davoodi-Dehaghani F, 2010, BIORESOURCE TECHNOL, V101, P1102, DOI 10.1016/j.biortech.2009.08.058; Elmi F, 2015, WORLD J MICROB BIOT, V31, P813, DOI 10.1007/s11274-015-1835-0; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Gun G, 2015, TURK J CHEM, V39, P255, DOI 10.3906/kim-1407-52; Karimi E, 2017, ENG LIFE SCI, V17, P528, DOI 10.1002/elsc.201600080; Khedkar S, 2015, J APPL MICROBIOL, V118, P62, DOI 10.1111/jam.12665; Kilbane JJ, 2006, CURR OPIN BIOTECH, V17, P305, DOI 10.1016/j.copbio.2006.04.005; Labana S, 2005, LETT APPL MICROBIOL, V40, P159, DOI 10.1111/j.1472-765X.2004.01648.x; Li YB, 2010, 2010 INTERNATIONAL CONFERENCE ON E-EDUCATION, E-BUSINESS, E-MANAGEMENT AND E-LEARNING: IC4E 2010, PROCEEDINGS, P17, DOI 10.1109/IC4E.2010.73; Luo MF, 2003, BIOCHEM ENG J, V13, P1, DOI 10.1016/S1369-703X(02)00078-5; Maass D, 2014, APPL BIOCHEM BIOTECH, V174, P2079, DOI 10.1007/s12010-014-1189-3; Marinov SP, 2010, THERMOCHIM ACTA, V497, P46, DOI 10.1016/j.tca.2009.08.012; Martinez I, 2017, BIOCHEM ENG J, V117, P89, DOI 10.1016/j.bej.2016.11.004; Mishra S, 2014, FUEL, V117, P415, DOI 10.1016/j.fuel.2013.09.049; Mishra S, 2016, FUEL PROCESS TECHNOL, V152, P325, DOI 10.1016/j.fuproc.2016.06.025; Mohebali G, 2007, ENZYME MICROB TECH, V40, P578, DOI 10.1016/j.enzmictec.2006.05.012; Mohebali G, 2016, INT BIODETER BIODEGR, V110, P163, DOI 10.1016/j.ibiod.2016.03.011; Ohnishi A, 2011, APPL ENVIRON MICROB, V77, P5533, DOI 10.1128/AEM.00359-11; Papizadeh M, 2017, POLLUTION, V3, P101, DOI 10.7508/pj.2017.01.010; PIDDINGTON CS, 1995, APPL ENVIRON MICROB, V61, P468, DOI 10.1128/AEM.61.2.468-475.1995; Seo JS, 2006, INT BIODETER BIODEGR, V58, P36, DOI 10.1016/j.ibiod.2006.04.005; Shavandi M, 2010, APPL MICROBIOL BIOT, V87, P1455, DOI 10.1007/s00253-010-2605-4; Yu B, 2006, APPL ENVIRON MICROB, V72, P54, DOI 10.1128/AEM.72.1.54-58.2006	36	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192536	10.1371/journal.pone.0192536	http://dx.doi.org/10.1371/journal.pone.0192536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518089	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900008
J	Mor, Z; Aharon, AA; Sheffer, R; Nehama, H				Mor, Zohar; Aharon, Anat Amit; Sheffer, Rivka; Nehama, Haim			Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis	PLOS ONE			English	Article							HEALTH; OVERWEIGHT; MIGRATION; OUTCOMES; OBESITY; MOTHERS	Introduction Israel has absorbed >40,000 Eritrean undocumented migrants since 2007, while the majority live in the southern neighborhoods of Tel-Aviv. As non-citizens and citizens infants in Israel receive free preventive treatment at the mother and child health clinics (MCHC), this study aimed to compare development and growth achievements between children of Enitrean mothers (CE) to children of Israeli mothers (CI), and assess their compliance to routine follow-up and vaccination-timeliness. Methods This cohort study included all Israeli-born CE between 2009 and 2011, compared with a random sample of Cl and treated at the same MCHC and followed-up to the age of 30-months. Dependent outcomes included anthropometric measurements, developmental achievements and adherence to immunization schedule. Results Of all 271 CE who were compared with 293 Cl, no statistically significant differences were found in birth anthropometric measurements. Yet, CE had increased weight and length than Cl after reaching one year of age (p<0.05). CE were more likely to fail in tests assessing fine-motor skills, linguistic and socio-emotional domains than Cl, while no statistical difference was found in gross-motor achievements. At the end of follow-up, 203 (74.9%) of the CE and 271 (74.1%) of the Cl completed the vaccination schedule, p = 0.9. Conclusion CE had greater anthropometric measurements than Cl after one year of age, and showed higher impairments in fine motor, linguistic and socio-emotional domains. Adherence to vaccination was similar. The inequalities in child health should be responded in the MCTC, and Eritrean mothers should be trained with the current recommendations for child well-being.	[Mor, Zohar; Sheffer, Rivka] Tel Aviv Dept Hlth, Tel Aviv, Israel; [Mor, Zohar] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Aharon, Anat Amit] Tel Aviv Univ, Nursing Dept, Sackler Fac Med, Tel Aviv, Israel; [Aharon, Anat Amit; Nehama, Haim] Tel Aviv Municipal, Dept Publ Hlth, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Mor, Z (corresponding author), Tel Aviv Dept Hlth, Tel Aviv, Israel.; Mor, Z (corresponding author), Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel.	zmor100@gmail.com	Amit Aharon, Anat/AAE-3616-2019		Roter grant of Maccabi Health Services in Israel	Roter grant of Maccabi Health Services in Israel	The study was partially supported by the Roter grant of Maccabi Health Services in Israel. There was no additional external funding received for this study.	Barker DJP, 1998, MOTHERS BABIES HLTH; Bustreo F, 2015, ARCH DIS CHILD, V100, pS34, DOI 10.1136/archdischild-2013-305693; Fernando A, 2007, PEDIATR DRUGS, V9, P143; Fleischman Y, 2015, SOC SCI MED, V147, P89, DOI 10.1016/j.socscimed.2015.10.046; GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X; Greier K, 2014, WIEN KLIN WOCHENSCHR, V126, P95, DOI 10.1007/s00508-013-0474-4; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; International Organization for Migration (IOM), 2013, INT MIGR HLTH HUM RI; Jaeger FN, 2012, INT J PUBLIC HEALTH, V57, P659, DOI 10.1007/s00038-012-0375-8; Janevic T, 2011, SOC SCI MED, V73, P429, DOI 10.1016/j.socscimed.2011.05.041; Labree LJW, 2011, OBES REV, V12, pe535, DOI 10.1111/j.1467-789X.2010.00839.x; Lasserre AM, 2007, OBESITY, V15, P2912, DOI 10.1038/oby.2007.347; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Mor Z, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2421-y; Nakash O, 2016, J IMMIGR MINOR HEALT, V18, P1232, DOI 10.1007/s10903-016-0348-8; Research department of the Israeli Parliament, 2016, NOND MIGR S TEL AV; Schmied V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-163; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Stich HL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-188; Vaughn LM, 2010, FAM COMMUNITY HEALTH, V33, P318, DOI 10.1097/FCH.0b013e3181f3b2be; Wingate MS, 2006, SOC SCI MED, V62, P491, DOI 10.1016/j.socscimed.2005.06.015	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193219	10.1371/journal.pone.0193219	http://dx.doi.org/10.1371/journal.pone.0193219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5UV	29518105	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900017
J	Kaida, K; Abe, T				Kaida, Kosuke; Abe, Takashi			Attentional lapses are reduced by repeated stimuli having own-name during a monotonous task	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; IN-CAR COUNTERMEASURES; DRIVER SLEEPINESS; OBJECTIVE PERFORMANCE; BRIGHT LIGHT; 20-MIN NAP; TEST PVT; ALERTNESS; NIGHT; SENSITIVITY	The goal of the present study was to examine the effect of listening to self-relevant words (i.e., one's own name) on vigilant attention, arousal, and subjective sleepiness during performance of a psychomotor vigilance test (PVT). Twenty-one participants aged 20-26 years (22.2 +/- 1.76) performed a PVT in four experimental conditions: one in which their own full name was pronounced every 20 s in the stimuli epochs, one in which their full name was pronounced in inverted form, one in which beeps were played, and a control condition with no stimuli. Listening to personal names reduced attentional lapses during the PVT (i.e., the number of reaction times no less than 500 ms). The results are a first step in applying the name effect to technologies and devices aimed at maintaining arousal levels and preventing accidents during a monotonous task, such as driving.	[Kaida, Kosuke; Abe, Takashi] Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan; [Abe, Takashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kaida, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan.	kaida.kosuke@aist.go.jp	Abe, Takashi/AAJ-9367-2020; Kaida, Kosuke/A-9979-2017	Abe, Takashi/0000-0002-4100-1427; Kaida, Kosuke/0000-0002-8975-4794	JSPS KAKENHI [16K13511]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from JSPS KAKENHI, Grant Number 16K13511 (http://www.jsps.go.jp/english/) to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Anund A, 2008, J SLEEP RES, V17, P16, DOI 10.1111/j.1365-2869.2008.00633.x; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Buckley RJ, 2016, CONSCIOUS COGN, V45, P174, DOI 10.1016/j.concog.2016.09.002; Carleton RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058067; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Dinges DF, 1997, SLEEP, V20, P267; DRORY A, 1985, HUM FACTORS, V27, P201, DOI 10.1177/001872088502700207; Fan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080289; Fischer T, 2008, J COGNITIVE NEUROSCI, V20, P1443, DOI 10.1162/jocn.2008.20101; Garbarino S, 2004, SLEEP, V27, P1295, DOI 10.1093/sleep/27.7.1295; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; Hayashi M, 1998, PSYCHIAT CLIN NEUROS, V52, P203, DOI 10.1111/j.1440-1819.1998.tb01031.x; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Horne JA, 2004, PSYCHOPHYSIOLOGY, V41, P161, DOI 10.1046/j.1469-8986.2003.00130.x; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87, DOI 10.4992/jjpsy.57.87; Johnson AJ, 2012, PHYSIOL BEHAV, V105, P815, DOI 10.1016/j.physbeh.2011.10.020; Kaida K, 2006, SLEEP, V29, P462, DOI 10.1093/sleep/29.4.462; Kaida K, 2007, CLIN NEUROPHYSIOL, V118, P1324, DOI 10.1016/j.clinph.2007.03.004; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Levin I, 2005, APPL PSYCHOLINGUIST, V26, P463, DOI 10.1017/S0142716405050253; Matsumoto Y, 2002, NEUROSCI LETT, V326, P133, DOI 10.1016/S0304-3940(02)00335-X; Maycock G, 1996, J SLEEP RES, V5, P229, DOI 10.1111/j.1365-2869.1996.00229.x; McVay JC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00570; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Oron-Gilad T, 2008, ACCIDENT ANAL PREV, V40, P851, DOI 10.1016/j.aap.2007.09.026; Peiris MTR, 2006, J SLEEP RES, V15, P291, DOI 10.1111/j.1365-2869.2006.00545.x; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reyner LA, 1998, SLEEP, V21, P46; Reyner LA, 1997, PSYCHOPHYSIOLOGY, V34, P721, DOI 10.1111/j.1469-8986.1997.tb02148.x; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schmidt EA, 2009, ACCIDENT ANAL PREV, V41, P1087, DOI 10.1016/j.aap.2009.06.007; Schwarz JFA, 2012, J SLEEP RES, V21, P595, DOI 10.1111/j.1365-2869.2012.01009.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Stawarczyk D, 2014, ACTA PSYCHOL, V148, P25, DOI 10.1016/j.actpsy.2014.01.007; Tacikowski P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00194; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhao K, 2009, NEUROSCI LETT, V464, P57, DOI 10.1016/j.neulet.2009.07.017; Zhou X, 2012, J SLEEP RES, V21, P40, DOI 10.1111/j.1365-2869.2011.00924.x	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194065	10.1371/journal.pone.0194065	http://dx.doi.org/10.1371/journal.pone.0194065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513737	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800099
J	Mao, G; Srivastava, AS; Wu, SY; Kosek, D; Lindell, M; Kirsebom, LA				Mao, Guanzhong; Srivastava, Abhishek S.; Wu, Shiying; Kosek, David; Lindell, Magnus; Kirsebom, Leif A.			Critical domain interactions for type A RNase P RNA catalysis with and without the specificity domain	PLOS ONE			English	Article							CLEAVAGE-SITE SELECTION; METAL-ION BINDING; RIBONUCLEASE-P; ESCHERICHIA-COLI; MEDIATED CLEAVAGE; FUNCTIONAL RECONSTITUTION; PROTEIN COFACTORS; SUBSTRATE; RIBOZYME; ARCHITECTURE	The natural trans-acting ribozyme RNase P RNA (RPR) is composed of two domains in which the catalytic (C-) domain mediates cleavage of various substrates. The C-domain alone, after removal of the second specificity (S-) domain, catalyzes this reaction as well, albeit with reduced efficiency. Here we provide experimental evidence indicating that efficient cleavage mediated by the Escherichia coli C-domain (Eco CP RPR) with and without the C5 protein likely depends on an interaction referred to as the "P6-mimic". Moreover, the P18 helix connects the C-and S-domains between its loop and the P8 helix in the S-domain (the P8/P18-interaction). In contrast to the "P6-mimic", the presence of P18 does not contribute to the catalytic performance by the C-domain lacking the S-domain in cleavage of an all ribo model hairpin loop substrate while deletion or disruption of the P8/P18-interaction in full-size RPR lowers the catalytic efficiency in cleavage of the same model hairpin loop substrate in keeping with previously reported data using precursor tRNAs. Consistent with that P18 is not required for cleavage mediated by the C-domain we show that the archaeal Pyrococcus furiosus RPR C-domain, which lacks the P18 helix, is catalytically active in trans without the S-domain and any protein. Our data also suggest that the S-domain has a larger impact on catalysis for E. coli RPR compared to P. furiosus RPR. Finally, we provide data indicating that the absence of the S-domain and P18, or the P8/P18-interaction in full-length RPR influences the charge distribution near the cleavage site in the RPR-substrate complex to a small but reproducible extent.	[Mao, Guanzhong; Srivastava, Abhishek S.; Wu, Shiying; Kosek, David; Lindell, Magnus; Kirsebom, Leif A.] Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Srivastava, Abhishek S.] AstraZeneca R&D, Discovery Sci, Cambridge Sci Pk, Cambridge, England	AstraZeneca	Kirsebom, LA (corresponding author), Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	Leif.Kirsebom@icm.uu.se		, Leif/0000-0002-5092-512X; Kosek, David/0000-0002-0192-4761	Swedish Research Council (N/T) [621-2011-5848, 2016-04602]; Uppsala RNA Research Center (Swedish Research Council Linneus support) [349-2008-6593]; Carl Tryggers Foundation for Research [CTS 12:240]; Swedish Research Council (N/T); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research	Swedish Research Council (N/T)(Swedish Research Council); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research; Swedish Research Council (N/T)(Swedish Research Council); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research	This work was supported by the Swedish Research Council (N/T), Grant numbers 621-2011-5848 and 2016-04602, Uppsala RNA Research Center (Swedish Research Council Linneus support), Grant number 349-2008-6593 and the Carl Tryggers Foundation for Research Grant number CTS 12:240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues for discussions throughout this work. Dr V. Gopalan and Ms T. Bergfors are acknowledged for critical reading of the manuscript. We thank Dr A. C. Forster for discussions about the title. This work was supported by the Swedish Research Council (N/T), Uppsala RNA Research Center (Swedish Research Council Linneus support) and the Carl Tryggers Foundation for Research. LAK is a shareholder in Bioimics AB.	Brannvall M, 2007, J MOL BIOL, V372, P1149, DOI 10.1016/j.jmb.2007.07.030; Brannvall M, 2004, NUCLEIC ACIDS RES, V32, P5418, DOI 10.1093/nar/gkh883; Brannvall M, 1999, J MOL BIOL, V292, P53, DOI 10.1006/jmbi.1999.3048; Brannvall M, 2001, P NATL ACAD SCI USA, V98, P12943, DOI 10.1073/pnas.221456598; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Chan PP, 2012, RNA BIOL, V9, P1155, DOI 10.4161/rna.21502; Chen WY, 2010, NUCLEIC ACIDS RES, V38, P8316, DOI 10.1093/nar/gkq668; Cho IM, 2010, P NATL ACAD SCI USA, V107, P14573, DOI 10.1073/pnas.1005556107; Christian EL, 2006, RNA, V12, P1463, DOI 10.1261/rna.158606; CIESIOLKA J, 1994, EUR J BIOCHEM, V219, P49, DOI 10.1111/j.1432-1033.1994.tb19913.x; DOWD JE, 1965, J BIOL CHEM, V240, P863; Feltens R, 2003, P NATL ACAD SCI USA, V100, P5724, DOI 10.1073/pnas.0931462100; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Green CJ, 1996, NUCLEIC ACIDS RES, V24, P1497, DOI 10.1093/nar/24.8.1497; GUERRIERTAKADA C, 1992, P NATL ACAD SCI USA, V89, P1266, DOI 10.1073/pnas.89.4.1266; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1998, NUCLEIC ACIDS RES, V26, P4093, DOI 10.1093/nar/26.18.4093; HAAS ES, 1994, P NATL ACAD SCI USA, V91, P2527, DOI 10.1073/pnas.91.7.2527; HAAS ES, 1991, SCIENCE, V254, P853, DOI 10.1126/science.1719634; Hardt WD, 1996, J MOL BIOL, V259, P422, DOI 10.1006/jmbi.1996.0329; Hofstee BHJ., 1952, EVALUATION CONSTANTS; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Kikovska E, 2006, J MOL BIOL, V359, P572, DOI 10.1016/j.jmb.2006.03.040; Kikovska E, 2012, NUCLEIC ACIDS RES, V40, P2224, DOI 10.1093/nar/gkr1001; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Krummel DAP, 1999, P NATL ACAD SCI USA, V96, P11200, DOI 10.1073/pnas.96.20.11200; Kufel J, 1996, J MOL BIOL, V263, P685, DOI 10.1006/jmbi.1996.0608; Kufel J, 1998, RNA, V4, P777, DOI 10.1017/S1355838298970923; Lai LB, 2010, P NATL ACAD SCI USA, V107, P22493, DOI 10.1073/pnas.1013969107; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Li D, 2011, CHEMBIOCHEM, V12, P1536, DOI 10.1002/cbic.201100054; Li D, 2009, NUCLEIC ACIDS RES, V37, P231, DOI 10.1093/nar/gkn915; Loria A, 1999, BIOCHEMISTRY-US, V38, P8612, DOI 10.1021/bi990691f; Marszalkowski M, 2008, RNA, V14, P127, DOI 10.1261/rna.762508; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Persson T, 2003, J BIOL CHEM, V278, P43394, DOI 10.1074/jbc.M305939200; Pulukkunat DK, 2008, NUCLEIC ACIDS RES, V36, P4172, DOI 10.1093/nar/gkn360; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; SCHLEGL J, 1994, EMBO J, V13, P4863, DOI 10.1002/j.1460-2075.1994.tb06813.x; Sinapah S, 2011, NUCLEIC ACIDS RES, V39, P1105, DOI 10.1093/nar/gkq732; Stage-Zimmermann TK, 1998, RNA, V4, P875, DOI 10.1017/S1355838298980876; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; Walczyk D, 2016, RNA, V22, P1699, DOI 10.1261/rna.057422.116; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wu SY, 2014, NUCLEIC ACIDS RES, V42, P631, DOI 10.1093/nar/gkt853; Wu SY, 2012, J MOL BIOL, V422, P204, DOI 10.1016/j.jmb.2012.05.020; Wu SY, 2011, J MOL BIOL, V411, P384, DOI 10.1016/j.jmb.2011.05.049; Zahler NH, 2005, J MOL BIOL, V345, P969, DOI 10.1016/j.jmb.2004.10.080; 2010, PROTEIN REVIEWS, V10, P1	55	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192873	10.1371/journal.pone.0192873	http://dx.doi.org/10.1371/journal.pone.0192873			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509761	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200007
J	Pokhrel, V; DeLisi, NA; Danka, RG; Walker, TW; Ottea, JA; Healy, KB				Pokhrel, Vivek; DeLisi, Nicholas A.; Danka, Robert G.; Walker, Todd W.; Ottea, James A.; Healy, Kristen B.			Effects of truck-mounted, ultra low volume mosquito adulticides on honey bees (Apis mellifera) in a suburban field setting	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; NOZZLE SYSTEM; INSECTICIDE; EXPOSURE; HYMENOPTERA; APIDAE; PRODUCTIVITY; PYRETHROIDS; POPULATIONS; PESTICIDES	Few studies have examined the impact of mosquito adulticides on honey bees under conditions that reflect actual field exposure. Whereas several studies have evaluated the toxicity of mosquito control products on honey bees, most have been laboratory based and have focused solely on acute mortality as a measure of impact. The goal of this study was to determine effects of routine applications of truck-based ultra-low volume ( ULV) mosquito adulticides ( i.e., Scourge, Duet, and Deltagard) on honey bees in a suburban setting. The mosquito adulticides used in this study were pyrethroids with active ingredients resmethrin ( Scourge), prallethrin and sumithrin ( Duet), and deltamethrin ( Deltagard), in which resmethrin, prallethrin, and sumithrin were synergized with piperonyl butoxide. We measured and compared mortality and detoxification enzyme activities ( esterase and glutathione S-transferase) from sentinel beehives within and outside of mosquito control areas. Concurrently, colony health ( i.e., number of adult bees, brood quantity and brood quality) was compared throughout the study period. No significant differences were observed in honey bee mortality, colony health or detoxification enzyme activities between treated ( five sprayed areas each received one to three insecticide treatment) and control sites ( four unsprayed areas that did not receive insecticide treatment) over the seven week study period. However, our laboratory study showed that exposure to resmethrin, the active ingredient in Scourge, caused significant inhibition of esterase activity compared with the control group. Our findings suggest that proper application of truck based insecticides for mosquito control results in little or no exposure and therefore minimal effects on domestic honey bees.	[Pokhrel, Vivek; Ottea, James A.; Healy, Kristen B.] Louisiana State Univ, Agr Ctr, Dept Entomol, Baton Rouge, LA 70803 USA; [DeLisi, Nicholas A.] St Tammany Parish Mosquito Abatement Dist, Slidell, LA USA; [Danka, Robert G.] USDA ARS, Honey Bee Breeding Genet & Physiol Lab, Baton Rouge, LA USA; [Walker, Todd W.] East Baton Rouge Parish Mosquito Abatement & Rode, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA)	Pokhrel, V (corresponding author), Louisiana State Univ, Agr Ctr, Dept Entomol, Baton Rouge, LA 70803 USA.	vpokhr1@lsu.edu		Healy, Kristen/0000-0002-3208-6537	US Environmental Protection Agency (EPA) [83558201]; Louisiana State University Agricultural Center	US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Louisiana State University Agricultural Center	This work was funded by a grant from the US Environmental Protection Agency to assess the effects of mosquito adulticides on honey bees (EPA Grant#83558201 to KBH, TWW, and JAO) and by the Louisiana State University Agricultural Center. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Atkins E, P PAP ANN C CAL MOSQ; Badawy MEI, 2015, APIDOLOGIE, V46, P177, DOI 10.1007/s13592-014-0315-0; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; Boyce WM, 2007, J AM MOSQUITO CONTR, V23, P335, DOI 10.2987/8756-971X(2007)23[335:NEOTMA]2.0.CO;2; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; CARON DM, 1979, J ECON ENTOMOL, V72, P148, DOI 10.1093/jee/72.1.148; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Carvalho SM, 2013, ENVIRON TOXICOL CHEM, V32, P2117, DOI 10.1002/etc.2288; Chaskopoulou A, 2014, J MED ENTOMOL, V51, P720, DOI 10.1603/ME13242; Colburn R, 1970, MOSQUITO NEWS, V30; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Dauterman W., 1976, INSECTICIDE BIOCH PH, P149; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; GOMORI G, 1952, INT REV CYTOL, V1, P323, DOI 10.1016/S0074-7696(08)60016-9; GRANT DF, 1989, INSECT BIOCHEM, V19, P741, DOI 10.1016/0020-1790(89)90055-3; Hashimoto JH, 2003, SOCIOBIOL, V42; Hendriksma HP, 2010, J APICULT RES, V49, P215, DOI 10.3896/IBRA.1.49.2.13; Hester PG, 2001, J AM MOSQUITO CONTR, V17, P2; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; LOUCIF-AYAD W, 2008, EUR J SCI RES, V21, P642; Lu CS, 2014, B INSECTOL, V67, P125; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; PANKIW T, 1992, J ECON ENTOMOL, V85, P687, DOI 10.1093/jee/85.3.687; Rinkevich FD, 2017, B ENTOMOL RES, P1; Rumpf S, 1997, J ECON ENTOMOL, V90, P102, DOI 10.1093/jee/90.1.102; Sanchez- Bayo F, 2017, ENV RISK ASSESSMENT; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; Stark J, 2005, DECIS ENG, P1; Steinhauer N, COLONY LOSS 2014 201, P26; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Tew J., 1998, ALABAMA A M U AUBURN; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Womeldorf D.J., 1974, California Vector Views, V21, P51; Zhong H, 2004, J ECON ENTOMOL, V97, P1, DOI 10.1603/0022-0493-97.1.1; Zhong H, 2003, ARCH ENVIRON CON TOX, V45, P216, DOI 10.1007/s00244-002-0185-8	46	6	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193535	10.1371/journal.pone.0193535	http://dx.doi.org/10.1371/journal.pone.0193535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494661	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200062
J	Singh, M; Toribio, JA; Scott, AB; Groves, P; Barnes, B; Glass, K; Moloney, B; Black, A; Hernandez-Jover, M				Singh, Mini; Toribio, Jenny-Ann; Scott, Angela Bullanday; Groves, Peter; Barnes, Belinda; Glass, Kathryn; Moloney, Barbara; Black, Amanda; Hernandez-Jover, Marta			Assessing the probability of introduction and spread of avian influenza (AI) virus in commercial Australian poultry operations using an expert opinion elicitation	PLOS ONE			English	Article							HIGH-PATHOGENICITY; WILD BIRDS; CHICKENS; OUTBREAK; SURVEILLANCE; H5N1; EPIDEMIOLOGY; TRANSMISSION; FARMS; WATER	The objective of this study was to elicit experts' opinions and gather estimates on the perceived probability of introduction and spread of avian influenza (AI) virus in the Australian broiler and layer industry. Using a modified Delphi method and a 4-step elicitation process, 11 experts were asked to give initial individual estimates for the various pathways and practices in the presented scenarios using a questionnaire. Following this, a workshop was conducted to present group averages of estimates and discussion was facilitated to obtain final individual estimates. For each question, estimates for all experts were combined using a discrete distribution, with weights allocated representing the level of expertise. Indirect contact with wild birds either via a contaminated water source or fomites was considered the most likely pathway of introduction of low pathogenic avian influenza (LPAI) on poultry farms. Presence of a water body near the poultry farm was considered a potential pathway for introduction only when the operation type was free range and the water body was within 500m distance from the shed. The probability that LPAI will mutate to highly pathogenic avian influenza (HPAI) was considered to be higher in layer farms. Shared personnel, equipment and aerosol dispersion were the most likely pathways of shed to shed spread of the virus. For LPAI and HPAI spread from farm to farm, shared pick-up trucks for broiler and shared egg trays and egg pallets for layer farms were considered the most likely pathways. Findings from this study provide an insight on most influential practices on the introduction and spread of AI virus among commercial poultry farms in Australia, as elicited from opinions of experts. These findings will be used to support parameterization of a modelling study assessing the risk of AI introduction and spread among commercial poultry farms in Australia.	[Singh, Mini; Toribio, Jenny-Ann; Scott, Angela Bullanday; Groves, Peter] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Barnes, Belinda] Dept Agr & Water Resources, Quantitat Sci, Canberra, ACT, Australia; [Glass, Kathryn] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Moloney, Barbara] NSW Dept Primary Ind, Orange, NSW, Australia; [Black, Amanda] NSW Dept Primary Ind, Menangle, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Graham Ctr Agr Innovat, Locked Bag 588, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, NSW Dept Primary Ind, Locked Bag 588, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, Locked Bag 588, Wagga Wagga, NSW, Australia	University of Sydney; Australian National University; NSW Department of Primary Industries; NSW Department of Primary Industries; Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University	Singh, M (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	mini.singh@sydney.edu.au	Hernandez-Jover, Marta/F-8688-2016; Toribio, Jenny-Ann LML/B-5032-2011; Singh, Mini/AAE-5906-2019; Moloney, Barbara Jean/G-2003-2011	Moloney, Barbara Jean/0000-0002-4416-3579; Groves, Peter/0000-0002-8984-3156; Glass, Kathryn/0000-0001-5905-1310; Barnes, Belinda/0000-0003-3295-4063; Hernandez-Jover, Marta/0000-0001-8803-9062	Poultry Cooperative Research Centre (CRC) [1.5.7]; Woolworths Limited; Poultry CRC; Woolworths; Australian Government's Cooperative Research Centers Program	Poultry Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths Limited; Poultry CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths; Australian Government's Cooperative Research Centers Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was supported by Poultry Cooperative Research Centre (CRC), (Grant no: 1.5.7) and Woolworths Limited, https.//www.woolworths.com.au/. The Poultry CRC provided the majority of funding for this project included postdoc activities and a stipend for the PhD student, while Woolworths provided additional financial support for the project and a top up to the stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centers Program. The authors would also like to acknowledge financial support by Woolworths Limited. Finally, the authors would like to thank all the experts who participated in this study.	Adegboye OA, 2014, EPIDEMIOL INFECT, V142, P940, DOI 10.1017/S0950268813002136; AECL, 2016, AUSTR EGG CORP LTD A; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arzey G, 2005, AUST VET J, V83, P445, DOI 10.1111/j.1751-0813.2005.tb13090.x; Australia B, 2002, IMP FRESH BAN PHIL D; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Berhane Y, 2009, EMERG INFECT DIS, V15, P1492, DOI 10.3201/eid1509.080231; Bos MEH, 2007, VET RES, V38, P493, DOI 10.1051/vetres:2007008; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Comin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035956; de Jong MCM, 2009, REV SCI TECH OIE, V28, P333; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Edmunds KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072279; Fusaro A, 2016, J VIROLOGY; Gigerenzer G., 2002, RECKONING RISK LEARN; Gonzales JL, 2014, PREV VET MED, V117, P251, DOI 10.1016/j.prevetmed.2014.08.015; Grillo VL, 2015, AUST VET J, V93, P387, DOI 10.1111/avj.12379; Guerrini L, 2014, GEOSPATIAL HEALTH, V8, P445, DOI 10.4081/gh.2014.33; Haase M, 2010, INFECT GENET EVOL, V10, P1075, DOI 10.1016/j.meegid.2010.07.005; Hamilton SA, 2009, AUST VET J, V87, P165, DOI 10.1111/j.1751-0813.2009.00423.x; Hamilton SE., 2011, IMPACT SHRIMP FARMIN; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Haynes L, 2009, AUST VET J, V87, P266, DOI 10.1111/j.1751-0813.2009.00446.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hernandez-Jover M, 2015, PREV VET MED, V118, P128, DOI 10.1016/j.prevetmed.2014.11.018; Hop GE, 2010, PREV VET MED, V97, P270, DOI 10.1016/j.prevetmed.2010.09.016; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Kapczynski DR, 2013, J VIROL, V87, P9086, DOI 10.1128/JVI.00666-13; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kuster K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144533; Marangon S, 2006, DEV BIOLOGICALS, V124, P109; Marche S, 2014, TRANSBOUND EMERG DIS, V61, P526, DOI 10.1111/tbed.12056; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Nishiguchi A, 2005, REV SCI TECH OIE, V24, P933, DOI 10.20506/rst.24.3.1623; Nishiguchi A, 2009, J VET MED SCI, V71, P979, DOI 10.1292/jvms.71.979; Poolkhet C, 2013, RES VET SCI, V95, P82, DOI 10.1016/j.rvsc.2013.02.016; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Saito T, 2015, REV MED VIROL, V25, P388, DOI 10.1002/rmv.1857; Schaal T., 2016, AUSTR POULTR SCI S S, P190; Selleck PW, 2003, AVIAN DIS, V47, P806, DOI 10.1637/0005-2086-47.s3.806; Selleck PW, 1997, AUST VET J, V75, P289, DOI 10.1111/j.1751-0813.1997.tb10099.x; Shigematsu S, 2014, INFLUENZA OTHER RESP, V8, P123, DOI 10.1111/irv.12179; Shoham Dany, 2012, Influenza Res Treat, V2012, P912326, DOI 10.1155/2012/912326; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Ssematimba A, 2013, PREV VET MED, V109, P106, DOI 10.1016/j.prevetmed.2012.09.001; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; Vieira AR, 2009, AVIAN DIS, V53, P55, DOI 10.1637/8364-051608-Reg.1; Vose D., 2008, RISK ANAL QUANTITATI; Wakawa A. M., 2012, Sokoto Journal of Veterinary Sciences, V10, P40; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yoon H, 2005, J VET MED B, V52, P428, DOI 10.1111/j.1439-0450.2005.00891.x; Zhang HB, 2014, J GEN VIROL, V95, P1430, DOI 10.1099/vir.0.063438-0; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42	63	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193730	10.1371/journal.pone.0193730	http://dx.doi.org/10.1371/journal.pone.0193730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494696	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200091
J	Crooks, DR; Maio, N; Lane, AN; Jarnik, M; Higashi, RM; Haller, RG; Yang, Y; Fan, TWM; Linehan, WM; Rouault, TA				Crooks, Daniel R.; Maio, Nunziata; Lane, Andrew N.; Jarnik, Michal; Higashi, Richard M.; Haller, Ronald G.; Yang, Ye; Fan, Teresa W-M.; Linehan, W. Marston; Rouault, Tracey A.			Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; iron-sulfur protein; fatty acid metabolism; cell metabolism; metabolomics; mitochondria; lipid synthesis; iron deficiency; metabolic reprogramming; steatosis; iron; Fe-S clusters; mitochondrial disease; lipoic acid; fatty acid biosynthesis	FATTY LIVER-DISEASE; ACETYL-COA CARBOXYLASE; ACID BIOSYNTHESIS; 4FE-4S CLUSTER; HOMEOSTASIS; ISCU; PHOSPHOFRUCTOKINASE; BIOGENESIS; DEFICIENCY; MITOCHONDRIA	Iron-sulfur (Fe-S) clusters are ancient cofactors in cells and participate in diverse biochemical functions, including electron transfer and enzymatic catalysis. Although cell lines derived from individuals carrying mutations in the Fe-S cluster biogenesis pathway or siRNA-mediated knockdown of the Fe-S assembly components provide excellent models for investigating Fe-S cluster formation in mammalian cells, these experimental strategies focus on the consequences of prolonged impairment of Fe-S assembly. Here, we constructed and expressed dominant-negative variants of the primary Fe-S biogenesis scaffold protein iron-sulfur cluster assembly enzyme 2 (ISCU2) in human HEK293 cells. This approach enabled us to study the early metabolic reprogramming associated with loss of Fe-S-containing proteins in several major cellular compartments. Using multiple metabolomics platforms, we observed a approximate to 12-fold increase in intracellular citrate content in Fe-S-deficient cells, a surge that was due to loss of aconitase activity. The excess citrate was generated from glucose-derived acetyl-CoA, and global analysis of cellular lipids revealed that fatty acid biosynthesis increased markedly relative to cellular proliferation rates in Fe-S-deficient cells. We also observed intracellular lipid droplet accumulation in both acutely Fe-S-deficient cells and iron-starved cells. We conclude that deficient Fe-S biogenesis and acute iron deficiency rapidly increase cellular citrate concentrations, leading to fatty acid synthesis and cytosolic lipid droplet formation. Our findings uncover a potential cause of cellular steatosis in nonadipose tissues.	[Crooks, Daniel R.; Yang, Ye; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Maio, Nunziata; Rouault, Tracey A.] Eunice Kennedy Shriver NICHD, Sect Human Iron Metab, NIH, Bethesda, MD 20892 USA; [Jarnik, Michal] Eunice Kennedy Shriver NICHD, Sect Cell Biol & Metab, NIH, Bethesda, MD 20892 USA; [Lane, Andrew N.; Higashi, Richard M.] Univ Kentucky, Ctr Environm & Syst Biochem, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Lane, Andrew N.; Higashi, Richard M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Haller, Ronald G.] Vet Affairs North Texas Med Ctr, Dallas, TX 75216 USA; [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Kentucky; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rouault, TA (corresponding author), Eunice Kennedy Shriver NICHD, Sect Human Iron Metab, NIH, Bethesda, MD 20892 USA.	rouault@mail.nih.gov		Maio, Nunziata/0000-0002-6225-6058	NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA177558]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814, ZIAHD001602] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA177558, ZIABC011038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022191] Funding Source: NIH RePORTER	NCI, National Institutes of Health, Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Marc Warmoes, Qiushi Sun, Teresa Cassel, and Manik Ghosh for technical expertise and Hiroshi Nakai, Thanemoji Natarajan, and Wing-Hang Tong for providing ideas and suggestions that greatly improved the quality of this work. NMR spectra were recorded at the Center for Environmental Systems Biochemistry, University of Kentucky, supported in part by NCI, National Institutes of Health, Cancer Center Support Grant P30 CA177558.	Ahmed U, 2012, WORLD J GASTROENTERO, V18, P4651, DOI 10.3748/wjg.v18.i34.4651; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393; Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889; Fan T. W.-M., 2016, BIO-PROTOCOL, V6, pe1730, DOI [DOI 10.21769/BI0PR0T0C.1730, 10.21769/BioProtoc.1730, DOI 10.21769/BIOPROTOC.1730]; Fan TWM, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000893; Fan TWM, 2011, J BIOMOL NMR, V49, P267, DOI 10.1007/s10858-011-9484-6; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; GREGOLIN C, 1966, P NATL ACAD SCI USA, V56, P1751, DOI 10.1073/pnas.56.6.1751; Higashi Richard M, 2014, Methods Mol Biol, V1198, P147, DOI 10.1007/978-1-4939-1258-2_11; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Kim KS, 2018, HUM MOL GENET, V27, P837, DOI 10.1093/hmg/ddy004; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Krishnan B, 2002, HUM PATHOL, V33, P68, DOI 10.1053/hupa.2002.30210; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Lee J, 2015, BIOCHEM BIOPH RES CO, V464, P229, DOI 10.1016/j.bbrc.2015.06.121; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKENZIE CG, 1970, J LIPID RES, V11, P571; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2012, DIS MODEL MECH, V5, P860, DOI 10.1242/dmm.009829; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Obis E, 2014, FREE RADICAL BIO MED, V73, P21, DOI 10.1016/j.freeradbiomed.2014.04.016; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; PARMEGGIANI A, 1963, BIOCHEM BIOPH RES CO, V12, P268, DOI 10.1016/0006-291X(63)90294-8; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Siddique A, 2014, CLIN GASTROENTEROL H, V12, P1170, DOI 10.1016/j.cgh.2013.11.017; Spengler EK, 2015, MAYO CLIN PROC, V90, P1233, DOI 10.1016/j.mayocp.2015.06.013; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Sun RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01518-z; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tort F, 2016, J INHERIT METAB DIS, V39, P781, DOI 10.1007/s10545-016-9975-4; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wettersten HI, 2015, CANCER RES, V75, P2541, DOI 10.1158/0008-5472.CAN-14-1703; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	68	48	48	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8297	8311		10.1074/jbc.RA118.001885	http://dx.doi.org/10.1074/jbc.RA118.001885			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29523684	Green Published, hybrid			2022-12-26	WOS:000433224600034
J	Pollan, SG; Huang, FJ; Sperger, JM; Lang, JM; Morrissey, C; Cress, AE; Chu, CY; Bhowmick, NA; You, S; Freeman, MR; Spassov, DS; Moasser, MM; Carter, WG; Satapathy, SR; Shah, K; Knudsen, BS				Pollan, Sara G.; Huang, Fangjin; Sperger, Jamie M.; Lang, Joshua M.; Morrissey, Colm; Cress, Anne E.; Chu, C. Y.; Bhowmick, Neil A.; You, Sungyong; Freeman, Michael R.; Spassov, Danislav S.; Moasser, Mark M.; Carter, William G.; Satapathy, Shakti Ranjan; Shah, Kavita; Knudsen, Beatrice S.			Regulation of inside-out beta 1-integrin activation by CDCP1	ONCOGENE			English	Article							DOMAIN-CONTAINING PROTEIN-1; CYCLIN-DEPENDENT KINASE-5; SURFACE GLYCOPROTEIN CDCP1; PROSTATE-CANCER CELLS; PKC-DELTA; C-DELTA; INTEGRIN ACTIVATION; MONOCLONAL-ANTIBODY; ANOIKIS RESISTANCE; ANDROGEN RECEPTOR	Tumor metastasis depends on the dynamic regulation of cell adhesion through beta 1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. Here, we demonstrate reduced CDCP1 expression in high-grade, primary prostate cancers, circulating tumor cells and tumor metastases of patients with castrate-resistant prostate cancer. CDCP1 is expressed in epithelial and not mesenchymal cells, and its cell surface and mRNA expression declines upon stimulation with TGF beta 1 and epithelial-to-mesenchymal transition. Silencing of CDCP1 in DU145 and PC3 cells resulted in 3.4-fold higher proliferation of non-adherent cells and 4.4-fold greater anchorage independent growth. CDCP1-silenced tumors grew in 100% of mice, compared to 30% growth of CDCP1-expressing tumors. After CDCP1 silencing, cell adhesion and migration diminished 2.1-fold, caused by loss of inside-out activation of beta 1-integrin. We determined that the loss of CDCP1 reduces CDK5 kinase activity due to the phosphorylation of its regulatory subunit, CDK5R1/p35, by c-SRC on Y234. This generates a binding site for the C2 domain of PKC delta, which in turn phosphorylates CDK5 on T77. The resulting dissociation of the CDK5R1/CDK5 complex abolishes the activity of CDK5. Mutations of CDK5-T77 and CDK5R1-Y234 phosphorylation sites re-establish the CDK5/CDKR1 complex and the inside-out activity of beta 1-integrin. Altogether, we discovered a new mechanism of regulation of CDK5 through loss of CDCP1, which dynamically regulates beta 1-integrin in non-adherent cells and which may promote vascular dissemination in patients with advanced prostate cancer.	[Pollan, Sara G.; Huang, Fangjin; Chu, C. Y.; Bhowmick, Neil A.; You, Sungyong; Freeman, Michael R.; Knudsen, Beatrice S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Sperger, Jamie M.; Lang, Joshua M.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Morrissey, Colm] Univ Washington, Seattle, WA 98195 USA; [Cress, Anne E.] Univ Arizona, Ctr Canc, Tucson, AZ 85704 USA; [Spassov, Danislav S.; Moasser, Mark M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Carter, William G.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Satapathy, Shakti Ranjan; Shah, Kavita] Purdue Univ, W Lafayette, IN 47907 USA	Cedars Sinai Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of Arizona; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Knudsen, BS (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.	Beatrice.Knudsen@cshs.org	Shah, Kavita/Y-9755-2019; Spassov, Danislav S/GQA-4368-2022; Bhowmick, Neil/AAA-7302-2019; Satapathy, Shakti Ranjan/L-3124-2018; Cress, Anne/V-6527-2019; You, Sungyong/AAJ-7372-2020; Satapathy, Shakti Ranjan/AAB-5787-2021	Shah, Kavita/0000-0002-0451-1305; Spassov, Danislav S/0000-0002-6680-877X; Bhowmick, Neil/0000-0001-8747-5989; Satapathy, Shakti Ranjan/0000-0002-3212-8960; Cress, Anne/0000-0001-6194-0061; You, Sungyong/0000-0003-3513-1783; Satapathy, Shakti Ranjan/0000-0002-3212-8960	Pacific Northwest Prostate Cancer SPORE [P50CA97186]; Richard M. LUCAS Foundation; Department of Defense Synergistic Idea Development Award [W81XWH-08-1-0268]; Cedars-Sinai Medical Center; NATIONAL CANCER INSTITUTE [P50CA097186, R01CA159406] Funding Source: NIH RePORTER	Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Richard M. LUCAS Foundation; Department of Defense Synergistic Idea Development Award(United States Department of Defense); Cedars-Sinai Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We heartily acknowledge Wen-Chin Huang for assistance in animal surgery, L. Chung for support in in vivo experiments, and to C. Pospisil for cloning PKCd mutant with inactive kinase into vector. We thank the patients and their families, Robert Vessella, Eva Corey, Celestia Higano, Bruce Montgomery, Peter Nelson, Paul Lange, Martine Roudier, and Lawrence True for their contributions to the University of Washington Medical Center Prostate Cancer Donor Rapid Autopsy Program supported by funding by the Pacific Northwest Prostate Cancer SPORE (P50CA97186) and the Richard M. LUCAS Foundation. We are thankful to Jennifer Kitchel and the Biobank and Translational Research Core at Cedars-Sinai Medical Center for xenograft embedding, tissue processing, and IHC staining. This work was supported by Department of Defense Synergistic Idea Development Award W81XWH-08-1-0268 and start-up funding from Cedars-Sinai Medical Center.	Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Bosutti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075538; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cantu E, 2013, AM J TRANSPLANT, V13, P1898, DOI 10.1111/ajt.12283; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Chang KH, 2011, MOL BIOL CELL, V22, P1452, DOI 10.1091/mbc.E10-07-0654; Das L, 2017, J CELL BIOCHEM, V118, P1038, DOI 10.1002/jcb.25673; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dickreuter E, 2016, ONCOGENE, V35, P1353, DOI 10.1038/onc.2015.212; Dong Y, 2012, J BIOL CHEM, V287, P9792, DOI 10.1074/jbc.M111.335448; Fukuchi K, 2010, MOL PHARMACEUT, V7, P245, DOI 10.1021/mp900236t; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Gao C, 2002, MOL CANCER RES, V1, P12; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; GLASER KB, 1993, BIOCHEM PHARMACOL, V45, P711, DOI 10.1016/0006-2952(93)90147-O; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hoffmann A, 2017, US Patent, Patent No. 9555110; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Jin J, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931629; Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kimura H, 2006, LEUKEMIA, V20, P1551, DOI 10.1038/sj.leu.2404312; Knudsen BS, 2009, APPL IMMUNOHISTO M M, V17, P57, DOI 10.1097/PAI.0b013e3181816ae2; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; Li XY, 2016, ONCOTARGET, V7, P12869, DOI 10.18632/oncotarget.7331; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Mamat S, 2010, ONCOL REP, V23, P1221, DOI 10.3892/or_00000753; Minciacchi VR, 2017, PROSTATE CANCER P D, V20, P251, DOI 10.1038/pcan.2017.7; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nakano N, 2005, BRIT J DERMATOL, V153, P37, DOI 10.1111/j.1365-2133.2005.06583.x; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Ohlsson L, 2012, INT J CANCER, V130, P1833, DOI 10.1002/ijc.26182; Orchard-Webb DJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-754; Parvani JG, 2013, MOL BIOL CELL, V24, P3449, DOI 10.1091/mbc.E12-10-0776; Provasi D, 2014, PROTEINS, V82, P3231, DOI 10.1002/prot.24540; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Rai AC, 2014, BIOMETALS, V27, P1231, DOI 10.1007/s10534-014-9785-9; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Sato K, 2007, J NEUROSCI RES, V85, P3071, DOI 10.1002/jnr.21438; Sawada G, 2014, ANN SURG ONCOL, V21, pS640, DOI 10.1245/s10434-014-3740-4; Schehr JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159397; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Siva AC, 2008, J IMMUNOL METHODS, V330, P109, DOI 10.1016/j.jim.2007.11.008; Spassov DS, 2012, ONCOGENE, V31, P419, DOI 10.1038/onc.2011.246; Spassov DS, 2013, CANCER RES, V73, P1168, DOI 10.1158/0008-5472.CAN-12-2496; Spassov DS, 2011, CELL CYCLE, V10, P1225, DOI 10.4161/cc.10.8.15343; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Sperger JM, 2016, CLIN CANCER RES, V23, P746; Stahelin RV, 2012, J BIOL CHEM, V287, P30518, DOI 10.1074/jbc.M112.391557; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Twardowski PW, 2013, ANTI-CANCER DRUG, V24, P743, DOI 10.1097/CAD.0b013e328361feb0; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Wright HJ, 2016, ONCOGENE, V35, P4762, DOI 10.1038/onc.2016.7; Yang J, 2013, ANAT REC, V296, P1501, DOI 10.1002/ar.22769; Yang LF, 2015, ONCOTARGET, V6, P43743, DOI 10.18632/oncotarget.6193; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119	78	15	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2817	2836		10.1038/s41388-018-0142-2	http://dx.doi.org/10.1038/s41388-018-0142-2			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511352	Green Accepted			2022-12-26	WOS:000432929800005
J	Liu, YC; Huang, Y				Liu, Yanchao; Huang, Ying			Uncovering the mechanistic basis for specific recognition of monomethylated H3K4 by the CW domain of Arabidopsis histone methyltransferase SDG8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; histone modification; epigenetics; Arabidopsis thaliana; chromatin modification; ASHH2; CW domain; H3K4me1 reader; recognition of low methylation level; SDG8	CHROMATIN MODIFICATIONS; EPIGENETIC REGULATION; STRUCTURAL INSIGHT; GENE-EXPRESSION; METHYLATION; REPRESSION; FAMILY; TRANSCRIPTION; ENGAGEMENT; LANDSCAPE	Chromatin consists of DNA and histones, and specific histone modifications that determine chromatin structure and activity are regulated by three types of proteins, called writer, reader, and eraser. Histone reader proteins from vertebrates, vertebrate-infecting parasites, and higher plants possess a CW domain, which has been reported to read histone H3 lysine 4 (H3K4). The CW domain of Arabidopsis SDG8 (also called ASHH2), a histone H3 lysine 36 methyltransferase, preferentially binds monomethylated H3K4 (H3K4me1), unlike the mammalian CW domain protein, which binds trimethylated H3K4 (H3K4me3). However, the molecular basis of the selective binding by the CW domain of SDG8 (SDG8-CW) remains unclear. Here, we solved the 1.6--resolution structure of SDG8-CW in complex with H3K4me1, which revealed that residues in the C-terminal -helix of SDG8-CW determine binding specificity for low methylation levels at H3K4. Moreover, substitutions of key residues, specifically Ile-915 and Asn-916, converted SDG8-CW binding preference from H3K4me1 to H3K4me3. Sequence alignment and mutagenesis studies revealed that the CW domain of SDG725, the homolog of SDG8 in rice, shares the same binding preference with SDG8-CW, indicating that preference for low methylated H3K4 by the CW domain of ASHH2 homologs is conserved among higher-order plants. Our findings provide first structural insights into the molecular basis for specific recognition of monomethylated H3K4 by the H3K4me1 reader protein SDG8 from Arabidopsis.	[Liu, Yanchao; Huang, Ying] Univ Chinese Acad Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Shanghai Key Lab Mol Androl, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, Y (corresponding author), Univ Chinese Acad Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Shanghai Key Lab Mol Androl, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai 201210, Peoples R China.	huangy@sibcb.ac.cn	Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874	National Natural Science Foundation of China [91640102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010202]; Ministry of Science and Technology of the People's Republic of China [2012CB910500]; Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	This work was supported by grants from the National Natural Science Foundation of China (91640102 to Y. H.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010202 to Y. H.), the Ministry of Science and Technology of the People's Republic of China (2012CB910500 to Y. H.), the Chinese Academy of Sciences Facility-based Open Research Program, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Andrews FH, 2016, CELL REP, V16, P3195, DOI 10.1016/j.celrep.2016.08.050; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Cazzonelli CI, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00533; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Cazzonelli CI, 2009, PLANT SIGNAL BEHAV, V4, P339, DOI 10.4161/psb.4.4.8193; Chen F, 2013, CELL RES, V23, P306, DOI 10.1038/cr.2013.17; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong GF, 2008, BIOCHEM BIOPH RES CO, V373, P659, DOI 10.1016/j.bbrc.2008.06.096; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; He FH, 2010, STRUCTURE, V18, P1127, DOI 10.1016/j.str.2010.06.012; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hoppmann V, 2011, EMBO J, V30, P1939, DOI 10.1038/emboj.2011.108; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0640-2; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Liu YL, 2016, CURR PROTEIN PEPT SC, V17, P497, DOI 10.2174/1389203717666160125115130; Liu YL, 2016, J BIOL CHEM, V291, P9000, DOI 10.1074/jbc.M116.718973; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel DJ, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018754; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Sequeira-Mendes J, 2014, PLANT CELL, V26, P2351, DOI 10.1105/tpc.114.124578; Shafiq S, 2014, NEW PHYTOL, V201, P312, DOI 10.1111/nph.12493; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Tang XR, 2012, J EXP BOT, V63, P1391, DOI 10.1093/jxb/err383; Wang GL, 2010, ANAT REC, V293, P1002, DOI 10.1002/ar.21119; Wang XL, 2014, MOL PLANT, V7, P1303, DOI 10.1093/mp/ssu056; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Z, 2017, PLANT SCI, V263, P168, DOI 10.1016/j.plantsci.2017.06.013; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	60	19	21	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6470	6481		10.1074/jbc.RA117.001390	http://dx.doi.org/10.1074/jbc.RA117.001390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496997	hybrid, Green Published			2022-12-26	WOS:000431108600020
J	Robinson, JI; Beverley, SM				Robinson, John I.; Beverley, Stephen M.			Concentration of 2 ' C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; viral polymerase; nucleoside; nucleotide analogue; parasite metabolism; RNA virus; ds RNA virus; Totivirus; trypanosomatid protozoa	CAPSID ENDORIBONUCLEASE; SACCHAROMYCES-CEREVISIAE; CUTANEOUS LEISHMANIASIS; ADENOSINE KINASE; IN-VITRO; REPLICATION; MECHANISM; DONOVANI; ANALOGS; IDENTIFICATION	Leishmania is a widespread trypanosomatid protozoan parasite causing significant morbidity and mortality in humans. The endobiont dsRNA virus Leishmania RNA virus 1 (LRV1) chronically infects some strains, where it increases parasite numbers and virulence in murine leishmaniasis models, and correlates with increased treatment failure in human disease. Previously, we reported that 2-C-methyladenosine (2CMA) potently inhibited LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis, leading to viral eradication at concentrations above 10 m. Here we probed the cellular mechanisms of 2CMA inhibition, involving metabolism, accumulation, and inhibition of the viral RNA-dependent RNA polymerase (RDRP). Activation to 2CMA triphosphate (2CMA-TP) was required, as 2CMA showed no inhibition of RDRP activity from virions purified on cesium chloride gradients. In contrast, 2CMA-TP showed IC50 values ranging from 150 to 910 m, depending on the CsCl density of the virion (empty, ssRNA-, and dsRNA-containing). Lgy parasites incubated in vitro with 10 m 2CMA accumulated 2CMA-TP to 410 m, greater than the most sensitive RDRP IC50 measured. Quantitative modeling showed good agreement between the degree of LRV1 RDRP inhibition and LRV1 levels. These results establish that 2CMA activity is due to its conversion to 2CMA-TP, which accumulates to levels that inhibit RDRP and cause LRV1 loss. This attests to the impact of the Leishmania purine uptake and metabolism pathways, which allow even a weak RDRP inhibitor to effectively eradicate LRV1 at micromolar concentrations. Future RDRP inhibitors with increased potency may have potential therapeutic applications for ameliorating the increased Leishmania pathogenicity conferred by LRV1.	[Robinson, John I.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Sch Med, Campus Box 8230,660 S Euclid Ave, Washington, MO 63110 USA.	stephen.beverley@wustl.edu		Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [R01AI029646, R56AI099364]; Sigma-Aldrich Predoctoral fellowship; Sondra Schlesinger Graduate Student fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099364, R01AI029646, R01AI130222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigma-Aldrich Predoctoral fellowship; Sondra Schlesinger Graduate Student fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI029646 and R56AI099364 (to S. M. B.) and Sigma-Aldrich Predoctoral and Sondra Schlesinger Graduate Student fellowships (to J. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354; ADLER J, 1976, J VIROL, V17, P472, DOI 10.1128/JVI.17.2.472-476.1976; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ARMSTRONG TC, 1993, P NATL ACAD SCI USA, V90, P1736, DOI 10.1073/pnas.90.5.1736; ARMSTRONG TC, 1994, J PARASITOL, V80, P1030, DOI 10.2307/3283454; AU JLS, 1989, CLIN CHEM, V35, P48; Banuls AL, 2011, CLIN MICROBIOL INFEC, V17, P1451, DOI 10.1111/j.1469-0691.2011.03640.x; BHAUMIK D, 1988, MOL BIOCHEM PARASIT, V28, P181, DOI 10.1016/0166-6851(88)90002-3; Boitz JM, 2013, MOL BIOCHEM PARASIT, V190, P51, DOI 10.1016/j.molbiopara.2013.06.005; Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355; Brettmann EA, 2016, P NATL ACAD SCI USA, V113, P11998, DOI 10.1073/pnas.1615085113; CADD TL, 1994, J VIROL, V68, P358, DOI 10.1128/JVI.68.1.358-365.1994; Cantanhede LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004079; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Castellucci LC, 2014, MEM I OSWALDO CRUZ, V109, P279, DOI 10.1590/0074-0276140028; Castiglioni P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005240; DATTA AK, 1987, J BIOL CHEM, V262, P5515; Eldrup AB, 2004, J MED CHEM, V47, P5284, DOI 10.1021/jm040068f; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; Eren RO, 2016, CELL HOST MICROBE, V20, P318, DOI 10.1016/j.chom.2016.08.001; ESTEBAN R, 1986, MOL CELL BIOL, V6, P1552, DOI 10.1128/MCB.6.5.1552; FERNANDEZLARSSON R, 1989, ANTIMICROB AGENTS CH, V33, P1668, DOI 10.1128/AAC.33.10.1668; Fox J., 2019, R COMPANION APPL REG, V.; Freitas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124183; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Ginouves M, 2016, AM J TROP MED HYG, V94, P102, DOI 10.4269/ajtmh.15-0419; Hartley MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005852; Hartley MA, 2014, TRENDS PARASITOL, V30, P412, DOI 10.1016/j.pt.2014.05.006; Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020; Ito MM, 2015, BRAZ J OTORHINOLAR, V81, P533, DOI 10.1016/j.bjorl.2015.07.014; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kim SG, 2005, PACE, V28, P1, DOI 10.1111/j.1540-8159.2004.09533.x; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Kuhlmann FM, 2017, P NATL ACAD SCI USA, V114, pE811, DOI 10.1073/pnas.1619114114; LAFON SW, 1985, J BIOL CHEM, V260, P9660; Lee SE, 1996, J BIOCHEM-TOKYO, V120, P22, DOI 10.1093/oxfordjournals.jbchem.a021387; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; MacBeth KJ, 1997, J BIOCHEM-TOKYO, V122, P193, DOI 10.1093/oxfordjournals.jbchem.a021728; MACBETH KJ, 1995, P NATL ACAD SCI USA, V92, P8994, DOI 10.1073/pnas.92.19.8994; McGuigan C, 2010, J MED CHEM, V53, P4949, DOI 10.1021/jm1003792; MOAL J, 1989, COMP BIOCHEM PHYS B, V93, P307, DOI 10.1016/0305-0491(89)90086-2; Murakami E, 2007, ANTIMICROB AGENTS CH, V51, P503, DOI 10.1128/AAC.00400-06; OLIVER SG, 1977, J BACTERIOL, V130, P1303, DOI 10.1128/JB.130.3.1303-1309.1977; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Parmentier L, 2016, AM J TROP MED HYG, V94, P840, DOI 10.4269/ajtmh.15-0803; Pigott D. M., 2014, ELIFE, V3; RAINEY P, 1983, P NATL ACAD SCI-BIOL, V80, P288, DOI 10.1073/pnas.80.1.288; Pereira LDR, 2013, MEM I OSWALDO CRUZ, V108, P665, DOI 10.1590/0074-0276108052013021; RANKIN JT, 1989, VIROLOGY, V168, P147, DOI 10.1016/0042-6822(89)90413-3; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ro Y, 2003, J MICROBIOL, V41, P239; Ro YT, 2004, EXP MOL MED, V36, P145, DOI 10.1038/emm.2004.21; Ro YT, 1997, J VIROL, V71, P8991, DOI 10.1128/JVI.71.12.8991-8998.1997; Ro YT, 2000, J VIROL, V74, P130, DOI 10.1128/JVI.74.1.130-138.2000; Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schriefer A, 2008, CURR OPIN INFECT DIS, V21, P483, DOI 10.1097/QCO.0b013e32830d0ee8; SCOTTI PD, 1985, J VIROL METHODS, V12, P149, DOI 10.1016/0166-0934(85)90015-1; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596; TARR PI, 1988, P NATL ACAD SCI USA, V85, P9572, DOI 10.1073/pnas.85.24.9572; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; WIDMER G, 1990, J VIROL, V64, P3712, DOI 10.1128/JVI.64.8.3712-3715.1990; WIDMER G, 1995, NUCLEIC ACIDS RES, V23, P2300, DOI 10.1093/nar/23.12.2300; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979; Zangger H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002006; Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695	72	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6460	6469		10.1074/jbc.RA117.001515	http://dx.doi.org/10.1074/jbc.RA117.001515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511088	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000431108600019
J	Sinha, R; Weissenburger-Moser, LA; Clarke, JL; Smith, LM; Heires, AJ; Rornberger, DJ; Levan, TD				Sinha, Rohita; Weissenburger-Moser, Lisa A.; Clarke, Jennifer L.; Smith, Lynette M.; Heires, Art J.; Rornberger, Debra J.; LeVan, Tricia D.			Short term dynamics of the sputum microbiome among COPD patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HEALTHY NONSMOKERS; AIRWAY MICROBIOTA; LUNG MICROBIOME; EXACERBATIONS; SMOKERS	Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. The complexity of the lung microbial community in COPD patients has been highlighted in recent years. Evidence suggests that trans plantation, medications, age, and disease severity influence microbial community membership. However, the dynamics of the lung microbiome in stable COPD patients remain poorly understood. In this study, we completed a longitudinal 16S ribosomal RNA survey of the lung microbiome on replicate sputum samples collected from 4 former smokers with COPD (Stage 2) within a 2-day time period. Samples from each individual over the two-day period were similar based on a -diversity, principle component analysis and taxonomy at the phyla and genera level. Sputum samples from COPD patients were also collected between 2-9 months of follow-up. Data suggest an increased variability of the sputum microbiota when comparing samples collected <= 3 months compared to those collected >= 4 months; however, no statistically significant shifts in the abundance (>2-fold) of taxa between the two time points was observed. Bacterial composition and the number of operational taxonomic units (OTUs) remained similar over time. Results from this study suggest that the sputum microbiome,is relatively stable in clinically stable COPD patients (Stage 2). This study furthers our understanding of the dynamics of the lung microbiome in CORD patients.	[Sinha, Rohita; Clarke, Jennifer L.; LeVan, Tricia D.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Weissenburger-Moser, Lisa A.] Univ Nebraska Med Ctr, Dept Epidemiol, Omaha, NE USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Heires, Art J.; Rornberger, Debra J.; LeVan, Tricia D.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Rornberger, Debra J.; LeVan, Tricia D.] Vet Nebraska Western Iowa Healthcare Syst, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Levan, TD (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.; Levan, TD (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.; Levan, TD (corresponding author), Vet Nebraska Western Iowa Healthcare Syst, Omaha, NE 68105 USA.	tlevan@unmc.edu		Clarke, Jennifer/0000-0002-2723-7249	VA Merit Awards [1101 CX000434-01]; Central States-Center for Agriculture, Safety and Health (CS-CASH); National Institute for General Medical Science (NIGMS) [INBRE-P20GM103427-14, COBRE 1 P3OGM1 10768-01]; Fred & Pamela Buffett Cancer Center [P30CA036727]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH010162] Funding Source: NIH RePORTER	VA Merit Awards; Central States-Center for Agriculture, Safety and Health (CS-CASH); National Institute for General Medical Science (NIGMS); Fred & Pamela Buffett Cancer Center; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	The authors would like to acknowledge their VA Merit funding for this collaboration [VA Merit Awards to TDL (1101 CX000434-01) and DJR], as well as funding from the Central States-Center for Agriculture, Safety and Health (CS-CASH). The University of Nebraska DNA Sequencing Core receives partial support from the National Institute for General Medical Science (NIGMS) INBRE-P20GM103427-14 and COBRE 1 P3OGM1 10768-01 grants as well as The Fred & Pamela Buffett Cancer Center Support Grant - P30CA036727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis N, 2000, CLIN IMMUNOL, V97, P21, DOI 10.1006/clim.2000.4911; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Barker BL, 2015, CHEST, V147, P46, DOI 10.1378/chest.14-0764; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boissy RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095578; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2016, GLOBAL STRATEGY DIAG; Hewitt R, 2016, THER ADV RESPIR DIS, V10, P158, DOI 10.1177/1753465815618113; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Martin M, 2011, EMBNET J, V17; Millares L, 2014, EUR J CLIN MICROBIOL, V33, P1101, DOI 10.1007/s10096-013-2044-0; Miravitlles M, 2015, CURR OPIN PULM MED, V21, P278, DOI 10.1097/MCP.0000000000000154; Molyneaux PL, 2013, AM J RESP CRIT CARE, V188, P1224, DOI 10.1164/rccm.201302-0341OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Weissenburger-Moser L, 2016, J EXPO SCI ENV EPIDE; World Health Organization, 2014, CHRON OBSTR PULM DIS	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0191499	10.1371/journal.pone.0191499	http://dx.doi.org/10.1371/journal.pone.0191499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518088	gold, Green Published			2022-12-26	WOS:000426902900002
J	Duku, C; Zwart, SJ; Hein, L				Duku, Confidence; Zwart, Sander J.; Hein, Lars			Impacts of climate change on cropping patterns in a tropical, sub-humid watershed	PLOS ONE			English	Article							CO2 CONCENTRATION; ELEVATED CO2; PART 1; AFRICA; RIVER; VARIABILITY; SWAT; AVAILABILITY; SCENARIOS; FRAMEWORK	In recent decades, there have been substantial increases in crop production in sub-Saharan Africa (SSA) as a result of higher yields, increased cropping intensity, expansion of irrigated cropping systems, and rainfed cropland expansion. Yet, to date much of the research focus of the impact of climate change on crop production in the coming decades has been on crop yield responses. In this study, we analyse the impact of climate change on the potential for increasing rainfed cropping intensity through sequential cropping and irrigation expansion in central Benin. Our approach combines hydrological modelling and scenario analysis involving two Representative Concentration Pathways (RCPs), two water-use scenarios for the watershed based on the Shared Socioeconomic Pathways (SSPs), and environmental water requirements leading to sustained streamflow. Our analyses show that in Benin, warmer temperatures will severely limit crop production increases achieved through the expansion of sequential cropping. Depending on the climate change scenario, between 50% and 95% of cultivated areas that can currently support sequential cropping or will need to revert to single cropping. The results also show that the irrigation potential of the watershed will be at least halved by mid-century in all scenario combinations. Given the urgent need to increase crop production to meet the demands of a growing population in SSA, our study outlines challenges and the need for planned development that need to be overcome to improve food security in the coming decades.	[Duku, Confidence; Hein, Lars] Wageningen Univ, Environm Syst Anal Grp, Wageningen, Netherlands; [Zwart, Sander J.] Africa Rice Ctr AfricaRice, Cotonou, Benin; [Zwart, Sander J.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands	Wageningen University & Research; CGIAR; Africa Rice Center; University of Twente	Duku, C (corresponding author), Wageningen Univ, Environm Syst Anal Grp, Wageningen, Netherlands.	confidence.duku@wur.nl	Zwart, Sander/GQA-3460-2022; Zwart, Sander J/D-8366-2011	Zwart, Sander J/0000-0002-5091-1801; Duku, Confidence/0000-0002-1670-3451	European Commission through the International Fund for Agricultural Development (IFAD)	European Commission through the International Fund for Agricultural Development (IFAD)	This research was conducted at Wageningen University as part of the project "Realizing the agricultural potential of inland valley lowlands in sub-Saharan Africa while maintaining their environmental services" (RAP-IV). The project is implemented by the Africa Rice Center and its national partners and is funded by the European Commission through the International Fund for Agricultural Development (IFAD).; This research was conducted at Wageningen University as part of the project "Realizing the agricultural potential of inland valley lowlands in sub-Saharan Africa while maintaining their environmental services" (RAP -IV). The project is implemented by the Africa Rice Center and its national partners and is funded by the European Commission through the International Fund for Agricultural Development (IFAD). We thank Rik Leemans for his invaluable comments on an earlier version of this manuscript.	Abbaspour K.C., 2008, SWAT CUP SWAT CALIBR; Alexandratos N., WORLD AGR 2030 2050; AMMA-CATCH, 2014, AMM CATCH OBS; Anandhi A, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009104; Arnold JG, 2010, T ASABE, V53, P1433; Barnard J. D., 1948, CANNER, V106, P28; Ben Mohamed A, 2002, CLIMATIC CHANGE, V54, P327, DOI 10.1023/A:1016189605188; Bright E. A., 2011, LANDSCAN 2010 DIGITA; Burney J, 2010, P NATL ACAD SCI USA, V107, P1848, DOI 10.1073/pnas.0909678107; Cohn AS, 2016, NAT CLIM CHANGE, V6, P601, DOI [10.1038/nclimate2934, 10.1038/NCLIMATE2934]; Diaz-Nieto J, 2005, CLIMATIC CHANGE, V69, P245, DOI 10.1007/s10584-005-1157-6; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Dillon A., 2008, ACCESS IRRIGATION ES; Duku C, 2015, HYDROL EARTH SYST SC, V19, P4377, DOI 10.5194/hess-19-4377-2015; Duku C, 2016, AGR ECOSYST ENVIRON, V230, P105, DOI 10.1016/j.agee.2016.06.001; Duku C, 2016, CLIMATIC CHANGE, V135, P569, DOI 10.1007/s10584-015-1580-2; FAO, 2008, WAT RUR POOR INT IMP; FAO, 2011, RUR STRUCT TROP; FAO, 2016, AQ MAIN DAT; Farahmand A, 2015, ADV WATER RESOUR, V76, P140, DOI 10.1016/j.advwatres.2014.11.012; Faramarzi M, 2013, J HYDROL, V480, P85, DOI 10.1016/j.jhydrol.2012.12.016; Fink AH, IMPACTS GLOBAL CHANG; Francis CA, 1986, MULTIPLE CROPPING SY; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Giertz S, 2012, ERDKUNDE, V66, P239, DOI 10.3112/erdkunde.2012.03.04; Giorgi F, 2010, CLIMATIC CHANGE, V100, P787, DOI [10.1007/s10584-010-9864-z, 10.1007/s10584-010-9864-Z]; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Hadjer K, 2005, PHYS CHEM EARTH, V30, P357, DOI 10.1016/j.pce.2005.06.014; Hanasaki N, 2013, HYDROL EARTH SYST SC, V17, P2375, DOI 10.5194/hess-17-2375-2013; Hao ZC, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.1; HARGREAVES GL, 1985, J IRRIG DRAIN ENG, V111, P113, DOI 10.1061/(ASCE)0733-9437(1985)111:2(113); Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hollermann B, 2010, WATER RESOUR MANAG, V24, P3591, DOI 10.1007/s11269-010-9622-z; IIASA FAO, 2012, GLOB AGR EC ZON GAEZ; INSD, 2022, CINQ REC GEN POP HAB; Jones B, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/8/084003; Jones P D, 2013, U E ANGLIA CLIMATIC; Jones PG, 2013, AGR SYST, V114, P1, DOI 10.1016/j.agsy.2012.08.002; Jones PG, 2009, ENVIRON SCI POLICY, V12, P427, DOI 10.1016/j.envsci.2008.08.006; Judex M, 2008, RES RESULTS 2000 200; K Frenken, 1997, FAO LAND WAT B, V4; Karambiri H, 2011, ATMOS SCI LETT, V12, P109, DOI 10.1002/asl.317; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Lambert SJ, 2001, CLIM DYNAM, V17, P83, DOI 10.1007/PL00013736; Luo YZ, 2013, SCI TOTAL ENVIRON, V450, P72, DOI 10.1016/j.scitotenv.2013.02.004; Mahe G, 2013, HYDROL PROCESS, V27, P2105, DOI 10.1002/hyp.9813; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moss R., 2008, NEW SCENARIOS ANAL E; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Neitsch S.L., 2011, SOIL WATER ASSESSMEN; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Nkhata R, 2014, DOES IRRIGATION HAVE; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Phillips E. E., 1950, CANCER, V27, P13; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Rathjens H, 2015, HYDROL PROCESS, V29, P900, DOI 10.1002/hyp.10197; Rathjens H, 2012, COMPUT GEOSCI-UK, V45, P161, DOI 10.1016/j.cageo.2011.11.004; Rathjens H., 2012, ADV GEOSCI, V32, P55, DOI DOI 10.5194/ADGE0-32-55-2012; Roudier P, 2011, GLOBAL ENVIRON CHANG, V21, P1073, DOI 10.1016/j.gloenvcha.2011.04.007; Rowell DP, 2012, CLIM DYNAM, V39, P1929, DOI 10.1007/s00382-011-1210-2; Shiau JT, 2007, HYDROL PROCESS, V21, P2157, DOI 10.1002/hyp.6400; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; Sonneveld BGJS, 2012, WATER RESOUR MANAG, V26, P553, DOI 10.1007/s11269-011-9931-x; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; United Nations, 2015, ESAPWP241 UN; Van Loon AF, 2015, HYDROL EARTH SYST SC, V19, P1993, DOI 10.5194/hess-19-1993-2015; Van Oort PAJ, 2017, GLOBAL CHANGE BIOL; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Waha K, 2013, GLOBAL ENVIRON CHANG, V23, P130, DOI 10.1016/j.gloenvcha.2012.11.001; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; World Bank, 2013, REP WORLD BANK POSTD; Yira Y, 2017, HYDROL EARTH SYST SC, V21, P2143, DOI 10.5194/hess-21-2143-2017; You L., 2016, SPATIAL PRODUCTION A; You LZ, 2011, FOOD POLICY, V36, P770, DOI 10.1016/j.foodpol.2011.09.001	78	22	23	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192642	10.1371/journal.pone.0192642	http://dx.doi.org/10.1371/journal.pone.0192642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513753	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800018
J	Latchere, O; Mehn, V; Gaertner-Mazouni, N; Le Moullac, G; Fievet, J; Belliard, C; Cabral, P; Saulnier, D				Latchere, Oihana; Mehn, Vincent; Gaertner-Mazouni, Nabila; Le Moullac, Gilles; Fievet, Julie; Belliard, Corinne; Cabral, Philippe; Saulnier, Denis			Influence of water temperature and food on the last stages of cultured pearl mineralization from the black-lip pearl oyster Pinctada margaritifera	PLOS ONE			English	Article							ACIDIC MATRIX PROTEIN; ENVIRONMENTAL CONTROLS; GROWTH-RATES; SHELL GROWTH; EXPRESSION; COLOR; IRIDESCENCE; ACCLIMATION; RESPONSES; INSIGHTS	Environmental parameters, such as food level and water temperature, have been shown to be major factors influencing pearl oyster shell growth and molecular mechanisms involved in this biomineralization process. The present study investigates the effect of food level (i.e., microalgal concentration) and water temperature, in laboratory controlled conditions, on the last stages of pearl mineralization in order to assess their impact on pearl quality. To this end, grafted pearl oysters were fed at different levels of food and subjected to different water temperatures one month prior to harvest to evaluate the effect of these factors on 1) pearl and shell deposition rate, 2) expression of genes involved in biomineralization in pearl sacs, 3) nacre ultrastructure (tablet thickness and number of tablets deposited per day) and 4) pearl quality traits. Our results revealed that high water temperature stimulates both shell and pearl deposition rates. However, low water temperature led to thinner nacre tablets, a lower number of tablets deposited per day and impacted pearl quality with better luster and fewer defects. Conversely, the two tested food level had no significant effects on shell and pearl growth, pearl nacre ultrastructure or pearl quality. However, one gene, Aspein, was significantly downregulated in high food levels. These results will be helpful for the pearl industry. A wise strategy to increase pearl quality would be to rear pearl oysters at a high water temperature to increase pearl growth and consequently pearl size; and to harvest pearls after a period of low water temperature to enhance luster and to reduce the number of defects.	[Latchere, Oihana; Mehn, Vincent; Le Moullac, Gilles; Fievet, Julie; Belliard, Corinne; Saulnier, Denis] IFREMER, Ctr Pacifique, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France; [Latchere, Oihana; Gaertner-Mazouni, Nabila] Univ Polynesie Francaise, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France; [Cabral, Philippe] Gauguins Pearl Farm, Rangiroa, French Polynesi, France	Ifremer; Ifremer	Saulnier, D (corresponding author), IFREMER, Ctr Pacifique, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France.	denis.saulnier@ifremer.fr	saulnier, denis/A-6690-2011	saulnier, denis/0000-0003-1422-0242; Le Moullac, Gilles/0000-0003-3749-8239	ANR [ANR-11-AGRO-006]; IFREMER; Direction des Ressources Marines; TripaGEN	ANR(French National Research Agency (ANR)); IFREMER; Direction des Ressources Marines; TripaGEN	This work was financially supported by ANR funding (POLYPERL project, reference ANR-11-AGRO-006). This study was also supported by grants from IFREMER, the Direction des Ressources Marines, and private partners through the TripaGEN project (2015-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarsmawi K, 1984, MANUAL PEARL CULTURE; ALAGARSWAMI K, 1975, Indian Journal of Fisheries, V22, P300; Alagarswami K., 1987, CMFRI B, V39, P107; Anestis A, 2007, AM J PHYSIOL-REG I, V293, pR911, DOI 10.1152/ajpregu.00124.2007; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k; Bayne ABL, 2011, INT ASS ECOL, V37, P137; Blay C, 2014, INFLUENCE NACRE DEPO, P937; Blay C, 2016, ESTUAR COAST SHELF S, V182, P254, DOI 10.1016/j.ecss.2016.05.020; Cuif JP, 2011, AQUAT LIVING RESOUR, V24, P411, DOI 10.1051/alr/2011149; DELRIOPORTILLA MA, 1992, MAR ECOL PROG SER, V89, P221, DOI 10.3354/meps089221; Ellis S, 1999, AQUAFARMER INF SHEET, P1; Haws M., 2002, USITC PUBL, V127; Isowa Y, 2012, J MOL EVOL, V75, P11, DOI 10.1007/s00239-012-9514-3; Joubert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103944; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kishore P, 2016, AQUAC RES, V47, P2215, DOI 10.1111/are.12674; Kishore P, 2015, AQUAC RES, V46, P769, DOI 10.1111/are.12228; Kocot KM, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0155-z; Ky C, 2016, PHENOTYPIC INDICATOR, P1; Ky CL, 2013, AQUAT LIVING RESOUR, V26, P133, DOI 10.1051/alr/2013055; Laing I, 2000, AQUACULTURE, V183, P325, DOI 10.1016/S0044-8486(99)00262-8; Larsen JB, 2005, MAR BIOL, V146, P1119, DOI 10.1007/s00227-004-1524-2; Latchere O, 2017, AQUACULTURE, V479, P176, DOI 10.1016/j.aquaculture.2017.05.046; Le Moullac G, 2016, ESTUAR COAST SHELF S, V182, P261, DOI 10.1016/j.ecss.2016.04.011; Le Moullac G, 2013, AQUAC RES, V44, P404, DOI 10.1111/j.1365-2109.2011.03045.x; Le Pabic L, 2016, ESTUAR COAST SHELF S, V182, P294, DOI 10.1016/j.ecss.2016.03.009; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; Linard C., 2010, ECOPHYSIOLOGY SHELL; Linard C, 2011, AQUACULTURE, V313, P149, DOI 10.1016/j.aquaculture.2011.01.008; Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F, 2012, FRONT BIOSCI S, VS4, P321; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsui Y., 1958, PERSPECTIVES MARINE; Mavuti KM, 2005, AFR J MAR SCI, V27, P567, DOI 10.2989/18142320509504117; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; Menzel W., 1991, ESTUARINE MARINE BIV; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Muhammad G, 2017, AQUACULTURE, V477, P35, DOI 10.1016/j.aquaculture.2017.04.032; NIELSEN MV, 1988, J EXP MAR BIOL ECOL, V123, P227, DOI 10.1016/0022-0981(88)90044-5; Olson IC, 2012, J AM CHEM SOC, V134, P7351, DOI 10.1021/ja210808s; Pouvreau S, 2000, AQUACULTURE, V186, P117, DOI 10.1016/S0044-8486(99)00373-7; Saucedo PE, 2004, AQUACULTURE, V229, P377, DOI 10.1016/S0044-8486(03)00327-2; Schone BR, 2003, MAR BIOL, V142, P473, DOI 10.1007/s00227-002-0970-y; Schone BR, 2005, PALAIOS, V20, P78, DOI 10.2110/palo.2003.p03-101; Shi YW, 2013, J SHELLFISH RES, V32, P271, DOI 10.2983/035.032.0204; Snow MR, 2004, AM MINERAL, V89, P1353; Southgate PC, 2008, PEARL OYSTER, P303, DOI 10.1016/B978-0-444-52976-3.00009-7; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Tayale A, 2012, AQUAT LIVING RESOUR, V25, P269, DOI 10.1051/alr/2012034; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Thebault J, 2008, AQUAT LIVING RESOUR, V21, P45, DOI 10.1051/alr:2008021; Tomaru Y, 2002, AQUAC RES, V33, P109, DOI 10.1046/j.1365-2109.2002.00653.x; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wada K, 1999, J GEMMOL SOC JPN, V20, P47; Yukihira H, 1998, MAR ECOL PROG SER, V171, P71, DOI 10.3354/meps171071	61	11	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193863	10.1371/journal.pone.0193863	http://dx.doi.org/10.1371/journal.pone.0193863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505601	Green Published, gold			2022-12-26	WOS:000426548200038
J	Lee, MJ; Kim, HJ				Lee, Mi Jin; Kim, Ho Jin			Development of an immunoaffinity chromatography and LC-MS/MS method for the determination of 6 zearalenones in animal feed	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MYCOTOXINS; METABOLITES; VALIDATION; CEREALS; OPTIMIZATION; GUIDELINES; CHICKEN; MAIZE; HPLC	A novel and simple method for detecting 6 zearalenones in animal feed using liquid chromatography coupled with triple quadrupole mass spectrometry (LC-MS/MS) and immunoaffinity columns (IAC) was developed. The chromatographic peaks of the 6 zearalenones were successfully identified by comparing their retention times and mass spectrum with reference standards. The mobile phase was composed of mobile phase A (water) and B (0.5% formic acid in ACN). Method validation was performed with linearity, sensitivity, selectivity, accuracy and precision. The limits of detection (LODs) for the instrument used to study zearalenones ranged from 0.3 to 1.1 mu g/kg, and the limits of quantification (LOQs) ranged from 1.0 to 2.2 mu g/kg. Average recoveries of the 6 zearalenones ranged from 82.5% to 106.4%. Method replication resulted in intra-day and inter-day peak area variation of < 3.8%. The developed method was specific and reliable and is suited for the routine analysis of zearalenones in animal feed.	[Lee, Mi Jin; Kim, Ho Jin] Natl Agr Prod Qual Management Serv, Kimchun, South Korea		Kim, HJ (corresponding author), Natl Agr Prod Qual Management Serv, Kimchun, South Korea.	rex7878@korea.kr		Kim, Ho Jin/0000-0001-5296-0618				Bae IK, 2015, FOOD CHEM, V172, P469, DOI 10.1016/j.foodchem.2014.09.050; Belhassen H, 2014, J CHROMATOGR B, V962, P68, DOI 10.1016/j.jchromb.2014.05.019; Berthiller F, 2007, INT J FOOD MICROBIOL, V119, P33, DOI 10.1016/j.ijfoodmicro.2007.07.022; Branch SK, 2005, J PHARMACEUT BIOMED, V38, P798, DOI 10.1016/j.jpba.2005.02.037; Cavaliere C, 2007, FOOD CHEM, V105, P700, DOI 10.1016/j.foodchem.2006.12.057; De Baere S, 2012, ANAL CHIM ACTA, V756, P37, DOI 10.1016/j.aca.2012.10.027; Ferreira I, 2012, FOOD CONTROL, V27, P188, DOI 10.1016/j.foodcont.2012.03.014; Geary PA, 2016, FOOD CONTROL, V68, P337, DOI 10.1016/j.foodcont.2016.04.018; Iqbal SZ, 2014, FOOD CONTROL, V43, P98, DOI 10.1016/j.foodcont.2014.02.046; Kim HJ, 2016, FOOD CHEM, V196, P1144, DOI 10.1016/j.foodchem.2015.10.014; Kinani S, 2008, J CHROMATOGR A, V1190, P307, DOI 10.1016/j.chroma.2008.02.115; Molina-Molina JM, 2014, FOOD CHEM TOXICOL, V74, P233, DOI 10.1016/j.fct.2014.10.008; Ok HE, 2014, FOOD CHEM, V163, P252, DOI 10.1016/j.foodchem.2014.04.111; Onji Y, 1998, J CHROMATOGR A, V815, P59, DOI 10.1016/S0021-9673(98)00357-4; Qian MR, 2015, FOOD CHEM, V166, P23, DOI 10.1016/j.foodchem.2014.05.133; Tanaka K, 2007, INT J FOOD MICROBIOL, V119, P59, DOI 10.1016/j.ijfoodmicro.2007.08.002; Tanaka T, 2000, J CHROMATOGR A, V882, P23, DOI 10.1016/S0021-9673(00)00063-7; Thompson M, 2002, PURE APPL CHEM, V74, P835, DOI 10.1351/pac200274050835	18	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193584	10.1371/journal.pone.0193584	http://dx.doi.org/10.1371/journal.pone.0193584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505591	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200021
J	Rubio, M; Bustamante, M; Hernandez-Ferrer, C; Fernandez-Orth, D; Pantano, L; Sarria, Y; Pique-Borras, M; Vellve, K; Agramunt, S; Carreras, R; Estivill, X; Gonzalez, JR; Mayor, A				Rubio, Mercedes; Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Pantano, Lorena; Sarria, Yaris; Pique-Borras, Maria; Vellve, Kilian; Agramunt, Silvia; Carreras, Ramon; Estivill, Xavier; Gonzalez, Juan R.; Mayor, Alfredo			Circulating miRNAs, isomiRs and small RNA clusters in human plasma and breast milk	PLOS ONE			English	Article							NONCODING RNAS; MICRORNA; BIOMARKERS; REGULATORS; SIGNATURES; ABUNDANT; DISEASE; PIRNAS; GENES; BLOOD	Circulating small RNAs, including miRNAs but also isomiRs and other RNA species, have the potential to be used as non-invasive biomarkers for communicable and non-communicable diseases. This study aims to characterize and compare small RNA profiles in human biofluids. For this purpose, RNA was extracted from plasma and breast milk samples from 15 healthy postpartum mothers. Small RNA libraries were prepared with the NEBNext (R) small RNA library preparation kit and sequenced in an Illumina HiSeq2000 platform. miRNAs, isomiRs and clusters of small RNAs were annotated using seqBuster/seqCluster framework in 5 plasma and 10 milk samples that passed the initial quality control. The RNA yield was 81 ng/mL [standard deviation (SD): 41] and 3985 ng/mL (SD: 3767) for plasma and breast milk, respectively. Mean number of good quality reads was 4.04 million (M) (40.01% of the reads) in plasma and 12.5M (89.6%) in breast milk. One thousand one hundred eighty two miRNAs, 12,084 isomiRs and 1,053 small RNA clusters that included piwi-interfering RNAs (piRNAs), tRNAs, small nucleolar RNAs (snoRNA) and small nuclear RNAs (snRNAs) were detected. Samples grouped by biofluid, with 308 miRNAs, 1,790 isomiRs and 778 small RNA clusters differentially detected. In summary, plasma and milk showed a different small RNA profile. In both, miRNAs, piRNAs, tRNAs, snRNAs, and snoRNAs were identified, confirming the presence of non-miRNA species in plasma, and describing them for the first time in milk.	[Rubio, Mercedes; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Gonzalez, Juan R.] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona] CRG, Genom & Dis Grp, Bioinformat & Genom Program, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Gonzalez, Juan R.] UPF, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Gonzalez, Juan R.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Pantano, Lorena] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Sarria, Yaris] IMIM Hosp Mar Med Res Inst, Microarray Anal Serv, Barcelona, Spain; [Pique-Borras, Maria] Univ Basel, Dept Biomed, Lab Childhood Leukemia, Basel, Switzerland; [Pique-Borras, Maria] Basel Univ, Childrens Hosp, Hebelestr, Basel, Switzerland; [Vellve, Kilian; Agramunt, Silvia; Carreras, Ramon] Hosp Mar, Obstet & Gynaecol Dept, Parc Salut Mar, Barcelona, Spain; [Carreras, Ramon] Univ Autonoma Barcelona, Pediat Obstet & Gynecol & Prevent Med Dept, Barcelona, Spain; [Estivill, Xavier] Sidra Med & Res Ctr, Res Dept, Genet Child & Womans Hlth Grp, Doha, Qatar; [Estivill, Xavier] Dexeus Womans Hlth, Genet Unit, Barcelona, Spain; [Mayor, Alfredo] CISM, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard T.H. Chan School of Public Health; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Basel; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Sidra Medical & Research Center; Centro de Investigacao em Saude de Manhica	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Gonzalez, JR (corresponding author), ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.; Gonzalez, JR (corresponding author), UPF, Barcelona, Spain.; Gonzalez, JR (corresponding author), CIBER Epidemiol & Salud Publ, Barcelona, Spain.; Mayor, A (corresponding author), CISM, Maputo, Mozambique.	juanr.gonzalez@isglobal.org; alfredo.mayor@isglobal.org	Bustamante, Mariona/ABB-9142-2021; Hernandez-Ferrer, Carles/HIA-0007-2022; Mayor, Alfredo/H-7488-2017; Gonzalez, Juan R/B-7860-2018; Martinez, Mercedes Rubio/N-3636-2014; Orth, Dietmar Fernandez/P-2925-2019; Rubio, Mercedes/K-9249-2015; Hernandez-Ferrer, Carles/AAH-2040-2019; Estivill, Xavier/A-3125-2013	Bustamante, Mariona/0000-0003-0127-2860; Hernandez-Ferrer, Carles/0000-0002-8029-7160; Mayor, Alfredo/0000-0003-3890-2897; Gonzalez, Juan R/0000-0003-3267-2146; Martinez, Mercedes Rubio/0000-0002-4331-3280; Orth, Dietmar Fernandez/0000-0002-1237-3192; Hernandez-Ferrer, Carles/0000-0002-8029-7160; Estivill, Xavier/0000-0002-0723-2256; Vellve, Kilian/0000-0002-2376-7664	ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I; Fondo Europeo de Desarrollo Regional [FEDER] [PI13/01478]; Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)) [2014SGR263]; CERCA Institutes Integration Program (SUMA); CERCA Institutes Integration Program (Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna); CERCA Institutes Integration Program (AGAUR); CERCA Institutes Integration Program (Fundacion Institucio dels Centres de Recerca de Catalunya);  [CES10/021-I3SNS]	ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I; Fondo Europeo de Desarrollo Regional [FEDER](European Commission); Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)); CERCA Institutes Integration Program (SUMA); CERCA Institutes Integration Program (Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna); CERCA Institutes Integration Program (AGAUR); CERCA Institutes Integration Program (Fundacion Institucio dels Centres de Recerca de Catalunya); 	This work was supported by ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I 2013-2016 (grant PI13/01478 cofunded by the Fondo Europeo de Desarrollo Regional [FEDER] and CES10/021-I3SNS to AM), the Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR); grant 2014SGR263 to AM) and the CERCA Institutes Integration Program (SUMA 2013 to JRG, AM; Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna, AGAUR and Fundacion Institucio dels Centres de Recerca de Catalunya). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.	Alsaweed M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20680; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Amorim M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1025-3; Bagci C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145065; Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilsland Alan E., 2013, Critical Reviews in Oncogenesis, V18, P373; Clark JP, 2014, ADV EXP MED BIOL, V825, P159, DOI 10.1007/978-1-4939-1221-6_5; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dhahbi Joseph M, 2014, Biomark Cancer, V6, P37, DOI 10.4137/BIC.S20764; Dhahbi JM, 2014, AGEING RES REV, V17, P86, DOI 10.1016/j.arr.2014.02.005; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; Duy J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1299-5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Follert P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00005; Freedman JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11106; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Ghai V, 2016, ARCH TOXICOL, V90, P2959, DOI 10.1007/s00204-016-1828-2; Hakimi MA, 2011, TRENDS PARASITOL, V27, P481, DOI 10.1016/j.pt.2011.07.001; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Isaacs SR, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0819-2; Karlsson O, 2016, EPIGENETICS-US, V11, P721, DOI 10.1080/15592294.2016.1216285; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Omran A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291826; Pantano L, 2016, BIOINFORMATICS, V32, P673, DOI 10.1093/bioinformatics/btv632; Pantano L, 2011, BIOINFORMATICS, V27, P3202, DOI 10.1093/bioinformatics/btr527; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Panwar B., 2017, BIOINFORMATICS; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Pua HH, 2015, CURR OPIN IMMUNOL, V36, P101, DOI 10.1016/j.coi.2015.07.006; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Siddeek B, 2014, MUTAT RES-GEN TOX EN, V764, P46, DOI 10.1016/j.mrgentox.2014.01.010; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Simpson MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143496; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tam S, 2015, BRIEF BIOINFORM, V16, P950, DOI 10.1093/bib/bbv019; Tan GC, 2015, MALAY J PATHOL, V37, P73; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tonge DP, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0057-9; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Vrijens K, 2015, ENVIRON HEALTH PERSP, V123, P399, DOI 10.1289/ehp.1408459; Wang SQ, 2016, GENE, V584, P167, DOI 10.1016/j.gene.2016.02.020; Wang YC, 2016, ONCOL LETT, V12, P1635, DOI 10.3892/ol.2016.4901; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Xie T, 2016, CELL PHYSIOL BIOCHEM, V40, P62, DOI 10.1159/000452525; Yeri A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44061; Zempleni J, 2016, J NUTR; Zhang JH, 2013, PLANTA, V237, P1047, DOI 10.1007/s00425-012-1823-7; Zhang P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau110; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	64	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193527	10.1371/journal.pone.0193527	http://dx.doi.org/10.1371/journal.pone.0193527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505615	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200019
J	Saraiva, JF; Souto, RNP; Scarpassa, VM				Saraiva, Jose Ferreira; Picanco Souto, Raimundo Nonato; Scarpassa, Vera Margarete			Molecular taxonomy and evolutionary relationships in the Oswaldoi-Konderi complex (Anophelinae: Anopheles: Nyssorhynchus) from the Brazilian Amazon region	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SENSU-LATO DIPTERA; AN. NYS. OSWALDOI; PLASMODIUM-FALCIPARUM; MALARIA VECTORS; RIBOSOMAL DNA; COMPARATIVE SUSCEPTIBILITY; PHYLOGENETIC INFERENCE; SPECIES DELIMITATION; COMPUTER-PROGRAM	Recent studies have shown that Anopheles oswaldoi sensu lato comprises a cryptic species complex in South America. Anopheles konderi, which was previously raised to synonymy with An. oswaldoi, has also been suggested to form a species complex. An. oswaldoi has been incriminated as a malaria vector in some areas of the Brazilian Amazon, Colombia, Peru and Venezuela, but was not recognized as a vector in the remaining regions in its geographic distribution. The role of An. konderi as a malaria vector is unknown or has been misattributed to An. oswaldoi. The focus of this study was molecular identification to infer the evolutionary relationships and preliminarily delimit the geographic distribution of the members of these complexes in the Brazilian Amazon region. The specimens were sampled from 18 localities belonging to five states in the Brazilian Amazon and sequenced for two molecular markers: the DNA barcode region (COI gene of mitochondrial DNA) and Internal Transcribed Spacer 2 (ITS2 ribosomal DNA). COI (83 sequences) and ITS2 (27 sequences) datasets generated 43 and 10 haplotypes, respectively. Haplotype networks and phylogenetic analyses generated with the barcode region (COI gene) recovered five groups corresponding to An. oswaldoi s. s., An. oswaldoi B, An. oswaldoi A, An. konderi and An. sp. nr. konderi; all pairwise genetic distances were greater than 3%. The group represented by An. oswaldoi A exhibited three strongly supported lineages. The molecular dating indicated that the diversification process in these complexes started approximately 2.8 Mya, in the Pliocene. These findings confirm five very closely related species and present new records for these species in the Brazilian Amazon region. The paraphyly observed for the An. oswaldoi complex suggests that An. oswaldoi and An. konderi complexes may comprise a unique species complex named Oswaldoi-Konderi. Anopheles oswaldoi B may be a potential malaria vector in the extreme north of the Brazilian Amazon, whereas evidence of sympatry for the remaining species in other parts of the Brazilian Amazon (Acre, Amazonas, Para A and Rondo A nia) precluded identification of probable vectors in those areas.	[Saraiva, Jose Ferreira; Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Lab Genet Populacoes & Evolucao Mosquitos Vetores, Manaus, Amazonas, Brazil; [Picanco Souto, Raimundo Nonato] Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Arthropoda, Macapa, Amapa, Brazil	Institute Nacional de Pesquisas da Amazonia; Fundacao Universidade Federal do Amapa	Scarpassa, VM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Lab Genet Populacoes & Evolucao Mosquitos Vetores, Manaus, Amazonas, Brazil.	vera@inpagov.br	Saraiva, José Ferreira/S-8376-2016; Scarpassa, Vera M./H-4125-2013; Picanço Souto, Raimundo Nonato/GOV-5047-2022; Saraiva, Jose Ferreira/X-9256-2018	Saraiva, José Ferreira/0000-0002-7813-2607; Picanço Souto, Raimundo Nonato/0000-0002-8795-1217; Saraiva, Jose Ferreira/0000-0002-7813-2607; Scarpassa, Vera/0000-0003-1607-9246	MCTIC/INPA; Amazonas Research Foundation (FAPEAM) [1501/2008, 3111/2012-Universal, 062.01832/2015-PAPAC-FAPEAM]; INCT-CENBAM/CNPq/FAPEAM/INPA [722069/2009]; CNPQ-BR-BOL; PRO-EQUIPAMENT/CAPES, Brazil; CAPES, Brazil	MCTIC/INPA; Amazonas Research Foundation (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); INCT-CENBAM/CNPq/FAPEAM/INPA; CNPQ-BR-BOL; PRO-EQUIPAMENT/CAPES, Brazil; CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by MCTIC/INPA and grants from the Amazonas Research Foundation (FAPEAM), process numbers 1501/2008, 3111/2012-Universal and 062.01832/2015-PAPAC-FAPEAM granted to VMS, from the INCT-CENBAM/CNPq/FAPEAM/INPA, process number 722069/2009, granted to William Ernest Magnusson, from the CNPQ-BR-BOL granted to Fernando Araujo Monteiro and from the PRO-EQUIPAMENT/CAPES, Brazil. JFS received a fellowship from the CAPES, Brazil. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], CHROM LIT SOFTW; Arrivillaga JC, 2002, INFECT GENET EVOL, V2, P83, DOI 10.1016/S1567-1348(02)00087-4; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergo ES, 2007, MEM I OSWALDO CRUZ, V102, P373, DOI 10.1590/S0074-02762007005000053; FARAN M E, 1980, Contributions of the American Entomological Institute, V15, P1; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; BRANQUINHO MS, 1993, T ROY SOC TROP MED H, V87, P391, DOI 10.1016/0035-9203(93)90008-E; Branquinho MS, 1996, T ROY SOC TROP MED H, V90, P233, DOI 10.1016/S0035-9203(96)90225-4; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Causey OR, 1944, AM J HYG, V39, P1; Causey OR, 1946, MONOGR SER AM J HYG, V18, P21; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Conn JE, 2007, HEREDITY, V99, P245, DOI 10.1038/sj.hdy.6801002; Correa MM, 2014, 8 CUB C MICR PAR 5 N; Barbosa LMC, 2016, ACTA TROP, V164, P216, DOI 10.1016/j.actatropica.2016.09.018; Barbosa LMC, 2014, REV SOC BRAS MED TRO, V47, P313, DOI 10.1590/0037-8682-0239-2013; Costa Lima A. da., 1928, Supplemento das Memorias Instituto Oswaldo Cruz Rio de Janeiro, V3, P91; Crabtree MB, 1997, J MED ENTOMOL, V34, P532, DOI 10.1093/jmedent/34.5.532; Curry DP, 1932, AM J HYG, V15, P566, DOI 10.1093/oxfordjournals.aje.a117832; da Rocha JAM, 2008, AM J TROP MED HYG, V78, P872, DOI 10.4269/ajtmh.2008.78.872; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEANE L. M., 1948, REV SERV ESPECIAL SAUDE PUBLICA, V1, P827; DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; dos Santos RL, 2005, REV SOC BRAS MED TRO, V38, P202, DOI 10.1590/S0037-86822005000200018; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Dusfour I, 2012, MEM I OSWALDO CRUZ, V107, P429, DOI 10.1590/S0074-02762012000300021; Dyar HG, 1925, MONTHLY J ENTOMOLOGY, V13, P101; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Emerson KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130773; Ezard T, 2009, PACKAGE SPLITS SPECI; FARAN M E, 1981, Mosquito Systematics, V13, P1; Flores-Mendoza C, 2004, P ENTOMOL SOC WASH, V106, P118; Foley DH, 2007, MOL PHYLOGENET EVOL, V43, P283, DOI 10.1016/j.ympev.2006.10.008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; Galvao A. L. Ayroza, 1942, FOLIA CLINICA ET BIOL [SAO PAULO], V14, P115; Galvao AL, 1937, AN FAC MED U SAO PAU, V13, P211; Garros C, 2004, AM J TROP MED HYG, V70, P260, DOI 10.4269/ajtmh.2004.70.260; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harbach RE, 2007, ZOOTAXA, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYES J, 1987, J AM MOSQUITO CONTR, V3, P418; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITZMILLER JB, 1973, B WORLD HEALTH ORGAN, V48, P435; KLEIN TA, 1991, AM J TROP MED HYG, V44, P598, DOI 10.4269/ajtmh.1991.44.598; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; LANE J., 1953, Neotropical Culioidae. Volumes I & II.; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; Lounibos L. Philip, 2000, American Entomologist, V46, P238; Lounibos LP, 1998, J MED ENTOMOL, V35, P830, DOI 10.1093/jmedent/35.5.830; Lounibos LP, 1997, J MED ENTOMOL, V34, P136, DOI 10.1093/jmedent/34.2.136; Marrelli MT, 2006, MEM I OSWALDO CRUZ, V101, P817, DOI 10.1590/S0074-02762006000800002; Marrelli MT, 1999, T ROY SOC TROP MED H, V93, P381, DOI 10.1016/S0035-9203(99)90123-2; Marrelli MT, 1999, J MED ENTOMOL, V36, P679, DOI 10.1093/jmedent/36.6.679; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Mayr E., 1998, ED UNB, V1, P1107; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mirabello L, 2008, MED VET ENTOMOL, V22, P109, DOI 10.1111/j.1365-2915.2008.00731.x; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Moreno M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-47; Motoki MT, 2009, NEOTROP ENTOMOL, V38, P144, DOI 10.1590/S1519-566X2009000100017; Motoki MT, 2011, J AM MOSQUITO CONTR, V27, P191, DOI 10.2987/10-6094.1; Motoki Maysa Tiemi, 2007, Zootaxa, V1588, P31; NATAL D, 1992, REV SAUDE PUBL, V26, P129, DOI 10.1590/S0034-89101992000200010; Peryassu A., 1922, Folha Medica Rio de Janeiro, V3, P179; PORTER CH, 1991, AM J TROP MED HYG, V45, P271, DOI 10.4269/ajtmh.1991.45.271; Povoa MM, 2001, MEM I OSWALDO CRUZ, V96, P179, DOI 10.1590/S0074-02762001000200008; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; Quinones ML, 2006, MEM I OSWALDO CRUZ, V101, P617, DOI 10.1590/S0074-02762006000600007; Rambaut A., 2009, FIGTREE TREE FIGURE; Ramirez CCL, 2000, GENOME, V43, P143, DOI 10.1139/gen-43-1-143; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rona LDP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-60; Rosa-Freitas MG, 1998, MEM I OSWALDO CRUZ, V93, P651, DOI 10.1590/S0074-02761998000500016; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rubio-Palis Y, 2013, MEM I OSWALDO CRUZ, V108, P220, DOI 10.1590/0074-0276108022013015; RUBIOPALIS Y, 1994, AM J TROP MED HYG, V50, P420, DOI 10.4269/ajtmh.1994.50.420; RUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325, DOI 10.1111/j.1365-2915.1992.tb00628.x; Ruiz F, 2005, MEM I OSWALDO CRUZ, V100, P155, DOI 10.1590/S0074-02762005000200008; Ruiz F, 2010, MEM I OSWALDO CRUZ, V105, P899, DOI 10.1590/S0074-02762010000700010; Ruiz-Lopez F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-324; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Russell D. W., 2001, MOL CLONING LAB MANU, V1, P2100; Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2; Scarpassa VM, 2006, GENET MOL RES, V5, P493; Scarpassa VM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1217-6; Scarpassa VM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-258; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scarpassa VM, 2005, J MED ENTOMOL, V42, P319, DOI 10.1603/0022-2585(2005)042[0319:ISIAOS]2.0.CO;2; Senevet G., 1938, Arch Inst Pasteur Alger Algiers, V16, P486; SHANNON RAYMOND C., 1939, AMER JOUR TROP MED, V19, P131; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; TADEI W P, 1983, Acta Amazonica, V13, P103; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Tadei WP, 1993, BASES CIENTIFICAS ES, P167; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; Wilkerson RC, 1995, MEM I OSWALDO CRUZ, V90, P721, DOI 10.1590/S0074-02761995000600013; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zwickl DJ, GARLI GENETIC ALGORI	120	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193591	10.1371/journal.pone.0193591	http://dx.doi.org/10.1371/journal.pone.0193591			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505595	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200023
J	Farras, M; Chandwe, K; Mayneris-Perxachs, J; Amadi, B; Louis-Auguste, J; Besa, E; Zyambo, K; Guerrant, R; Kelly, P; Swann, JR				Farras, Marta; Chandwe, Kanta; Mayneris-Perxachs, Jordi; Amadi, Beatrice; Louis-Auguste, John; Besa, Ellen; Zyambo, Kanekwa; Guerrant, Richard; Kelly, Paul; Swann, Jonathan Richard			Characterizing the metabolic phenotype of intestinal villus blunting in Zambian children with severe acute malnutrition and persistent diarrhea	PLOS ONE			English	Article							PERMEABILITY; ENTEROPATHY; UNDERNUTRITION; MORTALITY; TIME; DIET; HIV	Background Environmental enteric dysfunction (EED) is widespread throughout the tropics and in children is associated with stunting and other adverse health outcomes. One of the hallmarks of EED is villus damage. In children with severe acute malnutrition (SAM) the severity of enteropathy is greater and short term mortality is high, but the metabolic consequences of enteropathy are unknown. Here, we characterize the urinary metabolic alterations associated with villus health, classic enteropathy biomarkers and anthropometric measurements in severely malnourished children in Zambia. Methods/Principal findings We analysed 20 hospitalised children with acute malnutrition aged 6 to 23 months in Zambia. Small intestinal biopsies were assessed histologically (n = 15), anthropometric and gut function measurements were collected and the metabolic phenotypes were characterized by H-1 nuclear magnetic resonance (NMR) spectroscopy. Endoscopy could not be performed on community controls children. Growth parameters were inversely correlated with enteropathy biomarkers (p = 0.011) and parameters of villus health were inversely correlated with translocation and permeability biomarkers (p = 0.000 and p = 0.015). Shorter villus height was associated with reduced abundance of metabolites related to gut microbial metabolism, energy and muscle metabolism (p = 0.034). Villus blunting was also related to increased sucrose excretion (p = 0.013). Conclusions/Significance Intestinal villus blunting is associated with several metabolic perturbations in hospitalized children with severe undernutrition. Such alterations include altered muscle metabolism, reinforcing the link between EED and growth faltering, and a disruption in the biochemical exchange between the gut microbiota and host. These findings extend study are the lack of comparative control group and gut microbiota characterization.	[Farras, Marta; Mayneris-Perxachs, Jordi; Swann, Jonathan Richard] Imperial Coll, Div Surg & Canc, Computat & Syst Med Grp, London, England; [Farras, Marta] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain; [Chandwe, Kanta; Amadi, Beatrice; Louis-Auguste, John; Besa, Ellen; Zyambo, Kanekwa; Kelly, Paul] Univ Zambia, Sch Med, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia; [Louis-Auguste, John; Kelly, Paul] Queen Mary Univ London, Barts & London Sch Med, London, England; [Guerrant, Richard] Univ Virginia, Charlottesville, VA USA	Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zambia; University of London; Queen Mary University London; University of Virginia	Farras, M; Swann, JR (corresponding author), Imperial Coll, Div Surg & Canc, Computat & Syst Med Grp, London, England.; Farras, M (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain.	m.farras-mane@imperial.ac.uk; j.swann@imperial.ac.uk	Farràs, Marta/AAA-9418-2021; Mayneris-Perxachs, Jordi/B-2589-2018	Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Besa, Ellen/0000-0001-5606-9435; Kelly, Paul/0000-0003-0844-6448; Swann, Jonathan/0000-0002-6485-4529; Chandwe, Kanta/0000-0003-1403-8432; Farras Mane, Marta/0000-0001-9776-3773	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain; CIBEROBN; BBSRC [BB/M006484/1] Funding Source: UKRI	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain; CIBEROBN; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain. M.F. received a short-term stay fellowship from the CIBEROBN to work in this project. http://www.ciberobn.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi B, 2005, J TROP PEDIATRICS, V51, P5, DOI 10.1093/tropej/fmh064; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; Amadi B, 2017, EBIOMEDICINE, V22, P191, DOI 10.1016/j.ebiom.2017.07.017; Amadi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149218; Attia S, 2016, AM J CLIN NUTR, V104, P1441, DOI 10.3945/ajcn.116.130518; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Burgstad CM, 2013, CRIT CARE MED, V41, P1221, DOI 10.1097/CCM.0b013e31827ca2fa; Central Statistical Office (CSO) Ministry of Health (MOH) Tropical Diseases Research Centre (TDRC) University of Zambia and Macro International Inc, 2015, ZAMB DEM HLTH SURV 2; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Eley, 2007, AM J PHYSL ENDOCRINO; Eley HL, 2008, AM J PHYSIOL-ENDOC M, V295, pE1417, DOI 10.1152/ajpendo.90567.2008; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Giorgio V, 2014, DIGEST LIVER DIS, V46, P556, DOI 10.1016/j.dld.2014.02.010; Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Kelly P, 1997, GUT, V41, P811, DOI 10.1136/gut.41.6.811; Kelly P, 2004, AM J TROP MED HYG, V70, P412; Kelly P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004600; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Louis-Auguste J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-15; Mayneris-Perxachs J, 2016, AM J CLIN NUTR, V104, P1253, DOI 10.3945/ajcn.116.131797; Mayneris-Perxachs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19780; Mujagic Z, 2014, ALIMENT PHARM THER, V40, P288, DOI 10.1111/apt.12829; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Prendergast AJ, 2016, CURR OPIN INFECT DIS, V29, P229, DOI 10.1097/QCO.0000000000000261; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trehan I, 2016, ARCH DIS CHILD, V101, P741, DOI 10.1136/archdischild-2015-309534; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2013, WHO GUID UPD MAN SEV	35	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192092	10.1371/journal.pone.0192092	http://dx.doi.org/10.1371/journal.pone.0192092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499047	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000426472300002
J	Adjepong, M; Pickens, CA; Jain, R; Harris, WS; Annan, RA; Fenton, JI				Adjepong, Mary; Pickens, C. Austin; Jain, Raghav; Harris, William S.; Annan, Reginald A.; Fenton, Jenifer I.			Association of whole blood n-6 fatty acids with stunting in 2-to-6-year-old Northern Ghanaian children: A cross-sectional study	PLOS ONE			English	Article							LINEAR GROWTH; MEAD ACID; PLASMA; DEFICIENCY; METABOLISM	In Northern Ghana, 33% of children are stunted due to economic disparities. Dietary fatty acids ( FA) are critical for growth, but whether blood FA levels are adequate in Ghanaian children is unknown. The objective of this study was to determine the association between whole blood FAs and growth parameters in Northern Ghanaian children 2-6 years of age. A drop of blood was collected on an antioxidant treated card and analyzed for FA composition. Weight and height were measured and z-scores were calculated. Relationships between FAs and growth parameters were analyzed by Spearman correlations, linear regressions, and factor analysis. Of the 307 children who participated, 29.7% were stunted and 8% were essential FA deficient ( triene/tetraene ratio>0.02). Essential FA did not differ between stunted and non-stunted children and was not associated with height-for-age z-score ( HAZ) or weight-for-age z-score ( WAZ). In hemoglobin adjusted regression models, both HAZ and WAZ were positively associated with arachidonic acid ( p <= 0.01), dihomo-gamma-linolenic acid ( DGLA, p <= 0.05), docosatetraenoic acid ( p <= 0.01) and the ratio of DGLA/linoleic acid ( p <= 0.01). These data add to the growing body of evidence indicating n-6 FAs are critical in childhood linear growth. Our findings provide new insights into the health status of an understudied Northern Ghanaian population.	[Adjepong, Mary; Pickens, C. Austin; Jain, Raghav; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Harris, William S.] Omega Quant Analyt LLC, Sioux Falls, SD USA; [Annan, Reginald A.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	Michigan State University; University of South Dakota; Kwame Nkrumah University Science & Technology	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Annan, Reginald Adjetey/0000-0002-6559-1636; Fenton, Jenifer/0000-0002-8875-3239; Jain, Raghav/0000-0002-1284-6762	Borlaug Higher Education in Research and Agricultural Development (BHEARD); Borlaug Leadership Enhancement and Agricultural Program (LEAP)	Borlaug Higher Education in Research and Agricultural Development (BHEARD); Borlaug Leadership Enhancement and Agricultural Program (LEAP)	This project was funded by Borlaug Higher Education in Research and Agricultural Development (BHEARD) and Borlaug Leadership Enhancement and Agricultural Program (LEAP) to MA, all of USAID. No research funds or salary support were provided by OmegaQuant for this project or for Dr. Harris at the time this study was conducted.	Adjepong M, 2016, FASEB J, P30; Adu-Afarwuah S, 2007, FASEB J, V21, pA99; Adu-Afarwuah S., 2015, FASEB J, V29; Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Alhassan L., 2008, NUTR STATUS STATUS P; [Anonymous], 2015, NAT NUTR DAT STAND R; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Burdge GC, 2000, J CELL BIOCHEM, V80, P266; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; Cormier H, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0437-z; Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; Fokkema MR, 2002, PROSTAG LEUKOTR ESS, V67, P345, DOI 10.1054/plef.2002.0440; FULCO AJ, 1959, J BIOL CHEM, V234, P1411; Fumagalli IM, 2015, SCIENCE, V349; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Ghana Statistical Service Accra G Ghana Health Service Accra Ghana, 2014, GHAN DEM HLTH SURV K; Ghana Statistical Service GHS ICF Macro, 2008, GHAN DEM HLTH SURV 2; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; Hadley KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040216; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Ho PP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003831; Holman RT, 1960, J NUTR, V70; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; Jumbe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154715; Kuipers RS, 2011, PROSTAG LEUKOTR ESS, V85, P387, DOI 10.1016/j.plefa.2011.06.004; Ling PR, 2002, DIGEST DIS SCI, V47, P1679, DOI 10.1023/A:1016415805637; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; METSS U, 2017, SAV NANT; Min YJ, 2011, PROSTAG LEUKOTR ESS, V84, P13, DOI 10.1016/j.plefa.2010.10.002; MORRISON WR, 1964, J LIPID RES, V5, P600; NATIONS FAAOOTU, 2009, GHAN NUTR PROF NUTR; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Polreis J, 2016, ANN CLIN LAB RES, V4; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Service GS, 2014, POP HOUS CENS SAV DA; Siguel E, 1998, CIRCULATION, V97, P2580, DOI 10.1161/01.CIR.97.25.2580; SIGUEL EN, 1987, CLIN CHEM, V33, P1869; Simko V., 2017, R PACKAGE CORRPLOT V; Smit EN, 2004, PROSTAG LEUKOTR ESS, V71, P241, DOI 10.1016/j.plefa.2004.03.019; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267; WENE JD, 1975, J CLIN INVEST, V56, P127, DOI 10.1172/JCI108061; WHO. WHO anthro for personal computers, 2016, WHO ANTHR PERS COMP, V3; World Health Organization, 2013, GUID UPD MAN SEV AC; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193301	10.1371/journal.pone.0193301	http://dx.doi.org/10.1371/journal.pone.0193301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494645	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200036
J	Kanemura, A; Yoshikawa, Y; Fukuda, W; Tsumoto, K; Kenmotsu, T; Yoshikawa, K				Kanemura, Ai; Yoshikawa, Yuko; Fukuda, Wakao; Tsumoto, Kanta; Kenmotsu, Takahiro; Yoshikawa, Kenichi			Opposite effect of polyamines on In vitro gene expression: Enhancement at low concentrations but inhibition at high concentrations	PLOS ONE			English	Article							INDUCED DNA CONDENSATION; TRANSCRIPTIONAL ACTIVITY; CONFORMATIONAL TRANSITION; GIANT DNA; MOLECULES; COMPACTION; SPERMINE	Background Polyamines have various biological functions including marked effects on the structure and function of genomic DNA molecules. Changes in the higher-order structure of DNA caused by polyamines are expected to be closely related to genetic activity. To clarify this issue, we examined the relationship between gene expression and the higher-order structure of DNA under different polyamine concentrations. Principal findings We studied the effects of polyamines, spermidine SPD(3+) and spermine SP(4+), on gene expression by a luciferase assay. The results showed that gene expression is increased by ca. 5-fold by the addition of SPD(3+) at 0.3 mM, whereas it is completely inhibited above 2 mM. Similarly, with SP(4+), gene expression is maximized at 0.08 mM and completely inhibited above 0.6 mM. We also performed atomic force microscopy (AFM) observations on DNA under different polyamine concentrations. AFM revealed that a flower-like conformation is generated at polyamine concentrations associated with maximum expression as measured by the luciferase assay. On the other hand, DNA molecules exhibit a folded compact conformation at polyamine concentrations associated with the complete inhibition of expression. Based on these results, we discuss the plausible mechanism of the opposite effect, i.e., enhancement and inhibition, of polyamines on gene expression. Conclusion and significance It was found that polyamines exert opposite effect, enhancement and inhibition, on gene expression depending on their concentrations. Such an opposite effect is argued in relation to the conformational change of DNA: enhancement is due to the parallel ordering of DNA segments that is accompanied by a decrease in the negative charge of double-stranded DNA, and inhibition is caused by the compaction of DNA into a tightly packed state with almost perfect charge-neutralization.	[Kanemura, Ai; Yoshikawa, Yuko; Kenmotsu, Takahiro; Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Fukuda, Wakao] Ritsumeikan Univ, Coll Life Sci, Shiga, Japan; [Tsumoto, Kanta] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie, Japan	Doshisha University; Ritsumeikan University; Mie University	Yoshikawa, K (corresponding author), Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan.	keyoshik@mail.doshisha.ac.jp	Yoshikawa, Kenichi/N-1867-2019; Tsumoto, Kanta/AAK-2684-2021	Yoshikawa, Kenichi/0000-0002-2751-7136; Tsumoto, Kanta/0000-0002-7882-3635	JSPS KAKENHI Grant [15H02121, 25103012]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by JSPS KAKENHI Grant Number 15H02121 and 25103012 (https://www.jsps.go.jp/english/e-grants/) to KY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZA I, 1987, BIOCHEMISTRY-US, V26, P6387, DOI 10.1021/bi00394a012; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; CHELM BK, 1979, NUCLEIC ACIDS RES, V7, P1851, DOI 10.1093/nar/7.7.1851; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Cortini R, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.025002; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; Estevez-Torres A, 2011, SOFT MATTER, V7, P6746, DOI 10.1039/c1sm05373f; Fang Y, 1998, J AM CHEM SOC, V120, P8903, DOI 10.1021/ja981332v; FENLEY MO, 1990, BIOPOLYMERS, V30, P1191, DOI 10.1002/bip.360301305; Garrett RH., 2013, BIOCHEMISTRY-US, V5th; Gevrekci AO, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2370-y; GOSULE LC, 1978, J MOL BIOL, V121, P311, DOI 10.1016/0022-2836(78)90366-2; Hibino K, 2006, CHEM PHYS LETT, V426, P405, DOI 10.1016/j.cplett.2006.05.120; Korolev N, 2009, NUCLEIC ACIDS RES, V37, P7137, DOI 10.1093/nar/gkp683; Luckel F, 2005, FEBS LETT, V579, P5119, DOI 10.1016/j.febslet.2005.07.095; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Muramatsu A, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4972066; Oosawa F., 1971, POLYELECTROLYTES; Ou ZY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940054; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Qiu XY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.228101; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Saminathan M, 2002, NUCLEIC ACIDS RES, V30, P3722, DOI 10.1093/nar/gkf503; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Takahashi M, 1997, J PHYS CHEM B, V101, P9396, DOI 10.1021/jp9716391; Tongu C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4950749; Tsumoto K, 2003, BIOPHYS CHEM, V106, P23, DOI 10.1016/S0301-4622(03)00138-8; Turner D., 2000, BLOOMFIELD, P259; Vijayanathan V, 2001, BIOCHEMISTRY-US, V40, P13644, DOI 10.1021/bi010993t; Vilfan ID, 2006, BIOCHEMISTRY-US, V45, P8174, DOI 10.1021/bi060396c; Yamada A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1937990; Yamasaki Y, 2001, BIOPHYS J, V80, P2823, DOI 10.1016/S0006-3495(01)76249-2; Yoshikawa K, 1996, PHYS REV LETT, V76, P3029, DOI 10.1103/PhysRevLett.76.3029; Yoshikawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3712, DOI 10.1002/anie.201209144; Yoshikawa Y, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3666845	36	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193595	10.1371/journal.pone.0193595	http://dx.doi.org/10.1371/journal.pone.0193595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494707	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200071
J	Schrapers, KT; Sponder, G; Liebe, F; Liebe, H; Stumpff, F				Schrapers, Katharina T.; Sponder, Gerhard; Liebe, Franziska; Liebe, Hendrik; Stumpff, Friederike			The bovine TRPV3 as a pathway for the uptake of Na+, Ca2+, and NH4+	PLOS ONE			English	Article							SHEEP RUMEN EPITHELIUM; GATED ION-CHANNEL; CATION CHANNEL; ACTIVE-TRANSPORT; PATCH-CLAMP; DAIRY-COWS; AMINO-ACID; AMMONIA; METABOLISM; EXPRESSION	Absorption of ammonia from the gastrointestinal tract results in problems that range from hepatic encephalopathy in humans to poor nitrogen efficiency of cattle with consequences for the global climate. Previous studies on epithelia and cells from the native ruminal epithelium suggest functional involvement of the bovine homologue of TRPV3 ( bTRPV3) in ruminal NH4+ transport. Since the conductance of TRP channels to NH4+ has never been studied, bTRPV3 was overexpressed in HEK-293 cells and investigated using the patch-clamp technique and intracellular calcium imaging. Control cells contained the empty construct. Divalent cations blocked the conductance for monovalent cations in both cell types, with effects higher in cells expressing bTRPV3. In bTRPV3 cells, but not in controls, menthol, thymol, carvacrol, or 2-APB stimulated whole cell currents mediated by Na+, Cs+, NH4+, and K+, with a rise in intracellular Ca2+ observed in response to menthol. While only 25% of control patches showed single-channel events ( with a conductance of 40.8 +/- 11.9 pS for NH4+ and 25.0 +/- 5.8 pS for Na+), 90% of bTRPV3 patches showed much larger conductances of 127.8 +/- 4.2 pS for Na+, 240.1 +/- 3.6 pS for NH4+, 34.0 +/- 1.7 pS for Ca2+, and similar to 36 pS for NMDG(+). Open probability, but not conductance, rose with time after patch excision. In conjunction with previous research, we suggest that bTRPV3 channels may play a role in the transport of Na+, K+, Ca2+ and NH4+ across the rumen with possible repercussions for understanding the function of TRPV3 in other epithelia.	[Schrapers, Katharina T.; Sponder, Gerhard; Liebe, Franziska; Liebe, Hendrik; Stumpff, Friederike] Free Univ Berlin, Fac Vet Med, Inst Vet Physiol, Berlin, Germany	Free University of Berlin	Stumpff, F (corresponding author), Free Univ Berlin, Fac Vet Med, Inst Vet Physiol, Berlin, Germany.	stumpff@zedat.fu-berlin.de		Liebe, Franziska/0000-0002-4722-3709	German Science Foundation [DFG Stu258/7-1]; Akademie fur Tiergesundheit; Sonnenfeld-Stiftung	German Science Foundation(German Research Foundation (DFG)); Akademie fur Tiergesundheit; Sonnenfeld-Stiftung	This study was performed for purely scientific reasons within a conventional academic framework. Friederike Stumpff was the co-holder of a patent which was transferred to a startup company which now employs Katharina Schrapers. This publication will have no impact on the commercial success or failure of that enterprise and there is no conflict of interest. Funding was provided by the German Science Foundation (DFG Stu258/7-1, Franziska Liebe), the Akademie fur Tiergesundheit (Katharina T. Schrapers) and the Sonnenfeld-Stiftung (Hendrik Liebe).	Abdoun K, 2005, AM J PHYSIOL-GASTR L, V289, pG508, DOI 10.1152/ajpgi.00436.2004; Amarouch MY, 2013, NEUROSCI LETT, V541, P105, DOI 10.1016/j.neulet.2013.02.011; Balemans D, 2017, AM J PHYSIOL-GASTR L, V312, pG635, DOI 10.1152/ajpgi.00401.2016; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Behera SN, 2013, ENVIRON SCI POLLUT R, V20, P8092, DOI 10.1007/s11356-013-2051-9; Billen B, 2015, J BIOL CHEM, V290, P12964, DOI 10.1074/jbc.M114.628925; Bodeker D, 1996, COMP BIOCHEM PHYS A, V114, P305, DOI 10.1016/0300-9629(96)00012-6; Bouwman AF, 1997, GLOBAL BIOGEOCHEM CY, V11, P561, DOI 10.1029/97GB02266; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P83, DOI 10.1007/BF00378645; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Delgado-Elorduy A, 2002, J DAIRY SCI, V85, P148, DOI 10.3168/jds.S0022-0302(02)74063-0; DOBSON A, 1959, J PHYSIOL-LONDON, V146, P235, DOI 10.1113/jphysiol.1959.sp006191; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Ferreira LGB, 2016, J BIOENERG BIOMEMBR, V48, P1, DOI 10.1007/s10863-015-9634-8; Gartner K, 1964, Dtsch Tierarztl Wochenschr, V71, P57; Georgi MI, 2014, PFLUG ARCH EUR J PHY, V466, P1689, DOI 10.1007/s00424-013-1386-x; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARMEYER J, 1980, J DAIRY SCI, V63, P1707, DOI 10.3168/jds.S0022-0302(80)83132-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hsu YJ, 2007, BBA-MOL BASIS DIS, V1772, P928, DOI 10.1016/j.bbadis.2007.02.001; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Janssens A, 2016, ELIFE, V5, DOI 10.7554/eLife.17240; JERLING L, 1982, HOLARCTIC ECOL, V5, P405; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Lang I, 1999, AM J PHYSIOL-GASTR L, V277, pG609, DOI 10.1152/ajpgi.1999.277.3.G609; Leonhard-Marek S, 2005, AM J PHYSIOL-GASTR L, V288, pG630, DOI 10.1152/ajpgi.00275.2004; Leonhard-Marek S, 2010, ANIMAL, V4, P1037, DOI 10.1017/S1751731110000261; Leonhard-Marek S, 2002, J COMP PHYSIOL B, V172, P635, DOI 10.1007/s00360-002-0292-x; LeonhardMarek S, 1996, AM J PHYSIOL-GASTR L, V271, pG1034, DOI 10.1152/ajpgi.1996.271.6.G1034; Luo JL, 2012, J INVEST DERMATOL, V132, P2158, DOI 10.1038/jid.2012.144; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Marini J. C., 2006, P155; MEIJER GAL, 1993, METABOLISM, V42, P358, DOI 10.1016/0026-0495(93)90087-5; Metges CC, 1999, AM J CLIN NUTR, V70, P1046; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Oehlschlaeger V, 2014, ANIM PROD SCI, V54, P1394, DOI 10.1071/AN14344; Ott P, 2014, METABOLIC BRAIN DIS; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Ramezani A, 2016, AM J KIDNEY DIS, V67, P483, DOI 10.1053/j.ajkd.2015.09.027; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reynolds C K, 2008, J Anim Sci, V86, pE293; Rosendahl J, 2016, PFLUG ARCH EUR J PHY, V468, P1333, DOI 10.1007/s00424-016-1835-4; Sarria I, 2011, J NEUROPHYSIOL, V106, P3056, DOI 10.1152/jn.00544.2011; Schweigel M, 2008, MAGNESIUM RES, V21, P118; SELLERS A. F., 1960, RES VET SCI, V1, P95; Stumpff F, 2013, J COMP PHYSIOL B, V183, P1053, DOI 10.1007/s00360-013-0771-2; Stumpff F, 2011, J EXP BIOL, V214, P2871, DOI 10.1242/jeb.055582; Taylor L, 2004, BIOCHEM MOL BIOL EDU, V32, P291, DOI 10.1002/bmb.2004.494032050388; Ueda T, 2009, BIOCHEM BIOPH RES CO, V383, P130, DOI 10.1016/j.bbrc.2009.03.143; Varghese A, 2006, PROG BIOPHYS MOL BIO, V90, P26, DOI 10.1016/j.pbiomolbio.2005.05.002; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644; WEBER A, 1989, PFLUG ARCH EUR J PHY, V414, P564, DOI 10.1007/BF00580992; Weiner ID, 2017, PHYSIOL REV, V97, P465, DOI 10.1152/physrev.00011.2016; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	73	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193519	10.1371/journal.pone.0193519	http://dx.doi.org/10.1371/journal.pone.0193519			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494673	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200060
J	Chakraborty, PK; Murphy, B; Mustafi, SB; Dey, A; Xiong, XH; Rao, G; Naz, S; Zhang, M; Yang, D; Dhanasekaran, DN; Bhattacharya, R; Mukherjee, P				Chakraborty, Prabir Kumar; Murphy, Brennah; Mustafi, Soumyajit Banerjee; Dey, Anindya; Xiong, Xunhao; Rao, Geeta; Naz, Sarwat; Zhang, Min; Yang, Da; Dhanasekaran, Danny N.; Bhattacharya, Resham; Mukherjee, Priyabrata			Cystathionine -synthase regulates mitochondrial morphogenesis in ovarian cancer	FASEB JOURNAL			English	Article						mitofusin; ROS; JNK; fission	HYDROGEN-SULFIDE; BETA-SYNTHASE; MITOFUSIN 2; FUSION; FISSION; PROTEIN; MORPHOLOGY; PHOSPHORYLATION; BIOENERGETICS; DEGRADATION	Deregulation of mitochondrial morphogenesis, a dynamic equilibrium between mitochondrial fusion and fission processes, is now evolving as a key metabolic event that fuels tumor growth and therapy resistance. However, fundamental knowledge underpinning how cancer cells reprogram mitochondrial morphogenesis remains incomplete. Here, we report that cystathionine -synthase (CBS) reprograms mitochondrial morphogenesis in ovarian cancer (OvCa) cells by selectively regulating the stability of mitofusin 2 (MFN2). Clinically, high expression of both CBS and MFN2 implicates poor overall survival of OvCa patients, and a significant association between CBS and MFN2 expression exists in individual patients in the same data set. The silencing of CBS by small interfering RNA or inhibition of its catalytic activity by a small molecule inhibitor creates oxidative stress that activates JNK. Activated JNK phosphorylates MFN2 to recruit homologous to the E6-AP carboxyl terminus' domain-containing ubiquitin E3 ligase for its degradation via the ubiquitin-proteasome system. Supplementation with hydrogen sulfide or glutathione (the catalytic products of CBS enzymatic activity), anti-oxidants, or a JNK inhibitor restores MFN2 expression. In CBS-silenced orthotopic xenograft tumor tissues, MFN2 but not MFN1 is selectively downregulated. In summary, this report reveals a role for deregulated mitochondrial morphogenesis in OvCa, suggests one of the mechanisms for this deregulation, and provides a way to correct it through modulation of the metabolic enzyme CBS.Chakraborty, P. K., Murphy, B., Mustafi, S. B., Dey, A., Xiong, X., Rao, G., Naz, S., Zhang, M., Yang, D., Dhanasekaran, D. N., Bhattacharya, R., Mukherjee, P. Cystathionine -synthase regulates mitochondrial morphogenesis in ovarian cancer.	[Chakraborty, Prabir Kumar; Murphy, Brennah; Xiong, Xunhao; Rao, Geeta; Naz, Sarwat; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Mustafi, Soumyajit Banerjee; Dey, Anindya; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Chakraborty, Prabir Kumar; Xiong, Xunhao; Dhanasekaran, Danny N.; Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA; [Zhang, Min; Yang, Da] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chakraborty, PK; Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA.	prabir-chakraborty@ouhsc.edu; priyabrata-mukherjee@ouhsc.edu	Naz, Sarwat/J-2794-2019		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL120585, CA136494, CA213278, CA157481]; Foundation for Women's Cancer (FWC); Laura Crandall Brown Foundation [05101101]; NATIONAL CANCER INSTITUTE [R01CA136494, R01CA213278, R01CA157481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Women's Cancer (FWC); Laura Crandall Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL120585 (to P.M. and R.B.), CA136494 and CA213278 (to P.M.), and CA157481 (to R.B.) and Foundation for Women's Cancer (FWC), Laura Crandall Brown Foundation Grant 05101101 (to P.K.C.). The authors declare no conflicts of interest.	Abe K, 1996, J NEUROSCI, V16, P1066; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chakraborty PK, 2015, ONCOTARGET, V6, P37367, DOI 10.18632/oncotarget.5424; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Hellmich MR, 2015, ANTIOXID REDOX SIGN, V22, P424, DOI 10.1089/ars.2014.5933; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Kashatus DF, 2018, BIOCHEM BIOPH RES CO, V500, P9, DOI 10.1016/j.bbrc.2017.06.192; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kong B, 2015, ANN NY ACAD SCI, V1350, P1, DOI 10.1111/nyas.12883; Kong B, 2014, J BIOL CHEM, V289, P27134, DOI 10.1074/jbc.M114.594812; Kruger WD, 2017, MOL GENET METAB, V121, P199, DOI 10.1016/j.ymgme.2017.05.011; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Liu JQ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0099-1; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Modis K, 2016, PHARMACOL RES, V113, P116, DOI 10.1016/j.phrs.2016.08.023; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Snyder S. H., 2009, SCI SIGNAL, V2; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Veeranki S, 2015, AM J PHYSIOL-HEART C, V309, pH325, DOI 10.1152/ajpheart.00099.2015; Wang SSS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.18; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Xu Y, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.40; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	51	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4145	4157		10.1096/fj.201701095R	http://dx.doi.org/10.1096/fj.201701095R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29494264	Green Published			2022-12-26	WOS:000439325400008
J	Blair, MW; Cortes, AJ; Farmer, AD; Huang, W; Ambachew, D; Penmetsa, RV; Carrasquilla-Garcia, N; Assefa, T; Cannon, SB				Blair, Matthew W.; Cortes, Andres J.; Farmer, Andrew D.; Huang, Wei; Ambachew, Daniel; Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia; Assefa, Teshale; Cannon, Steven B.			Uneven recombination rate and linkage disequilibrium across a reference SNP map for common bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							MARKER DIVERSITY; GENOME; GENE; IDENTIFICATION; SOFTWARE; PATTERNS; SEQUENCE; WILD	Recombination (R) rate and linkage disequilibrium (LD) analyses are the basis for plant breeding. These vary by breeding system, by generation of inbreeding or outcrossing and by region in the chromosome. Common bean (Phaseolus vulgaris L.) is a favored food legume with a small sequenced genome (514 Mb) and n = 11 chromosomes. The goal of this study was to describe R and LD in the common bean genome using a 768-marker array of single nucleotide polymorphisms (SNP) based on Trans-legume Orthologous Group (TOG) genes along with an advanced-generation Recombinant Inbred Line reference mapping population (BAT93 x Jalo EEP558) and an internationally available diversity panel. A whole genome genetic map was created that covered all eleven linkage groups (LG). The LGs were linked to the physical map by sequence data of the TOGs compared to each chromosome sequence of common bean. The genetic map length in total was smaller than for previous maps reflecting the precision of allele calling and mapping with SNP technology as well as the use of gene-based markers. A total of 91.4% of TOG markers had singleton hits with annotated Pv genes and all mapped outside of regions of resistance gene clusters. LD levels were found to be stronger within the Mesoamerican genepool and decay more rapidly within the Andean genepool. The recombination rate across the genome was 2.13 cM / Mb but R was found to be highly repressed around centromeres and frequent outside peri-centromeric regions. These results have important implications for association and genetic mapping or crop improvement in common bean.	[Blair, Matthew W.; Ambachew, Daniel] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Cortes, Andres J.] Colombian Corp Agr Res CORPOICA, CI La Selva, Dept Antioquia, Rionegro, Colombia; [Farmer, Andrew D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Huang, Wei; Assefa, Teshale; Cannon, Steven B.] Iowa State Univ, Ames, IA USA; [Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia] Univ Calif Davis, US D, Davis, CA 95616 USA; [Assefa, Teshale; Cannon, Steven B.] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA	Tennessee State University; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; National Center for Genome Resources (NCGR); Iowa State University; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Blair, MW (corresponding author), Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA.	mblair@tnstate.edu	Demissie, Daniel Ambachew/AAD-5460-2020	Demissie, Daniel Ambachew/0000-0003-3578-6712; Cortes, Andres J./0000-0003-4178-0675; Blair, Matthew/0000-0003-3655-3726	CG Generation Challenge Program; Bill and Melinda Gates Foundation through the Tropical Legume I grant; Tennessee State University; Generation Challenge Program / Bill and Melinda Gates Foundation through the Tropical Legume I grant; Div Of Biological Infrastructure [1444806] Funding Source: National Science Foundation	CG Generation Challenge Program; Bill and Melinda Gates Foundation through the Tropical Legume I grant; Tennessee State University; Generation Challenge Program / Bill and Melinda Gates Foundation through the Tropical Legume I grant; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Generation Challenge Program / Bill and Melinda Gates Foundation through the Tropical Legume I grant to MWB as PI for common beans and to DC as PI for comparative legume genomics. Evans Allen funds from Tennessee State University are recognized for senior author's writing time.; The authors thank UC-Davis departments of Agronomy and Plant Pathology for seed of the BAT x Jalo mapping population and for SNP genotyping. Bean Germplasm Lab technicians are acknowledged for some DNA extractions. This research was supported by the CG Generation Challenge Program and Bill and Melinda Gates Foundation through the Tropical Legume I grant to MWB as PI for common beans. Evans Allen funds from Tennessee State University are recognized for senior author's writing time.	Afanador L.K., 1993, ANN REP BEAN IMPROV, V36, P10; Alvarez MF, 2014, USE ASS GENETICS APP, V38; Ariani A, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0512-9; Bhakta MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116822; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2016, PLANT SCI, V242, P250, DOI 10.1016/j.plantsci.2015.08.004; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Blair MW, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-79; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Cordoba JM, 2010, PLANT GENOME-US, V3, P154, DOI 10.3835/plantgenome2010.06.0013; Cortes A. J., 2013, American Journal of Plant Sciences, V4, P1998, DOI 10.4236/ajps.2013.410248; Cortes A.J., 2012, BMC GENET, V13; Cortes AJ, 2012, THEOR APPL GENET, V125, P1069, DOI 10.1007/s00122-012-1896-5; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Galeano CH, 2012, BMC GENET, P13; Gepts Paul, 2008, V1, P113; Gioia T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075974; Grisi MCM, 2007, GENET MOL RES, V6, P691; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; McClean PE, 2017, CROP SCI, V57, P3129, DOI 10.2135/cropsci2017.04.0244; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; Mezard C, 2007, TRENDS GENET, V23, P91, DOI 10.1016/j.tig.2006.12.007; Moghaddam SM, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.02.0012; NODARI RO, 1993, THEOR APPL GENET, V85, P513, DOI 10.1007/BF00220907; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Perseguini JMKC, 2016, PLOS ONE, V11, P1; Pritchard JK, 2000, GENETICS, V155, P945; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schroder S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0431-1; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Vallejos CE, 2006, GENETICS, V172, P1229, DOI 10.1534/genetics.105.050815; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458; Zou XL, 2014, MOL BREEDING, V33, P769, DOI 10.1007/s11032-013-9997-7; Zuiderveen GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156391	57	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0189597	10.1371/journal.pone.0189597	http://dx.doi.org/10.1371/journal.pone.0189597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522524	gold, Green Submitted, Green Published			2022-12-26	WOS:000427030800001
J	Elbaum, D; Beconi, MG; Monteagudo, E; Di Marco, A; Quinton, MS; Lyons, KA; Vaino, A; Harper, S				Elbaum, Daniel; Beconi, Maria G.; Monteagudo, Edith; Di Marco, Annalise; Quinton, Maria S.; Lyons, Kathryn A.; Vaino, Andrew; Harper, Steven			Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models	PLOS ONE			English	Article							BRAIN-BARRIER MODEL; HALLERVORDEN-SPATZ-SYNDROME; ESCHERICHIA-COLI; COENZYME; SYNTHETASE; DEFICIENCY; SYSTEMS	In cells, phosphorylation of pantothenic acid to generate phosphopantothenic acid by the pantothenate kinase enzymes is the first step in coenzyme A synthesis. Pantothenate kinase 2, the isoform localized in neuronal cell mitochondria, is dysfunctional in patients with pantothenate kinase-associated neurodegeneration. Fosmetpantotenate is a phosphopantothenic acid prodrug in clinical development for treatment of pantothenate kinase-associated neurodegeneration, which aims to replenish phosphopantothenic acid in patients. Fosmetpantotenate restored coenzyme A in short-hairpin RNA pantothenate kinase 2 gene-silenced neuroblastoma cells and was permeable in a blood-brain barrier model. The rate of fosmetpantotenate metabolism in blood is species-dependent. Following up to 700 mg/kg orally, blood exposure to fosmetpantotenate was negligible in rat and mouse, but measurable in monkey. Consistent with the difference in whole blood half-life, fosmetpantotenate dosed orally was found in the brains of the monkey (striatal dialysate) but was absent in mice. Following administration of isotopically labeled-fosmetpantotenate to mice, similar to 40% of liver coenzyme A (after 500 mg/kg orally) and similar to 50% of brain coenzyme A (after 125 mu g intrastriatally) originated from isotopically labeled-fosmetpantotenate. Additionally, 10-day dosing of isotopically labeled-fosmetpantotenate, 12.5 mu g, intracerebroventricularly in mice led to similar to 30% of brain coenzyme A containing the stable isotopic labels. This work supports the hypothesis that fosmetpantotenate acts to replace reduced phosphopantothenic acid in pantothenate kinase 2-deficient tissues.	[Elbaum, Daniel; Beconi, Maria G.; Quinton, Maria S.; Vaino, Andrew] Retrophin Inc, Res & Dev, Cambridge, MA 02139 USA; [Monteagudo, Edith] IRBM Sci Pk SpA, Preclin Res, Rome, Italy; [Di Marco, Annalise] IRBM Sci Pk SpA, In Vitro Pharmacol, Rome, Italy; [Harper, Steven] IRBM Sci Pk SpA, Med Chem, Rome, Italy; [Beconi, Maria G.] Goldfinch Biopharma Inc, Cambridge, MA USA; [Quinton, Maria S.] Rodin Therapeut, Cambridge, MA USA; [Vaino, Andrew] LB Pharmaceut, New York, NY USA		Elbaum, D (corresponding author), Retrophin Inc, Res & Dev, Cambridge, MA 02139 USA.	Daniel.Elbaum@retrophin.com			Retrophin, Inc.	Retrophin, Inc.	Retrophin, Inc. funded the work reported in this manuscript. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; Balibar CJ, 2011, J BACTERIOL, V193, P3304, DOI 10.1128/JB.00334-11; Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012; Bowden D.M, 2000, PRIMATE BRAIN MAPS S, V1st; Christou YP, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/3247034; Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016; Dagenais C, 2009, EUR J PHARM SCI, V38, P121, DOI 10.1016/j.ejps.2009.06.009; Di Marco A, 2016, MOV DIS SOC C JUN 19; Hartig MB, 2006, ANN NEUROL, V59, P248, DOI 10.1002/ana.20771; Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Lee CH, 2013, SCI WORLD J, DOI 10.1155/2013/860539; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Leoni V, 2012, MOL GENET METAB, V105, P463, DOI 10.1016/j.ymgme.2011.12.005; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Patabendige A, 2013, BRAIN RES, V1521, P16, DOI 10.1016/j.brainres.2013.04.006; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Roa P., 2017, INT J RARE DIS ORPHA, V2, P1006; Rump P, 2005, NEUROGENETICS, V6, P201, DOI 10.1007/s10048-005-0018-9; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650; Thornton PJ, 2016, J MED CHEM, V59, P10400, DOI 10.1021/acs.jmedchem.6b00523; Timmermann L, 2010, BRAIN, V133, P701, DOI 10.1093/brain/awq022; VASQUEZ B, 1982, IN VITRO CELL DEV B, V18, P643; Yu HS, 1997, J PHARM SCI-US, V86, P1448, DOI 10.1021/js960524q; Zano SP, 2015, MOL GENET METAB, V116, P281, DOI 10.1016/j.ymgme.2015.10.011; Zhang Y, 2006, DRUG METAB DISPOS, V34, P1935, DOI 10.1124/dmd.105.006437	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0192028	10.1371/journal.pone.0192028	http://dx.doi.org/10.1371/journal.pone.0192028			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522513	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800007
J	Schirripa, M; Zhang, W; Yang, DY; Cao, S; Okazaki, S; Loupakis, F; Berger, MD; Ning, Y; Miyamoto, Y; Suenaga, M; Alberti, G; West, JD; Lonardi, S; Khoukaz, T; Bergamo, F; Battaglin, F; Antoniotti, C; Falcone, A; Stintzing, S; Heinemann, V; Lenz, HJ				Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D.; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker; Lenz, Heinz-Josef			NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FOLFIRI PLUS BEVACIZUMAB; TUMOR-ASSOCIATED MACROPHAGES; OPEN-LABEL; PHASE-3 TRIAL; IRINOTECAN; CETUXIMAB; FLUOROURACIL; LEUCOVORIN; EXPRESSION	Background Macrophages play a crucial role in the interaction between tumor and immune system, and iNOS is known as a surrogate marker of M1 macrophages activation. The goal of the study was to investigate the role of iNOS polymorphisms as prognostic marker in mCRC patients. Materials and methods Functional significant polymorphisms in the promoter of INOS gene were analyzed by PCR-based and direct DNA sequencing in 4 cohorts of patients receiving bevacizumab based first-line chemotherapy: two evaluation cohorts (TRIBE ARM A and ARM B) and two validation cohorts (FIRE 3 arm A and MOMA). The relation of the SNPs with PFS and OS was evaluated through Kaplan-Meier method and log-rank test. Subgroup analyses according to RAS status were preplanned. Results In the exploratory cohort 1 (TRIBE A), patients with CCTTT any> 13repeats (N = 57) showed improved median PFS compared with patients carrying the <= 13/<= 13 repeats variant (N = 152) (HR, 0.64; 95% CI 0.44-0.92, p = 0.010). Similar results were shown adopting the >26repeats/<= 26 repeats (HR, 0.56; 95% CI 0.36-0.87, p = 0.005). In RAS mutant, patient with any> 13 repeats (N = 24) had improved PFS results compared with those carrying the <= 13/<= 13 repeats variant (N = 81) (HR, 0.51; 95% CI 0.30-0.87, p = 30.009). Similar results were found adopting the >26 repeats/<= 26 repeats cut off: (HR, 0.52; 95% CI 0.27-0.98, p = 0.035). These data were partially confirmed in the exploratory cohort 2 (TRIBE B): a better median PFS was observed in patients with >26 repeats vs repeats/<= 2626 repeats (N = 205) patients. However, these data were not confirmed in the two validation cohorts. Conclusion We failed to replicate the exploratory findings in both validation sets. The CCTTT polymorphic region of the INOS gene does not predict outcome in mCRC receiving bevacizumab based first line chemotherapy. Further investigations are needed to reveal mechanisms between tumor, immune system and chemotherapy response.	[Schirripa, Marta; Zhang, Wu; Okazaki, Satoshi; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; West, Jordan D.; Khoukaz, Taline; Battaglin, Francesca; Lenz, Heinz-Josef] Univ Southern Calif, Norris Comprehens Canc Ctr, Med Oncol, Los Angeles, CA USA; [Yang, Dongyun; Cao, Shu] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Loupakis, Fotios; Alberti, Giulia; Lonardi, Sara; Bergamo, Francesca] IRCCS, Ist Oncol Veneto, Dept Clin & Expt Oncol, Unit Med Oncol 1, Padua, Italy; [Alberti, Giulia] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Antoniotti, Carlotta; Falcone, Alfredo] Azienda Osped Univ Pisana, Polo Oncol, Pisa, Italy; [Stintzing, Sebastian; Heinemann, Volker] Univ Munich, Med Oncol & Comprehens Canc Ctr, Munich, Germany; [Schirripa, Marta] IRCCS, Unit Med Oncol 1, Dept Clin & Expt Oncol, Ist Oncol Veneto, Padua, Italy	University of Southern California; University of Southern California; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Munich; IRCCS Istituto Oncologico Veneto (IOV)	Lenz, HJ (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Med Oncol, Los Angeles, CA USA.	lenz@usc.edu	Berger, Martin D./AAR-4415-2021; Bergamo, Francesca/G-3134-2014; Alberti, Giulia/ABC-3936-2021; Lonardi, Sara/F-4228-2014; Loupakis, Fotios/I-7243-2012; Schirripa, Marta/F-3688-2017; Bergamo, Francesca/AAB-9010-2019; Battaglin, Francesca/C-2746-2017; Yang, Dongyun/M-2579-2019; Berger, Martin D./AAS-1238-2021; Stintzing, Sebastian/I-4538-2016	Bergamo, Francesca/0000-0002-8795-4653; Alberti, Giulia/0000-0003-2616-7477; Lonardi, Sara/0000-0002-7593-8138; Loupakis, Fotios/0000-0001-9651-0395; Schirripa, Marta/0000-0001-8316-4411; Bergamo, Francesca/0000-0002-8795-4653; Battaglin, Francesca/0000-0002-9869-0163; Yang, Dongyun/0000-0003-0736-4977; Berger, Martin D./0000-0001-9224-7104; Stintzing, Sebastian/0000-0002-3297-5801; Miyamoto, Yuji/0000-0003-3948-5044; Falcone, Alfredo/0000-0001-5840-2529	National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (grant number P30CA014089). There was no additional external funding received for this study.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andre T, 2017, P AN M AM SOC CLIN, V2017, P35; Barbera-Guillem E, 2002, CANCER RES, V62, P7042; Bupathi M, 2016, J GASTROINTEST ONCOL, V7, P713, DOI 10.21037/jgo.2016.07.03; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Falcone A, 2016, ANN ONCOLOGY S6, V27; Falcone A, 2007, J CLIN ONCOL, V25, P1670, DOI 10.1200/JCO.2006.09.0928; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kaise M, 2007, EUR J GASTROEN HEPAT, V19, P139, DOI 10.1097/01.meg.0000252637.11291.1d; Kostourou V, 2011, BRIT J CANCER, V104, P83, DOI 10.1038/sj.bjc.6606034; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Lizotte PH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28926; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Lynch D, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.29; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motallebipour M, 2005, MOL VIS, V11, P950; Norton SE, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.21; Nozoe T, 2002, ONCOL REP, V9, P521; Ropponen KM, 2000, SCAND J GASTROENTERO, V35, P1204; Stathopoulos GP, 2010, ONCOLOGY-BASEL, V78, P376, DOI 10.1159/000320520; Stintzing S, 2016, LANCET ONCOL, V17, P1426, DOI 10.1016/S1470-2045(16)30269-8; Sunakawa Y, 2015, ANN ONCOL, V26, P2450, DOI 10.1093/annonc/mdv474; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Warpeha KM, 1999, FASEB J, V13, P1825, DOI 10.1096/fasebj.13.13.1825; Wiegertjes GF, 2016, MOL IMMUNOL, V69, P146, DOI 10.1016/j.molimm.2015.09.026	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193640	10.1371/journal.pone.0193640	http://dx.doi.org/10.1371/journal.pone.0193640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522543	Green Published, Green Submitted, gold			2022-12-26	WOS:000427030800018
J	Cheung, SH; Lau, JYW				Cheung, Sau Ha; Lau, James Yun Wong			Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration	PLOS ONE			English	Article							FATTY-ACID OXIDATION; GLUTATHIONE PEROXIDASE-1; LIPID-PEROXIDATION; METABOLISM; LIVER; GAMMA; ATHEROSCLEROSIS; INFLAMMATION; CONTRIBUTES; GLYCOLYSIS	S-sulfhydration is a signalling pathway of hydrogen sulfide (H2S), which is suggested as an anti-atherogenic molecule that may protect against atherosclerosis. The identification of S-sulfhydrated proteins by proteomic approach could be a major step towards understanding the mechanisms of H2S in response to atherosclerosis. The present study studied targeted S-sulfhydrated proteins using the modified biotin switch method followed by matrix-assisted laser desorption/ionisation time of flight tandem mass spectrometry identification. The results showed that H2S can protect against atherosclerosis by reducing body weight gain and alleviating aortic plaque formation. In addition, H2S treatment can increase aortic protein S-sulfhydration. Seventy targeted S-sulfhydrated aortic proteins were identified, mainly involved in metabolism, stimulus response and biological regulation, as determined by gene ontology database analysis. H2S also induced S-sulfhydration of glutathione peroxidase 1 and further reduced lipid peroxidation and increased antioxidant defence in the aorta by prompting glutathione synthesis. Our data suggest that H2S is a cardiovascular-protective molecule that S-sulfhydrates a subset of proteins that are mainly responsible for lipid metabolism and exerts its cytoprotective effects to clear free radicals and inhibit oxidative stress through cysteine S-sulfhydration.	[Cheung, Sau Ha; Lau, James Yun Wong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Cheung, SH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	maggie@surgery.ouhk.edu.hk	Lau, James Y. W./O-2612-2016	Lau, James Y. W./0000-0003-0122-4068	Chinese University of Hong Kong [2015.1.085]	Chinese University of Hong Kong(Chinese University of Hong Kong)	JYWL received the a Direct Grant [2015.1.085] from The Chinese University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Barr LA, 2014, CIRC J, V78, P2111, DOI 10.1253/circj.CJ-14-0728; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bojic LA, 2014, ARTERIOSCL THROM VAS, V34, P52, DOI 10.1161/ATVBAHA.113.301830; Cai JY, 2016, BBA-MOL CELL BIOL L, V1861, P419, DOI 10.1016/j.bbalip.2016.03.001; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Carter RN, 2016, J PATHOL, V238, P321, DOI 10.1002/path.4659; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Cheng LH, 2004, BIOCHEM BIOPH RES CO, V313, P277, DOI 10.1016/j.bbrc.2003.11.127; Cheung SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113038; Cyrus T, 2001, CIRCULATION, V103, P2277; D'Alessandro A, 2014, ONCOTARGET, V5, P7722, DOI 10.18632/oncotarget.2300; Guo C, 2014, EUR J PHARMACOL, V725, P70, DOI 10.1016/j.ejphar.2014.01.009; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Ju YJ, 2015, BBA-GEN SUBJECTS, V1850, P2293, DOI 10.1016/j.bbagen.2015.08.003; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lin Y, 2016, BIOMED PHARMACOTHER, V83, P466, DOI 10.1016/j.biopha.2016.07.003; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Paul BD, 2015, METHOD ENZYMOL, V555, P79, DOI 10.1016/bs.mie.2014.11.021; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Saha S, 2016, FASEB J, V30, P441, DOI 10.1096/fj.15-278648; Schnabel R, 2005, J AM COLL CARDIOL, V45, P1631, DOI 10.1016/j.jacc.2005.02.053; Vlahos R, 2013, REDOX REP, V18, P142, DOI 10.1179/1351000213Y.0000000053; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y; Xie MX, 2014, J INORG BIOCHEM, V136, P47, DOI 10.1016/j.jinorgbio.2014.03.011; Zarei M, 2016, ARYA ATHEROSCLER, V12, P118; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041147	41	24	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194176	10.1371/journal.pone.0194176	http://dx.doi.org/10.1371/journal.pone.0194176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518145	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900072
J	Lugassy, D; Levanon, Y; Pilo, R; Shelly, A; Rosen, G; Meirowitz, A; Brosh, T				Lugassy, Diva; Levanon, Yafi; Pilo, Raphael; Shelly, Asaf; Rosen, Gal; Meirowitz, Avi; Brosh, Tamar			Predicting the clinical performance of dental students with a manual dexterity test	PLOS ONE			English	Article							MOTOR SKILL; SELECTION; APTITUDE	Dentists must be skilled when using dental mirrors. Working with mirrors requires spatial perception, bimanual coordination, perceptual learning and fine motor skills. Many studies have attempted to determine the predictors of manual skills among pre-clinical students, but consensus has yet to be reached. We hypothesized that valid and reliable occupational therapy test performance regarding indirect vision would differ between dental students and junior dentists and would explain the variance in manual skill performance in pre-clinical courses. To test this hypothesis, we applied the Purdue Pegboard test and O'Connor Tweezer Dexterity test under different conditions of direct and indirect vision. We administered these tests to students in phantom-head academic courses in 2015 and 2016 and to junior dentists. Students performed the tests at three time points: before phantom training (TO), at the end of the training (Ti) and in the middle of the following year of study (T2), Dentists performed the same tests twice at 1st and 2nd trials one week apart. The results showed that indirect tasks were significantly more difficult to perform for both groups. These dexterity tests were sensitive enough to detect students' improvement after phantom training. The dentists' performances were significantly better than those of students at TO, specifically with regard to the use of tweezers under direct and indirect vision (the O'Connor test). A regression analysis showed that students' manual grades obtained at the beginning of the phantom course, their performance on the Purdue test using both hands, and their performance on the O'Connor test under indirect vision predicted phantom course success in 80% of cases. The O'Connor test under indirect vision is the most informative means of monitoring and predicting the manual skills required in the pre-clinical year of dentistry studies.	[Lugassy, Diva; Pilo, Raphael; Rosen, Gal; Meirowitz, Avi] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Rehabil, Sackler Fac Med, Tel Aviv, Israel; [Levanon, Yafi] Tel Aviv Univ, Stanley Steyer Sch Hlth Profess, Dept Occupat Therapy, Sackler Fac Med, Tel Aviv, Israel; [Shelly, Asaf] Private Clin, Rishon Leziyyon, Israel; [Brosh, Tamar] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Brosh, T (corresponding author), Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, Sackler Fac Med, Tel Aviv, Israel.	tbrosh@post.tau.ac.il		Brosh, Tamar/0000-0001-6181-3310	Ministry of Science, Technology and Space, Israel [3-12439]	Ministry of Science, Technology and Space, Israel	This work was supported by the Ministry of Science, Technology and Space, Israel No. 3-12439.; This study was partially supported by a grant provided by Ministry of Science, Technology and Space, Israel No. 3-12439.	Boyd M A, 1987, J Dent Educ, V51, P98; Boyle A M, 1986, J Dent Educ, V50, P176; Case-Smith J, 2000, AM J OCCUP THER, V54, P372, DOI 10.5014/ajot.54.4.372; Causby R, 2014, PERCEPT MOTOR SKILL, V118, P765, DOI 10.2466/25.27.PMS.118k27w2; de Andres Alfonso Garcia, 2004, Eur J Dent Educ, V8, P24, DOI 10.1111/j.1600-0579.2004.00296.x; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Gansky Stuart A, 2004, J Dent Educ, V68, P985; Gillet Dominique, 2002, Eur J Dent Educ, V6, P69, DOI 10.1034/j.1600-0579.2002.60205.x; Giuliani M, 2007, BRIT DENT J, V203, P149, DOI 10.1038/bdj.2007.688; Gray Sarah A, 2002, J Dent Educ, V66, P721; Kirby T J, 1979, Trans Am Ophthalmol Soc, V77, P294; Kothe C, 2014, GMS Z MED AUSBILD, V31; Luck O, 2000, Eur J Dent Educ, V4, P10, DOI 10.1034/j.1600-0579.2000.040103.x; Lundergan WP, 2007, J DENT EDUC, V71, P1090; MATHIOWETZ V, 1986, AM J OCCUP THER, V40, P174, DOI 10.5014/ajot.40.3.174; Muscio B, 1922, B J PSYCHOL-GEN SECT, V13, P157, DOI 10.1111/j.2044-8295.1922.tb00091.x; OLIVER CE, 1990, AM J OCCUP THER, V44, P111, DOI 10.5014/ajot.44.2.111; OSGOOD CE, 1949, PSYCHOL REV, V56, P132, DOI 10.1037/h0057488; Oswald FL, 2004, J APPL PSYCHOL, V89, P187, DOI 10.1037/0021-9010.89.2.187; Provins KA, 1997, J MOTOR BEHAV, V29, P183, DOI 10.1080/00222899709600832; Sandow Pamela L, 2002, J Dent Educ, V66, P385; Schmidt R.A., 1988, MOTOR CONTROL LEARNI, V2nd Edn; Schwibbe A, 2016, ADV HEALTH SCI EDUC, V21, P841, DOI 10.1007/s10459-016-9670-0; SPRATLEY MH, 1990, AUST DENT J, V35, P159, DOI 10.1111/j.1834-7819.1990.tb05883.x; Suddick R P, 1983, J Dent Educ, V47, P149; Suksudaj N, 2012, EUR J DENT EDUC, V16, pE187, DOI 10.1111/j.1600-0579.2011.00696.x; Thorndike EL, 1908, AM J PSYCHOL, V19, P374, DOI 10.2307/1413197; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Weinstein P, 1981, J Dent Educ, V45, P71; Willis D O, 1983, J Dent Educ, V47, P311; WILSON SG, 1991, EVAL HEALTH PROF, V14, P41, DOI 10.1177/016327879101400103	32	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193980	10.1371/journal.pone.0193980	http://dx.doi.org/10.1371/journal.pone.0193980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5UV	29518127	gold, Green Submitted, Green Published			2022-12-26	WOS:000426902900054
J	Moron-Calvente, V; Romero-Pinedo, S; Toribio-Castello, S; Plaza-Diaz, J; Abadia-Molina, AC; Rojas-Barros, DI; Beug, ST; LaCasse, EC; MacKenzie, A; Korneluk, R; Abadia-Molina, F				Moron-Calvente, Virginia; Romero-Pinedo, Salvador; Toribio-Castello, Sofia; Plaza-Diaz, Julio; Abadia-Molina, Ana C.; Rojas-Barros, Domingo I.; Beug, Shawn T.; LaCasse, Eric C.; MacKenzie, Alex; Korneluk, Robert; Abadia-Molina, Francisco			Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CELLULAR INHIBITOR; GENE-EXPRESSION; PHORBOL ESTER; CANCER-CELLS; ACTIVATION; SMAC; TISSUE; PROLIFERATION; CONTRIBUTES	Monocytes and macrophages constitute the first line of defense of the immune system against external pathogens. Macrophages have a highly plastic phenotype depending on environmental conditions; the extremes of this phenotypic spectrum are a pro-inflammatory defensive role (M1 phenotype) and an anti-inflammatory tissue-repair one (M2 phenotype). The Inhibitor of Apoptosis (IAP) proteins have important roles in the regulation of several cellular processes, including innate and adaptive immunity. In this study we have analyzed the differential expression of the lAPs, NAIP, cIAP1 and cIAP2, during macrophage differentiation and polarization into M1 or M2. In polarized THP-1 cells and primary human macrophages, NAIP is abundantly expressed in M2 macrophages, while cIAP1 and cIAP2 show an inverse pattern of expression in polarized macrophages, with elevated expression levels of cIAP1 in M2 and cIAP2 preferentially expressed in M1. Interestingly, treatment with the lAP antagonist SMG-LGL161, induced the upregulation of NAIP in M2, the downregulation of cIAP1 in M1 and M2 and an induction of cIAP2 in M1 macrophages.	[Moron-Calvente, Virginia; Abadia-Molina, Francisco] Univ Granada, Dept Cell Biol, Granada, Spain; [Moron-Calvente, Virginia; Romero-Pinedo, Salvador; Toribio-Castello, Sofia; Plaza-Diaz, Julio; Abadia-Molina, Ana C.; Abadia-Molina, Francisco] Univ Granada, Biomed Res Ctr, Granada, Spain; [Romero-Pinedo, Salvador; Abadia-Molina, Ana C.] Univ Granada, Dept Biochem & Mol Biol & Immunol 3, Granada, Spain; [Plaza-Diaz, Julio] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Plaza-Diaz, Julio; Abadia-Molina, Francisco] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Rojas-Barros, Domingo I.] CSIC, Spanish Natl Res Council, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Beug, Shawn T.; LaCasse, Eric C.; MacKenzie, Alex; Korneluk, Robert] Univ Ottawa, Eastern Ontario Res Inst, Childrens Hosp, Apoptosis Res Ctr, Ottawa, ON, Canada; [MacKenzie, Alex] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Korneluk, Robert] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Granada; University of Granada; University of Granada; University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Abadia-Molina, F (corresponding author), Univ Granada, Dept Cell Biol, Granada, Spain.; Abadia-Molina, F (corresponding author), Univ Granada, Biomed Res Ctr, Granada, Spain.; Abadia-Molina, F (corresponding author), Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain.	fmolina@ugr.es	Abadia-Molina, Ana/H-7855-2015; Morón-Calvente, Virginia/ABH-7350-2020; Toribio-Castelló, Sofía/AAT-1857-2021; Plaza-Diaz, Julio/C-8094-2016	Morón-Calvente, Virginia/0000-0001-9181-4269; Toribio-Castelló, Sofía/0000-0001-8879-3057; Plaza-Diaz, Julio/0000-0002-5171-9408; Rojas-Barros, Domingo/0000-0001-8625-2564	Universidad de Granada, Plan Propio; Universidad de Granada CEI BioTic [CAEP2-84]; Canadian Institutes of Health Research [231421, 318176, 361847]	Universidad de Granada, Plan Propio; Universidad de Granada CEI BioTic; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Universidad de Granada, Plan Propio 2015;#P3B: FAM, VMC (http://investigacion.ugr.es/pages/planpropio/2015/resoluciones/p3b_def_28072015); Universidad de Granada CEI BioTic;#CAEP2-84: VMC (http://biotic.ugr.es/pages/resolucionprovisionalenseaanzapractica22demayo/l); and Canadian Institutes of Health Research;#231421, #318176, #361847: STB, ECL, RK (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia-Molina F, 2017, SCI REP-UK, V7, DOI 10.1038/srep39981; Alisi A, 2017, MEDIAT INFLAMM, V2017, P1; Ascoli BM, 2016, AUST NZ J PSYCHIAT, V50, P618, DOI 10.1177/0004867416642846; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Beug ST, 2015, INT J DEV BIOL, V59, P141, DOI [10.1387/ijdb.150084e1, 10.1387/ijdb.150084el]; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Chen KF, 2012, BIOCHEM PHARMACOL, V84, P268, DOI 10.1016/j.bcp.2012.04.023; Chesi M, 2016, NAT MED, V22, P1411, DOI 10.1038/nm.4229; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Cui XF, 2000, BBA-GEN SUBJECTS, V1524, P178, DOI 10.1016/S0304-4165(00)00155-0; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Davoodi J, 2010, INT J BIOCHEM CELL B, V42, P958, DOI 10.1016/j.biocel.2010.02.008; Dobson CC, 2017, ONCOTARGET, V8, P3495, DOI 10.18632/oncotarget.13849; Dubrez L, 2013, ONCOTARGETS THER, V6, P1285, DOI 10.2147/OTT.S33375; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Fulda S, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0399-3; Fulda S, 2015, SEMIN CELL DEV BIOL, V39, P132, DOI 10.1016/j.semcdb.2014.12.005; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Girodet PO, 2016, AM J RESP CELL MOL, V55, P467, DOI 10.1165/rcmb.2015-0295OC; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graber TE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.20; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hass R, 1997, LEUKEMIA RES, V21, P589, DOI 10.1016/S0145-2126(97)00010-6; Heard KN, 2015, EMBO J, V34, P2393, DOI 10.15252/embj.201592060; Huang ZK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129744; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kim DS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00324-x; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lawlor KE, 2017, CELL REP, V20, P668, DOI 10.1016/j.celrep.2017.06.073; Lecis D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.449; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; Littlefield M.J., 2014, INT J IMMUNOL IMMUNO, V1, DOI [10.23937/2378-3672/1410001, DOI 10.23937/2378-3672/1410001]; Liu WX, 2015, CELL PHYSIOL BIOCHEM, V35, P2483, DOI 10.1159/000374048; Luo WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44612; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Maier JKX, 2007, J HISTOCHEM CYTOCHEM, V55, P911, DOI 10.1369/jhc.6A7144.2007; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pineros AR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41240; Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065; Poma P, 2006, INT J ONCOL, V28, P923; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Saha D, 2017, CANCER CELL, V32, P253, DOI 10.1016/j.ccell.2017.07.006; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Spiller KL, 2016, EXP CELL RES, V347, P1, DOI 10.1016/j.yexcr.2015.10.017; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Van Overmeire E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00127; Verdeguer F, 2017, EXP CELL RES, V360, P35, DOI 10.1016/j.yexcr.2017.03.043; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wang X.C., 2014, LEATHER SCI ENG, V2, P5; Wei J, 2015, J SURG RES, V197, P126, DOI 10.1016/j.jss.2015.03.023; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhang YQ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0016-3; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zotes TM, 2013, PLOS ONE, V8, P1	74	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193643	10.1371/journal.pone.0193643	http://dx.doi.org/10.1371/journal.pone.0193643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518103	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900030
J	Gray, MJ; Spatz, JA; Carter, ED; Yarber, CM; Wilkes, RP; Miller, DL				Gray, Matthew J.; Spatz, Jennifer A.; Carter, E. Davis; Yarber, Christian M.; Wilkes, Rebecca P.; Miller, Debra L.			Poor biosecurity could lead to disease outbreaks in animal populations	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; RANAVIRUS INFECTION; ACINETOBACTER-BAUMANNII; NORTH-AMERICA; GLOVES; AMPHIBIANS; PATHOGENS; TADPOLES; CHYTRIDIOMYCOSIS; CONTAMINATION	Human-mediated disease outbreaks due to poor biosecurity practices when processing animals in wild populations have been suspected. We tested whether not changing nitrile gloves between processing wood frog (Lithobates sylvaticus) tadpoles and co-housing individuals increased pathogen transmission and subsequent diseased-induced mortality caused by the emerging pathogen, ranavirus. We found that not changing gloves between processing infected and uninfected tadpoles resulted in transmission of ranavirus and increased the risk of mortality of uninfected tadpoles by 30X. Co-housing tadpoles for only 15 minutes with 10% of individuals infected resulted in ranavirus transmission and 50% mortality of uninfected tadpoles. More extreme mortality was observed when the co-housing infection prevalence was >10%. Our results illustrate that human-induced disease outbreaks due to poor biosecurity practices are possible in wild animal populations.	[Gray, Matthew J.; Spatz, Jennifer A.; Carter, E. Davis; Yarber, Christian M.; Miller, Debra L.] Univ Tennessee, Inst Agr, Ctr Wildlife Hlth, Knoxville, TN 37901 USA; [Wilkes, Rebecca P.] Univ Georgia, Vet Diagnost & Invest Lab, Tifton, GA USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Gray, MJ (corresponding author), Univ Tennessee, Inst Agr, Ctr Wildlife Hlth, Knoxville, TN 37901 USA.	mgray11@utk.edu		Gray, Matthew/0000-0001-8243-9217	USDA National Institute of Food and Agriculture [1012932]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the USDA National Institute of Food and Agriculture (Hatch Project 1012932) to MJG and DLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, HERPETOL REV; Birnbach DJ, 2015, ANESTH ANALG, V120, P848, DOI 10.1213/ANE.0000000000000230; Brunner J.L., 2015, RANAVIRUSES LETHAL P, P71, DOI [10.1007/978-3-319-13755-1_4, DOI 10.1007/978-3-319-13755-1_4]; Brunner JL, 2017, ECOLOGY, V98, P576, DOI 10.1002/ecy.1644; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Cashins Scott D., 2008, Herpetological Review, V39, P298; Claytor SC, 2017, VIROLOGY, V511, P330, DOI 10.1016/j.virol.2017.07.028; Cox D. R., 1984, ANAL SURVIVAL DATA; Cunningham AA, 2003, J PARASITOL, V89, P78; Gerhold R, 2016, WILDLIFE SOC B, V40, P25, DOI 10.1002/wsb.638; Gosner K. L., 1960, Herpetologica, V16, P183; Gray MJ, 2012, DIS AQUAT ORGAN, V99, P1, DOI 10.3354/dao02436; Gray MJ, WETLAND TECHNIQUES, V2; Gray MJ, 2015, RANAVIRUSES LETHAL P; Gray MJ, 2015, RANAVIRUSES, P209; Greene C, 2015, AM J INFECT CONTROL, V43, P928, DOI 10.1016/j.ajic.2015.05.008; Greer Amy L., 2009, Herpetological Review, V40, P145; Gutleb AC, 2001, ENVIRON TOXICOL PHAR, V10, P119, DOI 10.1016/S1382-6689(01)00091-6; Haislip NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022307; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217; Johnson AF, 2014, DIS AQUAT ORGAN, V111, P129, DOI 10.3354/dao02774; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Officer K, 2014, J VET DIAGN INVEST, V26, P705, DOI 10.1177/1040638714547256; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Mendez D, 2008, DIS AQUAT ORGAN, V82, P97, DOI 10.3354/dao01975; Miller DL, 2007, EMERG INFECT DIS, V13, P342, DOI 10.3201/eid1302.061073; Miller DL., 2015, RANAVIRUSES, P171, DOI DOI 10.1007/978-3-319-13755-1_7; Monaghan JM, 2016, LETT APPL MICROBIOL, V62, P299, DOI 10.1111/lam.12549; Munro J, 2016, J WILDLIFE DIS, V52, P138, DOI 10.7589/2015-02-033; Oh JK, 2016, J FOOD ENG, V187, P82, DOI 10.1016/j.jfoodeng.2016.04.018; Pedrosa PBS, 2011, INT J INFECT DIS, V15, pE366, DOI 10.1016/j.ijid.2011.03.005; Pessier A.P., 2017, MANUAL CONTROL INFEC; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Picco AM, 2007, J WILDLIFE DIS, V43, P286, DOI 10.7589/0090-3558-43.2.286; Reitzel R, 2014, AM J INFECT CONTROL, V42, P55, DOI 10.1016/j.ajic.2013.07.005; Retallick RWR, 2006, DIS AQUAT ORGAN, V72, P77, DOI 10.3354/dao072077; Robertson LS, 2013, DIS AQUAT ORGAN, V104, P225, DOI 10.3354/dao02601; Rollins-Smith LA, 2017, DEV COMP IMMUNOL, V66, P111, DOI 10.1016/j.dci.2016.07.002; Schmeller DS, 2011, LAB ANIM-UK, V45, P25, DOI 10.1258/la.2010.010101; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; Tomas ME, 2015, JAMA INTERN MED, V175, P1904, DOI 10.1001/jamainternmed.2015.4535; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Ye D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0917-9	49	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3								10.1371/journal.pone.0193243	http://dx.doi.org/10.1371/journal.pone.0193243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513691	gold, Green Submitted, Green Published			2022-12-26	WOS:000426896800047
J	Khan, A; Kamran, S; Ponirakis, G; Akhtar, N; Khan, R; George, P; Babu, BM; Ibrahim, FM; Petropoulos, IN; Canibano, BG; Wilins, SS; Deleu, D; Shuaib, A; Malik, RA				Khan, Adnan; Kamran, Saadat; Ponirakis, Georgios; Akhtar, Naveed; Khan, Rabia; George, Pooja; Babu, Blessy M.; Ibrahim, Faiza M.; Petropoulos, Ioannis N.; Canibano, Beatriz G.; Wilins, Stacy S.; Deleu, Dirk; Shuaib, Ashfaq; Malik, Rayaz A.			Peripheral neuropathy in patients with multiple sclerosis	PLOS ONE			English	Article							CORNEAL CONFOCAL MICROSCOPY; SUDOMOTOR DYSFUNCTION; PAIN; POLYNEUROPATHY; THRESHOLD; SUDOSCAN; TOOL	Objectives To determine the prevalence and severity of neuropathic pain, sudomotor dysfunction and abnormal vibration perception in patients with MS. Methods 73 patients with MS and 32 age-matched healthy controls underwent assessment of expanded disability severity score (EDSS), DN4 to assess neuropathic pain, electrochemical skin conductance (ESC) to assess sudomotor function and vibration perception threshold (VPT). Results Patients with MS had a higher DN4 score (p<0.001) with 14% fulfilling the criteria for neuropathic pain elevated VPT (p<0.001) and lower ESC on the feet (p<0.001) and hands (p<0.001) compared to control participants. ESC on the feet (32% of MS patients) and hands (30% of MS patients) were lower, and DN4 (77% of MS patients) and VPT (64% of MS patients) were greater than 2SD of the healthy control values, respectively. EDSS correlated with the number of relapses (r = 0.564, p<0.001), VPT (r = -0.457,<0.001) and ESC on the feet (r = -0.268, p = 0.023). Conclusions Patients with multiple sclerosis have evidence of sudomotor dysfunction and elevated vibration perception, which were associated with neurological disability from MS.	[Khan, Adnan; Ponirakis, Georgios; Petropoulos, Ioannis N.; Malik, Rayaz A.] Qatar Fdn, Weill Cornell Med Qatar, Educ City, Doha, Qatar; [Kamran, Saadat; Akhtar, Naveed; Khan, Rabia; George, Pooja; Babu, Blessy M.; Ibrahim, Faiza M.; Canibano, Beatriz G.; Wilins, Stacy S.; Deleu, Dirk; Shuaib, Ashfaq] Hamad Gen Hosp, Inst Neurosci, Doha, Qatar; [Shuaib, Ashfaq] Univ Alberta, Dept Neurol, Edmonton, AB, Canada	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Hamad General Hospital; University of Alberta	Malik, RA (corresponding author), Qatar Fdn, Weill Cornell Med Qatar, Educ City, Doha, Qatar.	ram2045@qatar-med.cornell.edu	Kamran, Saadat/AAG-7499-2019; Ponirakis, Georgios/T-7207-2019	Kamran, Saadat/0000-0002-0260-2086; Ponirakis, Georgios/0000-0002-6936-1248; Khan, Adnan/0000-0003-4647-6672; Khan, Rabia/0000-0003-1338-3568	Qatar Foundation-BMRP [20038654]; Multiple Sclerosis Innovation [2016-201701.10249.POT]	Qatar Foundation-BMRP; Multiple Sclerosis Innovation	This work was supported by Qatar Foundation-BMRP 20038654 and Multiple Sclerosis Innovation 2016-201701.10249.POT to Dr Rayaz A Malik.	Ayoub H, 2010, ELECTROANAL, V22, P2483, DOI 10.1002/elan.201000307; Beiske AG, 2004, EUR J NEUROL, V11, P479, DOI 10.1111/j.1468-1331.2004.00815.x; Bitirgen G, 2017, JAMA OPHTHALMOL, V135, P777, DOI 10.1001/jamaophthalmol.2017.1590; Castro J, 2016, CLIN NEUROPHYSIOL, V127, P2222, DOI 10.1016/j.clinph.2016.02.013; Crnosija L, 2016, CLIN NEUROPHYSIOL, V127, P864, DOI 10.1016/j.clinph.2015.06.010; Fernandez-de-las-Penas C, 2015, CLIN J PAIN, V31, P66, DOI 10.1097/AJP.0000000000000084; Gin H, 2011, DIABETES METAB, V37, P527, DOI 10.1016/j.diabet.2011.05.003; Grau-Lopez L, 2011, NEUROLOGIA, V26, P208, DOI 10.1016/j.nrl.2010.07.014; Guclu-Gunduz A, 2012, NEUROREHABILITATION, V30, P369, DOI 10.3233/NRE-2012-0768; Guler T, 2016, J PHYS MED REHABILIT, V19; GUTRECHT JA, 1993, J NEUROL SCI, V118, P88, DOI 10.1016/0022-510X(93)90251-S; Habek M, 2016, CLIN AUTON RES, V26, P385, DOI 10.1007/s10286-016-0370-x; HALONEN P, 1986, ACTA NEUROL SCAND, V74, P63, DOI 10.1111/j.1600-0404.1986.tb04627.x; Jahanroshan J, 2017, NEUROLOGY S, V88; Jamali A., 2017, GAIT POSTURE; Leocani L, 2003, MULT SCLER, V9, P275, DOI 10.1191/1352458503ms908oa; Leocani L, 2014, HAND CLINIC, V122, P671, DOI 10.1016/B978-0-444-52001-2.00028-5; Meh D, 1999, ELECTROMYOGRAPHY CLI, V40, P131; Mikolajczak J, 2017, MULT SCLER J, V23, P1847, DOI 10.1177/1352458516677590; Muller R, 1951, ACTA PSYCH NEUROL SC, V74, P32; Newsome SD, 2011, J NEUROL SCI, V305, P103, DOI 10.1016/j.jns.2011.03.003; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Petropoulos IN, 2017, INVEST OPHTH VIS SCI, V58, P3677, DOI 10.1167/iovs.17-22050; Pinter A, 2015, INT J MOL SCI, V16, P16920, DOI 10.3390/ijms160816920; Saari A, 2008, ACTA NEUROL SCAND, V118, P226, DOI 10.1111/j.1600-0404.2008.01003.x; Saari A, 2010, CLIN AUTON RES, V20, P199, DOI 10.1007/s10286-009-0052-z; Sahuc P, 2016, THER CLIN RISK MANAG, V12, P135, DOI 10.2147/TCRM.S99241; Solaro C, 2004, NEUROLOGY, V63, P919, DOI 10.1212/01.WNL.0000137047.85868.D6; Spallone V, 2012, DIABETIC MED, V29, P578, DOI 10.1111/j.1464-5491.2011.03500.x; Truini A, 2012, PAIN, V153, P2048, DOI 10.1016/j.pain.2012.05.024; Uszynski M, 2015, GAIT POSTURE, V41, P228, DOI 10.1016/j.gaitpost.2014.10.010; Vinik AI, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00094; Wang I-C, 2017, SCI REPORTS, P7; Xia ZQ, 2017, JAMA NEUROL, V74, P291, DOI 10.1001/jamaneurol.2016.5056	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193270	10.1371/journal.pone.0193270	http://dx.doi.org/10.1371/journal.pone.0193270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513761	gold, Green Submitted, Green Published			2022-12-26	WOS:000426896800050
J	Bierings, RAJM; Kuiper, M; van Berkel, CM; Overkempe, T; Jansonius, NM				Bierings, Ronald A. J. M.; Kuiper, Marleen; van Berkel, Casper M.; Overkempe, Tom; Jansonius, Nomdo M.			Foveal light and dark adaptation in patients with glaucoma and healthy subjects: A case-control study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AGE-RELATED-CHANGE; SENSITIVITY; FREQUENCY; SENSE	Introduction To determine whether foveal light and dark adaptation are affected in glaucoma. Methods Case-control study with 23 glaucoma patients and 51 controls. Light and dark adaptation were measured twice. After 10 minutes pre-adaptation to 0.0032 cd/m2, the background luminance increased stepwise to 320 (5 log unit step) or 10,000 cd/m2 (6.5 log unit step) for 10 minutes, then it decreased back to 0.0032 cd/m2 for 30 minutes. Foveal contrast sensitivity [CS]) as a function of time was determined using a 1.15 degree increment. Time resolution of the experiments was 30 seconds. Multiple linear regression was used to analyse the effect of glaucoma on the CS plateau and adaptation time (time to reach the plateau minus 3 dB); analyses were adjusted for age and gender. Results After light adaptation to 320 and 10,000 cd/m2, glaucoma patients had a 0.22 (P<0.001) and 0.13 (P = 0.010) log unit lower CS plateau than controls, respectively. After dark adaptation, this difference was 0.21 (P = 0.018) and 0.30 (P<0.001) log unit, respectively. Light adaptation occurred too fast to determine an accurate light adaptation time. Dark adaptation times of glaucoma patients and controls were similar, for both the 5 (7.2 versus 5.5 minutes; P = 0.10) and the 6.5 (18.2 versus 16.6 minutes; P = 0.14) log unit step. Conclusion After a sudden increase or decrease in luminance, the logCS adaptation curves of glaucoma patients are shifted downwards compared to the curves of healthy subjects. Glaucoma patients have a lower CS plateau than healthy subjects, for both light and dark adaptation; dark adaptation times are similar.	[Bierings, Ronald A. J. M.; Kuiper, Marleen; van Berkel, Casper M.; Overkempe, Tom; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands	University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl		Jansonius, Nomdo/0000-0002-6495-6568	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands [2012-09, 2013-23]	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands(Netherlands Government)	Funded by Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands (NJ; grant numbers 2012-09 and 2013-23) to NMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-20; BAKER HD, 1949, J OPT SOC AM, V39, P172, DOI 10.1364/JOSA.39.000172; Bierings RAJM, LIGHTING RE IN PRESS; Bierings RAJM, ACTA OPHTHA IN PRESS; BRABYN LB, 1979, PERCEPT PSYCHOPHYS, V26, P319, DOI 10.3758/BF03199887; Casten V, 1933, ARCH OPHTHALMOL-CHIC, V9, P52; Chauvenet W., 1906, MANUAL SPHERICAL PRA, P469; Chua BE, 2004, EYE, V18, P765, DOI 10.1038/sj.eye.6701366; Derby G S, 1926, Trans Am Ophthalmol Soc, V24, P92; Derby GS, 1929, ARCH OPHTHALMOL-CHIC, V1, P692; Duke -Elder S, 1969, SYSTEM OPHTHALMOLOGY, V11, P443; Feldman JB, 1936, ARCH OPHTHALMOL-CHIC, V15, P1004, DOI 10.1001/archopht.1936.00840180048005; GOLDTHWAITE D, 1976, CAN J OPHTHALMOL, V11, P55; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; Hecht S, 1935, J GEN PHYSIOL, V19, P321, DOI 10.1085/jgp.19.2.321; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hu CX, 2014, AM J MED SCI, V348, P403, DOI 10.1097/MAJ.0000000000000319; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; JONAS JB, 1990, GRAEF ARCH CLIN EXP, V228, P321, DOI 10.1007/BF00920055; Lee BL, 1998, ARCH OPHTHALMOL-CHIC, V116, P861, DOI 10.1001/archopht.116.7.861; Mandelbaum J, 1941, ARCH OPHTHALMOL-CHIC, V26, P203, DOI 10.1001/archopht.1941.00870140053003; MOTE FA, 1951, J GEN PHYSIOL, V34, P657, DOI 10.1085/jgp.34.5.657; Nelson P, 1999, BRIT J OPHTHALMOL, V83, P546, DOI 10.1136/bjo.83.5.546; Nio YK, 2000, OPHTHAL PHYSL OPT, V20, P323, DOI 10.1016/S0275-5408(99)00103-9; Nomura H, 2003, JPN J OPHTHALMOL, V47, P299, DOI 10.1016/S0021-5155(03)00011-X; Panos GD, 2017, KLIN MONATSBL AUGENH, V234, P464, DOI 10.1055/s-0042-119562; Rufer F, 2005, CORNEA, V24, P259; Sia DIT, 2013, ACTA OPHTHALMOL, V91, P312, DOI 10.1111/j.1755-3768.2011.02379.x; Tatemichi M, 2012, ACTA OPHTHALMOL, V90, P546, DOI 10.1111/j.1755-3768.2010.01988.x; Waite JH, 1925, T OPHTHAL SOC UK, V45, P324; WERBLIN FS, 1973, SCI AM, V228, P71; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; ZIHL J, 1990, CLIN VISION SCI, V5, P185; ZUEGE P, 1967, AM J OPHTHALMOL, V64, P56, DOI 10.1016/0002-9394(67)93343-0	34	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193663	10.1371/journal.pone.0193663	http://dx.doi.org/10.1371/journal.pone.0193663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509787	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200022
J	Bultum, JA; Yigzaw, N; Demeke, W; Alemayehu, M				Bultum, Jemal Abdella; Yigzaw, Niguse; Demeke, Wubit; Alemayehu, Mekuriaw			Alcohol use disorder and associated factors among human immunodeficiency virus infected patients attending antiretroviral therapy clinic at Bishoftu General Hospital, Oromiya region, Ethiopia	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; IDENTIFICATION TEST; SOUTH-AFRICA; HIV; HIV/AIDS; DISEASE	Background Alcohol consumption among patients with HIV/AIDS increases the burden of the disease. HIV/AIDS is an epidemic among Sub-Saharan African countries. Excessive use of alcohol causes a large degree of health problems, social and economic burden in societies. However, the prevalence and associated factors of alcohol use disorder among this group of people has not been studied very well. Therefore, this study sought to assess the magnitude and associated factors of alcohol use disorder among HIV patients attending the antiretroviral (ART) clinic. Methods A hospital based cross sectional study design was conducted at Bishoftu General Hospital from May to June 2015. Systematic random sampling technique was used to select the study participants. Data was collected by face to face interview and chart review. Alcohol Use Disorder Identification Test (AUDIT) was used to assess alcohol use disorder. Bivariate and multivariate logistic regression analysis was carried out to identify associated factors and P-value < 0.05 was taken as statistically significant. Results A total of 527 participants were enrolled in the study with a response rate of 100%. The prevalence of alcohol use disorder (AUD) was 14.2%. Factors associated with alcohol use disorder were educational status AOR = 8.5 (95% CI: 1.70, 42.99), social support AOR = 0.5 (95% CI: 0.26, 0.95), cigarette smoking AOR = 3.49(95% CI: 1.01, 12.13), khat chewing AOR = 5.11 (95% CI: 1.60, 16.33), family history of alcohol use AOR = 3.58 (95% CI: 1.52, 8.47), and missing ART drugs AOR 3.05 (95% CI: 1.302, 7.131). Conclusion The prevalence of alcohol use disorder was high as compared to similar epidemiological studies. Educational status, social support, cigarette smoking, khat chewing, and family history of alcohol use were independent predictors. Providing health education about alcohol use and proper screening of alcohol use disorder among patients with HIV/AIDS is crucial. Strengthening the referral linkage with the psychiatric unit will decrease the burdens of the problem.	[Bultum, Jemal Abdella] Bishoftu Gen Hosp, Bishoftu, Oromia Region, Ethiopia; [Yigzaw, Niguse] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia; [Demeke, Wubit] Amanuel Mental Specialized Hosp, Out Patient Dept, Addis Ababa, Ethiopia; [Alemayehu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar; University of Gondar	Yigzaw, N (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia.	neglideta@yahoo.com		Muluneh, Niguse Yigzaw/0000-0002-7507-3242	Amanuel Mental Specialized Hospital; University of Gondar	Amanuel Mental Specialized Hospital; University of Gondar	The study was supported by Amanuel Mental Specialized Hospital.; The Authors would like to acknowledge the University of Gondar and Amanuel Mental Specialized Hospital for ethical clearance and financial support. The Authors would also like to thank Bishoftu Hospital staffs and study participants	Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P77, DOI 10.1111/j.1600-0447.1999.tb10698.x; Allen JP, 2001, PREV MED, V33, P428, DOI 10.1006/pmed.2001.0910; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Chander G, 2008, HIV MED, V9, P196, DOI 10.1111/j.1468-1293.2008.00545.x; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chander Geetanjali, 2011, Top Antivir Med, V19, P143; deLuna J, 2014, J AIDS CLIN RES, V5; Derek D, 2011, ALCOHOL CLIN EXPRES, V35, P695; Farley John, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P218, DOI 10.1177/1545109710371133; Fekadu A., 2007, AFR J DRUG ALCOHOL S, V6, P40; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Justice A, 2010, ALCOHOL RES HEALTH, V33, P258; Kim TW, 2007, AIDS CARE, V19, P1039, DOI 10.1080/09540120701294245; Marsano LS, 2003, ALCOHOL RES HEALTH, V27, P247; Miguez-Burbano MJ, 2009, ALCOHOL ALCOHOLISM, V44, P366, DOI 10.1093/alcalc/agp024; Naimi TS, 2006, PREVENTING CHRONIC D, V3; Peltzer K, 2012, INT J ENV RES PUB HE, V9, P3245, DOI 10.3390/ijerph9093245; Pengpid S, 2011, INT J ENV RES PUB HE, V8, P2629, DOI 10.3390/ijerph8072629; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Stein M, 2005, ALCOHOL CLIN EXP RES, V29, P837, DOI 10.1097/01.ALC.0000164363.40533.E0; WHO, 2021, NORD ALC MARK REP; Wiener C., 2012, HARRISONS PRINCIPLES, V18th; Znenbe Y, 2015, J ALCOHOL DRUG DEPEN, V3, P3	27	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0189312	10.1371/journal.pone.0189312	http://dx.doi.org/10.1371/journal.pone.0189312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509771	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200001
J	Kim, SY; Min, C; Lee, WH; Choi, HG				Kim, So Young; Min, Chanyang; Lee, Woo Hyun; Choi, Hyo Geun			Tonsillectomy increases the risk of retropharyngeal and parapharyngeal abscesses in adults, but not in children: A national cohort study	PLOS ONE			English	Article							UNITED-STATES; SERUM; RATES; AGE	Objectives The purpose of this study is to evaluate the risk of retropharyngeal and parapharyngeal abscesses (deep neck infection) after tonsillectomy in Koreans using national cohort data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, participants who had undergone a tonsillectomy (5,299) and control participants (21,196) were selected and matched 1:4 (for age, sex, income, region of residence, and pre-operative upper respiratory infection visits). The Cox-proportional hazard model was used. A crude model and an adjusted model for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia were used in this analysis. For the subgroup analyses, the participants were divided into 2 groups: children (<= 14 years old) and adolescents and adults (>= 15 years old). Results The adjusted hazard ratio of deep neck infection after tonsillectomy was 1.43 (95% confidence interval, CI = 1.18-1.72, P < 0.001). In subgroup analysis, this ratio was 1.12 (95% CI = 0.86-1.47, P = 0.390) in children and 1.87 (95% CI = 1.43-2.45, P < 0.001) in adolescents and adults. The crude hazard ratios were almost the same as the adjusted ratios. Conclusion The risk of deep neck infection was higher in the tonsillectomy group. The subgroup analysis showed a similar finding in the adolescent and adult group but not in the child group.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Min, Chanyang] Hallym Univ, Coll Med, Hallym Data Sci Lab, Anyang, South Korea; [Lee, Woo Hyun] Natl Police Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Ballester JC, 2007, CLIN IMMUNOL, V123, P289, DOI 10.1016/j.clim.2007.02.004; Boss EF, 2012, J PEDIATR-US, V160, P814, DOI 10.1016/j.jpeds.2011.11.041; Burton MJ, 2014, COCHRANE DB SYST REV, V19; Chi TH, 2014, OTOLARYNG HEAD NECK, V151, P586, DOI 10.1177/0194599814542589; Choi HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169264; Choi HG, 2014, EUR ARCH OTO-RHINO-L, V271, P2293, DOI 10.1007/s00405-013-2759-7; Duval M, 2008, INT J PEDIATR OTORHI, V72, P1765, DOI 10.1016/j.ijporl.2008.07.007; FREEMAN JL, 1982, AM J PUBLIC HEALTH, V72, P488, DOI 10.2105/AJPH.72.5.488; Huang CM, 2017, J MICROBIOL IMMUNOL, V50, P627, DOI 10.1016/j.jmii.2015.08.020; Kaygusuz I, 2009, INT J PEDIATR OTORHI, V73, P445, DOI 10.1016/j.ijporl.2008.11.014; Klug TE, 2014, EUR ARCH OTO-RHINO-L, V271, P1701, DOI 10.1007/s00405-013-2667-x; Paradise JL, 2002, PEDIATRICS, V110; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; van den Akker EH, 2006, ANN ALLERG ASTHMA IM, V97, P251, DOI 10.1016/S1081-1206(10)60022-1; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; Wang YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117535	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193913	10.1371/journal.pone.0193913	http://dx.doi.org/10.1371/journal.pone.0193913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509810	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200041
J	Milanovic, JZ; Milanovic, P; Kragic, R; Kostic, M				Milanovic, Jovana Z.; Milanovic, Predrag; Kragic, Rastislav; Kostic, Mirjana			"Do-It-Yourself" reliable pH-stat device by using open-source software, inexpensive hardware and available laboratory equipment	PLOS ONE			English	Article							TEMPO-MEDIATED OXIDATION; CELLULOSE FIBERS; NATIVE CELLULOSE; SYSTEM	In this paper, we present the construction of a reliable and inexpensive pH stat device, by using open-source "OpenPhControl" software, inexpensive hardware (a peristaltic and a syringe pump, Arduino, a step motor...), readily available laboratory devices: a pH meter, a computer, a webcam, and some 3D printed parts. We provide a methodology for the design, development and test results of each part of the device, as well as of the entire system. In addition to dosing reagents by means of a low-cost peristaltic pump, we also present carefully controlled dosing of reagents by an open-source syringe pump. The upgrading of the basic open-source syringe pump is given in terms of pump control and application of a larger syringe. In addition to the basic functions of pH stat, i.e. pH value measurement and maintenance, an improvement allowing the device to be used for potentiometric titration has been made as well. We have demonstrated the device's utility when applied for cellulose fibers oxidation with 2,2,6,6-tetramethylpiperidine-1-oxyl radical, i.e. for TEMPO-mediated oxidation. In support of this, we present the results obtained for the oxidation kinetics, the consumption of added reagent and experimental repeatability. Considering that the open-source scientific tools are available to everyone, and that researchers can construct and adjust the device according to their needs, as well as, that the total cost of the open-source pH stat device, excluding the existing laboratory equipment (pH meter, computer and glossary) was less than 150 EUR, we believe that, at a small fraction of the cost of available commercial offers, our open-source pH stat can significantly improve experimental work where the use of pH stat is necessary.	[Milanovic, Jovana Z.] Univ Belgrade, Fac Technol & Met, Innovat Ctr, Belgrade, Serbia; [Milanovic, Predrag; Kostic, Mirjana] Univ Belgrade, Fac Technol & Met, Belgrade, Serbia; [Kragic, Rastislav] Minist Min & Energy, Belgrade, Serbia	University of Belgrade; University of Belgrade	Milanovic, JZ (corresponding author), Univ Belgrade, Fac Technol & Met, Innovat Ctr, Belgrade, Serbia.	jovana@tmf.bg.ac.rs	Kostic, Mirjana/S-1905-2017	Kostic, Mirjana/0000-0001-9925-4884; Milanovic, Predrag/0000-0002-6058-6811; Milanovic, Jovana/0000-0001-5777-7302	Ministry of Education, Science and Technological Development of the Republic of Serbia [OI 172029]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This study has been created as a result of the work on Project of the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project OI 172029).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SENS SENS INT; [Anonymous], 1988, 2621988 ISO; Anzalone GC, 2013, SENSORS-BASEL, V13, P5338, DOI 10.3390/s130405338; Archanjo GA, 2008, PROGR SOL 3D CAD MOD, P5; Arevalo-Ramirez T, 2016, ANDESCON 2016 IEEE, P1; Bruns B, 2001, NANOTECHNOLOGY, V12, P198, DOI 10.1088/0957-4484/12/3/303; Carney GD, 2015, EUROPEAN INT J SCI T, V4, P65; Chagas AM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002702; Christian W, 2011, SCIENCE, V334, P1077, DOI 10.1126/science.1196984; Debian, UN OP SYST; Deek FP, 2008, OPEN SOURCE: TECHNOLOGY AND POLICY, P1; DENOOY AEJ, 1994, RECL TRAV CHIM PAY B, V113, P165; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Feller Joseph, 2001, UNDERSTANDING OPEN S; Garbacz G, 2013, AAPS PHARMSCITECH, V14, P517, DOI 10.1208/s12249-013-9933-5; Honorato C, 2015, J MATER SCI, V50, P7343, DOI 10.1007/s10853-015-9291-7; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Jin LQ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40450; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; Li B, 2015, CARBOHYD POLYM, V133, P605, DOI 10.1016/j.carbpol.2015.07.033; Litronix, 1980, DISPLAYS, V1, P181; OpenSCAD, PROGR SOL 3D CAD MOD; Pearce J.M., 2010, J SUSTAINABLE DEV, V3, P17, DOI [DOI 10.5539/JSD.V3N4P17, 10.5539/jsd.v3n4p17]; Pearce J.M., 2013, OPEN SOURCE LAB BUIL, V1st; Pearce JM, 2013, NANO TODAY, V8, P339, DOI 10.1016/j.nantod.2013.04.001; Pearce JM, 2012, NATURE, V491, P519, DOI 10.1038/491519a; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Praskalo J, 2009, CARBOHYD POLYM, V77, P791, DOI 10.1016/j.carbpol.2009.02.028; ROSSOTTI FJ, 1965, J CHEM EDUC, V42, P375, DOI 10.1021/ed042p375; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Saito T, 2005, CARBOHYD POLYM, V61, P414, DOI 10.1016/j.carbpol.2005.05.014; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; Saito T, 2006, COLLOID SURFACE A, V289, P219, DOI 10.1016/j.colsurfa.2006.04.038; Smith R, 2007, PROC INT CONF DOC, P629, DOI 10.1109/icdar.2007.4376991; Steffens S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179636; Stokstad E, 2011, SCIENCE, V334, P308, DOI 10.1126/science.334.6054.308; Sun B, 2005, CELLULOSE, V12, P59, DOI 10.1023/B:CELL.0000049409.56806.da; Tahiri C, 2000, CELLULOSE, V7, P177, DOI 10.1023/A:1009276009711; Webcam Capture, GEN WEBC JAV API; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Xu QH, 2014, BIORESOURCES, V9, P994; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840	43	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193744	10.1371/journal.pone.0193744	http://dx.doi.org/10.1371/journal.pone.0193744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509793	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200027
J	Chao, YJ; Wu, WH; Balazova, M; Wu, TY; Lin, J; Liu, YW; Hsu, YHH				Chao, Yu-Jen; Wu, Wen-Hsin; Balazova, Maria; Wu, Ting-Yuan; Lin, Jamie; Liu, Yi-Wen; Hsu, Yuan-Hao Howard			Chlorella diet alters mitochondrial cardiolipin contents differentially in organs of Danio rerio analyzed by a lipidomics approach	PLOS ONE			English	Article							HEART SUBMITOCHONDRIAL PARTICLES; FATTY-ACID-COMPOSITION; BARTH-SYNDROME; ACYLTRANSFERASE CONTROLS; ENDOTHELIAL LINEAGES; MASS-SPECTROMETRY; ZEBRAFISH MODEL; HUMAN-DISEASE; ATP SYNTHASE; IN-VITRO	The zebrafish (Danio rerio) is an important and widely used vertebrate model organism for the study of human diseases which include disorders caused by dysfunctional mitochondria. Mitochondria play an essential role in both energy metabolism and apoptosis, which are mediated through a mitochondrial phospholipid cardiolipin (CL). In order to examine the cardiolipin profile in the zebrafish model, we developed a CL analysis platform by using liquid chromatography-mass spectrometry (LC-MS). Meanwhile, we tested whether chlorella diet would alter the CL profile in the larval fish, and in various organs of the adult fish. The results showed that chlorella diet increased the chain length of CL in larval fish. In the adult zebrafish, the distribution patterns of CL species were similar between the adult brain and eye tissues, and between the heart and muscles. Interestingly, monolyso-cardiolipin (MLCL) was not detected in brain and eyes but found in other examined tissues, indicating a different remodeling mechanism to maintain the CL integrity. While the adult zebrafish were fed with chlorella for four weeks, the CL distribution showed an increase of the species of saturated acyl chains in the brain and eyes, but a decrease in the other organs. Moreover, chlorella diet led to a decrease of MLCL percentage in organs except the non-MLCL-containing brain and eyes. The CL analysis in the zebrafish provides an important tool for studying the mechanism of mitochondria diseases, and may also be useful for testing medical regimens targeting against the Barth Syndrome.	[Chao, Yu-Jen; Wu, Wen-Hsin; Wu, Ting-Yuan; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung, Taiwan; [Balazova, Maria] Slovak Acad Sci, Ctr Biosci, Inst Anim Biochem & Genet, Bratislava, Slovakia; [Lin, Jamie; Liu, Yi-Wen] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Lin, Jamie; Liu, Yi-Wen; Hsu, Yuan-Hao Howard] Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan	Tunghai University; Slovak Academy of Sciences; Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung, Taiwan.; Liu, YW (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.; Liu, YW; Hsu, YHH (corresponding author), Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan.	dlslys@thu.edu.tw; howardhsu@thu.edu.tw	liu, yi/GXE-9662-2022; Balazova, Maria/AAC-1280-2019; hsu, yuan-hao/B-5744-2009	Balazova, Maria/0000-0001-8113-6855; 	Ministry of Science and Technology, Taiwan [MOST 105-2113-M-029-009, MOST 106-2923-M-029-001-MY3, MOST 105-2313-B-029-002, MOST 106-2313-B-029-002-MY3]; National Health Research Institutes, Taiwan [NHRI-EX105-10236SC]; Slovak Academy of Sciences [SAS-MOST JRP 2016/4]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Slovak Academy of Sciences(Slovak Academy of Sciences)	The work was supported by Ministry of Science and Technology, Taiwan (MOST 105-2113-M-029-009 and MOST 106-2923-M-029-001-MY3) and National Health Research Institutes, Taiwan (NHRI-EX105-10236SC) to YHH, Ministry of Science and Technology, Taiwan (MOST 105-2313-B-029-002 and MOST 106-2313-B-029-002-MY3) to YWL and Slovak Academy of Sciences (SAS-MOST JRP 2016/4) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Science and Technology, Taiwan (MOST 105-2113-M-029-009 and MOST 106-2923-M-029-001-MY3) and National Health Research Institutes, Taiwan (NHRI-EX105-102365C) to YHH, Ministry of Science and Technology, Taiwan (MOST 105-2313-B-029-002 and MOST 106-2313-B-029-002-MY3) to YWL and Slovak Academy of Sciences (SAS-MOST JRP 2016/4) to MB. We would like to thank Hsin-Yu Hou for the maintenance of the zebrafish stock.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; Almaida-Pagan PF, 2015, J COMP PHYSIOL B, V185, P73, DOI 10.1007/s00360-014-0870-8; Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200; Betancor MB, 2015, FISH PHYSIOL BIOCHEM, V41, P1187, DOI 10.1007/s10695-015-0079-0; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowron A, 2015, J INHERIT METAB DIS, V38, P279, DOI 10.1007/s10545-014-9747-y; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Cha KH, 2008, J AGR FOOD CHEM, V56, P10521, DOI 10.1021/jf802111x; Chao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113680; Fraher D, 2016, CELL REP, V14, P1317, DOI 10.1016/j.celrep.2016.01.016; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; Khuchua Z, 2004, CIRCULATION, V110, P46; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; KONISHI F, 1985, CANCER IMMUNOL IMMUN, V19, P73; Kralovec JA, 2005, INT IMMUNOPHARMACOL, V5, P689, DOI 10.1016/j.intimp.2004.11.016; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Lesnefsky EJ, 2009, J MOL CELL CARDIOL, V46, P1008, DOI 10.1016/j.yjmcc.2009.03.007; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Otles S, 2001, J AOAC INT, V84, P1708; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Ramesh T, 2010, DIS MODEL MECH, V3, P652, DOI 10.1242/dmm.005538; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Soontornchaiboon W, 2012, BIOL PHARM BULL, V35, P1137, DOI 10.1248/bpb.b12-00187; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Steele SL, 2014, TRANSL RES, V163, P79, DOI 10.1016/j.trsl.2013.08.008; Ting HC, 2015, J NUTR BIOCHEM, V26, P769, DOI 10.1016/j.jnutbio.2015.02.005; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Wang HM, 2010, PROCESS BIOCHEM, V45, P1865, DOI 10.1016/j.procbio.2010.05.023; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xiong JW, 2007, CIRCULATION, V116, P71; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]	46	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193042	10.1371/journal.pone.0193042	http://dx.doi.org/10.1371/journal.pone.0193042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494608	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200019
J	Esler, TB; Kerr, RR; Tahayori, B; Grayden, DB; Meffin, H; Burkitt, AN				Esler, Timothy B.; Kerr, Robert R.; Tahayori, Bahman; Grayden, David B.; Meffin, Hamish; Burkitt, Anthony N.			Minimizing activation of overlying axons with epiretinal stimulation: The role of fiber orientation and electrode configuration	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ELECTRICAL-STIMULATION; MOUSE RETINA; PROSTHESIS; THRESHOLDS; MORPHOLOGY; DESIGN; CLASSIFICATION; MODEL; SHAPE	Currently, a challenge in electrical stimulation of the retina with a visual prosthesis (bionic eye) is to excite only the cells lying directly under the electrode in the ganglion cell layer, while avoiding excitation of axon bundles that pass over the surface of the retina in the nerve fiber layer. Stimulation of overlying axons results in irregular visual percepts, limiting perceptual efficacy. This research explores how differences in fiber orientation between the nerve fiber layer and ganglion cell layer leads to differences in the electrical activation of the axon initial segment and axons of passage. Approach. Axons of passage of retinal ganglion cells in the nerve fiber layer are characterized by a narrow distribution of fiber orientations, causing highly anisotropic spread of applied current. In contrast, proximal axons in the ganglion cell layer have a wider distribution of orientations. A four-layer computational model of epiretinal extracellular stimulation that captures the effect of neurite orientation in anisotropic tissue has been developed using a volume conductor model known as the cellular composite model. Simulations are conducted to investigate the interaction of neural tissue orientation, stimulating electrode configuration, and stimulation pulse duration and amplitude. Main results. Our model shows that simultaneous stimulation with multiple electrodes aligned with the nerve fiber layer can be used to achieve selective activation of axon initial segments rather than passing fibers. This result can be achieved while reducing required stimulus charge density and with only modest increases in the spread of activation in the ganglion cell layer, and is shown to extend to the general case of arbitrary electrode array positioning and arbitrary target volume. Significance. These results elucidate a strategy for more targeted stimulation of retinal ganglion cells with experimentally-relevant multi-electrode geometries and achievable stimulation requirements.	[Esler, Timothy B.; Kerr, Robert R.; Grayden, David B.; Burkitt, Anthony N.] Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia; [Kerr, Robert R.] Seer Med, Melbourne, Vic, Australia; [Tahayori, Bahman] Monash Univ, Monash Inst Med Engn, Clayton, Vic, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Parkville, Vic, Australia; [Meffin, Hamish] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia; [Meffin, Hamish] Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct Optometry, Parkville, Vic, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne	Esler, TB (corresponding author), Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia.	tesler@student.unimelb.edu.au	Grayden, David B/L-5782-2018	Grayden, David B/0000-0002-5497-7234; Meffin, Hamish/0000-0003-4307-6841	Australian Postgraduate Award from the Australian Government; University of Melbourne; Gowrie Scholarship Fund of the Australian National University; IBM Research, Melbourne; Australian Research Council Centre of Excellence for Integrative Brain Function [CE140100007]; Australian Research Council's Discovery Projects funding scheme [DP140104533]; Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC) [APP1106390]; Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne [VR0138]	Australian Postgraduate Award from the Australian Government(Australian Research CouncilAustralian Government); University of Melbourne(University of Melbourne); Gowrie Scholarship Fund of the Australian National University; IBM Research, Melbourne; Australian Research Council Centre of Excellence for Integrative Brain Function(Australian Research Council); Australian Research Council's Discovery Projects funding scheme(Australian Research Council); Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne	TE was supported by an Australian Postgraduate Award from the Australian Government and The University of Melbourne, and the Gowrie Scholarship Fund of the Australian National University. TE and RRK acknowledge the support of IBM Research, Melbourne. IBM Research, Melbourne provided support in the form of a salary for RRK and an internship for TE for part of the period during which this research was completed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. HM acknowledges funding from the Australian Research Council Centre of Excellence for Integrative Brain Function (project number CE140100007). ANB acknowledges the support of the Australian Research Council's Discovery Projects funding scheme (project number DP140104533). DBG, HM and ANB acknowledge the support of the Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC Grant APP1106390). This research was supported by Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne (grant number VR0138).	ABRAMIAN M, 2011, J NEURAL ENG, V8; Abramian M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/025002; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Ayton LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115239; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; Behrend MR, 2008, IEEE T BIO-MED ENG, V55, P1056, DOI 10.1109/TBME.2008.915723; BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P440, DOI 10.1109/TBME.1977.326179; Cao X, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0065-x; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Colbert CM, 1996, J NEUROSCI, V16, P6676; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; da Cruz L, 2013, BRIT J OPHTHALMOL, V97, P632, DOI 10.1136/bjophthalmol-2012-301525; Eiber CD, 2016, MED BIOL ENG COMPUT, P1; Eickenscheidt M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036006; FitzGibbon T, 2012, JPN J OPHTHALMOL, V56, P631, DOI 10.1007/s10384-012-0185-9; Fletcher LN, 2014, J COMP NEUROL, V522, P750, DOI 10.1002/cne.23441; Frenkel S, 2005, EYE, V19, P491, DOI 10.1038/sj.eye.6701569; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Gleixner R, 2006, BIOPHYS J, V90, P2600, DOI 10.1529/biophysj.105.072587; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Grosberg LE, 2017, J NEUROPHYSIOL; Jeng J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036022; Jensen RJ, 2006, EXP EYE RES, V83, P367, DOI 10.1016/j.exer.2006.01.012; Jensen RJ, 2003, INVEST OPHTH VIS SCI, V44, P3533, DOI 10.1167/iovs.02-1041; Jepson LH, 2013, J NEUROSCI, V33, P7194, DOI 10.1523/JNEUROSCI.4967-12.2013; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lee S, 2007, P NATL ACAD SCI USA, V104, P12931, DOI 10.1073/pnas.0705469104; Maturana MI, 2014, J COMPUT NEUROSCI, V36, P157, DOI 10.1007/s10827-013-0463-7; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Meffin H, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065004; Meffin H, 2013, IEEE ENG MED BIO, P5946, DOI 10.1109/EMBC.2013.6610906; Meffin H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065005; Nanduri D, 2008, IEEE ENG MED BIO, P1785, DOI 10.1109/IEMBS.2008.4649524; Oishi A, 2009, EYE, V23, P561, DOI 10.1038/eye.2008.63; Poria D, 2015, J NEUROPHYSIOL, V113, P420, DOI 10.1152/jn.00702.2014; Radivojevic M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31332; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 2004, IEEE T BIO-MED ENG, V51, P1659, DOI 10.1109/TBME.2004.828044; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5355, DOI 10.1167/iovs.02-0819; Rodger J, 2012, PLOS ONE, V7; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Snider J, 2010, NEURON, V66, P45, DOI 10.1016/j.neuron.2010.02.013; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; SUMBUL U, 2014, NAT COMMUN, V5; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tahayori B, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065005; Tahayori B, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065006; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; TORIS CB, 1995, J COMP NEUROL, V352, P535, DOI 10.1002/cne.903520405; Twyford P, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/025001; Wang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066763; Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042; Weitz AC, 2013, J NEUROPHYSIOL, V109, P1979, DOI 10.1152/jn.00852.2012; Werginz P, 2015, MINERVA MED, V106, P65; Werginz P, 2014, NEUROSCIENCE, V266, P162, DOI 10.1016/j.neuroscience.2014.01.067; Zeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020810; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	64	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193598	10.1371/journal.pone.0193598	http://dx.doi.org/10.1371/journal.pone.0193598			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494655	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200072
J	Zhao, ZH; Kudej, RK; Wen, HR; Fefelova, N; Yan, L; Vatner, DE; Vatner, SF; Xie, LH				Zhao, Zhenghang; Kudej, Raymond K.; Wen, Hairuo; Fefelova, Nadezhda; Yan, Lin; Vatner, Dorothy E.; Vatner, Stephen F.; Xie, Lai-Hua			Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck)	FASEB JOURNAL			English	Article						hibernating animals; ischemia; oxidative stress; CaMKII; triggered activity	CALMODULIN KINASE-II; REGIONAL MYOCARDIAL-ISCHEMIA; PROTEIN-KINASE; HYDROGEN-PEROXIDE; VENTRICULAR MYOCYTES; OXIDATIVE STRESS; LOW-TEMPERATURE; ADAPTIVE-MECHANISMS; ATRIAL-FIBRILLATION; GROUND-SQUIRREL	Hibernating animals show resistance to hypothermia-induced cardiac arrhythmias. However, it is not clear whether and how mammalian hibernators are resistant to ischemia-induced arrhythmias. The goal of this investigation was to determine the susceptibility of woodchucks (Marmota monax) to arrhythmias and their mechanisms after coronary artery occlusion at the same room temperature in both winter, the time for hibernation, and summer, when they do not hibernate. By monitoring telemetric electrocardiograms, we found significantly higher arrhythmia scores, calculated as the severity of arrhythmias, with incidence of ventricular tachycardia, ventricular fibrillation, and thus sudden cardiac death (SCD) in woodchucks in summer than they had in winter. The level of catalase expression in woodchuck hearts was significantly higher, whereas the level of oxidized Ca2+/calmodulin-dependent protein kinase II (CaMKII) was lower in winter than it was in summer. Ventricular myocytes isolated from woodchucks in winter were more resistant to H2O2-induced early afterdepolarizations (EADs) compared with myocytes isolated from woodchucks in summer. The EADs were eliminated by inhibiting CaMKII (with KN-93), l-type Ca current (with nifedipine), or late Na+ current (with ranolazine). In woodchucks, in the summer, the arrhythmia score was significantly reduced by overexpression of catalase (via adenoviral vectors) or the inhibition of CaMKII (with KN-93) in the heart. This study suggests that the heart of the mammalian hibernator is more resistant to ischemia-induced arrhythmias and SCD in winter. Increased antioxidative capacity and reduced CaMKII activity may confer resistance in woodchuck hearts against EADs and arrhythmias during winter. The profound protection conferred by catalase overexpression or CaMKII inhibition in this novel natural animal model may provide insights into clinical directions for therapy of arrhythmias.Zhao, Z., Kudej, R. K., Wen, H., Fefelova, N., Yan, L., Vatner, D. E., Vatner, S. F., Xie, L.-H. Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck).	[Zhao, Zhenghang] Xi An Jiao Tong Univ, Sch Med, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Zhao, Zhenghang; Kudej, Raymond K.; Wen, Hairuo; Fefelova, Nadezhda; Vatner, Dorothy E.; Vatner, Stephen F.; Xie, Lai-Hua] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 South Orange Ave,MSB G609, Newark, NJ 07103 USA; [Yan, Lin] Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Kudej, Raymond K.] Tufts Univ, Dept Clin Sci, North Grafton, MA USA; [Wen, Hairuo] Natl Inst Food & Drug Control, Key Lab Beijing Nonclin Safety Evaluat Res Drugs, Natl Ctr Safety Evaluat Drugs, Beijing, Peoples R China	Xi'an Jiaotong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University; National Institute of Food & Drug Control - China	Xie, LH (corresponding author), Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 South Orange Ave,MSB G609, Newark, NJ 07103 USA.	xiela@njms.rutgers.edu		zhenghang, Zhao/0000-0003-0421-2046	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL97979, R01HL133294, R01HL130848]; American Heart Association [16GRNT31100022]; National Natural Science Foundation of China [81470510, 81503068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102472, R01HL137368, R01HL119464, R01HL097979, R01HL106511, R01HL133294, R01HL130848, R01HL137405, R01HL124282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG053514] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Mark Anderson (Johns Hopkins, Baltimore, MD, USA) for kindly providing oxidized CaMKII antibodies. This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grants R01HL97979 and R01HL133294 to L.-H.X and R01HL130848 to S.F.V.), the American Heart Association (Grant 16GRNT31100022 to L.-H.X.), and the National Natural Science Foundation of China (Grants 81470510 to Z.Z. and 81503068 to H.W.). The authors declare no conflicts of interest.	Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; BURLINGTON RF, 1988, PHYSIOL ZOOL, V61, P387, DOI 10.1086/physzool.61.5.30161260; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P407, DOI 10.1016/0891-5849(90)90017-D; CAPRETTE DR, 1984, AM J PHYSIOL, V247, pR722, DOI 10.1152/ajpregu.1984.247.4.R722; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Couchonnal LF, 2008, PHYSIOLOGY, V23, P151, DOI 10.1152/physiol.00043.2007; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fedorov VV, 2005, HEART RHYTHM, V2, P966, DOI 10.1016/j.hrthm.2005.06.012; Foteinou PT, 2015, BIOPHYS J, V109, P838, DOI 10.1016/j.bpj.2015.06.064; FRANZ MR, 1984, CIRCULATION, V69, P593, DOI 10.1161/01.CIR.69.3.593; Franz MR, 1999, CARDIOVASC RES, V41, P25, DOI 10.1016/S0008-6363(98)00268-5; Gao JH, 2008, J PHYSIOL SCI, V58, P389, DOI 10.2170/physiolsci.RP007108; Gbadebo TD, 2002, CIRCULATION, V105, P770, DOI 10.1161/hc0602.103724; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hinata M, 2007, J PHARMACOL SCI, V103, P283, DOI 10.1254/jphs.FP0060015; Hool LC, 2008, CLIN EXP PHARMACOL P, V35, P229, DOI 10.1111/j.1440-1681.2007.04727.x; JOHANSSON BW, 1985, EUR HEART J, V6, P53, DOI 10.1093/eurheartj/6.suppl_D.53; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; Kinugawa S, 2000, CIRC RES, V87, P392; Kirchhof P, 2004, J MOL CELL CARDIOL, V36, P691, DOI 10.1016/j.yjmcc.2004.03.007; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Luczak ED, 2014, J MOL CELL CARDIOL, V73, P112, DOI 10.1016/j.yjmcc.2014.02.004; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Morin PJ, 2007, ARCH BIOCHEM BIOPHYS, V461, P59, DOI 10.1016/j.abb.2007.01.035; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ohta H, 2006, COMP BIOCHEM PHYS C, V143, P484, DOI 10.1016/j.cbpc.2006.05.002; Rodrigo R, 2008, PHARMACOL THERAPEUT, V118, P104, DOI 10.1016/j.pharmthera.2008.01.005; ROSEN MR, 1984, ANN NY ACAD SCI, V427, P84, DOI 10.1111/j.1749-6632.1984.tb20776.x; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Said M, 2008, AM J PHYSIOL-HEART C, V295, pH1669, DOI 10.1152/ajpheart.00010.2008; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; SLEZAK J, 1995, AM J PATHOL, V147, P772; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Tomaselli GF, 2010, NAT MED, V16, P648, DOI 10.1038/nm0610-648; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Vittone L, 2002, J MOL CELL CARDIOL, V34, P39, DOI 10.1006/jmcc.2001.1488; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang SQ, 2002, J EXP BIOL, V205, P2957; Ward CA, 1997, J PHYSIOL-LONDON, V500, P631, DOI 10.1113/jphysiol.1997.sp022048; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; XIE JT, 1990, METHOD FIND EXP CLIN, V12, P419; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; YAN L, 2015, BASIC RES CARDIOL, V110; Yang XL, 2011, BASIC RES CARDIOL, V106, P421, DOI 10.1007/s00395-011-0165-0; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003; Zhao ZH, 2015, AM J PHYSIOL-HEART C, V308, pH240, DOI 10.1152/ajpheart.00630.2014; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011; Zipes Douglas P., 1999, Journal of the American College of Cardiology, V34, P959; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 2000, CIRCULATION, V102, P52	60	8	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4229	4240		10.1096/fj.201701516R	http://dx.doi.org/10.1096/fj.201701516R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490168	Green Published			2022-12-26	WOS:000439325400014
J	Zhang, P; Song, YR; Sun, YD; Li, XC; Chen, LF; Yang, LK; Xing, YF				Zhang, Peng; Song, Yarong; Sun, Yadong; Li, Xuechao; Chen, Lifeng; Yang, Likun; Xing, Yifei			AMPK/GSK3 beta/beta-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming	FASEB JOURNAL			English	Article						KIAA1199; apoptosis; metabolism; metastasis; prostatic carcinoma	GENE-EXPRESSION; LACTATE-DEHYDROGENASE; UP-REGULATION; TUMOR; SURVIVAL; PROTEIN; ACTIVATION; KIAA1199; KINASE; METASTASIS	Prostate cancer (PCa) represents one of the most common solid neoplasms, and metastasis is the second leading cause of death in adult males. Anoikis is a programmed cell death that is induced upon cell detachment from the extracellular matrix (ECM), which behaves as a critical protective mechanism for anchorage-independent cell growth and metastasis formation. However, in the absence of ECM attachment, shift of metabolic pattern and tolerance to anoikis facilitate the survival of aggressive cancer cells in the circulatory system as well as their metastasis to distant sites. Few molecular targets in PCa have thus far been reported to prevent anoikis resistance, metabolic reprogramming, and metastasis simultaneously. In the present study, elevated migration, invasion, pyruvate production, lactate generation, ATP level, and impaired detachment-induced apoptosis were found in anoikis-resistant PCa cells, and genome microarray analysis demonstrated that the cell migration-inducing protein (CEMIP) was a potential molecular target for the regulation of the aforementioned malignant behaviors. Additional investigation revealed that the AMPK/glycogen synthase kinase 3 (GSK3)/-catenin cascade-triggered CEMIP overexpression in anoikis-resistant PCa cells might be implicated in local progression, metabolic shift, and cellular migration and invasion, whereas knockout of CEMIP by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 in anoikis-resistant PCa cells reversed the described bioeffects by reducing expressions of matrix metalloproteinase 2 (MMP2), VEGF, pyruvate dehydrogenase kinase isoform 4 (PDK4), and lactate dehydrogenase A. In addition, inhibition of glycolysis by CEMIP-mediated PDK4 down-regulation impaired the migration and invasion of anoikis-resistant PCa cells by attenuating MMP2 and VEGF expressions. Our findings establish that AMPK/GSK3/-catenin cascade-triggered CEMIP overexpression might promote migration and invasion in anoikis-resistant PCa cells by enhancing PDK4-associated metabolic reprogramming, which may provide a novel, promising therapeutic target for the treatment of advanced PCa.Zhang, P., Song, Y., Sun, Y., Li, X., Chen, L., Yang, L., Xing, Y. AMPK/GSK3/-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.	[Zhang, Peng; Song, Yarong; Sun, Yadong; Li, Xuechao; Chen, Lifeng; Yang, Likun; Xing, Yifei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Zhang, Peng] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Li, Xuechao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China; [Chen, Lifeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xing, YF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	yifei_xing@163.com		Sun, Yadong/0000-0003-0384-4121; Zhang, Peng/0000-0002-9967-1597	National Natural Science Foundation of China [81272847, 81772751]; Program for New Century Excellent Talents in University [NCET-13-0239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was funded by the National Natural Science Foundation of China (Grants 81272847 and 81772751) and the Program for New Century Excellent Talents in University (NCET-13-0239; to Y.X.). The authors declare no conflicts of interest.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma M, 2006, J CLIN ONCOL, V24, p153S; Bragayrac LAN, 2017, PROSTATE, V77, P1076, DOI 10.1002/pros.23364; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011; Emami KH, 2007, CANCER LETT, V253, P170, DOI 10.1016/j.canlet.2006.12.040; Evensen NA, 2013, JNCI-J NATL CANCER I, V105, P1402, DOI 10.1093/jnci/djt224; Fossati N, 2015, EUR UROL, V67, P3, DOI 10.1016/j.eururo.2014.08.056; Freeman J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0475-1; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hasanuzzaman M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-34; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Jefferies Matthew T, 2017, Biomark Cancer, V9, p1179299X17710944, DOI 10.1177/1179299X17710944; Jeon JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1640-z; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim H, 2017, BRIT J CANCER, V116, P370, DOI 10.1038/bjc.2016.440; Kroon J, 2014, ONCOTARGET, V5, P8986, DOI 10.18632/oncotarget.1510; Kunhiraman H, 2017, J CELL BIOCHEM, V118, P252, DOI 10.1002/jcb.25629; Liu XX, 2011, PROSTATE, V71, P766, DOI 10.1002/pros.21293; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; Mengual L, 2014, ACTAS UROL ESP, V38, P143, DOI 10.1016/j.acuro.2013.07.012; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Rellinger EJ, 2015, PEDIATR BLOOD CANCER, V62, P581, DOI 10.1002/pbc.25348; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Sun AJ, 2016, PROSTATE, V76, P172, DOI 10.1002/pros.23106; Sundararaman A, 2016, J BIOL CHEM, V291, P14410, DOI 10.1074/jbc.M116.731257; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Tucci M, 2016, EUR UROL, V69, P563, DOI 10.1016/j.eururo.2015.09.013; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Weber GF, 2016, INT J CANCER, V138, P2061, DOI 10.1002/ijc.29839; Wong N, 2017, ONCOTARGET, V8, P19218, DOI 10.18632/oncotarget.15168; Xian ZY, 2015, TUMOR BIOL, V36, P8093, DOI 10.1007/s13277-015-3540-x; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Zhang P, 2016, EXP CELL RES, V347, P350, DOI 10.1016/j.yexcr.2016.08.019; Zhang P, 2016, INT J ONCOL, V48, P1417, DOI 10.3892/ijo.2016.3356; Zhang YS, 2014, ONCOL REP, V31, P1503, DOI 10.3892/or.2014.3038	54	37	38	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3924	3935		10.1096/fj.201701078R	http://dx.doi.org/10.1096/fj.201701078R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29505302				2022-12-26	WOS:000435104500037
J	Gerlach, D; Tontsch-Grunt, U; Baum, A; Popow, J; Scharn, D; Hofmann, MH; Engelhardt, H; Kaya, O; Beck, J; Schweifer, N; Gerstberger, T; Zuber, J; Savarese, F; Kraut, N				Gerlach, Daniel; Tontsch-Grunt, Ulrike; Baum, Anke; Popow, Johannes; Scharn, Dirk; Hofmann, Marco H.; Engelhardt, Harald; Kaya, Onur; Beck, Janina; Schweifer, Norbert; Gerstberger, Thomas; Zuber, Johannes; Savarese, Fabio; Kraut, Norbert			The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; P-TEFB; SELECTIVE-INHIBITION; CELL IDENTITY; PROTEIN BRD4; C-MYC; ELONGATION; CANCER	Bromodomain and extra-terminal (BET) protein inhibitors have been reported as treatment options for acute myeloid leukemia (AML) in preclinical models and are currently being evaluated in clinical trials. This work presents a novel potent and selective BET inhibitor (BI 894999), which has recently entered clinical trials (NCT02516553). In preclinical studies, this compound is highly active in AML cell lines, primary patient samples, and xenografts. HEXIM1 is described as an excellent pharmacodynamic biomarker for target engagement in tumors as well as in blood. Mechanistic studies show that BI 894999 targets super-enhancer-regulated oncogenes and other lineage-specific factors, which are involved in the maintenance of the disease state. BI 894999 is active as monotherapy in AML xenografts, and in addition leads to strongly enhanced antitumor effects in combination with CDK9 inhibitors. This treatment combination results in a marked decrease of global p-Ser2 RNA polymerase II levels and leads to rapid induction of apoptosis in vitro and in vivo. Together, these data provide a strong rationale for the clinical evaluation of BI 894999 in AML.	[Gerlach, Daniel; Tontsch-Grunt, Ulrike; Baum, Anke; Popow, Johannes; Scharn, Dirk; Hofmann, Marco H.; Engelhardt, Harald; Kaya, Onur; Beck, Janina; Schweifer, Norbert; Gerstberger, Thomas; Savarese, Fabio; Kraut, Norbert] Boehringer Ingelheim RCV GmbH & Co KG, A-1120 Vienna, Austria; [Zuber, Johannes] Vienna BioCtr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Zuber, Johannes] Med Univ Vienna, Vienna BioCtr VBC, A-1030 Vienna, Austria	Boehringer Ingelheim; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; Vienna Biocenter (VBC)	Savarese, F; Kraut, N (corresponding author), Boehringer Ingelheim RCV GmbH & Co KG, A-1120 Vienna, Austria.	fabio.savarese@boehringer-ingelheim.com; norbert.kraut@boehringer-ingelheim.com	Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835; Gerlach, Daniel/0000-0001-9338-3765; Hofmann, Marco/0000-0001-7557-1156				Aftimos PG, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.2504; Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Berenguer-Daize C, 2016, INT J CANCER, V139, P2047, DOI 10.1002/ijc.30256; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Boi M, 2015, CLIN CANCER RES, V21, P1628, DOI 10.1158/1078-0432.CCR-14-1561; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Coude MM, 2015, ONCOTARGET, V6, P17698, DOI 10.18632/oncotarget.4131; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaraj SGT, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-3686; Doroshow DB, 2017, ANN ONCOL, V28, P1776, DOI 10.1093/annonc/mdx157; Dukler N, 2017, NAT GENET, V49, P2, DOI 10.1038/ng.3759; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Henssen A, 2016, CLIN CANCER RES, V22, P2470, DOI 10.1158/1078-0432.CCR-15-1449; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee YS, 2015, MOL CANCER THER, V14, pC202; Lin XY, 2017, MOL CANCER THER, V16, P388, DOI 10.1158/1535-7163.MCT-16-0475; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Moreno N, 2017, ONCOTARGET, V8, P84986, DOI 10.18632/oncotarget.18583; Muralidharan SV, 2016, ONCOGENE, V35, P4689, DOI 10.1038/onc.2015.521; Najafova Z, 2017, NUCLEIC ACIDS RES, V45, P127, DOI 10.1093/nar/gkw826; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Rudolph D, 2015, J PHARMACOL EXP THER, V352, P579, DOI 10.1124/jpet.114.221150; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Schuller R, 2016, MOL CELL, V61, P305, DOI 10.1016/j.molcel.2015.12.003; Shahbazi J, 2016, CLIN CANCER RES, V22, P2534, DOI 10.1158/1078-0432.CCR-15-1666; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Siegel MB, 2015, ONCOTARGET, V6, P18921, DOI 10.18632/oncotarget.4214; Simo-Riudalbas L, 2015, BRIT J PHARMACOL, V172, P2716, DOI 10.1111/bph.12844; Waizenegger IC, 2016, MOL CANCER THER, V15, P354, DOI 10.1158/1535-7163.MCT-15-0617; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785; Yeh TC, 2017, CLIN CANCER RES, V23, P1025, DOI 10.1158/1078-0432.CCR-16-1658; Yokoyama Y, 2016, CANCER RES, V76, P6320, DOI 10.1158/0008-5472.CAN-16-0854; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	63	50	52	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2687	2701		10.1038/s41388-018-0150-2	http://dx.doi.org/10.1038/s41388-018-0150-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29491412	hybrid, Green Published			2022-12-26	WOS:000432545100006
J	Li, K; Zhang, TT; Wang, F; Cui, B; Zhao, CX; Yu, JJ; Lv, XX; Zhang, XW; Yang, ZN; Huang, B; Li, X; Hua, F; Hu, ZW				Li, Ke; zhang, Ting-ting; Wang, Feng; Cui, Bing; Zhao, Chen-xi; Yu, Jiao-jiao; Lv, Xiao-xi; Zhang, Xiao-wei; Yang, Zhao-na; Huang, Bo; Li, Xia; Hua, Fang; Hu, Zhuo-wei			Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression	ONCOGENE			English	Article							CELL-MIGRATION; BREAST-CANCER; DOUBLE-BLIND; TIP60; TRB3; PHOSPHORYLATION; PATHWAY; GROWTH; INVASION; KINASE	Metformin has beneficial effects of preventing and treating cancers on type 2 diabetic patients. However, the role of metformin in non-diabetic cancer patients and the precise molecular mechanisms against cancer have not yet been sufficiently elucidated. We recently reported that the pseudokinase protein TRIB3 acts as a stress sensor linking metabolic stressors to cancer promotion by inhibiting autophagy and ubiquitin-proteasomal degradation systems; genetically abrogating of TRIB3 expression reduces tumourigenesis and cancer progression. Thus, TRIB3 is a potential therapeutic target for diverse cancers. In this study, we found that metformin attenuates melanoma growth and metastasis by reducing TRIB3 expression in non-diabetic C57BL/6 mice and diabetic KK-Ay mice; overexpression of TRIB3 protects metformin from the activation of autophagic flux, the clearance of accumulated tumour-promoting factors and the attenuation of tumour progression. We further elucidated that TRIB3 acts as an adaptor to recruit lysine acetyltransferase 5 (KAT5) to SMAD3 and induce a phosphorylation-dependent K333 acetylation of SMAD3, which sustains transcriptional activity of SMAD3 and subsequently enhances TRIB3 transcription. Metformin suppresses SMAD3 phosphorylation and decreases the KAT5/SMAD3 interaction, to attenuate the KAT5-mediated K333 acetylation of SMAD3, reduce the SMAD3 transcriptional activity and subsequent TRIB3 expression, thereby antagonizes melanoma progression. Together, our study not only defines a molecular mechanism by which metformin protects against melanoma progression by disturbing the KAT5/TRIB3/SMAD3 positive feedback loop in diabetes and non-diabetes mice, but also suggests a candidate diverse utility of metformin in tumour prevention and therapy because of suppressing stress protein TRIB3 expression.	[Li, Ke; Wang, Feng; Cui, Bing; Zhao, Chen-xi; Yu, Jiao-jiao; Lv, Xiao-xi; Zhang, Xiao-wei; Yang, Zhao-na; Hua, Fang; Hu, Zhuo-wei] Chinese Acad Med Sci, Inst Mat Med, Immunol & Canc Pharmacol Grp, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Li, Ke; Wang, Feng; Cui, Bing; Zhao, Chen-xi; Yu, Jiao-jiao; Lv, Xiao-xi; Zhang, Xiao-wei; Yang, Zhao-na; Huang, Bo; Hua, Fang; Hu, Zhuo-wei] Peking Union Med Coll, Beijing 100050, Peoples R China; [Li, Ke] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [zhang, Ting-ting; Li, Xia] Shandong Univ, Weihai 264209, Peoples R China; [Huang, Bo] Chinese Acad Med Sci, Inst Basic Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College	Hua, F; Hu, ZW (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Immunol & Canc Pharmacol Grp, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.; Hua, F; Hu, ZW (corresponding author), Peking Union Med Coll, Beijing 100050, Peoples R China.	huafang@imm.ac.cn; huzhuowei@imm.ac.cn	Cui, Bing/F-3599-2018	Cui, Bing/0000-0001-8374-7801; hu, zhuowei/0000-0001-9569-1016	National Key R&D Program of China [2017YFA0205400]; National Natural Science Foundation of China [81530093, 81773781, 81101595, 81472717, 81400140, 81503128]; Beijing Natural Science Foundation [7162133]; CAMS Innovation Found for Medical Sciences [2016-I2M1-007, 2016-I2M-1-011, 2016-I2M-3-008, 2016-I2M-1-008]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); CAMS Innovation Found for Medical Sciences	This work was supported by grants from National Key R&D Program of China (2017YFA0205400), from National Natural Science Foundation of China (81530093, 81773781 to Z.W.H.; 81101595, 81472717 to F.H.; 81400140 to K.L., 81503128 to X.X.L.), from Beijing Natural Science Foundation (7162133 to F.H.), and from CAMS Innovation Found for Medical Sciences (2016-I2M1-007 to Z.W.H., F.H. and C.X.Z.; 2016-I2M-1-011 to K.L.; 2016-I2M-3-008 to B.C. and J.J.Y.; 2016-I2M-1-008 to X.X.L.).	Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Cerezo M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12267; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chen GD, 2012, J INVEST DERMATOL, V132, P2632, DOI 10.1038/jid.2012.193; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Higurashi T, 2016, LANCET ONCOL, V17, P475, DOI 10.1016/S1470-2045(15)00565-3; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hua F, 2015, AUTOPHAGY, V11, P1929, DOI 10.1080/15548627.2015.1084458; Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Jiang ZH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-88; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kordes S, 2015, LANCET ONCOL, V16, P839, DOI 10.1016/S1470-2045(15)00027-3; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Li K, 2017, CANCER CELL, V31, P697, DOI 10.1016/j.ccell.2017.04.006; Li K, 2016, CANCER MED-US, V5, P1647, DOI 10.1002/cam4.706; Liang GZ, 2015, ONCOL LETT, V10, P1527, DOI 10.3892/ol.2015.3475; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Montaudie H, 2017, PIGM CELL MELANOMA R, V30, P378, DOI 10.1111/pcmr.12576; Morales DR, 2015, ANNU REV MED, V66, P17, DOI 10.1146/annurev-med-062613-093128; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Parker BL, 2014, J BIOL CHEM, V289, P25890, DOI 10.1074/jbc.M114.556035; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Preston MA, 2014, EUR UROL, V66, P1012, DOI 10.1016/j.eururo.2014.04.027; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Sayed Rana, 2015, Asian Pac J Cancer Prev, V16, P6621; Shiota M, 2010, PROSTATE, V70, P540, DOI 10.1002/pros.21088; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Takino T, 2016, CLIN EXP METASTAS, V33, P45, DOI 10.1007/s10585-015-9756-8; Tang PMK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14677; Tomcik M, 2016, ANN RHEUM DIS, V75, P609, DOI 10.1136/annrheumdis-2014-206234; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Wahdan-Alaswad R, 2016, CELL CYCLE, V15, P1046, DOI 10.1080/15384101.2016.1152432; Wang LK, 2012, NUCLEIC ACIDS RES, V40, pW376, DOI 10.1093/nar/gks437; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wu IJ, 2017, ARCH BIOCHEM BIOPHYS, V622, P26, DOI 10.1016/j.abb.2017.04.008; Wu LF, 2016, CELL, V167, P1705, DOI 10.1016/j.cell.2016.11.055; Xiao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28597; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xu WH, 2017, INT J MACH LEARN CYB, V8, P1, DOI 10.1007/s13042-016-0600-5; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou H, 2013, MOL MED REP, V8, P47, DOI 10.3892/mmr.2013.1453	58	29	32	6	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2967	2981		10.1038/s41388-018-0172-9	http://dx.doi.org/10.1038/s41388-018-0172-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29520103				2022-12-26	WOS:000433936300005
J	Nyakatura, EK; Zak, SE; Wec, AZ; Hofmann, D; Shulenin, S; Bakken, RR; Aman, MJ; Chandran, K; Dye, JM; Lai, JR				Nyakatura, Elisabeth K.; Zak, Samantha E.; Wec, Anna Z.; Hofmann, Daniel; Shulenin, Sergey; Bakken, Russell R.; Aman, M. Javad; Chandran, Kartik; Dye, John M.; Lai, Jonathan R.			Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS GLYCOPROTEIN; FAMILY FILOVIRIDAE; NONHUMAN-PRIMATES; BROAD PROTECTION; STRUCTURAL BASIS; ENTRY REQUIRES; HUMAN SURVIVOR; MARBURG VIRUS; SUDAN VIRUSES; EBOLAVIRUSES	Filoviruses (family Filoviridae) include five ebolaviruses and Marburg virus. These pathogens cause a rapidly progressing and severe viral disease with high mortality rates (generally 30-90%). Outbreaks of filovirus disease are sporadic and, until recently, were limited to less than 500 cases. However, the 2013-2016 epidemic in western Africa, caused by Ebola virus (EBOV), illustrated the potential of filovirus outbreaks to escalate to a much larger scale (over 28,000 suspected cases). mAbs against the envelope glycoprotein represent a promising therapeutic platform for managing filovirus infections. However, mAbs that exhibit neutralization or protective properties against multiple filoviruses are rare. Here we examined a panel of engineered bi- and trispecific antibodies, in which variable domains of mAbs that target epitopes from multiple filoviruses were combined, for their capacity to neutralize viral infection across filovirus species. We found that bispecific combinations targeting EBOV and Sudan virus (another ebolavirus), provide potent cross-neutralization and protection in mice. Furthermore, trispecific combinations, targeting EBOV, Sudan virus, and Marburg virus, exhibited strong neutralization potential against all three viruses. These results provide important insights into multispecific antibody engineering against filoviruses and will inform future immunotherapeutic discoveries.	[Nyakatura, Elisabeth K.; Hofmann, Daniel; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wec, Anna Z.; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Zak, Samantha E.; Bakken, Russell R.; Dye, John M.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Shulenin, Sergey; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lai, JR (corresponding author), Dept Biochem, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu		Dye, John/0000-0002-0883-5016	NIAID, National Institutes of Health Centers of Excellence for Translational Research [U19 AI109762]; National Institutes of Health [R01-AI125462, R41-AI122403]; Deutscher Akademischer Austauschdienst (German Academic Exchange Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109762, R01AI134824, R42AI122403, R01AI125462, R01AI132256, R41AI122403] Funding Source: NIH RePORTER	NIAID, National Institutes of Health Centers of Excellence for Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Centers of Excellence for Translational Research Grant U19 AI109762 and National Institutes of Health Grants R01-AI125462 (to J.R.L.) and R41-AI122403 (to J.R.L. and M.J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Opinions, conclusions, interpretations, and recommendations are those of the authors and are not necessarily endorsed by the United States Army. The mention of trade names or commercial products does not constitute endorsement or recommendation for use by the Department of the Army or the Department of Defense.; Supported in part by a postdoctoral fellowship from the Deutscher Akademischer Austauschdienst (German Academic Exchange Service).	Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447; Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15; Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; de La Vega MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005221; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Frei JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19193; Furuyama W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20514; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hofmann D, 2017, IMMUNOL LETT, V190, P289, DOI 10.1016/j.imlet.2017.09.002; Holtsberg FW, 2016, J VIROL, V90, P266, DOI 10.1128/JVI.02171-15; Howell KA, 2016, CELL REP, V15, P1514, DOI 10.1016/j.celrep.2016.04.026; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Keck ZY, 2016, J VIROL, V90, P279, DOI 10.1128/JVI.02172-15; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Mire CE, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8711; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nyakatura EK, 2017, HUM VACC IMMUNOTHER, V13, P836, DOI 10.1080/21645515.2016.1251536; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Wec AZ, 2016, SCIENCE, V354, P350, DOI 10.1126/science.aag3267; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630	38	5	5	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6201	6211		10.1074/jbc.RA117.001627	http://dx.doi.org/10.1074/jbc.RA117.001627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29500195	Green Published, hybrid			2022-12-26	WOS:000430497300035
J	Dangisso, MH; Woldesemayat, EM; Datiko, DG; Lindtjorn, B				Dangisso, Mesay Hailu; Woldesemayat, Endrias Markos; Datiko, Daniel Gemechu; Lindtjorn, Bernt			Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study	PLOS ONE			English	Article							RISK-FACTORS; PULMONARY TUBERCULOSIS; FOLLOW-UP; MORTALITY; REINFECTION; RELAPSE; RECURRENCE; SURVIVAL; ETHIOPIA; INDEXES	Background The status of tuberculosis (TB) patients since initiation of treatment is unknown in South Ethiopia. The objective of this study was to assess the long-term outcomes of smear-positive TB patients since initiation and completion of treatment, which includes TB recurrence and mortality of TB patients. Methods We did a retrospective cohort study on 2,272 smear-positive TB patients who initiated treatment for TB from September 1, 2002-October 10, 2012 in health facilities in Dale district and Yirgalem town administration. We followed them from the date of start of treatment to either the date of interview or date of death. Results Recurrence rate of TB was 15.2 per 1000 person-years. Recurrence was higher for re-treatment cases (adjusted hazard ratio (aHR), 2.7; 95% CI, 1.4-5.3). Mortality rate of TB patients was 27.1 per 1,000 person-years. The risk was high for patients above 34 years of age (aHR, 2.1; 95% CI, 1.2-3.9), poor patients (aHR, 1.3; 95% CI, 1.0-1.8), patients with poor treatment outcomes (aHR, 6.7; 95% CI, 5.1-8.9) and for patients treated at least 3 times (aHR 4.8; 95% CI, 2.1-11.1). The excess mortality occurred among patients aged above 34 years was high (41.2/1000 person years). Conclusion High TB recurrence and death of TB patients was observed among our study participants. Follow-up of TB patients with the risk factors and managing them could reduce the TB burden.	[Dangisso, Mesay Hailu; Woldesemayat, Endrias Markos; Lindtjorn, Bernt] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia; [Woldesemayat, Endrias Markos] Univ Bergen, Fac Med, Ctr Int Hlth, Bergen, Norway; [Datiko, Daniel Gemechu] HHA REACH ETHIOPIA Project, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Hawassa University; University of Bergen; Liverpool School of Tropical Medicine	Woldesemayat, EM (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.; Woldesemayat, EM (corresponding author), Univ Bergen, Fac Med, Ctr Int Hlth, Bergen, Norway.	endromark@yahoo.com	Datiko, Daniel/AAE-7019-2020; Datiko, Daniel G./AAE-6856-2020; Lindtjorn, Bernt/K-9465-2018; Dangisso, Mesay Hailu/AAU-7743-2020	Datiko, Daniel/0000-0002-8556-3069; Lindtjorn, Bernt/0000-0002-6267-6984; Woldesemayat, Endrias/0000-0003-4275-3695	University of Bergen in Norway; Hawassa University	University of Bergen in Norway; Hawassa University	University of Bergen in Norway and Hawassa University provided funds for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayneh B, 2015, PLOS ONE, V10; Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; Central Statistical Agency of Ethiopia, 2007, POPULATION HOUSING C; Christensen ASH, 2014, CLIN EPIDEMIOL, V6, P405, DOI 10.2147/CLEP.S65331; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Dangisso MH, 2015, GLOB HLTH ACTION, V8, P429; Datiko DG, 2010, INT J TUBERC LUNG D, V14, P866; Datiko DG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-348; de Boer AS, 2003, INT J TUBERC LUNG D, V7, P145; FMH, 2008, TUB LEPR TB HIV PREV TUB LEPR TB HIV PREV; FMH, 2005, HLTH SECT STRAT PLAN; FMH. Federal Ministry of Health of Ethiopia, 2011, TB CONTR PROGR ANN P; Getahun B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-127; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Kantipong P, 2012, HIV AIDS-RES PALLIAT, V4, P159, DOI 10.2147/HIV.S33535; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kolappan C, 2006, B WORLD HEALTH ORGAN, V84, P555, DOI 10.2471/BLT.05.022087; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lin CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-5; Mikhail C, 2011, CHEST J, V140; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Millet JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025315; Mohamed M, 2016, BMC PULMONARY MED, V16; Negusse Haile, 2007, Hum Resour Health, V5, P21, DOI 10.1186/1478-4491-5-21; Nguyen LT, 2011, INT J TUBERC LUNG D, V15, P257; Pedro DP, 2007, J BRAS PNEUMOL, V33; Sadacharam K, 2007, Indian J Tuberc, V54, P199; Sonnenberg P, 2002, LANCET, V359, P2120; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Vasantha M, 2008, Indian J Tuberc, V55, P64; Vree M, 2007, INT J TUBERC LUNG D, V11, P392; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wang XH, 2015, EUR REV MED PHARMACO, V19, P2016; WHO, 2017, GLOB TUB REP; Woldesemayat EM, 2014, INT J TUBERC LUNG D, V18, P67, DOI 10.5588/ijtld.12.0980; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193396	10.1371/journal.pone.0193396	http://dx.doi.org/10.1371/journal.pone.0193396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529036	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000427189300019
J	Foster, CC; Lee, AY; Furtado, LV; Hart, J; Alpert, L; Xiao, SY; Hyman, NH; Sharma, MR; Liauw, S				Foster, Corey C.; Lee, Andrew Y.; Furtado, Larissa V.; Hart, John; Alpert, Lindsay; Xiao, Shu-Yuan; Hyman, Neil H.; Sharma, Manish R.; Liauw, Stanley			Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RTOG 0529; CHEMORADIATION; MITOMYCIN; TRIAL; RADIOTHERAPY; MULTICENTER; COMBINATION; PREDICTORS	Background Intensity-modulated radiation therapy (IMRT) has been used to limit treatment-related toxicity for patients with anal squamous cell carcinoma (SCC). The treatment outcomes and HPV characteristics for a cohort of patients receiving definitive concurrent chemotherapy and IMRT are reported. Materials and methods 52 patients with anal SCC were treated with IMRT and concurrent chemotherapy. Radiation was delivered sequentially to the pelvis and inguinal lymph nodes (45 Gy) and anal tumor (median dose, 54 Gy). Multiplex real-time PCR for 7 high-risk HPV subtypes (n = 22) and p16 immunohistochemistry (n = 21, rated on a 0, 1, and 2+ scale) were performed on available specimens. Survival was estimated using Kaplan-Meier analysis, and toxicities were recorded. Results Median follow-up was 33 months. Three-year freedom from locoregional failure (FFLRF), freedom from distant metastasis (FFDM), freedom from colostomy (FFC), and overall survival (OS) were 94%, 85%, 91%, and 90%, respectively. Acute grade 2+ skin, GI, and GU toxicities occurred in 83%, 71%, and 19% of evaluable patients, respectively. The rates of late grade 2+ GI and GU toxicities for evaluable patients (n = 32) were 28% and 9%, respectively. Of patients with available pathology, 91% and 71% were positive for HPV and p16 (2+), respectively. HPV genotypes included 16 (n = 17), 33 (n = 2), 18 (n = 1), and 45 (n = 1). HPV and p16 status were associated on Chi-square analysis (p = 0.07). Neither HPV nor p16 status was significantly associated with any clinical outcome. For HPV+ patients, 3-year FFLRF, FFDM, FFC, and OS were 100%, 69%, 100%, and 88%, respectively. Conclusions In this patient cohort, disease control was excellent for anal SCC treated with definitive concurrent chemotherapy and IMRT, and treatment was well tolerated. HPV and p16 status were not prognostic for treatment outcomes which may be related to our small sample size.	[Foster, Corey C.; Lee, Andrew Y.; Liauw, Stanley] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Furtado, Larissa V.] Univ Utah, ARUP Labs, Dept Pathol, Salt Lake City, UT USA; [Hart, John; Alpert, Lindsay; Xiao, Shu-Yuan] Univ Chicago Med, Dept Pathol, Chicago, IL USA; [Hyman, Neil H.] Univ Chicago Med, Dept Colon & Rectal Surg, Chicago, IL USA; [Sharma, Manish R.] Univ Chicago Med, Sect Hematol Oncol, Dept Med, Chicago, IL USA	Utah System of Higher Education; University of Utah; ARUP Laboratories	Liauw, S (corresponding author), Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	sliauw@radonc.uchicago.edu	Xiao, Shu-Yuan/AAR-7167-2020; Lee, Andrew/GVU-2817-2022	Xiao, Shu-Yuan/0000-0003-0484-932X; Foster, Corey/0000-0002-3893-834X; Liauw, Stanley/0000-0002-4701-2469				Allen CT, 2010, LARYNGOSCOPE, V120, P1756, DOI 10.1002/lary.20936; Bartelink H, 1997, J CLIN ONCOL, V15, P2040, DOI 10.1200/JCO.1997.15.5.2040; Call JA, 2016, AM J CLIN ONCOL-CANC, V39, P8, DOI 10.1097/COC.0000000000000009; Flam M, 1996, J CLIN ONCOL, V14, P2527, DOI 10.1200/JCO.1996.14.9.2527; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Gomez DR, 2016, LANCET ONCOL, V17, P1672, DOI 10.1016/S1470-2045(16)30532-0; Gunderson LL, 2012, J CLIN ONCOL, V30, P4344, DOI 10.1200/JCO.2012.43.8085; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; James RD, 2013, LANCET ONCOL, V14, P516, DOI 10.1016/S1470-2045(13)70086-X; Kachnic LA, 2013, INT J RADIAT ONCOL, V86, P27, DOI 10.1016/j.ijrobp.2012.09.023; Kosary C.L, 2017, SEER CANC STAT REV 1; Lee AY, 2017, INT J RADIAT ONCOL, V97, P306, DOI 10.1016/j.ijrobp.2016.10.010; Mai S, 2015, INT J RADIAT ONCOL, V93, P819, DOI 10.1016/j.ijrobp.2015.08.004; Meyer Joshua E, 2013, J Gastrointest Cancer, V44, P450, DOI 10.1007/s12029-013-9543-1; Milano MT, 2005, INT J RADIAT ONCOL, V63, P354, DOI 10.1016/j.ijrobp.2005.02.030; Mitra D, 2017, ADV RADIAT ONCOL, V2, P110, DOI 10.1016/j.adro.2017.01.009; NIGRO ND, 1983, CANCER, V51, P1826, DOI 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L; Northover J, 2010, BRIT J CANCER, V102, P1123, DOI 10.1038/sj.bjc.6605605; Olsen JR, 2017, INT J RADIAT ONCOL, V98, P400, DOI 10.1016/j.ijrobp.2017.02.005; Ouhoummane N, 2013, CANCER EPIDEMIOL, V37, P807, DOI 10.1016/j.canep.2013.09.015; Roldan Urgoiti GB, 2014, PLOS ONE, V9; Ryan DP, 2000, NEW ENGL J MED, V342, P792, DOI 10.1056/NEJM200003163421107; Salama JK, 2007, J CLIN ONCOL, V25, P4581, DOI 10.1200/JCO.2007.12.0170; Serup-Hansen E, 2014, J CLIN ONCOL, V32, P1812, DOI 10.1200/JCO.2013.52.3464; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Yhim HY, 2011, INT J CANCER, V129, P1752, DOI 10.1002/ijc.25825	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194234	10.1371/journal.pone.0194234	http://dx.doi.org/10.1371/journal.pone.0194234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522569	gold, Green Published, Green Submitted			2022-12-26	WOS:000427030800048
J	Carvalho, DO; Chuffi, S; Ioshino, RB; Marques, ICS; Fini, R; Costa, MK; Araujo, HRC; Costa-da-Silva, AL; Kojin, BB; Capurro, ML				Carvalho, Danilo O.; Chuffi, Samira; Ioshino, Rafaella B.; Marques, Isabel C. S.; Fini, Regina; Costa, Maria Karina; Araujo, Helena R. C.; Costa-da-Silva, Andre L.; Kojin, Bianca Burin; Capurro, Margareth L.			Mosquito pornoscopy: Observation and interruption of Aedes aegypti copulation to determine female polyandric event and mixed progeny	PLOS ONE			English	Article							DENGUE VECTOR MOSQUITO; GENETIC-CONTROL; BODY-SIZE; DIPTERA; POPULATION; INFECTION; CAPACITY; SURVIVAL; FITNESS; BIOLOGY	Ades aegypti is the most important arbovirus vector in the world, and new strategies are under evaluation. Biological studies mentioning the occurrence of a second mate in Aedes aegyptican interfere with vector control program planning, which involves male mosquito release technique. This study presents different experiments to show the occurrence of mixed progeny. Mixed male crosses (using a combination of different type of males in confinement with virgin females) showed no polyandric female. Individual crosses with male substitution in every gonotrophic cycle also did not show any polyandric female. Individual crosses with a 20 minutes interval, with subsequent male change, showed that only a few females presented mixed offspring. The copulation breach in three different moments, group A with full coitus length, group B the coitus was interrupted in 5-7 seconds after the start; and group C, which the copulation was interrupted 3 seconds after started. In summary, group A showed a majority of unique progeny from the first male; group B showed the higher frequency of mixed offspring and group C with the majority of the crosses belonging to the second male. To conclude, the occurrence of a viable second mate and mixed offspring is only possible when the copulation is interrupted; otherwise, the first mate is responsible for mixed progeny.	[Carvalho, Danilo O.; Chuffi, Samira; Ioshino, Rafaella B.; Marques, Isabel C. S.; Fini, Regina; Costa, Maria Karina; Araujo, Helena R. C.; Costa-da-Silva, Andre L.; Kojin, Bianca Burin; Capurro, Margareth L.] Univ Sao Paulo, Inst Ciencia Biomed, Dept Parasitol, Sao Paulo, SP, Brazil; [Carvalho, Danilo O.; Ioshino, Rafaella B.; Marques, Isabel C. S.; Fini, Regina; Costa, Maria Karina; Araujo, Helena R. C.; Costa-da-Silva, Andre L.; Kojin, Bianca Burin; Capurro, Margareth L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo	Carvalho, DO; Capurro, ML (corresponding author), Univ Sao Paulo, Inst Ciencia Biomed, Dept Parasitol, Sao Paulo, SP, Brazil.; Carvalho, DO; Capurro, ML (corresponding author), Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.	cdanilo@usp.br; mcapurro@icb.usp.br	Chuffi, Samira/AAE-9959-2019; Capurro, Margareth/M-5286-2019; Araujo, Helena/J-9209-2015; Carvalho, Danilo Oliveira/AAL-7270-2020; Ioshino, Rafaella Sayuri/P-9814-2016; Capurro, Margareth L/F-8679-2012; Costa-Da-Silva, André Luis/J-8913-2019	Chuffi, Samira/0000-0002-6779-5405; Araujo, Helena/0000-0002-2021-2217; Carvalho, Danilo Oliveira/0000-0001-8168-4050; Ioshino, Rafaella Sayuri/0000-0002-9225-0140; Capurro, Margareth L/0000-0002-7480-2116; Costa-Da-Silva, André Luis/0000-0002-7615-7376; Kojin, Bianca/0000-0002-2986-2435				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bader CA, 2012, PHYSIOL ENTOMOL, V37, P136, DOI 10.1111/j.1365-3032.2011.00818.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579; Christophers SR, 2009, ADDES AEGYPTI L YELL; Clements AN, 2006, SENSORY RECEPTION BE; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Degner EC, 2016, AM J TROP MED HYG, V94, P780, DOI 10.4269/ajtmh.15-0893; Duvall LB, 2017, CURR BIOL, V27, P3734, DOI 10.1016/j.cub.2017.10.074; Dyck V.A., 2006, STERILE INSECT TECHN; Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004; Forattini OP, 2002, CULICIDOLOGIA MED; GOMULSKI L, 1990, B ENTOMOL RES, V80, P393, DOI 10.1017/S0007485300050641; GWADZ RW, 1970, MOSQ NEWS, V30, P355; Helinski MEH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1131, DOI 10.1007/s00265-012-1365-9; Helinski MEH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-65; HISS EA, 1972, J INSECT PHYSIOL, V18, P2217, DOI 10.1016/0022-1910(72)90250-8; Jasinskiene N, 2007, AM J TROP MED HYG, V76, P1072, DOI 10.4269/ajtmh.2007.76.1072; JONES JC, 1974, J ENTOMOL SER A, V48, P185; JONES JC, 1973, J INSECT PHYSIOL, V19, P435, DOI 10.1016/0022-1910(73)90118-2; Koenraadt CJM, 2008, J MED ENTOMOL, V45, P331, DOI 10.1603/0022-2585(2008)45[331:PDAPOA]2.0.CO;2; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lee SS, 2013, J THEOR BIOL, V331, P78, DOI 10.1016/j.jtbi.2013.04.014; Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005; Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235; Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Okamoto KW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004695; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Richardson JB, 2015, AM J TROP MED HYG, V93, P189, DOI 10.4269/ajtmh.14-0718; Robert MA, 2012, J MED ENTOMOL, V49, P1177, DOI 10.1603/ME11205; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Sawadogo SP, 2013, J MED ENTOMOL, V50, P285, DOI 10.1603/ME12041; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989; Spiegel CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074898; SPIELMAN A, 1969, J INSECT PHYSIOL, V15, P1471, DOI 10.1016/0022-1910(69)90168-1; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; Team RStudio, 2015, RSTUDIO INT DEV ENV; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058; YUVAL B, 1994, B ENTOMOL RES, V84, P137, DOI 10.1017/S0007485300032326	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193164	10.1371/journal.pone.0193164	http://dx.doi.org/10.1371/journal.pone.0193164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518112	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900015
J	Estevez-Mujica, CP; Quintane, E				Estevez-Mujica, Claudia P.; Quintane, Eric			E-mail communication patterns and job burnout	PLOS ONE			English	Article							INFORMATION OVERLOAD; WORK; DEMANDS; STRESSORS; INDIVIDUALS; PERFORMANCE; INTEGRATION; DEPRESSION; WORKPLACE; CONFLICT	A considerable body of research has documented the negative effects of job burnout on employees and their organizations, emphasizing the importance of the identification of early signs of the phenomenon for the purposes of prevention and intervention. However, such timely identification is difficult due to the time and cost of assessing the burnout levels of all employees in an organization using established scales. In this paper, we propose an innovative way to identify employees at risk of job burnout by analyzing their e-mail communication patterns. Building on the Job Demands Resources model, we theorize about the relationship between e-mail communication patterns and levels of employee exhaustion and disengagement (two dimensions of burnout). We analyzed 52,190 e-mails exchanged between 57 employees of a medium sized R&D company over a five-month period. We then related these employees' communication patterns to their levels of burnout, collected using an established scale (the OLBI Oldenburg Burnout Inventory). Our results provide support for the overall proposition of the paper, that e-mail communications can be used to identify individuals at risk of job burnout. Our models explain up to 34% of the variance of burnout and up to 37% and 19% respectively of the variance of exhaustion and disengagement. They also successfully distinguish between employees with a higher risk of burnout and those with lower levels of risk (F1 score of 84% with recall of 100% and 73% precision). We discuss the implications of our results and present suggestions for future research.	[Estevez-Mujica, Claudia P.] Univ Los Andes, Dept Psychol, Bogota, DC, Colombia; [Quintane, Eric] Univ Los Andes, Sch Management, Bogota, DC, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Estevez-Mujica, CP (corresponding author), Univ Los Andes, Dept Psychol, Bogota, DC, Colombia.; Quintane, E (corresponding author), Univ Los Andes, Sch Management, Bogota, DC, Colombia.	cp.estevez68@uniandes.edu.co; e.quintane20@uniandes.edu.co	Quintane, Eric/I-6487-2012	Quintane, Eric/0000-0002-9204-059X	Universidad de Los Andes, Colombia; COLCIENCIAS scholarship [cn.727]	Universidad de Los Andes, Colombia; COLCIENCIAS scholarship	Research was sponsored by Universidad de Los Andes, Colombia (www.uniandes.edu.co). C. P. Estevez-Mujica acknowledges support from the COLCIENCIAS scholarship for doctoral studies (cn.727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2014, BURNOUT WORK PSYCHOL, P10, DOI [10.4324/978131589416, DOI 10.4324/978131589416]; ALBRECHT TL, 1982, SOC WORK, V27, P229, DOI 10.1093/sw/27.3.229; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Ayyagari R, 2011, MIS QUART, V35, P831; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2016, J OCCUP HLT IN PRESS; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Barley SR, 2011, ORGAN SCI, V22, P887, DOI 10.1287/orsc.1100.0573; BAVELAS A, 1950, J ACOUST SOC AM, V22, P723; Bellotti V, 2005, HUM-COMPUT INTERACT, V20, P89, DOI 10.1207/s15327051hci2001&2_4; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Brewer E., 2004, HUMAN RESOURCE DEV R, V3, P102, DOI [10.1177/1534484304263335, DOI 10.1177/1534484304263335]; Brown R, 2014, INT J STRESS MANAGE, V21, P325, DOI 10.1037/a0037464; Burt R. S, 1992, STRUCTURAL HOLES; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Camargo MR, 2008, INFORM RES, V13; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CORDES CL, 1993, ACAD MANAGE REV, V18, P621, DOI 10.2307/258593; Dabbish L.A., 2006, P 2006 20 ANNIVERSAR, P431, DOI [10.1145/1180875.1180941, DOI 10.1145/1180875.1180941]; Dabbish L. A., 2005, P SIGCHI C HUM FACT, P691; Day A, 2012, J OCCUP HEALTH PSYCH, V17, P473, DOI 10.1037/a0029837; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Derks D., 2010, CYBERPSYCHOLOGY, V4, P1; Derks D, 2014, APPL PSYCHOL-INT REV, V63, P411, DOI 10.1111/j.1464-0597.2012.00530.x; Ducheneaut N., 2001, Interactions, V8, P30, DOI 10.1145/382899.383305; Eppler MJ, 2004, INFORM SOC, V20, P325, DOI 10.1080/01972240490507974; Fang RL, 2015, ORGAN SCI, V26, P1243, DOI 10.1287/orsc.2015.0972; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Goh J, 2016, MANAGE SCI, V62, P608, DOI 10.1287/mnsc.2014.2115; GOLEMBIEWSKI RT, 1993, S AP PSYC S, P217; HOSMER DW, 2000, WILEY PS TX, P1; Johnson PR, 1990, B ASS BUSINESS COMMU, V53, P5; KAHILL S, 1988, CAN PSYCHOL, V29, P284, DOI 10.1037/h0079772; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kleinbaum AM, 2012, ADMIN SCI QUART, V57, P407, DOI 10.1177/0001839212461141; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; LEAVITT HJ, 1951, J ABNORM SOC PSYCH, V46, P38, DOI 10.1037/h0057189; Leiter MP, 1996, ANXIETY STRESS COPIN, V9, P229, DOI 10.1080/10615809608249404; LEITER MP, 1988, J ORGAN BEHAV, V9, P297, DOI 10.1002/job.4030090402; Lepine JA, 2005, ACAD MANAGE J, V48, P764, DOI 10.2307/20159696; Lerner J, 2013, CORVINUS J SOCIOL PO, V4, P3; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1997, EVALUATING STRESS BO, P191; Maslach C., 2009, OXFORD HDB ORG WELL, P86; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; McCulloh I, 2008, P 26 ARM SCI C DEC 1; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; OREILLY CA, 1980, ACAD MANAGE J, V23, P684, DOI 10.2307/255556; Pines A., 1981, BURNOUT TEDIUM PERSO; Quintane E., 2011, CONNECTIONS, V31, P22; Ray E. B., 1991, COMMUNICATION Q, V39, P91; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Schieman S, 2013, WORK STRESS, V27, P244, DOI 10.1080/02678373.2013.817090; Sharma R. R, 2016, EXECUTIVE BURNOUT E; Shirom A., 2003, HDB OCCUPATIONAL HLT, P245, DOI DOI 10.1037/10474-012; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Sumecki D, 2011, INT J INFORM MANAGE, V31, P407, DOI 10.1016/j.ijinfomgt.2010.12.008; Taris TW, 2006, WORK STRESS, V20, P316, DOI 10.1080/02678370601065893; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Toker S, 2012, J APPL PSYCHOL, V97, P699, DOI 10.1037/a0026914; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Wright KB, 2014, MANAGE COMMUN Q, V28, P507, DOI 10.1177/0893318914533332; Wright TA, 1997, J ORGAN BEHAV, V18, P491, DOI 10.1002/(SICI)1099-1379(199709)18:5<491::AID-JOB804>3.0.CO;2-I; Xuan Q, 2014, 36TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2014), P222, DOI 10.1145/2568225.2568238; Xuan Q, 2014, ADV COMPLEX SYST, V17, DOI 10.1142/S0219525915500058	71	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193966	10.1371/journal.pone.0193966	http://dx.doi.org/10.1371/journal.pone.0193966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5UV	29518128	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900052
J	de Madrid, BH; Casanova, J				Hernandez de Madrid, Beatriz; Casanova, Jordi			GATA factor genes in the Drosophila midgut embryo	PLOS ONE			English	Article							DIFFERENTIATION; ENDODERM	The Drosophila GATA factor gene serpent (srp) is required for the early differentiation of the anterior and posterior midgut primordia. In particular, srp is sufficient and necessary for the primordial gut cells to undertake an epithelial-to-mesenchimal transition (EMT). Two other GATA factor genes, dGATAe and grain (grn), are also specifically expressed in the midgut. On the one hand, dGATAe expression is activated by srp. Embryos homozygous for a deficiency uncovering dGATAe were shown to lack the expression of some differentiated midgut genes. Moreover, ectopic expression of dGATAe was sufficient to drive the expression of some of these differentiation marker genes, thus establishing the role of dGATAe in the regulation of their expression. However, due to the gross abnormalities associated with this deficiency, it was not possible to assess whether, similarly to srp, dGATAe might play a role in setting the midgut morphology. To further investigate this role we decided to generate a dGATAe mutant. On the other hand, gm is expressed in the midgut primordia around stage 11 and remains expressed until the end of embryogenesis. Yet, no midgut function has been described for gm. First, here we report that, as for dGATAe, midgut gm expression is dependent on srp; conversely, dGATAe and grn expression are independent of each other. Our results also indicate that, unlike srp, dGATAe and gm are not responsible for setting the general embryonic midgut morphology. We also show that the analysed midgut genes whose expression is lacking in embryos homozygous for a deficiency uncovering dGATAe are indeed dGATAe-dependent genes. Conversely, we do not find any midgut gene to be grn-dependent, with the exception of midgut repression of the proventriculus iroquois (iro) gene. In conclusion, our results clarify the expression patterns and function of the GATA factor genes expressed in the embryonic midgut.	[Hernandez de Madrid, Beatriz; Casanova, Jordi] CSIC, IBMB, Barcelona, Catalonia, Spain; [Hernandez de Madrid, Beatriz; Casanova, Jordi] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	de Madrid, BH; Casanova, J (corresponding author), CSIC, IBMB, Barcelona, Catalonia, Spain.; de Madrid, BH; Casanova, J (corresponding author), BIST, Inst Res Biomed IRB Barcelona, Barcelona, Catalonia, Spain.	beatriz.hernandez@irbbarcelona.org; jordi.casanova@ibmb.csic.es	Casanova, Jordi/L-5181-2014	Casanova, Jordi/0000-0001-6121-8589	Ministerio de Economia y Competitividad, Generalitat de Catalunya, Marie Curie Cofund	Ministerio de Economia y Competitividad, Generalitat de Catalunya, Marie Curie Cofund	This work was supported by Ministerio de Economia y Competitividad, Generalitat de Catalunya, Marie Curie Cofund. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Aronson BE, 2014, AM J PHYSIOL-GASTR L, V306, pG474, DOI 10.1152/ajpgi.00119.2013; Ayanbule F, 2011, WORLD J SURG, V35, P1757, DOI 10.1007/s00268-010-0950-1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Okumura T, 2005, DEV BIOL, V278, P576, DOI 10.1016/j.ydbio.2004.11.021; Okumura T, 2016, DEV BIOL, V410, P24, DOI 10.1016/j.ydbio.2015.12.017; Okumura T, 2007, GENE EXPR PATTERNS, V7, P178, DOI 10.1016/j.modgep.2006.07.001; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; REUTER R, 1994, DEVELOPMENT, V120, P1123; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193612	10.1371/journal.pone.0193612	http://dx.doi.org/10.1371/journal.pone.0193612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518114	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900028
J	Diele-Viegas, LM; Vitt, LJ; Sinervo, B; Colli, GR; Werneck, FP; Miles, DB; Magnusson, WE; Santos, JC; Sette, CM; Caetano, GHO; Pontes, E; Avila-Pires, TCS				Diele-Viegas, Luisa M.; Vitt, Laurie J.; Sinervo, Barry; Colli, Guarino R.; Werneck, Fernanda P.; Miles, Donald B.; Magnusson, William E.; Santos, Juan C.; Sette, Carla M.; Caetano, Gabriel H. O.; Pontes, Emerson; Avila-Pires, Teresa C. S.			Thermal physiology of Amazonian lizards (Reptilia: Squamata)	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; LIFE-HISTORY; CLIMATE-CHANGE; FOOD ASSIMILATION; BODY-TEMPERATURE; PHENOTYPIC PLASTICITY; TRANSITIONAL FOREST; WESTERN AMAZON; ROCK OUTCROPS; FENCE LIZARD	We summarize thermal-biology data of 69 species of Amazonian lizards, including mode of thermoregulation and field-active body temperatures (T-b). We also provide new data on preferred temperatures (T-pref), voluntary and thermal-tolerance ranges, and thermal-performance curves (TPC's) for 27 species from nine sites in the Brazilian Amazonia. We tested for phylogenetic signal and pairwise correlations among thermal traits. We found that species generally categorized as thermoregulators have the highest mean values for all thermal traits, and broader ranges for T-b, critical thermal maximum (CTmax) and optimal (T-opt) temperatures. Species generally categorized as thermoconformers have large ranges for Tpref, critical thermal minimum (CTmin), and minimum voluntary (VTmin) temperatures for performance. Despite these differences, our results show that all thermal characteristics overlap between both groups and suggest that Amazonian lizards do not fit into discrete thermoregulatory categories. The traits are all correlated, with the exceptions of (1) T-opt, which does not correlate with CTmax, and (2) CTmin, and correlates only with T-opt. Weak phylogenetic signals for T-b, T-pref and VTmin indicate that these characters may be shaped by local environmental conditions and influenced by phylogeny. We found that open-habitat species perform well under present environmental conditions, without experiencing detectable thermal stress from high environmental temperatures induced in lab experiments. For forest-dwelling lizards, we expect warming trends in Amazonia to induce thermal stress, as temperatures surpass the thermal tolerances for these species.	[Diele-Viegas, Luisa M.; Avila-Pires, Teresa C. S.] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Vitt, Laurie J.] Univ Oklahoma, Sam Noble Museum, Norman, OK 73019 USA; [Sinervo, Barry; Sette, Carla M.; Caetano, Gabriel H. O.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Colli, Guarino R.] Univ Brasilia, Brasilia, DF, Brazil; [Werneck, Fernanda P.; Magnusson, William E.; Pontes, Emerson] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Miles, Donald B.] Ohio Univ, Athens, OH 45701 USA; [Santos, Juan C.] Brigham Young Univ, Provo, UT 84602 USA; [Diele-Viegas, Luisa M.] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Santos, Juan C.] St Johns Univ, Queens, NY USA	Museu Paraense Emilio Goeldi; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Santa Cruz; Universidade de Brasilia; Institute Nacional de Pesquisas da Amazonia; University System of Ohio; Ohio University; Brigham Young University; Universidade do Estado do Rio de Janeiro; Saint John's University	Diele-Viegas, LM (corresponding author), Museu Paraense Emilio Goeldi, Belem, Para, Brazil.; Diele-Viegas, LM (corresponding author), Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.	luisa.mviegas@gmail.com	Diele-Viegas, Luisa Maria/ABI-2494-2020; Colli, Guarino Rinaldi/A-5368-2008; Diele-Viegas, Luisa M./D-8930-2018; Werneck, Fernanda P./J-9629-2013; Miles, Donald B./AFW-0480-2022	Diele-Viegas, Luisa Maria/0000-0002-9225-4678; Colli, Guarino Rinaldi/0000-0002-2628-5652; Diele-Viegas, Luisa M./0000-0002-9225-4678; Werneck, Fernanda P./0000-0002-8779-2607; Miles, Donald/0000-0001-5768-179X; Sette, Carla/0000-0001-7105-7512	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475559/2013-4]; CNPq; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM) [062.00665/2015]; U.S. National Academy of Sciences; U.S. Agency of International Development (PEER NAS/USAID PGA) [2000005316]; Fundacao de Amparo a Pesquisa do Para - ICAAF [011/2012]; Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF); National Science Foundation [1241885]; National Science Foundation Emerging Frontiers [241848]; Emerging Frontiers [1241848] Funding Source: National Science Foundation	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); U.S. National Academy of Sciences; U.S. Agency of International Development (PEER NAS/USAID PGA)(United States Agency for International Development (USAID)); Fundacao de Amparo a Pesquisa do Para - ICAAF; Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Emerging Frontiers; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - graduate fellowship to LDV and financial support to GRC (http://www.capes.gov.br/): Allowed the development of the research and the data collection. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - research fellowship to TAP and financial support to FPW (475559/2013-4) (http//cnpq.br/): Allowed the data collection. PVE (Pesquisador Visitante Especial) grant from CNPq (http://cnpq.br/) - BRS: Allowed the development of the research. Fundacao de Amparo a Pesquisa do Amazonas financial support to FPW and WM (FAPEAM, 062.00665/2015) (http.//www.fapeam.am.gov.br/): Allowed the study design and decision to publish. Partnerships for Enhanced Engagement in Research from the U.S. National Academy of Sciences and U.S. Agency of International Development (PEER NAS/USAID PGA 2000005316) financial support to GRC and FPW (http://sites.nationalacademies.org/pga/peer/index. htm): Allowed the development of the research and the decision to publish. Fundacao de Amparo a Pesquisa do Para - ICAAF number 011/2012 SISBIOTA Herpeto-Helminto financial support to LDV and TAP (http://www.fapespa.pa.gov.br/): Allowed the data collection. *Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF)- financial support to GRC (http://www.fap.df.gov.br/ <http://www.fap.df.gov.br/>)* -Allowed the data collection. National Science Foundation Emerging Frontiers [grant number 1241885, Collaborative Research: "Quantifying Climate-forced Extinction Risks for Lizards, Amphibians, Fishes, and Plants"] LDV, BRS, GRC and FPW (https://www.nsf.gov/): Allowed the data collection, analysis and reparation of the manuscript. National Science Foundation Emerging Frontiers [grant number 241848] BRS and DBM: Allowed the data collection, analysis and preparation of the manuscript. Research Council via a George Lynn Cross Research Professorship of the University of Oklahoma and the Sam Noble Museum support to LJV (http://samnoblemuseum.ou.edu/): Allowed the decision to publish.	ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Bartholomew G .A., 1958, Publications of the American Association for the Advancement of Science, V51, P81; BENNETT AF, 1980, ANIM BEHAV, V28, P752, DOI 10.1016/S0003-3472(80)80135-7; BENNETT AF, 1990, AM J PHYSIOL, V259, pR253, DOI 10.1152/ajpregu.1990.259.2.R253; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Cheng H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2415; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Colli GR, 2003, J HERPETOL, V37, P694, DOI 10.1670/180-02A; D'Apolito C, 2013, QUATERNARY SCI REV, V76, P140, DOI 10.1016/j.quascirev.2013.07.013; DEWITT CB, 1967, PHYSIOL ZOOL, V40, P49, DOI 10.1086/physzool.40.1.30152438; DIXON J R, 1975, Milwaukee Public Museum Contributions in Biology and Geology, V4, P1; Du WG, 2000, J THERM BIOL, V25, P197, DOI 10.1016/S0306-4565(99)00022-4; Eva H., 2005, PROPOSAL DEFINING GE; Fearnside PM, 2009, OECOLOGIA BRASILIENS, V13, P609, DOI DOI 10.4257/0EC0.2009.1304.05; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P3606, DOI 10.1111/gcb.12012; Feldpausch TR, 2016, GLOBAL BIOGEOCHEM CY, V30, P964, DOI 10.1002/2015GB005133; Felenstein J, 2004, INFERRING PHYLOGENIE; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Salazar LF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043538; Fitch H. S., 1968, Herpetologica, V24, P35; GASNIER TR, 1994, J HERPETOL, V28, P187, DOI 10.2307/1564619; Henderson R.W., 2009, NATURAL HIST W INDIA; Hoorn C, 2017, GLOBAL PLANET CHANGE, V153, P51, DOI 10.1016/j.gloplacha.2017.02.005; Huey R.B., 1982, Biology of Reptilia, V12, P25; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; Huey RB, 2011, NATURE, V470, P479; Huey RB, 1975, THESIS; Irschick DJ, 2001, ANNU REV ECOL SYST, V32, P367, DOI 10.1146/annurev.ecolsys.32.081501.114048; Ji X, 1997, NETH J ZOOL, V47, P103; Ji X, 1996, J THERM BIOL, V21, P155, DOI 10.1016/0306-4565(95)00037-2; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Kohlsdorf T, 2006, EVOL ECOL, V20, P549, DOI 10.1007/s10682-006-9116-x; Kubisch EL, 2016, CAN J ZOOL, V94, P49, DOI 10.1139/cjz-2015-0024; Licht P., 1966, Copeia, V1966, P97; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; MAGNUSSON WE, 1985, HERPETOLOGICA, V41, P324; MAGNUSSON WE, 1993, J HERPETOL, V27, P53, DOI 10.2307/1564905; Mesquita DO, 2006, COPEIA, P460, DOI 10.1643/0045-8511(2006)2006[460:EOACLA]2.0.CO;2; Mesquita DO, 2006, J HERPETOL, V40, P221, DOI 10.1670/123-05A.1; Mesquita DO, 2003, COPEIA, P285; Miranda JP, 2010, ZOOLOGIA-CURITIBA, V27, P35, DOI 10.1590/S1984-46702010000100006; Nobre CA, 2016, P NATL ACAD SCI USA, V113, P10759, DOI 10.1073/pnas.1605516113; NUNES V S, 1984, Papeis Avulsos de Zoologia (Sao Paulo), V35, P147; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paranjpe DA, 2012, P MEAS BEH 2012 8 IN; Paranjpe DA, 2013, EVOL ECOL; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pianka E R, 1994, LIZARD MAN SPEAKS, P26; Pough F.H., 1982, Biology of Reptilia, V12, P17; R Core Team, 2021, R LANGUAGE ENV STAT; Recoder Renato, 2012, Herpetology Notes, V5, P49; Revell LJ, 2012, METHODS ECOL EVOL; Ribeiro-Junior Marco, 2016, Neotropical Biodiversity, V2, P195; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rocha Carlos Frederico D., 2009, Oecologia Brasiliensis, V13, P115; Sartorius SS, 1999, BIOL CONSERV, V90, P91, DOI 10.1016/S0006-3207(99)00019-1; Savage J.M., 2002, AMPHIBIANS REPTILES; Sears MW, 2016, P NATL ACAD SCI USA, V113, P10595, DOI 10.1073/pnas.1604824113; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Simmons PM, 2005, HERPETOLOGICA, V61, P124, DOI 10.1655/04-24; SINERVO B, 1990, OECOLOGIA, V83, P228, DOI 10.1007/BF00317757; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; STAMPS JA, 1976, COPEIA, P467; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; VANDAMME R, 1991, FUNCT ECOL, V5, P507; Vitt Laurie J., 2007, PHYLLOMEDUSA, V6, P11; Vitt LJ, 2008, COPEIA, P144, DOI 10.1643/CP-06-251; Vitt Laurie J., 1995, Occasional Papers of the Oklahoma Museum of Natural History, V1, P1; Vitt LJ, 1998, COPEIA, P570, DOI 10.2307/1447787; Vitt LJ, 2005, HERPETOL MONOGR, V19, P137, DOI 10.1655/0733-1347(2005)019[0137:SIABWE]2.0.CO;2; VITT LJ, 1995, COPEIA, P305; Vitt LJ, 2003, J HERPETOL, V37, P276, DOI 10.1670/0022-1511(2003)037[0276:SARTEO]2.0.CO;2; Vitt LJ, 1996, HERPETOLOGICA, V52, P121; Vitt LJ, 1996, CAN J ZOOL, V74, P1313, DOI 10.1139/z96-147; Vitt LJ, 1997, CAN J ZOOL, V75, P1876, DOI 10.1139/z97-817; Vitt LJ, 2003, CAN J ZOOL, V81, P142, DOI 10.1139/Z02-230; Vitt LJ, 1996, J TROP ECOL, V12, P81, DOI 10.1017/S0266467400009329; VITT LJ, 1993, CAN J ZOOL, V71, P2370, DOI 10.1139/z93-333; VITT LJ, 1993, J HERPETOL, V27, P46, DOI 10.2307/1564904; VITT LJ, 1991, J HERPETOL, V25, P79, DOI 10.2307/1564798; Vitt LJ, 2003, CAN J ZOOL, V81, P302, DOI 10.1139/Z03-004; VITT LJ, 1991, COPEIA, P916, DOI 10.2307/1446087; Vitt LJ, 2002, COPEIA, P275; Vitt LJ, 1997, HERPETOLOGICA, V53, P165; Vitt LJ, 2001, CAN J ZOOL, V79, P1855, DOI 10.1139/cjz-79-10-1855; VITT LJ, 1992, CAN J ZOOL, V70, P1995, DOI 10.1139/z92-270; VITT LJ, 1995, CAN J ZOOL, V73, P691, DOI 10.1139/z95-081; VITT LJ, 1991, CAN J ZOOL, V69, P2791, DOI 10.1139/z91-393; Vitt LJ, 2001, COPEIA, P401, DOI 10.1643/0045-8511(2001)001[0401:LOTLLT]2.0.CO;2; Vitt LJ, 1998, J TROP ECOL, V14, P63, DOI 10.1017/S0266467498000066; Vitt LJ, 2000, COPEIA, V2000, P3; Vrcibradic D, 1998, J HERPETOL, V32, P229, DOI 10.2307/1565302; Wang XF, 2017, NATURE, V541, P204, DOI 10.1038/nature20787; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yannas S, 1995, PASCOOL HDB DESIGNIN; Zajitschek SRK, 2012, BIOL J LINN SOC, V107, P573, DOI 10.1111/j.1095-8312.2012.01963.x; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009; Zuur Alain F., 2009, P1	114	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192834	10.1371/journal.pone.0192834	http://dx.doi.org/10.1371/journal.pone.0192834			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513695	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800023
J	Roberts, CP; Uden, DR; Allen, CR; Twidwell, D				Roberts, Caleb P.; Uden, Daniel R.; Allen, Craig R.; Twidwell, Dirac			Doublethink and scale mismatch polarize policies for an invasive tree	PLOS ONE			English	Article							REDCEDAR JUNIPERUS-VIRGINIANA; TALLGRASS PRAIRIE; BIOLOGICAL INVASIONS; MANAGEMENT; FIRE; CONSEQUENCES; PLANTS; CONVERSION; DYNAMICS; INVADERS	Mismatches between invasive species management policies and ecological knowledge can lead to profound societal consequences. For this reason, natural resource agencies have adopted the scientifically-based density-impact invasive species curve to guide invasive species management. We use the density-impact model to evaluate how well management policies for a native invader (Juniperus virginiana) match scientific guidelines. Juniperus virginiana invasion is causing a sub-continental regime shift from grasslands to woodlands in central North America, and its impacts span collapses in endemic diversity, heightened wildfire risk, and crashes in grazing land profitability. We (1) use land cover data to identify the stage of Juniperus virginiana invasion for three ecoregions within Nebraska, USA, (2) determine the range of invasion stages at individual land parcel extents within each ecoregion based on the density-impact model, and (3) determine policy alignment and mismatches relative to the density-impact model in order to assess their potential to meet sustainability targets and avoid societal impacts as Juniperus virginiana abundance increases. We found that nearly all policies evidenced doublethink and policy-ecology mismatches, for instance, promoting spread of Juniperus virginiana regardless of invasion stage while simultaneously managing it as a native invader in the same ecoregion. Like other invasive species, theory and literature for this native invader indicate that the consequences of invasion are unlikely to be prevented if policies fail to prioritize management at incipient invasion stages. Theory suggests a more realistic approach would be to align policy with the stage of invasion at local and ecoregion management scales. There is a need for scientists, policy makers, and ecosystem managers to move past ideologies governing native versus non-native invader classification and toward a framework that accounts for the uniqueness of native species invasions, their anthropogenic drivers, and their impacts on ecosystem services.	[Roberts, Caleb P.; Twidwell, Dirac] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Roberts, Caleb P.; Uden, Daniel R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Allen, Craig R.] Univ Nebraska, US Geol Survey, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Roberts, CP (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.; Roberts, CP (corresponding author), Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.	caleb.powell.roberts@gmail.com			Department of Defense Strategic Environmental Research Development Program [W912HQ-15-C-0018]; Nebraska Game & Parks Commission [W-125-R-1]; University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources; U.S. Geological Survey; Nebraska Game and Parks Commission,; University of Nebraska Agricultural Research Division, Lincoln, Nebraska; United States Fish and Wildlife Service; Wildlife Management Institute	Department of Defense Strategic Environmental Research Development Program; Nebraska Game & Parks Commission; University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission,; University of Nebraska Agricultural Research Division, Lincoln, Nebraska; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	This work was supported by Department of Defense Strategic Environmental Research Development Program W912HQ-15-C-0018 (https://www.serdp-estcp.org/), Nebraska Game & Parks Commission W-125-R-1 (http://outdoornebraska.gov/) and the University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources. The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by Hatch Act funds through a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska Agricultural Research Division, Lincoln, Nebraska, the United States Fish and Wildlife Service and the Wildlife Management Institute. We thank the Eastern Redcedar Working Group for conceptual development assistance. We extend special thanks to the Rainwater Basin Joint Venture for use of their land classification data. We also thank Ritch Nelson for management policy information. Any use of trade, firm or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV QUAL INC PROGR; [Anonymous], 2015, ACT NOW PAY LATER EV; [Anonymous], 2014, E RED PROBL OPP; Bessey C. E., 1899, FORESTS FOREST TREES; Bidwell T. G., 1990, INVASION OKLAHOMA RA; Bishop A., 2011, RAINWATER BASIN JOIN; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Chaffin BC, 2016, J ENVIRON MANAGE, V183, P399, DOI 10.1016/j.jenvman.2016.04.040; Charles E, BESSEY TREE NURSERY; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Donovan V. M., PREDICTORS AFFORESTA; Engle D. M., 2008, ECOL STUD-ANAL SYNTH, P253; Epanchin-Niell RS, 2015, ECOL ECON, V116, P146, DOI 10.1016/j.ecolecon.2015.04.014; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Fremont JC., 1845, REPORT EXPLORING EXP; Fuhlendorf S.D., 2008, ECOL STU AN, P219; Fuhlendorf S. D., ECOLOGICAL MODELLING, V90, P245; Ganguli Amy C., 2008, Rangelands, V30, P27, DOI 10.2111/1551-501X-30.6.27; Garmestani A. S., 2013, ECOLOGY SOC, V18; Head L, 2015, CONSERV SOC, V13, P311, DOI 10.4103/0972-4923.170411; Horncastle VJ, 2005, J MAMMAL, V86, P1144, DOI 10.1644/05-MAMM-A-015R1.1; Institute of Agriculture and Natural Resources University of Nebraska-Lincoln, E RED SCI LIT PROJ; Johnsgard P., 2005, NATURE NEBRASKA ECOL; Lawson E.R., 1990, SILVICS N AM, V1, P131; Limb RF, 2010, RANGELAND ECOL MANAG, V63, P638, DOI 10.2111/REM-D-09-00056.1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meneguzzo DM, 2015, J FOREST, V113, P325, DOI 10.5849/jof.14-093; Nackley LL, 2017, TRENDS ECOL EVOL, V32, P814, DOI 10.1016/j.tree.2017.08.003; Nebraska Department of Natural Resources, EL DAT; Nebraska Forest Service, FUELS RED FOR REST; Nebraska Forest Service, WINDBR DES; Nebraska Invasive Species Council, NEBR INV SPEC PROGR; Nel JL, 2004, S AFR J SCI, V100, P53; OWENSBY CE, 1973, J RANGE MANAGE, V26, P256, DOI 10.2307/3896570; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ratajczak Z, 2016, RANGELAND ECOL MANAG, V69, P280, DOI 10.1016/j.rama.2016.03.004; Schneider R., 2011, NEBRASKA NATURAL LEG; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2013, INVASIVE SPECIES WHA; Simberloff D, 2012, ECOLOGY, V93, P598, DOI 10.1890/11-1232.1; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stewart-Koster B, 2015, J APPL ECOL, V52, P366, DOI 10.1111/1365-2664.12395; Streit Krug A., 2017, ECOLOGY SOC IN PRESS; Twidwell D., 2013, FRONTIERS ECOLOGY EN, V11; Twidwell D, 2017, COMMUNICATION; Twidwell D, 2016, ECOSYSTEMS, V19, P356, DOI 10.1007/s10021-015-9937-y; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; Twidwell D, 2013, J APPL ECOL, V50, P603, DOI 10.1111/1365-2664.12063; U. S. Geological Survey, N AM CLIM MONTHL MEA; Uden DR, 2015, BIOL INVASIONS, V17, P2831, DOI 10.1007/s10530-015-0914-3; United States Forest Service, DEC MEM MCKELVIE WOO; United States Forest Service, BESS WOOD ENCR PROJ; Van Wilgen B. W., DIVERSITY DISTRIBUTI, V17, P1060; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitkova M, 2017, FOREST ECOL MANAG, V384, P287, DOI 10.1016/j.foreco.2016.10.057; Ware Eugene F., 1960, INDIAN WAR 1864; Wittmann MJ, 2014, OIKOS, V123, P441, DOI 10.1111/j.1600-0706.2013.01025.x; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1	65	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0189733	10.1371/journal.pone.0189733	http://dx.doi.org/10.1371/journal.pone.0189733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513675	gold, Green Published			2022-12-26	WOS:000426896800002
J	Vitek, NS				Vitek, Natasha S.			Delineating modern variation from extinct morphology in the fossil record using shells of the Eastern Box Turtle (Terrapene carolina)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; CLINAL VARIATION; SUBSPECIFIC DIVERSIFICATION; PHENOTYPIC DIVERGENCE; POPULATION-STRUCTURE; GEOGRAPHIC-VARIATION; AVIAN POPULATIONS; MEASUREMENT ERROR; FRESH-WATER; PLEISTOCENE	Characterization of morphological variation in the shells of extant Eastern Box Turtles, Terrapene carolina, provides a baseline for comparison to fossil populations. It also provides an example of the difficulties inherent to recognizing intraspecific diversity in the fossil record. The degree to which variation in fossils of T. carolina can be accommodated by extant variation in the species has been disagreed upon for over eighty years. Using morphometric analyses of the carapace, I address the relationship between modern and fossil T. carolina in terms of sexual dimorphism, geographic and subspecific variation, and allometric variation. Modern T. carolina display weak male-biased sexual size dimorphism. Sexual shape dimorphism cannot be reliably detected in the fossil record. Rather than a four-part subspecific division, patterns of geographic variation are more consistent with clinal variation between various regions in the species distribution. Allometric patterns are qualitatively similar to those documented in other emydid turtles and explain a significant amount of shape variation. When allometric patterns are accounted for, Holocene specimens are not significantly different from modern specimens. In contrast, several geologically older specimens have significantly different carapace shape with no modern analogue. Those large, fossilized specimens represent extinct variation occupying novel portions of morphospace. This study highlights the need for additional documentation of modern osteological variation that can be used to test hypotheses of intraspecific evolution in the fossil record.	[Vitek, Natasha S.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Vitek, Natasha S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Vitek, Natasha S.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA	University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vitek, NS (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.; Vitek, NS (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Vitek, NS (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	nvitek@ufl.edu		Vitek, Natasha/0000-0003-0587-8907	James M. and Thomas J. M. Schopf Award from the Paleontological Society; Paleontological Society of Austin Research Grant; Lundelius Scholarship; Jackson School of Geosciences; National Science Foundation [DGE-1315138]	James M. and Thomas J. M. Schopf Award from the Paleontological Society; Paleontological Society of Austin Research Grant; Lundelius Scholarship; Jackson School of Geosciences; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a James M. and Thomas J. M. Schopf Award from the Paleontological Society, a Paleontological Society of Austin Research Grant, a Lundelius Scholarship, funding from the Jackson School of Geosciences, and the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1315138 to NSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D.C., 2017, GEOMORPH SOFTWARE GE; ARCHIBALD JD, 1994, SYST BIOL, V43, P27, DOI 10.2307/2413579; AUFFENBERG W, 1967, COPEIA, P319, DOI 10.2307/1442120; AUFFENBERG WALTER, 1958, BULL FLORIDA STATE MUS BIOL SER, V3, P53; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; BALL RM, 1992, AUK, V109, P626; BARBOUR THOMAS, 1931, BULL MUS COMP ZOOL, V72, P293; BASKIN JA, 1991, J PALEONTOL, V65, P995, DOI 10.1017/S0022336000033308; Becker OS, 2016, MAPS DRAW GEOGRAPHIC; Bell Christopher J., 2004, P232; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY CC, 1994, BRIMLEYANA, P1; Bentley CC, 1998, TURTLES TESTUDINES A, P25; BERRY JF, 1980, OECOLOGIA, V44, P185, DOI 10.1007/BF00572678; Bivand R, 2015, COMP IMPLEMENTATIONS; BLAIR W F, 1976, Southwestern Naturalist, V21, P89, DOI 10.2307/3670328; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Brenneman RA, 2016, INT J PRIMATOL, V37, P460, DOI 10.1007/s10764-016-9911-3; Budischak SA, 2006, SOUTHEAST NAT, V5, P191, DOI 10.1656/1528-7092(2006)5[191:NHOTCB]2.0.CO;2; Butler JM, 2011, BIOL J LINN SOC, V102, P889, DOI 10.1111/j.1095-8312.2011.01625.x; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Cardini A, 2016, SYST BIOL, V65, P1096, DOI 10.1093/sysbio/syw043; Congdon JD, 2013, EVOL ECOL, V27, P445, DOI 10.1007/s10682-012-9595-x; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Darwin C, 1859, ORIGIN SPECIES MEANS; Dodd CK, 2008, J ZOOL, V275, P18, DOI 10.1111/j.1469-7998.2007.00402.x; Dodd CK, 2012, CHELONIAN CONSERV BI, V11, P44, DOI 10.2744/CCB-0927.1; Dodd C. Kenneth Jr, 1993, Herpetological Review, V24, P47; Dodd CK, 1997, CAN J ZOOL, V75, P1495, DOI 10.1139/z97-773; DODD CK, 2001, N AM BOX TURTLES NAT; Donald PF, 2017, IBIS, V159, P699, DOI 10.1111/ibi.12487; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dupuis J.R., 2016, NEWS LEPIDOPTERISTSS, V58, P202; Ehret D, 2011, J VERTEBRATE PALEONT, V104; Ehret Dana J., 2013, Bulletin of Zoological Nomenclature, V70, P193; Ennen JR, 2014, BIOL J LINN SOC, V111, P810, DOI 10.1111/bij.12234; Ernst Carl H., 1998, Chelonian Conservation and Biology, V3, P99; Fields SE, 2010, GROUND SLOTH MEGALON; Fitzpatrick John W., 2010, Ornithological Monographs, V67, P54; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Franz Richard, 2005, Bulletin of the Florida Museum of Natural History, V45, P179; Fritz U, 2007, AMPHIBIA-REPTILIA, V28, P97, DOI 10.1163/156853807779799135; Fritz U, 2014, ZOOTAXA, V3835, P295, DOI 10.11646/zootaxa.3835.2.10; Frost Darrel R., 1992, Herpetological Review, V23, P46; FROST DR, 1990, HERPETOLOGICA, V46, P87; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Fuller TL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1237; Fulton R., 1987, G OGRAPHIE PHYS QUAT, V41, P181, DOI DOI 10.7202/032676AR; Gibbons J.W., 1990, Herpetological Monographs, P1; Gidley JW, 1927, SMITHSONIAN MISCELLA, V78, P168; GILMORE CHARLES W., 1927, PROC U S NATION MUS, V71, P1; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; GOODWIN HT, 1995, J MAMMAL, V76, P100, DOI 10.2307/1382319; Graham R.W., 1976, THESIS; Grossnickle DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2110; Groves Colin P., 1992, Archaeology in Oceania, V27, P153; Guilday JE., 1978, B CARN MUS NAT HIST, V11, P1; Gut H. J., 1963, Quarterly Journal of the Florida Academy of Sciences, V26, P315; Haber A., 2011, OSYMM; Hadly EA, 1997, BIOL J LINN SOC, V60, P277; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Haig S. M., 2010, ORNITHOLOGICAL MONOG, V67, P172, DOI DOI 10.1525/0M.2010.67.1.172; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hay OP, 1906, B AM MUS NAT HIST, V22, P27; Hay OP., 1916, FL GEOL SURV ANN REP, V8, P39; Hendges CD, 2016, BIOL J LINNEAN SOC; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans R., 2016, GEOSPHERE SPHERICAL; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Holman JA, 2005, HERPETOL J, V15, P81; HOLMAN JA, 1978, HERPETOLOGICA, V34, P228; Hone DWE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0947; Hulbert RC, 2001, FOSSIL VERTEBRATEF; Inger RF, 1961, VERTEBRATE SPECIATIO, P262; Jass CN, 2011, J VERTEBR PALEONTOL, V31, P684, DOI 10.1080/02724634.2011.563764; Jones MT, 2016, J HERPETOL, V50, P94, DOI 10.1670/13-149; Joyce WG, 2012, J PALEONTOL, V86, P177, DOI 10.1666/11-073.1; Kahle D, 2013, R J, V5, P144; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kiester AR, 2015, CONSERVATION BIOL FR; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Koch PL, 2004, PALAEOGEOGR PALAEOCL, V207, P331, DOI 10.1016/j.palaeo.2003.09.034; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kowalewski M, 2010, QUANTITATIVE METHODS; LANYON WE, 1982, AUK, V99, P603; Legendre SD, 2016, PACKFOR FORWARD SELE, P46; Legler JM, 2013, TURTLES OF MEXICO: LAND AND FRESHWATER FORMS, P1; Lemon J., 2006, R R NEWS; Letts B, 2012, METHODS MOL BIOL, V840, P87, DOI 10.1007/978-1-61779-516-9_12; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lundelius Jr I.L., 1972, U TEXAS BUR EC GEOL, V77, P1; Macfadden BJ, 2012, J VERTEBR PALEONTOL, V32, P708, DOI 10.1080/02724634.2012.655639; Martin BT, 2013, MOL PHYLOGENET EVOL, V68, P119, DOI 10.1016/j.ympev.2013.03.006; Martin PR, 2008, EVOLUTION, V62, P2775, DOI 10.1111/j.1558-5646.2008.00489.x; MAYR E, 1982, AUK, V99, P593; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; McGee Ray M., 1994, FLORIDA ANTHR, V47, P333; Meloro C, 2017, J ZOOL SYST EVOL RES, V55, P269, DOI 10.1111/jzs.12171; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; MILSTEAD W W, 1969, Bulletin of the Florida State Museum Biological Sciences, V14, P1; Milstead W. W., 1965, COPEIA, V4, P513; MILSTEAD WILLIAM W., 1956, COPEIA, V1956, P162, DOI 10.2307/1439631; Minx P, 1996, HERPETOLOGICA, V52, P584; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; MONTANUCCI R R, 1992, Herpetological Review, V23, P9; Morgan Gary S., 1995, Bulletin of the Florida Museum of Natural History, V37, P1; MOSIMANN J. E., 1958, REV CANADIENNE BIOL, V17, P137; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Neuwirth E., 2014, RCOLORBREWER COLORBR; Nichols J.T., 1939, COPEIA, V1939, P14, DOI DOI 10.2307/1436010; Nichols JT., 1917, COPEIA, V46, P66; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Otvos E.G., 1996, T GULF COAST ASS GEO, V46, P333; Oyler-McCance Sara J., 2010, Ornithological Monographs, V67, P114; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Patterson DB, 2012, SOUTHEAST NAT, V11, P163, DOI 10.1656/058.011.0201; Patton JL, 2017, J MAMMAL, V98, P1010, DOI 10.1093/jmammal/gyx074; Perez SI, 2010, J EVOLUTION BIOL, V23, P237, DOI 10.1111/j.1420-9101.2009.01905.x; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; Phillimore AB, 2007, EVOLUTION, V61, P942, DOI 10.1111/j.1558-5646.2007.00068.x; Pilgrim Melissa A., 1997, Chelonian Conservation and Biology, V2, P483; Pluckhahn TJ, 2012, J FIELD ARCHAEOL, V37, P289, DOI 10.1179/0093469012Z.00000000026; Polly PD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111225; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Pratt H.D., 2010, AVIAN SUBSPECIES, V67, P78, DOI DOI 10.1525/0M.2010.67.1.79; Purdy B. A., 2015, PALEOAMERICA, V1, P266; R Core Team, 2013, R LANG ENV STAT COMP; Railsback LB, 2015, QUATERNARY SCI REV, V111, P94, DOI 10.1016/j.quascirev.2015.01.012; Ram K., 2015, WESANDERSON W ANDERS; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Rohlf, 2010, TPSDIG2 VERSION 216; Rohlf F.J., 1990, SPECIAL PUBLICATION, V2, p[227, 380]; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2010, TPSRELW VERSION 1 49, P11794; Ross JD, 2014, AUK, V131, P298, DOI 10.1642/AUK-13-246.1; Ryan PG, 2008, BIRD CONSERV INT, V18, P20, DOI 10.1017/S095927090800004X; Schwartz C.W., 1974, 3 TOED BOX TURTLE CE; Schwartz ER, 1984, 3 TOED BOX TURTLE CE; Schweizer RM, 2016, MOL ECOL, V25, P380, DOI 10.1111/mec.13364; Scrucca L, 2016, R J, V8, P289; Sheets HD, 2014, CVAGEN 8; Skalski JR, 2008, J AGR BIOL ENVIR ST, V13, P199, DOI 10.1198/108571108X310771; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; St Clair RC, 1998, OECOLOGIA, V115, P501, DOI 10.1007/s004420050547; Stayton CT, 2011, ZOOLOGY, V114, P213, DOI 10.1016/j.zool.2011.03.002; Stewart TD, 1946, REEXAMANIATION HUMAN; Steyer JS, 2000, B SOC GEOL FR, V171, P127; STICKEL LF, 1950, ECOL MONOGR, V20, P353, DOI 10.2307/1943570; STICKEL LF, 1989, J HERPETOL, V23, P216, DOI 10.2307/1564442; STORER RW, 1982, AUK, V99, P599; Trewick SA, 2016, IBIS, V158, P747, DOI 10.1111/ibi.12398; Van Bocxlaer B, 2013, P NATL ACAD SCI USA, V110, P13892, DOI 10.1073/pnas.1308588110; Verdon E, 2005, J HERPETOL, V39, P572, DOI 10.1670/131-04A.1; Vitek NS, 2012, J VERTEBR PALEONTOL, V32, P189; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; Webb S.D., 1974, P5; West JM, 2016, HERPETOL CONSERV BIO, V11, P459; Wickham H., 2016, SCALES SCALE FUNCTIO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson DS, 2003, HERPETOLOGICA, V59, P178, DOI 10.1655/0018-0831(2003)059[0178:EAOTFG]2.0.CO;2; Winker Kevin, 2010, Ornithological Monographs, V67, P6; Yann LT, 2014, PALAEOGEOGR PALAEOCL, V414, P370, DOI 10.1016/j.palaeo.2014.09.020; Yann LT, 2016, PALAEOGEOGRAPHY PALA; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2016, AUK, V133, P59, DOI 10.1642/AUK-15-63.1; Zug G.R., 1991, Society for the Study of Amphibians and Reptiles Herpetological Circular, P1; ZUSI RL, 1982, AUK, V99, P606	175	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193437	10.1371/journal.pone.0193437	http://dx.doi.org/10.1371/journal.pone.0193437			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513709	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800060
J	Huang, YY; Hu, Y; Chen, LC; Yang, T; Huang, HF; Shi, RP; Lu, P; Zhong, CH				Huang, Yaoyao; Hu, Yang; Chen, Lvcun; Yang, Tao; Huang, Hanfang; Shi, Runping; Lu, Peng; Zhong, Chenghua			Selective biosorption of thorium (IV) from aqueous solutions by ginkgo leaf	PLOS ONE			English	Article							NITRIC-ACID SOLUTION; SOLID-PHASE EXTRACTION; HEAVY-METAL IONS; SOLVENT-EXTRACTION; SACCHAROMYCES-CEREVISIAE; RARE-EARTHS; WHEAT BRAN; ADSORPTION; URANIUM; REMOVAL	Low-cost biosorbents (ginkgo leaf, osmanthus leaf, banyan leaf, magnolia leaf, holly leaf, walnut shell, and grapefruit peel) were evaluated in the simultaneous removal of La3+, Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Gd3+, Yb3+, Lu3+, UO22+, Th4+, Y3+, Co2+, Zn2+, Ni2+, and Sr2+ from aqueous solutions. In single metal systems, all adsorbents exhibited good to excellent adsorption capacities toward lanthanides and actinides. In a simulated multicomponent mixed solution study, higher selectivity and efficiency were observed for Th4+ over other metal cations, with ginkgo leaves providing the highest adsorptivity (81.2%) among the seven biosorbents. Through optimization studies, the selectivity of Th4+ biosorption on ginkgo leaf was found to be highly pH-dependent, with optimum Th4+ removal observed at pH 4. Th4+ adsorption was found to proceed rapidly with an equilibrium time of 120 min and conform to pseudo-second-order kinetics. The Langmuir isotherm model best described Th4+ biosorption, with a maximum monolayer adsorption capacity of 103.8 mg g(-1). Thermodynamic calculations indicated that Th4+ biosorption was spontaneous and endothermic. Furthermore, the physical and chemical properties of the adsorbent were determined by scanning electron microscopy, Brunauer-Emmett-Teller, X-ray powder diffraction, and Fourier transform infrared analysis. The biosorption of Th from a real sample (monazite mineral) was studied and an efficiency of 90.4% was achieved from nitric acid at pH 4 using ginkgo leaves.	[Huang, Yaoyao; Chen, Lvcun; Huang, Hanfang; Shi, Runping; Lu, Peng; Zhong, Chenghua] Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing, Peoples R China; [Hu, Yang; Yang, Tao; Zhong, Chenghua] Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China	Chongqing Technology & Business University; Chongqing University	Zhong, CH (corresponding author), Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing, Peoples R China.; Zhong, CH (corresponding author), Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China.	zhongchenghua2007@163.com	huang, yao/GWR-5388-2022	zhong, cheng hua/0000-0002-5510-7564	Innovative Entrepreneurship Training Program of Chongqing [201711799019]; Innovative project from Chongqing Technology and Business University (CTBU) [yjscxx2017-066-66]; Science and Technology Innovation Fund projects from CTBU [173020, 179028]; Science and Technology Research Project of Chongqing Municipal Education Commission [KJ130704]	Innovative Entrepreneurship Training Program of Chongqing; Innovative project from Chongqing Technology and Business University (CTBU); Science and Technology Innovation Fund projects from CTBU; Science and Technology Research Project of Chongqing Municipal Education Commission	This research was financially supported by the Innovative Entrepreneurship Training Program of Chongqing (201711799019), the Innovative project from Chongqing Technology and Business University (CTBU) (yjscxx2017-066-66), and the Science and Technology Innovation Fund projects from CTBU (173020 and 179028), and the Science and Technology Research Project of Chongqing Municipal Education Commission (KJ130704).The funders had no role in study	Abbasizadeh S, 2013, CHEM ENG J, V220, P161, DOI 10.1016/j.cej.2013.01.029; Akkaya R, 2013, J ENVIRON RADIOACTIV, V120, P58, DOI 10.1016/j.jenvrad.2012.11.015; Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4; Amer TE, 2013, INT J MINER PROCESS, V125, P106, DOI 10.1016/j.minpro.2013.10.004; Anirudhan TS, 2013, J ENVIRON RADIOACTIV, V116, P141, DOI 10.1016/j.jenvrad.2012.10.001; [Anonymous], [No title captured]; Arisaka M, 2011, SOLVENT EXTR ION EXC, V29, P72, DOI 10.1080/07366299.2011.539127; Avivar J, 2012, J ANAL ATOM SPECTROM, V27, P327, DOI 10.1039/c2ja10304d; Bagherifam S, 2010, J RADIOANAL NUCL CH, V283, P289, DOI 10.1007/s10967-009-0348-4; Baybas D, 2011, APPL CLAY SCI, V51, P138, DOI 10.1016/j.clay.2010.11.020; Berry L, 2017, MINER ENG, V109, P32, DOI 10.1016/j.mineng.2017.02.007; Bhainsa KC, 2009, J HAZARD MATER, V165, P670, DOI 10.1016/j.jhazmat.2008.10.033; Bhatnagar A, 2015, CHEM ENG J, V270, P244, DOI 10.1016/j.cej.2015.01.135; Bishay AF, 2010, J RADIOANAL NUCL CH, V286, P81, DOI 10.1007/s10967-010-0620-7; Bursali EA, 2010, J RADIOANAL NUCL CH, V283, P471, DOI 10.1007/s10967-009-0365-3; Chen SH, 2012, BIORESOURCE TECHNOL, V113, P114, DOI 10.1016/j.biortech.2011.11.110; Cho NS, 1999, J WOOD SCI, V45, P266, DOI 10.1007/BF01177738; Chu HZ, 2014, J HAZARD MATER, V264, P211, DOI 10.1016/j.jhazmat.2013.11.021; Das D, 2014, MINER ENG, V69, P40, DOI 10.1016/j.mineng.2014.06.013; Deb AKS, 2013, J RADIOANAL NUCL CH, V295, P1161, DOI 10.1007/s10967-012-1899-3; El-Ashtoukhy ESZ, 2008, DESALINATION, V223, P162, DOI 10.1016/j.desal.2007.01.206; Faghihian H, 2012, J RADIOANAL NUCL CH, V293, P463, DOI 10.1007/s10967-012-1814-y; Fang YY, 2015, DALTON T, V44, P14584, DOI 10.1039/c5dt00089k; Farinella NV, 2007, BIORESOURCE TECHNOL, V98, P1940, DOI 10.1016/j.biortech.2006.07.043; Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030; GADD GM, 1989, ENVIRON POLLUT, V61, P187, DOI 10.1016/0269-7491(89)90240-6; Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0; Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065; He LT, 2013, J CHEM TECHNOL BIOT, V88, P1930, DOI 10.1002/jctb.4055; Hinwood AL, 2015, ENVIRON POLLUT, V204, P256, DOI 10.1016/j.envpol.2015.04.024; Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012; Hritcu D, 2012, CARBOHYD POLYM, V87, P1185, DOI 10.1016/j.carbpol.2011.08.095; Hu C, 2016, J RADIOANAL NUCL CH, V308, P251, DOI 10.1007/s10967-015-4306-z; Huang H, 2014, SEP PURIF TECHNOL, V138, P65, DOI 10.1016/j.seppur.2014.10.008; Huang H, 2014, SEP PURIF TECHNOL, V123, P235, DOI 10.1016/j.seppur.2013.12.039; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Raju CSK, 2007, SEP PURIF TECHNOL, V55, P16, DOI 10.1016/j.seppur.2006.10.013; Keshtkar AR, 2014, KOREAN J CHEM ENG, V31, P289, DOI 10.1007/s11814-013-0220-7; KHAN SA, 1995, WASTE MANAGE, V15, P271, DOI 10.1016/0956-053X(95)00025-U; Kul M, 2008, HYDROMETALLURGY, V93, P129, DOI 10.1016/j.hydromet.2007.11.008; Kutahyali C, 2010, J NUCL MATER, V396, P251, DOI 10.1016/j.jnucmat.2009.11.018; Lara E, 2015, RADIAT PHYS CHEM, V116, P317, DOI 10.1016/j.radphyschem.2015.02.017; Li L, 2017, SEP PURIF TECHNOL, V188, P485, DOI 10.1016/j.seppur.2017.07.003; Li Q, 2010, CHEM ENG J, V158, P489, DOI 10.1016/j.cej.2010.01.033; Li Q, 2012, J RADIOANAL NUCL CH, V293, P67, DOI 10.1007/s10967-012-1720-3; Li RF, 2017, SEP PURIF TECHNOL, V188, P219, DOI 10.1016/j.seppur.2017.07.038; Li XL, 2013, J RADIOANAL NUCL CH, V298, P47, DOI 10.1007/s10967-013-2617-5; Liao XP, 2004, J RADIOANAL NUCL CH, V260, P619, DOI 10.1023/B:JRNC.0000028222.85988.40; Lugo-Lugo V, 2009, J HAZARD MATER, V161, P1255, DOI 10.1016/j.jhazmat.2008.04.087; Mastren T, 2018, ANAL CHIM ACTA, V998, P75, DOI 10.1016/j.aca.2017.10.020; Mastren T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08506-9; Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402; Mitrovic B, 2016, ENVIRON POLLUT, V215, P273, DOI 10.1016/j.envpol.2016.05.031; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Monji AB, 2015, J RADIOANAL NUCL CH, V303, P949, DOI 10.1007/s10967-014-3559-2; Monji AB, 2008, SEP SCI TECHNOL, V43, P597, DOI 10.1080/01496390701787453; Monji AB, 2016, J HAZARD TOXIC RADIO, V20, DOI 10.1061/(ASCE)HZ.2153-5515.0000296; Mu JX, 2012, APPL MECH MATER, V130-134, P829, DOI 10.4028/www.scientific.net/AMM.130-134.829; Nakajima A., 2002, J NUCL SCI TECHNOL, V39, P528, DOI [10.1080/00223131.2002.10875523, DOI 10.1080/00223131.2002.10875523]; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Nilchi A, 2013, DESALINATION, V321, P67, DOI 10.1016/j.desal.2012.06.022; Oyewo OA, 2016, J ENVIRON RADIOACTIV, V164, P369, DOI 10.1016/j.jenvrad.2016.08.014; Pool JA, 2005, J AM CHEM SOC, V127, P1338, DOI 10.1021/ja044153o; Radchenko V, 2017, TALANTA, V175, P318, DOI 10.1016/j.talanta.2017.07.057; Rao A, 2016, SEP PURIF TECHNOL, V161, P159, DOI 10.1016/j.seppur.2016.01.027; Seydoux-Guillaume AM, 2002, CHEM GEOL, V191, P165, DOI 10.1016/S0009-2541(02)00155-9; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Tan ML, 2015, SEP PURIF TECHNOL, V146, P192, DOI 10.1016/j.seppur.2015.03.027; Torab-Mostaedi M, 2015, RES CHEM INTERMEDIAT, V41, P559, DOI 10.1007/s11164-013-1210-4; Torun FE, 2006, J HAZARD MATER, V137, P293, DOI 10.1016/j.jhazmat.2006.02.003; Vearrier D, 2009, CLIN TOXICOL, V47, P393, DOI 10.1080/15563650902997849; Vijayalakshmi R, 2001, HYDROMETALLURGY, V61, P75, DOI 10.1016/S0304-386X(00)00159-6; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; Wang GH, 2009, J HAZARD MATER, V168, P1053, DOI 10.1016/j.jhazmat.2009.02.157; Wen J, 2016, CHEM-ASIAN J, V11, P49, DOI 10.1002/asia.201500834; Wen J, 2013, J HAZARD MATER, V263, P638, DOI 10.1016/j.jhazmat.2013.10.025; Xie F, 2014, MINER ENG, V56, P10, DOI 10.1016/j.mineng.2013.10.021; Yaftian MR, 2003, SEP PURIF TECHNOL, V31, P261, DOI 10.1016/S1383-5866(02)00203-4; Yang S, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0307-1; Yuan LY, 2014, ACS APPL MATER INTER, V6, P4786, DOI 10.1021/am405584h; Zehra T, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5255-8; Zhu L, 2016, J POLYM ENVIRON, V24, P148, DOI 10.1007/s10924-016-0757-8; Zhu M, 2016, J RADIOANAL NUCL CH, V310, P1; Zhu XK, 1999, CONTRIB MINERAL PETR, V137, P351, DOI 10.1007/s004100050555; Zou WH, 2012, J RADIOANAL NUCL CH, V292, P1303, DOI 10.1007/s10967-011-1602-0	86	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193659	10.1371/journal.pone.0193659	http://dx.doi.org/10.1371/journal.pone.0193659			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509801	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200021
J	Wang, WX; Said, A; Wang, BQ; Qu, GG; Xu, QQ; Liu, B; Shen, ZQ				Wang, Wenxiu; Said, Abdelrahman; Wang, Baoqin; Qu, Guanggang; Xu, Qingqing; Liu, Bo; Shen, Zhiqiang			Establishment and evaluation of the goose embryo epithelial (GEE) cell line as a new model for propagation of avian viruses	PLOS ONE			English	Article							CULTURE	In this study, we report the establishment and characterization of a new epithelial cell line, goose embryonated epithelial cell line (GEE), derived from embryonic goose tissue. The purified GEE cell line can efficiently grow over 65 passages in the M199 medium supplemented with 10% fetal bovine serum at 37 degrees C. Immunofluorescence assay was used to identify purified GEE cells as epithelial cell line by detecting expression of the Keratin-18 and -19. Further characterizations demonstrated that the GEE cell line can be continuously sub-cultured with (i) a high capacity to replicate for over 65 passages, (ii) a spontaneous epithelial-like morphology, (iii) constant chromosomal features and (iv) without an evidence of converting to tumorigenic cells either in vitro or in vivo study. Moreover, the GEE cell line can be effectively transfected with plasmids expressing reporter genes of different avian viruses, such as VP3, VP1 and F of goose parvo virus (GPV), duck hepatitis virus (DHV), and Newcastle disease virus (NDV), respectively. Finally, the established GEE cell line was evaluated for avian viruses infection susceptibility. Our results showed that the tested GPV, DHAV and NDV were capable to replicate in the new cell line with titers a comparatively higher to the ones detected in the traditional culture system. Accordingly, our established GEE cell line is apparently a suitable in vitro model for transgenic, and infection manipulation studies.	[Wang, Wenxiu; Qu, Guanggang; Xu, Qingqing; Shen, Zhiqiang] Anim Sci & Vet Med Acad, Binzhou, Shandong, Peoples R China; [Wang, Wenxiu; Liu, Bo; Shen, Zhiqiang] Shandong Lvdu Biosci & Technol Co Ltd, Binzhou, Shandong, Peoples R China; [Said, Abdelrahman] Natl Res Ctr, Parasitol & Anim Dis Dept, Giza, Egypt; [Wang, Baoqin] Binzhou Univ, Sch Bioengn, Binzhou, Peoples R China; [Said, Abdelrahman] Univ Saskatchewan, Vaccine & Infect Dis Org VIDO, Saskatoon, SK, Canada	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Binzhou University; University of Saskatchewan	Wang, WX; Shen, ZQ (corresponding author), Anim Sci & Vet Med Acad, Binzhou, Shandong, Peoples R China.; Wang, WX; Shen, ZQ (corresponding author), Shandong Lvdu Biosci & Technol Co Ltd, Binzhou, Shandong, Peoples R China.	wwx1997@126.com; bzshenzq@163.com	Said, Abdelrahman/AAL-2522-2020	Said, Abdo/0000-0002-3960-6670	Shandong research awards for outstanding Young and Middle-aged Scientist [BS2011SW026, ZR2016CB32]; Animal Science & Veterinary Medicine Academy; Shandong Lvdu Bio-Sciences &Technology Co. Ltd.; Shandong research awards for outstanding Young and Middle-aged Scientist of People's Republic of China [BS2011SW026, ZR2016CB32]	Shandong research awards for outstanding Young and Middle-aged Scientist; Animal Science & Veterinary Medicine Academy; Shandong Lvdu Bio-Sciences &Technology Co. Ltd.; Shandong research awards for outstanding Young and Middle-aged Scientist of People's Republic of China	This work was supported by Shandong research awards for outstanding Young and Middle-aged Scientist (BS2011SW026) and ZR2016CB32. Authors WW, GQ, QX, and ZS received support in the form of salaries from the Animal Science & Veterinary Medicine Academy. Authors BL received support in the form of salaries from Shandong Lvdu Bio-Sciences &Technology Co. Ltd. Authors WW and ZS have a part-time job in the Shandong Lvdu Bio-Sciences &Technology Co. Ltd beside their main job in Animal Science & Veterinary Medicine Academy. The specific roles of each authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Shandong research awards for outstanding Young and Middle-aged Scientist (BS2011SW026) and ZR2016CB32 of People's Republic of China. We thank Dr. Suresh Tikoo for the gift of the pCDNA-HA that we used in this study. We are grateful my colleague Dr. Li Shuguang, Miao Lizhong, and Zhang Songlin for excellent technical assistance.	Ahamed T., 2004, International Journal of Poultry Science, V3, P153; Aldarmahi Ahmed, 2017, J Microsc Ultrastruct, V5, P105, DOI 10.1016/j.jmau.2016.07.004; ALEXANDER DJ, 2012, THE VETERINARY RECOR; BEUG H, 1977, EXP CELL RES, V107, P417, DOI 10.1016/0014-4827(77)90363-9; BLOOM SE, 1969, J HERED, V60, P35, DOI 10.1093/oxfordjournals.jhered.a107925; CRISSMAN HA, 2010, CYTOMETRY, V1002, P84; DORMITZER PR, 1959, HUMAN VACCINES IMMUN; FU Y, 2012, JOURNAL OF VIROLOGIC, V5, P4; FUCHS E, 1988, TRENDS GENET, V4, P277, DOI 10.1016/0168-9525(88)90169-2; GEY GO, 1974, EXP CELL RES, V84, P63, DOI 10.1016/0014-4827(74)90380-2; HARDY CT, 1995, VIROLOGY, V1405, P5225; HU H, 1936, PLOS ONE; JAT PS, 1981, CELL; JELKMANN W, 1988, CELL TISSUE RES, V252, P429; KAMBARA H, 2011, JOURNAL OF VIROLOGY; Kong BW, 2007, VIRUS RES, V127, P106, DOI 10.1016/j.virusres.2007.03.028; Li Q, 2017, ANIM CELLS SYST, V21, P233, DOI 10.1080/19768354.2017.1354915; Mehrabanpour M. J., 2007, Archives of Razi Institute, V62, P7; MELIXETIAN MB, 1989, HYBRIDOMA; Meszaros I, 2014, AVIAN PATHOL, V43, P379, DOI 10.1080/03079457.2014.939941; QUARONI A, 1931, THE JOURNAL OF BIOLO; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1995, VACCINE, V13, P1583, DOI 10.1016/0264-410X(95)00085-F; Rzeski W, 2003, AN APPLICATION OF TH, P261; SAID A, 2008, VIROLOGY JOURNAL; SCHNEIDE.H, 1965, EXP CELL RES, V39, P631, DOI 10.1016/0014-4827(65)90066-2; SKINNER BM, 1957, BMC GENOMICS; SVOBODA KK, 2010, DEV DYNAM, V1002, P1637; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110916; WANG W, 2015, VIRUS RESEARCH, V12, P21; WONG SS, 2012, CMR; YAMANO S, 2002, MOLECULAR BIOTECHNOL; ZIPPEL R, 2012, CYTOMETRY	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193876	10.1371/journal.pone.0193876	http://dx.doi.org/10.1371/journal.pone.0193876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494688	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200098
J	Zou, ML; Zhou, GF; Angessa, TT; Zhang, XQ; Li, CD				Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao			Polymorphism of floral type gene Cly1 and its association with thermal stress in barley	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SELF-POLLINATION; CLEISTOGAMY; ALLELE; QTL; IDENTIFICATION; AMPLIFICATION; INHERITANCE; EXPRESSION; PATTERNS	Cleistogamy refers to a type of sexual breeding system with closed flowers. Cleistogamous flowers shed their pollen before flower opening, which leads to autogamy. Two SNPs in the open reading frame region of the Cly1 gene are associated with floral type. In the present study, we investigated the floral type of 436 barley accessions. Molecular markers were developed to genotype these barley accessions based on the two SNPs in the Cly1 gene region. The molecular markers explained floral type in 90% of the accessions. The Cly1 gene was sequenced in accessions with inconsistent genotype and phenotype. Thirteen SNPs were detected with ten new SNPs in the gene region. We further investigated whether floral type was associated with temperature stress tolerance in four field trials. One site experienced frost stress with a minimum temperature of -3.4 degrees C during flowering. Grain fertility rates as low as 85% were observed at this site but ranged from 92-96% at the other three sites. The relationship between grain fertility rate and floral type under temperature stress was inconclusive. Some lines with higher grain fertility rates were identified under frost stress, and would be useful for frost stress studies in barley.	[Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA, Australia; [Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA, Australia	Murdoch University; Murdoch University	Li, CD (corresponding author), Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA, Australia.	C.li@murdoch.edu.au	Angessa, Tefera/GLU-7090-2022	Angessa, Tefera Tolera/0000-0002-2400-1732	Australian Grains Research and Development Corporation [UMU00049]	Australian Grains Research and Development Corporation(Grains R&D Corp)	CL reveived the funding (UMU00049) from Australian Grains Research and Development Corporation (https://grdc.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Abiko M, 2005, SEX PLANT REPROD, V18, P91, DOI 10.1007/s00497-005-0004-2; Ball MP, 2009, NAT BIOTECHNOL, V27, P485, DOI 10.1038/nbt0509-485b; BILLADEAU D, 1991, BLOOD, V78, P3021; Calderini DF, 2001, EUPHYTICA, V119, P199, DOI 10.1023/A:1017597923568; Chen A, 2009, THEOR APPL GENET, V118, P1465, DOI 10.1007/s00122-009-0995-4; Cheplick Gregory P., 2007, Aliso, V23, P286; CHHABRA AK, 1991, EUPHYTICA, V55, P147, DOI 10.1007/BF00025227; Culley TM, 2007, BOT REV, V73, P1, DOI 10.1663/0006-8101(2007)73[1:TCBSAR]2.0.CO;2; Culley TM, 2002, INT J PLANT SCI, V163, P113, DOI 10.1086/324180; Dahleen LS, 2012, PLANT BREEDING, V131, P237, DOI 10.1111/j.1439-0523.2012.01952.x; Daniell H, 2002, NAT BIOTECHNOL, V20, P843, DOI 10.1038/nbt0802-843c; Fujii M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1726; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Honda I, 2005, PHYSIOL PLANTARUM, V124, P524, DOI 10.1111/j.1399-3054.2005.00541.x; Hori K, 2006, BREEDING SCI, V56, P25, DOI 10.1270/jsbbs.56.25; HOWARD PL, 1991, TRANSFUSION, V31, P441, DOI 10.1046/j.1537-2995.1991.31591263200.x; JOHANSEN B, 1994, SEX PLANT REPROD, V7, P259, DOI 10.1007/BF00227707; Karsai I, 2013, ANN APPL BIOL, V162, P309, DOI 10.1111/aab.12023; Koike S, 2015, PLANT PROD SCI, V18, P111, DOI 10.1626/pps.18.111; Liu XQ, 2008, J MULTIVARIATE ANAL, V99, P1503, DOI 10.1016/j.jmva.2008.01.004; LO ESF, 1991, HEPATOLOGY, V14, pA66; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Ma San-mei, 2004, Yichuan, V26, P556; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matsui T, 2003, ANN BOT-LONDON, V91, P473, DOI 10.1093/aob/mcg045; MERWINE NC, 1981, CROP SCI, V21, P953, DOI 10.2135/cropsci1981.0011183X002100060036x; Morinaga S, 2008, J ECOL, V96, P1086, DOI 10.1111/j.1365-2745.2008.01392.x; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Peter CI, 2006, ANN BOT-LONDON, V97, P345, DOI 10.1093/aob/mcj041; PINDER SJ, 1990, BIOCHEM SOC T, V18, P675, DOI 10.1042/bst0180675; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; SILVERMAN LM, 1991, AM J HUM GENET, V49, P204; SUZUKI Y, 1991, ANAL BIOCHEM, V192, P82, DOI 10.1016/0003-2697(91)90188-Y; Takahashi R, 2001, J HERED, V92, P89, DOI 10.1093/jhered/92.1.89; Turuspekov Y, 2004, THEOR APPL GENET, V109, P480, DOI 10.1007/s00122-004-1673-1; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Wang N, 2015, GENETICS, V199, P95, DOI 10.1534/genetics.114.171652; Wang N, 2013, THEOR APPL GENET, V126, P2753, DOI 10.1007/s00122-013-2169-7; Yoshida H, 2007, PLANT BIOTECHNOL J, V5, P835, DOI 10.1111/j.1467-7652.2007.00291.x	41	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193390	10.1371/journal.pone.0193390	http://dx.doi.org/10.1371/journal.pone.0193390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494631	Green Published, gold			2022-12-26	WOS:000426363200042
J	Shiroishi, M; Ito, Y; Shimokawa, K; Lee, JM; Kusakabe, T; Ueda, T				Shiroishi, Mitsunori; Ito, Yuji; Shimokawa, Kenta; Lee, Jae Man; Kusakabe, Takahiro; Ueda, Tadashi			Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; complex; crystal structure; IgG; structural biology	B-CELLS; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCES; MOLECULAR ANALYSIS; GENE SEGMENTS; FC REVEALS; ARTHRITIS; HEAVY; NEUTRALIZATION; LYMPHOMAS	Rheumatoid factors (RFs) are autoantibodies against the fragment-crystallizable (Fc) region of IgG. In individuals with hematological diseases such as cryoglobulinemia and certain B cell lymphoma forms, the RFs derived from specific heavy- and light-chain germline pairs, so-called stereotypic RFs, are frequently produced in copious amounts and form immune complexes with IgG in serum. Of note, many structural details of the antigen recognition mechanisms in RFs are unclear. Here we report the crystal structure of the RF YES8c derived from the IGHV1-69/IGKV3-20 germline pair, the most common of the stereotypic RFs, in complex with human IgG1-Fc at 2.8 resolution. We observed that YES8c binds to the CH2-CH3 elbow in the canonical antigen-binding manner involving a large antigen-antibody interface. On the basis of this observation, combined with mutational analyses, we propose a recognition mechanism common to IGHV1-69/IGKV3-20 RFs: (1) the interaction of the Leu(432)-His(435) region of Fc enables the highly variable complementarity-determining region (CDR)-H3 to participate in the binding, (2) the hydrophobic tip in the CDR-H2 typical of IGHV1-69 antibodies recognizes the hydrophobic patch on Fc, and (3) the interaction of the highly conserved RF light chain with Fc is important for RF activity. These features may determine the putative epitope common to the IGHV1-69/IGKV3-20 RFs. We also showed that some mutations in the binding site of RF increase the affinity to Fc, which may aggravate hematological diseases. Our findings unravel the structural basis for germline-encoded antibody autoreactivity.	[Shiroishi, Mitsunori; Ito, Yuji; Shimokawa, Kenta; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Fukuoka 8128582, Japan; [Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Insect Genome Sci, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Shiroishi, M; Ueda, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	shiroish@phar.kyushu-u.ac.jp; ueda@phar.kyushu-u.ac.jp		Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Society for the Promotion of Science (JSPS) KAKENHI [23655160, 15K15184]; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grants 23655160 and 15K15184 (to T.U.) and the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; ARTANDI SE, 1991, J IMMUNOL, V146, P603; ARTANDI SE, 1992, P NATL ACAD SCI USA, V89, P94, DOI 10.1073/pnas.89.1.94; Bende RJ, 2015, ARTHRITIS RHEUMATOL, V67, P1074, DOI 10.1002/art.39002; Bende RJ, 2005, J EXP MED, V201, P1229, DOI 10.1084/jem.20050068; BONAGURA VR, 1993, J IMMUNOL, V151, P3840; BORRETZEN M, 1995, J IMMUNOL, V155, P3630; Carayannopoulos MO, 2000, SCAND J IMMUNOL, V51, P327; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Charles ED, 2013, ARTHRITIS RHEUM-US, V65, P2430, DOI 10.1002/art.38041; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; De Re V, 2002, EUR J IMMUNOL, V32, P903, DOI 10.1002/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Duquerroy S, 2007, J MOL BIOL, V368, P1321, DOI 10.1016/j.jmb.2007.02.085; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERMEL RW, 1993, ARTHRITIS RHEUM-US, V36, P380, DOI 10.1002/art.1780360314; EZAKI I, 1991, ARTHRITIS RHEUM, V34, P343, DOI 10.1002/art.1780340312; Fujii T, 2007, J BIOCHEM, V141, P699, DOI 10.1093/jb/mvm075; Ivanovski M, 1998, BLOOD, V91, P2433, DOI 10.1182/blood.V91.7.2433.2433_2433_2442; Jones JD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4152; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; MANTOVANI L, 1993, J IMMUNOL, V151, P473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; PASCUAL V, 1992, SCAND J IMMUNOL, V36, P349, DOI 10.1111/j.1365-3083.1992.tb03108.x; PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; RANDEN I, 1992, J IMMUNOL, V148, P3296; RANDEN I, 1992, IMMUNOL REV, V128, P49, DOI 10.1111/j.1600-065X.1992.tb00832.x; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; SASSO EH, 1988, J IMMUNOL, V140, P3098; Sene D, 2009, ARTHRITIS RHEUM-US, V60, P3848, DOI 10.1002/art.25000; SILVERMAN GJ, 1988, J CLIN INVEST, V82, P469, DOI 10.1172/JCI113620; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; THOMPSON KM, 1994, EUR J IMMUNOL, V24, P1771, DOI 10.1002/eji.1830240808; VICTOR KD, 1991, J CLIN INVEST, V87, P1603, DOI 10.1172/JCI115174; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeung YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13376; Ying TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9223; YOUNGBLOOD K, 1994, J CLIN INVEST, V93, P852, DOI 10.1172/JCI117040	48	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7008	7016		10.1074/jbc.M117.814475	http://dx.doi.org/10.1074/jbc.M117.814475			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29523691	hybrid, Green Published			2022-12-26	WOS:000431487300031
J	Liu, Q; Gheorghiu, L; Drumm, M; Clayman, R; Eidelman, A; Wszolek, MF; Olumi, A; Feldman, A; Wang, M; Marcar, L; Citrin, DE; Wu, CL; Benes, CH; Efstathiou, JA; Willers, H				Liu, Qi; Gheorghiu, Liliana; Drumm, Michael; Clayman, Rebecca; Eidelman, Alec; Wszolek, Matthew F.; Olumi, Aria; Feldman, Adam; Wang, Meng; Marcar, Lynnette; Citrin, Deborah E.; Wu, Chin-Lee; Benes, Cyril H.; Efstathiou, Jason A.; Willers, Henning			PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53	ONCOGENE			English	Article							HOMOLOGOUS RECOMBINATION REPAIR; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; SYNTHETIC LETHALITY; BLADDER-CANCER; TUMOR-CELLS; NSCLC CELLS; IN-VIVO; PLATFORM	Biomarkers and mechanisms of poly (ADP-ribose) polymerase (PARP) inhibitor-mediated cytotoxicity in tumor cells lacking a BRCA-mutant or BRCA-like phenotype are poorly defined. We sought to explore the utility of PARP-1 inhibitor (PARPi) treatment with/without ionizing radiation in muscle-invasive bladder cancer (MIBC), which has poor therapeutic outcomes. We assessed the DNA damaging and cytotoxic effects of the PARPi olaparib in nine bladder cancer cell lines. Olaparib radiosensitized all cell lines with dose enhancement factors from 1.22 to 2.27. Radiosensitization was correlated with the induction of potentially lethal DNA double-strand breaks (DSB) but not with RAD51 foci formation. The ability of olaparib to radiosensitize MIBC cells was linked to the extent of cell kill achieved with the drug alone. Unexpectedly, increased levels of reactive oxygen species (ROS) resulting from PARPi treatment were the cause of DSB throughout the cell cycle in vitro and in vivo. ROS originated from mitochondria and were required for the radiosensitizing effects of olaparib. Consistent with the role of TP53 in ROS regulation, loss of p53 function enhanced radiosensitization by olaparib in non-isogenic and isogenic cell line models and was associated with increased PARP-1 expression in bladder cancer cell lines and tumors. Impairment of ATM in addition to p53 loss resulted in an even more pronounced radiosensitization. In conclusion, ROS suppression by PARP-1 in MIBC is a potential therapeutic target either for PARPi combined with radiation or drug alone treatment. The TP53 and ATM genes, commonly mutated in MIBC and other cancers, are candidate biomarkers of PARPi-mediated radiosensitization.	[Liu, Qi; Gheorghiu, Liliana; Drumm, Michael; Clayman, Rebecca; Eidelman, Alec; Wang, Meng; Marcar, Lynnette; Efstathiou, Jason A.; Willers, Henning] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Liu, Qi] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Wszolek, Matthew F.; Olumi, Aria; Feldman, Adam] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA USA; [Citrin, Deborah E.] NIH, Radiat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Wu, Chin-Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Benes, Cyril H.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Willers, H (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA.	hwillers@partners.org	Liu, Qi/AAE-7874-2020	Liu, Qi/0000-0002-3285-7864; Citrin, Deborah/0000-0002-4391-2734	Massachusetts General Hospital [C06 CA059267]; Proton Therapy Research and Treatment Center; UK Wellcome Trust [102696]; NATIONAL CANCER INSTITUTE [C06CA059267, ZIABC010850, ZIABC011552] Funding Source: NIH RePORTER	Massachusetts General Hospital(General Electric); Proton Therapy Research and Treatment Center; UK Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Federal Share of program income earned by Massachusetts General Hospital on C06 CA059267, Proton Therapy Research and Treatment Center (J. A. Efstathiou, H. Willers), UK Wellcome Trust 102696 (C.H. Benes).	Ameziane-El-Hassani R, 2013, BIO-PROTOCOL, V3, pe313, DOI [10.21769/bioprotoc.313, DOI 10.21769/BIOPROTOC.313]; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Birkelbach M, 2013, J THORAC ONCOL, V8, P279, DOI 10.1097/JTO.0b013e31827ecf83; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Bridges KA, 2014, ONCOTARGET, V5, P5076, DOI 10.18632/oncotarget.2083; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chalmers AJ, 2010, SEMIN RADIAT ONCOL, V20, P274, DOI 10.1016/j.semradonc.2010.06.001; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Coleman CN, 2016, CLIN CANCER RES, V22, P3138, DOI 10.1158/1078-0432.CCR-16-0069; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Dulaney C, 2017, SEMIN CELL DEV BIOL, V63, P144, DOI 10.1016/j.semcdb.2017.01.007; Engert F, 2015, MOL CANCER THER, V14, P2818, DOI 10.1158/1535-7163.MCT-15-0587; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Gani C, 2015, RADIOTHER ONCOL, V116, P486, DOI 10.1016/j.radonc.2015.08.003; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hempel N, 2009, FREE RADICAL BIO MED, V46, P42, DOI 10.1016/j.freeradbiomed.2008.09.020; Ireno IC, 2014, CARCINOGENESIS, V35, P2273, DOI 10.1093/carcin/bgu160; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Kamsler A, 2001, CANCER RES, V61, P1849; Kotter A, 2014, MOL ONCOL, V8, P1616, DOI 10.1016/j.molonc.2014.06.008; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; Lee HJ, 2013, MOL CANCER THER, V12, P2591, DOI 10.1158/1535-7163.MCT-13-0338; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Liu Q, 2015, MOL CANCER RES, V13, P713, DOI 10.1158/1541-7786.MCR-14-0570; Liu Q, 2015, INT J RADIAT ONCOL, V91, P1081, DOI 10.1016/j.ijrobp.2014.12.046; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martin-Cordero C, 2012, CURR DRUG TARGETS, V13, P1006, DOI 10.2174/138945012802009044; Michels J, 2014, ONCOGENE, V33, P3894, DOI 10.1038/onc.2013.352; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Paxinou E, 2001, P NATL ACAD SCI USA, V98, P11575, DOI 10.1073/pnas.201293198; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Senra JM, 2011, MOL CANCER THER, V10, P1949, DOI 10.1158/1535-7163.MCT-11-0278; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; Verhagen CVM, 2015, RADIOTHER ONCOL, V116, P358, DOI 10.1016/j.radonc.2015.03.028; Wang M, 2014, CANCER RES, V74, P2825, DOI 10.1158/0008-5472.CAN-13-3157; Wang M, 2011, CANCER RES, V71, P6261, DOI 10.1158/0008-5472.CAN-11-0213; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wurster S, 2016, ONCOTARGET, V7, P9732, DOI 10.18632/oncotarget.6947	53	33	33	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2793	2805		10.1038/s41388-018-0130-6	http://dx.doi.org/10.1038/s41388-018-0130-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511347	Green Accepted			2022-12-26	WOS:000432929800003
J	Rasheed, M; Battu, A; Kaur, R				Rasheed, Mubashshir; Battu, Anamika; Kaur, Rupinder			Aspartyl proteases in Candida glabrata are required for suppression of the host innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; chemotaxis; interleukin 1 (IL-1); macrophage; spleen tyrosine kinase (Syk); Yapsins; cell wall remodeling; mouse organ colonization; IL-1beta; Syk; THP-1 macrophages; intracellular survival	NLRP3 INFLAMMASOME; CELL-WALL; BETA-GLUCAN; GENE LISTS; ALBICANS; DEFENSE; RECOGNITION; EXPRESSION; DECTIN-1; ADHESIN	A family of 11 cell surface-associated aspartyl proteases (CgYps1-11), also referred as yapsins, is a key virulence factor in the pathogenic yeast Candida glabrata. However, the mechanism by which CgYapsins modulate immune response and facilitate survival in the mammalian host remains to be identified. Here, using RNA-Seq analysis, we report that genes involved in cell wall metabolism are differentially regulated in the Cgyps1-11 mutant. Consistently, the mutant contained lower -glucan and mannan levels and exhibited increased chitin content in the cell wall. As cell wall components are known to regulate the innate immune response, we next determined the macrophage transcriptional response to C. glabrata infection and observed differential expression of genes implicated in inflammation, chemotaxis, ion transport, and the tumor necrosis factor signaling cascade. Importantly, the Cgyps1-11 mutant evoked a different immune response, resulting in an enhanced release of the pro-inflammatory cytokine IL-1 in THP-1 macrophages. Further, Cgyps1-11-induced IL-1 production adversely affected intracellular proliferation of co-infected WT cells and depended on activation of spleen tyrosine kinase (Syk) signaling in the host cells. Accordingly, the Syk inhibitor R406 augmented intracellular survival of the Cgyps1-11 mutant. Finally, we demonstrate that C. glabrata infection triggers elevated IL-1 production in mouse organs and that the CgYPS genes are required for organ colonization and dissemination in the murine model of systemic infection. Altogether, our results uncover the basis for macrophage-mediated killing of Cgyps1-11 cells and provide the first evidence that aspartyl proteases in C. glabrata are required for suppression of IL-1 production in macrophages.	[Rasheed, Mubashshir; Battu, Anamika; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, Andhra Pradesh, India; [Rasheed, Mubashshir; Battu, Anamika] Manipal Acad Higher Educ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, Andhra Pradesh, India.	rkaur@cdfd.org.in		Kaur, Rupinder/0000-0003-3287-1700; Rasheed, Mubashshir/0000-0002-1597-6976	Wellcome Trust/DBT India Alliance Senior Fellowship [IA/S/15/1/501831]; Council of Scientific and Industrial Research, India; Department of Biotechnology, Government of India	Wellcome Trust/DBT India Alliance Senior Fellowship(Wellcome Trust DBT India Alliance); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Wellcome Trust/DBT India Alliance Senior Fellowship IA/S/15/1/501831 (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Junior and Senior Fellowship sponsored by the Council of Scientific and Industrial Research, India.; Recipient of a Junior Fellowship sponsored by the Department of Biotechnology, Government of India.	Amsen Derk, 2009, V511, P107, DOI 10.1007/978-1-59745-447-6_5; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Barker KS, 2005, J INFECT DIS, V192, P901, DOI 10.1086/432487; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SM, 2017, VIRULENCE, V8, P1643, DOI 10.1080/21505594.2017.1346756; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Duggan S, 2015, CELL MICROBIOL, V17, P1259, DOI 10.1111/cmi.12443; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; Gagnon-Arsenault I, 2006, FEMS YEAST RES, V6, P966, DOI 10.1111/j.1567-1364.2006.00129.x; Garlanda C., 2008, GROWTH, V23, P1; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Kan VL, 1996, ANTIMICROB AGENTS CH, V40, P1717, DOI 10.1128/AAC.40.7.1717; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kasper L, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov042; Kasper L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096015; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kim HS, 2005, INFECT IMMUN, V73, P3714, DOI 10.1128/IAI.73.6.3714-3724.2005; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Montagna MT, 2014, EUR REV MED PHARMACO, V18, P661; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pietrella D, 2013, EUR J IMMUNOL, V43, P679, DOI 10.1002/eji.201242691; Priebe S, 2015, BIOINFORMATICS, V31, P445, DOI 10.1093/bioinformatics/btu627; Quintin J, 2013, J IMMUNOL, V190, P2818, DOI 10.4049/jimmunol.1201861; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Seider K, 2014, EUKARYOT CELL, V13, P170, DOI 10.1128/EC.00262-13; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zordan RE, 2013, G3-GENES GENOM GENET, V3, P1675, DOI 10.1534/g3.113.006908	56	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6410	6433		10.1074/jbc.M117.813741	http://dx.doi.org/10.1074/jbc.M117.813741			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29491142	Green Published, hybrid			2022-12-26	WOS:000431108600016
J	Sen, M; Koksal, AC; Yuki, K; Wang, JC; Springer, TA				Sen, Mehmet; Koksal, Adem C.; Yuki, Koichi; Wang, Jianchuan; Springer, Timothy A.			Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-I DOMAIN; INTERCELLULAR-ADHESION MOLECULE-1; RAY SOLUTION SCATTERING; ELECTRON-MICROSCOPY; INTERNAL LIGAND; CELL-SURFACE; ACTIVATION; ICAM-1; ALPHA(X)BETA(2); RECOGNITION	In alpha I integrins, including leukocyte function-associated antigen 1 (LFA-1), ligand-binding function is delegated to the alpha I domain, requiring extra steps in the relay of signals that activate ligand binding and coordinate it with cytoplasmic signals. Crystal structures reveal great variation in orientation between the alpha I domain and the remainder of the integrin head. Here, we investigated the mechanisms involved in signal relay to the alpha I domain, including whether binding of the ligand intercellular adhesion molecule-1 (ICAM-1) to the alpha I domain is linked to headpiece opening and engenders a preferred alpha I domain orientation. Using small-angle X-ray scattering and negative-stain EM, we define structures of ICAM-1, LFA-1, and their complex, and the effect of activation by Mn2+. Headpiece opening was substantially stabilized by substitution of Mg2+ with Mn2+ and became complete upon ICAM-1 addition. These agents stabilized alpha I-headpiece orientation, resulting in a well-defined orientation of ICAM-1 such that its tandem Ig-like domains pointed in the opposite direction from the beta-subunit leg of LFA-1. Mutations in the integrin alpha I domain alpha 1/alpha 1' helix stabilizing either the open or the closed alpha I-domain conformation indicated that alpha 1/alpha 1' helix movements are linked to ICAM-1 binding by the alpha I domain and to the extended-open conformation of the ectodomain. The LFA-1-ICAM-1 orientation described here with ICAM-1 pointing anti-parallel to the LFA-1 beta-subunit leg is the same orientation that would be stabilized by tensile force transmitted between the ligand and the actin cytoskeleton and is consistent with the cytoskeletal force model of integrin activation.	[Sen, Mehmet; Koksal, Adem C.; Wang, Jianchuan; Springer, Timothy A.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Mol Pharmacol, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Sen, Mehmet] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Houston System; University of Houston	Sen, M; Springer, TA (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Mol Pharmacol, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Sen, M (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	msen2@central.uh.edu; Springer_lab@crystal.harvard.edu		Koksal, Adem/0000-0002-3163-7421	National Institutes of Health NCI Grant [CA031798]; GlaxoSmithKline fellowship; National Institutes of Health [NIGMS R01GM118277]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277] Funding Source: NIH RePORTER	National Institutes of Health NCI Grant; GlaxoSmithKline fellowship(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NCI Grant CA031798 (to T.A.S.), by a GlaxoSmithKline fellowship (to M. S.), and by National Institutes of Health Grant NIGMS R01GM118277 (to K. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057951; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BILSLAND CAG, 1994, J IMMUNOL, V152, P4582; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KIRCHHAUSEN T, 1993, J LEUKOCYTE BIOL, V53, P342, DOI 10.1002/jlb.53.3.342; Li J, 2017, P NATL ACAD SCI USA, V114, P4685, DOI 10.1073/pnas.1704171114; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nordenfelt P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01848-y; Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Recacha R, 2014, ACTA CRYSTALLOGR D, V70, P1934, DOI 10.1107/S1399004714009468; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Springer TA, 2016, P NATL ACAD SCI USA, V113, P2940, DOI 10.1073/pnas.1601379113; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Weitz-Schmidt G, 2011, J BIOL CHEM, V286, P42115, DOI 10.1074/jbc.M111.282830; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xu ST, 2017, P NATL ACAD SCI USA, V114, P3403, DOI 10.1073/pnas.1620881114; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	49	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6565	6577		10.1074/jbc.RA117.000710	http://dx.doi.org/10.1074/jbc.RA117.000710			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29507098	Green Published, hybrid			2022-12-26	WOS:000431108600027
J	Tian, N; Han, LM; Chen, C; Wang, ZZ				Tian, Na; Han, Limin; Chen, Chen; Wang, Zhezhi			The complete chloroplast genome sequence of Epipremnum aureum and its comparative analysis among eight Araceae species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; OPEN READING FRAMES; SOMATIC EMBRYOGENESIS; GENE ORGANIZATION; DNA; EVOLUTION; PLANTS; PHYLOGENOMICS; FAMILY; POTHOS	Epipremnum aureum is an important foliage plant in the Araceae family. In this study, we have sequenced the complete chloroplast genome of E. aureum by using Illumina Hiseq sequencing platforms. This genome is a double-stranded circular DNA sequence of 164,831 bp that contains 35.8% GC. The two inverted repeats (IRa and IRb; 26,606 bp) are spaced by a small single-copy region (22,868 bp) and a large single-copy region (88,751 bp). The chloroplast genome has 131 (113 unique) functional genes, including 86 (79 unique) protein-coding genes, 37 (30 unique) tRNA genes, and eight (four unique) rRNA genes. Tandem repeats comprise the majority of the 43 long repetitive sequences. In addition, 111 simple sequence repeats are present, with mononucleotides being the most common type and di- and tetranucleotides being infrequent events. Positive selection pressure on rps12 in the E. aureum chloroplast has been demonstrated via synonymous and nonsynonymous substitution rates and selection pressure sites analyses. Ycf15 and infA are pseudogenes in this species. We constructed a Maximum Likelihood phylogenetic tree based on the complete chloroplast genomes of 38 species from 13 families. Those results strongly indicated that E. aureum is positioned as the sister of Colocasia esculenta within the Araceae family. This work may provide information for further study of the molecular phylogenetic relationships within Araceae, as well as molecular markers and breeding novel varieties by chloroplast genetic-transformation of E. aureum in particular.	[Tian, Na; Han, Limin; Chen, Chen; Wang, Zhezhi] Shaanxi Normal Univ, Coll Life Sci,Key Lab, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Dev Endangered Crude Drugs, Xian, Shaanxi, Peoples R China; [Han, Limin] Shaanxi Xueqian Normal Univ, Dept Biosci & Biotechnol, Xian, Shaanxi, Peoples R China; [Chen, Chen] Xian Bot Garden Shaanxi Prov, Inst Bot Shaanxi Prov, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Shaanxi Xueqian Normal University	Wang, ZZ (corresponding author), Shaanxi Normal Univ, Coll Life Sci,Key Lab, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Dev Endangered Crude Drugs, Xian, Shaanxi, Peoples R China.	zzwang@snnu.edu.cn	tian, na/GVR-9226-2022	Wang, Zhezhi/0000-0002-6111-1551	National Natural Science Fund of China [31670299]; Fundamental Research Funds for the Central Universities [GK201302044]; Scientific and Technological Research and Development Project of Shaanxi Province, China [2012K19-02-04]; Major Project of Shaanxi Province, China [2017ZDXM-SF-005]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific and Technological Research and Development Project of Shaanxi Province, China; Major Project of Shaanxi Province, China	This work was supported by: The National Natural Science Fund of China (31670299) (ZW) (http//www.nsfc.gov.cn/); Fundamental Research Funds for the Central Universities (GK201302044) (NT) (http//www.snnu.edu.cn/); and Scientific and Technological Research and Development Project of Shaanxi Province, China (2012K19-02-04) (LH); Major Project of Shaanxi Province, China (2017ZDXM-SF-005) (http://www.sninfo.gov.cn/).	Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; BEDBROOK JR, 1976, P NATL ACAD SCI USA, V73, P4309, DOI 10.1073/pnas.73.12.4309; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bolter B, 2017, MOL PLANT, V10, P219, DOI 10.1016/j.molp.2016.10.012; Boudreau E, 1997, MOL GEN GENET, V253, P649, DOI 10.1007/s004380050368; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; de Vries J, 2015, PLANT CELL, V27, P1827, DOI 10.1105/tpc.114.135541; Ding P, 2015, MITOCHONDR DNA, V2015, P1, DOI DOI 10.HTTPS://D0I.0RG/1; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Fay MF., 2011, BOT J LINN SOC, V166, P444; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; George B, 2015, CURR GENET, V61, P665, DOI 10.1007/s00294-015-0495-9; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Henriquez CL, 2014, MOL PHYLOGENET EVOL, V75, P91, DOI 10.1016/j.ympev.2014.02.017; Hung CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28598; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jensen Poul Erik, 2014, F1000Prime Rep, V6, P40, DOI 10.12703/P6-40; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kim NR, 2016, MITOCHONDRIAL DNA A, V27, P4353, DOI 10.3109/19401736.2015.1089497; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Les DH, 2013, SYST ASSOC SPEC VOL, V83, P118; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo Y, 2016, GENOME BIOL EVOL, V8, P932, DOI 10.1093/gbe/evv260; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Meshram A, 2015, J CRIT REV, V2, P21; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Nakai M, 2015, PLANT CELL, V27, P1834, DOI 10.1105/tpc.15.00363; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Peter E, 2011, J PLANT PHYSIOL, V168, P1380, DOI 10.1016/j.jplph.2011.01.014; Petersen G, 2016, CLADISTICS, V32, P141, DOI 10.1111/cla.12120; Nguyen PAT, 2015, PLANTA, V242, P223, DOI 10.1007/s00425-015-2303-7; Raman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141329; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Redwan RM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0587-1; Ross TG, 2016, CLADISTICS, V32, P160, DOI 10.1111/cla.12133; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Sawada A, 2008, ATMOS ENVIRON, V42, P594, DOI 10.1016/j.atmosenv.2007.10.028; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Sherman-Broyles S, 2014, G3-GENES GENOM GENET, V4, P2023, DOI 10.1534/g3.114.012690; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Sugita M, 1997, MOL GEN GENET, V257, P23, DOI 10.1007/s004380050619; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WIMPEE CF, 1992, CURR GENET, V21, P417, DOI 10.1007/BF00351704; WOLFE KH, 1994, CURR GENET, V25, P379, DOI 10.1007/BF00351493; Wu ZH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0289-0; Yang ZH, 2000, GENETICS, V155, P431; Zhang Y, 2014, GENE, V549, P58, DOI 10.1016/j.gene.2014.07.041; Zhao JT, 2013, PLANT CELL TISS ORG, V114, P237, DOI 10.1007/s11240-013-0319-x; Zhao JT, 2012, ACTA PHYSIOL PLANT, V34, P1461, DOI 10.1007/s11738-012-0944-8	58	24	27	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0192956	10.1371/journal.pone.0192956	http://dx.doi.org/10.1371/journal.pone.0192956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529038	gold, Green Published, Green Submitted			2022-12-26	WOS:000427189300008
J	Valero-Jimenez, A; Zuniga, J; Cisneros, J; Becerril, C; Salgado, A; Checa, M; Buendia-Roldan, I; Mendoza-Milla, C; Gaxiola, M; Pardo, A; Selman, M				Valero-Jimenez, Ana; Zuniga, Joaquin; Cisneros, Jose; Becerril, Carina; Salgado, Alfonso; Checa, Marco; Buendia-Roldan, Ivette; Mendoza-Milla, Criselda; Gaxiola, Miguel; Pardo, Annie; Selman, Moises			Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-MESENCHYMAL TRANSITION; SURFACE PROTEOLYTIC-ENZYMES; GENE-EXPRESSION; MAST-CELLS; CANCER; INVASION; MATRIX; MICE; PATHOGENESIS	Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by epithelial cell activation, expansion of the fibroblast population and excessive extracellular matrix accumulation. The mechanisms are incompletely understood but evidence indicates that the deregulation of several proteases contributes to its pathogenesis. Transmembrane protease serine 4 (TMPRSS4) is a novel type II transmembrane serine protease that may promote migration and facilitate epithelial to mesenchymal transition (EMT), two critical processes in the pathogenesis of IPF. Thus, we hypothesized that over-expression of TMPRSS4 in the lung could promote the initiation and/or progression of IPF. In this study we first evaluated the expression and localization of TMPRSS4 in IPF lungs by real time PCR, western blot and immunohistochemistry. Then we examined the lung fibrotic response in wild-type and TMPRSS4 deficient mice using the bleomycin-induced lung injury model. We found that this protease is upregulated in IPF lungs, where was primarily expressed by epithelial and mast cells. Paralleling the findings in vivo, TMPRSS4 was expressed by alveolar and bronchial epithelial cells in vitro and unexpectedly, provoked an increase of E-cadherin. No expression was observed in normal human or IPF lung fibroblasts. The lung fibrotic response evaluated at 28 days after bleomycin injury was markedly attenuated in the haplodeficient and deficient TMPRSS4 mice. By morphology, a significant reduction of the fibrotic index was observed in KO and heterozygous mice which was confirmed by measurement of collagen content (hydroxyproline: WT: 164 +/- 21.1 mu g/lung versus TMPRSS4 haploinsufficient: 110.2 +/- 14.3 mu g/lung and TMPRSS4 deficient mice: 114.1 +/- 24.2 mu g/lung (p<0.01). As in IPF, TMPRSS4 was also expressed in epithelial and mast cells. These findings indicate that TMPRSS4 is upregulated in IPF lungs and that may have a profibrotic role.	[Valero-Jimenez, Ana; Zuniga, Joaquin; Cisneros, Jose; Becerril, Carina; Salgado, Alfonso; Checa, Marco; Buendia-Roldan, Ivette; Mendoza-Milla, Criselda; Gaxiola, Miguel; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ciudad De Mexico, Mexico; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico	Selman, M (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Ciudad De Mexico, Mexico.	mselmanl@yahoo.com.mx	MENDOZA-MILLA, CRISELDA/AAC-5311-2020	MENDOZA-MILLA, CRISELDA/0000-0003-0304-2313; Zuniga, Joaquin/0000-0002-7143-0281; Cisneros, Jose/0000-0002-4592-4464; Salgado, Alfonso/0000-0001-8102-3690; Buendia, Ivette/0000-0002-8230-0749	Consejo Nacional de Ciencia y Tecnologia, CONACYT [234088, 251636]; Universidad Nacional Autonoma de Mexico (UNAM); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Consejo Nacional de Ciencia y Tecnologia, CONACYT (numbers 234088 and 251636) and Universidad Nacional Autonoma de Mexico (UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183854; Andersson CK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-139; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bardou O, 2016, AM J RESP CRIT CARE, V193, P847, DOI 10.1164/rccm.201502-0299OC; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Choi SY, 2008, DRUG NEWS PERSPECT, V21, P417, DOI 10.1358/dnp.2008.21.8.1272135; Cruse G, 2016, EUR J PHARMACOL, V778, P125, DOI 10.1016/j.ejphar.2015.04.046; Herrera I, 2013, J BIOL CHEM, V288, P25964, DOI 10.1074/jbc.M113.459784; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Semi, 2014, Genomics & Informatics, V12, P12, DOI 10.5808/GI.2014.12.1.12; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lahiry P, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-126; Lee Y, 2016, ONCOTARGET, V7, P50315, DOI 10.18632/oncotarget.10382; Li T, 2011, CANCER GENE THER, V18, P617, DOI 10.1038/cgt.2011.29; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Min HJ, 2014, CELL SIGNAL, V26, P398, DOI 10.1016/j.cellsig.2013.08.002; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo A, 2003, AM J RESP CRIT CARE, V167, P925, DOI 10.1164/rccm.200209-1007OC; Pardo A, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0343-6; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Revenu C, 2009, CURR OPIN GENET DEV, V19, P338, DOI 10.1016/j.gde.2009.04.007; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Short S.P., 2017, J CLIN INVEST; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu X, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0100-y; Wygrecka M, 2013, AM J PATHOL, V182, P2094, DOI 10.1016/j.ajpath.2013.02.013; Yamaguchi M, 2017, LAB INVEST, V97, P232, DOI 10.1038/labinvest.2016.135; Zeng P, 2016, ONCOTARGET, V7, P76327, DOI 10.18632/oncotarget.10153; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0192963	10.1371/journal.pone.0192963	http://dx.doi.org/10.1371/journal.pone.0192963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529050	gold, Green Submitted, Green Published			2022-12-26	WOS:000427189300009
J	Matveev, AL; Krylov, VB; Emelyanova, LA; Solovev, AS; Khlusevich, YA; Baykovl, IK; Fontaine, T; Latge, JP; Tikunova, NV; Nifantiev, NE				Matveev, Andrey L.; Krylov, Vadim B.; Emelyanova, Ljudmila A.; Solovev, Arsenil S.; Khlusevich, Yana A.; Baykovl, Ivan K.; Fontaine, Thierry; Latge, Jean-Paul; Tikunova, Nina V.; Nifantiev, Nikolay E.			Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INTO-FURANOSIDE REARRANGEMENT; ENZYME-IMMUNOASSAY; INVASIVE ASPERGILLOSIS; CROSS-REACTIVITY; TESTING SERUM; INFECTIONS; PCR; IDENTIFICATION; PERFORMANCE	A panel of specific monoclonal antibodies (mAbs) against synthetic pentasaccharide beta-D-Galf-(1 -> 5)-[beta-D-Galf-(1 -> 5)](3)-alpha-D-Manp, structurally related to Aspergillus fumigatus galactomannan, was generated using mice immunized with synthetic pentasaccharide-BSA conjugate and by hybridoma technology. Two selected mAbs, 7B8 and 8G4, could bind with the initial pentasaccharide with affinity constants of approximately 5.3 nM and 6.4 nM, respectively, based on surface plasmon resonance-based biosensor assay. The glycoarray, built from a series of synthetic oligosaccharide derivatives representing different galactomannan fragments, demonstrated that mAb 8G4 could effectively recognize the parental pentasaccharide while mAb 7B8 recognizes its constituting trisaccharide parts. Immunofluorescence studies showed that both 788 and 8G4 could stain A. fumigatus cells in culture efficiently, but not the mutant strain lacking galactomannan. In addition, confocal microscopy demonstrated that Candida albicans, Bifidobacterium longum, Lactobacillus plantarum, and numerous gram-positive and gram-negative bacteria were not labeled by mAbs 7B8 and 8G4. The generated mAbs can be considered promising for the development of a new specific enzyme-linked assay for detection of A. fumigatus, which is highly demanded for medical and environmental controls.	[Matveev, Andrey L.; Emelyanova, Ljudmila A.; Khlusevich, Yana A.; Baykovl, Ivan K.; Tikunova, Nina V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Prosp Lavrentieva 8, Novosibirsk, Russia; [Krylov, Vadim B.; Solovev, Arsenil S.; Nifantiev, Nikolay E.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Leninsky Prospect 47, Moscow, Russia; [Emelyanova, Ljudmila A.; Tikunova, Nina V.] Novosibirsk State Univ, Pirogova Str, Novosibirsk, Russia; [Fontaine, Thierry; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, Paris, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Novosibirsk State University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tikunova, NV (corresponding author), Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Prosp Lavrentieva 8, Novosibirsk, Russia.; Nifantiev, NE (corresponding author), Russian Acad Sci, ND Zelinsky Inst Organ Chem, Leninsky Prospect 47, Moscow, Russia.; Tikunova, NV (corresponding author), Novosibirsk State Univ, Pirogova Str, Novosibirsk, Russia.	tikunova@niboch.nsc.ru; non@ioc.ac.ru	Fontaine, thierry/Q-2201-2018; Khlusevich, Yana/U-1203-2019; Emelyanova, Ljudmila/AAH-4790-2020; Fontaine, Thierry/F-8227-2011; Krylov, Vadim B./AAE-9936-2022; Emelyanova, Ljudmila/T-9384-2018; Krylov, Vadim B./AES-8666-2022; Matveev, Andrey/AAG-3888-2020; Nifantiev, Nikolay E/O-6579-2015; Tikunova, Nina/J-5701-2014	Fontaine, thierry/0000-0002-8184-789X; Krylov, Vadim B./0000-0001-9477-4610; Emelyanova, Ljudmila/0000-0002-8799-7135; Krylov, Vadim B./0000-0001-9477-4610; Nifantiev, Nikolay E/0000-0002-0727-4050; Baykov, Ivan/0000-0003-4839-5673	Russian Science Foundation [14-23-00199, 16-14-00083]; Russian Federal Agency of Scientific Organizations [0309-2017-0008]; French National Research Agency; French ANR agency; Russian Science Foundation [16-14-00083] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Federal Agency of Scientific Organizations; French National Research Agency(French National Research Agency (ANR)); French ANR agency(French National Research Agency (ANR)); Russian Science Foundation(Russian Science Foundation (RSF))	Synthesis of biotinylated oligosaccharids and of BSA-based glycoconjugate, and assaying of antibodies on glycoarray were supported by Russian Science Foundation (http://rscf.ru; grant 14-23-00199 to N.E. Nifantiev); development of mouse mAbs, SPR-study, and confocal microscopy were supported by Russian Science Foundation (http://rscf.ru; grant 16-14-00083 to N.V/Tikunova); microorganisms used in this work were provided by the Collection of Extremophile Microorganisms and Type Cultures (developed within Project 0309-2017-0008 granted by the Russian Federal Agency of Scientific Organizations; http://fano.gov.ru); study of the recognition ofc ell cultures by monoclonal antibodies was supported by The French National Research Agency (http://www.agence-nationale-recherche.fr/en/; provided support to J.-P. Latgd; there is no grant number).; Synthesis of biotinylated oligosaccharids and of BSA-based glycoconjugate, and assaying of antibodies on glycoarray were supported by Russian Science Foundation (grant 14-23-00199); development of mouse mAbs, SPR-study, and confocal microscopy were supported by Russian Science Foundation (grant 16-14-00083); microorganisms used in this work were provided by the Collection of Extremophile Microorganisms and Type Cultures (developed within Project 0309-2017-0008 granted by the Russian Federal Agency of Scientific Organizations); study of the recognition of cell cultures by monoclonal antibodies was supported by the French ANR agency.	Argunov DA, 2015, ORG BIOMOL CHEM, V13, P3255, DOI 10.1039/c4ob02634a; Argunov DA, 2016, ORG LETT, V18, P5504, DOI 10.1021/acs.orglett.6b02735; Aubry A, 2006, J CLIN MICROBIOL, V44, P389, DOI 10.1128/JCM.44.2.389-394.2006; Blijlevens N M A, 2002, Transpl Infect Dis, V4, P64, DOI 10.1034/j.1399-3062.2002.00015.x; Bonini A, 2008, DIAGN MICR INFEC DIS, V62, P450, DOI 10.1016/j.diagmicrobio.2008.08.008; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; KAPPE R, 1993, J CLIN MICROBIOL, V31, P2489, DOI 10.1128/JCM.31.9.2489-2490.1993; Karelin AA, 2017, RUSS CHEM REV+, V86, P1073, DOI 10.1070/RCR4750; Kohno S., 2008, HIGH MORTALITY INVAS; Krylov VB, 2017, PURE APPL CHEM, V89, P885, DOI 10.1515/pac-2016-1011; Krylov VB, 2016, SYNLETT, V27, P1659, DOI 10.1055/s-0035-1561595; Krylov VB, 2014, CHEM-EUR J, V20, P16516, DOI 10.1002/chem.201405083; Krylov VB, 2018, ORG BIOMOL CHEM; Kudoh A, 2015, GLYCOBIOLOGY, V25, P74, DOI 10.1093/glycob/cwu091; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Loeffler J, 2017, J CLIN MICROBIOL, V55, P101, DOI 10.1128/JCM.01682-16; Mennink-Kersten MAS, 2005, J CLIN MICROBIOL, V43, P3925, DOI 10.1128/JCM.43.8.3925-3931.2005; Mennink-Kersten MASH, 2004, LANCET, V363, P325, DOI 10.1016/S0140-6736(03)15393-7; NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084; Paulovicova E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01273; Requena T, 2002, APPL ENVIRON MICROB, V68, P2420, DOI 10.1128/AEM.68.5.2420-2427.2002; Siemann M, 1998, MYCOSES, V41, P373, DOI 10.1111/j.1439-0507.1998.tb00356.x; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Swanink CMA, 1997, J CLIN MICROBIOL, V35, P257, DOI 10.1128/JCM.35.1.257-260.1997; Tsvetkov YE, 2012, J AM CHEM SOC, V134, P426, DOI 10.1021/ja2083015; Varki A., 1999, ESSENTIALS GLYCOBIOL; Verweij PE, 2006, MED MYCOL, V44, pS179, DOI 10.1080/13693780600904918; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wheat LJ, 2008, EUR J CLIN MICROBIOL, V27, P245, DOI 10.1007/s10096-007-0437-7; Wheat LJ, 2007, CLIN VACCINE IMMUNOL, V14, P638, DOI 10.1128/CVI.00479-06; White PL, 2015, J CLIN MICROBIOL, V53, P2832, DOI 10.1128/JCM.00905-15; White PL, 2013, CLIN VACCINE IMMUNOL, V20, P636, DOI 10.1128/CVI.00730-12; Wurm FR, 2013, CHEM SOC REV, V42, P8220, DOI 10.1039/c3cs60153f; Xavier MO, 2009, CLIN VACCINE IMMUNOL, V16, P132, DOI 10.1128/CVI.00310-08	43	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193938	10.1371/journal.pone.0193938	http://dx.doi.org/10.1371/journal.pone.0193938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518144	gold, Green Published, Green Submitted			2022-12-26	WOS:000426902900051
J	Basile, L; de la Fuente, MO; Torner, N; Martinez, A; Jane, M				Basile, Luca; Oviedo de la Fuente, Manuel; Torner, Nuria; Martinez, Ana; Jane, Mireia			Real-time predictive seasonal influenza model in Catalonia, Spain	PLOS ONE			English	Article							CONTROL STRATEGIES; EPIDEMIC	Influenza surveillance is critical to monitoring the situation during epidemic seasons and predictive mathematic models may aid the early detection of epidemic patterns. The objective of this study was to design a real-time spatial predictive model of ILI (Influenza Like Illness) incidence rate in Catalonia using one- and two-week forecasts. The available data sources used to select explanatory variables to include in the model were the statutory reporting disease system and the sentinel surveillance system in Catalonia for influenza incidence rates, the official climate service in Catalonia for meteorological data, laboratory data and Google Flu Trend. Time series for every explanatory variable with data from the last 4 seasons (from 2010-2011 to 2013-2014) was created. A pilot test was conducted during the 2014-2015 season to select the explanatory variables to be included in the model and the type of model to be applied. During the 2015-2016 season a real-time model was applied weekly, obtaining the intensity level and predicted incidence rates with 95% confidence levels one and two weeks away for each health region. At the end of the season, the confidence interval success rate (CISR) and intensity level success rate (ILSR) were analysed. For the 2015-2016 season a CISR of 85.3% at one week and 87.1% at two weeks and an ILSR of 82.9% and 82% were observed, respectively. The model described is a useful tool although it is hard to evaluate due to uncertainty. The accuracy of prediction at one and two weeks was above 80% globally, but was lower during the peak epidemic period. In order to improve the predictive power, new explanatory variables should be included.	[Basile, Luca; Torner, Nuria; Martinez, Ana; Jane, Mireia] Publ Hlth Agcy Catalonia, Barcelona, Spain; [Oviedo de la Fuente, Manuel] Technol Inst Ind Math ITMATI, Campus Vida, Santiago De Compostela, Spain; [Oviedo de la Fuente, Manuel] Univ Santiago de Compostela, Dept Stat Math Anal & Optimizat, MODESTYA Grp, Santiago De Compostela, Spain; [Torner, Nuria] Univ Barcelona Barcelona, Dept Med, Barcelona, Spain; [Torner, Nuria; Martinez, Ana; Jane, Mireia] Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Torner, N (corresponding author), Publ Hlth Agcy Catalonia, Barcelona, Spain.; Torner, N (corresponding author), Univ Barcelona Barcelona, Dept Med, Barcelona, Spain.; Torner, N (corresponding author), Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	nuria.torner@gencat.cat	, Nuria/AAG-8951-2019; de la Fuente, Manuel Oviedo/AAB-8040-2019	, Nuria/0000-0003-0143-5295; de la Fuente, Manuel Oviedo/0000-0001-7360-3249; Basile, Luca/0000-0002-4707-2621	GIBER epidemiologia y Salud Publica CIBERESP; Ministerio de Economia y Competitividad [MTM2016-76969-P]	GIBER epidemiologia y Salud Publica CIBERESP; Ministerio de Economia y Competitividad(Spanish Government)	This work was partially funded by GIBER epidemiologia y Salud Publica CIBERESP and Ministerio de Economia y Competitividad (grant number MTM2016-76969-P; recipient Manuel Oviedo de la Fuente).	Agencia de Salut PUblica de Catalunya, 2016, PLA INF INF RESP AG; Agencia de Salut Publica de Catalunya, 2017, MOD PRED ACT GRIP; Agencia de Salut PUblica de Catalunya, 2017, MAL DECL OBL BROTS E; Ajelli M, 2011, EPIDEMIOL INFECT, V139, P68, DOI 10.1017/S0950268810001317; Balcan D, P NATLACAD SCI US, V106, P21484; Bento AI, 2016, CLIN INFECT DIS, V63, pS205, DOI 10.1093/cid/ciw557; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Brauer F., 2012, MATH MODELS POPULATI, V2; Chatterjee C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004726; Chen SC, 2006, INDOOR AIR, V16, P469, DOI 10.1111/j.1600-0668.2006.00443.x; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Goufo EF, 2014, FRACTIONAL SEIR EPID; Havers F, 2014, CLIN INFECT DIS, V59, P774, DOI 10.1093/cid/ciu422; Held L, BIOMJ, V54, P824; Hervas D, 2015, EUR J CLIN MICROBIOL, V34, P439, DOI 10.1007/s10096-014-2243-3; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Kariya T, 2004, GEN LEAST SQUARES; Legrand J, 2004, EPIDEMIOL INFECT, V132, P19, DOI 10.1017/S0950268803001390; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Martin R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-532; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; Meteocat, 2017, SERV MET CAT; Muller HG, 2005, ANN STAT, V33, P774, DOI 10.1214/009053604000001156; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Oviedo M, 2016, PREDICTING SEASONAL; Pica N, 2014, PEDIATR INFECT DIS J, V33, P311, DOI 10.1097/INF.0000000000000235; Pinheiro J, 2001, MIXED EFFECTS MODELS; Roberts MG, 2000, EPIDEMIOL INFECT, V124, P279, DOI 10.1017/S0950268899003556; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Team Rs, 2017, RSTUDIO INT DEV R; Torner N, 2015, HUM VACC IMMUNOTHER, V11, P225, DOI 10.4161/hv.36155; Van Der Zander B, 2009, TEXSTUDIO; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; Yang S, P NATL ACAD SCI US, V112, P14473; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583; Yu Hye-Kyung, 2013, Osong Public Health Res Perspect, V4, P358, DOI 10.1016/j.phrp.2013.10.009	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193651	10.1371/journal.pone.0193651	http://dx.doi.org/10.1371/journal.pone.0193651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513710	Green Submitted, gold, Green Published			2022-12-26	WOS:000426896800067
J	Epstein, D; Berger, G; Barda, N; Marcusohn, E; Barak-Corren, Y; Muhsen, K; Balicer, RD; Azzam, ZS				Epstein, Danny; Berger, Gidon; Barda, Noam; Marcusohn, Erez; Barak-Corren, Yuval; Muhsen, Khitam; Balicer, Ran D.; Azzam, Zaher S.			The incidence of acute pulmonary embolism following syncope in anticoagulant-naive patients: A retrospective cohort study	PLOS ONE			English	Article							POPULATION-BASED-COHORT; VENOUS THROMBOEMBOLISM; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; DIAGNOSIS; MANAGEMENT; PREDICTORS; OUTCOMES; CT	Background A recently published, large prospective study showed unexpectedly high prevalence of acute pulmonary embolism (APE) among patients hospitalized for syncope. In such a case, a high incidence of recurrent pulmonary embolism is expected among patients who were discharged without APE workup. Objectives To determine the incidence of symptomatic APE among patients hospitalized for a first episode of syncope and discharged without APE workup or anticoagulation. Methods This retrospective cohort study included patients hospitalized at Rambam Health Care Campus between January 2006 and February 2017 with a primary admission diagnosis of syncope, who were not investigated for APE and were not taking anticoagulants. The patients were followed up for up to three years after discharge. The occurrence of venous thromboembolism (VTE) during the follow-up period was documented. Results The median follow-up duration was 33 months. 1,126 subjects completed a three-year follow-up. During this period, 38 patients (3.38%) developed VTE, 17 (1.51%) of them had APE. The cumulative incidence of VTE and APE was 1.9% (95% CI 1.3%-2.5%) and 0.9% (95% CI 0.4%-1.3%) respectively. Only seven subjects developed APE during the first year of follow-up. The median times from the event of syncope to the development of APE and VTE were 18 and 19 months respectively. Conclusions The cumulative incidence of VTE during a three-year follow-up period after an episode of syncope is low. In the absence of clinical suspicion, a routine diagnostic workup for APE in patients with syncope cannot be recommended.	[Epstein, Danny; Berger, Gidon; Marcusohn, Erez; Azzam, Zaher S.] Dept Internal Med B, Rambam Hlth Care Campus, Haifa, Israel; [Berger, Gidon] Div Pulm Med, Rambam Hlth Care Campus, Haifa, Israel; [Barda, Noam; Balicer, Ran D.] Clalit Res Inst, Chief Phys Off, Clalit Hlth Serv, Tel Aviv, Israel; [Barak-Corren, Yuval] Boston Childrens Hosp, Predict Med Grp, Boston, MA USA; [Barak-Corren, Yuval] Shaare Tzedek Med Ctr, Jerusalem, Israel; [Muhsen, Khitam] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel; [Balicer, Ran D.] Ben Gurion Univ Negev, Epidemiol Dept, Beer Sheva, Israel; [Azzam, Zaher S.] Technion Inst, Rappaports Fac Med, Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Clalit Health Services; Harvard University; Boston Children's Hospital; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Technion Israel Institute of Technology	Epstein, D (corresponding author), Dept Internal Med B, Rambam Hlth Care Campus, Haifa, Israel.	danyep@gmail.com	Barda, Noam/AAC-9434-2020	Barda, Noam/0000-0002-3400-235X; Marcusohn, Erez/0000-0003-1004-0826				Altinsoy B, 2016, THER CLIN RISK MANAG, V12, P1023, DOI 10.2147/TCRM.S105722; BARRITT DW, 1960, LANCET, V1, P1309; Costantino G, 2018, JAMA INT MED; D'Ascenzo F, 2013, INT J CARDIOL, V167, P57, DOI 10.1016/j.ijcard.2011.11.083; DAGAN N, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6755; Desai SR, 2007, THORAX, V62, P470, DOI 10.1136/thx.2006.067884; Engelke C, 2006, RADIOLOGY, V239, P563, DOI 10.1148/radiol.2392050118; Gandhi R, 2012, J ARTHROPLASTY, V27, P730, DOI 10.1016/j.arth.2011.10.019; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2012, AM J HEMATOL, V87, pS63, DOI 10.1002/ajh.23128; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P255, DOI 10.1160/TH13-09-0793; O'Connell C, 2015, BLOOD, V125, P1877, DOI 10.1182/blood-2014-08-551879; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Prandoni P, 2016, NEW ENGL J MED, V375, P1524, DOI 10.1056/NEJMoa1602172; Raskob GE, 2016, THROMB HAEMOSTASIS, V115, P1; Runser LA, 2017, AM FAM PHYSICIAN, V95, P303; Ruwald MH, 2013, EUROPACE, V15, P595, DOI 10.1093/europace/eus359; Saklani P, 2013, CIRCULATION, V127, P1330, DOI 10.1161/CIRCULATIONAHA.112.138396; Shen W-K, 2017, HEAR RHYTHM, V8, P122; Solbiati M, 2015, EUROPACE, V17, P300, DOI 10.1093/europace/euu327; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Spyropoulos AC, 2009, THROMB HAEMOSTASIS, V102, P951, DOI 10.1160/TH09-02-0073; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; THAMES MD, 1977, JAMA-J AM MED ASSOC, V238, P2509, DOI 10.1001/jama.238.23.2509; Verma A, 2017, JAMA INTERN MED, V15, P595; Wiener RS, 2011, ARCH INTERN MED, V171, P1827; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193725	10.1371/journal.pone.0193725	http://dx.doi.org/10.1371/journal.pone.0193725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513729	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800072
J	Huang, J; Wei, HL; Li, LB; Yu, SX				Huang, Juan; Wei, Hengling; Li, Libei; Yu, Shuxun			Transcriptome analysis of nitric oxide-responsive genes in upland cotton (Gossypium hirsutum)	PLOS ONE			English	Article							ABIOTIC STRESS; CELL-DEATH; ARABIDOPSIS; ACID; ACCUMULATION; IDENTIFICATION; EXPRESSION; GENERATION; PATHWAYS; PATHOGEN	Nitric oxide (NO) is an important signaling molecule with diverse physiological functions in plants. It is therefore important to characterize the downstream genes and signal transduction networks modulated by NO. Here, we identified 1,932 differentially expressed genes (DEGs) responding to NO in upland cotton using high throughput tag sequencing. The results of quantitative real-time polymerase chain reaction (qRT-PCR) analysis of 25 DEGs showed good consistency. Gene Ontology (GO) and KEGG pathway were analyzed to gain a better understanding of these DEGs. We identified 157 DEGs belonging to 36 transcription factor (TF) families and 72 DEGs related to eight plant hormones, among which several TF families and hormones were involved in stress responses. Hydrogen peroxide and malondialdehyde (MDA) contents were increased, as well related genes after treatment with sodium nitroprusside (SNP) (an NO donor), suggesting a role for NO in the plant stress response. Finally, we compared of the current and previous data indicating a massive number of NO-responsive genes at the large-scale transcriptome level. This study evaluated the landscape of NO-responsive genes in cotton and identified the involvement of NO in the stress response. Some of the identified DEGs represent good candidates for further functional analysis in cotton.	[Huang, Juan] Guizhou Normal Univ, Res Ctr Buckwheat Ind Technol, Guiyang, Guizhou, Peoples R China; [Huang, Juan; Wei, Hengling; Li, Libei; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Guizhou Normal University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn		Li, Libei/0000-0003-1138-134X	National Natural Science Foundation of China [31301366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is financially supported by the National Natural Science Foundation of China (grant 31301366), http://www.nsfc.gov.cn/.r This research was financially supported by the National Natural Science Foundation of China (grant 31301366).	Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Begara-Morales JC, 2014, PLANT CELL PHYSIOL, V55, P1080, DOI 10.1093/pcp/pcu044; Besson-Bard A, 2009, PLANT PHYSIOL, V149, P1302, DOI 10.1104/pp.108.133348; Besson-Bard A, 2009, PLANT SCI, V177, P302, DOI 10.1016/j.plantsci.2009.06.006; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Ferrarini A, 2008, MOL PLANT MICROBE IN, V21, P781, DOI 10.1094/MPMI-21-6-0781; Garcia MJ, 2011, PLANT PHYSIOL BIOCH, V49, P537, DOI 10.1016/j.plaphy.2011.01.019; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu XQ, 2015, INT J MOL SCI, V16, P28582, DOI 10.3390/ijms161226117; Hussain A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00975; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu WW, 2015, BIOL PLANTARUM, V59, P115, DOI 10.1007/s10535-014-0466-x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manjunatha G, 2012, PLANT SIGNAL BEHAV, V7, P476, DOI 10.4161/psb.19523; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Ohama N, 2016, PLANT CELL, V28, P181, DOI 10.1105/tpc.15.00435; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Perezrodriguez P, 2010, NUCLEIC ACIDS RES, P38; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Polverari A, 2003, MOL PLANT MICROBE IN, V16, P1094, DOI 10.1094/MPMI.2003.16.12.1094; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Simontacchi M, 2013, PLANT CELL REP, V32, P853, DOI 10.1007/s00299-013-1434-1; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Tewari RK, 2012, PLANTA, V235, P99, DOI 10.1007/s00425-011-1495-8; Van Ree K, 2011, PLANT J, V68, P225, DOI 10.1111/j.1365-313X.2011.04680.x; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Xuan Y, 2010, PLANT PHYSIOL, V153, P1895, DOI 10.1104/pp.110.160424; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zeng F, 2014, PLOS ONE, V9; Zhang HY, 2011, PLANT CELL REP, V30, P1153, DOI 10.1007/s00299-011-1024-z; Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022	49	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192367	10.1371/journal.pone.0192367	http://dx.doi.org/10.1371/journal.pone.0192367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513679	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800013
J	Moreira, TF; Facury, EJ; Carvalho, AU; Strube, ML; Nielsen, MW; Klitgaard, K; Jensen, TK				Moreira, Tiago F.; Facury Filho, Elias J.; Carvalho, Antonio U.; Strube, Mikael L.; Nielsen, Martin W.; Klitgaard, Kirstine; Jensen, Tim K.			Pathology and bacteria related to digital dermatitis in dairy cattle in all year round grazing system in Brazil	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DICHELOBACTER-NODOSUS; GUGGENHEIMELLA-BOVIS; TREPONEMA SPP.; FOOT DISORDERS; RIBOSOMAL-RNA; LESIONS; COWS; RESERVOIRS; INFECTION	Digital dermatitis (DD) is one of the main causes of lameness in dairy cattle worldwide, and it is frequently reported in high-yielding, free stall dairy herds from regions with a temperate climate. However, DD is also observed with high prevalence in grazing cattle with a low milk yield in tropical regions. To clarify whether these differences have an impact on the etiology of the disease, we studied DD lesions from all year round grazing cattle of mixed breed in Brazil using high-throughput 16S rRNA gene sequencing and fluorescent in situ hybridization. The study included samples from 66 skin lesions and 5 healthy skins collected from five farms. Both techniques showed Treponema spp. to be the most abundant bacteria, present in all but one of the samples with minimal epidermal alterations. We identified eleven different Treponema strains belonging to the six major phylotypes of Treponema which have all previously been identified in DD lesions. Furthermore, we identify Dichelobacter nodosus in DD lesions by gene sequencing and also by fluorescent in situ hybridization in almost half of biopsy specimens in areas with mild epithelial damage and together with Treponema. The present data support the hypothesis that Treponema constitutes the main pathogen responsible for DD, independent of the environment and region where cows are kept, and it further suggests D. nodosus as another potentially important pathogen.	[Moreira, Tiago F.; Facury Filho, Elias J.; Carvalho, Antonio U.] Univ Fed Minas Gerais, Sch Vet Med, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil; [Strube, Mikael L.; Nielsen, Martin W.; Klitgaard, Kirstine; Jensen, Tim K.] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark	Universidade Federal de Minas Gerais; Technical University of Denmark	Moreira, TF (corresponding author), Univ Fed Minas Gerais, Sch Vet Med, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil.	tiagofacuryvet@gmail.com	Strube, Mikael/G-7949-2016; Moreira, Tiago/AAK-4190-2020	Strube, Mikael/0000-0003-0905-5705; Klitgaard, Kirstine/0000-0002-8379-9430; Moreira, Tiago Facury/0000-0002-0808-1955; Jensen, Tim Kare/0000-0002-8048-4695				Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; Borges J, 1992, ARQU ARQ ESC MED VET, V1992, P15; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Capion N., 2013, Open Journal of Veterinary Medicine, V3, P192, DOI 10.4236/ojvm.2013.32030; Cruz CEF, 2005, VET REC, V157, P834, DOI 10.1136/vr.157.26.834; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Evans NJ, 2016, VET J, V211, P3, DOI 10.1016/j.tvjl.2015.10.028; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2012, VET MICROBIOL, V156, P102, DOI 10.1016/j.vetmic.2011.09.029; Haskell MJ, 2006, J DAIRY SCI, V89, P4259, DOI 10.3168/jds.S0022-0302(06)72472-9; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Krull AC, 2014, INFECT IMMUN, V82, P3359, DOI 10.1128/IAI.02077-14; Marcatili P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3341-7; Moreira T. F., 2012, P 27 WORLD BUIATR C, P265; Nascimento LV, 2015, J CLIN MICROBIOL, V53, P1935, DOI 10.1128/JCM.03586-14; Nielsen MW, 2016, VET MICROBIOL, V186, P139, DOI 10.1016/j.vetmic.2016.03.003; Palmer MA, 2015, ANIMALS, V5, P512, DOI 10.3390/ani5030369; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Silveira JAS, 2009, PESQUI VET BRASIL, V29, P905, DOI 10.1590/S0100-736X2009001100007; Sullivan LE, 2015, J CLIN MICROBIOL, V53, P1628, DOI 10.1128/JCM.00180-15; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wyss C, 2005, INT J SYST EVOL MICR, V55, P667, DOI 10.1099/ijs.0.63116-0; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zinicola M, 2015, PLOS ONE, V10, P1	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193870	10.1371/journal.pone.0193870	http://dx.doi.org/10.1371/journal.pone.0193870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513739	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800084
J	Ogawa-Akiyama, A; Sugiyama, H; Kitagawa, M; Tanaka, K; Onishi, A; Yamanari, T; Morinaga, H; Uchida, HA; Nakamura, K; Ito, H; Wade, J				Ogawa-Akiyama, Ayu; Sugiyama, Hitoshi; Kitagawa, Masashi; Tanaka, Keiko; Onishi, Akifumi; Yamanari, Toshio; Morinaga, Hiroshi; Uchida, Haruhito Adam; Nakamura, Kazufumi; Ito, Hiroshi; Wade, Jun			Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease	PLOS ONE			English	Article							DOPPLER ULTRASONOGRAPHY; VASCULAR DAMAGE; CARDIOVASCULAR EVENTS; HEART-FAILURE; ATHEROSCLEROSIS; ULTRASOUND; NEPHROPATHY; MARKER; RISK; HYPERTENSION	Cystatin C is a cysteine protease inhibitor that is produced by nearly all human cells. The serum level of cystatin C is a stronger predictor of the renal outcome and the risk of cardiovascular events than the creatinine level. The resistive index (RI) on renal Doppler ultrasonography is a good indicator of vascular resistance as well as the renal outcomes in patients with chronic kidney disease (CKD). However, it is unclear whether serum cystatin C is associated with signs of vascular dysfunction, such as the renal RI. We measured the serum cystatin C levels in 101 CKD patients and investigated the relationships between cystatin C and markers of vascular dysfunction, including the renal RI, ankle-brachial pulse wave velocity (baPWV), intima-media thickness (IMT), and cardiac function. The renal RI was significantly correlated with the serum cystatin C level (p < 0.0001, r = 0.6920). The serum cystatin C level was found to be a significant determinant of the renal RI (p < 0.0001), but not the baPWV, in a multivariate regression analysis. The multivariate odds ratio of the serum cystatin C level for a renal RI of more than 0.66 was statistically significant (2.92, p = 0.0106). The area under the receiver-operating characteristic curve comparing the sensitivity and specificity of cystatin C for predicting an RI of more than 0.66 was 0.882 (cutoff value: 2.04 mg/L). In conclusion, the serum cystatin C level is an independent biomarker associated with the renal RI in patients with CKD.	[Ogawa-Akiyama, Ayu; Sugiyama, Hitoshi; Kitagawa, Masashi; Tanaka, Keiko; Onishi, Akifumi; Yamanari, Toshio; Morinaga, Hiroshi; Uchida, Haruhito Adam; Wade, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Sugiyama, Hitoshi; Onishi, Akifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan; [Uchida, Haruhito Adam] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan	Okayama University; Okayama University; Okayama University; Okayama University	Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.; Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan.	hitashis@md.okayama-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011; WADA, Jun/B-2023-2011	Sugiyama, Hitoshi/0000-0002-4127-6471; WADA, Jun/0000-0003-1468-5170				Bige N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-139; Boddi M, 2006, AM J NEPHROL, V26, P16, DOI 10.1159/000090786; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Delsart P, 2015, J ENDOVASC THER, V22, P801, DOI 10.1177/1526602815599964; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Doi Y, 2012, HYPERTENSION, V60, P770, DOI 10.1161/HYPERTENSIONAHA.112.196717; Hamano K, 2008, DIABETES CARE, V31, P1853, DOI 10.2337/dc08-0168; HANDA N, 1990, STROKE, V21, P1567, DOI 10.1161/01.STR.21.11.1567; Heine GH, 2007, NEPHROL DIAL TRANSPL, V22, P163, DOI 10.1093/ndt/gfl484; Iida N, 2016, JACC-HEART FAIL, V4, P674, DOI 10.1016/j.jchf.2016.03.016; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Izumi M, 2000, AM J KIDNEY DIS, V35, P713, DOI 10.1016/S0272-6386(00)70020-5; Kawai T, 2011, NEPHROL DIAL TRANSPL, V26, P3256, DOI 10.1093/ndt/gfr054; Kimura N, 2015, CLIN EXP NEPHROL; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kitagawa M, 2011, NEPHRON EXTRA, V1, P166, DOI 10.1159/000333801; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Menon V, 2007, ANN INTERN MED, V147, P19, DOI 10.7326/0003-4819-147-1-200707030-00004; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Nosaka Kazumasa, 2013, Congest Heart Fail, V19, pE35, DOI 10.1111/chf.12039; Odden MC, 2010, NEPHROL DIAL TRANSPL, V25, P463, DOI 10.1093/ndt/gfp474; Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01; Parolini C, 2009, RADIOLOGY, V252, P888, DOI 10.1148/radiol.2523080351; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; PLANIOL T, 1974, REV EEG NEUROPHYSIOL, V4, P221, DOI 10.1016/S0370-4475(74)80006-7; Prats M, 2010, BLOOD PRESSURE, V19, P20, DOI 10.3109/08037050903416386; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Sugiura T, 2004, CLIN NEPHROL, V61, P119; Sugiura T, 2011, CLIN EXP NEPHROL, V15, P114, DOI 10.1007/s10157-010-0371-3; Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121; Toledo C, 2015, HYPERTENSION, V66, P382, DOI 10.1161/HYPERTENSIONAHA.115.05536; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashita H, 2013, J ATHEROSCLER THROMB, V20, P548, DOI 10.5551/jat.13193; Yuksel UC, 2012, J INVASIVE CARDIOL, V24, P504; 2004, AM J KIDNEY DIS S1, V43, pS1	41	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193695	10.1371/journal.pone.0193695	http://dx.doi.org/10.1371/journal.pone.0193695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513723	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800069
J	Ghosh, S; Chisholm, SA; Dans, M; Lakkavaram, A; Kennedy, K; Ralph, SA; Counihan, NA; de Koning-Ward, TF				Ghosh, Sreejoyee; Chisholm, Scott A.; Dans, Madeline; Lakkavaram, Asha; Kennedy, Kit; Ralph, Stuart A.; Counihan, Natalie A.; de Koning-Ward, Tania F.			The cysteine protease dipeptidyl aminopeptidase 3 does not contribute to egress of Plasmodium falciparum from host red blood cells	PLOS ONE			English	Article							MALARIA PARASITE; IDENTIFICATION; LOCALIZATION; RHOPTRIES; INVASION; RUPTURE; ANTIGEN; PLAYS	The ability of Plasmodium parasites to egress from their host red blood cell is critical for the amplification of these parasites in the blood. Previous forward chemical genetic approaches have implicated the subtilisin-like protease (SUB1) and the cysteine protease dipeptidyl aminopeptidase 3 (DPAP3) as key players in egress, with the final step of SUB1 maturation thought to be due to the activity of DPAP3. In this study, we have utilized a reverse genetics approach to engineer transgenic Plasmodium falciparum parasites in which dpap3 expression can be conditionally regulated using the glmS ribozyme based RNA-degrading system. We show that DPAP3, which is expressed in schizont stages and merozoites and localizes to organelles distinct from the micronemes, rhoptries and dense granules, is not required for the trafficking of apical proteins or processing of SUB1 substrates, nor for parasite maturation and egress from red blood cells. Thus, our findings argue against a role for DPAP3 in parasite egress and indicate that the phenotypes observed with DPAP3 inhibitors are due to off-target effects.	[Ghosh, Sreejoyee; Chisholm, Scott A.; Dans, Madeline; Lakkavaram, Asha; Counihan, Natalie A.; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Kennedy, Kit; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Deakin University; University of Melbourne	de Koning-Ward, TF (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.	taniad@deakin.edu.au	Chisholm, Scott/K-2661-2019; Ghosh, Sreejoyee/AAQ-8421-2020; Ralph, Stuart/C-8590-2014; de Koning-Ward, Tania/N-3572-2017	Chisholm, Scott/0000-0002-3833-8854; Ralph, Stuart/0000-0003-0114-7808; Dans, Madeline/0000-0001-9386-0648; de Koning-Ward, Tania/0000-0001-5810-8063	Australian National Health and Medical Research Council [1082157]; National Health and Medical Research Council (NHMRC) of Australia [1082157]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	TFdeK-W was the recipient of an Australian National Health and Medical Research Council project grant 1082157 (www.nhmrc.gov.au) that funded this project. However, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ross Coppel, Robin Anders and James Beeson for antibodies used in the study and the Australian Red Cross for red blood cells and serum. This work was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (Project 1082157).	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 2013, CURR OPIN MICROBIOL, V16, P459, DOI 10.1016/j.mib.2013.04.008; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Collins CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006453; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Hale VL, 2017, P NATL ACAD SCI USA, V114, P3439, DOI 10.1073/pnas.1619441114; Howard RF, 1998, MOL BIOCHEM PARASIT, V92, P111, DOI 10.1016/S0166-6851(97)00238-7; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miller SK, 2002, J BIOL CHEM, V11; Nasamu AS, 2017, SCIENCE, V358, P518, DOI 10.1126/science.aan1478; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; Schwach F, 2015, NUCLEIC ACIDS RES, V43, pD1176, DOI 10.1093/nar/gku1143; Stallmach R, 2015, MOL MICROBIOL, V96, P368, DOI 10.1111/mmi.12941; Tanaka TQ, 2013, ANTIMICROB AGENTS CH, V57, P4645, DOI 10.1128/AAC.02495-12; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weiss GE, 2016, TRENDS PARASITOL, V32, P284, DOI 10.1016/j.pt.2015.12.007; WHO, 2016, WORLD MALARIA REPORT; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193538	10.1371/journal.pone.0193538	http://dx.doi.org/10.1371/journal.pone.0193538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509772	gold, Green Submitted, Green Published			2022-12-26	WOS:000426813200015
J	Medic, S; Katsilieris, M; Lozanov-Crvenkovic, Z; Siettos, CI; Petrovic, V; Milosevic, V; Brkic, S; Andrews, N; Ubavic, M; Anastassopoulou, C				Medic, Snezana; Katsilieris, Michalis; Lozanov-Crvenkovic, Zagorka; Siettos, Constantinos I.; Petrovic, Vladimir; Milosevic, Vesna; Brkic, Snezana; Andrews, Nick; Ubavic, Milan; Anastassopoulou, Cleo			Varicella zoster virus transmission dynamics in Vojvodina, Serbia	PLOS ONE			English	Article							SEROEPIDEMIOLOGY; INFECTION; VACCINE; MEASLES; FORCE; WOMEN	This study aimed at establishing baseline key epidemiological parameters for varicella zoster virus (VZV) infection in Vojvodina, Serbia, with the ultimate goal to quantify the VZV transmission potential in the population. Seroprevalence data generated during the first large cross-sectional VZV serosurvey were modelled, using a two-tiered modelling approach to calculate age-specific forces of infection (FOI), the basic reproduction number (R-0) and herd immunity threshold (H). Seroprevalence and modelling data were compared with corresponding pre-vaccination epidemiological parameters from 11 countries participating in the European Sero-Epidemiology Network 2 (ESEN2) project. Serbia fits into the general dynamic VZV transmission patterns in Europe in the pre-vaccine era, with estimated R-0 = 4.12, (95% CI: 2.69 +/- 7.07) and H = 0.76 (95% CI: 0.63 +/- 0.86). The highest VZV transmission occurs among preschool children, as evidenced by the estimation of the highest FOI (0.22, 95% CI: 0.11 +/- 0.34) in the 0.5 +/- 4 age group, with a peak FOI of 0.25 at 2.23 years. Seroprevalence was consistently lower in 5 +/- 14 year-olds, resulting in considerable shares of VZV-susceptible adolescents (7.3%), and young adults (6%), resembling the situation in a minority of European countries. The obtained key epidemiological parameters showed most intense VZV transmission in preschool children aged < 4 years, justifying the consideration of universal childhood immunization in the future. National immunization strategy should consider programs for VZV serologic screening and immunization of susceptible groups, including adolescents and women of reproductive age. This work is an important milestone towards the evaluation of varicella immunization policy options in Serbia.	[Medic, Snezana; Petrovic, Vladimir; Milosevic, Vesna] Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia; [Medic, Snezana; Petrovic, Vladimir; Milosevic, Vesna; Brkic, Snezana] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Katsilieris, Michalis; Siettos, Constantinos I.] Natl Tehn Univ Athens, Sch Appl Math & Phys Sci, Athens, Greece; [Lozanov-Crvenkovic, Zagorka] Univ Novi Sad, Fac Sci, Dept Math & Comp Sci, Novi Sad, Serbia; [Brkic, Snezana] Clin Ctr Vojvodina, Clin Infect Dis, Novi Sad, Serbia; [Andrews, Nick] Publ Hlth England, Stat Modelling & Econ Dept, Natl Infect Serv, London, England; [Ubavic, Milan] Hlth Inst, Medlab, Novi Sad, Serbia; [Anastassopoulou, Cleo] Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, Patras, Greece	University of Novi Sad; University of Novi Sad; Public Health England; University of Patras	Medic, S (corresponding author), Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia.; Medic, S (corresponding author), Univ Novi Sad, Fac Med, Novi Sad, Serbia.	snezana.medic@izjzv.org.rs	Anastassopoulou, Cleo/AAO-8539-2020; Petrovic, Vladimir/L-7149-2018	Anastassopoulou, Cleo/0000-0001-7666-9198; Petrovic, Vladimir/0000-0002-2052-6232; N.Medic, Sneza/0000-0002-5778-9861	Institute of Public Health of Vojvodina; Serbian Ministry of Education, Science and Technological Development [174019]	Institute of Public Health of Vojvodina; Serbian Ministry of Education, Science and Technological Development	This work was supported by Institute of Public Health of Vojvodina (SM, VP, VM), Serbian Ministry of Education, Science and Technological Development (ZL-C, Grant number 174019 for the period 2011-2017).	ANDERSON R M, 1991; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P265; [Anonymous], VAR VACC EUR UN; Batut Milan Jovanovic, 2017, ANN REPORT IMMUNIZAT; Baxter R, 2013, PEDIATRICS, V131, pE1389, DOI 10.1542/peds.2012-3303; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Bonanni P, 2013, PEDIATR INFECT DIS J, V32, pE305, DOI 10.1097/INF.0b013e31828b7def; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Cohen DI, 2006, INFECTION, V34, P208, DOI 10.1007/s15010-006-6604-4; de Ory F, 2006, J CLIN VIROL, V36, P111, DOI 10.1016/j.jcv.2006.01.017; Del Fava E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163636; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; GERSHON AA, 1976, PEDIATRICS, V58, P692; Gershon AA, 2013, CLIN MICROBIOL REV, V26, P728, DOI 10.1128/CMR.00052-13; GRIFFITHS DA, 1974, ROY STAT SOC C-APP, V23, P330; Helmuth IG, 2015, VACCINE, V33, P2406, DOI 10.1016/j.vaccine.2015.03.055; Institute of Public Health of of Vojvodina, 2016, ANN REPORT; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Mossong J, 2004, EPIDEMIOL INFECT, V132, P1121, DOI 10.1017/S0950268804002754; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; REMME J, 1984, INT J EPIDEMIOL, V13, P332, DOI 10.1093/ije/13.3.332; Riera-Montes M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2445-2; Santermans E, 2015, EPIDEMICS-NETH, V11, P14, DOI 10.1016/j.epidem.2014.12.005; Socan M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-360; Statistical Office of the Republic of Serbia, 2015, STAT YB REP SERB; StatSoft Inc, STAT 13; Vilibic-Cavlek T, 2012, ARCH GYNECOL OBSTET, V286, P901, DOI 10.1007/s00404-012-2398-z; Vujic S, 2012, INVESTING EARLY ED E; Wilson SE, 2012, CAN MED ASSOC J, V184, pE70, DOI 10.1503/cmaj.110506; Xiao X, 2016, EPIDEMICS-NETH, V17, P1, DOI 10.1016/j.epidem.2016.08.001	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193838	10.1371/journal.pone.0193838	http://dx.doi.org/10.1371/journal.pone.0193838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505590	gold, Green Published, Green Submitted			2022-12-26	WOS:000426548200035
J	Cerqueira-Rodrigues, B; Mendes, A; Correia-Neves, M; Nobrega, C				Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia			Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TUBERCULOSIS INFECTION; FACTOR-ALPHA; MICE; ANTIGEN; EXPRESSION; CD4(+); GENE; MACROPHAGES; REPERTOIRE	CD4(+) T cells are essential players for the control of mycobacterial infections. Several mycobacterial antigens have been identified for eliciting a relevant CD4(+) T cell mediated-immune response, and numerous studies explored this issue in the context of Mycobacterium tuberculosis infection. Antigen 85 (Ag85), a highly conserved protein across Mycobacterium species, is secreted at the early phase of M. tuberculosis infection leading to the proliferation of Ag85-specific CD4(+) T cells. However, in the context of Mycobacterium avium infection, little is known about the expression of this antigen and the elicited immune response. In the current work, we investigated if a T cell receptor (TCR) repertoire mostly, but not exclusively, directed at Ag85 is sufficient to mount a protective immune response against M. avium. We show that P25 mice, whose majority of T cells express a transgenic TCR specific for Ag85, control M. avium infection at the same level as wild type (WT) mice up to 20 weeks post-infection (wpi). During M. avium infection, Ag85 antigen is easily detected in the liver of 20 wpi mice by immunohistochemistry. In spite of the propensity of P25 CD4(+) T cells to produce higher amounts of interferon-gamma (IFN gamma) upon ex vivo stimulation, no differences in serum IFN gamma levels are detected in P25 compared to WT mice, nor enhanced immunopathology is detected in P25 mice. These results indicate that a T cell response dominated by Ag85-specific T cells is appropriate to control M. avium infection with no signs of immunopathology.	[Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, Braga, Portugal; [Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal	Universidade do Minho	Nobrega, C (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, Braga, Portugal.; Nobrega, C (corresponding author), PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.	claudianobrega@med.uminho.pt	Mendes, Ana/T-5165-2018; Claudia, Nobrega/D-7537-2014; Correia-Neves, Margarida/C-9122-2009; Correia-Neves, Margarida/AAH-4636-2020; Nóbrega, Cláudia/T-6430-2018	Mendes, Ana/0000-0003-4724-0784; Claudia, Nobrega/0000-0002-0282-9619; Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Nóbrega, Cláudia/0000-0002-0282-9619	Northern Portugal Regional Operational Programme (NORTE), through the European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013]; Portuguese Foundation for Science and Technoloy (FCT) [SFRH/BD/80352/2011, SFRH/BPD/112001/2015]	Northern Portugal Regional Operational Programme (NORTE), through the European Regional Development Fund (FEDER); Portuguese Foundation for Science and Technoloy (FCT)	This work was developed under the scope of the project NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). Fellowships from the Portuguese Foundation for Science and Technoloy (FCT) were attributed to BCR (SFRH/BD/80352/2011; QREN-POPH through the Fundo Social Europeu (FSE) and national funds from MEC] and to CN (SFRH/BPD/112001/2015; POPH through FSE and national funds from MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; APPELBERG R, 1995, INFECT IMMUN, V63, P1145; Bean AGD, 1999, J IMMUNOL, V162, P3504; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Florido M, 2004, INFECT IMMUN, V72, P6139, DOI 10.1128/IAI.72.10.6139-6141.2004; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gomes MS, 1999, J IMMUNOL, V162, P6734; Grace PS, 2016, J IMMUNOL, V196, P357, DOI 10.4049/jimmunol.1501494; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Islam N, 2004, J INFECT DIS, V190, P341, DOI 10.1086/421522; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Karbalaei M, 2017, BIOLOGY IMMUNE PATHO; Kariyone A, 1999, INFECT IMMUN, V67, P4312, DOI 10.1128/IAI.67.9.4312-4319.1999; Luo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048117; Moguche AO, 2017, CELL HOST MICROBE, V21, P695, DOI 10.1016/j.chom.2017.05.012; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412; Nunes-Alves C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004849; Pais TF, 2000, INFECT IMMUN, V68, P4805, DOI 10.1128/IAI.68.8.4805-4810.2000; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Thomsen BV, 2001, J COMP PATHOL, V125, P137, DOI 10.1053/jcpa.2001.0491; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Wilkinson RJ, 2001, MOL MICROBIOL, V39, P813, DOI 10.1046/j.1365-2958.2001.02280.x; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Yahagi A, 2010, INT IMMUNOL, V22, P307, DOI 10.1093/intimm/dxq010; Yanagisawa S, 1997, INT IMMUNOL, V9, P227, DOI 10.1093/intimm/9.2.227	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193596	10.1371/journal.pone.0193596	http://dx.doi.org/10.1371/journal.pone.0193596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499041	Green Submitted, Green Published, gold			2022-12-26	WOS:000426472300017
J	Lin, YH				Lin, Yuhui			AFT survival model to capture the rate of aging and age-specific mortality trajectories among first-allogeneic hematopoietic stem cells transplant patients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ADVANTAGE	Accelerated failure time (AFT) model is commonly applied in engineering studies to address the failure rate of a machine. In humans, survival profile of transplant patients is among the rare scenarios whereby AFT is applicable. To date, it is uncertain whether reliable risk estimates and age-specific mortality trajectories have been published using conventional statistics approach. By investigating mortality trajectory, the rate of aging d(log(mu(x)))/dx of Hematopoietic Stem Cells Transplants (HSCTs) patients who had underwent first-allogeneic transplants can be obtained, and to unveil the possibility of elasticity of human aging rate in HSCTs. A modified parametric frailty survival model was introduced to the survival profiles of 11,160 patients who had underwent first-allogeneic HSCTs in the United States between 1995 and 2006; data was shared by Center for International Bone and Marrow Transplant Research. In comparison to stratification, the modification permits two entities in relation to time to be presented; age and calendar time. To consider its application in empirical studies, the data contains arbitrary right-censoring, a statistical condition which is preferred by choice in many transplant studies. The finalized multivariate AFT model was adjusted for clinical and demographic covariates, and age-specific mortality trajectories were presented by donor source and post-transplant time-lapse intervals. Two unexpected findings are presented: i) an inverse J-shaped hazard in unrelated donor-source t <= 100-day; ii) convergence of unrelated-related hazard lines in 100-day<t <= 365-day suggests maximum manifestation of senescence among survivors. Analyses of long-term survivors (t> 365-day) must consider for periodic medical improvements, and transplant year as a standalone time-variable is not sufficient for statistical adjustment in the finalized multivariate model. In relevance to clinical studies, biennial event-history analysis and age-specific mortality trajectories of long-term survivors provide a more relevant intervention audit report for transplant protocols than the popular statistical presentation; i.e. survival probabilities among donor-source.	[Lin, Yuhui] The Waterhouse, NaoRococo, Singapore, Singapore		Lin, YH (corresponding author), The Waterhouse, NaoRococo, Singapore, Singapore.	yuhui.linney@gmail.com		Lin, Yuhui/0000-0001-6597-1885	Waterhouse; Max Planck Institution for Demographic Research	Waterhouse; Max Planck Institution for Demographic Research	The commercial affiliation, NaoRococo, The Waterhouse provided support in the form of salary for Y Lin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Max Planck Institution for Demographic Research provided scholarship stipend support to Y Lin during her doctorate studies. The specific roles of the author are articulated in the author contributions section.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; BOXENBAUM H, 1991, ARCH GERONTOL GERIAT, V13, P125, DOI 10.1016/0167-4943(91)90055-U; Brunner AM, 2013, BIOL BLOOD MARROW TR, V19, P1374, DOI 10.1016/j.bbmt.2013.06.008; Burra P, 2010, LDOTS TRANSPLANT; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Giaimo S., 2013, J THEOR BIOL; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; Golubev A, 2009, J THEOR BIOL, V258, P1, DOI 10.1016/j.jtbi.2009.01.009; Gondos A, 2013, TRANSPLANTATION, V95, P267, DOI 10.1097/TP.0b013e3182708ea8; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Koopman JJE, 2011, AGING CELL, V10, P233, DOI 10.1111/j.1474-9726.2010.00659.x; Lin YH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010965; Nayor Matthew E DM, 2016, CIRC-HEART FAIL, V9; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P1727, DOI 10.1016/j.bbmt.2012.06.014; Wienke A, 2001, Twin Res, V4, P266, DOI 10.1375/twin.4.4.266; Wienke A., 2003, DEMOGR RES, V49; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yashin AI, 1997, DEMOGRAPHY, V34, P31, DOI 10.2307/2061658; Yashin AI, 2008, THEOR POPUL BIOL, V73, P1, DOI 10.1016/j.tpb.2007.09.001	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193287	10.1371/journal.pone.0193287	http://dx.doi.org/10.1371/journal.pone.0193287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499050	Green Published, gold, Green Submitted			2022-12-26	WOS:000426472300009
J	Garay, J; Csiszar, V; Mori, TF; Szilagyi, A; Varga, Z; Szamado, S				Garay, Jozsef; Csiszar, Villo; Mori, Tamas F.; Szilagyi, Andras; Varga, Zoltan; Szamado, Szabolcs			Juvenile honest food solicitation and parental investment as a life history strategy: A kin demographic selection model	PLOS ONE			English	Article							TRADE-OFF; NEED; EVOLUTION; SIGNALS; HUNGER; CONFLICT; QUESTION; QUALITY; BIRDS	Parent-offspring communication remains an unresolved challenge for biologist. The difficulty of the challenge comes from the fact that it is a multifaceted problem with connections to life-history evolution, parent-offspring conflict, kin selection and signalling. Previous efforts mainly focused on modelling resource allocation at the expense of the dynamic interaction during a reproductive season. Here we present a two-stage model of begging where the first stage models the interaction between nestlings and parents within a nest and the second stage models the life-history trade-offs. We show in an asexual population that honest begging results in decreased variance of collected food between siblings, which leads to mean number of surviving offspring. Thus, honest begging can be seen as a special bet-hedging against informational uncertainty, which not just decreases the variance of fitness but also increases the arithmetic mean.	[Garay, Jozsef; Szilagyi, Andras] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Res Grp Theoret Biol & Evolutionary Ecol, Budapest, Hungary; [Garay, Jozsef; Szilagyi, Andras; Szamado, Szabolcs] MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary; [Csiszar, Villo; Mori, Tamas F.] Eotvos Lorand Univ, Dept Probabil Theory & Stat, Budapest, Hungary; [Varga, Zoltan] Szent Istvan Univ, Dept Math, Godollo, Hungary; [Szamado, Szabolcs] MTA Ctr Social Sci, RECENS Lendulet Res Grp, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University; Hungarian University of Agriculture & Life Sciences; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences	Garay, J (corresponding author), Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Res Grp Theoret Biol & Evolutionary Ecol, Budapest, Hungary.; Garay, J (corresponding author), MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary.	garayj@caesar.elte.hu	Varga, Zoltán/W-6418-2018; Varga, Zoltan/AAA-9201-2019; Móri, Tamás F/N-1283-2019; Számadó, Szabolcs/A-9804-2013; Csiszár, Villő/I-8546-2018; Móri, Tamás F/B-5507-2012	Varga, Zoltan/0000-0002-4889-3376; Móri, Tamás F/0000-0002-9328-7471; Számadó, Szabolcs/0000-0003-2204-9705; Csiszár, Villő/0000-0002-7021-3162; Móri, Tamás F/0000-0002-9328-7471; Garay, Jozsef/0000-0003-0860-2252; Szilagyi, Andras/0000-0002-6894-4652	Hungarian National Research, Development and Innovation Office NKFIH [K 125569, K 108974, K 119347]; European Structural and Investment Funds (ESIF) in Hungary [GINOP 2.3.2-15-2016-00057]; European Research Council [648693]	Hungarian National Research, Development and Innovation Office NKFIH; European Structural and Investment Funds (ESIF) in Hungary; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Hungarian National Research, Development and Innovation Office NKFIH: K 125569 (T.M.), K 108974 (J.G. and SZ.SZ), K 119347 (A.SZ) (http://nkfih.gov.hu/english); European Structural and Investment Funds (ESIF) in Hungary (GINOP 2.3.2-15-2016-00057) (https://www.palyazat.gov.hu/evaluation); and European Research Council (No 648693) (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebbington K, 2017, EVOL LETT, V1, P132, DOI 10.1002/evl3.18; Bossan B, 2013, P R SOC B; Caro SM, 2016, P NATL ACAD SCI USA, V113, P13803, DOI 10.1073/pnas.1606378113; Caro SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10985; Dugas M. B., 2016, P NATL ACAD SCI USA; Garay J, 2016, ECOL MODEL, V334, P51, DOI 10.1016/j.ecolmodel.2016.05.001; Garay J, 2012, B MATH BIOL, V74, P2676, DOI 10.1007/s11538-012-9772-7; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grantham ME, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0654; Hinde CA, 2011, BEHAV ECOL, V22, P1147, DOI 10.1093/beheco/arr117; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Johnstone RA, 2011, BEHAV ECOL, V22, P918, DOI 10.1093/beheco/arr095; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2011, BEHAV ECOL, V22, P919, DOI 10.1093/beheco/arr081; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; Noldeke G, 1999, J THEOR BIOL, V197, P527, DOI 10.1006/jtbi.1998.0893; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Ripa J, 2010, P ROY SOC B-BIOL SCI, V277, P1153, DOI 10.1098/rspb.2009.2023; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wright J, 2011, BEHAV ECOL, V22, P920, DOI 10.1093/beheco/arr080	24	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193420	10.1371/journal.pone.0193420	http://dx.doi.org/10.1371/journal.pone.0193420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494630	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000426363200047
J	Hussain, A; Yong, C; Tkaczuk, KHR; Qian, Y; Arellano, J; Mullins, CD; Onukwugha, E				Hussain, Arif; Yong, Candice; Tkaczuk, Katherine H. R.; Qian, Yi; Arellano, Jorge; Mullins, C. Daniel; Onukwugha, Eberechukwu			Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; BONE METASTASES; PROSTATE-CANCER; ZOLEDRONIC ACID; COMPETING RISKS; DOUBLE-BLIND; EVENTS; STATISTICS; CARCINOMA; MORTALITY	Objective Real-world data regarding patient factors associated with the occurrence of spinal cord compression (SCC) or pathological fracture (PF), or need for bone surgery (BS), or use of radiation therapy (RAD) (i.e. skeletal complications and radiation therapy; SCRT) are limited for women with metastatic breast cancer (BCa). Given the substantial clinical and economic burden of these events in advanced BCa, we conducted the present study to understand the prevalence and identify the risk factors associated with these events among elderly women presenting with de novo metastatic BCa. Methods Using linked Surveillance, Epidemiology, and End Results and Medicare data, we identified women with incident metastatic BCa diagnosed during 2005 +/- 2009. Associations between patient demographics and select clinically relevant factors, and SCRT were examined using the Cox proportional hazards model, accounting for death as a competing risk. Results Of 3,731 Medicare beneficiaries with incident metastatic BCa, 1,808 (48.5%) experienced at least one SCRT event during a median follow-up of 13.2 months; a majority (69%) experienced a subsequent SCRT event. The proportions of women who had RAD, PF, BS, and SCC were: 32%, 28%, 8%, and 4%. Older women (80+ years), or those with more comorbid conditions (CCI >= 2) had a statistically significant lower risk of SCRT (HR 0.78 [CI: 0.67- 0.92, p<0.01]; HR 0.77 [CI: 0.67-0.89, p<0.01], respectively), primarily due to lower frequency of radiotherapy (p<0.01). Compared to Caucasians, African Americans had lower risk of SCRT (HR 0.70 [CI: 0.60-0.82, p<0.01]), as well as all SCRT subtypes defining this group except for SCC, which was the same for both race groups. Conclusion This study highlights that certain patient characteristics and clinical factors are associated with the risk of spinal cord compression or pathologic fractures, or need for bone surgery or radiation among women with metastatic BCa. In future studies, it will also be important to consider the clinical and economic burden based on these components of skeletal complications and radiation therapy use in order to guide and improve the management of women with advanced BCa.	[Hussain, Arif; Tkaczuk, Katherine H. R.] Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA; [Hussain, Arif] Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Yong, Candice; Mullins, C. Daniel; Onukwugha, Eberechukwu] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Qian, Yi; Arellano, Jorge] Amgen Inc, Thousand Oaks, CA 91320 USA; [Yong, Candice] AstraZeneca, Gaithersburg, MD USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore; Amgen; AstraZeneca	Hussain, A (corresponding author), Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA.; Hussain, A (corresponding author), Vet Affairs Med Ctr, Baltimore, MD 21201 USA.	ahussain@som.umaryland.edu			Amgen Inc.; Merit Review Award [101 BX000545]; Department of Veterans Affairs; California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C, HHSN261201000035C, HHSN261201000034C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862-01]; Medical Research Service, Department of Veterans Affairs; Veterans Affairs [I01BX000545] Funding Source: NIH RePORTER	Amgen Inc.(Amgen); Merit Review Award(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Financial support for this study was provided by a contract with Amgen Inc. The funding agreement ensured the authors' independence in designing the study, collecting the data, interpreting the data, writing the paper, and submitting the paper for publication. Part of author AH's time was supported by a Merit Review Award (101 BX000545), Department of Veterans Affairs. There was no additional external funding received for this study. Amgen Inc. provided support in the form of salaries for authors YQ and JA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Pharmaceutical Research Computing for programming assistance on the primary datasets. This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER -Medicare database. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement # U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred. Part of AH's research time was supported by a Merit Review Award (I01 BX000545), Medical Research Service, Department of Veterans Affairs.	Abdulhalim AM, 2014, 2014 GEN CANC S SAN; AJCC, 2002, MANUAL STAGING CANC; Body Jean-Jacques, 2013, J Med Econ, V16, P539, DOI 10.3111/13696998.2013.774279; Choksi P, 2017, J CLIN ENDOCR METAB, V102, P1254, DOI 10.1210/jc.2016-3906; Costa L, 2008, SUPPORT CARE CANCER, V16, P879, DOI 10.1007/s00520-008-0418-0; Delea Thomas, 2006, J Support Oncol, V4, P341; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Duran I, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12452; Hagiwara May, 2014, J Med Econ, V17, P223, DOI 10.3111/13696998.2014.890937; Hussain A, 2016, CANCER MED-US, V5, P3300, DOI 10.1002/cam4.914; Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; McDougall JA, 2016, ONCOLOGIST, V21, P320, DOI 10.1634/theoncologist.2015-0327; McKay R, 2017, PROSTATE CANCER P D, V20, P276, DOI 10.1038/pcan.2017.4; Onukwugha Eberechukwu, 2017, PLoS One, V12, pe0175956, DOI 10.1371/journal.pone.0175956; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sathiakumar N, 2012, BREAST CANCER RES TR, V131, P231, DOI 10.1007/s10549-011-1721-x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Svendsen Marie Louise, 2013, Clin Epidemiol, V5, P97, DOI 10.2147/CLEP.S42325; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Yong M, 2011, BREAST CANCER RES TR, V129, P495, DOI 10.1007/s10549-011-1475-5	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193661	10.1371/journal.pone.0193661	http://dx.doi.org/10.1371/journal.pone.0193661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494653	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200078
J	Sekita-Hatakeyama, Y; Nishikawa, T; Takeuchi, M; Morita, K; Takeda, M; Hatakeyama, K; Nakai, T; Uchiyama, T; Itami, H; Fujii, T; Mitoro, A; Sho, M; Ohbayashi, C				Sekita-Hatakeyama, Yoko; Nishikawa, Takeshi; Takeuchi, Mao; Morita, Kouhei; Takeda, Maiko; Hatakeyama, Kinta; Nakai, Tokiko; Uchiyama, Tomoko; Itami, Hiroe; Fujii, Tomomi; Mitoro, Akira; Sho, Masayuki; Ohbayashi, Chiho			K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							TERM-FOLLOW-UP; GENE MUTATION; PROGNOSTIC VALUE; KRAS MUTATION; CANCER; NEOPLASMS; METAANALYSIS; BIOMARKERS; CARCINOMA; BIOPSIES	Background Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) technology is widely used for the diagnosis of pancreatic masses. However, in some cases, inadequate tissue volume or difficulty of morphological diagnosis are constraining factors for adequate cytopathological evaluation. K-ras mutation is the most frequently acquired genetic abnormality, occurring in approximately 90% of all patients with pancreatic ductal adenocarcinoma (PDAC). In the present study, the clinical utility of residual liquid-based cytology (LBC) specimens obtained using EUS-FNA for K-ras mutation analysis was evaluated. Methods In this study, 81 patients with pancreatic lesions were examined. The cell block (CB) specimens separated from EUS-FNA samples were morphologically evaluated by hematoxylin-eosin (HE) staining. Final diagnoses were confirmed by CB specimens, surgical resection specimens, diagnostic imaging, and clinical follow-up. Genomic DNA of residual LBC specimens stored at 4 degrees C for several months were extracted and assessed for K-ras mutations using a fluorescence resonance energy transfer-based preferential homoduplex formation assay. Results K-ras mutation analysis using residual LBC samples was successful in all cases. The sensitivity, specificity, and accuracy of CB examination alone were 77.4%, 100%, and 81.3%, respectively, and those of the combination of CB examination and K-ras mutation analysis were 90.3%, 92.3%, and 90.7%, respectively. Furthermore, K-ras mutations were detected in 8 (57.1%) of 14 PDAC samples for which the CB results were inconclusive. Conclusion These findings suggest that K-ras mutation analysis using residual LBC specimens improves the diagnostic accuracy of EUS-FNA.	[Sekita-Hatakeyama, Yoko; Nishikawa, Takeshi; Takeuchi, Mao; Morita, Kouhei; Takeda, Maiko; Hatakeyama, Kinta; Nakai, Tokiko; Uchiyama, Tomoko; Itami, Hiroe; Fujii, Tomomi; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan; [Mitoro, Akira] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan; [Sho, Masayuki] Nara Med Univ, Dept Surg, Kashihara, Nara, Japan	Nara Medical University; Nara Medical University; Nara Medical University	Hatakeyama, K (corresponding author), Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan.	kpathol@naramed-u.ac.jp						Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bournet B, 2009, ENDOSCOPY, V41, P552, DOI 10.1055/s-0029-1214717; Brunetti O, 2015, ONCOTARGET, V6, P23323, DOI 10.18632/oncotarget.4492; Buscail L, 2006, PANCREATOLOGY, V6, P7, DOI 10.1159/000090022; Frampton AE, 2015, EUR J CANCER, V51, P1389, DOI 10.1016/j.ejca.2015.04.006; Furuya N, 1997, GASTROENTEROLOGY, V113, P593, DOI 10.1053/gast.1997.v113.pm9247481; GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Hashimoto S, 2017, DIGEST ENDOSC, V29, P608, DOI 10.1111/den.12827; Hijioka S, 2017, CLIN CANCER RES, V23, P4625, DOI 10.1158/1078-0432.CCR-16-3135; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamisawa T, 2011, HEPATO-GASTROENTEROL, V58, P174; Kim WY, 2016, DIAGN CYTOPATHOL, V44, P450, DOI 10.1002/dc.23441; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kloppel G, 2014, SEMIN DIAGN PATHOL, V31, P452, DOI 10.1053/j.semdp.2014.08.005; Kwon H, 2016, ENDOCRINOL METAB, V31, P586, DOI 10.3803/EnM.2016.31.4.586; LeBlanc JK, 2014, PANCREAS, V43, P440, DOI 10.1097/MPA.0000000000000047; Linder J, 1998, DIAGN CYTOPATHOL, V18, P24, DOI 10.1002/(SICI)1097-0339(199801)18:1<24::AID-DC5>3.0.CO;2-U; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Ma MZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-71; Malapelle U, 2012, J CLIN PATHOL, V65, P87, DOI 10.1136/jclinpath-2011-200296; Moris D, 2017, ANTICANCER RES, V37, P2185, DOI 10.21873/anticanres.11553; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Park JK, 2017, ONCOTARGET, V8, P64440, DOI 10.18632/oncotarget.16135; Park JK, 2017, ONCOTARGET, V8, P3519, DOI 10.18632/oncotarget.13864; Qin SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108762; Rossi ED, 2013, CANCER CYTOPATHOL, V121, P291, DOI 10.1002/cncy.21258; Rossi ED, 2013, EUR J ENDOCRINOL, V168, P853, DOI 10.1530/EJE-13-0023; Springer S, 2015, GASTROENTEROLOGY, V149, P1501, DOI 10.1053/j.gastro.2015.07.041; Tada M, 2002, AM J GASTROENTEROL, V97, P2263; TADA M, 1991, GASTROENTEROLOGY, V100, P233, DOI 10.1016/0016-5085(91)90606-L; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Zhao H, 2017, ONCOTARGET, V8	37	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193692	10.1371/journal.pone.0193692	http://dx.doi.org/10.1371/journal.pone.0193692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494669	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200085
J	Chang, JH; Zhao, JH; Tian, XL				Chang, Juhua; Zhao, Jianhua; Tian, Xiaoli			In silico prediction of neuropeptides in Hymenoptera parasitoid wasps	PLOS ONE			English	Article							SULFATED INSECT NEUROPEPTIDE; RED FLOUR BEETLE; PROTEIN HORMONES; PEPTIDE-HORMONES; FOOD-INTAKE; EVOLUTION; LEUCOSULFAKININ; IDENTIFICATION; PHYLOGENY; RECEPTORS	Parasitoid wasps of the order Hymenoptera, the most diverse groups of animals, are important natural enemies of arthropod hosts in natural ecosystems and can be used in biological control. To date, only one neuropeptidome of a parasitoid wasp, Nasonia vitripennis, has been identified. This study aimed to identify more neuropeptides of parasitoid wasps, by using a well-established workflow that was previously adopted for predicting insect neuropeptide sequences. Based on publicly accessible databases, totally 517 neuropeptide precursors from 24 parasitoid wasp species were identified; these included five neuropeptides (CNMamide, FMRFamide-like, ITG-like, ion transport peptide-like and orcokinin B) that were identified for the first time in parasitoid wasps, to our knowledge. Next, these neuropeptides from parasitoid wasps were compared with those from other insect species. Phylogenetic analysis suggested the divergence of AST-CCC within Hymenoptera. Further, the encoding patterns of CAPA/PK family genes were found to be different between Hymenoptera species and other insect species. Some neuropeptides that were not found in some parasitoid superfamilies (e.g., sulfakinin), or considerably divergent between different parasitoid superfamilies (e.g., sNPF) might be related to distinct physiological processes in the parasitoid life. Information of neuropeptide sequences in parasitoid wasps can be useful for better understanding the phylogenetic relationships of Hymenoptera and further elucidating the physiological functions of neuropeptide signaling systems in parasitoid wasps.	[Chang, Juhua; Tian, Xiaoli] Yangtze Univ, Coll Life Sci, Jingzhou, Peoples R China; [Chang, Juhua] Yangtze Univ, Pesticide Res Inst, Jingzhou, Peoples R China; [Zhao, Jianhua] Vegetable Technol Ctr Xiyang Cty, Xiyang, Peoples R China	Yangtze University; Yangtze University	Chang, JH (corresponding author), Yangtze Univ, Coll Life Sci, Jingzhou, Peoples R China.; Chang, JH (corresponding author), Yangtze Univ, Pesticide Res Inst, Jingzhou, Peoples R China.	juhua1756@163.com			National Natural Science Foundation of China [31601672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31601672) (Dr. Juhua Chang).; Financial support was provided by National Natural Science Foundation of China (31601672).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audsley N, 2015, PEPTIDES, V68, P33, DOI 10.1016/j.peptides.2014.08.006; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Christie AE, 2017, GEN COMP ENDOCR, V243, P22, DOI 10.1016/j.ygcen.2016.10.008; Christie AE, 2016, GEN COMP ENDOCR, V230, P1, DOI 10.1016/j.ygcen.2016.03.008; Christie AE, 2015, GEN COMP ENDOCR, V224, P69, DOI 10.1016/j.ygcen.2015.06.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Derst C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0621-4; Gade G, 2016, AMINO ACIDS, V48, P1677, DOI 10.1007/s00726-016-2229-9; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Kean L, 2002, AM J PHYSL REGUL INT, V282; LaSalle J., 1991, Redia, V74, P315; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; MATSUMOTO S, 1989, INSECT BIOCHEM, V19, P277, DOI 10.1016/0020-1790(89)90073-5; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V140, P357, DOI 10.1016/0006-291X(86)91098-3; NACHMAN RJ, 1986, SCIENCE, V234, P71, DOI 10.1126/science.3749893; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Predel R, 2012, SYST BIOL, V61, P609, DOI 10.1093/sysbio/sys003; Predel R, 2012, PEPTIDES, V34, P39, DOI 10.1016/j.peptides.2011.10.008; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Roller L, 2016, CELL TISSUE RES, V364, P499, DOI 10.1007/s00441-015-2352-z; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Schmitt F, 2015, J PROTEOME RES, V14, P1504, DOI 10.1021/pr5011636; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Sterkel M, 2011, J PROTEOME RES, V10, P3363, DOI 10.1021/pr2001012; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Uchiyama H, GEN COMP ENDOCRINOL; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2016, GEN COMP ENDOCR, V230, P153, DOI 10.1016/j.ygcen.2016.04.013; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, PEPTIDES, V35, P122, DOI 10.1016/j.peptides.2012.02.019; Whitfield JB, 1998, ANNU REV ENTOMOL, V43, P129, DOI 10.1146/annurev.ento.43.1.129; Xu G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28976; Yu N, 2013, PEPTIDES, V41, P107, DOI 10.1016/j.peptides.2012.12.005; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193561	10.1371/journal.pone.0193561	http://dx.doi.org/10.1371/journal.pone.0193561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489917	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000091
J	Tang, YD; Guo, JC; Wang, TY; Zhao, K; Liu, JT; Gao, JC; Tian, ZJ; An, TQ; Cai, XH				Tang, Yan-Dong; Guo, Jin-Chao; Wang, Tong-Yun; Zhao, Kuan; Liu, Ji-Ting; Gao, Jia-Cong; Tian, Zhi-Jun; An, Tong-Qing; Cai, Xue-Hui			CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing	FASEB JOURNAL			English	Article						herpesvirus; knockout; knockin; recombination; DNA virus	HEPATITIS-B-VIRUS; EPSTEIN-BARR-VIRUS; REAL-TIME PCR; HUMAN-CELLS; GENOME; SYSTEM; MUTAGENESIS; CHINA; PIGS; RECOMBINATION	Several groups have used CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) for DNA virus editing. In most cases, one single-guide RNA (sgRNA) is used, which produces inconsistencies in gene editing. In this study, we used a swine herpesvirus, pseudorabies virus, as a model to systematically explore the application of CRISPR/Cas9 in DNA virus editing. In our current report, we demonstrated that cotransfection of 2 sgRNAs and a viral genome resulted in significantly better knockout efficiency than the transfection-infection-based approach. This method could result in 100% knockout of 3500 bp of viral nonessential large fragments. Furthermore, knockin efficiency was significantly improved by using 2 sgRNAs and was also correlated with the number of background viruses. We also demonstrated that the background viruses were all 2-sgRNA-mediated knockout mutants. Finally, this study demonstrated that the efficacy of gene knockin is determined by the replicative kinetics of background viruses. We propose that CRISPR/Cas9 coupled with 2 sgRNAs creates a powerful tool for DNA virus editing and offers great potential for future applications.Tang, Y.-D., Guo, J.-C., Wang, T.-Y., Zhao, K., Liu, J.-T., Gao, J.-C., Tian, Z.-J., An, T.-Q., Cai, X.-H. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.	[Tang, Yan-Dong; Guo, Jin-Chao; Wang, Tong-Yun; Zhao, Kuan; Liu, Ji-Ting; Gao, Jia-Cong; Tian, Zhi-Jun; An, Tong-Qing; Cai, Xue-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	An, TQ; Cai, XH (corresponding author), CAAS, Harbin Vet Res Inst, 678 HaPing Rd, Harbin 150069, Heilongjiang, Peoples R China.	antongqing@163.com; cai139@hvri.ac.cn	Tang, Yan-Dong/ABE-7678-2021	Tang, Yan-Dong/0000-0002-5690-2690	National Key Research and Development Program of China [2016YFD0500100]; National Natural Science Foundation of China [31270045]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Xing-Yu Meng (Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences) for assistance with qPCR. This study was supported by the National Key Research and Development Program of China (Grant 2016YFD0500100) and the National Natural Science Foundation of China (Grant 31270045). The authors declare no conflicts of interest.	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Balasch M, 1998, VET MICROBIOL, V60, P99, DOI 10.1016/S0378-1135(97)00156-9; Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090; Bierle CJ, 2016, J VIROL, V90, P6989, DOI 10.1128/JVI.00139-16; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Guo JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02110; Hall RN, 2012, VIRUSES-BASEL, V4, P211, DOI 10.3390/v4020211; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16; Kennedy EM, 2015, ANTIVIR RES, V123, P188, DOI 10.1016/j.antiviral.2015.10.004; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091; Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176; Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531; Lin GG, 2015, INT J MOL SCI, V16, P26077, DOI 10.3390/ijms161125950; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Meng XY, 2016, ARCH VIROL, V161, P2425, DOI 10.1007/s00705-016-2925-5; Mettenleiter TC, 2000, VET RES, V31, P99, DOI 10.1051/vetres:2000059; Peng C, 2015, VIROL SIN, V30, P317, DOI 10.1007/s12250-015-3660-x; Peng ZY, 2016, VIRUS RES, V223, P197, DOI 10.1016/j.virusres.2016.08.001; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Sanchala DS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00270; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Tang Y, 2017, SCI REP-UK, V7; Tang YD, 2017, ARCH VIROL, V162, P3881, DOI 10.1007/s00705-017-3553-4; Tang YD, 2016, VIRUS RES, V225, P33, DOI 10.1016/j.virusres.2016.09.004; Tang YD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040090; van Diemen FR, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12694; Xu AT, 2015, BIOTECHNOL LETT, V37, P1265, DOI 10.1007/s10529-015-1796-2; Ye C, 2016, VIROLOGY, V491, P56, DOI 10.1016/j.virol.2016.01.016; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yoon HA, 2006, J VET MED SCI, V68, P143, DOI 10.1292/jvms.68.143; Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012	38	18	19	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4293	4301		10.1096/fj.201701129R	http://dx.doi.org/10.1096/fj.201701129R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509513				2022-12-26	WOS:000439325400020
J	Bolin, S; Borgenvik, A; Persson, CU; Sundstrom, A; Qi, J; Bradner, JE; Weiss, WA; Cho, YJ; Weishaupt, H; Swartling, FJ				Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundstrom, Anders; Qi, Jun; Bradner, James E.; Weiss, William A.; Cho, Yoon-Jae; Weishaupt, Holger; Swartling, Fredrik J.			Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma	ONCOGENE			English	Article							SELECTIVE-INHIBITION; KINASE INHIBITOR; BRAIN-TUMORS; PHOSPHORYLATION; STABILIZATION; DISCOVERY; APOPTOSIS; SUBTYPES; POTENT	Medulloblastoma (MB) is the most common malignant brain tumor in children. MYC genes are frequently amplified and correlate with poor prognosis in MB. BET bromodomains recognize acetylated lysine residues and often promote and maintain MYC transcription. Certain cyclin-dependent kinases (CDKs) are further known to support MYC stabilization in tumor cells. In this report, MB cells were suppressed by combined targeting of MYC expression and MYC stabilization using BET bromodomain inhibition and CDK2 inhibition, respectively. Such combination treatment worked synergistically and caused cell cycle arrest as well as massive apoptosis. Immediate transcriptional changes from this combined MYC blockade were found using RNA-Seq profiling and showed remarkable similarities to changes in MYC target gene expression when MYCN was turned off with doxycycline in our MYCN-inducible animal model for Group 3 MB. In addition, the combination treatment significantly prolonged survival as compared to single-agent therapy in orthotopically transplanted human Group 3 MB with MYC amplifications. Our data suggest that dual inhibition of CDK2 and BET bromodomains can be a novel treatment approach for suppressing MYC-driven cancer.	[Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundstrom, Anders; Weishaupt, Holger; Swartling, Fredrik J.] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden; [Qi, Jun; Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Knight Canc Inst, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Uppsala University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University	Swartling, FJ (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden.	fredrik.swartling@igp.uu.se	Swartling, Fredrik J/B-8170-2014	Swartling, Fredrik J/0000-0002-8460-4367; Borgenvik, Anna/0000-0003-4696-7703; Weiss, William/0000-0003-2230-9132; Persson, Camilla/0000-0002-1312-6177	Swedish Childhood Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Ragnar Soderberg Foundation; Swedish Society of Medicine; Swedish Brain Fund; Ake Wiberg Foundation; Worldwide Cancer Research/Association for International Cancer Research; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER	Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Swedish Society of Medicine; Swedish Brain Fund; Ake Wiberg Foundation; Worldwide Cancer Research/Association for International Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support from the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Ragnar Soderberg Foundation, the Swedish Society of Medicine, the Swedish Brain Fund, the Ake Wiberg Foundation, and Worldwide Cancer Research/Association for International Cancer Research.	Albanese C, 2013, BRIT J PHARMACOL, V169, P156, DOI 10.1111/bph.12112; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Baker EK, 2015, SCI REP-UK, V5, DOI 10.1038/srep10120; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Benassi B, 2012, CANCER DISCOV, V2, P236, DOI 10.1158/2159-8290.CD-11-0219; Brasca MG, 2009, J MED CHEM, V52, P5152, DOI 10.1021/jm9006559; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Caporali S, 2010, PHARMACOL RES, V61, P437, DOI 10.1016/j.phrs.2009.12.009; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Fiaschetti G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-39; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Hede SM, 2014, ONCOGENE, V33, P4709, DOI 10.1038/onc.2013.445; Henssen A, 2013, ONCOTARGET, V4, DOI 10.18632/oncotarget.1534; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li MH, 2012, CANCER GENET-NY, V205, P220, DOI 10.1016/j.cancergen.2012.03.002; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKeown MR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014266; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rahmanto AS, 2016, EMBO J, V35, P2192, DOI 10.15252/embj.201693889; Roussel MF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014308; Ryan SL, 2012, ACTA NEUROPATHOL, V123, P501, DOI 10.1007/s00401-011-0923-y; Schmidt AL, 2010, CNS NEUROL DISORD-DR, V9, P335, DOI 10.2174/187152710791292602; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Tailor J, 2013, J NEUROSCI, V33, P12407, DOI 10.1523/JNEUROSCI.0130-13.2013; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Weiss GJ, 2012, INVEST NEW DRUG, V30, P2334, DOI 10.1007/s10637-011-9774-6; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785	49	42	45	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2850	2862		10.1038/s41388-018-0135-1	http://dx.doi.org/10.1038/s41388-018-0135-1			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511348	Green Published, hybrid			2022-12-26	WOS:000432929800007
J	Jiao, WJ; Chen, YJ; Song, HJ; Li, D; Mei, H; Yang, F; Fang, E; Wang, XJ; Huang, K; Zheng, LD; Tong, QS				Jiao, Wanju; Chen, Yajun; Song, Huajie; Li, Dan; Mei, Hong; Yang, Feng; Fang, Erhu; Wang, Xiaojing; Huang, Kai; Zheng, Liduan; Tong, Qiangsong			HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis	ONCOGENE			English	Article							INTELECTIN 1 SUPPRESSES; HEPARANASE EXPRESSION; NEUROBLASTOMA-CELLS; GASTRIC-CANCER; GENE-TRANSCRIPTION; GROWTH; INVASION; METASTASIS; ACTIVATION; ANGIOGENESIS	Recent studies reveal the emerging functions of enhancer RNAs (eRNAs) in gene expression. However, the roles of eRNAs in regulating the expression of heparanase (HPSE), an established endo-beta-D-glucuronidase essential for cancer invasion and metastasis, still remain elusive. Herein, through comprehensive analysis of publically available FANTOM5 expression atlas and chromatin interaction dataset, we identified a super enhancer and its derived eRNA facilitating the HPSE expression (HPSE eRNA) in cancers. Gain-of-function and loss-of-function experiments indicated that HPSE eRNA facilitated the in vitro and in vivo tumorigenesis and aggressiveness of cancer cells. Mechanistically, as a p300-regulated nuclear noncoding RNA, HPSE eRNA bond to heterogeneous nuclear ribonucleoprotein U (hnRNPU) to facilitate its interaction with p300 and their enrichment on super enhancer, resulting in chromatin looping between super enhancer and HPSE promoter, p300-mediated transactivation of transcription factor early growth response 1 (EGR1), and subsequent elevation of HPSE expression. In addition, rescue studies in HPSE overexpressing or silencing cancer cells indicated that HPSE eRNA exerted oncogenic properties via driving HPSE expression. In clinical cancer tissues, HPSE eRNA was highly expressed and positively correlated with HPSE levels, and served as an independent prognostic factor for poor outcome of cancer patients. Therefore, these findings indicate that as a novel noncoding RNA, HPSE eRNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.	[Jiao, Wanju; Chen, Yajun; Zheng, Liduan] Huazhong Univ Sci & Technol, Union Hosp, Dept Pathol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Song, Huajie; Li, Dan; Mei, Hong; Yang, Feng; Fang, Erhu; Wang, Xiaojing; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat Surg, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Huang, Kai; Zheng, Liduan; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Clin Ctr Human Genom Res, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zheng, LD (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Pathol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.; Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat Surg, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.; Zheng, LD; Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Clin Ctr Human Genom Res, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.	ld_zheng@hotmail.com; qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [81272779, 81372667, 81472363, 81402301, 81402408, 81572423, 81672500, 81773094, 81772967]; Natural Science Foundation of Hubei Province [2014CFA012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	We appreciate Dr. Tso-Pang Yao for providing vectors. This work was granted by the National Natural Science Foundation of China (81272779, 81372667, 81472363, 81402301, 81402408, 81572423, 81672500, 81773094, and 81772967), and Natural Science Foundation of Hubei Province (2014CFA012).	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bi HS, 2013, BBA-GEN SUBJECTS, V1830, P4899, DOI 10.1016/j.bbagen.2013.06.026; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Assal ON, 2001, CLIN CANCER RES, V7, P1299; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Fang F, 2014, STEM CELLS, V32, P1805, DOI 10.1002/stem.1705; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; He B, 2014, P NATL ACAD SCI USA, V111, pE2191, DOI 10.1073/pnas.1320308111; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YW, 2013, BBA-GENE REGUL MECH, V1829, P963, DOI 10.1016/j.bbagrm.2013.04.006; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; Li D, 2015, ONCOTARGET, V6, P16168, DOI 10.18632/oncotarget.3753; Li D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0320-6; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Masola V, 2014, CURR CANCER DRUG TAR, V14, P286, DOI 10.2174/1568009614666140224155124; Matsuoka Y, 2009, ONCOL REP, V22, P249, DOI 10.3892/or_00000431; Mattern KA, 1999, EXP CELL RES, V246, P461, DOI 10.1006/excr.1998.4267; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Puvvula PK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6323; Qu HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep32628; Qu HX, 2015, HUM MOL GENET, V24, P2539, DOI 10.1093/hmg/ddv018; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Silverman ES, 1998, BIOCHEM J, V336, P183, DOI 10.1042/bj3360183; Stadlmann S, 2003, EUR J CANCER, V39, P2229, DOI 10.1016/S0959-8049(03)00457-X; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Xiang X, 2015, CANCER LETT, V359, P187, DOI 10.1016/j.canlet.2015.01.008; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733; Zhang H, 2014, ONCOGENE, V33, P387, DOI 10.1038/onc.2012.574; Zhao X, 2016, ONCOGENE, V35, P3565, DOI 10.1038/onc.2015.422; Zheng LD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.293; Zheng LD, 2016, ONCOTARGET, V7, P40314, DOI 10.18632/oncotarget.9739; Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719; Zheng LD, 2013, MOL CANCER RES, V11, P182, DOI 10.1158/1541-7786.MCR-12-0534; Zheng LD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-74; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	53	51	53	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2728	2745		10.1038/s41388-018-0128-0	http://dx.doi.org/10.1038/s41388-018-0128-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29511351				2022-12-26	WOS:000432545100009
J	Hamiaux, C; Drummond, RSM; Luo, ZW; Lee, HW; Sharma, P; Janssen, BJ; Perry, NB; Denny, WA; Snowden, KC				Hamiaux, Cyril; Drummond, Revel S. M.; Luo, Zhiwei; Lee, Hui Wen; Sharma, Prachi; Janssen, Bart J.; Perry, Nigel B.; Denny, William A.; Snowden, Kimberley C.			Inhibition of strigolactone receptors by N-phenylanthranilic acid derivatives: Structural and functional insights	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; LEAF SENESCENCE; STRIGA-HERMONTHICA; PLANT HORMONES; GERMINATION; ARABIDOPSIS; KARRIKIN; DWARF14; GROWTH; OPTIMIZATION	The strigolactone (SL) family of plant hormones regulates a broad range of physiological processes affecting plant growth and development and also plays essential roles in controlling interactions with parasitic weeds and symbiotic fungi. Recent progress elucidating details of SL biosynthesis, signaling, and transport offers many opportunities for discovering new plant-growth regulators via chemical interference. Here, using high-throughput screening and downstream biochemical assays, we identified N-phenylanthranilic acid derivatives as potent inhibitors of the SL receptors from petunia (DAD2), rice (OsD14), and Arabidopsis (AtD14). Crystal structures of DAD2 and OsD14 in complex with inhibitors further provided detailed insights into the inhibition mechanism, and in silico modeling of 19 other plant strigolactone receptors suggested that these compounds are active across a large range of plant species. Altogether, these results provide chemical tools for investigating SL signaling and further define a framework for structure-based approaches to design and validate optimized inhibitors of SL receptors for specific plant targets.	[Hamiaux, Cyril; Drummond, Revel S. M.; Luo, Zhiwei; Lee, Hui Wen; Sharma, Prachi; Janssen, Bart J.; Snowden, Kimberley C.] New Zealand Inst Plant & Food Res Ltd, Private Bag 92169, Auckland 1142, New Zealand; [Lee, Hui Wen; Sharma, Prachi] Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand; [Perry, Nigel B.] Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand; [Perry, Nigel B.] Univ Otago, New Zealand Inst Plant & Food Res Ltd, Dept Chem, POB 56, Dunedin, New Zealand; [Denny, William A.] Univ Auckland, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland 1142, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; University of Otago; New Zealand Institute for Plant & Food Research Ltd; University of Otago; University of Auckland	Hamiaux, C; Snowden, KC (corresponding author), New Zealand Inst Plant & Food Res Ltd, Private Bag 92169, Auckland 1142, New Zealand.	cyril.hamiaux@plantandfood.co.nz; kimberley.snowden@plantandfood.co.nz	Hamiaux, Cyril/U-9978-2017; Drummond, Revel/P-6408-2019; Snowden, Kimberley C/J-8270-2012; Janssen, Bart J/J-4880-2014; Perry, Nigel/G-5574-2010	Hamiaux, Cyril/0000-0001-9198-3441; Drummond, Revel/0000-0001-5238-7604; Snowden, Kimberley C/0000-0001-9640-4015; Janssen, Bart J/0000-0002-5871-2831; Perry, Nigel/0000-0003-3196-3945; Lee, Hui Wen/0000-0002-4107-0350; Luo, Zhiwei/0000-0002-7605-9768; SHARMA, PRACHI/0000-0002-6932-8472	AGMARDT (Agribusiness Innovation) [1323]; Marsden grant [PAF1301]	AGMARDT (Agribusiness Innovation); Marsden grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by funding from AGMARDT (Agribusiness Innovation Grant 1323), Plant and Food Research, and a Marsden grant (contract PAF1301). C. H., K. C. S., and the New Zealand Institute for Plant and Food Research Limited have filed a New Zealand provisional patent application (734620) that relates to the specific topic "Strigolactone receptor antagonists."	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.74, 10.1038/NPLANTS.2016.74]; Boyer FD, 2014, MOL PLANT, V7, P675, DOI 10.1093/mp/sst163; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Cohen M, 2013, MOL PLANT, V6, P141, DOI 10.1093/mp/sss134; de Saint Germain A, 2016, NAT CHEM BIOL, V12, P787, DOI 10.1038/nchembio.2147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukui K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00936; Gaglioti K, 2014, CRYSTENGCOMM, V16, P8252, DOI 10.1039/c4ce00549j; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Griffiths CA, 2016, NATURE, V540, P574, DOI 10.1038/nature20591; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Harrison PJ, 2015, FEBS J, V282, P3986, DOI 10.1111/febs.13400; Holbrook-Smith D, 2016, NAT CHEM BIOL, V12, P724, DOI 10.1038/nchembio.2129; James P, 1996, GENETICS, V144, P1425; Jamil M, 2018, J EXP BOT, V69, P2319, DOI 10.1093/jxb/erx438; Jamil M, 2010, ARCH BIOCHEM BIOPHYS, V504, P123, DOI 10.1016/j.abb.2010.08.005; Janssen BJ, 2014, CURR OPIN PLANT BIOL, V17, P28, DOI 10.1016/j.pbi.2013.11.004; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Khosla A, 2016, CURR OPIN PLANT BIOL, V33, P57, DOI 10.1016/j.pbi.2016.06.001; Liu Q, 2014, NEW PHYTOL, V202, P531, DOI 10.1111/nph.12692; Lumba Shelley, 2017, F1000Res, V6, P975, DOI 10.12688/f1000research.11379.1; Maier RH, 2008, BIOTECHNIQUES, V45, P235, DOI 10.2144/000112897; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1066, DOI 10.1021/jf00018a032; Mashita O, 2016, J PESTIC SCI, V41, P71, DOI 10.1584/jpestics.D16-028; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00623; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Soundappan I, 2015, PLANT CELL, V27, P3143, DOI 10.1105/tpc.15.00562; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanga JP, 2016, PLANTA, V243, P1397, DOI 10.1007/s00425-015-2458-2; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang L, 2015, PLANT CELL, V27, P3128, DOI 10.1105/tpc.15.00605; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Xiang HB, 2017, CELL RES, V27, P1525, DOI 10.1038/cr.2017.105; Yamada Y, 2014, PLANTA, V240, P399, DOI 10.1007/s00425-014-2096-0; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zwanenburg B, 2013, BIOORG MED CHEM LETT, V23, P5182, DOI 10.1016/j.bmcl.2013.07.004	63	28	28	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6530	6543		10.1074/jbc.RA117.001154	http://dx.doi.org/10.1074/jbc.RA117.001154			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523686	Green Published, hybrid			2022-12-26	WOS:000431108600024
J	Zhang, YB; Zhang, ZW; Ge, W				Zhang, Yibo; Zhang, Zhiwei; Ge, Wei			An efficient platform for generating somatic point mutations with germline transmission in the zebrafish by CRISPR/Cas9-mediated gene editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-DIRECTED REPAIR; MEDIATED KNOCK-IN; ZINC-FINGER TARGETER; STEM-CELLS; GENOME; RECOMBINATION; TALEN; CRISPR-CAS9; PRECISE; DNA	Homology-directed recombination (HDR)-mediated genome editing is a powerful approach for both basic functional study and disease modeling. Although some studies have reported HDR-mediated precise editing in nonrodent models, the efficiency of establishing pure mutant animal lines that carry specific amino acid substitutions remains low. Furthermore, because the efficiency of nonhomologous end joining (NHEJ)-induced insertion and deletion (indel) mutations is normally much higher than that of HDR-induced point mutations, it is often difficult to identify the latter in the background of indel mutations. Using zebrafish as the model organism and Y box-binding protein 1 (Ybx1/ybx1) as the model molecule, we have established an efficient platform for precise CRISPR/Cas9-mediated gene editing in somatic cells, yielding an efficiency of up to 74% embryos. Moreover, we established a procedure for screening germline transmission of point mutations out of indel mutations even when germline transmission efficiency was low (<2%). To further improve germline transmission of HDR-induced point mutations, we optimized several key factors that may affect HDR efficiency, including the type of DNA donor, suppression of NHEJ, stimulation of HDR pathways, and use of Cas9 protein instead of mRNA. The optimized combination of these factors significantly increased the efficiency of germline transmission of point mutation up to 25%. In summary, we have developed an efficient procedure for creating point mutations and differentiating mutant individuals from those carrying knockouts of entire genes.	[Zhang, Yibo; Zhang, Zhiwei; Ge, Wei] Univ Macau, CRDA, Fac Hlth Sci, Macau 999078, Peoples R China	University of Macau	Ge, W (corresponding author), Univ Macau, CRDA, Fac Hlth Sci, Macau 999078, Peoples R China.	weige@umac.mo		Zhang, Bob/0000-0003-2497-9519; Zhang, Yibo/0000-0002-0893-4962				Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Ahrabi S, 2016, NUCLEIC ACIDS RES, V44, P5743, DOI 10.1093/nar/gkw326; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2015, METHODS MOL BIOL, V1239, P291, DOI 10.1007/978-1-4939-1862-1_17; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; Fiala O, 2016, TUMOR BIOL, V37, P6823, DOI 10.1007/s13277-015-4523-7; Guo X, 2016, NAT CELL BIOL, V18, P202, DOI 10.1038/ncb3289; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang P, 2014, METHODS, V69, P67, DOI 10.1016/j.ymeth.2014.02.010; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumari P, 2013, ELIFE, V2, DOI 10.7554/eLife.00683; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Mao PS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12154; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ota S, 2014, CONGENIT ANOM, V54, P8, DOI 10.1111/cga.12040; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Petrezselyova S, 2015, CELL MOL BIOL LETT, V20, P773, DOI 10.1515/cmble-2015-0047; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Samarut E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2881-1; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sauer NJ, 2016, PLANT BIOTECHNOL J, V14, P496, DOI 10.1111/pbi.12496; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Shah AN, 2016, DEV CELL, V36, P595, DOI 10.1016/j.devcel.2016.03.004; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Shinkuma S, 2016, P NATL ACAD SCI USA, V113, P5676, DOI 10.1073/pnas.1512028113; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Sueda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep18949; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vannocci T, 2015, DIS MODEL MECH, V8, P711, DOI 10.1242/dmm.020545; Varshney GK, 2015, ADV GENET, V92, P1, DOI 10.1016/bs.adgen.2015.09.002; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256; Zhu B, 2018, GEN COMP ENDOCR, V257, P3, DOI 10.1016/j.ygcen.2017.09.011	66	27	28	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6611	6622		10.1074/jbc.RA117.001080	http://dx.doi.org/10.1074/jbc.RA117.001080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29500194	Green Published, hybrid			2022-12-26	WOS:000431108600031
J	Yokoyama, CC; Baldridge, MT; Leung, DW; Zhao, GY; Desai, C; Liu, TC; Diaz-Ochoa, VE; Huynh, JP; Kimmey, JM; Sennott, EL; Hole, CR; Idol, RA; Park, S; Storek, KM; Wang, CH; Hwang, S; Milam, AV; Chen, E; Kerrinnes, T; Starnbach, MN; Handley, SA; Mysorekar, IU; Allen, PM; Monack, DM; Dinauer, MC; Doering, TL; Tsolis, RM; Dworkin, JE; Stallings, CL; Amarasinghe, GK; Micchelli, CA; Virgin, HW				Yokoyama, Christine C.; Baldridge, Megan T.; Leung, Daisy W.; Zhao, Guoyan; Desai, Chandni; Liu, Ta-Chiang; Diaz-Ochoa, Vladimir E.; Huynh, Jeremy P.; Kimmey, Jacqueline M.; Sennott, Erica L.; Hole, Camaron R.; Idol, Rachel A.; Park, Sunmin; Storek, Kelly M.; Wang, Caihong; Hwang, Seungmin; Milam, Ashley Viehmann; Chen, Eric; Kerrinnes, Tobias; Starnbach, Michael N.; Handley, Scott A.; Mysorekar, Indira U.; Allen, Paul M.; Monack, Denise M.; Dinauer, Mary C.; Doering, Tamara L.; Tsolis, Renee M.; Dworkin, Jonathan E.; Stallings, Christina L.; Amarasinghe, Gaya K.; Micchelli, Craig A.; Virgin, Herbert W.			LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE; IMMUNE-RESPONSES; GENE-EXPRESSION; T-CELLS; INNATE; AUTOPHAGY; MICE; ESTABLISHMENT; RECOGNITION; INFECTION	Germline-encoded receptors recognizing common pathogen-associated molecular patterns are a central element of the innate immune system and play an important role in shaping the host response to infection. Many of the innate immune molecules central to these signaling pathways are evolutionarily conserved. LysMD3 is a novel molecule containing a putative peptidoglycan-binding domain that has orthologs in humans, mice, zebrafish, flies, and worms. We found that the lysin motif (LysM) of LysMD3 is likely related to a previously described peptidoglycan-binding LysM found in bacteria. Mouse LysMD3 is a type II integral membrane protein that co-localizes with GM130+ structures, consistent with localization to the Golgi apparatus. We describe here two lines of mLysMD3-deficient mice for in vivo characterization of mLysMD3 function. We found that mLysMD3-deficient mice were born at Mendelian ratios and had no obvious pathological abnormalities. They also exhibited no obvious immune response deficiencies in a number of models of infection and inflammation. mLysMD3-deficient mice exhibited no signs of intestinal dysbiosis by 16S analysis or alterations in intestinal gene expression by RNA sequencing. We conclude that mLysMD3 contains a LysM with cytoplasmic orientation, but we were unable to define a physiological role for the molecule in vivo.	[Yokoyama, Christine C.; Leung, Daisy W.; Zhao, Guoyan; Desai, Chandni; Liu, Ta-Chiang; Park, Sunmin; Milam, Ashley Viehmann; Handley, Scott A.; Mysorekar, Indira U.; Allen, Paul M.; Amarasinghe, Gaya K.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Baldridge, Megan T.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Huynh, Jeremy P.; Kimmey, Jacqueline M.; Hole, Camaron R.; Doering, Tamara L.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Idol, Rachel A.; Dinauer, Mary C.; Dworkin, Jonathan E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wang, Caihong; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Micchelli, Craig A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Diaz-Ochoa, Vladimir E.; Kerrinnes, Tobias; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Sennott, Erica L.; Starnbach, Michael N.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Hwang, Seungmin] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Chen, Eric] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Dworkin, Jonathan E.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Storek, Kelly M.] Genentech Inc, San Francisco, CA 95688 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; Harvard University; Harvard Medical School; Stanford University; University of Chicago; University of California System; University of California Berkeley; Columbia University; Roche Holding; Genentech	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Kimmey, Jacqueline/GXV-9323-2022; Desai, Chandni/AAA-5477-2020; Baldridge, Megan/T-7274-2019; Mysorekar, Indira U./GRS-4574-2022	Desai, Chandni/0000-0002-3708-3634; Baldridge, Megan/0000-0002-7030-6131; Mysorekar, Indira U./0000-0003-3917-8677; Kimmey, Jacqueline M/0000-0003-1330-8525; Liu, Ta-Chiang/0000-0002-2800-9360; Hole, Camaron/0000-0002-9363-3020; Hwang, Seungmin/0000-0003-0846-5462; Allen, Paul/0000-0003-3796-6047; Zhao, Guoyan/0000-0001-5615-6774; Monack, Denise/0000-0003-3804-2209	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Crohn's and Colitis Foundation Genetics Initiative [274415]; National Science Foundation Fellowships [DGE-1143954]; National Institutes of Health [T32AI007163, T32GM007067, T32AI007172, F32AI108089, R01DK100644, R01AI24157, R01AI095396, R01AI102882, U19AI109725]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award; Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095396, F32AI108089, U19AI109725, T32AI007163, R01AI109799, T32AI007172, R01AI102882, U19AI113187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Crohn's and Colitis Foundation Genetics Initiative; National Science Foundation Fellowships; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital (to M.C.D.), Grant 274415 from the Crohn's and Colitis Foundation Genetics Initiative (to H.W.V.), National Science Foundation Fellowships DGE-1143954 (to J.P.H.) and DGE-1143954 (to J.M.K.), and National Institutes of Health Grants T32AI007163 (to C.C.Y.), T32GM007067 (to J.M.K.), T32AI007172 (to C.R.H.), F32AI108089 (to K.M.S.), R01DK100644 (to I.U.M.), R01AI24157 (to P.M.A.), R01AI095396 (to D.M.M.), R01AI102882 (to T.L.D.), and U19AI109725 (to H.W.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award.r Supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation and a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Byndloss MX, 2016, ANNU REV ANIM BIOSCI, V4, P111, DOI 10.1146/annurev-animal-021815-111326; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703; Djordjevic MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112635; Dolat L, 2017, TRENDS CELL BIOL, V27, P877, DOI 10.1016/j.tcb.2017.09.004; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Laroche RJF, 2013, GENE EXPR PATTERNS, V13, P212, DOI 10.1016/j.gep.2013.02.007; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002297; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu Q, 2016, CELL HOST MICROBE, V19, P102, DOI 10.1016/j.chom.2015.12.011; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monach Paul, 2007, V136, P269; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Park S, 2016, CELL HOST MICROBE, V19, P91, DOI 10.1016/j.chom.2015.12.010; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Redmann V, 2016, SCI REP-UK, V6, DOI 10.1038/srep23326; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; SCHAUER DB, 1993, INFECT IMMUN, V61, P4654, DOI 10.1128/IAI.61.11.4654-4661.1993; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Stemler KM, 2013, J UROLOGY, V189, P343, DOI 10.1016/j.juro.2012.08.189; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Symington JW, 2015, MUCOSAL IMMUNOL, V8, P1388, DOI 10.1038/mi.2015.7; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22598; Terlizzi ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01566; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Wang ZP, 2012, J IMMUNOL, V188, P3993, DOI 10.4049/jimmunol.1103301; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	87	6	6	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6022	6038		10.1074/jbc.RA117.001246	http://dx.doi.org/10.1074/jbc.RA117.001246			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496999	hybrid, Green Published			2022-12-26	WOS:000430497300022
J	Chen, CH; Lin, CL; Jeng, LB				Chen, Chien-Hua; Lin, Cheng-Li; Jeng, Long-Bin			Association between chronic pancreatitis and urolithiasis: A population-based cohort study	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY-STONES; PREVALENCE; RISK; NEPHROLITHIASIS; EPIDEMIOLOGY; MANAGEMENT; NATIONWIDE	Purpose Chronic pancreatitis (CP) can cause fat or bile acid malabsorption due to exocrine insufficiency. Fat or bile acid malabsorption has been reported to increase the risk of urolithiasis through increased intestinal oxalate absorption. However, no studies have reported an association between CP and urolithiasis. Methods We identified 15,848 patients (age: >= 20 years) diagnosed as having CP between 2000 and 2010 from the National Health Insurance Research Database as the study cohort. Beneficiaries without a history of CP were randomly selected and propensity-matched with the study cohort in a 1: 4 ratio according to age; sex; comorbidities of hyperlipidemia, diabetes, obesity, hypertension, chronic obstructive pulmonary disease, alcohol-related illness, stroke, and coronary artery disease; and the index date. The prevalence of inflammatory bowel disease (0.44%), hyperparathyroidism (0.10%), or end stage renal disease (1.55%) in CP patients was low, but these comorbidities were also considered in the analysis. All patients were followed until the end of 2011 or withdrawal from the National Health Insurance program to determine the incidence of urolithiasis. Results The cumulative incidence of urolithiasis was higher in the CP cohort than that in the non-CP cohort (log-rank test, P < 0.001) with a 1.89-fold risk of urolithiasis (95% confidence interval [CI] = 1.74-2.06). The prevalence of CP was higher in men (81.9%) and in patients younger than 49 years (63.5%; mean age: 48.5-15.3 years). CP was associated with the development of urolithiasis in each age group (<= 49 years: aHR = 2.00, 95% CI = 1.81-2.22; 50-64 years: aHR = 1.71, 95% CI = 1.40-2.09; >= 65 years: aHR = 1.54, 95% CI = 1.20-1.98) and each sex (women: aHR = 2.10, 95% CI = 1.67-2.66; men; aHR = 1.86, 95% CI = 1.70-2.04). Among the patients without comorbidities, the rate of urolithiasis increased from 2.93/1,000 person-years in non-CP patients to 8.28/1,000 person-years in CP patients. Among the patients with comorbidities, the rate of urolithiasis increased from 6.12/1,000 personyears in non-CP patients to 10.9/1,000 person-years in CP patients. The contribution of CP to the relative risk of urolithiasis was greater in patients without comorbidities (without comorbidities: aHR = 2.81, 95% CI = 2.30-3.44) than in those with comorbidities (aHR = 1.76, 95% CI = 1.61-1.94). Conclusion CP is associated with urolithiasis in this population-based cohort study. The contribution of CP to the relative risk of urolithiasis was even greater in patients with a lower risk of urolithiasis, such as those without other comorbidities. Our findings warrant a survey and education on urolithiasis for patients with CP.	[Chen, Chien-Hua] Show Chwan Mem Hosp, Digest Dis Ctr, Changhua, Taiwan; [Chen, Chien-Hua] Changbing Show Chwan Mem Hosp, Digest Dis Ctr, Lukang Township, Changhua, Taiwan; [Chen, Chien-Hua] Hungkuang Univ, Dept Food Sci & Technol, Taichung, Taiwan; [Chen, Chien-Hua] Chung Chou Univ Sci & Technol, Yuanlin Township, Changhua, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan	Show Chwan Memorial Hospital; Hungkuang University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Jeng, LB (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan.	otc.Jeng@gmail.com			Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-6-039-005-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 106-2321-6-039-005-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang UC, 2014, GASTROENTEROLOGY, V146, P989, DOI 10.1053/j.gastro.2013.12.033; Besiroglu H, 2015, RENAL FAILURE, V37, P1, DOI 10.3109/0886022X.2014.976133; Cartery C, 2011, CLIN J AM SOC NEPHRO, V6, P1895, DOI 10.2215/CJN.00010111; Chen CH, 2016, ONCOTARGET, V7, P64380, DOI 10.18632/oncotarget.9062; Chen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002192; Conwell DL, 2014, PANCREAS, V43, P1143, DOI 10.1097/MPA.0000000000000237; Conwell DL, 2012, CLIN GASTROENTEROL H, V10, P1088, DOI 10.1016/j.cgh.2012.05.015; Cupisti A, 2007, BIOMED PHARMACOTHER, V61, P86, DOI 10.1016/j.biopha.2006.09.012; Demoulin N, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006758; DOBBINS JW, 1976, GASTROENTEROLOGY, V70, P1096; Munoz JED, 2010, BEST PRACT RES CL GA, V24, P233, DOI 10.1016/j.bpg.2010.03.008; Ferrarz RRN, 2004, KIDNEY INT, V66, P672; Forsmark CE, 2013, GASTROENTEROLOGY, V144, P1282, DOI 10.1053/j.gastro.2013.02.008; Garg Pramod Kumar, 2012, Curr Gastroenterol Rep, V14, P118, DOI 10.1007/s11894-012-0241-0; Gershman B, 2012, UROLOGY, V80, P38, DOI 10.1016/j.urology.2011.12.019; Goldfarb DS, 2015, MED HYPOTHESES, V85, P953, DOI 10.1016/j.mehy.2015.09.003; Hall TC, 2014, J EVAL CLIN PRACT, V20, P203, DOI 10.1111/jep.12117; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; Hueppelshaeuser R, 2012, PEDIATR NEPHROL, V27, P1103, DOI 10.1007/s00467-012-2126-8; Indridason OS, 2006, SCAND J UROL NEPHROL, V40, P215, DOI 10.1080/00365590600589898; Keddis MT, 2013, CURR OPIN NEPHROL HY, V22, P390, DOI 10.1097/MNH.0b013e32836214b9; Keller J, 2005, GUT, V54, P1, DOI 10.1136/gut.2005.065946; Keller J., 2015, PANCREAPEDIA EXOCRIN; Kim S, 2018, AM J KIDNEY DIS, V71, P35, DOI 10.1053/j.ajkd.2017.06.026; Kumar R, 2011, SURGERY, V149, P654, DOI 10.1016/j.surg.2010.11.015; Li BR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21381; Lin JN, 2015, LANCET ONCOL, V16, P1335, DOI 10.1016/S1470-2045(15)00060-1; Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu YQ, 2014, AM J KIDNEY DIS, V64, P402, DOI 10.1053/j.ajkd.2014.03.017; Lotan Y, 2004, J UROLOGY, V172, P2275, DOI 10.1097/01.ju.0000141498.11720.20; Majumder S, 2016, LANCET, V387, P1957, DOI 10.1016/S0140-6736(16)00097-0; Matlaga BR, 2010, UROL RES, V38, P453, DOI 10.1007/s00240-010-0327-9; Mello MF, 2016, INT BRAZ J UROL, V42, P1150, DOI [10.1590/S1677-5538.IBJU.2015.0743, 10.1590/s1677-5538.ibju.2015.0743]; Nikolis L, 2017, J PEDIATR UROL, V13, DOI 10.1016/j.jpurol.2016.07.017; Osther PJS, UROLITHIASIS BASIC S, P3; Sorokin I, 2017, WORLD J UROL, V3, P72; Soueidan M, 2015, CUAJ-CAN UROL ASSOC, V9, P257, DOI 10.5489/cuaj.2879; Strohmaier WL, 2013, UROLITHIASIS, V41, P475, DOI 10.1007/s00240-013-0606-3; Strohmaier WL, 2012, UROL RES, V40, P171, DOI 10.1007/s00240-011-0403-9; Tae BS, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e13; Vijaya T, 2013, GEN PHYTOPHARMACOLOG, V2, P1; Wang LW, 2009, PANCREAS, V38, P248, DOI 10.1097/MPA.0b013e31818f6ac1; Wong YV, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/570674; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Zechner O, 1981, ALCOHOL EPIDEMIOLOGI; Zou WB, 2016, GASTROENTEROLOGY, V150, P1558, DOI 10.1053/j.gastro.2016.02.071	49	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194019	10.1371/journal.pone.0194019	http://dx.doi.org/10.1371/journal.pone.0194019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522553	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800034
J	King, W; Lacey, A; White, J; Farewell, D; Dunstan, F; Fone, D				King, William; Lacey, Arron; White, James; Farewell, Daniel; Dunstan, Frank; Fone, David			Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study	PLOS ONE			English	Article							CROSS-SECTIONAL ANALYSIS; LIPID-LOWERING THERAPY; INVERSE CARE LAW; OUTCOMES FRAMEWORK; MYOCARDIAL-INFARCTION; GENERAL PRACTICES; ADHERENCE; ENGLAND; STATIN; QUALITY	Background Coronary heart disease (CHD) mortality in England fell by 36% between 2000 and 2007 and it is estimated that approximately 50% of the fall was due to improved treatment uptake. Marked socio-economic inequalities in CHD mortality in the United Kingdom (UK) remain, with higher age-adjusted rates in more deprived groups. Inequalities in the persistence of medication for primary and secondary prevention of CHD may contribute to the observed social gradient and we investigated this possibility in the population of Wales (UK). Methods and findings An electronic cohort of individuals aged over 20 (n = 1,199,342) in Wales (UK) was formed using linked data from primary and secondary care and followed for six years (2004-2010). We identified indications for medication (statins, aspirin, ACE inhibitors, clopidogrel) recommended in UK National Institute for Clinical Excellence (NICE) guidance for CHD (high risk, stable angina, stable angina plus diabetes, unstable angina, and myocardial infarction) and measured the persistence of indicated medication (time from initiation to discontinuation) across quintiles of the Welsh Index of Multiple Deprivation, an area-based measure of socio-economic inequality, using Cox regression frailty models. In models adjusted for demographic factors, CHD risk and comorbidities across 15 comparisons for persistence of the medications, none favoured the least deprived quintile, two favoured the most deprived quintile and 13 showed no significant differences. Conclusions During our study period (2004-2010) we found no significant evidence of socio-economic inequality in the persistence of recommended medication for primary and secondary prevention of CHD.	[King, William] Publ Hlth Wales, Cardiff, S Glam, Wales; [Lacey, Arron] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [White, James] Cardiff Univ, Ctr Dev & Evaluat Complex Publ Hlth Intervent, Cardiff, S Glam, Wales; [White, James] Cardiff Univ, South East Wales Trials Unit, Cardiff, S Glam, Wales; [Farewell, Daniel; Dunstan, Frank; Fone, David] Cardiff Univ, Div Populat Med, Cardiff, S Glam, Wales	Swansea University; Cardiff University; Cardiff University; Cardiff University	King, W (corresponding author), Publ Hlth Wales, Cardiff, S Glam, Wales.	william.king@wales.nhs.uk	Lacey, Arron/AAO-5415-2021	Farewell, Daniel/0000-0002-8871-1653; White, James/0000-0001-8371-8453	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; British Heart Foundation [MR/K0232331/1]; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Welsh Government; Wellcome Trust, under the UK Clinical Research Collaboration; Health and Care Research Wales; Medical Research Council Methodology Fellowship; Medical Research Council [G0902108] Funding Source: researchfish; MRC [G0902108, MR/K023233/1] Funding Source: UKRI	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); Health and Care Research Wales; Medical Research Council Methodology Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/K0232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged (Dr White). While carrying out this work, WK was funded as a Welsh Clinical Academic Track Fellow. AL was employed by the Cardiovascular Research Group Cymru, funded by a grant from Health and Care Research Wales (formerly National Institute for Social Care and Health Research). Part of DFa's work was supported by a Medical Research Council Methodology Fellowship. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All Wales Medicines Strategy Group, 2013, ALL WAL REV GUID PRE; [Anonymous], 2001, NAT SERV FRAM COR HE; [Anonymous], 2008, TECHNICAL REPORT; Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; Avery AJ, 2002, BRIT J GEN PRACT, V52, pS17; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Bentley T., 1996, P 1996 ANN C PRIM HL; Boggon R, 2011, EUR HEART J, V32, P2376, DOI 10.1093/eurheartj/ehr340; Bradshaw NS, 1998, PHARM J, V261, pR11; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Carey IM, 2012, NUTR METAB CARDIOVAS, V22, P400, DOI 10.1016/j.numecd.2010.09.010; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Eagle KA, 2004, AM J MED, V117, P73, DOI 10.1016/j.amjmed.2003.12.041; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Harris CM, 1996, BRIT J GEN PRACT, V46, P649; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hawkins N, 2013, CIRCULATION CARDIOVA, V111; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; King W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172618; Kulkarni SP, 2006, AM HEART J, V151, P185, DOI 10.1016/j.ahj.2005.02.038; Liberopoulos EN, 2008, EXPERT OPIN DRUG SAF, V7, P717, DOI [10.1517/14740330802396984, 10.1517/14740330802396984 ]; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Mann DM, 2007, CARDIOVASC DRUG THER, V21, P311, DOI 10.1007/s10557-007-6040-4; McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737; McGovern MP, 2008, DIABETIC MED, V25, P1083, DOI 10.1111/j.1464-5491.2008.02544.x; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; National Institute for Clinical Excellence, 2002, MAN TYP 2 DIAB MAN B; National Institute for Clinical Excellence, 2001, PROPH PAT WHO HAV EX; National Institute for Health and Clinical Excellence, 2004, CG18 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2006, CG34 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2008, LIP MOD CARD RISK AS; O'Dowd A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2410; Packham C, 2000, BMJ-BRIT MED J, V320, P1583, DOI 10.1136/bmj.320.7249.1583; Packham C, 1999, J PUBLIC HEALTH MED, V21, P60, DOI 10.1093/pubmed/21.1.60; Petty DR, 2008, J PUBLIC HEALTH-UK, V30, P494, DOI 10.1093/pubmed/fdn048; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; Therneau T, 2012, R PACKAGE VERSION, V2; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vinogradova Y, 2009, GASTROENTEROLOGY, V136, pA69; Ward Paul R, 2007, Int J Equity Health, V6, P2, DOI 10.1186/1475-9276-6-2; Ward Paul R, 2005, Int J Equity Health, V4, P3, DOI 10.1186/1475-9276-4-3; Ward PR, 2004, J EPIDEMIOL COMMUN H, V58, P89, DOI 10.1136/jech.58.2.89	52	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194081	10.1371/journal.pone.0194081	http://dx.doi.org/10.1371/journal.pone.0194081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522561	gold, Green Published, Green Submitted			2022-12-26	WOS:000427030800042
J	Monai, N; Yamauchi, K; Tanabu, R; Gonome, T; Ishiguro, S; Nakazawa, M				Monai, Natsuki; Yamauchi, Kodai; Tanabu, Reiko; Gonome, Takayuki; Ishiguro, Sei-ichi; Nakazawa, Mitsuru			Characterization of photoreceptor degeneration in the rhodopsin P23H transgenic rat line 2 using optical coherence tomography	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; RETINAL DYSTROPHY; SD-OCT; THICKNESS; MUTATION; RECEPTOR; GENE; ELECTRORETINOGRAM; FAMILIES; IMAGES	Purpose To characterize the optical coherence tomography (OCT) appearances of photoreceptor degeneration in the rhodopsin P23H transgenic rat (line 2) in relation to the histological, ultrastructural, and electroretinography (ERG) findings. Materials and methods Homozygous rhodopsin P23H transgenic albino rats (line 2, very-slow degeneration model) were employed. Using OCT (Micron IV (R); Phoenix Research Labs, Pleasanton, CA, USA), the natural course of photoreceptor degeneration was recorded from postnatal day (P) 15 to P 287. The OCT images were qualitatively observed by comparing them to histological and ultrastructural findings at P 62 and P 169. In addition, each retinal layer was quantitatively analyzed longitudinally during degeneration, compared it to that observed in wild type Sprague-Dawley (SD) rats. The relationships between the ERG (full-field combined rod-cone response, 3.0 cds/m(2) stimulation) findings and OCT images were also analyzed. Results In the qualitative study, the two layers presumably corresponding to the photoreceptor inner segment ellipsoid zone (EZ) and interdigitation zone (IZ) were identified in the P23H rat until PN day 32. However, the photoreceptor inner and outer segment (IS/OS) layer became diffusely hyperreflective on OCT after P 46, and the EZ and IZ zones could no longer be identified on OCT. In contrast, in the SD rats, the EZ and IZ were clearly distinguished until at least P 247. The ultrastructural study showed partial disarrangements of the photoreceptor outer segment discs in the P23H rats at P 62, although a light-microscopic histological study detected almost no abnormality in the outer segment. In the quantitative study, the outer retinal layer including the outer plexiform layer (OPL) and the outer nuclear layer (ONL) became significantly thinner in the P23H rats than in the SD rats after P 71. The thickness of the IS/OS layer was maintained in the P23H rats until P 130, and it became statistically thinner than in the SD rats at P 237. The longitudinal attenuation in the amplitude of the a-and b-waves of ERG was significantly correlated with the thickness of the combined OPL and ONL but not with that of the IS/OS layer. Conclusion OCT showed the degenerated photoreceptor IS/OS layer in rhodopsin P23H transgenic rats (line 2) as a diffuse hyperreflective zone, even in the early stage, with the partially disarranged and destabilized OS discs recognizable by ultrastructural assessment but not by a histological study. The amplitude of the a-and b-waves mainly depends on the thickness of the OPL and ONL layer rather than the thickness of the photoreceptor IS/OS layer in P23H rats.	[Monai, Natsuki; Yamauchi, Kodai; Tanabu, Reiko; Gonome, Takayuki; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan; [Ishiguro, Sei-ichi] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan	Hirosaki University; Tohoku University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712	Japan Society for the Promotion of Science [C-16K11313, B-17K16954]; Pfizer; Santen; Alcon; Novartis; K-vision; AMO	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Pfizer(Pfizer); Santen; Alcon(Novartis); Novartis(Novartis); K-vision; AMO	This study was supported in part by a Grant-in Aid for Scientific Research, C-16K11313 (MN) from Japan Society for the Promotion of Science, http://www.jsps.go.jp/, and a Grant-in Aid for Young Scientists, B-17K16954 (NM) from Japan Society for the Promotion of Science, http://www.jsps.go.jp/. Research Fundings from Pfizer, Santen, Alcon, Novartis, K-vision, AMO also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162835; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Grover S, 2006, AM J OPHTHALMOL, V141, P850, DOI 10.1016/j.ajo.2005.12.030; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Levine ES, 2014, VISION RES, V102, P71, DOI 10.1016/j.visres.2014.07.011; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Nakazawa M, 2014, EXPERT OPIN ORPHAN D, V2, P37, DOI 10.1517/21678707.2014.858596; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Oishi M, 2014, INVEST OPHTH VIS SCI, V55, P7369, DOI 10.1167/iovs.14-15458; Orhan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127319; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Ryals RC, 2017, INVEST OPHTH VIS SCI, V58, P1378, DOI 10.1167/iovs.16-20363; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P4568, DOI 10.1167/iovs.08-1992; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493	37	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193778	10.1371/journal.pone.0193778	http://dx.doi.org/10.1371/journal.pone.0193778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522537	gold, Green Submitted, Green Published			2022-12-26	WOS:000427030800022
J	Carlsson, R; Ozen, I; Barbariga, M; Gaceb, A; Roth, M; Paul, G				Carlsson, Robert; Ozen, Ilknur; Barbariga, Marco; Gaceb, Abderahim; Roth, Michaele; Paul, Gesine			STAT3 precedes HIF1 alpha transcriptional responses to oxygen and oxygen and glucose deprivation in human brain pericytes	PLOS ONE			English	Article							SIGNAL TRANSDUCER; HYPOXIA; CELLS; ANGIOGENESIS; EXPRESSION; STROKE; VEGF; INTERLEUKIN-6; GENOME; NEUROPROTECTION	Brain pericytes are important to maintain vascular integrity of the neurovascular unit under both physiological and ischemic conditions. Ischemic stroke is known to induce an inflammatory and hypoxic response due to the lack of oxygen and glucose in the brain tissue. How this early response to ischemia is molecularly regulated in pericytes is largely unknown and may be of importance for future therapeutic targets. Here we evaluate the transcriptional responses in in vitro cultured human brain pericytes after oxygen and/or glucose deprivation. Hypoxia has been widely known to stabilise the transcription factor hypoxia inducible factor 1-alpha (HIF1 alpha) and mediate the induction of hypoxic transcriptional programs after ischemia. However, we find that the transcription factors Jun Proto-Oncogene (c-JUN), Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells (NF kappa B) and signal transducer and activator of transcription 3 (STAT3) bind genes regulated after 2hours (hs) of omitted glucose and oxygen before HIF1 alpha. Potent HIF1 alpha responses require 6hs of hypoxia to substantiate transcriptional regulation comparable to either c-JUN or STAT3. Phosphorylated STAT3 protein is at its highest after 5 min of oxygen and glucose (OGD) deprivation, whereas maximum HIF1 alpha stabilisation requires 120 min. We show that STAT3 regulates angiogenic and metabolic pathways before HIF1 alpha, suggesting that HIF1 alpha is not the initiating trans-acting factor in the response of pericytes to ischemia.	[Carlsson, Robert; Ozen, Ilknur; Barbariga, Marco; Gaceb, Abderahim; Roth, Michaele; Paul, Gesine] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Translat Neurol Grp, Lund, Sweden; [Paul, Gesine] Scania Univ Hosp, Dept Neurol, Lund, Sweden; [Paul, Gesine] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden	Lund University; Lund University	Paul, G (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Translat Neurol Grp, Lund, Sweden.; Paul, G (corresponding author), Scania Univ Hosp, Dept Neurol, Lund, Sweden.; Paul, G (corresponding author), Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden.	gesine.paul-visse@med.lu.se		Roth, Michaela/0000-0001-7565-7574; Carlsson, Robert/0000-0001-5955-2916	Swedish Medical Research Council [2015-02468]; Crafoord Foundation [2015-02468]; Olle Engkvist Foundation [2014/185]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Olle Engkvist Foundation	This study was funded by the Swedish Medical Research Council ( Grant No. 2015-02468), the Crafoord Foundation ( Grant No. 2015-02468) and Olle Engkvist Foundation ( Grant No. 2014/185) to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Swedish Medical Research Council, the Crafoord Foundation and Olle Engkvist Foundation.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Beckman JD, 2006, ENDOCRINE, V29, P467, DOI 10.1385/ENDO:29:3:467; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frost J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13312; Gaceb A, 2017, J CEREB BLOOD FLOW M; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Gough DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083395; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hoffmann CJ, 2015, CIRCULATION, V131, P1772, DOI 10.1161/CIRCULATIONAHA.114.013003; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kashiwamura Y, 2011, NEUROCHEM RES, V36, P849, DOI 10.1007/s11064-011-0413-6; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/jcp.1041180311; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwaninger M, 1997, J NEUROCHEM, V69, P1145; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Svensson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123553; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09210-4; Watanabe S, 1997, ATHEROSCLEROSIS, V130, P101, DOI 10.1016/S0021-9150(96)06050-9; Wen Z, CELL, V82, P241; Winkler EA, 2011, DEV CELL, V20, P279, DOI 10.1016/j.devcel.2011.03.002; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517; Yu PC, 2017, NATURE, V545, P224, DOI 10.1038/nature22322	47	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194146	10.1371/journal.pone.0194146	http://dx.doi.org/10.1371/journal.pone.0194146			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518129	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900070
J	Ebonwu, J; Mumbauer, A; Uys, M; Wainberg, ML; Medina-Marino, A				Ebonwu, Joy; Mumbauer, Alexandra; Uys, Margot; Wainberg, Milton L.; Medina-Marino, Andrew			Determinants of late antenatal care presentation in rural and pen-urban communities in South Africa: A cross-sectional study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; JOHANNESBURG; BOOKING; WOMEN; HIV	Objective To investigate and compare determinates for delayed first presentation to antenatal care (ANC) services. Methods A cross-sectional study was conducted amongst pregnant women attending their first ANC visit in rural Capricorn District and pen-urban Tlokwe sub-district communities in South Africa. Data collection included questionnaires and medical record abstraction. Bivariate and multivariate analyses assessed factors associated with late ANC presentation. Results We recruited 807 pregnant women. Of these, 51% of rural women and 28% of pen-urban women presented late for first ANC. Rural women were more likely to present late for first ANC (AOR = 2.65; 95% Cl 1.98-3.55) and report barriers to accessing ANC services (P<0.0001). Late ANC presentation in rural communities was associated with being married (AOR = 2.36; 95 % CI 1.33-4.19), employed (AOR = 1.90; 95% CI 1.03-3.50), <20 years of age (AOR = 2.19; 95% CI 1.10-4.37), and reporting an unplanned pregnancy (AOR = 2.21; 95% Cl 1.40-3.50). Late presentation in pen-urban communities was associated with unplanned pregnancy (AOR = 1.67; 95% Cl 1.01-2.74), being told to come back later to initiate ANC after presenting early (AOR 0.51; 95% Cl 0.30-0.89) and being pregnant for the first time (AOR = 0.56; 95% Cl 0.34-0.94) Conclusion Both rural and pen-urban women had high rates of late presentation for first ANC. However, women in the rural communities were more likely to present late. Unplanned pregnancy was an independent risk factor in both rural and pen-urban communities. Interventions around family planning, especially for adolescent girls and young women, are needed to improve early presentation for ANC.	[Ebonwu, Joy; Mumbauer, Alexandra; Medina-Marino, Andrew] Fdn Profess Dev, Res Unit, Pretoria, South Africa; [Uys, Margot] Fdn Profess Dev, Integrated Hlth Syst Strengthening Dept, Pretoria, South Africa; [Wainberg, Milton L.] Columbia Univ, New York State Psychiat Inst, New York, NY USA	Columbia University; New York State Psychiatry Institute	Medina-Marino, A (corresponding author), Fdn Profess Dev, Res Unit, Pretoria, South Africa.	andrewmedinamarino@gmail.com		, Andrew/0000-0002-0095-4141; Wainberg, Milton/0000-0002-9390-4652	United States President's Emergency Plan for AIDS Relief (PEPFAR) [AID-674-A-12-00017, U2GPS001137-03]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the United States President's Emergency Plan for AIDS Relief (PEPFAR) Cooperative agreements AID-674-A-12-00017 and U2GPS001137-03. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Banda I, 2014, MED J ZAMBIA, V39; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Gebremeskel F, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/971506; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Gudayu TW, 2015, AFR J REPROD HEALTH, V19, P94; Gudayu TW, BMC PREGNANCY CHILDB; Haddad DN, 2016, INT J GYNECOL OBSTET, V132, P64, DOI 10.1016/j.ijgo.2015.06.041; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Manzi A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-290; Massyn N, 2016, DURB HLTH SYST TRUST; Mcintyre P., 2006, PREGNANT ADOLESCENTS; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Department of Health, 2013 NAT ANT SENT HI; National Department of Health Republic of South Africa, 2015, GUID MAT CAR S AFR M; Ndidi E, 2011, GHANA MED J, V44; Pattinson R.C., 2007, BASIC ANTENATAL CARE; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Sibeko S, 2006, S AFR FAM PRACT, V48, P17, DOI 10.1080/20786204.2006.10873478; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Solarin I, 2013, MATERN CHILD HLTH J, V17, P359, DOI 10.1007/s10995-012-1019-6; Statistics South Africa, 2016, S AFR DEM HLTH SURV; *WHO, WHO REC ANT CAR POS; Zegeye Amtatachew M, 2013, Afr J Reprod Health, V17, P130	27	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0191903	10.1371/journal.pone.0191903	http://dx.doi.org/10.1371/journal.pone.0191903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518082	Green Submitted, gold, Green Published			2022-12-26	WOS:000426902900004
J	Boffa, J; Mayan, M; Ndlovu, S; Mhlaba, T; Williamson, T; Sauve, R; Fisher, D				Boffa, Jody; Mayan, Maria; Ndlovu, Sithembile; Mhlaba, Tsholofelo; Williamson, Tyler; Sauve, Reginald; Fisher, Dina			The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa	PLOS ONE			English	Article							ANTHROPOLOGY; BURDEN	Introduction In response to revisions in global and national policy in 2011, six-month isoniazid preventive therapy (IPT) became freely available as a preventive measure for people living with HIV in the uMgungundlovu District of KwaZulu-Natal province, South Africa. Given a difference in uptake and completion by sex, we sought to explore the reasons why Zulu women were more likely to accept and complete IPT compared to men in an effort to inform future implementation. Methods Utilising a community-based participatory research approach and ethnographic methods, we undertook 17 individual and group interviews, and met regularly with grassroots community advisory teams in three Zulu communities located in uMgungundlovu District between March 2012 December 2016. Findings & discussion Three categories described women's willingness to initiate IPT: women are caregivers, women are obedient, and appearance is important. The findings suggest that the success of IPT implementation amongst clinic-utilising women of uMgungundlovu is related to the cultural gender norms of uMakoti, isiZulu for "the bride" or "the wife." We invoke the cultural concept of inhlonipho, meaning "to show respect," to discuss how the cultural values of uMakoti may conflict with biomedical expectations of adherence. Such conflict can result in misinterpretations by healthcare providers or patients, and lead some patients to fear the repercussions of asking questions or contemplating discontinuation with the provider, preferring instead to appear obedient. We propose a shift in emphasis from adherence-focussed strategies, characteristic of the current biomedical approach, to practices that promote patient agency in an effort to offer IPT more appropriately. Implications Building on existing tools, namely the harm reduction model and the use of mini-ethnography, we provide guidance on how to support women to participate as agents in the decision to initiate or continue IPT, decisions which may also impact the health and choices of the family.	[Boffa, Jody; Williamson, Tyler; Sauve, Reginald; Fisher, Dina] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Boffa, Jody] Stellenbosch Univ, Desmond Tutu TB Ctr, Cape Town, Western Cape, South Africa; [Mayan, Maria] Univ Alberta, Fac Extens, Community Univ Partnerships, Edmonton, AB, Canada; [Ndlovu, Sithembile] Izlmbali Zesizwe, Pietermaritzburg, KwaZulu Natal, South Africa; [Mhlaba, Tsholofelo] Univ KwaZulu Natal, Div Publ Hlth Med, Durban, KwaZulu Natal, South Africa; [Sauve, Reginald] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Fisher, Dina] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; Stellenbosch University; University of Alberta; University of Kwazulu Natal; University of Calgary; University of Calgary	Boffa, J (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.; Boffa, J (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Cape Town, Western Cape, South Africa.	jboffa@sun.ac.za		Boffa, Jody/0000-0002-8183-6461	International Development Research Centre; Canadian Institutes of Health Research (CIHR) [278917]	International Development Research Centre; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The International Development Research Centre provided a Doctoral Research Grant (idrc. ca) to JB and Canadian Institutes of Health Research provided Catalyst funding (CIHR No. 278917) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Apers L, 2009, TUBERCULOSIS COMPREH, P780; Beckmann N, 2013, ANTHROPOL MED, V20, P160, DOI 10.1080/13648470.2013.800805; Bhana D, 2016, CROSSCULT R HLTH ILL, P127, DOI 10.1007/978-3-319-29936-5_7; Boffa J, PLOS ONE; Boffa J, 2016, INT J TUBERC LUNG S1, V20, pS109; Boffa J, 2015, INT J TUBERC LUNG S2, V19, pS279; Cote L, 2005, MED TEACH, V27, P71, DOI 10.1080/01421590400016308; Dawson S., 1993, MANUAL USE FOCUS GRO; De Laine M., 1997, ETHNOGRAPHY THEORY A; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Frieden Thomas R, 2007, World Hosp Health Serv, V43, P30; Health Service Executive, 2016, CLIN GUID OP SUBST T; Holloway I., 2003, QUAL RES, V3, P345, DOI [https://doi.org/10.1177/1468794103033004, DOI 10.1177/1468794103033004, 10.1177/1468794103033004]; Hunter M., 2010, LOVE TIME AIDS; Kielmann K, 2010, AIDS CARE, V22, P21, DOI 10.1080/09540121003721000; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Kvale S, 2009, INTERVIEWS LEARNING, P143; Lawn SD, 2009, TUBERCULOSIS COMPREH, P96; Marlatt GA, 1996, ADDICT BEHAV, V21, P779, DOI 10.1016/0306-4603(96)00042-1; Mayan M., 2009, ESSENTIALS QUALITATI; Menzies D, 2006, REICHMAN HERSHFIELDS; Minkler M, 2008, COMMUNITY BASED PART; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Municipalities of South Africa, UMG DISTR MUN DEM IN; Nardell E, 2011, NEW ENGL J MED, V365, P79, DOI 10.1056/NEJMe1105555; Ngozo J., 2016, FAITH LEAD S 18 JUL; Ngwenya T., 2006, SO AFRICAN LINGUISTI, V24, P165; Posel D, 2014, AFR STUD REV, V57, P51, DOI 10.1017/asr.2014.47; Rifkin S., 2001, PARTNERS PLANNING; Robins S, 2006, AM ANTHROPOL, V108, P312, DOI 10.1525/aa.2006.108.2.312; Rudwick S, 2009, AGENDA-EMPOWER WOMEN, V23, P66, DOI 10.1080/10130950.2009.9676276; Rudwick Stephanie Inge, 2008, NORDIC J AFRICAN STU, V17, P152; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Shefer T, 2016, GLOB PUBLIC HEALTH, V11, P211, DOI 10.1080/17441692.2015.1029959; South Africa Department of Health, 2010, GUID TUB PREV THER H; Statistics South Africa, STAT PLAC CENS 2011; Stop TB Partnership, 2015, PAR SHIFT GLOB PLAN; uMgungundlovu District Health Office, 2015, DISTR HLTH PLAN 2015; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2015, S AFR HIV AIDS EST; Wickstrom A, 2010, J ROY ANTHROPOL INST, V16, P532, DOI 10.1111/j.1467-9655.2010.01638.x; World Health Organisation, 2008, WHO 3 M INT CAS FIND; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, END TB STRAT GLOB ST; World Health Organization, 2017, TUB FACT SHEET	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193571	10.1371/journal.pone.0193571	http://dx.doi.org/10.1371/journal.pone.0193571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513719	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800064
J	Budai, D; Vizvari, AD; Bali, ZK; Marki, B; Nagy, LV; Konya, Z; Madarasz, D; Henn-Mike, N; Varga, C; Hernadi, I				Budai, Denes; Vizvari, Attila D.; Bali, Zsolt K.; Marki, Balazs; Nagy, Lili V.; Konya, Zoltan; Madarasz, Daniel; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan			A novel carbon tipped single micro-optrode for combined optogenetics and electrophysiology	PLOS ONE			English	Article							NEURONS IN-VIVO; MILLISECOND-TIMESCALE; NEURAL INTERFACES; BRAIN STRUCTURES; OPTICAL CONTROL; MOTOR CORTEX; DOPAMINE; MICROELECTRODES; VOLTAMMETRY; STRIATUM	Optical microelectrodes (optrodes) are used in neuroscience to transmit light into the brain of a genetically modified animal to evoke and record electrical activity from light-sensitive neurons. Our novel micro-optrode solution integrates a light-transmitting 125 micrometer optical fiber and a 9 micrometer carbon monofilament to form an electrical lead element, which is contained in a borosilicate glass sheathing coaxial arrangement ending with a micrometersized carbon tip. This novel unit design is stiff and slender enough to be used for targeting deep brain areas, and may cause less tissue damage compared with previous models. The center-positioned carbon fiber is less prone to light-induced artifacts than side-lit metal microelectrodes previously presented. The carbon tip is capable of not only recording electrical signals of neuronal origin but can also provide valuable surface area for electron transfer, which is essential in electrochemical (voltammetry, amperometry) or microbiosensor applications. We present details of design and manufacture as well as operational examples of the newly developed single micro-optrode, which includes assessments of 1) carbon tip length-impedance relationship, 2) light transmission capabilities, 3) photoelectric artifacts in carbon fibers, 4) responses to dopamine using fast-scan cyclic voltammetry in vivo, and 5) optogenetic stimulation and spike or local field potential recording from the rat brain transfected with channelrhodopsin- 2. With this work, we demonstrate that our novel carbon tipped single microoptrode may open up new avenues for use in optogenetic stimulation when needing to be combined with extracellular recording, electrochemical, or microbiosensor measurements performed on a millisecond basis.	[Budai, Denes; Vizvari, Attila D.; Marki, Balazs] Kation Sci LLC, Minneapolis, MN 55413 USA; [Bali, Zsolt K.; Nagy, Lili V.; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Bali, Zsolt K.; Nagy, Lili V.; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan] Univ Pecs, Ctr Neurosci, Pecs, Hungary; [Bali, Zsolt K.; Nagy, Lili V.; Hernadi, Istvan] Univ Pecs, Dept Expt Neurobiol, Pecs, Hungary; [Konya, Zoltan; Madarasz, Daniel] Univ Szeged, Dept Appl & Environm Chem, Szeged, Hungary; [Henn-Mike, Nora; Varga, Csaba] Univ Pecs, Dept Physiol, NAP B Entorhinal Microcircuits Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; Szeged University; University of Pecs	Budai, D (corresponding author), Kation Sci LLC, Minneapolis, MN 55413 USA.	denes@kationscientific.com	Konya, Zoltan/C-2492-2009; Bali, Zsolt Kristóf/L-1653-2014	Konya, Zoltan/0000-0002-9406-8596; Bali, Zsolt Kristóf/0000-0003-0712-0788; Varga, Csaba/0000-0002-9188-1282; Budai, Denes/0000-0001-6204-236X	"Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs [EFOP-3.6.1.-16-2016-00004]; The role of neuro-inflammation in neurodegeneration [EFOP-3.6.2-16-2017-00008]	"Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs; The role of neuro-inflammation in neurodegeneration	ZKB, LVN and IH were supported by the EFOP-3.6.1.-16-2016-00004 grant; Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs. NHM and CV were supported by the grant The role of neuro-inflammation in neurodegeneration: from molecules to clinics, EFOP-3.6.2-16-2017-00008. Kation Scientific LLC provided support in the form of salaries for the authors DB, ADV, and BM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the author contributions section.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARMSTRONGJAMES M, 1979, J NEUROSCI METH, V1, P279, DOI 10.1016/0165-0270(79)90039-6; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Belle AM, 2013, ACS CHEM NEUROSCI, V4, P761, DOI 10.1021/cn400031v; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Budai Denes, 2001, Acta Biologica Szegediensis, V45, P65; Budai D, 2010, INTELLIGENT AND BIOSENSORS, P269; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chaves-Coira I, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00028; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; CRESPI F, 1992, J NEUROSCI METH, V42, P149, DOI 10.1016/0165-0270(92)90094-T; Dai J, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031202; Danis L, 2015, ANAL CHEM, V87, P2565, DOI 10.1021/ac503767n; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dufour S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031205; Dufour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057703; Dugue GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105941; Fan B, 2015, LAB CHIP, V15, P3838, DOI 10.1039/c5lc00588d; Garris PA, 2003, NEUROSCIENCE, V118, P819, DOI 10.1016/S0306-4522(03)00005-8; Garris PA, 1997, J NEUROCHEM, V68, P152; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hoffmann P, 1995, ULTRAMICROSCOPY, V61, P165, DOI 10.1016/0304-3991(95)00122-0; Iseri E, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa60b3; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kozai TDY, 2015, J MATER CHEM B, V3, P4965, DOI 10.1039/c5tb00108k; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Kruse W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105589; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lu C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600955; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Millar J, 2001, J NEUROSCI METH, V110, P1, DOI 10.1016/S0165-0270(01)00411-3; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2010, PHARMACOL BIOCHEM BE, V97, P138, DOI 10.1016/j.pbb.2010.05.010; Smith AR, 2015, J CHEM NEUROANAT, V66-67, P28, DOI 10.1016/j.jchemneu.2015.04.002; Stauffer WR, 2016, CELL, V166, P1564, DOI 10.1016/j.cell.2016.08.024; SUGIYAMA K, 1994, J NEUROSCI METH, V53, P73, DOI 10.1016/0165-0270(94)90146-5; Tamura K, 2012, J NEUROSCI METH, V211, P49, DOI 10.1016/j.jneumeth.2012.08.004; Warden MR, 2014, ANNU REV BIOMED ENG, V16, P103, DOI 10.1146/annurev-bioeng-071813-104733; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193836	10.1371/journal.pone.0193836	http://dx.doi.org/10.1371/journal.pone.0193836			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513711	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000426896800081
J	Kadle, RL; Abdou, SA; Villarreal-Ponce, AP; Soares, MA; Sultan, DL; David, JA; Massie, J; Rifkin, WJ; Rabbani, P; Ceradini, DJ				Kadle, Rohini L.; Abdou, Salma A.; Villarreal-Ponce, Alvaro P.; Soares, Marc A.; Sultan, Darren L.; David, Joshua A.; Massie, Jonathan; Rifkin, William J.; Rabbani, Piul; Ceradini, Daniel J.			Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion	PLOS ONE			English	Article							MARROW STROMAL CELLS; TISSUE ALLOTRANSPLANT SURVIVAL; REDUCED OXYGEN-TENSION; BONE-MARROW; ALLOGRAFT SURVIVAL; INDOLEAMINE 2,3-DIOXYGENASE; LYMPHOCYTE PROLIFERATION; DIFFERENTIATION CAPACITY; IN-VITRO; SUPPRESSION	Mesenchymal stem cells (MSCs) are known to both have powerful immunosuppressive properties and promote allograft tolerance. Determining the environmental oxygen tension and inflammatory conditions under which MSCs are optimally primed for this immunosuppressive function is essential to their utilization in promoting graft tolerance. Of particular interest is the mechanisms governing the interaction between MSCs and regulatory T cells (Tregs), which is relatively unknown. We performed our experiments utilizing rat bone marrow derived MSCs. We observed that priming MSCs in hypoxia promotes maintenance of stem-like characteristics, with greater expression of typical MSC cell-surface markers, increased proliferation, and maintenance of differentiation potential. Addition of autologous MSCs to CD4+/allogeneic endothelial cell (EC) co-culture increases regulatory T cell (Treg) proliferation, which is further enhanced when MSCs are primed in hypoxia. Furthermore, MSC-mediated Treg expansion does not require direct cell-cell contact. The expression of indolamine 2,3-dioxygenase, a mediator of MSC immunomodulation, increases when MSCs are primed in hypoxia, and inhibition of IDO significantly decreases the expansion of Tregs. Priming with inflammatory cytokines IFN gamma and TNF alpha increases also expression of markers associated with MSC immunomodulatory function, but decreases MSC proliferation. The expression of IDO also increases when MSCs are primed with inflammatory cytokines. However, there is no increase in Treg expansion when MSCs are primed with IFN gamma, suggesting an alternate mechanism for inflammatory-stimulated MSC immunomodulation. Overall, these results suggest that MSCs primed in hypoxia or inflammatory conditions are optimally primed for immunosuppressive function. These results provide a clearer picture of how to enhance MSC immunomodulation for clinical use.	[Kadle, Rohini L.; Abdou, Salma A.; Villarreal-Ponce, Alvaro P.; Soares, Marc A.; Sultan, Darren L.; David, Joshua A.; Massie, Jonathan; Rifkin, William J.; Rabbani, Piul; Ceradini, Daniel J.] NYU, Langone Med Ctr, Dept Plast Surg, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Ceradini, DJ (corresponding author), NYU, Langone Med Ctr, Dept Plast Surg, New York, NY 10016 USA.	Daniel.Ceradini@nyumc.org	/ABE-5226-2021; Rifkin, William/AAG-1533-2020	Rifkin, William/0000-0002-2314-4125; Rabbani, Piul/0000-0001-8302-8225; Villarreal-Ponce, Alvaro/0000-0003-2398-165X	Department of defense, AFIRM II [WFUHS 441038]; American Association of Plastic Surgery Academic Scholar Award; Howard Hughes Medical Institute [57008244]; NIH NCI [T32CA160002]; National Institutes of Health/National Cancer Institute [P30CA016087]	Department of defense, AFIRM II(United States Department of Defense); American Association of Plastic Surgery Academic Scholar Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of defense, AFIRM II (WFUHS 441038 DJC; D. Ceradini); American Association of Plastic Surgery Academic Scholar Award (D. Ceradini); Howard Hughes Medical Institute Medical Research Fellow (Grant Number 57008244, J. Massie); NIH NCI Institutional Training Grant (T32CA160002; D. Ceradini).; We are grateful to NYU Langone's Cytometry and Cell Sorting Laboratory, and Microscopy Core, which are supported in part by grant P30CA016087 from the National Institutes of Health/National Cancer Institute.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aksu AE, 2008, CLIN IMMUNOL, V127, P348, DOI 10.1016/j.clim.2008.02.003; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Del Fattore A, 2015, CELL TRANSPLANT, P1; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kuo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035459; Kuo YR, 2011, PLAST RECONSTR SURG, V127, P569, DOI 10.1097/PRS.0b013e318200a92c; Kuo YR, 2009, TRANSPLANTATION, V87, P1769, DOI 10.1097/TP.0b013e3181a664f1; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2015, IMMUNOL LETT, V168, P140, DOI 10.1016/j.imlet.2015.05.004; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Obermajer N, 2014, J IMMUNOL, V193, P4988, DOI 10.4049/jimmunol.1401776; Paquet J, 2015, STEM CELL TRANSL MED, V4, P1; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Popp FC, 2008, TRANSPL IMMUNOL, V20, P55, DOI 10.1016/j.trim.2008.08.004; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Prado-Lopez S, 2014, IMMUNOL CELL BIOL, P1; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Raemer PC, 2009, TRANSPLANTATION, V87, P340, DOI 10.1097/TP.0b013e3181957308; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roemeling-Van Rhijn M, 2013, FRONT IMMUNOL, V4, P8; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang Linxia, 2010, J Vis Exp, DOI 10.3791/1852; Zhou HP, 2006, TRANSPL P, V38, P3046, DOI 10.1016/j.transproceed.2006.10.002; Zhou SH, 2005, J BIOL CHEM, V280, P22688, DOI 10.1074/jbc.M412953200; Zhuang JW, 2014, EXP THER MED, V8, P237, DOI 10.3892/etm.2014.1714	54	40	42	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193178	10.1371/journal.pone.0193178	http://dx.doi.org/10.1371/journal.pone.0193178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513756	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800043
J	Mercado, CI; Gregg, E; Gillespie, C; Loustalot, F				Mercado, Carla I.; Gregg, Edward; Gillespie, Cathleen; Loustalot, Fleetwood			Trends in lipid profiles and descriptive characteristics of US adults with and without diabetes and cholesterol-lowering medication use-National Health and Nutrition Examination Survey, 2003-2012, United States	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DYSLIPIDEMIA; MANAGEMENT; COMPLICATIONS; METAANALYSIS; INDIVIDUALS; MORTALITY; MELLITUS	Background With a cholesterol-lowering focus for diabetic adults and in the age of polypharmacy, it is important to understand how lipid profile levels differ among those with and without diabetes. Objective Investigate the means, differences, and trends in lipid profile measures [TC, total cholesterol; LDL-c, low-density lipoprotein; HDL-c, high-density lipoprotein; and TG, triglycerides] among US adults by diabetes status and cholesterol-lowering medication. Methods Population number and proportion of adults aged >= 21 years with diabetes and taking cholesterol-lowering medication were estimated using data on 10,384 participants from NHANES 2003-2012. Age-standardized means, trends, and differences in lipid profile measures were estimated by diabetes status and cholesterol medication use. For trends and differences, linear regression analysis were used adjusted for age, gender, and race/ethnicity. Results Among diabetic adults, 52% were taking cholesterol-lowering medication compared to the 14% taking cholesterol-lowering medication without diabetes. Although diabetic adults had significantly lower TC and LDL-c levels than non-diabetic adults [% difference (95% confidence interval): TC = -5.2% (-6.8--3.5), LDL-c = -8.0% (-10.4--5.5)], the percent difference was greater among adults taking cholesterol medication [TC = -8.0% (-10.3--5.7); LDL-c = -13.7% (-17.1--10.2)] than adults not taking cholesterol medication [TC = -3.5% (-5.2 +/- -1.6); LDL-c = -4.3% (-7.1--1.5)] (interaction p-value: TC = < 0.001; LDL-c = < 0.001). From 2003-2012, mean TC and HDL-c significantly decreased among diabetic adults taking cholesterol medication [% difference per survey cycle (p-value for linear trend): TC = -2.3% (0.003) and HDL-c = -2.3% (0.033)]. Mean TC, HDL-c, and LDL-c levels did not significantly change from 2003 to 2012 in non-diabetic adults taking cholesterol medication or for adults not taking cholesterol medications. Conclusions Diabetic adults were more likely to have lower lipid levels, except for triglyceride levels, than non-diabetic adults with profound differences when considering cholesterol medication use, possibly due to the positive effects from clinical diabetes management.	[Mercado, Carla I.; Gregg, Edward] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30333 USA; [Gillespie, Cathleen; Loustalot, Fleetwood] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mercado, CI (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30333 USA.	CMercado@cdc.gov		Gregg, Edward/0000-0003-2381-6822; Mercado, Carla/0000-0002-0490-9532				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Andersson C, 2014, AM HEART J, V168, P878, DOI 10.1016/j.ahj.2014.08.007; [Anonymous], 2016, Diabetes Care, V39 Suppl 1, pS4, DOI 10.2337/dc16-S003; [Anonymous], 2014, VITAL HLTH STAT; Bowyer N., 2001, OPTOMETRY VISION SCI, V78, P253; Chehade JM, 2013, DRUGS, V73, P327, DOI 10.1007/s40265-013-0023-5; Eliasson B, 2014, EUR J PREV CARDIOL, V21, P1420, DOI 10.1177/2047487313494292; Eliasson B, 2011, DIABETES CARE, V34, P2095, DOI 10.2337/dc11-0209; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Martin SS, 2014, CIRCULATION, V129, P77, DOI 10.1161/CIRCULATIONAHA.113.003625; Massing MW, 2003, DIABETES CARE, V26, P991, DOI 10.2337/diacare.26.4.991; Mercado C, 2015, MMWR-MORBID MORTAL W, V64, DOI 10.15585/mmwr.mm6447a1; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Reasner CA, 2005, ATHEROSCLEROSIS SUPP, V6, P21, DOI 10.1016/j.atherosclerosissup.2005.06.005; Siebel AL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00258; Simmons RK, 2014, DIABETIC MED, V31, P1577, DOI 10.1111/dme.12574; Sone H, 2012, DIABETES CARE, V35, P1150, DOI 10.2337/dc11-1412; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tohidi M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-6; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193756	10.1371/journal.pone.0193756	http://dx.doi.org/10.1371/journal.pone.0193756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509776	gold, Green Published			2022-12-26	WOS:000426813200028
J	Preiss, A; Nagel, AC; Praxenthaler, H; Maier, D				Preiss, Anette; Nagel, Anja C.; Praxenthaler, Heiko; Maier, Dieter			Complex genetic interactions of novel Suppressor of Hairless alleles deficient in corepressor binding	PLOS ONE			English	Article							NOTCH SIGNALING PATHWAY; ASYMMETRIC CELL-DIVISION; ORGAN PRECURSOR CELLS; DROSOPHILA-MELANOGASTER; DEFAULT REPRESSION; EXPRESSION; ACTIVATION; RECEPTOR; HOMOLOG; PROTEIN	Throughout the animal kingdom, the Notch signalling pathway allows cells to acquire diversified cell fates. Notch signals are translated into activation of Notch target genes by CSL transcription factors. In the absence of Notch signals, CSL together with co-repressors functions as a transcriptional repressor. In Drosophila, repression of Notch target genes involves the CSL homologue Suppressor of Hairless (Su(H)) and the Notch (N) antagonist Hairless (H) that together form a repressor complex. Guided by crystal structure, three mutations Su (H)(LL), Su(H)(LLF) and Su(H)(LLL) were generated that specifically affect interactions with the repressor H, and were introduced into the endogenous Su(H) locus by gene engineering. In contrast to the wild type isoform, these Su(H) mutants are incapable of repressor complex formation. Accordingly, Notch signalling activity is dramatically elevated in the homozygotes, resembling complete absence of H activity. It was noted, however, that heterozygotes do not display a dominant H loss of function phenotype. In this work we addressed genetic interactions the three H-binding deficient Su(H) mutants display in combination with H and N null alleles. We included a null mutant of Delta (Dl), encoding the ligand of the Notch receptor, as well as of Su(H) itself in our genetic analyses. H, N or Dl mutations cause dominant wing phenotypes that are sensitive to gene dose of the others. Moreover, H heterozygotes lack bristle organs and develop bristle sockets instead of shafts. The latter phenotype is suppressed by Su(H) null alleles but not by H-binding deficient Su(H) alleles which we attribute to the socket cell specific activity of Su(H). Modification of the dominant wing phenotypes of either H, N or Dl, however, suggested some lack of repressor activity in the Su(H) null allele and likewise in the H-binding deficient Su(H) alleles. Overall, Su(H) mutants are recessive perhaps reflecting self-adjusting availability of Su(H) protein.	[Preiss, Anette; Nagel, Anja C.; Praxenthaler, Heiko; Maier, Dieter] Univ Hohenheim, Inst Genet 240, Stuttgart, Germany; [Praxenthaler, Heiko] Heidelberg Univ Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany	University Hohenheim; Ruprecht Karls University Heidelberg	Maier, D (corresponding author), Univ Hohenheim, Inst Genet 240, Stuttgart, Germany.	dieter.maier@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Nagel, Anja/0000-0002-2733-3249	DFG grant [MA 1328/11-1]; University of Hohenheim; National Science Foundation	DFG grant(German Research Foundation (DFG)); University of Hohenheim; National Science Foundation(National Science Foundation (NSF))	This work was funded by a DFG grant MA 1328/11-1 (http://www.dfg.de) to DM and by the University of Hohenheim. Some Drosophila fly stocks were obtained from the Bloomington Drosophila Stock Center BDSC, funded by the National Science Foundation (http://flystocks.bio.Indiana.edu/lnst/funding.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHBURNER M, 1982, GENETICS, V101, P447; BANG AG, 1991, DEVELOPMENT, V111, P89; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bridges C. B., 1923, Carnegie Institution Publication, V327, P1; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Chandler CH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007075; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; De Celis JF, 1998, INT J DEV BIOL, V42, P335; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DECELIS JF, 1994, GENETICS, V136, P183; deCelis JF, 1997, DEVELOPMENT, V124, P3241; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hartenstein V., 2005, P379; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; HOUSE VL, 1959, ANAT REC, V134, P581; Kavaler J, 1999, DEVELOPMENT, V126, P2261; Klein T, 2000, DEVELOPMENT, V127, P3553; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lindsley DL, 1968, CARNEGIE I WASHINGTO, V627; LYMAN DF, 1995, GENETICS, V141, P1491; MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller SW, 2009, DEV BIOL, V329, P386, DOI 10.1016/j.ydbio.2009.02.009; Mohler JD, 1956, DROS INFORM SERV, V30, P78; Mohr O. L., 1923, Z INDUKT ABSTAMM VER, V32, P108; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nagel AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151477; Nagel AC, 2011, HEREDITAS, V148, P77, DOI 10.1111/j.1601-5223.2011.02221.x; NASH D, 1970, GENETICS, V64, P471; NASH D, 1965, GENET RES, V6, P175, DOI 10.1017/S0016672300004079; Plunkett CR, 1926, J EXP ZOOL, V46, P181, DOI 10.1002/jez.1400460204; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Praxenthaler H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006774; Praxenthaler H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140007; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Schweisguth F, 2015, WIRES DEV BIOL, V4, P299, DOI 10.1002/wdev.175; SIREN M, 1989, GENET RES, V54, P23, DOI 10.1017/S0016672300028330; Skalska L, 2015, EMBO J, V34, P1889, DOI 10.15252/embj.201489923; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; Wang SW, 1997, DEVELOPMENT, V124, P4435; Yuan ZY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002509	66	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193956	10.1371/journal.pone.0193956	http://dx.doi.org/10.1371/journal.pone.0193956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509808	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200046
J	Rimoldi, S; Terova, G; Ascione, C; Giannico, R; Brambilla, F				Rimoldi, Simona; Terova, Genciana; Ascione, Chiara; Giannico, Riccardo; Brambilla, Fabio			Next generation sequencing for gut microbiome characterization in rainbow trout (Oncorhynchus mykiss) fed animal by-product meals as an alternative to fishmeal protein sources	PLOS ONE			English	Article							SALMON SALMO-SALAR; MORONE-SAXATILIS MALE; HYBRID STRIPED BASS; EUROPEAN SEA BASS; CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; GROWTH-PERFORMANCE; SOYBEAN-MEAL; GASTROINTESTINAL MICROBIOTA; ANTINUTRITIONAL FACTORS	Animal by-product meals from the rendering industry could provide a sustainable and commercially viable alternative to fishmeal (FM) in aquaculture, as they are rich in most essential amino acids and contain important amounts of water-soluble proteins that improve feed digestibility and palatability. Among them, poultry by-product meal (PBM) have given encouraging results in rainbow trout (Oncorhynchus mykiss). However, the introduction of new ingredients in the diet needs to be carefully evaluated since diet is one of the main factors affecting the gut microbiota, which is a complex community that contributes to host metabolism, nutrition, growth, and disease resistance. Accordingly, we investigated the effects of partial replacement of dietary FM with a mix of animal by-product meals and plant proteins on intestinal microbiota composition of rainbow trout in relation to growth and feeding efficiency parameters. We used 1540 trout with an initial mean body weight of 94.6 +/- 14.2 g. Fish were fed for 12 weeks with 7 different feed formulations. The growth data showed that trout fed on diets rich in animal by-product meals grew as well as fish fed on control diet, which was rich in FM (37.3%) and PBM-free. High-throughput 16S rRNA gene amplicon sequencing (MiSeq platform, Illumina) was utilised to study the gut microbial community profile. After discarding Cyanobacteria (class Chloroplast) and mitochondria reads a total of 2,701,274 of reads taxonomically classified, corresponding to a mean of 96,474 +/- 68,056 reads per sample, were obtained. Five thousand three hundred ninety-nine operational taxonomic units (OTUs) were identified, which predominantly mapped to the phyla of Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria. The ratio between vegetable and animal proteins proved to play a central role in determining microbiome profiles and Firmicutes and Proteobacteria phyla were particularly discriminatory for diet type in trout. Plant ingredients favoured a higher Firmicutes: Proteobacteria ratio than animal proteins. Acceptable abundance of Firmicutes was guaranteed by including at least 25% of vegetable proteins in the diet regardless of animal protein source and percentage. In summary animal by-product meals, as replacements to FM, gave good results in terms of growth performances and did not induce significant changes in gut microbial richness, thus proving to be a suitable protein source for use in rainbow trout aqua feed.	[Rimoldi, Simona; Terova, Genciana; Ascione, Chiara] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Terova, Genciana] Polytech Univ Milan, Interuniv Ctr Res Prot Biotechnol Prot Factory, Varese, Italy; [Terova, Genciana] Univ Insubria, Varese, Italy; [Giannico, Riccardo] Fdn Parco Tecnol Padano, Lodi, Italy; [Brambilla, Fabio] VRM Srl Naturalleva, Verona, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria	Terova, G (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.; Terova, G (corresponding author), Polytech Univ Milan, Interuniv Ctr Res Prot Biotechnol Prot Factory, Varese, Italy.; Terova, G (corresponding author), Univ Insubria, Varese, Italy.	genciana.terova@uninsubria.it	Brambilla, Fabio/ABC-9259-2021; Terova, Genciana/AAL-6412-2021; Terova, Genciana/G-1779-2010	Brambilla, Fabio/0000-0002-3711-3370; Terova, Genciana/0000-0002-7532-7951; Terova, Genciana/0000-0002-7532-7951; Ascione, Chiara/0000-0002-3823-6399; Rimoldi, Simona/0000-0002-1995-263X	Naturalleva	Naturalleva	We declare that the commercial company "Naturalleva" employs one of the authors, Fabio Brambilla, who receives a salary. We declare that Naturalleva provided support by manufacturing the fish diets and conducting fish feeding trial, but did not have any additional role in the study design, microbiota data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of Fabio Brambilla is articulated in the 'author contributions' section.	Andrews S., 2010, FASTQC QUALITY CONTR; Apper E, 2016, AQUACULTURE, V453, P40, DOI 10.1016/j.aquaculture.2015.11.018; Araujo C, 2015, ANAEROBE, V32, P7, DOI 10.1016/j.anaerobe.2014.11.001; Askarian F, 2011, AQUACULT NUTR, V17, P488, DOI 10.1111/j.1365-2095.2010.00826.x; Badillo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107523; Barlow S., 2000, GLOBAL AQUACULT ADVO, V4, P85; Barreto-Curiel F, 2016, LAT AM J AQUAT RES, V44, P327, DOI 10.3856/vol44-issue2-fulltext-13; Batista S, 2016, AQUACULTURE, V458, P149, DOI 10.1016/j.aquaculture.2016.03.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CASTELL JD, 1972, J NUTR, V102, P77, DOI 10.1093/jn/102.1.77; Cheng ZJJ, 2002, J WORLD AQUACULT SOC, V33, P458, DOI 10.1111/j.1749-7345.2002.tb00025.x; Choi WM, 2016, ENVIRON SCI POLLUT R, V23, P7178, DOI 10.1007/s11356-015-5465-8; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davies SJ, 2009, AQUAC RES, V40, P1759, DOI 10.1111/j.1365-2109.2009.02281.x; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dong C, 2016, J OCEAN U CHINA, V15, P561, DOI 10.1007/s11802-016-2898-8; El-Haroun ER, 2009, AQUACULTURE, V290, P269, DOI 10.1016/j.aquaculture.2009.02.014; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; Etyemez M, 2015, RES VET SCI, V100, P8, DOI 10.1016/j.rvsc.2015.03.026; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gajardo K, APPL ENV MICROBIOLOG, V83; Galfi P, 2002, FOOD RES INT, V345, P81; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gaylord TG, 2017, AQUACULT NUTR, V23, P1319, DOI 10.1111/anu.12507; Ghanbari M, 2015, AQUACULTURE, V448, P464, DOI 10.1016/j.aquaculture.2015.06.033; Givens CE, 2015, MAR ECOL PROG SER, V518, P209, DOI 10.3354/meps11034; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Granada CE, 2018, RENEW ENERG, V118, P840, DOI 10.1016/j.renene.2017.11.077; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hartviksen M, 2014, AQUACULT NUTR, V20, P381, DOI 10.1111/anu.12087; Hartviksen M, 2014, FISH PHYSIOL BIOCHEM, V40, P1621, DOI 10.1007/s10695-014-9953-4; Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012; Hernandez C, 2010, AQUACULT NUTR, V16, P44, DOI 10.1111/j.1365-2095.2008.00639.x; Hovda MB, 2007, AQUACULTURE, V272, P581, DOI 10.1016/j.aquaculture.2007.08.045; Hu H, PLOS ONE, V11; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Ingerslev HC, 2014, FISH SHELLFISH IMMUN, V40, P624, DOI 10.1016/j.fsi.2014.08.021; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kim SK, 2012, ADV FOOD NUTR RES, V65, P353, DOI 10.1016/B978-0-12-416003-3.00023-8; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kristofersson D, 2006, MAR POLICY, V30, P721, DOI 10.1016/j.marpol.2005.11.004; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; LEE DJ, 1967, J NUTR, V92, P93, DOI 10.1093/jn/92.1.93; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; LIU HJ, 1995, J AOAC INT, V78, P736; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Balcazar JL, 2007, BRIT J NUTR, V97, P522, DOI 10.1017/S0007114507432986; Lyons PP, 2017, J APPL MICROBIOL, V122, P347, DOI 10.1111/jam.13347; Lyons PP, 2017, AQUAC RES, V48, P2438, DOI 10.1111/are.13080; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Matis G, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-12; Morris PC, 2005, AQUACULTURE, V248, P147, DOI 10.1016/j.aquaculture.2005.04.021; National Research Council, 2011, NUTR REQ FISH SHRIMP; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Pares-Sierra G, 2014, AQUAC RES, V45, P1459, DOI 10.1111/are.12092; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pike I. H., 2005, International Aquafeed, V8, P38; Rawles SD, 2006, AQUACULTURE, V259, P377, DOI 10.1016/j.aquaculture.2006.05.053; Rawles SD, 2009, J WORLD AQUACULT SOC, V40, P141, DOI 10.1111/j.1749-7345.2009.00238.x; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Refstie S, 2005, AQUACULTURE, V246, P331, DOI 10.1016/j.aquaculture.2005.01.001; Rimoldi Simona, 2016, Fisheries and Aquatic Sciences, V19, P40, DOI 10.1186/s41240-016-0041-9; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rosenlund G, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.10; Santigosa E, 2011, AQUAC RES, V42, P962, DOI 10.1111/j.1365-2109.2010.02679.x; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Savas S, 2005, ISR J AQUACULT-BAMID, V57, P3; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Shepherd CJ, 2013, J FISH BIOL, V83, P1046, DOI 10.1111/jfb.12224; Subhadra B, 2006, AQUACULTURE, V260, P221, DOI 10.1016/j.aquaculture.2006.06.029; Sun H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01558; Tacon AGJ, 2004, AQUAT RESOUR CULT DE, V1, P3; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Terova G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160332; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Twibell RG, 2012, AQUACULTURE, V360, P69, DOI 10.1016/j.aquaculture.2012.07.019; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; YU TC, 1979, AQUACULTURE, V16, P31, DOI 10.1016/0044-8486(79)90169-8; Yu Y, 2007, ALTERNATIVE PROTEIN, P51; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou QC, 2011, AQUACULTURE, V322, P122, DOI 10.1016/j.aquaculture.2011.09.042; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	98	73	76	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193652	10.1371/journal.pone.0193652	http://dx.doi.org/10.1371/journal.pone.0193652			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509788	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200020
J	Tassi, F; Fazi, S; Rossetti, S; Pratesi, P; Ceccotti, M; Cabassi, J; Capecchiacci, F; Venturi, S; Vaselli, O				Tassi, Franco; Fazi, Stefano; Rossetti, Simona; Pratesi, Paolo; Ceccotti, Marco; Cabassi, Jacopo; Capecchiacci, Francesco; Venturi, Stefania; Vaselli, Orlando			The biogeochemical vertical structure renders a meromictic volcanic lake a trap for geogenic CO2 (Lake Averno, Italy)	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; ANAEROBIC METHANE OXIDATION; CRATER LAKES; MT. VULTURE; GAS BUILDUP; GEN. NOV.; WATER; NYOS; BACTERIAL; CAMEROON	Volcanic lakes are characterized by physicochemical favorable conditions for the development of reservoirs of C- bearing greenhouse gases that can be dispersed to air during occasional roll-over events. By combining a microbiological and geochemical approach, we showed that the chemistry of the CO2- and CH4-rich gas reservoir hosted within the meromictic Lake Averno (Campi Flegrei, southern Italy) are related to the microbial niche differentiation along the vertical water column. The simultaneous occurrence of diverse functional groups of microbes operating under different conditions suggests that these habitats harbor complex microbial consortia that impact on the production and consumption of greenhouse gases. In the epilimnion, the activity of aerobic methanotrophic bacteria and photosynthetic biota, together with CO2 dissolution at relatively high pH, enhanced CO2- and CH4 consumption, which also occurred in the hypolimnion. Moreover, results from computations carried out to evaluate the dependence of the lake stability on the CO2/CH4 ratios, suggested that the water density vertical gradient was mainly controlled by salinity and temperature, whereas the effect of dissolved gases was minor, excepting if extremely high increases of CH4 are admitted. Therefore, biological processes, controlling the composition of CO2 and CH4, contributed to stabilize the lake stratification of the lake. Overall, Lake Averno, and supposedly the numerous worldwide distributed volcanic lakes having similar features (namely bio- activity lakes), acts as a sink for the CO2 supplied from the hydrothermal/magmatic system, displaying a significant influence on the local carbon budget.	[Tassi, Franco; Pratesi, Paolo; Cabassi, Jacopo; Capecchiacci, Francesco; Venturi, Stefania; Vaselli, Orlando] Univ Florence, Dept Earth Sci, Via G La Pira 4, Florence, Italy; [Tassi, Franco; Cabassi, Jacopo; Venturi, Stefania; Vaselli, Orlando] Natl Res Council Italy, CNR, IGG, Inst Geosci & Earth Resources, Via La Pira 4, Florence, Italy; [Fazi, Stefano; Rossetti, Simona; Ceccotti, Marco] Natl Res Council Italy, CNR Water Res Inst, IRSA, Via Salaria, Rome, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sulle Acque (IRSA-CNR)	Tassi, F (corresponding author), Univ Florence, Dept Earth Sci, Via G La Pira 4, Florence, Italy.; Tassi, F (corresponding author), Natl Res Council Italy, CNR, IGG, Inst Geosci & Earth Resources, Via La Pira 4, Florence, Italy.	franco.tassi@unifi.it	Vaselli, Orlando/A-4268-2016; FAZI, STEFANO/L-3976-2017; Cabassi, Jacopo/B-1231-2016; FAZI, STEFANO/AAX-5609-2020; Tassi, Franco/G-7857-2012	FAZI, STEFANO/0000-0001-7688-7179; Cabassi, Jacopo/0000-0001-7778-8498; FAZI, STEFANO/0000-0001-7688-7179; Tassi, Franco/0000-0002-3319-4257; Rossetti, Simona/0000-0001-9474-0496; Vaselli, Orlando/0000-0001-8121-4438	Italian National Flag program RITMARE [SP3-WP2-AZ2-U05]	Italian National Flag program RITMARE	The Italian National Flag program RITMARE SP3-WP2-AZ2-U05 financed the costs of the fieldtrip and microbiological analysis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Allgaier M, 2006, AQUAT MICROB ECOL, V45, P115, DOI 10.3354/ame045115; Amalfitano S, 2014, WATER RES, V65, P384, DOI 10.1016/j.watres.2014.08.004; Atekwana EA, 1998, J HYDROL, V205, P265; Bergen B, 2014, ENV MICROBIOL REP, V6, P625, DOI 10.1111/1758-2229.12178; Bhattarai S, 2012, MICROB ECOL, V64, P291, DOI 10.1007/s00248-012-0034-x; Bianchi L, 2010, INT J HYDROGEN ENERG, V35, P12216, DOI 10.1016/j.ijhydene.2010.08.038; Boehrer B, 2010, LIMNOL OCEANOGR-METH, V8, P567, DOI 10.4319/lom.2010.8.0567; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolognesi L., 1986, STUDIO CHIMICO ISOTO, V41, P281; Cabassi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102456; Cabassi J, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-012-0683-0; Caliro S, 2007, GEOCHIM COSMOCHIM AC, V71, P3040, DOI 10.1016/j.gca.2007.04.007; Caliro S, 2008, J VOLCANOL GEOTH RES, V178, P305, DOI 10.1016/j.jvolgeores.2008.06.023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caracausi A, 2013, GEOCHEM GEOPHY GEOSY, V14, P1411, DOI 10.1002/ggge.20111; Caracausi A, 2009, TERRA NOVA, V21, P83, DOI 10.1111/j.1365-3121.2008.00858.x; Carapezza ML, 2008, J VOLCANOL GEOTH RES, V178, P297, DOI 10.1016/j.jvolgeores.2008.06.031; Carpenter JR, 2012, J PHYS OCEANOGR, V42, P840, DOI 10.1175/JPO-D-11-0118.1; Chandler DP, 2013, APPL ENVIRON MICROB, V79, P799, DOI 10.1128/AEM.02664-12; Chau HF, 1996, J GEOPHYS RES-SOL EA, V101, P28253, DOI 10.1029/96JB01904; Christenson B, 2015, ADV VOLCANOL, P125, DOI 10.1007/978-3-642-36833-2_5; Cotel AJ, 1999, J VOLCANOL GEOTH RES, V88, P343, DOI 10.1016/S0377-0273(99)00017-7; Di Vito MA, 2011, B VOLCANOL, V73, P295, DOI 10.1007/s00445-010-0417-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; EVANS WC, 1994, GEOCHEM J, V28, P139, DOI 10.2343/geochemj.28.139; EVANS WC, 1993, APPL GEOCHEM, V8, P207, DOI 10.1016/0883-2927(93)90036-G; Faure G., 1986, INORGANIC GEOCHEMIST, P627; Fazi S, 2007, SYST APPL MICROBIOL, V30, P463, DOI 10.1016/j.syapm.2007.03.003; Fazi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064109; Fillol M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv020; Funiciello R, 2003, J VOLCANOL GEOTH RES, V123, P43, DOI 10.1016/S0377-0273(03)00027-1; Garrity G, BERGEYS MANUAL SYSTE, V2; GIGGENBACH WF, 1990, J VOLCANOL GEOTH RES, V42, P337, DOI 10.1016/0377-0273(90)90031-A; GUGLIELMINETTI M, 1986, GEOTHERMICS, V15, P781, DOI 10.1016/0375-6505(86)90091-X; Hahn MW, 2007, INT J SYST EVOL MICR, V57, P936, DOI 10.1099/ijs.0.64807-0; Halbwachs M., 2004, EOS, V85, P281, DOI [10.1029/2004EO300001, DOI 10.1029/2004EO300001]; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hatamoto M, 2011, BIORESOURCE TECHNOL, V102, P10299, DOI 10.1016/j.biortech.2011.08.099; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hirslund F, 2012, J LIMNOL, V71, P45, DOI 10.4081/jlimnol.2012.e4; Illumina I., 2015, OAISTER; Karr EA, 2005, APPL ENVIRON MICROB, V71, P6353, DOI 10.1128/AEM.71.10.6353-6359.2005; Karst SM, 2016, WASTEWATER TREATMENT, P301; Kling GW, 2005, P NATL ACAD SCI USA, V102, P14185, DOI 10.1073/pnas.0502274102; KLING GW, 1987, SCIENCE, V237, P1022, DOI 10.1126/science.237.4818.1022; KLING GW, 1989, J VOLCANOL GEOTH RES, V39, P151, DOI 10.1016/0377-0273(89)90055-3; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Kusakabe M, 2000, J VOLCANOL GEOTH RES, V97, P241, DOI 10.1016/S0377-0273(99)00170-5; Kusakabe M, 1996, MONITORING MITIGATIO, P573; Kusakabe M, 2008, GEOCHEM J, V42, P93, DOI 10.2343/geochemj.42.93; LEGUERN F, 1989, J VOLCANOL GEOTH RES, V39, P97; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McGinnis DF, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006557; McNichols AP, NUCL INSTRUM METH B; Millero FJ, 2002, DEEP-SEA RES PT I, V49, P1705, DOI 10.1016/S0967-0637(02)00093-6; Montegrossi G, 2006, APPL GEOCHEM; Moreira S, 2016, HYDROL EARTH SYST SC, V20, P2975, DOI 10.5194/hess-20-2975-2016; Mortimer C. H., 1953, AQUAT SCI, V15, P94, DOI DOI 10.1007/BF02486219; Mott RW, 2010, J VOLCANOL GEOTH RES, V192, P151, DOI 10.1016/j.jvolgeores.2010.02.009; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Noguchi T, 2010, J FLUID MECH, V651, P443, DOI 10.1017/S0022112009994150; Orlygsson J., 2014, PROKARYOTES ALPHAPRO, P859, DOI DOI 10.1007/978-3-642-30197-1_244; Oswald K, 2016, LIMNOL OCEANOGR, V61, pS101, DOI 10.1002/lno.10312; Oswald K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132574; Paganin P, 2013, FEMS MICROBIOL ECOL, V84, P176, DOI 10.1111/1574-6941.12048; Parkhurst D., 1999, WATER RESOURCES INVE, V99, P4259; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasternack GB, 1997, B VOLCANOL, V58, P528, DOI 10.1007/s004450050160; Quero GM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01053; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rice A, 2000, J VOLCANOL GEOTH RES, V97, P233, DOI 10.1016/S0377-0273(99)00179-1; Rouwet D, 2014, J VOLCANOL GEOTH RES, V272, P78, DOI 10.1016/j.jvolgeores.2013.12.009; Sabroux JC, 1987, P INT C LAK NYOS GAS; Salata GG, 2000, MAR CHEM, V69, P153, DOI 10.1016/S0304-4203(99)00102-4; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2002, ACTA VULCANOL, V14, P115, DOI DOI 10.1400/19084; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; SCHOELL M, 1980, GEOCHIM COSMOCHIM AC, V44, P649, DOI 10.1016/0016-7037(80)90155-6; SCHOELL M, 1988, CHEM GEOL, V71, P257, DOI 10.1016/0009-2541(88)90119-2; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shivlata L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01014; SHY SS, 1990, J FLUID MECH, V214, P1, DOI 10.1017/S0022112090000015; SIGURDSSON H, 1987, J VOLCANOL GEOTH RES, V31, P1, DOI 10.1016/0377-0273(87)90002-3; Siniscalchi LAB, 2015, ENV TECHNOL, V36; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Takai K, 1999, GENETICS, V152, P1285; Takeuchi M, 2014, INT J SYST EVOL MICR, V64, P3240, DOI 10.1099/ijs.0.063503-0; Tanaka M, 2001, METROLOGIA, V38, P301, DOI 10.1088/0026-1394/38/4/3; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tassi F., 2008, INT REP, P11; Tassi F, 2014, J LIMNOL, V73, P55, DOI 10.4081/jlimnol.2014.836; TAZIEFF H, 1989, J VOLCANOL GEOTH RES, V39, P109, DOI 10.1016/0377-0273(89)90051-6; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tietze K., 1980, GEOL RUNDSCH, V69, P452, DOI [DOI 10.1007/BF02104549, 10.1007/BF02104549]; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; Valentino GM, 2004, J VOLCANOL GEOTH RES, V133, P261, DOI 10.1016/S0377-0273(03)00402-5; van Teeseling MCF, 2014, APPL ENVIRON MICROB, V80, P6782, DOI 10.1128/AEM.01838-14; Vaselli O., 2006, ACTA VULCANOL, V18, P65; Von Rohden C, 2010, HYDROL EARTH SYST SC, V6, P7483; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2005, APPL ENVIRON MICROB, V71, P5551, DOI 10.1128/AEM.71.9.5551-5559.2005; Watanabe T, 2014, SYST APPL MICROBIOL, V37, P387, DOI 10.1016/j.syapm.2014.05.010; Wetzel RG, LIMNOLOGY LAKE RIVER, P3; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003; Woods AW, 1999, J VOLCANOL GEOTH RES, V92, P259, DOI 10.1016/S0377-0273(99)00028-1; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D; Zhang YX, 2006, ANNU REV EARTH PL SC, V34, P293, DOI 10.1146/annurev.earth.34.031405.125001; Zhang YX, 1998, B VOLCANOL, V59, P281, DOI 10.1007/s004450050192; Zhang YX, 1996, NATURE, V379, P57, DOI 10.1038/379057a0	118	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193914	10.1371/journal.pone.0193914	http://dx.doi.org/10.1371/journal.pone.0193914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509779	Green Submitted, Green Published, gold			2022-12-26	WOS:000426813200042
J	Acar, S; Bin Essai, HA; Demir, K; Al-Rijjal, RA; Zou, M; Catli, G; Anik, A; Al-Enezi, AF; Ozisik, S; Al-Faham, MSA; Abaci, A; Dundar, B; Kattan, WE; Alsagob, M; Kavukcu, S; Tamimi, HE; Meyer, BF; Bober, E; Shi, Y				Acar, Sezer; Bin Essai, Huda A.; Demir, Korcan; Al-Rijjal, Roua A.; Zou, Minjing; Catli, Gonul; Anik, Ahmet; Al-Enezi, Anwar F.; Ozisik, Secil; Al-Faham, Manar S. A.; Abaci, Ayhan; Dundar, Bumin; Kattan, Walaa E.; Alsagob, Maysoon; Kavukcu, Salih; Tamimi, Hamdi E.; Meyer, Brian F.; Bober, Ece; Shi, Yufei			Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3	PLOS ONE			English	Article							PEX GENE; PHOSPHATE HOMEOSTASIS; RICKETS; HYPERCALCIURIA; CLCN5; DMP1; HETEROGENEITY; EXPRESSION; DISORDERS; SECRETION	Background Hereditary hypophosphatemia is a group of rare renal phosphate wasting disorders. The diagnosis is based on clinical, radiological, and biochemical features, and may require genetic testing to be confirmed. Methodology Clinical features and mutation spectrum were investigated in patients with hereditary hypophosphatemia. Genomic DNA of 23 patients from 15 unrelated families were screened sequentially by PCR-sequencing analysis for mutations in the following genes: PHEX, FGF23, DMP1, ENPP1, CLCN5, SLC34A3 and SLC34A1. CytoScan HD Array was used to identify large deletions. Results Genetic evaluation resulted in the identification of an additional asymptomatic but intermittent hypophosphatemic subject. Mutations were detected in 21 patients and an asymptomatic sibling from 13 families (86.6%, 13/15). PHEX mutations were identified in 20 patients from 12 families. Six of them were novel mutations present in 9 patients: c.983_987dupCTACC, c.1586+2T>G, c.1206delA,c.436+1G>T,c.1217G>T, and g.22,215,887 +/- 22,395,767del (179880 bp deletion including exon 16 +/- 22 and ZNF645). Six previously reported mutations were found in 11 patients. Among 12 different PHEX mutations, 6 were de novo mutations. Patients with de novo PHEX mutations often had delayed diagnosis and significantly shorter in height than those who had inherited PHEX mutations. Novel compound heterozygous mutations in SLC34A3 were found in one patient and his asymptomatic sister: c.1335+2T>A and c.1639_1652del14. No mutation was detected in two families. Conclusions This is the largest familial study on Turkish patients with hereditary hypophosphatemia. PHEX mutations, including various novel and de novo variants, are the most common genetic defect. More attention should be paid to hypophosphatemia by clinicians since some cases remain undiagnosed both during childhood and adulthood.	[Acar, Sezer; Demir, Korcan; Abaci, Ayhan; Bober, Ece] Dokuz Eylul Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Bin Essai, Huda A.; Al-Rijjal, Roua A.; Zou, Minjing; Al-Enezi, Anwar F.; Al-Faham, Manar S. A.; Kattan, Walaa E.; Alsagob, Maysoon; Tamimi, Hamdi E.; Meyer, Brian F.; Shi, Yufei] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Catli, Gonul; Dundar, Bumin] Katip Celebi Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Anik, Ahmet] Adnan Menderes Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Ozisik, Secil] Dokuz Eylul Univ, Sch Med, Dept Endocrinol, Izmir, Turkey; [Kavukcu, Salih] Dokuz Eylul Univ, Sch Med, Div Pediat Nephrol, Izmir, Turkey	Dokuz Eylul University; King Faisal Specialist Hospital & Research Center; Izmir Katip Celebi University; Adnan Menderes University; Dokuz Eylul University; Dokuz Eylul University	Shi, Y (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.	yufei@kfshrc.edu.sa	Abaci, Ayhan/A-4356-2016; kavukcu, salih/K-3336-2019; demir, korcan/F-5371-2012; Catli, Gönül/AFT-1499-2022; Shi, Yufei/ABG-5228-2020; Hamdi Tamimi, MBBS/AAZ-6176-2020; Acar, Sezer/ACD-4928-2022	Abaci, Ayhan/0000-0002-1812-0321; kavukcu, salih/0000-0002-9959-881X; demir, korcan/0000-0002-8334-2422; Shi, Yufei/0000-0002-6999-0191; 	KACST [13-MED1765-20]	KACST	The study is supported by a KACST grant 13-MED1765-20 to YS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2010, EUR J CLIN INVEST, V40, P552, DOI 10.1111/j.1365-2362.2010.02286.x; Bastepe M, 2008, REV ENDOCR METAB DIS, V9, P171, DOI 10.1007/s11154-008-9075-3; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck-Nielsen SS, 2012, J HUM GENET, V57, P453, DOI 10.1038/jhg.2012.56; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Capelli S, 2015, BONE, V79, P143, DOI 10.1016/j.bone.2015.05.040; Carpenter TO, 1997, PEDIATR CLIN N AM, V44, P443, DOI 10.1016/S0031-3955(05)70485-5; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Dasgupta D, 2014, J AM SOC NEPHROL, V25, P2366, DOI 10.1681/ASN.2013101085; Menezes Filho Hamilton de, 2006, Arq Bras Endocrinol Metab, V50, P802, DOI 10.1590/S0004-27302006000400025; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Durmaz E, 2013, BONE, V52, P286, DOI 10.1016/j.bone.2012.10.012; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; FISHER SE, 1995, GENOMICS, V29, P598, DOI 10.1006/geno.1995.9960; Francis F, 1997, GENOME RES, V7, P573, DOI 10.1101/gr.7.6.573; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Guven A, 2017, CLIN ENDOCRINOL, V87, P103, DOI 10.1111/cen.13347; Hoopes RR, 2004, KIDNEY INT, V65, P1615, DOI 10.1111/j.1523-1755.2004.00571.x; Ichikawa S, 2008, BONE, V43, P663, DOI 10.1016/j.bone.2008.06.002; Ichikawa S, 2014, BONE, V59, P53, DOI 10.1016/j.bone.2013.10.018; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu Shuang, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P518; Liu YQ, 2010, ASIAN J ANDROL, V12, P658, DOI 10.1038/aja.2010.54; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; Morey M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-116; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Razali NN, 2015, J PEDIATR ENDOCR MET, V28, P1009, DOI 10.1515/jpem-2014-0366; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Schlingmann KP, 2016, J AM SOC NEPHROL, V27, P604, DOI 10.1681/ASN.2014101025; Streeten EA, 2011, NEW ENGL J MED, V365, P1741, DOI 10.1056/NEJMc1110226; Strom TM, 2008, CURR OPIN NEPHROL HY, V17, P357, DOI 10.1097/MNH.0b013e3282fd6e5b; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamamoto K, 2000, J AM SOC NEPHROL, V11, P1460, DOI 10.1681/ASN.V1181460; Zou MJ, 2015, LAB INVEST, V95, P1269, DOI 10.1038/labinvest.2015.90; Zou MJ, 2015, J PEDIATR ENDOCR MET, V28, P211, DOI 10.1515/jpem-2014-0103	45	12	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193388	10.1371/journal.pone.0193388	http://dx.doi.org/10.1371/journal.pone.0193388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505567	Green Submitted, Green Published, gold			2022-12-26	WOS:000426548200013
J	Richie, DL; Wang, LS; Chan, H; De Pascale, G; Six, DA; Wei, JR; Dean, CR				Richie, Daryl L.; Wang, Lisha; Chan, Helen; De Pascale, Gianfranco; Six, David A.; Wei, Jun-Rong; Dean, Charles R.			A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; SYNTHASE-III FABH; ESCHERICHIA-COLI; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PSEUDOMONAS-AERUGINOSA; CHAIN SPECIFICITY; LPXC INHIBITORS; REDUCTASE FABI	Acinetobacter baumannii ATCC 19606 can grow without lipooligosaccharide (LOS). Lack of LOS can result from disruption of the early lipid A biosynthetic pathway genes lpxA, lpxC or lpxD. Although LOS itself is not essential for growth of A. baumannii ATCC 19606, it was previously shown that depletion of the lipid A biosynthetic enzyme LpxK in cells inhibited growth due to the toxic accumulation of lipid A pathway intermediates. Growth of LpxK-depleted cells was restored by chemical inhibition of LOS biosynthesis using CHIR-090 (LpxC) and fatty acid biosynthesis using cerulenin (FabB/F) and pyridopyrimidine (acetylCoA-carboxylase). Here, we expand on this by showing that inhibition of enoyl-acyl carrier protein reductase (FabI), responsible for converting trans-2-enoyl-ACP into acyl-ACP during the fatty acid elongation cycle also restored growth during LpxK depletion. Inhibition of fatty acid biosynthesis during LpxK depletion rescued growth at 37 degrees C, but not at 30 degrees C, whereas rescue by LpxC inhibition was temperature independent. We exploited these observations to demonstrate proof of concept for a targeted medium-throughput growth restoration screening assay to identify small molecule inhibitors of LOS and fatty acid biosynthesis. The differential temperature dependence of fatty acid and LpxC inhibition provides a simple means by which to separate growth stimulating compounds by pathway. Targeted cell-based screening platforms such as this are important for faster identification of compounds inhibiting pathways of interest in antibacterial discovery for clinically relevant Gram-negative pathogens.	[Richie, Daryl L.; Wang, Lisha; Chan, Helen; De Pascale, Gianfranco; Six, David A.; Wei, Jun-Rong; Dean, Charles R.] Novartis Inst BioMed Resd, Emeryville, CA 94608 USA		Richie, DL (corresponding author), Novartis Inst BioMed Resd, Emeryville, CA 94608 USA.	Daryl.Richie@novartis.com	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711	Novartis organization	Novartis organization	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funder provided support in the form of salaries for authors [DLR, LW, HC, GP, DAS, J-RW, CRD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altinok I, 2016, FISH SHELLFISH IMMUN, V55, P21, DOI 10.1016/j.fsi.2016.04.018; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bogdanovich T, 2007, ANTIMICROB AGENTS CH, V51, P4191, DOI 10.1128/AAC.00550-07; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Botos I, 2016, STRUCTURE, V24, P965, DOI 10.1016/j.str.2016.03.026; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Brown DG, 2016, BIOORGAN MED CHEM, V24, P6320, DOI 10.1016/j.bmc.2016.05.004; Chen WL, 2009, ACS CHEM BIOL, V4, P893, DOI 10.1021/cb900259w; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Cram ED, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0992-8; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLucia AM, 2011, MBIO, V2, DOI 10.1128/mBio.00142-11; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Eichberg MJ, 2015, HEALTH SECUR, V13, P156, DOI 10.1089/hs.2014.0081; Emiola A, 2016, P NATL ACAD SCI USA, V113, P3108, DOI 10.1073/pnas.1521168113; Emiola A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121216; Flamm RK, 2015, ANTIMICROB AGENTS CH, V59, P2583, DOI 10.1128/AAC.05119-14; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Gu YH, 2015, STRUCTURE, V23, P496, DOI 10.1016/j.str.2015.01.001; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jenkins RJ, 2014, J BIOL CHEM, V289, P15527, DOI 10.1074/jbc.M114.564278; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Kalinin DV, 2017, EXPERT OPIN THER PAT, V27, P1227, DOI 10.1080/13543776.2017.1360282; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; Kawai T, 2017, BIOORG MED CHEM LETT, V27, P1045, DOI 10.1016/j.bmcl.2016.12.059; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; Lemaitre N, 2017, MBIO, V8, DOI 10.1128/mBio.00674-17; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Machutta CA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16081; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Matano LM, 2016, BIOORGAN MED CHEM, V24, P6307, DOI 10.1016/j.bmc.2016.08.003; May J.M., 2015, PHILOS T R SOC LON B, V370; Moche M, 2001, J MOL BIOL, V305, P491, DOI 10.1006/jmbi.2000.4272; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Piizzi G, 2017, J MED CHEM, V60, P5002, DOI 10.1021/acs.jmedchem.7b00377; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Qiu XY, 2005, PROTEIN SCI, V14, P2087, DOI 10.1110/ps.051501605; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schulz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062768; Sengyee S, 2017, AM J TROP MED HYG, V97, P62, DOI 10.4269/ajtmh.16-0858; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simpson B.W., 2015, PHILOS T R SOC LON B, V370; Singh SB, 2017, BIOCHEM PHARMACOL, V133, P63, DOI 10.1016/j.bcp.2017.01.003; Sperandeo P, 2016, STRUCTURE, V24, P847, DOI 10.1016/j.str.2016.05.005; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Wallace J, 2015, ANTIMICROB AGENTS CH, V59, P5775, DOI 10.1128/AAC.00686-15; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Weber BS, 2016, J BACTERIOL, V198, P880, DOI 10.1128/JB.00906-15; Wei JR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00199-17; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yao J., 2016, BIOCH BIOPHYS ACTA; Yao JW, 2016, J BIOL CHEM, V291, P171, DOI 10.1074/jbc.M115.699462; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Yum JH, 2007, ANTIMICROB AGENTS CH, V51, P2591, DOI 10.1128/AAC.01562-06; Zhang J, 2017, BIOORG MED CHEM LETT, V27, P1670, DOI 10.1016/j.bmcl.2017.03.006; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200; Zuo K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050761	92	8	8	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193851	10.1371/journal.pone.0193851	http://dx.doi.org/10.1371/journal.pone.0193851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505586	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200036
J	Iima, M; Kataoka, M; Kanao, S; Kawai, M; Onishi, N; Koyasu, S; Murata, K; Ohashi, A; Sakaguchi, R; Togashi, K				Iima, Mami; Kataoka, Masako; Kanao, Shotaro; Kawai, Makiko; Onishi, Natsuko; Koyasu, Sho; Murata, Katsutoshi; Ohashi, Akane; Sakaguchi, Rena; Togashi, Kaori			Variability of non-Gaussian diffusion MRI and intravoxel incoherent motion (IVIM) measurements in the breast	PLOS ONE			English	Article							GADOLINIUM DEPOSITION; CLINICAL-APPLICATIONS; DIAGNOSTIC-ACCURACY; MENSTRUAL-CYCLE; WEIGHTED MRI; LESIONS; CANCER; REPRODUCIBILITY; REPEATABILITY; PROSTATE	We prospectively examined the variability of non-Gaussian diffusion magnetic resonance imaging ( MRI) and intravoxel incoherent motion ( IVIM) measurements with different numbers of b-values and excitations in normal breast tissue and breast lesions. Thirteen volunteers and fourteen patients with breast lesions ( seven malignant, eight benign; one patient had bilateral lesions) were recruited in this prospective study ( approved by the Internal Review Board). Diffusion-weighted MRI was performed with 16 b-values ( 0-2500 s/mm(2) with one number of excitations [ NEX]) and five b-values ( 0-2500 s/mm(2), 3 NEX), using a 3T breast MRI. Intravoxel incoherent motion ( flowing blood volume fraction [ fIVIM] and pseudo-diffusion coefficient [ D*]) and non-Gaussian diffusion ( theoretical apparent diffusion coefficient [ ADC] at b value of 0 sec/mm(2) [ ADC(0)] and kurtosis [ K]) parameters were estimated from IVIM and Kurtosis models using 16 b-values, and synthetic apparent diffusion coefficient ( sADC) values were obtained from two key b-values. The variabilities between and within subjects and between different diffusion acquisition methods were estimated. There were no statistical differences in ADC(0), K, or sADC values between the different b-values or NEX. A good agreement of diffusion parameters was observed between 16 b-values ( one NEX), five b-values ( one NEX), and five b-values ( three NEX) in normal breast tissue or breast lesions. Insufficient agreement was observed for IVIM parameters. There were no statistical differences in the non-Gaussian diffusion MRI estimated values obtained from a different number of b-values or excitations in normal breast tissue or breast lesions. These data suggest that a limited MRI protocol using a few b-values might be relevant in a clinical setting for the estimation of non-Gaussian diffusion MRI parameters in normal breast tissue and breast lesions.	[Iima, Mami; Kataoka, Masako; Kanao, Shotaro; Kawai, Makiko; Onishi, Natsuko; Koyasu, Sho; Ohashi, Akane; Sakaguchi, Rena; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Iima, Mami] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan; [Murata, Katsutoshi] Siemens Healthcare KK, Shinagawa Ku, Tokyo, Japan	Kyoto University; Kyoto University; Siemens AG	Iima, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.; Iima, M (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan.	mamiiima@kuhp.kyoto-u.ac.jp	Iima, Mami/W-2390-2019; Kataoka, Masako/AAA-3475-2019; Koyasu, Sho/I-5747-2019	Iima, Mami/0000-0002-1991-2494; Kataoka, Masako/0000-0002-6212-3351; Koyasu, Sho/0000-0002-6690-7460; Ohashi, Akane/0000-0003-0291-3893; Onishi, Natsuko/0000-0003-4495-9187	Hakubi Project; Japan Society for Promotion of Science [15K19786]	Hakubi Project; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Hakubi Project and the Japan Society for Promotion of Science Grant-in-Aid for Young Scientists (B) (15K19786). The funder (Hakubi Project) provided support in the form of salaries for authors [Mami lima], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliu SO, 2014, TRANSL ONCOL, V7, P130, DOI 10.1593/tlo.13841; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Cho GY, 2016, EUR RADIOL, V26, P2547, DOI 10.1007/s00330-015-4087-3; Clendenen TV, 2013, MAGN RESON IMAGING, V31, P1, DOI 10.1016/j.mri.2012.06.022; Giannotti E, 2015, EUR J RADIOL, V84, P1729, DOI 10.1016/j.ejrad.2015.05.032; Iima M., 2017, RADIOLOGY; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Iima M, 2015, INVEST RADIOL, V50, P205, DOI 10.1097/RLI.0000000000000094; Jambor I, 2014, J MAGN RESON IMAGING, V39, P1213, DOI 10.1002/jmri.24271; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanda T, 2016, MAGN RESON IMAGING, V34, P1346, DOI 10.1016/j.mri.2016.08.024; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Meeus EM, 2017, J MAGN RESON IMAGING, V45, P1325, DOI 10.1002/jmri.25411; Nissan N, 2014, RADIOLOGY, V271, P672, DOI 10.1148/radiol.14132084; O'Flynn EAM, 2012, EUR RADIOL, V22, P1512, DOI 10.1007/s00330-012-2399-0; Partridge SC, 2017, J MAGN RESON IMAGING, V45, P337, DOI 10.1002/jmri.25479; Partridge SC, 2001, J MAGN RESON IMAGING, V14, P433, DOI 10.1002/jmri.1204; Richard R, 2013, EUR RADIOL, V23, P2420, DOI 10.1007/s00330-013-2850-x; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Spick C, 2016, NMR BIOMED, V29, P1445, DOI 10.1002/nbm.3596; Sun K, 2015, RADIOLOGY, V277, P46, DOI 10.1148/radiol.15141625; Thomassin-Naggara I, 2013, EUR J RADIOL, V82, P435, DOI 10.1016/j.ejrad.2012.03.002; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Woodhams R, 2011, RADIOGRAPHICS, V31, P1059, DOI 10.1148/rg.314105160; Wu DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113240	28	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193444	10.1371/journal.pone.0193444	http://dx.doi.org/10.1371/journal.pone.0193444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494639	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200050
J	Ladrera, R; Goma, J; Prat, N				Ladrera, Ruben; Goma, Joan; Prat, Narcis			Effects of Didymosphenia geminata massive growth on stream communities: Smaller organisms and simplified food web structure	PLOS ONE			English	Article							DIATOM DIDYMOSPHENIA; BIODIVERSITY; ASSEMBLAGES; SCHMIDT; ECOLOGY; HABITAT; QUALITY; DIPTERA; BIOLOGY; ALTERS	This study aims to contribute to the understanding of the impact of Didymosphenia geminata massive growths upon river ecosystem communities' composition and functioning. This is the first study to jointly consider the taxonomic composition and functional structure of diatom and macroinvertebrate assemblages in order to determine changes in community structure, and the food web alterations associated with this invasive alga. This study was carried out in the Lumbreras River ( Ebro Basin, La Rioja, Northern Spain), which has been affected by a considerable massive growth of D. geminata since 2011. The study shows a profound alteration in both the river community composition and in the food web structure at the sites affected by the massive growth, which is primarily due to the alteration of the environmental conditions, thus demonstrating that D. geminata has an important role as an ecosystem engineer in the river. Thick filamentous mats impede the movement of large invertebrates D especially those that move and feed up on it D and favor small, opportunistic, herbivorous organisms, mainly chironomids, that are capable of moving between filaments and are aided by the absence of large trophic competitors and predators - prey release effect-. Only small predators, such as hydra, are capable of surviving in the new environment, as they are favored by the increase in chironomids, a source of food, and by the reduction in both their own predators and other midge predators - mesopredator release-. This change in the top-down control affects the diatom community, since chironomids may feed on large diatoms, increasing the proportion of small diatoms in the substrate. The survival of small and fast-growing pioneer diatoms is also favored by the mesh of filaments, which offers them a new habitat for colonization. Simultaneously, D. geminata causes a significant reduction in the number of diatoms with similar ecological requirements ( those attached to the substrate). Overall, D. geminata creates a community dominated by small organisms that is clearly different from the existing communities in the same stream where there is an absence of massive growths.	[Ladrera, Ruben; Goma, Joan; Prat, Narcis] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Freshwater Ecol & Management FEM Res Grp, Barcelona, Catalonia, Spain	University of Barcelona	Ladrera, R (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Freshwater Ecol & Management FEM Res Grp, Barcelona, Catalonia, Spain.	rubenladreraf@hotmail.com	Ladrera, Rubén/AAE-5460-2019	Ladrera, Rubén/0000-0002-5172-3271	Government of La Rioja; Ebro Hydrographic Confederation (CHE)	Government of La Rioja; Ebro Hydrographic Confederation (CHE)	This study was partially supported by the Government of La Rioja and the Ebro Hydrographic Confederation (CHE).	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albertson LK, 2016, FRESHW SCI, V35, P644, DOI 10.1086/685860; ALLAN JD, 1993, BIOSCIENCE, V43, P32, DOI 10.2307/1312104; Anderson IJ, 2015, SW NAT, V59, P389; Anderson M.J., 2008, PRIMER PERMANOVA GU; [Anonymous], 1991, BACILLARIOPHYCEAE 3; [Anonymous], 1988, SUSSWASSERFLORA MITT; Beltrami ME, 2008, PLANT BIOSYST, V142, P126, DOI 10.1080/11263500701872788; Bhatt JP, 2008, AQUAT ECOL, V42, P347, DOI 10.1007/s10452-007-9106-2; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bothwell ML, 2014, DIATOM RES, V29, P229, DOI 10.1080/0269249X.2014.889041; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Cranston PS, 2005, AUST J ENTOMOL, V44, P252, DOI 10.1111/j.1440-6055.2005.00465.x; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cullis James D. S., 2012, Journal of Geophysical Research: Biogeosciences, V117, DOI 10.1029/2011JG001891; Ector L., 2005, P7; Edlund MB, 1999, J FRESHWATER ECOL, V14, P293, DOI 10.1080/02705060.1999.9663684; Floder S, 2009, BIODIVERS CONSERV, V18, P3809, DOI 10.1007/s10531-009-9681-8; Garcia-Berthou E., 2015, Ecosistemas, V24, P36, DOI 10.7818/ECOS.2015.24-1.07; Gillis CA, 2014, DIATOM RES, V29, P281, DOI 10.1080/0269249X.2014.924437; Gillis CA, 2010, HYDROBIOLOGIA, V647, P63, DOI 10.1007/s10750-009-9832-7; Gozlan RE, 2010, AQUAT INVASIONS, V5, P231, DOI 10.3391/ai.2010.5.3.02; Hayes JW, 2000, T AM FISH SOC, V129, P315, DOI 10.1577/1548-8659(2000)129<0315:DATOAW>2.0.CO;2; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; Jellyman PG, 2016, BIOL INVASIONS, V18, P3419, DOI 10.1007/s10530-016-1233-z; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kawecka B, 2003, HYDROBIOLOGIA, V495, P193, DOI 10.1023/A:1025469500265; Kilroy C, 2009, FRESHWATER BIOL, V54, P1990, DOI 10.1111/j.1365-2427.2009.02247.x; Kilroy C, 2016, FRESHWATER BIOL, V61, P1550, DOI 10.1111/fwb.12798; Kilroy C, 2014, DIATOM RES, V29, P237, DOI 10.1080/0269249X.2014.889043; Kovacevic G, 2012, INT J DEV BIOL, V56, P627, DOI 10.1387/ijdb.123510gk; Krammer K., 1985, BIBLIOTHECA DIATOMOL, V9; Krammer K., 1986, BACILLARIOPHYCEAE; Krammer K., 1997, BIBLIOTHECA DIATOMOL, V36; Ladrera R, 2014, PAGINAS INF AMBIENT, V43, P24; Ladrera R, 2016, AQUAT INVASIONS, V11, P355, DOI 10.3391/ai.2016.11.4.02; Ladrera R, 2015, RIVER RES APPL, V31, P216, DOI 10.1002/rra.2731; Ladrera R, 2013, LIMNETICA, V32, P353; Lange-Bertalot H., 1989, BIBLIOTHECA DIATOMOL, V18; Larson AM, 2007, RELATIONSHIPS NUISAN; Maceda-Veiga A, 2013, REV FISH BIOL FISHER, V23, P1, DOI 10.1007/s11160-012-9275-5; Marker AF, 1986, P 9 DIAT S, P143; Munne A, 2003, AQUAT CONSERV, V13, P147, DOI 10.1002/aqc.529; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NUNEZ M., 2010, TECNOLOGIA AGUA, V320, P46; Pardo Isabel, 2002, Limnetica, V21, P115; Prat N, 2014, LIMNETICA, V33, P47; Reichardt E., 1999, GOMPHONEMA ICONOGRAP; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Rodriguez-Lozano P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117630; ROEMER SC, 1984, CAN J BOT, V62, P1799, DOI 10.1139/b84-244; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanmiguel A, 2016, BIOL INVASIONS, V18, P1467, DOI 10.1007/s10530-016-1095-4; Spaulding S., 2007, INCREASE NUISANCE BL; Statzner B, 2004, ECOGRAPHY, V27, P470, DOI 10.1111/j.0906-7590.2004.03836.x; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Tachet H, 2006, INVERTEBRES EAU DOUC; Whitton BA, 2009, HYDROBIOLOGIA, V630, P1, DOI 10.1007/s10750-009-9753-5; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	62	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193545	10.1371/journal.pone.0193545	http://dx.doi.org/10.1371/journal.pone.0193545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494699	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200063
J	Ni, J; Dong, LX; Jiang, ZF; Yang, XL; Chen, ZY; Wu, YH; Xu, MJ				Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Chen, Ziying; Wu, Yuhuan; Xu, Maojun			Comprehensive transcriptome analysis and flavonoid profiling of Ginkgo leaves reveals flavonoid content alterations in day-night cycles	PLOS ONE			English	Article							CIRCADIAN CLOCKS; RNA-SEQ; BILOBA; BIOSYNTHESIS; GENE; EXPRESSION; GROWTH; ACCUMULATION; ALIGNMENT; EXTRACT	Ginkgo leaves are raw materials for flavonoid extraction. Thus, the timing of their harvest is important to optimize the extraction efficiency, which benefits the pharmaceutical industry. In this research, we compared the transcriptomes of Ginkgo leaves harvested at midday and midnight. The differentially expressed genes with the highest probabilities in each step of flavonoid biosynthesis were down-regulated at midnight. Furthermore, real-time PCR corroborated the transcriptome results, indicating the decrease in flavonoid biosynthesis at midnight. The flavonoid profiles of Ginkgo leaves harvested at midday and midnight were compared, and the total flavonoid content decreased at midnight. A detailed analysis of individual flavonoids showed that most of their contents were decreased by various degrees. Our results indicated that circadian rhythms affected the flavonoid contents in Ginkgo leaves, which provides valuable information for optimizing their harvesting times to benefit the pharmaceutical industry.	[Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Chen, Ziying; Wu, Yuhuan; Xu, Maojun] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Qual & Safety Agr Prod, Hangzhou, Zhejiang, Peoples R China; [Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Xu, Maojun] Hangzhou Normal Univ, Zhejiang Prov Key Lab Genet Improvement & Qual Co, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Ni, J; Xu, MJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Qual & Safety Agr Prod, Hangzhou, Zhejiang, Peoples R China.; Ni, J; Xu, MJ (corresponding author), Hangzhou Normal Univ, Zhejiang Prov Key Lab Genet Improvement & Qual Co, Hangzhou, Zhejiang, Peoples R China.	nijun@hznu.edu.cn; maojunxu@163.com			Zhejiang Provincial Natural Science Foundation of China [LY18C060008]; Independent Projects for Agricultural Research [20170432607]; National Natural Science Foundation of China [81673539, 81373907]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Independent Projects for Agricultural Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Zhejiang Provincial Natural Science Foundation of China (Grant No. LY18C060008) (JN), Independent Projects for Agricultural Research (Grant No. 20170432607) (JN), National Natural Science Foundation of China (Grant No. 81673539 and 81373907) (MX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes PW, 2016, OECOLOGIA, V181, P55, DOI 10.1007/s00442-016-3558-9; Chen Y, 2014, ACTA PHYSIOL PLANT, V36, P3173, DOI 10.1007/s11738-014-1684-8; Cheng H, 2011, PLANT CELL REP, V30, P49, DOI 10.1007/s00299-010-0943-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; DeFeudis FV, 2003, PHARMACOPSYCHIATRY, V36, pS2; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Du SH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00871; Fan Yimei, 1998, Zhongguo Zhongyao Zazhi, V23, P267; Farre EM, 2012, CURR OPIN PLANT BIOL, V15, P293, DOI 10.1016/j.pbi.2012.01.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Guan R, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0154-1; Han SM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0868-8; He B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00819; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kang SZ, 2004, J EXP BOT, V55, P2437, DOI 10.1093/jxb/erh249; Kaur P, 2012, CHEM BIODIVERS, V9, P409, DOI 10.1002/cbdv.201100082; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XG, 2015, J PHARMACEUT BIOMED, V113, P212, DOI 10.1016/j.jpba.2015.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Ni J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00920; Pang YZ, 2005, PLANT SCI, V168, P1525, DOI 10.1016/j.plantsci.2005.02.003; Pang YZ, 2004, DNA SEQUENCE, V15, P283, DOI 10.1080/10425170412331283814; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rimbach G, 2001, BIOFACTORS, V15, P39, DOI 10.1002/biof.5520150104; Schulz E, 2015, PLANT CELL ENVIRON, V38, P1658, DOI 10.1111/pce.12518; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Sun MY, 2010, INNOV FOOD SCI EMERG, V11, P672, DOI 10.1016/j.ifset.2010.08.006; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tobin EM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00261; Veit M, 1996, J PLANT PHYSIOL, V148, P478, DOI 10.1016/S0176-1617(96)80282-3; Wang Gui-bin, 2013, Yingyong Shengtai Xuebao, V24, P3077; Wang L, 2016, GINKGO BILOBA, V47, P377; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie HY, 2014, MOLECULES, V19, P4466, DOI 10.3390/molecules19044466; Xu F, 2014, FUNCT INTEGR GENOMIC, V14, P177, DOI 10.1007/s10142-013-0352-1; Xu F, 2012, MOL BIOL REP, V39, P2285, DOI 10.1007/s11033-011-0978-9; Xu MJ, 2012, ENVIRON EXP BOT, V75, P114, DOI 10.1016/j.envexpbot.2011.09.005; Xu MJ, 2009, PLANT CELL ENVIRON, V32, P960, DOI 10.1111/j.1365-3040.2009.01976.x; Xu Y, 2014, NEW FOREST, V45, P765, DOI 10.1007/s11056-014-9435-7; Yerushalmi S, 2011, MOL ECOL, V20, P1155, DOI 10.1111/j.1365-294X.2010.04962.x; Zhang YY, 2015, J EXP BOT, V66, P2535, DOI 10.1093/jxb/erv043; Zhou ZY., 2009, PALAEOWORLD, V18, P1, DOI [10.1016/j.palwor.2009.01.001, DOI 10.1016/j.palwor.2009.01.001]; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534	54	23	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193897	10.1371/journal.pone.0193897	http://dx.doi.org/10.1371/journal.pone.0193897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494702	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200101
J	Zhou, J; Zhang, ZP; Zhang, YC; Wei, Y; Jiang, ZP				Zhou, Jian; Zhang, Zhaopei; Zhang, Yichuan; Wei, Yuan; Jiang, Zeping			Effects of lead stress on the growth, physiology, and cellular structure of privet seedlings	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; HEAVY-METAL; ROBINIA-PSEUDOACACIA; PHOTOSYNTHESIS; TOXICITY; ROOT; L.; ULTRASTRUCTURE; ACCUMULATION; MORPHOLOGY	In this study, we investigated the effects of different lead (Pb) concentrations (0, 200, 600, 1000, 1400 mg kg(-1) soil) on the growth, ion enrichment in the tissues, photosynthetic and physiological characteristics, and cellular structures of privet seedlings. We observed that with the increase in the concentrations of Pb, the growth of privet seedlings was restricted, and the level of Pb ion increased in the roots, stem, and leaves of the seedlings; however, most of the ions were concentrated in the roots. Moreover, a decreasing trend was observed for chlorophyll a, chlorophyll b, total chlorophyll, net photosynthesis (Pn), transpiration rate (Tr), stomatal conductance (Gs), sub-stomatal CO2 concentration (Ci), maximal photochemical efficiency (Fv/Fm), photochemical quenching (qP), and quantum efficiency of photosystem II (Phi PSII). In contrast, the carotene levels, minimum fluorescence (F-0), and non-photochemical quenching (qN) showed an increasing trend. Under Pb stress, the chloroplasts were swollen and deformed, and the thylakoid lamellae were gradually expanded, resulting in separation from the cell wall and eventual shrinkage of the nucleus. Using multiple linear regression analysis, we found that the content of Pb in the leaves exerted the maximum effect on the seedling growth. We observed that the decrease in photosynthetic activation energy, increase in pressure because of the excess activation energy, and decrease in the transpiration rate could result in maximum effect on the photosynthetic abilities of the seedlings under Pb stress. Our results should help in better understanding of the effects of heavy metals on plants and in assessing their potential for use in bioremediation.	[Zhou, Jian; Zhang, Yichuan] Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China; [Zhou, Jian; Wei, Yuan; Jiang, Zeping] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Zhang, Zhaopei] Henan Inst Sci & Technol, Expt Ctr, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Henan Institute of Science & Technology	Jiang, ZP (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China.	jiangzp@caf.ac.cn	Zhang, Yichuan/GXZ-6873-2022		National Science & Technology Pillar Program; Research Institute of Forestry Chinese Academy of Forestry [2015BAD07B0103]; School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology [162102110133, 162102310088]	National Science & Technology Pillar Program; Research Institute of Forestry Chinese Academy of Forestry; School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology	This work was supported by: National Science & Technology Pillar Program during the 12th Five-Year Plan Period and the Research Institute of Forestry Chinese Academy of Forestry (http://www.most.gov.cn/) 2015BAD07B0103 to ZJ; and School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology (http://www.hnkjt.gov.cn/) 162102110133 to JZ and 162102310088 to YZ.	Adams WW, 2001, PHOTOSYNTH RES, V67, P51, DOI 10.1023/A:1010688528773; Ahmad MSA, 2011, BIOL TRACE ELEM RES, V144, P1229, DOI 10.1007/s12011-011-9099-5; Akinci IE, 2010, AFR J AGR RES, V5, P416; Arya SK, 2013, NUCLEUS CALCUTTA, V56, P183, DOI 10.1007/s13237-013-0099-z; Bai XY, 2015, BIOL PLANTARUM, V59, P163, DOI 10.1007/s10535-014-0476-8; Bruno Gloria, 2007, Bol. Soc. Argent. Bot., V42, P231; Chen FC, 2016, HUNAN FORESTRY SCI T, V43, P64; Chen YiTai, 2012, Scientia Silvae Sinicae, V48, P22; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; Dabrowski P, 2015, ZEMDIRBYSTE, V102, P305; Dahmani-Muller H, 2000, ENVIRON POLLUT, V109, P231, DOI 10.1016/S0269-7491(99)00262-6; Fei F, 2006, J YUEYANG VOCATIONAL, V21, P61; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Huang Hua, 2008, Scientia Silvae Sinicae, V44, P145; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jiang WS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-40; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Kang Wei, 2014, Journal of Plant Resources and Environment, V23, P78, DOI 10.3969/j.issn.1674-7895.2014.01.12; Kodera H, 2008, ANAL SCI, V24, P1545, DOI 10.2116/analsci.24.1545; Kopittke PM, 2007, ENVIRON POLLUT, V150, P280, DOI 10.1016/j.envpol.2007.01.011; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Lamhamdi M, 2013, SAUDI J BIOL SCI, V20, P29, DOI 10.1016/j.sjbs.2012.09.001; Lamhamdi M, 2011, CR BIOL, V334, P118, DOI 10.1016/j.crvi.2010.12.006; Li CL, 2010, POLLUTION EVALUATION; [李贵 Li Gui], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P61; Li X, 2012, SCI WORLD J, DOI 10.1100/2012/936149; [李亚斌 Li Yabin], 2007, [电工技术学报, Transactions of China Electrotechnical Society], V22, P84; Li Y, 2007, P INT COMP SOFTW APP, P71; Li Zhi, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P546; Liu Jian, 2007, Xibei Zhiwu Xuebao, V27, P2024; Liu Ying, 2016, Acta Prataculturae Sinica, V25, P254; Monfared SH, 2013, J FORESTRY RES, V24, P391, DOI 10.1007/s11676-012-0313-x; Ogwuegbu M.O.C., 2005, J ENV, V1, P66; OQUIST G, 1993, PLANTA, V189, P150, DOI 10.1007/BF00201355; Ragab GA, 2014, EGYPTIAN SOC EXPT BI, V10, P37; Rossini Oliva S, 2004, ENVIRON MONIT ASSESS, V96, P221, DOI 10.1023/B:EMAS.0000031729.62970.fa; Santos RW, 2015, PROTOPLASMA, V252, P1203, DOI 10.1007/s00709-014-0751-8; Segui SJ, 2005, PLANTA, V223, P223; Seregin IV, 2008, RUSS J PLANT PHYSL+, V55, P1, DOI 10.1134/S1021443708010019; Seregin IV, 2004, RUSS J PLANT PHYSL+, V51, P525, DOI 10.1023/B:RUPP.0000035747.42399.84; Shi Xiang, 2016, Forest Research, V29, P147; Tuba Z, 2010, CURR SCI INDIA, V98, P1505; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wang Z, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120482, 10.1371/journal.pone.0145726]; Winska-Krysiak M, 2015, J ELEMENTOL, V20, P491, DOI 10.5601/jelem.2014.19.4.721; Xu S, 2008, SCI CHINA SER C, V51, P827, DOI 10.1007/s11427-008-0112-y; Yan ZZ, 2011, MAR POLLUT BULL, V63, P438, DOI 10.1016/j.marpolbul.2011.04.027; [张富运 Zhanh Fuyun], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P92; Zhou J, 2017, ENVIRON SCI POLLUT R, V24, P10718, DOI 10.1007/s11356-017-8713-2	50	58	63	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191139	10.1371/journal.pone.0191139	http://dx.doi.org/10.1371/journal.pone.0191139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494617	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200005
J	Evangelista, LS; Cho, WK; Kim, Y				Evangelista, Lorraine S.; Cho, Won-Kyung; Kim, Youngmee			Obesity and chronic kidney disease: A population-based study among South Koreans	PLOS ONE			English	Article							BODY-MASS INDEX; ASSOCIATION; RISK; CKD; TRENDS; ADOLESCENTS; PREVALENCE; OVERWEIGHT; MORTALITY; MEN	Obesity and chronic kidney disease (CKD) are major global health problems. There are very little data concerning the prevalence and its associated factors of obesity in non-dialyzed patients who have different stages of CKD. Therefore, in this study, we examined the prevalence of obesity and its associated factors according to the stages of CKD. We used nationwide representative data from the Korean National Health and Nutrition Examination Survey, which was conducted over a 7-year period from 2008 to 2014 by the Korea Centers for Disease Control and Prevention. The results indicated that: (1) general obesity and abdominal obesity were more prevalent in patients with CKD compared to those without CKD; (2) the prevalence of general obesity and abdominal obesity was highest in stage 2 CKD; (3) stages 3a and 3b were the factors associated with general obesity, and stage 3a was significantly associated with abdominal obesity; (4) the association between general obesity/abdominal obesity and CKD disappeared in people with advanced stage 4/5 CKD; and (5) the presence of comorbidities contributed to the development of both general obesity and abdominal obesity. The findings of this study might support the idea that weight loss is a good potential intervention for the prevention of disease progression in moderate CKD (stage 3), but not severe CKD (stage 4/5).	[Evangelista, Lorraine S.] Univ Calif Irvine, Sue & Bill Gross Sch Nursing, Irvine, CA USA; [Cho, Won-Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Int Hlth Care Ctr, Seoul, South Korea; [Kim, Youngmee] Chung Ang Univ, Red Cross Coll Nursing, Seoul, South Korea	University of California System; University of California Irvine; University of Ulsan; Asan Medical Center; Chung Ang University	Cho, WK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Int Hlth Care Ctr, Seoul, South Korea.; Kim, Y (corresponding author), Chung Ang Univ, Red Cross Coll Nursing, Seoul, South Korea.	wonkyungcho@hotmail.com; youngkim234@gmail.com		Evangelista, Lorraine/0000-0003-1708-4186; Cho, Won-Kyung/0000-0003-1540-545X; Kim, Youngmee/0000-0002-0206-7300	Chung-Ang University Research Grant	Chung-Ang University Research Grant	This study was supported by the 2015 Chung-Ang University Research Grant. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Cheung WW, 2010, INT J PEPT, V2010; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Gunta SS, 2013, PEDIATR NEPHROL, V28, P611, DOI 10.1007/s00467-012-2380-9; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Kopple JD, 2011, J RENAL NUTR, V21, P66, DOI 10.1053/j.jrn.2010.10.009; Korea Centers for Disease Control and Prevention(KCDC), 2016, WORK SHOP REP GUID U; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Munkhaugen J, 2009, AM J KIDNEY DIS, V54, P638, DOI 10.1053/j.ajkd.2009.03.023; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85	28	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193559	10.1371/journal.pone.0193559	http://dx.doi.org/10.1371/journal.pone.0193559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489920	gold, Green Published			2022-12-26	WOS:000426276000090
J	Montgomery, NT; Zientek, KD; Pokidysheva, EN; Bachinger, HP				Montgomery, Nathan T.; Zientek, Keith D.; Pokidysheva, Elena N.; Bachinger, Hans Peter			Post-translational modification of type IV collagen with 3-hydroxyproline affects its interactions with glycoprotein VI and nidogens 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; PROLYL 3-HYDROXYLASE; HIGH MYOPIA; OSTEOGENESIS IMPERFECTA; INHIBITORY RECEPTOR; STRUCTURAL BASIS; 4-HYDROXYLASE; MUTATIONS; PROTEIN; ENZYME	Type IV collagen is a major component of the basement membrane and interacts with numerous other basement membrane proteins. Many of these interactions are poorly characterized. Type IV collagen is abundantly post-translationally modified with 3-hydroxyproline (3-Hyp), but 3-Hyp's biochemical role in type IV collagen's interactions with other proteins is not well established. In this work, we present binding data consistent with a major role of 3-Hyp in interactions of collagen IV with glycoprotein VI and nidogens 1 and 2. The increased binding interaction between type IV collagen without 3-Hyp and glycoprotein VI has been the subject of some controversy, which we sought to explore, whereas the lack of binding of nidogens to type IV collagen without 3-Hyp is novel. Using tandem MS, we show that the putative glycoprotein VI-binding site is 3-Hypmodified in WT PFHR-9 type IV collagen, but not in PFHR-9 cells in which prolyl-3-hydroxylase 2 (P3H2) has been knocked out (KO). Moreover, we observed altered 3-Hyp occupancy across many other sites. Using amino acid analysis of type IV collagen from the WT and P3H2 KO cell lines, we confirm that P3H2 is the major, but not the only 3-Hyp-modifying enzyme of type IV collagen. These findings underscore the importance of post-translational modifications of type IV collagen for interactions with other proteins.	[Montgomery, Nathan T.; Zientek, Keith D.; Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Montgomery, Nathan T.; Bachinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Pokidysheva, Elena N.] Vanderbilt Univ, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA	Oregon Health & Science University; Vanderbilt University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org			Shriners Hospital for Children [85100, 85500]	Shriners Hospital for Children	This work was supported by Shriners Hospital for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aro E, 2015, J BIOL CHEM, V290, P16964, DOI 10.1074/jbc.M115.662635; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Guo H, 2015, GENET MED, V17, P300, DOI 10.1038/gim.2015.28; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Kang SH, 2000, MOL BIOL CELL, V11, P3911, DOI 10.1091/mbc.11.11.3911; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; SCHUPPAN D, 1984, BIOCHEM J, V220, P227, DOI 10.1042/bj2200227; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1977, BIOCHEM BIOPH RES CO, V76, P275, DOI 10.1016/0006-291X(77)90722-7; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Watkins NA, 2006, J THROMB HAEMOST, V4, P1197, DOI 10.1111/j.1538-7836.2006.01937.x; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Zahid M, 2012, J THROMB HAEMOST, V10, P2418, DOI 10.1111/jth.12009	40	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5987	5999		10.1074/jbc.RA117.000406	http://dx.doi.org/10.1074/jbc.RA117.000406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491144	hybrid, Green Published			2022-12-26	WOS:000430497300019
J	Van Peer, G; Mets, E; Claeys, S; De Punt, I; Lefever, S; Ongenaert, MA; Rondou, P; Speleman, F; Mestdagh, P; Vandesompele, J				Van Peer, Gert; Mets, Evelien; Claeys, Shana; De Punt, Ines; Lefever, Steve; Ongenaert, Mate A.; Rondou, Pieter; Speleman, Frank; Mestdagh, Pieter; Vandesompele, Jo			A high-throughput 3 ' UTR reporter screening identifies microRNA interactomes of cancer genes	PLOS ONE			English	Article							TARGET RECOGNITION; CELL-PROLIFERATION; MESSENGER-RNAS; BINDING; SITES; PROTEIN; CLIP; INFORMATION; PREDICTION; LYMPHOMA	Introduction Despite the established contribution of deregulated microRNA (miRNA) function to carcinogenesis, relatively few miRNA-cancer gene interactions have been validated, making it difficult to appreciate the true complexity of miRNA-cancer gene regulatory networks. Results In this effort, we identify miRNA interactomes of 17 well-established cancer genes, involved in various cancer types, through a miRNome-wide 3' UTR reporter screening. Using a novel and performant strategy for high-throughput screening data analysis, we identify 390 interactions, quadrupling the size of the known miRNA interactome for the cancer genes under investigation. Clear enrichments of established and predicted interactions underscore the validity of the interactome data set. Interactomes appear to be primarily driven by canonical binding site interactions. Nonetheless, non-canonical binding sites, such as offset 6mer and seed-mismatched or G:U wobble sites, also have regulatory activity, albeit clearly less pronounced. Furthermore, we observe enhanced regulation in the presence of 3' supplementary pairing for both canonical and non-canonical binding sites. Conclusions Altogether, the cancer gene-miRNA interactome data set represents a unique resource that will aid in the unraveling of regulatory miRNA networks and the dynamic regulation of key protein-coding cancer genes. In addition, it uncovers aspects of the functional miRNA binding site's architecture and the relative contributions of different binding site types.	[Van Peer, Gert; Mets, Evelien; Claeys, Shana; De Punt, Ines; Lefever, Steve; Ongenaert, Mate A.; Rondou, Pieter; Speleman, Frank; Mestdagh, Pieter; Vandesompele, Jo] Univ Ghent, Dept Pediat & Genet, Ctr Med Genet, Ghent, Belgium	Ghent University	Van Peer, G (corresponding author), Univ Ghent, Dept Pediat & Genet, Ctr Med Genet, Ghent, Belgium.	vanpeer.gert@gmail.com	Ongenaert, Maté/AAA-2826-2019; Van Peer, Gert/AAV-6861-2020; Vandesompele, Jo/W-3411-2018; speleman, frank/AAR-5184-2020	Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; Ongenaert, Mate/0000-0001-7520-871X; Van Peer, Gert/0000-0001-7597-5521; Mestdagh, Pieter/0000-0001-7821-9684	Belgian Foundation against Cancer (Stichting Tegen Kanker) [SCIE 2010-177]; Flemish League against Cancer; Ghent University Research Fund [BOF 01D35609, BOF12/PDO/067, BOF10/PDO/140, 01G01910//BOF10/GOA/019]; Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) [11J8313N, 1.5.210.11N, G.0869.10N, G.0530.12N]; Fournier-Majoie Foundation (FFM); Cancer Plan from the Federal Public Service of Health (Kankerplan FOD Volksgezondheid); Children Cancer Fund Ghent (Kinderkankerfonds); Belgian Program of Interuniversity Poles of Attraction [IUAP P7/03, IUAP P7/07]; ASSET FP7 Consortium [ASSET FP7-259348]	Belgian Foundation against Cancer (Stichting Tegen Kanker); Flemish League against Cancer; Ghent University Research Fund(Ghent University); Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen)(FWO); Fournier-Majoie Foundation (FFM); Cancer Plan from the Federal Public Service of Health (Kankerplan FOD Volksgezondheid); Children Cancer Fund Ghent (Kinderkankerfonds); Belgian Program of Interuniversity Poles of Attraction; ASSET FP7 Consortium	This work was supported by the Belgian Foundation against Cancer (Stichting Tegen Kanker; research grant SCIE 2010-177 to J.V.); the Flemish League against Cancer (Vlaamse Liga tegen Kanker; Emmanuel van der Schueren research grant to G.V.P.); the Ghent University Research Fund (PhD grant BOF 01D35609 to G.V. P.; postdoctoral grants BOF12/PDO/067 to S.L. and BOF10/PDO/140 to P.R.; GOA grant 01G01910//BOF10/GOA/019 to F.S.); the Fund for Scientific Research Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen; PhD grant 11J8313N to S. C.; postdoctoral grants to P.R. and P.M.; research grant 1.5.210.11N to P.R.; research grants G.0869.10N, G.0530.12N to F.S.); the Fournier-Majoie Foundation (FFM; to M.O.); the Cancer Plan from the Federal Public Service of Health (Kankerplan FOD Volksgezondheid; to F.S.); the Children Cancer Fund Ghent (Kinderkankerfonds; F. S.); the Belgian Program of Interuniversity Poles of Attraction (IUAP P7/03 and IUAP P7/07 to F.S.); and the ASSET FP7 Consortium (ASSET FP7-259348).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Clark PM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05947; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Majoros WH, 2013, NAT METHODS, V10, P630, DOI 10.1038/nmeth.2489; Markopoulos GS, 2017, CELLULAR ONCOLOGY, P1; Mavrakis KJ, 2011, CELL CYCLE, V10, P2845, DOI 10.4161/cc.10.17.16959; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rinck A, 2013, RNA BIOL, V10, P1125, DOI 10.4161/rna.24955; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241; Van Peer G, 2014, DATABASE, V2014; Van Peer G, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1260; Van Peer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00222; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	56	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194017	10.1371/journal.pone.0194017	http://dx.doi.org/10.1371/journal.pone.0194017			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522551	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800033
J	Plouchart, D; Milferstedt, K; Guizard, G; Latrille, E; Hamelin, J				Plouchart, Diane; Milferstedt, Kim; Guizard, Guillaume; Latrille, Eric; Hamelin, Jerome			Multiplexed chemostat system for quantification of biodiversity and ecosystem functioning in anaerobic digestion	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; CONTINUOUS-CULTURE; METHANE; SCALE; DIVERSITY; DISPERSAL; BACTERIA; ECOLOGY	Continuous cultures in chemostats have proven their value in microbiology, microbial ecology, systems biology and bioprocess engineering, among others. In these systems, microbial growth and ecosystem performance can be quantified under stable and defined environmental conditions. This is essential when linking microbial diversity to ecosystem function. Here, a new system to test this link in anaerobic, methanogenic microbial communities is introduced. Rigorously replicated experiments or a suitable experimental design typically require operating several chemostats in parallel. However, this is labor intensive, especially when measuring biogas production. Commercial solutions for multiplying reactors performing continuous anaerobic digestion exist but are expensive and use comparably large reactor volumes, requiring the preparation of substantial amounts of media. Here, a flexible system of Lab-scale Automated and Multiplexed Anaerobic Chemostat system (LAMACs) with a working volume of 200 mL is introduced. Sterile feeding, biomass wasting and pressure monitoring are automated. One module containing six reactors fits the typical dimensions of a lab bench. Thanks to automation, time required for reactor operation and maintenance are reduced compared to traditional lab-scale systems. Several modules can be used together, and so far the parallel operation of 30 reactors was demonstrated. The chemostats are autoclavable. Parameters like reactor volume, flow rates and operating temperature can be freely set. The robustness of the system was tested in a two-month long experiment in which three inocula in four replicates, i.e., twelve continuous digesters were monitored. Statistically significant differences in the biogas production between inocula were observed. In anaerobic digestion, biogas production and consequently pressure development in a closed environment is a proxy for ecosystem performance. The precision of the pressure measurement is thus crucial. The measured maximum and minimum rates of gas production could be determined at the same precision. The LAMACs is a tool that enables us to put in practice the often-demanded need for replication and rigorous testing in microbial ecology as well as bioprocess engineering.	[Plouchart, Diane; Milferstedt, Kim; Guizard, Guillaume; Latrille, Eric; Hamelin, Jerome] Univ Montpellier, INRA, LBE, Narbonne, France	INRAE; Universite de Montpellier	Hamelin, J (corresponding author), Univ Montpellier, INRA, LBE, Narbonne, France.	jerome.harnelin@inra.fr	Hamelin, Jérôme/F-4981-2013	Hamelin, Jérôme/0000-0003-3601-6349	'Institut National de la Recherche Agronomique' (INRA), France, through the ENIGME project from Meta-omic and Microbial Ecosystem program	'Institut National de la Recherche Agronomique' (INRA), France, through the ENIGME project from Meta-omic and Microbial Ecosystem program	This research was funded by the 'Institut National de la Recherche Agronomique' (INRA), France, through the ENIGME project from Meta-omic and Microbial Ecosystem program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; [Anonymous], 2021, LANG ENV STAT COMP; Badshah M, 2012, BIORESOURCE TECHNOL, V114, P262, DOI 10.1016/j.biortech.2012.02.022; Berner AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077772; Bier RL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv113; Braun F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125552; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; De Roy K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2392; Eskicioglu C, 2017, WATER RES, V120, P32, DOI 10.1016/j.watres.2017.04.068; Gebhardt G, 2011, BIOTECHNOL PROGR, V27, P684, DOI 10.1002/btpr.570; Hagen LH, 2015, APPL MICROBIOL BIOT, V99, P5749, DOI 10.1007/s00253-015-6623-0; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kerckhof FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099517; Kusterer A, 2008, BIOPROC BIOSYST ENG, V31, P207, DOI 10.1007/s00449-007-0195-z; Laperriere W, 2017, BIORESOUR TECHNOL; Lennon JT, 2011, ENVIRON MICROBIOL, V13, P1383, DOI 10.1111/j.1462-2920.2011.02445.x; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; McDonald JAK, 2013, J MICROBIOL METH, V95, P167, DOI 10.1016/j.mimet.2013.08.008; Mosbaek F., 2016, ISME J, V2, P1, DOI DOI 10.1038/ISMEJ.2016.39; Pereira MG, 2004, CHEMOSPHERE, V54, P297, DOI 10.1016/S0045-6535(03)00665-9; Perrotta AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171369; Pohlert T, 2016, PMCMR CALCULATE PAIR; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Rafrafi Y, 2013, INT J HYDROGEN ENERG, V38, P4975, DOI 10.1016/j.ijhydene.2013.02.008; Raposo F, 2011, J CHEM TECHNOL BIOT, V86, P1088, DOI 10.1002/jctb.2622; Schmideder A, 2015, J BIOTECHNOL, V210, P19, DOI 10.1016/j.jbiotec.2015.06.402; Shade A, 2009, ISME J, V3, P881, DOI 10.1038/ismej.2009.56; Sierocinski P, 2017, CURR BIOL, V27, P3390, DOI 10.1016/j.cub.2017.09.056; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Steinberg LM, 2011, BIORESOURCE TECHNOL, V102, P8790, DOI 10.1016/j.biortech.2011.07.017; Steinhaus B, 2007, APPL ENVIRON MICROB, V73, P1653, DOI 10.1128/AEM.01827-06; Sun L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0543-9; Van de Wiele T., 2015, IMPACT FOOD BIOACTIV, P305, DOI [10.1007/978-3-319-16104-4, DOI 10.1007/978-3-319-16104-4_27]; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Venkiteshwaran K, 2017, WATER RES, V110, P161, DOI 10.1016/j.watres.2016.12.010; Vuono DC, 2014, ISME J, P1; Wang SP, 2015, PEERJ, V3, DOI 10.7717/peerj.1295; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; WOLFAARDT GM, 1994, APPL ENVIRON MICROB, V60, P434, DOI 10.1128/AEM.60.2.434-446.1994	41	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193748	10.1371/journal.pone.0193748	http://dx.doi.org/10.1371/journal.pone.0193748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518106	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900036
J	Raizada, N; Khaparde, SD; Swaminathan, S; Sarin, S; Salhotra, VS; Kalra, A; Khanna, A; Chopra, KK; Hanif, M; Umadevi, KR; Hissar, S; Nair, SA; Prakash, CHS; Saha, BK; Rao, R; Denkinger, C; Boehme, C				Raizada, Neeraj; Khaparde, Sunil D.; Swaminathan, Soumya; Sarin, Sanjay; Salhotra, Virender Singh; Kalra, Aakshi; Khanna, Ashwani; Chopra, K. K.; Hanif, M.; Umadevi, K. R.; Hissar, Syed; Nair, Sreenivas Achuthan; Prakash, C. H. Surya; Saha, B. K.; Rao, Raghuram; Denkinger, Claudia; Boehme, Catharina			Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; XPERT MTB/RIF; RESISTANT TUBERCULOSIS; ADVOCACY; CHILDREN; IMPACT	Background Unlike in adults, diagnosis of TB can be challenging in children, as signs and symptoms of paediatric TB can be very non-specific and similar to other common childhood chest infections, which may lead to under or delayed diagnosis of TB disease. In spite of the increasing availability of rapid high-sensitivity diagnostics in public and private sectors, majority of paediatric TB cases are empirically diagnosed, without laboratory confirmation. To address these diagnostic challenges, World Health Organization (WHO) has recommended upfront Xpert MTB/RIF (Xpert) testing for the diagnosis of TB in paediatric presumptive pulmonary and extra-pulmonary TB (EPTB) cases. However, in spite of the increasing availability of rapid high-sensitivity diagnostics, a significant gap exists in its application with Xpert being rarely used as an upfront diagnostic among patients presumed to have TB. Under an ongoing paediatric project since April 2014, which provided free-of-cost upfront Xpert testing, several low-cost outreach and education interventions were undertaken to increase the diagnostic uptake by different providers catering to the paediatric population, thereby increasing adherence to global guidance. Methods Providers catering to paediatric population in the project cities were systematically mapped and contacted using different outreach strategies. The focus of outreach efforts was to increase provider literacy and increase their awareness of the availability of free rapid diagnostic services with the goal of changing their diagnostic approaches. Results From April 2014 to June 2016, more than 5,700 providers/facilities were mapped and 3,670 of them were approached. The number of providers/facilities engaged under the project increased more than 10-fold (43 in April, 2014 to 466 in June, 2016), with significant increase in project uptake, both from public and private sector. Overall 42,238 paediatric presumptive TB cases were enrolled in the project, across the four cities. Over the project period, quarterly diagnostic uptake and paediatric TB cases detection rates increased more than two-fold. TB detection rates were similar in patients from public and private sectors. Conclusions Ongoing efforts in scaling up new rapid diagnostics involves significant investments. These efforts need to be complemented with proactive provider engagement to ensure provider-literacy and awareness, for maximizing impact of this scale-up. The current project demonstrated the usefulness of outreach and education interventions for the effective uptake of newer diagnostics.	[Raizada, Neeraj; Sarin, Sanjay; Kalra, Aakshi] Fdn Innovat New Diagnost, New Delhi, India; [Khaparde, Sunil D.; Salhotra, Virender Singh; Rao, Raghuram] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Khanna, Ashwani] Govt NCT, State TB Off, New Delhi, India; [Chopra, K. K.; Hanif, M.] New Delhi TB Ctr, New Delhi, India; [Umadevi, K. R.; Hissar, Syed] Natl Inst Res TB, Madras, Tamil Nadu, India; [Nair, Sreenivas Achuthan] World Hlth Org, Country Off India, New Delhi, India; [Prakash, C. H. Surya] Intermediate Reference Lab, Hyderabad, Andhra Pradesh, India; [Saha, B. K.] Intermediate Reference Lab, Kolkata, India; [Denkinger, Claudia; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; Foundation For Innovative New Diagnostics	Kalra, A (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	aakshi.kalra@finddx.org		Nair, Sreenivas/0000-0002-2586-6797; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) under Challenge TB project	United States Agency for International Development (USAID) under Challenge TB project(United States Agency for International Development (USAID))	The project was funded by United States Agency for International Development (USAID) under Challenge TB project. FIND was responsible for implementation, training, coordination, monitoring, data analysis and writing of the reporting in close coordination with Central TB Division, Ministry of Health and Family Welfare, Government of India.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; Cao H, 2012, J BIOL DYNAM, V6, P663, DOI 10.1080/17513758.2012.677483; Central TB Division; Government of India, 2017, TB IND 2017, V2017, P1; Cruz AT, 2014, LANCET GLOBAL HLTH, V2; DeLuca A, 2014, LANCET RESP MED, V2, P258, DOI 10.1016/S2213-2600(14)70035-9; Dodd PJ, 2014, LANCET GLOB HLTH, V2; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Hanrahan CF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw068; Hsiang E, 2016, INT J TUBERC LUNG D, V20, P1212, DOI 10.5588/ijtld.16.0200; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Kamineni VV, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-463; Kr S, 2014, COCHRANE LIB; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lolekha R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-94; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nguyen TQN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-31; Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008; Organisation W. H., 2013, GLOB TUB REP 2013, P306; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105346; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; UNITAID Diagnostics Technology and Market Landscape, 2014, UNITAID DIAGN TECHN; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2013, STATE SCI ENDOCRINE, p[1, 5]; Wikipedia, 2016, PAR PRINC, P5; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193341	10.1371/journal.pone.0193341	http://dx.doi.org/10.1371/journal.pone.0193341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509803	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000426813200013
J	Lin, FY; Yang, YC; Lin, CL; Lee, LJH				Lin, Fu-Yu; Yang, Yi-Chien; Lin, Cheng-Li; Lee, Lukas Jyuhn-Hsiarn			Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study	PLOS ONE			English	Article							URINARY-TRACT DYSFUNCTION; SYMPTOMS; PREVALENCE; MANAGEMENT; INCONTINENCE; EPIDEMIOLOGY; DEGENERATION	Background Idiopathic Parkinson's disease (IPD) is a progressive neurodegenerative disorder characterized by typical motor impairment. However, lower urinary tract symptoms, including urinary urgency or frequency, which are non-motor phenomena, occur frequently among patients with IPD. In this study, we assess the risk of overactive bladder (OAB) in patients with IPD. Methods The National Health Insurance Research Database of Taiwan was used to identify patients with IPD (IPD cohort) and four-fold controls (non-IPD cohort) from 2000 to 2010. The non-IPD cohort was matched according to age, sex, and baseline comorbidities, including benign prostate hyperplasia, stress incontinence, diabetes, and cerebrovascular diseases. The occurrence of OAB was monitored until the end of 2011. Hazard ratios of OAB were estimated using Cox proportional hazards regression models. Results In total, 4,571 and 18,255 patients were included in IPD and non-IPD cohorts, respectively. Results showed a significantly higher overall incidence rate of OAB in the IPD cohort compared with the non-IPD cohort (14.5 vs. 6.37 per 10,000 person-years), with a 2.3-fold increased risk of OAB (95% confidence interval [CI] = 1.51-3.51) after controlling for benign prostate hyperplasia and stress incontinence. The mean follow-up period for the IPD cohort was 5.0 years. This cohort study showed that the cumulative incidence of OAB was 0.65% at the fifth year and 1.54% at the tenth year after IPD diagnosis; this risk was highest in the age group 65-74 years. Conclusion This study reveals that IPD is independently associated with an increased risk of OAB in patients with IPD. The probability of OAB was 1.54% over a 10-year period after IPD diagnosis; the risk of OAB is considered to be age-dependent and most substantial in patients aged 65-74 years.	[Lin, Fu-Yu; Yang, Yi-Chien] China Med Univ, China Med Univ Hosp, Sch Med, Dept Neurol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; Kaohsiung Medical University	Lee, LJH (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.; Lee, LJH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.; Lee, LJH (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan.	lukasneuro@gmail.com	Lee, Lukas Jyuhn-Hsiarn/AAB-6424-2021	Lee, Lukas Jyuhn-Hsiarn/0000-0003-1095-6877	China Medical University Hospital [DMR-106-171]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW106-TDU-B-212-113004]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10601010036]; Taiwan Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; Taiwan Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by China Medical University Hospital (DMR-106-171), Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10601010036), Taiwan Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Blackett H, 2009, PARKINSONISM RELAT D, V15, P81, DOI 10.1016/j.parkreldis.2007.10.016; Bonnet AM, 1997, MOVEMENT DISORD, V12, P509, DOI 10.1002/mds.870120406; Campos-Sousa RN, 2003, ARQ NEURO-PSIQUIAT, V61, P359, DOI 10.1590/S0004-282X2003000300007; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; GRAY R, 1995, AGE AGEING, V24, P499, DOI 10.1093/ageing/24.6.499; Hu WS, 2017, MAYO CLIN PROC, V92, P370, DOI 10.1016/j.mayocp.2016.08.019; McDonald C, 2017, PARKINSONISM RELAT D, V35, P8, DOI 10.1016/j.parkreldis.2016.10.024; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Ruffion A, 2013, NEUROEPIDEMIOLOGY, V41, P146, DOI 10.1159/000353274; Sakakibara R, 2014, INT J UROL, V21, P638, DOI 10.1111/iju.12421; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; Sakakibara R, 2010, MOVEMENT DISORD, V25, P2, DOI 10.1002/mds.22519; Shen TC, 2017, LIVER INT, V37, P862, DOI 10.1111/liv.13330; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Walter U, 2006, EUR J NEUROL, V13, P1291, DOI 10.1111/j.1468-1331.2006.01463.x; Wenning GK, 1999, J NEUROL NEUROSUR PS, V67, P620, DOI 10.1136/jnnp.67.5.620; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Yeo L, 2012, INT UROL NEPHROL, V44, P415, DOI 10.1007/s11255-011-9969-y	19	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							SICI e0193783	10.1371/journal.pone.0193783	http://dx.doi.org/10.1371/journal.pone.0193783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499067	Green Published, gold, Green Submitted			2022-12-26	WOS:000426472300022
J	Marlicz, W; Poniewierska-Baran, A; Rzeszotek, S; Bartoszewski, R; Skonieczna-Zydecka, K; Starzynska, T; Ratajczak, MZ				Marlicz, Wojciech; Poniewierska-Baran, Agata; Rzeszotek, Sylwia; Bartoszewski, Rafal; Skonieczna-Zydecka, Karolina; Starzynska, Teresa; Ratajczak, Mariusz Z.			A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							STEM/PROGENITOR CELLS EXPRESS; STIMULATING-HORMONE RECEPTOR; SEX-HORMONES; STEM-CELLS; BREAST-CANCER; RISK; GROWTH; PROLACTIN; DEGARELIX; THERAPY	Background Colorectal cancer (CRC) is a leading cause of death in the western world, and its incidence increases with patient age. It is also known that with age there occur changes in the levels of certain hormones, including an increase in the secretion of pituitary gonadotropins (PtGs) as a result of the loss of gonadal hormone feedback. We recently reported that functional PtG receptors are expressed in human lung cancer cells, rhabdomyosarcoma cells, and malignant hematopoietic stem cells. Findings Here we report for the first time that the receptors for follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are expressed in primary tumor samples isolated from CRC patients as well as in the established human CRC cell lines HTC116 and HTB37. Moreover, we also report that PtGs stimulate chemotaxis, adhesion, and proliferation of these cell lines. Conclusions Our results suggest that PtGs play an important and underappreciated role in CRC pathogenesis, and we call for further studies to better define their role in gastrointestinal malignancies and their direct effect on putative CRC cancer stem cells.	[Marlicz, Wojciech; Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Poniewierska-Baran, Agata] Pomeranian Med Univ, Dept Physiol, Szczecin, Poland; [Poniewierska-Baran, Agata] Univ Szczecin, Fac Biol, Dept Immunol, Szczecin, Poland; [Rzeszotek, Sylwia] Pomeranian Med Univ, Dept Histol & Embryol, Szczecin, Poland; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Skonieczna-Zydecka, Karolina] Pomeranian Med Univ, Dept Biochem & Human Nutr, Szczecin, Poland; [Ratajczak, Mariusz Z.] Univ Louisville, James Graham Brown Canc Ctr, Stem Cell Inst, Louisville, KY 40292 USA; [Ratajczak, Mariusz Z.] Warsaw Med Univ, Dept Regenerat Med, Warsaw, Poland	Pomeranian Medical University; Pomeranian Medical University; University of Szczecin; Pomeranian Medical University; Fahrenheit Universities; Medical University Gdansk; Pomeranian Medical University; University of Louisville; Medical University of Warsaw	Marlicz, W (corresponding author), Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland.; Poniewierska-Baran, A (corresponding author), Pomeranian Med Univ, Dept Physiol, Szczecin, Poland.; Poniewierska-Baran, A (corresponding author), Univ Szczecin, Fac Biol, Dept Immunol, Szczecin, Poland.	marlicz@hotmail.com; agata.poniewierska@gmail.com	Poniewierska-Baran, Agata/AFQ-4324-2022; Rzeszotek, Sylwia/D-2158-2017; Ratajczak, Mariusz Z/I-2376-2014; Marlicz, Wojciech/G-5007-2013; Starzynska, Teresa/B-1549-2015; Skonieczna-Żydecka, Karolina/K-7252-2014; Bartoszewski, Rafal A/D-6311-2011	Poniewierska-Baran, Agata/0000-0001-6719-803X; Rzeszotek, Sylwia/0000-0002-2157-0315; Ratajczak, Mariusz Z/0000-0002-0071-0198; Marlicz, Wojciech/0000-0002-2649-5967; Starzynska, Teresa/0000-0001-5573-2397; Skonieczna-Żydecka, Karolina/0000-0002-3430-9079; Bartoszewski, Rafal A/0000-0002-2864-6757	Harmonia NCN [UMO-2014/14/M/NZ3/00475]; Pomeranian Medical University, Department of Gastroenterology statutory funds	Harmonia NCN; Pomeranian Medical University, Department of Gastroenterology statutory funds	This work was partially supported by Harmonia NCN grant UMO-2014/14/M/NZ3/00475 to MZR and Pomeranian Medical University, Department of Gastroenterology statutory funds. We acknowledge Dr. Paul Todd for expert English proof reading in his native language.; This work was partially supported by Harmonia NCN grant UMO-2014/14/M/NZ3/00475 to MZR and Pomeranian Medical University, Department of Gastroenterology statutory funds (TS).	Abdelbaset-Ismail A, 2017, INT J ONCOL, V50, P317, DOI 10.3892/ijo.2016.3787; Abdelbaset-Ismail A, 2016, ONCOTARGET, V7, P3033, DOI 10.18632/oncotarget.6698; Abdelbaset-Ismail A, 2016, J CELL MOL MED, V20, P134, DOI 10.1111/jcmm.12712; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; BELLONE G, 1995, J CELL PHYSIOL, V163, P221, DOI 10.1002/jcp.1041630202; Ben Khedher S, 2017, INT J CANCER, V141, P309, DOI 10.1002/ijc.30750; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brusselaers N, 2017, INT J CANCER, V140, P1693, DOI 10.1002/ijc.30588; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; CESARIO TC, 1994, P SOC EXP BIOL MED, V205, P89; Chlebowski RT, 2014, STEROIDS, V90, P53, DOI 10.1016/j.steroids.2014.06.001; Clinton TN, 2017, EXPERT OPIN PHARMACO, V18, P825, DOI 10.1080/14656566.2017.1328056; Cohnheim J., 1875, VIRCHOWS ARCH, V65, P64, DOI DOI 10.1007/BF01978936; Deivaraju C, 2016, HORM MOL BIOL CLIN I, V28, P105, DOI 10.1515/hmbci-2016-0001; Feng DQ, 2017, ONCOL REP, V38, P1091, DOI 10.3892/or.2017.5784; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Forman S, 1999, J BIOCHEM MOL TOXIC, V13, P11, DOI 10.1002/(SICI)1099-0461(1999)13:1<11::AID-JBT2>3.0.CO;2-R; Gao R, 2017, EUR J CLIN MICROBIOL; Gharwan H, 2015, ENDOCR-RELAT CANCER, V22, pR339, DOI 10.1530/ERC-14-0550; Ghiringhelli F, 2013, WORLD J GASTROENTERO, V19, P769, DOI 10.3748/wjg.v19.i5.769; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Huang WQ, 2001, LIFE SCI, V68, P1727; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Korbut E, 2012, J PHYSIOL PHARMACOL, V63, P565; Lin JH, 2013, CLIN GASTROENTEROL H, V11, P419, DOI 10.1016/j.cgh.2012.11.012; Lu YX, 2016, CANCER EPIDEMIOL, V41, P57, DOI 10.1016/j.canep.2016.01.006; Majek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068077; Marlicz W, 2016, ONCOL REP, V36, P3635, DOI 10.3892/or.2016.5179; Sanchez AM, 2016, MOL CELL ENDOCRINOL, V437, P22, DOI 10.1016/j.mce.2016.08.009; Mierzejewska K, 2015, STEM CELLS DEV, V24, P927, DOI 10.1089/scd.2014.0546; Morch LS, 2016, EUR J EPIDEMIOL, V31, P481, DOI 10.1007/s10654-016-0116-z; Murphy N, 2017, BRIT J CANCER, V116, P117, DOI 10.1038/bjc.2016.345; Murphy N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv210; Parrott JA, 2001, MOL CELL ENDOCRINOL, V172, P213, DOI 10.1016/S0303-7207(00)00340-3; Poniewierska-Baran A, 2016, INT J ONCOL, V48, P1815, DOI 10.3892/ijo.2016.3439; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Raica M, 2010, ANTICANCER RES, V30, P3981; Ratajczak MZ, 2017, LEUKEMIA, V31, P1671, DOI 10.1038/leu.2017.148; Ratajczak MZ, 2017, STEM CELL REV REP, V13, P443, DOI 10.1007/s12015-017-9728-2; Ratajczak MZ, 2017, CIRC RES, V120, P166, DOI 10.1161/CIRCRESAHA.116.309362; Ratajczak MZ, 2016, POL ARCH MED WEWN, V126, P879, DOI 10.20452/pamw.3644; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rennert G., 2016, BRIT J CANCER, V116, P1; Rick FG, 2015, UROL ONCOL-SEMIN ORI, V33, P270, DOI 10.1016/j.urolonc.2014.11.006; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sayyid RK, 2017, CLIN CANCER RES, V23, P1974, DOI 10.1158/1078-0432.CCR-16-1790; Schernhammer ES, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3438; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siraj A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-246; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Szarynska M, 2016, POSTEP HIG MED DOSW, V70, P1469, DOI 10.5604/17322693.1227897; Szepeshazi K, 2007, INT J ONCOL, V30, P1485; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tripathy M, 2017, STEROIDS, V128, P23, DOI 10.1016/j.steroids.2017.10.005; VIRCHOW R, 1855, ARCH PATHOLOGISCHE A, V8, P23; Wang X, 2017, FREE RADICAL BIO MED, V105, P3, DOI 10.1016/j.freeradbiomed.2016.10.504; Wu S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1143079; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	59	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0189337	10.1371/journal.pone.0189337	http://dx.doi.org/10.1371/journal.pone.0189337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494614	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200001
J	Metghalchi, S; Vandestienne, M; Haddad, Y; Esposito, B; Dairou, J; Tedgui, A; Mallat, Z; Potteaux, S; Taleb, S				Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Dairou, Julien; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya			Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; IN-VIVO; ATHEROSCLEROSIS; EXPRESSION; ELASTASE; LESIONS; MODELS; CELLS	Aims Abdominal aortic aneurysm (AAA) is an age-associated disease characterized by chronic inflammation, vascular cell apoptosis and metalloproteinase-mediated extracellular matrix degradation. Despite considerable progress in identifying targets involved in these processes, therapeutic approaches aiming to reduce aneurysm growth and rupture are still scarce. Indoleamine 2-3 dioxygenase 1 (IDO) is the first and rate-limiting enzyme involved in the conversion of tryptophan (Trp) into kynurenine (Kyn) pathway. In this study, we investigated the role of IDO in two different models of AAA in mice. Methods and results Mice with deficiencies in both low density receptor-deficient (Ldlr(-/-)) and IDO (Ldlr(-/-)Ido1(-/-)) were generated by cross-breeding Ido1(-/-) mice with Ldlr(-/-) mice. To induce aneurysm, these mice were infused with angiotensin II (Ang II) (1000 ng/min/kg) and fed with high fat diet (HFD) during 28 days. AAAs were present in almost all Ldlr(-/-) infused with AngII, but only in 50% of Ldlr(-/-)Ido1(-/-) mice. Immunohistochemistry at an early time point (day 7) revealed no changes in macrophage and T lymphocyte infiltration within the vessel wall, but showed reduced apoptosis, as assessed by TUNEL assay, and increased a-actin staining within the media of Ldlr(-/-)Ido1(-/-) mice, suggesting enhanced survival of vascular smooth muscle cells (VSMCs) in the absence of IDO. In another model of elastase-induced AAA in C57Bl/6 mice, IDO deficiency had no effect on aneurysm formation. Conclusion Our study showed that the knockout of IDO prevented VSMC apoptosis in AngII-treated Ldlr(-/-) mice fed with HFD, suggesting a detrimental role of IDO in AAA formation and thus would be an important target for the treatment of aneurysm.	[Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya] Paris Cardiovasc Res Ctr, Inst Natl Sante & Rech Med Inserm, Paris, France; [Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya] Univ Paris 05, Paris, France; [Dairou, Julien] Univ Paris 05, Sorbonne Paris Cite, UMR CNRS 8601, Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Mallat, Ziad] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Taleb, S (corresponding author), Paris Cardiovasc Res Ctr, Inst Natl Sante & Rech Med Inserm, Paris, France.; Taleb, S (corresponding author), Univ Paris 05, Paris, France.	soraya.taleb@inserm.fr	Mallat, Ziad/D-4041-2012; Taleb, Soraya/K-8176-2017	Mallat, Ziad/0000-0003-0443-7878; Taleb, Soraya/0000-0002-6650-619X; Potteaux, Stephane/0000-0003-3068-8769	INSERM; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, Fondation pour la Recherche Medicale and Agence Nationale de la Recherche (S.T.).	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P2374, DOI 10.1161/ATVBAHA.113.301280; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Cole JE, 2015, P NATL ACAD SCI USA, V112, P13033, DOI 10.1073/pnas.1517820112; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Eussen SJPM, 2015, INT J CARDIOL, V189, P18, DOI 10.1016/j.ijcard.2015.03.413; Hellmann DB, 2007, JAMA-J AM MED ASSOC, V297, P395, DOI 10.1001/jama.297.4.395; Lu H, 2017, ARTERIOSCL THROM VAS, V37, pE59, DOI 10.1161/ATVBAHA.117.309578; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metghalchi S, 2015, CELL METAB, V22, P460, DOI 10.1016/j.cmet.2015.07.004; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pedersen ER, 2014, ARTERIOSCLER TH 1218; Pedersen ER, 2011, ARTERIOSCL THROM VAS, V31, P698, DOI 10.1161/ATVBAHA.110.219329; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; Van Vickle-Chavez SJ, 2006, J VASC SURG, V43, P1010, DOI 10.1016/j.jvs.2006.01.004; Wang QX, 2017, CIRCULATION, V136, P2271, DOI 10.1161/CIRCULATIONAHA.117.030972; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092	21	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193737	10.1371/journal.pone.0193737	http://dx.doi.org/10.1371/journal.pone.0193737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494675	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200093
J	Saraiva, C; Talhada, D; Rai, A; Ferreira, R; Ferreira, L; Bernardino, L; Ruscher, K				Saraiva, Claudia; Talhada, Daniela; Rai, Akhilesh; Ferreira, Raquel; Ferreira, Lino; Bernardino, Liliana; Ruscher, Karsten			MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; BLOOD-BRAIN-BARRIER; SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; INFLAMMATION; MACROPHAGES; ACTIVATION; MICRORNAS; MICROGLIA; MIR-124	There is a high quest for novel therapeutic strategies to enhance recovery after stroke. MicroRNA-124 (miR-124) has been described as neuroprotective and anti-inflammatory molecule. Moreover, miR-124 is a well described enhancer of adult neurogenesis that could offer potentially beneficial effects. Herein, we used miR-124-loaded nanoparticles (miR-124 NPs) to evaluate their therapeutic potential in an in vitro and in vivo model of stroke. For that, neuroprotective and neurogenic responses were assessed in an in vitro model of stroke. Here, we found that miR-124 NPs decreased cell death and improved neuronal differentiation of subventricular zone (SVZ) neural stem cell cultures after oxygen and glucose deprivation. In contrast, intravenous injection of miR-124 NPs immediately after permanent focal ischemia induced by photothrombosis (PT) did not provide a better neurological outcome. In addition, treatment did not affect the number of 5-bromo2'- deoxyuridine (BrdU)-and doublecortin/BrdU-positive cells in the SVZ at the study endpoint of 14 days after PT. Likewise, the ischemic insult did not affect the numbers of neuronal progenitors in the SVZ. However, in PT mice miR-124 NPs were able to specifically augment interleukin-6 levels at day 2 post-stroke. Furthermore, we also showed that NPs reached the brain parenchyma and were internalized by brain resident cells. Although, promising in vitro data could not be verified in vivo as miR-124 NPs treatment did not improve functional outcome nor presented beneficial actions on neurogenesis or poststroke inflammation, we showed that our NP formulation can be a safe alternative for drug delivery into the brain.	[Saraiva, Claudia; Talhada, Daniela; Ferreira, Raquel; Bernardino, Liliana] Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal; [Saraiva, Claudia; Talhada, Daniela; Ruscher, Karsten] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurosurg,Lab Expt Brain Res, Lund, Sweden; [Saraiva, Claudia] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Caparica, Portugal; [Rai, Akhilesh; Ferreira, Lino] CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ferreira, Lino] Univ Coimbra, Fac Med, IIIUC, Coimbra, Portugal	Universidade da Beira Interior; Lund University; Universidade Nova de Lisboa; Universidade de Coimbra; Universidade de Coimbra	Bernardino, L (corresponding author), Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal.; Ruscher, K (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurosurg,Lab Expt Brain Res, Lund, Sweden.	libernardino@fcsaude.ubi.pt; karsten.ruscher@med.lu.se	Rai, Akhilesh/ABE-9904-2021; Saraiva, Cláudia/AAT-6772-2020; Ferreira, Raquel/AAA-7401-2021	Rai, Akhilesh/0000-0001-5352-5415; Saraiva, Cláudia/0000-0003-4866-8790; Ferreira, Raquel/0000-0003-1014-0499; Talhada, Daniela/0000-0002-5424-1438; Ruscher, Karsten/0000-0001-7211-2499; Bernardino, Liliana/0000-0003-3395-5973; ferreira, lino/0000-0001-8985-9302	FEDER funds through the POCI - COMPETE Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation [POCI-01-0145-FEDER-007491, 3386]; National Funds by FCT - Foundation for Science and Technology [SFRH/BD/90365/2012, UID/Multi/00709/2013]; Swedish Brain Fund; Crafoord Foundation; Swedish Research Council; Sveriges Stroke Riksfbrbundet; Hans-Christian and Alice Wachtmeister Foundation; Stiftelsen Sven-Olof Jansons livsverk	FEDER funds through the POCI - COMPETE Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation; National Funds by FCT - Foundation for Science and Technology; Swedish Brain Fund; Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sveriges Stroke Riksfbrbundet; Hans-Christian and Alice Wachtmeister Foundation; Stiftelsen Sven-Olof Jansons livsverk	This work was supported by FEDER funds through the POCI - COMPETE 2020 Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation (Project POCI-01-0145-FEDER-007491; Project 3386 - "StrokeTherapy") and National Funds by FCT - Foundation for Science and Technology (grant SFRH/BD/90365/2012 and Project UID/Multi/00709/2013) to LB, the Swedish Brain Fund, the Crafoord Foundation to KR, the Swedish Research Council, Sveriges Stroke Riksfbrbundet to KR, the Hans-Christian and Alice Wachtmeister Foundation and the Stiftelsen Sven-Olof Jansons livsverk to KR.; This work was supported by FEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalisation in Axis I-Strengthening research, technological development and innovation (Project POCI-01-0145-FEDER-007491; Project 3386 - "StrokeTherapy") and National Funds by FCT-Foundation for Science and Technology (grant SFRH/BD/90365/2012 and Project UID/Multi/00709/2013), the Swedish Brain Fund, the Crafoord Foundation, the Swedish Research Council, Sveriges Stroke Riksforbundet, the Hans-Christian and Alice Wachtmeister Foundation and the Stiftelsen Sven-Olof Jansons livsverk. We thank Professor Tadeusz Wieloch and Niklas Marklund for valuable discussions and Cai Owain Birch for critical revision of the manuscript.	Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Chapman KZ, 2009, J CEREBR BLOOD F MET, V29, P1764, DOI 10.1038/jcbfm.2009.113; Chen Y, 2015, PHARMAZIE, V70, P147, DOI 10.1691/ph.2015.4774; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gomes RSM, 2013, ACS NANO, V7, P3362, DOI 10.1021/nn400171w; Hoff EI, 2005, J NEUROSCI METH, V141, P135, DOI 10.1016/j.jneumeth.2004.06.004; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kuric E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0145-z; Lagace DC, 2012, BEHAV BRAIN RES, V227, P426, DOI 10.1016/j.bbr.2011.08.045; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Liu X., 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0023461; Liu XR, 2013, STROKE, V44, P1973, DOI 10.1161/STROKEAHA.111.000613; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Maia J, 2011, ACS NANO, V5, P97, DOI 10.1021/nn101724r; Marlier Q, 2015, FRONT NEUROSCI, P9; Nahirney PC, 2015, J CEREB BLOOD FLOW M; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Piao MS, 2009, ACTA NEUROCHIR, V151, P1649, DOI 10.1007/s00701-009-0431-1; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qiu SW, 2015, J IMMUNOL, V194, P1021, DOI 10.4049/jimmunol.1400106; Rainer TH, 2016, CLIN BIOCHEM, V49, P663, DOI 10.1016/j.clinbiochem.2016.02.016; Ruscher K, 2013, J CEREBR BLOOD F MET, V33, P1225, DOI 10.1038/jcbfm.2013.71; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h; Saraiva C, 2016, J CONTROL RELEASE, V235, P291, DOI 10.1016/j.jconrel.2016.06.005; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Simats A, 2016, EXPERT REV NEUROTHER, V16, P1013, DOI 10.1080/14737175.2016.1219252; Sun Y, 2016, ACTA PHARMACOL SIN, V37, P889, DOI 10.1038/aps.2016.16; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Taj SH, 2016, J NEUROIMMUNE PHARM, V11, P733, DOI 10.1007/s11481-016-9700-y; Taj SH, 2016, BIOMATERIALS, V91, P151, DOI 10.1016/j.biomaterials.2016.03.025; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; van der Maten G, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0325-0; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Walter HL, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0232-1; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao Y, 2016, J CROHNS COLITIS, V10, P703, DOI 10.1093/ecco-jcc/jjw010; Zhu F, 2014, J MOL NEUROSCI, V52, P148, DOI 10.1007/s12031-013-0155-9	56	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193609	10.1371/journal.pone.0193609	http://dx.doi.org/10.1371/journal.pone.0193609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494665	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200074
J	Crespi, A; Plutino, S; Sciaccaluga, M; Righi, M; Borgese, N; Fucile, S; Gotti, C; Colombo, SF				Crespi, Arianna; Plutino, Simona; Sciaccaluga, Miriam; Righi, Marco; Borgese, Nica; Fucile, Sergio; Gotti, Cecilia; Colombo, Sara Francesca			The fifth subunit in alpha 3 beta 4 nicotinic receptor is more than an accessory subunit	FASEB JOURNAL			English	Article						nAChR trafficking; nAChR subtypes; stoichiometry; ER export signal	ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; AUXILIARY SUBUNITS; GABA(A) RECEPTORS; MEMBRANE-PROTEIN; ALPHA-5 SUBUNIT; AMPA RECEPTOR; UP-REGULATION; TRAFFICKING; SUBTYPES	The alpha 3 beta 4 subtype is the predominant neuronal nicotinic acetylcholine receptor present in the sensory and autonomic ganglia and in a subpopulation of brain neurons. This subtype can form pentameric receptors with either 2 or 3 4 subunits that have different pharmacologic and functional properties. To further investigate the role of the fifth subunit, we coexpressed a dimeric construct coding for a single polypeptide containing the 4 and 3 subunit sequences, with different monomeric subunits. With this strategy, which allowed the formation of single populations of receptors with unique stoichiometry, we demonstrated with immunofluorescence and biochemical and functional assays that only the receptors with 3 4 subunits are efficiently expressed at the plasma membrane. Moreover, the LFM export motif of 4 subunit in the fifth position exerts a unique function in the regulation of the intracellular trafficking of the receptors, their exposure at the cell surface, and consequently, their function, whereas the same export motif present in the 4 subunits forming the acetylcholine binding site is dispensable.Crespi, A., Plutino, S., Sciaccaluga, M., Righi, M., Borgese, N., Fucile, S., Gotti, C., Colombo, S. F. The fifth subunit in alpha 3 beta 4 nicotinic receptor is more than an accessory subunit.	[Crespi, Arianna; Righi, Marco; Borgese, Nica; Gotti, Cecilia; Colombo, Sara Francesca] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Crespi, Arianna; Righi, Marco; Borgese, Nica; Gotti, Cecilia; Colombo, Sara Francesca] CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy; [Plutino, Simona; Fucile, Sergio] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, Rome, Italy; [Sciaccaluga, Miriam; Fucile, Sergio] Ist Neurol Mediterraneo, Ist Ricovero & Cura Carattere Sci IRCCS Neuromed, Pozzilli, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; IRCCS Neuromed	Colombo, SF (corresponding author), CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.	s.colombo@in.cnr.it	Sciaccaluga, Miriam/AAF-5535-2021; Righi, Marco/P-4332-2019; Fucile, Sergio/B-3934-2010; Borgese, Nica/GWZ-8895-2022; Righi, Marco Giovanni Enea/M-9003-2019	Fucile, Sergio/0000-0003-0698-1148; Borgese, Nica/0000-0002-7537-3974; Righi, Marco Giovanni Enea/0000-0003-1181-0327; Sciaccaluga, Miriam/0000-0001-7951-8045; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961; Plutino, Simona/0000-0002-6945-3134	CNR Research Project on Aging; AMANDA project from Regione Lombardia [CUP_B42F16000440005]; Fondazione Monzino (Milano)	CNR Research Project on Aging(Consiglio Nazionale delle Ricerche (CNR)); AMANDA project from Regione Lombardia; Fondazione Monzino (Milano)	The authors thank Prof. Francesco Clementi (University of Milan, Milan, Italy) for critical reading of the manuscript. The authors thank Dr. Milena Moretti (University of Milan, Milan, Italy) for performing the [<SUP>3</SUP>H] epibatidine-binding studies. This work was supported by the CNR Research Project on Aging, the AMANDA project (CUP_B42F16000440005) from Regione Lombardia, and by a grant from the Fondazione Monzino (Milano). The authors declare no conflicts of interest.	Araud T, 2010, BIOCHEM PHARMACOL, V80, P160, DOI 10.1016/j.bcp.2010.03.017; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Boudreau Amy C, 2012, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0530s59; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; CHINI B, 1992, P NATL ACAD SCI USA, V89, P1572, DOI 10.1073/pnas.89.5.1572; Colombo SF, 2013, BIOCHEM PHARMACOL, V86, P1063, DOI 10.1016/j.bcp.2013.06.023; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Crespi A., 2017, BR J PHARM; Dallanoce C, 2011, CHEMMEDCHEM, V6, P889, DOI 10.1002/cmdc.201000514; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fossati M, 2014, EMBO J, V33, P2080, DOI 10.15252/embj.201488367; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Harlow E., 1998, ANTIBODIES LAB MANUA, P522; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MRD, 2010, ONCOGENE, V29, P4874, DOI 10.1038/onc.2010.256; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matta JA, 2017, CELL REP, V19, P688, DOI 10.1016/j.celrep.2017.04.008; Mazzo F, 2013, J NEUROSCI, V33, P12316, DOI 10.1523/JNEUROSCI.2393-13.2013; Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015; Molas S, 2017, TRENDS PHARMACOL SCI, V38, P169, DOI 10.1016/j.tips.2016.11.001; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mucchietto V, 2018, BRIT J PHARMACOL, V175, P1957, DOI 10.1111/bph.13954; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Pistillo F, 2015, PROG NEUROBIOL, V124, P1, DOI 10.1016/j.pneurobio.2014.10.002; Ray C, 2017, ACS CHEM BIOL, V12, P702, DOI 10.1021/acschembio.6b01117; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; Schroeder KM, 2003, J NEUROCHEM, V85, P581, DOI 10.1046/j.1471-4159.2003.01658.x; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2014, J NEUROSCI, V34, P12104, DOI 10.1523/JNEUROSCI.0595-14.2014; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; Stokes C, 2012, NEUROPHARMACOLOGY, V63, P538, DOI 10.1016/j.neuropharm.2012.04.035; STORRIE B, 1994, J CELL SCI, V107, P1309; Sumioka A, 2013, J BIOCHEM, V153, P331, DOI 10.1093/jb/mvt015; TARTAKOFF AM, 1986, EMBO J, V5, P1477, DOI 10.1002/j.1460-2075.1986.tb04385.x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Valles AS, 2012, BBA-BIOMEMBRANES, V1818, P718, DOI 10.1016/j.bbamem.2011.10.012; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yamasaki T, 2017, NEURON, V93, P1138, DOI 10.1016/j.neuron.2017.02.023; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	57	5	5	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4190	4202		10.1096/fj.201701377R	http://dx.doi.org/10.1096/fj.201701377R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29505300				2022-12-26	WOS:000439325400011
J	Wan, QW; Okashah, N; Inoue, A; Nehme, R; Carpenter, B; Tate, CG; Lambert, NA				Wan, Qingwen; Okashah, Najeah; Inoue, Asuka; Nehme, Rony; Carpenter, Byron; Tate, Christopher G.; Lambert, Nevin A.			Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; arrestin; biosensor; molecular pharmacology; BRET; mini G protein; NanoLuc; protein complementation	FLUORESCENT PROTEIN; LIVING CELLS; ACTIVATION; REVEAL; BRET	G protein-coupled receptors (GPCRs) are key signaling proteins that regulate nearly every aspect of cell function. Studies of GPCRs have benefited greatly from the development of molecular tools to monitor receptor activation and downstream signaling. Here, we show that mini G proteins are robust probes that can be used in a variety of assay formats to report GPCR activity in living cells. Mini G (mG) proteins are engineered GTPase domains of G subunits that were developed for structural studies of active-state GPCRs. Confocal imaging revealed that mG proteins fused to fluorescent proteins were located diffusely in the cytoplasm and translocated to sites of receptor activation at the cell surface and at intracellular organelles. Bioluminescence resonance energy transfer (BRET) assays with mG proteins fused to either a fluorescent protein or luciferase reported agonist, superagonist, and inverse agonist activities. Variants of mG proteins (mGs, mGsi, mGsq, and mG12) corresponding to the four families of G subunits displayed appropriate coupling to their cognate GPCRs, allowing quantitative profiling of subtype-specific coupling to individual receptors. BRET between luciferase-mG fusion proteins and fluorescent markers indicated the presence of active GPCRs at the plasma membrane, Golgi apparatus, and endosomes. Complementation assays with fragments of NanoLuc luciferase fused to GPCRs and mG proteins reported constitutive receptor activity and agonist-induced activation with up to 20-fold increases in luminescence. We conclude that mG proteins are versatile tools for studying GPCR activation and coupling specificity in cells and should be useful for discovering and characterizing G protein subtype-biased ligands.	[Wan, Qingwen; Okashah, Najeah; Lambert, Nevin A.] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Nehme, Rony; Carpenter, Byron; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge CB20QH, England; [Nehme, Rony] Creoptix AG, Einsiedlerstr 34, CH-8820 Wadenswil, Switzerland; [Carpenter, Byron] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England	University System of Georgia; Augusta University; Tohoku University; University of Warwick	Lambert, NA (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA.	nelambert@augusta.edu	Carpenter, Byron/S-5206-2019	Carpenter, Byron/0000-0003-1712-3528	National Institutes of Health [GM078319, GM109879]; Medical Research Council; European Research Council; Heptares Therapeutics [MC_U105197215, EMPSI 339995]; Japan Science and Technology Agency (JST) [JPMJPR1331]; Japan Agency for Medical Research and Development (AMED) [JP17gm5910013]; MRC [MC_U105197215] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109879, R01GM078319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Heptares Therapeutics; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM078319 and GM109879 (to N. A. L.) and Medical Research Council, European Research Council, and Heptares Therapeutics Grants MC_U105197215 and EMPSI 339995 (to C. G. T.). C. G. T. is a shareholder and member of the scientific advisory board of Heptares Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Japan Science and Technology Agency (JST) Grant JPMJPR1331 and Japan Agency for Medical Research and Development (AMED) Grant JP17gm5910013.	Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS17, DOI 10.1111/bph.13878; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin BR, 2016, J BIOL CHEM, V291, P20295, DOI 10.1074/jbc.M116.729731; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Schrage R, 2013, BRIT J PHARMACOL, V169, P357, DOI 10.1111/bph.12003; SIDHU A, 1991, J NEUROCHEM, V57, P1445, DOI 10.1111/j.1471-4159.1991.tb08312.x; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038	26	129	130	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7466	7473		10.1074/jbc.RA118.001975	http://dx.doi.org/10.1074/jbc.RA118.001975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29523687	Green Published, hybrid			2022-12-26	WOS:000432174500037
J	Jansova, D; Tetkova, A; Koncicka, M; Kubelka, M; Susor, A				Jansova, Denisa; Tetkova, Anna; Koncicka, Marketa; Kubelka, Michal; Susor, Andrej			Localization of RNA and translation in the mammalian oocyte and embryo	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; IN-VITRO MATURATION; CAP-DEPENDENT TRANSLATION; MESSENGER-RNA; BINDING PROTEIN; MOUSE OOCYTES; SELECTIVE DEGRADATION; NUCLEAR TRANSLATION; MEIOTIC MATURATION; GENE-EXPRESSION	The tight correlation between mRNA distribution and subsequent protein localization and function indicate a major role for mRNA localization within the cell. RNA localization, followed by local translation, presents a mechanism for spatial and temporal gene expression regulation utilized by various cell types. However, little is known about mRNA localization and translation in the mammalian oocyte and early embryo. Importantly, fully-grown oocyte becomes transcriptionally inactive and only utilizes transcripts previously synthesized and stored during earlier development. We discovered an abundant RNA population in the oocyte and early embryo nucleus together with RNA binding proteins. We also characterized specific ribosomal proteins, which contribute to translation in the oocyte and embryo. By applying selected markers to mouse and human oocytes, we found that there might be a similar mechanism of RNA metabolism in both species. In conclusion, we visualized the localization of RNAs and translation machinery in the oocyte, that could shed light on this terra incognita of these unique cell types in mouse and human.	[Jansova, Denisa; Tetkova, Anna; Koncicka, Marketa; Kubelka, Michal; Susor, Andrej] CAS, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Jansova, Denisa; Tetkova, Anna; Koncicka, Marketa] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 2, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague	Jansova, D; Susor, A (corresponding author), CAS, Inst Anim Physiol & Genet, Libechov, Czech Republic.; Jansova, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 2, Czech Republic.	jansova@iapg.cas.cz; susor@iapg.cas.cz	Jansova, Denisa/AAL-4362-2020; Jindrova, Anna/E-3968-2018; Koncicka, Marketa/T-2058-2017	Jindrova, Anna/0000-0003-4334-3268; Susor, Andrej/0000-0003-2926-4096; Jansova, Denisa/0000-0003-1179-9623; Koncicka, Marketa/0000-0003-2056-6370	Charles University in Prague, Faculty of Cell Biology-GAUK [243-227026]; Academy of Sciences of the Czech Republic [GACR13-12291S, GACR15-227655, EXCELLENCECZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE]; Institutional Research Concept [RVO67985904]	Charles University in Prague, Faculty of Cell Biology-GAUK; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institutional Research Concept	This work was supported by Charles University in Prague, Faculty of Cell Biology-GAUK 243-227026 to DJ. The Academy of Sciences of the Czech Republic, http://www.cas.cz/, GACR13-12291S to AS, GACR15-227655 to MK, EXCELLENCECZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE and Institutional Research Concept RVO67985904.	AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; Alizadeh Z, 2005, MOL REPROD DEV, V72, P281, DOI 10.1002/mrd.20340; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; AZZAM ME, 1973, P NATL ACAD SCI USA, V70, P3866, DOI 10.1073/pnas.70.12.3866; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Benesova V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147096; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; CLEGG KB, 1982, NATURE, V295, P342, DOI 10.1038/295342a0; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Ellederova Z, 2006, MOL REPROD DEV, V73, P68, DOI 10.1002/mrd.20368; Ellederova Z, 2008, MOL REPROD DEV, V75, P309, DOI 10.1002/mrd.20690; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Flemr M, 2010, BIOL REPROD, V82, P1008, DOI 10.1095/biolreprod.109.082057; Ford CL, 1999, CANCER RES, V59, P704; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GORLACH M, 1993, MOL BIOL REP, V18, P73, DOI 10.1007/BF00986759; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; INOUE K, 1989, GENE DEV, V3, P1472, DOI 10.1101/gad.3.9.1472; Jambor H, 2015, ELIFE, V4, DOI 10.7554/eLife.05003; Jansova D., 2015, BIOPROTOCOL, V2015, pe1666; Jansova D, 2017, CELL CYCLE, V16, P927, DOI 10.1080/15384101.2017.1295178; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim TH, 2014, ONCOTARGET, V5, P860, DOI 10.18632/oncotarget.1784; King ML, 2005, BIOL CELL, V97, P19; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Komrskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101222; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KRIEG J, 1988, J BIOL CHEM, V263, P11473; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/NMETH.1448, 10.1038/nmeth.1448]; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Machleidt T, 2007, METH MOL B, V356, P209; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; MEYUHAS O, 1990, J BIOL CHEM, V265, P11465; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Monti M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103887; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Reid DW, 2012, J CELL BIOL, V197, P7, DOI 10.1083/jcb.201202140; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Romasko EJ, 2013, GENETICS, V195, P349, DOI 10.1534/genetics.113.154005; Rosner M, 2011, AMINO ACIDS, V40, P595, DOI 10.1007/s00726-010-0684-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; SCHULTZ RM, 1977, J CELL SCI, V24, P167; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Siemer C, 2009, MOL REPROD DEV, V76, P1208, DOI 10.1002/mrd.21096; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Susor A, 2008, MOL REPROD DEV, V75, P1716, DOI 10.1002/mrd.20913; Susor A, 2017, RESULTS PROBL CELL D, V63, P257, DOI 10.1007/978-3-319-60855-6_12; Susor A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7078; Tetkova A., 2016, CULTIV RNA MICROBIOP, V6, pe1729; Tolino M, 2012, EUR J NEUROSCI, V35, P1818, DOI 10.1111/j.1460-9568.2012.08160.x; Tomek W, 2002, BIOL REPROD, V66, P1274, DOI 10.1095/biolreprod66.5.1274; Trcek T, 2012, NAT PROTOC, V7, P408, DOI 10.1038/nprot.2011.451; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Wang Z, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0551-7; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zhou Xiaoya, 2012, J Biomed Biotechnol, V2012, P743879, DOI 10.1155/2012/743879	86	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0192544	10.1371/journal.pone.0192544	http://dx.doi.org/10.1371/journal.pone.0192544			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529035	Green Submitted, Green Published, gold			2022-12-26	WOS:000427189300005
J	Meckes, JK; Lim, PH; Wert, SL; Luo, WD; Gacek, SA; Platt, D; Jankord, R; Saar, K; Redei, EE				Meckes, Jeanie K.; Lim, Patrick H.; Wert, Stephanie L.; Luo, Wendy; Gacek, Stephanie A.; Platt, Dana; Jankord, Ryan; Saar, Kathrin; Redei, Eva E.			Brain region-specific expression of genes mapped within quantitative trait loci for behavioral responsiveness to acute stress in Fisher 344 and Wistar Kyoto male rats	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; CONTEXTUAL FEAR; CANDIDATE GENES; COMPLEX TRAITS; BURYING TEST; ANXIETY; MICE; ASSOCIATION; INHERITANCE; MECHANISMS	Acute stress responsiveness is a quantitative trait that varies in severity from one individual to another; however, the genetic component underlying the individual variation is largely unknown. Fischer 344 (F344) and Wistar Kyoto (WKY) rat strains show large differences in behavioral responsiveness to acute stress, such as freezing behavior in response to foot-shock during the conditioning phase of contextual fear conditioning (CFC). Quantitative trait loci (QTL) have been identified for behavioral responsiveness to acute stress in the defensive burying (DB) and open field test (OFT) from a reciprocal F2 cross of F344 and WKY rat strains. These included a significant QTL on chromosome 6 (Stresp10). Here, we hypothesized that the Stresp10 region harbors genes with sequence variation(s) that contribute to differences in multiple behavioral response phenotypes between the F344 and WKY rat strains. To test this hypothesis, first we identified differentially expressed genes within the Stresp10 QTL in the hippocampus, amygdala, and frontal cortex of F344 and WKY male rats using genome-wide microarray analyses. Genes with both expression differences and non-synonymous sequence variations in their coding regions were considered candidate quantitative trait genes (QTGs). As a proof-of-concept, the F344. WKY-Stresp10 congenic strain was generated with the Stresp10 WKY donor region into the F344 recipient strain. This congenic strain showed behavioral phenotypes similar to those of WKYs. Expression patterns of Gpatch11 (G-patch domain containing 11), Cdkl4 (Cyclin dependent kinase like 4), and Drc1 (Dynein regulatory complex subunit 1) paralleled that of WKY in the F344. WKY-Stresp10 strain matching the behavioral profiles of WKY as opposed to F344 parental strains. We propose that these genes are candidate QTGs for behavioral responsiveness to acute stress.	[Meckes, Jeanie K.; Lim, Patrick H.; Wert, Stephanie L.; Luo, Wendy; Gacek, Stephanie A.; Platt, Dana; Redei, Eva E.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Jankord, Ryan] US Air Force, Human Performance Wing 711, Warfighter Interface Div, Appl Neurosci,Res Lab, Wright Patterson AFB, OH USA; [Saar, Kathrin] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany	Northwestern University; Feinberg School of Medicine; United States Department of Defense; United States Air Force; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Redei, EE (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA.	e-redei@northwestern.edu		Lim, Patrick/0000-0002-4901-9875; Luo, Wendy/0000-0002-7041-823X; Wert, Stephanie/0000-0003-0969-6983	Air Force Research laboratory [FA8650-15-2-5518]	Air Force Research laboratory	This material is based on research sponsored by the Air Force Research laboratory (http://www.wpafb.af.mil/afri/) under agreement number FA8650-15-2-5518. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of Air Force Research Laboratory or the U.S. Government.	Ahmadiyeh N, 2005, BEHAV GENET, V35, P189, DOI 10.1007/s10519-004-1018-5; Ahmadiyeh N, 2004, BIOL PSYCHIAT, V55, P1069, DOI 10.1016/j.biopsych.2004.02.014; Ahmadiyeh N, 2003, MAMM GENOME, V14, P748, DOI 10.1007/s00335-003-2292-x; Aklillu E, 2002, MOL PHARMACOL, V61, P586, DOI 10.1124/mol.61.3.586; Almli LM, 2015, AM J MED GENET B, V168, P327, DOI 10.1002/ajmg.b.32315; Andolina D., 2014, INT J NEUROPSYCHOPHA, V18; Andolina D, 2013, NEUROPSYCHOPHARMACOL, V38, P2057, DOI 10.1038/npp.2013.107; Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Bailey LR, 1998, CANCER RES, V58, P5038; Barth A, 2014, J NEUROCHEM, V128, P807, DOI 10.1111/jnc.12517; Baud A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.11; Baum AE, 2006, BEHAV BRAIN RES, V169, P220, DOI 10.1016/j.bbr.2006.01.007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brigman JL, 2009, BEHAV PHARMACOL, V20, P204, DOI 10.1097/FBP.0b013e32830c368c; Bryois J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004461; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Cheng YY, 2016, BRAIN BEHAV IMMUN, V53, P207, DOI 10.1016/j.bbi.2015.12.012; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ebner K, 2017, CURR OPIN BEHAV SCI, V14, P54, DOI 10.1016/j.cobeha.2016.11.016; Elomaa AP, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-2; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Federenko IS, 2004, J CLIN ENDOCR METAB, V89, P6244, DOI 10.1210/jc.2004-0981; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hettema JM, 2011, BIOL PSYCHIAT, V70, P888, DOI 10.1016/j.biopsych.2011.07.012; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Hoyo-Becerra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083149; Hsu J., 1996, MULTIPLE COMP THEORY; Huggins CE, 2008, J MOL CELL CARDIOL, V44, P270, DOI 10.1016/j.yjmcc.2007.11.020; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Lin MB, 2015, ONCOTARGET, V6, P16774, DOI 10.18632/oncotarget.3736; Mapping C, 2013, NATURE GENETICS, V45; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Nata K, 1997, GENE, V186, P285, DOI 10.1016/S0378-1119(96)00723-8; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Park J, 2007, FEBS LETT, V581, P3211, DOI 10.1016/j.febslet.2007.06.009; Pascucci T, 2007, CEREB CORTEX, V17, P2796, DOI 10.1093/cercor/bhm008; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sandbak T, 1998, ALCOHOL CLIN EXP RES, V22, P2050, DOI 10.1111/j.1530-0277.1998.tb05915.x; Shelton RC, 2011, MOL PSYCHIAT, V16; SHISHIMI A, 1977, ANIM LEARN BEHAV, V5, P259, DOI 10.3758/BF03209237; Shumake J, 2014, ANIM COGN, V17, P1207, DOI 10.1007/s10071-014-0752-1; Sluyter F, 1996, PHARMACOL BIOCHEM BE, V54, P113, DOI 10.1016/0091-3057(95)02164-7; Sokoloff G, 2011, GENES BRAIN BEHAV, V10, P604, DOI 10.1111/j.1601-183X.2011.00699.x; Solberg LC, 2003, MOL PSYCHIATR, V8, P423, DOI 10.1038/sj.mp.4001255; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Swanson RM, 2013, J IMMUNOL, V190, P2027, DOI 10.4049/jimmunol.1201760; Tabak BA, 2016, CLIN PSYCHOL SCI, V4, P17, DOI 10.1177/2167702615577470; Taguchi YH, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-11; Thifault S, 2008, HUM MOL GENET, V17, P331, DOI 10.1093/hmg/ddm277; Trampush JW, 2017, MOL PSYCHIAT; Tunc-Ozcan E, 2016, HORM BEHAV, V82, P1, DOI 10.1016/j.yhbeh.2016.04.002; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Verma S, 2017, J CLIN DIAGN RES, V11, pBC1, DOI 10.7860/JCDR/2017/22196.9324; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wilcoxon JS, 2005, MOL PSYCHIATR, V10, P961, DOI 10.1038/sj.mp.4001694; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Woods LCS, 2010, AM J PHYSIOL-RENAL, V298, pF1484, DOI 10.1152/ajprenal.00002.2010; Woudstra S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.29; Xiao X, 2017, MOL PSYCHIATR, V22, P497, DOI 10.1038/mp.2016.241; Yoshihara M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2975-9; Zhang WN, 2014, BEHAV BRAIN RES, V262, P47, DOI 10.1016/j.bbr.2013.10.044	77	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194293	10.1371/journal.pone.0194293	http://dx.doi.org/10.1371/journal.pone.0194293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529077	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000427189300049
J	Ribitsch, I; Peham, C; Ade, N; Durr, J; Handschuh, S; Schramel, JP; Vogl, C; Walles, H; Egerbacher, M; Jenner, F				Ribitsch, Iris; Peham, Christian; Ade, Nicole; Duerr, Julia; Handschuh, Stephan; Schramel, Johannes Peter; Vogl, Claus; Walles, Heike; Egerbacher, Monika; Jenner, Florien			Structure-Function relationships of equine menisci	PLOS ONE			English	Article							HUMAN MEDIAL MENISCUS; ARTICULAR-CARTILAGE; BIOMECHANICAL PROPERTIES; COMPRESSIVE PROPERTIES; HUMAN KNEE; COLLAGEN; INJURIES; MODELS; REPAIR; OSTEOARTHRITIS	Meniscal pathologies are among the most common injuries of the femorotibial joint in both human and equine patients. Pathological forces and ensuing injuries of the cranial horn of the equine medial meniscus are considered analogous to those observed in the human posterior medial horn. Biomechanical properties of human menisci are site-and depth-specific. However, the influence of equine meniscus topography and composition on its biomechanical properties is yet unknown. A better understanding of equine meniscus composition and biomechanics could advance not only veterinary therapies for meniscus degeneration or injuries, but also further substantiate the horse as suitable translational animal model for (human) meniscus tissue engineering. Therefore, the aim of this study was to investigate the composition and structure of the equine knee meniscus in a site-and age-specific manner and their relationship with potential site-specific biomechanical properties. The meniscus architecture was investigated histologically. Biomechanical testing included evaluation of the shore hardness (SH), stiffness and energy loss of the menisci. The SH was found to be subjected to both age and site-specific changes, with an overall higher SH of the tibial meniscus surface and increase in SH with age. Stiffness and energy loss showed neither site nor age related significant differences. The macroscopic and histologic similarities between equine and human menisci described in this study, support continued research in this field.	[Ribitsch, Iris; Peham, Christian; Ade, Nicole; Schramel, Johannes Peter; Jenner, Florien] Univ Equine Hosp, Vetmeduni Vienna, Dept Compan Anim & Horses, Veterm, Vienna, Austria; [Ade, Nicole] ETH, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland; [Duerr, Julia; Egerbacher, Monika] Vetmeduni Vienna, Unit Histol & Embryol, Dept Pathobiol, Vienna, Austria; [Handschuh, Stephan] Vetmeduni Vienna, Vetcore Facil Res, Vienna, Austria; [Vogl, Claus] Vetmeduni Vienna, Unit Mol Genet, Dept Biomed Sci, Vienna, Austria; [Walles, Heike] Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med TERM, Wurzburg, Baveria, Germany; [Walles, Heike] Translat Ctr Wuerzburg, Wurzburg, Baveria, Germany; [Ade, Nicole] Belimed AG, Zug, Zug, Switzerland; [Duerr, Julia] Pferdeklin Ludwigshafen, Ludwigshafen, Rheinlad Pfalz, Germany	University of Veterinary Medicine Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Wurzburg	Ribitsch, I (corresponding author), Univ Equine Hosp, Vetmeduni Vienna, Dept Compan Anim & Horses, Veterm, Vienna, Austria.	iris.ribitsch@vetmeduni.ac.at	Jenner, Florien/H-2679-2013; peham, christian/V-4488-2019	peham, christian/0000-0002-8363-5751; Jenner, Florien/0000-0002-6977-1984; Walles, Heike/0000-0002-1512-7448; Handschuh, Stephan/0000-0002-2140-7892; Ribitsch, Iris/0000-0001-6618-2669				Abdelgaied A, 2015, J BIOMECH, V48, P1389, DOI 10.1016/j.jbiomech.2015.02.044; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; Arnoczky SP, 2010, TISSUE ENG PART B-RE, V16, P31, DOI [10.1089/ten.teb.2009.0428, 10.1089/ten.TEB.2009.0428]; ASPDEN RM, 1981, CONNECT TISSUE RES, V9, P83, DOI 10.3109/03008208109160244; Borges PD, 2014, OSTEOARTHR CARTILAGE, V22, P1419, DOI 10.1016/j.joca.2014.07.014; Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X; CHEUNG HS, 1987, CONNECT TISSUE RES, V16, P343, DOI 10.3109/03008208709005619; Chevrier A, 2009, J ORTHOP RES, V27, P1197, DOI 10.1002/jor.20869; Chia HN, 2008, J ORTHOP RES, V26, P951, DOI 10.1002/jor.20573; Clayton HM, 2005, CLIN ANATOMY HORSE; Danso EK, 2015, J BIOMECH, V48, P1499, DOI 10.1016/j.jbiomech.2015.01.048; Danso EK, 2017, J MECH BEHAV BIOMED, V67, P51, DOI 10.1016/j.jmbbm.2016.12.002; Day B, 1985, Arthroscopy, V1, P58, DOI 10.1016/S0749-8063(85)80080-3; De Busscher V, 2006, J EQUINE VET SCI, V26, P453, DOI 10.1016/j.jevs.2006.08.003; Drosos GI, 2004, KNEE, V11, P143, DOI 10.1016/S0968-0160(03)00105-4; DYE SF, 1987, J BONE JOINT SURG AM, V69A, P976, DOI 10.2106/00004623-198769070-00004; Erbagci H, 2004, SURG RADIOL ANAT, V26, P28, DOI 10.1007/s00276-003-0182-2; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Haut TL, 2000, J ORTHOP RES, V18, P228, DOI 10.1002/jor.1100180210; JOSHI MD, 1995, J BIOMED MATER RES, V29, P823, DOI 10.1002/jbm.820290706; Kawamura S, 2003, OPER TECHN SPORT MED, V11, P68, DOI 10.1053/otsm.2003.35899; Kremer A, 2017, TISSUE ENG PT A, V23, P390, DOI [10.1089/ten.tea.2016.0317, 10.1089/ten.TEA.2016.0317]; Lai JH, 2010, OSTEOARTHR CARTILAGE, V18, P1291, DOI 10.1016/j.joca.2010.05.020; Lechner K, 2000, J ORTHOPAED RES, V18, P945, DOI 10.1002/jor.1100180614; Ling Levenston, 2012, ORS ANN M; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Madry Henning, 2015, J Exp Orthop, V2, P9, DOI 10.1186/s40634-015-0025-1; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; McNulty AL, 2015, J BIOMECH, V48, P1469, DOI 10.1016/j.jbiomech.2015.02.008; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mononen ME, 2015, COMPUT METHOD BIOMEC, V18, P141, DOI 10.1080/10255842.2013.783575; Moyer JT, 2012, J BIOMECH, V45, P2230, DOI 10.1016/j.jbiomech.2012.06.017; Nemery E, 2016, ANAT HISTOL EMBRYOL, V45, P131, DOI 10.1111/ahe.12181; NEMETSCHEK T, 1979, J MOL BIOL, V133, P67, DOI 10.1016/0022-2836(79)90251-1; Nickel R, 2003, LEHRBUCH ANATOMIE HA; Osterhoff G, 2011, KNEE, V18, P98, DOI 10.1016/j.knee.2010.02.001; Pereira H, 2014, OSTEOARTHR CARTILAGE, V22, P1271, DOI 10.1016/j.joca.2014.07.001; Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141; PROCTOR CS, 1989, J ORTHOP RES, V7, P771, DOI 10.1002/jor.1100070602; Saeed F, 2012, J APPL POLYM SCI, V123, P1518, DOI 10.1002/app.34221; Sanchez-Adams J, 2011, J APPL PHYSIOL, V111, P1590, DOI 10.1152/japplphysiol.00848.2011; Sandmann GH, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-324; SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B; SPILKER RL, 1992, J BIOMECH ENG-T ASME, V114, P191, DOI 10.1115/1.2891371; Sweigart MA, 2004, ANN BIOMED ENG, V32, P1569, DOI 10.1114/B:ABME.0000049040.70767.5c; THOMPSON WO, 1991, AM J SPORT MED, V19, P210, DOI 10.1177/036354659101900302; Tischer T, 2009, KNEE SURG SPORT TR A, V17, P935, DOI 10.1007/s00167-009-0784-2; Tucker Bethan, 2012, Open Orthop J, V6, P348, DOI 10.2174/1874325001206010348; Walmsley JP, 2005, VET CLIN N AM-EQUINE, V21, P651, DOI 10.1016/j.cveq.2005.08.003	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194052	10.1371/journal.pone.0194052	http://dx.doi.org/10.1371/journal.pone.0194052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522550	gold, Green Published, Green Submitted			2022-12-26	WOS:000427030800037
J	Egger, S; Hughes, S; Smith, DP; Chambers, S; Kahn, C; Moxey, A; O'Connell, DL				Egger, Sam; Hughes, Suzanne; Smith, David P.; Chambers, Suzanne; Kahn, Clare; Moxey, Annette; O'Connell, Dianne L.			Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNPROVED METHODS; MEN; HEALTH; INDEX; RELIABILITY; VALIDATION; THERAPIES; WOMEN; CAM	Objective To assess whether the use of complementary and alternative medicines therapies (CAMs) for prostate cancer and/or its treatment side effects by long-term survivors is associated with selected socio-demographic, clinical, health-related quality-of-life (HRQOL) and/or psychological factors. Design, setting and participants The Prostate Cancer Care and Outcomes Study (PCOS) is a population-based cohort study of men with prostate cancer who were aged less than 70 years at diagnosis in New South Wales, Australia. Included in these analyses were men who returned a 10-year follow-up questionnaire, which included questions about CAM use. Methods Validated instruments assessed patient's HRQOL and psychological well-being. Poisson regression with robust variance estimation was used to estimate the adjusted relative risks of current CAM use for prostate cancer according to socio-demographic, clinical, HRQOL and psychological factors. Results 996 of 1634 (61%) living PCOS participants completed the 10-year questionnaire. Of these 996 men, 168 (17%) were using CAMs for prostate cancer and 525 (53%) were using CAMs for any reason (including prostate cancer). Those using CAM for prostate cancer were more likely to be regular or occasional support group participants (vs. no participation RR = 2.02; 95%Cl 1.41-2.88), born in another country (vs. Australian born RR = 1.59; 95%Cl 1.17-2.16), have received androgen deprivation treatment (ADT) since diagnosis (RR = 1.60; 95%Cl 1.12-2.28) or in the past two years (RR = 2.34; 95%Cl 1.56-3.52). CAM use was associated with greater fear of recurrence (RR =1.29; 95%Cl 1.12-1.48), cancer-specific distress (RR = 1.15; 95%Cl 1.01-1.30), cancer -specific hyperarousal (RR = 1.17; 95%Cl 1.04-1.31), cancer locus of control (RR = 1.16; 95%Cl 1.01-1.34) and less satisfaction with medical treatments (RR = 0.86; 95%Cl 0.76-0.97), but not with intrusive thinking, cognitive avoidance, depression, anxiety or any HRQOL domains. Conclusions In this study, about one in six long term prostate cancer survivors used CAMs for their prostate cancer with use centred around ADT, country of birth, distress, cancer control, fear of recurrence and active help seeking.	[Egger, Sam; Hughes, Suzanne; Smith, David P.; Kahn, Clare; O'Connell, Dianne L.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Smith, David P.; O'Connell, Dianne L.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.; Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Chambers, Suzanne] Canc Council Queensland, Canc Res Ctr, Brisbane, Qld, Australia; [Chambers, Suzanne] Prostate Canc Fdn Australia, Sydney, NSW, Australia; [Chambers, Suzanne] Edith Cowan Univ, Exercise Med Res Inst, Perth, WA, Australia; [Chambers, Suzanne] Univ Southern Queensland, Inst Resilient Reg, Toowoomba, Qld, Australia; [Moxey, Annette; O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Edith Cowan University; University of Southern Queensland; University of Newcastle	Egger, S (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.	same@nswcc.org.au	Chambers, Suzanne K/H-5957-2012	Chambers, Suzanne K/0000-0003-2369-6111; Smith, David/0000-0002-1474-3214; Egger, Sam/0000-0003-1808-6909	Prostate Cancer Foundation of Australia [PG40]; Career Development Fellowship from the Cancer Institute NSW [15/CDF/1-10]	Prostate Cancer Foundation of Australia; Career Development Fellowship from the Cancer Institute NSW	This work was supported by the Prostate Cancer Foundation of Australia (PG40) (to Dianne O'Connell). David Smith was supported by a Career Development Fellowship from the Cancer Institute NSW (#15/CDF/1-10).	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Australian Bureau of Statistics, 2001, CENS POP HOUS SOC EC; Australian Institute of Health and Welfare, 2017, CANC SERIES, V101; Bishop FL, 2011, PROSTATE CANCER P D, V14, P1, DOI 10.1038/pcan.2010.38; Boon H, 2003, UROLOGY, V62, P849, DOI 10.1016/S0090-4295(03)00668-X; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Chambers SK, 2016, PSYCHOL MEN MASCULIN, V17, P228, DOI 10.1037/men0000018; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Diefenbach MA, 2003, J UROLOGY, V170, P166, DOI 10.1097/01.ju.0000070963.12496.cc; DOWNER SM, 1994, BRIT MED J, V309, P86, DOI 10.1136/bmj.309.6947.86; Glover J, 2002, REMOTE AREAS STAT GE; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Greenberg DB, 1997, CANCER-AM CANCER SOC, V80, P1936, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1936::AID-CNCR10>3.0.CO;2-Z; Hall JD, 2003, BJU INT, V91, P603, DOI 10.1046/j.1464-410X.2003.04181.x; Henderson JW, 2003, PSYCHO-ONCOL, V12, P59, DOI 10.1002/pon.636; Hyde MK, 2016, SEX MED-UK, V4, pE7, DOI 10.1016/j.esxm.2015.12.004; Jagtenberg T, 2006, J ALTERN COMPLEM MED, V12, P323, DOI 10.1089/acm.2006.12.323; Lee MM, 2002, AM J PUBLIC HEALTH, V92, P1606, DOI 10.2105/AJPH.92.10.1606; Lippert MC, 1999, CANCER, V86, P2642, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2642::AID-CNCR8>3.3.CO;2-W; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Miller M, 1998, SUPPORT CARE CANCER, V6, P337, DOI 10.1007/s005200050175; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Schraub S, 2000, SUPPORT CARE CANCER, V8, P10; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Steginga SK, 2004, PATIENT EDUC COUNS, V55, P70, DOI 10.1016/j.pec.2003.07.007; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Tascilar M, 2006, ONCOLOGIST, V11, P732, DOI 10.1634/theoncologist.11-7-732; Taylor KL, 2012, J CLIN ONCOL, V30, P2768, DOI 10.1200/JCO.2011.41.2767; Walach H, 2009, J ALTERN COMPLEM MED, V15, P1139, DOI 10.1089/acm.2009.0423; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Weiss Daniel S., 1997, P399; Wilkinson S, 2008, EUR J CANCER CARE, V17, P492, DOI 10.1111/j.1365-2354.2007.00904.x; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193686	10.1371/journal.pone.0193686	http://dx.doi.org/10.1371/journal.pone.0193686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513724	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000426896800068
J	Yu, C; Yang, S; Kim, W; Jung, J; Chung, KY; Lee, SW; Oh, B				Yu, Chanki; Yang, Sejung; Kim, Wonoh; Jung, Jinwoong; Chung, Kee-Yang; Lee, Sang Wook; Oh, Byungho			Acral melanoma detection using a convolutional neural network for dermoscopy images	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; DIAGNOSIS; CLASSIFICATION; PATTERN	Background/Purpose Acral melanoma is the most common type of melanoma in Asians, and usually results in a poor prognosis due to late diagnosis. We applied a convolutional neural network to dermoscopy images of acral melanoma and benign nevi on the hands and feet and evaluated its usefulness for the early diagnosis of these conditions. Methods A total of 724 dermoscopy images comprising acral melanoma (350 images from 81 patients) and benign nevi (374 images from 194 patients), and confirmed by histopathological examination, were analyzed in this study. To perform the 2-fold cross validation, we split them into two mutually exclusive subsets: half of the total image dataset was selected for training and the rest for testing, and we calculated the accuracy of diagnosis comparing it with the dermatologist's and non-expert's evaluation. Results The accuracy (percentage of true positive and true negative from all images) of the convolutional neural network was 83.51% and 80.23%, which was higher than the non-expert's evaluation (67.84%, 62.71%) and close to that of the expert (81.08%, 81.64%). Moreover, the convolutional neural network showed area-under-the-curve values like 0.8, 0.84 and Youden's index like 0.6795, 0.6073, which were similar score with the expert. Conclusion Although further data analysis is necessary to improve their accuracy, convolutional neural networks would be helpful to detect acral melanoma from dermoscopy images of the hands and feet.	[Yu, Chanki] Sogang Univ, Grad Sch Media, Dept Media Technol, Seoul, South Korea; [Yang, Sejung] Stanford Univ, Sch Med, Dept Radiat Oncol, Med Phys Div, Palo Alto, CA 94304 USA; [Yang, Sejung; Lee, Sang Wook] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea; [Kim, Wonoh; Jung, Jinwoong; Oh, Byungho] Keimyung Univ, Coll Med, Dept Dermatol, Daegu, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea	Sogang University; Stanford University; Ewha Womans University; Keimyung University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SW (corresponding author), Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea.; Oh, B (corresponding author), Keimyung Univ, Coll Med, Dept Dermatol, Daegu, South Korea.	slee@sogang.a.c.kr; obh505@gmail.com		Chung, Kee Yang/0000-0003-3257-0297; Oh, Byung Ho/0000-0001-9575-5665	National Research Foundation of Korea [2013R1A2A2A04015894, NRF-2017R1D1A1B03033288, NRF-2015M3A9A7029725]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea, No. 2013R1A2A2A04015894, to Kee-Yang Chung (http://www.nrf.re.kr/index); National Research Foundation of Korea, NRF-2017R1D1A1B03033288, to Sang Wook Lee; and National Research Foundation of Korea, NRF-2015M3A9A7029725, to Sejung Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 1996, CANCER, V78, P252, DOI 10.1002/(SICI)1097-0142(19960715)78:2<252::AID-CNCR10>3.0.CO;2-V; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fink C, 2017, SKIN RES TECHNOL, V23, P261, DOI 10.1111/srt.12350; Franke W, 2000, MELANOMA RES, V10, P571, DOI 10.1097/00008390-200012000-00009; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; GREEN A, 1994, J AM ACAD DERMATOL, V31, P958, DOI 10.1016/S0190-9622(94)70264-0; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; KATO T, 1993, CLIN EXP DERMATOL, V18, P107, DOI 10.1111/j.1365-2230.1993.tb00988.x; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lallas A, 2015, BRIT J DERMATOL, V173, P1041, DOI 10.1111/bjd.14045; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Muller MP, 2005, CLIN INFECT DIS, V40, P1079, DOI 10.1086/428577; Rajpara SM, 2009, BRIT J DERMATOL, V161, P591, DOI 10.1111/j.1365-2133.2009.09093.x; Roh MR, 2010, YONSEI MED J, V51, P562, DOI 10.3349/ymj.2010.51.4.562; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; She ZS, 2007, SKIN RES TECHNOL, V13, P25, DOI 10.1111/j.1600-0846.2007.00181.x; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tkaczyk ER, 2017, ACTA DERM-VENEREOL, V97, P5, DOI 10.2340/00015555-2717; Tran KT, 2008, J AM ACAD DERMATOL, V59, P852, DOI 10.1016/j.jaad.2008.05.027; Vedaldi A, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P689, DOI 10.1145/2733373.2807412; Yang S, 2017, BIOMED SIGNAL PROCES, V32, P90, DOI 10.1016/j.bspc.2016.09.019; 2013, ATLAS DERMOSCOPY, P1	28	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193321	10.1371/journal.pone.0193321	http://dx.doi.org/10.1371/journal.pone.0193321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513718	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800053
J	Dabbaghizadeh, A; Morrow, G; Amer, YO; Chatelain, EH; Pichaud, N; Tanguay, RM				Dabbaghizadeh, Afrooz; Morrow, Genevieve; Amer, Yasmine Ould; Chatelain, Etienne Hebert; Pichaud, Nicolas; Tanguay, Robert M.			Identification of proteins interacting with the mitochondrial small heat shock protein Hsp22 of Drosophila melanogaster: Implication in mitochondrial homeostasis	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; OXIDATIVE STRESS; PREMATURE SENESCENCE; PROTEOMICS ANALYSIS; EXPRESSION; CELL; CHAPERONE; PROTEOSTASIS; DYSFUNCTION; MECHANISMS	The small heat shock protein (sHsp) Hsp22 from Drosophila melanogaster (DmHsp22) is part of the family of sHsps in this diptera. This sHsp is characterized by its presence in the mitochondrial matrix as well as by its preferential expression during ageing. Although DmHsp22 has been demonstrated to be an efficient in vitro chaperone, its function within mitochondria in vivo remains largely unknown. Thus, determining its protein-interaction network (interactome) in the mitochondrial matrix would help to shed light on its function(s). In the present study we combined immunoaffinity conjugation (IAC) with mass spectroscopy analysis of mitochondria from HeLa cells transfected with DmHsp22 in non-heat shock condition and after heat shock (HS). 60 common DmHsp22-binding mitochondrial partners were detected in two independent IACs. Immunoblotting was used to validate interaction between DmHsp22 and two members of the mitochondrial chaperone machinery; Hsp60 and Hsp70. Among the partners of DmHsp22, several ATP synthase subunits were found. Moreover, we showed that expression of DmHsp22 in transiently transfected HeLa cells increased maximal mitochondrial oxygen consumption capacity and ATP contents, providing a mechanistic link between DmHsp22 and mitochondrial functions.	[Dabbaghizadeh, Afrooz; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Fac Med, IBIS, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada; [Dabbaghizadeh, Afrooz; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, PROTEO, Quebec City, PQ, Canada; [Amer, Yasmine Ould; Chatelain, Etienne Hebert] Univ Moncton, Dept Biol, Lab Signalisat Mitochondriale, Moncton, NB, Canada; [Pichaud, Nicolas] Univ Moncton, Dept Chim & Biochim, Lab Biochim & Physiol Comparee, Moncton, NB, Canada	Laval University; Laval University; University of Moncton; University of Moncton	Tanguay, RM (corresponding author), Univ Laval, Fac Med, IBIS, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, PROTEO, Quebec City, PQ, Canada.	robert.tanguay@fmed.ulaval.ca		Pichaud, Nicolas/0000-0002-2820-8124	Canadian Institutes of Health Research (CIHR); PROTEO; Alzheimer Society of Canada, Brain Canada; Natural Sciences and Engineering Research Council (NSERC); Canadian Breast Cancer Foundation; New Brunswick Innovation Foundation; New Brunswick Health Research Foundation; Universite de Moncton; NSERC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); PROTEO; Alzheimer Society of Canada, Brain Canada; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); New Brunswick Innovation Foundation; New Brunswick Health Research Foundation; Universite de Moncton; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work has been supported by grants from the Canadian Institutes of Health Research (CIHR) to RMT and a scholarship from PROTEO to AD. The authors would like to thank Dr. Sylvie Bourassa from Proteomics platform of CHU de Quebec Research Center-CHUL for help with Mass Spectrometry.The work of E.Hebert-Chatelain is supported by the Alzheimer Society of Canada, Brain Canada, Natural Sciences and Engineering Research Council (NSERC), Canadian Breast Cancer Foundation, New Brunswick Innovation Foundation, New Brunswick Health Research Foundation 606 and Universite de Moncton. N. Pichaud is supported by grants from the NSERC and the Universite de Moncton.	Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; CARBAJAL EM, 1993, EXP CELL RES, V207, P300, DOI 10.1006/excr.1993.1197; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top074542; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Dabbaghizadeh A, 2017, CELL STRESS CHAPERON, V22, P577, DOI 10.1007/s12192-017-0784-y; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030; Dimmer KS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-209; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gregersen N, 2012, J INHERIT METAB DIS, V35, P715, DOI 10.1007/s10545-012-9480-3; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; Groebe K, 2010, EXP GERONTOL, V45, P632, DOI 10.1016/j.exger.2010.02.006; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hirano Y, 2012, GENES BRAIN BEHAV, V11, P79, DOI 10.1111/j.1601-183X.2011.00748.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857; Jang JY, 2006, CELL IMMUNOL, V241, P14, DOI 10.1016/j.cellimm.2006.07.006; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kawasaki F, 2016, DIS MODEL MECH, V9, P953, DOI 10.1242/dmm.026385; Kim HJ, 2010, EXP GERONTOL, V45, P611, DOI 10.1016/j.exger.2009.12.012; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Koc EC, 2012, BBA-GENE REGUL MECH, V1819, P1055, DOI 10.1016/j.bbagrm.2012.03.003; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499; Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021; Laplante AF, 1998, J HISTOCHEM CYTOCHEM, V46, P1291, DOI 10.1177/002215549804601109; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow G, 2016, MECH AGEING DEV, V155, P36, DOI 10.1016/j.mad.2016.02.011; Morrow G, 2016, BIOGERONTOLOGY, V17, P61, DOI 10.1007/s10522-015-9591-y; Morrow G, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00103, 10.3389/fpsyg.2015.01652]; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Poon HF, 2006, NEUROBIOL AGING, V27, P1020, DOI 10.1016/j.neurobiolaging.2005.05.014; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Poon HF, 2006, ANTIOXID REDOX SIGN, V8, P381, DOI 10.1089/ars.2006.8.381; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Runkel ED, 2014, EXP GERONTOL, V56, P194, DOI 10.1016/j.exger.2014.02.013; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shen J, 2013, CELL CYCLE, V12, P3237, DOI 10.4161/cc.26354; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tower J, 2014, J GERONTOL A-BIOL, V69, P253, DOI 10.1093/gerona/glt078; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Wadhwa R, 2010, J BIOL CHEM, V285, P3833, DOI 10.1074/jbc.M109.080424; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5	85	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193771	10.1371/journal.pone.0193771	http://dx.doi.org/10.1371/journal.pone.0193771			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509794	Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200030
J	Seo, JW; Han, K; Lee, J; Kim, EK; Moon, HJ; Yoon, JH; Park, VY; Baek, HM; Kwak, JY				Seo, Ji Won; Han, Kyunghwa; Lee, Jandee; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Park, Vivian Youngjean; Baek, Hyeon-Man; Kwak, Jin Young			Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MAGNETIC-RESONANCE-SPECTROSCOPY; THYROGLOBULIN MEASUREMENT; BRAF MUTATION; CANCER; LACTATE; NODULES; SPECIMENS; DIAGNOSIS; SURVIVAL	Purpose The aim of this study was to find useful metabolites to predict lymph node (LN) metastasis in patients with papillary thyroid cancer (PTC) through a metabolomics approach and investigate the potential role of metabolites as a novel prognostic marker. Materials and methods Fifty-two consecutive patients (median age: 41.5 years, range 15-74 years) were enrolled who underwent total thyroidectomy and central LN dissection with or without lateral LN dissection in Severance Hospital between October 2013 and July 2015. The study specimens were provided by the Severance Hospital Gene Bank, and consisted of PTC from each patient. The specimens were prepared for proton nuclear magnetic resonance (H-1-NMR) spectroscopy. Spectral data by H-1-NMR spectroscopy were acquired, processed, and analyzed. Patients were grouped in three ways, according to the presence of LN metastasis, central LN metastasis and lateral LN metastasis. Chi-square test and the student t-test were used to analyze categorical variables and continuous variables, respectively. The Mann-Whitney U test was used for univariate analysis of metabolites. Orthogonal projections to latent structure discriminant analysis (OPLS-DA) was used for multivariate analysis to discriminate metabolic differences between the two groups. Results Among 52 patients, 32 had central LN metastasis and 19 had lateral LN metastasis. No clinical or histopathological characteristic was significantly different for all comparisons. On univariate analysis, no metabolite showed significant difference for all comparisons. On multivariate analysis, OPLS-DA did not discriminate the presence and absence of LN metastasis. Lactate was found to be the most promising metabolite. Conclusions No metabolite could discriminate the presence of LN metastasis. However, lactate was found to be the most promising metabolite for discrimination. Further studies with larger sample sizes are needed to elucidate significant metabolites which can indicate the presence of LN metastasis in patients with PTC.	[Seo, Ji Won; Han, Kyunghwa; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Park, Vivian Youngjean; Kwak, Jin Young] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, Seoul, South Korea; [Lee, Jandee] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Baek, Hyeon-Man] Gachon Univ, Dept Biomed Engn, Incheon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Kwak, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea.; Baek, HM (corresponding author), Gachon Univ, Dept Biomed Engn, Incheon, South Korea.	hmbaek98@gachon.ac.kr; docjin@yuhs.ac	; Kim, Eun-Kyung/E-5211-2017	Yoon, Jung Hyun/0000-0002-2100-3513; Park, Vivian/0000-0002-5135-4058; Moon, Hee Jung/0000-0002-5643-5885; Kwak, Jin Young/0000-0002-6212-1495; Han, Kyunghwa/0000-0002-5687-7237; Kim, Eun-Kyung/0000-0002-3368-5013; Lee, Jandee/0000-0003-4090-0049	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education [2016R1D1A1B03930375]	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375, https://www.nrf.re.kr/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chung J, 2014, HEAD NECK-J SCI SPEC, V36, P795, DOI 10.1002/hed.23371; Deja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084637; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Gaude E, 2012, R PACKAGE VERSION, P1; Han PA, 2016, THYROID, V26, P532, DOI 10.1089/thy.2015.0378; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jordan KW, 2011, ACTA CYTOL, V55, P584, DOI 10.1159/000333271; Kelly RS, 2016, CANC EPIDEMIOLOGY BI; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim KE, 2013, WORLD J SURG, V37, P385, DOI 10.1007/s00268-012-1826-3; Kim MJ, 2009, CLIN ENDOCRINOL, V70, P145, DOI 10.1111/j.1365-2265.2008.03297.x; King AD, 2005, EUR J RADIOL, V54, P112, DOI 10.1016/j.ejrad.2004.05.003; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Liu RT, 2005, CLIN ENDOCRINOL, V63, P461, DOI 10.1111/j.1365-2265.2005.02367.x; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Miccoli P, 2012, SURGERY, V152, P1118, DOI 10.1016/j.surg.2012.08.037; Moon HJ, 2009, ANN SURG ONCOL, V16, P3125, DOI 10.1245/s10434-009-0644-9; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Podnos YD, 2005, AM SURGEON, V71, P731; Quagliariello V, 2016, J CELLULAR PHYSL; Ryoo I, 2016, SCI REP-UK, V6, DOI 10.1038/srep30075; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Shang X, 2016, TUMOR BIOL, V37, P1; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sjobakk TE, 2008, NMR BIOMED, V21, P175, DOI 10.1002/nbm.1180; Skov T, 2006, J CHEMOMETR, V20, P484, DOI 10.1002/cem.1031; Sohn YM, 2010, AM J ROENTGENOL, V194, P38, DOI 10.2214/AJR.09.3128; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Torregrossa L, 2012, J PROTEOME RES, V11, P3317, DOI 10.1021/pr300105e; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Wojakowska A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/258763; Wojtowicz W, 2016, METABOLOMICS OPEN AC, V2016; Wojtowicz W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09203-3; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Yao ZZ, 2011, MOL BIOSYST, V7, P2608, DOI 10.1039/c1mb05029j	48	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193883	10.1371/journal.pone.0193883	http://dx.doi.org/10.1371/journal.pone.0193883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509799	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200038
J	Wairagkar, M; Hayashi, Y; Nasuto, SJ				Wairagkar, Maitreyee; Hayashi, Yoshikatsu; Nasuto, Slawomir J.			Exploration of neural correlates of movement intention based on characterisation of temporal dependencies in electroencephalography	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; SINGLE-TRIAL EEG; MOTOR-IMAGERY; THETA-BAND; BCI; DESYNCHRONIZATION; (DE)SYNCHRONIZATION; MODULATION; ERD/ERS; POWER	Brain computer interfaces (BCIs) provide a direct communication channel by using brain signals, enabling patients with motor impairments to interact with external devices. Motion intention detection is useful for intuitive movement-based BCI as movement is the fundamental mode of interaction with the environment. The aim of this paper is to investigate the temporal dynamics of brain processes using electroencephalography (EEG) to explore novel neural correlates of motion intention. We investigate the changes in temporal dependencies of the EEG by characterising the decay of autocorrelation during asynchronous voluntary finger tapping movement. The evolution of the autocorrelation function is characterised by its relaxation time, which is used as a robust marker for motion intention. We observed that there was reorganisation of temporal dependencies in EEG during motion intention. The autocorrelation decayed slower during movement intention and faster during the resting state. There was an increase in temporal dependence during movement intention. The relaxation time of the autocorrelation function showed significant (p < 0.05) discrimination between movement and resting state with the mean sensitivity of 78.37 +/- 8.83%. The relaxation time provides movement related information that is complementary to the well-known event-related desynchronisation (ERD) by characterising the broad band EEG dynamics which is frequency independent in contrast to ERD. It can also detect motion intention on average 0.51s before the actual movement onset. We have thoroughly compared autocorrelation relaxation time features with ERD in four frequency bands. The relaxation time may therefore, complement the well-known features used in motion-based BCI leading to more robust and intuitive BCI solutions. The results obtained suggest that changes in autocorrelation decay may involve reorganisation of temporal dependencies of brain activity over longer duration during motion intention. This opens the possibilities of investigating further the temporal dynamics of fundamental neural processes underpinning motion intention.	[Wairagkar, Maitreyee; Hayashi, Yoshikatsu; Nasuto, Slawomir J.] Univ Reading, Sch Biol Sci, Brain Embodiment Lab, Biomed Engn, Reading, Berks, England	University of Reading	Wairagkar, M (corresponding author), Univ Reading, Sch Biol Sci, Brain Embodiment Lab, Biomed Engn, Reading, Berks, England.	m.n.wairagkar@pgr.reading.ac.uk		Wairagkar, Maitreyee/0000-0002-9546-2843	University of Reading International Research Studentship [GS14-46]	University of Reading International Research Studentship	This research was funded by University of Reading International Research Studentship awarded to MW (reference number: GS14-46, URL:http://www.reading.ac.uk/).The funders had no role in study design, data collection and analysis, decision to publish, o rpreparation of the manuscript.	Amiri S, 2013, ADV HUM-COMPUT INTER, V2013, DOI 10.1155/2013/187024; Ang KK, 2017, IEEE T NEUR SYS REH, V25, P392, DOI 10.1109/TNSRE.2016.2646763; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Bastiaansen MCM, 2002, NEUROSCI LETT, V323, P13, DOI 10.1016/S0304-3940(01)02535-6; Blankertz B., 2008, SIGNAL PROCESSING MA, P41, DOI DOI 10.1109/MSP.2008; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Breitwieser C, 2012, IEEE T BIO-MED ENG, V59, P852, DOI 10.1109/TBME.2011.2174637; Bularka S, 2016, 2016 12TH IEEE INTERNATIONAL SYMPOSIUM ON ELECTRONICS AND TELECOMMUNICATIONS (ISETC'16), P219, DOI 10.1109/ISETC.2016.7781096; Clochon P, 1996, ELECTROEN CLIN NEURO, V98, P126, DOI 10.1016/0013-4694(95)00192-1; Crevecoeur F, 2010, J NEUROSCI METH, V192, P163, DOI 10.1016/j.jneumeth.2010.07.017; Daly I, 2015, IEEE T NEUR SYS REH, V23, P725, DOI 10.1109/TNSRE.2014.2346621; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demandt E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00065; Dimitriadis SI, 2016, CLIN NEUROPHYSIOL, V127, P2878, DOI 10.1016/j.clinph.2016.05.359; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Durka PJ, 2001, MED BIOL ENG COMPUT, V39, P315, DOI 10.1007/BF02345286; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2017, SPRBRIEF ELECT, P105, DOI 10.1007/978-3-319-64373-1_11; Hamedi M, 2016, NEURAL COMPUT, V28, P999, DOI 10.1162/NECO_a_00838; Hayashi Y, 2013, CONVERGING CLIN ENG, P569; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; HOLM S, 1979, SCAND J STAT, V6, P65; Hwang HJ, 2013, INT J HUM-COMPUT INT, V29, P814, DOI 10.1080/10447318.2013.780869; Ibanez J, 2014, IEEE ENG MED BIO, P1646, DOI 10.1109/EMBC.2014.6943921; Ibanez J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056009; Jausovec N, 2001, NEUROSCI LETT, V311, P93, DOI 10.1016/S0304-3940(01)02141-3; Jin J, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6213; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Lew E, 2012, J FRONT NEUROENG, V5, P2012, DOI 10.3389/fneng.2012.00013; Lew EYL, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00222; Li AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116429; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Lotte F., 2014, GUIDE BRAIN COMPUTER, DOI [10.1007/978-1-4471-6584-2_7, DOI 10.1007/978-1-4471-6584-2_7]; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Meng F, 2008, IEEE IJCNN, P4103, DOI 10.1109/IJCNN.2008.4634388; Mrachacz-Kersting N, 2012, J PHYSIOL-LONDON, V590, P1669, DOI 10.1113/jphysiol.2011.222851; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Osuagwu BCA, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/065002; Pan CP, 2004, PHYS LETT A, V329, P130, DOI 10.1016/j.physleta.2004.06.070; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Reis PMR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00156; Robinson N, 2017, I IEEE EMBS C NEUR E, P572, DOI 10.1109/NER.2017.8008416; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Solis-Escalante T, 2012, CLIN NEUROPHYSIOL, V123, P1182, DOI 10.1016/j.clinph.2012.01.013; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; Wairagkar M., 2014, INT C BRAIN COMP INT; Wairagkar M., 2017, EEG DATA VOLUNTARY F; Wairagkar M, 2015, LECT NOTES ARTIF INT, V9250, P212, DOI 10.1007/978-3-319-23344-4_21; Wang HQ, 2016, IEEE T NEUR SYS REH, V24, P532, DOI 10.1109/TNSRE.2016.2519350; Xu R, 2014, IEEE T BIO-MED ENG, V61, P288, DOI 10.1109/TBME.2013.2294203; Zhigalov A, 2016, CLIN NEUROPHYSIOL, V127, P2882, DOI 10.1016/j.clinph.2016.04.028	71	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193722	10.1371/journal.pone.0193722	http://dx.doi.org/10.1371/journal.pone.0193722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509785	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000426813200026
J	Chem, ED; Anong, DN; Akoachere, JFKT				Chem, Elvis Dzelamonyuy; Anong, Damian Nota; Akoachere, Jane-Francis K. T.			Prescribing patterns and associated factors of antibiotic prescription in primary health care facilities of Kumbo East and Kumbo West Health Districts, North West Cameroon	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RESISTANCE; CHILDREN; PREDICTORS; PHYSICIANS; CENTERS; EUROPE; DRUGS	Background Inappropriate use of antibiotics is a global public health challenge and has been associated with antibiotic resistance. WHO reports show that efforts to promote rational antibiotic use in developing countries are poor. With the growing number of infections with antibiotic resistant bacteria, rational drug use becomes imperative and studies that promote rational drug use are highly necessary. Considering this, we investigated prescribing patterns and predictors of antibiotic prescription in primary health care facilities in Kumbo East (KE) and Kumbo West (KW) health districts in North West Cameroon, to contribute data which could influence policy on antibiotic use. Methods and findings A cross sectional retrospective study was conducted from April 2014 to April 2015 in 26 randomly selected primary care facilities. Questionnaires were administered to 59 antibiotic prescribers to determine factors that predict antibiotic prescribing. Data on antibiotic prescription were collected by review of consultation registers. Prescription rates and demographics, prescriber and institution factors were analyzed using ANOVA. The best predictor of prescription was determined using multiple linear regression analysis. Results A total of 30,096 prescriptions were reviewed. Overall antibiotic prescription rate was 36.71%, with a mean of 1.14 antibiotics prescribed per patient. Amoxicillin was the most prescribed (29.9%). The most prevalent indications for prescribing were respiratory tract infections (21.27%). All antibiotics prescribed were broad- spectrum. Antibiotics were prescribed for patients with malaria and also in situations where diagnosis was uncertain. Prescribing by generic name was 98.36% while 99.87% was from Essential Drug List. Use of laboratory results, patient turnout and Performance Based Financing (PBF) were significantly associated with antibiotic prescribing rates (p < 0.05). PBF moderated prescribing. Conclusion There was misuse of antibiotics in primary care facilities in study area. We recommend all primary care health facilities in study area to be included in the PBF scheme and that prescribing should only be done by physicians as the have adequate training.	[Chem, Elvis Dzelamonyuy; Anong, Damian Nota; Akoachere, Jane-Francis K. T.] Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon		Akoachere, JFKT (corresponding author), Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon.	jakoachere@yahoo.com		Dzelamonyuy, Chem Elvis/0000-0002-1346-8871				Akkerman AE, 2005, BRIT J GEN PRACT, V55, P114; Akoachere Jane-Francis Tatah Kihla, 2012, BMC Res Notes, V5, P219, DOI 10.1186/1756-0500-5-219; [Anonymous], 2015, NAT MAL CONTR PROGR, P22; [Anonymous], EDM RES SER; Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008; Bharathiraja R, 2005, INDIAN J PEDIATR, V72, P1; Bilal AI, BMC HLTH SERV RES, V16, P144; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Carneiro M, 2011, REV ASSOC MED BRAS, V57, P421, DOI 10.1590/S0104-42302011000400016; Charan N, 2013, J BIOMEDICAL PHARM R, V2, P71; Chareonkul Chanin, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P418; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Consortium AEDES/IRESCO, PERF BAS FIN IMPL MA; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Department of human resources, 2009, REV EQ OPP WOM WORKP, P3; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Donkor ES, INT J ENV RES PUBLIC, V9, P3519; Dyar OJ, 2016, EXPERT REV ANTI-INFE, V14, P403, DOI 10.1586/14787210.2016.1151353; Erah P. O., 2003, Tropical Journal of Pharmaceutical Research, V2, P175; Fadare JO, 2016, EXPERT REV PHARM OUT, V16, P639, DOI 10.1586/14737167.2016.1120673; Finch R, 2007, J ANTIMICROB CHEMOTH, V60, pI79, DOI 10.1093/jac/dkm165; Fitchett JR, 2016, LANCET INFECT DIS, V16, P388, DOI 10.1016/S1473-3099(15)00410-7; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Gebeyehu E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138179; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; HOGERZEIL HV, 1993, LANCET, V342, P1408, DOI 10.1016/0140-6736(93)92760-Q; Holloway K., 2011, WHO WORLD MED SITUAT, V3rd; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Horwood J, 2016, BRIT J GEN PRACT, V66, pE207, DOI 10.3399/bjgp16X683821; Huang AM, 2005, CLIN INFECT DIS, V57, P1237; Jubulis J, 2015, INT J TUBERC LUNG D, V19, P823, DOI 10.5588/ijtld.14.0527; Kesah FNC, 2013, ANN TROP MED PUBLIC, V6, P446, DOI 10.4103/1755-6783.127797; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Laing R., 2001, W AFR J PHARM DRUG R, V18, P6, DOI [10.4314/wajpdr.v18i1.14718, DOI 10.4314/WAJPDR.V18I1.14718]; Lim Y.-P., 2012, EVID BASED COMPLEMEN, V2012, P1; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Lloyd W, 2013, ANTIBIOTIC PRESCRIBI, P2; Mahmoud R., 2014, SUDAN MED MONIT, V9, P61, DOI [10.4103/1858-5000.146575, DOI 10.4103/1858-5000.146575]; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Mashalla Y, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.13042; Mbam LA, 2015, J HLTH SCI DIS, V6, P1; Mbonye AK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010632; Naseeb TA, 2005, SAUDI MED J, V26, P1436; National Institute for Health and Clinical Excellence (UK), 2008, RESP TRACT INF ANT S; Ndhlovu M, 2015, TROP MED INT HEALTH, V20, P1696, DOI 10.1111/tmi.12591; Ofori-Asenso R, BMC PUBLIC HLTH, V16, P724; Otoom S., 2010, Eastern Mediterranean Health Journal, V16, P511; Pavin M, 2003, TROP MED INT HEALTH, V8, P182, DOI 10.1046/j.1365-3156.2003.00992.x; Petersen I, 2007, J ANTIMICROB CHEMOTH, V60, pI43, DOI 10.1093/jac/dkm156; Piovani D, 2015, PHARMACOEPIDEM DR S, V24, P121, DOI 10.1002/pds.3654; Rezal RSM, 2015, EXPERT REV ANTI-INFE, V13, P665, DOI 10.1586/14787210.2015.1025057; Rudasingwa M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1327241; Shankar Ravi Pathiyil, 2003, Ann Clin Microbiol Antimicrob, V2, P7; Smith RD, 2012, TECHNICAL REPORT; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005; van der Velden AW, 2013, INT J CLIN PRACT, V67, P10, DOI 10.1111/ijcp.12336; Veronin MA, 2011, J PHARM HEALTH SERV, V2, P135, DOI 10.1111/j.1759-8893.2011.00059.x; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Bank, 2014, PERF BAS FIN CAM INN; Wu YQ, 2016, EUR J CLIN PHARMACOL, V72, P359, DOI 10.1007/s00228-015-1997-6	64	46	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193353	10.1371/journal.pone.0193353	http://dx.doi.org/10.1371/journal.pone.0193353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505584	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200011
J	Fu, CF; Huang, JD; Wang, JT; Lin, SW; Wu, CC				Fu, Chien-Fang; Huang, Jiun-Da; Wang, Jann-Tay; Lin, Shu-Wen; Wu, Chien-Chih			The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia	PLOS ONE			English	Article							CONCENTRATION-TIME CURVE; HIGH-FLUX HEMODIALYSIS; INFECTIONS; MORTALITY; BIOFILMS; AREA	Background Vancomycin is a standard treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, and its efficacy is closely linked to the recommended serum trough concentration of 15 +/- 20 mg/L. However, it is unknown how the pre-dialysis trough serum concentration (Cpre-HD) correlates with MRSA eradication in renal failure patients undergoing intermittent hemodialysis (HD). Objective To evaluate the relationship between Cpre-HD and the treatment outcomes in this population. Materials and methods A retrospective study was conducted to enroll renal failure patients undergoing HD who had received vancomycin treatment for MRSA bacteremia during January 2013 to June 2016. Treatment failure was defined as persistent bacteremia after >= 7 days of vancomycin therapy or recurrent MRSA infection within 30 days. Patient characteristics, vancomycin dosing regimen, Cpre-HD, vancomycin minimum inhibitory concentration (MIC), and subsequent culture data were reviewed. The receiver operating characteristic (ROC) curve was used to find the optimal cut-off point of Cpre-HD. Results 42 patients were enrolled and 64% had treatment failure. Although there were no significant differences in demographics or Cpre-HD between the two groups, Cpre-HD/MIC was significantly higher in the success group than that in the failure group (22.80 +/- 10.90 vs. 14.94 +/- 6.11, p = 0.019). The area under the ROC curve was 0.74, while the sensitivity, specificity, positive predictive value, and negative predictive value were 67%, 78%, 62.5%, and 81%, respectively, at the optimal Cpre-HD/MIC of. 18.6. Conclusions Cpre-HD/MIC was associated with vancomycin treatment outcome in MRSA bacteremia, and targeting to achieve a Cpre-HD/MIC of. 18.6 may improve treatment outcomes in renal failure patients who are on intermittent HD.	[Fu, Chien-Fang; Huang, Jiun-Da; Lin, Shu-Wen; Wu, Chien-Chih] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Shu-Wen; Wu, Chien-Chih] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wu, CC (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan.	101440@ntuh.gov.tw		LIN, SHU-WEN/0000-0002-9940-0850; WANG, JANN-TAY/0000-0002-0924-3469; Wu, Chien Chih/0000-0002-9517-2176				Ariano RE, 2005, AM J KIDNEY DIS, V46, P681, DOI 10.1053/j.ajkd.2005.07.018; Barth RH, 1996, KIDNEY INT, V50, P929, DOI 10.1038/ki.1996.393; Brown J, 2012, ANTIMICROB AGENTS CH, V56, P634, DOI 10.1128/AAC.05609-11; Brown M, 2011, CLIN INFECT DIS, V53, P164, DOI 10.1093/cid/cir322; Centers for Disease C, 2005, MMWR-MORBID MORTAL W, V56, P197; Clinical and Laboratory Standards Institute (CLSI), 2009, CLSI PUBL, VM07-A8; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Crew P, 2015, AM J HEALTH-SYST PH, V72, P1856, DOI 10.2146/ajhp150051; DASGUPTA MK, 1991, ADV PERIT D, V7, P165; DASGUPTA MK, 1989, BLOOD PURIFICAT, V7, P144, DOI 10.1159/000169586; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Jung Y, 2014, INT J ANTIMICROB AG, V43, P179, DOI 10.1016/j.ijantimicag.2013.10.017; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lin SY, 2014, INT J ANTIMICROB AG, V43, P384, DOI 10.1016/j.ijantimicag.2014.01.002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2014, CLIN INFECT DIS, V59, P666, DOI 10.1093/cid/ciu398; Marr KA, 1997, ANN INTERN MED, V127, P275, DOI 10.7326/0003-4819-127-4-199708150-00003; Moise-Broder PA, 2004, CLIN PHARMACOKINET, V43, P925, DOI 10.2165/00003088-200443130-00005; Pai AB, 2004, AM J HEALTH-SYST PH, V61, P1812, DOI 10.1093/ajhp/61.17.1812; Raad Issam I., 1994, Middle East Journal of Anesthesiology, V12, P381; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Siala W, 2014, ANTIMICROB AGENTS CH, V58, P6385, DOI 10.1128/AAC.03482-14; Song KH, 2015, INT J ANTIMICROB AG, V46, P689, DOI 10.1016/j.ijantimicag.2015.09.010; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; Vandecasteele SJ, 2011, CLIN INFECT DIS, V53, P124, DOI 10.1093/cid/cir337	26	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193585	10.1371/journal.pone.0193585	http://dx.doi.org/10.1371/journal.pone.0193585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505620	Green Submitted, Green Published, gold			2022-12-26	WOS:000426548200022
J	Rivera, MG; Hair, PS; Cunnion, KM; Krishna, NK				Rivera, Magdielis Gregory; Hair, Pamela S.; Cunnion, Kenji M.; Krishna, Neel K.			Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)	PLOS ONE			English	Article							MECHANISMS; INJURY	Reactive oxygen species (ROS) are natural byproducts of oxidative respiration that are toxic to organs and tissues. To mitigate ROS damage, organisms have evolved a variety of antioxidant systems to counteract these harmful molecules, however in certain pathological conditions these protective mechanisms can be overwhelmed. We have recently demonstrated that Peptide Inhibitor of Complement C1 (PIC1) mitigates peroxidase activity of the heme bearing proteins myeloperoxidase, hemoglobin, and myoglobin through a reversible process. To determine if this property of PIC1 was antioxidant in nature, we tested PIC1 in a number of well-established antioxidant assays. PIC1 showed dose-dependent antioxidant activity in a total antioxidant (TAC) assay, hydroxyl radical antioxidant capacity (HORAC) assay, oxygen radical antioxidant capacity (ORAC) assay as well as the thiobarbituric acid reactive substances (TBARS) assay to screen for PIC1 antioxidant activity in human plasma. The antioxidant activity of PIC1 in the TAC assay, as well as the HORAC/ORAC assay demonstrated that this peptide acts via the single electron transport (SET) and hydrogen atom transfer (HAT) mechanisms, respectively. Consistent with this mechanism of action, PIC1 did not show activity in a metal chelating activity (MCA) assay. PIC1 contains two vicinal cysteine residues and displayed similar antioxidant activity to the well characterized cysteine-containing tripeptide antioxidant molecule glutathione (GSH). Consistent with the role of the cysteine residues in the antioxidant activity of PIC1, oxidation of these residues significantly abrogated antioxidant activity. These results demonstrate that in addition to its described complement inhibiting activity, PIC1 displays in vitro antioxidant activity.	[Rivera, Magdielis Gregory; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Hair, Pamela S.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.; Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	krishnnk@evms.edu		Krishna, Neel/0000-0002-4615-4035	Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA [7364]	Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA	Funded by Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA. Grant #7364 to KMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, FREE RADICAL BIO MED, V50, P1659, DOI 10.1016/j.freeradbiomed.2011.03.012; Billings FT, 2011, FREE RADICAL BIO MED, V50, P1480, DOI 10.1016/j.freeradbiomed.2011.02.011; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Hair PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170203; Hair PS, INT J PEPT; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kumar PS, 2016, TRANSFUSION, V56, P2133, DOI 10.1111/trf.13674; Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Sudhakar S, 2015, LWT-FOOD SCI TECHNOL, V64, P593, DOI 10.1016/j.lwt.2015.06.031; Tian M, 2015, DAIRY SCI TECHNOL, V95, P451, DOI 10.1007/s13594-015-0226-5; Tipple Trent E, 2012, Methods Mol Biol, V889, P315, DOI 10.1007/978-1-61779-867-2_20; Wong FC, 2014, IRAN J PHARM RES, V13, P1409; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	20	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193931	10.1371/journal.pone.0193931	http://dx.doi.org/10.1371/journal.pone.0193931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499069	gold, Green Submitted, Green Published			2022-12-26	WOS:000426472300027
J	Yu, KKH; Taylor, JT; Pathmanaban, ON; Youshani, AS; Beyit, D; Dutko-Gwozdz, J; Benson, R; Griffiths, G; Peers, I; Cueppens, P; Telfer, BA; Williams, KJ; McBain, C; Kamaly-Asl, ID; Bigger, BW				Yu, Kenny Kwok-Hei; Taylor, Jessica T.; Pathmanaban, Omar N.; Youshani, Amir Saam; Beyit, Deniz; Dutko-Gwozdz, Joanna; Benson, Roderick; Griffiths, Gareth; Peers, Ian; Cueppens, Peter; Telfer, Brian A.; Williams, Kaye J.; McBain, Catherine; Kamaly-Asl, Ian D.; Bigger, Brian W.			High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma	PLOS ONE			English	Article							PHASE-II TRIAL; CENTRAL-NERVOUS-SYSTEM; STEM-LIKE CELLS; RECURRENT GLIOBLASTOMA; IN-VITRO; DRUG-RESISTANCE; GLIOMA; TEMOZOLOMIDE; TUMOR; BORTEZOMIB	Background Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim of personalizing therapy at recurrence, we have established a high content screening (HCS) platform to analyze the sensitivity profile of seven patient-derived cancer stem cell lines to 83 FDA-approved chemotherapy drugs, with and without irradiation. Methods Seven cancer stem cell lines were derived from patients with GBM and, along with the established cell line U87-MG, each patient-derived line was cultured in tandem in serum-free conditions as adherent monolayers and three-dimensional neurospheres. Chemotherapeutics were screened at multiple concentrations and cells double-stained to observe their effect on both cell death and proliferation. Sensitivity was classified using high-throughput algorithmic image analysis. Results Cell line specific drug responses were observed across the seven patient-derived cell lines. Few agents were seen to have radio-sensitizing effects, yet some drug classes showed a marked difference in efficacy between monolayers and neurospheres. In vivo validation of six drugs suggested that cell death readout in a three-dimensional culture scenario is a more physiologically relevant screening model and could be used effectively to assess the chemosensitivity of patient-derived GBM lines. Conclusion The study puts forward a number of non-standard chemotherapeutics that could be useful in the treatment of recurrent GBM, namely mitoxantrone, bortezomib and actinomycin D, whilst demonstrating the potential of HCS to be used for personalized treatment based on the chemosensitivity profile of patient tumor cells.	[Yu, Kenny Kwok-Hei; Taylor, Jessica T.; Youshani, Amir Saam; Bigger, Brian W.] Univ Manchester, Stem Cell & Neurotherapies Lab, Brain Tumour Res Grp, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Pathmanaban, Omar N.] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Manchester Ctr Clin Neurosci, Salford, Lancs, England; [Beyit, Deniz; Dutko-Gwozdz, Joanna; Benson, Roderick; Griffiths, Gareth] Imagen Therapeut, Manchester, Lancs, England; [Peers, Ian; Cueppens, Peter] Inferstats Consulting, Alderley Pk, Biohub, Cheshire, England; [Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Sch Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England; [McBain, Catherine] Christie NHS FT, Dept Clin Oncol, Manchester, Lancs, England; [Kamaly-Asl, Ian D.] Royal Manchester Childrens Hosp, CBTRN, Manchester, Lancs, England; [Kamaly-Asl, Ian D.] Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Dept Neurosurg, Manchester, Lancs, England	University of Manchester; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Christie NHS Foundation Trust; Royal Manchester Children's Hospital; Royal Manchester Children's Hospital; University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Stem Cell & Neurotherapies Lab, Brain Tumour Res Grp, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.	brian.bigger@manchester.ac.uk		Taylor, Jessica/0000-0001-8565-8589; Yu, Kenny/0000-0002-2394-4990; Telfer, Brian/0000-0003-1857-5120; Pathmanaban, Omar/0000-0002-5083-9416	Christie Charitable Fund; BBSRC; Wellcome; University of Manchester Strategic Fund	Christie Charitable Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; University of Manchester Strategic Fund	ONP was The Brain Tumour Charity Christopher Clarke Fellow. JTT, ONP and BWB received grant funding from the Christie Charitable Fund. Imagen Therapeutics provided support in the form of salaries for authors DB, JDG, RB & GG, and Inferstats Consulting provided support in the form of salaries for authors IP & PC. Neither of these commercial companies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome and the University of Manchester Strategic Fund.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Badr CE, 2011, ASSAY DRUG DEV TECHN, V9, P281, DOI 10.1089/adt.2010.0324; Benesch M, 2014, BONE MARROW TRANSPL, V49, P370, DOI 10.1038/bmt.2013.208; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boiardi A, 2008, J NEURO-ONCOL, V88, P105, DOI 10.1007/s11060-008-9540-6; Bota DA, 2013, J NEUROSURG, V119, P1415, DOI 10.3171/2013.7.JNS1323; Chowdhary SA, 2015, J NEURO-ONCOL, V122, P367, DOI 10.1007/s11060-015-1724-2; Cisternino S, 2004, CANCER RES, V64, P3296, DOI 10.1158/0008-5472.CAN-03-2033; De Bacco F, 2016, EMBO MOL MED, V8, P550, DOI 10.15252/emmm.201505890; Friday BB, 2012, NEURO-ONCOLOGY, V14, P215, DOI 10.1093/neuonc/nor198; Friedman HS, 1999, J CLIN ONCOL, V17, P1516, DOI 10.1200/JCO.1999.17.5.1516; GREEN RM, 1988, J NEURO-ONCOL, V6, P75, DOI 10.1007/BF00163544; Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021; Hasselbalch B, 2010, NEURO-ONCOLOGY, V12, P508, DOI 10.1093/neuonc/nop063; Hirst TC, 2013, BRIT J CANCER, V108, P64, DOI 10.1038/bjc.2012.504; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Jackson M, 2015, CARCINOGENESIS, V36, P177, DOI 10.1093/carcin/bgu243; Jiang PF, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-13; LEVI F, 1994, INT J CANCER, V59, P543, DOI 10.1002/ijc.2910590418; Lieber J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-362; Liffers K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/427518; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; MATTERN J, 1988, BRIT J CANCER, V58, P30, DOI 10.1038/bjc.1988.155; Narita Y, 2000, CANCER CHEMOTH PHARM, V45, P149, DOI 10.1007/s002800050023; Castro GN, 2015, CELL STRESS CHAPERON, V20, P253, DOI 10.1007/s12192-014-0537-0; Odia Y, 2015, J NEURO-ONCOL, V125, P191, DOI 10.1007/s11060-015-1894-y; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pitz MW, 2011, J NEURO-ONCOL, V104, P629, DOI 10.1007/s11060-011-0564-y; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Quartararo CE, 2015, ACS MED CHEM LETT, V6, P948, DOI 10.1021/acsmedchemlett.5b00128; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; Raizer JJ, 2016, J NEURO-ONCOL, V129, P139, DOI 10.1007/s11060-016-2156-3; Rosso L, 2009, CANCER RES, V69, P120, DOI 10.1158/0008-5472.CAN-08-2356; Schmidt F, 2006, NEUROLOGY, V66, P587, DOI 10.1212/01.wnl.0000197792.73656.c2; Sengupta R, 2015, ONCOTARGET, V6, P18282, DOI 10.18632/oncotarget.4957; Sergijenko A, 2013, MOL THER, V21, P1938, DOI 10.1038/mt.2013.141; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tzaridis T, 2016, ONCOTARGET, V7, P61860, DOI 10.18632/oncotarget.11452; Vogelbaum MA, 2015, NEURO-ONCOLOGY, V17, pII3, DOI 10.1093/neuonc/nou354; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	46	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193694	10.1371/journal.pone.0193694	http://dx.doi.org/10.1371/journal.pone.0193694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499065	Green Published, gold, Green Submitted			2022-12-26	WOS:000426472300019
J	De Tomasi, LC; Campos, DHS; Sant'Ana, PG; Okoshi, K; Padovani, CR; Murata, GM; Nguyen, S; Kolwicz, SC; Cicogna, AC				De Tomasi, Loreta Casquel; Salome Campos, Dijon Henrique; Sant'Ana, Paula Grippa; Okoshi, Katashi; Padovani, Carlos Roberto; Murata, Gilson Masahiro; Nguyen, Son; Kolwicz, Stephen C., Jr.; Cicogna, Antonio Carlos			Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism	PLOS ONE			English	Article							HEART-FAILURE; PRESSURE-OVERLOAD; ADIPOSE-TISSUE; DIET; OXIDATION; STRESS; IMPROVES; DISEASE; OBESITY; RATS	Pathological cardiac hypertrophy leads to derangements in lipid metabolism that may contribute to the development of cardiac dysfunction. Since previous studies, using high saturated fat diets, have yielded inconclusive results, we investigated whether provision of a high-unsaturated fatty acid ( HUFA) diet was sufficient to restore impaired lipid metabolism and normalize diastolic dysfunction in the pathologically hypertrophied heart. Male, Wistar rats were subjected to supra-valvar aortic stenosis ( SVAS) or sham surgery. After 6 weeks, diastolic dysfunction and pathological hypertrophy was confirmed and both sham and SVAS rats were treated with either normolipidic or HUFA diet. At 18 weeks post-surgery, the HUFA diet failed to normalize decreased E/A ratios or attenuate measures of cardiac hypertrophy in SVAS animals. Enzymatic activity assays and gene expression analysis showed that both normolipidic and HUFA-fed hypertrophied hearts had similar increases in glycolytic enzyme activity and down-regulation of fatty acid oxidation genes. Mass spectrometry analysis revealed depletion of unsaturated fatty acids, primarily linoleate and oleate, within the endogenous lipid pools of normolipidic SVAS hearts. The HUFA diet did not restore linoleate or oleate in the cardiac lipid pools, but did maintain body weight and adipose mass in SVAS animals. Overall, these results suggest that, in addition to decreased fatty acid oxidation, aberrant unsaturated fatty acid metabolism may be a maladaptive signature of the pathologically hypertrophied heart. The HUFA diet is insufficient to reverse metabolic remodeling, diastolic dysfunction, or pathologically hypertrophy, possibly do to preferentially partitioning of unsaturated fatty acids to adipose tissue.	[De Tomasi, Loreta Casquel; Salome Campos, Dijon Henrique; Sant'Ana, Paula Grippa; Okoshi, Katashi; Cicogna, Antonio Carlos] Sao Paulo State Univ, Dept Internal Med, Botucatu, SP, Brazil; [De Tomasi, Loreta Casquel; Nguyen, Son; Kolwicz, Stephen C., Jr.] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA; [Padovani, Carlos Roberto] Sao Paulo State Univ, Dept Biostat, Botucatu, SP, Brazil; [Murata, Gilson Masahiro] Univ Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil; [Kolwicz, Stephen C., Jr.] Ursinus Coll, Hlth & Exercise Physiol Dept, Heart & Muscle Metab Lab, Collegeville, PA 19426 USA	Universidade Estadual Paulista; University of Washington; University of Washington Seattle; Universidade Estadual Paulista; Universidade de Sao Paulo	De Tomasi, LC (corresponding author), Sao Paulo State Univ, Dept Internal Med, Botucatu, SP, Brazil.; De Tomasi, LC (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA.	loreta@fmb.unesp.br	Kolwicz, Stephen/GRF-6823-2022; Okoshi, Katashi/A-3955-2011	Okoshi, Katashi/0000-0001-8980-8839; Kolwicz Jr, Stephen/0000-0002-1164-9556; Nguyen, Son/0000-0003-0735-850X; Cicogna, Antonio Carlos/0000-0002-4402-6523	American Heart Association [14SDG18590020]; Sao Paulo Research Foundation [2012/19679-0, 2014/06030-1]	American Heart Association(American Heart Association); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the American Heart Association (14SDG18590020 to SCK) and the Sao Paulo Research Foundation (2012/19679-0; 2014/06030-1 to LCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2012, BBA-BIOMEMBRANES, V1818, P1309, DOI 10.1016/j.bbamem.2012.01.011; Ablorh NAD, 2014, J BIOL CHEM, V289, P29397, DOI 10.1074/jbc.M114.556621; Akki A, 2009, CARDIOVASC RES, V81, P610, DOI 10.1093/cvr/cvn316; Banack HR, 2015, ANN EPIDEMIOL, V25, P342, DOI 10.1016/j.annepidem.2015.02.008; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; Berthiaume JM, 2010, AM J PHYSIOL-HEART C, V299, pH410, DOI 10.1152/ajpheart.00270.2010; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; Boluyt MO, 2005, AM J HYPERTENS, V18, P202, DOI 10.1016/j.amjhyper.2004.08.034; Bregagnollo EA, 2007, INT J CARDIOL, V117, P109, DOI 10.1016/j.ijcard.2006.06.006; Bruininx E, 2011, J NUTR, V141, P1657, DOI 10.3945/jn.111.142562; Chess DJ, 2008, J CARD FAIL, V14, P82, DOI 10.1016/j.cardfail.2007.09.004; Chess DJ, 2009, AM J PHYSIOL-HEART C, V297, pH1585, DOI 10.1152/ajpheart.00599.2009; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Duda MK, 2008, J CARD FAIL, V14, P327, DOI 10.1016/j.cardfail.2007.11.003; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; Jones PJH, 2008, METABOLISM, V57, P1198, DOI 10.1016/j.metabol.2008.04.012; Kolwicz SC, 2016, BBA-MOL CELL BIOL L, V1861, P1472, DOI 10.1016/j.bbalip.2016.03.028; Kolwicz SC, 2015, DIABETES, V64, P2817, DOI 10.2337/db14-1943; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Lahey R, 2014, CIRCULATION, V130, P1790, DOI 10.1161/CIRCULATIONAHA.114.011687; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Le CH, 2014, CIRC-HEART FAIL, V7, P172, DOI 10.1161/CIRCHEARTFAILURE.113.000744; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Mendes OD, 2010, ARQ BRAS CARDIOL, V94, P62, DOI 10.1590/S0066-782X2010000100011; Mills GD, 2006, AM J PHYSIOL-HEART C, V291, pH61, DOI 10.1152/ajpheart.01353.2005; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; O'Donnell JM, 2008, J MOL CELL CARDIOL, V44, P315, DOI 10.1016/j.yjmcc.2007.11.006; Okere IC, 2005, CLIN EXP PHARMACOL P, V32, P825, DOI 10.1111/j.1440-1681.2005.04272.x; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Picklo MJ, 2017, PROSTAG LEUKOTR ESS, V119, P25, DOI 10.1016/j.plefa.2017.03.001; Ribeiro Henrique Barbosa, 2003, Arq. Bras. Cardiol., V81, P569, DOI 10.1590/S0066-782X2003001400003; Timmers S, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.7	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193553	10.1371/journal.pone.0193553	http://dx.doi.org/10.1371/journal.pone.0193553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494668	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200066
J	Kapusta, A; Kuczynska, B; Puppel, K				Kapusta, Aleksandra; Kuczynska, Beata; Puppel, Kamila			Relationship between the degree of antioxidant protection and the level of malondialdehyde in high-performance Polish Holstein-Friesian cows in peak of lactation	PLOS ONE			English	Article							CHOLESTEROL OXIDATION-PRODUCTS; DAIRY-COWS; STRESS; MILK; STABILITY; MALONALDEHYDE; CAROTENOIDS; PLASMA; PERIOD; STAGE	Lipid peroxidation can be described as a process under which free radicals attack carbon double bonds of omega-3 and omega-6 fatty acids. Whereas the end products of this process are reactive aldehydes, such as malondialdehyde ( MDA). Lipid peroxidation leads to adverse changes in the nutritional value of milk; therefore, higher degree of antioxidant protection ( DAP) ensures higher stability of dairy products by effecting their high antioxidative potential. Therefore, the purpose of this study was to demonstrate the relationship between the DAP and the level of MDA in high-performance Polish Holstein-Friesian cows in peak of lactation. Sixty-three Polish Holstein-Friesian cows were selected to the experiment according to: parity ( all in the 2nd lactation), phase of lactation ( peak of lactation), cytological quality of milk ( somatic cell count < 150 thousand/ml) and without diagnosed metabolic diseases. The data obtained were analyzed statistically by two-way ANOVA, and Tukey's post-hoc test. After analysis of performance the cows were divided into 3 groups ( twenty one cows in each group) based on milk yield and MDA concentration. The study revealed a significant effect of the lactation performance of cows on MDA levels in milk ( P <= 0.01). The highest concentration of MDA ( 61.137 nM/mL) was shown in milk of cows yielding between 50.00 and 55.80 kg/day. The highest concentration of fat was found in milk in which the MDA level ranged from 48 to 86 nM/mL. Whereas, the inverse relationship was demonstrated in case of protein concentration. The highest level of protein was found in cows with MDA levels in the range of 18-28 nM/ mL ( P <= 0.01). The lowest MDA level ( in the range of 18-28 nM/mL) was associated with the highest concentration of vitamin E, beta-carotene, total antioxidant status ( TAS) and DAP, measured in both milk and plasma. The obtained results show that lipid peroxidation leads to adverse changes in the nutritional value of milk; the highest DAP ( 7.89 x 10(-3)) was found in the cows with the lowest MDA concentration in milk.	[Kapusta, Aleksandra; Kuczynska, Beata; Puppel, Kamila] Warsaw Univ Life Sci, Anim Breeding & Prod Dept, Cattle Breeding Div, Warsaw, Poland	Warsaw University of Life Sciences	Puppel, K (corresponding author), Warsaw Univ Life Sci, Anim Breeding & Prod Dept, Cattle Breeding Div, Warsaw, Poland.	kamila_puppel@sggw.pl	Beata, Kuczyńska/ABB-3267-2020; Kuczyńska, Beata/AAC-7166-2022	Beata, Kuczyńska/0000-0002-9093-9905; Puppel, Kamila/0000-0003-2909-2087	National Science Center;  [NN 311 55 8840]	National Science Center(National Science Centre, Poland); 	This research was supported by the National Science Center and realized within the project NN 311 55 8840 entitled 'Relationship between concentration of bioactive substances in milk during standard lactation and blood biochemical parameters of high yielding Polish Holstein-Friesian cows'.	[Anonymous], 5509 ISO; Armonk N, 2017, IBM SPSS STAT WINDOW; Association of Official Analytical Chemists, 1990, OFFICIAL METHODS ANA, V1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BENDICH A, 1990, ANN NY ACAD SCI, V587, P168, DOI 10.1111/j.1749-6632.1990.tb00144.x; Castillo C, 2006, RES VET SCI, V80, P133, DOI 10.1016/j.rvsc.2005.06.003; Celi P, 2011, IMMUNOPHARM IMMUNOT, V33, P233, DOI 10.3109/08923973.2010.514917; Chew BP, 1993, J ANIM SCI, P710; Diplock AT, 1981, SELENIUM BIOL MED, P303; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Gabryszuk M, 2013, FOOD SCI TECHNOL QUA, V3, P16; Havemose MS, 2006, J DAIRY SCI, V89, P1970, DOI 10.3168/jds.S0022-0302(06)72264-0; Havemose MS, 2004, INT DAIRY J, V14, P563, DOI 10.1016/j.idairyj.2003.11.005; Heidarpour M, 2012, REV MED VET-TOULOUSE, V163, P628; Ingvartsen KL, 2003, LIVEST PROD SCI, V83, P277, DOI 10.1016/S0301-6226(03)00110-6; Kaneai N., 2012, Advances in Bioscience and Biotechnology, V3, P1199, DOI 10.4236/abb.2012.38146; Krzyzewski J., 2012, ZYWN-NAUK TECHNOL JA, P3; Manuelian CL, 2017, J DAIRY SCI, V100, P3384, DOI 10.3168/jds.2016-12059; Mayasari N, 2017, J DAIRY SCI, V100, P4961, DOI 10.3168/jds.2016-11857; Min JS, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0074-6; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; O'Grady MN, 2001, J ANIM SCI, V79, P2827; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Pintea A, 2006, B U AGR MED VET M-VE, V63, P130; Pizzoferrato L, 2007, J DAIRY SCI, V90, P4569, DOI 10.3168/jds.2007-0093; Pressman AH, 2006, ZAKTAD POLIGRATICZNO; Puppel K, 2017, J FOOD SCI, V82, P523, DOI 10.1111/1750-3841.13594; Puppel K, 2016, J SCI FOOD AGR, V96, P2240, DOI 10.1002/jsfa.7341; Puppel K, 2015, J SCI FOOD AGR, V95, P2179, DOI 10.1002/jsfa.7015; Puppel K, 2013, ARCH TIERZUCHT, V56, P178, DOI 10.7482/0003-9438-56-017; RiceEvans CA, 1997, FREE RADICAL RES, V26, P381, DOI 10.3109/10715769709097818; SANDER BD, 1988, J DAIRY SCI, V71, P3173, DOI 10.3168/jds.S0022-0302(88)79921-X; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P479, DOI 10.5713/ajas.2011.10220; Son J, 1996, J DAIRY SCI, V79, P822, DOI 10.3168/jds.S0022-0302(96)76430-5; Strzalkowska N, 2009, ANIM SCI PAP REP, V27, P95; Suriyasathaporn W, 2010, J SCI TECHNOL, V32, P23; Tomaszewski A., 2005, AR WE WROC O AWIU, P235; Turk R., 2003, Proceedings of the IV Central European Buiatric Congress, Zagreb, Croatia, 23-27 April 2003, P400; Vu HV, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-87; Wartanowicz M., 1999, GASTROENTR HEP ZYW D, V1, P97; WONG SHY, 1987, CLIN CHEM, V33, P214	41	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193512	10.1371/journal.pone.0193512	http://dx.doi.org/10.1371/journal.pone.0193512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494660	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200058
J	Furlong, EJ; Choudhury, HG; Kurth, F; Duff, AP; Whitten, AE; Martin, JL				Furlong, Emily J.; Choudhury, Hassanul G.; Kurth, Fabian; Duff, Anthony P.; Whitten, Andrew E.; Martin, Jennifer L.			Disulfide isomerase activity of the dynamic, trimeric Proteus mirabilis ScsC protein is primed by the tandem immunoglobulin-fold domain of ScsB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; NEUTRON-SCATTERING; BOND ISOMERASE; DSBA; OXIDOREDUCTASE; ISOMERIZATION; MEMBRANE; SOFTWARE	Correct disulfide bond formation is essential for proper folding of many proteins, including bacterial virulence factors. The suppressor of copper sensitivity (Scs) proteins have roles in dithiol/disulfide interchange and the bacterial response to copper stress. Encoded in a four-gene cassette (ScsABCD) present in many Gram-negative bacteria, the Scs proteins are enigmatic and poorly characterized. Here, we show that the periplasmic alpha-domain of the membrane protein ScsB in the Gram-negative bacterium Proteus mirabilis forms a redox relay with the soluble periplasmic protein PmScsC. We also found that the periplasmic alpha-domain is sufficient to activate the disulfide isomerase activity of PmScsC. The crystal structure of PmScsB alpha at a resolution of 1.54 angstrom revealed that it comprises two structurally similar immunoglobulin-like folds, one of which includes a putative redox-active site with the sequence CXXXC. We confirmed the importance of these cysteine residues for PmScsB alpha function, and in addition, we engineered cysteine variants that produced a stable complex between PmScsC and PmScsB alpha. Using smallangle X-ray and neutron scattering analyses with contrast variation, we determined a low-resolution structure of the PmScsC-PmScsB alpha complex. The structural model of this complex suggested that PmScsB alpha uses both of its immunoglobulinlike folds to interact with PmScsC and revealed that the highly dynamic PmScsC becomes ordered upon PmScsB alpha binding. These findings add to our understanding of the poorly characterized Scs proteins.	[Furlong, Emily J.; Choudhury, Hassanul G.; Kurth, Fabian; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Furlong, Emily J.; Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia; [Duff, Anthony P.; Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia; [Choudhury, Hassanul G.] Cello Hlth Consulting, Farnham GU9 7DN, Surrey, England; [Kurth, Fabian] Bristol Myers Squibb Co, Arnulfstr 29, D-80636 Munich, Germany	University of Queensland; Griffith University; Australian Nuclear Science & Technology Organisation; Bristol-Myers Squibb	Martin, JL (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia.; Whitten, AE (corresponding author), Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia.	awh@ansto.gov.au; jlm@griffith.edu.au	Furlong, Emily J/S-5044-2016; Martin, Jennifer L./A-6039-2010	Furlong, Emily J/0000-0002-9086-2979; Duff, Anthony/0000-0003-3586-360X; Whitten, Andrew/0000-0001-8856-3120; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council [FL0992138, DP130100576]; Australian postgraduate award; Institute for Molecular Bioscience research advancement award	Australian Research Council(Australian Research Council); Australian postgraduate award(Australian Government); Institute for Molecular Bioscience research advancement award	This work was supported by Australian Research Council Laureate Fellowship FL0992138 (to J.L.M.), Australian Research Council Discovery Project DP130100576 (to J.L.M.; H.G.C. salary), an Australian postgraduate award (to E.J.F.), and an Institute for Molecular Bioscience research advancement award (to E.J.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Duff AP, 2015, METHOD ENZYMOL, V565, P3, DOI 10.1016/bs.mie.2015.06.014; Edeling MA, 2004, J BACTERIOL, V186, P4030, DOI 10.1128/JB.186.12.4030-4033.2004; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert EP, 2006, PHYSICA B, V385-86, P1180, DOI 10.1016/j.physb.2006.05.385; Goldstone D, 2001, P NATL ACAD SCI USA, V98, P9551, DOI 10.1073/pnas.171315498; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mudie S, 2015, SCATTERBRAIN SOFTWAR; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepherd M, 2013, ANTIOXID REDOX SIGN, V19, P1494, DOI 10.1089/ars.2012.4939; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5793	5805		10.1074/jbc.RA118.001860	http://dx.doi.org/10.1074/jbc.RA118.001860			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491145	Green Published, hybrid			2022-12-26	WOS:000430497300004
J	He, F; Luo, PF; Tang, T; Zhang, F; Fang, H; Ji, SZ; Sun, Y; Wu, GS; Pan, BH; Huo, ZB; Wang, GY; Xia, ZF				He, Fang; Luo, Peng-Fei; Tang, Tao; Zhang, Fang; Fang, He; Ji, Shi-Zhao; Sun, Yu; Wu, Guo-Sheng; Pan, Bo-Han; Huo, Zhi-Bao; Wang, Guang-Yi; Xia, Zhao-Fan			Targeted release of stromal cell-derived factor-1 alpha by reactive oxygen species-sensitive nanoparticles results in bone marrow stromal cell chemotaxis and homing, and repair of vascular injury caused by electrical burns	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OXIDATIVE STRESS; PROGENITOR CELLS; EXPRESSION; PATHWAY; INFLAMMATION; APOPTOSIS; MIGRATION; THERAPY	Rapid repair of vascular injury is an important prognostic factor for electrical burns. This repair is achieved mainly via stromal cell-derived factor (SDF)-1 alpha promoting the mobilization, chemotaxis, homing, and targeted differentiation of bone marrow mesenchymal stem cells (BMSCs) into endothelial cells. Forming a concentration gradient from the site of local damage in the circulation is essential to the role of SDF-1 alpha. In a previous study, we developed reactive oxygen species (ROS)-sensitive PPADT nanoparticles containing SDF-1 alpha that could degrade in response to high concentration of ROS in tissue lesions, achieving the goal of targeted SDF-1 alpha release. In the current study, a rat vascular injury model of electrical burns was used to evaluate the effects of targeted release of SDF-1 alpha using PPADT nanoparticles on the chemotaxis of BMSCs and the repair of vascular injury. Continuous exposure to 220 V for 6 s could damage rat vascular endothelial cells, strip off the inner layer, significantly elevate the local level of ROS, and decrease the level of SDF-1 alpha. After injection of Cy5-labeled SDF-1 alpha-PPADT nanoparticles, the distribution of Cy5 fluorescence suggested that SDF-1 alpha was distributed primarily at the injury site, and the local SDF-1 alpha levels increased significantly. Seven days after injury with nanoparticles injection, aggregation of exogenous green fluorescent protein-labeled BMSCs at the injury site was observed. Ten days after injury, the endothelial cell arrangement was better organized and continuous, with relatively intact vascular morphology and more blood vessels. These results showed that SDF-1 alpha-PPADT nanoparticles targeted the SDF-1a release at the site of injury, directing BMSC chemotaxis and homing, thereby promoting vascular repair in response to electrical burns.	[He, Fang; Luo, Peng-Fei; Tang, Tao; Zhang, Fang; Fang, He; Ji, Shi-Zhao; Sun, Yu; Wu, Guo-Sheng; Pan, Bo-Han; Wang, Guang-Yi; Xia, Zhao-Fan] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China; [He, Fang] Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Burn Surg, Nanjing, Jiangsu, Peoples R China; [Tang, Tao] Navy Hosp PLA, Dept Surg, Shanghai, Peoples R China; [Huo, Zhi-Bao] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai, Peoples R China	Naval Medical University; Nanjing Medical University; Shanghai Jiao Tong University	Wang, GY; Xia, ZF (corresponding author), Second Mil Med Univ, Affiliated Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China.; Huo, ZB (corresponding author), Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai, Peoples R China.	hzb410@sjtu.edu.cn; southeast000@163.com; xiazhaofan@163.com		Ji, Shizhao/0000-0002-5083-288X	National Natural Science Foundation of China [81171806, 81671911]; Scientific Research Innovation Project of Shanghai Municipal Commission of Education [12ZZ074]; Logistics Scientific Research Program [AWS14C001-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Innovation Project of Shanghai Municipal Commission of Education; Logistics Scientific Research Program	This work was supported by the National Natural Science Foundation of China (81171806, 81671911), (http://www.nsfc.gov.cn), the Scientific Research Innovation Project of Shanghai Municipal Commission of Education (12ZZ074), (http://www.shmec.gov.cn) and the Logistics Scientific Research Program (AWS14C001-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker H, 2005, PHILOS T R SOC B, V360, P2201, DOI 10.1098/rstb.2005.1760; Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Cao YJ, 2015, INT IMMUNOPHARMACOL, V28, P1018, DOI 10.1016/j.intimp.2015.07.037; Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065; Foresta C, 2011, J TRAUMA, V70, P459, DOI 10.1097/TA.0b013e3181fcf83c; Gomez C, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140122; Handschin AE, 2009, J BURN CARE RES, V30, P400, DOI 10.1097/BCR.0b013e3181a289a6; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Kimura A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2817252; Kommareddy S, 2007, J PHARM SCI-US, V96, P397, DOI 10.1002/jps.20813; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lee SH, 2013, ADV HEALTHC MATER, V2, P908, DOI 10.1002/adhm.201200423; Ling XX, 2015, TETRAHEDRON LETT, V56, P5242, DOI 10.1016/j.tetlet.2015.07.059; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Okuda T, 2006, J CONTROL RELEASE, V116, P330, DOI 10.1016/j.jconrel.2006.09.012; Pannucci CJ, 2010, J BURN CARE RES, V31, P882, DOI 10.1097/BCR.0b013e3181f93597; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Restivo TE, 2010, J TRAUMA, V69, P392, DOI 10.1097/TA.0b013e3181e772b0; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015; Tang T, 2015, INT J NANOMED, V10, P6571, DOI 10.2147/IJN.S88384; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142571; Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166790; Yamada T, 2010, FREE RADICAL BIO MED, V48, P120, DOI 10.1016/j.freeradbiomed.2009.10.032; Zheng XT, 2017, MOL CELL BIOCHEM, V425, P125, DOI 10.1007/s11010-016-2868-x; 万立华, 2001, 中国法医学杂志, V16, P19	37	7	8	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0194298	10.1371/journal.pone.0194298	http://dx.doi.org/10.1371/journal.pone.0194298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529067	Green Published, gold, Green Submitted			2022-12-26	WOS:000427189300050
J	Bose, C; Awasthi, S; Sharma, R; Benes, H; Hauer-Jensen, M; Boerma, M; Singh, SP				Bose, Chhanda; Awasthi, Sanjay; Sharma, Rajendra; Benes, Helen; Hauer-Jensen, Martin; Boerma, Marjan; Singh, Sharda P.			Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED CACHEXIA; CYTOCHROME-C; DUAL ROLES; CELL-DEATH; NRF2; EXPRESSION; METABOLISM; FACTOR-2; TARGET	Breast cancer is the most common malignancy in women of the Western world. Doxorubicin (DOX) continues to be used extensively to treat early-stage or node-positive breast cancer, human epidermal growth factor receptor-2 (HER2)-positive breast cancer, and metastatic disease. We have previously demonstrated in a mouse model that sulforaphane (SFN), an isothiocyanate isolated from cruciferous vegetables, protects the heart from DOX-induced toxicity and damage. However, the effects of SFN on the chemotherapeutic efficacy of DOX in breast cancer are not known. Present studies were designed to investigate whether SFN alters the effects of DOX on breast cancer regression while also acting as a cardioprotective agent. Studies on rat neonatal cardiomyocytes and multiple rat and human breast cancer cell lines revealed that SFN protects cardiac cells but not cancer cells from DOX toxicity. Results of studies in a rat orthotopic breast cancer model indicated that SFN enhanced the efficacy of DOX in regression of tumor growth, and that the DOX dosage required to treat the tumor could be reduced when SFN was administered concomitantly. Additionally, SFN enhanced mitochondria! respiration in the hearts of DOX-treated rats and reduced cardiac oxidative stress caused by DOX, as evidenced by the inhibition of lipid peroxidation, the activation of NF-E2 related factor 2 (Nrf2) and associated antioxidant enzymes. These studies indicate that SFN not only acts synergistically with DOX in cancer regression, but also protects the heart from DOX toxicity through Nrf2 activation and protection of mitochondrial integrity and functions.	[Bose, Chhanda] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA; [Awasthi, Sanjay; Singh, Sharda P.] Texas Tech Hlth Sci Ctr, Dept Internal Med, Div Hematol & Oncol, Lubbock, TX 79409 USA; [Sharma, Rajendra; Singh, Sharda P.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Benes, Helen] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Hauer-Jensen, Martin; Boerma, Marjan] Univ Arkansas Med Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Singh, Sharda P.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; Texas Tech University System; Texas Tech University Health Science Center; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Singh, SP (corresponding author), Texas Tech Hlth Sci Ctr, Dept Internal Med, Div Hematol & Oncol, Lubbock, TX 79409 USA.; Singh, SP (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.; Singh, SP (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.	sharda.singh@ttuhsc.edu	Awasthi, Sanjay/R-4904-2019	singh, sharda/0000-0003-4361-4558; Awasthi, Sanjay/0000-0002-5214-5717	National Institutes of Health [R01 AG032643]; American Heart Association [14GRNT18890084]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM109005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health (R01 AG032643 to SPS), a grant from the American Heart Association (14GRNT18890084 to SPS), and through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (www.nigms.nih.gov) under grant number P20 GM109005 to MHJ.; This work was supported in part by a grant from the National Institutes of Health (R01 AG032643), a grant from the American Heart Association (14GRNT18890084), and through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (www.nigms.nih.gov) under grant number P20 GM109005. The authors thank Dr. Lee Ann MacMillan-Crow for her advice and experimental protocol for the high resolution respirometry assays. The authors also thank Vetriselvan Malavan and Mecit Kaplan for their technical help in experiments.	Ali Khan M, 2015, EVID-BASED COMPL ALT, V2015; Alumkal JJ, 2015, INVEST NEW DRUG, V33, P480, DOI 10.1007/s10637-014-0189-z; Amjad Ali I, 2015, Curr Pharmacol Rep, V1, P382; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Awasthi S, 2010, DIABETES, V59, P714, DOI 10.2337/db09-0911; Bai Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/407580; Benes H, 2013, CARDIOVASC TOXICOL, V13, P347, DOI 10.1007/s12012-013-9215-1; Caram MEV, 2015, BREAST CANCER RES TR, V152, P163, DOI 10.1007/s10549-015-3454-8; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chen L, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/9092871; Clementi ME, 2003, ANTICANCER RES, V23, P2445; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Angelis Antonella, 2016, Cardiooncology, V2, P2, DOI 10.1186/s40959-016-0012-4; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dirks-Naylor AJ, 2013, LIFE SCI, V93, P913, DOI 10.1016/j.lfs.2013.10.013; Durham WJ, 2009, CURR OPIN CLIN NUTR, V12, P72, DOI 10.1097/MCO.0b013e32831cef61; El-Agamy DS, 2016, EXP BIOL MED, V241, P1577, DOI 10.1177/1535370216643418; Fan HT, 2012, EPIGENETICS-US, V7, P1379, DOI 10.4161/epi.22609; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Force T, 2013, CIRCULATION; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Furtado CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030462; Geisberg Carrie, 2012, Curr Heart Fail Rep, V9, P211, DOI 10.1007/s11897-012-0098-4; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Gholamin M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-261; Hinch ECA, 2013, J CACHEXIA SARCOPENI, V4, P287, DOI 10.1007/s13539-013-0116-8; Hu LG, 2010, CANCER CHEMOTH PHARM, V66, P467, DOI 10.1007/s00280-009-1182-7; Hughey CC, 2011, J VISUALIZED EXPT JO; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jensen BC, 2013, PHARMACOGENOMICS, V14, P205, DOI [10.2217/PGS.12.205, 10.2217/pgs.12.205]; Jirkovsky E, 2012, J PHARMACOL EXP THER, V343, P468, DOI 10.1124/jpet.112.198358; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Khan SI, 2012, CHEM RES TOXICOL, V25, P61, DOI 10.1021/tx200378c; Klement GL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00113; Kombairaju Ponvijay, 2012, J Carcinog, V11, P8, DOI 10.4103/1477-3163.98459; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Kwatra M, 2016, PHARM BIOL, V54, P637, DOI 10.3109/13880209.2015.1070879; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Maki T, 1996, J CLIN INVEST, V97, P656, DOI 10.1172/JCI118462; Mantovani G, 2012, CURR PHARM DESIGN, V18, P4813, DOI 10.2174/138161212803216889; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; McElhanon K.E., 2013, OPEN J APOPTOSIS, V2, P11; Mein J, 2014, FASEB J S, V28; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Mitry MA, 2016, IJC HEART VASC, V10, P17, DOI 10.1016/j.ijcha.2015.11.004; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Montaigne D, 2010, TOXICOL APPL PHARM, V244, P300, DOI 10.1016/j.taap.2010.01.006; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ohkoshi A, 2013, CANCER PREV RES, V6, P149, DOI 10.1158/1940-6207.CAPR-12-0401-T; Parajuli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048590; Patel AG, 2012, ELIFE, V1, DOI 10.7554/eLife.00387; Pawlik A, 2013, EUR J NUTR, V52, P1949, DOI 10.1007/s00394-013-0499-5; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Piquereau J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00102; Rahman AM, 2007, INT J NANOMED, V2, P567; Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68; Schimmel KJM, 2004, CANCER TREAT REV, V30, P181, DOI 10.1016/j.ctrv.2003.07.003; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Sin TK, 2015, J GERONTOLOGY A; Singh P, 2015, FREE RADICAL BIO MED, V86, P90, DOI 10.1016/j.freeradbiomed.2015.05.028; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Smith TAD, 2016, ANTICANCER RES, V36, P87; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Strom J, 2016, FASEB J, V30, P66, DOI 10.1096/fj.14-268904; Sun CC, 2015, J BIOL CHEM, V290, P17784, DOI 10.1074/jbc.M115.655019; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tian M, 2011, INT J ONCOL, V39, P1321, DOI 10.3892/ijo.2011.1150; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Tien CC, 2016, REGUL TOXICOL PHARM, V81, P69, DOI 10.1016/j.yrtph.2016.08.002; Todorova VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048398; Todorova VK, 2011, ANTICANCER RES, V31, P215; van Dalen EC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub2; van den Hurk C, 2015, ANTI-CANCER DRUG, V26, P687, DOI 10.1097/CAD.0000000000000239; Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Wang LF, 2015, AM J TRANSL RES, V7, P1724; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Yoon DS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.3; Zhang CY, 2013, BIOCHEM PHARMACOL, V85, P1398, DOI 10.1016/j.bcp.2013.02.010; Zhang YY, 2015, J PHARMACOL EXP THER, V352, P166, DOI 10.1124/jpet.114.219261	85	42	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193918	10.1371/journal.pone.0193918	http://dx.doi.org/10.1371/journal.pone.0193918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518137	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900048
J	Alemayehu, M; Deyessa, N; Medihin, G; Fekadu, A				Alemayehu, Melkam; Deyessa, Negussie; Medihin, Girmay; Fekadu, Abebaw			A descriptive analysis of depression and pain complaints among patients with cancer in a low income country	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; ETHIOPIA; PREVALENCE; ANXIETY; ASSOCIATION; HEALTH; IMPACT	Background In high income countries, cancer is one of the leading causes of death, with co-morbid depression contributing to the risk of increased mortality. However, both cancer and depression are neglected conditions in low income countries. The current study assessed the magnitude of depression and the association of pain complaints with depression among patients with cancer in a low income country. Method In this cross-sectional study participants were 390 patients with established diagnosis of cancer, who were recruited consecutively when visiting a tertiary treatment centre in Addis Ababa, Ethiopia. The occurrence of depression was determined using the nine items Patient Health Questionnaire (PHQ-9). Major depressive disorder was confirmed: (1) when five or more of the PHQ-9 symptoms were endorsed as occurring for at least 'more than seven days', with the exception of suicidal ideation item which counted as a positive rating if it had occurred even once in the previous fifteen days. (2) one of the symptoms has to be either depressed mood or loss of interest. Pain complaint was measured by Numeral Rating Scale (NRS) and severity of pain was assessed using Verbal Rating Scale (VRS). Results The prevalence of major depressive disorder was 16.4% (95%Cl: 13.1%, 20.4%), and subthreshold depression was 17.4% (95%Cl: 14.0%, 21.5%). Pain complaints occurred in 69.0% (95%Cl: 64.3%, 73.4%) of the participants. The odds of having a major depressive symptom was over four times higher among participants who had pain. Limitations The study was cross sectional and liable to recall bias. Recruitment was carried out in a tertiary referral hospital, which might lead to the selection of more economically well-off and educated participants limiting generalizability of the study. Moreover, we did not control for cancer types, which may be related to pain and the experience of depression. Some of the somatic symptoms in PHQ9 may also be related to the cancer itself. Conclusions This study highlights the clinical significance of both depression and pain complaints in patients with cancer in a low income country. Exploration of the impact of depressive disorders on quality of life and outcome of cancer is an important area for further research in low income countries.	[Alemayehu, Melkam; Fekadu, Abebaw] Addis Ababa Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia; [Deyessa, Negussie] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Medihin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Univ Sussex, Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Fekadu, Abebaw] Kings Coll London, Inst Psychiat, Dept Psychol Med, Ctr Affect Disorders, London, England	Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; University of Brighton; University of Sussex; University of London; King's College London	Alemayehu, M (corresponding author), Addis Ababa Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia.	melkish2002@gmail.com		Kebede, Melkam/0000-0003-0710-3435; Wassie, Abebaw Fekadu/0000-0003-2219-0952	MRC [MR/M025470/1] Funding Source: UKRI; Medical Research Council [MR/M025470/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AFCRN, 2017, ADD AB CIT CANC REG; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Awas M, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10695.x; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Brown LF, 2010, PSYCHO-ONCOLOGY, V19, P734, DOI 10.1002/pon.1627; Brunelli C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-42; Cancer Research UK, 2012, WORLDW CANC MORT STA; Chen ML, 2000, J ADV NURS, V32, P944, DOI 10.1046/j.1365-2648.2000.01560.x; Ciaramella A, 2001, PSYCHO-ONCOLOGY, V10, P156, DOI 10.1002/pon.505; Cousins S., 2013, MIDDLE E N AFRICA SU; Deyessa N, 2008, SCAND J PUBLIC HEALT, V36, P589, DOI 10.1177/1403494808086976; Dogar I., 2009, MED SCI, V25; Drug Administration and Control Authority of Ethiopia (DACA), 2004, STAND TREATM GUID DI; EPHA, 2011, BASELINE EVALUATION, V1; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Everdingen MHJVDBV, 2007, PAIN, V132, P312, DOI 10.1016/j.pain.2007.08.022; Ferreira-Valente M. P-RJ A, 2011, VALIDITY 4 PAIN INTE, V152, P6; Gasto-Johansson F., 1997, CANCER PRACT, V7, P240; GBD, 2015, LANCET, V388, P65; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; GLOBOCAN, 2012, EST CANC INC MORT PR; Hailemariam S, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-23; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hanna T., 2009, BMC INT HLTH HUMAN R, V10; Hjermstad MJ FP, 2011, J PAIN SYMPTOM MANAG, V41, P20; Jadoon NA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-594; Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6; Klien ND, 2009, J AM ACAD CHILD PSY, V48, P7; Kroenke K., 2001, J GED INTER MED, V16; Kroenke K, 2010, J PAIN SYMPTOM MANAG, V40, P327, DOI 10.1016/j.jpainsymman.2009.12.023; Lakew Serawit, 2015, BMC Res Notes, V8, P657, DOI 10.1186/s13104-015-1630-x; Massie M., 2004, J NATL CANC I MONOGR; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ng C., 2010, J AFRICAN DISORDERS, V131; Nuhu FT, 2009, AFR J PSYCHIATRY, V12, P64; Pandey M., 2005, WORLD J SURG ONCOLOG; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Satin J., 2009, DEPRESSION PREDICT D, V10; Sherif T., 2001, Eastern Mediterranean Health Journal, V7, P502; SPIEGEL D, 1994, CANCER, V74, P2570, DOI 10.1002/1097-0142(19941101)74:9<2570::AID-CNCR2820740927>3.0.CO;2-3; Spoletini I., 2009, SURG ONCOLOGY, V10; Tavoli A., 2007, BMC CANCER, V8, P1471; Tavoli A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-28; Walker J, 2013, ANN ONCOL, V24, P895, DOI 10.1093/annonc/mds575; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, 2011, CANC FACT SHEET; World Health Organization: Regional Office for Africa, 2012, ETH COUNTR HLTH PROF	52	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							0193713	10.1371/journal.pone.0193713	http://dx.doi.org/10.1371/journal.pone.0193713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513716	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000426896800071
J	Edmunds, K; Gislason, M; Sigurdsson, S; Gudnason, V; Harris, T; Carraro, U; Gargiulo, P				Edmunds, Kyle; Gislason, Magnus; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Harris, Tamara; Carraro, Ugo; Gargiulo, Paolo			Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; HUMAN SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; PHYSICAL FUNCTION; TISSUE CHANGES; OLDER-PEOPLE; AGE; HEALTH; STRENGTH; MORTALITY	Sarcopenic muscular degeneration has been consistently identified as an independent risk factor for mortality in aging populations. Recent investigations have realized the quantitative potential of computed tomography (CT) image analysis to describe skeletal muscle volume and composition; however, the optimum approach to assessing these data remains debated. Current literature reports average Hounsfield unit (HU) values and/or segmented soft tissue cross-sectional areas to investigate muscle quality. However, standardized methods for CT analyses and their utility as a comorbidity index remain undefined, and no existing studies compare these methods to the assessment of entire radiodensitometric distributions. The primary aim of this study was to present a comparison of nonlinear trimodal regression analysis (NTRA) parameters of entire radiodensitometric muscle distributions against extant CT metrics and their correlation with lower extremity function (LEF) biometrics (normal/fast gait speed, timed up-and-go, and isometric leg strength) and biochemical and nutritional parameters, such as total solubilized cholesterol (SCHOL) and body mass index (BMI). Data were obtained from 3,162 subjects, aged 66-96 years, from the population-based AGES-Reykjavik Study. 1-D k-means clustering was employed to discretize each biometric and comorbidity dataset into twelve subpopulations, in accordance with Sturges' Formula for Class Selection. Dataset linear regressions were performed against eleven NTRA distribution parameters and standard CT analyses (fat/muscle cross-sectional area and average HU value). Parameters from NTRA and CT standards were analogously assembled by age and sex. Analysis of specific NTRA parameters with standard CT results showed linear correlation coefficients greater than 0.85, but multiple regression analysis of correlative NTRA parameters yielded a correlation coefficient of 0.99 (P<0.005). These results highlight the specificities of each muscle quality metric to LEF biometrics, SCHOL, and BMI, and particularly highlight the value of the connective tissue regime in this regard.	[Edmunds, Kyle; Gislason, Magnus; Gargiulo, Paolo] Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland; [Sigurdsson, Sigurdur; Gudnason, Vilmundur] Iceland Heart Assoc Hjartavernd, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Harris, Tamara] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Carraro, Ugo] IRRCS Fdn Osped San Camillo, Venice, Italy; [Gargiulo, Paolo] Landspitali, Dept Rehabil, Reykjavik, Iceland	Reykjavik University; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS Ospedale San Camillo	Edmunds, K (corresponding author), Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland.	kyle14@ru.is	Gudnason, Vilmundur/AAE-7126-2019; Gíslason, Magnús/AAB-6761-2020	Gudnason, Vilmundur/0000-0001-5696-0084; Carraro, Ugo/0000-0002-0924-4998; Gargiulo, Paolo/0000-0002-5049-4817; Edmunds, Kyle/0000-0002-6591-4116	Landspitali Scientific Fund [A-2014-072]	Landspitali Scientific Fund	This work was funded by the Landspitali Scientific Fund, PI: Paolo Gargiulo, A-2014-072 (http://www.landspitali.is/).	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Buford TW, 2012, EXP GERONTOL, V47, P38, DOI 10.1016/j.exger.2011.10.001; Carraro U, 2015, EUR J TRANSL MYOL, V25, P129, DOI 10.4081/ejtm.2015.5133; Carraro U, 2015, EUR J TRANSL MYOL, V25, P77, DOI 10.4081/ejtm.2015.4832; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Chang M, 2013, J AM GERIATR SOC, V61, P237, DOI 10.1111/jgs.12077; COOPER R, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4467; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; Ding J, 2015, JAMA NEUROL, V72, P682, DOI 10.1001/jamaneurol.2015.0174; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Edmunds KJ, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8932950; Edmunds KJ, 2015, EUR J TRANSL MYOL, V25, P63, DOI 10.4081/ejtm.2015.4847; Edmunds KJ, 2016, EUR J TRANSL MYOL, V26, P93, DOI 10.4081/ejtm.2016.6015; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Gargiulo P, 2010, NEUROL RES, V32, P13, DOI 10.1179/016164109X12536042424171; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Helgason T, 2005, ARTIF ORGANS, V29, P440, DOI 10.1111/j.1525-1594.2005.29073.x; Hicks GE, 2005, J GERONTOL A-BIOL, V60, P882, DOI 10.1093/gerona/60.7.882; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Johannesdottir F, 2012, CALCIFIED TISSUE INT, V90, P354, DOI 10.1007/s00223-012-9585-6; Jubrias SA, 1997, PFLUG ARCH EUR J PHY, V434, P246, DOI 10.1007/s004240050392; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lang T, 2008, BONE, V42, P798, DOI 10.1016/j.bone.2007.12.002; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Larsson L, 1997, AM J PHYSIOL-CELL PH, V272, pC638, DOI 10.1152/ajpcell.1997.272.2.C638; LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mah P, 2010, DENTOMAXILLOFAC RAD, V39, P323, DOI 10.1259/dmfr/19603304; Maslove DM, 2013, J AM MED INFORM ASSN, V20, P544, DOI 10.1136/amiajnl-2012-000929; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Overend TJ, 1992, J GERONTOLOGY, V47; Petursson Edmunds KJ, 2015, COMP MATH MATH PHYS; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rantanen T, 1999, J GERONTOL A-BIOL, V54, pM172, DOI 10.1093/gerona/54.4.M172; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; REED RL, 1991, J AM GERIATR SOC, V39, P555, DOI 10.1111/j.1532-5415.1991.tb03592.x; Reinders I, 2016, AM J EPIDEMIOL, V183, P53, DOI 10.1093/aje/kwv153; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Scott D, 2016, MED J AUSTRALIA, V205, P329, DOI 10.5694/mja16.00446; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Sur MD, 2015, ANN SURG ONCOL, V22, P3897, DOI 10.1245/s10434-015-4763-1; SWASH M, 1995, MUSCLE NERVE, V18, P708, DOI 10.1002/mus.880180706; Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2; von Bonsdorff MB, 2013, AGE, V35, P1401, DOI 10.1007/s11357-012-9427-5; Wang HZ, 2011, R J, V3, P29, DOI 10.32614/rj-2011-015; YOUNG A, 1984, EUR J CLIN INVEST, V14, P282, DOI 10.1111/j.1365-2362.1984.tb01182.x	70	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193241	10.1371/journal.pone.0193241	http://dx.doi.org/10.1371/journal.pone.0193241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513690	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800046
J	Kong, HH; Lee, SW; You, SH; Ahn, CK				Kong, Hyun Ho; Lee, Seo Won; You, Sung Hyun; Ahn, Choon Ki			Novel vehicle detection system based on stacked DoG kernel and AdaBoost	PLOS ONE			English	Article							TRACKING	This paper proposes a novel vehicle detection system that can overcome some limitations of typical vehicle detection systems using AdaBoost-based methods. The performance of the AdaBoost-based vehicle detection system is dependent on its training data. Thus, its performance decreases when the shape of a target differs from its training data, or the pattern of a preceding vehicle is not visible in the image due to the light conditions. A stacked Difference of Gaussian (DoG)-based feature extraction algorithm is proposed to address this issue by recognizing common characteristics, such as the shadow and rear wheels beneath vehicles of vehicles under various conditions. The common characteristics of vehicles are extracted by applying the stacked DoG shaped kernel obtained from the 3D plot of an image through a convolution method and investigating only certain regions that have a similar patterns. A new vehicle detection system is constructed by combining the novel stacked DoG feature extraction algorithm with the AdaBoost method. Experiments are provided to demonstrate the effectiveness of the proposed vehicle detection system under different conditions.	[Kong, Hyun Ho; You, Sung Hyun; Ahn, Choon Ki] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Lee, Seo Won] Korea Univ, Dept Automot Convergence, Seoul, South Korea	Korea University; Korea University	Ahn, CK (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	hironaka@korea.ac.kr	Ahn, Choon Ki/I-2737-2012	Ahn, Choon Ki/0000-0003-0993-9658	NRF through the Ministry of Science, ICT, and Future Planning [NRF-2017R1A1A1A05001325]; "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry AMP; Energy, Requblic of Korea [20174030201820]	NRF through the Ministry of Science, ICT, and Future Planning; "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry AMP; Energy, Requblic of Korea	This work was supported partially by the NRF through the Ministry of Science, ICT, and Future Planning under Grant NRF-2017R1A1A1A05001325, and partially by "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Requblic of Korea (No. 20174030201820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CK, 2016, IEEE T CIRCUITS-I, V63, P1210, DOI 10.1109/TCSI.2016.2573281; Ahn CK, 2015, IEEE T AUTOMAT CONTR, V60, P1745, DOI 10.1109/TAC.2015.2398887; Chang WC, 2010, IEEE T SYST MAN CY B, V40, P892, DOI 10.1109/TSMCB.2009.2032527; Di Cairano S, 2013, IEEE T CONTR SYST T, V21, P1236, DOI 10.1109/TCST.2012.2198886; Fu Z, 2012, MEASUREMENT, V45; Gwang Yul Song, 2008, 2008 IEEE Intelligent Vehicles Symposium (IV), P428, DOI 10.1109/IVS.2008.4621139; Han J, 2011, INT J AUTOMOTIVE TEC, V17, P483; Jin LS, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P356; Kim G, 2012, OPT REV, V19, P388, DOI 10.1007/s10043-012-0063-1; Kosaka N, 2015, IEEE T INTELL TRANSP, V16, P2599, DOI 10.1109/TITS.2015.2413971; Krose B., 1996, INTRO NEURAL NETWORK, VEighth; Lin BF, 2012, IEEE T INTELL TRANSP, V13, P737, DOI 10.1109/TITS.2011.2182649; Ling Mao, 2010, 2010 International Conference on Communications, Circuits and Systems (ICCCAS), P354, DOI 10.1109/ICCCAS.2010.5581983; Liu JX, 2018, IEEE T SYST MAN CY-S, V48, P1771, DOI 10.1109/TSMC.2017.2758598; Liu JX, 2017, IEEE T IND INFORM, V13, P1742, DOI 10.1109/TII.2017.2654323; Liu JX, 2017, IEEE T IND ELECTRON, V64, P22, DOI 10.1109/TIE.2016.2610400; Liu LC, 2017, IEEE T INTELL TRANSP, V18, P937, DOI 10.1109/TITS.2016.2597299; Liu SM, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/57382; Motai Y, 2012, SIGNAL PROCESS-IMAGE, V27, P83, DOI 10.1016/j.image.2011.06.005; Mukhtar A, 2015, IEEE T INTELL TRANSP, V16, P2318, DOI 10.1109/TITS.2015.2409109; Pak JM, 2016, IEEE T CONTR SYST T, V24, P1052, DOI 10.1109/TCST.2015.2472990; Pak JM, 2015, IEEE T IND INFORM, V11, P1089, DOI 10.1109/TII.2015.2462771; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P1773, DOI 10.1109/TITS.2013.2266661; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P906, DOI 10.1109/TITS.2013.2246835; Sivaraman S, 2010, IEEE T INTELL TRANSP, V11, P267, DOI 10.1109/TITS.2010.2040177; Sum Z, 2002, IEEE WORKSH APPL COM; Sun C, 2015, IEEE T CONTR SYST T, V23, P1197, DOI 10.1109/TCST.2014.2359176; Sun X, 2012, IEEE ICC, P6371, DOI 10.1109/ICC.2012.6364925; Sun ZH, 2002, DSP 2002: 14TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING PROCEEDINGS, VOLS 1 AND 2, P1019, DOI 10.1109/ICDSP.2002.1028263; Teoh SS, 2012, MACH VISION APPL, V23, P831, DOI 10.1007/s00138-011-0355-7; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wu C, 2009, INT C INF ENG COMP S; Xue-Fei Y, 2017, IEEE INT C DIG SIGN; 송광열, 2009, [Transactions of KSAE, 한국자동차공학회 논문집], V17, P1	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193733	10.1371/journal.pone.0193733	http://dx.doi.org/10.1371/journal.pone.0193733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513727	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800074
J	Dell'Arti, L; Barteselli, G; Riva, L; Carini, E; Graziadei, G; Benatti, E; Invernizzi, A; Cappellini, MD; Viola, F				Dell'Arti, Laura; Barteselli, Giulio; Riva, Lorenzo; Carini, Elisa; Graziadei, Giovanna; Benatti, Eleonora; Invernizzi, Alessandro; Cappellini, Maria D.; Viola, Francesco			Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINOPATHY; DISEASE; PATHOGENESIS; ISCHEMIA; AGE	Purpose To identify systemic risk factors for sickle cell maculopathy, and to analyze the microstructure of the macula of Sickle Cell Disease ( SCD) patients by using automated segmentation of individual retinal layers. Methods Thirty consecutive patients with SCD and 30 matched controls underwent spectral-domain optical coherence tomography ( SD-OCT) and automated thickness measurement for each retinal layer; thicknesses for SCD patients were then compared to normal controls. Demographic data, systemic data, and lab results were collected for each SCD patient; multivariate logistic regression analysis was used to identify potential risk factors for sickle cell maculopathy. Results Ongoing chelation treatment ( p = 0.0187) was the most predictive factor for the presence of sickle cell maculopathy; the odds were 94.2% lower when chelation was present. HbF level tended to influence sickle cell maculopathy ( p = 0.0775); the odds decreased by 12.9% when HbF increased by 1%. Sickle cell maculopathy was detected in 43% of SCD patients as patchy areas of retinal thinning on SD-OCT thickness map, mostly located temporally to the macula, especially in eyes with more advanced forms of sickle cell retinopathy ( p = 0.003). In comparison to controls, SCD patients had a subtle thinning of the overall macula and temporal retina compared to controls ( most p<0.0001), involving inner and outer retinal layers. Thickening of the retinal pigment epithelium was also detected in SCD eyes ( p<0.0001). Conclusions Chronic chelation therapy and, potentially, high levels of HbF are possible protective factors for the presence of sickle cell maculopathy, especially for patients with more advanced forms of sickle cell retinopathy. A subtle thinning of the overall macula occurs in SCD patients and involves multiple retinal layers, suggesting that ischemic vasculopathy may happen in both superficial and deep capillary plexi. Thinning of the outer retinal layers suggests that an ischemic insult of the choriocapillaris may also occur in SCD patients.	[Dell'Arti, Laura; Cappellini, Maria D.; Viola, Francesco] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Dell'Arti, Laura; Riva, Lorenzo; Carini, Elisa; Benatti, Eleonora; Viola, Francesco] Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Ophthalmol Unit, Milan, Italy; [Barteselli, Giulio] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Graziadei, Giovanna] Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Rare Dis Ctr,Dept Med & Med Specialties, Milan, Italy; [Invernizzi, Alessandro] Univ Milan, Luigi Sacco Hosp, Eye Clin, Dept Biomed & Clin Sci L Sacco, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Roche Holding; Genentech; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Luigi Sacco Hospital	Viola, F (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.; Viola, F (corresponding author), Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Ophthalmol Unit, Milan, Italy.	francesco.viola@unimi.it	viola, francesco/AAK-5583-2020; Dell'Arti, Laura/AAB-9520-2019; CAPPELLINI, MARIA DOMENICA/B-4475-2017	viola, francesco/0000-0003-1208-913X; Dell'Arti, Laura/0000-0001-7710-7867; Graziadei, Giovanna/0000-0002-6801-5730; Barteselli, Giulio/0000-0003-0533-1135; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864				Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Brasileiro F, 2015, RETINA-J RET VIT DIS, V35, P257, DOI 10.1097/IAE.0000000000000309; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Chhablani J, 2012, INVEST OPHTH VIS SCI, V53, P2274, DOI 10.1167/iovs.12-9435; Cruz PRS, 2015, BLOOD CELL MOL DIS, V54, P33, DOI 10.1016/j.bcmd.2014.08.003; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; DIZON RV, 1979, SURV OPHTHALMOL, V23, P297, DOI 10.1016/0039-6257(79)90159-0; Elagouz M, 2010, SURV OPHTHALMOL, V55, P359, DOI 10.1016/j.survophthal.2009.11.004; Estepp JH, 2013, BRIT J HAEMATOL, V161, P402, DOI 10.1111/bjh.12238; FOX PD, 1990, BRIT J OPHTHALMOL, V74, P172, DOI 10.1136/bjo.74.3.172; Ghasemi Falavarjani K, 2016, RETINA; Gnana-Prakasam JP, 2009, BIOCHEM J, V424, P243, DOI 10.1042/BJ20090424; GOLDBAUM MH, 1978, AM J OPHTHALMOL, V86, P45, DOI 10.1016/0002-9394(78)90013-2; GOLDBERG MF, 1971, AM J OPHTHALMOL, V71, P649, DOI 10.1016/0002-9394(71)90429-6; Han IC, 2017, AM J OPHTHALMOL; Hoang QV, 2011, AM J OPHTHALMOL, V151, P990, DOI 10.1016/j.ajo.2010.12.010; Jung JJ, 2016, RETIN CASES BRIEF RE; LEE CM, 1987, BRIT J OPHTHALMOL, V71, P540, DOI 10.1136/bjo.71.7.540; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Martin GC, 2017, JAMA OPHTHALMOL, V135, P1100, DOI 10.1001/jamaophthalmol.2017.3008; Mathew R, 2015, BRIT J OPHTHALMOL, V99, P967, DOI 10.1136/bjophthalmol-2014-305532; Minvielle W, 2016, AM J OPHTHALMOL, V164, P137, DOI 10.1016/j.ajo.2015.12.023; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Romayanada N, 1973, T AM ACAD OPHTHALMOL, V77; Sanfilippo Christian J, 2015, Retin Cases Brief Rep, V9, P360, DOI 10.1097/ICB.0000000000000210; STEIN MR, 1970, ARCH OPHTHALMOL-CHIC, V84, P485, DOI 10.1001/archopht.1970.00990040487017; Tan CS, 2016, BRIT J OPHTHALMOL, V100, P235, DOI 10.1136/bjophthalmol-2015-306652; Tan CSH, 2012, INVEST OPHTH VIS SCI, V53, P1639, DOI 10.1167/iovs.12-9566; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027	31	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193582	10.1371/journal.pone.0193582	http://dx.doi.org/10.1371/journal.pone.0193582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494697	gold, Green Published			2022-12-26	WOS:000426363200069
J	Dibra, D; Xia, XQ; Gagea, M; Lozano, G; Li, SL				Dibra, Denada; Xia, Xueqing; Gagea, Mihai; Lozano, Guillermina; Li, Shulin			A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA(-/-) and mutant-p53	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ARTHRITIS; OSTEOCLASTOGENESIS; SPONDYLITIS	Spondyloarthropathies, the second most frequently occurring form of chronic inflammatory arthritis, affects young adults in particular. However, a proper model with which to study the biology of this disease and to develop therapeutics is lacking. One of the most accepted animal models for this disease uses HLA-B27/Hu-beta 2m transgenic rats; however, only 30%-50% of male HLA-B27/Hu-beta 2m rats develop spontaneous, clinically apparent spondylitis and have a variable time until disease onset. Here, we report a high-incidence, low-variation spontaneous mouse model that delineates how the combination of inflammatory cytokine interleukin-27 ( IL-27) signaling deficiency and mitogenic signaling ( mutant p53(R172H)) in vivo, leads to bone loss in the vertebral bodies and ossification of the cartilage in the intervertebral discs. In this human disease-like mouse model, bone loss and pathogenic bone development are seen as early as 4 months of age in the absence of inflammatory aggregates in the enthesis or intervertebral disc.	[Dibra, Denada; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Xia, Xueqing; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dibra, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Li, SL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	ddibra@mdanderson.org; sli4@mdanderson.org	Li, Shulin/D-6478-2011	Li, Shulin/0000-0001-5657-4183	National Cancer Institute [R01 CM 20985]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01 CM 20985 to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2013, CYTOKINE GROWTH F R, V24, P115, DOI 10.1016/j.cytogfr.2012.10.001; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bankson JA, 2008, J MAGN RESON IMAGING, V27, P57, DOI 10.1002/jmri.21221; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Edwards CK, 2006, ARTHRITIS RHEUM-US, V54, P2872, DOI 10.1002/art.22077; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Gupta R, 2009, CLIN EXP NEPHROL, V13, P667, DOI 10.1007/s10157-009-0217-z; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Kalliolias GD, 2010, ARTHRITIS RHEUM-US, V62, P402, DOI 10.1002/art.27200; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; McHugh J, 2017, NAT REV RHEUMATOL, V13, P3, DOI [10.1038/nrrheum.2017.94, 10.1038/nrrheum.2016.199]; Moon SJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.89; Nash P, 2017, LANCET, V389, P2317, DOI 10.1016/S0140-6736(17)31429-0; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; SHU KH, 1986, CLIN NEPHROL, V25, P169; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; van Duivenvoorde LM, 2012, ARTHRITIS RHEUM-US, V64, P3210, DOI 10.1002/art.34600; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145; Zhang SZ, 2011, FASEB J, V25, P2387, DOI 10.1096/fj.10-175299	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193485	10.1371/journal.pone.0193485	http://dx.doi.org/10.1371/journal.pone.0193485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494633	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200055
J	Phung, D; Nguyen, HX; Nguyen, HLT; Luong, AM; Do, CM; Tran, QD; Chu, C				Dung Phung; Huong Xuan Nguyen; Huong Lien Thi Nguyen; Anh Mai Luong; Cuong Manh Do; Quang Dai Tran; Chu, Cordia			The effects of socioecological factors on variation of communicable diseases: A multiple-disease study at the national scale of Vietnam	PLOS ONE			English	Article							HIGH-TEMPERATURE; PREDICTION MODEL; DENGUE; HUMIDITY; HOSPITALIZATIONS; TRANSMISSION; ASSOCIATION; DIARRHEA; RISK; SEASONALITY	Objective To examine the effects of socioecological factors on multiple communicable diseases across Vietnam. Methods We used the Moran's I tests to evaluate spatial clusters of diseases and applied multilevel negative binomial regression models using the Bayesian framework to analyse the association between socioecological factors and the diseases queried by oral, airborne, vector-borne, and animal transmission diseases. Results and significance The study found that oral-transmission diseases were spatially distributed across the country; whereas, the airborne-transmission diseases were more clustered in the Northwest and vector-borne transmission diseases were more clustered in the South. Most of diseases were sensitive with climatic factors. For instance, a 1 degrees C increase in average temperature is significantly associated with 0.4% ( 95CI, 0.3 +/- 0.5), 2.5% ( 95% CI, 1.4 +/- 3.6), 0.9% ( 95% CI, 0.6 +/- 1.4), 1.1% ( 95% CI), 5% ( 95% CI, 3-.7.4), 0.4% ( 95% CI, 0.2 +/- 0.7), and 2% ( 95% CI, 1.5 +/- 2.8) increase in risk of diarrhoea, shigellosis, mumps, influenza, dengue, malaria, and rabies respectively. The influences of socio-economic factors on risk of communicable diseases are varied by factors with the biggest influence of population density. The research findings reflect an important implication for the climate change adaptation strategies of health sectors. A development of weather-based early warning systems should be considered to strengthen communicable disease prevention in Vietnam.	[Dung Phung; Chu, Cordia] Griffith Univ, Menzies Hlth Inst Queensland, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia; [Huong Xuan Nguyen] Da Nang Univ Med Technol & Pharm, Da Nang, Vietnam; [Huong Lien Thi Nguyen; Anh Mai Luong; Cuong Manh Do] Minist Hlth, Hlth Environm Management Agcy, Hanoi, Vietnam; [Quang Dai Tran] Minist Hlth, Gen Dept Prevent Med, Hanoi, Vietnam	Griffith University; Menzies Health Institute Queensland; Danang University of Medical Technology & Pharmacy	Phung, D (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia.	d.phung@griffith.edu.au	Xuan Huong, Nguyen/GRR-6055-2022; Phung, Dung/ABC-9218-2021	Phung, Dung/0000-0002-1615-3234; Chu, Cordia/0000-0002-3683-5638				Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bentham G., 2001, INT J BIOMETEOROL; Black R, 1995, EPIDEMIOLOGY DIARRHO, P13; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Chaudhry P., 2008, CLIMATE CHANGE HUMAN; Christophers SR, 1960, AEDES AEGYPTY YELLOW; Chuang TW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1874-0; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Phung D, 2018, SCI TOTAL ENVIRON, V610, P983, DOI 10.1016/j.scitotenv.2017.08.158; Phung D, 2017, SCI TOTAL ENVIRON, V580, P805, DOI 10.1016/j.scitotenv.2016.12.027; Phung D, 2015, ACTA TROP, V141, P88, DOI 10.1016/j.actatropica.2014.10.005; Phung D, 2014, ENVIRON RES, V135, P212, DOI 10.1016/j.envres.2014.08.035; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; GSO, 2014, GEN STAT OFF STAT YB; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Ho YC, 2015, HUM VACC IMMUNOTHER, V11, P1406, DOI 10.1080/21645515.2015.1029687; Hondula DM, 2014, ENVIRON HEALTH PERSP, V122, P831, DOI 10.1289/ehp.1307496; INPONRE, 2009, VIETN ASS REP CLIM C; IPCC, 2014, CLIM CHANG 2014 IM F; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kabaria CW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1694-2; Kamigaki T, 2016, PLOS ONE, V11, P1; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Kipruto EK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1848-2; Kuhn K., 2005, USING CLIMATE PREDIC; Lee Hahn-Ey, 2013, J Biomark, V2013, P413853, DOI 10.1155/2013/413853; Levy K, 2016, ENVIRON SCI TECHNOL, V50, P4905, DOI 10.1021/acs.est.5b06186; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Ministry of Health, 2013, HLTH STAT YB; MOE K, 1982, ARCH VIROL, V72, P179, DOI 10.1007/BF01348963; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1692, DOI 10.1017/S0950268810002967; Ostfeld RS, 2015, PHILOS T R SCO LON B, V370, P140; Paynter S, 2015, EPIDEMIOL INFECT, V143, P1110, DOI 10.1017/S0950268814002702; Thai PQ, 2015, EPIDEMICS-NETH, V13, P65, DOI 10.1016/j.epidem.2015.06.002; Phung D, 2015, INT J BIOMETEOROL; Phung D, 2017, ENV POLLUTION; Phung D., 2015, EPIDEMIOL INFECT, V2015, P1; Phung D, 2016, TROP MED INT HEALTH, V21, P1324, DOI 10.1111/tmi.12754; Phung D, 2016, ENVIRON INT, V92-93, P77, DOI 10.1016/j.envint.2016.03.034; Rifakis Pedro M, 2006, Int J Biomed Sci, V2, P1; Rodo X, 2013, CLIMATIC CHANGE, V118, P625, DOI 10.1007/s10584-013-0744-1; Semenza JC, 2009, LANCET INFECT DIS, V8, P92; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Thompson CN, 2015, HEALTH PLACE, V35, P147, DOI 10.1016/j.healthplace.2015.08.001; Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Ud-Dean SMM, 2010, J THEOR BIOL, V264, P822, DOI 10.1016/j.jtbi.2010.03.013; UNEP, 2009, ASS REP CLIM CHANG; VN MONRE, 2016, CLIM CHANG IMP AD EF; Wu XX, 2014, SCI CHINA EARTH SCI, V57, P189, DOI 10.1007/s11430-013-4635-0; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Yao HW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003502; Yusuf A, 2009, EEPSEA SPECIAL TECHN; Zhang YM, 2017, SCI TOTAL ENVIRON, V598, P71, DOI 10.1016/j.scitotenv.2017.04.112	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193246	10.1371/journal.pone.0193246	http://dx.doi.org/10.1371/journal.pone.0193246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494623	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200032
J	Pretorius, E; Page, MJ; Mbotwe, S; Kell, DB				Pretorius, Etheresia; Page, Martin J.; Mbotwe, Sthembile; Kell, Douglas B.			Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXTRACELLULAR ALPHA-SYNUCLEIN; SCANNING-ELECTRON-MICROSCOPY; THIOFLAVIN-T BINDING; SYSTEMS BIOLOGY; CLOT STRUCTURE; MOLECULAR-MECHANISM; NETWORK STRUCTURE; IRON; ALZHEIMERS	The thrombin-induced polymerisation of fibrinogen to form fibrin is well established as a late stage of blood clotting. It is known that Parkinson's Disease (PD) is accompanied by dysregulation in blood clotting, but it is less widely known as a coagulopathy. In recent work, we showed that the presence of tiny amounts of bacterial lipopolysaccharide (LPS) in healthy individuals could cause clots to adopt an amyloid form, and this could be observed via scanning electron microscopy (SEM) or via the fluorescence of thioflavin-T. This could be prevented by the prior addition of lipopolysaccharide-binding protein (LBP). We had also observed by SEM this unusual clotting in the blood of patients with Parkinson's Disease. We hypothesised, and here show, that this too can be prevented by LBP in the context of PD. This adds further evidence implicating inflammatory microbial cell wall products as an accompaniment to the disease, and may be part of its aetiology. This may lead to novel treatment strategies in PD designed to target microbes and their products.	[Pretorius, Etheresia; Page, Martin J.; Kell, Douglas B.] Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa; [Mbotwe, Sthembile] Univ Pretoria, Fac Hlth Sci, Dept Physiol, Arcadia, South Africa; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	Stellenbosch University; University of Pretoria; University of Manchester; University of Manchester	Pretorius, E; Kell, DB (corresponding author), Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa.; Kell, DB (corresponding author), Univ Manchester, Sch Chem, Manchester, Lancs, England.; Kell, DB (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	resiap@sun.ac.za; dbk@manchester.ac.uk	Page, Martin/AAB-7740-2019; Page, Martin/P-2348-2019; Pretorius, Etheresia/ACH-6368-2022; Kell, Douglas/E-8318-2011	Page, Martin/0000-0002-2479-9182; Pretorius, Etheresia/0000-0002-9108-2384; Kell, Douglas/0000-0001-5838-7963; Sibanda, Sthembile/0000-0002-5897-660X	National Research Foundation [91548]; Biotechnology and Biological Sciences Research Council [BB/L025752/1]; BBSRC [BB/L025752/1] Funding Source: UKRI	National Research Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Research Foundation grant 91548: Competitive Program and South African Medical Research Council to EP, and the Biotechnology and Biological Sciences Research Council Grant BB/L025752/1 to DBK. Some reagent funds were supplied as a philanthropic gift by an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation grant 91548: Competitive Program and South African Medical Research Council to EP. Biotechnology and Biological Sciences Research Council Grant BB/L025752/1 to DBK. Some reagent funds were supplied as a philanthropic gift by an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Alzahrani SH, 2010, DIABETES VASC DIS RE, V7, P260, DOI 10.1177/1479164110383723; Alzahrani SH, 2012, J CLIN ENDOCR METAB, V97, pE2282, DOI 10.1210/jc.2012-2128; Antony PMA, 2013, FEBS J, V280, P5981, DOI 10.1111/febs.12335; Averett LE, 2008, LANGMUIR, V24, P4979, DOI 10.1021/la703264x; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Berg D, 2008, FUTUR NEUROL, V3, P447, DOI 10.2217/14796708.3.4.447; Bester J, 2015, ONCOTARGET, V6, P35284, DOI 10.18632/oncotarget.6074; Bhattacharjee P, 2014, FRAMEWORK WIRELESS N, P1; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dickneite G, 2015, THROMB HAEMOSTASIS, V113, P686, DOI 10.1160/TH14-07-0625; Domingue GJ, 2010, DISCOV MED, V10, P234; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Double KL, 2000, ADV RES NEURODEGENER, V8, P37; Dunn EJ, 2004, HERZ, V29, P470, DOI 10.1007/s00059-004-2607-z; Dunn EJ, 2005, DIABETOLOGIA, V48, P1198, DOI 10.1007/s00125-005-1742-2; Dunn EJ, 2006, DIABETOLOGIA, V49, P1071, DOI 10.1007/s00125-006-0197-4; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Freire S, 2014, DYES PIGMENTS, V110, P97, DOI 10.1016/j.dyepig.2014.05.004; Friedman A, 2012, J NEURAL TRANSM, V119, P1507, DOI 10.1007/s00702-012-0894-8; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funke C, 2013, NEUROCHEM INT, V62, P637, DOI 10.1016/j.neuint.2012.11.015; Gabrielli M, 2011, MOVEMENT DISORD, V26, P889, DOI 10.1002/mds.23566; Gerlach Manfred, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS185, DOI 10.1016/j.parkreldis.2008.04.028; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haidinger M, 2013, AMYLOID, V20, P72, DOI 10.3109/13506129.2013.781998; Hare DJ, 2014, CHEM SCI, V5, P2160, DOI 10.1039/c3sc53461h; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Infante J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.026; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Jameson GNL, 2011, MONATSH CHEM, V142, P325, DOI 10.1007/s00706-011-0475-9; Jones BC, 2007, AM J PHYSIOL-REG I, V293, pR116, DOI 10.1152/ajpregu.00608.2006; Jones BC, 2013, NEUROTOXICOLOGY, V37, P26, DOI 10.1016/j.neuro.2013.03.010; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kakkar AK, 2015, EUR J PHARMACOL, V750, P74, DOI 10.1016/j.ejphar.2015.01.030; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kalia LV, 2015, CURR OPIN NEUROL, V28, P375, DOI 10.1097/WCO.0000000000000215; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Kell DB, 2017, SEMINARS THROMBOSIS; Kell Douglas, 2015, F1000Res, V4, P179, DOI 10.12688/f1000research.6709.2; Kell DB, 2017, PROG BIOPHYS MOL BIO, V123, P16, DOI 10.1016/j.pbiomolbio.2016.08.006; Kell DB, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00060; Kell DB, 2015, INTEGR BIOL-UK, V7, P1339, DOI 10.1039/c5ib00158g; Kell DB, 2015, INTEGR BIOL-UK, V7, P24, DOI 10.1039/c4ib00173g; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krishna A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1154; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; Levenson CW, 2003, NUTR REV, V61, P311, DOI 10.1301/nr.2003.sept.311-313; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005631.pub2; Litvinov RI, 2012, BIOPHYS J, V103, P1020, DOI 10.1016/j.bpj.2012.07.046; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Mattman L., 2001, CELL WALL DEFICIENT; McDowall JS, 2016, METALLOMICS, V8, P385, DOI 10.1039/c6mt00026f; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P845, DOI 10.1097/MBC.0000000000000160; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Park SM, 2013, PRION, V7, P121, DOI 10.4161/pri.22850; Perez Carlos A, 2008, Curr Bioact Compd, V4, P150, DOI 10.2174/157340708786305952; Picken MM, 2010, BLOOD, V115, P2985, DOI 10.1182/blood-2009-12-236810; Pieters M, 2006, THROMB HAEMOSTASIS, V96, P623, DOI 10.1160/TH06-07-0390; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Pretorius E, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00257; Pretorius E, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0624-5; Pretorius E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09860-4; Pretorius E, 2017, EXP BIOL MED, V242, P355, DOI 10.1177/1535370216681549; Pretorius E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0539; Pretorius E, 2016, CELL PHYSIOL BIOCHEM, V39, P1977, DOI 10.1159/000447895; Pretorius E, 2016, J ALZHEIMERS DIS, V53, P1237, DOI 10.3233/JAD-160318; Pretorius E, 2016, BLOOD REV, V30, P263, DOI 10.1016/j.blre.2016.01.001; Pretorius E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0192-5; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; Pretorius E, 2014, INTEGR BIOL-UK, V6, P486, DOI 10.1039/c4ib00025k; Pretorius E, 2014, RHEUMATOL INT, V34, P1005, DOI 10.1007/s00296-013-2817-x; Pretorius E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085271; Pretorius E, 2013, TOXICOL MECH METHOD, V23, P352, DOI 10.3109/15376516.2012.762082; Pretorius E, 2013, MICROSC RES TECHNIQ, V76, P268, DOI 10.1002/jemt.22163; Pretorius E, 2011, BLOOD COAGUL FIBRIN, V22, P696, DOI 10.1097/MBC.0b013e32834bdb32; Pretorius E, 2011, BLOOD COAGUL FIBRIN, V22, P463, DOI 10.1097/MBC.0b013e3283468a0d; Pretorius E, 2012, RHEUMATOL INT, V32, P1611, DOI 10.1007/s00296-011-1805-2; Pretorius E, 2011, J THROMB THROMBOLYS, V31, P507, DOI 10.1007/s11239-010-0538-5; Protopopova AD, 2015, J THROMB HAEMOST, V13, P570, DOI 10.1111/jth.12785; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Rodriguez-Violante M, 2015, NEUROLOGIA, V30, P257, DOI 10.1016/j.nrl.2014.01.008; Rosenbaum H, 2013, SEMIN THROMB HEMOST, V39, P928, DOI 10.1055/s-0033-1357485; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sato Y, 2003, J NEUROL SCI, V212, P55, DOI 10.1016/S0022-510X(03)00101-1; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Serpell LC, 2007, AMYLOID, V14, P199, DOI 10.1080/13506120701461111; Stangou AJ, 2010, BLOOD, V115, P2998, DOI 10.1182/blood-2009-06-223792; Stocchi F, 1997, J NEUROL NEUROSUR PS, V62, P507, DOI 10.1136/jnnp.62.5.507; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Tipping KW, 2015, TRENDS BIOCHEM SCI, V40, P719, DOI 10.1016/j.tibs.2015.10.002; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; Yermolenko IS, 2011, BIOMACROMOLECULES, V12, P370, DOI 10.1021/bm101122g; Zhmurov A, 2011, STRUCTURE, V19, P1615, DOI 10.1016/j.str.2011.08.013; Zhmurov A, 2012, J AM CHEM SOC, V134, P20396, DOI 10.1021/ja3076428	122	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192121	10.1371/journal.pone.0192121	http://dx.doi.org/10.1371/journal.pone.0192121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494603	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200011
J	Zhang, J; Yin, JM; Wang, YJ; Li, B; Zeng, XJ				Zhang, Jia; Yin, Jiming; Wang, Yangjia; Li, Bin; Zeng, Xiangjun			Apelin impairs myogenic response to induce diabetic nephropathy in mice	FASEB JOURNAL			English	Article						smooth muscle cell; renal blood flow; endothelial cell; APJ; kidney	VASCULAR SMOOTH-MUSCLE; RENAL BLOOD-FLOW; PEPTIDE APELIN; PHOSPHORYLATION; MECHANISMS; RECEPTORS; TONE; AUTOREGULATION; PROMOTES; APJ	The cause of the invalid reaction of smooth muscle cells to mechanical stimulation that results in a dysfunctional myogenic response that mediates the disruption of renal blood flow (RBF) in patients with diabetes is debatable. The present study revealed that increased apelin concentration in serum of diabetic mice neutralized the myogenic response mediated by apelin receptor (APJ) and resulted in increased RBF, which promoted the progression of diabetic nephropathy. The results showed that apelin concentration, RBF, and albuminuria:creatinine ratio were all increased in kkAy mice, and increased RBF correlated positively with serum apelin both in C57 and diabetic mice. The increased RBF was accompanied by decreased phosphorylation of myosin light chain (MLC), -arrestin, and increased endothelial NOS in glomeruli. Meanwhile, calcium, phosphorylation of MLC, and -arrestin were decreased by high glucose and apelin treatment in cultured smooth muscle cells, as well. eNOS was increased by high glucose and increased by apelin in cultured endothelial cells (ECs). Knockdown of -arrestin expression in smooth muscle cells cancelled phosphorylation of MLC induced by apelin. Therefore, apelin may induce the progression of diabetic nephropathy by counteracting the myogenic response in smooth muscle cells.Zhang, J., Yin, J., Wang, Y., Li, B., Zeng, X. Apelin impairs myogenic response to induce diabetic nephropathy in mice.	[Zhang, Jia; Wang, Yangjia; Li, Bin; Zeng, Xiangjun] Capital Med Univ, Dept Pathophysiol, Beijing You An Hosp, Beijing, Peoples R China; [Yin, Jiming] Capital Med Univ, Beijing Inst Hepatol, Beijing You An Hosp, Beijing, Peoples R China; [Zhang, Jia; Wang, Yangjia; Li, Bin; Zeng, Xiangjun] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zeng, XJ (corresponding author), Capital Med Univ, You Anmen Wai 10, Beijing 100069, Peoples R China.	megan_zeng@163.com			Natural Science Foundation of China [81270815]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Wei Wang, Haixia Huang, and Sitao Zhang (Capital Medical University) for assistance with the ex vivo study. The work was supported by the Natural Science Foundation of China Grant 81270815. The authors declare no conflicts of interest.	Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Czogalla J, 2016, JOVE-J VIS EXP, DOI 10.3791/54712; Dautzenberg M, 2011, J PHYSIOL-LONDON, V589, P4731, DOI 10.1113/jphysiol.2011.215897; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Guo CX, 2015, J CELL MOL MED, V19, P2273, DOI 10.1111/jcmm.12619; Habchi M, 2014, CLIN ENDOCRINOL, V81, P696, DOI 10.1111/cen.12404; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Jensen EP, 2015, AM J PHYSIOL-RENAL, V308, pF867, DOI 10.1152/ajprenal.00527.2014; Kauffenstein G, 2012, CARDIOVASC RES, V95, P223, DOI 10.1093/cvr/cvs152; Khavandi K, 2009, NEPHROL DIAL TRANSPL, V24, P361, DOI 10.1093/ndt/gfn583; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Loutzenhiser R, 2002, CIRC RES, V90, P1316, DOI 10.1161/01.RES.0000024262.11534.18; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; O'Brien SP, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/498925; O'Harte FPM, 2017, BIOCHEM PHARMACOL, V146, P165, DOI 10.1016/j.bcp.2017.10.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pihl L, 2012, AM J PHYSIOL-REG I, V303, pR39, DOI 10.1152/ajpregu.00582.2011; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Seo KW, 2015, J MOL CELL CARDIOL, V85, P13, DOI 10.1016/j.yjmcc.2015.05.006; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tomino Yasuhiko, 2012, Nephrourol Mon, V4, P524, DOI 10.5812/numonthly.1954; Wang L, 2016, CIRCULATION, V134, P1353, DOI 10.1161/CIRCULATIONAHA.115.020754; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; ZHANG W, 2013, PLOS ONE, V8; Zhong JC, 2007, REGUL PEPTIDES, V144, P109, DOI 10.1016/j.regpep.2007.06.010; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002	31	6	7	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4315	4327		10.1096/fj.201701257R	http://dx.doi.org/10.1096/fj.201701257R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29522374				2022-12-26	WOS:000439325400022
J	Appikonda, S; Thakkar, KN; Shah, PK; Dent, SYR; Andersen, JN; Barton, MC				Appikonda, Srikanth; Thakkar, Kaushik N.; Shah, Parantu K.; Dent, Sharon Y. R.; Andersen, Jannik N.; Barton, Michelle C.			Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SUMOylation; chromatin modification; histone acetylation; cell adhesion; breast cancer; epigenetics; bromodomain; histone reader; reader protein; TRIM24	NUCLEAR RECEPTORS; HISTONE; GROWTH; METABOLISM; MECHANISMS; CANCER; POTENT; LINKS	Proteins with domains that recognize and bind post-translational modifications (PTMs) of histones are collectively termed epigenetic readers. Numerous interactions between specific reader protein domains and histone PTMs and their regulatory outcomes have been reported, but little is known about how reader proteins may in turn be modulated by these interactions. Tripartite motif-containing protein 24 (TRIM24) is a histone reader aberrantly expressed in multiple cancers. Here, our investigation revealed functional cross-talk between histone acetylation and TRIM24 SUMOylation. Binding of TRIM24 to chromatin via its tandem PHD-bromodomain, which recognizes unmethylated lysine 4 and acetylated lysine 23 of histone H3 (H3K4me0/K23ac), led to TRIM24 SUMOylation at lysine residues 723 and 741. Inactivation of the bromodomain, either by mutation or with a small-molecule inhibitor, IACS-9571, abolished TRIM24 SUMOylation. Conversely, inhibition of histone deacetylation markedly increased TRIM24's interaction with chromatin and its SUMOylation. Of note, gene expression profiling of MCF7 cells expressing WT versus SUMO-deficient TRIM24 identified cell adhesion as the major pathway regulated by the cross-talk between chromatin acetylation and TRIM24 SUMOylation. In conclusion, our findings establish a new link between histone H3 acetylation and SUMOylation of the reader protein TRIM24, a functional connection that may bear on TRIM24's oncogenic function and may inform future studies of PTM cross-talk between histones and epigenetic regulators.	[Appikonda, Srikanth; Thakkar, Kaushik N.; Dent, Sharon Y. R.; Barton, Michelle C.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Thakkar, Kaushik N.; Dent, Sharon Y. R.; Barton, Michelle C.] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Shah, Parantu K.; Andersen, Jannik N.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Appikonda, Srikanth] Counsyl, 180 Kimball Way, San Francisco, CA 94080 USA; [Shah, Parantu K.] EMD Serono Res & Dev Inst Inc, 45A Middlesex Turnpike, Billerica, MA 01821 USA; [Andersen, Jannik N.] Xios Therapeut, 465 Waverley Oaks Rd, Waltham, MA 02452 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Merck KGaA; EMD Serono Inc.	Barton, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Unit 1011,1515 Holcombe Blvd, Houston, TX 77030 USA.	mbarton@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269	Innovation Award from the Center for Cancer Epigenetics; University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant [CA016672];  [CPRIT RP110471]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Innovation Award from the Center for Cancer Epigenetics; University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by CPRIT RP110471 and an Innovation Award from the Center for Cancer Epigenetics (to M.C.B.) and University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant CA016672. The authors declare that they have no conflicts of interest with the contents of this article.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appikonda Srikanth, 2016, Drug Discov Today Technol, V19, P57, DOI 10.1016/j.ddtec.2016.05.001; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Cui ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063887; Delhomme N, 2012, BIOINFORMATICS, V28, P2532, DOI 10.1093/bioinformatics/bts477; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Demont EH, 2014, ACS MED CHEM LETT, V5, P1190, DOI 10.1021/ml5002932; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2011, CELL, V146, P709, DOI 10.1016/j.cell.2011.07.025; LeDouarin B, 1996, PHILOS T R SOC B, V351, P569, DOI 10.1098/rstb.1996.0056; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; Liu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085462; Miao ZF, 2015, VIRCHOWS ARCH, V466, P525, DOI 10.1007/s00428-015-1737-4; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Palmer WS, 2016, J MED CHEM, V59, P1440, DOI 10.1021/acs.jmedchem.5b00405; Pathiraja TN, 2015, ONCOGENE, V34, P2836, DOI 10.1038/onc.2014.220; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Thakkar KN, 2015, AGING-US, V7, P736, DOI 10.18632/aging.100822; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhan YN, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0026-4	41	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7476	7485		10.1074/jbc.RA118.002233	http://dx.doi.org/10.1074/jbc.RA118.002233			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29523690	Green Published, hybrid			2022-12-26	WOS:000432174500039
J	Dong, L; Yu, L; Bai, CR; Liu, L; Long, H; Shi, L; Lin, ZH				Dong, Ling; Yu, Le; Bai, Chunrong; Liu, Liu; Long, Hua; Shi, Lei; Lin, Zhenghong			USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis	ONCOGENE			English	Article							BREAST-CANCER; E OVEREXPRESSION; PROGNOSTIC-SIGNIFICANCE; S-PHASE; TRANSCRIPTIONAL ACTIVATION; LUNG-CANCER; PROTEIN; EXPRESSION; PHOSPHORYLATION; AMPLIFICATION	Overexpression of Cyclin E has been seen in many types of cancers. However, the underlying mechanism remains enigmatic. Herein, we identified ubiquitin-specific peptidase 27 (USP27) as a Cyclin E interactor. We found that USP27 promoted Cyclin E stability by negatively regulating its ubiquitination. In addition, suppression of USP27 expression resulted in the inhibition of the growth, migration, and invasion of hepatocellular carcinoma. Furthermore, we detected a positive correlation between USP27 and Cyclin E expression in hepatocellular carcinoma tissues. Finally, we found that USP27 expression is inhibited by 5-fluorouracil (5-FU) treatment and USP27 depletion sensitizes Hep3B cells to 5-FU-induced apoptosis. USP27-mediated Cyclin E stabilization is involved in tumorigenesis, suggesting that targeting USP27 may represent a new therapeutic strategy to treat cancers with aberrant overexpression of Cyclin E protein.	[Dong, Ling; Yu, Le; Bai, Chunrong; Liu, Liu; Long, Hua; Shi, Lei; Lin, Zhenghong] Chongqing Univ, Sch Life Sci, Lab Pathol, Chongqing 401331, Peoples R China	Chongqing University	Lin, ZH (corresponding author), Chongqing Univ, Sch Life Sci, Lab Pathol, Chongqing 401331, Peoples R China.	zhenghonglin@cqu.edu.cn		Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [31571454]; Fundamental Research Funds for the Central Universities [106112017CDJQJ298833]; starting funds of '100 talent scholar program' from Chongqing University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); starting funds of '100 talent scholar program' from Chongqing University	This study was supported by the National Natural Science Foundation of China (Grant Number 31571454 to Z. Lin), the Fundamental Research Funds for the Central Universities (Project Number 106112017CDJQJ298833 to Z. Lin), and the starting funds of '100 talent scholar program' from Chongqing University.	Atanassov BS, 2016, MOL CELL, V62, P558, DOI 10.1016/j.molcel.2016.03.030; Berglund P, 2005, CANCER RES, V65, P9727, DOI 10.1158/0008-5472.CAN-04-3984; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Das T, 2017, NUCLEIC ACIDS RES, V45, P5010, DOI 10.1093/nar/gkx062; Dong YY, 2000, CLIN CANCER RES, V6, P4253; Ear PH, 2013, P NATL ACAD SCI USA, V110, P15716, DOI 10.1073/pnas.1305420110; Erlanson M, 2001, LEUKEMIA LYMPHOMA, V40, P461, DOI 10.3109/10428190109097645; Fukuse T, 2000, CANCER RES, V60, P242; Geng Y, 1996, ONCOGENE, V12, P1173; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lin ZH, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.28; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Luhtala S, 2016, TUMOR BIOL, V37, P9813, DOI 10.1007/s13277-016-4870-z; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Molendini L, 1998, INT J ONCOL, V12, P1007; Muller-Tidow C, 2001, CANCER RES, V61, P647; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schraml P, 2003, J PATHOL, V200, P375, DOI 10.1002/path.1356; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Siu KT, 2012, CELL CYCLE, V11, P57, DOI 10.4161/cc.11.1.18775; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Swaffer MP, 2016, CELL, V167, P1750, DOI 10.1016/j.cell.2016.11.034; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Wolowiec D, 1996, BRIT J HAEMATOL, V95, P518, DOI 10.1046/j.1365-2141.1996.d01-1930.x; Yasui W, 1996, J Exp Ther Oncol, V1, P88; Yasui W, 1996, VIRCHOWS ARCH, V429, P13	42	30	36	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2702	2713		10.1038/s41388-018-0137-z	http://dx.doi.org/10.1038/s41388-018-0137-z			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29497124	Green Published, hybrid			2022-12-26	WOS:000432545100007
J	Chia, J; Louber, J; Glauser, I; Taylor, S; Bass, GT; Dower, SK; Gleeson, PA; Verhagen, AM				Chia, Jenny; Louber, Jade; Glauser, Isabelle; Taylor, Shirley; Bass, Greg T.; Dower, Steve K.; Gleeson, Paul A.; Verhagen, Anne M.			Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; coagulation factor; endocytosis; Fc receptor; intracellular trafficking; Hemophilia B; extended half-life; factor IX; neonatal Fc receptor (FcRn); recombinant coagulation factor IX albumin-fusion protein (rIX-FP)	RECEPTOR-RELATED PROTEIN; HEMOPHILIA-B PATIENTS; RIX-FP; STRUCTURAL INSIGHTS; IGG HOMEOSTASIS; SERUM IGG; TRANSPORT; PHARMACOKINETICS; DYNAMICS; ANTIBODY	The neonatal Fc receptor (FcRn) has a pivotal role in albumin and IgG homeostasis. Internalized IgG captured by FcRn under acidic endosomal conditions is recycled to the cell surface where exocytosis and a shift to neutral pH promote extracellular IgG release. Although a similar mechanism is proposed for FcRn-mediated albumin intracellular trafficking and recycling, this pathway is less well defined but is relevant to the development of therapeutics exploiting FcRn to extend the half-life of short-lived plasma proteins. Recently, a long-acting recombinant coagulation factor IX-albumin fusion protein (rIX-FP) has been approved for the management of hemophilia B. Fusion to albumin potentially enables internalized proteins to engage FcRn and escape lysosomal degradation. In this study, we present for the first time a detailed investigation of the FcRn-mediated recycling of albumin and the albumin fusion protein rIX-FP. We demonstrate that following internalization via FcRn at low pH, rIX-FP, like albumin, is detectable within the early endosome and rapidly (within 10-15 min) traffics into the Rab11+ recycling endosomes, from where it is exported from the cell. Similarly, rIX-FP and albumin taken up by fluid-phase endocytosis at physiological pH traffics into the Rab11+ recycling compartment in FcRn-positive cells but into the lysosomal compartment in FcRn-negative cells. As expected, recombinant factor IX (without albumin fusion) and an FcRn interaction-defective albumin variant localized to the lysosomal compartments of both FcRn-expressing and nonexpressing cells. These results indicate that FcRn-mediated recycling via the albumin moiety is a mechanism for the half-life extension of rIX-FP observed in clinical studies.	[Chia, Jenny; Glauser, Isabelle; Taylor, Shirley; Bass, Greg T.; Dower, Steve K.; Verhagen, Anne M.] CSL Ltd, Mol Sci & Biotechnol Inst Bio21, Res, Melbourne, Vic 3010, Australia; [Louber, Jade; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Bass, Greg T.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic 3010, Australia	CSL; University of Melbourne; University of Melbourne	Verhagen, AM (corresponding author), CSL Ltd, Inst Bio21, Res, 30 Flemington Rd, Parkville, Vic 3010, Australia.	Anne.Verhagen@csl.com.au		Gleeson, Paul/0000-0002-5336-6503; dower, steve/0000-0002-4675-4225	Australian Research Council [LP130100531]; Internship Scholarship AMSIIntern [INT-0265]; CSL Limited through Australian Research Council	Australian Research Council(Australian Research Council); Internship Scholarship AMSIIntern; CSL Limited through Australian Research Council	This work was supported in part by Linkage Grant LP130100531 from the Australian Research Council and by Internship Scholarship AMSIIntern INT-0265 (to G. T. B.). J. C., I. G., S. T., S. K. D., and A. M. V. are employees of CSL Limited and are able to partake in employee share option schemes. J. L. and P. A. G. are supported by research funding from CSL Limited through an Australian Research Council linkage grant collaboration.	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Anderson CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00540; Bjorkman S, 2001, HAEMOPHILIA, V7, P133, DOI 10.1046/j.1365-2516.2001.00465.x; Blasko E, 2013, BIOCHEM BIOPH RES CO, V440, P485, DOI 10.1016/j.bbrc.2013.09.001; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; Challa DK, 2014, CURR TOP MICROBIOL, V382, P249, DOI 10.1007/978-3-319-07911-0_12; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Ewenstein BM, 2002, TRANSFUSION, V42, P190, DOI 10.1046/j.1537-2995.2002.00039.x; Fujimoto K, 2015, MOL PHARMACOL, V88, P660, DOI 10.1124/mol.115.099184; Gailani D, 2009, J THROMB HAEMOST, V7, P1840, DOI 10.1111/j.1538-7836.2009.03591.x; Gan Z, 2013, J CELL SCI, V126, P1176, DOI 10.1242/jcs.116327; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Herzog E, 2014, THROMB RES, V133, P900, DOI 10.1016/j.thromres.2014.02.010; Jerdeva GV, 2010, TRAFFIC, V11, P1205, DOI 10.1111/j.1600-0854.2010.01083.x; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Martinowitz U, 2015, HAEMOPHILIA, V21, P784, DOI 10.1111/hae.12721; Mathur A, 2013, J IMMUNOL METHODS, V390, P81, DOI 10.1016/j.jim.2013.01.011; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Metzner HJ, 2009, THROMB HAEMOSTASIS, V102, P634, DOI 10.1160/TH09-04-0255; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; Nolte MW, 2012, J THROMB HAEMOST, V10, P1591, DOI 10.1111/j.1538-7836.2012.04826.x; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Panousis C., 2015, MABS, V8, P436, DOI DOI 10.1080/19420862.2015.1119352; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Pyzik M, 2017, P NATL ACAD SCI USA, V114, pE2862, DOI 10.1073/pnas.1618291114; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Rath T, 2015, CRIT REV BIOTECHNOL, V35, P235, DOI 10.3109/07388551.2013.834293; Sand KMK, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00682; Santagostino E, 2016, BLOOD, V127, P1761, DOI 10.1182/blood-2015-09-669234; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Sarav M, 2009, J AM SOC NEPHROL, V20, P1941, DOI 10.1681/ASN.2008090976; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Schulte S, 2009, THROMB RES, V124, pS6, DOI 10.1016/S0049-3848(09)70157-4; Seested T, 2011, NEPHRON EXP NEPHROL, V117, pE82, DOI 10.1159/000321161; Sleep D, 2015, EXPERT OPIN DRUG DEL, V12, P793, DOI 10.1517/17425247.2015.993313; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Trujillo JM, 2014, ANN PHARMACOTHER, V48, P1494, DOI 10.1177/1060028014545807; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Ward ES, 2015, MOL IMMUNOL, V67, P131, DOI 10.1016/j.molimm.2015.02.007; Ward ES, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00351; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; Watson D, 1965, Adv Clin Chem, V8, P237; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; White GC, 1997, THROMB HAEMOSTASIS, V78, P261; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	58	20	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6363	6373		10.1074/jbc.M117.817064	http://dx.doi.org/10.1074/jbc.M117.817064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523681	Green Published, hybrid			2022-12-26	WOS:000431108600012
J	Jensen, RK; Pihl, R; Gadeberg, TAF; Jensen, JK; Andersen, KR; Thiel, S; Laursen, NS; Andersen, GR				Jensen, Rasmus K.; Pihl, Rasmus; Gadeberg, Trine A. F.; Jensen, Jan K.; Andersen, Kasper R.; Thiel, Steffen; Laursen, Nick S.; Andersen, Gregers R.			A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; complement; convertase; antibody; inhibitor; structural biology; alternative pathway	STRUCTURAL BASIS; FACTOR-H; C3B; BINDING; COMPSTATIN; ACTIVATION; DISEASE; SYSTEM; CONVERTASE; THERAPY	The complement system is a complex, carefully regulated proteolytic cascade for which suppression of aberrant activation is of increasing clinical relevance, and inhibition of the complement alternative pathway is a subject of intense research. Here, we describe the nanobody hC3Nb1 that binds to multiple functional states of C3 with subnanomolar affinity. The nanobody causes a complete shutdown of alternative pathway activity in human and murine serum when present in concentrations comparable with that of C3, and hC3Nb1 is shown to prevent proconvertase assembly, as well as binding of the C3 substrate to C3 convertases. Our crystal structure of the C3b-hC3Nb1 complex and functional experiments demonstrate that proconvertase formation is blocked by steric hindrance between the nanobody and an Asn-linked glycan on complement factor B. In addition, hC3Nb1 is shown to prevent factor H binding to C3b, rationalizing its inhibition of factor I activity. Our results identify hC3Nb1 as a versatile, inexpensive, and powerful inhibitor of the alternative pathway in both human and murine in vitro model systems of complement activation.	[Jensen, Rasmus K.; Gadeberg, Trine A. F.; Jensen, Jan K.; Andersen, Kasper R.; Laursen, Nick S.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark; [Pihl, Rasmus; Thiel, Steffen] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	gra@mbg.au.dk	Laursen, Nick Stub/Q-5051-2017; Jensen, Rasmus Kjeldsen/T-9219-2019	Laursen, Nick Stub/0000-0002-7512-2649; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Andersen, Gregers Rom/0000-0001-6292-3319; Thiel, Steffen/0000-0002-4817-155X; Jensen, Rasmus Kjeldsen/0000-0001-5472-4862	Lundbeck Foundation BRAIN-STRUC Centre [R155-2015-2666]; Danscatt; Novo Nordisk Foundation; Danish Research Council for Nature and Universe; Lundbeck Foundation; Danish Council for Independent Research, Medical Sciences; Lundbeck Foundation [R155-2015-2666, R192-2015-726] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0022058] Funding Source: researchfish	Lundbeck Foundation BRAIN-STRUC Centre; Danscatt; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council for Nature and Universe; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by funds from the Lundbeck Foundation BRAIN-STRUC Centre (R155-2015-2666), Danscatt, the Novo Nordisk Foundation, and the Danish Research Council for Nature and Universe (to G. R. A.); from the Lundbeck Foundation (to N. S. L. and K. R. A.); and from the Danish Council for Independent Research, Medical Sciences (to R. P. and S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZA, 2016, MOL CELL PROTEOMICS, V15, P2730, DOI 10.1074/mcp.M115.056473; Croll TI, 2016, ACTA CRYSTALLOGR D, V72, P1006, DOI 10.1107/S2059798316012201; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Hansen SB, 2017, ACTA CRYSTALLOGR D, V73, P804, DOI 10.1107/S2059798317013171; Harboe M, 2017, P NATL ACAD SCI USA, V114, pE534, DOI 10.1073/pnas.1612385114; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Konning D, 2017, CURR OPIN STRUC BIOL, V45, P10, DOI 10.1016/j.sbi.2016.10.019; Kolev M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00001; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Krishna M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00021; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastellos DC, 2017, TRENDS IMMUNOL, V38, P383, DOI 10.1016/j.it.2017.03.003; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nilsson B, 1998, BLOOD, V92, P1661, DOI 10.1182/blood.V92.5.1661; Pedersen DV, 2017, EMBO J, V36, P1084, DOI 10.15252/embj.201696173; Pleiner T, 2015, ELIFE, V4, DOI [10.7554/eLife.11349, 10.7554/eLife.15597]; Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Rodriguez E, 2015, J BIOL CHEM, V290, P2334, DOI 10.1074/jbc.M114.605691; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schroedinger LLC, 2015, THE PYMOL MOLECULAR; Sottrup-Jensen L, 2014, METHODS MOL BIOL, V1100, P93, DOI 10.1007/978-1-62703-724-2_7; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	63	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6269	6281		10.1074/jbc.RA117.001179	http://dx.doi.org/10.1074/jbc.RA117.001179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29497000	Green Published, hybrid			2022-12-26	WOS:000431108600005
J	Bojovic, O; Medenica, M; Zivkovic, D; Rakocevic, B; Trajkovic, G; Kisic-Tepavcevic, D; Grgurevic, A				Bojovic, Olivera; Medenica, Milic; Zivkovic, Danko; Rakocevic, Bozidarka; Trajkovic, Goran; Kisic-Tepavcevic, Darija; Grgurevic, Anita			Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS	Background Fundamental measures of control of tuberculosis are early detection and timely treatment of the affected. The aim of this study was to identify factors associated with patient-related and health system-related delays among patients with tuberculosis in the Republic of Montenegro. Methods A cross-sectional study included 130 tuberculosis patients older than 15 years of age. The inclusion criteria were diagnosis of tuberculosis based on clinical, pathohistological and microbiological findings. Patient delay referred to the number of days between the onset of symptoms and the first consultation with general practitioner (GP). Health system delay represented the number of days between the first consultation with GP and the initiation of tuberculosis treatment. We classified delays longer than median delay length as 'prolonged delays'. Delays greater than 75th percentile of the maximum length of delay were classified as 'extreme delays'. Results Distribution of patient and health system delay in the overall delay was apprioximately equal (49% vs. 51%). Being married (OR = 2.54, p = 0.026) and having more negative attitudes towards tuberculosis (OR = 4.00, p = 0.045) were associated with extreme patient delay. Greater knowledge on tuberculosis was associated with lower likelihood of prolonged (OR = 0.24, p = 0.031) and extreme (OR = 0.30, p = 0.012) patient delay. Persons with negative sputum smear were more likely to experience prolonged (OR = 7.01, p<0.001) and extreme (OR = 4.40, p = 0.032) health system delay. Persons older than 47 years of age were more likely to experience prolonged health system delay (OR = 2.61, p = 0.042). Specialist consultation delay was associated with prolonged (OR = 1.08, p = 0.001) and extreme (OR = 1.05, p<0.001) health system delay. Conclusion Contribution to overall delay is equally distributed between the patients and the health care system. Improvement of knowledge in the general population and continuing medical education of the health care workers on tuberculosis could lead to reduction in patient and health system delays in treatment of tuberculosis.	[Bojovic, Olivera; Medenica, Milic] Hosp Lung Dis & TB Brezovik, Dept TB, Niksic, Montenegro; [Zivkovic, Danko] Univ Montenegro, Fac Med, Podgorica, Montenegro; [Zivkovic, Danko] Clin Hosp Ctr, Dept Pulm Internal Med, Podgorica, Montenegro; [Rakocevic, Bozidarka] Inst Publ Hlth, Ctr Dis Control & Prevent, Podgorica, Montenegro; [Trajkovic, Goran] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia; [Kisic-Tepavcevic, Darija; Grgurevic, Anita] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia	University of Montenegro; University of Belgrade; University of Belgrade	Grgurevic, A (corresponding author), Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia.	anita.grgurevic@gmail.com		Grgurevic, Anita/0000-0002-6611-9931	Ministry of Education, Science and Technological Development of the Republic of Serbia [175042, 175087]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This investigation was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 175042 and No. 175087).	[Anonymous], 2006, WHOEMTDR009; Aoki M, 1985, B INT UNION TUBERC, V60, P128; Cai J, 2015, PLOS ONE, V10; Chen HG, 2014, INT J TUBERC LUNG D, V18, P267, DOI 10.5588/ijtld.13.0140; Chiang CY, 2005, INT J TUBERC LUNG D, V9, P1006; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33; Institute of Public Health of Montenegro, 2016, HLTH STAT YB 2014 MO; Jurcev-Savicevic A, 2011, CENT EUR J PUBL HEAL, V22, P573; Jurcev-Savicevic A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-250; Jurcev-Savicevic A, 2012, ARH HIG RADA TOKSIKO, V63, P385, DOI 10.2478/10004-1254-63-2012-2129; Lewis K E, 2003, Commun Dis Public Health, V6, P133; Liam CK, 1997, INT J TUBERC LUNG D, V1, P326; Madebo, 1999, MedGenMed, pE6; Mahato RK, 2015, J CLIN DIAGN RES, V9, pLC05, DOI 10.7860/JCDR/2015/16307.6633; Ministry of Health of Montenegro, 2012, NAT TUB CONTR PROGR; Mor Z, 2013, EUROSURVEILLANCE, V18, P43; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Rakocevic B, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA1522; Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; van der Werf MJ, 2006, INT J TUBERC LUNG D, V10, P390; Ward J, 2001, INT J TUBERC LUNG D, V5, P1021; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2014, 67 WORLD HLTH ASS 20; World Health Organization, 2015, SYSTEMATIC SCREENING; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	30	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193997	10.1371/journal.pone.0193997	http://dx.doi.org/10.1371/journal.pone.0193997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522545	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800029
J	Rubilar, PS; Barra, GN; Gabastou, JM; Alarcon, P; Araya, P; Hormazabal, JC; Fernandez, J				Rubilar, Paulina S.; Barra, Gisselle N.; Gabastou, Jean-Marc; Alarcon, Pedro; Araya, Pamela; Hormazabal, Juan C.; Fernandez, Jorge			Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents	PLOS ONE			English	Article							MENINGOCOCCAL CARRIAGE; UNIVERSITY-STUDENTS; YOUNG-ADULTS; SEROGROUP W; EPIDEMIOLOGY; SURVEILLANCE; VACCINATION; PREVALENCE; LACTAMICA; CHILDREN	Neisseria meningitidis is a human exclusive pathogen that can lead to invasive meningococcal disease or may be carried in the upper respiratory tract without symptoms. The relationship between carriage and disease remains poorly understood but it is widely accepted that decreasing carriage by immunization should lead to a reduction of invasive cases. Latin America has experienced an increased incidence of serogroup W invasive cases of Neisseria meningitidis in the last decade. Specifically in Chile, despite low total incidence of invasive cases, serogroup W has become predominant since 2011 and has been associated with elevated mortality. Expecting to gain insight into the epidemiology of this disease, this study has used molecular typing schemes to compare Neisseria meningitidis isolates causing invasive disease with those isolates collected from adolescent carriers during the same period in Chile. A lower carriage of the serogroup W clonal complex ST-11/ET37 than expected was found; whereas, the same clonal complex accounted for 66% of total invasive meningococcal disease cases in the country that year. A high diversity of PorA variable regions and fHbp peptides was also ascertained in the carrier isolates compared to the invasive ones. According to the results shown here, the elevated number of serogroup W invasive cases in our country cannot be explained by a rise of carriage of pathogenic isolates. Overall, this study supports the idea that some strains, as W:cc11 found in Chile, possess an enhanced virulence to invade the host. Notwithstanding hypervirulence, this strain has not caused an epidemic in Chile. Finally, as genetic transfer occurs often, close surveillance of Neisseria meningitidis strains causing disease, and particularly hypervirulent W:cc11, should be kept as a priority in our country, in order to prepare the best response to face genetic changes that could lead to enhanced fitness of this pathogen.	[Rubilar, Paulina S.; Barra, Gisselle N.; Fernandez, Jorge] Publ Hlth Inst, Biomed Dept, Subdept Mol Genet, Santiago, Chile; [Rubilar, Paulina S.; Gabastou, Jean-Marc] WHO, Pan Amer Hlth Org, Washington, DC USA; [Alarcon, Pedro; Araya, Pamela] Publ Hlth Inst, Bacteriol Sect, Biomed Dept, Infect Dis Subdept, Santiago, Chile; [Hormazabal, Juan C.] Publ Hlth Inst, Biomed Lab Dept, Infect Dis Subdept, Santiago, Chile	Pan American Health Organization; World Health Organization	Fernandez, J (corresponding author), Publ Hlth Inst, Biomed Dept, Subdept Mol Genet, Santiago, Chile.	jfernand@ispch.cl			Chilean government; Pan American Health Organization/Wold Health Organization	Chilean government; Pan American Health Organization/Wold Health Organization	This project was funded by the Chilean government and the Pan American Health Organization/Wold Health Organization. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript	Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; Ali O, 2016, LANCET GLOB HEALTH, V4, pE989, DOI 10.1016/S2214-109X(16)30244-3; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P145; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P609; Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P107, DOI 10.1016/S0924-8579(02)00356-4; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Barra GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066006; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Biolchi A, MENINGOCOCCAL ANTIGE; Borgono J M, 1981, Rev Chil Pediatr, V52, P146; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Deasy AM, 2015, CLIN INFECT DIS, V60, P1512, DOI 10.1093/cid/civ098; Diaz J, 2016, J INFECT PUBLIC HEAL, V9, P506, DOI 10.1016/j.jiph.2015.12.011; Diomande FVK, 2015, CLIN INFECT DIS, V61, pS467, DOI 10.1093/cid/civ499; ESR, 2017, NOT DIS NZ ANN REP 2; Gabutti G, 2015, J PREV MED HYG, V56, pE116; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; Gonzales MLA, 2017, EPIDEMIOL INFECT, V145, P126, DOI 10.1017/S0950268816002119; Hedberg ST, 2011, EUROSURVEILLANCE, V16, P8; Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006; Koutangni T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116725; Kristiansen PA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0663-4; Kristiansen PA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-363; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Ladhani SN, 2016, EMERG INFECT DIS, V22, P309, DOI 10.3201/eid2202.150369; Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597; Lucidarme J, 2017, J INFECT; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Mowlaboccus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158315; Mustapha MM, 2016, GENOME BIOL EVOL, V8, P2065, DOI 10.1093/gbe/evw122; Mustapha MM, 2015, EBIOMEDICINE, V2, P1447, DOI 10.1016/j.ebiom.2015.09.007; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Oldfield NJ, 2017, EMERG INFECT DIS, V23, P1009, DOI 10.3201/eid2306.161768; Pajon R, 2011, NIH PUBLIC ACCES, V28, P2122; Pelton SI, 2016, J ADOLESCENT HEALTH, V59, pS3, DOI 10.1016/j.jadohealth.2016.04.012; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Rodriguez P, 2014, VACCINE, V32, P5677, DOI 10.1016/j.vaccine.2014.08.015; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Safadi MAP, 2015, VACCINE, V33, P6529, DOI 10.1016/j.vaccine.2015.10.055; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Swain CL, 2017, EPIDEMIOL INFECT, P1; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Valenzuela MT, 2013, REV MED CHILE, V141, P959, DOI 10.4067/S0034-98872013000800001; Watkins ER, 2017, SCI REP, V7, P1; Whittaker R, 2017, VACCINE, V35, P2034, DOI 10.1016/j.vaccine.2017.03.007; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yezli S, 2016, INT J INFECT DIS, V47, P65, DOI 10.1016/j.ijid.2015.11.014	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193572	10.1371/journal.pone.0193572	http://dx.doi.org/10.1371/journal.pone.0193572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518095	gold, Green Published, Green Submitted			2022-12-26	WOS:000426902900026
J	Sanghvi, MM; Aung, N; Cooper, JA; Paiva, JM; Lee, AM; Zemrak, F; Fung, K; Thomson, RJ; Lukaschuk, E; Carapella, V; Kim, YJ; Harvey, NC; Piechnik, SK; Neubauer, S; Petersen, SE				Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Lee, Aaron M.; Zemrak, Filip; Fung, Kenneth; Thomson, Ross J.; Lukaschuk, Elena; Carapella, Valentina; Kim, Young Jin; Harvey, Nicholas C.; Piechnik, Stefan K.; Neubauer, Stefan; Petersen, Steffen E.			The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; CLINICAL-IMPLICATIONS; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; OUTCOMES; FAILURE; RISK	Background The effect of menopausal hormone therapy (MHT) previously known as hormone replacement therapy on cardiovascular health remains unclear and controversial. This cross-sectional study examined the impact of MHT on left ventricular (LV) and left atrial (LA) structure and function, alterations in which are markers of subclinical cardiovascular disease, in a population-based cohort. Methods Post-menopausal women who had never used MHT and those who had used MHT >= 3 years participating in the UK Biobank who had undergone cardiovascular magnetic resonance (CMR) imaging and free of known cardiovascular disease were included. Multivariable linear regression was performed to examine the relationship between cardiac parameters and MHT use >= 3 years. To explore whether MHT use on each of the cardiac outcomes differed by age, multivariable regression models were constructed with a cross product of age and MHT fitted as an interaction term. Results Of 1604 post-menopausal women, 513 (32%) had used MHT >= 3 years. In the MHT cohort, median age at menopause was 50 (IQR: 45-52) and median duration of MHT was 8 years. In the non-MHT cohort, median age at menopause was 51 (IQR: 48-53). MHT use was associated with significantly lower LV end-diastolic volume (122.8 ml vs 119.8 ml, effect size = -2.4%, 95% Cl: -4.2% to -0.5%; p = 0.013) and LA maximal volume (60.2 ml vs 57.5 ml, effect size = -4.5%, 95% Cl: -7.8% to -1.0%; p = 0.012). There was no significant difference in LV mass. MHT use significantly modified the effect between age and CMR parameters; MHT users had greater decrements in LV end-diastolic volume, LV end-systolic volume and LA maximal volume with advancing age. Conclusions MHT use was not associated with adverse, subclinical changes in cardiac structure and function. Indeed, significantly smaller LV and LA chamber volumes were observed which have been linked to favourable cardiovascular outcomes. These findings represent a nave approach to examining MHT's effect on the cardiovascular system.	[Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Lee, Aaron M.; Zemrak, Filip; Fung, Kenneth; Thomson, Ross J.; Petersen, Steffen E.] Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England; [Lukaschuk, Elena; Carapella, Valentina; Kim, Young Jin; Piechnik, Stefan K.; Neubauer, Stefan] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Kim, Young Jin] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Harvey, Nicholas C.] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Harvey, Nicholas C.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Harvey, Nicholas C.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of London; Queen Mary University London; University of Oxford; Yonsei University; Yonsei University Health System; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Petersen, SE (corresponding author), Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England.	s.e.petersen@qmul.ac.uk	Thomson, Ross/AAU-6636-2020; Thomson, Ross/GXV-0334-2022; Petersen, Steffen E/A-8389-2011	Thomson, Ross/0000-0002-8229-8060; Petersen, Steffen E/0000-0003-4622-5160; Harvey, Nicholas/0000-0002-8194-2512; Neubauer, Stefan/0000-0001-9017-5645; Sanghvi, Mihir/0000-0002-1914-4149; Zemrak, Filip/0000-0001-6730-4955; Aung, Nay/0000-0001-5095-1611; Carapella, Valentina/0000-0001-9750-9425	Medical College of Saint Bartholomews Hospital Trust; NIHR Cardiovascular Biomedical Research Centre at Barts; SmartHeart Engineering and Physical Sciences Research Council [EP/P001009/1]; Oxford NIHR Biomedical Research Centre; Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council [MR/L016311/1]; Wellcome Trust Research Training Fellowship [203553/Z/Z]; British Heart Foundation [PG/14/89/31194]; EPSRC [EP/P001009/1] Funding Source: UKRI; MRC [MC_U147585819, MC_U147585827, G0400491] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/P001009/1] Funding Source: researchfish	Medical College of Saint Bartholomews Hospital Trust; NIHR Cardiovascular Biomedical Research Centre at Barts; SmartHeart Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Research Training Fellowship(Wellcome Trust); British Heart Foundation(British Heart Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the following institutions: KF is supported by The Medical College of Saint Bartholomews Hospital Trust (www.barts-londonschooltrust.org.uk), an independent registered charity that promotes and advances medical and dental education and research at Barts and The London School of Medicine and Dentistry. AL and SEP acknowledge support from the NIHR Cardiovascular Biomedical Research Centre at Barts (www.whri.qmul.ac.uk) and from the SmartHeart Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) program grant (EP/P001009/1). SN and SKP are supported by the Oxford NIHR Biomedical Research Centre (www.oxfordbrc.nihr.ac.uk) and the Oxford British Heart Foundation Centre of Research Excellence (http://www.cardioscience.ox.ac.uk/bhf-centre-of-research-excellence). This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant number MR/L016311/1) (www.emedlab.ac.uk). NA is supported by a Wellcome Trust Research Training Fellowship (203553/Z/Z) (www.wellcome.ac.uk). The authors SEP, SN and SKP acknowledge the British Heart Foundation (www.bhf.org.uk) for funding the manual analysis to create a cardiovascular magnetic resonance imaging reference standard for the UK Biobank imaging resource in 5000 CMR scans (PG/14/89/31194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, ACOG COMM OP; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barrett-Connor E, 2007, AM J EPIDEMIOL, V166, P506, DOI 10.1093/aje/kwm214; Boardman HMP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002229.pub4; Clarkson TB, 2013, MENOPAUSE, V20, P342, DOI [10.1097/gme.0b013e3182843aad, 10.1097/GME.0b013e3182843aad]; Cohen J, 1988, BEHAV SCI; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Harvey RE, 2015, WOMENS HEALTH, V11, P239, DOI [10.2217/whe.14.64, 10.2217/WHE.14.64]; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kerkhof PLM, 2015, CLIN MED INSIGHTS-CA, V9, P11, DOI [10.4137/CMC.s18744, 10.4137/CMC.S18744]; Kizer JR, 2006, AM HEART J, V151, P412, DOI 10.1016/j.ahj.2005.04.031; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Marjoribanks J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8141; Mathias A, 2016, J AM COLL CARDIOL, V68, P1268, DOI 10.1016/j.jacc.2016.06.051; Petersen SE, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0327-9; Petersen SE, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0227-4; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; Pines Amos, 2010, J Midlife Health, V1, P41, DOI 10.4103/0976-7800.66990; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Rodstrom K, 1999, BMJ, V319; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tu YK, 2004, J DENT, V32, P143, DOI 10.1016/j.jdent.2003.09.004; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903	34	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194015	10.1371/journal.pone.0194015	http://dx.doi.org/10.1371/journal.pone.0194015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518141	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000426902900060
J	Timm, DE; Bowman, V; Madsen, R; Rauch, C				Timm, David E.; Bowman, Valorie; Madsen, Russell; Rauch, Charles			Cryo-electron microscopy structure of a human PRMT5:MEP50 complex	PLOS ONE			English	Article							ARGININE METHYLTRANSFERASE PRMT5; CRYO-EM STRUCTURE; ELECTRON CRYOMICROSCOPY; UCSF CHIMERA; PROTEIN; METHYLATION; TRANSCRIPTION; CANCER; ACTIVATION; INHIBITOR	Protein arginine methyl transferase 5 (PRMT5) is a signaling protein and histone modifying enzyme that is important in many cellular processes, including regulation of eukaryotic gene transcription. Reported here is a 3.7 angstrom structure of PRMT5, solved in complex with regulatory binding subunit MEP50 (methylosome associated protein 50, WDR77, p44), by single particle (SP) cryo-Electron Microscopy (cryo-EM) using micrographs of particles that are visibly crowded and aggregated. Despite suboptimal micrograph appearance, this cryo-EM structure is in good agreement with previously reported crystal structures of the complex, which revealed a 450 kDa hetero-octameric assembly having internal D2 symmetry. The catalytic PRMT5 subunits form a core tetramer and the MEP50 subunits are arranged peripherally in complex with the PRMT5 N-terminal domain. The cryo-EM reconstruction shows good side chain definition and shows a well-resolved peak for a bound dehydrosine-fungin inhibitor molecule. These results demonstrate the applicability of cryo-EM in determining structures of human protein complexes of biomedical significance and suggests cryo-EM could be further utilized to understand PRMT5 interactions with other biologically important binding proteins and ligands.	[Timm, David E.] Eli Lilly & Co, Lilly Corp Ctr, Struct Biol Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Bowman, Valorie] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Madsen, Russell; Rauch, Charles] Eli Lilly & Co, Lilly Biotechnol Ctr, Struct Biol Discovery Chem Res & Technol, San Diego, CA USA	Eli Lilly; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Eli Lilly	Timm, DE (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Struct Biol Discovery Chem Res & Technol, Indianapolis, IN 46285 USA.	d-timm@sbcglobal.net			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This research was funded in its entirety by Eli Lilly and Company. Eli Lilly and Company provided support in the form of salaries for authors [DET, RM, CR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Disclosure of this work in the form of a published manuscript has been approved by Eli Lilly and Company.	Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Burgos ES, 2015, J BIOL CHEM, V290, P9674, DOI 10.1074/jbc.M115.636894; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Duncan KW, 2016, ACS MED CHEM LETT, V7, P162, DOI 10.1021/acsmedchemlett.5b00380; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Khoshouei M, 2017, J MOL BIOL, V429, P2611, DOI 10.1016/j.jmb.2017.07.004; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lawson CL, 2016, NUCLEIC ACIDS RES, V44, pD396, DOI 10.1093/nar/gkv1126; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Z, 2016, STRUCTURE, V24, P319, DOI 10.1016/j.str.2015.12.006; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Niitsuma M, 2010, J ANTIBIOT, V63, P673, DOI 10.1038/ja.2010.102; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039	48	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193205	10.1371/journal.pone.0193205	http://dx.doi.org/10.1371/journal.pone.0193205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518110	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900016
J	van der Kooij, K; Wijdenes, LO; Rigterink, T; Overvliet, KE; Smeets, JBJ				van der Kooij, Katinka; Wijdenes, Leonie Oostwoud; Rigterink, Tessa; Overvliet, Krista E.; Smeets, Joeren B. J.			Reward abundance interferes with error-based learning in a visuomotor adaptation task	PLOS ONE			English	Article							MOTOR CONTROL; EXPLICIT; SKILL; REINFORCEMENT; MODELS	The brain rapidly adapts reaching movements to changing circumstances by using visual feedback about errors. Providing reward in addition to error feedback facilitates the adaptation but the underlying mechanism is unknown. Here, we investigate whether the proportion of trials rewarded (the 'reward abundance') influences how much participants adapt to their errors. We used a 3D multi-target pointing task in which reward alone is insufficient for motor adaptation. Participants (N = 423) performed the pointing task with feedback based on a shifted hand-position. On a proportion of trials we gave them rewarding feedback that their hand hit the target. Half of the participants only received this reward feedback. The other half also received feedback about endpoint errors. In different groups, we varied the proportion of trials that was rewarded. As expected, participants who received feedback about their errors did adapt, but participants who only received reward-feedback did not. Critically, participants who received abundant rewards adapted less to their errors than participants who received less reward. Thus, reward abundance negatively influences how much participants learn from their errors. Probably participants used a mechanism that relied more on the reward feedback when the reward was abundant. Because participants could not adapt to the reward, this interfered with adaptation to errors.	[van der Kooij, Katinka; Rigterink, Tessa; Smeets, Joeren B. J.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Wijdenes, Leonie Oostwoud] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Overvliet, Krista E.] Univ Hamburg, Dept Biol Psychol & Neuropsychol, Hamburg, Germany	Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Hamburg	van der Kooij, K (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	k.vander.kooij@vu.nl	Oostwoud Wijdenes, Leonie/M-1262-2015; Smeets, Jeroen/B-4198-2008; Overvliet, Krista/J-9214-2014	Oostwoud Wijdenes, Leonie/0000-0002-7264-7853; Smeets, Jeroen/0000-0002-3794-0579; Overvliet, Krista/0000-0002-3537-8172; van der Kooij, Katinka/0000-0002-4190-7827	Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) [12668]; European Commission; Marie-Curie IEF fellowship [624297]; FP7 Marie-Curie IEF fellowship [624297]; FP7 Marie-Curie IEF fellowship by the European Commission [624297]	Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie IEF fellowship; FP7 Marie-Curie IEF fellowship; FP7 Marie-Curie IEF fellowship by the European Commission	Katinka van der Kooij and Joeren Smeets were funded by Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) grant 12668 awarded to Joeren Smeets and European Commission. Krista Overvliet was additionally funded by Marie-Curie IEF fellowship grant number 624297. Leonie Oostwoud Wijdenes and Tessa Rigterink received no funding for this research. The funders played no role in the research. Krista Overvliet was additionally funded by FP7 Marie-Curie IEF fellowship grant number 624297. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was part of Science Live, the innovative research programme of Science Center NEMO that enables scientists to carry out real, publishable, peer-reviewed research using NEMO visitors as volunteers. The research was funded by Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) grant 12668 awarded to Jeroen Smeets. We thank Jasper van de Lagemaat for testing participants in the museum, Tim Groeneboom (www.timgroeneboom.com) for programming the experiment and Stefan de Graaff (www.stefandegraaff.nl) for the video impression of the experiment. KO was supported by a FP7 Marie-Curie IEF fellowship by the European Commission (624297).	Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Brenner E, 2011, EXP BRAIN RES, V213, P153, DOI 10.1007/s00221-011-2786-9; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Dayan E, 2014, LEARN MEMORY, V21, P140, DOI 10.1101/lm.032417.113; Festini SB, 2016, EXP BRAIN RES, V234, P1385, DOI 10.1007/s00221-015-4542-z; Gajda K, 2016, EXP BRAIN RES, V234, P2859, DOI 10.1007/s00221-016-4688-3; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Huberdeau DM, 2015, J NEUROPHYSIOLOGY, V114; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Mawase F, 2017, J NEUROSCI, V37, P2673, DOI 10.1523/JNEUROSCI.3303-16.2017; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nikooyan AA, 2015, J NEUROPHYSIOL, V113, P633, DOI 10.1152/jn.00032.2014; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Redding GM, 2006, J EXP PSYCHOL HUMAN, V32, P1006, DOI 10.1037/0096-1523.32.4.1006; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Shadmehr R, 2016, CURR BIOL, V26, P1929, DOI 10.1016/j.cub.2016.05.065; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Song Y, 2017, EXPT BRAIN RES, P1; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Therrien AS, 2016, BRAIN, V139, P101, DOI 10.1093/brain/awv329; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2016, EXP BRAIN RES, V234, P1441, DOI 10.1007/s00221-015-4540-1; Widmer M, 2016, PROG BRAIN RES, V229, P303, DOI 10.1016/bs.pbr.2016.05.006; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NATURE NEUROSCIENCE	31	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193002	10.1371/journal.pone.0193002	http://dx.doi.org/10.1371/journal.pone.0193002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513681	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800028
J	Almotwaa, S; Elrobh, M; AbdulKarim, H; Alanazi, M; Aldaihan, S; Shaik, J; Arafa, M; Warsy, AS				Almotwaa, Sahar; Elrobh, Mohamed; AbdulKarim, Huda; Alanazi, Mohamed; Aldaihan, Sooad; Shaik, Jilani; Arafa, Maha; Warsy, Arjumand Sultan			Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; HSP90 INHIBITORS; GROWTH; PROTEIN; TRANSFORMATION; TUMORIGENESIS; METASTASIS; APOPTOSIS; THERAPY; TUMORS	The transcription factor, heat shock factor 1 (HSF1), influences the expression of heat shock proteins as well as other activities like the induction of tumor suppressor genes, signal transduction pathway, and glucose metabolism. We hypothesized that single nucleotide polymorphisms (SNPs) in HSF1 gene might affect its expression or function which might have an influence on the development of breast cancer. The study group included 242 individuals (146 breast cancer patients and 96 healthy controls). From the cancer patients, genomic DNA was extracted from 96 blood samples and 50 Formalin-Fixed Paraffin Embedded (FFPE) tissues, while from the controls DNA were extracted from blood only. Genotype was carried out for four SNPs in the HSF1 gene (rs78202224, rs35253356, rs4977219 and rs34404564) using Taqman genotyping assay method. The HSF1 expression was investigated using immunohistochemistry on FFPE tissues (cancer tissue and adjacent normal tissue). The SNP rs78202224 (G>T) was significantly associated with increased risk of breast cancer. The combined TT + GT genotype (OR: 6.91; p: 0.035) and the T allele showed high risk (OR: 5.81; p: 0.0085) for breast cancer development. The SNP rs34404564 (A>G) had a protective effect against the development of breast cancer. The genotype AG (OR: 0.41; p = 0.0059) and GG+AG (OR: 0.52; p: 0.026) occurred at a significantly lower frequency in the breast cancer patients compared to the frequency in healthy controls. No significant relationship was identified between either rs35253356 (A>G) or rs4977219 (A>C) and breast cancer in Saudi. The HSF1 protein expression was higher in all invasive and in situ breast carcinoma compared to the normal tissue. A stronger positive staining for HSF1 was found in the nucleus compared to the cytoplasm. Our results show that HSF1 gene expression is elevated in breast cancer tissue and two of the studied SNPs correlate significantly with cancer development.	[Almotwaa, Sahar; Elrobh, Mohamed; Alanazi, Mohamed; Aldaihan, Sooad] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia; [AbdulKarim, Huda] King Fahad Med City Hosp, Comprehens Canc Ctr, Hematol Oncol Unit, Riyadh, Saudi Arabia; [Shaik, Jilani] King Saud Univ, Dept Biochem, Coll Sci, Genome Res Chair, Riyadh, Saudi Arabia; [Arafa, Maha] King Saud Univ, Dept Pathol, Coll Med, Riyadh, Saudi Arabia; [Warsy, Arjumand Sultan] King Saud Univ, Cent Lab, Ctr Sci & Med Studies Girls, Riyadh, Saudi Arabia	King Saud University; King Fahad Medical City; King Saud University; King Saud University; King Saud University	Warsy, AS (corresponding author), King Saud Univ, Cent Lab, Ctr Sci & Med Studies Girls, Riyadh, Saudi Arabia.	aswarsy@ksu.edu.sa	almotwaa, sahar/GQY-9950-2022; Warsy, Arjumand/D-5274-2015; Elrobh, Mohamed S/H-5696-2012	almotwaa, sahar/0000-0003-1378-7140; Warsy, Arjumand/0000-0001-6957-203X; , Mohamed/0000-0003-1967-8850	King Saud University; King Abdulaziz city of Science and Technology	King Saud University(King Saud University); King Abdulaziz city of Science and Technology	The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs. The authors also acknowledge the support of King Abdulaziz city of Science and Technology.; The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs. The authors also acknowledge the support of King Abdulaziz city of Science and Technology.	Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; Chen YY, 2013, ONCOTARGET, V4, P816, DOI 10.18632/oncotarget.991; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dudeja V, 2011, AM J PHYSIOL-GASTR L, V300, pG948, DOI 10.1152/ajpgi.00346.2010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Home T, 2015, CANCER RES, V75, P907, DOI 10.1158/0008-5472.CAN-14-2905; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Jiang SF, 2015, TUMOR BIOL, V36, P4923, DOI 10.1007/s13277-015-3674-x; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang GY, 2015, ONCOTARGET, V6, P29712, DOI 10.18632/oncotarget.5073; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Neckers L, 2003, NATURE, V425, P357, DOI 10.1038/425357a; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Sam SS, 2012, PATHOL RES PRACT, V208, P705, DOI 10.1016/j.prp.2012.08.008; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sarkar R, 2012, BIOCHEM BIOPH RES CO, V427, P80, DOI 10.1016/j.bbrc.2012.09.006; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Vydra N, 2014, CURR CANCER DRUG TAR, V14, P144, DOI 10.2174/1568009614666140122155942; Wang B, 2015, BREAST CANCER RES TR, V153, P57, DOI 10.1007/s10549-015-3521-1; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; Yamaki H, 2011, J ANTIBIOT, V64, P635, DOI 10.1038/ja.2011.60	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193095	10.1371/journal.pone.0193095	http://dx.doi.org/10.1371/journal.pone.0193095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494616	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200022
J	Mayordomo, AC; Silva, JE; Gorlino, CV; Arias, JL; Beron, W; Di Genaro, MS				Constanza Mayordomo, Andrea; Eduardo Silva, Juan; Virginia Gorlino, Carolina; Luis Arias, Jose; Beron, Walter; Silvia Di Genaro, Maria			IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55(-/-) mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; IMMUNE-RESPONSE; TNF-ALPHA; FACTOR RECEPTOR; PEYERS-PATCHES; INTERLEUKIN-12; ACTIVATION; CYTOKINE; EXPRESSION	Dendritic cells ( DCs) play critical functions in the initiation of immune responses. Understanding their role in reactive arthritis ( ReA) will help delineate the pathogenesis of this arthropathy. In early studies, we detected IL-12/23p40 deregulation in Yersinia entercolitica ( Ye)-induced ReA in TNFRp55-deficient ( TNFRp55(-/-)) mice. In this study, we assessed the contribution of DCs in this overproduction. First, greater levels of IL-12/23p40, IFN-gamma and IL-17A were confirmed in supernatants of lipopolysaccharide ( LPS)-stimulated TNFRp55(-/-) splenocytes obtained on arthritis onset ( day 14 after Ye infection). Later, DCs were identified as a precise source of IL-12/23p40 since increased frequency of splenic IL-12/23p40(+) DCs was detected in TNFRp55(-/-) mice. After robust in vivo amplification of DCs by injection of Fms-like tyrosine kinase 3-Ligand ( Flt3L)-transfected BL16 melanoma, DCs were purified. These cells recapitulated the higher production of IL-12/23p40 under TNFRp55deficiency. In agreement with these results, TNFRp55(-/-) DCs promoted Th1 and Th17 programs by co-culture with WT CD4(+) lymphocytes. A mechanistic study demonstrated that JNK and p38 MAPK pathways are involved in IL-12/23p40 overproduction in purified TNFRp55(-/)- DCs as well as in the JAWS II cell line. This deregulation was once again attributed to TNFRp55 deficiency since CAY10500, a specific inhibitor of this pathway, compromised TNF-mediated IL-12/23p40 control in LPS-stimulated WT DCs. Simultaneously, this inhibition reduced IL-10 production, suggesting its role mediating IL-12/23p40 regulation by TNFRp55 pathway. These results provide experimental data on the existence of a TNFRp55-mediated anti-inflammatory circuit in DCs. Moreover, these cells may be considered as a novel target in the treatment of ReA.	[Constanza Mayordomo, Andrea; Eduardo Silva, Juan; Virginia Gorlino, Carolina; Luis Arias, Jose; Silvia Di Genaro, Maria] Univ Nacl San Luis, Fac Qum Bioquim & Farm, Div Inmunol, San Luis, Argentina; [Eduardo Silva, Juan; Silvia Di Genaro, Maria] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol IMIBIO, San Luis, Argentina; [Beron, Walter] Univ Nacl Cuyo, CONICET, Inst Histol & Embriol, Fac Ciencias Med, Mendoza, Argentina	Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Di Genaro, MS (corresponding author), Univ Nacl San Luis, Fac Qum Bioquim & Farm, Div Inmunol, San Luis, Argentina.; Di Genaro, MS (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol IMIBIO, San Luis, Argentina.	sdigena@unsl.edu.ar		Mayordomo, Andrea Constanza/0000-0002-0399-9644	National Agency for Promotion of Science and Technology [PICT-2011-0732]; Universidad Nacional de San Luis [PROICO-2-1114]; Alexander von Humboldt Foundation; CONICET-DFG cooperation Project	National Agency for Promotion of Science and Technology(ANPCyT); Universidad Nacional de San Luis; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); CONICET-DFG cooperation Project	This work was supported by grants from the National Agency for Promotion of Science and Technology (PICT-2011-0732), the Universidad Nacional de San Luis (PROICO-2-1114), the Alexander von Humboldt Foundation, and the CONICET-DFG cooperation Project to MSDG. CVG, WB and MSDG are members of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); ACM, JLA and JES are fellows from the CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Autenrieth IB, 1996, INFECT IMMUN, V64, P1357, DOI 10.1128/IAI.64.4.1357-1368.1996; AUTENRIETH IB, 1993, IMMUNOBIOLOGY, V187, P1; AUTENRIETH IB, 1992, INFECT IMMUN, V60, P1140, DOI 10.1128/IAI.60.3.1140-1149.1992; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Bohn E, 1998, INFECT IMMUN, V66, P2213, DOI 10.1128/IAI.66.5.2213-2220.1998; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Cargnelutti E, 2013, IMMUNOL CELL BIOL, V91, P159, DOI 10.1038/icb.2012.65; Carter JD, 2009, ARTHRITIS RHEUM, V60, P1311, DOI 10.1002/art.24431; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen X, 2011, FEBS LETT, V585, P3611, DOI 10.1016/j.febslet.2011.04.025; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Di Genaro MS, 2007, RHEUMATOLOGY, V46, P590, DOI 10.1093/rheumatology/kel348; Di Genaro MS, 2003, INFECT IMMUN, V71, P1804, DOI 10.1128/IAI.71.4.1804-1812.2003; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Elicabe RJ, 2010, J IMMUNOL, V185, P4485, DOI 10.4049/jimmunol.0902245; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Inman RD, 2009, ADV EXP MED BIOL, V649, P300; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; KVIEN TK, 1994, J RHEUMATOL, V21, P115; Leirisalo-Repo M, 2005, SCAND J RHEUMATOL, V34, P251, DOI 10.1080/03009740500202540; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Lis K, 2014, ARCH MED SCI, V10, P1175, DOI 10.5114/aoms.2014.47827; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mitoma H, 2016, CYTOKINE, P30468; Mitsuhashi M, 2004, J LEUKOCYTE BIOL, V76, P322, DOI 10.1189/jlb.1203641; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Quan JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141550; Selmi C, 2014, AUTOIMMUN REV, V13, P546, DOI 10.1016/j.autrev.2014.01.005; Singh R, 2007, J RHEUMATOL, V34, P2285; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; Valimaki E, 2013, SCAND J RHEUMATOL, V42, P294, DOI 10.3109/03009742.2012.754940; Vieira LQ, 1996, J IMMUNOL, V157, P827; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Williams-Skipp C, 2009, ARTHRITIS RHEUM-US, V60, P408, DOI 10.1002/art.24260; Wright P, 2013, CURR OPIN RHEUMATOL, V25, P440, DOI 10.1097/BOR.0b013e32836202dc; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Yu MB, 2017, RHEUMATOL INT, V37, P1043, DOI 10.1007/s00296-017-3671-z; Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024; Zhang Y, BLOOD; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193573	10.1371/journal.pone.0193573	http://dx.doi.org/10.1371/journal.pone.0193573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494692	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200067
J	Erturk, G; Hedstrom, M; Mattiasson, B; Ruzgas, T; Lood, R				Erturk, Gizem; Hedstrom, Martin; Mattiasson, Bo; Ruzgas, Tautgirdas; Lood, Rolf			Highly sensitive detection and quantification of the secreted bacterial benevolence factor RoxP using a capacitive biosensor: A possible early detection system for oxidative skin diseases	PLOS ONE			English	Article							MOLECULARLY IMPRINTED POLYMERS; PROPIONIBACTERIUM-ACNES; IMMUNOSENSOR; INFECTION; HYDROMIPS; DEFENSE; STRESS	The impact of the microbiota on our health is rapidly gaining interest. While several bacteria have been associated with disease, and others being indicated as having a probiotic effect, the individual biomolecules behind these alterations are often not known. A major problem in the study of these factors in vivo is their low abundance in complex environments. We recently identified the first secreted bacterial antioxidant protein, RoxP, from the skin commensal Propionibacterium acnes, suggesting its relevance for maintaining the redox homeostasis on the skin. In order to study the effect, and prevalence, of RoxP in vivo, a capacitive biosensor with a recognition surface based on molecular imprinting was used to detect RoxP on skin in vivo. In vitro analyses demonstrated the ability to detect and quantify RoxP in a concentration range of 1 x 10(-13) M to 1 x 10(-8) M from human skin swabs; with a limit of detection of 2.5 x 10(-19) M in buffer systems. Further, the biosensor was highly selective, not responding to any other secreted protein from P. acnes. Thus, it was possible to demonstrate the presence, and quantity, of RoxP on human skin. Therefore, the developed biosensor is a very promising tool for the detection of RoxP from clinical samples, offering a rapid, cost-effective and sensitive means of detecting low-abundant bacterial proteins in vivo in complex milieus.	[Erturk, Gizem; Lood, Rolf] Lund Univ, Biomed Ctr B14, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden; [Hedstrom, Martin; Mattiasson, Bo] Lund Univ, Dept Biotechnol, Lund, Sweden; [Hedstrom, Martin; Mattiasson, Bo] CapSenze Biosyst AB, Lund, Sweden; [Ruzgas, Tautgirdas] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, Malmo, Sweden	Lund University; Lund University; Malmo University	Lood, R (corresponding author), Lund Univ, Biomed Ctr B14, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden.	Rolf.Lood@med.lu.se	Ruzgas, Tautgirdas/C-4646-2008	Ruzgas, Tautgirdas/0000-0003-0304-7528; Erturk Bergdahl, Gizem/0000-0001-9719-6609	Crafoord Foundation [20170669]; Foundation Tornspiran; Foundation Alfred Osterlund; Foundation Magnus Bergvall; Foundation Ake Wiberg; Foundation Langmanska Kulturfonden; Foundation Zoegas; Foundation Lars Hierta; Foundation Sigurd; Foundation Elsa Golje's Memory; Royal PhysiographicSociety Lund; Swedish Medical Society	Crafoord Foundation; Foundation Tornspiran; Foundation Alfred Osterlund; Foundation Magnus Bergvall; Foundation Ake Wiberg; Foundation Langmanska Kulturfonden; Foundation Zoegas; Foundation Lars Hierta; Foundation Sigurd; Foundation Elsa Golje's Memory; Royal PhysiographicSociety Lund; Swedish Medical Society	This work was supported by grants from the Crafoord Foundation (20170669) to TR, and the Foundations Tornspiran, Alfred Osterlund, Magnus Bergvall, Ake Wiberg, Langmanska Kulturfonden, Zoegas, Lars Hierta, Sigurd and Elsa Golje's Memory, the Royal PhysiographicSociety Lund, and the Swedish Medical Society to RL. Bo Mattiasson and Martin Hedstrom are associated with the company CapSenze, on whose instrument the analyses were performed, providing support in the form of instrument leasing, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Allhorn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36412; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bek-Thomsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107908; Berggren C, 2001, ELECTROANALYSIS; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bossi O, 2008, J CELL BIOCHEM, V105, P194, DOI 10.1002/jcb.21817; El-Sharif HF, 2014, ANAL CHIM ACTA, V809, P155, DOI 10.1016/j.aca.2013.11.052; Erlandsson D, 2014, SENSOR ACTUAT B-CHEM, V190, P295, DOI 10.1016/j.snb.2013.08.076; Erturk G, 2017, ADV MOLECULARLY IMPR; Erturk G, 2016, BIOSENS BIOELECTRON, V86, P557, DOI 10.1016/j.bios.2016.07.046; Erturk G, 2016, J CHROMATOGR B, V1021, P30, DOI 10.1016/j.jchromb.2015.12.025; Erturk G, 2015, ANAL CHIM ACTA, V891, P120, DOI 10.1016/j.aca.2015.07.055; Erturk Gizem, 2014, Biotechnol Rep (Amst), V3, P65, DOI 10.1016/j.btre.2014.06.006; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Gutierrez R Alvaro V, 2015, Biotechnol Rep (Amst), V8, P144, DOI 10.1016/j.btre.2015.10.001; Haupt K, 2003, ANAL CHEM, V75, p376A, DOI 10.1021/ac031385h; Hawkins DM, 2006, BIOMACROMOLECULES, V7, P2560, DOI 10.1021/bm060494d; Hawkins DM, 2005, ANAL CHIM ACTA, V542, P61, DOI 10.1016/j.aca.2005.01.052; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Kadam DP, 2010, INDIAN J CLIN BIOCHE, V25, P388, DOI 10.1007/s12291-010-0043-9; Lebogang L, 2014, ANAL CHIM ACTA, V826, P69, DOI 10.1016/j.aca.2014.03.028; Lenain P, 2015, BIOSENS BIOELECTRON, V69, P34, DOI 10.1016/j.bios.2015.02.016; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Reddy SM, 2012, BIOMACROMOLECULES, V13, P3959, DOI 10.1021/bm301189f; Shu M, 2013, CURR MED CHEM, V20, P562; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Teeparuksapun K, 2010, ANAL CHEM, V82, P8406, DOI 10.1021/ac102144a; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473; Webster GF, 2002, BMJ-BRIT MED J, V325, P475, DOI 10.1136/bmj.325.7362.475; Wernersson E, BIOTECHNOL REP; Wilson R, 2013, EXPERT REV PROTEOMIC, V10, P135, DOI [10.1586/EPR.13.7, 10.1586/epr.13.7]	36	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193754	10.1371/journal.pone.0193754	http://dx.doi.org/10.1371/journal.pone.0193754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494704	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200095
J	Penitente, JM; Villadiego, FAC; Silva, FFE; Camilo, BS; Leon, VG; Peixoto, T; Diaz, E; Okano, D; Maitan, P; Lima, D; Guimaraes, SF; Siqueira, JB; Pinho, R; Guimaraes, JD				Penitente-Filho, Jurandy Mauro; Castano Villadiego, Faider Alberto; Fonseca e Silva, Fabyano; Camilo, Breno Soares; Leon, Victor Gomez; Peixoto, Thiago; Diaz, Edgar; Okano, Denise; Maitan, Paula; Lima, Daniel; Guimaraes, Simone Facioni; Siqueira, Jeanne Broch; Pinho, Rogerio; Guimaraes, Jose Domingos			Can scrotal circumference-based selection discard bulls with good productive and reproductive potential?	PLOS ONE			English	Article							ADDITIVE GENETIC-RELATIONSHIPS; HEIFER PREGNANCY; NONLINEAR MODELS; SPERM PRODUCTION; GROWTH; TRAITS; PARAMETERS; PERFORMANCE; CARCASS; AGE	Nonlinear mixed models were used to describe longitudinal scrotal circumference (SC) measurements of Nellore bulls. Models comparisons were based on Akaike's information criterion, Bayesian information criterion, error sum of squares, adjusted R-2 and percentage of convergence. Sequentially, the best model was used to compare the SC growth curve in bulls divergently classified according to SC at 18-21 months of age. For this, bulls were classified into five groups: SC < 28cm; 28cm <= SC < 30cm, 30cm <= SC < 32cm, 32cm <= SC < 34cm and SC >= 34cm. Michaelis-Menten model showed the best fit according to the mentioned criteria. In this model, beta(1) is the asymptotic SC value and beta(2) represents the time to half-final growth and may be related to sexual precocity. Parameters of the individual estimated growth curves were used to create a new dataset to evaluate the effect of the classification, farms, and year of birth on beta(1) and beta(2) parameters. Bulls of the largest SC group presented a larger predicted SC along all analyzed periods; nevertheless, smaller SC group showed predicted SC similar to intermediate SC groups (28cm <= SC < 32cm), around 1200 days of age. In this context, bulls classified as improper for reproduction at 18-21 months old can reach a similar condition to those considered as good condition. In terms of classification at 18-21 months, asymptotic SC was similar among groups, farms and years; however, beta(2) differed among groups indicating that differences in growth curves are related to sexual precocity. In summary, it seems that selection based on SC at too early ages may lead to discard bulls with suitable reproductive potential.	[Penitente-Filho, Jurandy Mauro; Castano Villadiego, Faider Alberto; Camilo, Breno Soares; Leon, Victor Gomez; Peixoto, Thiago; Diaz, Edgar; Okano, Denise; Maitan, Paula; Lima, Daniel; Pinho, Rogerio; Guimaraes, Jose Domingos] Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano; Guimaraes, Simone Facioni] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Siqueira, Jeanne Broch] Univ Fed Vales Jequitinhonha & Mucuri, Inst Agr Sci, Unai, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Penitente, JM (corresponding author), Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil.	penitentefilho@yahoo.com.br	Silva, Fabyano Fonseca/D-8158-2017; Silva, Fabyano/Y-9223-2019; Penitente-Filho, Jurandy/G-3017-2012; facioni guimaraes, simone eliza/HHZ-5341-2022	Penitente-Filho, Jurandy/0000-0002-8592-4020; Okano, Denise/0000-0002-6176-806X; facioni guimaraes, simone eliza/0000-0003-3704-8131	CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)	CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	JMPF received financial support from CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior - http://www.capes.gov.br/), Post-doctoral fellowship. Other financial support was received from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://cnpq.br/) and FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - http://www.fapemig.br/).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2006, SAS MIXED MODELS; Bailey TL, 1998, THERIOGENOLOGY, V49, P581, DOI 10.1016/S0093-691X(98)00009-0; Bailey TL, 1996, THERIOGENOLOGY, V46, P881, DOI 10.1016/S0093-691X(96)00245-2; Barbosa V, 2010, BIOSCI J, V26, P789; Barth AD, 2000, CAN VET J, V41, P541; Bergmann JAG, 1998, C BRASILEIRO RACAS Z, V3, P145; Bilgin OC, 2004, SMALL RUMINANT RES, V52, P155, DOI 10.1016/S0921-4488(03)00251-7; Brinks J. S., 1994, Factors affecting calf crop., P363; Brody S., 1945, BIOENERGETICS GROWTH; Buzanskas ME, 2017, THERIOGENOLOGY, V92, P204, DOI 10.1016/j.theriogenology.2016.09.057; Cabrera ME, 2002, ARQUIVOS CIENCIA VET, V5, P225; Carreira JT, 2017, BASIC CLIN ANDROL, V27, DOI 10.1186/s12610-017-0056-9; Costa e Silva EV, 2015, REV BRAS REPROD ANIM, V39, P22; COULTER GH, 1979, THERIOGENOLOGY, V11, P297, DOI 10.1016/0093-691X(79)90072-4; Eler JP, 2006, GENET MOL RES, V5, P569; Eler JP, 2004, J ANIM SCI, V82, P2519; Ferraz J. B. S., 2007, Revista Brasileira de Reproducao Animal, V31, P167; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Fortes MRS, 2014, ANDROLOGY-US, V2, P370, DOI 10.1111/j.2047-2927.2014.00196.x; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; GRESSLER SL, 2000, REV BRAS ZOOTECN, V29, P427, DOI DOI 10.1590/S1516-35982000000200016; Grossi DA, 2009, J ANIM BREED GENET, V126, P387, DOI 10.1111/j.1439-0388.2008.00791.x; Henry M, 2013, BUFFALO BULL, V32, P439; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Kizilkaya K, 2006, ARCH GEFLUGELKD, V70, P181; KNIGHTS SA, 1984, J ANIM SCI, V58, P887, DOI 10.2527/jas1984.584887x; Loaiza-Echeverri AM, 2013, THERIOGENOLOGY, V79, P751, DOI 10.1016/j.theriogenology.2012.11.031; Lopez S, 2000, J ANIM SCI, V78, P1816; Lunstra D.D., 1982, BEEF RES PROGR PROG, V1, P26; LUNSTRA DD, 1978, J ANIM SCI, V46, P1054, DOI 10.2527/jas1978.4641054x; Marques EG, 2013, BIOSCI J, V29, P159; Meloun M, 1996, SBIRKA ULOH STAT ZPR; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moser DW, 1996, J ANIM SCI, V74, P2052; Nieto LM, 2006, VET ZOOLOGIA UNIPAR, V9, P99; NOTTER DR, 1985, J ANIM SCI, V60, P622, DOI 10.2527/jas1985.603622x; Notter DR, 1993, RELATIONSHIP YEARLIN, P180; OLTJEN JW, 1986, J ANIM SCI, V62, P86, DOI 10.2527/jas1986.62186x; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Pereira E, 2001, ARQ BRAS MED VET ZOO, V53, P720, DOI 10.1590/S0102-09352001000600019; Quirino CR, 1999, THERIOGENOLOGY, V52, P25, DOI 10.1016/S0093-691X(99)00107-7; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rochetti RL, 2007, REUN SOC BRAS ZOOT, V44; ROOK AJ, 1993, J AGR SCI, V121, P97, DOI 10.1017/S002185960007684X; Santana ML, 2015, THERIOGENOLOGY, V83, P1534, DOI 10.1016/j.theriogenology.2015.02.003; Santana ML, 2012, ANIMAL, V6, P565, DOI 10.1017/S1751731111001856; SAS, 2002, SAS STAT US GUID STA; Schinckel A. P., 2004, Professional Animal Scientist, V20, P79; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sesana RC, 2007, BRASILEIRA ZOOTECNIA, V44; Silva AEDF, 2002, REV BRAS ZOOTECN, V31, P1157, DOI 10.1590/S1516-35982002000500012; Silva LSPM, 2014, THESIS; Silveira FG, 2010, THESIS; Silveira TD, 2010, REV BRAS ZOOTECN, V39, P503, DOI 10.1590/S1516-35982010000300008; Siqueira J. B., 2013, Revista Brasileira de Reproducao Animal, V37, P3; Souza LD, 2013, REV BRAS ZOOTECN, V42, P651, DOI 10.1590/S1516-35982013000900007; TOELLE VD, 1985, J ANIM SCI, V60, P89, DOI 10.2527/jas1985.60189x; Unanian MM, 2000, REV BRAS ZOOTECN, V29, P136, DOI 10.1590/S1516-35982000000100019; Van Melis MH, 2010, J ANIM SCI, V88, P3809, DOI 10.2527/jas.2009-2127; Vargas CA, 1998, J ANIM SCI, V76, P2536; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Yokoo MJ, 2007, REV BRAS ZOOTECN, V36, P1761, DOI 10.1590/S1516-35982007000800008	64	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193103	10.1371/journal.pone.0193103	http://dx.doi.org/10.1371/journal.pone.0193103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494597	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200023
J	Serjeant, GR; Chin, N; Asnani, MR; Serjeant, BE; Mason, KP; Hambleton, IR; Knight-Madden, JM				Serjeant, Graham R.; Chin, Nicki; Asnani, Monika R.; Serjeant, Beryl E.; Mason, Karlene P.; Hambleton, Ian R.; Knight-Madden, Jennifer M.			Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth	PLOS ONE			English	Article							BETA-GLOBIN GENE; ALPHA-THALASSEMIA; ADVERSE OUTCOMES; RISK-FACTORS; CHILDREN; MORTALITY; ANEMIA; POPULATION; PREVALENCE; PREDICTION	Globally, the majority of persons born with sickle cell disease do not have access to hydroxyurea or more expensive interventions. The objectives were to estimate the survival in homozygous sickle cell disease, unbiased by symptomatic selection and to ascertain the causes of death in a pre-hydroxyurea population. The utility of early life biomarkers and genetically determined phenotypes to predict survival was assessed. A cohort study based on neonatal diagnosis was undertaken at the Sickle Cell Unit, a specialist clinic delivering care to persons with sickle cell disease in Jamaica. Screening of 100,000 deliveries detected 315 babies with homozygous sickle cell disease of whom 311 have been followed from birth for periods up to 43 years. Pneumococcal prophylaxis and teaching mothers splenic palpation were important, inexpensive interventions. Anticipatory guidance, routine care and out-patient acute care were provided. Each participant was classified as alive, dead, or defaulted (usually emigration). Causes of death were ascertained from clinical records and/or post-mortem reports. Survival was assessed using the Kaplan-Meier function. Sex-adjusted Cox semi-parametric proportional hazards and Weibull modelling were used to assess the effects on survival of biomarkers. Survival to 40 years was 55.5% (95% CI 48.7% to 61.7%). Acute Chest Syndrome (n = 31) and septicemia (n = 14) were significant causes of death at all ages. Acute splenic sequestration (n = 12) was the most common cause of early deaths. Survival was significantly shorter in those with lower hemoglobin at 1 year, high total nucleated count at 1 year, and a history of dactylitis ever. In these hydroxyurea naive patients, survival into midlife was common. Causes of death were often age specific and some may be preventable. Early life biomarkers predictive of decreased survival in SS disease identify a patient group likely to benefit from close clinical supervision and potentially high risk therapies.	[Serjeant, Graham R.; Serjeant, Beryl E.; Mason, Karlene P.] Sickle Cell Trust Jamaica, Kingston, Jamaica; [Chin, Nicki; Asnani, Monika R.; Knight-Madden, Jennifer M.] Univ West Indies, Caribbean Inst Hlth Res, Sickle Cell Unit, Kingston, Jamaica; [Hambleton, Ian R.] Univ West Indies, Chron Dis Res Ctr, Caribbean Inst Hlth Res, Cave Hill, Barbados	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Knight-Madden, JM (corresponding author), Univ West Indies, Caribbean Inst Hlth Res, Sickle Cell Unit, Kingston, Jamaica.	jennifer.knightmadden@uwimona.edu.jm	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794	Medical Research Council of Great Britain; University of the West Indies; Caribbean Public Health Agency; National Health Fund of Jamaica	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the West Indies; Caribbean Public Health Agency; National Health Fund of Jamaica	The Cohort Study was established with funding from the Medical Research Council of Great Britain. Recent work was supported by the University of the West Indies, the Caribbean Public Health Agency, and the National Health Fund of Jamaica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; Gardner K, 2016, BLOOD, V128, P1436, DOI 10.1182/blood-2016-05-716910; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Hardie R, 2009, ANN TROP PAEDIATR, V29, P197, DOI 10.1179/027249309X12467994693851; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; King L, 2011, W INDIAN MED J, V60, P177; King L, 2011, ARCH DIS CHILD, V96, P1135, DOI 10.1136/archdischild-2011-300628; King LGC, 2015, J PEDIATR-US, V167, P702, DOI 10.1016/j.jpeds.2015.06.028; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; Maitra P, 2017, HAEMATOLOGICA, V102, P626, DOI 10.3324/haematol.2016.153791; MEARS JG, 1983, BLOOD, V62, P286; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; NAGEL RL, 1990, SEMIN HEMATOL, V27, P342; Old J M, 1996, Methods Mol Med, V5, P169, DOI 10.1385/0-89603-346-5:169; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2008, BLOOD, V111, P544, DOI 10.1182/blood-2007-07-100719; ROGERS DW, 1978, BRIT MED J, V1, P1515, DOI 10.1136/bmj.1.6126.1515; SERJEANT BE, 1974, CLIN CHEM, V20, P666; SERJEANT GR, 1986, BRIT J HAEMATOL, V64, P253, DOI 10.1111/j.1365-2141.1986.tb04117.x; Serjeant GR, 2001, SICKLE CELL DIS; Serjeant GR, 2007, NEW ENGL J MED, V356, P642, DOI 10.1056/NEJMc066547; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Wang Y, 2015, GENET MED, V17, P452, DOI 10.1038/gim.2014.123; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5; Wonkam A, 2014, AM J HEMATOL, V89, P664, DOI 10.1002/ajh.23711	35	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192710	10.1371/journal.pone.0192710	http://dx.doi.org/10.1371/journal.pone.0192710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494636	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200013
J	Vilardell, J; Girardi, C; Marin, O; Cozza, G; Pinna, LA; Ruzzene, M				Vilardell, Jordi; Girardi, Cristina; Marin, Oriano; Cozza, Giorgio; Pinna, Lorenzo A.; Ruzzene, Maria			The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SECONDARY STRUCTURE PREDICTION; CASEIN KINASE-2; SUBSTRATE RECOGNITION; CONSENSUS SEQUENCES; MOLECULAR-DYNAMICS; BREAST-CANCER; PHOSPHORYLATION; SPECIFICITY; REGULATOR	CK2 is a pleiotropic S/T protein kinase ( formerly known as casein kinase 2) which is attracting increasing interest as therapeutic target, and the identification of its substrates is a crucial step in determining its involvement in different pathological conditions. We recently found that S131 of Akt2 ( homologous to the well established CK2 target S129 of Akt1) is not phosphorylated by CK2 either in vitro or in vivo, although the consensus sequence recognized by CK2 ( S/T-x-x-E/D/pS/pT) is conserved in it. Here, by exploiting synthetic peptides, in cell transfection experiments, and computational analysis, we show that a single sequence element, a T at position n+1, hampers phosphorylation, causing an alpha-helix structure organization which prevents the recognition of its own consensus by CK2. Our results highlight the role of negative determinants as crucial modulators of CK2 targeting and corroborate the concept that Akt1 and Akt2 display isoform specific features. Experiments with synthetic peptides suggest that Akt2 S131 could be phosphorylated by kinases of the Plk ( Polo-like kinase) family, which are insensitive to the presence of the n+1 T. The low phylogenetic conservation of the Akt2 sequence around S131, as opposed to the extremely well-conserved Akt1 homologous sequence, would indicate a dominant positive role in the selective pressure only for the Akt1 phosphoacceptor site committed to undergo phosphorylation by CK2. By contrast, Akt2 S131 may mediate the response to specific physio/pathological conditions, being consequently shielded against basal CK2 targeting.	[Vilardell, Jordi; Girardi, Cristina; Marin, Oriano; Pinna, Lorenzo A.; Ruzzene, Maria] Univ Padua, Dept Biomed Sci, Padua, Italy; [Cozza, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Pinna, Lorenzo A.; Ruzzene, Maria] CNR, Neurosci Inst, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Ruzzene, M (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.; Ruzzene, M (corresponding author), CNR, Neurosci Inst, Padua, Italy.	maria.ruzzene@unipd.it		COZZA, GIORGIO/0000-0002-5155-4682; Ruzzene, Maria/0000-0001-8712-8151	"Associazione Italiana per la Ricerca sul Cancro", AIRC [IG-14180]; University of Padova	"Associazione Italiana per la Ricerca sul Cancro", AIRC; University of Padova	This work was supported by "Associazione Italiana per la Ricerca sul Cancro", AIRC project IG-14180 to LAP, by University of Padova (institutional funds to MR, and Progetto Giovani Ricercatori to GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borgo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42409; Carpino LA, 2001, J ORG CHEM, V66, P5245, DOI 10.1021/jo001616+; Castello J, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010007; Chin YR, 2011, CELL ADHES MIGR, V5, P211, DOI 10.4161/cam.5.3.15790; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Di Maira G, 2009, CELL MOL LIFE SCI, V66, P3363, DOI 10.1007/s00018-009-0108-1; Foka P, 2014, CELL MOL LIFE SCI, V71, P4243, DOI 10.1007/s00018-014-1621-4; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Ka SO, 2015, SCI REP-UK, V5, DOI 10.1038/srep14816; Koch S, 2013, MUCOSAL IMMUNOL, V6, P136, DOI 10.1038/mi.2012.57; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Ottaviani D, 2017, HUM MOL GENET, V26, P611, DOI 10.1093/hmg/ddw420; Pagano MA, 2010, BIOCHEM J, V426, P19, DOI 10.1042/BJ20090813; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; PERICH JW, 1992, BIOCHEMISTRY-US, V31, P5893, DOI 10.1021/bi00140a027; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rossi M, 2015, P NATL ACAD SCI USA, V112, pE6818, DOI 10.1073/pnas.1519430112; Ruzzene Maria, 2017, Advances in Biological Regulation, V64, P1, DOI 10.1016/j.jbior.2017.03.002; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/S0076-6879(10)84024-8, 10.1016/B978-0-12-381298-8.00024-1]; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; SARNO S, 1995, BIOCHEM BIOPH RES CO, V206, P171, DOI 10.1006/bbrc.1995.1024; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Wadhwa B, 2017, ANTI-CANCER DRUG, V28, P569, DOI 10.1097/CAD.0000000000000496; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193479	10.1371/journal.pone.0193479	http://dx.doi.org/10.1371/journal.pone.0193479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494643	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200052
J	Jin, H; Roy, U; Lee, G; Scharer, OD; Cho, Y				Jin, Hyeonseok; Roy, Upasana; Lee, Gwangrog; Scharer, Orlando D.; Cho, Yunje			Structural mechanism of DNA interstrand cross-link unhooking by the bacterial FAN1 nuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; protein-nucleic acid interaction; enzyme mechanism; molecular biology; DNA repair; protein structure; bacterial FAN1; basic pocket; DNA interstrand cross-link; FANCD2-FANCI-associated nuclease; ICL unhooking	KARYOMEGALIC INTERSTITIAL NEPHRITIS; ANEMIA-ASSOCIATED NUCLEASE; SINGLE-STRANDED-DNA; FANCONI-ANEMIA; SENSITIZES CELLS; IDENTIFIES FAN1; EXONUCLEASE 1; REPAIR; DAMAGE; KIAA1018/FAN1	DNA interstrand cross-links (ICLs) block the progress of the replication and transcription machineries and can weaken chromosomal stability, resulting in various diseases. FANCD2-FANCI-associated nuclease (FAN1) is a conserved structure-specific nuclease that unhooks DNA ICLs independently of the Fanconi anemia pathway. Recent structural studies have proposed two different mechanistic features for ICL unhooking by human FAN1: a specific basic pocket that recognizes the terminal phosphate of a 1-nucleotide (nt) 5 flap or FAN1 dimerization. Herein, we show that despite lacking these features, Pseudomonas aeruginosa FAN1 (PaFAN1) cleaves substrates at approximate to 3-nt intervals and resolves ICLs. Crystal structures of PaFAN1 bound to various DNA substrates revealed that its conserved basic Arg/Lys patch comprising Arg-228 and Lys-260 recognizes phosphate groups near the 5 terminus of a DNA substrate with a 1-nt flap or a nick. Substitution of Lys-260 did not affect PaFAN1's initial endonuclease activity but significantly decreased its subsequent exonuclease activity and ICL unhooking. The Arg/Lys patch also interacted with phosphates at a 3-nt gap, and this interaction could drive movement of the scissile phosphates into the PaFAN1-active site. In human FAN1, the ICL-resolving activity was not affected by individual disruption of the Arg/Lys patch or basic pocket. However, simultaneous substitution of both FAN1 regions significantly reduced its ICL-resolving activity, suggesting that these two basic regions play a complementary role in ICL repair. On the basis of these findings, we propose a conserved role for two basic regions in FAN1 to guide ICL unhooking and to maintain genomic stability.	[Jin, Hyeonseok; Cho, Yunje] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Roy, Upasana; Scharer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Roy, Upasana; Scharer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Lee, Gwangrog] Gwangju Inst Sci & Technol, Dept Biol, Gwangju 61005, South Korea; [Scharer, Orlando D.] Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Scharer, Orlando D.] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Dept Biol Sci, Ulsan 44919, South Korea	Pohang University of Science & Technology (POSTECH); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gwangju Institute of Science & Technology (GIST); Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Cho, Y (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	yunje@postech.ac.kr	Schärer, Orlando D./AAF-8613-2021		National Research Foundation of Korea (NRF) - Korea government (Ministry of Education, Science, and Technology) [2015R1A2A1A05001694, 2017M3A9F6029733, NRF-2013M3A6A4044580]; BK21 Program from the Ministry of Education; National Institutes of Health [CA165911]; Korean Institute for Basic Science [IBS-R022-A1-2017]; NATIONAL CANCER INSTITUTE [R01CA165911] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government (Ministry of Education, Science, and Technology); BK21 Program from the Ministry of Education(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Institute for Basic Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Research Foundation of Korea (NRF), funded by the Korea government (Ministry of Education, Science, and Technology), Grants 2015R1A2A1A05001694, 2017M3A9F6029733, and NRF-2013M3A6A4044580, BK21 Program from the Ministry of Education (to Y. C.), National Institutes of Health Grant CA165911, and Korean Institute for Basic Science Grant IBS-R022-A1-2017 (to O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gwon GH, 2014, GENE DEV, V28, P2276, DOI 10.1101/gad.248492.114; Hodskinson MRG, 2014, MOL CELL, V54, P472, DOI 10.1016/j.molcel.2014.03.014; Huang J, 2013, MOL CELL, V52, P434, DOI 10.1016/j.molcel.2013.09.021; Huang YL, 2013, TRANSL CANCER RES, V2, P144, DOI 10.3978/j.issn.2218-676X.2013.03.01; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Jin H, 2017, DNA REPAIR, V56, P135, DOI 10.1016/j.dnarep.2017.06.016; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Klein D. D., 2014, CELL, V54, P460, DOI DOI 10.1016/j.molcel.2014.03.015; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lachaud C, 2016, GENE DEV, V30, P639, DOI 10.1101/gad.276287.115; Lachaud C, 2016, SCIENCE, V351, P846, DOI 10.1126/science.aad5634; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mukherjee S, 2014, NUCLEIC ACIDS RES, V42, P7429, DOI 10.1093/nar/gku328; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myler LR, 2016, P NATL ACAD SCI USA, V113, pE1170, DOI 10.1073/pnas.1516674113; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pizzolato J, 2015, J BIOL CHEM, V290, P22602, DOI 10.1074/jbc.M115.663666; Porro A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02130-x; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rolseth V, 2013, BBA-MOL CELL RES, V1833, P1157, DOI 10.1016/j.bbamcr.2012.12.024; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Segui N, 2015, GASTROENTEROLOGY, V149, P563, DOI 10.1053/j.gastro.2015.05.056; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Smith AL, 2016, CANCER LETT, V370, P302, DOI 10.1016/j.canlet.2015.10.030; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Thongthip S, 2016, GENE DEV, V30, P645, DOI 10.1101/gad.276261.115; VOSBERG HP, 1982, J BIOL CHEM, V257, P6595; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Wang S, 2016, NUCLEIC ACIDS RES, V44, P187, DOI 10.1093/nar/gkv949; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6726; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	52	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6482	6496		10.1074/jbc.RA118.002171	http://dx.doi.org/10.1074/jbc.RA118.002171			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29514982	Green Published, hybrid			2022-12-26	WOS:000431108600021
J	Gosney, JA; Wilkey, DW; Merchant, ML; Ceresa, BP				Gosney, Julie A.; Wilkey, Daniel W.; Merchant, Michael L.; Ceresa, Brian P.			Proteomics reveals novel protein associations with early endosomes in an epidermal growth factor-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; STOMATIN-LIKE PROTEIN-2; NA+-K+-ATPASE; FACTOR RECEPTOR; EGF-RECEPTOR; HELA-CELLS; TRAFFICKING; PATHWAY; EXPRESSION; CANCER	The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is an integral component of proliferative signaling. EGFRs on the cell surface become activated upon EGF binding and have an increased rate of endocytosis. Once in the cytoplasm, the EGF.EGFR complex is trafficked to the lysosome for degradation, and signaling is terminated. During trafficking, the EGFR kinase domain remains active, and the internalized EGFR can continue signaling to downstream effectors. Although effector activity varies based on the EGFR's endocytic location, it is not clear how this occurs. In an effort to identify proteins that uniquely associate with the internalized, liganded EGFR in the early endosome, we developed an early endosome isolation strategy to analyze their protein composition. Post-nuclear supernatant from HeLa cells stimulated with and without EGF were separated on an isotonic 17% Percoll gradient. The gradient was fractionated, and early endosomal fractions were pooled and immunoisolated with an EEA1 mAb. The isolated endosomes were validated by immunoblot using antibodies against organelle-specific marker proteins and transmission EM. These early endosomes were also subjected to LC-MS/MS for proteomic analysis. Five proteins were detected in endosomes in a ligand-dependent manner: EGFR, RUFY1, STOML2, PTPN23, and CCDC51. Knockdown of RUFY1 or PTPN23 by RNAi indicated that both proteins play a role in EGFR trafficking. These experiments indicate that endocytic trafficking of activated EGFR changes the protein composition, membrane trafficking, and signaling potential of the early endosome.	[Gosney, Julie A.; Ceresa, Brian P.] Univ Louisville, Dept Pharmacol & Toxicol, 505 S Hancock St,Ste 305, Louisville, KY 40202 USA; [Wilkey, Daniel W.; Merchant, Michael L.] Univ Louisville, Dept Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Ceresa, BP (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, 505 S Hancock St,Ste 305, Louisville, KY 40202 USA.	brian.ceresa@louisville.edu	Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Merchant, Michael/0000-0003-4128-4057	NEI, National Institutes of Health [EY027032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024337] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded in part by NEI, National Institutes of Health Grant EY027032 (to B. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; BERGERON JJM, 1986, BIOCHEMISTRY-US, V25, P1756, DOI 10.1021/bi00355a046; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Cao WF, 2007, AM J CLIN PATHOL, V128, P430, DOI 10.1309/C6X54HRB580EP2NQ; Cao WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063890; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gosney JA, 2017, METHODS MOL BIOL, V1652, P145, DOI 10.1007/978-1-4939-7219-7_11; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hashimoto A, 1999, J BIOL CHEM, V274, P20139, DOI 10.1074/jbc.274.29.20139; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Jackson NM, 2016, EXP CELL RES, V346, P224, DOI 10.1016/j.yexcr.2016.07.001; Jensen ON, 1999, METH MOL B, V112, P513; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Khundmiri SJ, 2004, J BIOL CHEM, V279, P17418, DOI 10.1074/jbc.M311715200; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oksvold MP, 2001, EUR J CELL BIOL, V80, P285, DOI 10.1078/0171-9335-00160; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rush JS, 2014, INVEST OPHTH VIS SCI, V55, P4691, DOI 10.1167/iovs.14-14133; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Song LB, 2012, J PATHOL, V226, P534, DOI 10.1002/path.3008; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vendeville A, 2009, J VIROL, V83, P4678, DOI 10.1128/JVI.02401-08; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vukmirica J, 2006, J BIOL CHEM, V281, P36360, DOI 10.1074/jbc.M602920200; WALLACH DFH, 1966, J CELL BIOL, V30, P601, DOI 10.1083/jcb.30.3.601; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; [Злобина М.В. Zlobina M.V.], 2014, [Цитология, Cell and Tissue Biology, Tsitologiya], V56, P741	53	14	15	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5895	5908		10.1074/jbc.RA117.000632	http://dx.doi.org/10.1074/jbc.RA117.000632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29523688	Green Published, hybrid			2022-12-26	WOS:000430497300012
J	Mas, S; Bosch-Panadero, E; Abaigar, P; Camarero, V; Mahillo, I; Civantos, E; Sanchez-Ospina, D; Ruiz-Priego, A; Egido, J; Ortiz, A; Gonzalez-Parra, E				Mas, Sebastian; Bosch-Panadero, Enrique; Abaigar, Pedro; Camarero, Vanesa; Mahillo, Ignacio; Civantos, Esther; Sanchez-Ospina, Didier; Ruiz-Priego, Alberto; Egido, Jesus; Ortiz, Alberto; Gonzalez-Parra, Emilio			Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration	PLOS ONE			English	Article							HEMODIALYSIS; EXPOSURE; ADULTS	Introduction Bisphenol A (BPA) is an ubiquitous environmental toxin that is also found in dialyzers. Online hemodiafiltration (OL-HDF) more efficiently clears high molecular weight molecules, and this may improve BPA clearance. However, the BPA contents of dialysis membranes may be a source of BPA loading during OL-HDF. Methods A prospective study assessed plasma BPA levels in OL-HDF patients using BPA-free (polynephron) or BPA-containing (polysulfone) dialyzers in a crossover design with two arms, after a run-in OL-HDF period of at least 6 months with the same membrane: 31 patients on polynephron at baseline were switched to polysulfone membranes for 3 months (polynephron-to-polysulfone) and 29 patients on polysulfone were switched to polynephron for 3 months (polysulfone-to-polynephron). Results After a run-in OL-HDF period of at least 6 months with the same membrane, baseline pre-dialysis BPA was lower in patients on polynephron (8.79 +/- 7.97 ng/ml) than in those on polysulfone (23.42 +/- 20.38 ng/mL, p<0.01), but still higher than in healthy controls (<2 ng/mL). After 3 months of polynephron-to-polysulfone switch, BPA was unchanged (8.98 +/- 7.88 to 11.14 +/- 15.98 ng/mL, ns) while it decreased on the polysulfone-to-polynephron group (23.42 +/- 20.38 to 11.41 +/- 12.38 ng/mL, p<0.01). Conclusion OL-HDF for 3 months with BPA-free dialyzer membranes was associated to a significant decrease in predialysis BPA levels when compared to baseline BPA levels while on a BPA-containing membrane.	[Mas, Sebastian; Bosch-Panadero, Enrique; Civantos, Esther; Ruiz-Priego, Alberto; Egido, Jesus; Ortiz, Alberto; Gonzalez-Parra, Emilio] IIS Fdn Jimenez Diaz UAM, Renal Vasc & Diabet Lab, Madrid, Spain; [Mas, Sebastian; Civantos, Esther; Egido, Jesus] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Abaigar, Pedro; Camarero, Vanesa] Hosp Univ Burgos, Div Nephrol, Burgos, Spain; [Mahillo, Ignacio] IIS Fdn Jimenez Diaz UAM, Dept Biostat & Epidemiol, Madrid, Spain; [Sanchez-Ospina, Didier; Egido, Jesus; Ortiz, Alberto; Gonzalez-Parra, Emilio] IIS Fdn Jimenez Diaz UAM, Div Nephrol & Hypertens, Madrid, Spain; [Egido, Jesus; Ortiz, Alberto; Gonzalez-Parra, Emilio] UAM, Dept Med, Madrid, Spain; [Ortiz, Alberto; Gonzalez-Parra, Emilio] Kidney Res Network REDINREN, Madrid, Spain	Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; Autonomous University of Madrid	Mas, S; Gonzalez-Parra, E (corresponding author), IIS Fdn Jimenez Diaz UAM, Renal Vasc & Diabet Lab, Madrid, Spain.; Mas, S (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.; Gonzalez-Parra, E (corresponding author), IIS Fdn Jimenez Diaz UAM, Div Nephrol & Hypertens, Madrid, Spain.; Gonzalez-Parra, E (corresponding author), UAM, Dept Med, Madrid, Spain.; Gonzalez-Parra, E (corresponding author), Kidney Res Network REDINREN, Madrid, Spain.	smas@fjd.es; EGParra@fjd.es	Mas, S/T-1489-2018; ortiz, alberto/Y-7582-2018; Mahillo-Fernandez, Ignacio/T-2042-2018	Mas, S/0000-0001-6604-3327; ortiz, alberto/0000-0002-9805-9523; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541	Ministerio de Economia, lndustria y competitividad: FIS ISCIII FEDER funds [PI16/01298, PI15/00298, PI16/02057, PI16/01900]; ISCIII-RETIC REDinREN [RD12/0021 RD16/0009]; CYTED IBERERC; Sociedad Madrilena de Nefrologia, Programa Intensificacion Actividad Investigadora (ISCIII); Nipro corporation; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)	Ministerio de Economia, lndustria y competitividad: FIS ISCIII FEDER funds; ISCIII-RETIC REDinREN; CYTED IBERERC; Sociedad Madrilena de Nefrologia, Programa Intensificacion Actividad Investigadora (ISCIII); Nipro corporation; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)(Fonds de la Recherche Scientifique - FNRS)	The Renal, Vascular and Diabetes Laboratory is funded by Ministerio de Economia, lndustria y competitividad: FIS ISCIII FEDER funds PI16/01298, PI15/00298, PI16/02057, PI16/01900, ISCIII-RETIC REDinREN RD12/0021 RD16/0009, CYTED IBERERC and Sociedad Madrilena de Nefrologia, Programa Intensificacion Actividad Investigadora (ISCIII) to AO. This work was supported by a grant from Nipro corporation, and Fundacion Renal Inigo Alvarez de Toledo (FRIAT). The funders had no role in the design of the study, interpretation of the results, or the writing of the manuscript.; The Renal, Vascular and Diabetes Laboratory is funded by Ministerio de Economia, Industria y Competitividad: FIS ISCIII FEDER funds PI16/01298, PI15/00298, PI16/02057, PI16/01900, ISCIII-RETIC REDinREN RD12/0021 RD16/0009, CYTED IBERERC and Sociedad Madrilena de Nefrologia. Programa Intensificacion Actividad Investigadora (ISCIII) to AO. This study was funded by a grant from Nipro corporation. The funders had no role in the design of the study, interpretation of the results, or the writing of the manuscript.	BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Bosch-Panadero E, 2016, J AM SOC NEPHROL, V27, P1566, DOI 10.1681/ASN.2015030312; Cornelis T, 2015, NEPHROL DIAL TRANSPL, V30, P1395, DOI 10.1093/ndt/gfv038; Csanady GA, 2002, ARCH TOXICOL, V76, P299, DOI 10.1007/s00204-002-0339-5; Gonzalez-Parra E, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/437857; Haishima Y, 2001, J BIOMED MATER RES, V58, P209, DOI 10.1002/1097-4636(2001)58:2<209::AID-JBM1009>3.0.CO;2-7; Krieter DH, 2013, ARTIF ORGANS, V37, P283, DOI 10.1111/j.1525-1594.2012.01556.x; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li MA, 2012, KIDNEY INT, V81, P1131, DOI 10.1038/ki.2012.6; Quiroga B, 2017, THER APHER DIAL, V21, P96, DOI 10.1111/1744-9987.12475; Shintani H, 2001, CHROMATOGRAPHIA, V53, P331, DOI 10.1007/BF02490435; Testai E, 2016, REGUL TOXICOL PHARM, V79, P106, DOI 10.1016/j.yrtph.2016.01.014; Tetta Ciro, 2006, Hemodial Int, V10 Suppl 1, pS60, DOI 10.1111/j.1542-4758.2006.01194.x; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	14	10	11	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193288	10.1371/journal.pone.0193288	http://dx.doi.org/10.1371/journal.pone.0193288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529055	Green Submitted, Green Published, gold			2022-12-26	WOS:000427189300016
J	Niechwiej-Szwedo, E; Gonzalez, D; Nouredanesh, M; Tung, J				Niechwiej-Szwedo, Ewa; Gonzalez, David; Nouredanesh, Mina; Tung, James			Evaluation of the Leap Motion Controller during the performance of visually-guided upper limb movements	PLOS ONE			English	Article							ONLINE CONTROL; VISUOMOTOR BEHAVIOR; DIRECTED MOVEMENTS; ACCURACY; KINEMATICS; FEEDBACK; HAND; PREHENSION; PRINCIPLES; AMBLYOPIA	Kinematic analysis of upper limb reaching provides insight into the central nervous system control of movements. Until recently, kinematic examination of motor control has been limited to studies conducted in traditional research laboratories because motion capture equipment used for data collection is not easily portable and expensive. A recently developed markerless system, the Leap Motion Controller (LMC), is a portable and inexpensive tracking device that allows recording of 3D hand and finger position. The main goal of this study was to assess the concurrent reliability and validity of the LMC as compared to the Optotrak, a criterion-standard motion capture system, for measures of temporal accuracy and peak velocity during the performance of upper limb, visually-guided movements. In experiment 1, 14 participants executed aiming movements to visual targets presented on a computer monitor. Bland-Altman analysis was conducted to assess the validity and limits of agreement for measures of temporal accuracy (movement time, duration of deceleration interval), peak velocity, and spatial accuracy (endpoint accuracy). In addition, a one-sample t-test was used to test the hypothesis that the error difference between measures obtained from Optotrak and LMC is zero. In experiment 2, 15 participants performed a Fitts' type aiming task in order to assess whether the LMC is capable of assessing a well-known speed-accuracy trade-off relationship. Experiment 3 assessed the temporal coordination pattern during the performance of a sequence consisting of a reaching, grasping, and placement task in 15 participants. Results from the t-test showed that the error difference in temporal measures was significantly different from zero. Based on the results from the 3 experiments, the average temporal error in movement time was 40 +/- 44 ms, and the error in peak velocity was 0.024 +/- 0.103 m/s. The limits of agreement between the LMC and Optotrak for spatial accuracy measures ranged between 2-5 cm. Although the LMC system is a low-cost, highly portable system, which could facilitate collection of kinematic data outside of the traditional laboratory settings, the temporal and spatial errors may limit the use of the device in some settings.	[Niechwiej-Szwedo, Ewa; Gonzalez, David] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Nouredanesh, Mina; Tung, James] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Niechwiej-Szwedo, E (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	eniechwi@uwaterloo.ca	Tung, James/J-6728-2019	Tung, James/0000-0002-0771-2313; Nouredanesh, Mina/0000-0002-5768-0348				Alramis F, 2016, HUM MOVEMENT SCI, V46, P52, DOI 10.1016/j.humov.2015.12.006; Aprile I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/636123; Bachmann D, 2015, SENSORS-BASEL, V15, P214, DOI 10.3390/s150100214; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Bourgeois F, 2003, J MOTOR BEHAV, V35, P183, DOI 10.1080/00222890309602132; Carey DP, 1996, EXP BRAIN RES, V112, P496; Elliott D, 2006, MOTOR CONTROL, V10, P34, DOI 10.1123/mcj.10.1.34; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; FISK JD, 1985, EXP BRAIN RES, V60, P159; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Glazebrook CM, 2009, AUTISM, V13, P411, DOI 10.1177/1362361309105659; Gnanaseelan R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00959; Gonzalez DA, 2016, VISION RES, V128, P30, DOI 10.1016/j.visres.2016.08.006; Grierson LEM, 2009, AM J PSYCHOL, V122, P309; Grierson LEM, 2009, MOTOR CONTROL, V13, P280, DOI 10.1123/mcj.13.3.280; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Gulde P, 2017, FRONT HUM NEUROSCI, P11; Guna J, 2014, SENSORS-BASEL, V14, P3702, DOI 10.3390/s140203702; Hamill J, 1997, J APPL BIOMECH, V13, P226, DOI 10.1123/jab.13.2.226; Hansen S, 2007, PERCEPTION, V36, P268, DOI 10.1068/p5629; HAY L, 1991, ACTA PSYCHOL, V77, P203, DOI 10.1016/0001-6918(91)90035-X; HAY L, 1979, J MOTOR BEHAV, V11, P189, DOI 10.1080/00222895.1979.10735187; Hornsey RL, 2015, EVALUATION ACCURACY; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; Liddy JJ, 2017, BEHAV RES METHODS, V49, P1030, DOI 10.3758/s13428-016-0764-7; MACKENZIE CL, 1987, Q J EXP PSYCHOL-A, V39, P629, DOI 10.1080/14640748708401806; McCrea PH, 2002, DISABIL REHABIL, V24, P534, DOI 10.1080/09638280110115393; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Newell K.M, 1993, VARIABILITY MOTOR CO; Niechwiej-Szwedo E, 2017, HUM MOV SCI IN PRESS; Niechwiej-Szwedo E, 2014, INVEST OPHTH VIS SCI, V55, P3857, DOI 10.1167/iovs.14-14543; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; Nowak D. A., 2009, SENSORIMOTOR CONTROL; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Smeragliuolo AH, 2016, J BIOMECH, V49, P1742, DOI 10.1016/j.jbiomech.2016.04.006; Smyth MM, 2004, Q J EXP PSYCHOL-A, V57, P269, DOI 10.1080/02724980343000215; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tung JY, 2015, PHYSIOL MEAS, V36, P1025, DOI 10.1088/0967-3334/36/5/1025; Van Waelvelde H, 2004, HUM MOVEMENT SCI, V23, P49, DOI 10.1016/j.humov.2004.04.004; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Weichert F, 2013, SENSORS-BASEL, V13, P6380, DOI 10.3390/s130506380; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Yang LL, 2015, IEEE J BIOMED HEALTH, V19, P22, DOI 10.1109/JBHI.2014.2327635	46	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193639	10.1371/journal.pone.0193639	http://dx.doi.org/10.1371/journal.pone.0193639			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY9MC	29529064	Green Submitted, gold, Green Published			2022-12-26	WOS:000427189300026
J	Pierro, A; Pica, G; Giannini, AM; Higgins, ET; Kruglanski, AW				Pierro, Antonio; Pica, Gennaro; Giannini, Anna Maria; Higgins, E. Tory; Kruglanski, Arie W.			"Letting myself go forward past wrongs": How regulatory modes affect self-forgiveness	PLOS ONE			English	Article							CLOSE RELATIONSHIPS; AGE-DIFFERENCES; LOCOMOTION; BEHAVIOR; TIME; SHAME; GUILT; PROCRASTINATION; RESPONSIBILITY; ORIENTATIONS	The present research addresses the question of whether regulatory-mode orientations affect self-forgiveness. We expected that people with a strong locomotion orientation would be more inclined to self-forgiveness because of their tendencies toward movement and change, which focus them on the future, whereas people with a strong assessment orientation would refrain from self-forgiveness due to their evaluative tendencies which focus them on the past. These hypotheses were supported by the results in four studies that tested the relation between regulatory modes and self-forgiveness by measuring (Studies 1, 3 and 4) and manipulating (Study 2) regulatory-mode-orientations. Finally, in Study 4 we examined more closely our hypothesis that the relation between self-forgiveness and regulatory modes is mediated by past and future temporal foci. The implications of the results for regulatory mode theory are also discussed.	[Pierro, Antonio; Pica, Gennaro; Giannini, Anna Maria] Univ Roma La Sapienza, Rome, Italy; [Higgins, E. Tory] Columbia Univ, New York, NY USA; [Kruglanski, Arie W.] Univ Maryland, College Pk, MD 20742 USA	Sapienza University Rome; Columbia University; University System of Maryland; University of Maryland College Park	Pica, G (corresponding author), Univ Roma La Sapienza, Rome, Italy.	gennaro.pica@uniroma1.it	Pica, Gennaro/ABF-7936-2021; GIANNINI, Anna Maria/AAE-5896-2021	Pica, Gennaro/0000-0003-3739-7462; GIANNINI, Anna Maria/0000-0002-0614-4457	University of Rome "La Sapienza" [C26A15CT93]; Fondazione Ania per la sicurezza stradale, Progetto ANIACARES	University of Rome "La Sapienza"; Fondazione Ania per la sicurezza stradale, Progetto ANIACARES	This work was supported by the University of Rome "La Sapienza" (2015) prot. C26A15CT93 to Prof. Antonio Pierro and "Fondazione Ania per la sicurezza stradale, Progetto ANIACARES" to Prof. Anna Maria Giannini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato C, 2014, INT J PSYCHOL, V49, P192, DOI 10.1002/ijop.12047; [Anonymous], 2005, HDB FORGIVENESS, DOI DOI 10.1017/CBO9781107415324.004; Avnet T, 2003, J EXP SOC PSYCHOL, V39, P525, DOI 10.1016/S0022-1031(03)00027-1; Baumeister R.F., 1997, REV GEN PSYCHOL, V1, P145, DOI [10.1037/1089-2680.1.2.145, DOI 10.1037/1089-2680.1.2.145]; Burnette JL, 2014, SOC PSYCHOL PERS SCI, V5, P443, DOI 10.1177/1948550613502991; Carpenter TP, 2014, J POSIT PSYCHOL, V9, P389, DOI 10.1080/17439760.2014.910823; Cheng ST, 2008, PSYCHOL AGING, V23, P676, DOI 10.1037/0882-7974.23.3.676; Cloninger C Robert, 2013, Mens Sana Monogr, V11, P16, DOI 10.4103/0973-1229.109288; Cloninger CR, 2004, FEELING GOOD SCI WEL; Dillon RS, 2001, ETHICS, V112, P53, DOI 10.1086/339140; Enright R. D., 1996, COUNSELING VALUES, V40, P107, DOI DOI 10.1002/J.2161-007X.1996.TB00844.X; Fisher ML, 2006, SELF IDENTITY, V5, P127, DOI 10.1080/15298860600586123; Fisher ML, 2010, SOC PERSONAL PSYCHOL, V4, P548, DOI 10.1111/j.1751-9004.2010.00276.x; Griffin BJ, 2016, SELF IDENTITY, V15, P650, DOI 10.1080/15298868.2016.1187669; Hall JH, 2005, J SOC CLIN PSYCHOL, V24, P621, DOI 10.1521/jscp.2005.24.5.621; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Higgins ET, 2003, ADV EXP SOC PSYCHOL, V35, P293, DOI 10.1016/S0065-2601(03)01005-0; Hoyle R. H., 2004, HDB METHODS SOCIAL P, P213; JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85; Kruglanski AW, 2016, PERS SOC PSYCHOL REV, V20, P100, DOI 10.1177/1088868315581120; Kruglanski AW, 2013, SOC PERSONAL PSYCHOL, V7, P79, DOI 10.1111/spc3.12015; Kruglanski AW, 2000, J PERS SOC PSYCHOL, V79, P793, DOI 10.1037/0022-3514.79.5.793; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Lucas T, 2010, PERS INDIV DIFFER, V49, P851, DOI 10.1016/j.paid.2010.07.014; Mauger PA., 1992, J PSYCHOL CHRISTIANI, V11, P170; McConnell JM, 2015, BASIC APPL SOC PSYCH, V37, P143, DOI 10.1080/01973533.2015.1016160; McCullough ME, 1997, J PERS SOC PSYCHOL, V73, P321, DOI 10.1037/0022-3514.73.2.321; McCullough ME, 2000, J SOC CLIN PSYCHOL, V19, P43, DOI 10.1521/jscp.2000.19.1.43; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; McGaffin BJ, 2013, SUBST ABUS, V34, P396, DOI 10.1080/08897077.2013.781564; Pierro A, 2008, J EXP SOC PSYCHOL, V44, P321, DOI 10.1016/j.jesp.2007.06.002; Pierro A, 2012, TPM-TEST PSYCHOM MET, V19, P247, DOI 10.4473/TPM19.4.1; Pierro A, 2013, MOTIV EMOTION, V37, P653, DOI 10.1007/s11031-013-9350-9; Pierro A, 2011, J PERS SOC PSYCHOL, V101, P1317, DOI 10.1037/a0025943; Preacher K. J., 2008, SAGE SOURCEBOOK ADV, P13, DOI DOI 10.4135/9781452272054.N2; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ross SR, 2004, J PERS ASSESS, V82, P207, DOI 10.1207/s15327752jpa8202_8; Seybold K, 2001, J PSYCHOL CHRISTIANI, V20, P250; Shipp AJ, 2009, ORGAN BEHAV HUM DEC, V110, P1, DOI 10.1016/j.obhdp.2009.05.001; Spencer SJ, 2005, J PERS SOC PSYCHOL, V89, P845, DOI 10.1037/0022-3514.89.6.845; Squires EC, 2012, J GAMBL STUD, V28, P337, DOI 10.1007/s10899-011-9272-y; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Thompson LY, 2005, J PERS, V73, P313, DOI 10.1111/j.1467-6494.2005.00311.x; vanOyen Witvliet C, 2001, PSYCHOL SCI, V12, P117, DOI 10.1111/1467-9280.00320; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Webb CE, 2017, J PERS SOC PSYCHOL, V112, P621, DOI 10.1037/pspp0000131; Wenzel M, 2012, EUR J SOC PSYCHOL, V42, P617, DOI 10.1002/ejsp.1873; Wohl M.J.A., 2017, HDB PSYCHOL SELF FOR, P147; Wohl MJA, 2014, SOC PERSONAL PSYCHOL, V8, P422, DOI 10.1111/spc3.12119; Wohl MJA, 2011, BRIT J SOC PSYCHOL, V50, P354, DOI 10.1111/j.2044-8309.2010.02010.x; Wohl MJA, 2010, PERS INDIV DIFFER, V48, P803, DOI 10.1016/j.paid.2010.01.029; Wohl MJA, 2008, CAN J BEHAV SCI, V40, P1, DOI 10.1037/0008-400x.40.1.1.1; Woodyatt L, 2013, J SOC CLIN PSYCHOL, V32, P225, DOI 10.1521/jscp.2013.32.2.225; Worthington EL, 2007, J BEHAV MED, V30, P291, DOI 10.1007/s10865-007-9105-8; WORTHINGTON Jr EVERETT L., 2006, FORGIVENESS RECONCIL	56	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193357	10.1371/journal.pone.0193357	http://dx.doi.org/10.1371/journal.pone.0193357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY9MC	29529065	gold, Green Submitted, Green Published			2022-12-26	WOS:000427189300017
J	Vlot, MC; Grijsen, ML; Prins, JM; de Jongh, RT; de Jonge, R; den Heijer, M; Heijboer, AC				Vlot, Mariska C.; Grijsen, Marlous L.; Prins, Jan M.; de Jongh, Renate T.; de Jonge, Robert; den Heijer, Martin; Heijboer, Annemieke C.			Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection	PLOS ONE			English	Article							VITAMIN-D; TENOFOVIR; ADULTS; EMTRICITABINE; OSTEOPOROSIS; INFLAMMATION; PREVALENCE; INITIATION; INCREASE; IMPACT	Introduction Previous studies indicate that human immunodeficiency virus (HIV)-infection and combination antiretroviral therapy (cART) can affect bone turnover. Furthermore, HIV-infected patients have lower bone mineral density (BMD) compared to a healthy reference population. Objective To evaluate the longitudinal effect of HIV-infection and cART on bone turnover markers (BTMs) and BMD in men with primary HIV-infection (PHI). Design, methods Thirty-five PHI-men were divided into two groups, those that received cART for the first time (n = 26) versus no-cART (n = 9). Dual-energy X-ray absorptiometry (DXA) was performed on femoral neck (FN), total hip (TH) and lumbar spine (LS) and BTMs (P1NP, alkaline phosphatase, osteocalcin, ICTP and CTX) were measured at baseline and follow-up. Results At baseline, the median CD4+ T-cell count was 455 cells/mm3 (IQR 320-620) and plasma viral load 5.4 log10 copies/mL (IQR 4.7-6.0) in the cART treated group, compared to 630 (IQR 590-910) and 4.8 (IQR 4.2-5.1) in the untreated group. The median follow-up time was 60.7 weeks (IQR 24.7-96.0). All BTMs, except ICTP, showed a significant increase during cART versus no changes of BTMs in the untreated group. FN and TH BMD showed a significant decrease in both groups. LS BMD did not change in both groups. Conclusion Bone turnover increased in PHI-men treated with cART which was accompanied by a decrease in FN and TH BMD. No increase of bone turnover was seen in untreated PHI-men. Our study suggests that cART results in increased bone turnover and decreased BMD of the hip in PHI-men.	[Vlot, Mariska C.; de Jonge, Robert; Heijboer, Annemieke C.] Vrije Univ Amsterdam Med Ctr, Endocrine Lab, Dept Clin Chem, Amsterdam, Netherlands; [Vlot, Mariska C.; de Jongh, Renate T.; den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Endocrinol, Amsterdam, Netherlands; [Grijsen, Marlous L.; Prins, Jan M.] Acad Med Ctr, Infect Dis, Dept Internal Med, Ctr Infect & Immun, Amsterdam, Netherlands; [Grijsen, Marlous L.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Heijboer, Annemieke C.] Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Heijboer, AC (corresponding author), Vrije Univ Amsterdam Med Ctr, Endocrine Lab, Dept Clin Chem, Amsterdam, Netherlands.; Heijboer, AC (corresponding author), Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands.	a.heijboer@vumc.nl	Prins, Jan M./AAF-4945-2020; den Heijer, Martin/J-8036-2015	den Heijer, Martin/0000-0003-3620-5617; Prins, Jan/0000-0002-5415-8933; Heijboer, Annemieke/0000-0002-6712-9955	Abbott diagnostics (Chicago, IL, United States of America)	Abbott diagnostics (Chicago, IL, United States of America)	This work was supported by an unrestricted grant from Abbott diagnostics (Chicago, IL, United States of America) to MV and AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansouri Abdulrahman Y, 2016, J Bone Metab, V23, P16, DOI 10.11005/jbm.2016.23.1.16; Alvarez E, 2016, CURR OPIN HIV AIDS, V11, P268, DOI 10.1097/COH.0000000000000269; Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Bedimo R, 2016, HIV CLIN TRIALS, V17, P246, DOI 10.1080/15284336.2016.1243363; Bedimo R, 2016, AIDS, V30, P601, DOI 10.1097/QAD.0000000000000952; Bolland MJ, 2007, CLIN ENDOCRINOL, V67, P270, DOI 10.1111/j.1365-2265.2007.02875.x; Bolland MJ, 2015, LANCET DIABETES ENDO, V3, P63, DOI 10.1016/S2213-8587(13)70181-5; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2011, ANTIVIR THER, V16, P1063, DOI 10.3851/IMP1874; Cotter AG, 2014, AIDS, V28, P2051, DOI 10.1097/QAD.0000000000000353; Cotter AG, 2014, CURR OPIN HIV AIDS, V9, P17, DOI 10.1097/COH.0000000000000028; Cotter EJ, 2007, AIDS RES HUM RETROV, V23, P1521, DOI 10.1089/aid.2007.0112; De Clercq E, 2016, BIOCHEM PHARMACOL, V119, P1, DOI 10.1016/j.bcp.2016.04.015; European AIDS Clinical Society, 2016, EUR INN SCOR 2016, P96; Foca E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-38; Gohda J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0139-7; Grace A., 2010, CLIN INFECT DIS, V51, P937; Grant PM, 2016, J INFECT DIS, V214, P607, DOI 10.1093/infdis/jiw204; Grant PM, 2016, CURR OPIN HIV AIDS, V11, P326, DOI 10.1097/COH.0000000000000248; Grijsen ML, 2013, J INFECT DIS, V207, P386, DOI 10.1093/infdis/jis687; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Grijsen ML, 2010, AIDS, V24, P2233, DOI 10.1097/QAD.0b013e32833c93fe; Harris VW, 2012, J INFECT DIS, V205, pS391, DOI 10.1093/infdis/jis199; Haskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377; Hileman CO, 2014, AIDS, V28, P1759, DOI 10.1097/QAD.0000000000000320; Madeddu G, 2004, Q J NUCL MED MOL IM, V48, P39; Madeddu G, 2015, EUR REV MED PHARMACO, V19, P4576; Barbosa EGMD, 2013, BONE, V57, P62, DOI 10.1016/j.bone.2013.07.019; de Menezes EGM, 2017, J BONE MINER METAB, V35, P234, DOI 10.1007/s00774-016-0749-8; Mondy K, 2003, CLIN INFECT DIS, V36, P482, DOI 10.1086/367569; Ofotokun I, 2016, AIDS, V30, P405, DOI 10.1097/QAD.0000000000000918; Overton ET, 2015, ANN INTERN MED, V162, P815, DOI 10.7326/M14-1409; Piso RJ, J ACQUIR IMMUNE DEFI, V56, P320; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; Rey D, 2015, INFECT DIS-NOR, V47, P88, DOI 10.3109/00365548.2014.968610; Samarawickrama A, 2014, J INT AIDS SOC, V17, P54, DOI 10.7448/IAS.17.4.19568; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2015, AIDS, V29, P1; Zhang LX, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-224	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193679	10.1371/journal.pone.0193679	http://dx.doi.org/10.1371/journal.pone.0193679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522570	gold, Green Published, Green Submitted			2022-12-26	WOS:000427030800020
J	Dowarah, R; Verma, AK; Agarwal, N; Singh, P; Singh, BR				Dowarah, Runjun; Verma, Ashok Kumar; Agarwal, Neeta; Singh, Putan; Singh, Bhoj Raj			Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health and antioxidant status in weaned piglets	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS; IN-VITRO; GASTROINTESTINAL-TRACT; SERUM-CHOLESTEROL; PERFORMANCE; SUPPLEMENTATION; CEREVISIAE; STRAINS; FECES; MILK	The present study was aimed to develop an effective probiotic lactic acid bacteria (LAB) from piglet feces and in vitro characterization of probiotic properties. To confirm host-species specificity of probiotics, the efficacy of isolated LAB on growth, nutrient utilization, health and antioxidant status was observed in early weaned piglets. A total of 30 LAB were isolated from feces of five healthy piglets (28d old). All isolates were Gram positive, cocco-bacilli and catalase negative. Out of thirty LAB isolates, twenty were shortlisted on the basis of their tolerance to pH (3.0, 4.0, 7.0 and 8.0) and bile salts (0.075, 0.15, 0.3 and 1.0%). Whereas, fourteen isolates were selected for further in vitro probiotic characterization due higher (P<0.05) cell surface hydrophobicity to toluene (>45 percent). These isolates fermented twenty-seven different carbohydrates but were negative for ONPG, citrate and malonate. Also enabled to synthesize amylase, protease, lipase and phytase. They were sensitive to penicillin, azithromycin, lincomycin, clindamycin, erythromycin, cephalothin and chloramphenicol and resistant to ciprofloxacin, ofloxacin, gatifloxacin, vancomycin and co-trimoxazole. Except three isolates, all showed antagonistic activity (>60% co-culture activity) against Escherichia coli, Salmonella Enteritidis, Salmonella serotype (ser.) Typhimurium, Staphylococcus intermedius, Staph. chromogenes, Proteus mirabillis, Areomonas veonii, Bordetella bronchioseptica and Klebsialla oxytoca. The isolate Lacp28 exhibited highest tolerance to acidic pH and bile salts (up to 0.3%), phytase activity, cell surface hydrophobicity, antagonistic activity and co-culture assay (>80% growth inhibition). Host specificity of Lacp28 was further confirmed by heavy in vitro adhesion to pig intestinal epithelium cells compared to chicken. Hence, Lacp28 was selected and identified by phylogenetic analysis of 16S rRNA as Pediococcus acidilacticistrain FT28 with 100% similarity (GenBank accession nos. KU837245, KU837246 and KU837247). The Pediococcus acidilactici FT28 was selected as potential probiotic candidature for in vivo efficacy in weaned pigs. Thirty-six crossbred piglets (28d) were randomly distributed into three groups (four replicates of three each) namely, basal diet without probiotics (TO) or with Lactobacillus acidophilus NCDC15 (conventional dairy-specific probiotic; T1) or Pediococcus acidilactici FT28 (swine-specific probiotic; T2). At end of the experiment, six piglets of similar body weight were selected to conduct digestion trial for estimation of nutrient digestibility. Results of the study indicated that supplementation of both probiotics improved (P<0.001) FCR compared to control without significant effect in average daily gain and DM intake. However, the apparent digestibility of crude protein and ether extract was better (P<0.01) in pigs fed P. acidilactici FT28 compared control and L. acidophilus fed groups. The total WBC and RBC count, serum glucose, total protein, albumin and globulin concentration was higher (P<0.05) in P. acidilactici FT28 fed group with better (P<0.05) catalase and superoxide dismutase activity measured in erythrocyte. It is concluded that species-specific Pediococcus acidilactici FT28 isolated with potential in vitro probiotic properties and also hold probiotic candidature by showing the potential capabilities with higher nutrient digestibility, heamato-biochemical and antioxidant status compared to control and Lactobacillus acidophilus NCDC15.	[Dowarah, Runjun; Verma, Ashok Kumar; Agarwal, Neeta; Singh, Putan] ICAR Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, Izatnagar, UP, India; [Singh, Bhoj Raj] ICAR Indian Vet Res Inst, Div Epidemiol, Izatnagar, UP, India; [Dowarah, Runjun] Assam Agr Univ, Coll Vet Sci, Dept Anim Nutr, Gauhati, Assam, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Assam Agricultural University	Verma, AK (corresponding author), ICAR Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, Izatnagar, UP, India.	vermaak62@mail.com			Department of Science and Technology, Govt. of India	Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	Infrastructure facility and support for this research work was provided by Director, ICAR-IVRI, Izatnagar and the INSPIRE Fellowship to the first author provided by Department of Science and Technology, Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasiliasi S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-260; Aebi H., 1983, METHODS ENZYMATIC AN, P273, DOI 10.1016/B978-0-12-091302-2.50032-3; Agarwal N, 2002, LETT APPL MICROBIOL, V34, P329, DOI 10.1046/j.1472-765X.2002.01092.x; Ahn YT, 2002, ASIAN AUSTRAL J ANIM, V15, P1790, DOI 10.5713/ajas.2002.1790; Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; Ashmaig A, 2009, AFR J MICROBIOL RES, V3, P451; Balasingham K, 2017, VET WORLD, V10, P825, DOI 10.14202/vetworld.2017.825-829; Balasubramanian B., 2017, P 20 INT C INF FUS X, P1, DOI [DOI 10.1109/ITEC-INDIA.2017.8333825, 10.1109/ITEC-India.2017.8333825]; BARROW PA, 1980, J APPL BACTERIOL, V48, P147, DOI 10.1111/j.1365-2672.1980.tb05216.x; Cai CJ, 2014, J ANIM FEED SCI, V23, P222, DOI 10.22358/jafs/65684/2014; Chiang ML, 2015, ASIAN AUSTRAL J ANIM, V28, P1163, DOI 10.5713/ajas.14.0780; Cho IJ, 2009, J BIOSCI BIOENG, V108, P194, DOI 10.1016/j.jbiosc.2009.03.015; Choubey M, 2015, ANIM PROD SCI; De Angelis M, 2006, RES MICROBIOL, V157, P792, DOI 10.1016/j.resmic.2006.05.003; Dong X., 2013, J BASIC MICROB, V49, P220; Dowarah R, 2016, ANIM NUTR FEED TECHN, V16, P451, DOI 10.5958/0974-181X.2016.00042.1; Dowarah R, 2018, RES VET SCI IN PRESS; Dowarah R, 2017, ANIM NUTR, V3, P1, DOI 10.1016/j.aninu.2016.11.002; Dowarah R, 2017, LIVEST SCI, V195, P74, DOI 10.1016/j.livsci.2016.11.006; du Toit M, 1998, INT J FOOD MICROBIOL, V40, P93, DOI 10.1016/S0168-1605(98)00024-5; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Friendship RM., 1992, DIS SWINE, V7th ed, P3; GILLILAND SE, 1985, APPL ENVIRON MICROB, V49, P377, DOI 10.1128/AEM.49.2.377-381.1985; Gotcheva V, 2002, FOOD BIOTECHNOL, V16, P211, DOI 10.1081/FBT-120016668; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hossein AA, 2014, INT J FOOD NUTR SCI, V3, P8; Iniguez-Palomares C., 2007, REV LATINOAMER MICRO, V49, P46; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Kim PI, 2007, APPL MICROBIOL BIOT, V74, P1103, DOI 10.1007/s00253-006-0741-7; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Kumar S, 2012, VET WORLD, V5, P663, DOI 10.5455/vetworld.2012.663-666; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lim SM, 2009, J MICROBIOL BIOTECHN, V19, P178, DOI 10.4014/jmb.0804.269; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MINAMI M, 1979, CLIN CHIM ACTA, V92, P337; Mishra DK, 2014, ANIM NUTR FEED TECHN, V14, P283, DOI 10.5958/0974-181X.2014.01336.5; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Onifade AA, 1997, NAHRUNG, V41, P370, DOI 10.1002/food.19970410612; Ouwehand AC, 1999, INT DAIRY J, V9, P43, DOI 10.1016/S0958-6946(99)00043-6; Guerra NP, 2007, ANIM FEED SCI TECH, V134, P89, DOI 10.1016/j.anifeedsci.2006.05.010; Petsuriyawong B., 2011, Kasetsart Journal, Natural Sciences, V45, P245; Prieto ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088599; Pringsulaka O, 2015, LIVEST SCI, V174, P66, DOI 10.1016/j.livsci.2015.01.016; Prins H.K., 1969, BIOCH METHODS RED CE, P127; Quilodran-Vega SR, 2016, CAN J MICROBIOL, V62, P514, DOI 10.1139/cjm-2015-0811; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Shazali N, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-1; Shon K.S., 2005, J ANIM SCI, V3, P370; Singh BR, 2013, AXONE PROBIOTIC PIGS; Singh Kamlesh, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS287; Smith AL, 2008, J SWINE HEALTH PROD, V16, P131; Soleimani NA, 2010, AFR J MICROBIOL RES, V4; Taheri HR, 2009, POULTRY SCI, V88, P1586, DOI 10.3382/ps.2009-00041; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toit MD, 2003, LETT APPL MICROBIOL, V37, P12, DOI 10.1046/j.1472-765X.2003.01334.x; Venkatesan S., 2012, INT J PLANT ANIM ENV, P94; Vlkova E, 2006, LIVEST SCI, V105, P253, DOI 10.1016/j.livsci.2006.04.011; Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x; Wang J, 2012, ASIAN AUSTRAL J ANIM, V25, P1153, DOI 10.5713/ajas.2012.12079; Wang J, 2011, AFR J BIOTECHNOL, V10, P11303; Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129; Yadav R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01683; Zhao PY, 2015, ANIM FEED SCI TECH, V200, P86, DOI 10.1016/j.anifeedsci.2014.12.010	66	94	104	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0192978	10.1371/journal.pone.0192978	http://dx.doi.org/10.1371/journal.pone.0192978			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518093	Green Submitted, gold, Green Published			2022-12-26	WOS:000426902900013
J	Anderson, KB; Simasathien, S; Watanaveeradej, V; Weg, AL; Ellison, DW; Suwanpakdee, D; Klungthong, C; Phonpakobsin, T; Kerdpanich, P; Phiboonbanakit, D; Gibbons, RV; Fernandez, S; Macareo, LR; Yoon, IK; Jarman, RG				Anderson, Kathryn B.; Simasathien, Sriluck; Watanaveeradej, Veerachai; Weg, Alden L.; Ellison, Damon W.; Suwanpakdee, Detchvijitr; Klungthong, Chonticha; Phonpakobsin, Thipwipha; Kerdpanich, Phirangkul; Phiboonbanakit, Danabhand; Gibbons, Robert V.; Fernandez, Stefan; Macareo, Louis R.; Yoon, In-Kyu; Jarman, Richard G.			Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; SEASONAL INFLUENZA; DIAGNOSTIC-TEST; YOUNG-CHILDREN; PERFORMANCE; VACCINE; ADULTS; IMPACT; TESTS	Early diagnosis of influenza infection maximizes the effectiveness of antiviral medicines. Here, we assess the ability for clinical characteristics and rapid influenza tests to predict PCR-confirmed influenza infection in a sentinel, cross-sectional study for influenza-like illness (ILI) in Thailand. Participants meeting criteria for acute ILI (fever >38 degrees C and cough or sore throat) were recruited from inpatient and outpatient departments in Bangkok, Thailand, from 2009-2014. The primary endpoint for the study was the occurrence of virologically-confirmed influenza infection (based upon detection of viral RNA by RT-PCR) among individuals presenting for care with ILI. Nasal and throat swabs were tested by rapid influenza test (QuickVue) and by RT-PCR. Vaccine effectiveness (VE) was calculated using the case test-negative method. Classification and Regression Tree (CART) analysis was used to predict influenza RT-PCR positivity based upon symptoms reported. We enrolled 4572 individuals with ILI; 32.7% had detectable influenza RNA by RT-PCR. Influenza cases were attributable to influenza B (38.6%), A(H1N1) pdm09 (35.1%), and A(H3N2) (26.3%) viruses. VE was highest against influenza A(H1N1) pdm09 virus and among adults. The most important symptoms for predicting influenza PCR-positivity among patients with ILI were cough, runny nose, chills, and body aches. The accuracy of the CART predictive model was 72.8%, with an NPV of 78.1% and a PPV of 59.7%. During epidemic periods, PPV improved to 68.5%. The PPV of the QuickVue assay relative to RT-PCR was 93.0% overall, with peak performance during epidemic periods and in the absence of oseltamivir treatment. Clinical criteria demonstrated poor predictive capability outside of epidemic periods while rapid tests were reasonably accurate and may provide an acceptable alternative to RT-PCR testing in resource-limited areas.	[Anderson, Kathryn B.; Weg, Alden L.; Ellison, Damon W.; Klungthong, Chonticha; Phonpakobsin, Thipwipha; Gibbons, Robert V.; Fernandez, Stefan; Macareo, Louis R.; Yoon, In-Kyu] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Anderson, Kathryn B.] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Simasathien, Sriluck; Watanaveeradej, Veerachai; Suwanpakdee, Detchvijitr; Kerdpanich, Phirangkul; Phiboonbanakit, Danabhand] Phramongkutklao Hosp, Dept Pediat, Bangkok, Thailand; [Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Minnesota System; University of Minnesota Twin Cities; Phramongkutklao Hospital; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Anderson, KB (corresponding author), Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand.; Anderson, KB (corresponding author), Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	ande7622@umn.edu			Global Emerging Infections Surveillance and Response System	Global Emerging Infections Surveillance and Response System	This work was supported by Global Emerging Infections Surveillance and Response System (https://www.health.mil/Military-Health-Topics/Health-Readiness/Armed-Forces-Health-Surveillance-Branch/Global-Emerging-Infections-Surveillance-and-Response), Grant numbers: various. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashyam HS, 2005, AM J TROP MED HYG, V73, P240; Campe H, 2016, EPIDEMIOL INFECT, V144, P1045, DOI 10.1017/S0950268815002228; Centers for Disease Control and Prevention (CDC) CDC Realtime RT-PCR, 2007, I00705 CDCP; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ferdinands JM, 2016, CLIN INFECT DIS; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Gordon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007907; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Kittikraisak W, 2016, PEDIATR INFECT DIS J, V35, pE318, DOI 10.1097/INF.0000000000001280; Lacroix S, 2015, J CLIN VIROL, V72, P141, DOI 10.1016/j.jcv.2015.08.002; Levy JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134318; Liao QH, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0127-0; Loubet P, 2016, J CLIN VIROL, V79, P68, DOI 10.1016/j.jcv.2016.04.005; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Olsen SJ, 2014, PEDIATR INFECT DIS J, V33, P117, DOI 10.1097/INF.0000000000000089; Petrie JG, 2016, J INFECT DIS, V214, P1142, DOI 10.1093/infdis/jiw105; Rouleau I, 2009, J CLIN MICROBIOL, V47, P2699, DOI 10.1128/JCM.00762-09; Stebbins S, 2011, INFLUENZA OTHER RESP, V5, P104, DOI 10.1111/j.1750-2659.2010.00171.x; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Vardakas KZ, 2016, ARCH VIROL, V161, P2511, DOI 10.1007/s00705-016-2941-5; Velasco JMS, 2010, J CLIN VIROL, V48, P120, DOI 10.1016/j.jcv.2010.03.010; World Health Organization, 2009, CDC PROT REALT RTPCR; Zimmerman RK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1839-x	29	10	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193050	10.1371/journal.pone.0193050	http://dx.doi.org/10.1371/journal.pone.0193050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513698	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800033
J	Ding, N; Jiang, J; Qin, PP; Wang, QX; Hu, JT; Li, ZG				Ding, Ning; Jiang, Jing; Qin, Pingping; Wang, Qiaoxia; Hu, Jiatong; Li, Zhigang			Mast cells are important regulator of acupoint sensitization via the secretion of tryptase, 5-hydroxytryptamine, and histamine	PLOS ONE			English	Article							OSTEOARTHRITIS; ACUPUNCTURE; KNEE; PAIN; ELECTROACUPUNCTURE; ACTIVATION; RECEPTORS; SEROTONIN; MECHANISM; RESPONSES	Mast cells (MCs) play a crucial role in mediating the establishment of networks among the circulatory, nervous and immune system at acupoints. However, the changes which occur in MCs during acupoint sensitization, i.e. the dynamic transformation of an acupoint from a "silenced" to an "activated" status, remain uncharacterized. To investigate the morphological and functional changes of MCs as an aid to understanding the cellular mechanism underlying acupoint sensitization, a rat model of knee osteoarthritis (OA) was induced by an injection of mono-iodoacetate (MIA) on day 0. On day 14, toluidine blue and immunofluorescence staining were used to observe the recruitment and degranulation of MCs and the release of mast cell co-expressed mediators: tryptase, 5-hydroxytryptamine (5-HT) and histamine (HA) at the acupoints Yanglingquan (GB34), Heding (EX-LE2) and Weizhong (BL40). Results showed that the number of MCs as well as the percentages of degranulated and extensively degranulated MCs at the acupoints GB34 and EX-LE2 in the light (A), mild (B), heavy (C) osteoarthritis groups were larger than those in the normal control (N) and normal saline (NS) groups (p < 0.01). Comparisons among the A, B and C groups suggested that the number and the degranulation extent of the MCs at the acupoints GB34 and EXLE2 were positively correlated with the severity of the disease. Some MCs in the A, B and C group showed the release of 5-HT, HA, and tryptase in degranulation at the acupoints GB34 and EX-LE2. Such changes in MCs were not observed at the acupoint BL40. In conclusion, this study confirmed that acupoint sensitization is associated with the increase in recruitment and degranulation levels of MCs on a acupoint-specific and disease severity-dependent manner. The release of tryptase, 5-HT, and HA during MC degranulation is likely to be one of the cellular mechanisms occurring during acupoint sensitization.	[Ding, Ning; Qin, Pingping; Wang, Qiaoxia; Hu, Jiatong; Li, Zhigang] Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China; [Jiang, Jing] Beijing Univ Chinese Med, Sch Nursing, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Li, ZG (corresponding author), Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China.	lizhigang620@126.com			National Natural Science Foundation of China [81590952]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81590952).	Ahsin S, 2009, PAIN, V147, P60, DOI 10.1016/j.pain.2009.08.004; Bhaskaran S, 2014, AM J PHYSIOL-CELL PH, V306, pC143, DOI 10.1152/ajpcell.00247.2013; Chen B, 2017, CHIN J INTEGR MED, V23, P878, DOI 10.1007/s11655-016-2269-8; Chen S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/158012; Chen XY, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0071-9; Corbett MS, 2013, OSTEOARTHR CARTILAGE, V21, P1290, DOI 10.1016/j.joca.2013.05.007; de Souza DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/142359; Dudeck A, 2010, EXP DERMATOL, V19, P424, DOI 10.1111/j.1600-0625.2010.01073.x; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Glatzer F, 2013, J ALLERGY CLIN IMMUN, V132, P1358, DOI 10.1016/j.jaci.2013.06.023; GRUBER BL, 1995, BLOOD, V86, P2488; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Hinman RS, 2014, JAMA-J AM MED ASSOC, V312, P1313, DOI 10.1001/jama.2014.12660; Hough LB, 2011, J PHARMACOL EXP THER, V336, P30, DOI 10.1124/jpet.110.171264; Islam MZ, 2014, J VET MED SCI, V76, P1339, DOI 10.1292/jvms.14-0223; Karner M, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/427265; Keles N, 2012, EXP TOXICOL PATHOL, V64, P713, DOI 10.1016/j.etp.2011.01.005; Kushnir-Sukhov NM, 2006, J IMMUNOL, V177, P6422, DOI 10.4049/jimmunol.177.9.6422; Li L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/931283; Liu X, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6431574; Ma XP, 2009, WORLD J GASTROENTERO, V15, P5211, DOI 10.3748/wjg.15.5211; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Mavrommatis CI, 2012, PAIN, V153, P1720, DOI 10.1016/j.pain.2012.05.005; Mei ZG, 2011, J TRADIT CHIN MED, V31, P311, DOI 10.1016/S0254-6272(12)60010-7; Mingfu L., 2013, EVID-BASED COMPL ALT, V2013; Nilsson G, 2000, IMMUNOLOGY, V99, P314, DOI 10.1046/j.1365-2567.2000.00972.x; Ohtsu H, 2012, INT ARCH ALLERGY IMM, V158, P2, DOI 10.1159/000337735; Oliveira MCG, 2007, NEUROSCIENCE, V145, P708, DOI 10.1016/j.neuroscience.2006.12.021; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Purepong N, 2012, ACUPUNCT MED, V30, P187, DOI 10.1136/acupmed-2012-010140; Rong PJ, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/516851; Rong PJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/742195; Rosa AC, 2013, BRIT J PHARMACOL, V170, P38, DOI 10.1111/bph.12266; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Shi Y, 2011, WORLD J GASTROENTERO, V17, P3733, DOI 10.3748/wjg.v17.i32.3733; Suarez-Almazor ME, 2010, ARTHRIT CARE RES, V62, P1229, DOI 10.1002/acr.20225; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Wang Guangjun, 2014, Medicines (Basel), V1, P56, DOI 10.3390/medicines1010056; Wetterberg J, 2011, J EUR ACAD DERMATOL, V25, P1200, DOI 10.1111/j.1468-3083.2010.03952.x; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Wu HG, 2008, DIGEST DIS SCI, V53, P1644, DOI 10.1007/s10620-007-0062-4; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0916-4; Wu ML, 2015, J CHEM NEUROANAT, V68, P14, DOI 10.1016/j.jchemneu.2015.06.002; Xie DX, 2013, ACUPUNCT MED, V31, P422, DOI 10.1136/acupmed-2013-010409; Yang W., 2014, EVID-BASED COMPL ALT, V2014; Yao W, 2014, INT J BIOL SCI, V10, P511, DOI 10.7150/ijbs.8631; Yu L.-L., 2014, EVID-BASED COMPL ALT, V2014; Yu YX, 2016, EUR J PHARMACOL, V778, P33, DOI 10.1016/j.ejphar.2015.07.017; Zhu HN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08855-5	52	22	25	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194022	10.1371/journal.pone.0194022	http://dx.doi.org/10.1371/journal.pone.0194022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513755	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800097
J	Monroe, JD; Hruska, HL; Ruggles, HK; Williams, KM; Smith, ME				Monroe, Jerry D.; Hruska, Heidi L.; Ruggles, Hannah K.; Williams, Kevin M.; Smith, Michael E.			Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand	PLOS ONE			English	Article							INDUCED HEARING-LOSS; BRAIN-STEM RESPONSE; HAIR CELL-DEATH; INDUCED APOPTOSIS; MECHANISM; NEPHROTOXICITY; METHIONINE; STRESS; CIS-DIAMMINEDICHLOROPLATINUM(II); DIETHYLDITHIOCARBAMATE	Unlike cisplatin, which forms bifunctional DNA adducts, monofunctional platinum(II) complexes bind only one strand of DNA and might target cancer without causing auditory sideeffects associated with cisplatin treatment. We synthesized the monofunctional triamineligated platinum(II) complexes, Pt(diethylenetriamine) Cl, [Pt(dien) Cl]+, and Pt(N, N-diethyldiethylenetriamine) Cl, [Pt(Et2dien) Cl]+, and the monofunctional heterocyclic-ligated platinum( II) complexes, pyriplatin and phenanthriplatin, and compared their 5'-GMP binding rates, cellular compartmental distribution and cellular viability effects. A zebrafish inner ear model was used to determine if the monofunctional complexes and cisplatin caused hearing threshold shifts and reduced auditory hair cell density. The four monofunctional complexes had varied relative GMP binding rates, but similar cytosolic and nuclear compartmental uptake in three cancer cell lines (A549, Caco2, HTB16) and a control cell line (IMR90). Phenanthriplatin had the strongest effect against cellular viability, comparable to cisplatin, followed by [Pt(Et2dien) Cl](+), pyriplatin and [Pt(dien) Cl](+). Phenanthriplatin also produced the highest hearing threshold shifts followed by [Pt(dien) Cl](+), [Pt(Et2dien) Cl](+), cisplatin and pyriplatin. Hair cell counts taken from four regions of the zebrafish saccule showed that cisplatin significantly reduced hair cell density in three regions and phenanthriplatin in only one region, with the other complexes having no significant effect. Utricular hair cell density was not reduced by any of the compounds. Our results suggest that placing greater steric hindrance cis to one side of the platinum coordinating center in monofunctional complexes promotes efficient targeting of the nuclear compartment and guanosine residues, and may be responsible for reducing cancer cell viability. Also, the monofunctional compounds caused hearing threshold shifts with minimal effect on hair cell density, which suggests that they may affect different pathways than cisplatin.	[Monroe, Jerry D.; Smith, Michael E.] Western Kentucky Univ, Dept Biol, 1906 Coll Hts Blvd, Bowling Green, KY 42101 USA; [Hruska, Heidi L.; Ruggles, Hannah K.; Williams, Kevin M.] Western Kentucky Univ, Dept Chem, 1906 Coll Hts Blvd, Bowling Green, KY 42101 USA	Western Kentucky University; Western Kentucky University	Smith, ME (corresponding author), Western Kentucky Univ, Dept Biol, 1906 Coll Hts Blvd, Bowling Green, KY 42101 USA.	rnichaeLsmith1@wku.edu	Smith, Michael/AAM-8542-2020; Williams, Kevin/C-3804-2011	Williams, Kevin/0000-0003-4019-8528; Smith, Michael/0000-0002-2174-9825	National Institutes of Health [R15 CA188890-01A1, P20 GM103436-14, P20 GM103436-16]; Kentucky Science and Engineering Foundation [14850214325]; Research and Creative Activities Program grant from Western Kentucky University (WKU) [17-8031]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Science and Engineering Foundation; Research and Creative Activities Program grant from Western Kentucky University (WKU)	This research was supported by National Institutes of Health awards R15 CA188890-01A1, P20 GM103436-14, P20 GM103436-16, a Kentucky Science and Engineering Foundation grant (14850214325), and a Research and Creative Activities Program grant (17-8031) from Western Kentucky University (WKU). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Institutes of Health awards R15 CA188890-01A1, P20 GM103436-14, P20 GM103436-16, a Kentucky Science and Engineering Foundation grant (14850214325), and a Research and Creative Activities Program grant (17-8031) from Western Kentucky University (WKU). The authors would like to thank Madison Heine and Taylor Billings for zebrafish hearing tests and dissection and quantification of auditory tissue samples. We also thank Pauline Norris of the WKU Advanced Materials Institute for assistance with atomic absorption spectrometry and the WKU Biotechnology Center for providing facilities support.	Alian OM, 2012, CLIN TRANSL MED, V1, P1; BARNHAM KJ, 1994, J CHEM SOC CHEM COMM, P721, DOI 10.1039/c39940000721; BORCH RF, 1979, P NATL ACAD SCI USA, V76, P6611, DOI 10.1073/pnas.76.12.6611; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Clifford RE, 2011, OTOLARYNG HEAD NECK, V145, P999, DOI 10.1177/0194599811414496; Coffin AB, 2013, APOPTOSIS, V18, P393, DOI 10.1007/s10495-013-0816-8; CORWIN JT, 1982, ELECTROEN CLIN NEURO, V54, P629, DOI 10.1016/0013-4694(82)90117-1; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; DJURAN MI, 1991, INORG CHEM, V30, P2648, DOI 10.1021/ic00012a016; Feng H, 2011, MOL CELL BIOCHEM, V353, P291, DOI 10.1007/s11010-011-0798-1; Giordano P, 2006, Acta Otorhinolaryngol Ital, V26, P198; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; HOFFMAN RE, 1988, MAGN RESON CHEM, V26, P523, DOI 10.1002/mrc.1260260617; HOLLIS LS, 1991, CANCER RES, V51, P1866; Jaganyi D, 2001, ANGEW CHEM INT EDIT, V40, P1680, DOI 10.1002/1521-3773(20010504)40:9<1680::AID-ANIE16800>3.3.CO;2-B; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Johnstone TC, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0185; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Karasawa T, 2015, TOXICOL LETT, V237, P219, DOI 10.1016/j.toxlet.2015.06.012; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; KNOX RJ, 1986, CANCER RES, V46, P1972; Landier W, 2016, CANCER-AM CANCER SOC, V122, P1647, DOI 10.1002/cncr.29779; Langer T, 2013, TRENDS PHARMACOL SCI, V34, P458, DOI 10.1016/j.tips.2013.05.006; Lanvers-Kaminsky C, 2017, CLIN PHARMACOL THER, V101, P491, DOI 10.1002/cpt.603; LEMPERS ELM, 1990, INORG CHEM, V29, P217, DOI 10.1021/ic00327a014; Lorito G, 2011, MED SCI MONITOR, V17, pBR179, DOI 10.12659/MSM.881894; Lovejoy KS, 2008, P NATL ACAD SCI USA, V105, P8902, DOI 10.1073/pnas.0803441105; Lovejoy KS, 2011, MOL CANCER THER, V10, P1709, DOI 10.1158/1535-7163.MCT-11-0250; Lovejoy KS, 2009, DALTON T, P10651, DOI 10.1039/b913896j; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mariggio M, 2004, INVEST NEW DRUG, V22, P3, DOI 10.1023/B:DRUG.0000006170.38419.c9; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Oxman DS, 2007, CAN J FISH AQUAT SCI, V64, P1469, DOI 10.1139/F07-106; Paken J, 2016, J TOXICOL-US, V2016, DOI 10.1155/2016/1809394; Park GY, 2012, P NATL ACAD SCI USA, V109, P11987, DOI 10.1073/pnas.1207670109; PINTO AL, 1985, P NATL ACAD SCI USA, V82, P4616, DOI 10.1073/pnas.82.14.4616; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; Raymond E, 2002, MOL CANCER THER, V1, P227; Sandlin RD, 2012, INORG CHIM ACTA, V391, P135, DOI 10.1016/j.ica.2012.05.008; Sandlin RD, 2010, J INORG BIOCHEM, V104, P214, DOI 10.1016/j.jinorgbio.2009.10.013; Schuck JB, 2009, HEARING RES, V253, P67, DOI 10.1016/j.heares.2009.03.008; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Sun H, PLOS ONE, V6; Thomas AJ, 2013, J NEUROSCI, V33, P4405, DOI 10.1523/JNEUROSCI.3940-12.2013; Wang D, 2010, P NATL ACAD SCI USA, V107, P9584, DOI 10.1073/pnas.1002565107; Wang JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15943; Wang SS, 2010, CHEM RES TOXICOL, V23, P1653, DOI 10.1021/tx1003547; Westerfield M., 1994, ZEBRAFISH BOOK GUIDE, V4; Williams KM, 2017, INORG CHIM ACTA, V458, P163, DOI 10.1016/j.ica.2017.01.010; Williams KM, 2011, INORG CHIM ACTA, V368, P187, DOI 10.1016/j.ica.2011.01.002; Williams KM, 2005, J INORG BIOCHEM, V99, P2119, DOI 10.1016/j.jinorgbio.2005.07.010; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Zhu GY, 2012, CANCER RES, V72, P790, DOI 10.1158/0008-5472.CAN-11-3151	60	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192505	10.1371/journal.pone.0192505	http://dx.doi.org/10.1371/journal.pone.0192505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513752	gold, Green Submitted, Green Published			2022-12-26	WOS:000426896800016
J	van Schaik, JE; Hunnius, S				van Schaik, Johanna E.; Hunnius, Sabine			Modulating mimicry: Exploring the roles of inhibitory control and social understanding in 5-year-olds' behavioral mimicry	PLOS ONE			English	Article							EXECUTIVE FUNCTION; CHILDREN; AFFILIATION; MIND; COLLABORATION; COORDINATION; CHAMELEON; OSTRACISM; FIDELITY	During adult interactions, behavioral mimicry, the implicit copying of an interaction partner's postures and mannerisms, communicates liking and affiliation. While this social behavior likely develops during early childhood, it is unclear which factors contribute to its emergence. Here, the roles of inhibitory control and social understanding on 5-year-olds' behavioral mimicry were investigated. Following a social manipulation in which one experimenter shared a sticker with the child and the other experimenter kept two stickers for herself, children watched a video in which these experimenters each told a story. During this story session, children in the experimental group(n = 28) observed the experimenters perform face and hand rubbing behaviors whereas the control group (n = 23) did not see these behaviors. Children's inhibitory control was assessed using the day-night task and their social understanding was measured through a parental questionnaire. Surprisingly, group-level analyses revealed that the experimental group performed the behaviors significantly less than the control group (i.e. a negative mimicry effect) for both the sticker-sharer and sticker-keeper. Yet, the hypothesized effects of inhibitory control and social understanding were found. Inhibitory control predicted children's selective mimicry of the sticker-keeper versus sticker sharer and children's overall mimicry was correlated with social understanding. These results provide the first indications to suggest that factors of social and cognitive development dynamically influence the emergence and specificity of behavioral mimicry during early childhood.	[van Schaik, Johanna E.; Hunnius, Sabine] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [van Schaik, Johanna E.] Leiden Univ, Educ & Child Studies, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC	van Schaik, JE (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; van Schaik, JE (corresponding author), Leiden Univ, Educ & Child Studies, Leiden, Netherlands.	j.e.van.schaik@fsw.leidenuniv.nl	Hunnius, Sabine/D-5834-2012	van Schaik, Johanna E/0000-0001-5865-4523	Donders Institute for Brain, Cognition, and Behaviour	Donders Institute for Brain, Cognition, and Behaviour	JEvS was funded by an internal PhD grant of the Donders Institute for Brain, Cognition, and Behaviour.	Caputi M, 2012, DEV PSYCHOL, V48, P257, DOI 10.1037/a0025402; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Catmur C, 2013, COGNITIVE SCI, V37, P1541, DOI 10.1111/cogs.12071; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Chernyak N, 2016, SOC DEV, V25, P340, DOI 10.1111/sode.12136; Emanuel L. L., 2012, THESIS; Endedijk HM, 2015, SOC DEV, V24, P521, DOI 10.1111/sode.12106; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hogeveen J, 2012, J NEUROSCI, V32, P5984, DOI 10.1523/JNEUROSCI.5938-11.2012; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leander NP, 2012, PSYCHOL SCI, V23, P772, DOI 10.1177/0956797611434535; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; Meyer M, 2015, J EXP CHILD PSYCHOL, V139, P203, DOI 10.1016/j.jecp.2015.06.005; Meyer M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0371; Montgomery DE, 2010, DEV REV, V30, P308, DOI 10.1016/j.dr.2010.07.001; Oostenbroek J, 2015, J EXP CHILD PSYCHOL, V139, P234, DOI 10.1016/j.jecp.2015.05.009; Paulus M, 2013, J EXP CHILD PSYCHOL, V116, P78, DOI 10.1016/j.jecp.2012.12.014; Plotner M, 2015, J EXP CHILD PSYCHOL, V139, P161, DOI 10.1016/j.jecp.2015.05.008; Tahiroglu D, 2014, DEV PSYCHOL, V50, P2485, DOI 10.1037/a0037914; van Baaren RB, 2004, J PERS SOC PSYCHOL, V86, P453, DOI 10.1037/0022-3514.86.3.453; Van Schaik J.E., 2013, P 35 ANN C COGN SCI, P1516; van Schaik JE, 2016, J EXP CHILD PSYCHOL, V147, P71, DOI 10.1016/j.jecp.2016.03.003; van Schaik JE, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.7016.00321, 10.3389/fpsyg.2016.00321]; Watson-Jones RE, 2016, PSYCHOL SCI, V27, P34, DOI 10.1177/0956797615607205; Watson-Jones RE, 2014, EVOL HUM BEHAV, V35, P204, DOI 10.1016/j.evolhumbehav.2014.01.004; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6	35	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194102	10.1371/journal.pone.0194102	http://dx.doi.org/10.1371/journal.pone.0194102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513741	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800102
J	Pizzitutti, F; Pan, W; Feingold, B; Zaitchik, B; Alvarez, CA; Mena, CF				Pizzitutti, Francesco; Pan, William; Feingold, Beth; Zaitchik, Ben; Alvarez, Carlos A.; Mena, Carlos F.			Out of the net: An agent-based model to study human movements influence on local-scale malaria transmission	PLOS ONE			English	Article							ANOPHELES-DARLINGI; SEASONAL DISTRIBUTION; PLASMODIUM-VIVAX; EPIDEMIOLOGY; BEHAVIOR; ELIMINATION; STRATEGIES; INFECTION; MOSQUITOS; POPULATION	Though malaria control initiatives have markedly reduced malaria prevalence in recent decades, global eradication is far from actuality. Recent studies show that environmental and social heterogeneities in low-transmission settings have an increased weight in shaping malaria micro-epidemiology. New integrated and more localized control strategies should be developed and tested. Here we present a set of agent-based models designed to study the influence of local scale human movements on local scale malaria transmission in a typical Amazon environment, where malaria is transmission is low and strongly connected with seasonal riverine flooding. The agent-based simulations show that the overall malaria incidence is essentially not influenced by local scale human movements. In contrast, the locations of malaria high risk spatial hotspots heavily depend on human movements because simulated malaria hotspots are mainly centered on farms, were laborers work during the day. The agent-based models are then used to test the effectiveness of two different malaria control strategies both designed to reduce local scale malaria incidence by targeting hotspots. The first control scenario consists in treat against mosquito bites people that, during the simulation, enter at least once inside hotspots revealed considering the actual sites where human individuals were infected. The second scenario involves the treatment of people entering in hotspots calculated assuming that the infection sites of every infected individual is located in the household where the individual lives. Simulations show that both considered scenarios perform better in controlling malaria than a randomized treatment, although targeting household hotspots shows slightly better performance.	[Pizzitutti, Francesco; Mena, Carlos F.] Univ San Francisco Quito, Inst Geog, Quito, Ecuador; [Pizzitutti, Francesco; Pan, William] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Feingold, Beth] SUNY Albany, Sch Publ Hlth, Albany, NY USA; [Zaitchik, Ben] Johns Hopkins Univ, Morton K Blaustein Dept Earth & Planetary Sci, Baltimore, MD USA; [Alvarez, Carlos A.] DIRESA Loreto, Epidemiol Dept, Iquitos, Loreto, Peru	Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Johns Hopkins University	Mena, CF (corresponding author), Univ San Francisco Quito, Inst Geog, Quito, Ecuador.; Pan, W (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.	wkp@duke.edu; cmena@usfq.edu.ec	Zaitchik, Benjamin/AAB-3298-2020; Mena, Carlos F./AAI-3570-2020	Zaitchik, Benjamin/0000-0002-0698-0658; Mena, Carlos F./0000-0003-0825-6476; Feingold, Beth/0000-0001-6670-5845	NASA [NNH13ZDA001N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065563] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by NASA (NNH13ZDA001N-Health to Pan).; Funding was provided by NASA (NNH13ZDA001N-Health to Pan). Malaria data were provided by DIRESA-Loreto Epidemiology Department. Spatial data from each community were provided by CA (PC) and WP (TC). Special thanks to Paige Meier who provided extensive feedback on the manuscript.	Alonso WJ, 2006, MED VET ENTOMOL, V20, P157, DOI 10.1111/j.1365-2915.2006.00623.x; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2015, REG PROF WORLD MAL R, P122; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bomblies A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-308; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carrillo-Larco RM, 2014, PEERJ, V2, DOI 10.7717/peerj.345; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P291, DOI 10.1590/S0034-89101987000400002; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Gu W, 2009, T R SOC TROP MED HYG, V103, P1; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Illangakoon C, 2014, 2014 IEEE CAN INT HU, P1; Instituto nacional de estadistica e informatica (INEI), 2014, REV INF, P1; Jarvis A, 2008, HOLE FILLED SEAMLESS; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lana JT, 2012, THESIS; Lansang MAD, 1997, ACTA TROP, V63, P257, DOI 10.1016/S0001-706X(96)00625-0; Luke S., 2005, SIMULATION, P1; Marshall JM, 2016, TRENDS PARASITOL, V32, P752, DOI 10.1016/j.pt.2016.07.004; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; McCall PJ, 2002, TRENDS PARASITOL, V18, P429, DOI 10.1016/S1471-4922(02)02370-X; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Mosha JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-53; Neumann K, 2015, HUM ECOL, V43, P309, DOI 10.1007/s10745-015-9733-5; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pizzitutti F., 2014, JASSS-J ARTIF SOC S, V17, P1; Pizzitutti F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1030-7; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pullan RL, 2010, PLASMODIUM INFECT IT, P1; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; ROZENDAAL JA, 1989, J AM MOSQUITO CONTR, V5, P351; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Turell MJ, 2008, J MED ENTOMOL, V45, P1165, DOI 10.1603/0022-2585(2008)45[1165:SDBAHA]2.0.CO;2; URIEL Kitron, 1998, LANDSCAPE ECOLOGY EP; Utzinger J, 2002, NATURE, V419, P431, DOI 10.1038/419431a; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WHO, 2016, WORLD MALARIA REPORT; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	71	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193493	10.1371/journal.pone.0193493	http://dx.doi.org/10.1371/journal.pone.0193493			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509795	Green Published, gold, Green Submitted			2022-12-26	WOS:000426813200014
J	Ramadan, RM; Gasser, SM; El-Mahallawy, MS; Supsup, KH; El Bakly, AM				Ramadan, Rahab M.; Gasser, Safa M.; El-Mahallawy, Mohamed S.; Supsup, Karim Hammad; El Bakly, Ahmed M.			A memetic optimization algorithm for multi-constrained multicast routing in ad hoc networks	PLOS ONE			English	Article							GENETIC ALGORITHM; ENERGY-EFFICIENT	A mobile ad hoc network is a conventional self-configuring network where the routing optimization problem-subject to various Quality-of-Service (QoS) constraints-represents a major challenge. Unlike previously proposed solutions, in this paper, we propose a memetic algorithm (MA) employing an adaptive mutation parameter, to solve the multicast routing problem with higher search ability and computational efficiency. The proposed algorithm utilizes an updated scheme, based on statistical analysis, to estimate the best values for all MA parameters and enhance MA performance. The numerical results show that the proposed MA improved the delay and jitter of the network, while reducing computational complexity as compared to existing algorithms.	[Ramadan, Rahab M.; El Bakly, Ahmed M.] Arab Acad Sci Technol & Maritime Transport, Dept Basic & Appl Sci, Cairo, Egypt; [Gasser, Safa M.; El-Mahallawy, Mohamed S.; Supsup, Karim Hammad] Arab Acad Sci Technol & Maritime Transport, Dept Elect & Commun, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport; Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	Ramadan, RM (corresponding author), Arab Acad Sci Technol & Maritime Transport, Dept Basic & Appl Sci, Cairo, Egypt.	rahabmz@aast.edu						Abbass H. A., 2001, P GEN EV COMP C GECC, P807; Abdelhaq M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120715; Abdelkader TAMM, 2008, THESIS; Al-Nahari A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156670; Alajmi A., 2014, INT J SUSTAINABLE BU, V3, P18, DOI [10.1016/j.ijsbe.2014.07.003, DOI 10.1016/J.IJSBE.2014.07.003]; ALANDER JT, 1992, COMPUTER SYSTEMS AND SOFTWARE ENGINEERING, P65, DOI 10.1109/CMPEUR.1992.218485; Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P531, DOI 10.1109/ICEC.1994.350004; Back T., 1996, Foundations of Intelligent Systems. 9th International Symposium, ISMIS '96. Proceedings, P158; Baumann R., 2007, 262 TIK ETH ZENTR CO; Bitam S, 2013, J NETW COMPUT APPL, V36, P981, DOI 10.1016/j.jnca.2012.01.023; Chen L, 2005, IEEE J SEL AREA COMM, V23, P561, DOI 10.1109/JSAC.2004.842560; Cheng H, 2010, ENG APPL ARTIF INTEL, V23, P806, DOI 10.1016/j.engappai.2010.01.021; Chitra C., 2011, THESIS; De Jong K.A., 1975, THESIS ANN ARBOR; De Oliveira HCB, 2006, 6 INT C HYBR INT SYS, P1; Dey D. K., 2014, COMPUSOFT INT J ADV, V3, P1116; FOGARTY TC, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P104; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; Haghighat AT, 2003, KNOWL-BASED SYST, V16, P305, DOI 10.1016/S0950-7051(03)00032-7; Haupt R. L., 2000, Applied Computational Electromagnetics Society Journal, V15, P94; Hessler C., 1990, P 1 WORKSH PAR PROBL, P23; Huang CJ, 2009, ENG APPL ARTIF INTEL, V22, P1188, DOI 10.1016/j.engappai.2009.03.004; Hwang RH, 2000, J INF SCI ENG, V16, P885; Keppel G., 1982, DESIGN ANAL RES HDB; Khuri S., 1994, PROC GENET ALGORITHM, P86; Khuri S., 1994, P ACM S APPL COMPUTI, P188, DOI DOI 10.1145/326619.326694.(HTTP://D0LACM.0RG/10.1145/326619.326694); Koyama Akio, 2008, International Journal of High Performance Computing and Networking, V5, P381, DOI 10.1504/IJHPCN.2008.025557; Liang MX, 2017, NAT COMPUT, V16, P85, DOI 10.1007/s11047-016-9545-6; Lu T, 2013, IEEE COMMUN LETT, V17, P31, DOI 10.1109/LCOMM.2012.112012.121467; Man KF, 1997, GENETIC ALGORITHMS C; McCall J, 2005, J COMPUT APPL MATH, V184, P205, DOI 10.1016/j.cam.2004.07.034; MUHLENBEIN H, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P15; Onwuka E., 2011, J RES NATL DEV TRANS; Pham D. T., 2006, INTELLIGENT PRODUCTI, P454, DOI [10.1016/B978-008045157-2/50081-X, DOI 10.1016/B978-008045157-2/50081-X]; Rudolph G, 2001, IEEE T EVOLUT COMPUT, V5, P410, DOI 10.1109/4235.942534; Sabar NR, 2016, LECT NOTES COMPUT SC, V9810, P406, DOI 10.1007/978-3-319-42911-3_34; Sabar NR, 2015, INT C PAR DISTRIB SY, P60, DOI 10.1109/ICPADS.2015.16; Santhi G., 2014, THESIS; SCHAFFER JD, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P51; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Skiena S. S., 2008, ALGORITHM DESIGN MAN; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Tseng SY, 2008, EXPERT SYST APPL, V35, P1473, DOI 10.1016/j.eswa.2007.08.018; Vadivel R, 2012, PROC TECH, V4, P703, DOI 10.1016/j.protcy.2012.05.114; Wang ZY, 2001, COMPUT COMMUN, V24, P685, DOI 10.1016/S0140-3664(00)00273-5; Yuan B, 2007, STUD COMPUT INTELL, V54, P121; Zhang L, 2009, COMPUT COMMUN, V32, P105, DOI 10.1016/j.comcom.2008.09.023	48	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193142	10.1371/journal.pone.0193142	http://dx.doi.org/10.1371/journal.pone.0193142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509760	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200010
J	Honma, K; Abe, S; Endo, T; Uno, N; Oshimura, M; Ohbayashi, T; Kazuki, Y				Honma, Kazuhisa; Abe, Satoshi; Endo, Takeshi; Uno, Narumi; Oshimura, Mitsuo; Ohbayashi, Tetsuya; Kazuki, Yasuhiro			Development of a multiple-gene-loading method by combining multi-integration system-equipped mouse artificial chromosome vector and CRISPR-Cas9	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; REPORTER	Mouse artificial chromosome (MAC) vectors have several advantages as gene delivery vectors, such as stable and independent maintenance in host cells without integration, transferability from donor cells to recipient cells via microcell-mediated chromosome transfer (MMCT), and the potential for loading a megabase-sized DNA fragment. Previously, a MAC containing a multi-integrase platform (MI-MAC) was developed to facilitate the transfer of multiple genes into desired cells. Although the MI system can theoretically hold five geneloading vectors (GLVs), there are a limited number of drugs available for the selection of multiple-GLV integration. To overcome this issue, we attempted to knock out and reuse drug resistance genes (DRGs) using the CRISPR-Cas9 system. In this study, we developed new methods for multiple-GLV integration. As a proof of concept, we introduced five GLVs in the MI-MAC by these methods, in which each GLV contained a gene encoding a fluorescent or luminescent protein (EGFP, mCherry, BFP, Eluc, and Cluc). Genes of interest (GOI) on the MI-MAC were expressed stably and functionally without silencing in the host cells. Furthermore, the MI-MAC carrying five GLVs was transferred to other cells by MMCT, and the resultant recipient cells exhibited all five fluorescence/luminescence signals. Thus, the MI-MAC was successfully used as a multiple-GLV integration vector using the CRISPRCas9 system. The MI-MAC employing these methods may resolve bottlenecks in developing multiple-gene humanized models, multiple-gene monitoring models, disease models, reprogramming, and inducible gene expression systems.	[Honma, Kazuhisa; Uno, Narumi; Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Abe, Satoshi; Uno, Narumi; Oshimura, Mitsuo; Kazuki, Yasuhiro] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Endo, Takeshi] Tottori Ind Promot Org, Tottori, Tottori, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University	Kazuki, Y (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan.; Kazuki, Y (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	kazuki@grapp.methottori-u.ac.jp	Narumi, Uno/AAP-3936-2021	Narumi, Uno/0000-0002-4218-1167; Kazuki, Yasuhiro/0000-0003-4818-4710	Takeda Science Foundation; Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED; JSPS KAKENHI [25221308, 15H04285]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by The Takeda Science Foundation (Y.K.), the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K. and M.O.), the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) (Y.K.), the Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and Development, AMED (Y.K.), and JSPS KAKENHI Grant Numbers 25221308 (M.O.) and 15H04285 (Y.K.). There was no additional external funding received for this study.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Endo T, 2016, YONAGO ACTA MED, V59, P174; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Hansen K, 2012, JOVE-J VIS EXP, DOI 10.3791/3304; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kameyama Y, 2010, BIOTECHNOL BIOENG, V105, P1106, DOI 10.1002/bit.22619; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kazuki K, 2013, BIOCHEM BIOPH RES CO, V442, P44, DOI 10.1016/j.bbrc.2013.10.171; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kokura K, 2016, J GENE MED, V18, P273, DOI 10.1002/jgm.2925; Kurosaki H, 2011, J HUM GENET, V56, P727, DOI 10.1038/jhg.2011.88; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Oshimura M, 2015, CHROMOSOME RES, V23, P111, DOI 10.1007/s10577-014-9459-z; Ren XY, 2005, STEM CELLS, V23, P1608, DOI 10.1634/stemcells.2005-0021; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Tsuchiya M, 2016, FEBS LETT, V590, P2671, DOI 10.1002/1873-3468.12262; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Watanabe T, 2010, ANAL BIOCHEM, V402, P107, DOI 10.1016/j.ab.2010.03.014; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimura Y, 2015, TRANSGENIC RES, V24, P717, DOI 10.1007/s11248-015-9884-6	29	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193642	10.1371/journal.pone.0193642	http://dx.doi.org/10.1371/journal.pone.0193642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505588	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200024
J	Critchell, K; Hoogenboom, MO				Critchell, Kay; Hoogenboom, Mia O.			Effects of microplastic exposure on the body condition and behaviour of planktivorous reef fish (Acanthochromis polyacanthus)	PLOS ONE			English	Article							PLASTIC INGESTION; NORTH-SEA; FOOD ACQUISITION; 1ST OBSERVATIONS; TERRITORY SIZE; MYTILUS-EDULIS; DEMERSAL FISH; SOCIAL RANK; MARINE; JUVENILE	The effect of a pollutant on the base of the food web can have knock-on effects for trophic structure and ecosystem functioning. In this study we assess the effect of microplastic exposure on juveniles of a planktivorous fish ( Acanthochromis polyacanthus), a species that is widespread and abundant on Indo-Pacific coral reefs. Under five different plastic concentration treatments, with plastics the same size as the natural food particles ( mean 2mm diameter), there was no significant effect of plastic exposure on fish growth, body condition or behaviour. The amount of plastics found in the gastro-intestinal ( GI) tract was low, with a range of one to eight particles remaining in the gut of individual fish at the end of a 6-week plastic-exposure period, suggesting that these fish are able to detect and avoid ingesting microplastics in this size range. However, in a second experiment the number of plastics in the GI tract vastly increased when plastic particle size was reduced to approximately one quarter the size of the food particles, with a maximum of 2102 small (<300 mu m diameter) particles present in the gut of individual fish after a 1-week plastic exposure period. Under conditions where food was replaced by plastic, there was a negative effect on the growth and body condition of the fish. These results suggest plastics could become more of a problem as they break up into smaller size classes, and that environmental changes that lead to a decrease in plankton concentrations combined with microplastic presence is likely have a greater influence on fish populations than microplastic presence alone.	[Critchell, Kay; Hoogenboom, Mia O.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Critchell, Kay] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia; [Hoogenboom, Mia O.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University; James Cook University	Critchell, K (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; Critchell, K (corresponding author), James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia.	kay.critchell@my.jcu.edu.au	Critchell, Kay/E-3150-2017; Hoogenboom, Mia O/D-3664-2012; Critchell, Kay/M-8859-2019	Critchell, Kay/0000-0003-0599-2355; Hoogenboom, Mia O/0000-0003-3709-6344; Critchell, Kay/0000-0003-0599-2355				Acampora H, 2014, MAR POLLUT BULL, V78, P63, DOI 10.1016/j.marpolbul.2013.11.009; Adams CE, 1998, AQUACULTURE, V167, P17, DOI 10.1016/S0044-8486(98)00302-0; ADAMS CE, 1995, ENVIRON BIOL FISH, V43, P213, DOI 10.1007/BF00002494; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; Avio CG, 2015, MAR ENVIRON RES, V111, P18, DOI 10.1016/j.marenvres.2015.06.014; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; Bengfort M, 2014, ECOL COMPLEX, V20, P185, DOI 10.1016/j.ecocom.2014.10.003; Berry KLE, 2016, SCI REP-UK, V6, DOI 10.1038/srep25894; Besseling E, 2013, ENVIRON SCI TECHNOL, V47, P593, DOI 10.1021/es302763x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Browne MA, 2007, INTEGR ENVIRON ASSES, V3, P559, DOI 10.1002/ieam.5630030412; CARPENTE.EJ, 1972, SCIENCE, V178, P749, DOI 10.1126/science.178.4062.749; Carson HS, 2011, MAR POLLUT BULL, V62, P1708, DOI 10.1016/j.marpolbul.2011.05.032; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Chua EM, 2014, ENVIRON SCI TECHNOL, V48, P8127, DOI 10.1021/es405717z; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; David BO, 2007, ANIM BEHAV, V74, P259, DOI 10.1016/j.anbehav.2006.08.015; de Sa LC, 2015, ENVIRON POLLUT, V196, P359, DOI 10.1016/j.envpol.2014.10.026; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Bello A, 2013, DIS AQUAT ORGAN, V106, P93, DOI 10.3354/dao02641; Dunbrack RL, 1996, J FISH BIOL, V48, P615, DOI 10.1111/j.1095-8649.1996.tb01456.x; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; ELLIOTT JM, 1975, FRESHWATER BIOL, V5, P287, DOI 10.1111/j.1365-2427.1975.tb00142.x; ELLIOTT JM, 1973, OECOLOGIA, V12, P329, DOI 10.1007/BF00345047; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; EMERY AR, 1973, B MAR SCI, V23, P649; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Garcia-Berthou E, 1999, J FISH BIOL, V55, P135, DOI 10.1111/j.1095-8649.1999.tb00663.x; Garvey JE, 2004, ECOLOGY, V85, P2860, DOI 10.1890/03-0329; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Carman VG, 2014, MAR POLLUT BULL, V78, P56, DOI 10.1016/j.marpolbul.2013.11.012; Hall NM, 2015, MAR BIOL, V162, P725, DOI 10.1007/s00227-015-2619-7; Hermsen E, 2017, MAR POLLUT BULL, V122, P253, DOI 10.1016/j.marpolbul.2017.06.051; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Hoogenboom MO, 2013, BEHAV ECOL, V24, P253, DOI 10.1093/beheco/ars161; Hoss D, 1989, INGESTION PLASTICS T; HUGHES NF, 1992, CAN J FISH AQUAT SCI, V49, P1994, DOI 10.1139/f92-222; Hurst TP, 2005, MAR ECOL PROG SER, V293, P233, DOI 10.3354/meps293233; Imre I, 2004, OECOLOGIA, V138, P371, DOI 10.1007/s00442-003-1432-z; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Kinan I, 2000, MARINE ORNITHOLOGY, V28; LOW RM, 1971, ECOLOGY, V52, P648, DOI 10.2307/1934153; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Ma ZH, 2015, AQUAC RES, V46, P2593, DOI 10.1111/are.12413; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; Neves D, 2015, MAR POLLUT BULL, V101, P119, DOI 10.1016/j.marpolbul.2015.11.008; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; PEREIRA JJ, 1993, ARCH ENVIRON CON TOX, V24, P427, DOI 10.1007/BF01146157; PHILLIPS RR, 1979, ANIM BEHAV, V27, P1113, DOI 10.1016/0003-3472(79)90059-9; Pierce Kathryn E., 2004, Marine Ornithology, V32, P187; Possatto FE, 2011, MAR POLLUT BULL, V62, P1098, DOI 10.1016/j.marpolbul.2011.01.036; R Core Team, 2016, R LANG ENV STAT COMP; Rebolledo ELB, 2013, MAR POLLUT BULL, V67, P200, DOI 10.1016/j.marpolbul.2012.11.035; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Romeo T, 2015, MAR POLLUT BULL, V95, P358, DOI 10.1016/j.marpolbul.2015.04.048; Rummel CD, 2016, MAR POLLUT BULL, V102, P134, DOI 10.1016/j.marpolbul.2015.11.043; RYAN PG, 1988, MAR POLLUT BULL, V19, P125, DOI 10.1016/0025-326X(88)90708-4; RYAN PG, 1987, MAR ENVIRON RES, V23, P175, DOI 10.1016/0141-1136(87)90028-6; Ryer CH, 2009, MAR ECOL PROG SER, V391, P97, DOI 10.3354/meps08168; Savoca MS, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1000; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; SPARKS RE, 1972, J FISH RES BOARD CAN, V29, P1356, DOI 10.1139/f72-208; SPEAR LB, 1995, MAR ENVIRON RES, V40, P123, DOI 10.1016/0141-1136(94)00140-K; Staddon J., 2016, ADAPTIVE BEHAV LEARN; Thompson IC., 2009, PHILOS T R SOC BIOL, V1, P1; Toobaie A, 2013, ANIM BEHAV, V85, P241, DOI 10.1016/j.anbehav.2012.10.032; Tsang YY, 2017, MAR POLLUT BULL, V115, P20, DOI 10.1016/j.marpolbul.2016.11.003; Van Cauwenberghe L, 2015, ENVIRON POLLUT, V199, P10, DOI 10.1016/j.envpol.2015.01.008; Vendel AL, 2017, MAR POLLUT BULL, V117, P448, DOI 10.1016/j.marpolbul.2017.01.081; Verlis KM, 2013, MAR POLLUT BULL, V72, P244, DOI 10.1016/j.marpolbul.2013.03.017; Watts AJR, 2014, ENVIRON SCI TECHNOL, V48, P8823, DOI 10.1021/es501090e; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zhao SY, 2014, MAR POLLUT BULL, V86, P562, DOI 10.1016/j.marpolbul.2014.06.032	81	115	122	15	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193308	10.1371/journal.pone.0193308	http://dx.doi.org/10.1371/journal.pone.0193308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494635	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200038
J	Diederich, B; Wartmann, R; Schadwinkel, H; Heintzmann, R				Diederich, Benedict; Wartmann, Rolf; Schadwinkel, Harald; Heintzmann, Rainer			Using machine-learning to optimize phase contrast in a low-cost cellphone microscope	PLOS ONE			English	Article							FOURIER PTYCHOGRAPHY; ILLUMINATION; INTENSITY; RETRIEVAL	Cellphones equipped with high-quality cameras and powerful CPUs as well as GPUs are widespread. This opens new prospects to use such existing computational and imaging resources to perform medical diagnosis in developing countries at a very low cost. Many relevant samples, like biological cells or waterborn parasites, are almost fully transparent. As they do not exhibit absorption, but alter the light's phase only, they are almost invisible in brightfield microscopy. Expensive equipment and procedures for microscopic contrasting or sample staining often are not available. Dedicated illumination approaches, tailored to the sample under investigation help to boost the contrast. This is achieved by a programmable illumination source, which also allows to measure the phase gradient using the differential phase contrast (DPC) [1, 2] or even the quantitative phase using the derived qDPC approach [3]. By applying machine-learning techniques, such as a convolutional neural network (CNN), it is possible to learn a relationship between samples to be examined and its optimal light source shapes, in order to increase e.g. phase contrast, from a given dataset to enable real-time applications. For the experimental setup, we developed a 3D-printed smartphone microscope for less than 100 $ using off-the-shelf components only such as a low-cost video projector. The fully automated system assures true Koehler illumination with an LCD as the condenser aperture and a reversed smartphone lens as the microscope objective. We show that the effect of a varied light source shape, using the pre-trained CNN, does not only improve the phase contrast, but also the impression of an improvement in optical resolution without adding any special optics, as demonstrated by measurements.	[Diederich, Benedict; Wartmann, Rolf; Schadwinkel, Harald] Carl Zeiss Microscopy GmbH, Res Dept, Gottingen, Germany; [Diederich, Benedict; Heintzmann, Rainer] Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany; [Diederich, Benedict; Heintzmann, Rainer] Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany; [Diederich, Benedict; Heintzmann, Rainer] Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany	Carl Zeiss AG; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Diederich, B (corresponding author), Carl Zeiss Microscopy GmbH, Res Dept, Gottingen, Germany.; Diederich, B (corresponding author), Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany.; Diederich, B (corresponding author), Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany.; Diederich, B (corresponding author), Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany.	benedict.diederich@ipht-jena.de	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936	Carl-Zeiss Microscopy GmbH Gottingen as a RD project; free state of Thuringia	Carl-Zeiss Microscopy GmbH Gottingen as a RD project; free state of Thuringia(European Commission)	The work was funded by the Carl-Zeiss Microscopy GmbH Gottingen as a R&D project and by the free state of Thuringia. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section. Hereby I declare that Carl Zeiss Microscopy GmbH did not play a role in the design of the study and the experimental setups. CZ supported the study with professional lab equipment, like the microscope and the microscope objective lenses. The contributing authors were free in formulating their working hypothesis and the ways to proof it.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Behrens J., 1915, Z WISSENSCHAFTLICHE, V32, P508; Bian Z., 2015, THESIS, V746; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cobb N., 1998, FAST OPTICAL PROCESS; Diederich B., 2017, BEAMERSCOPE TENSORFL; Diederich B., 2017, BEAMERSCOPE ANDROID; Diederich B., 2017, BEAMERSCOPE CAD GITH; Diederich B., 2017, MATLAB; Eberhart R.C., 2007, COMPUTATIONAL INTELL; Electronics L, LG CONS BUS EL; Garetto A, 2012, ADV OPT TECHNOL, V1, P289, DOI 10.1515/aot-2012-0124; Granik Y, 2004, J MICROLITH MICROFAB, V3, P509, DOI 10.1117/1.1794708; Greenbaum A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076475; Gross H, 2006, HDB OPTICAL SYSTEMS, V2; HAMILTON DK, 1984, J MICROSC-OXFORD, V135, P275, DOI 10.1111/j.1365-2818.1984.tb02533.x; Hofmann C., 1980, OPTISCHE ABBILDUNG; HOPKINS HH, 1953, PROC R SOC LON SER-A, V217, P408, DOI 10.1098/rspa.1953.0071; Iglesias I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026015; Jung D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07703-w; Kamilov US, 2015, OPTICA, V2, P517, DOI 10.1364/OPTICA.2.000517; Kingma D, 2014, OPTIMIZATION; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar M., 2010, THESIS; Larry Page SB, GOOGLE BILDER; LeCun Y., 1989, ADV NEURAL INFORM PR, V2, DOI DOI 10.1111/DSU.12130; Liebling M, 2004, J OPT SOC AM A, V21, P367, DOI 10.1364/JOSAA.21.000367; Liu Z, 2015, INT SOC OPTICS PHOTO; Losa GA, 2011, ENCY MOL CELL BIOL M; Mehta SB, 2009, OPT LETT, V34, P1924, DOI 10.1364/OL.34.001924; Ou XZ, 2015, OPT EXPRESS, V23, P3472, DOI 10.1364/OE.23.003472; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Ryde N., 2006, LINEAR PHASE IMAGING, V214, P7; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Skandarajah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096906; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tian L, 2014, BIOMED OPT EXPRESS, V5, P2376, DOI 10.1364/BOE.5.002376; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wu XF, 2014, OPT EXPRESS, V22, P3924, DOI 10.1364/OE.22.003924; Yamazoe K., 2008, STACKED PUPIL SHIFT, V25, P3111; Yamazoe K, 2009, J MICRO-NANOLITH MEM, V8, DOI 10.1117/1.3206980; Zheng G, MICROSCOPY, P1; Zuo C, 2015, OPT LASER ENG, V71, P20, DOI 10.1016/j.optlaseng.2015.03.006	49	19	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192937	10.1371/journal.pone.0192937	http://dx.doi.org/10.1371/journal.pone.0192937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494620	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200017
J	Herindrainy, P; Rabenandrasana, MAN; Andrianirina, ZZ; Rakotoarimanana, FMJ; Padget, M; de Lauzanne, A; Ndir, A; Kermorvant-Duchemin, E; Garin, B; Piola, P; Collard, JM; Guillemot, D; Huynh, BT; Delarocque-Astagneau, E				Herindrainy, Perlinot; Rabenandrasana, Mamitiana Alain Noah; Andrianirina, Zafitsara Zo; Rakotoarimanana, Feno Manitra Jacob; Padget, Michael; de Lauzanne, Agathe; Ndir, Awa; Kermorvant-Duchemin, Elsa; Garin, Benoit; Piola, Patrice; Collard, Jean-Marc; Guillemot, Didier; Huynh, Bich-Tram; Delarocque-Astagneau, Elisabeth		BIRDY Study Grp	Acquisition of extended spectrum beta-lactamase-producing enterobacteriaceae in neonates: A community based cohort in Madagascar	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE ACQUISITION; CESAREAN-SECTION RATES; GRAM-NEGATIVE BACILLI; INTENSIVE-CARE-UNIT; RISK-FACTORS; ESCHERICHIA-COLI; LOW-INCOME; ANTIMICROBIAL RESISTANCE; PREGNANT-WOMEN; FECAL CARRIAGE	In low and middle income countries ( LMICs), where the burden of neonatal sepsis is the highest, the spread of extended spectrum beta-lactamase-producing enterobacteriaceae ( ESBL-PE) in the community, potentially contributing to the neonatal mortality, is a public health concern. Data regarding the acquisition of ESBL-PE during the neonatal period are scarce. The routes of transmission are not well defined and particularly the possible key role played by pregnant women. This study aimed to understand the neonatal acquisition of ESBL-PE in the community in Madagascar. The study was conducted in urban and semi-rural areas. Newborns were included at birth and followed-up during their first month of life. Maternal stool samples at delivery and six stool samples in each infant were collected to screen for ESBL-PE. A Cox proportional hazards model was performed to identify factors associated with the first ESBL-PE acquisition. The incidence rate of ESBL-PE acquisition was 10.4 cases/1000 newborn-days [ 95% CI: 8.0-13.4 cases per 1000 newborn-days]. Of the 83 ESBL-PE isolates identified, Escherichia coli was the most frequent species ( n = 28, 34.1%), followed by Klebsiella pneumoniae ( n = 20, 24.4%). Cox multivariate analysis showed that independent risk factors for ESBL-PE acquisition were low birth weight ( adjusted Hazard-ratio ( aHR) = 2.7, 95% CI [ 1.2; 5.9]), cesarean-section, ( aHR = 3.4, 95% CI [ 1.7; 7.1]) and maternal use of antibiotics at delivery ( aHR = 2.2, 95% CI [ 1.1; 4.5]). Our results confirm that mothers play a significant role in the neonatal acquisition of ESBL-PE. In LMICs, public health interventions during pregnancy should be reinforced to avoid unnecessary caesarean section, unnecessary antibiotic use at delivery and low birth weight newborns.	[Herindrainy, Perlinot; Rakotoarimanana, Feno Manitra Jacob; Piola, Patrice] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Rabenandrasana, Mamitiana Alain Noah; Garin, Benoit; Collard, Jean-Marc] Inst Pasteur Madagascar, Expt Bacteriol Unit, Antananarivo, Madagascar; [Andrianirina, Zafitsara Zo] Ctr Hosp Soavinandriana, Peadiat Ward, Antananarivo, Madagascar; [Padget, Michael; Guillemot, Didier; Huynh, Bich-Tram; Delarocque-Astagneau, Elisabeth] UVSQ, INSERM, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis Un, Paris, France; [de Lauzanne, Agathe] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Ndir, Awa] Inst Pasteur, Epidemiol & Infect Dis Unit, Dakar, Senegal; [Kermorvant-Duchemin, Elsa] Paris Descartes Univ, Paris, France; [Kermorvant-Duchemin, Elsa] Enfants Malades Univ Hosp, AP HP, Dept Neonatol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Huynh, BT (corresponding author), UVSQ, INSERM, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis Un, Paris, France.	bich-tram.huynh@pasteur.fr	Collard, Jean-Marc/Q-2342-2019; Guillemot, Didier/AAN-3051-2020; delarocque-astagneau, elisabeth/E-4706-2016	Collard, Jean-Marc/0000-0002-1490-3978; Huynh, Bich-Tram/0000-0001-6340-9557; Herindrainy, Perlinot/0000-0002-5146-8100; Guillemot, Didier/0000-0002-8497-1765; delarocque-astagneau, elisabeth/0000-0002-5129-9300	Department of International Cooperation of the Principality of Monaco; Institut Pasteur	Department of International Cooperation of the Principality of Monaco; Institut Pasteur(European Commission)	This work was undertaken as part of the Bacterial Infections and antibiotic Resistant Diseases among Young children (BIRDY) project (http://www.birdyprogram.org/), which is made possible by the funding of the Department of International Cooperation of the Principality of Monaco. Also this work was supported by the Institut Pasteur (PTR call). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady H, 2008, J PERINATOL, V28, P685, DOI 10.1038/jp.2008.73; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; [Anonymous], 2015, REC JANV, pV1; Baral Pankaj, 2012, BMC Res Notes, V5, P38, DOI 10.1186/1756-0500-5-38; Basu S, 2015, EUR J CLIN MICROBIOL, V34, P215, DOI 10.1007/s10096-014-2232-6; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Beukes LS, 2017, INT J HYG ENVIR HEAL, V220, P1279, DOI 10.1016/j.ijheh.2017.08.002; Bhattacharya S, 2013, VIRULENCE, V4, P172, DOI 10.4161/viru.23326; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; Buekens P, 2003, BRIT MED J, V326, P136, DOI 10.1136/bmj.326.7381.136; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Chan GJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001502; Chereau F, 2015, ANTIMICROB AGENTS CH, V59, P3652, DOI 10.1128/AAC.00029-15; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; Das P, 2011, J MED MICROBIOL, V60, P1651, DOI 10.1099/jmm.0.033803-0; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Graham K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3541-8; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Hijazi SM, 2016, J INFECT DEV COUNTR, V10, P947, DOI 10.3855/jidc.7593; Hsu AJ, 2014, CLIN INFECT DIS, V58, P1439, DOI 10.1093/cid/ciu069; Huynh B-T, 2017, EMERG INFECT DIS; Huynh BT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0843-x; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Koleva PT, 2015, BIRTH DEFECTS RES C, V105, P265, DOI 10.1002/bdrc.21117; Kothari C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-136; Li X, 2017, INT J ANTIMICROB AG; Liu L, 2016, REPROD MATERNAL NEWB, V2; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Mammina C, 2007, AM J INFECT CONTROL, V35, P222, DOI 10.1016/j.ajic.2006.04.210; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Mylonas I, 2011, ARCH GYNECOL OBSTET, V283, P7, DOI 10.1007/s00404-010-1646-3; Nelson JP, 2017, PAN AFR MED J, V26, DOI 10.11604/pamj.2017.26.64.9555; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Peretz A, 2016, DIAGN MICROBIOL INFE; Persaud RR, 2015, J MATERN-FETAL NEO M, V28, P1190, DOI 10.3109/14767058.2014.947578; Platell JL, 2011, ANTIMICROB AGENTS CH, V55, P3782, DOI 10.1128/AAC.00306-11; Rettedal S, 2015, J PERINATOL, V35, P907, DOI 10.1038/jp.2015.82; Rettedal S, 2013, SCAND J INFECT DIS, V45, P54, DOI 10.3109/00365548.2012.713116; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P3135, DOI 10.1128/AAC.00139-09; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shakil S, 2010, J TROP PEDIATRICS, V56, P90, DOI 10.1093/tropej/fmp060; Shallcross LJ, 2014, BRIT J GEN PRACT, V64, P604, DOI 10.3399/bjgp14X682561; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Stoesser N, 2015, J ANTIMICROB CHEMOTH, V70, P1893, DOI 10.1093/jac/dkv021; Tellevik MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168024; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; World Health Organization, 2018, LEVELS TRENDS CHILD; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	66	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193325	10.1371/journal.pone.0193325	http://dx.doi.org/10.1371/journal.pone.0193325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494706	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200039
J	Hogwood, J; Naggi, A; Torri, G; Page, C; Rigsby, P; Mulloy, B; Gray, E				Hogwood, J.; Naggi, A.; Torri, G.; Page, C.; Rigsby, P.; Mulloy, B.; Gray, E.			The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; ADVERSE CLINICAL EVENTS; OVERSULFATED CHONDROITIN; DERMATAN SULFATE; CONTACT SYSTEM; HUMAN-PLASMA; FACTOR-XII; INHIBITOR; CONTAMINANT; THROMBIN	Oversulfated chondroitin sulfate ( OSCS) was identified as a contaminant in certain heparin preparations as the cause of adverse reactions in patients. OSCS was found to possess both plasma anticoagulant activity and the ability to activate prekallikrein to kallikrein. Differentially sulfated chondroitin sulfates were prepared by synthetic modification of chondroitin sulfate and were compared to the activity of OSCS purified from contaminated heparin. Whilst chondroitin sulfate was found to have minimal anticoagulant activity, increasing sulfation levels produced an anticoagulant response which we directly show for the first time is mediated through heparin cofactor II. However, the tetra-sulfated preparations did not possess any higher anticoagulant activity than several tri-sulfated variants, and also had lower heparin cofactor II mediated activity. Activation of prekallikrein was concentration dependent for all samples, and broadly increased with the degree of sulfation, though the di-sulfated preparation was able to form more kallikrein than some of the tri-sulfated preparations. The ability of the samples to activate the kinin system, as measured by bradykinin, was observed to be through kallikrein generation. These results show that whilst an increase in sulfation of chondroitin sulfate did cause an increase in anticoagulant activity and activation of the kinin system, there may be subtler structural interactions other than sulfation at play given the different responses observed.	[Hogwood, J.; Rigsby, P.; Gray, E.] Natl Inst Biol Stand & Controls, Blanche Lane, Potters Bar, Herts, England; [Hogwood, J.; Page, C.; Mulloy, B.; Gray, E.] Kings Coll London, Inst Pharmaceut Sci, Sacker Inst Pulm Pharmacol, London, England; [Naggi, A.; Torri, G.] Inst Chem & Biochem Res G Ronzoni, Milan, Italy	National Institute for Biological Standards & Control; University of London; King's College London	Hogwood, J (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane, Potters Bar, Herts, England.; Hogwood, J (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Sacker Inst Pulm Pharmacol, London, England.	john.hogwood@nibsc.org		Rigsby, Peter/0000-0002-8954-9475; Torri, Giangiacomo/0000-0002-2077-1203; Hogwood, John/0000-0002-2595-1510				Adam A, 2010, BIOMATERIALS, V31, P5741, DOI 10.1016/j.biomaterials.2010.03.074; [Anonymous], 2008, EUROPEAN PHARMACOPOE, V01, P50300; [Anonymous], 2008, EUROPEAN PHARMACOPOE, V01, P20705; Bertini S, 2005, BIOMACROMOLECULES, V6, P168, DOI 10.1021/bm049693s; Bjorkqvist J, 2014, THROMB HAEMOSTASIS, V112, P868, DOI 10.1160/TH14-04-0311; Boothello RS, 2015, METHODS MOL BIOL, V1229, P335, DOI 10.1007/978-1-4939-1714-3_27; Carranza YE, 2008, BLOOD COAGUL FIBRIN, V19, P483, DOI 10.1097/MBC.0b013e3282f2a99e; Citarella F, 1997, BRIT J HAEMATOL, V99, P197, DOI 10.1046/j.1365-2141.1997.3513165.x; Corbier A, 2011, TOXICOL SCI, V121, P417, DOI 10.1093/toxsci/kfr072; Dace R, 1997, THROMB RES, V87, P113, DOI 10.1016/S0049-3848(97)00110-2; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P119, DOI 10.1055/s-0028-1086092; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hogwood J, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030059; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAIMONE MM, 1991, J BIOL CHEM, V266, P14830; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; McMahon AW, 2010, PHARMACOEPIDEM DR S, V19, P921, DOI 10.1002/pds.1991; Mulloy B, 2014, ANAL BIOANAL CHEM, V406, P4815, DOI 10.1007/s00216-014-7940-3; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; PRATT CW, 1989, ANN NY ACAD SCI, V556, P104; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P261, DOI 10.1177/1076029610362073; SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547; Sommers CD, 2012, J PHARMACEUT BIOMED, V67-68, P28, DOI 10.1016/j.jpba.2012.04.017; TOLLEFSEN DM, 1981, J CLIN INVEST, V68, P589, DOI 10.1172/JCI110292; Tollefsen DM, 2002, ARCH PATHOL LAB MED, V126, P1394; VANDERGRAAF F, 1982, BLOOD, V59, P1225; Xu XY, 2002, INT J BIOL MACROMOL, V30, P151, DOI 10.1016/S0141-8130(02)00015-6; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193482	10.1371/journal.pone.0193482	http://dx.doi.org/10.1371/journal.pone.0193482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494632	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200053
J	Li, DC; Jiang, Y; Lv, SS; Liu, XJ; Gu, JY; Chen, QF; Zhang, YH				Li, Decai; Jiang, Yang; Lv, Shanshan; Liu, Xiaojing; Gu, Jiyou; Chen, Qifeng; Zhang, Yanhua			Preparation of plasticized poly (lactic acid) and its influence on the properties of composite materials	PLOS ONE			English	Article							POLY(LACTIC ACID); MECHANICAL-PROPERTIES; CRYSTALLIZATION BEHAVIOR; POLY(ETHYLENE GLYCOL); THERMAL-PROPERTIES; PLA; BLENDS; STARCH; IMPROVEMENT; MORPHOLOGY	Plasticized poly ( lactic acid) ( PPLA) was prepared by melt blending poly ( lactic acid) ( PLA) with 10 wt% of poly ( ethylene glycol) ( PEG), with varied molecular weights range from 400 to 4000. The structure, thermal property, morphology, and surface free energy of the PPLA were investigated by Fourier transform infrared spectroscopy ( FTIR), differential scanning calorimeter ( DSC), thermogravimetric analysis ( TGA), scanning electron microscopy ( SEM), and contact angles ( CA). The resulting PPLA results indicated that the introduction of PEG to the blend systems resulted in a ductile fracture, a decrease in the melt temperature ( T-m) and glass transfer temperature ( T-g), and an increase in the degree of crystallization (chi(c)), which indicated an improved flexibility. In addition, the polarity of the PPLA increased and the surface free energy decreased. The resulting PPLA was subsequently used as matrix to blend with wood flour to prepare composites. The mechanical strength, melting behavior, thermal stability, and microscopy of the PPLA/wood flour composites were also evaluated. These results illustrated that the plasticized PPLA matrix was beneficial to the interfacial compatibility between the polar filler and the substrate.	[Li, Decai; Jiang, Yang; Lv, Shanshan; Liu, Xiaojing; Gu, Jiyou; Chen, Qifeng; Zhang, Yanhua] Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Zhang, YH (corresponding author), Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Heilongjiang, Peoples R China.	zhangyanhua@nefu.edu.cn			National Natural Science Foundation of China [31670569]; Fundamental Research Funds for the Central Universities [2572017E606, 2572016DB01]; National Forestry Public Welfare Industry Major Projects of Scientific Research [201504502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Forestry Public Welfare Industry Major Projects of Scientific Research	The work was supported by the National Natural Science Foundation of China (No. 31670569). This work was also supported by Fundamental Research Funds for the Central Universities (No. 2572017E606; 2572016DB01) and the National Forestry Public Welfare Industry Major Projects of Scientific Research (No. 201504502).	Akrami M, 2016, CARBOHYD POLYM, V144, P254, DOI 10.1016/j.carbpol.2016.02.035; Arrieta MP, 2014, POLYM DEGRAD STABIL, V108, P307, DOI 10.1016/j.polymdegradstab.2014.01.034; Dubey SP, 2017, VACUUM, V146, P655, DOI 10.1016/j.vacuum.2017.07.009; Gurau V, 2006, J POWER SOURCES, V160, P1156, DOI 10.1016/j.jpowsour.2006.03.016; Hassouna F, 2011, EUR POLYM J, V47, P2134, DOI 10.1016/j.eurpolymj.2011.08.001; Ho MP, 2015, COMPOS PART B-ENG, V81, P14, DOI 10.1016/j.compositesb.2015.05.048; Ljungberg N, 2002, J APPL POLYM SCI, V86, P1227, DOI 10.1002/app.11077; Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6; Meng XT, 2018, MATER DESIGN, V139, P188, DOI 10.1016/j.matdes.2017.11.012; Murariu M, 2008, POLYM ADVAN TECHNOL, V19, P636, DOI 10.1002/pat.1131; Oh HJ, 2014, POLYMER, V55, P1574, DOI 10.1016/j.polymer.2014.02.011; Okubo K, 2009, COMPOS PART A-APPL S, V40, P469, DOI 10.1016/j.compositesa.2009.01.012; Onteniente JP, 2000, STARCH-STARKE, V52, P112, DOI 10.1002/1521-379X(200006)52:4<112::AID-STAR112>3.0.CO;2-O; Ortega-Toro R, 2016, FOOD HYDROCOLLOID, V56, P9, DOI 10.1016/j.foodhyd.2015.11.029; Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Ozkoc G, 2009, J APPL POLYM SCI, V114, P2481, DOI 10.1002/app.30772; Petchwattana N, 2014, POLYM BULL, V71, P1947, DOI 10.1007/s00289-014-1165-7; Phuphuak Y, 2013, POLYMER, V54, P7058, DOI 10.1016/j.polymer.2013.10.006; Qiu ZB, 2003, POLYMER, V44, P7781, DOI 10.1016/j.polymer.2003.10.045; Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t; Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p; Sharma P, 2013, IONICS, V19, P1285, DOI 10.1007/s11581-013-0851-z; Shibata M, 2004, J APPL POLYM SCI, V92, P3857, DOI 10.1002/app.20405; Shibata M, 2007, POLYMER, V48, P2768, DOI 10.1016/j.polymer.2007.02.065; Siddalingappa B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118824; Sun Y, 2015, J MATER CHEM A, V3, P3699, DOI 10.1039/c4ta05991c; Thakur S, 2017, VACUUM, V146, P342, DOI 10.1016/j.vacuum.2017.08.011; Wang H, 2001, J APPL POLYM SCI, V82, P1761, DOI 10.1002/app.2018; Young WB, 2015, J COMPOS MATER, V49, P2803, DOI 10.1177/0021998314554437; Yu T, 2015, COMPOS PART A-APPL S, V76, P20, DOI 10.1016/j.compositesa.2015.05.010	31	52	53	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193520	10.1371/journal.pone.0193520	http://dx.doi.org/10.1371/journal.pone.0193520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494654	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200061
J	Kauschke, V; Gebert, A; Calin, M; Eckert, J; Scheich, S; Heiss, C; Lips, KS				Kauschke, Vivien; Gebert, Annett; Calin, Mariana; Eckert, Juergen; Scheich, Sebastian; Heiss, Christian; Lips, Katrin Susanne			Effects of new beta-type Ti-40Nb implant materials, brain-derived neurotrophic factor, acetylcholine and nicotine on human mesenchymal stem cells of osteoporotic and non osteoporotic donors	PLOS ONE			English	Article							MARROW STROMAL CELLS; BIOMEDICAL APPLICATIONS; TITANIUM-ALLOY; IN-VITRO; BONE; EXPRESSION; DIFFERENTIATION; OSTEOBLAST; RECEPTORS; PROLIFERATION	Introduction Treatment of osteoporotic fractures is still challenging and an urgent need exists for new materials, better adapted to osteoporotic bone by adjusted Young's modulus, appropriate surface modification and pharmaceuticals. Materials and methods Titanium-40-niobium alloys, mechanically ground or additionally etched and titanium-6-aluminium-4-vanadium were analyzed in combination with brain-derived neurotrophic factor, acetylcholine and nicotine to determine their effects on human mesenchymal stem cells in vitro over 21 days using lactate dehydrogenase and alkaline phosphatase assays, live cell imaging and immunofluorescence microscopy. Results Cell number of human mesenchymal stem cells of osteoporotic donors was increased after 14 d in presence of ground titanium-40-niobium or titanium-6-aluminium-4-vanadium, together with brain-derived neurotrophic factor. Cell number of human mesenchymal stem cells of non osteoporotic donors increased after 21 d in presence of titanium-6-aluminium-4-vanadium without pharmaceuticals. No significant increase was measured for ground or etched titanium-40-niobium after 21 d. Osteoblast differentiation of osteoporotic donors was significantly higher than in non osteoporotic donors after 21 d in presence of etched, ground titanium-40-niobium or titanium-6-aluminium-4-vanadium accompanied by all pharmaceuticals tested. In presence of all alloys tested brain-derived neurotrophic factor, acetylcholine and nicotine increased differentiation of cells of osteoporotic donors and accelerated it in that no competing interests exist. non osteoporotic donors. Conclusion We conclude that ground titanium-40-niobium and brain-derived neurotrophic factor might be most suitable for subsequent in vivo testing.	[Kauschke, Vivien; Scheich, Sebastian; Heiss, Christian; Lips, Katrin Susanne] Justus Liebig Univ Giessen, Expt Trauma Surg, Giessen, Germany; [Gebert, Annett; Calin, Mariana] Leibniz Inst Solid State & Mat Res Dresden, Dresden, Germany; [Eckert, Juergen] Austrian Acad Sci, Erich Schmid Inst Mat Sci, Leoben, Austria; [Eckert, Juergen] Univ Leoben, Dept Mat Phys, Leoben, Austria; [Heiss, Christian] Univ Hosp Giessen Marburg, Dept Trauma Hand & Reconstruct Surg, Campus Giessen, Giessen, Germany	Justus Liebig University Giessen; Leibniz Institute for Solid State & Materials Research Dresden; Austrian Academy of Sciences; University of Leoben; University Hospital of Giessen & Marburg	Kauschke, V (corresponding author), Justus Liebig Univ Giessen, Expt Trauma Surg, Giessen, Germany.	Vivien.Kauschke@chiru.med.uni-giessen.de	Calin, Mariana/J-6398-2015; Eckert, Jurgen/U-8328-2019	Eckert, Jurgen/0000-0003-4112-3181; Kauschke, Vivien/0000-0002-4342-6875; Calin, Mariana/0000-0002-4852-2583	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79	This work was supported by Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79 (projects B7 and M1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga A, 2006, ACTA MED OKAYAMA, V60, P267; Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Asri RIM, 2017, MAT SCI ENG C-MATER, V77, P1261, DOI 10.1016/j.msec.2017.04.102; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Cai XX, 2010, INT J ORAL SCI, V2, P74, DOI 10.4248/IJOS10039; Chung R, 2014, J ENDOCRINOL, V221, P63, DOI 10.1530/JOE-13-0539; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cordeiro JM, 2017, MAT SCI ENG C-MATER, V71, P1201, DOI 10.1016/j.msec.2016.10.025; Costa-Rodrigues J, 2018, J CELL PHYSIOL, V233, P1029, DOI 10.1002/jcp.25956; de Andrade DP, 2015, MAT SCI ENG C-MATER, V56, P538, DOI 10.1016/j.msec.2015.07.026; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Engelhart S, 2017, CUTIS, V99, P245; Garg P, 2017, ORTHOP SURG, V9, P13, DOI 10.1111/os.12304; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Guo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30558; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Helth A, 2017, J MECH BEHAV BIOMED, V65, P137, DOI 10.1016/j.jmbbm.2016.08.017; Helth A, 2014, J BIOMED MATER RES B, V102, P31, DOI 10.1002/jbm.b.32976; Ida-Yonemochi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169201; Kilian O, 2014, ANN ANAT, V196, P286, DOI 10.1016/j.aanat.2014.06.001; Kim BS, 2012, LIFE SCI, V90, P109, DOI 10.1016/j.lfs.2011.10.019; Liu PS, 2011, EUR J PHARMACOL, V650, P34, DOI 10.1016/j.ejphar.2010.09.031; Nauth A, 2011, J ORTHOP TRAUMA, V25, pS51, DOI 10.1097/BOT.0b013e31821b8c52; Nicoara M, 2016, ACTA BIOMATER, V36, P323, DOI 10.1016/j.actbio.2016.03.020; Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Nune KC, 2017, DENT MATER, V33, P152, DOI 10.1016/j.dental.2016.11.005; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pauksch L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114740; PECK WA, 1993, AM J MED, V94, P646; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Rothem DE, 2009, J BONE MINER METAB, V27, P555, DOI 10.1007/s00774-009-0075-5; Sato T, 2010, FEBS LETT, V584, P817, DOI 10.1016/j.febslet.2010.01.001; Shen Y, 2013, J CELL BIOCHEM, V114, P1720, DOI 10.1002/jcb.24512; Shotorbani BB, 2017, MAT SCI ENG C-MATER, V71, P1192, DOI 10.1016/j.msec.2016.10.013; Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013; Su YW, 2018, J CELL PHYSIOL, V233, P2133, DOI 10.1002/jcp.25936; Tang JM, 2012, J CELL BIOCHEM, V113, P2704, DOI 10.1002/jcb.24148; Tsai TL, 2017, STEM CELL REP, V8, P387, DOI 10.1016/j.stemcr.2017.01.004; Valenti MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020363; Wang C, 2016, APPL BIONICS BIOMECH, V2016, P1, DOI DOI 10.3389/FPLS.2016.01082; Wang CD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.238; Wenisch S, 2005, BONE, V36, P74, DOI 10.1016/j.bone.2004.09.019; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Zhang ZT, 2017, MOL MED REP, V15, P1362, DOI 10.3892/mmr.2017.6110	48	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193468	10.1371/journal.pone.0193468	http://dx.doi.org/10.1371/journal.pone.0193468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489907	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000079
J	Sunwoo, JS; Hwangbo, Y; Kim, WJ; Chu, MK; Yun, CH; Yang, KI				Sunwoo, Jun-Sang; Hwangbo, Young; Kim, Won-Joo; Chu, Min Kyung; Yun, Chang-Ho; Yang, Kwang Ik			Prevalence, sleep characteristics, and comorbidities in a population at high risk for obstructive sleep apnea: A nationwide questionnaire study in South Korea	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; POSITIVE AIRWAY PRESSURE; BERLIN QUESTIONNAIRE; PHYSICAL-ACTIVITY; RESPIRATORY DISTURBANCE; RESISTANT HYPERTENSION; DAYTIME SLEEPINESS; CLINICAL-PRACTICE; IDENTIFY PATIENTS; VASCULAR-DISEASE	Objective To determine the prevalence, sleep characteristics, and comorbidities associated with a high risk for obstructive sleep apnea (OSA) in the Korean adult population. Methods We analyzed data from 2,740 subjects who responded to a nationwide questionnaire survey of sleep characteristics. Those who qualified under two or more symptom categories of the Berlin questionnaire were defined as "at high risk for OSA". We investigated their socio-demographic information, sleep habits, and medical and psychiatric comorbidities. Logistic regression analyses were performed to identify factors and consequences significantly associated with a high risk for OSA. Results The prevalence of a high risk for OSA was 15.8% (95% confidence interval [CI] 14.5-17.2%). Multiple logistic regression analysis showed that old age (>= 70 years, odds ratio [OR] 2.68) and body mass index >= 25 kg/m(2) (OR 10.75) were significantly related with a high risk for OSA, whereas regular physical activity (OR 0.70) had a protective effect. Subjective sleep characteristics associated with a high risk for OSA were perceived insufficient sleep (OR 1.49), excessive daytime sleepiness (OR 1.88), and insomnia (OR 3.70). In addition, hypertension (OR 5.83), diabetes mellitus (OR 2.54), hyperlipidemia (OR 2.85), and anxiety (OR 1.63) were comorbid conditions independently associated with a high risk for OSA. Conclusions This is the first study to demonstrate the prevalence of a high risk for OSA in a nationwide representative sample of the Korean adult population. These findings elucidate the epidemiology and clinical characteristics of those at high risk for OSA.	[Sunwoo, Jun-Sang] Soonchunhyang Univ, Dept Neurol, Coll Med, Seoul Hosp, Seoul, South Korea; [Hwangbo, Young] Soonchunhyang Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Kim, Won-Joo] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; [Chu, Min Kyung] Hallym Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Yun, Chang-Ho] Seoul Natl Univ, Bundang Hosp, Bundang Clin Neurosci Ctr, Dept Neurol, Seongnam, South Korea; [Yang, Kwang Ik] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Sleep Disorders Ctr,Dept Neurol, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University; Yonsei University; Yonsei University Health System; Hallym University; Seoul National University (SNU); Soonchunhyang University	Kim, WJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.; Yang, KI (corresponding author), Soonchunhyang Univ, Coll Med, Cheonan Hosp, Sleep Disorders Ctr,Dept Neurol, Cheonan, South Korea.	kzoo@yuhs.ac; neurofan@schmc.ac.kr		Kim, Won-Joo/0000-0002-5850-010X; Hwangbo, Young/0000-0002-8447-8372; Chu, Min Kyung/0000-0001-6221-1346; Sunwoo, Jun-Sang/0000-0001-8834-0568	Korean Neurological Association [KNA-10-MI-03]; Soonchunhyang University Research Fund	Korean Neurological Association; Soonchunhyang University Research Fund	This study was supported by grants from Korean Neurological Association (grant # KNA-10-MI-03) and Soonchunhyang University Research Fund (grant # N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2008, SLEEP BREATH, V12, P39, DOI 10.1007/s11325-007-0125-y; Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Amra B, 2011, SLEEP BREATH, V15, P425, DOI 10.1007/s11325-010-0353-4; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Martinez-Garcia MA, 2015, EUR RESPIR J, V46, P142, DOI 10.1183/09031936.00064214; Awad KM, 2012, AM J MED, V125, P485, DOI 10.1016/j.amjmed.2011.11.025; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bjornsdottir E, 2012, J SLEEP RES, V21, P131, DOI 10.1111/j.1365-2869.2011.00972.x; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Campos-Rodriguez F, 2016, AM J RESP CRIT CARE, V194, P1286, DOI 10.1164/rccm.201602-0265OC; Costa LE, 2015, HEART, V101, P1288, DOI 10.1136/heartjnl-2014-307276; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; Garbarino S, 2016, SLEEP, V39, P1211, DOI 10.5665/sleep.5834; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gus M, 2008, AM J HYPERTENS, V21, P832, DOI 10.1038/ajh.2008.184; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Hwangbo Y, 2016, J CLIN NEUROL, V12, P194, DOI 10.3988/jcn.2016.12.2.194; Hwangbo Y, 2013, SLEEP MED, V14, P549, DOI 10.1016/j.sleep.2013.02.009; Iftikhar IH, 2014, LUNG, V192, P175, DOI 10.1007/s00408-013-9511-3; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kang K, 2014, J CLIN NEUROL, V10, P42, DOI 10.3988/jcn.2014.10.1.42; Kang K, 2013, SLEEP BREATH, V17, P803, DOI 10.1007/s11325-012-0767-2; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kendzerska T, 2014, AM J RESP CRIT CARE, V190, P218, DOI 10.1164/rccm.201312-2209OC; Kim J, 2004, AM J RESP CRIT CARE, V170, P1108, DOI 10.1164/rccm.200404-519OC; Kimoff RJ, 1996, SLEEP, V19, pS61, DOI 10.1093/sleep/19.suppl_9.S61; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li JG, 2007, J APPL PHYSIOL, V102, P557, DOI 10.1152/japplphysiol.01081.2006; Liu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-84; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Magnavita N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111347; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McArdle N, 2007, AM J RESP CRIT CARE, V175, P190, DOI 10.1164/rccm.200602-270OC; Mendelson M, 2014, RESP CARE, V59, P1218, DOI 10.4187/respcare.02948; Moreno CRC, 2004, CHRONOBIOL INT, V21, P871, DOI 10.1081/CBI-200036880; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; PAFFENBARGER RS, 1983, AM J EPIDEMIOL, V117, P245, DOI 10.1093/oxfordjournals.aje.a113537; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2004, SLEEP, V27, P480, DOI 10.1093/sleep/27.3.480; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pillar G, 1998, CHEST, V114, P697, DOI 10.1378/chest.114.3.697; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Quan SF, 2007, SLEEP BREATH, V11, P149, DOI 10.1007/s11325-006-0095-5; Rahaghi Franck, 1999, Sleep Breath, V3, P119, DOI 10.1007/s11325-999-0119-z; Redline S, 1998, SEM RESP CRIT CARE M, V19, P113; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sunwoo JS, 2017, SLEEP MED, V40, P4, DOI 10.1016/j.sleep.2017.08.020; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Yue WH, 2003, CAN J PSYCHIAT, V48, P318, DOI 10.1177/070674370304800507	70	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193549	10.1371/journal.pone.0193549	http://dx.doi.org/10.1371/journal.pone.0193549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489913	Green Published, gold			2022-12-26	WOS:000426276000088
J	Lu, YN; Rafiq, A; Zhang, ZG; Aslani, F; Fijak, M; Lei, T; Wang, M; Kumar, S; Klug, J; Bergmann, M; Chakraborty, T; Meinhardt, A; Bhushan, S				Lu, Yongning; Rafiq, Amir; Zhang, Zhengguo; Aslani, Ferial; Fijak, Monika; Lei, Tao; Wang, Ming; Kumar, Sanjeev; Klug, Joerg; Bergmann, Martin; Chakraborty, Trinad; Meinhardt, Andreas; Bhushan, Sudhanshu			Uropathogenic Escherichia coli virulence factor hemolysin A causes programmed cell necrosis by altering mitochondrial dynamics	FASEB JOURNAL			English	Article						apoptosis; caspase; HMGB1; histone 3; ATP	HOST-PATHOGEN INTERACTIONS; TOXIN ALPHA-HEMOLYSIN; DEATH; INFECTION; TESTIS; CONVERGENCE; APOPTOSIS; PATHWAYS; TARGET; MEN	Uropathogenic Escherichia coli (UPEC) is the most common cause of urinary tract infections. In this study, UPEC strains harboring hemolysin A (HlyA) did not induce programmed cell death pathways by the activation of caspases. Instead, the UPEC pore-forming toxin HlyA triggered an increase in mitochondrial Ca2+ levels and manipulated mitochondrial dynamics by causing fragmentation of the mitochondrial network. Alterations in mitochondrial dynamics resulted in severe impairment of mitochondrial functions by loss of membrane potential, increase in reactive oxygen species production, and ATP depletion. Moreover, HlyA caused disruption of plasma membrane integrity that was accompanied by extracellular release of the danger-associated molecules high-mobility group box 1 (HMGB1) and histone 3 (H3). Our results indicate that UPEC induced programmed cell necrosis by irreversibly impairing mitochondrial function. This finding suggests a strategy devised by UPEC at the onset of infection to escape early innate immune response and silently propagate inside host cells.Lu, Y., Rafiq, A., Zhang, Z., Aslani, F., Fijak, M., Lei, T., Wang, M., Kumar, S., Klug, J., Bergmann, M., Chakraborty, T., Meinhardt, A., Bhushan, S. Uropathogenic Escherichia coli virulence factor hemolysin A causes programmed cell necrosis by altering mitochondrial dynamics.	[Lu, Yongning; Rafiq, Amir; Zhang, Zhengguo; Aslani, Ferial; Fijak, Monika; Lei, Tao; Wang, Ming; Klug, Joerg; Meinhardt, Andreas; Bhushan, Sudhanshu] Justus Liebig Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany; [Kumar, Sanjeev; Chakraborty, Trinad] Justus Liebig Univ Giessen, Dept Med Microbiol, Giessen, Germany; [Bergmann, Martin] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Bhushan, S (corresponding author), Justus Liebig Univ Giessen, Dept Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.	sudhanshu.bhushan@anatomie.med.uni-giessen.de	; kumar, Sanjeev/P-8547-2014	Fijak, Monika/0000-0002-7384-3872; kumar, Sanjeev/0000-0003-0562-2645	Deutsche Forschungsgemeinschaft (DFG) [BH 93/1-1]; China Scholarship Council; Justus-Liebig-University of Giessen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Justus-Liebig-University of Giessen	The authors thank Vanesa Herlaxi (National University of La Plata, Buenos Aires, Argentina) for generously providing the purified hemolysin A, Suada Frohlich (Justus-Liebig-University Giessen), for technical assistance with Western blot analysis, and Matthew Jones (a native English speaker; University of Giessen) for proofreading the manuscript for grammatical and typographical errors. This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, BH 93/1-1). The fellowship support of the China Scholarship Council (to L.Y., Z.Z., T.L., and M.W.) and Justus-Liebig-University of Giessen (to Z.Z.) are gratefully acknowledged. The authors declare no conflicts of interest.	Arck P, 2014, MOL CELL ENDOCRINOL, V382, P509, DOI 10.1016/j.mce.2013.09.022; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2016, JOVE-J VIS EXP, DOI 10.3791/53389; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Eguchi Y, 1997, CANCER RES, V57, P1835; El Kebir D, 2006, CELL SIGNAL, V18, P2302, DOI 10.1016/j.cellsig.2006.05.013; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Gonzalez-Juarbe N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005337; Green D.R., 2015, COLD SPRING HARB PER, V7; Jiang JH, 2012, IUBMB LIFE, V64, P397, DOI 10.1002/iub.1021; Johnson JR, 2005, CLIN INFECT DIS, V40, P813, DOI 10.1086/428048; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LEE SJ, 2015, CELL DEATH DIS, V6; Lipsky BA, 1999, AM J MED, V106, P327, DOI 10.1016/S0002-9343(99)00017-0; Lobet E, 2015, BIOCHEM PHARMACOL, V94, P173, DOI 10.1016/j.bcp.2015.02.007; Lu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052919; MERINO G, 1995, ARCH ANDROLOGY, V35, P43, DOI 10.3109/01485019508987852; Michel V, 2015, ASIAN J ANDROL, V17, P756, DOI 10.4103/1008-682X.155770; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Parham NJ, 2005, J CLIN MICROBIOL, V43, P4076, DOI 10.1128/JCM.43.8.4076-4082.2005; Rudel T, 2010, NAT REV MICROBIOL, V8, P693, DOI 10.1038/nrmicro2421; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Wang M, 2017, J IMMUNOL, V198, P4327, DOI 10.4049/jimmunol.1700162; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiles TJ, 2013, FUTURE MICROBIOL, V8, P73, DOI [10.2217/fmb.12.131, 10.2217/FMB.12.131]; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Zhang ZG, 2016, J INFECT DIS, V213, P1198, DOI 10.1093/infdis/jiv569	42	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4107	4120		10.1096/fj.201700768R	http://dx.doi.org/10.1096/fj.201700768R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490169				2022-12-26	WOS:000439325400005
J	Itou, J; Li, WZ; Ito, S; Tanaka, S; Matsumoto, Y; Sato, F; Toi, M				Itou, Junji; Li, Wenzhao; Ito, Shinji; Tanaka, Sunao; Matsumoto, Yoshiaki; Sato, Fumiaki; Toi, Masakazu			Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; GENE; LOCALIZATION; HOMEOSTASIS; METASTASIS; MUTATIONS; CARCINOMA; TRIM21; SIGNAL	Sal-like 4 (SALL4) is a transcription factor that enhances proliferation and migration in breast cancer cells. SALL4 expression therefore has the potential to promote cancer malignancy. However, the regulatory mechanisms involved in SALL4 protein expression have not been thoroughly elucidated. In this study, we observed that treating MCF-7 and SUM159 breast cancer cell lines with a proteasome inhibitor increases SALL4 protein levels, suggesting that SALL4 is degraded by the ubiquitin-proteasome system. Using immunoprecipitation to uncover SALL4-binding proteins, we identified an E3 ubiquitin-protein ligase, tripartite motif-containing 21 (TRIM21). Using an EGFP reporter probe of the major SALL4 isoform SALL4B, we observed that shRNA-mediated knockdown of TRIM21 increases cellular SALL4B levels. Immunostaining experiments revealed that TRIM21 localizes to the nucleus, and a K64R substitution in the nuclear localization motif in SALL4B increased SALL4B levels in the cytoplasm. These results suggested that TRIM21 is involved in nuclear SALL4 degradation. To identify the amino acid residue that is targeted by TRIM21, we fragmented the SALL4B sequence, fused it to EGFP, and identified Lys-190 in SALL4B as TRIM21's target residue. Amino acid sequence alignments of SALL family members indicated that the region around SALL4 Lys-190 is conserved in both SALL1 and SALL3. Because SALL1 and SALL4 have similar functions, we constructed a SALL1-EGFP probe and found that the TRIM21 knockdown increases SALL1 levels, indicating that TRIM21 degrades both SALL1 and SALL4. Our findings extend our understanding of SALL4 and SALL1 regulation and may contribute to the development of SALL4-targeting therapies.	[Itou, Junji; Li, Wenzhao; Tanaka, Sunao; Matsumoto, Yoshiaki; Sato, Fumiaki; Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Ito, Shinji] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Itou, J (corresponding author), Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	junji-itou@umin.ac.jp			Taiho Pharmaceutical Co., Ltd.; Japan Society for the Promotion of Science [25870384]	Taiho Pharmaceutical Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Taiho Pharmaceutical Co., Ltd. and by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 25870384. J. I. is an employee of Kyoto University's Sponsored Research Program funded by Taiho Pharmaceutical Co., Ltd. M. T. received research funding from Taiho Pharmaceutical Co., Ltd.	Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Bohm J, 2006, BIOCHEM BIOPH RES CO, V348, P898, DOI 10.1016/j.bbrc.2006.07.124; Dirican E, 2016, TUMOR BIOL, V37, P11701, DOI 10.1007/s13277-016-5150-7; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; He J, 2013, INT J BIOCHEM CELL B, V45, P1962, DOI 10.1016/j.biocel.2013.06.008; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Itou J, 2017, BBA-MOL CELL RES, V1864, P76, DOI 10.1016/j.bbamcr.2016.10.012; Itou J, 2013, FEBS LETT, V587, P3115, DOI 10.1016/j.febslet.2013.07.049; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Lazzari E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103609; Lin YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09995; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015006; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Nicole L, 2017, ONCOTARGET, V8, P22968, DOI 10.18632/oncotarget.14952; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Tatetsu H, 2016, GENE, V584, P111, DOI 10.1016/j.gene.2016.02.019; Wang MC, 2015, ONCOL LETT, V10, P583, DOI 10.3892/ol.2015.3361; Wilson CH, 2012, EMBO J, V31, P2486, DOI 10.1038/emboj.2012.91; Wu M, 2014, CELL CYCLE, V13, P1456, DOI 10.4161/cc.28418; Yang FK, 2012, J BIOL CHEM, V287, P38600, DOI 10.1074/jbc.M112.391441; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang MY, 2016, ONCOL REP, V35, P1796, DOI 10.3892/or.2016.4545; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297	29	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6556	6564		10.1074/jbc.RA117.000245	http://dx.doi.org/10.1074/jbc.RA117.000245			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511085	Green Published, hybrid			2022-12-26	WOS:000431108600026
J	Bonnard, D; Le Rouzic, E; Eiler, S; Amadori, C; Orlov, I; Bruneau, JM; Brias, J; Barbion, J; Chevreuil, F; Spehner, D; Chasset, S; Ledoussal, B; Moreau, F; Saib, A; Klaholz, BP; Emiliani, S; Ruff, M; Zamborlini, A; Benarous, R				Bonnard, Damien; Le Rouzic, Erwann; Eiler, Sylvia; Amadori, Celine; Orlov, Igor; Bruneau, Jean-Michel; Brias, Julie; Barbion, Julien; Chevreuil, Francis; Spehner, Daniele; Chasset, Sophie; Ledoussal, Benoit; Moreau, Francois; Saib, Ali; Klaholz, Bruno P.; Emiliani, Stephane; Ruff, Marc; Zamborlini, Alessia; Benarous, Richard			Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ANTIVIRAL ACTIVITY; BI 224436; PROTEIN; REPLICATION; LEDGF/P75; SITE; MULTIMERIZATION; RESISTANCE; POTENCY	Recently, a new class of HIV-1 integrase (IN) inhibitors with a dual mode of action, called IN-LEDGF/p75 allosteric inhibitors (INLAIs), was described. Designed to interfere with the IN-LEDGF/p75 interaction during viral integration, unexpectedly, their major impact was on virus maturation. This activity has been linked to induction of aberrant IN multimerization, whereas inhibition of the IN-LEDGF/p75 interaction accounts for weaker antiretroviral effect at integration. Because these dual activities result from INLAI binding to IN at a single binding site, we expected that these activities co-evolved together, driven by the affinity for IN. Using an original INLAI, MUT-A, and its activity on an Ala-125 (A125) IN variant, we found that these two activities on A125-IN can be fully dissociated: MUT-A-induced IN multimerization and the formation of eccentric condensates in viral particles, which are responsible for inhibition of virus maturation, were lost, whereas inhibition of the IN-LEDGF/p75 interaction and consequently integration was fully retained. Hence, the mere binding of INLAI to A125 IN is insufficient to promote the conformational changes of IN required for aberrant multimerization. By analyzing the X-ray structures of MUT-A bound to the IN catalytic core domain (CCD) with or without the Ala-125 polymorphism, we discovered that the loss of IN multimerization is due to stabilization of the A125-IN variant CCD dimer, highlighting the importance of the CCD dimerization energy for IN multimerization. Our study reveals that affinity for the LEDGF/p75-binding pocket is not sufficient to induce INLAI-dependent IN multimerization and the associated inhibition of viral maturation.	[Bonnard, Damien; Le Rouzic, Erwann; Amadori, Celine; Bruneau, Jean-Michel; Brias, Julie; Barbion, Julien; Chevreuil, Francis; Chasset, Sophie; Ledoussal, Benoit; Moreau, Francois; Benarous, Richard] Biodim Mutabilis, F-93230 Romainville, France; [Bonnard, Damien; Saib, Ali; Zamborlini, Alessia] Univ Paris Diderot, Conservatoire Natl Arts & Metiers, Inserm U944, CNRS UMR 7212, F-75010 Paris, France; [Eiler, Sylvia; Orlov, Igor; Spehner, Daniele; Klaholz, Bruno P.; Ruff, Marc] Univ Strasbourg, CNRS, INSERM, IGBMC,Ctr Integrat Biol, F-67404 Illkirch Graffenstaden, France; [Amadori, Celine; Emiliani, Stephane] INSERM, Inst Cochin, U1016, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bonnard, D (corresponding author), 102 Ave Gaston Roussel, F-93230 Romainville, France.; Ruff, M (corresponding author), LGBS IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.; Zamborlini, A (corresponding author), UMR7212, 16 Rue Grange Belles, F-75010 Paris, France.; Benarous, R (corresponding author), 19 Rue Croulebarbe, F-75013 Paris, France.	damien.bonnard@mutabilis.fr; ruff@igbmc.fr; alessia.zamborlini@lecnam.net; benarous.r@wanadoo.fr	ruff, marc/J-3011-2013; Zamborlini, Alessia/ABE-2256-2021	ruff, marc/0000-0001-5451-6377; Zamborlini, Alessia/0000-0002-8902-1996; Bonnard, Damien/0000-0001-9529-5785	Biodim Mutabilis under Authorization [DUO 2145]; EU [305137]; Eurostars Grant ResistAids [E!10239]; French National Research Agency against AIDS (ANRS); SIDACTION; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct-ERIC; French National Association for Research and Technology (ANRT)	Biodim Mutabilis under Authorization; EU(European Commission); Eurostars Grant ResistAids; French National Research Agency against AIDS (ANRS)(ANRSFrench National Research Agency (ANR)); SIDACTION; French Infrastructure for Integrated Structural Biology (FRISBI); Instruct-ERIC; French National Association for Research and Technology (ANRT)(French National Research Agency (ANR))	This work was supported in part by Biodim Mutabilis under Authorization Number DUO 2145, assigned by the French Ministry of Research for work with genetically modified organisms, by Grants EU FP7 (to Biodim, S. Emiliani, A. S., and A. Z.) under the HIVINNOV Consortium, Grant Agreement 305137, and by Eurostars Grant ResistAids (to Biodim), Grant Agreement E!10239. D. B., E. L. R., C. A., J. -M. B., J. Brias, J. Barbion, F. C., F. L. S., S. C., B. L., F. M., R. B. are or were employees of Biodim Mutabilis at the time of this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the French National Research Agency against AIDS (ANRS) and SIDACTION.; Supported by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by Instruct-ERIC.; Supported by the French National Association for Research and Technology (ANRT).	Amadori C, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0373-2; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Benarous R., 2014, Patent No. [2014053666 A1, 2014053666]; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demeulemeester J, 2014, EXPERT OPIN THER PAT, V24, P609, DOI 10.1517/13543776.2014.898753; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fader LD, 2016, ACS MED CHEM LETT, V7, P797, DOI 10.1021/acsmedchemlett.6b00194; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2016, ACS CHEM BIOL, V11, P1313, DOI 10.1021/acschembio.6b00167; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fenwick C, 2014, ANTIMICROB AGENTS CH, V58, P3233, DOI 10.1128/AAC.02719-13; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Hazuda DJ, 2012, CURR OPIN HIV AIDS, V7, P383, DOI 10.1097/COH.0b013e3283567309; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lataillade M, 2007, ANTIVIR THER, V12, P563; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Madison MK, 2017, J VIROL, V91, DOI 10.1128/JVI.00821-17; Metifiot M, 2011, AIDS, V25, P1175, DOI 10.1097/QAD.0b013e3283473599; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shkriabai N, 2014, J BIOL CHEM, V289, P26430, DOI 10.1074/jbc.M114.589572; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; Vranckx LS, 2016, EBIOMEDICINE, V8, P248, DOI 10.1016/j.ebiom.2016.04.039; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wares M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-7	55	23	24	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6172	6186		10.1074/jbc.M117.816793	http://dx.doi.org/10.1074/jbc.M117.816793			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29507092	hybrid, Green Published			2022-12-26	WOS:000430497300033
J	Dickmanns, A; Zschiedrich, CP; Arens, J; Parfentev, I; Gundlach, J; Hofele, R; Neumann, P; Urlaub, H; Gorke, B; Ficner, R; Stulke, J				Dickmanns, Achim; Zschiedrich, Christopher P.; Arens, Johannes; Parfentev, Iwan; Gundlach, Jan; Hofele, Romina; Neumann, Piotr; Urlaub, Henning; Goerke, Boris; Ficner, Ralf; Stuelke, Joerg			Structural basis for the regulatory interaction of the methylglyoxal synthase MgsA with the carbon flux regulator Crh in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HPR-LIKE PROTEIN; CATABOLITE REPRESSION; ESCHERICHIA-COLI; ANTITERMINATOR PROTEIN; CRYSTAL-STRUCTURE; CCPA; PHOSPHORYLATION; IDENTIFICATION; BIOSYNTHESIS; BACILLITHIOL	Utilization of energy-rich carbon sources such as glucose is fundamental to the evolutionary success of bacteria. Glucose can be catabolized via glycolysis for feeding the intermediary metabolism. The methylglyoxal synthase MgsA produces methylglyoxal from the glycolytic intermediate dihydroxyacetone phosphate. Methylglyoxal is toxic, requiring stringent regulation of MgsA activity. In the Gram-positive bacterium Bacillus subtilis, an interaction with the phosphoprotein Crh controls MgsA activity. In the absence of preferred carbon sources, Crh is present in the nonphosphorylated state and binds to and thereby inhibits MgsA. To better understand the mechanism of regulation of MgsA, here we performed biochemical and structural analyses of B. subtilis MgsA and of its interaction with Crh. Our results indicated thatMgsAforms a hexamer (i.e. a trimer of dimers) in the crystal structure, whereas it seems to exist in an equilibrium between a dimer and hexamer in solution. In the hexamer, two alternative dimers could be distinguished, but only one appeared to prevail in solution. Further analysis strongly suggested that the hexamer is the biologically active form. In vitro cross-linking studies revealed that Crh interacts with the N-terminal helices of MgsA and that the Crh-MgsA binding inactivates MgsA by distorting and thereby blocking its active site. In summary, our results indicate that dimeric and hexameric MgsA species exist in an equilibrium in solution, that the hexameric species is the active form, and that binding to Crh deforms and blocks the active site in MgsA.	[Dickmanns, Achim; Arens, Johannes; Neumann, Piotr; Ficner, Ralf] Georg August Univ Gottingen, GZMB, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Zschiedrich, Christopher P.; Gundlach, Jan; Goerke, Boris; Stuelke, Joerg] Georg August Univ Gottingen, GZMB, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Parfentev, Iwan; Hofele, Romina; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Parfentev, Iwan; Hofele, Romina; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, D-37075 Gottingen, Germany; [Goerke, Boris] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, A-1030 Vienna, Austria	University of Gottingen; University of Gottingen; Max Planck Society; University of Gottingen; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Dickmanns, A (corresponding author), Georg August Univ Gottingen, Dept Mol Struct Biol, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.; Stulke, J (corresponding author), Georg August Univ Gottingen, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390; Gorke, Boris/0000-0002-1682-5387; Parfentev, Iwan/0000-0002-0203-2167	Deutsche Forschungsgemeinschaft (DFG) [HI 291/13-1, SFB860]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant HI 291/13-1 and SFB860. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bachem S, 1998, J BACTERIOL, V180, P5319, DOI 10.1128/JB.180.20.5319-5326.1998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; BOCK A, 1966, J BACTERIOL, V92, P470; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chandrangsu P, 2014, MOL MICROBIOL, V91, P706, DOI 10.1111/mmi.12489; Christian H, 2014, NUCLEIC ACIDS RES, V42, P1162, DOI 10.1093/nar/gkt985; COOPER RA, 1974, EUR J BIOCHEM, V44, P81, DOI 10.1111/j.1432-1033.1974.tb03459.x; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falahati H, 2013, PROTEIN ENG DES SEL, V26, P445, DOI 10.1093/protein/gzt014; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Gaballa A, 2013, MICROBIOL-SGM, V159, P2025, DOI 10.1099/mic.0.070482-0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorke B, 2004, J BACTERIOL, V186, P2992, DOI 10.1128/JB.186.10.2992-2995.2004; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; Hatti K, 2017, J STRUCT BIOL, V197, P372, DOI 10.1016/j.jsb.2017.01.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPPER DJ, 1972, BIOCHEM J, V128, P321, DOI 10.1042/bj1280321; Huang KX, 1999, APPL ENVIRON MICROB, V65, P3244; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landmann JJ, 2012, FEMS MICROBIOL LETT, V327, P47, DOI 10.1111/j.1574-6968.2011.02456.x; Landmann JJ, 2011, MOL MICROBIOL, V82, P770, DOI 10.1111/j.1365-2958.2011.07857.x; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; Maass S, 2014, MOL CELL PROTEOMICS, V13, P2260, DOI 10.1074/mcp.M113.035741; Marks GT, 2001, BIOCHEMISTRY-US, V40, P6805, DOI 10.1021/bi0028237; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Meyer FM, 2011, J BACTERIOL, V193, P6939, DOI 10.1128/JB.06197-11; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pazhang M, 2010, APPL BIOCHEM BIOTECH, V162, P1519, DOI 10.1007/s12010-010-8933-0; Penin F, 2001, J MOL MICROB BIOTECH, V3, P429; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saadat D, 1999, STRUCT FOLD DES, V7, P309, DOI 10.1016/S0969-2126(99)80041-0; Saadat D, 2000, BIOCHEMISTRY-US, V39, P2950, DOI 10.1021/bi992666f; Saadat D, 1998, BIOCHEMISTRY-US, V37, P10074, DOI 10.1021/bi980409p; Sambrook J., 2001, MOL CLONING LAB MANU; Schmalisch MH, 2003, J BIOL CHEM, V278, P51108, DOI 10.1074/jbc.M309972200; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Seidel G, 2005, FEBS J, V272, P2566, DOI 10.1111/j.1742-4658.2005.04682.x; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Shin SM, 2017, INT J BIOCHEM CELL B, V91, P14, DOI 10.1016/j.biocel.2017.08.005; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	73	2	2	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5781	5792		10.1074/jbc.RA117.001289	http://dx.doi.org/10.1074/jbc.RA117.001289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29514981	hybrid, Green Published			2022-12-26	WOS:000430497300003
J	Gautier, C; Guenin, SP; Riest-Fery, I; Perry, TJ; Legros, C; Nosjean, O; Simonneaux, V; Grutzner, F; Boutin, JA				Gautier, Celia; Guenin, Sophie-Penelope; Riest-Fery, Isabelle; Perry, Tahlia Jade; Legros, Celine; Nosjean, Olivier; Simonneaux, Valerie; Grutzner, Frank; Boutin, Jean A.			Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus)	PLOS ONE			English	Article							ORPHAN GPR50 RECEPTOR; MT2 RECEPTORS; MOLECULAR PHARMACOLOGY; XENOPUS MELANOPHORES; SEX-CHROMOSOMES; ANTAGONISTS; AGONISTS; CLONING; EVOLUTION; RODENT	Melatonin is a neurohormone produced in both animals and plants. It binds at least three G-protein-coupled receptors: MT1 and MT2, and Mel1cGPR. Mammalian GPR50 evolved from the reptilian/avian Mel1c and lost its capacity to bind melatonin in all the therian mammal species that have been tested. In order to determine if binding is lost in the oldest surviving mammalian lineage of monotremes we investigated whether the melatonin receptor has the ability to bind melatonin in the platypus (Ornithorhynchus anatinus), and evaluated its pharmacological profile. Sequence and phylogenetic analysis showed that platypus has in fact retained the ancestral Mel1c and has the capacity to bind melatonin similar to other mammalian melatonin receptors (MT1 and MT2), with an affinity in the 1 nM range. We also investigated the binding of a set of melatoninergic ligands used previously to characterize the molecular pharmacology of the melatonin receptors from sheep, rats, mice, and humans and found that the general profiles of these compounds make Mel1c resemble human MT1 more than MT2. This work shows that the loss of GPR50 binding evolved after the divergence of monotremes less than 190MYA in therian mammals.	[Gautier, Celia; Guenin, Sophie-Penelope; Riest-Fery, Isabelle; Legros, Celine; Nosjean, Olivier; Boutin, Jean A.] Inst Rech Servier, PEX Biotechnol Chim & Biol, Croissy Sur Seine, France; [Gautier, Celia; Simonneaux, Valerie] Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Perry, Tahlia Jade; Grutzner, Frank] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Nosjean, Olivier; Boutin, Jean A.] Inst Rech Int Servier, Suresnes, France	Servier; Institut de Recherches Internationales Servier; University of Adelaide; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech Servier, PEX Biotechnol Chim & Biol, Croissy Sur Seine, France.; Boutin, JA (corresponding author), Inst Rech Int Servier, Suresnes, France.	jean.boutin@servier.com	Perry, Tahlia/AAV-9784-2021; Grutzner, Frank/AAD-5834-2020; Boutin, Jean Albert/W-9103-2019; Grutzner, Frank/ABB-2820-2021	Perry, Tahlia/0000-0002-1592-5343; Boutin, Jean Albert/0000-0003-0068-7204; Grutzner, Frank/0000-0002-3088-7314	Australian Research Council; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	JAB is thankful to Dr. Laurent Ripoll for numerous helpful discussions and M. Xavier Deguercy for his help. Frank Grutzner is supported by an Australian Research Council Fellowship. Tahlia J. Perry is supported by an Australian Postgraduate Award.	Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Batailler M, 2012, J NEUROENDOCRINOL, V24, P798, DOI 10.1111/j.1365-2826.2012.02274.x; BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531; Clement N, 2017, BRIT J PHARMACOL, V16, P168; Coge F, 2009, BRIT J PHARMACOL, V158, P1248, DOI 10.1111/j.1476-5381.2009.00453.x; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Daish TJ, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0215-4; Devavry S, 2012, EUR J PHARMACOL, V677, P15, DOI 10.1016/j.ejphar.2011.12.009; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Dufourny L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-105; EBISAWA T, 1994, P NATL ACAD SCI USA, V91, P6133, DOI 10.1073/pnas.91.13.6133; Faust R, 2000, J MED CHEM, V43, P1050, DOI 10.1021/jm980684+; GARRATT PJ, 1995, J MED CHEM, V38, P1132, DOI 10.1021/jm00007a010; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; Gubitz AK, 1999, GENOMICS, V55, P248, DOI 10.1006/geno.1998.5661; He C, 2013, GEN COMP ENDOCR, V191, P74, DOI 10.1016/j.ygcen.2013.06.003; Hu QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130188; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Jockers R, 1997, MOL ENDOCRINOL, V11, P1070, DOI 10.1210/me.11.8.1070; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Legros C, 2014, BRIT J PHARMACOL, V171, P186, DOI 10.1111/bph.12457; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Li DY, 2013, INT J MOL SCI, V14, P11208, DOI 10.3390/ijms140611208; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mailliet F, 2004, BIOCHEM PHARMACOL, V67, P667, DOI 10.1016/j.bcp.2003.09.037; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; Pala D, 2013, INT J MOL SCI, V14, P8093, DOI 10.3390/ijms14048093; Pegurier C, 2003, BIOORGAN MED CHEM, V11, P789, DOI 10.1016/S0968-0896(02)00328-0; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Pickering H, 1996, BRIT J PHARMACOL, V119, P379, DOI 10.1111/j.1476-5381.1996.tb15997.x; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; Reppert SM, 1996, FEBS LETT, V386, P219, DOI 10.1016/0014-5793(96)00437-1; Sidibe A, 2010, J PINEAL RES, V48, P263, DOI 10.1111/j.1600-079X.2010.00750.x; SUGDEN D, 1994, EUR J PHARMACOL, V254, P271, DOI 10.1016/0014-2999(94)90464-2; Sugden D, 1999, REPROD NUTR DEV, V39, P335, DOI 10.1051/rnd:19990306; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Teh MT, 1998, N-S ARCH PHARMACOL, V358, P522, DOI 10.1007/PL00005288; Tsend-Ayush E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37744; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0191904	10.1371/journal.pone.0191904	http://dx.doi.org/10.1371/journal.pone.0191904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529033	Green Published, gold			2022-12-26	WOS:000427189300002
J	Bergstrom, BE; Abdelkhalek, A; Younis, W; Hammac, GK; Townsend, WM; Seleem, MN				Bergstrom, Benjamin E.; Abdelkhalek, Ahmed; Younis, Waleed; Hammac, G. Kenitra; Townsend, Wendy M.; Seleem, Mohamed N.			Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water	PLOS ONE			English	Article							METHICILLIN-RESISTANT STAPHYLOCOCCUS; ACID AQUEOUS-SOLUTION; ANTIMICROBIAL PEPTIDES; POLYMYXIN-B; PSEUDOMONAS-AERUGINOSA; CERAGENINS; PH; INFECTIONS; PREVALENCE; EFFICACY	Antibiotic resistance of bacteria common to the ocular surface is an evolving problem. Thus, novel treatment options with new modes of action are required. We investigated the antibacterial activity and safety of three commercially available topical veterinary ophthalmic products (cationic steroid antibiotics, products A and B, and a neutral superoxidized water, product C) to determine their potential use as antimicrobial alternatives. The minimum inhibitory concentrations (MIC) of the three products were determined against 17 antibiotic resistant bacterial clinical isolates from the ocular surface. Using a standard cytotoxicity assay, the products at varying concentrations were evaluated with a corneal fibroblast cell line and a macrophage- like cell line to determine their potential toxic effect in vitro. The commercial ophthalmic solutions, ofloxacin 0.3%, tobramycin 0.3% and gentamicin 0.3% were used as positive controls for the MIC and tobramycin 0.3% was used as positive control for the cytotoxicity assays. For the MIC, Product C showed no inhibition of growth for any organisms, while Products A and B showed inhibition of growth similar to slightly less than the positive controls. For the cytotoxicity assays, Product C exhibited minimal toxicity while Products A and B exhibited toxicity similar to the controls. In conclusion, Product C had no antibacterial activity in these assays, while Products A and B had antibacterial profiles similar to slightly less than common topical ophthalmic antibiotics and cytotoxicity profiles similar to common topical ophthalmic antibiotics. To our knowledge, this is the first report on the antibacterial activity and safety of the cationic steroid antibiotics and superoxidized water.	[Bergstrom, Benjamin E.; Townsend, Wendy M.] Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Abdelkhalek, Ahmed; Younis, Waleed; Hammac, G. Kenitra; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Townsend, WM (corresponding author), Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.	townsenw@purdue.edu	Seleem, Mohamed/H-2774-2018; Younis, Wlaeed/AAA-1743-2022	Seleem, Mohamed/0000-0003-0939-0458; Younis, Wlaeed/0000-0001-5572-0142; Townsend, Wendy/0000-0001-8761-9380	Purdue University Armstrong Fund for Research in Anomalies of the Eye	Purdue University Armstrong Fund for Research in Anomalies of the Eye	Publication costs were supported by the Purdue University Armstrong Fund for Research in Anomalies of the Eye.	[Anonymous], 2015, M07 A10 METHODS DILU; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bruch MD, 1999, J AM CHEM SOC, V121, P11993, DOI 10.1021/ja992376m; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Clarkson RM, 2001, AUST DENT J, V46, P269, DOI 10.1111/j.1834-7819.2001.tb00291.x; da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014; Ding BW, 2004, J AM CHEM SOC, V126, P13642, DOI 10.1021/ja046909p; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Howell MD, 2009, J INVEST DERMATOL, V129, P2668, DOI 10.1038/jid.2009.120; Inoue Y, 1997, ARTIF ORGANS, V21, P28; Iwasawa A, 1996, Kansenshogaku Zasshi, V70, P915; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kang MH, 2014, CAN VET J, V55, P678; Kapur V, 2011, INDIAN J SURG, V73, P48, DOI 10.1007/s12262-010-0189-y; Landa-Solis C, 2005, J HOSP INFECT, V61, P291, DOI 10.1016/j.jhin.2005.04.021; Ledbetter EC, 2016, VET OPHTHALMOL, V19, P220, DOI [10.1111/vop.12287, 10.1111/vop.12200]; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Len SV, 2002, J AGR FOOD CHEM, V50, P209, DOI 10.1021/jf010822v; Li CH, 1998, J AM CHEM SOC, V120, P2961, DOI 10.1021/ja973881r; Loy JD, 2014, J VET DIAGN INVEST, V26, P761, DOI 10.1177/1040638714551403; Martinez JA, 2011, EVALUATION BACTERIAL; Martinez JA, 2015, P 47 ANN C AM COLL V; Martinez-Munive A., 2005, P AM COLL SURG 91 AN, P190; Mohammad H, 2015, CURR PHARM DESIGN, V21, P2073, DOI 10.2174/1381612821666150310102702; Moscoso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101037; Mouney MC, 2015, VET OPHTHALMOL, V18, P123, DOI 10.1111/vop.12130; Nagant C, 2013, MICROBIOLOGYOPEN, V2, P318, DOI 10.1002/mbo3.77; Nelson D, 2000, Gastrointest Endosc Clin N Am, V10, P319; NELSON JD, 1990, CURR EYE RES, V9, P277, DOI 10.3109/02713689009044524; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Ohno H, 2000, SURG TODAY, V30, P1055, DOI 10.1007/s005950070035; Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6; Polat ZA, 2011, J OCUL PHARMACOL TH, V27, P1, DOI 10.1089/jop.2010.0041; Rutala WA, 2001, EMERG INFECT DIS, V7, P348, DOI 10.3201/eid0702.010241; Saha S, 2008, J APPL MICROBIOL, V105, P822, DOI 10.1111/j.1365-2672.2008.03820.x; Sakashita Mikako, 2002, Kansenshogaku Zasshi, V76, P373; Sampson MN, 2002, J HOSP INFECT, V52, P227; Sauer K, 2009, BIOFOULING, V25, P45, DOI 10.1080/08927010802441412; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Seitz B, 1996, INVEST OPHTH VIS SCI, V37, P656; Sekiya S, 1997, ARTIF ORGANS, V21, P32; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Suter A, 2016, P 47 ANN C AM COLL V, P32; Tanaka H, 1996, J HOSP INFECT, V34, P43, DOI 10.1016/S0195-6701(96)90124-3; Thomas CJ, 1998, J AM CHEM SOC, V120, P12428, DOI 10.1021/ja981777j; Tincu JA, 2003, J BIOL CHEM, V278, P13546, DOI 10.1074/jbc.M211332200; van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072; Walker S, 1996, P NATL ACAD SCI USA, V93, P1585, DOI 10.1073/pnas.93.4.1585	52	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193217	10.1371/journal.pone.0193217	http://dx.doi.org/10.1371/journal.pone.0193217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513686	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800044
J	Dahlmann, J; Awad, G; Dolny, C; Weinert, S; Richter, K; Fischer, KD; Munsch, T; Lessmann, V; Volleth, M; Zenker, M; Chen, Y; Merkl, C; Schnieke, A; Baraki, H; Kutschka, I; Kensah, G				Dahlmann, Julia; Awad, George; Dolny, Carsten; Weinert, Soenke; Richter, Karin; Fischer, Klaus-Dieter; Munsch, Thomas; Lessmann, Volkmar; Volleth, Marianne; Zenker, Martin; Chen, Yaoyao; Merkl, Claudia; Schnieke, Angelika; Baraki, Hassina; Kutschka, Ingo; Kensah, George			Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture	PLOS ONE			English	Article							CARDIAC DIFFERENTIATION; INFARCT MODEL; HEARTS; MYOCYTES; MOUSE; TRANSPLANTATION; INTEGRATION; BLASTOCYSTS; MATURATION; SURVIVAL	The possibility to generate cardiomyocytes from pluripotent stem cells in vitro has enormous significance for basic research, disease modeling, drug development and heart repair. The concept of heart muscle reconstruction has been studied and optimized in the rat model using rat primary cardiovascular cells or xenogeneic pluripotent stem cell derived-cardiomyocytes for years. However, the lack of rat pluripotent stem cells (rPSCs) and their cardiovascular derivatives prevented the establishment of an authentic clinically relevant syngeneic or allogeneic rat heart regeneration model. In this study, we comparatively explored the potential of recently available rat embryonic stem cells (rESCs) and induced pluripotent stem cells (riPSCs) as a source for cardiomyocytes (CMs). We developed feeder cell-free culture conditions facilitating the expansion of undifferentiated rPSCs and initiated cardiac differentiation by embryoid body (EB)-formation in agarose microwell arrays, which substituted the robust but labor-intensive hanging drop (HD) method. Ascorbic acid was identified as an efficient enhancer of cardiac differentiation in both rPSC types by significantly increasing the number of beating EBs (3.6 +/- 1.6-fold for rESCs and 17.6 +/- 3.2-fold for riPSCs). These optimizations resulted in a differentiation efficiency of up to 20% cTnT pos rPSC-derived CMs. CMs showed spontaneous contractions, expressed cardiac markers and had typical morphological features. Electrophysiology of riPSC-CMs revealed different cardiac subtypes and physiological responses to cardio-active drugs. In conclusion, we describe rPSCs as a robust source of CMs, which is a prerequisite for detailed preclinical studies of myocardial reconstruction in a physiologically and immunologically relevant small animal model.	[Dahlmann, Julia; Awad, George; Dolny, Carsten; Baraki, Hassina; Kutschka, Ingo; Kensah, George] Otto von Guericke Univ, Clin Cardiothorac Surg, Magdeburg, Germany; [Weinert, Soenke] Otto von Guericke Univ, Clin Cardiol & Angiol, Magdeburg, Germany; [Richter, Karin; Fischer, Klaus-Dieter] Otto von Guericke Univ, Inst Biochem & Cell Biol, Magdeburg, Germany; [Munsch, Thomas; Lessmann, Volkmar] Otto von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Volleth, Marianne; Zenker, Martin] Otto von Guericke Univ, Inst Human Genet, Magdeburg, Germany; [Chen, Yaoyao] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Merkl, Claudia; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Dahlmann, Julia; Awad, George; Baraki, Hassina; Kutschka, Ingo; Kensah, George] Univ Med Ctr Gottingen, DZHK German Ctr Cardiovasc Res, Clin Thorac & Cardiovasc Surg, Partner Site Gottingen, Gottingen, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; University of Cambridge; Technical University of Munich; German Centre for Cardiovascular Research; University of Gottingen	Kensah, G (corresponding author), Otto von Guericke Univ, Clin Cardiothorac Surg, Magdeburg, Germany.; Kensah, G (corresponding author), Univ Med Ctr Gottingen, DZHK German Ctr Cardiovasc Res, Clin Thorac & Cardiovasc Surg, Partner Site Gottingen, Gottingen, Germany.	george.kensah@mectuni-goettingen.de	Leßmann, Volkmar/E-8125-2013; Dahlmann, Julia/GPP-6981-2022	Leßmann, Volkmar/0000-0002-6863-323X; Weinert, Sonke/0000-0002-7201-0836; Schnieke, Angelika/0000-0002-5761-9635	German Research Foundation [KU-2752]; European Commission FP7 Project EURATRANS [HEALTH-F4-2010-241504]; Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/H012737/1]; BBSRC [BB/H012737/1] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); European Commission FP7 Project EURATRANS; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the German Research Foundation [KU-2752; DFG grant to HB and IK, www.dfg.de], the European Commission FP7 Project EURATRANS [grant no. HEALTH-F4-2010-241504; grant to YC; www.euratrans.eu] and the Biotechnology and Biological Sciences Research Council of the United Kingdom [grant no. BB/H012737/1; grant to YC; www.bbsrc.ac.uk]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Beckmann A, 2016, HISTOCHEM CELL BIOL, P1; Bergstrom G, 2015, LAB CHIP, V15, P3242, DOI 10.1039/c5lc00449g; Blair K, 2012, BIOL OPEN, V1, P58, DOI 10.1242/bio.2011029; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Chen Z, 2016, EUROPEAN HEART J; Chong J. J., 2014, NATURE; Dahlmann J, 2013, BIOMATERIALS, P1; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Funakoshi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19111; Gerbin KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131446; Hamta A, 2006, CYTOGENET GENOME RES, V115, P158, DOI 10.1159/000095237; Hartman ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093033; Ivanyuk D, 2015, CELL PHYSIOL BIOCHEM, V36, P810, DOI 10.1159/000430140; Jung JJ, 2014, STEM CELL REP, V2, P592, DOI 10.1016/j.stemcr.2014.03.006; Kadota S, 2017, STEM CELL REP, V8, P278, DOI 10.1016/j.stemcr.2016.10.009; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawamura T, 2016, STEM CELL REP, V6, P312, DOI 10.1016/j.stemcr.2016.01.012; Ke Q, 2013, HUM MOL GENET, V22, P2221, DOI 10.1093/hmg/ddt074; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kempf H, 2014, STEM CELL REP, V3, P1132, DOI 10.1016/j.stemcr.2014.09.017; Kensah G, 2012, EUROPEAN HEART J, V34; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kokkinopoulos I, 2016, DEV DYNAM, V245, P157, DOI [10.1002/DVDY.24366, 10.1002/dvdy.24366]; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lamm N, 2016, CELL STEM CELL, V18, P253, DOI 10.1016/j.stem.2015.11.003; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Mannhardt I, 2016, STEM CELL REP, V7, P29, DOI 10.1016/j.stemcr.2016.04.011; Masumoto H., 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716; Matsumoto Takeshi, 2015, Saikaku Tsushin, V31, P1; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Ogasawara T, 2017, SCI REP, P1; Oyamada M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00085; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Peterson SE, 2014, J BIOL CHEM, P289; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Seabright M., 1971, LANCET, V2; Shao Y, 2014, NAT PROTOC, P9; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Thomson A, 2008, CLONING STEM CELLS, V10, P89, DOI 10.1089/clo.2007.0072; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Veerman CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30967; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wendel JS, 2015, STEM CELL TRANSL MED, V4, P1324, DOI 10.5966/sctm.2015-0044; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10	67	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192652	10.1371/journal.pone.0192652	http://dx.doi.org/10.1371/journal.pone.0192652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513687	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800019
J	Marrone, L; Bus, C; Schondorf, D; Fitzgerald, JC; Kubler, M; Schmid, B; Reinhardt, P; Reinhardt, L; Deleidi, M; Levin, T; Meixner, A; Klink, B; Glatza, M; Gloeckner, CJ; Gasser, T; Sterneckert, J				Marrone, Lara; Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Reinhardt, Peter; Reinhardt, Lydia; Deleidi, Michela; Levin, Tanya; Meixner, Andrea; Klink, Barbara; Glatza, Michael; Gloeckner, Christian Johannes; Gasser, Thomas; Sterneckert, Jared			Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; GENE; MUTATIONS; MITOPHAGY; CELL; AGE; NEURODEGENERATION; DUPLICATION; DEGRADATION; DYSFUNCTION	Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson's disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases.	[Marrone, Lara; Reinhardt, Peter; Reinhardt, Lydia; Levin, Tanya; Glatza, Michael; Sterneckert, Jared] DFG Ctr Regenerat Therapies Tech Univ Dresden CRT, Dresden, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Deleidi, Michela; Gasser, Thomas] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, Tubingen, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Deleidi, Michela; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Deleidi, Michela; Meixner, Andrea; Gloeckner, Christian Johannes; Gasser, Thomas] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Reinhardt, Lydia; Glatza, Michael] Max Planck Inst Mol Biomed, Munster, Germany; [Klink, Barbara] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Klin Genet, Dresden, Germany; [Gloeckner, Christian Johannes] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Schmid, Benjamin] Bioneer AS, Horsholm, Denmark; [Reinhardt, Peter] AbbVie Deutschland GmbH & Co KG, Neurosci Discovery Biol Dept, Ludwigshafen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bioneer A/S; AbbVie	Sterneckert, J (corresponding author), DFG Ctr Regenerat Therapies Tech Univ Dresden CRT, Dresden, Germany.; Gasser, T (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, Tubingen, Germany.; Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany.; Gasser, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.	thomas.gasser@uni-tuebingen.de; jared.sternecked@gtu-dresden.de	Gloeckner, Christian Johannes/R-5374-2019; Gasser, Thomas/GNH-5293-2022	Gasser, Thomas/0000-0002-1069-1146; Deleidi, Michela/0000-0003-0357-0124; Gloeckner, Christian Johannes/0000-0001-6494-6944; Sterneckert, Jared/0000-0002-7688-3124; Klink, Barbara/0000-0002-8753-8238	Hans and Ilse Breuer Stiftung; Michael J. Fox Foundation for Parkinson's Research; Deutsche Forschungsgemeinschaft (DFG) [GA 402/18-1]; DFG Research Center [DFG FZ 111]; DFG Cluster of Excellence [DFG EXC 168]	Hans and Ilse Breuer Stiftung; Michael J. Fox Foundation for Parkinson's Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Research Center(German Research Foundation (DFG)); DFG Cluster of Excellence(German Research Foundation (DFG))	Lara Marrone was sponsored by a fellowship from the Hans and Ilse Breuer Stiftung. This work was supported by a grant from the Michael J. Fox Foundation for Parkinson's Research, GA 402/18-1 from the Deutsche Forschungsgemeinschaft (DFG) awarded to both T. G. and J.S. as well as by DFG Research Center (DFG FZ 111) and Cluster of Excellence (DFG EXC 168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731; Botta-Orfila T, 2012, J MOL NEUROSCI, V48, P245, DOI 10.1007/s12031-012-9820-7; Bravo-San Pedro JM, 2012, CELL MOL LIFE SCI; Brockmann K, 2013, MOVEMENT DISORD, V28, P1217, DOI 10.1002/mds.25469; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Daher JPL, 2015, J BIOL CHEM, V290, P19433, DOI 10.1074/jbc.M115.660001; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giesert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063778; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Golub Y, 2009, PARKINSONISM RELAT D, V15, P539, DOI 10.1016/j.parkreldis.2008.10.008; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Illarioshkin SN, 2007, EUR J NEUROL, V14, P413, DOI 10.1111/j.1468-1331.2007.01685.x; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Liu GH, 2012, NATURE; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nimsanor N, 2016, STEM CELL RES, V17, P550, DOI 10.1016/j.scr.2016.09.019; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paull D, 2015, NAT METHODS, V12, P885, DOI [10.1038/NMETH.3507, 10.1038/nmeth.3507]; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schwab AJ, 2015, STEM CELL REP, V5, P1039, DOI 10.1016/j.stemcr.2015.11.004; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Trabzuni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070724; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Volpicelli-Daley LA, 2016, J NEUROSCI, V36, P7415, DOI 10.1523/JNEUROSCI.3642-15.2016; Wang B, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0065-1; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Williams-Gray CH, 2006, J NEUROL NEUROSUR PS, V77, P665, DOI 10.1136/jnnp.2005.085019; Yao C, 2013, HUM MOL GENET, V22, P328, DOI 10.1093/hmg/dds431; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192497	10.1371/journal.pone.0192497	http://dx.doi.org/10.1371/journal.pone.0192497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513666	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800015
J	Romanelli, A; Affinito, A; Avitabile, C; Catuogno, S; Ceriotti, P; Laboni, M; Modica, J; Condorelli, G; Catalucci, D				Romanelli, Alessandra; Affinito, Alessandra; Avitabile, Concetta; Catuogno, Silvia; Ceriotti, Paola; Laboni, Margherita; Modica, Jessica; Condorelli, Geroloma; Catalucci, Daniele			An anti-PDGFR ss aptamer for selective delivery of small therapeutic peptide to cardiac cells	PLOS ONE			English	Article							CALCIUM-CHANNEL; GROWTH-FACTOR; CA2+ CHANNEL; LIGANDS; PROTEIN; HEART	Small therapeutic peptides represent a promising field for the treatment of pathologies such as cardiac diseases. However, the lack of proper target-selective carriers hampers their translation towards a potential clinical application. Aptamers are cell-specific carriers that bind with high affinity to their specific target. However, some limitations on their conjugation to small peptides and the functionality of the resulting aptamer-peptide chimera exist. Here, we generated a novel aptamer-peptide chimera through conjugation of the PDGFR ss-targeting Gint4. T aptamer to MP, a small mimetic peptide that via targeting of the Ca-v ss 2 subunit of the L-type calcium channel (LTCC) can recover myocardial function in pathological heart conditions associated with defective LTCC function. The conjugation reaction was performed by click chemistry in the presence of N,N,N', N',N"-pentamethyldiethylenetriamine as a Cu (I) stabilizing agent in a DMSO-free aqueous buffer. When administered to cardiac cells, the Gint4. T-MP aptamer-peptide chimera was successfully internalized in cells, allowing the functional targeting of MP to LTCC. This approach represents the first example of the use of an internalizing aptamer for selective delivery of a small therapeutic peptide to cardiac cells.	[Romanelli, Alessandra] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Affinito, Alessandra; Laboni, Margherita; Condorelli, Geroloma] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Avitabile, Concetta] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Catuogno, Silvia; Condorelli, Geroloma] CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, Naples, Italy; [Ceriotti, Paola; Modica, Jessica; Catalucci, Daniele] Humanitas Clin & Res Ctr, Milan, Italy; [Catalucci, Daniele] CNR, Inst Genet & Biomed Res, Milan Unit, Milan, Italy; [Laboni, Margherita] Bracco Imaging SpA, Turin, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Bracco	Condorelli, G (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.; Condorelli, G (corresponding author), CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, Naples, Italy.; Catalucci, D (corresponding author), Humanitas Clin & Res Ctr, Milan, Italy.; Catalucci, D (corresponding author), CNR, Inst Genet & Biomed Res, Milan Unit, Milan, Italy.	gecondor@unina.it; daniele.catalucci@cnr.it	Catuogno, Silvia/AAB-9969-2019; Catalucci, Daniele/B-6745-2015; Affinito, Alessandra/Q-7859-2018	Catuogno, Silvia/0000-0002-1653-4205; Catalucci, Daniele/0000-0001-7041-6114; Modica, Jessica/0000-0002-4986-8009; Avitabile, Concetta/0000-0001-5542-6920; Affinito, Alessandra/0000-0002-3887-6513	Italian Ministry of Health [GR-2011-02352546]; AIRC - IG [18473]; Federazione Italiana Ricerca sul Cancro (FIRC); Italian Ministry of Health [GR-2011-02352546]; AIRC - IG [18473]; Federazione Italiana Ricerca sul Cancro (FIRC)	Italian Ministry of Health(Ministry of Health, Italy); AIRC - IG(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); AIRC - IG(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Health (http://www.salute.gov.it/portale/ home html; GR-2011-02352546) to DC and by Associazione Italiana Ricerca sul Cancro (http://www.airc.it/aiutare-la-ricerca/bomboniere-solidali.aps?ets_cmmk=3123&ets_sgmt=16923&gclid=cjwKEAjwvYPKBRCYr5GLgNCJ_isSJABqwfw7 DMtnt2m8pISbXCI0XMmSHgRPg495q6IIUt4jeXObjhoCIrrw_wcB; AIRC - IG 2016 Id. 18473) to GC. MI was supported by the Federazione Italiana Ricerca sul Cancro (FIRC, http://www.fondazionefirc.it) Post-Doctoral Research Fellowship.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Avitabile C, 2013, BBA-GEN SUBJECTS, V1830, P3767, DOI 10.1016/j.bbagen.2013.01.026; Blaich A, 2012, J BIOL CHEM, V287, P22616, DOI 10.1074/jbc.M112.357921; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Brugada P, 2013, EUR HEART J, V34, P3610, DOI 10.1093/eurheartj/eht113; Camorani S, 2014, MOL THER, V22, P828, DOI 10.1038/mt.2013.300; Catuogno S, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040069; Catuogno S, 2015, J CONTROL RELEASE, V210, P147, DOI 10.1016/j.jconrel.2015.05.276; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; El-Sagheer AH, 2010, P NATL ACAD SCI USA, V107, P15329, DOI 10.1073/pnas.1006447107; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esposito CL, 2016, J CONTROL RELEASE, V238, P43, DOI 10.1016/j.jconrel.2016.07.032; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Hacker DE, 2017, ACS CHEM BIOL, V12, P795, DOI 10.1021/acschembio.6b01006; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Lee J, 2013, ANAL CHEM, V85, P9692, DOI 10.1021/ac402038t; Miragoli M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6205; Paredes E, 2011, CHEMBIOCHEM, V12, P125, DOI 10.1002/cbic.201000466; Patel A, 2014, THER DELIV, V5, P337, DOI [10.4155/TDE.14.5, 10.4155/tde.14.5]; Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d; Rusconi F, 2016, CIRCULATION, V134, P534, DOI 10.1161/CIRCULATIONAHA.116.021347; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Thiel WH, 2016, MOL THERAPY J AM SOC; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Weiss N, 2014, PATHOLOGIES CALCIUM, Vxviii; Zahid M, 2015, MOLECULES, V20, P13055, DOI 10.3390/molecules200713055; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	30	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193392	10.1371/journal.pone.0193392	http://dx.doi.org/10.1371/journal.pone.0193392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513717	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800057
J	Ye, BB; Chu, ZS; Wu, AP; Hou, ZY; Wang, SR				Ye, Bibi; Chu, Zhaosheng; Wu, Aiping; Hou, Zeying; Wang, Shengrui			Optimum water depth ranges of dominant submersed macrophytes in a natural freshwater lake	PLOS ONE			English	Article							CERATOPHYLLUM-DEMERSUM; COMMUNITY COMPOSITION; DIVERSITY; BIOMASS; PLANTS; LIGHT; EUTROPHICATION; VEGETATION; WETLAND; GROWTH	Macrophytes show a zonal distribution along the lake littoral zone because of their specific preferred water depths while the optimum growth water depths of dominant submersed macrophytes in natural lakes are not well known. We studied the seasonal biomass and frequency patterns of dominant and companion submersed macrophytes along the water depth gradient in Lake Erhai in 2013. The results showed that the species richness and community biomass showed hump-back shaped patterns along the water depth gradient both in polydominant and monodominant communities. Biomass percentage of Potamogenton maackianus showed a hump-back pattern while biomass percentages of Ceratophyllum demersum and Vallisneria natans appeared U-shaped patterns across the water depth gradient in polydominant communities whereas biomass percentage of V. natans increased with the water depth in monodominant communities. Dominant species demonstrated a broader distribution range of water depth than companion species. Frequency and biomass of companion species declined drastically with the water depth whereas those of dominant species showed non-linear patterns across the water depth gradient. Namely, along the water depth gradient, biomass of P. maackianus and V. natans showed hump-back patterns and biomasses of C. demersum displayed a U-shaped pattern in the polydominant communities but biomass of V. natans demonstrated a hump-back pattern in the monodominant communities; frequency of P. maackianus showed a hump-back pattern and C. demersum and V. natans maintained high frequencies in the two types of communities. We can speculate that in Lake Erhai the optimum growth water depths of P. maackianus and C. demersum in the polydominant communities are 2.5-4.5 m and 1-2 m or 5-6 m, respectively and that of V. natans is 3-5 m in the polydominant communities and 2.5-5 m in the monodominant communities. This is the first report that the optimum water depth ranges in the horizontal direction of three dominant submersed macrophytes in a natural freshwater lake were determined.	[Ye, Bibi; Chu, Zhaosheng; Hou, Zeying; Wang, Shengrui] CRAES, Res Ctr Lake Ecol & Environm, State Environm Protect Key Lab Lake Pollut Contro, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Wu, Aiping] Hunan Agr Univ, Coll Biosci & Biotechnol, Ecol Dept, Hunan Prov Key Lab Rural Ecosyst Hlth Dongting La, Changsha, Hunan, Peoples R China	Chinese Research Academy of Environmental Sciences; Hunan Agricultural University	Chu, ZS (corresponding author), CRAES, Res Ctr Lake Ecol & Environm, State Environm Protect Key Lab Lake Pollut Contro, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.; Wu, AP (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Ecol Dept, Hunan Prov Key Lab Rural Ecosyst Hlth Dongting La, Changsha, Hunan, Peoples R China.	chuzs@craes.org.cn; wuaip8101@126.com	Wu, Aiping/AAU-8710-2020		Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07105-002]; State Scholarship Found of China Scholarship Council (CSC) [2016-3035]; National Natural Science Foundation of China [31301725]	Major Science and Technology Program for Water Pollution Control and Treatment; State Scholarship Found of China Scholarship Council (CSC); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07105-002), the State Scholarship Found of China Scholarship Council (CSC) (No: 2016-3035) and the National Natural Science Foundation of China (No. 31301725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao T, 2011, FRESHWATER BIOL, V56, P1620, DOI 10.1111/j.1365-2427.2011.02601.x; CHAMBERS PA, 1987, J ECOL, V75, P621, DOI 10.2307/2260194; Chen JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34028; Chu CJ, 2008, ECOL LETT, V11, P1189, DOI 10.1111/j.1461-0248.2008.01228.x; Chu ZhaoSheng, 2014, Research of Environmental Sciences, V27, P1; Dong BL, 2014, J GREAT LAKES RES, V40, P646, DOI 10.1016/j.jglr.2014.04.007; Ervin GN, 2002, OECOLOGIA, V130, P626, DOI 10.1007/s00442-001-0844-x; Fu H, 2014, FRESHWATER BIOL, V59, P2462, DOI 10.1111/fwb.12443; Fu Hui, 2013, Hupo Kexue, V25, P854; Gross EM, 2003, HYDROBIOLOGIA, V506, P583, DOI 10.1023/B:HYDR.0000008539.32622.91; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Istvanovics V, 2008, AQUAT BOT, V88, P317, DOI 10.1016/j.aquabot.2007.12.008; Jones JI, 2002, J ECOL, V90, P12, DOI 10.1046/j.0022-0477.2001.00620.x; Kahmen A, 2005, OECOLOGIA, V142, P606, DOI 10.1007/s00442-004-1749-2; Li Enhua, 2011, Hupo Kexue, V23, P738; Li Wei, 2014, Hupo Kexue, V26, P585; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; MADSEN JD, 1989, HYDROBIOLOGIA, V171, P111, DOI 10.1007/BF00008171; Maemets H, 2005, HYDROBIOLOGIA, V547, P175, DOI 10.1007/s10750-005-4158-6; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; May L, 2010, HYDROBIOLOGIA, V646, P123, DOI 10.1007/s10750-010-0176-0; Ni LY, 2001, J FRESHWATER ECOL, V16, P249, DOI 10.1080/02705060.2001.9663809; Pelechata A, 2010, OCEANOL HYDROBIOL ST, V39, P95, DOI 10.2478/v10009-010-0004-x; Schultz JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00324; Schutten J, 2004, ANN BOT-LONDON, V93, P333, DOI 10.1093/aob/mch043; Smith RGB, 2007, PLANT ECOL, V188, P103, DOI 10.1007/s11258-006-9151-2; Sousa WTZ, 2010, AQUAT BOT, V92, P40, DOI 10.1016/j.aquabot.2009.10.002; Timoney KP, 2006, ECOSCIENCE, V13, P308, DOI 10.2980/i1195-6860-13-3-308.1; Wells RDS, 1997, NEW ZEAL J MAR FRESH, V31, P449, DOI 10.1080/00288330.1997.9516778; Wersal RM, 2006, WETLANDS, V26, P313, DOI 10.1672/0277-5212(2006)26[313:EFABAD]2.0.CO;2; Xu AnLun, 2011, Transactions of Atmospheric Sciences, V34, P225; Yuan GX, 2016, ENVIRON EXP BOT, V122, P94, DOI 10.1016/j.envexpbot.2015.09.009; Zhang L, 2015, ENVIRON EARTH SCI, V74, P3887, DOI 10.1007/s12665-015-4136-x	34	21	23	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193176	10.1371/journal.pone.0193176	http://dx.doi.org/10.1371/journal.pone.0193176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513707	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800042
J	Foltynski, P				Foltynski, Piotr			Ways to increase precision and accuracy of wound area measurement using smart devices: Advanced app Planimator	PLOS ONE			English	Article								Introduction Wound surface area measurement is important as therapeutic decisions may depend on the change of wound surface area over time. Digital planimetry is a popular technique in wound area measurement. It is accurate and repeatable when calibration is performed with 2 rulers placed at opposite sides of a wound. The aim of the current study was improving accuracy and precision of wound area measurement using capabilities of smart devices. Methods The correction of area measurement based on calculated camera tilt angle and the calculation of calibration coefficient of linear dimensions as weighted average were proposed. These and other improvements were applied in the Planimator app for Android, which was then used in the study. Accuracy and precision of the Planimator app were compared to the Visitrak device, the SilhouetteMobile device, the AreaMe software, and to the digital planimetry based on 2-ruler calibration with pictures taken by the smartphone, compact, and D-SLR cameras. Areas of 40 wound shapes of area ranged from 0.14 to 31.72 cm(2) were measured with each device. Medians of relative errors (REs) were compared in the accuracy tests and standard deviations (SDs) of relative differences (RDs) were compared in the tests of precision. Results The median of REs for the Planimator app was not significantly different from the medians of REs for the digital planimetry based on pictures from the compact or D-SLR cameras, but it was significantly lower than the medians of REs for the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smart phone camera. The SD of RDs for the Planimator app was not significantly different from the SDs of RDs for the digital planimetry based on pictures from the compact or D-SLR cameras, but it was significantly lower than the SDs of RDs for the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smart phone camera. The Planimator app installed at a smartphone revealed to be 2-fold more accurate and 1.5-fold more precise than the measurements with using ImageJ software based on pictures taken with the same smartphone. Conclusions The Planimator app occurred to have the same accuracy and precision as measurements with digital planimetry with 2-ruler calibration and based on pictures from a compact camera or a D-SLR camera. This app showed better accuracy and precision than the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smartphone camera.	[Foltynski, Piotr] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Foltynski, P (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	pfoltynski@ibib.waw.pl	Foltynski, Piotr/D-7708-2013	Foltynski, Piotr/0000-0002-6678-1968				[Anonymous], US, Patent No. 20150141841; Chang Angela Christine, 2011, Eplasty, V11, pe18; Foltynski P, WOUND SHAPES 1 D 20; Foltynski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134622; Foltynski P, 2014, ARTIF ORGANS, V38, P346, DOI 10.1111/aor.12169; Foltynski P, 2013, DIABETES TECHNOL THE, V15, P711, DOI 10.1089/dia.2013.0026; Ladyzynski P, 2011, DIABETES TECHNOL THE, V13, P1101, DOI 10.1089/dia.2011.0082; Li PN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038069; Molik M, 2010, BIOCYBERN BIOMED ENG, V30, P3; Moore K, 2005, J Wound Care, V14, P229; Mrozikiewicz-Rakowska B, 2017, DIABETOLOGIA, V60, pS549; Pavlovcic U, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0031-7; Plassmann P, 1995, J Wound Care, V4, P269; Rennert R, 2009, ADV SKIN WOUND CARE, V22, P32, DOI 10.1097/01.ASW.0000343718.30567.cb; Ring EFJ, 2004, RHEUMATOLOGY, V43, P800, DOI 10.1093/rheumatology/keg009; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Treuillet S, 2009, IEEE T MED IMAGING, V28, P752, DOI 10.1109/TMI.2008.2012025; Wendland DM, 2017, J ACUTE CARE PHYS TH, V8, P42, DOI 10.1097/JAT.0000000000000050	18	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0192485	10.1371/journal.pone.0192485	http://dx.doi.org/10.1371/journal.pone.0192485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505569	Green Submitted, gold, Green Published			2022-12-26	WOS:000426548200001
J	Krause, RGE; Goldring, JPD				Krause, Robert G. E.; Goldring, J. P. Dean			Phosphoethanolamine-N-methyltransferase is a potential biomarker for the diagnosis of P. knowlesi and P. falciparum malaria	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN; PARASITE LACTATE-DEHYDROGENASE; ISOTHERMAL AMPLIFICATION ASSAY; PLASMODIUM-KNOWLESI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; MONOCLONAL-ANTIBODIES; HUMAN INFECTIONS; EGG-YOLK; MALAYSIA	Background Plasmodium knowlesi is recognised as the main cause of human malaria in Southeast Asia. The disease is often misdiagnosed as P. falciparum or P. malariae infections by microscopy, and the disease is difficult to eliminate due to its presence in both humans and monkeys. P. knowlesi infections can rapidly cause severe disease and require prompt diagnosis and treatment. No protein biomarker exists for the rapid diagnostic test (RDT) detection of P. knowlesi infections. Plasmodium knowlesi infections can be diagnosed by PCR. Methods and principal findings Phosphoethanolamine-N-methyltransferase (PMT) is involved in malaria lipid biosynthesis and is not found in the human host. The P. falciparum, P. vivax and P. knowlesi PMT proteins were recombinantly expressed in BL21(DE3) Escherichia coli host cells, affinity purified and used to raise antibodies in chickens. Antibodies against each recombinant PMT protein all detected all three recombinant proteins and the native 29 kDa P. falciparum PMT protein on western blots and in ELISA. Antibodies against a PMT epitope (PLENNQYT-DEGVKC) common to all three PMT orthologues detected all three proteins. Antibodies against unique peptides from each orthologue of PMT, PfCEVEHKYLHENKE, PvVYSI-KEYNSLKDC, PkLYPTDEYNSLKDC detected only the parent protein in western blots and P. falciparum infected red blood cell lysates or blood lysates spiked with the respective proteins. Similar concentrations of PfPMT and the control, PfLDH, were detected in the same parasite lysate. The recombinant PfPMT protein was detected by a human anti-malaria antibody pool. Conclusion PMT, like the pan-specific LDH biomarker used in RDT tests, is both soluble, present at comparable concentrations in the parasite and constitutes a promising antimalarial drug target. PMT is absent from the human proteome. PMT has the potential as a biomarker for human malaria and in particular as the first P. knowlesi specific protein with diagnostic potential for the identification of a P. knowlesi infection.	[Krause, Robert G. E.; Goldring, J. P. Dean] Univ KwaZulu Natal, Biochem, Pietermaritzburg, South Africa	University of Kwazulu Natal	Goldring, JPD (corresponding author), Univ KwaZulu Natal, Biochem, Pietermaritzburg, South Africa.	goldringd@ukzn.ac.za		Goldring, James Philip Dean/0000-0001-6713-9515; Krause, Robert/0000-0003-1558-0397	South African National Research Foundation [92740]; South African Medical Research Council; University of KwaZulu-Natal; South African National Research Foundation; Medical Research Council	South African National Research Foundation(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of KwaZulu-Natal; South African National Research Foundation(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African National Research Foundation. Grant No: 92740 (http://www.nrf.ac.za/) to DG; South African Medical Research Council to DG. Self Initiated Grant Goldring 2011 (http://www.mrc.ac.za/) to DG; University of KwaZulu-Natal to DG; South African National Research Foundation. Post Doctoral funding to RGEK and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ben Mamoun (Yale University School of Medicine) for vectors expressing the three PMT orthologues, all members of the Goldring laboratory, Theresa Coetzer for reading the manuscript and Annemarie Krause for blood collections. We thank the South African National Research Foundation, Medical Research Council and the University of KwaZulu-Natal for funding. RK thanks the South African NRF for PostDoctoral funding.	Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britton S, 2016, AM J TROP MED HYG, V95, P120, DOI 10.4269/ajtmh.15-0670; Burke A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43779; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; CARMENES RS, 1989, BIOCHEM BIOPH RES CO, V159, P687, DOI 10.1016/0006-291X(89)90049-1; CHIN W, 1965, SCIENCE, V149, P865, DOI 10.1126/science.149.3686.865; Chiodini P, 2017, AM J HEMATOL, V92, P716, DOI 10.1002/ajh.24697; Choveaux David, 2012, Methods Mol Biol, V869, P585, DOI 10.1007/978-1-61779-821-4_53; Choveaux DL, 2015, EXP PARASITOL, V148, P30, DOI 10.1016/j.exppara.2014.11.001; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Dechamps S, 2010, J LIPID RES, V51, P81, DOI 10.1194/jlr.M900166-JLR200; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Fatih FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-425; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; FONG YL, 1971, T ROY SOC TROP MED H, V65, P839, DOI 10.1016/0035-9203(71)90103-9; Fornace KM, 2016, J INFECT DIS, V213, P784, DOI 10.1093/infdis/jiv475; Foster D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-60; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; Ginsburg H., 2017, MALARIA PARASITE MET; GOLDRING JD, 1992, BRIT J HAEMATOL, V81, P413, DOI 10.1111/j.1365-2141.1992.tb08249.x; Goldring JPD, 2003, BIOCHEM MOL BIOL EDU, V31, P185, DOI 10.1002/bmb.2003.494031030213; Grigg MJ, 2017, LANCET PLANET HEALTH, V1, pE97, DOI [10.1016/S2542-5196(17)30031-1, 10.1016/s2542-5196(17)30031-1]; Grigg MJ, 2014, J CLIN MICROBIOL, V52, P2053, DOI 10.1128/JCM.00181-14; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Hurdayal R, 2010, PEPTIDES, V31, P525, DOI 10.1016/j.peptides.2010.01.002; Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10; Jeslyn WPS, 2011, VECTOR-BORNE ZOONOT, V11, P131, DOI 10.1089/vbz.2010.0024; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Kaushal Deep C., 1995, Indian Journal of Experimental Biology, V33, P6; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Knowles R, 1932, Ind Med Gaz, V67, P301; Krause RGE, 2017, EXP PARASITOL, V179, P7, DOI 10.1016/j.exppara.2017.05.007; Krause RGE, 2015, IMMUNOL INVEST, V44, P627, DOI 10.3109/08820139.2015.1070268; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau YL, 2016, AM J TROP MED HYG, V94, P336, DOI 10.4269/ajtmh.15-0569; Lau YL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-197; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Leow CH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-277; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Marchand RP, 2011, EMERG INFECT DIS, V17, P1232, DOI 10.3201/eid1707.101551; Martin SK, 2009, AM J TROP MED HYG, V80, P516, DOI 10.4269/ajtmh.2009.80.516; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; McCoy J P Jr, 2001, Curr Protoc Cytom, VChapter 5, DOI 10.1002/0471142956.cy0501s00; McCutchan TF, 2008, EMERG INFECT DIS, V14, P1750, DOI 10.3201/eid1411.080840; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Piera KA, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1676-9; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Ravaoarisoa E, 2010, MABS-AUSTIN, V2, P416, DOI 10.4161/mabs.12438; Ravyn MD, 1999, AM J TROP MED HYG, V61, P171, DOI 10.4269/ajtmh.1999.61.171; Richards J, 2017, LANCET PLANET HEALTH, V1, pE83, DOI 10.1016/S2542-5196(17)30053-0; Schade R, 2001, FOODS; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Sermwittayawong N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-36; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2016, MICROBIOL AUST, V37, P39, DOI 10.1071/MA16014; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Singh V, 2012, PROTEIN EXPRES PURIF, V84, P195, DOI 10.1016/j.pep.2012.05.008; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Verma P, 2013, INDIAN J MED RES, V138, P977; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2016, WORLD MAL REP 2016; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07; Yusof R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-168	92	9	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193833	10.1371/journal.pone.0193833	http://dx.doi.org/10.1371/journal.pone.0193833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505599	Green Published, Green Submitted, gold			2022-12-26	WOS:000426548200033
J	Olech, M; Valas, S; Kuzmak, J				Olech, Monika; Valas, Stephen; Kuzmak, Jacek			Epidemiological survey in single-species flocks from Poland reveals expanded genetic and antigenic diversity of small ruminant lentiviruses	PLOS ONE			English	Article							CAPRINE-ARTHRITIS-ENCEPHALITIS; PHYLOGENETIC ANALYSIS; MIXED FLOCKS; IMMUNODOMINANT EPITOPE; NATURAL TRANSMISSION; ANTIBODY-RESPONSE; SUBTYPE B1; SHEEP; VIRUS; GOATS	Small ruminant lentivirus (SRLV) infections are widespread in Poland and circulation of subtypes A1, A12, A13, B1 and B2 was detected. The present work aimed at extending previous study based on the analysis of a larger number of animals from single-species flocks. Animals were selected for genetic analysis based on serological reactivity towards a range of recombinant antigens derived from Gag and Env viral proteins. Phylogenetic analysis revealed the existence of subtypes B2 and A12 in both goats and sheep and subtypes A1 and B1 in goats only. In addition, two novel subtypes, A16 and A17, were found in goats. Co-infections with strains belonging to different subtypes within A and B groups were detected in 1 sheep and 4 goats originating from four flocks. Although the reactivity of serum samples towards the recombinant antigens confirmed immunological relatedness between Gag epitopes of different subtypes and the cross-reactive nature of Gag antibodies, eleven serum samples failed to react with antigens representing all subtypes detected up-to-date in Poland, highlighting the limitations of the serological diagnosis. These data showed the complex nature of SRLV subtypes circulating in sheep and goats in Poland and the need for improving SRLV-related diagnostic capacity.	[Olech, Monika; Kuzmak, Jacek] Natl Vet Res Inst, Dept Biochem, Pulawy, Poland; [Valas, Stephen] Anses Niort Lab, Niort, France	National Veterinary Institute - National Research Institute	Olech, M (corresponding author), Natl Vet Res Inst, Dept Biochem, Pulawy, Poland.	monika.olech@piwet.pulawy.pl		Olech, Monika/0000-0002-8356-5423	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Ministry of Science and Higher Education [05-1/KNOW2/2015]; National Science Centre [2016/21/D/NZ7/00626]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	This study was funded by the KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", Ministry of Science and Higher Education Resolution no. 05-1/KNOW2/2015 and National Science Centre project no. 2016/21/D/NZ7/00626.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; [Anonymous], 2017, PREV VET MED, V147, P66; [Anonymous], 2015, PRESENCE ANTIBODIES; Carrozza ML, 2009, VET MICROBIOL, V137, P369, DOI 10.1016/j.vetmic.2009.01.032; CORK LC, 1974, J INFECT DIS, V129, P134, DOI 10.1093/infdis/129.2.134; de Andres X, 2013, VET IMMUNOL IMMUNOP, V152, P277, DOI 10.1016/j.vetimm.2012.12.017; Deubelbeiss M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-65; Fras M, 2013, INFECT GENET EVOL, V19, P97, DOI 10.1016/j.meegid.2013.06.019; Germain K, 2006, VIRUS RES, V120, P156, DOI 10.1016/j.virusres.2006.03.002; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gjerset B, 2006, J GEN VIROL, V87, P573, DOI 10.1099/vir.0.81201-0; GOGOLEWSKI RP, 1985, J GEN VIROL, V66, P1233, DOI 10.1099/0022-1317-66-6-1233; Grego E, 2005, VET MICROBIOL, V106, P179, DOI 10.1016/j.vetmic.2004.12.007; Grego E, 2002, CLIN DIAGN LAB IMMUN, V9, P828, DOI 10.1128/CDLI.9.4.828-832.2002; Grego E, 2007, J GEN VIROL, V88, P3423, DOI 10.1099/vir.0.83292-0; Hayward JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-76; Kuhar U, 2013, VET MICROBIOL, V162, P201, DOI 10.1016/j.vetmic.2012.08.024; L'Homme Y, 2015, VIROLOGY, V475, P159, DOI 10.1016/j.virol.2014.11.006; Lacerenza D, 2006, VET IMMUNOL IMMUNOP, V112, P264, DOI 10.1016/j.vetimm.2006.03.016; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mordasini F, 2006, J CLIN MICROBIOL, V44, P981, DOI 10.1128/JCM.44.3.981-991.2006; NARAYAN O, 1989, J GEN VIROL, V70, P1617, DOI 10.1099/0022-1317-70-7-1617; Olech M, 2012, VIRUS RES, V163, P528, DOI 10.1016/j.virusres.2011.11.019; Pisoni G, 2005, VIROLOGY, V339, P147, DOI 10.1016/j.virol.2005.06.013; Pisoni G, 2007, J VIROL, V81, P4948, DOI 10.1128/JVI.00126-07; Rachid A, 2013, J GEN VIROL, V94, P634, DOI 10.1099/vir.0.044768-0; Ramirez H, 2011, VET J, V190, P169, DOI 10.1016/j.tvjl.2010.09.005; Ramirez H, 2013, VIRUSES-BASEL, V5, P1175, DOI 10.3390/v5041175; Reina R, 2010, VET MICROBIOL, V144, P24, DOI 10.1016/j.vetmic.2009.12.020; Santry LA, 2013, VIRUS RES, V175, P30, DOI 10.1016/j.virusres.2013.03.019; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valas S, 1997, VIROLOGY, V237, P307, DOI 10.1006/viro.1997.8800; Valas S, 2000, J VIROL, V74, P6178, DOI 10.1128/JVI.74.13.6178-6185.2000	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e193892	10.1371/journal.pone.0193892	http://dx.doi.org/10.1371/journal.pone.0193892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505612	Green Submitted, Green Published, gold			2022-12-26	WOS:000426548200040
J	Zinne, N; Krueger, M; Hoeltig, D; Tuemmler, B; Boyle, EC; Biancosino, C; Hoeffler, K; Braubach, P; Rajab, TK; Ciubotaru, A; Rohde, J; Waldmann, KH; Haverich, A				Zinne, Norman; Krueger, Marcus; Hoeltig, Doris; Tuemmler, Burkhard; Boyle, Erin C.; Biancosino, Christian; Hoeffler, Klaus; Braubach, Peter; Rajab, Taufiek K.; Ciubotaru, Anatol; Rohde, Judith; Waldmann, Karl-Heinz; Haverich, Axel			Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PNEUMONIA; COLISTIN; TRANSPLANTATION; RESISTANCE; THERAPY; MODEL	The emergence of multi-drug resistant bacteria threatens to end the era of antibiotics. Drug resistant bacteria have evolved mechanisms to overcome antibiotics at therapeutic doses and further dose increases are not possible due to systemic toxicity. Here we present a pilot study of ex vivo lung perfusion (EVLP) with high dose antibiotic therapy followed by auto transplantation as a new therapy of last resort for otherwise incurable multidrug resistant lung infections. Severe Pseudomonas aeruginosa pneumonia was induced in the lower left lungs (LLL) of 18 Mini-Lewe pigs. Animals in the control group (n = 6) did not receive colistin. Animals in the conventional treatment group (n = 6) received intravenous application of 2 mg/kg body weight colistin daily. Animals in the EVLP group (n = 6) had their LLL explanted and perfused ex vivo with a perfusion solution containing 200 mu g/ml colistin. After two hours of ex vivo treatment, autotransplantation of the LLL was performed. All animals were followed for 4 days following the initiation of treatment. In the control and conventional treatment groups, the infection-related mortality rate after five days was 66.7%. In the EVLP group, there was one infection-related mortality and one procedure-related mortality, for an overall mortality rate of 33.3%. Moreover, the clinical symptoms of infection were less severe in the EVLP group than the other groups. Ex vivo lung perfusion with very high dose antibiotics presents a new therapeutic option of last resort for otherwise incurable multidrug resistant pneumonia without toxic side effects on other organs.	[Zinne, Norman; Krueger, Marcus; Boyle, Erin C.; Biancosino, Christian; Hoeffler, Klaus; Ciubotaru, Anatol; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany; [Hoeltig, Doris; Waldmann, Karl-Heinz] Univ Vet Med Hannover, Clin Swine Small Ruminants Forens Med & Ambulator, Hannover, Lower Saxony, Germany; [Tuemmler, Burkhard] Hannover Med Sch, Clin Paediat Pneumol Allergol & Neonatol, Hannover, Lower Saxony, Germany; [Tuemmler, Burkhard; Braubach, Peter; Haverich, Axel] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Lower Saxony, Germany; [Braubach, Peter] Hannover Med Sch, Inst Pathol, Hannover, Lower Saxony, Germany; [Rajab, Taufiek K.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Rajab, Taufiek K.] Harvard Med Sch, Boston, MA USA; [Rohde, Judith] Univ Vet Med Hannover, Inst Microbiol, Dept Infect Dis, Hannover, Lower Saxony, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Veterinary Medicine Hannover, Foundation	Zinne, N (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany.	zinne.norman@mh-hannover.de	Krüger, Marcus/C-4809-2019; Haverich, Axel/AAC-7552-2022	Boyle, Erin C./0000-0002-5963-3633	German Federal Ministry of Education and Research - DZL German Center for Lung Research [82DZL00201]; German Science Foundation - REBIRTH Cluster of Excellence [DFG EXC 62]	German Federal Ministry of Education and Research - DZL German Center for Lung Research; German Science Foundation - REBIRTH Cluster of Excellence	We report grants from German Federal Ministry of Education and Research - DZL German Center for Lung Research (82DZL00201; http://www.dzi.de/index.php.de/), grants from German Science Foundation - REBIRTH Cluster of Excellence (DFG EXC 62; http:///www.rebirth-hannover.de/de/home html), during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner C, 2012, AM J TRANSPLANT, V12, P1839, DOI 10.1111/j.1600-6143.2012.04027.x; Bassetti M, 2014, FUTURE MICROBIOL, V9, P465, DOI 10.2217/fmb.14.7; Casanova J, 2011, ANESTH ANALG, V113, P742, DOI 10.1213/ANE.0b013e3182288e01; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Ferrari F, 2009, INTENS CARE MED, V35, P1792, DOI 10.1007/s00134-009-1605-2; Florescu DF, 2012, CLIN INFECT DIS, V54, P670, DOI 10.1093/cid/cir934; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Ghlissi Z, 2013, RENAL FAILURE, V35, P1130, DOI 10.3109/0886022X.2013.815091; HANNAN PCT, 1982, RES VET SCI, V33, P76, DOI 10.1016/S0034-5288(18)32364-6; Hoeltig D, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-14; Kruger M, 2016, INTERACT CARDIOV TH, V23, P358, DOI 10.1093/icvts/ivw160; Lu Q, 2012, ANESTHESIOLOGY, V117, P1335, DOI 10.1097/ALN.0b013e31827515de; Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4; Luna CM, 2009, EUR RESPIR J, V33, P182, DOI 10.1183/09031936.00046308; Luna CM, 2007, CHEST, V132, P523, DOI 10.1378/chest.07-0185; Maas A, 2006, VACCINE, V24, P7226, DOI 10.1016/j.vaccine.2006.06.047; MacNair CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02875-z; Mahida K, 2010, CURR MICROBIOL, V61, P19, DOI 10.1007/s00284-009-9570-0; Micek ST, 2015, CRIT CARE, V19, P1; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Nakajima D, 2016, AM J TRANSPLANT, V16, P1229, DOI 10.1111/ajt.13562; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P2740, DOI 10.1128/AAC.02476-13; Ratjen F, 2006, J ANTIMICROB CHEMOTH, V57, P306, DOI 10.1093/jac/dki461; Sage E, 2014, EUR J CARDIO-THORAC, V46, P794, DOI 10.1093/ejcts/ezu245; Satoh S, 2001, CLIN EXP IMMUNOL, V126, P266, DOI 10.1046/j.1365-2249.2001.01656.x; Souilamas R, 2011, J HEART LUNG TRANSPL, V30, P847, DOI 10.1016/j.healun.2011.02.005; Sun HY, 2011, CHEST, V139, P1172, DOI 10.1378/chest.10-0167; Tamma PD, 2013, PEDIATR INFECT DIS J, V32, P17, DOI 10.1097/INF.0b013e3182703790; Tedja R, 2014, AM J INFECT CONTROL, V42, P542, DOI 10.1016/j.ajic.2013.12.009; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; Warnecke G, 2012, LANCET, V380, P1851, DOI 10.1016/S0140-6736(12)61344-0; Xiao H, 2013, BIOMED REP, V1, P589, DOI 10.3892/br.2013.94	33	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193168	10.1371/journal.pone.0193168	http://dx.doi.org/10.1371/journal.pone.0193168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505574	gold, Green Published, Green Submitted			2022-12-26	WOS:000426548200006
J	Monteiro, LMC; Cruz, GND; Fontes, JM; Salles, TRDS; Boechat, MCB; Monteiro, AC; Moreira, MEL				Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin; Dias Saad Salles, Tania Regina; Bastos Boechat, Marcia Cristina; Monteiro, Ana Carolina; Lopes Moreira, Maria Elizabeth			Neurogenic bladder findings in patients with Congenital Zika Syndrome: A novel condition	PLOS ONE			English	Article							NEUROPATHIC BLADDER; VIRUS-INFECTION; URINARY-TRACT; CHILDREN; INFANTS; BRAZIL	Introduction Congenital Zika Syndrome ( CZS) has been associated with microcephaly and other central nervous system abnormalities including areas that have been implicated in the control of the lower urinary tract. As such, this descriptive case series has aimed to investigate whether CZS is linked with neurogenic bladder. Identifying such an association is paramount in the effort to recognize CZS complications that have putative treatment options that could mitigate the impact of CZS in infected children. Methods Following IRB approval, urological assessment was performed in all patients referred to our clinic between June 2016 and May 2017 who presented with confirmed CZS-associated microcephaly. The research protocol consisted of obtaining clinical history, laboratory tests, lower and upper urinary tract ultrasounds, as well as a diagnostic urodynamic evaluation. ZIKA virus infection was previously confirmed by maternal history and positive PCR in babies and mothers. Microcephaly and other central nervous system abnormalities were established based on neurological assessment and associated imaging of the central nervous system ( CT head and/or Brain MRI). Results Twenty-two consecutive CZS patients were tested and confirmed to have neurogenic bladder. Of the 22 patients assessed, 21 presented with an overactive bladder combined with reduced bladder capacity and elevated detrusor filling pressures. Clinically significant increases in postvoid residual ( PVR) were confirmed in 40% of cases while a urinary tract infection ( UTI) was identified in 23% of cases. Conclusion Neurogenic bladder, a known treatable health condition, was confirmed in 100% of patients tested in this study, most presenting with high-risk urodynamic patterns known to lead to renal damage when left untreated. Follow up studies are necessary to provide further insight onto long-term disease progression and to investigate the response to standard therapies for neurogenic bladder. Nonetheless, we emphasize the importance of proactive management of neurogenic bladder and prompt referral so as to help mitigate CZS disease burden for patients and their families.	[Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin] Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Dias Saad Salles, Tania Regina] Fiocruz MS, Dept Pediat Neurol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Bastos Boechat, Marcia Cristina] Fiocruz MS, Dept Pediat Radiol & Imagining, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Monteiro, Ana Carolina] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA; [Lopes Moreira, Maria Elizabeth] Fiocruz MS, Dept Neonatol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; Fundacao Oswaldo Cruz	Monteiro, LMC (corresponding author), Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.	lucia@iff.fiocruz.br	Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Costa Monteiro, Lucia Maria/O-7903-2014	Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Costa Monteiro, Lucia Maria/0000-0002-7612-7249; Costa Monteiro, Ana Carolina/0000-0002-1501-4435; Marin Fontes, Juliana/0000-0003-4098-7324	CNPq; CAPES (Brazil) [440580/2016-1]; National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS) [14/2016]; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The research is funded by a grant from CNPq and CAPES (Brazil), process number 440580/2016-1, from the National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Com bate ao virus Zika). Lucia M Costa Monteiro is the grant coordinator. Maria Elizabeth Lopes Moreira is funded by FAPERJ.	Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783; Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Costa Monteiro LM, 2017, CRITERIA EVALUATE NE; Costa Monteiro LM, 2017, J PEDIAT RIO J, DOI 10.1016/j.jped.2016.11.010; de Groat WC, 2014, COMPREHENSIVE PHYSL, P327; de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584; Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056; Drzewiecki BA, 2011, J UROLOGY, V186, P1190, DOI 10.1016/j.juro.2011.02.2692; Filler G, 2012, INT UROL NEPHROL, V44, P817, DOI 10.1007/s11255-010-9894-5; Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814; Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2; Kari JA, 2006, PEDIATR NEPHROL, V21, P517, DOI 10.1007/s00467-006-0034-5; Lehnert T, 2012, INT UROL NEPHROL, V44, P335, DOI 10.1007/s11255-011-0030-y; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3; McKibben MJ, 2015, UROL CLIN N AM, V42, P527, DOI 10.1016/j.ucl.2015.05.006; Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Rodriguez-Ruiz M, 2016, ACTAS UROL ESP, V40, P37, DOI [10.1016/j.acuroe.2015.11.005, 10.1016/j.acuro.2015.06.002]; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; STEINHARDT GF, 1988, J UROLOGY, V140, P1293, DOI 10.1016/S0022-5347(17)42028-3; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Verpoorten C, 2008, PEDIATR NEPHROL, V23, P717, DOI 10.1007/s00467-007-0691-z; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6	30	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193514	10.1371/journal.pone.0193514	http://dx.doi.org/10.1371/journal.pone.0193514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494684	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200059
J	Ferretti, C; Sarti, FM; Nitrini, R; Ferreira, FF; Brucki, SMD				Ferretti, Ceres; Sarti, Flavia M.; Nitrini, Ricardo; Ferreira, Fernando F.; Brucki, Sonia M. D.			An assessment of direct and indirect costs of dementia in Brazil	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ECONOMIC-IMPACT; HEALTH; ASSOCIATION; PREVALENCE; OUTCOMES; PEOPLE; BURDEN; RISK	Background To analyze costs associated with dementia based on a cross-sectional study in the Brazilian health system. Methods Direct and indirect costs were estimated by conducting comprehensive interviews on the use of resources in a sample of 156 patients with dementia treated at an outpatient memory clinic of a tertiary hospital. A regression model was used to determine the main determinants of costs associated with dementia. Results Global costs of dementia were US$1,012.35; US$1,683.18 and US$1,372.30 per patient/month for mild, moderate and severe stages, respectively. Indirect costs ranged from US $536.62 to US$545.17 according to severity. Dementia costs were influenced by medication, FAST score, and educational level of caregiver. Discussion The study represents an original contribution toward establishing direct and indirect costs of dementia in Brazil. Results indicate significant economic impacts, including projection of annual costs of US$16,548.24 per patient.	[Ferretti, Ceres; Nitrini, Ricardo; Brucki, Sonia M. D.] Univ Sao Paulo, Sch Med, Cognit & Behav Neurol Unit, Dept Neurol, Sao Paulo, SP, Brazil; [Ferretti, Ceres] Univ Taubate, Dept Nursing & Nutr, Taubate, SP, Brazil; [Sarti, Flavia M.; Ferreira, Fernando F.] Univ Sao Paulo, USP Leste, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil; [Brucki, Sonia M. D.] Hosp Santa Marcelina, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Taubate; Universidade de Sao Paulo	Ferretti, C (corresponding author), Univ Sao Paulo, Sch Med, Cognit & Behav Neurol Unit, Dept Neurol, Sao Paulo, SP, Brazil.; Ferretti, C (corresponding author), Univ Taubate, Dept Nursing & Nutr, Taubate, SP, Brazil.	cereseloah@gmail.com	Brucki, Sonia/L-4201-2019; Sarti, Flavia Mori/D-4767-2009; del Lucena Ferretti, Ceres Eloah/U-5810-2019	Brucki, Sonia/0000-0002-8303-6732; Sarti, Flavia Mori/0000-0003-2834-2005; Ferretti, Ceres Eloah del Lucena/0000-0001-5615-8489				Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; Allegri RF, 2007, INT PSYCHOGERIATR, V19, P705, DOI 10.1017/S1041610206003784; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Alzheimer's Disease International /, 2013, REL ADI BUP DEM AM C; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brucki Sonia Maria Dozzi, 2014, Dement. neuropsychol., V8, P345, DOI 10.1590/S1980-57642014DN84000007; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Burla A C, 2013, CIENC SAUDE COLETIVA, V18, P2949; Cesar KG, 2015, J NEUROL SCI, V357, pE123, DOI 10.1016/j.jns.2015.08.396; Chow SC., 2007, SAMPLE SIZE CALCULAT, V2nd; DeKosky ST, 2014, JAMA NEUROL, V71, P273, DOI 10.1001/jamaneurol.2013.6031; Engedal Knut, 2016, Dement. neuropsychol., V10, P74, DOI 10.1590/S1980-5764-2016DN1002002; Facchini L.A., 2006, CIENC SAUDE COLETIVA, V11, P669, DOI [10.1590/S1413-81232006000300015, DOI 10.1590/S1413-81232006000300015]; Ferretti CEL, 2013, DESCRIPTION METHODS; Ferretti Ceres Eloah Lucena, 2015, Dement. neuropsychol., V9, P42, DOI 10.1590/S1980-57642015DN91000007; Ferri CP, 2012, REV BRAS PSIQUIATR, V34, P371, DOI 10.1016/j.rbp.2012.08.005; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2014, PESQ NAC SAUD 2013; Laks J, 2016, INT J GERIATR PSYCH, V31, P176, DOI 10.1002/gps.4309; Liu, 2008, DESIGN ANAL BIOAVAIL; Liu Z., 2012, EC COSTS DEMENTIA LO; Lopes MA, 2012, J ALZHEIMERS DIS, V32, P307, DOI 10.3233/JAD-2012-120847; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; Mendes Eugênio Vilaça, 2013, Estud. av., V27, P27, DOI 10.1590/S0103-40142013000200003; Meyer HJC, 2016, S AFR PHARM J, V83, P48; Neri AL, 2013, CAD SAUDE PUBLICA, V29, P778, DOI 10.1590/S0102-311X2013000800015; Gutierrez BAO, 2014, CIENC SAUDE COLETIVA, V19, P4479, DOI 10.1590/1413-812320141911.03562013; Parkinson M, 2017, J PUBLIC HEALTH-UK, V39, pE290, DOI 10.1093/pubmed/fdw100; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Prince M, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Brandao CMR, 2011, VALUE HEALTH, V14, pS71, DOI 10.1016/j.jval.2011.05.028; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Scazufca Marcia, 2002, Rev. Bras. Psiquiatr., V24, P12, DOI 10.1590/S1516-44462002000100006; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; Serra-Prat M, 2016, EUR GERIATR MED, V7, P531, DOI 10.1016/j.eurger.2016.09.005; Veras Renato Peixoto, 2007, Arch. Clin. Psychiatry (São Paulo), V34, P5; WHO, 2015, 1 WHO MIN C GLOB ACT; Wimo A, 2014, J INTERN MED, V275, P304, DOI 10.1111/joim.12167; Wimo A, 2010, WORLD ALZHEIMER REPO; Wimo A, 2009, HLTH EC ASPECTS DEME; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P429, DOI 10.1016/j.jalz.2012.06.008; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; World Health Organization (WHO), 2012, EP IMP DEM CURR STAT; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Xu JF, 2017, B WORLD HEALTH ORGAN, V95, P18, DOI [10.2471/BLT.15.167726, 10.2471/blt.15.167726]; Zarit SH, 2012, AGING MENT HEALTH, V16, P673, DOI 10.1080/13607863.2012.692768	49	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193209	10.1371/journal.pone.0193209	http://dx.doi.org/10.1371/journal.pone.0193209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494693	Green Published, gold			2022-12-26	WOS:000426363200031
J	Yamazaki, H; Ishida, M; Hinokio, R; Yamashiki, YA; Azuma, R				Yamazaki, Hideo; Ishida, Masanobu; Hinokio, Ryoichi; Yamashiki, Yosuke Alexandre; Azuma, Ryokei			Spatiotemporal distribution and fluctuation of radiocesium in Tokyo Bay in the five years following the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident	PLOS ONE			English	Article							ATOMIC-BOMB; NISHIYAMA RESERVOIR; CESIUM ADSORPTION; CLAY-MINERALS; SEDIMENTS; CS-137; MICROPARTICLES; PLUTONIUM; MIGRATION; FIXATION	A monitoring survey was conducted from August 2011 to July 2016 of the spatiotemporal distribution in the 400 km(2) area of the northern part of Tokyo Bay and in rivers flowing into it of radiocesium released from the Fukushima Daiichi Nuclear Power Plant ( FDNPP) accident. The average inventory in the river mouth ( 10 km(2)) was 131 kBq.m(-2) and 0.73 kBq.m(-2) in the central bay ( 330 km(2)) as the decay corrected value on March 16, 2011. Most of the radiocesium that flowed into Tokyo Bay originated in the northeastern section of the Tokyo metropolitan area, where the highest precipitation zone of Cs-137 in soil was almost the same level as that in Fukushima City, then flowed into and was deposited in the Old-Edogawa River estuary, deep in Tokyo Bay. The highest precipitation of radiocesium measured in the high contaminated zone was 460 kBq.m(-2). The inventory in sediment off the estuary of Old-Edogawa was 20.1 kBq.m(-2) in August 2011 immediately after the accident, but it increased to 104 kBq.m(-2) in July 2016. However, the radiocesium diffused minimally in sediments in the central area of Tokyo Bay in the five years following the FDNPP accident. The flux of radiocesium off the estuary decreased slightly immediately after the accident and conformed almost exactly to the values predicted based on its radioactive decay. Contrarily, the inventory of radiocesium in the sediment has increased. It was estimated that of the 8.33 TBq precipitated from the atmosphere in the catchment regions of the rivers Edogawa and Old-Edogawa, 1.31 TBq migrated through rivers and was deposited in the sediments of the Old-Edogawa estuary by July 2016. Currently, 0.25 TBq.yr(-1) of radiocesium continues to flow into the deep parts of Tokyo Bay.	[Yamazaki, Hideo; Ishida, Masanobu] Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan; [Hinokio, Ryoichi] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga, Japan; [Yamashiki, Yosuke Alexandre] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Kyoto, Kyoto, Japan; [Azuma, Ryokei] Osaka Inst Technol, Dept Civil Engn & Urban Design, Osaka, Osaka, Japan	Kindai University (Kinki University); Ryukoku University; Kyoto University; Osaka Institute of Technology	Ishida, M (corresponding author), Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan.	masanobuijp1989@gmail.com			 [24310014];  [26289155];  [15J10109];  [26303004];  [24110006]; Grants-in-Aid for Scientific Research [26303004] Funding Source: KAKEN	; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following: Grant number: 24310014 (HY), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-24310014/. Principal investigator is Hideo Yamazaki. He plays roles in Conceptualization, Investigation, Writing - Review & Editing. Grant number: 26289155 (HY, RA), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-2289155/. Co-investigators are Hideo Yamazaki and Ryokei Azuma. Ryokei Azuma plays a role in Formal Analysis. Grant number: 15J10109 (MI), https://www.jsps.go.jp/j-pd/data/saiyo_ichiran/h27_dc1_09_sougou.pdf [in Japanese]. The URL is described the adopters for JSPS DC1; Under the URL, the overview of DC1 is described; https://www.jsps.go.jp/english/e-pd/index.html. Principal investigator is Masanobu Ishida. He plays roles in Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Visualization and Writing - Original Draft Preparation. Grant number: 26303004 (RA, HY), https://kaken.ni.ac.jp/en/grant/KAKENHI-PROJECT-26303004/. Principal investigator is Ryokei Azuma. Co-investigator is Hideo Yamazaki. Grant number: 24110006 (YY), https://kaken.ni.ac.jp/en/grant/KAKENHI-PLANNED-24110006/. Co-investigator is Yosuke Yamashiki. He plays a role in Formal Analysis and Investigation.	Abe Y, 2014, ANAL CHEM, V86, P8521, DOI 10.1021/ac501998d; Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; [Anonymous], 2014, FUK DAIICH NUCL POW; [Anonymous], 2020, FUK DAIICH ACC; Aoyama M, 2008, RADIOACTIVITY ENV, P137; Bera G, 2015, ESTUAR COAST SHELF S, V157, P32, DOI 10.1016/j.ecss.2015.02.004; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Chaisan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02520; EVANS DW, 1983, GEOCHIM COSMOCHIM AC, V47, P1041, DOI 10.1016/0016-7037(83)90234-X; Forstner U, 1983, METAL POLLUTION AQUA, P121; Forstner U., 1983, METAL POLLUTION AQUA, P247; Furuki G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42731; Gallego E, 2006, J ENVIRON RADIOACTIV, V85, P247, DOI 10.1016/j.jenvrad.2004.10.017; GOHDA S, 1987, BUNSEKI KAGAKU, V36, P199; GSI (Geospatial Information Authority of Japan), 2014, EXT SIT DISTR MAP RA; Hakanson L, 2004, J ENVIRON RADIOACTIV, V77, P247, DOI 10.1016/j.jenvrad.2004.03.010; Hakanson L, 2004, J ENVIRON RADIOACTIV, V73, P267, DOI 10.1016/j.jenvrad.2003.10.003; HIRAO Y, 1986, GEOCHEM J, V20, P1, DOI 10.2343/geochemj.20.1; IAEA (International Atomic Energy Agency), 2006, IAEA RAD ASS REP SER; Investigation Committee on the Accident at Fukushima Nuclear Power Stations of Tokyo Electric Power Company, 2012, FIN REP; Ishida M, 2017, PLOS ONE, V12, P1; Itoh S, 2014, SOIL SCI PLANT NUTR, V60, P540, DOI 10.1080/00380768.2014.907735; JCAC (Japan Chemical Analysis Center), RAD SURV DAT JAP ENV; JCG (Japan Coast Guard), REP RAD SURV RES SUR; Kakehi S, 2016, J ENVIRON RADIOACTIV, V153, P1, DOI 10.1016/j.jenvrad.2015.11.015; Kashiwa City Government, 2013, DEC PROJ KASH CIT; Koibuchi Y, 2013, COASTAL PROCESSES, V169, P191; Komori M, 2013, BUNSEKI KAGAKU, V62, P475, DOI 10.2116/bunsekikagaku.62.475; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2012, RES SURV RES DISTR S; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), RIV MAN REP 2015; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), 2015, OV KANT TOH HEAV RAI; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), 2005, OV TOK BAY CATCHM AR; Monte L, 2005, J ENVIRON RADIOACTIV, V79, P273, DOI 10.1016/j.jenvrad.2004.08.002; Motokawa R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06585; NDJ (The National Diet of Japan), 2012, OFF REP FUK NUCL ACC; Nishizawa Y, 2016, J NUCL SCI TECHNOL, V53, P468, DOI 10.1080/00223131.2015.1071721; NRA (Nuclear Regulation Authority Japan), 2013, READ SEA WAT TOK BAY; NSAC (Nuclear Science Advisory Committee), 1980, NSAC801; Oikawa S, 2013, BUNSEKI KAGAKU, V62, P455, DOI 10.2116/bunsekikagaku.62.455; Pratama MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08408; Qin HB, 2012, GEOCHEM J, V46, P297, DOI 10.2343/geochemj.2.0214; Saegusa H, 2016, J ENVIRON RADIOACTIV, V164, P36, DOI 10.1016/j.jenvrad.2016.04.020; Saito-Kokubu Y, 2008, J ENVIRON RADIOACTIV, V99, P211, DOI 10.1016/j.jenvrad.2007.11.010; Saito-Kokubu Y, 2007, J RADIOANAL NUCL CH, V273, P183, DOI 10.1007/s10967-007-0733-9; Saito-Kokubu Y, 2007, APPL RADIAT ISOTOPES, V65, P465, DOI 10.1016/j.apradiso.2006.10.010; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Sekiguchi H, 2013, J JSCE, V69, P691; Smith JT, 2004, ENVIRON SCI TECHNOL, V38, P850, DOI 10.1021/es0300463; STUMM W, 1996, AQUAT CHEM, P818; Stumm W., 1996, AQUAT CHEM, P516; Tanaka K, 2015, J ENVIRON RADIOACTIV, V139, P390, DOI 10.1016/j.jenvrad.2014.05.002; Thill A, 2001, CONT SHELF RES, V21, P2127, DOI 10.1016/S0278-4343(01)00047-4; Tokuda Y., 2016, RADIOLOGICAL ISSUES, P3; Tsuruta H., 2012, Chikyukagaku (Geochemistry), V46, P99; USGS (US Geological Survey), 1973, GEOLOGICAL SURVEY PR; USNRC (US Nuclear Regulatory Commision), 1989, PROGR ENV IMP STAT R; Yamada M, 2000, J RADIOANAL NUCL CH, V245, P273, DOI 10.1023/A:1006741917854; Yamaguchi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20548; Yamasaki S, 2016, SCI TOTAL ENVIRON, V551, P155, DOI 10.1016/j.scitotenv.2016.01.155; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714; Yasuhara M, 2005, MAR MICROPALEONTOL, V55, P63, DOI 10.1016/j.marmicro.2005.02.005; Zachara JM, 2002, GEOCHIM COSMOCHIM AC, V66, P193, DOI 10.1016/S0016-7037(01)00759-1	62	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193414	10.1371/journal.pone.0193414	http://dx.doi.org/10.1371/journal.pone.0193414			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494667	Green Published, gold			2022-12-26	WOS:000426363200044
J	Zaniboni, M				Zaniboni, Massimiliano			Short-term action potential memory and electrical restitution: A cellular computational study on the stability of cardiac repolarization under dynamic pacing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-FIBRILLATION; CYCLE LENGTH; CALCIUM CURRENT; ALTERNANS; HYSTERESIS; MECHANISM; DURATION; EXCITABILITY; DEPENDENCE	Electrical restitution ( ER) is a major determinant of repolarization stability and, under fast pacing rate, it reveals memory properties of the cardiac action potential ( AP), whose dynamics have never been fully elucidated, nor their ionic mechanisms. Previous studies have looked at ER mainly in terms of changes in AP duration ( APD) when the preceding diastolic interval ( DI) changes and described dynamic conditions where this relationship shows hysteresis which, in turn, has been proposed as a marker of short-term AP memory and repolarization stability. By means of numerical simulations of a non-propagated human ventricular AP, we show here that measuring ER as APD versus the preceding cycle length ( CL) provides additional information on repolarization dynamics which is not contained in the companion formulation. We focus particularly on fast pacing rate conditions with a beat-to-beat variable CL, where memory properties emerge from APD vs CL and not from APD vs DI and should thus be stored in APD and not in DI. We provide an ion-currents characterization of such conditions under periodic and random CL variability, and show that the memory stored in APD plays a stabilizing role on AP repolarization under pacing rate perturbations. The gating kinetics of L-type calcium current seems to be the main determinant of this safety mechanism. We also show that, at fast pacing rate and under otherwise identical pacing conditions, a periodically beat-to-beat changing CL is more effective than a random one in stabilizing repolarization. In summary, we propose a novel view of short-term AP memory, differentially stored between systole and diastole, which opens a number of methodological and theoretical implications for the understanding of arrhythmia development.	[Zaniboni, Massimiliano] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci, Parma, Italy; [Zaniboni, Massimiliano] Univ Parma, Ctr Excellence Toxicol Res CERT, Parma, Italy	University of Parma; University of Parma	Zaniboni, M (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci, Parma, Italy.; Zaniboni, M (corresponding author), Univ Parma, Ctr Excellence Toxicol Res CERT, Parma, Italy.	massimiliano.zaniboni@unipr.it	Zaniboni, Massimiliano/M-8144-2015	Zaniboni, Massimiliano/0000-0001-8808-2239	University of Parma, Italy	University of Parma, Italy	This work was supported by the local funding of the University of Parma, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agarwal A, 2012, IEEE ENG MED BIO, P673, DOI 10.1109/EMBC.2012.6346021; Banville I, 2004, J CARDIOVASC ELECTR, V15, P455, DOI 10.1046/j.1540-8167.2004.03330.x; BASS BG, 1975, AM J PHYSIOL, V228, P1717, DOI 10.1152/ajplegacy.1975.228.6.1717; Berger CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058101; Berger RD, 2004, CIRC RES, V94, P567, DOI 10.1161/01.RES.0000124605.03595.E4; Boyett M. R, 1987, J PHYSL, V285, P359; Carmeliet Edward, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS2, DOI 10.1111/j.1540-8167.2006.00378.x; Cheng JH, 1999, CARDIOVASC RES, V43, P135, DOI 10.1016/S0008-6363(99)00061-9; Cherry EM, 2007, AM J PHYSIOL-HEART C, V292, pH43, DOI 10.1152/ajpheart.00955.2006; Cherry EM, 2017, CHAOS, V27, DOI 10.1063/1.4999354; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; CHIALVO DR, 1990, CIRC RES, V66, P525, DOI 10.1161/01.RES.66.2.525; Choi BR, 2004, J CARDIOVASC ELECTR, V15, P1188, DOI 10.1046/j.1540-8167.2004.04070.x; Crotti L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-18; Dvir H, 2014, BIOPHYS J, V107, P1023, DOI 10.1016/j.bpj.2014.07.004; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; ELHARRAR V, 1983, AM J PHYSIOL, V244, pH782, DOI 10.1152/ajpheart.1983.244.6.H782; Fenton FH, 1999, PHYS REV LETT, V83, P3964, DOI 10.1103/PhysRevLett.83.3964; Fossa AA, 2006, J PHARMACOL EXP THER, V316, P498, DOI 10.1124/jpet.105.095471; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garny A, 2008, PHILOS T R SOC A, V366, P3017, DOI 10.1098/rsta.2008.0094; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Guzman KM, 2010, PACE, V33, P451, DOI 10.1111/j.1540-8159.2009.02637.x; Hall GM, 1999, PHYS REV LETT, V82, P2995, DOI 10.1103/PhysRevLett.82.2995; Ideker RE, 2002, J CARDIOVASC ELECTR, V13, P1173, DOI 10.1046/j.1540-8167.2002.01173.x; Jing LY, 2010, J ELECTROCARDIOL, V43, P425, DOI 10.1016/j.jelectrocard.2010.02.006; Kalb SS, 2004, J CARDIOVASC ELECTR, V15, P698, DOI 10.1046/j.1540-8167.2004.03550.x; Kimotsuki T, 2010, J BIOL PHYS, V36, P299, DOI 10.1007/s10867-009-9185-5; Lemay M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002399; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; O'Hara T, 2012, AM J PHYSIOL-HEART C, V302, pH1023, DOI 10.1152/ajpheart.00785.2011; OPTHOF T, 1987, J MOL CELL CARDIOL, V19, P923, DOI 10.1016/S0022-2828(87)80621-1; Otani NF, 1997, J THEOR BIOL, V187, P409, DOI 10.1006/jtbi.1997.0447; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Shattock MJ, 2017, CARDIOVASC RES, V113, P817, DOI 10.1093/cvr/cvx063; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Tolkacheva EG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031904; Tolkacheva EG, 2007, J BIOL PHYS, V33, P35, DOI 10.1007/s10867-007-9040-5; Watanabe MA, 2002, AM J PHYSIOL-HEART C, V282, pH1534, DOI 10.1152/ajpheart.00351.2001; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Wu R, 2004, CIRC RES, V94, P634, DOI 10.1161/01.RES.0000119322.87051.A9; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Yehia AR, 1999, CHAOS, V9, P916, DOI 10.1063/1.166465; Zaniboni M., 2017, EP EUROPACE, V19, P141; Zaniboni M, 2007, EXP PHYSIOL, V92, P859, DOI 10.1113/expphysiol.2007.037986; Zaniboni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100242; Zlochiver S, 2017, CHAOS, V27, DOI 10.1063/1.4999355	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193416	10.1371/journal.pone.0193416	http://dx.doi.org/10.1371/journal.pone.0193416			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494628	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200045
J	Zhu, ZC; Liu, JW; Li, K; Zheng, J; Xiong, ZQ				Zhu, Zhi-Chuan; Liu, Ji-Wei; Li, Kui; Zheng, Jing; Xiong, Zhi-Qi			KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells	ONCOGENE			English	Article							IMPORTIN-BETA; NUCLEAR IMPORT; MYELOMA CELLS; RECEPTOR; TRANSPORT; DEATH; PROLIFERATION; KPN-BETA-1; PHOSPHORYLATION; INDUCTION	The nuclear import receptor karyopherin beta 1 (KPNB1) is involved in the nuclear import of most proteins and in the regulation of multiple mitotic events. Upregulation of KPNB1 has been observed in cancers including glioblastoma. Depletion of KPNB1 induces mitotic arrest and apoptosis in cancer cells, but the underlying mechanism is not clearly elucidated. Here, we found that downregulation and functional inhibition of KPNB1 in glioblastoma cells induced growth arrest and apoptosis without apparent mitotic arrest. KPNB1 inhibition upregulated Puma and Noxa and freed Mcl-1-sequestered Bax and Bak, leading to mitochondrial outer membrane permeabilization (MOMP) and apoptosis. Moreover, combination of Bcl-xL inhibitors and KPNB1 inhibition enhanced apoptosis in glioblastoma cells. KPNB1 inhibition promoted cytosolic retention of its cargo and impaired cellular proteostasis, resulting in elevated polyubiquitination, formation of aggresome-like-induced structure (ALIS), and unfolded protein response (UPR). Ubiquitination elevation and UPR activation in KPNB1-deficient cells were reversed by KPNB1 overexpression or inhibitors of protein synthesis but aggravated by inhibitors of autophagylysosome or proteasome, indicating that rebalance of cytosolic/nuclear protein distribution and alleviation of protein overload favor proteostasis and cell survival. Chronic activation of eIF2 alpha/ATF4 cascade of UPR was responsible for the upregulation of Puma and Noxa, apoptosis and ABT-263 sensitivity. Taken together, our findings demonstrate that KPNB1 is required for proteostasis maintenance and its inhibition induces apoptosis in glioblastoma cells through UPR-mediated deregulation of Bcl-2 family members.	[Zhu, Zhi-Chuan; Li, Kui; Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Liu, Ji-Wei; Zheng, Jing] East China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China; [Xiong, Zhi-Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xiong, Zhi-Qi] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; East China University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Xiong, ZQ (corresponding author), Chinese Acad Sci, Inst Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Shanghai 200031, Peoples R China.; Xiong, ZQ (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Xiong, ZQ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	xiongzhiqi@ion.ac.cn	Zhu, Zhichuan/GYV-0605-2022	Zhu, Zhichuan/0000-0003-0327-9978	National Natural Science Foundation of China [31021063, 91332203, 31490591]; Chinese Academy of Sciences [XDB02020007, QYZDJ-SSW-SMC010]; Ministry of Science and Technology [2016YFA0501002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from National Natural Science Foundation of China (31021063, 91332203, and 31490591), Chinese Academy of Sciences (XDB02020007, QYZDJ-SSW-SMC010), and Ministry of Science and Technology (2016YFA0501002).	Angus L, 2014, CARCINOGENESIS, V35, P1121, DOI 10.1093/carcin/bgt491; Cang SD, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0224-3; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Cory S, 2016, TRENDS CANCER, V2, P443, DOI 10.1016/j.trecan.2016.07.001; Dai HM, 2018, CELL DEATH DIFFER, V25, P282, DOI 10.1038/cdd.2017.156; Dai HM, 2014, J BIOL CHEM, V289, P89, DOI 10.1074/jbc.M113.505701; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Dikovskaya D, 2010, J CELL SCI, V123, P736, DOI 10.1242/jcs.060806; Ding WX, 2007, APOPTOSIS, V12, P2233, DOI 10.1007/s10495-007-0142-0; El Fajoui Z, 2011, GASTROENTEROLOGY, V141, P663, DOI 10.1053/j.gastro.2011.04.055; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; He S, 2016, J CANCER RES CLIN, V142, P561, DOI 10.1007/s00432-015-2057-4; Kojima Y, 2011, J BIOL CHEM, V286, P43383, DOI 10.1074/jbc.M111.309377; Kuusisto HV, 2015, BBA-MOL CELL RES, V1853, P1870, DOI 10.1016/j.bbamcr.2015.05.002; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097; Lieu KG, 2014, J CELL BIOL, V205, P301, DOI 10.1083/jcb.201304055; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lu XL, 2010, J BIOL CHEM, V285, P33281, DOI 10.1074/jbc.M110.102368; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Polier G, 2015, INT J CANCER, V136, P688, DOI 10.1002/ijc.29009; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Quadroni M, 2015, J PROTEOMICS, V120, P215, DOI 10.1016/j.jprot.2015.02.020; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Roscioli E, 2012, J CELL BIOL, V196, P435, DOI 10.1083/jcb.201109104; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shao DC, 2015, EUR J PHARMACOL, V758, P89, DOI 10.1016/j.ejphar.2015.03.069; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Szczepny A, 2014, BIOCHEM J, V461, P469, DOI 10.1042/BJ20130709; Uvarov AV, 2008, BBA-MOL CELL RES, V1783, P1237, DOI 10.1016/j.bbamcr.2008.03.004; van der Watt PJ, 2016, MOL CANCER THER, V15, P560, DOI 10.1158/1535-7163.MCT-15-0052; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Vogler Meike, 2014, Adv Med, V2014, P943648, DOI 10.1155/2014/943648; Wong E, 2012, CURR BIOL, V22, pR966; Yan WQ, 2015, CELL SIGNAL, V27, P851, DOI 10.1016/j.cellsig.2015.01.013; Yang LL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0559-1; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5; Zhang PY, 2014, J PATHOL, V232, P308, DOI 10.1002/path.4294; Zhu ZC, 2013, J NEURO-ONCOL, V112, P17, DOI 10.1007/s11060-012-1032-z	54	22	23	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2936	2952		10.1038/s41388-018-0180-9	http://dx.doi.org/10.1038/s41388-018-0180-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29520102	Green Published, hybrid			2022-12-26	WOS:000433936300003
J	Mitok, KA; Freiberger, EC; Schueler, KL; Rabaglia, ME; Stapleton, DS; Kwiecien, NW; Malec, PA; Hebert, AS; Broman, AT; Kennedy, RT; Keller, MP; Coon, JJ; Attie, AD				Mitok, Kelly A.; Freiberger, Elyse C.; Schueler, Kathryn L.; Rabaglia, Mary E.; Stapleton, Donald S.; Kwiecien, Nicholas W.; Malec, Paige A.; Hebert, Alexander S.; Broman, Aimee T.; Kennedy, Robert T.; Keller, Mark P.; Coon, Joshua J.; Attie, Alan D.			Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; TYROSINE-HYDROXYLASE; MASS-SPECTROMETRY; NEUROPEPTIDE-Y; TYPE-2; ARCHITECTURE; RESPONSES; IDENTIFICATION	The mouse is a critical model in diabetes research, but most research in mice has been limited to a small number of mouse strains and limited genetic variation. Using the eight founder strains and both sexes of the Collaborative Cross (C57BL/6J (B6), A/J, 129S1/SvImJ (129), NOD/ShiLtJ (NOD), NZO/HILtJ (NZO), PWK/PhJ (PWK), WSB/EiJ (WSB), and CAST/EiJ (CAST)), we investigated the genetic dependence of diabetesrelated metabolic phenotypes and insulin secretion. We found that strain background is associated with an extraordinary range in body weight, plasma glucose, insulin, triglycerides, and insulin secretion. Our whole-islet proteomic analysis of the eight mouse strains demonstrates that genetic background exerts a strong influence on the islet proteome that can be linked to the differences in diabetes-related metabolic phenotypes and insulin secretion. We computed protein modules consisting of highly correlated proteins that enrich for biological pathways and provide a searchable database of the islet protein expression profiles. To validate the data resource, we identified tyrosine hydroxylase (Th), a key enzyme in catecholamine synthesis, as a protein that is highly expressed in beta-cells of PWK and CAST islets. We show that CAST islets synthesize elevated levels of dopamine, which suppresses insulin secretion. Prior studies, using only the B6 strain, concluded that adult mouse islets do not synthesize L-3,4-dihydroxyphenylalanine (L-DOPA), the product of Th and precursor of dopamine. Thus, the choice of the CAST strain, guided by our islet proteomic survey, was crucial for these discoveries. In summary, we provide a valuable data resource to the research community, and show that proteomic analysis identified a strain-specific pathway by which dopamine synthesized in beta-cells inhibits insulin secretion.	[Mitok, Kelly A.; Freiberger, Elyse C.; Schueler, Kathryn L.; Rabaglia, Mary E.; Stapleton, Donald S.; Keller, Mark P.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, 543A HF Deluca Biochem Labs,433 Babcock Dr, Madison, WI 53706 USA; [Kwiecien, Nicholas W.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 4426 Genet Biotechnol Ctr,425 Henry Mall, Madison, WI 53706 USA; [Broman, Aimee T.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Hebert, Alexander S.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Malec, Paige A.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, 543A HF Deluca Biochem Labs,433 Babcock Dr, Madison, WI 53706 USA.; Coon, JJ (corresponding author), Univ Wisconsin, Dept Chem, 4426 Genet Biotechnol Ctr,425 Henry Mall, Madison, WI 53706 USA.	jcoon@chem.wisc.edu; adattie@wisc.edu			University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101573, P30DK020572, R01DK102948, R01DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118110, P41GM108538] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy was performed at the University of Wisconsin-Madison Biochemistry Optical Core, which was established with support from the University of Wisconsin-Madison Department of Biochemistry Endowment.	Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bader E, 2016, NATURE, V535, P430, DOI 10.1038/nature18624; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Baughman JM, 2016, CELL REP, V16, P583, DOI 10.1016/j.celrep.2016.05.096; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; CEGRELL L, 1968, ACTA PHYSIOL SCAND, VS, P1; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Cirulli V, 2015, DIABETES, V64, P709, DOI 10.2337/db14-1662; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruciani-Guglielmacci C, 2017, MOL METAB, V6, P340, DOI 10.1016/j.molmet.2017.01.009; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; El Ouaamari A, 2015, J PROTEOME RES, V14, P3111, DOI 10.1021/acs.jproteome.5b00587; ERICSON LE, 1977, DIABETOLOGIA, V13, P117, DOI 10.1007/BF00745138; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; FELDMAN JM, 1970, DIABETES, V19, P480, DOI 10.2337/diab.19.7.480; Ferris ST, 2017, J EXP MED, V214, P2369, DOI 10.1084/jem.20170074; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LINDSTROM P, 1986, BIOCHIM BIOPHYS ACTA, V884, P276, DOI 10.1016/0304-4165(86)90174-1; LUNDQUIST I, 1991, PANCREAS, V6, P522, DOI 10.1097/00006676-199109000-00004; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Marullo L, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0551-8; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Omikorede O, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.35; Osterburg AR, 2013, P NATL ACAD SCI USA, V110, pE3370, DOI 10.1073/pnas.1306033110; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Parnaud G, 2015, DIABETES, V64, P887, DOI 10.2337/db14-0257; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Rackham CL, 2016, DIABETES, V65, P129, DOI 10.2337/db15-0990; Raffo A, 2008, J ENDOCRINOL, V198, P41, DOI 10.1677/JOE-07-0632; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Richards AL, 2015, NAT PROTOC, V10, P701, DOI 10.1038/nprot.2015.040; Riley NM, 2016, CELL SYST, V2, P142, DOI 10.1016/j.cels.2016.03.002; Roat R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086815; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Saisho Y, 2008, J MOL HISTOL, V39, P543, DOI 10.1007/s10735-008-9195-9; Schwetz TA, 2013, AM J PHYSIOL-ENDOC M, V304, pE211, DOI 10.1152/ajpendo.00374.2012; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shishkova E, 2016, CELL SYST, V3, P321, DOI 10.1016/j.cels.2016.10.007; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; SORENSON RL, 1979, DIABETES, V28, P899, DOI 10.2337/diabetes.28.10.899; Stefely JA, 2016, NAT BIOTECHNOL, V34, P1191, DOI 10.1038/nbt.3683; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang YJ, 2016, CELL METAB, V24, P616, DOI 10.1016/j.cmet.2016.09.007; Wieczorek G, 1998, EXP TOXICOL PATHOL, V50, P151, DOI 10.1016/S0940-2993(98)80078-X; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Wood AR, 2017, DIABETES, V66, P2296, DOI 10.2337/db16-1452; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	89	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5860	5877		10.1074/jbc.RA117.001102	http://dx.doi.org/10.1074/jbc.RA117.001102			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496998	Green Published, hybrid			2022-12-26	WOS:000430497300010
J	Narasimhulu, VGS; Bellamy-McIntyre, AK; Laumaea, AE; Lay, CS; Harrison, DN; King, HAD; Drummer, HE; Poumbourios, P				Narasimhulu, Vani G. S.; Bellamy-McIntyre, Anna K.; Laumaea, Annamarie E.; Lay, Chan-Sien; Harrison, David N.; King, Hannah A. D.; Drummer, Heidi E.; Poumbourios, Pantelis			Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; VIROLOGICAL SYNAPSE FORMATION; HUMAN MONOCLONAL-ANTIBODIES; ENV-MEDIATED FUSION; ENVELOPE GLYCOPROTEIN; T-CELLS; CYTOPLASMIC TAIL; EXTERNAL REGION; DENDRITIC CELLS	HIV-1 is spread by cell-free virions and by cell-cell viral transfer. We asked whether the structure and function of a broad neutralizing antibody (bNAb) epitope, the membrane-proximal ectodomain region (MPER) of the viral gp41 transmembrane glycoprotein, differ in cell-free and cell-cell-transmitted viruses and whether this difference could be related to Ab neutralization sensitivity. Whereas cell-free viruses bearing W666A and I675A substitutions in the MPER lacked infectivity, cell-associated mutant viruses were able to initiate robust spreading infection. Infectivity was restored to cell-free viruses by additional substitutions in the cytoplasmic tail (CT) of gp41 known to disrupt interactions with the viral matrix protein. We observed contrasting effects on cell-free virus infectivity when W666A was introduced to two transmitted/founder isolates, but both mutants could still mediate cell-cell spread. Domain swapping indicated that the disparate W666A phenotypes of the cell-free transmitted/founder viruses are controlled by sequences in variable regions 1, 2, and 4 of gp120. The sequential passaging of an MPER mutant (W672A) in peripheral blood mononuclear cells enabled selection of viral revertants with loss-of-glycan suppressor mutations in variable region 1, suggesting a functional interaction between variable region 1 and the MPER. An MPER-directed bNAb neutralized cell-free virus but not cell-cell viral spread. Our results suggest that the MPER of cell-cell-transmitted virions has a malleable structure that tolerates mutagenic disruption but is not accessible to bNAbs. In cell-free virions, interactions mediated by the CT impose an alternative MPER structure that is less tolerant of mutagenic alteration and is efficiently targeted by bNAbs.	[Narasimhulu, Vani G. S.; Bellamy-McIntyre, Anna K.; Laumaea, Annamarie E.; Harrison, David N.; King, Hannah A. D.; Drummer, Heidi E.; Poumbourios, Pantelis] Burnet Inst, Virus Entry & Vaccines Lab, Melbourne, Vic 3004, Australia; [Narasimhulu, Vani G. S.; Laumaea, Annamarie E.; King, Hannah A. D.; Drummer, Heidi E.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Bellamy-McIntyre, Anna K.; Drummer, Heidi E.; Poumbourios, Pantelis] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Lay, Chan-Sien; Poumbourios, Pantelis] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Burnet Institute; University of Melbourne; Monash University; Monash University	Poumbourios, P (corresponding author), Burnet Inst, Virus Entry & Vaccines Lab, GPO Box 2284, Melbourne, Vic 3001, Australia.	andy.poumbourios@burnet.edu.au		Laumaea, Annemarie/0000-0002-4934-597X; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council of Australia Grants [1070890, 1125822, 1041897]; Australian Centre for HIV and Hepatitis Virology Research; Australian Postgraduate Awards	National Health and Medical Research Council of Australia Grants(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; Australian Postgraduate Awards(Australian Government)	This work was supported by National Health and Medical Research Council of Australia Grants 1070890 and 1125822 (to P.P.) and 1041897 (to H.E.D.) and the Australian Centre for HIV and Hepatitis Virology Research (to P.P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Postgraduate Awards.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2016, J VIROL, V90, P5657, DOI 10.1128/JVI.00509-16; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; Bauby H, 2010, TRAFFIC, V11, P455, DOI 10.1111/j.1600-0854.2010.01036.x; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bjorndal A, 1997, J VIROL, V71, P7478; Blanchet F, 2011, CURR OPIN HIV AIDS, V6, P391, DOI 10.1097/COH.0b013e328349b0a0; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bracq L, 2017, J VIROL, V91, DOI 10.1128/JVI.01237-17; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Checkley MA, 2013, J VIROL, V87, P3561, DOI 10.1128/JVI.03299-12; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dev J, 2016, SCIENCE, V353, P172, DOI 10.1126/science.aaf7066; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Drummer HE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003218; Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13; Duncan CJA, 2013, AIDS, V27, P2201, DOI 10.1097/QAD.0b013e3283632ec4; Durham ND, 2015, J VIROL, V89, P9324, DOI 10.1128/JVI.00655-15; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1990, BIOPOLYMERS, V29, P171, DOI 10.1002/bip.360290122; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gardiner JC, 2016, J VIROL, V90, P6583, DOI 10.1128/JVI.00600-16; Gombos RB, 2015, J VIROL, V89, P7813, DOI 10.1128/JVI.00783-15; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Groppelli E, 2015, J VIROL, V89, P14, DOI 10.1128/JVI.02425-14; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iwami S, 2015, ELIFE, V4, DOI 10.7554/eLife.08150; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Jolly C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002226; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Khasawneh AI, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-44; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; KONDO S, 1994, BRIT J CANCER, V69, P627, DOI 10.1038/bjc.1994.123; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Law KM, 2016, CELL REP, V15, P2771, DOI 10.1016/j.celrep.2016.05.059; Lay CS, 2011, J BIOL CHEM, V286, P41331, DOI 10.1074/jbc.M111.299826; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lineberger JE, 2002, J VIROL, V76, P3522, DOI 10.1128/JVI.76.7.3522-3533.2002; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murphy RE, 2017, STRUCTURE, V25, P1708, DOI 10.1016/j.str.2017.09.010; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Orenstein JM, 2008, AIDS RES HUM RETROV, V24, P947, DOI 10.1089/aid.2008.0265; Orenstein JM, 2000, J INFECT DIS, V182, P338, DOI 10.1086/315640; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Putcharoen O, 2012, J VIROL, V86, P1119, DOI 10.1128/JVI.06421-11; Qi ML, 2015, P NATL ACAD SCI USA, V112, P7575, DOI 10.1073/pnas.1504174112; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reh L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004966; ROWELL JF, 1995, J IMMUNOL, V155, P473; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Russell RA, 2013, VIROLOGY, V443, P143, DOI 10.1016/j.virol.2013.05.005; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stauffer S, 2014, J VIROL, V88, P7893, DOI 10.1128/JVI.00428-14; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Sun ZYJ, 2014, J MOL BIOL, V426, P1095, DOI 10.1016/j.jmb.2013.09.030; Symeonides M, 2015, VIRUSES-BASEL, V7, P6590, DOI 10.3390/v7122959; Takikawa S, 2000, J VIROL, V74, P5066, DOI 10.1128/JVI.74.11.5066-5074.2000; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Tencza SB, 1997, ANTIMICROB AGENTS CH, V41, P2394, DOI 10.1128/AAC.41.11.2394; Do T, 2014, J VIROL, V88, P10327, DOI 10.1128/JVI.00788-14; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Titanji BK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-161; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; VENABLE RM, 1989, AIDS RES HUM RETROV, V5, P7, DOI 10.1089/aid.1989.5.7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang LL, 2017, J VIROL, V91, DOI 10.1128/JVI.01605-16; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Zhang CL, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/918305; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	145	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6099	6120		10.1074/jbc.RA117.000537	http://dx.doi.org/10.1074/jbc.RA117.000537			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496992	hybrid, Green Published			2022-12-26	WOS:000430497300028
J	Sakabe, T; Sakai, K; Maeda, T; Sunaga, A; Furuta, N; Schweitzer, R; Sasaki, T; Sakai, T				Sakabe, Tomoya; Sakai, Keiko; Maeda, Toru; Sunaga, Ataru; Furuta, Nao; Schweitzer, Ronen; Sasaki, Takako; Sakai, Takao			Transcription factor scleraxis vitally contributes to progenitor lineage direction in wound healing of adult tendon in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MOUSE ACHILLES-TENDON; EXTRACELLULAR-MATRIX; HETEROTOPIC OSSIFICATION; COLLAGEN-SYNTHESIS; CRUCIATE LIGAMENT; GROWTH-FACTOR; EXPRESSION; GENE; DIFFERENTIATION	Tendon is a dense connective tissue that transmits high mechanical forces from skeletal muscle to bone. The transcription factor scleraxis (Scx) is a highly specific marker of both precursor and mature tendon cells (tenocytes). Mice lacking scx exhibit a specific and virtually complete loss of tendons during development. However, the functional contribution of Scx to wound healing in adult tendon has not yet been fully characterized. Here, using ScxGFP-tracking and loss-of-function systems, we show in an adult mouse model of Achilles tendon injury that paratenon cells, representing a stem cell antigen-1 (Sca-1)positive and Scx-negative progenitor subpopulation, display Scx induction, migrate to the wound site, and produce extracellular matrix (ECM) to bridge the defect, whereas resident tenocytes exhibit a delayed response. Scx induction in the progenitors is initiated by transforming growth factor beta (TGF-beta) signaling. scx-deficient mice had migration of Sca-1-positive progenitor cell to the lesion site but impaired ECM assembly to bridge the defect. Mechanistically, scx-null progenitors displayed higher chondrogenic potential with up-regulation of SRY-box 9 (Sox9) coactivator PPAR-gamma coactivator-1 alpha (PGC-1 alpha) in vitro, and knock-in analysis revealed that forced expression of full-length scx significantly inhibited Sox9 expression. Accordingly, scxnull wounds formed cartilage-like tissues that developed ectopic ossification. Our findings indicate a critical role of Scx in a progenitor-cell lineage in wound healing of adult mouse tendon. These progenitor cells could represent targets in strategies to facilitate tendon repair. We propose that this lineage-regulatory mechanism in tissue progenitors could apply to a broader set of tissues or biological systems in the body.	[Sakabe, Tomoya; Sakai, Keiko; Furuta, Nao; Sakai, Takao] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC,Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England; [Sakabe, Tomoya; Sakai, Keiko; Maeda, Toru; Sunaga, Ataru; Sakai, Takao] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Schweitzer, Ronen] Shriners Hosp Children, Res Div, Portland, OR 97239 USA; [Sasaki, Takako] Oita Univ, Dept Biochem, Fac Med, Oita 8795593, Japan	University of Liverpool; Cleveland Clinic Foundation; Oita University	Sakai, T (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC,Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	sakait@liverpool.ac.uk	Schweitzer, Ronen/AAY-2127-2020	Schweitzer, Ronen/0000-0002-7425-5028	National Institutes of Health [DK074538]; Institute of Translational Medicine, University of Liverpool	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Translational Medicine, University of Liverpool	This work was supported by National Institutes of Health Grant DK074538 and the Institute of Translational Medicine, University of Liverpool (to T. Sakai). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Asai S, 2014, STEM CELLS, V32, P3266, DOI 10.1002/stem.1847; Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Dyment NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096113; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; GREENBERGER JS, 1979, IN VITRO CELL DEV B, V15, P823; Gross G, 2013, PATHOBIOLOGY, V80, P203, DOI 10.1159/000347059; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hsieh CF, 2016, NANOMEDICINE-UK, V11, P1153, DOI 10.2217/nnm.16.34; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Jann HW, 1999, VET SURG, V28, P268, DOI 10.1053/jvet.1999.0268; Jozsa L.G., 1997, HUMAN TENDONS ANATOM; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kumagai K, 2012, OSTEOARTHR CARTILAGE, V20, P1258, DOI 10.1016/j.joca.2012.07.013; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lin L, 2010, BONE, V46, P425, DOI 10.1016/j.bone.2009.08.057; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mienaltowski MJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt475; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.tea.2012.0182, 10.1089/ten.TEA.2012.0182]; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; O'Brien EJO, 2012, INT J EXP PATHOL, V93, P319, DOI 10.1111/j.1365-2613.2012.00829.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; ROONEY P, 1992, MATRIX, V12, P274, DOI 10.1016/S0934-8832(11)80079-X; Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki H, 2016, P NATL ACAD SCI USA, V113, P7840, DOI 10.1073/pnas.1522054113; Takimoto A, 2015, DEVELOPMENT, V142, P787, DOI 10.1242/dev.116228; Takimoto A, 2012, EXP CELL RES, V318, P1492, DOI 10.1016/j.yexcr.2012.04.002; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Yoshikawa T, 2006, KNEE SURG SPORT TR A, V14, P804, DOI 10.1007/s00167-006-0051-8; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang K, 2016, MATRIX BIOL, V52-54, P315, DOI 10.1016/j.matbio.2016.01.015	63	47	49	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5766	5780		10.1074/jbc.RA118.001987	http://dx.doi.org/10.1074/jbc.RA118.001987			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29507095	Green Published, hybrid			2022-12-26	WOS:000430497300002
J	Wiltshire, SW				Wiltshire, Serge W.			Using an agent-based model to evaluate the effect of producer specialization on the epidemiological resilience of livestock production networks	PLOS ONE			English	Article							DIARRHEA VIRUS-INFECTION; TRADE PATTERNS; PERCOLATION; EPIDEMICS; DYNAMICS; TRANSPORTATION; MATHEMATICS; ROBUSTNESS; TOLERANCE; OUTBREAKS	An agent-based computer model that builds representative regional U.S. hog production networks was developed and employed to assess the potential impact of the ongoing trend towards increased producer specialization upon network-level resilience to catastrophic disease outbreaks. Empirical analyses suggest that the spatial distribution and connectivity patterns of contact networks often predict epidemic spreading dynamics. Our model heuristically generates realistic systems composed of hog producer, feed mill, and slaughter plant agents. Network edges are added during each run as agents exchange livestock and feed. The heuristics governing agents' contact patterns account for factors including their industry roles, physical proximities, and the age of their livestock. In each run, an infection is introduced, and may spread according to probabilities associated with the various modes of contact. For each of three treatments-defined by one-phase, two-phase, and three-phase production systems-a parameter variation experiment examines the impact of the spatial density of producer agents in the system upon the length and size of disease outbreaks. Resulting data show phase transitions whereby, above some density threshold, systemic outbreaks become possible, echoing findings from percolation theory. Data analysis reveals that multi-phase production systems are vulnerable to catastrophic outbreaks at lower spatial densities, have more abrupt percolation transitions, and are characterized by less-predictable outbreak scales and durations. Key differences in network-level metrics shed light on these results, suggesting that the absence of potentially-bridging producer-producer edges may be largely responsible for the superior disease resilience of single-phase "farrow to finish" production systems.	[Wiltshire, Serge W.] Univ Vermont, Food Syst, Burlington, VT 05405 USA	University of Vermont	Wiltshire, SW (corresponding author), Univ Vermont, Food Syst, Burlington, VT 05405 USA.	serge.wiltshire@uvm.edu		Wiltshire, Serge/0000-0002-0474-2760	National Institute of Food and Agriculture, U.S. Department of Agriculture [2015-69004-23273]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture (https://nifa.usda.gov/), under award number 2015-69004-23273. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASV, 2015, PORC EP DIARRH VIR P; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amass SF, 1999, SWINE HEALTH PROD, V7, P217; ANDERSON R M, 1991; Auger P, 2008, LECT NOTES MATH, V1936, P209; Axelrod R., 2000, HARNESSING COMPLEXIT; Bagni R, 2002, JASSS-J ARTIF SOC S, V5; Bailey NTJ, 1975, MATH THEORY INFECT D; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Bradhurst RA, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P345; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Cliff A., 1981, SPATIAL DIFFUSION HI; Coelho FC, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-3; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Firestone SM, 2011, PREV VET MED, V102, P185, DOI 10.1016/j.prevetmed.2011.07.006; Fournie G, 2013, P NATL ACAD SCI USA, V110, P9177, DOI 10.1073/pnas.1220815110; Frias-Martinez E., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P57, DOI 10.1109/PASSAT/SocialCom.2011.142; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grimmett G, 1999, WHAT IS PERCOLATION; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Harko T, 2014, APPL MATH COMPUT, V236, P184, DOI 10.1016/j.amc.2014.03.030; Heesterbeek J., 2000, MATH EPIDEMIOLOGY IN, V5; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Janssen MA, 2006, ECOL SOC, V11; Johnson D, 1997, J ROY STAT SOC D-STA, V46, P387, DOI 10.1111/1467-9884.00091; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KINZEL W, 1985, Z PHYS B CON MAT, V58, P229, DOI 10.1007/BF01309255; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Mikler AR, 2005, J BIOL SYST, V13, P421, DOI 10.1142/S0218339005001604; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.028301; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; O'Dea EB, 2015, BIORXIV; OHTSUKI T, 1986, PHYS REV A, V33, P1223, DOI 10.1103/PhysRevA.33.1223; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Pfeifer Bernhard, 2008, Open Med Inform J, V2, P70, DOI 10.2174/1874431100802010070; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Sander LM, 2002, MATH BIOSCI, V180, P293, DOI 10.1016/S0025-5564(02)00117-7; Serrano MA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.088701; Sornette D, 2006, CRITICAL PHENOMENA N; STAUFFER D, 1994, INTRO PERCOLATION TH; USDA APHIS, 2006, REF SWIN HLTH HLTH M; USDA FSIS, 2015, MEAT POULTR EGG PROD; USDA NASS, 2012, HOGS PIGS INV TYP PR; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126	73	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0194013	10.1371/journal.pone.0194013	http://dx.doi.org/10.1371/journal.pone.0194013			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522574	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800032
J	Royo, JL; Valls, J; Acemel, RD; Gomez-Marin, C; Pascual-Pons, M; Lupianez, A; Gomez-Skarmeta, JL; Fibla, J				Luis Royo, Jose; Valls, Joan; Acemel, Rafael D.; Gomez-Marin, Carlos; Pascual-Pons, Marione; Lupianez, Arenbca; Luis Gomez-Skarmeta, Jose; Fibla, Joan			A common copy-number variant within SIRPB1 correlates with human Out-of-Africa migration after genetic drift correction	PLOS ONE			English	Article							ALLELE FREQUENCIES; DRD4 GENE; ARCHITECTURE; NEUROTICISM; EVOLUTION; SELECTION; DNA	Previous reports have proposed that personality may have played a role on human Out-Of-Africa migration, pinpointing some genetic variants that were positively selected in the migrating populations. In this work, we discuss the role of a common copy-number variant within the SIRPB1 gene, recently associated with impulsive behavior, in the human Out-Of-Africa migration. With the analysis of the variant distribution across forty-two different populations, we found that the SIRPB1 haplotype containing duplicated allele significantly correlated with human migratory distance, being one of the few examples of positively selected Ioci found across the human world colonization. Circular Chromosome Conformation Capture (4C-seq) experiments from the SIRPB1 promoter revealed important 3D modifications in the locus depending on the presence or absence of the duplication variant. In addition, a 3' enhancer showed neural activity in transgenic models, suggesting that the presence of the CNV may compromise the expression of SIRPB1 in the central nervous system, paving the way to construct a molecular explanation of the SIRPB1 variants role in human migration.	[Luis Royo, Jose; Pascual-Pons, Marione; Lupianez, Arenbca; Fibla, Joan] Univ Lleida, IRBlleida, Dept Basic Med Sci, Lleida, Spain; [Luis Royo, Jose] Univ Malaga, Dept Surg Biochem & Immunol, Malaga, Spain; [Valls, Joan] Univ Lleida, IRBlleida, Biostat & Epidemiol Unit, Lleida, Spain; [Acemel, Rafael D.; Gomez-Marin, Carlos; Luis Gomez-Skarmeta, Jose] CSIC Junta De Andalucia, Ctr Andaluz Biol Desarrollo, Seville, Spain	Universitat de Lleida; Universidad de Malaga; Universitat de Lleida; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Royo, JL; Fibla, J (corresponding author), Univ Lleida, IRBlleida, Dept Basic Med Sci, Lleida, Spain.; Royo, JL (corresponding author), Univ Malaga, Dept Surg Biochem & Immunol, Malaga, Spain.	jlroyo@uma.es; joan.fiba@cmb.udl.cat	Fibla, Joan/C-5561-2008; Gómez-Marín, Carlos/AAX-2173-2021; Gomez-Skarmeta, Jose Luis/B-5268-2014; Acemel, Rafael Dominguez/AAM-1957-2020; Valls, Joan/GXM-6532-2022; Royo, Jose Luis/H-6935-2012	Fibla, Joan/0000-0002-3255-2227; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Acemel, Rafael Dominguez/0000-0003-4120-0140; Royo, Jose Luis/0000-0003-2024-4363				1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Cheung KH, 2000, NUCLEIC ACIDS RES, V28, P361, DOI 10.1093/nar/28.1.361; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Drabant EM, 2011, NEUROIMAGE, V55, P401, DOI 10.1016/j.neuroimage.2010.11.040; Fouarge D., 2016, PERSONALITY TR UNPUB; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Laplana M, 2014, GENES BRAIN BEHAV, V13, P653, DOI 10.1111/gbb.12154; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Matthews LJ, 2011, AM J PHYS ANTHROPOL, V145, P382, DOI 10.1002/ajpa.21507; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Royo JL, 2015, MOL CELL PROBE, V29, P517, DOI 10.1016/j.mcp.2015.07.009; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Williams J, 2006, J R SOC INTERFACE, V3, P399, DOI 10.1098/rsif.2005.0102; Wilson GD, 2000, PERS INDIV DIFFER, V29, P1077, DOI 10.1016/S0191-8869(99)00255-X	31	4	4	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193614	10.1371/journal.pone.0193614	http://dx.doi.org/10.1371/journal.pone.0193614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518122	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900029
J	Sugiura, H; Matsushita, A; Futaya, M; Teraoka, A; Akiyama, K; Usui, N; Nagano, N; Nitta, K; Tsuchiya, K				Sugiura, Hidekazu; Matsushita, Al; Futaya, Mayuko; Teraoka, Atsuko; Akiyama, Ken-ichi; Usui, Noriyoshi; Nagano, Nobuo; Nitta, Kosaku; Tsuchiya, Ken			Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model	PLOS ONE			English	Article							KLOTHO REDUCES APOPTOSIS; VITAMIN-D; PARATHYROID-HORMONE; CIRCULATING LEVELS; PHOSPHATE; FGF23; EXPRESSION; INJURY; FGF-23; MOUSE	The hormone fibroblast growth factor 23 (FGF23) is secreted from bone and is involved in phosphorus (P) metabolism. FGF23 mainly binds the FGF receptor, which interacts with aKlotho in the kidney or parathyroid and regulates Na-dependent phosphate co-transporter type Ila (NaPi-lla) and typellc (NaPi-11c) expression, 1,25-dihydroxyvitamin D-3 (1,25 (OH)(2)D-3) activity, and parathyroid hormone (PTH) secretion. In this study, we utilized heminephrectomized rats fed a high-P diet (HP Nx), rats subjected to a partial nephrectomy (PN) and rats with doxorubicin-induced renal failure (DXR) as chronic kidney disease (CKD) animal models and analyzed the P metabolism and FGF23 expression in the kidneys in each CKD model. We cultured HK2 cells with a high level of P, 1,25(OH)(2)D-3 or transforming growth factor-beta 1 (TG9 beta 1) to investigate the FGF23 expression mechanism. In both the HP Nx and PN rats, the blood FGF23 and PTH levels were increased. However, the 1,25 (OH)(2)D-3 level was increased in the HP Nx rats and decreased in the PN rats. In all three animal models, the mRNA expression of aklotho, NaPi-lla and NaPi-lIc was decreased, and the mRNA expression of TGF,61, collagen 1a1, osteopontin and FGF23 was elevated in the kidney. FGF23 protein and mRNA were expressed at high levels in the extended tubule epithelium, which was an osteopontin-positive region in the HP and PN rats. FGF23 and osteopontin mRNAs were expressed in HK2 cells incubated with TGF beta 1; however, these levels were not altered in HK2 cells incubated with 1,25(OH)(2)D-3 and high P levels in vitro. Altogether, FGF23 is expressed in the kidneys in CKD model rats. Following stimulation with TGF beta 1, the injured renal tubular epithelial cells are strongly suspected to express both FGF23 and osteopontin. FGF23 produced in the kidney might contribute to P metabolism in subjects with CKD.	[Sugiura, Hidekazu; Matsushita, Al; Futaya, Mayuko; Teraoka, Atsuko; Akiyama, Ken-ichi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Internal Med 4, Shinjuku Ku, Tokyo, Japan; [Sugiura, Hidekazu] Saiseikai Kurihashi Hosp, Div Med, Dept Nephrol, Kuki, Saitama, Japan; [Usui, Noriyoshi] Univ Fukui, Div Dev Mental Funct, Res Ctr Child Mental Dev, Fukui, Japan; [Usui, Noriyoshi] Osaka Univ, Div Dev Higher Brain Funct, Dept Child Dev, United Grad Sch Child Dev, Osaka, Japan; [Nagano, Nobuo] Hidaka Hosp, Kidney Dis & Dialysis Ctr, Takasaki, Gunma, Japan; [Nagano, Nobuo] Tokyo Womens Med Univ, Dept Med, Med Ctr East, Tokyo, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University; University of Fukui; Osaka University; Tokyo Women's Medical University; Tokyo Women's Medical University	Sugiura, H (corresponding author), Tokyo Womens Med Univ, Dept Internal Med 4, Shinjuku Ku, Tokyo, Japan.; Sugiura, H (corresponding author), Saiseikai Kurihashi Hosp, Div Med, Dept Nephrol, Kuki, Saitama, Japan.	sugiura@twmu.ac.jp	Usui, Noriyoshi/ABC-7904-2020	Usui, Noriyoshi/0000-0001-8079-8013; Sugiura, Hidekazu/0000-0003-2950-4512	Ministry of Health, Labor and Welfare of Japan [C;26461243]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	Ken Tsuchiya is supported by a Grant-in-Aid for Scientific Research of Japan (C;26461243) (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/), and in part by a Grant-in-Aid for Progressive Renal Diseases Research from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/gaiyo.html). The funders of this study played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Di Marco GS, 2014, NEPHROL DIAL TRANSPL, V29, P2028, DOI 10.1093/ndt/gfu190; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lee Ji-Won, 2014, Bonekey Rep, V3, P543, DOI 10.1038/bonekey.2014.38; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; Mace ML, 2017, KIDNEY INT, V92, P165, DOI 10.1016/j.kint.2017.01.015; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Noiri E, 2006, NEPHRON EXP NEPHROL, V104, pE6, DOI 10.1159/000093258; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Prie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066182; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Sakan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086301; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimamura Y, 2012, CLIN EXP NEPHROL, V16, P722, DOI 10.1007/s10157-012-0621-7; Shimokado A, 2014, EXP MOL PATHOL, V97, P458, DOI 10.1016/j.yexmp.2014.10.005; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Sugiura H, 2010, AM J NEPHROL, V32, P137, DOI 10.1159/000315864; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Usui N, 2012, DEVELOPMENT, V139, P1125, DOI 10.1242/dev.069997; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Zanchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070775; Zhu DX, 2013, MOL CELL ENDOCRINOL, V372, P1, DOI 10.1016/j.mce.2013.03.008	37	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0191706	10.1371/journal.pone.0191706	http://dx.doi.org/10.1371/journal.pone.0191706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518087	Green Published, Green Submitted, gold			2022-12-26	WOS:000426902900003
J	Clark, BK; Winkler, EA; Brakenridge, CL; Trost, SG; Healy, GN				Clark, Bronwyn K.; Winkler, Elisabeth A.; Brakenridge, Charlotte L.; Trost, Stewart G.; Healy, Genevieve N.			Using Bluetooth proximity sensing to determine where office workers spend time at work	PLOS ONE			English	Article							SEDENTARY BEHAVIORS; PHYSICAL-ACTIVITY; HEALTH; TECHNOLOGIES; ASSOCIATIONS	Background Most wearable devices that measure movement in workplaces cannot determine the context in which people spend time. This study examined the accuracy of Bluetooth sensing (10-second intervals) via the ActiGraph GT9X Link monitor to determine location in an office setting, using two simple, bespoke algorithms. Methods For one work day (mean +/- SD 6.2 +/- 1.1 hours), 30 office workers (30% men, aged 38 +/- 11 years) simultaneously wore chest-mounted cameras (video recording) and Bluetoothenabled monitors (initialised as receivers) on the wrist and thigh. Additional monitors (initialised as beacons) were placed in the entry, kitchen, photocopy room, corridors, and the wearer's office. Firstly, participant presence/absence at each location was predicted from the presence/absence of signals at that location (ignoring all other signals). Secondly, using the information gathered at multiple locations simultaneously, a simple heuristic model was used to predict at which location the participant was present. The Bluetooth-determined location for each algorithm was tested against the camera in terms of F-scores. Results When considering locations individually, the accuracy obtained was excellent in the office (F-score = 0.98 and 0.97 for thigh and wrist positions) but poor in other locations (F-score = 0.04 to 0.36), stemming primarily from a high false positive rate. The multi-location algorithm exhibited high accuracy for the office location (F-score = 0.97 for both wear positions). It also improved the F-scores obtained in the remaining locations, but not always to levels indicating good accuracy (e.g., F-score for photocopy room approximate to 0.1 in both wear positions). Conclusions The Bluetooth signalling function shows promise for determining where workers spend most of their time (i.e., their office). Placing beacons in multiple locations and using a rule-based decision model improved classification accuracy; however, for workplace locations visited infrequently or with considerable movement, accuracy was below desirable levels. Further development of algorithms is warranted.	[Clark, Bronwyn K.; Winkler, Elisabeth A.; Brakenridge, Charlotte L.; Healy, Genevieve N.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Trost, Stewart G.] Queensland Univ Technol, Ctr Childrens Hlth Res, Inst Hlth & Biomed Innovat Queensland, South Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT)	Clark, BK (corresponding author), Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia.	b.clark3@uq.edu.au	Brakenridge, Charlotte/A-1589-2015; Clark, Bronwyn/F-8028-2010; Healy, Genevieve/A-7408-2008; Winkler, Elisabeth/AAD-7153-2022; Trost, Stewart G/B-5948-2012	Brakenridge, Charlotte/0000-0003-4540-7659; Clark, Bronwyn/0000-0001-7527-4311; Healy, Genevieve/0000-0001-7093-7892; Winkler, Elisabeth/0000-0003-1452-6102; Trost, Stewart G/0000-0001-9587-3944	University of Queensland Early Career Researcher Grant [611434]; National Health and Medical Research Council, NHMRC of Australia Early Career Fellowship [1107168]; NHMRC through a Centre of Research Excellence Grant [1057608]; NHMRC through a top up scholarship; NHMRC Career Development Fellowship [108029]; Australian Government Research Training Program Scholarship	University of Queensland Early Career Researcher Grant; National Health and Medical Research Council, NHMRC of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC through a Centre of Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC through a top up scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was funded by a University of Queensland Early Career Researcher Grant #611434 (http://www.uq.edu.au/research/research-management/) awarded to BKC. Salary for BKC is supported by a National Health and Medical Research Council, NHMRC (https://www.nhmrc.gov.au/) of Australia Early Career Fellowship (#1107168). The NHMRC through a Centre of Research Excellence Grant [#1057608] to ST and GNH, provides salary support to EAHW and a top up scholarship to CLB. GNH is also supported by an NHMRC Career Development Fellowship (#108029). CLB is also supported by an Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph, 2017, WHAT IS PROX TAGG DO; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Doherty AR, 2013, AM J PREV MED, V44, P320, DOI 10.1016/j.amepre.2012.11.008; Granat M, 2015, GAIT POSTURE, V42, P85, DOI 10.1016/j.gaitpost.2015.04.012; Healy GN, 2015, EUR HEART J, V36, P2643, DOI 10.1093/eurheartj/ehv308; Jung JY, 2016, IEEE ICCE; Kelly P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-44; Kozey-Keadle S, 2012, J OBES, V2012, DOI 10.1155/2012/282303; Lever J, 2016, NAT METHODS, V13, P703, DOI 10.1038/nmeth.3968; Loveday A, 2016, PHYSIOL MEAS, V37, P1834, DOI 10.1088/0967-3334/37/10/1834; Loveday A, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4761; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Madhavapeddy A, 2005, UBICOMP; Powers D.M.W., 2011, J MACH LEARN TECHNOL, V2, P3763; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Spinney R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127688; Steeves JA, 2015, MED SCI SPORT EXER, V47, P952, DOI 10.1249/MSS.0000000000000497; Stephens SK, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093524; Straker L, 2016, SEDENTARY WORK D EVI; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Van Haute T, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0034-z; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661; Wijndaele K, 2014, DIABETOLOGIA, V57, P305, DOI 10.1007/s00125-013-3102-y; Woznowski P, 2016, COMPUT COMMUN, V89-90, P34, DOI 10.1016/j.comcom.2016.03.006; Xu L, 2011, IEEE IC COMP COM NET; Yu D, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0405-1	26	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193971	10.1371/journal.pone.0193971	http://dx.doi.org/10.1371/journal.pone.0193971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513754	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800094
J	Luo, LN; Aubrecht, J; Li, DZ; Warner, RL; Johnson, KJ; Kenny, J; Colangelo, JL				Luo, Lina; Aubrecht, Jiri; Li, Dingzhou; Warner, Roscoe L.; Johnson, Kent J.; Kenny, Julia; Colangelo, Jennifer L.			Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; NONALCOHOLIC STEATOHEPATITIS; OBSTRUCTIVE-CHOLESTASIS; DUCT LIGATION; MICE; MOUSE; PROTECTS	To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury.	[Luo, Lina] Pfizer Inc, Pharmacokinet Dynam & Metab, Med Design, Groton, CT 06340 USA; [Aubrecht, Jiri; Li, Dingzhou; Colangelo, Jennifer L.] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA; [Warner, Roscoe L.; Johnson, Kent J.] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Kenny, Julia] Univ Prince Edward Isl, Charlottetown, PE, Canada	Pfizer; Pfizer; University of Michigan System; University of Michigan; University of Prince Edward Island	Luo, LN (corresponding author), Pfizer Inc, Pharmacokinet Dynam & Metab, Med Design, Groton, CT 06340 USA.	lina.luo@pfizer.com	Li, Dingzhou/AHC-2117-2022		Pfizer Inc.	Pfizer Inc.(Pfizer)	The project was funded by Pfizer Inc. in forms of research grant to K.J.J. (University of Michigan). Pfizer Inc. provided support in the form of salaries for authors [L.L., J.A., D.L., J.K., and J.L.C.] and reviewed the final manuscript but the funding organization did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aithal GP, 2015, MEDICINE, V43, P590; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Amacher DE, 2005, CLIN CHEM, V51, P1796, DOI 10.1373/clinchem.2005.049908; [Anonymous], 2016, TEST ID BAFS; Bathena SPR, 2015, TOXICOL SCI, V143, P308, DOI 10.1093/toxsci/kfu228; Bathena SPR, 2015, TOXICOL SCI, V143, P296, DOI 10.1093/toxsci/kfu227; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Costarelli V, 2006, NUTR FOOD SCI, V36, P153, DOI 10.1108/00346650610664887; Crosignani A, 2011, CLIN CHIM ACTA, V412, P2037, DOI 10.1016/j.cca.2011.07.028; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Frommherz L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153959; Fu ZD, 2014, J LIPID RES, V55, P2576, DOI 10.1194/jlr.M053124; Fu ZD, 2013, TOXICOL APPL PHARM, V273, P680, DOI 10.1016/j.taap.2013.10.020; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Guicciardi ME, 2013, COMPREHENSIVE PHYSL, V3; Hofmann AF, 1999, BILE ACIDS GOOD BAD, P24; Humbert L, 2012, J CHROMATOGR B, V899, P135, DOI 10.1016/j.jchromb.2012.05.015; Jang JH, 2012, HEPATOLOGY, V56, P209, DOI 10.1002/hep.25626; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; KAWASAKI H, 1986, TOHOKU J EXP MED, V150, P353, DOI 10.1620/tjem.150.353; Khurana S, 2011, CTS-CLIN TRANSL SCI, V4, P210, DOI 10.1111/j.1752-8062.2011.00272.x; Kullak-Ublick GA, 2017, GUT, V66, P1154, DOI 10.1136/gutjnl-2016-313369; Lake AD, 2013, TOXICOL APPL PHARM, V268, P132, DOI 10.1016/j.taap.2013.01.022; Li T, 2012, J LIPID, V2012, P9; Luo L, 2013, TOXICOLOGICAL SCI; Masubuchi N, CHEMICOBIOLOGICAL IN; MURPHY GM, 1972, GUT, V13, P201, DOI 10.1136/gut.13.3.201; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Pean N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Scherer M, 2009, J CHROMATOGR B, V877, P3920, DOI 10.1016/j.jchromb.2009.09.038; SHAFFER EA, 1978, AM J DIG DIS, V23, P392, DOI 10.1007/BF01072920; STARKEY BJ, 1982, CLIN CHIM ACTA, V119, P165, DOI 10.1016/0009-8981(82)90329-1; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Sugita T, 2015, GASTROENTEROLOGY RES, V2015, P10; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124; Trottier J, 2012, DIGEST LIVER DIS, V44, P303, DOI 10.1016/j.dld.2011.10.025; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Woolbright BL, 2014, TOXICOL SCI, V142, P436, DOI 10.1093/toxsci/kfu195; Woolbright BL, 2013, TOXICOL APPL PHARM, V273, P524, DOI 10.1016/j.taap.2013.09.023; Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x	45	81	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193824	10.1371/journal.pone.0193824	http://dx.doi.org/10.1371/journal.pone.0193824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513725	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800079
J	Wijkstrom, J; Jayasumana, C; Dassanayake, R; Priyawardane, N; Godakanda, N; Siribaddana, S; Rings, A; Hultenby, K; Soderberg, M; Elinder, CG; Wernerson, A				Wijkstrom, Julia; Jayasumana, Channa; Dassanayake, Rajeewa; Priyawardane, Nalin; Godakanda, Nimali; Siribaddana, Sisira; Rings, Anneli; Hultenby, Kjell; Soderberg, Magnus; Elinder, Carl-Gustaf; Wernerson, Annika			Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy	PLOS ONE			English	Article							NORTH CENTRAL PROVINCE; CHRONIC-RENAL-FAILURE; UNCERTAIN ETIOLOGY; FRACTIONAL EXCRETION; SUGARCANE CUTTERS; CADMIUM LEVELS; HEAVY-METALS; HANTAVIRUS; EXPOSURE; URINE	In Sri Lanka, an endemic of chronic kidney disease of unknown origin (CKDu) is affecting rural communities. The endemic has similarities with Mesoamerican Nephropathy (MeN) in Central America, however it has not yet been clarified if the endemics are related diagnostic entities. We designed this study of kidney biopsies from patients with CKDu in Sri Lanka to compare with MeN morphology. Eleven patients with CKDu were recruited at the General Hospital, Polonnaruwa, using similar inclusion and exclusion criteria as our previous MeN studies. Inclusion criteria were 20-65 years of age and plasma creatinine 100-220 mu mol/ L. Exclusion criteria were diabetes mellitus, uncontrolled hypertension and albuminuria >1g/24h. Kidney biopsies, blood and urine samples were collected, and participants answered a questionnaire. Included participants were between 27-61 years of age and had a mean eGFR of 38 +/- 14 ml/min/1.73m(2). Main findings in the biopsies were chronic glomerular and tubulointerstitial damage with glomerulosclerosis (8-75%), glomerular hypertrophy and mild to moderate tubulointerstitial changes. The morphology was more heterogeneous and interstitial inflammation and vascular changes were more common compared to our previous studies of MeN. In two patients the biopsies showed morphological signs of acute pyelonephritis but urine cultures were negative. Electrolyte disturbances with low levels of serum sodium, potassium, and/or magnesium were common. In the urine, only four patients displayed albuminuria, but many patients exhibited elevated alpha-1-microglobulin and magnesium levels. This is the first study reporting detailed biochemical and clinical data together with renal morphology, including electron microscopy, from Sri Lankan patients with CKDu. Our data show that there are many similarities in the biochemical and morphological profile of the CKDu endemics in Central America and Sri Lanka, supporting a common etiology.	[Wijkstrom, Julia; Elinder, Carl-Gustaf; Wernerson, Annika] Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Jayasumana, Channa] Rajarata Univ Sri Lanka, Fac Med, Dept Pharmacol, Saliyapura, Sri Lanka; [Dassanayake, Rajeewa; Priyawardane, Nalin; Godakanda, Nimali] Gen Hosp, Renal Unit, Polonnaruwa, Sri Lanka; [Siribaddana, Sisira] Rajarata Univ Sri Lanka, Fac Med, Saliyapura, Sri Lanka; [Rings, Anneli; Soderberg, Magnus] Karolinska Univ Hosp, Clin Pathol & Cytol, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Div CRC, Dept Lab Med, Stockholm, Sweden; [Soderberg, Magnus] AstraZeneca, IMED Biotech Unit, Pathol Drug Safety & Metab, Gothenburg, Sweden	Karolinska Institutet; Rajarata University of Sri Lanka; Rajarata University of Sri Lanka; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; AstraZeneca	Wijkstrom, J (corresponding author), Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	julia.wijkstrom@ki.se	Siribaddana, Sisira/I-2295-2016	Siribaddana, Sisira/0000-0001-5821-2557; Wijkstrom, Julia/0000-0001-6183-5878	Karolinska Institutet; Stockholm County Council; Martin Rind Foundation; International Society of Nephrology; Swedish Research Council [2016-05825]; Ministry of Health in Sri Lanka; Sri Lanka Embassy in Stockholm	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Martin Rind Foundation; International Society of Nephrology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Health in Sri Lanka; Sri Lanka Embassy in Stockholm	This study was funded by the regional agreement on medical training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council, the Martin Rind Foundation, the International Society of Nephrology, and the Swedish Research Council (Swedish Research Links 2016-05825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astra Zeneca provided support in the form of salaries for one author [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; The authors would like to thank the staff at the General Hospital Polonnaruwa for their support during the study; the Ministry of Health in Sri Lanka and the Sri Lanka Embassy in Stockholm for their support and assistance with administrative issues; and the Njur-KBC Research Department and Eva Blomen at Karolinska University Hospital for technical assistance.	Agency for Toxic Substances and Disease Registry, 2013, TOXGUIDE UR; Agency for Toxic Substances and Disease Registry, 2012, TOXGUIDE VAN; Akerstrom M, 2013, TOXICOL APPL PHARM, V268, P286, DOI 10.1016/j.taap.2013.02.009; [Anonymous], 2007, TOXGUIDE ARS; [Anonymous], 2012, ENVIRON HEALTH PREV, DOI [DOI 10.1007/S12199-011-0224-Z, 10.1007/s12199-011-0224-z]; Athuraliya NTC, 2011, KIDNEY INT, V80, P1212, DOI 10.1038/ki.2011.258; Athuraliya T N C, 2009, Ceylon Med J, V54, P23; Badurdeen Z, 2016, CLIN NEPHROL, V86, pS106, DOI 10.5414/CNP86S115; Bandara JMRS, 2008, ENVIRON GEOCHEM HLTH, V30, P465, DOI 10.1007/s10653-007-9129-6; Bandara JMRS, 2010, TOXICOL LETT, V198, P33, DOI 10.1016/j.toxlet.2010.04.016; Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046; Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; Caldwell KL, 2009, J EXPO SCI ENV EPID, V19, P59, DOI 10.1038/jes.2008.32; Castano A, 2012, INT J HYG ENVIR HEAL, V215, P191, DOI 10.1016/j.ijheh.2011.09.001; Chandrajith R, 2011, ENVIRON GEOCHEM HLTH, V33, P267, DOI 10.1007/s10653-010-9339-1; Colvin R.B., 2019, DIAGN PATHOL; Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166; De Silva P, 2016, PLOS NEGLECT TROP D, V10, P17; ELISAF M, 1995, POSTGRAD MED J, V71, P211, DOI 10.1136/pgmj.71.834.211; Elisaf M, 1997, MAGNESIUM RES, V10, P315; Fischer RSB, 2017, KIDNEY INT IN PRESS; Gamage CD, 2017, INT J INFECT DIS, V57, P77, DOI 10.1016/j.ijid.2017.02.004; Garcia-Trabanino R, 2015, ENVIRON RES, V142, P746, DOI 10.1016/j.envres.2015.07.007; George J, 1998, VIRAL IMMUNOL, V11, P103, DOI 10.1089/vim.1998.11.103; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Gokmen MR, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4000; Herrera R, 2014, MEDICC REV, V16, P39, DOI 10.37757/MR2014.V16.N2.7; Hotez PJ, 2014, INT J PARASITOL, V44, P597, DOI 10.1016/j.ijpara.2014.04.001; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Jayasekara KB, 2015, J EPIDEMIOL, V25, P275, DOI 10.2188/jea.JE20140074; Jayasumana C, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0109-2; Jayasumana C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-6; Jayatilake N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-180; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lee JW, 2012, INT J HYG ENVIR HEAL, V215, P449, DOI 10.1016/j.ijheh.2012.01.002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Murray KO, 2015, MICROBES INFECT, V17, P671, DOI 10.1016/j.micinf.2015.08.005; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P213, DOI 10.1007/s12199-011-0243-9; Paschal DC, 1998, ENVIRON RES, V76, P53, DOI 10.1006/enrs.1997.3793; PETER JB, 1994, LANCET, V343, P181, DOI 10.1016/S0140-6736(94)90976-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Roels HA, 1999, RENAL FAILURE, V21, P251, DOI 10.3109/08860229909085087; Roncal-Jimenez C, 2016, AM J KIDNEY DIS, V67, P20, DOI 10.1053/j.ajkd.2015.08.021; Selvarajah M, 2016, Indian J Nephrol, V26, P357; Sommar JN, 2014, J EXPO SCI ENV EPID, V24, P51, DOI 10.1038/jes.2013.4; Sunil-Chandra NP, 2015, EPIDEMIOL INFECT, V143, P2081, DOI 10.1017/S0950268814003707; United States Environmental Protection Agency EPA, 1994, METH 200 8 DET RAC E; UpToDate, MES NEPHR; UpToDate, EV AD PAT HYP; Wanigasuriya K, 2014, MEDICC REV, V16, P61, DOI 10.37757/MR2014.V16.N2.10; Wanigasuriya KP, 2007, T ROY SOC TROP MED H, V101, P1013, DOI 10.1016/j.trstmh.2007.05.006; Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6; Wegman D., 2016, MESOAMERICAN NEPHROP; Weiner DE, 2013, CLIN J AM SOC NEPHRO, V8, P504, DOI 10.2215/CJN.05050512; Wesseling C, 2016, ENVIRON RES, V147, P125, DOI 10.1016/j.envres.2016.02.002; Wijetunge S, 2015, Indian J Nephrol, V25, P274, DOI 10.4103/0971-4065.145095; Wijkstrom J, 2017, AM J KIDNEY DIS, V69, P626, DOI 10.1053/j.ajkd.2016.10.036; Wijkstrom J, 2013, AM J KIDNEY DIS, V62, P908, DOI 10.1053/j.ajkd.2013.05.019	60	47	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193056	10.1371/journal.pone.0193056	http://dx.doi.org/10.1371/journal.pone.0193056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513702	Green Submitted, gold, Green Published			2022-12-26	WOS:000426896800034
J	Yang, JH; Yu, X; Yang, Y; Yang, ZQ				Yang, Jing-Hu; Yu, Xiang; Yang, Yi; Yang, Zeng-Qiang			Physical simulation and theoretical evolution for ground fissures triggered by underground coal mining	PLOS ONE			English	Article							SOIL-STRUCTURE INTERACTION; SUBSIDENCE; SURFACE; BASIN; MINE; SEAM	Underground coal mining activities are prone to cause movement and breakage in geological strata and also lead to mining subsidence and even ground fissures. Along the direction working panel advancing, ground fissures may occur in roof in front and/or behind working panel. However, the investigations of previous similarity tests in lab only emphasize on the region behind working panel. By improving strata material property in construction and mounting artificial pressure devices, two physical simulation tests were conducted and successfully investigated the simulated results. Then, the mechanical model of "cantilever beam and elastic foundation beam" was proposed to calculate the stress distribution and the crack initiation angle in overlying strata and it well explains the mechanisms of ground fissures generation and propagation. Results show that, the maximum internal force in roof always occurred in front of working panel. However, because the void space in gob due to excavation is large enough to cause the bend and rotation of roof strata, compare to the triaxially compressed region in front of working panel, the roof always broke off at some positions above gob since the stress concentration resulting from such bend and rotation of strata could easily reach the limit strength of strata rocks. Also, the length of cantilever beam changed dynamically as respect to the panel advancing and the breakage intervals. Thus, the breakage position where the internal force first reached the limit tensile strength is not fixed and there will be two different kinds of relative positions between the crack initiation point and the working panel. The crack initiation direction is always perpendicular to the internal force, and the crack propagation direction is affected by the initiation angle, overburden-separation degree and the position of the hydraulic shields. If there is no overburden-separation or less, the roofs will break off as a composite beam and the propagation direction will be roughly along the central line between the initial broken point and the support position. Otherwise, the roof strata will bend with the support shields moving forward, then the fracture angle will be close to the initiation angle and the fault surface will be stepped.	[Yang, Jing-Hu; Yu, Xiang; Yang, Yi; Yang, Zeng-Qiang] China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China; [Yang, Jing-Hu] China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrowth Energy &, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology	Yang, JH (corresponding author), China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China.; Yang, JH (corresponding author), China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrowth Energy &, Beijing, Peoples R China.	yjh_cumtb@126.com			National Basic Research Program (973 Program) [2013CB227903]	National Basic Research Program (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program (973 Program) (2013CB227903) to JHY. The URL is http://973.cumt.edu.cn/xb/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez MI, 2005, ENG GEOL, V80, P1, DOI 10.1016/j.enggeo.2005.02.004; Can E, 2011, SCI RES ESSAYS, V6, P1317, DOI DOI 10.5897/SRE10.1017; Can E, 2012, INT J COAL GEOL, V89, P62, DOI 10.1016/j.coal.2011.08.006; Deck O, 2003, ENG STRUCT, V25, P435, DOI 10.1016/S0141-0296(02)00184-0; Deck O, 2010, COMPUT GEOTECH, V37, P802, DOI 10.1016/j.compgeo.2010.07.001; Diaz-Fernandez ME, 2010, COMPUTAT GEOSCI, V14, P83, DOI 10.1007/s10596-009-9134-1; Diez R.R., 2000, GEOTECH GEOL ENG, V18, P289, DOI [10.1023/A:1016650120053, DOI 10.1023/A:1016650120053]; Duzgun HSB, 2005, INT J COAL GEOL, V64, P104, DOI 10.1016/j.coal.2005.03.008; Hadi Haeri, 2013, ARAB J GEOSCI, V8, P2841; Haeri H, 2014, J CENT SOUTH UNIV, V21, P2404, DOI 10.1007/s11771-014-2194-y; [胡振琪 Hu Zhenqi], 2014, [煤炭学报, Journal of China Coal Society], V39, P11; Ju JF, 2015, INT J ROCK MECH MIN, V78, P27, DOI 10.1016/j.ijrmms.2015.05.003; Jung HC, 2007, ENG GEOL, V92, P1, DOI 10.1016/j.enggeo.2007.02.007; Kratzsch H., 1983, MINING SUBSIDENCE EN; Li X, 2004, ENG GEOL, V76, P93, DOI 10.1016/j.enggeo.2004.06.008; Long Y., 1981, CALCULATION ELASTIC; Nicieza CG, 2005, INT J ROCK MECH MIN, V42, P372, DOI 10.1016/j.ijrmms.2004.12.003; Peng JB, 2013, ENG GEOL, V155, P19, DOI 10.1016/j.enggeo.2013.01.001; Saeidi A, 2009, ENG STRUCT, V31, P2275, DOI 10.1016/j.engstruct.2009.04.010; Torano J, 2000, INT J ROCK MECH MIN, V37, P1161, DOI 10.1016/S1365-1609(00)00046-0; Wang Xi GY, 2010, COOPERATIVE EC SCI, V12, P10, DOI DOI 10.1016/J.NEULET.2010.12.038; Whittaker B.N., 1989, SUBSIDENCE OCCURRENC, DOI 10.1016/0148-9062(90)95372-8; Xu NG, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/531518; Zhao HJ, 2013, ENVIRON EARTH SCI, V68, P1903, DOI 10.1007/s12665-012-1877-7; Zhu X.-J., 2014, ELECT J GEOTECHNICAL, V19, P9543	25	12	13	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192886	10.1371/journal.pone.0192886	http://dx.doi.org/10.1371/journal.pone.0192886			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513703	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800024
J	Singh, V; Bala, M; Bhargava, A; Kakran, M; Bhatnagar, R				Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika; Bhatnagar, Ravi			In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; THERAPY; SYNERGY; SUSCEPTIBILITY; AZITHROMYCIN; INDIA; CEFTRIAXONE; FAILURE; PROFILE; ETEST	Background Recent WHO guidelines recommend dual therapy with ceftriaxone or cefixime plus azithromycin for gonorrhea. Azithromycin in combination with gentamicin or spectinomycin has been recommended in treatment failure cases. Due to emergence of multi-drug resistant (MDR) and extensively-drug resistant (XDR) Neisseria gonorrhoeae strains, it is important to look for efficacy of these combinations and also of others that might be used in future. Therefore, we aimed to evaluate in vitro synergy of 21 dual combinations including current and alternative WHO recommended treatment regimens and other dual combinations. Methods and findings The potential utility of in-vitro interactions of 21 combinations was investigated against 95 N. gonorrhoeae strains including 79 MDR and one XDR strain collected during March 2013 to July 2017 and fractional inhibitory concentration index (FICI) was calculated. These 21 combinations comprised of two WHO currently recommended (cefixime+ azithromycin, ceftriaxone+azithromycin); two WHO recommended in treatment failure cases (azithromycin + gentamicin, spectinomycin+azithromycin) and other 17 combinations. Results FICI of the four WHO recommended antimicrobial combinations were higher (> 1.0) than the five novel combinationbreeds (FICI range 0.603-0.951) in the study i.e. gentamicin+ertapenem, moxifloxacin+ertapenem, spectinomycin+ertapenem, azithromycin+moxifloxacin, cefixime+ gentamicin. No antagonistic effect of the above four WHO recommended combinations except spectinomycin+azithromycin (FICI = 4.25) was observed for the XDR strain. Out of above five novel combinations, four combinations produced high synergistic effects in overall 95 strains and also for the XDR strain with FICI of 0.13 to 0.38. Antagonistic effects varying from 3.2 to 12.6% were observed for 10 out of 21 tested combinations (azithromycin in combination with gentamicin and spectinomycin; ceftriaxone with moxifloxacin, gentamicin, spectinomycin and ertapenem; spectinomycin with moxifloxacin and gentamicin; cefixime and gentamicin combination with moxifloxacin). Conclusion WHO recommended cefixime+azithromycin, ceftriaxone+azithromycin combinations having no antagonism indicates their continuing clinical utility. Highest antagonism without any synergistic effect for the WHO recommended spectinomycin+azithromycin in treatment failure cases suggests that this combination should be evaluated further both in vitro and in vivo. Highest synergistic or additive effect without any antagonistic effect of the above five novel combinations suggests that these may be recommended for treatment in future.	[Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika] VMMC, Apex Reg STI Training Res & Reference Lab, New Delhi, India; [Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika] Safdarjang Hosp, New Delhi, India; [Singh, Vikram; Bhatnagar, Ravi] SunRise Univ, Alwar, Rajasthan, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Bala, M (corresponding author), VMMC, Apex Reg STI Training Res & Reference Lab, New Delhi, India.; Bala, M (corresponding author), Safdarjang Hosp, New Delhi, India.	manjubala_2@hotmail.com		Singh, Vikram/0000-0003-2737-8102	Indian Council of Medical Research, India [5/3/3/4/2013-ECD-I]; RFC [ECD/ADHOC/41/2014-15]	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); RFC	This study was funded by Indian Council of Medical Research, India (ID No. 5/3/3/4/2013-ECD-I dated 13.3.15, RFC NO. ECD/ADHOC/41/2014-15) to MB.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB Biodisk, 2007, ET APPL SHEET M00005; Alirol E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002366; Bala M, 2016, ANTIMICROB AGENTS CH, V60, P7518, DOI 10.1128/AAC.01907-16; Bala M, 2016, J ANTIMICROB CHEMOTH, V71, P1856, DOI 10.1093/jac/dkw102; Bala M, 2015, SEX TRANSM DIS, V42, P218, DOI 10.1097/OLQ.0000000000000261; Bala M, 2013, SEX TRANSM INFECT, V89, P28, DOI 10.1136/sextrans-2012-050904; Bala M, 2011, SEX TRANSM DIS, V38, P1056, DOI 10.1097/OLQ.0b013e31822e6361; Barbee LA, 2014, J ANTIMICROB CHEMOTH, V69, P1572, DOI 10.1093/jac/dkt540; Bell SM, 2016, ANTIBIOTIC SUSCEPTIB, P56; Brown LB, 2010, SEX TRANSM DIS, V37, P169, DOI 10.1097/OLQ.0b013e3181bf575c; Centers for Disease Control and Prevention, 2017, CTR DIS CONTR PREV S; Fifer H, 2016, NEW ENGL J MED, V374, P2504, DOI 10.1056/NEJMc1512757; Furuya Ryusaburo, 2006, Journal of Infection and Chemotherapy, V12, P172, DOI 10.1007/s10156-006-0445-z; Furuya R, 2013, J INFECT CHEMOTHER, V19, P1218, DOI 10.1007/s10156-013-0597-6; Golparian D, 2013, SEX TRANSM INFECT, V89, pA114, DOI 10.1136/sextrans-2013-051184.0351; Kirkcaldy RD, 2014, CLIN INFECT DIS, V59, P1083, DOI 10.1093/cid/ciu521; Lee H, 2017, DIAGN MICR INFEC DIS, V87, P160, DOI 10.1016/j.diagmicrobio.2016.10.022; Lorian V., 1996, ANTIBIOTICS LAB MED, Vxvi, P1238; National AIDS Control Organisation, 2014, NAT GUID PREV MAN CO; Pereira R, 2013, J ANTIMICROB CHEMOTH, V68, P640, DOI 10.1093/jac/dks449; Singh V, 2017, SEX TRANS DIS; Singh V, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000969; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Unemo M, 2014, ANTIMICROB AGENTS CH, V58, P624, DOI 10.1128/AAC.02093-13; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P3603, DOI 10.1128/AAC.00326-12; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Wind CM, 2015, INT J ANTIMICROB AG, V45, P305, DOI 10.1016/j.ijantimicag.2014.10.020; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2012, GLOB ACT PLAN CONTR	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193678	10.1371/journal.pone.0193678	http://dx.doi.org/10.1371/journal.pone.0193678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509792	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200024
J	Iwata, M; Hara, K; Kamura, Y; Honoki, H; Fujisaka, S; Ishiki, M; Usui, I; Yagi, K; Fukushima, Y; Takano, A; Kato, H; Murakami, S; Higuchi, K; Kobashi, C; Fukuda, K; Koshimizu, Y; Tobe, K				Iwata, Minoru; Hara, Kazuo; Kamura, Yutaka; Honoki, Hisae; Fujisaka, Shiho; Ishiki, Manabu; Usui, Isao; Yagi, Kunimasa; Fukushima, Yasuo; Takano, Atsuko; Kato, Hiromi; Murakami, Shihou; Higuchi, Kiyohiro; Kobashi, Chikaaki; Fukuda, Kazuhito; Koshimizu, Yukiko; Tobe, Kazuyuki			Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance	PLOS ONE			English	Article							PLASMA ADIPONECTIN; RISK-FACTOR; ADIPOSE; PROTEIN; LEVEL; PIOGLITAZONE; GLUCOSE; ASTHMA; FORM	Aim Among the three adiponectin isoforms, a lower ratio of high molecular weight (HMW) adiponectin to total adiponectin (TA) is well known to cause insulin resistance and type 2 diabetes (T2D). However, how the levels of other adiponectin isoforms, such as the middle molecular weight (MMW) and low molecular weight (LMW) isoforms, and their relative ratio to TA change in T2D subjects has not been determined. Therefore, we investigated the association of these adiponectin-related parameters with T2D. Methods We examined the associations between adiponectin-related parameters and diabetes in a group of 394 T2D subjects and 374 controls (1st group) randomly selected from among the participants in our previous study. The associations between these parameters and the HOMA-IR in a 2nd group, consisting of the subjects remaining in the 1st group after the exclusion of subjects receiving diabetic medication, were also examined. Result In the 1st group, after adjusting for confounding factor, the levels of all the adiponectin isoforms and the HMW/TA ratio were significantly lower among the diabetic subjects than among the controls (all P values < 0.01). On the contrary, the LMW/TA ratio was significantly higher among the diabetic subjects (P < 0.01) and was positively associated with T2D (odds ratio = 8.64, P < 0.01). In the 2nd group, the HMW/TA ratio was inversely associated with the HOMA-IR; however, the LMW/TA ratio was positively associated with the HOMA-IR (beta for LMW/TA ratio = 0.89, SE = 0.24, P < 0.001), similar to the association with T2D. The MMW/TA ratio was not associated with T2D or the HOMA-IR. Conclusion The current investigation demonstrated that, unlike the reduction in the levels of all the adiponectin isoforms and the HMW/TA ratio, an increased LMW/TA ratio was associated with T2D through its relation to insulin resistance.	[Iwata, Minoru; Kamura, Yutaka; Honoki, Hisae; Fujisaka, Shiho; Ishiki, Manabu; Usui, Isao; Yagi, Kunimasa; Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Toyama, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama, Toyama, Japan; [Hara, Kazuo] Jichi Med Univ, Saitama Med Ctr, Dept Comprehens Med, Div Endocrinol & Metab,Omiya Ku, Saitama, Japan; [Hara, Kazuo] Tokyo Med Univ, Dept Diabetol Endocrinol & Metab, Shinjuku Ku, Tokyo, Japan; [Fukushima, Yasuo] Asahi Gen Hosp, Dept Internal Med, Asahi, Toyama, Japan; [Takano, Atsuko] Saiseikai Takaoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Kato, Hiromi] Japan Community Hlth Care Org Takaoka Fushiki Hos, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Murakami, Shihou] Toyama Rosai Hosp, Dept Internal Med, Div Endocrinol & Metab, Uozu, Toyama, Japan; [Higuchi, Kiyohiro] JA Niigata Kouseiren Itoigawa Gen Hosp, Dept Internal Med, Itoigawa, Niigata, Japan; [Kobashi, Chikaaki] Kamiichi Gen Hosp, Dept Internal Med, Kamiichi, Toyama, Japan; [Fukuda, Kazuhito] Fukuda Clin, Dept Internal Med, Himi, Toyama, Japan; [Koshimizu, Yukiko] Urata Clin, Dept Internal Med, Kanazawa, Ishikawa, Japan	University of Toyama; University of Toyama; Jichi Medical University; Tokyo Medical University	Iwata, M (corresponding author), Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Toyama, Japan.; Iwata, M (corresponding author), Toyama Univ, Hlth Adm Ctr, Toyama, Toyama, Japan.	iwamino-tym@umin.ac.jp	Yagi, Kunimasa/AAA-8666-2021	Yagi, Kunimasa/0000-0002-6805-6428; Iwata, MInoru/0000-0003-2161-1313	Ministry of Education, Culture, Sports, Science and Technology, Japan [24510276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (approved number 24510276). There were no additional funding sources for this study.	Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908; Crispim F, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-20; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Drzewoski J, 2006, CURR MED RES OPIN, V22, P1921, DOI 10.1185/030079906X132424; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Ebinuma H, 2006, CLIN CHIM ACTA, V372, P47, DOI 10.1016/j.cca.2006.03.014; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goto M, 2014, OBESITY, V22, P401, DOI 10.1002/oby.20553; Graessler J, 2011, GERONTOLOGY, V57, P316, DOI 10.1159/000316575; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hayashikawal Y, 2015, ENDOCR J, V62, P695, DOI 10.1507/endocrj.EJ14-0626; Hiramatsu S, 2004, DIABETES OBES METAB, V6, P231, DOI 10.1111/j.1462-8902.2004.00333.x; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Isobe T, 2005, EUR J ENDOCRINOL, V153, P91, DOI 10.1530/eje.1.01930; Iwase Masanori, 2008, Diabetes Res Clin Pract, V82, pe19, DOI 10.1016/j.diabres.2008.09.001; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165523; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Katsiki N, 2011, EXPERT OPIN THER TAR, V15, P401, DOI 10.1517/14728222.2011.553609; Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787, DOI 10.5551/jat.11833; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsumoto Y, 2013, ENDOCR J, V60, P119, DOI 10.1507/endocrj.EJ12-0277; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Nagasaka S, 2003, DIABETES CARE, V26, P2215, DOI 10.2337/diacare.26.7.2215; Nakano Y, 2006, J LIPID RES, V47, P1572, DOI 10.1194/jlr.D600010-JLR200; Nishimura R, 2007, J PEDIATR-US, V151, P545, DOI 10.1016/j.jpeds.2007.07.047; Ochiai H, 2008, ENDOCR J, V55, P549, DOI 10.1507/endocrj.K07E-107; Ohbuchi Y, 2014, INT J CLIN ONCOL, V19, P667, DOI 10.1007/s10147-013-0603-0; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Rubenstein JH, 2009, GUT, V58, P1583, DOI 10.1136/gut.2008.171553; Satoh Hiroki, 2010, Nutr Metab Cardiovasc Dis, V20, pe9, DOI 10.1016/j.numecd.2009.05.009; Seino Y, 2007, METABOLISM, V56, P1493, DOI 10.1016/j.metabol.2007.06.015; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Steffes MW, 2004, ANN EPIDEMIOL, V14, P492, DOI 10.1016/j.annepidem.2003.10.006; Su JR, 2016, HORM METAB RES, V48, P92, DOI 10.1055/s-0035-1569287; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolf AM, 2006, J HEPATOL, V44, P537, DOI 10.1016/j.jhep.2005.08.019; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	50	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192609	10.1371/journal.pone.0192609	http://dx.doi.org/10.1371/journal.pone.0192609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494595	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200012
J	Mauro, L; Naimo, GD; Gelsomino, L; Malivindi, R; Bruno, L; Pellegrino, M; Tarallo, R; Memoli, D; Weisz, A; Panno, ML; Ando, S				Mauro, Loredana; Naimo, Giuseppina Daniela; Gelsomino, Luca; Malivindi, Rocco; Bruno, Leonardo; Pellegrino, Michele; Tarallo, Roberta; Memoli, Domenico; Weisz, Alessandro; Panno, Maria Luisa; Ando, Sebastiano			Uncoupling effects of estrogen receptor on LKB1/AMPK interaction upon adiponectin exposure in breast cancer	FASEB JOURNAL			English	Article						breast cancer cells; ER; adiponectin levels; LKB1; AMPK signaling; cell metabolism	IN-VITRO; TUMOR-GROWTH; PPAR-GAMMA; ALPHA; EXPRESSION; PATHWAY; COMPLEX; PROTEIN; OBESITY; ACTIVATION	Adipose tissue is a metabolic and endocrine organ that secretes bioactive molecules called adipocytokines. Among these, adiponectin has a crucial role in obesity-associated breast cancer. The key molecule of adiponectin signaling is AMPK, which is mainly activated by liver kinase B1 (LKB1). Here, we demonstrated that estrogen receptor- (ER)/LKB1 interaction may negatively interfere with the LKB1 capability to phosphorylate AMPK and inhibit its downstream signaling TSC2/mTOR/p70S6k. In adiponectin-treated MCF-7 cells, AMPK signaling was not working, resulting in its downstream target acetyl-CoA carboxylase (ACC) being still active. In contrast, in MDA-MB-231 cells, AMPK and ACC phosphorylation was enhanced by adiponectin, inhibiting lipogenesis and cell growth. Upon adiponectin, ER signaling switched the energy balance of breast cancer cells toward a lipogenic phenotype. Therefore, adiponectin played an inhibitory role on ER-negative cell growth and progression in vitro and in vivo. In contrast, low adiponectin levels, similar to those circulating in obese patients, acted on ER-positive cells as a growth factor, stimulating proliferation. The latter effect was blunted in vivo by high adiponectin concentration. All this may have translational relevance, addressing how the handling of adiponectin, as a therapeutic tool in breast cancer treatment, needs to be carefully considered in ER-positive obese patients, where circulating levels of this adipocytokine are relatively low. In other words, in ER-positive breast cancer obese patients, higher adiponectin doses should be administered with respect to ER-negative breast cancer, also opportunely combined with antiestrogen therapy. Mauro, L., Naimo, G. D., Gelsomino, L., Malivindi, R., Bruno, L., Pellegrino, M., Tarallo, R., Memoli, D., Weisz, A., Panno, M. L., And, S. Uncoupling effects of estrogen receptor on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.	[Mauro, Loredana; Naimo, Giuseppina Daniela; Gelsomino, Luca; Malivindi, Rocco; Pellegrino, Michele; Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [Bruno, Leonardo] Univ Calabria, Dept Biol Ecol & Earth Sci, Arcavacata Di Rende, Italy; [Tarallo, Roberta; Memoli, Domenico; Weisz, Alessandro] Scuola Med Salernitana, Lab Mol Med & Genom, Dept Med Surg & Dent, Baronissi, Italy	University of Calabria; University of Calabria	Mauro, L; Ando, S (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Via P Bucci, I-87036 Cosenza, Italy.	loredana.mauro@unical.it; sebastiano.ando@unical.it	Malivindi, Rocco/ABB-8562-2021; Memoli, Domenico/AAA-7500-2019; Weisz, Alessandro/A-1317-2014	Memoli, Domenico/0000-0001-5290-2709; Weisz, Alessandro/0000-0003-0455-2083; Naimo, Giuseppina Daniela/0000-0002-7300-0111; MALIVINDI, Rocco/0000-0002-8313-2492; Bruno, Leonardo/0000-0001-8260-4729; Gelsomino, Luca/0000-0003-3076-3482	Associazione Italiana Ricerca sul Cancro (AIRC) [IG-18602, IG-17426]; Fondazione Italiana per la Ricerca sul Cancro (FIRC) [16487]; Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca [2015B7M39T_001]; Lilli Funaro foundation	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Lilli Funaro foundation	The authors thank Dr. S. A. W. Fuqua (Baylor College of Medicine, Houston, TX, USA) for providing wild-type YFP-ER alpha plasmid, Dr. D. Picard (University of Geneva, Geneva, Switzerland) for the XETL plasmid, and Dr. A. Cossari (Department of Economics, Statistics, and Finance, University of Calabria, Italy) for performing in vivo statistical analysis. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Grants IG-18602 (to S.A., M.L.P., L.M.) and IG-17426 (to A.W.); by Fondazione Italiana per la Ricerca sul Cancro (FIRC) Grant 16487 (to L.G.), by Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca Grant 2015B7M39T_001, and by funds from the Lilli Funaro foundation (to G.D.N.). The authors declare no conflicts of interest.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Catalano S, 2013, INT J CANCER, V132, P2237, DOI 10.1002/ijc.27915; Catalano S, 2011, AM J PATHOL, V179, P1030, DOI 10.1016/j.ajpath.2011.04.026; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; De Amicis F, 2013, MOL NUTR FOOD RES, V57, P840, DOI 10.1002/mnfr.201200560; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Guan DY, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0051-9; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043362; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Katira A, 2016, CANCER BIOL MED, V13, P101, DOI 10.28092/j.issn.2095-3941.2015.0092; Kim SH, 2014, CANCER LETT, V346, P249, DOI 10.1016/j.canlet.2013.12.031; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Korsse SE, 2013, BBA-REV CANCER, V1835, P194, DOI 10.1016/j.bbcan.2012.12.006; Lam JBB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004968; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SF, 2018, ANTI-CANCER AGENT ME, V18, P314, DOI 10.2174/1871520617666170327120747; Li TG, 2009, PPAR RES, V2009, DOI 10.1155/2009/501739; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maccio A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787; Mancuso MR, 2016, CURR PROB CANCER, V40, P95, DOI 10.1016/j.currproblcancer.2016.09.001; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; Mauro L, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00157; Mauro L, 2015, FASEB J, V29, P2150, DOI 10.1096/fj.14-262808; Mauro L, 2014, CELL CYCLE, V13, P553, DOI 10.4161/cc.27455; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Medina-Gomez G, 2007, PUBLIC HEALTH NUTR, V10, P1132, DOI 10.1017/S1368980007000614; Nardone A, 2015, BREAST, V24, pS60, DOI 10.1016/j.breast.2015.07.015; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Panno ML, 2016, CURR OPIN PHARMACOL, V31, P1, DOI 10.1016/j.coph.2016.08.001; Panno ML, 2006, J MOL ENDOCRINOL, V36, P91, DOI 10.1677/jme.1.01848; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sisci D, 2013, CELL CYCLE, V12, P3405, DOI 10.4161/cc.26421; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Takahata C, 2007, CANCER LETT, V250, P229, DOI 10.1016/j.canlet.2006.10.006; Tarallo R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1321-0; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87	62	19	20	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4343	4355		10.1096/fj.201701315R	http://dx.doi.org/10.1096/fj.201701315R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513571				2022-12-26	WOS:000439325400024
J	Mukai, S; Ogawa, Y; Kawakami, Y; Mashima, Y; Tsubota, K				Mukai, Shin; Ogawa, Yoko; Kawakami, Yutaka; Mashima, Yukihiko; Tsubota, Kazuo			Inhibition of Vascular Adhesion Protein-1 for Treatment of Graft-Versus-Host Disease in Mice	FASEB JOURNAL			English	Article						age-associated disease; refractory disease; inhibitor; inflammation; fibrosis	TISSUE GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION; T-CELLS; VAP-1; EXPRESSION; BLOCKADE; GVHD; TRANSPLANTATION; INFLAMMATION; MECHANISM	Graft-versus-host disease (GVHD) is a potentially lethal complication of hematopoietic stem cell transplantation (HSCT). GVHD comprises acute and chronic forms. To date, several approaches to treat acute GVHD or chronic GVHD have been reported. However, there is no literature precedent regarding all-in-one methods to address the 2 GVHD types. Severe inflammation in organs affected by GVHD is highly problematic, and vascular adhesion protein-1 (VAP-1) is known to be detrimentally involved in various inflammatory diseases. Based on the previous reports, we envisaged that there would be a link between GVHD and VAP-1, and we strived to create effective therapies for the 2 types of GVHD using a mouse model of GVHD. Our investigation indicated that expression of VAP-1 was elevated in organs disordered by GVHD. Hence, we subsequently attempted to block VAP-1 by using a novel inhibitor. Our results indicate that systemic injection of the inhibitor prevented aberrant influx of inflammatory cells into tissues and thereby mitigate GVHD-elicited inflammation and fibrosis. Collectively, our study suggests that the increased expression of VAP-1 is detrimentally associated with the development of GVHD and that the blockade of VAP-1 could be a promising medical modality to combat the acute and chronic variants.Mukai, S., Ogawa, Y., Kawakami, Y., Mashima, Y., Tsubota, K. Inhibition of vascular adhesion protein-1 for treatment of graft-versus-host disease in mice.	[Mukai, Shin; Ogawa, Yoko; Mashima, Yukihiko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mukai, Shin; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Mashima, Yukihiko] Sucampo Pharmaceut Inc, Tokyo, Japan	Keio University; Keio University	Ogawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoko@z7.keio.jp	Ogawa, Yoko/AAV-1932-2021; Tsubota, Kazuo/M-1915-2013	Ogawa, Yoko/0000-0002-2906-9621; Tsubota, Kazuo/0000-0002-8874-7111	Japanese Ministry of Education, Science, Sports and Culture [26462668]; Sucampo Pharmaceuticals	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sucampo Pharmaceuticals	This research was subsidized by the Japanese Ministry of Education, Science, Sports and Culture (#26462668). The assistance of Dr. Toshihiro Nagai and Dr. Tetsuya Yano at the Keio University School of Medicine is also gratefully appreciated. Financial and non-financial support from Sucampo Pharmaceuticals was given to K.T. and Y.O. Y.M. is a special adviser for Sucampo Pharmaceuticals. The authors declare no other conflicts of interest.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Akin E, 2001, INFECT IMMUN, V69, P1774, DOI 10.1128/IAI.69.3.1774-1780.2001; Anderson Graeme, 1996, P47; Aronni S, 2006, EUR J OPHTHALMOL, V16, P17, DOI 10.1177/112067210601600104; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bligt-Linden E, 2013, J MED CHEM, V56, P9837, DOI 10.1021/jm401372d; Ceredig R, 2012, IMMUNOL CELL BIOL, V90, P253, DOI 10.1038/icb.2011.62; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Dziadzio M, 2005, QJM-INT J MED, V98, P485, DOI 10.1093/qjmed/hci078; Flowers MED, 2015, BLOOD, V125, P606, DOI 10.1182/blood-2014-08-551994; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; He J., 2018, CORNEA, DOI [10. 1097/ICO. 0000000000001487, DOI 10.1097/IC0.0000000000001487]; Hopwood D, 1996, THEORY PRACTICE HIST, P23; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; Kawai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02455; Kim SW, 2016, EXP HEMATOL, V44, P332, DOI 10.1016/j.exphem.2016.02.002; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kitko CL, 2012, BIOL BLOOD MARROW TR, V18, pS46, DOI 10.1016/j.bbmt.2011.10.021; Krupski MC, 2016, BIOL BLOOD MARROW TR, V22, pS404, DOI 10.1016/j.bbmt.2015.11.932; McGeough MD, 2012, J IMMUNOL, V189, P2707, DOI 10.4049/jimmunol.1101737; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Noda K, 2009, EXP EYE RES, V89, P774, DOI 10.1016/j.exer.2009.07.010; Noonan T, 2013, AM J CLIN EXP IMMUNO, V2, P172; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.09394; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Sampson MJ, 2006, DIABETOLOGIA, V49, P1726, DOI 10.1007/s00125-006-0322-4; Sato S, 2000, J RHEUMATOL, V27, P149; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Singh B, 2003, VIRCHOWS ARCH, V442, P491, DOI 10.1007/s00428-003-0802-6; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Solomon SR, 2003, BONE MARROW TRANSPL, V31, P783, DOI 10.1038/sj.bmt.1703928; Toubai T, 2008, BEST PRACT RES CL HA, V21, P101, DOI 10.1016/j.beha.2008.02.005; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Vogelsang GB, 2001, BLOOD, V97, P1196, DOI 10.1182/blood.V97.5.1196; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058397; Wu T, 2013, J IMMUNOL, V191, P488, DOI 10.4049/jimmunol.1300657; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Yoon HK, 2010, TRANSPLANTATION, V90, P853, DOI 10.1097/TP.0b013e3181f2c92b; Yoshikawa N, 2012, MOL VIS, V18, P593	44	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4085	4095		10.1096/fj.201700176R	http://dx.doi.org/10.1096/fj.201700176R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29490166				2022-12-26	WOS:000439325400003
J	Takahashi, K; Ehata, S; Koinuma, D; Morishita, Y; Soda, M; Mano, H; Miyazono, K				Takahashi, Kei; Ehata, Shogo; Koinuma, Daizo; Morishita, Yasuyuki; Soda, Manabu; Mano, Hiroyuki; Miyazono, Kohei			Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells	ONCOGENE			English	Article							DISTANT METASTASIS; NESTIN; EXPRESSION; PROLIFERATION; FIBROBLASTS; MARKER; GROWTH; PROGRESSION; PROGNOSIS; EVOLUTION	Tumor microenvironment plays a pivotal role in cancer progression; however, little is known regarding how differences in the microenvironment affect characteristics of cancer cells. Here, we investigated the effects of tumor microenvironment on cancer cells by using mouse tumor models. After three cycles of inoculation and extraction of human pancreatic cancer cells, including SUIT-2 and Panc-1 cells, from tumors, distinct cancer cell lines were established: 3P cells from the pancreas obtained using the orthotopic tumor model and 3sc cells from subcutaneous tissue obtained using the subcutaneous tumor model. On re-inoculation of these cells, the 3sc cells and, more prominently, the 3P cells, exhibited higher tumorigenic activity than the parental cells. The 3P cells specifically exhibited low E-cadherin expression and high invasiveness, suggesting that they were endowed with the highest malignant characteristics. RNA-sequence analysis demonstrated that distinct signaling pathways were activated in each cell line and that the 3P cells acquired a cancer stem cell-like phenotype. Among cancer stem cell-related genes, those specifically expressed in the 3P cells, including NES, may be potential new targets for cancer therapy. The mechanisms underlying the development of highly malignant cancer cell lines were investigated. Individual cell clones within the parental cells varied in tumor-forming ability, indicating the presence of cellular heterogeneity. Moreover, the tumor-forming ability and the gene expression profile of each cell clone were altered after serial orthotopic inoculations. The present study thus suggests that both selection and education processes by tumor microenvironment are involved in the development of highly malignant cancer cells.	[Takahashi, Kei; Ehata, Shogo; Koinuma, Daizo; Morishita, Yasuyuki; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Soda, Manabu; Mano, Hiroyuki] Univ Tokyo, Dept Cellular Signaling, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122; Ehata, Shogo/0000-0002-6740-9391; Takahashi-Yamashiro, Kei/0000-0002-7925-6636	Grand for Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED) [16ck0106193h0001]; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22112002]; KAKENHI from the Japan Society for the Promotion of Science (JSPS), [15K08393, 25-10991]; Yasuda Medical Foundation; Cell Science Research Foundation; Tokyo Society of Medical Sciences; Grants-in-Aid for Scientific Research [15H05774, 17H06326] Funding Source: KAKEN	Grand for Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI from the Japan Society for the Promotion of Science (JSPS),(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yasuda Medical Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Tokyo Society of Medical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Yoko Katsuno, Dr. Yuichiro Yokoyama, and Dr. Yukari Hoshino (The University of Tokyo) for their technical assistance, and Hiroyuki Miyoshi (Keio University) for providing the lentiviral vectors. This work was supported by a Grand for Practical Research for Innovative Cancer Control (16ck0106193h0001) from the Japan Agency for Medical Research and Development (AMED; K.M.), a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas, Integrative Research on Cancer Microenvironment Network (22112002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; K.M.), a KAKENHI Grant-in-Aid for Scientific Research (C; 15K08393; S.E.) and Research Fellowship for Young Scientists (25-10991; K.T.) from the Japan Society for the Promotion of Science (JSPS), Specific Research Grants from Yasuda Medical Foundation (K.M.), The Cell Science Research Foundation (S.E.), and The Tokyo Society of Medical Sciences (S.E.).	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arase M, 2014, CANCER SCI, V105, P974, DOI 10.1111/cas.12454; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Eguchi D, 2013, SURGERY, V154, P573, DOI 10.1016/j.surg.2013.03.010; Ehrmann J, 2005, J CLIN PATHOL, V58, P222, DOI 10.1136/jcp.2004.021238; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hippo Y, 2001, CANCER RES, V61, P889; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hoshino Y, 2015, AM J PATHOL, V185, P1457, DOI 10.1016/j.ajpath.2015.01.011; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Liu CG, 2010, CANCER SCI, V101, P815, DOI 10.1111/j.1349-7006.2009.01422.x; Ma J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.293; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Matsuda Y, 2016, PANCREAS, V45, P93, DOI 10.1097/MPA.0000000000000427; Murai F, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.26; Neradil J, 2015, CANCER SCI, V106, P803, DOI 10.1111/cas.12691; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Perera RM, 2015, CANCER DISCOV, V5, P1247, DOI 10.1158/2159-8290.CD-15-0671; Piras F, 2010, ONCOL REP, V23, P17, DOI 10.3892/or_00000601; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Qian LW, 2003, CANCER LETT, V190, P105, DOI 10.1016/S0304-3835(02)00517-7; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050; Takahashi K, 2015, CANCER SCI, V106, P867, DOI 10.1111/cas.12685; Takeda K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14607; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yokoyama Y, 2017, CANCER RES, V77, P4026, DOI 10.1158/0008-5472.CAN-17-0112; Zhao ZW, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0408-8	41	47	50	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2757	2772		10.1038/s41388-018-0144-0	http://dx.doi.org/10.1038/s41388-018-0144-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511349	hybrid, Green Published			2022-12-26	WOS:000432929800001
J	Zhao, YH; Hu, XD; Wei, L; Song, D; Wang, JJ; You, LF; Saiyin, H; Li, ZJ; Yu, WB; Yu, L; Ding, J; Wu, JX				Zhao, Yahui; Hu, Xiaoding; Wei, Li; Song, Dan; Wang, Juanjuan; You, Lifang; Saiyin, Hexige; Li, Zhaojie; Yu, Wenbo; Yu, Long; Ding, Jin; Wu, Jiaxue			PARP10 suppresses tumor metastasis through regulation of Aurora A activity	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA METASTASIS; ADP-RIBOSYLTRANSFERASE ARTD10; MESENCHYMAL TRANSITION; CANCER-THERAPY; KINASE; CELLS; POLY(ADP-RIBOSE); RIBOSYLATION; MIGRATION; TARGETS	ADP-ribosylation, including poly-ADP-ribosylation (PARylation) and mono-ADP-ribosylation (MARylation), is a multifunctional post-translational modification catalyzed by intracellular ADP-ribosyltransferases (ARTDs or PARPs). Although PARylation has been investigated most thoroughly, the function of MARylation is currently largely undefined. Here, we provide evidences that deficiency of PARP10, a mono-ADP-ribosyltransferase, markedly increased the migration and invasion of tumor cells through regulation of epithelial-mesenchymal transition (EMT), and PARP10 inhibited tumor metastasis in vivo, which was dependent on its enzyme activity. Mechanistically, we found that PARP10 interacted with and mono-ADP-ribosylated Aurora A, and inhibited its kinase activity, thereby regulating its downstream signaling. Moreover, the expression level of PARP10 was downregulated in intrahepatic metastatic hepatocellular carcinoma (HCC) compared with its corresponding primary HCC and adjacent non-tumorous tissues. Taken together, our results indicated that PARP10 has an important role in tumor metastasis suppression via negatively regulation of Aurora A activity.	[Zhao, Yahui; Hu, Xiaoding; Song, Dan; Wang, Juanjuan; You, Lifang; Saiyin, Hexige; Yu, Wenbo; Yu, Long; Wu, Jiaxue] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China; [Zhao, Yahui; Hu, Xiaoding; Song, Dan; Wang, Juanjuan; You, Lifang; Saiyin, Hexige; Yu, Wenbo; Yu, Long; Wu, Jiaxue] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Wei, Li] 401 Hosp PLA, Dept Oncol, Qingdao, Peoples R China; [Li, Zhaojie] Shanghai Appl Prot Technol Co Ltd, Shanghai, Peoples R China; [Ding, Jin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp Inst, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China	Fudan University; Fudan University; Naval Medical University	Wu, JX (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.; Wu, JX (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China.	jiaxue@fudan.edu.cn	wang, juanjuan/GYV-5540-2022	Wang, Juanjuan/0000-0001-5477-8860; Hu, xiaoding/0000-0002-3144-1859	national key research and development plan [2016YFC0902401]; National Natural Science Foundation of China [81272250, 81472619]; National Key Sci-Tech Special Project of China [2013ZX10002010-08]	national key research and development plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China	This work was supported by national key research and development plan (2016YFC0902401 to JW); the National Natural Science Foundation of China (81272250 and 81472619 to JW) and the National Key Sci-Tech Special Project of China (2013ZX10002010-08 to JW).	Chen T, 2017, NATURE COMMUN, V8, P1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; Forst AH, 2013, STRUCTURE, V21, P462, DOI 10.1016/j.str.2012.12.019; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Herzog N, 2013, FEBS J, V280, P1330, DOI 10.1111/febs.12124; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hu X, 2017, ONCOGENE, V36, P4047, DOI 10.1038/onc.2017.10; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaufmann M, 2015, CURR TOP MICROBIOL, V384, P167, DOI 10.1007/82_2014_379; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Kleine H, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-28; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Nicolae CM, 2014, J BIOL CHEM, V289, P13627, DOI 10.1074/jbc.M114.556340; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Tatsuka M, 2009, MOL CARCINOGEN, V48, P810, DOI 10.1002/mc.20525; Verheugd P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2672; Vyas S, 2014, NAT REV CANCER, V14, P502, DOI 10.1038/nrc3748; Wang JJ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.34; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang XX, 2012, MOL CANCER RES, V10, P588, DOI 10.1158/1541-7786.MCR-11-0416; Wu D, 2016, HEPATOLOGY, V64, P1148, DOI 10.1002/hep.28708; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399; Yang N, 2017, ONCOGENE, V36, P3428, DOI 10.1038/onc.2016.490; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zheng FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10180	33	28	29	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2921	2935		10.1038/s41388-018-0168-5	http://dx.doi.org/10.1038/s41388-018-0168-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29515234				2022-12-26	WOS:000433936300002
J	Zhao, XP; Zhao, L; Yang, H; Li, JJ; Min, XJ; Yang, FJ; Liu, JJ; Huang, G				Zhao, Xiaoping; Zhao, Li; Yang, Hao; Li, Jiajin; Min, Xuejie; Yang, Fajun; Liu, Jianjun; Huang, Gang			Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid metabolism; gene transcription; hepatocellular carcinoma; lipid synthesis; lipogenesis; cell proliferation; liver cancer; pyruvate kinase; PKM2; SREBP-1a; sterol regulatory element-binding protein	LIPID-METABOLISM; GENE-TRANSCRIPTION; CANCER-CELLS; TUMOR-GROWTH; TUMORIGENESIS; PATHWAY; EXPRESSION; PROGNOSIS; ISOFORM; SREBP1	Dysregulation of lipid metabolism is common in cancer cells, but the underlying mechanisms are poorly understood. Sterol regulatory element-binding proteins (SREBPs) stimulate lipid biosynthesis through transcriptional activation of lipogenic enzymes. However, SREBPs' roles and potential interacting partners in cancer cells are not fully defined. Using a biochemical approach, we found here that pyruvate kinase M2 (PKM2) physically interacts with the nuclear form of SREBP-1a (nBP1a), by binding to amino acids 43-56 in nBP1a. We also found that PKM2 activates SREBP target gene expression and lipid biosynthesis by stabilizing nBP1a proteins. Using a competitive peptide inhibitor to block the formation of the SREBP-1a/PKM2 complex, we observed that this blockade inhibited lipogenic gene expression. Of note, nBP1a phosphorylation at Thr-59 enhanced the binding to PKM2 and promoted cancer cell growth. Moreover, we show that PKM2 phosphorylates Thr-59 in vitro. Lastly, in human patients with hepatocellular carcinoma, nBP1a phosphorylation at Thr-59 was negatively correlated with clinical outcomes. Together, our results reveal that nBP1a/PKM2 interaction activates lipid metabolism genes in cancer cells and that Thr-59 phosphorylation of SREBP-1a plays an important role in cancer cell proliferation.	[Zhao, Xiaoping; Zhao, Li; Li, Jiajin; Min, Xuejie; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Dept Nucl Med, Ren Ji Hosp, Sch Med, Shanghai 200127, Peoples R China; [Yang, Hao; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200025, Peoples R China; [Yang, Fajun] Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, New York, NY 10461 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Yeshiva University	Zhao, XP; Liu, JJ; Huang, G (corresponding author), Shanghai Jiao Tong Univ, Dept Nucl Med, Ren Ji Hosp, Sch Med, Shanghai 200127, Peoples R China.; Huang, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200025, Peoples R China.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, New York, NY 10461 USA.	zxp0856@sina.com; fajun.yang@einstein.yu.edu; nuclearj@163.com; huang2802@163.com		Li, Jiajin/0000-0003-1300-6025	NIDDK NIH HHS [P30 DK026687, R01 DK098439, R01 DK110063, P60 DK020541, P30 DK020541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110063, P30DK026687, P30DK020541, R01DK098439, P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bluemlein K, 2011, ONCOTARGET, V2, P393; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Desai S, 2014, ONCOTARGET, V5, P8202, DOI 10.18632/oncotarget.1159; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Li N, 2017, HEPATOLOGY, V65, P1936, DOI 10.1002/hep.29018; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MEDES G, 1953, CANCER RES, V13, P27; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Sun Y, 2015, TUMOR BIOL, V36, P4133, DOI 10.1007/s13277-015-3047-5; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	29	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6623	6634		10.1074/jbc.RA117.000100	http://dx.doi.org/10.1074/jbc.RA117.000100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29514980	Green Published, hybrid			2022-12-26	WOS:000431108600032
J	Gujar, H; Liang, JW; Wong, NC; Mozhui, K				Gujar, Hemant; Liang, Jane W.; Wong, Nicholas C.; Mozhui, Khyobeni			Profiling DNA methylation differences between inbred mouse strains on the Illumina Human Infinium MethylationEPIC microarray	PLOS ONE			English	Article							FALSE DISCOVERY RATE; WIDE ASSOCIATION; GENE-EXPRESSION; CPG ISLANDS; EPIGENETIC MODIFICATIONS; BIOCONDUCTOR PACKAGE; HUMAN-DISEASE; HUMAN GENOME; STEM-CELLS; MICE	The Illumina Infinium MethylationEPIC provides an efficient platform for profiling DNA methylation in humans at over 850,000 CpGs. Model organisms such as mice do not currently benefit from an equivalent array. Here we used this array to measure DNA methylation in mice. We defined probes targeting conserved regions and performed differential methylation analysis and compared between the array-based assay and affinity-based DNA sequencing of methyl-CpGs (MBD-seq) and reduced representation bisulfite sequencing. Mouse samples consisted of 11 liver DNA from two strains, C57BL/6J (B6) and DBA/2J (D2), that varied widely in age. Linear regression was applied to detect differential methylation. In total, 13,665 probes (1.6% of total probes) aligned to conserved CpGs. Beta-values (a-value) for these probes showed a distribution similar to that in humans. Overall, there was high concordance in methylation signal between the EPIC array and MBD-seq (Pearson correlation r = 0.70, p-value < 0.0001). However, the EPIC probes had higher quantitative sensitivity at CpGs that are hypo-(beta-value < 0.3) or hypermethylated (beta-value > 0.7). In terms of differential methylation, no EPIC probe detected a significant difference between age groups at a Benjamini-Hochberg threshold of 10%, and the MBD-seq performed better at detecting age-dependent change in methylation. However, the top most significant probe for age (cg13269407; uncorrected p-value = 1.8 x 10(-5)) is part of the clock CpGs used to estimate the human epigenetic age. For strain, 219 EPIC probes detected significant differential methylation (FDR cutoff 10%) with similar to 80% CpGs associated with higher methylation in D2. This higher methylation profile in D2 compared to B6 was also replicated by the MBDseq data. To summarize, we found only a small subset of EPIC probes that target conserved sites. However, for this small subset the array provides a reliable assay of DNA methylation and can be effectively used to measure differential methylation in mice.	[Gujar, Hemant; Liang, Jane W.; Mozhui, Khyobeni] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN 38163 USA; [Wong, Nicholas C.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic, Australia; [Mozhui, Khyobeni] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; Monash University; University of Tennessee System; University of Tennessee Health Science Center	Mozhui, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN 38163 USA.; Mozhui, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	kmozhui@uthsc.edu	Wong, Nick Wong/AAF-8627-2021; Gujar, Hemant/DOZ-5236-2022	Wong, Nick Wong/0000-0003-4393-7541; Liang, Jane/0000-0002-2302-3809	University of Tennessee [UTCOM-2013KM]; National Institute of Aging [R01AG043930]	University of Tennessee; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by University of Tennessee Faculty AwardUTCOM-2013KM, National Institute of Aging grant number R01AG043930.	Aberg KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132205; Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]; Adjaye J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-83; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bar-Or C, 2007, TRENDS GENET, V23, P200, DOI 10.1016/j.tig.2007.02.003; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; De Meyer T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15375; De Meyer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059068; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang DH, 2010, AGING CLIN EXP RES, V22, P8, DOI 10.1007/BF03324809; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lovkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124; Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247; Laffita-Mesa JM, 2012, HUM GENET, V131, P625, DOI 10.1007/s00439-011-1101-y; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Morgan AP, 2016, G3-GENES GENOM GENET, V6, P263, DOI 10.1534/g3.115.022087; Mozhui K, 2017, MECH AGEING DEV, V162, P27, DOI 10.1016/j.mad.2017.02.006; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Mulligan MK, 2017, METHODS MOL BIOL, V1488, P75, DOI 10.1007/978-1-4939-6427-7_4; Needhamsen M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1870-y; Orozco LD, 2015, CELL METAB, V21, P905, DOI 10.1016/j.cmet.2015.04.025; Orozco LD, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r68; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Robinson MD, 2010, EPIGENOMICS-UK, V2, P587, DOI 10.2217/EPI.10.36; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Simeone P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12047; Sloane LB, 2011, J GERONTOL A-BIOL, V66, P170, DOI 10.1093/gerona/glq169; Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5; Swartz JR, 2017, MOL PSYCHIATR, V22, P209, DOI 10.1038/mp.2016.82; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Tryndyak VP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2617-2; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Wong NC, 2013, GENOMICS, V102, P38, DOI 10.1016/j.ygeno.2013.04.014; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9	64	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193496	10.1371/journal.pone.0193496	http://dx.doi.org/10.1371/journal.pone.0193496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529061	Green Published, Green Submitted, gold			2022-12-26	WOS:000427189300024
J	Xing, MM; Sun, C; Li, HL; Hu, SL; Lei, L; Kang, JG				Xing, Miaomiao; Sun, Chao; Li, Hailong; Hu, Shilin; Lei, Lei; Kang, Jungen			Integrated analysis of transcriptome and proteome changes related to the Ogura cytoplasmic male sterility in cabbage	PLOS ONE			English	Article							MITOCHONDRIAL RETROGRADE REGULATION; MALE GAMETOPHYTE DEVELOPMENT; POLLEN EXINE DEVELOPMENT; PROGRAMMED CELL-DEATH; ANTHER-SPECIFIC GENES; TRITICUM-AESTIVUM L.; ARABIDOPSIS-THALIANA; SPOROPOLLENIN SYNTHESIS; BRASSICA-OLERACEA; ABC TRANSPORTER	Cabbage (Brassica oleracea L. var. capitata), an important vegetable crop in the Brassicaceae family, is economically important worldwide. In the process of hybrid seed production, Ogura cytoplasmic male sterility (OguCMS), controlled by the mitochondrial gene orf138, has been extensively used for cabbage hybrid production with complete and stable male sterility. To identify the critical genes and pathways involved in the sterility and to better understand the underlying molecular mechanisms, the anther of OguCMS line R2P2CMS and the fertile line R2P2 were used for RNA-seq and iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) proteome analysis. RNA-seq analysis generated 13,037,109 to 13,066,594 SE50-clean reads, from the sterile and fertile lines, which were assembled into 36,890 unigenes. Among them, 1,323 differentially expressed genes (DEGs) were identified, consisting of 307 up-and 1016 down-regulated genes. For ITRAQ analysis, a total of 7,147 unique proteins were identified, and 833 were differentially expressed including 538 up-and 295 down-regulated proteins. These were mainly annotated to the ribosome, spliceosome and mRNA surveillance pathways. Combined transcriptomic and proteomic analyses identified 22 and 70 genes with the same and opposite expression profiles, respectively. Using KEGG analysis of DEGs, gibberellin mediated signaling pathways regulating tapetum programmed cell death and four different pathways involved in sporopollenin synthesis were identified. Secretion and translocation of the sporopollenin precursors were identified, and the key genes participating in these pathways were all significantly down-regulated in R2P2CMS. Light and transmission electron (TE) microscopy revealed fat abnormal tapetum rather than vacuolization and degradation at the tetrad and microspore stages of the OguCMS line. This resulted in the failed deposition of sporopollenin on the pollen resulting in sterility. This study provides a comprehensive understanding of the mechanism underlying OguCMS in cabbage.	[Xing, Miaomiao; Sun, Chao; Li, Hailong; Hu, Shilin; Lei, Lei; Kang, Jungen] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Kang, JG (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing, Peoples R China.	kangjungen@nercv.org		Jungen, Kang/0000-0002-9952-057X	Natural Science Foundation of China [31372065]; National Key Research and Development Program [2016YFD0101702, 2016YFD0101804]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period [2014BAD01B08]; National Natural Science Foundation of China [31372065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the Natural Science Foundation of China (31372065), the National Key Research and Development Program (2016YFD0101702, 2016YFD0101804) and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2014BAD01B08) to JK. The work reported here was carried out in the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (North China), Ministry of Agriculture, Beijing 100097, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Grants from the National key research and development program (2016YFD0101702, 2016YFD0101804), the National Natural Science Foundation of China (31372065), and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2014BAD01B08). We would like to thank the native English speaking scientists of Elixigen Company (Huntington Beach, California) for editing our manuscript.	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; Ariizumi T, 2008, PLANT CELL PHYSIOL, V49, P58, DOI 10.1093/pcp/pcm167; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Beerhues L, 1993, PL SYST EVOL S, V7, P117; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Chang ZY, 2016, P NATL ACAD SCI USA, V113, P14145, DOI 10.1073/pnas.1613792113; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Dong X, 2016, MOL GENET GENOMICS, V291, P531, DOI 10.1007/s00438-015-1123-6; Dong X, 2013, PLANT SCI, V199, P7, DOI 10.1016/j.plantsci.2012.11.001; Ducos E, 2001, PLANT J, V26, P171, DOI 10.1046/j.1365-313x.2001.01017.x; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Fujii S, 2008, PLANT CELL PHYSIOL, V49, P633, DOI 10.1093/pcp/pcn036; Fujii S, 2007, PLANT MOL BIOL, V63, P405, DOI 10.1007/s11103-006-9097-8; Guo Y, 2012, CABB FLOW 2012 6 INT; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hernandez-Pinzon I, 1999, PLANTA, V208, P588, DOI 10.1007/s004250050597; HESLOPHARRISON J, 1968, CAN J BOTANY, V46, P1185, DOI 10.1139/b68-158; Phan HA, 2011, PLANT CELL, V23, P2209, DOI 10.1105/tpc.110.082651; Kang JG, 2008, PLANT MOL BIOL, V66, P177, DOI 10.1007/s11103-007-9261-9; Kang JE, 2014, MOL BIOL REP, V41, P2005, DOI 10.1007/s11033-014-3048-2; Kurdyukov S, 2006, PLANTA, V224, P315, DOI 10.1007/s00425-005-0215-7; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li JJ, 2016, J PROTEOMICS, V138, P72, DOI 10.1016/j.jprot.2016.02.017; Liu HaiXia, 2010, Acta Horticulturae Sinica, V37, P1953; Ma Y, 2015, PLANT MOL BIOL, V87, P541, DOI 10.1007/s11103-015-0287-0; McNeil KJ, 2010, PLANTA, V231, P793, DOI 10.1007/s00425-009-1089-x; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Nishikawa SI, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-22; Pan ZY, 2012, J PROTEOMICS, V75, P4879, DOI 10.1016/j.jprot.2012.05.042; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rubinelli P, 1998, PLANT MOL BIOL, V37, P607, DOI 10.1023/A:1005964431302; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; SHEN JB, 1992, MOL GEN GENET, V234, P379, DOI 10.1007/BF00538697; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Tang LK, 2009, NEW PHYTOL, V181, P576, DOI 10.1111/j.1469-8137.2008.02692.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Wang AM, 2002, PLANT J, V30, P613, DOI 10.1046/j.1365-313X.2002.01313.x; Wang S, 2016, PLANT PHYSIOL BIOCH, V105, P224, DOI 10.1016/j.plaphy.2016.04.027; [王效维 WANG Xiaowei], 2011, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V20, P111; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Wu SB, 2008, PLANT CELL REP, V27, P1441, DOI 10.1007/s00299-008-0572-3; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yang JH, 2009, MOL BIOL REP, V36, P273, DOI 10.1007/s11033-007-9176-1; Yang Jing-Hua, 2007, Yichuan, V29, P1173, DOI 10.1360/yc-007-1173; Yang LiMei, 2011, China Vegetables, P1; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; Yang X., 2017, J ADV TRANSPORT, V2017, P1, DOI [10.1155/2017/4341532, DOI 10.1155/2017/4341532]; Yang YX, 2014, PLANT CELL TISS ORG, V119, P383, DOI 10.1007/s11240-014-0542-0; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282; Zhang FN, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2077-y; Zhang H, 2007, PLANT CELL REP, V26, P1065, DOI 10.1007/s00299-006-0293-4; Zhang Lei, 2012, Journal of Agricultural Biotechnology, V20, P627; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu J, 2010, SCI CHINA LIFE SCI, V53, P1112, DOI 10.1007/s11427-010-4060-y; Zinkl GM, 2000, ANN BOT-LONDON, V85, P15, DOI 10.1006/anbo.1999.1066	73	24	24	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193462	10.1371/journal.pone.0193462	http://dx.doi.org/10.1371/journal.pone.0193462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529074	gold, Green Published, Green Submitted			2022-12-26	WOS:000427189300022
J	Golenkina, S; Chaturvedi, V; Saint, R; Murray, MJ				Golenkina, Sofia; Chaturvedi, Vishal; Saint, Robert; Murray, Michael J.			Frazzled can act through distinct molecular pathways in epithelial cells to regulate motility, apical constriction, and localisation of E-Cadherin	PLOS ONE			English	Article							DROSOPHILA EMBRYONIC CNS; COLORECTAL-CANCER DCC; NETRIN RECEPTOR; AXON GUIDANCE; INTRACELLULAR DOMAIN; RECYCLING ENDOSOMES; MYOSIN-II; C-ELEGANS; ACTIVATION; ADHERENS	Netrin receptors of the DCC/NEO/UNC-40/Frazzled family have well established roles in cell migration and axon guidance but can also regulate epithelial features such as adhesion, polarity and adherens junction (AJ) stability. Previously, we have shown that overexpression of Drosophila Frazzled (Fra) in the peripodial epithelium (PE) inhibits wing disc eversion and also generates cellular protrusions typical of motile cells. Here, we tested whether the molecular pathways by which Fra inhibits eversion are distinct from those driving motility. We show that in disc proper (DP) epithelial cells Fra, in addition to inducing F-Actin rich protrusions, can affect localization of AJ components and columnar cell shape. We then show that these phenotypes have different requirements for the three conserved Fra cytoplasmic P-motifs and for downstream genes. The formation of protrusions required the P3 motif of Fra, as well as integrins (mys and mew), the Rac pathway (Racl, wave and, arpc3) and myosin regulatory light chain (Sqh). In contrast, apico-basal cell shape change, which was accompanied by increased myosin phosphorylation, was critically dependent upon the P1 motif and was promoted by RhoGef2 but inhibited by Reel. Fra also caused a loss of AJ proteins (DE-Cad and Arm) from basolateral regions of epithelial cells. This phenotype required all 3 P-motifs, and was dependent upon the polarity factor par6. par6 was not required for protrusions or cell shape change, but was required to block eversion suggesting that control of AJ components may underlie the ability of Fra to promote epithelial stability. The results imply that multiple molecular pathways act downstream of Fra in epithelial cells.	[Golenkina, Sofia; Chaturvedi, Vishal; Saint, Robert; Murray, Michael J.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Saint, Robert] Flinders Univ S Australia, Adelaide, SA, Australia	University of Melbourne; Flinders University South Australia	Murray, MJ (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.	murraym@unimelb.edu.au	Saint, Robert/A-4190-2008	Saint, Robert/0000-0002-7989-6043; Murray, Michael/0000-0002-7427-590X; Chaturvedi, Vishal/0000-0002-0421-7544	Australian Research Council Discovery Project [DP120104443]; National Health and Medical Research Council Australia Project [APP1107123]; International Postgraduate Research Scholarship	Australian Research Council Discovery Project(Australian Research Council); National Health and Medical Research Council Australia Project(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Scholarship(Australian Government)	This work was supported by Australian Research Council Discovery Project DP120104443 to RS and National Health and Medical Research Council Australia Project Grant APP1107123 to MJM. SG was supported by a International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Beamish IV, 2017, COLD SPRING HARB PER; Bruser L, 2017, COLD SPRING HARB PER, V9; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dorsten JN, 2008, INT J DEV NEUROSCI, V26, P753, DOI 10.1016/j.ijdevneu.2008.07.004; Dorsten JN, 2007, DEV BIOL, V308, P120, DOI 10.1016/j.ydbio.2007.05.012; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kondo T, 2015, DEV GROWTH DIFFER, V57, P313, DOI 10.1111/dgd.12224; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lee NK, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/2192053; Lee SJ, 2014, STEM CELLS DEV, V23, P1870, DOI 10.1089/scd.2013.0632; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Manhire-Heath R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3790; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; Mehlen P, 2005, BRIT J CANCER, V93, P1, DOI 10.1038/sj.bjc.6602656; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Murray MJ, 2017, CELLS TISSUES ORGANS, V203, P71, DOI 10.1159/000447424; Neuhaus-Follini A, 2015, NEURON, V87, P751, DOI 10.1016/j.neuron.2015.08.006; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Pert M, 2015, BIOL OPEN, V4, P233, DOI 10.1242/bio.201410827; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Priya R, 2015, CURR TOP DEV BIOL, V112, P65, DOI 10.1016/bs.ctdb.2014.11.016; Qu C, 2013, J CELL SCI; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Woichansky I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10834; Yashiro H, 2014, MOL BIOL CELL, V25, P2956, DOI 10.1091/mbc.E14-04-0894; Zhang LA, 2011, GENE EXPR PATTERNS, V11, P93, DOI 10.1016/j.gep.2010.09.008; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	57	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194003	10.1371/journal.pone.0194003	http://dx.doi.org/10.1371/journal.pone.0194003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518139	Green Submitted, Green Published, gold			2022-12-26	WOS:000426902900059
J	Iliev, FL; Stanev, VG; Vesselinov, VV; Alexandrov, BS				Iliev, Filip L.; Stanev, Valentin G.; Vesselinov, Velimir V.; Alexandrov, Boian S.			Nonnegative Matrix Factorization for identification of unknown number of sources emitting delayed signals	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; SHIFTED FACTOR-ANALYSIS; MODELS	Factor analysis is broadly used as a powerful unsupervised machine learning tool for reconstruction of hidden features in recorded mixtures of signals. In the case of a linear approximation, the mixtures can be decomposed by a variety of model-free Blind Source Separation (BSS) algorithms. Most of the available BSS algorithms consider an instantaneous mixing of signals, while the case when the mixtures are linear combinations of signals with delays is less explored. Especially difficult is the case when the number of sources of the signals with delays is unknown and has to be determined from the data as well. To address this problem, in this paper, we present a new method based on Nonnegative Matrix Factorization (NMF) that is capable of identifying: (a) the unknown number of the sources, (b) the delays and speed of propagation of the signals, and (c) the locations of the sources. Our method can be used to decompose records of mixtures of signals with delays emitted by an unknown number of sources in a nondispersive medium, based only on recorded data. This is the case, for example, when electromagnetic signals from multiple antennas are received asynchronously; or mixtures of acoustic or seismic signals recorded by sensors located at different positions; or when a shift in frequency is induced by the Doppler effect. By applying our method to synthetic datasets, we demonstrate its ability to identify the unknown number of sources as well as the waveforms, the delays, and the strengths of the signals. Using Bayesian analysis, we also evaluate estimation uncertainties and identify the region of likelihood where the positions of the sources can be found.	[Iliev, Filip L.; Stanev, Valentin G.; Alexandrov, Boian S.] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87545 USA; [Vesselinov, Velimir V.] Los Alamos Natl Lab, Computat Earth Sci Grp, Los Alamos, NM USA; [Alexandrov, Boian S.] Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87102 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico	Alexandrov, BS (corresponding author), Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87545 USA.; Alexandrov, BS (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87102 USA.	boian@lanl.gov			Environmental Programs Directorate of the Los Alamos National Laboratory; DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science) [11145687]; LANL LDRD grant [20180060]	Environmental Programs Directorate of the Los Alamos National Laboratory; DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science)(United States Department of Energy (DOE)); LANL LDRD grant	This research was funded by the Environmental Programs Directorate of the Los Alamos National Laboratory. In addition, VVV was supported by the DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science, Grant #11145687). VVV and BSA were supported by LANL LDRD grant 20180060.	Alexandrov BS, 2014, WATER RESOUR RES, V50, P7332, DOI 10.1002/2013WR015037; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amari S, 1996, ADV NEUR IN, V8, P757; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Bezanson J, 2012, JULIA FAST DYNAMIC L; Chandrasekhar V., 2006, P 1 ACM INT WORKSH U, DOI DOI 10.1145/1161039.1161047; Chen HC, 2012, MIS QUART, V36, P1165; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; FISCHLER MA, 1973, IEEE T COMPUT, VC 22, P67, DOI 10.1109/T-C.1973.223602; Harshman RA, 2003, J CHEMOMETR, V17, P363, DOI 10.1002/cem.808; Herault J., 1986, AIP Conference Proceedings, P206, DOI 10.1063/1.36258; Hong SJ, 2003, J CHEMOMETR, V17, P379, DOI 10.1002/cem.809; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li D, 2004, INT CONF PARA PROC, P443; Mathieu Lepot, 2017, WATER, V9, P796; Morup Morten, 2007, 2007 IEEE Workshop on Machine Learning for Signal Processing, P139, DOI 10.1109/MLSP.2007.4414296; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Pang-Ning T, 2006, INTRO DATA MINING; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; TORRIERI DJ, 1984, IEEE T AERO ELEC SYS, V20, P183, DOI 10.1109/TAES.1984.310439; Vesselinov V V, 2016, MADS JL MODEL ANAL D; Vesselinova N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165899; Vihola M, 2012, STAT COMPUT, V22, P997, DOI 10.1007/s11222-011-9269-5; Weiss R, 1996, J ROY STAT SOC B MET, V58, P739	27	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193974	10.1371/journal.pone.0193974	http://dx.doi.org/10.1371/journal.pone.0193974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518126	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900053
J	Gonzalez-Sanchez, ME; Cuquerella, M; Alunda, JM				Elena Gonzalez-Sanchez, Maria; Cuquerella, Montserrat; Alunda, Jose M.			Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE; ANTHELMINTIC RESISTANCE; IMMUNE-RESPONSE; INFECTION; SHEEP; PROTECTION; VACCINES; PROTEIN; CHALLENGE; PARASITES	Haemonchus contortus is the most pathogenic gastrointestinal helminth of small ruminants. Natural or experimental repeated infections and several native antigens confer a partially protective immune response but vaccination with subunit antigens has been elusive. Promising results have been obtained with a recombinant form of a somatic antigen (rHc23). In this paper we present the results obtained in vaccination trials in lambs using two dosages of rHc23 and standard adjuvants. Six-months old Manchego females lambs were vaccinated with rHc23 (50 or 200 mu g/dose) adjuvanted with 1mL aluminum hydroxide on days -42, -28 and -14 or with 200 mu g/dose rHc23 and 5 mg Quil A on days -49, -28 and -7. Control lambs were kept receiving only the adjuvants the same days or no treatment. Moreover one group did not receive any treatment or infection. On day 0 vaccinated lambs, untreated animals and those receiving the adjuvant were infected per os with a monospecific single infection of 4000 L3 of H. contortus. Infection was kept for 58 days and follow-up included the determination of serum specific antibody response (ELISA, WB), hematological parameters (eosinophil counts, hematocrit) and fecal egg counts (epg). Absence of hematocrit alterations, reduction of helminth's eggs output and abomasal parasite burden at the end of the experiment were the efficacy criteria of vaccination with the recombinant. Immunization with both adjuvants and antigen dosages elicited strong antibody responses particularly with Quil A. Vaccinated groups showed significant reduction of fecal egg excretion and abomasal helminth burdens. Highest protection of lambs against challenge was achieved with aluminum hydroxide and 200 mu g/dose rHc23 with a reduction of over 70% of the abomasal burden and over 80% of fecal egg output. Results suggest that rHc23 could be a valuable recombinant candidate for vaccination against haemonchosis. No clear relationship was found between antibody levels and protection this pointing towards involvement of both humoral and cellular components in the protective response elicited by rHc23.	[Elena Gonzalez-Sanchez, Maria; Cuquerella, Montserrat; Alunda, Jose M.] Univ Complutense Madrid, Fac Vet Med, Dept Anim Hlth, Madrid, Spain	Complutense University of Madrid	Alunda, JM (corresponding author), Univ Complutense Madrid, Fac Vet Med, Dept Anim Hlth, Madrid, Spain.	jmalunda@ucm.es	Cuquerella, Montserrat/R-8294-2018; Gonzalez, Elena/AAB-4455-2020	Cuquerella, Montserrat/0000-0002-0091-1328; Gonzalez, Elena/0000-0003-0448-7023; Alunda, Jose Maria/0000-0002-1491-8627	Spanish Ministerio de Economia y Competitividad [AGL2014-54049-R]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	Research was funded by the Spanish Ministerio de Economia y Competitividad, grant AGL2014-54049-R. Funders had no role in the study design, experiments carried out, analysis and publication.	Albrecht L, 2006, J ANIM SCI, V84, P124; Amarante AFT, 2005, VET PARASITOL, V128, P99, DOI 10.1016/j.vetpar.2004.11.021; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Bakker N, 2004, VACCINE, V22, P618, DOI 10.1016/j.vaccine.2003.08.025; BARNES EH, 1995, PARASITOL TODAY, V11, P56, DOI 10.1016/0169-4758(95)80117-0; Cachat E, 2010, PARASITE IMMUNOL, V32, P414, DOI 10.1111/j.1365-3024.2010.01208.x; CUQUERELLA M, 1991, VET PARASITOL, V38, P131, DOI 10.1016/0304-4017(91)90123-D; De Matos A.F.I.M., 2017, SMALL RUMINANT RES, V151, P1; Emery DL, 2016, INT J PARASITOL, V46, P755, DOI 10.1016/j.ijpara.2016.07.001; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Fawzi EM, 2015, VET PARASITOL, V211, P54, DOI 10.1016/j.vetpar.2015.04.029; Fawzi EM, 2014, INT J PARASITOL, V44, P429, DOI 10.1016/j.ijpara.2014.02.009; GAMBLE HR, 1992, VET PARASITOL, V41, P211, DOI 10.1016/0304-4017(92)90081-J; Gauly M, VET PARASITOL, V30, P55; Gomez-Munoz MT, 1999, VET PARASITOL, V81, P281, DOI 10.1016/S0304-4017(98)00260-X; Jacobs HJ, 1999, VACCINE, V17, P362, DOI 10.1016/S0264-410X(98)00206-0; Kandil OM, 2017, VET WORLD, V10, P758, DOI 10.14202/vetworld.2017.758-763; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Kotze AC, 2016, ADV PARASIT, V93, P397, DOI 10.1016/bs.apar.2016.02.012; Lacroux C, 2006, VET RES, V37, P607, DOI 10.1051/vetres:2006022; MAFF (Ministry of Agriculture Fisheries and Food), 1971, MAN VET PAR LAB TECH; Matthews JB, 2016, PARASITE IMMUNOL, V38, P744, DOI 10.1111/pim.12391; McRae KM, 2015, PARASITE IMMUNOL, V37, P605, DOI 10.1111/pim.12290; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Meier L, 2016, VET PARASITOL, V229, P15, DOI 10.1016/j.vetpar.2016.08.024; Newton SE, 1999, PARASITOL TODAY, V15, P116, DOI 10.1016/S0169-4758(99)01399-X; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Piedrafita D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078357; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Redmond DL, 2004, VACCINE, V22, P4252, DOI 10.1016/j.vaccine.2004.04.028; Rojo-Montejo S, 2011, VET PARASITOL, V175, P220, DOI 10.1016/j.vetpar.2010.10.028; Rose H, 2015, VET REC, V176, DOI 10.1136/vr.102982; Schallig HDFH, 1997, PARASITOLOGY, V114, P293, DOI 10.1017/S0031182096008517; Spickler AR, 2003, J VET INTERN MED, V17, P273, DOI 10.1892/0891-6640(2003)017&lt;0273:AIVVMO&gt;2.3.CO;2; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; WILLADSEN P, 1995, PARASITOLOGY, V110, pS43, DOI 10.1017/S0031182000001487; Yanming S, 2007, PARASITE IMMUNOL, V29, P319, DOI 10.1111/j.1365-3024.2007.00949.x	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193118	10.1371/journal.pone.0193118	http://dx.doi.org/10.1371/journal.pone.0193118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513692	Green Submitted, gold, Green Published			2022-12-26	WOS:000426896800039
J	Morales, G; Moragrega, C; Montesinos, E; Llorente, I				Morales, Gerard; Moragrega, Concepcio; Montesinos, Emilio; Llorente, Isidre			Effects of leaf wetness duration and temperature on infection of Prunus by Xanthomonas arboricola pv. pruni	PLOS ONE			English	Article							DISEASE WARNING SYSTEM; BACTERIAL SPOT; PERENNIAL RYEGRASS; FRUIT-TREES; STONE FRUIT; MODELS; ALMOND; PEACH	Xanthomonas arboricola pv. pruni is the causal agent of bacterial spot disease of stone fruits and almond. The bacterium is distributed throughout the major stone-fruit-producing areas of the World and is considered a quarantine organism in the European Union according to the Council Directive 2000/29/EC, and by the European and Mediterranean Plant Protection Organization. The effect of leaf wetness duration and temperature on infection of Prunus by X arboricola pv. pruni was determined in controlled environment experiments. Potted plants of the peach-almond hybrid GF-677 were inoculated with bacterial suspensions and exposed to combinations of six leaf wetness durations (from 0 to 24 h) and seven fixed temperatures (from 5 to 35 degrees C) during the infection period. Then, plants were transferred to a biosafety greenhouse, removed from bags, and incubated at optimal conditions for disease development. Although leaf wetness was required for infection of Prunus by X arboricola pv. pruni, temperature had a greater effect than leaf wetness duration on disease severity. The combined effect of wetness duration and temperature on disease severity was quantified using a modification of the Weibull equation proposed by Duthie. The reduced-form of Duthie's model obtained by nonlinear regression analysis fitted well to data (R = 0.87 and R-adj(2) = 0.85), and all parameters were significantly different from 0. The estimated optimal temperature for infection by X arboricola pv. pruni was 28.9 degrees C. Wetness periods longer than 10 h at temperatures close to 20 degrees C, or 5 h at temperatures between 25 and 35 degrees C were necessary to cause high disease severity. The predictive capacity of the model was evaluated using an additional set of data obtained from new wetness duration-temperature combinations. In 92% of the events the observed severity agreed with the predicted level of infection risk. The risk chart derived from the reduced form of Duthie's model can be used to estimate the potential risk for infection of Prunus by X arboricola pv. pruni based on observed or forecasted temperature and wetness duration.	[Morales, Gerard; Moragrega, Concepcio; Montesinos, Emilio; Llorente, Isidre] Univ Girona, Inst Food & Agr Technol XaRTA CIDSAV, Girona, Spain	Universitat de Girona	Llorente, I (corresponding author), Univ Girona, Inst Food & Agr Technol XaRTA CIDSAV, Girona, Spain.	isidre.llorente@udg.edu	MORAGREGA, CONCEPCIÓ/H-4441-2017; MONTESINOS, EMILIO/H-5246-2015; Morales, Gerard/O-1522-2015; Llorente, Isidre/L-7211-2017	MORAGREGA, CONCEPCIÓ/0000-0001-6270-9611; MONTESINOS, EMILIO/0000-0003-4455-8332; Morales, Gerard/0000-0002-4535-3438; Llorente, Isidre/0000-0003-1893-8649	Ministerio de Educacion, Ciencia y Deporte of Spain [AGL2013-41405-R, FPU13/04123]; University of Girona [SING12/13, MPCUdG2016/085, BR 2013/31]; European Union's Seventh Framework Programme for research, technological development and demonstration [613678]; Ministerio de Educacion, Ciencia y Deporte from Spain	Ministerio de Educacion, Ciencia y Deporte of Spain; University of Girona; European Union's Seventh Framework Programme for research, technological development and demonstration; Ministerio de Educacion, Ciencia y Deporte from Spain	Ministerio de Educacion, Ciencia y Deporte (AGL2013-41405-R, FPU13/04123) of Spain (https://www.mecd.gob.es/). University of Girona (SING12/13, MPCUdG2016/085) (www.udg.edu). European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number 613678 (DROPSA) (dropsaproject.eu). GM was the recipient of predocotoral fellowships from the University of Girona (BR 2013/31) (www.udg.edu)) and from Ministerio de Educacion, Ciencia y Deporte from Spain (https://www.mecd.gob.es/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaskaveg JE, 2005, EPIDEMIOLOGY MANAGEN, P281; Arauz LF, 2010, PHYTOPATHOLOGY, V100, P959, DOI 10.1094/PHYTO-100-9-0959; Baker R, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3857; Battilani P., 1999, Journal of Plant Pathology, V81, P161; Beresford RM, 2017, PHYTOPATHOLOGY, V107, P184, DOI 10.1094/PHYTO-04-16-0166-R; Billing E, 1999, ACTA HORTIC, V489, P399; Boudon S, 2005, PHYTOPATHOLOGY, V95, P1081, DOI 10.1094/PHYTO-95-1081; Bugiani R, 2008, IOBC WPRS B, V54, P565; Carisse O, 2000, PHYTOPATHOLOGY, V90, P1120, DOI 10.1094/PHYTO.2000.90.10.1120; Duthie JA, 1997, PHYTOPATHOLOGY, V87, P1088, DOI 10.1094/PHYTO.1997.87.11.1088; EPPO, 2017, XANTH ARB PV PRUN XA; EPPO, 2006, EPPO B, V36, P129, DOI DOI 10.1111/J.1365-2338.2006.00925.X; Furuya H, 2009, PHYTOPATHOLOGY, V99, P951, DOI 10.1094/PHYTO-99-8-0951; Garcin A, 2009, INFOS CTIFL, V254, P30; Garcin A., 2011, INFOS CTIFL, V268, P26; Garcin A, 2005, XANTHOMONAS ARBRES F; Gross MK, 1998, PLANT DIS, V82, P1012, DOI 10.1094/PDIS.1998.82.9.1012; Janse JD, 2012, J PLANT PATHOL, V94, pS5; Kim KS, 2006, PLANT DIS, V90, P650, DOI 10.1094/PD-90-0650; Lalancette N, 2007, PLANT DIS, V91, P1122, DOI 10.1094/PDIS-91-9-1122; Lamichhane JR, 2014, PLANT DIS, V98, P1600, DOI 10.1094/PDIS-08-14-0831-FE; Lightner Gary W., 1992, Computers and Electronics in Agriculture, V7, P249, DOI 10.1016/S0168-1699(05)80023-7; Linvill DE, 2002, ACTA HORTIC, P689; Llorente I, 2000, PLANT DIS, V84, P631, DOI 10.1094/PDIS.2000.84.6.631; Madden LV, 2000, PLANT DIS, V84, P549, DOI 10.1094/PDIS.2000.84.5.549; MAGAREY RD, 2007, INTEGR MANAG PLANT P, P3; Maniatis T., 1982, MOL CLONING; MONTESINOS E, 1995, PHYTOPATHOLOGY, V85, P586, DOI 10.1094/Phyto-85-586; Morales G, 2016, ACTA HORTIC, V1149, P1, DOI [10.17660/ActaHortic.2016.1149.1, 10.1109/PESGM.2016.7741838]; Morales G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177583; Palacio-Bielsa A, 2010, PLANT DIS, V94, P786, DOI 10.1094/PDIS-94-6-0786B; RANDHAWA PS, 1985, PHYTOPATHOLOGY, V75, P1060, DOI 10.1094/Phyto-75-1060; Sant'Ana AS, 2012, FOOD MICROBIOL, V30, P267, DOI 10.1016/j.fm.2011.11.003; Scortichini M, 2010, J PLANT PATHOL, V92, pS73; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Smith IM, 1997, QUARANTINE PESTS EUR, P1096; Smith T. J., 1993, ACTA HORTIC, V338, P153, DOI DOI 10.17660/ACTAHORTIC.1993.338.21; Stefani E, 2010, J PLANT PATHOL, V92, pS99; THOMSON SV, 1977, CALIF AGR, V31, P12; Uddin W, 2003, PHYTOPATHOLOGY, V93, P336, DOI 10.1094/PHYTO.2003.93.3.336; Vanneste J. L., 2005, New Zealand Plant Protection, V58, P101; Wu LJ, 1999, PHYTOPATHOLOGY, V89, P653, DOI 10.1094/PHYTO.1999.89.8.653; YOUNG JM, 1977, J APPL BACTERIOL, V42, P345, DOI 10.1111/j.1365-2672.1977.tb00702.x; Zehr EI, 1996, PLANT DIS, V80, P339, DOI 10.1094/PD-80-0339	44	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193813	10.1371/journal.pone.0193813	http://dx.doi.org/10.1371/journal.pone.0193813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513713	Green Submitted, Green Published, gold			2022-12-26	WOS:000426896800078
J	Hoischen, C; Yavas, S; Wohland, T; Diekmann, S				Hoischen, Christian; Yavas, Sibel; Wohland, Thorsten; Diekmann, Stephan			CENP-C/H/I/K/M/T/W/N/L and hMis12 but not CENP-S/X participate in complex formation in the nucleoplasm of living human interphase cells outside centromeres	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; BUDDING YEAST KINETOCHORE; FLUORESCENCE CORRELATION SPECTROSCOPY; OUTER KINETOCHORE; CHROMOSOME SEGREGATION; A NUCLEOSOMES; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MIS12 COMPLEX; HISTONE H3	Kinetochore proteins assemble onto centromeric chromatin and regulate DNA segregation during cell division. The inner kinetochore proteins bind centromeres while most outer kinetochore proteins assemble at centromeres during mitosis, connecting the complex to microtubules. Here, we measured the co-migration between protein pairs of the constitutive centromere associated network (CCAN) and hMis12 complexes by fluorescence cross-correlation spectroscopy (FCCS) in the nucleoplasm outside centromeres in living human interphase cells. FCCS is a method that can tell if in living cells two differently fluorescently labelled molecules migrate independently, or co-migrate and thus are part of one and the same soluble complex. We also determined the apparent dissociation constants (Kd) of the hetero-dimers CENP-T/W and CENP-S/X. We measured co-migration between CENP-K and CENP-T as well as between CENP-M and CENP-T but not between CENP-T/W and CENP-S/X. Furthermore, CENP-C co-migrated with CENP-H, and CENP-K with CENP-N as well as with CENP-L. Thus, in the nucleoplasm outside centromeres, a large fraction of the CENP-H/I/K/M proteins interact with CENP-C, CENP-N/L and CENP-T/W but not with CENP-S/X. Our FCCS analysis of the Mis12 complex showed that hMis12, Nsl1, Dsn1 and Nnf1 also form a complex outside centromeres of which at least hMis12 associated with the CENP-C/H/I/K/M/T/W/N/L complex.	[Hoischen, Christian; Diekmann, Stephan] FLI, Leibniz Inst Aging, Mol Biol, Jena, Germany; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, Lee Wee Kheng Buildung, Singapore, Singapore; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Lee Wee Kheng Buildung, Singapore, Singapore; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Ctr Bioimaging Sci, Lee Wee Kheng Buildung, Singapore, Singapore	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National University of Singapore; National University of Singapore; National University of Singapore	Hoischen, C; Diekmann, S (corresponding author), FLI, Leibniz Inst Aging, Mol Biol, Jena, Germany.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Biol Sci, Lee Wee Kheng Buildung, Singapore, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Chem, Lee Wee Kheng Buildung, Singapore, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Ctr Bioimaging Sci, Lee Wee Kheng Buildung, Singapore, Singapore.	christian.hoischen@leibniz-fli.de; twohland@nus.edu.sg; diekmann@fli-leibniz.de	WOHLAND, THORSTEN/R-6404-2019; Wohland, Thorsten/H-8285-2012	Wohland, Thorsten/0000-0002-0148-4321	Deutsche Forschungsgemeinschaft (DFG) [SPP1128, SPP1395]; Singapore Ministry of Education (SINGA Scholarship) [MOE2016-T2-2-121]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Singapore Ministry of Education (SINGA Scholarship)	This study was supported by Deutsche Forschungsgemeinschaft (DFG), SPP1128 (SD), SPP1395 (SD); and Singapore Ministry of Education (SINGA Scholarship), MOE2016-T2-2-121 (SY and TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altunkaya GP, 2016, CURR BIOL, V26, P2370, DOI 10.1016/j.cub.2016.07.005; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Basilico F, 2014, ELIFE, V3, DOI 10.7554/eLife.02978; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; D'Archivio S, 2017, J CELL BIOL, V216, P379, DOI 10.1083/jcb.201608043; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Diekmann S, 2014, PHYS LIFE REV, V11, P1, DOI 10.1016/j.plrev.2013.11.011; Dimitrova YN, 2016, CELL, V167, P1014, DOI 10.1016/j.cell.2016.10.011; Dornblut C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130229; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Eskat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044717; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Faesen AC, 2017, NATURE, V542, P498, DOI 10.1038/nature21384; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; Fang J., 2015, GENE DEV, V29, P1; Folco HD, 2015, CURR BIOL, V25, P348, DOI 10.1016/j.cub.2014.11.060; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guo LY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15775; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hellwig D, 2009, EUR BIOPHYS J BIOPHY, V38, P781, DOI 10.1007/s00249-009-0498-x; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hinshaw SM, 2013, CELL REP, V5, P29, DOI 10.1016/j.celrep.2013.08.036; Hoffmann S, 2016, CELL REP, V17, P2394, DOI 10.1016/j.celrep.2016.10.084; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2013, J CELL BIOL, V200, P45, DOI 10.1083/jcb.201210106; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hornung P, 2014, J CELL BIOL, V206, P509, DOI 10.1083/jcb.201403081; Huis int Veld PJ, 2016, ELIFE, V24; Hwang LC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862614; Hwang LC, 2004, CHEMPHYSCHEM, V5, P549, DOI 10.1002/cphc.200301057; Hwang LC, 2006, BIOPHYS J, V91, P715, DOI 10.1529/biophysj.105.074120; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kagawa N, 2014, CHROMOSOME RES, V22, P293, DOI 10.1007/s10577-014-9404-1; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Ladurner R, 2016, CELL, V167, P889, DOI 10.1016/j.cell.2016.10.036; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Logsdon GA, 2015, J CELL BIOL, V208, P521, DOI 10.1083/jcb.201412011; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Matson DR, 2014, J CELL BIOL, V205, P541, DOI 10.1083/jcb.201307137; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Mendiburo MJ, 2011, SCIENCE, V334, P686, DOI 10.1126/science.1206880; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Mosalaganti S, 2017, J CELL BIOL, V216, P961, DOI 10.1083/jcb.201611060; Musacchio A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010005; Nagpal H, 2016, CHROMOSOMA, V125, P645, DOI 10.1007/s00412-016-0608-3; Nagpal H, 2015, MOL BIOL CELL, V26, P3768, DOI 10.1091/mbc.E15-07-0531; Nechemia-Arbely Y, 2017, J CELL BIOL, V216, P607, DOI 10.1083/jcb.201608083; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pan D, 2017, ELIFE, V6, DOI 10.7554/eLife.23352; Pan XT, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2740053; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pesenti ME, 2016, CURR OPIN STRUC BIOL, V37, P152, DOI 10.1016/j.sbi.2016.03.003; Petrovic A, 2016, CELL, V167, P1028, DOI 10.1016/j.cell.2016.10.005; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Poddar A, 1999, MOL MICROBIOL, V31, P349, DOI 10.1046/j.1365-2958.1999.01179.x; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rago F, 2015, CURR BIOL, V25, P671, DOI 10.1016/j.cub.2015.01.059; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Ruttinger S, 2008, J MICROSC-OXFORD, V232, P343, DOI 10.1111/j.1365-2818.2008.02105.x; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Samejima I, 2015, J CELL BIOL, V211, P1141, DOI 10.1083/jcb.201508072; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; Sathyan KM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14678; Schalch T, 2016, CHROMOSOMA; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Schmitzberger F, 2012, EMBO REP, V13, P216, DOI 10.1038/embor.2012.1; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Stankovic A, 2017, MOL CELL, V65, P231, DOI 10.1016/j.molcel.2016.11.021; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Tachiwana H, 2015, CELL REP, V11, P22, DOI 10.1016/j.celrep.2015.03.013; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takeuchi K, 2014, NUCLEIC ACIDS RES, V42, P1644, DOI 10.1093/nar/gkt1124; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Thakur J, 2016, GENOME RES, V26, P1178, DOI 10.1101/gr.204784.116; Tschernyschkow S, 2013, PROG BIOPHYS MOL BIO, V113, P33, DOI 10.1016/j.pbiomolbio.2013.03.010; Vargiu G, 2017, P NATL ACAD SCI USA, V114, P3133, DOI 10.1073/pnas.1614145114; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Weir JR, 2016, NATURE, V537, P249, DOI 10.1038/nature19333; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2013, TRENDS CELL BIOL, V23, P260, DOI 10.1016/j.tcb.2013.01.010; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yang C., 2020, ELIFE, DOI [10.7554/eLife.51339, DOI 10.7554/ELIFE.02482, 10.7554/eLife.02482, DOI 10.7554/ELIFE.03254]; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	146	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192572	10.1371/journal.pone.0192572	http://dx.doi.org/10.1371/journal.pone.0192572			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509805	Green Submitted, Green Published, gold			2022-12-26	WOS:000426813200004
J	Ghimire, PR; Agho, KE; Renzaho, AMN; Dibley, M; Raynes-Greenow, C				Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre M. N.; Dibley, Michael; Raynes-Greenow, Camille			Association between health service use and diarrhoea management approach among caregivers of under-five children in Nepal	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; ORAL REHYDRATION THERAPY; CHILDHOOD DIARRHEA; NATIONAL CONTROL; NUTRITION; DISEASES; PROGRAM; INTERVENTIONS; PNEUMONIA; MOTHERS	Introduction Diarrhoea among children under-five is a serious public health problem in many developing countries, including Nepal. This study aimed to examine the association between health service utilization and diarrhoea management approaches among children under-five years in Nepal. Methods The combined 2001, 2006 and 2011 Nepal Demographic and Health Survey (NDHS) data sets were examined and the sample included 2,655 children aged 0-59 months who had diarrhoea 2-weeks prior to the each survey. Multilevel logistic regression analyses that adjust for clustering and sampling weight were used to examine the association between health service utilization and diarrhoea management approaches (Oral Rehydration Solution, increased fluids and/or continued feeding). Results The prevalence of extra fluids decreased significantly from 27% in 2001 to 15% in 2011 while that of ORS increased significantly from 32% in 2001 to 40% in 2011. The prevalence of continued feeding fluctuated between 83-89%. Multivariate analysis revealed that care-givers whose children received treatment or advice from health care providers during diarrhoea were 5.78 times more likely to treat diarrhoea with Oral Rehydration Solution (ORS) [adjusted Odds Ratio (aOR) 5.78, 95% confidence interval (CI) 4.50, 7.44-, 1.56 (aOR 1.56, 95% CI 1.19, 2.05) times more likely to offer extra fluids, and 2.25 (aOR 2.25, 95% CI 1.50, 3.39) times more likely to use continued feeding than those who did not seek advice. Conclusions Our findings indicate that health service utilization significantly improves diarrhoea management among under-five children. However, a broader national diarrhoeal disease control program to further reduce diarrhoea related morbidity and mortality in Nepal should focus on educating caregivers about the importance of the use of ORS as well as increase fluid intake to children under-five years with diarrhoea.	[Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Dibley, Michael; Raynes-Greenow, Camille] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Sydney	Ghimire, PR (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	prameshraj@hotmail.com	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Renzaho, Andre M.N./AAH-7679-2021	Agho, Kingsley/0000-0003-4111-3207; Ghimire, Pramesh/0000-0002-7902-7294; Ghimire, Pramesh Raj/0000-0003-2816-0463; RENZAHO, ANDRE/0000-0002-6844-0833				Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ansari Mukhtar, 2012, BMC Res Notes, V5, P576, DOI 10.1186/1756-0500-5-576; Baltazar JC, 2002, B WORLD HEALTH ORGAN, V80, P637; Bhandari G P, 2013, J Nepal Health Res Counc, V11, P6; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Collaborators Global Burden of Diseases, 2017, LANCET INFECT DIS; Datta Vikram, 2001, Indian Journal of Pediatrics, V68, P1035, DOI 10.1007/BF02722350; Duggan C, 1997, J PEDIATR-US, V131, P801, DOI 10.1016/S0022-3476(97)70024-6; Ghimire M, 2010, B WORLD HEALTH ORGAN, V88, P216, DOI 10.2471/BLT.09.065649; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Gurung H, 2005, NEPAL REGIONAL STRAT; HUDELSON PM, 1993, SOC SCI MED, V37, P97, DOI 10.1016/0277-9536(93)90322-U; International Federation of Red Cross and Red Crescent Socities, 2009, DIARRH OUTBR KILLS 1; Jha Nilambar, 2006, Nepal Med Coll J, V8, P27; JINADU MK, 1988, INT J NURS STUD, V25, P185, DOI 10.1016/0020-7489(88)90045-4; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KUMAR V, 1985, J TROP PEDIATRICS, V31, P109, DOI 10.1093/tropej/31.2.109; Masiha S. A., 2015, J RAWALPINDI MED COL, V19, P51; Mengistie B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1029; MILLER P, 1995, SOC SCI MED, V40, pS1, DOI 10.1016/0277-9536(95)00001-N; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Nanyonjo A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0202-y; Nel E., 2010, S AFRICAN J CLIN NUT, V23, P15; OLANGO P, 1990, SOC SCI MED, V31, P1245, DOI 10.1016/0277-9536(90)90131-B; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Pahwa S, 2010, J HEALTH POPUL NUTR, V28, P553; Pokhrel D, 2004, J WATER HEALTH, V2, P71, DOI 10.2166/wh.2004.0007; ROHDE J, 1988, Indian Pediatrics, V25, P914; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; UNICEF, 2014, PNEUM DIARRH TACKL D; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2005, TREATM DIARRH MAN PH	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191988	10.1371/journal.pone.0191988	http://dx.doi.org/10.1371/journal.pone.0191988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494611	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200007
J	Irvine, L; Crombie, IK; Swanson, V; Dimova, ED; Melson, AJ; Fraser, TM; Barbour, R; Rice, PM; Allan, S				Irvine, Linda; Crombie, Iain K.; Swanson, Vivien; Dimova, Elena D.; Melson, Ambrose J.; Fraser, Tracey M.; Barbour, Rosaline; Rice, Peter M.; Allan, Sheila			Design and feasibility testing of a novel group intervention for young women who binge drink in groups	PLOS ONE			English	Article							BRIEF MOTIVATIONAL INTERVENTIONS; BRIEF ALCOHOL INTERVENTIONS; COLLEGE-STUDENTS; PRIMARY-CARE; REDUCES DRINKING; CONSEQUENCES; METAANALYSIS; FRIENDSHIP; NORMS	Background Young women frequently drink alcohol in groups and binge drinking within these natural drinking groups is common. This study describes the design of a theoretically and empirically based group intervention to reduce binge drinking among young women. It also evaluates their engagement with the intervention and the acceptability of the study methods. Methods Friendship groups of women aged 18-35 years, who had two or more episodes of binge drinking (>6 UK units on one occasion; 48g of alcohol) in the previous 30 days, were recruited from the community. A face-to-face group intervention, based on the Health Action Process Approach, was delivered over three sessions. Components of the intervention were woven around fun activities, such as making alcohol free cocktails. Women were followed up four months after the intervention was delivered. Results The target of 24 groups ( comprising 97 women) was recruited. The common pattern of drinking was infrequent, heavy drinking ( mean consumption on the heaviest drinking day was UK 18.1 units). Process evaluation revealed that the intervention was delivered with high fidelity and acceptability of the study methods was high. The women engaged positively with intervention components and made group decisions about cutting down. Twenty two groups set goals to reduce their drinking, and these were translated into action plans. Retention of individuals at follow up was 87%. Conclusions This study successfully recruited groups of young women whose patterns of drinking place them at high risk of acute harm. This novel approach to delivering an alcohol intervention has potential to reduce binge drinking among young women. The high levels of engagement with key steps in the behavior change process suggests that the group intervention should be tested in a full randomised controlled trial.	[Irvine, Linda; Crombie, Iain K.; Dimova, Elena D.; Melson, Ambrose J.; Fraser, Tracey M.] Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland; [Swanson, Vivien] Univ Stirling, Fac Nat Sci, Psychol Div, Stirling, Scotland; [Barbour, Rosaline] Open Univ, Fac Wellbeing Educ & Language Studies, Milton Keynes, Bucks, England; [Rice, Peter M.] Univ Dundee, Sch Med, Div Neurosci, Dundee, Scotland; [Allan, Sheila] Dundee City Council, Dundee, Scotland; [Dimova, Elena D.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Melson, Ambrose J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Dundee; University of Stirling; Open University - UK; University of Dundee; University of Stirling; University of Glasgow	Irvine, L (corresponding author), Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland.	m.a.j.irvine@dundee.ac.uk	Dimova, Elena/I-1703-2019	Dimova, Elena/0000-0002-3256-7170; Irvine, Linda/0000-0002-8527-876X; Melson, Ambrose/0000-0003-1415-3801	National Prevention Research Initiative [MR/J000485/1]; Medical Research Council [MR/J000485/1] Funding Source: researchfish; MRC [MR/J000485/1] Funding Source: UKRI	National Prevention Research Initiative(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Prevention Research Initiative, MR/J000485/1 to LI (https://www.mrc.ac.uk/research/initiatives/national-prevention-research-initiative-npri/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086171; Bardsley D, 2017, SCOTTISH HLTH SURVEY; Bertholet N, 2014, ALCOHOL CLIN EXP RES, V38, P853, DOI 10.1111/acer.12274; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Borsari B, 2015, J CONSULT CLIN PSYCH, V83, P56, DOI 10.1037/a0037635; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brueton VC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003835; Carey KB, 2016, J CONSULT CLIN PSYCH, V84, P619, DOI 10.1037/a0040275; Craig P., 2008, DEV EVALUATING COMPL; Dupree CH, 2016, ADDICT RES THEORY, V24, P40, DOI 10.3109/16066359.2015.1060966; Engineer R, 2003, HOME OFFICE RES STUD; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Foster JH, 2014, ALCOHOL ALCOHOLISM, V49, P213, DOI 10.1093/alcalc/agt135; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Hagger MS, 2016, PSYCHOL HEALTH, V31, P814, DOI 10.1080/08870446.2016.1146719; Harkin B, 2016, PSYCHOL BULL, V142, P198, DOI 10.1037/bul0000025; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Health Development Agency and University of Wales College of Medicine, 2002, MAN FAST ALC SCREEN; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Home Office, 2012, GOV ALC STRAT; Huh D, 2015, ALCOHOL CLIN EXP RES, V39, P919, DOI 10.1111/acer.12714; Johnston KL, 2003, PSYCHOL HEALTH, V18, P63, DOI 10.1080/0887044021000037835; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; LaBrie JW, 2008, PSYCHOL ADDICT BEHAV, V22, P141, DOI 10.1037/0893-164X.22.1.141; LaBrie JW, 2008, PSYCHOL ADDICT BEHAV, V22, P149, DOI 10.1037/0893-164X.22.1.149; LaBrie JW, 2007, ADDICT BEHAV, V32, P2549, DOI 10.1016/j.addbeh.2007.05.014; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lange JE, 2011, ADDICT RES THEORY, V19, P312, DOI 10.3109/16066359.2010.507895; Lange JE, 2006, AM J DRUG ALCOHOL AB, V32, P261, DOI 10.1080/00952990500479597; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; MacLean S, 2016, SOCIOLOGY, V50, P93, DOI 10.1177/0038038514557913; MacNeela P, 2011, J HEALTH PSYCHOL, V16, P284, DOI 10.1177/1359105310372977; Michie S, 2012, ADDICTION, V107, P1431, DOI 10.1111/j.1360-0443.2012.03845.x; Miller W.R., 2013, MOTIVATIONAL INTERVI; Miller WR, 2015, BEHAV COGN PSYCHOTH, V43, P129, DOI 10.1017/S1352465813000878; Moore G, 2015, PROCESS EVALUATION C; Nazareth I, 2011, ALCOHOL ALCOHOLISM, V46, P600, DOI 10.1093/alcalc/agr078; Neighbors C, 2007, J STUD ALCOHOL DRUGS, V68, P556, DOI 10.15288/jsad.2007.68.556; Niland P, 2013, INT J DRUG POLICY, V24, P530, DOI 10.1016/j.drugpo.2013.05.013; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Office of National Statistics, 2017, AD DRINK HAB GREAT B; Previte J, 2015, J BUS RES, V68, P2146, DOI 10.1016/j.jbusres.2015.03.014; Raistrick D, 2006, REV EFFECTIVENESS TR; Ritchie J, 2014, QUALITATIVE RES PRAC; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Royal College of Obstetricians and Gynaecologists, 2006, ALC CONS OUTC PREGN; Samson JE, 2015, J STUD ALCOHOL DRUGS, V76, P530, DOI 10.15288/jsad.2015.76.530; Schoenfeld ER, 2000, ANN EPIDEMIOL, V10, P432, DOI 10.1016/S1047-2797(00)00067-3; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Scottish Funding Council, 2015, HIGH ED STUD QUAL SC; Scottish Government, 2004, SCOTTISH INDEX MULTI; Seaman P, 2010, DRINKING TO BELONG; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Sobell L.C., 2011, GROUP THERAPY SUBSTA; Sobell LC, 2003, ASSESSING ALCOHOL PR, P75; Southern DA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-57; Szmigin I, 2008, INT J DRUG POLICY, V19, P359, DOI 10.1016/j.drugpo.2007.08.009; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tough SC, 2005, CAN FAM PHYSICIAN, V51, P1199; Townshend JM, 2014, ALCOHOL CLIN EXP RES, V38, P1143, DOI 10.1111/acer.12333; Twigg L, 2013, SOC SCI MED, V91, P162, DOI 10.1016/j.socscimed.2013.03.023; UyBico SJ, 2007, J GEN INTERN MED, V22, P852, DOI 10.1007/s11606-007-0126-3	67	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193434	10.1371/journal.pone.0193434	http://dx.doi.org/10.1371/journal.pone.0193434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494683	Green Accepted, gold, Green Published			2022-12-26	WOS:000426363200049
J	Rumbou, A; Candresse, T; Marais, A; Theil, S; Langer, J; Jalkanen, R; Buttner, C				Rumbou, Artemis; Candresse, Thierry; Marais, Armelle; Theil, Sebastien; Langer, Juliane; Jalkanen, Risto; Buttner, Carmen			A novel badnavirus discovered from Betula sp. affected by birch leaf-roll disease	PLOS ONE			English	Article							PLANT-VIRUS; POPULATION; PUBESCENS; VIROIDS; POLLEN; BEECH	In declining birches (Betula sp.) from different European stands affected by the "birch leafroll disease" (BLRD) a novel virus is identified by means of RNA-Seq virome analysis. The virus represents a new member in the genus Badnavirus, family Caulimoviridae, tentatively named Birch leaf roll-associated virus (BLRaV) and it is the first badnavirus found to infect birch. Complete genome sequences (7,862-7,864 nucleotides) of three viral isolates of Finnish and German origin have been determined. The virus sequences show a typical badnavirus organization with three major open reading frames (ORFs) and a fourth potential ORF overlapping with the end of ORF3. ORFs 1-2-3 show low level of amino acid identity to the corresponding proteins encoded by other badnaviruses, reaching a maximum of 44% identity (ORF3). Grapevine vein-clearing virus appears as the closest badnavirus when considering the polymerase region. So far, we can exclude evidence for presence of endogenous BLRaV elements in the birch genome, while evidence for the episomal activity of BLRaV is provided. The viral population holds significant haplotype diversity, while co-infection by different BLRaV variants are observed in single hosts. BLRaV presence is associated with the BLRD in both silver (B. pendula) and downy birch (B. pubescens). These results challenge the earlier hypothesis of a causal role of Cherry leaf roll virus in BLRD. Further work is now needed to finally prove that BLRaV is the causal agent for the BLRD.	[Rumbou, Artemis; Langer, Juliane; Buttner, Carmen] Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst, Div Phytomed, Berlin, Germany; [Candresse, Thierry; Marais, Armelle; Theil, Sebastien] French Natl Inst Agr Res INRA, UMR BFP 1332, Equipe Virol, Villenave Dornon, France; [Jalkanen, Risto] Nat Resources Inst Luke, Finnish Forest Res Inst Metla, Rovaniemi Unit, Rovaniemi, Finland	Humboldt University of Berlin; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Natural Resources Institute Finland (Luke)	Rumbou, A (corresponding author), Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst, Div Phytomed, Berlin, Germany.	artemis.rumbou@agrar.hu-berlin.de	Rumbou, Artemis/AAD-5694-2019	Rumbou, Artemis/0000-0002-7237-7355; Candresse, Thierry/0000-0001-9757-1835	COST Action [FA1407]	COST Action(European Cooperation in Science and Technology (COST))	The work was supported by the COST Action FA1407 - DIVAS (Deep Investigation on Viral-Associated Sequences) European Cooperation in the field of Scientific and Technical Research Application of next generation sequencing for the study and diagnosis of plant viral diseases in agriculture Short Term Scientific Mission performed by Dr. Artemis Rumbou in INRA, Villenave d'Ornon Cedex, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Bhat AI, 2016, BADNAVIRUSES CURREN, V8; Borah BK, 2013, MOL PLANT PATHOL, V14, P759, DOI 10.1111/mpp.12046; Buttner C., 2011, VIRUS VIRUS LIKE DIS, P119; Gayral P, 2010, J VIROL, V84, P7346, DOI 10.1128/JVI.00401-10; Geering ADW, 2005, J GEN VIROL, V86, P511, DOI 10.1099/vir.0.80261-0; GEERING ADW, 2012, VIRUS TAXONOMY, P438; Hohn Thomas, 2008, P53, DOI 10.1007/978-3-540-75763-4_4; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; International Committee on Taxonomy of Viruses (ICTV), 2016, VIRUS TAXONOMY; Jalkanen R., 2013, Endophytes for plant protection: the state of the art. Proceedings of the 5th International Symposium on Plant Protection and Plant Health in Europe, Humboldt University Berlin, Berlin-Dahlem, Germany, 26-29 May, 2013, P305; Jalkanen R, 2007, SILVA FENN, V41, P755, DOI 10.14214/sf.927; JONES AT, 1990, J PHYTOPATHOL, V129, P339, DOI 10.1111/j.1439-0434.1990.tb04311.x; Kazmi SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134147; Kibbe W. A., 2007, NUCL ACIDS RES, V35; Langer J, 2016, FOREST PATHOL, V46, P595, DOI 10.1111/efp.12276; Maliogka VI, 2015, VIRUS RES, V203, P47, DOI 10.1016/j.virusres.2015.03.003; MASSALSKI PR, 1988, ANN APPL BIOL, V112, P415, DOI 10.1111/j.1744-7348.1988.tb02080.x; MASSALSKI PR, 1984, PLANT PATHOL, V33, P255, DOI 10.1111/j.1365-3059.1984.tb02647.x; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; NIENHAUS F, 1989, ANNU REV PHYTOPATHOL, V27, P165; Rebenstorf K, 2006, J VIROL, V80, P2453, DOI 10.1128/JVI.80.5.2453-2462.2006; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Rumbou A, 2016, SCAND J FOREST RES, V31, P546, DOI 10.1080/02827581.2016.1165283; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; von Bargen S, 2009, SILVA FENN, V43, P727, DOI 10.14214/sf.169; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Werner R, 1997, EUR J FOREST PATHOL, V27, P309; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193888	10.1371/journal.pone.0193888	http://dx.doi.org/10.1371/journal.pone.0193888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494687	Green Published, Green Submitted, gold			2022-12-26	WOS:000426363200100
J	Winder, JY; Roos, RAC				Winder, Jessica Y.; Roos, Raymund A. C.			Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; TRINUCLEOTIDE REPEAT; RATING-SCALE; OF-ONSET; LENGTH	Introduction Different oculomotor abnormalities have been reported to occur in premanifest Huntington's disease. The aim of this study is to investigate which oculomotor items of the Unified Huntington's Disease Rating Scale (UHDRS) are affected in premanifest individuals compared to healthy controls, and if CAG repeat length and age are correlated with oculomotor abnormalities in premanifest Huntington's disease gene carriers. Methods We compared baseline data of 70 premanifest individuals and 27 controls who participated in the Enroll-HD study at the Leiden University Medical Center, the Netherlands. Premanifest gene carriers were divided in individuals near to disease onset and individuals far from disease onset. Results Using a logistic regression model, only horizontal ocular pursuit of the six oculomotor items of the UHDRS was significantly more frequently affected in premanifest individuals close to disease onset compared to controls (p = 0.044, OR 13.100). Age was significantly higher in premanifest individuals with affected horizontal ocular pursuit (p = 0.016, OR 1.115) and with affected vertical ocular pursuit (p = 0.030, OR 1.065) compared to premanifest individuals without ocular pursuit deficits. Conclusions Our results suggest that horizontal ocular pursuit is the only affected oculomotor item of the UHDRS in premanifest individuals and could be used to assess early clinical signs of Huntington's disease. Saccade initiation and saccade velocity do not seem useful for detecting differences between premanifest individuals and controls.	[Winder, Jessica Y.; Roos, Raymund A. C.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Winder, JY (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands.	j.y.winder@lumc.nl			CHDI Foundation Inc.	CHDI Foundation Inc.	The LUMC received payment from the CHDI Foundation Inc. for participating in the Enroll HD study. The CHDI Foundation Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Blekher T, 2006, NEUROLOGY, V67, P394, DOI 10.1212/01.wnl.0000227890.87398.c1; Blekher TM, 2004, VISION RES, V44, P2729, DOI 10.1016/j.visres.2004.06.006; Cubo E, 2016, NEUROLOGY, V87, P571, DOI 10.1212/WNL.0000000000002944; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kirkwood SC, 2000, ARCH NEUROL-CHICAGO, V57, P1040, DOI 10.1001/archneur.57.7.1040; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MOSCHNER C, 1994, J GERONTOL, V49, pM235, DOI 10.1093/geronj/49.5.M235; Reilmann R., 2009, AKTUELLE NEUROL, V36, pP474, DOI DOI 10.1055/S-0029-1238568; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Seferlis F, 2015, J VESTIBUL RES-EQUIL, V25, P57, DOI 10.3233/VES-150548; Siesling S, 1997, MOVEMENT DISORD, V12, P229, DOI 10.1002/mds.870120214; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Youssov K, 2013, MOVEMENT DISORD, V28, P1995, DOI 10.1002/mds.25678	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193866	10.1371/journal.pone.0193866	http://dx.doi.org/10.1371/journal.pone.0193866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494703	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200097
J	Adrian-Segarra, JM; Schindler, N; Gajawada, P; Lorchner, H; Braun, T; Poling, J				Adrian-Segarra, Juan M.; Schindler, Natalie; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen			The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; signal transduction; STAT3; protein-protein interaction; leukemia inhibitory factor; LIF; Oncostatin M; OSM; OSMR	LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; SIGNAL-TRANSDUCING RECEPTOR; CRYSTAL-STRUCTURE; FACTOR LIF; HUMAN CHROMOSOME-22; HEPG2 CELLS; CYTOKINE; GENES; GP130	Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are closely related members of the interleukin-6 (IL-6) cytokine family. Both cytokines share a common origin and structure, and both interact through a specific region, termed binding site III, to activate a dimeric receptor complex formed by glycoprotein 130 (gp130) and LIF receptor (LIFR) in humans. However, only OSM activates the OSM receptor (OSMR)-gp130 complex. The molecular features that enable OSM to specifically activate the OSMR are currently unknown. To define specific sequence motifs within OSM that are critical for initiating signaling via OSMR, here we generated chimeric OSM-LIF cytokines and performed alanine-scanning experiments. Replacement of the OSM AB loop within OSM's binding site III with that of LIF abrogated OSMR activation, measured as STAT3 phosphorylation at Tyr-705, but did not compromise LIFR activation. Correspondingly, substitution of the AB loop and D-helix in LIF with their OSM counterparts was sufficient for OSMR activation. The alanine-scanning experiments revealed that residues Tyr-34, Gln-38, Gly-39, and Leu-45 (in the AB loop) and Pro-153 (in the D-helix) had specific roles in activating OSMR but not LIFR signaling, whereas Leu-40 and Cys-49 (in the AB loop), and Phe-160 and Lys-163 (in the D-helix) were required for activation of both receptors. Because most of the key amino acid residues identified here are conserved between LIF and OSM, we concluded that comparatively minor differences in a few amino acid residues within binding site III account for the differential biological effects of OSM and LIF.	[Adrian-Segarra, Juan M.; Schindler, Natalie; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Schindler, Natalie] Johannes Gutenberg Univ Mainz, Inst Entwicklungsbiol & Neurobiol IDN, Fachbereich Biol FB 10, Inst Mol Biol gGmbH IMB, D-55128 Mainz, Germany	Max Planck Society; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz	Braun, T; Poling, J (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de; jochen.poeling@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804; Adrian-Segarra, Juan M./0000-0002-3712-0554	Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants [SFB1213, TP A02, TP B02]; Foundation Leducq Grant [3CVD01]; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY; CardioNeT (Marie Curie) [ITN-2011-GA: 289600]; Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC)	Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants; Foundation Leducq Grant; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY; CardioNeT (Marie Curie); Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC)	This work was supported by the Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants SFB1213, TP A02, and TP B02; Foundation Leducq Grant 3CVD01; the German Center for Cardiovascular Research; and European Research Area Network on Cardiovascular Diseases Grant CLARIFY. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by CardioNeT (Marie Curie ITN-2011-GA: 289600) and the Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC).	Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Chollangi S, 2012, J BIOL CHEM, V287, P32848, DOI 10.1074/jbc.M112.387324; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drechsler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043155; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; GROVE RI, 1991, J BIOL CHEM, V266, P18194; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Guo S, 2015, J NEUROSCI, V35, P12047, DOI 10.1523/JNEUROSCI.1800-15.2015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Hu JQ, 2017, BBA-MOL BASIS DIS, V1863, P1951, DOI 10.1016/j.bbadis.2016.11.004; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Ichihara M, 1997, BLOOD, V90, P165; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Jahani-Asl A, 2016, NAT NEUROSCI, V19, P798, DOI 10.1038/nn.4295; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KALLESTAD JC, 1991, J BIOL CHEM, V266, P8940; Khrustalev VV, 2012, BIOCHIMIE, V94, P2706, DOI 10.1016/j.biochi.2012.08.008; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Levy G, 2015, NAT BIOTECHNOL, V33, P1264, DOI 10.1038/nbt.3377; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SPORENO E, 1994, CYTOKINE, V6, P255, DOI 10.1016/1043-4666(94)90021-3; Sun DD, 2015, J CELL MOL MED, V19, P1296, DOI 10.1111/jcmm.12501; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Wang YP, 2000, J BIOL CHEM, V275, P25273, DOI 10.1074/jbc.M002296200; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; YIN TG, 1993, J IMMUNOL, V151, P2555; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhang X., 2015, BIOMED RES INT, V2015	60	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7017	7029		10.1074/jbc.RA118.001920	http://dx.doi.org/10.1074/jbc.RA118.001920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29511087	Green Published, hybrid			2022-12-26	WOS:000431487300032
J	Zhu, Y; Lu, L; Qiao, C; Shan, Y; Li, HP; Qian, SX; Hong, M; Zhao, HH; Li, JY; Yang, ZF; Chen, YY				Zhu, Yu; Lu, Luo; Qiao, Chun; Shan, Yi; Li, Huapeng; Qian, Sixuan; Hong, Ming; Zhao, Huihui; Li, Jianyong; Yang, Zhongfa; Chen, Yaoyu			Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; IMATINIB-RESISTANCE; STEM-CELLS; IN-VITRO; THERAPY; GLYCOLYSIS; EXPRESSION; CANCER; PU.1	Resistance to the BCR-ABL tyrosine kinase inhibitor (TKI) remains a challenge for curing the disease in chronic myeloid leukemia (CML) patients as leukemia cells may survive through BCR-ABL kinase activity-independent signal pathways. To gain insight into BCR-ABL kinase activity-independent mechanisms, we performed an initial bioinformatics screen and followed by a quantitative PCR screen of genes that were elevated in CML samples. A total of 33 candidate genes were identified to be highly expressed in TKIs resistant patients. Among those genes, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), controlling the limiting step of glycolysis, was found to be strongly associated with TKIs resistance. PFKFB3 knockdown or pharmacological inhibition of its kinase activity markedly enhanced the sensitivity of CML cells to TKIs. Furthermore, pharmacological inhibition of PFKFB3 inhibited CML cells growth and significantly prolonged the survival of both allograft and xenograft CML mice. ChIP-seq data analysis combined with subsequent knockdown experiment showed that the Ets transcription factor PU.1 regulated the elevated expression of PFKFB3 in TKIs-resistant CML cells. Therefore, our results showed that targeting PFKFB3 sensitizes CML cells to TKIs and PFKFB3 may be a potential BCR-ABL kinase activity-independent mechanism in CML.	[Zhu, Yu; Lu, Luo; Qiao, Chun; Qian, Sixuan; Hong, Ming; Zhao, Huihui; Li, Jianyong; Chen, Yaoyu] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China; [Zhu, Yu; Lu, Luo; Qiao, Chun; Qian, Sixuan; Hong, Ming; Zhao, Huihui; Li, Jianyong; Chen, Yaoyu] Nanjing Med Univ, Key Lab Hematol, Jiangsu Prov Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, Yu; Lu, Luo; Qiao, Chun; Qian, Sixuan; Hong, Ming; Zhao, Huihui; Li, Jianyong; Chen, Yaoyu] Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, Yu; Shan, Yi; Li, Huapeng; Yang, Zhongfa] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Zhu, Y; Chen, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China.; Zhu, Y; Chen, YY (corresponding author), Nanjing Med Univ, Key Lab Hematol, Jiangsu Prov Hosp, Nanjing 210029, Jiangsu, Peoples R China.; Zhu, Y; Chen, YY (corresponding author), Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Jiangsu, Peoples R China.; Zhu, Y (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01655 USA.	zhuyu@jsph.org.cn; Yaoyu.chen@njmu.edu.cn	Li, Jing/GYU-5036-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of the People's Republic of China [81070437, 81270614, 81300379, 81570134, 81570141, 81522001, 81200362]; National Public Health Grand Research Foundation [201202017]; Priority Academic Program Development of Jiangsu Higher Education Institute [JX10231801]; Key Project of Jiangsu Province Health Agency [K201107]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Priority Academic Program Development of Jiangsu Higher Education Institute; Key Project of Jiangsu Province Health Agency	This work was supported by the National Natural Science Foundation of the People's Republic of China (Nos. 81070437, 81270614, 81300379, 81570134, 81570141, 81522001, 81200362), National Public Health Grand Research Foundation (No. 201202017), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute (No. JX10231801) and Key Project of Jiangsu Province Health Agency (K201107).	Antony-Debre I, 2017, J CLIN INVEST, V127, P4297, DOI 10.1172/JCI92504; Bar-Natan Michal, 2012, JAKSTAT, V1, P55, DOI 10.4161/jkst.20006; Bibi S, 2014, HAEMATOLOGICA, V99, P417, DOI 10.3324/haematol.2013.098442; Cang SD, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-15; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chen YY, 2014, J CLIN INVEST, V124, P3847, DOI 10.1172/JCI66129; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Chen Z, 2017, LEUKEMIA, V31, P585, DOI 10.1038/leu.2016.231; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Coller HA, 2014, AM J PATHOL, V184, P4, DOI 10.1016/j.ajpath.2013.07.035; Cruys B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12240; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Eadie LN, 2017, LEUKEMIA, V31, P75, DOI 10.1038/leu.2016.179; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Gotlib J, 2017, BLOOD, V129, P838, DOI 10.1182/blood-2016-08-693630; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Han SH, 2017, LEUKEMIA, V31, P1532, DOI 10.1038/leu.2017.72; Holyoake TL, 2017, BLOOD, V129, P1595, DOI 10.1182/blood-2016-09-696013; Lee CR, 2016, FEBS LETT, V590, P358, DOI 10.1002/1873-3468.12057; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Moon SH, 2013, CELL CYCLE, V12, P867, DOI 10.4161/cc.23911; Oaxaca DM, 2016, TUMOR BIOL, V37, P12643, DOI 10.1007/s13277-016-5179-7; Ohzono T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4735; Okabe S, 2008, CLIN CANCER RES, V14, P6181, DOI 10.1158/1078-0432.CCR-08-0461; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Qian SX, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0360-4; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; RAY D, 1990, ONCOGENE, V5, P663; Rodriguez OC, 2012, CELL CYCLE, V11, P4436, DOI 10.4161/cc.22778; Rosti G, 2017, NAT REV CLIN ONCOL, V14, P141, DOI 10.1038/nrclinonc.2016.139; Schutz C, 2017, LEUKEMIA, V31, P829, DOI 10.1038/leu.2017.9; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Sweet K, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-54; Wagle M, 2016, LEUKEMIA, V30, P1493, DOI 10.1038/leu.2016.51; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Yalcin A, 2017, BIOCHEM BIOPH RES CO, V484, P687, DOI 10.1016/j.bbrc.2017.01.178; Yamada Osamu, 2013, JAKSTAT, V2, pe25256, DOI 10.4161/jkst.25256; Yang Z, 2014, AUTOPHAGY, V10, P382, DOI 10.4161/auto.27345; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhou H, 2017, LEUKEMIA, V31, P2065, DOI 10.1038/leu.2017.87	44	16	16	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	21					2837	2849		10.1038/s41388-018-0157-8	http://dx.doi.org/10.1038/s41388-018-0157-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG8EE	29511345				2022-12-26	WOS:000432929800006
J	Lokau, J; Garbers, C				Lokau, Juliane; Garbers, Christoph			The length of the interleukin-11 receptor stalk determines its capacity for classic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; STAT3; cytokine; proliferation; signal transduction; interleukin-11; interleukin-11 receptor; gp130; stalk region	IL-11 RECEPTOR; MOLECULAR-CLONING; GP130; CYTOKINE; BINDING; CELLS; TUMORIGENESIS; INFLAMMATION; INHIBITION; ACTIVATION	Interleukin (IL)-11 is a multifunctional cytokine that was traditionally recognized for its hematopoietic and anti-inflammatory functions, but has recently been shown also to be involved in tumorigenesis. IL-11 signaling is initiated by binding of the cytokine to the IL-11 receptor (IL-11R), which is not directly involved in signaling but required for IL-11 binding to the signal-transducing receptor glycoprotein (gp) 130. In classic signaling, IL-11 binds to the membrane-bound IL-11R to initiate signal transduction. Additionally, IL-11 signaling can be initiated via soluble IL-11R, known as trans-signaling, and this pathway only requires the three extracellular domains of the IL-11R, but not stalk, transmembrane, or intracellular region. Here, we analyzed the role of the IL-11R stalk region, a 55 amino acid stretch connecting the extracellular domains with the transmembrane helix, in classic IL-11 signaling with the help of cytokine-dependent cell lines. We showed that the stalk region is crucial for IL-11 signaling via the membrane-bound IL-11R. Using different deletion variants, we found that a minimal length of 23 amino acid residues is required for efficient signal transduction. We further found that classic IL-11 signaling depended solely on the length, but not the sequence, of the IL-11R stalk region, suggesting that the stalk functions as a spacer in the signaling complex. We previously described the IL-11R stalk region as determinant of proteolysis and regulator of IL-11 trans-signaling. The results presented here reveal an additional function in classic IL-11 signaling, highlighting the importance of the IL-11R stalk in IL-11 signaling.	[Lokau, Juliane; Garbers, Christoph] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Kiel	Garbers, C (corresponding author), Rudolf Hoeber Str 1, D-24118 Kiel, Germany.	cgarbers@biochem.uni-kiel.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Lokau, Juliane/0000-0002-2573-7282	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was funded by Deutsche Forschungsgemeinschaft Grants SFB877 project A10 (Bonn, Germany) and the Cluster of Excellence "Inflammation at Interfaces." The authors declare that they have no conflicts of interest with the contents of this article.	Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Baumann H, 1996, J IMMUNOL, V157, P284; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Ernst M, 2014, CLIN CANCER RES, V20, P5579, DOI 10.1158/1078-0432.CCR-13-2492; Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Lokau J, 2016, CELL REP, V14, P1761, DOI 10.1016/j.celrep.2016.01.053; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Monhasery N, 2016, CELL REP, V16, P1067, DOI 10.1016/j.celrep.2016.06.062; Nandurkar HH, 1996, ONCOGENE, V12, P585; Nitz R, 2015, BIOCHIMIE, V119, P175, DOI 10.1016/j.biochi.2015.11.005; Orazi A, 1996, EXP HEMATOL, V24, P1289; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Pflanz S, 1999, FEBS LETT, V450, P117, DOI 10.1016/S0014-5793(99)00477-9; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Trepicchio WL, 1997, J IMMUNOL, V159, P5661; Xu DH, 2016, CANCER LETT, V373, P156, DOI 10.1016/j.canlet.2016.01.004; Xu YB, 2010, J BIOL CHEM, V285, P21214, DOI 10.1074/jbc.C110.129502	33	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6398	6409		10.1074/jbc.RA118.001879	http://dx.doi.org/10.1074/jbc.RA118.001879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523682	Green Published, hybrid			2022-12-26	WOS:000431108600015
J	Wang, JX; Abbas, M; Wen, YZ; Niu, DS; Wang, L; Sun, YH; Li, Y				Wang, Jinxing; Abbas, Manzar; Wen, Yanzhong; Niu, Dongsheng; Wang, Ling; Sun, Yuhan; Li, Yun			Selection and validation of reference genes for quantitative gene expression analyses in black locust (Robinia pseudoacacia L.) using real-time quantitative PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; INTERNAL STANDARDS; QUANTIFICATION; NORMALIZATION; ARABIDOPSIS; PLANT; SENESCENCE; TISSUES	Black locust (Robinia pseudoacacia L.) is an easy to raise, fast growing, medium-sized deciduous tree species highly tolerant to harsh eco-conditions, i.e., drought and harsh winters, and it is widely adaptable to sandy, loamy, and marshy soils. The basis for this adaptability remains to be investigated at the transcriptomic level using real-time quantitative PCR (qPCR). Selection of a reliable gene for the normalization of qPCR data is important for obtaining accurate results in gene expression. The goal of this study was to identify an appropriate reference gene from 12 candidate genes for gene expression analysis in black locust exposed to various stressors such as abscisic acid (ABA), NaCl, polyethylene glycol (PEG) and varying temperatures. In GeNorm and NormFinder analyses, ACT (actin) and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene expression were the most stable in all conditions except heat stress, but in BestKeeper analysis, GAPDH and helicase gene expression were the most stable under NaCl and heat stress. In contrast, ACT and GAPDH were highest under abscisic acid (ABA), GAPDH and beta TUB (beta tubulin) under cold stress, and helicase and EF1 alpha (elongation factor 1 alpha) under PEG stress. We found that the most stable reference gene combination for all conditions was ACT and GAPDH. Additionally, the expression pattern of NAC2 (a transcription factor) and BGL2 in different tissues and under different stress conditions was analyzed relative to ACT and GAPDH and UBQ (ubiquitin) the least stably expressed gene. NAC2 and BGL2 both had highest expression in flowers and pods under ABA stress at 48h. This study provides useful reference genes for future gene expression studies in black locust.	[Wang, Jinxing; Abbas, Manzar; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Wen, Yanzhong] Propagat & Breeding Farm Improved Forest Trees Ji, Linfen, Shanxi, Peoples R China; [Niu, Dongsheng; Wang, Ling] Badaling Forestry Farm Beijing, Beijing, Peoples R China	Beijing Forestry University	Li, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.	yunli@bjfu.edu.cn	Abbas, Manzar/F-1902-2016; Abbas, Manzar/O-2934-2019	Abbas, Manzar/0000-0001-7326-6318; Abbas, Manzar/0000-0001-7326-6318; Li, Yun/0000-0002-8426-565X	Fundamental Research Funds for the Central Universities [2015ZCQ-SW-03]; project of National Nature Science Foundation of China [31400562, 31570677]; State Forestry Administration of Science and Technology Development Center project [XPC-2015-3]; State Forestry Administration of science and technology promotion project [[2015]-53]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); project of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration of Science and Technology Development Center project; State Forestry Administration of science and technology promotion project	The authors appreciate financial support from the Fundamental Research Funds for the Central Universities (2015ZCQ-SW-03), the project of National Nature Science Foundation of China (31400562, 31570677) State Forestry Administration of Science and Technology Development Center project (XPC-2015-3) and the State Forestry Administration of science and technology promotion project (No. [2015]-53).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrett R.P., 1990, ADV NEW CROPS; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Castro P, 2012, MOL BREEDING, V29, P261, DOI 10.1007/s11032-010-9544-8; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Charrier B, 2002, PLANT PHYSIOL, V130, P577, DOI 10.1104/pp.009175; Chen H, 2016, TREES-STRUCT FUNCT, V30, P685, DOI 10.1007/s00468-015-1311-3; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Cottrell SE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh008; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Drobak BK, 2004, NEW PHYTOL, V163, P13, DOI 10.1111/j.1469-8137.2004.01076.x; Dundas J, 2012, THEOR BIOSCI, V131, P215, DOI 10.1007/s12064-012-0152-5; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goncalves S, 2005, PLANTA, V222, P556, DOI 10.1007/s00425-005-1562-0; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jian M, 2006, BIOCH BIOPHYSICAL RE, V345, P66; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Kang J J, 2000, Nucleic Acids Res, V28, pe2, DOI 10.1093/nar/28.2.e2; Keeler HL, 1900, OUR NATIVE TREES IDE; Kosova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P643, DOI 10.1134/S0006297917060013; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; [孙美莲 Meilian Sun], 2010, [植物学报, Chinese Bulletin of Botany], V45, P579; Moura Jullyana Cristina Magalhaes Silva, 2012, BMC Res Notes, V5, P634, DOI 10.1186/1756-0500-5-634; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sun P, 2013, ACTA BIOL HUNG, V64, P364, DOI 10.1556/ABiol.64.2013.3.9; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veistinen E, 2002, J IMMUNOL METHODS, V271, P113, DOI 10.1016/S0022-1759(02)00370-8; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wall SJ, 2002, ANAL BIOCHEM, V300, P269, DOI 10.1006/abio.2001.5458; Wang HL, 2015, INT J MOL SCI, V16, P20468, DOI 10.3390/ijms160920468; Wang JW, 2015, GENET MOL RES, V14, P14920, DOI 10.4238/2015.November.18.57; Wang JX, 2015, GENET MOL RES, V14, P12684, DOI 10.4238/2015.October.19.12; Wang Y.L., 2016, CHIN ED INFO, V10, P11, DOI [DOI 10.1016/J.EPSR.2016.11.025, DOI 10.1371/J0URNAL.P0NE]; Wang YL, 2010, J FOREST RES-JPN, V15, P241, DOI 10.1007/s10310-010-0184-y; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yuan CQ, 2013, GENET MOL RES, V12, P6249, DOI 10.4238/2013.December.4.12; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/srep40290	53	17	22	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193076	10.1371/journal.pone.0193076	http://dx.doi.org/10.1371/journal.pone.0193076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	29529054	Green Published, Green Submitted, gold			2022-12-26	WOS:000427189300010
J	Kim, C; Yang, J; Jeong, SH; Kim, H; Park, GH; Shin, HB; Ro, M; Kim, KY; Park, Y; Kim, KP; Kwack, K				Kim, Changshin; Yang, Jinmo; Jeong, Su-Hyun; Kim, Hayoung; Park, Geun-hee; Shin, Hwa Beom; Ro, MyungJa; Kim, Kyoung-Yeon; Park, YoungJoon; Kim, Keun Pil; Kwack, KyuBum			Yeast-based assays for characterization of the functional effects of single nucleotide polymorphisms in human DNA repair genes	PLOS ONE			English	Article							BREAK REPAIR; PROTEIN; COMPLEX; DISEASES; ASSOCIATION; VARIANTS; DAMAGE	DNA repair mechanisms maintain genomic integrity upon exposure to various types of DNA damage, which cause either single-or double-strand breaks in the DNA. Here, we propose a strategy for the functional study of single nucleotide polymorphisms (SNPs) in the human DNA repair genes XPD/ERCC2, RAD18, and KU70/XRCC6 and the checkpoint activation gene ATR that are essentially involved in the cell cycle and DNA damage repair. We analyzed the mutational effects of the DNA repair genes under DNA-damaging conditions, including ultraviolet irradiation and treatment with genotoxic reagents, using a Saccharomyces cerevisiae system to overcome the limitations of the human cell-based assay. We identified causal variants from selected SNPs in the present analyses. (i) R594C SNP in RAD3 (human XPD/ERCC2) caused severe reductions in the growth rate of mutant cells upon short-wavelength UV irradiation or chemical reagent treatment. (ii) The growth rates of the selected variants in RAD18, YKU70, and MEC1 were similar to those of wild-type cells on methyl methanesulfonate and hydroxyurea treated media. (iii) We also assessed the structural impact of the SNPs by analyzing differences in the structural conformation and calculating the root mean square deviation, which is a measure of the discordance of the Ca atoms between protein structures. Based on the above results, we propose that these analytical approaches serve as efficient methods for the identification of causal variants of human disease-causing genes and elucidation of yeast-cell based molecular mechanisms.	[Kim, Changshin; Yang, Jinmo; Jeong, Su-Hyun; Kim, Hayoung; Park, Geun-hee; Shin, Hwa Beom; Ro, MyungJa; Kim, Kyoung-Yeon; Park, YoungJoon; Kwack, KyuBum] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Keun Pil] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea	Pochon Cha University; Chung Ang University	Kwack, K (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seongnam Si, Gyeonggi Do, South Korea.; Kim, KP (corresponding author), Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea.	kpkim@cau.ac.kr; kbkwack@cha.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0093821]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) (www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology (2009-0093821) (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Cordon-Preciado V, 2006, NUCLEIC ACIDS RES, V34, P5852, DOI 10.1093/nar/gkl741; Fuss JO, 2006, PLOS BIOL, V4, P899, DOI 10.1371/journal.pbio.0040203; GETTS RC, 1994, J BIOL CHEM, V269, P15981; Gobbini E, 2016, MICROB CELL, V3, P329, DOI 10.15698/mic2016.08.517; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; KORN AP, 1994, PROTEIN ENG, V7, P961, DOI 10.1093/protein/7.8.961; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Larrivee M, 2006, NAT CELL BIOL, V8, P741, DOI 10.1038/ncb1429; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li SC, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maines S, 1998, GENETICS, V150, P963; Marra G, 1996, ONCOGENE, V13, P2189; Matakidou A, 2007, HUM MOL GENET, V16, P2333, DOI 10.1093/hmg/ddm190; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mjelle R, 2015, DNA REPAIR, V30, P53, DOI 10.1016/j.dnarep.2015.03.007; Mondal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056952; Nakken S, 2007, NEUROSCIENCE, V145, P1273, DOI 10.1016/j.neuroscience.2006.09.004; Nigham A, 2008, J COMPUT BIOL, V15, P813, DOI 10.1089/cmb.2007.0138; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Reiersen H, 2001, TRENDS BIOCHEM SCI, V26, P679, DOI 10.1016/S0968-0004(01)01957-0; Reisman D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/808934; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Rump A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006248; Shibuya T, 2007, J COMPUT BIOL, V14, P1201, DOI 10.1089/cmb.2007.0079; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Taylor EM, 1998, INT J RADIAT BIOL, V74, P277; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Weeda G, 1997, AM J HUM GENET, V60, P320; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0193823	10.1371/journal.pone.0193823	http://dx.doi.org/10.1371/journal.pone.0193823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522548	Green Published, gold, Green Submitted			2022-12-26	WOS:000427030800023
J	Martinez-Montes, AM; Fernandez, A; Munoz, M; Noguera, JL; Folch, JM; Fernandez, AI				Martinez-Montes, Angel M.; Fernandez, Almudena; Munoz, Maria; Luis Noguera, Jose; Folch, Josep M.; Fernandez, Ana I.			Using genome wide association studies to identify common QTL regions in three different genetic backgrounds based on Iberian pig breed	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MEAT QUALITY TRAITS; CARCASS COMPOSITION TRAITS; CHEMICAL BODY-COMPOSITION; FATTY-ACID-COMPOSITION; LARGE WHITE; JOINT ANALYSIS; GROWTH; LANDRACE; CHROMOSOME-4	One of the major limitation for the application of QTL results in pig breeding and QTN identification has been the limited number of QTL effects validated in different animal material. The aim of the current work was to validate QTL regions through joint and specific genome wide association and haplotype analyses for growth, fatness and premier cut weights in three different genetic backgrounds, backcrosses based on Iberian pigs, which has a major role in the analysis due to its high productive relevance. The results revealed nine common QTL regions, three segregating in all three backcrosses on SSC1, 0-3 Mb, for body weight, on SSC2, 3-9 Mb, for loin bone-in weight, and on SSC7, 3 Mb, for shoulder weight, and six segregating in two of the three backcrosses, on SSC2, SSC4, SSC6 and SSC10 for backfat thickness, shoulder and ham weights. Besides, 18 QTL regions were specifically identified in one of the three backcrosses, five identified only in BC_LD, seven in BC_DU and six in BC_PI. Beyond identifying and validating QTL, candidate genes and gene variants within the most interesting regions have been explored using functional annotation, gene expression data and SNP identification from RNA-Seq data. The results allowed us to propose a promising list of candidate mutations, those identified in PDE10A, DHCR7, MFN2 and CCNYgenes located within the common QTL regions and those identified near ssc-mir-103-1 considered PANK3 regulators to be further analysed.	[Martinez-Montes, Angel M.; Fernandez, Almudena; Munoz, Maria; Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Genet Anim, Madrid, Spain; [Munoz, Maria] Ctr I D Cerdo Iberico, Badajoz, Spain; [Luis Noguera, Jose] IRTA, Dept Genet & Millora Anim, Lleida, Spain; [Folch, Josep M.] UAB, Fac Vet, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain; [Folch, Josep M.] Consorci CSIC RTA UAB UB, Ctr Recerca Agrigen CRAG, Plant & Anim Genom, Campus UAB, Bellaterra, Spain; [Fernandez, Ana I.] Hosp Gen Univ Gregorio Maranon, Translat Res, Dept Cardiol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); General University Gregorio Maranon Hospital	Fernandez, AI (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Genet Anim, Madrid, Spain.; Fernandez, AI (corresponding author), Hosp Gen Univ Gregorio Maranon, Translat Res, Dept Cardiol, Madrid, Spain.	anaisabel.fernandez@cibercv.es	Folch, Josep M/I-4738-2015; Fernández, Ana Isabel/J-3265-2012; Muñoz, Almudena Fernández/AAB-4608-2019; Muñoz, María/S-1449-2019	Folch, Josep M/0000-0003-3689-1303; Fernández, Ana Isabel/0000-0002-1509-5191; Muñoz, Almudena Fernández/0000-0002-4495-9366; Muñoz, María/0000-0002-7018-6977; Martinez Montes, Angel Mario/0000-0003-1461-4516	Ministerio de Economia y Competitividad (MINECO) project [AGL2014-56369-C2]; Spanish Ministerio de Ciencia e Innovacion [BES-2012-056563];  [CPE03-010-C3]	Ministerio de Economia y Competitividad (MINECO) project; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); 	This work was funded by Ministerio de Economia y Competitividad (MINECO) project AGL2014-56369-C2. Angel Martinez-Montes was funded by a PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2012-056563). The animal material was generated under the CPE03-010-C3 INIA grant.; This work was funded by Ministerio de Economia y Competitividad (MINECO) project AGL2014-56369-C2. Angel Martinez-Montes was funded by a PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2012-056563). We want to thanks Fabian Garcia and Anna Mercade for technical assistance. The animal material was generated under the CPE03-010-C3 INIA grant. We would like to thank to all the members of the INIA, IRTA, and UAB institutions who contributed to the generation and sample recollection of the animal material used in this work.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Alonso R, 2015, NUCLEIC ACIDS RES, V43, pW117, DOI 10.1093/nar/gkv384; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; An WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132721; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Ashton DT, 2017, MOL ECOL, V26, P1465, DOI 10.1111/mec.13965; Ayuso M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167858; Ballester M, 2016, ANIM GENET, V47, P552, DOI 10.1111/age.12462; Benito J., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P113; Berg F, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-17; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Carrodeguas JA, 2005, MEAT SCI, V71, P577, DOI 10.1016/j.meatsci.2005.05.002; Cherel P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-76; Choi I, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-97; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Duthie C, 2008, ANIM GENET, V39, P130, DOI 10.1111/j.1365-2052.2007.01689.x; Dvorakova V, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-13; Estelle J, 2006, ANIM GENET, V37, P589, DOI 10.1111/j.1365-2052.2006.01535.x; Fernandez AI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-41; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Fontanesi L, 2010, MOL BIOL REP, V37, P491, DOI 10.1007/s11033-009-9678-0; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Grindflek E, 2001, MAMM GENOME, V12, P299, DOI 10.1007/s003350010278; Groenen MAM, 2015, PLANT ANIMAL GENOME; Hankir MK, 2016, EMBO MOL MED, V8, P796, DOI 10.15252/emmm.201506085; Hill WG, 2012, CURR GENOMICS, V13, P196, DOI 10.2174/138920212800543110; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Karssen Lennart C, 2016, F1000Res, V5, P914, DOI 10.12688/f1000research.8733.1; Kim JJ, 2005, J ANIM SCI, V83, P1229; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Kim YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156612; Knott SA, 1998, GENETICS, V149, P1069; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kristensen TN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00038; Lents CA, 2013, DOMEST ANIM ENDOCRIN, V45, P89, DOI 10.1016/j.domaniend.2013.06.002; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Li HX, 2012, MOL BIOL REP, V39, P1823, DOI 10.1007/s11033-011-0924-x; Li XP, 2011, MOL BIOL REP, V38, P3805, DOI 10.1007/s11033-010-0496-1; Lim KS, 2017, ANIM GENET, V48, P166, DOI 10.1111/age.12518; Lipina C, 2015, CELL SIGNAL, V27, P1742, DOI 10.1016/j.cellsig.2015.05.010; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Malek M, 2001, MAMM GENOME, V12, P630, DOI 10.1007/s003350020018; Marklund L, 1999, HEREDITY, V82, P134, DOI 10.1038/sj.hdy.6884630; Martinez-Montes AM, 2016, ANIM GENET; Mercade A, 2006, J ANIM SCI, V84, P2907, DOI 10.2527/jas.2005-663; Mercade A, 2005, MAMM GENOME, V16, P374, DOI 10.1007/s00335-004-2447-4; Milan D, 2002, GENET SEL EVOL, V34, P705, DOI [10.1051/gse:2002026, 10.1186/1297-9686-34-6-705]; Mohrmann M, 2006, ANIM GENET, V37, P435, DOI 10.1111/j.1365-2052.2006.01492.x; Munoz G, 2007, ANIM GENET, V38, P639, DOI 10.1111/j.1365-2052.2007.01668.x; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Munoz M, 2017, 36 INT SOC AN GEN C; Munoz Maria, 2012, Frontiers in Genetics, V2, P101, DOI 10.3389/fgene.2011.00101; Munoz M, 2013, ANIM BIOTECHNOL, V24, P168, DOI 10.1080/10495398.2012.763130; Nicolazzi EL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1497-1; Ojeda A, 2008, ANIM GENET, V39, P468, DOI 10.1111/j.1365-2052.2008.01752.x; Onteru SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061756; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Perez-Enciso M, 2000, GENETICS, V155, P391; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Perez-Montarelo D, 2014, PHYSIOL GENOMICS, V46, P195, DOI 10.1152/physiolgenomics.00151.2013; Pourteymour S, 2017, MOL METAB, V6, P352, DOI 10.1016/j.molmet.2017.01.007; Qi QB, 2015, DIABETOLOGIA, V58, P2791, DOI 10.1007/s00125-015-3750-1; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ros-Freixedes R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152496; Sanchez MP, 2006, J ANIM SCI, V84, P526, DOI 10.2527/2006.843526x; Sato S, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0368-3; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Stelzer G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2722-2; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stratz P, 2014, ANIM GENET, V45, P350, DOI 10.1111/age.12133; Su Yu-Hong, 2002, Acta Genetica Sinica, V29, P681; Sun R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1946-x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Terenina E, 2013, DOMEST ANIM ENDOCRIN, V44, P81, DOI 10.1016/j.domaniend.2012.09.004; Tortereau F, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-42; Tribout T, 2008, GENET SEL EVOL, V40, P61, DOI 10.1051/gse:2007035; Uemoto Y, 2008, J ANIM SCI, V86, P2833, DOI 10.2527/jas.2007-0293; Uemoto Y, 2012, ANIM SCI J, V83, P375, DOI 10.1111/j.1740-0929.2011.00963.x; Uemoto Y, 2010, ANIM SCI J, V81, P28, DOI 10.1111/j.1740-0929.2009.00713.x; Van Eenennaam AL, 2014, ANNU REV ANIM BIOSCI, V2, P105, DOI 10.1146/annurev-animal-022513-114119; van Wijk HJ, 2006, J ANIM SCI, V84, P789, DOI 10.2527/2006.844789x; Venny O.J.C., INTERACTIVE TOOL COM; Walling GA, 2000, GENETICS, V155, P1369; Wang KJ, 2017, INT J BIOL SCI, V13, P189, DOI 10.7150/ijbs.17386; Wang N, 2013, FEBS LETT, V587, P3032, DOI 10.1016/j.febslet.2013.07.033; Wurschum T, 2014, HEREDITY, V112, P463, DOI 10.1038/hdy.2013.126; Yoo CK, 2014, ANIM GENET, V45, P589, DOI 10.1111/age.12166; Zhang C, 2016, PLOS ONE, V11, P1; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou YL, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0372-6	99	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0190184	10.1371/journal.pone.0190184	http://dx.doi.org/10.1371/journal.pone.0190184			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522525	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800002
J	Vetter, BJ; Brey, MK; Mensinger, AF				Vetter, Brooke J.; Brey, Marybeth K.; Mensinger, Allen F.			Reexamining the frequency range of hearing in silver (Hypophthalmichthys molitrix) and bighead (H. nobilis) carp	PLOS ONE			English	Article							AUDITORY SACCULAR SENSITIVITY; ILLINOIS RIVER; ASIAN CARPS; FISH; DAMSELFISH; DETERRENCE; STIMULI	Silver (Hypophthalmichthys molitrix) and bighead (H. nobilis) carp (collectively bigheaded carp) are invasive fish that threaten aquatic ecosystems in the upper Midwest United States and the Laurentian Great Lakes. Controlling bigheaded carp is a priority of fisheries managers and one area of focus involves developing acoustic deterrents to prevent upstream migration. For an acoustic deterrent to be effective however, the hearing ability of bigheaded carp must be characterized. A previous study showed that bigheaded carp detected sound up to 3 kHz but this range is narrower than what has been reported for other ostariophysans. Therefore, silver and bighead carp frequency detection was evaluated in response to 100 Hz to 9 kHz using auditory evoked potentials (AEPs). AEPs were recorded from 100 Hz to 5 kHz. The lowest thresholds were at 500 Hz for both species (silver carp threshold: 80.6 +/- 3.29 dB re 1 mu Pa SPLrms, bighead carp threshold: 90.5 +/- 5.75 dB re 1 mu Pa SPLrms; mean +/- SD). These results provide fisheries managers with better insight on effective acoustic stimuli for deterrent systems, however, to fully determine bigheaded carp hearing abilities, these results need to be compared with behavioral assessments.	[Vetter, Brooke J.; Mensinger, Allen F.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Vetter, Brooke J.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Brey, Marybeth K.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	University of Minnesota System; University of Minnesota Duluth; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey	Vetter, BJ (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.; Vetter, BJ (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	bjvetter@uw.edu			USGS Ecosystem Mission Area Invasive Species Program; US Environmental Protection Agency's Great Lakes Restoration Initiative	USGS Ecosystem Mission Area Invasive Species Program; US Environmental Protection Agency's Great Lakes Restoration Initiative	Funding was provided by the USGS Ecosystem Mission Area Invasive Species Program to AFM and from the US Environmental Protection Agency's Great Lakes Restoration Initiative. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the US Government.	Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Bhandiwad AA, 2017, J COMP PHYSIOL A, V203, P211, DOI 10.1007/s00359-017-1157-9; Clarkson RW, 2004, N AM J FISH MANAGE, V24, P94, DOI 10.1577/M02-146; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; FAY RR, 1974, COMP BIOCHEM PHYSIOL, V49, P29, DOI 10.1016/0300-9629(74)90539-8; Hawkins A. D., 1993, BEHAV TELEOST FISHES, P114; Higgs D. M., 2001, JARO-J ASSOC RES OTO, V3, P174, DOI [10.1007/s101620020035, DOI 10.1007/S101620020035]; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; JEWETT DL, 1970, ELECTROEN CLIN NEURO, V28, P609, DOI 10.1016/0013-4694(70)90203-8; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kojima T, 2005, FISHERIES SCI, V71, P95, DOI 10.1111/j.1444-2906.2005.00935.x; Kolar KS, 2007, AM FISHERIES SOC SPE, V33, P204; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lovell JM, 2006, COMP BIOCHEM PHYS A, V143, P286, DOI 10.1016/j.cbpa.2005.11.015; Mann DA, 2001, J ACOUST SOC AM, V109, P3048, DOI 10.1121/1.1368406; Maruska KP, 2007, J EXP BIOL, V210, P3990, DOI 10.1242/jeb.004390; Moy P.B., 2011, AM FISHERIES SOC SPE, V74, P1; Murchy KA, 2017, FISHERIES MANAG ECOL, V24, P208, DOI 10.1111/fme.12220; Pegg M. A., 2004, ASEANS0101; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Popper Arthur N., 1999, Springer Handbook of Auditory Research, V11, P43; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sass GG, 2014, J GREAT LAKES RES, V40, P911, DOI 10.1016/j.jglr.2014.08.010; Sass GG, 2010, BIOL INVASIONS, V12, P433, DOI 10.1007/s10530-009-9462-z; Schrank SJ, 2003, T AM FISH SOC, V132, P1222, DOI 10.1577/T02-071; Sisneros JA, 2016, ADV EXP MED BIOL, V875, P1049, DOI 10.1007/978-1-4939-2981-8_130; Solomon LE, 2016, BIOL INVASIONS, V18, P2883, DOI 10.1007/s10530-016-1180-8; Taylor RM, 2005, FISHERIES MANAG ECOL, V12, P283, DOI 10.1111/j.1365-2400.2005.00446.x; Vasconcelos RO, 2011, J COMP PHYSIOL A, V197, P903, DOI 10.1007/s00359-011-0651-8; Vetter BJ, 2017, J GREAT LAKES RES, V43, P163, DOI 10.1016/j.jglr.2016.11.009; Vetter BJ, 2015, BIOL INVASIONS, V17, P3383, DOI 10.1007/s10530-015-0964-6; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562	34	16	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0192561	10.1371/journal.pone.0192561	http://dx.doi.org/10.1371/journal.pone.0192561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY7GW	29522536	gold, Green Published			2022-12-26	WOS:000427030800011
J	Hoppes, CW; Sparto, PJ; Whitney, SL; Furman, JM; Huppert, TJ				Hoppes, Carrie W.; Sparto, Patrick J.; Whitney, Susan L.; Furman, Joseph M.; Huppert, Theodore J.			Functional near-infrared spectroscopy during optic flow with and without fixation	PLOS ONE			English	Article							OPTOKINETIC STIMULATION; VESTIBULAR CORTEX; SIGNAL INCREASES; MOTION SICKNESS; CORTICAL AREAS; BRAIN-FUNCTION; REHABILITATION; FMRI; VECTION; TOMOGRAPHY	Background and purpose Individuals with visual vertigo describe symptoms of dizziness, disorientation, and/or impaired balance in environments with conflicting visual and vestibular information or complex visual stimuli. Physical therapists often prescribe habituation exercises using optic flow to treat these symptoms, but there are no evidence-based guidelines for delivering optic flow and it is unclear how the brain processes such stimuli. The purposes of this study were to use functional near-infrared spectroscopy (fNIRS) to explore cerebral activation during optic flow, and determine if visual fixation had a modulating effect on brain activity. Methods Fifteen healthy participants (7 males and 8 females; mean age 41 years old) stood in a virtual reality environment and viewed optic flow moving unidirectionally in the yaw plane with and without fixation. Changes in cerebral activation were recorded from the bilateral fronto-temporo-parietal and occipital lobes using fNIRS. Results Cerebral activation was greater with visual motion than while viewing a stationary scene. Greater cerebral activation in the bilateral fronto-temporo-parietal lobes was observed when optic flow was viewed with fixation. Discussion and conclusions Optic flow activates the bilateral fronto-temporo-parietal regions of the cerebral cortex. This activation is greater while viewing optic flow and a fixation target, providing preliminary evidence supporting the use of a fixation target during habituation exercises.	[Hoppes, Carrie W.; Sparto, Patrick J.; Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Huppert, Theodore J.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Sparto, Patrick J.; Whitney, Susan L.; Furman, Joseph M.] UPMC, Eye & Ear Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoppes, CW (corresponding author), Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA.	cwh27@pitt.edu	Huppert, Theodore/HGB-3534-2022	Sparto, Patrick/0000-0002-8351-3789; Hoppes, Carrie/0000-0001-5104-7448; Huppert, Theodore/0000-0001-8426-5759	Pittsburgh Claude D. Pepper Older Americans Independence Center [P30 AG024827]; Eye and Ear Foundation; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Pittsburgh Claude D. Pepper Older Americans Independence Center; Eye and Ear Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Partial support for this project was funded by a grant from the Pittsburgh Claude D. Pepper Older Americans Independence Center [P30 AG024827, 2012] and the Eye and Ear Foundation.	Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Becker-Bense S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-81; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Boas DA, 2005, APPL OPTICS, V44, P1957, DOI 10.1364/AO.44.001957; Boff K.R., 1986, HDB PERCEPTION HUMAN; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Cope M, 1988, Adv Exp Med Biol, V222, P183; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; Deutschlander A, 2008, BRAIN, V131, P1025, DOI 10.1093/brain/awn035; Deutschlander A, 2004, HUM BRAIN MAPP, V21, P143, DOI 10.1002/hbm.10155; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dieterich M, 2003, EXP BRAIN RES, V148, P117, DOI 10.1007/s00221-002-1267-6; Dieterich M, 1998, BRAIN, V121, P1479, DOI 10.1093/brain/121.8.1479; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Fushiki H, 2000, J VESTIBUL RES-EQUIL, V10, P151; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Herold F, 2017, HUM MOVEMENT SCI, V51, P51, DOI 10.1016/j.humov.2016.11.002; Huppert T., 2016, NEUROPHOTONICS, P3; Huppert TJ, 2009, FRONT NEUROSCI, P393; Indovina I, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00334; Karim H, 2012, GAIT POSTURE, V35, P367, DOI 10.1016/j.gaitpost.2011.10.007; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Palmisano S, 2015, FRONT PSYCHOL, P6; Pavlou M, 2004, J NEUROL, V251, P983, DOI 10.1007/s00415-004-0476-2; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; Pavlou M, 2010, J NEUROL PHYS THER, V34, P105, DOI 10.1097/NPT.0b013e3181dde6bf; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Stephan T, 2005, NEUROIMAGE, V26, P721, DOI 10.1016/j.neuroimage.2005.02.049; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Szturm T, 1994, J Vestib Res, V4, P461; Tarita-Nistor L, 2006, J VESTIBUL RES-EQUIL, V16, P265; Uesaki M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00775; Van Ombergen A, 2017, NEUROIMAGE-CLIN, V14, P538, DOI 10.1016/j.nicl.2017.02.020; VITTE E, 1994, EXP BRAIN RES, V102, P141; Wijeakumar S, 2013, J NEAR INFRARED SPEC, V21, P231, DOI 10.1255/jnirs.1056	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193710	10.1371/journal.pone.0193710	http://dx.doi.org/10.1371/journal.pone.0193710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513720	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800070
J	Miyauchi, E; Furuta, T; Ohtsuki, S; Tachikawa, M; Uchida, Y; Sabit, H; Obuchi, W; Baba, T; Watanabe, M; Terasaki, T; Nakada, M				Miyauchi, Eisuke; Furuta, Takuya; Ohtsuki, Sumio; Tachikawa, Masanori; Uchida, Yasuo; Sabit, Hemragul; Obuchi, Wataru; Baba, Tomoko; Watanabe, Michitoshi; Terasaki, Tetsuya; Nakada, Mitsutoshi			Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HIGH-GRADE GLIOMAS; CELL LUNG-CANCER; POTENTIAL SERUM BIOMARKERS; PANCREATIC-CANCER; UP-REGULATION; TRANSPORTER PROTEINS; PROGNOSTIC VALUE; PLASMA GELSOLIN; MARKER	Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n = 15) using SWATH mass spectrometry analysis. The results were validated by means of quantitative targeted absolute proteomics analysis. As a result, we identified eight biomarker candidates for GBM (leucine-rich alpha-2-glycoprotein (LRG1), complement component C9 (C9), C-reactive protein (CRP), alpha-1-antichymotrypsin (SERPINA3), apolipoprotein B-100 (APOB), gelsolin (GSN), Ig alpha-1 chain C region (IGHA1), and apolipoprotein A-IV (APOA4)). Among them, LRG1, C9, CRP, GSN, IGHA1, and APOA4 gave values of the area under the receiver operating characteristics curve of greater than 0.80. To investigate the relationships between the biomarker candidates and GBM biology, we examined correlations between plasma concentrations of biomarker candidates and clinical presentation (tumor size, progression-free survival time, or overall survival time) in GBM patients. The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R-2 = 0.534, 0.495, and 0.452, respectively).	[Miyauchi, Eisuke; Tachikawa, Masanori; Uchida, Yasuo; Obuchi, Wataru; Baba, Tomoko; Watanabe, Michitoshi; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan; [Furuta, Takuya] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Furuta, Takuya; Sabit, Hemragul; Nakada, Mitsutoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Dept Pharmaceut Microbiol, Fac Life Sci, Kumamoto, Kumamoto, Japan	Tohoku University; Kurume University; Kanazawa University; Kumamoto University	Terasaki, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan.	terasaki.tetsuya@m.tohoku.ac.jp	Terasaki, Tetsuya/K-6730-2012; Nakada, Mitsutoshi/B-2790-2012; Ohtsuki, Sumio/S-4360-2016	Terasaki, Tetsuya/0000-0002-6332-7575; Nakada, Mitsutoshi/0000-0001-9419-6101; Ohtsuki, Sumio/0000-0003-4634-7133; Miyauchi, Eisuke/0000-0003-0258-2633	AMED-CREST [16gm0710013h0103]; Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16K15645, 17K15012] Funding Source: KAKEN	AMED-CREST; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aids from AMED-CREST (16gm0710013h0103) from Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (to SO). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Furukawa K, 2015, PANCREAS, V44, P93, DOI 10.1097/MPA.0000000000000205; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Giganti MG, 2016, ONCOL LETT, V12, P2119, DOI 10.3892/ol.2016.4887; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gollapalli K, 2012, PROTEOMICS, V12, P2378, DOI 10.1002/pmic.201200002; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Guergova-Kuras M, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010298-1, 10.1074/mcp.M111.010298]; Guo XC, 2011, J CRIT CARE, V26, P608, DOI 10.1016/j.jcrc.2011.02.007; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Iliadis G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-3; Ilzecka J, 2006, EUR CYTOKINE NETW, V17, P276; Iwamoto FM, 2011, NEURO-ONCOLOGY, V13, P1244, DOI 10.1093/neuonc/nor117; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jayaram S, 2014, EXPERT REV PROTEOMIC, V11, P621, DOI 10.1586/14789450.2014.939634; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kataoka H, 2002, PATHOL INT, V52, P89, DOI 10.1046/j.1440-1827.2002.01320.x; Khakzad MR, 2012, RES AUTISM SPECT DIS, V6, P1032, DOI 10.1016/j.rasd.2011.10.002; Kros JM, 2015, NEURO-ONCOLOGY, V17, P343, DOI 10.1093/neuonc/nou207; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Lee JG, 2009, LUNG CANCER, V63, P106, DOI 10.1016/j.lungcan.2008.04.011; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu Y, 2013, EXPERT REV MOL DIAGN, V13, P811, DOI 10.1586/14737159.2013.845089; Liu YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051748; Lokamani I, 2014, PATHOL ONCOL RES, V20, P119, DOI 10.1007/s12253-013-9670-9; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luo DY, 2017, ONCOTARGETS THER, V10, P2173, DOI 10.2147/OTT.S133022; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyauchi E, 2016, MOL PHARMACEUT, V13, P2631, DOI 10.1021/acs.molpharmaceut.6b00085; Nakamura K, 2016, PROTEOMICS, V15, P3508; Nijaguna MB, 2015, J PROTEOMICS, V128, P251, DOI 10.1016/j.jprot.2015.07.026; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Nurdin A, 2016, J PHARM SCI-US, V105, P3440, DOI 10.1016/j.xphs.2016.08.013; Ohnishi M, 2009, PATHOL INT, V59, P797, DOI 10.1111/j.1440-1827.2009.02447.x; Park J, 2017, ONCOTARGET, V8, P42761, DOI 10.18632/oncotarget.17463; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Pierredon S, 2017, ONCOL LETT, V13, P4965, DOI 10.3892/ol.2017.6096; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Popescu ID, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0047-0; Quaranta M, 2007, TUMORI J, V93, P275; Radunovic M, 2016, J BUON, V21, P597; Rauniyar N, 2017, BIOMARK INSIGHTS, V12, DOI 10.1177/1177271917710948; ROBEY FA, 1987, J BIOL CHEM, V262, P7053; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shao SY, 2015, BBA-PROTEINS PROTEOM, V1854, P519, DOI 10.1016/j.bbapap.2014.12.012; SHEPHARD EG, 1989, J IMMUNOL, V143, P2974; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; Shieh DB, 2006, ORAL ONCOL, V42, P599, DOI 10.1016/j.oraloncology.2005.10.021; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Somasundaram K, 2009, EXPERT REV MOL DIAGN, V9, P695, DOI 10.1586/ERM.09.52; Song SH, 2012, QJM-INT J MED, V105, P973, DOI 10.1093/qjmed/hcs113; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Strojnik T, 2014, ANTICANCER RES, V34, P339; TANAKA M, 1995, CANCER RES, V55, P3228; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Wu JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114495; Yang J, 2004, LUNG CANCER-J IASLC, V46, P29, DOI 10.1016/j.lungcan.2004.03.022; Yokoyama K, 1998, J LIPID RES, V39, P103; Yoneyama T, 2013, J PROTEOME RES, V12, P753, DOI 10.1021/pr3008144; Zhong D, 2015, TUMOR BIOL, V36, P4271, DOI 10.1007/s13277-015-3065-3; Zhou JY, 2017, ONCOTARGET, V8, P18712, DOI 10.18632/oncotarget.9409; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815	80	56	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193799	10.1371/journal.pone.0193799	http://dx.doi.org/10.1371/journal.pone.0193799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513714	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800076
J	Cotrim, CA; Soares, JSM; Kobe, B; Menossi, M				Cotrim, Camila A.; Soares, Jose Sergio M.; Kobe, Bostjan; Menossi, Marcelo			Crystal structure and insights into the oligomeric state of UDP-glucose pyrophosphorylase from sugarcane	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; METABOLISM; LOCALIZATION; MECHANISM; SYNTHASE	UDP-glucose pyrophosphorylase (UGPase) is found in all organisms and catalyses the formation of UDP-glucose. In sugarcane, UDP-glucose is a branch-point in the carbon channelling into other carbohydrates, such as sucrose and cellulose, which are the major factors for sugarcane productivity. In most plants, UGPase has been described to be enzymatically active in the monomeric form, while in human and yeast, homo-octamers represent the active form of the protein. Here, we present the crystal structure of UGPase from sugarcane (ScUGPase-1) at resolution of 2.0 angstrom. The crystals of ScUGPase-1 reveal the presence of two molecules in the asymmetric unit and the multi-angle light scattering analysis shows that ScUGPase-1 forms a mixture of species ranging from monomers to larger oligomers in solution, suggesting similarities with the orthologs from yeast and human.	[Cotrim, Camila A.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Cotrim, Camila A.; Kobe, Bostjan] Univ Queensland, Australia Infect Dis Res Ctr, Brisbane, Qld, Australia; [Soares, Jose Sergio M.; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao Microbiol & Imunol, Campinas, SP, Brazil; [Cotrim, Camila A.] Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Universidade de Sao Paulo; Universidade Estadual de Campinas; Griffith University	Cotrim, CA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.; Cotrim, CA (corresponding author), Univ Queensland, Australia Infect Dis Res Ctr, Brisbane, Qld, Australia.; Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao Microbiol & Imunol, Campinas, SP, Brazil.; Cotrim, CA (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia.	c.cotrim@griffith.edu.au; menossi@lgf.ib.unicamp.br	Soares, Jose Sergio/D-6450-2014; Cotrim, Camila A/Q-9560-2019; Kobe, Bostjan/D-1292-2009; Menossi, Marcelo/A-4364-2012	Soares, Jose Sergio/0000-0003-3908-0741; Cotrim, Camila A/0000-0002-9176-5767; Kobe, Bostjan/0000-0001-9413-9166; Menossi, Marcelo/0000-0002-9211-3787	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/15576-5, 2008/06767-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant 2013/15576-5 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br/; grant 2008/06767-3 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br/ to JSMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fuhring J, 2013, ACS CATAL, V3, P2976, DOI 10.1021/cs4007777; Fuehring JI, 2015, SCI REP-UK, V5, DOI 10.1038/srep09618; Gibeaut DM, 2000, PLANT PHYSIOL BIOCH, V38, P69, DOI 10.1016/S0981-9428(00)00167-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLECZKOWSKI LA, 1994, PHYTOCHEMISTRY, V37, P1507, DOI 10.1016/S0031-9422(00)89568-0; Kleczkowski LA, 2005, PHYTOCHEMISTRY, V66, P2815, DOI 10.1016/j.phytochem.2005.09.034; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Marino K, 2010, GLYCOBIOLOGY, V20, P1619, DOI 10.1093/glycob/cwq115; Martz F, 2002, BIOCHEM J, V367, P295, DOI 10.1042/BJ20020772; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mccoy JG, 2007, J MOL BIOL, V366, P830, DOI 10.1016/j.jmb.2006.11.059; Meng M, 2009, BBA-PROTEINS PROTEOM, V1794, P1734, DOI 10.1016/j.bbapap.2009.08.009; Payyavula RS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0265-8; Roeben A, 2006, J MOL BIOL, V364, P551, DOI 10.1016/j.jmb.2006.08.079; Soares JSM, 2014, J BIOL CHEM, V289, P33364, DOI 10.1074/jbc.M114.590125; Steiner T, 2007, J BIOL CHEM, V282, P13003, DOI 10.1074/jbc.M609984200; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Winter H, 2000, CRIT REV BIOCHEM MOL, V35, P253, DOI 10.1080/10409230008984165	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193667	10.1371/journal.pone.0193667	http://dx.doi.org/10.1371/journal.pone.0193667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494650	Green Submitted, gold, Green Published			2022-12-26	WOS:000426363200079
J	Sato, A; Shibuya, H				Sato, Atsushi; Shibuya, Hiroshi			Glycogen synthase kinase 3 beta functions as a positive effector in the WNK signaling pathway	PLOS ONE			English	Article							ALANINE-RICH KINASE; NEUROPATHY TYPE-II; PROTEIN-KINASE; SPAK; COTRANSPORTERS; OSR1; PHOSPHORYLATION; MUTATIONS; GENE	The with no lysine (WNK) protein kinase family is conserved among many species. Some mutations in human WNK gene are associated with pseudohypoaldosteronism type II, a form of hypertension, and hereditary sensory and autonomic neuropathy type 2A. In kidney, WNK regulates the activity of STE20/SPS1-related, proline alanine-rich kinase and/or oxidative-stress responsive 1, which in turn regulate ion co-transporters. The misregulation of this pathway is involved in the pathogenesis of pseudohypoaldosteronism type II. In the neural system, WNK is involved in the specification of the cholinergic neuron, but the pathogenesis of hereditary sensory and autonomic neuropathy type 2A is still unknown. To better understand the WNK pathway, we isolated WNK-associated genes using Drosophila. We identified Glycogen synthase kinase 3 beta (GSK3 beta)/Shaggy (Sgg) as a candidate gene that was shown to interact with the WNK signaling pathway in both Drosophila and mammalian cells. Furthermore, GSK3 beta was involved in neural specification downstream of WNK. These results suggest that GSK3 beta/Sgg functions as a positive effector in the WNK signaling pathway.	[Sato, Atsushi; Shibuya, Hiroshi] TMDU, Dept Mol Cell Biol & Joint Usage, Res Ctr Intractable Dis, Med Res Inst,Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Shibuya, H (corresponding author), TMDU, Dept Mol Cell Biol & Joint Usage, Res Ctr Intractable Dis, Med Res Inst,Bunkyo Ku, Tokyo, Japan.	shibuya.mcb@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26460386]; Nanken-Kyoten, TMDU [17M03]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nanken-Kyoten, TMDU	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 26460386, to Dr. Atsushi Sato; and Nanken-Kyoten, TMDU, 17M03, to Prof. Hiroshi Shibuya.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kahle KT, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0163; Lawrence P.A., 1986, P229; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Naguro I, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2283; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Riviere JB, 2004, ANN NEUROL, V56, P572, DOI 10.1002/ana.20237; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009	28	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193204	10.1371/journal.pone.0193204	http://dx.doi.org/10.1371/journal.pone.0193204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494638	gold, Green Submitted, Green Published			2022-12-26	WOS:000426363200030
J	Zhao, LX; Ge, YH; Xiong, CH; Tang, L; Yan, YH; Law, PY; Qiu, Y; Chen, HZ				Zhao, Lan-Xue; Ge, Yan-Hui; Xiong, Cai-Hong; Tang, Ling; Yan, Ying-Hui; Law, Ping-Yee; Qiu, Yu; Chen, Hong-Zhuan			M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit	FASEB JOURNAL			English	Article						learning and memory; GluA1 phosphorylation at Ser845; postsynaptic densities	LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTORS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; M-1 RECEPTORS; SK CHANNELS; MEMORY; PHOSPHORYLATION; HIPPOCAMPUS; ACTIVATION	M1 muscarinic acetylcholine receptors (M1 mAChRs) are the most abundant muscarinic receptors in the hippocampus and have been shown to have procognitive effects. AMPA receptors (AMPARs), an important subtype of ionotropic glutamate receptors, are key components in neurocognitive networks. However, the role of AMPARs in procognitive effects of M1 mAChRs and how M1 mAChRs affect the function of AMPARs remain poorly understood. Here, we found that basal expression of GluA1, a subunit of AMPARs, and its phosphorylation at Ser845 were maintained by M1 mAChR activity. Activation of M1 mAChRs promoted membrane insertion of GluA1, especially to postsynaptic densities. Impairment of hippocampus-dependent learning and memory by antagonism of M1 mAChRs paralleled the reduction of GluA1 expression, and improvement of learning and memory by activation of M1 mAChRs was accompanied by the synaptic insertion of GluA1 and its increased phosphorylation at Ser845. Furthermore, abrogation of phosphorylation of Ser845 residue of GluA1 ablated M1 mAChR-mediated improvement of learning and memory. Taken together, these results show a functional correlation of M1 mAChRs and GluA1 and the essential role of GluA1 in M1 mAChR-mediated cognitive improvement.Zhao, L.-X., Ge, Y.-H., Xiong, C.-H., Tang, L., Yan, Y.-H., Law, P.-Y., Qiu, Y., Chen, H.-Z. M1 muscarinic receptor facilitates cognitive function by interplay with AMPA receptor GluA1 subunit.	[Zhao, Lan-Xue; Ge, Yan-Hui; Xiong, Cai-Hong; Tang, Ling; Yan, Ying-Hui; Qiu, Yu; Chen, Hong-Zhuan] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA	Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities	Qiu, Y; Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	qiuy@shsmu.edu.cn; yaoli@shsmu.edu.cn			National Natural Science Foundation of China [81473217, 81573415]; International Science and Technology Cooperation Program of China [2011DFA33180]; General Financial Grant from the China Postdoctoral Science Foundation [2016M601619]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201403]; Shanghai Jiao Tong University Medical-Science Cross Fund [YG2017ZD14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; General Financial Grant from the China Postdoctoral Science Foundation; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University Medical-Science Cross Fund	The authors thank Dr. Dezhi Liao (University of Minnesota) for technical help. This work was supported by the National Natural Science Foundation of China (81473217, 81573415), International Science and Technology Cooperation Program of China (2011DFA33180), General Financial Grant from the China Postdoctoral Science Foundation (2016M601619), Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201403), and Shanghai Jiao Tong University Medical-Science Cross Fund (YG2017ZD14). The authors declare no conflicts of interest.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Aronica E, 1998, NEUROSCIENCE, V82, P979; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; Bradley SR, 2010, NEUROPHARMACOLOGY, V58, P365, DOI 10.1016/j.neuropharm.2009.10.003; Bubser M., 2012, HDB EXP PHARM, V208, P121; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Crombag HS, 2008, EUR J NEUROSCI, V27, P3284, DOI 10.1111/j.1460-9568.2008.06299.x; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Davis AA, 2010, J NEUROSCI, V30, P4190, DOI 10.1523/JNEUROSCI.6393-09.2010; Dennis SH, 2016, CEREB CORTEX, V26, P414, DOI 10.1093/cercor/bhv227; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; Douchamps V, 2017, BEHAV PHARMACOL, V28, P112, DOI 10.1097/FBP.0000000000000300; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Hagena H, 2016, CEREB CORTEX, V26, P1349, DOI 10.1093/cercor/bhv330; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Jo J, 2010, NAT NEUROSCI, V13, P1216, DOI 10.1038/nn.2636; Kam AYF, 2010, J NEUROSCI, V30, P15304, DOI 10.1523/JNEUROSCI.4255-10.2010; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kibaly C, 2016, BIOL PSYCHIAT, V79, P906, DOI 10.1016/j.biopsych.2015.04.019; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Maltese M, 2014, MOVEMENT DISORD, V29, P1655, DOI 10.1002/mds.26009; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Potter PE, 2011, ACTA NEUROPATHOL, V122, P49, DOI 10.1007/s00401-011-0831-1; Puri V, 2015, BEHAV BRAIN RES, V287, P96, DOI 10.1016/j.bbr.2015.03.029; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sarter M, 2014, EUR J NEUROSCI, V39, P1912, DOI 10.1111/ejn.12515; Sheffler DJ, 2009, MOL PHARMACOL, V76, P356, DOI 10.1124/mol.109.056531; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Spires TL, 2004, REV NEUROSCIENCE, V15, P267, DOI 10.1515/REVNEURO.2004.15.4.267; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Watt ML, 2011, J PHARMACOL EXP THER, V338, P622, DOI 10.1124/jpet.111.182063; Williams MR, 2013, EUR ARCH PSY CLIN N, V263, P485, DOI 10.1007/s00406-012-0387-7	55	14	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4247	4257		10.1096/fj.201800029R	http://dx.doi.org/10.1096/fj.201800029R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29509512				2022-12-26	WOS:000439325400016
J	Cheng, Y; Gao, XH; Li, XJ; Cao, QH; Zhao, DD; Zhou, JR; Wu, HX; Wang, Y; You, LJ; Yang, HB; He, YL; Li, YR; Bian, JS; Zhu, QY; Birnbaumer, L; Yang, Y				Cheng, Yan; Gao, Xing-Hua; Li, Xian-Jing; Cao, Qiu-Hua; Zhao, Dan-Dan; Zhou, Jin-Rong; Wu, Hong-Xi; Wang, Yun; You, Lin-Jun; Yang, Hong-Bao; He, Yun-Long; Li, Yong-Ren; Bian, Jin-Song; Zhu, Qing-Yi; Birnbaumer, Lutz; Yang, Yong			Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway	ONCOGENE			English	Article							TUMOR-GROWTH; CHRONIC STRESS; MILD STRESS; RECEPTOR; MODEL; PROGRESSION; ACTIVATION; ONCOLOGY; MICE; PHOSPHORYLATION	Depression drives cancer progression and induces poor clinical outcome. However, the mechanisms underlying depression and cancer outcomes are unclear. In this work, we investigated 98 prostate cancer patients and found that patients with high score of psychological depression were correlated with tumor invasion and metastasis. We found focal adhesion kinase (FAK) was increased in cancer patients with metastatic features and high score of depression. FAK knockdown completely blocked depression-promoted tumor invasion in orthotopic transplantation tumors. In Hi-myc mice and a murine model of depression, sympathetic activation was detected in the prostate tissue. Further we showed that FAK activation was dependent on a cAMP-PKA signaling pathway. Our results demonstrated that the activation of a sympathetic-FAK signaling pathway in prostate cancer patients with high degrees of depression facilitates tumor invasion. We suggest that blocking beta 2AR with propranolol or inhibiting FAK activation with PF562 271 may be novel strategies for depressed patients with invasive prostate cancer.	[Cheng, Yan; Gao, Xing-Hua; Li, Xian-Jing; Cao, Qiu-Hua; Zhao, Dan-Dan; Wu, Hong-Xi; Wang, Yun; You, Lin-Jun; Yang, Hong-Bao; He, Yun-Long; Li, Yong-Ren; Yang, Yong] China Pharmaceut Univ, Ctr New Drug Safety Evaluat & Res, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing 211198, Jiangsu, Peoples R China; [Zhou, Jin-Rong] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Nutr Metab Lab, Boston, MA 02138 USA; [Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Zhu, Qing-Yi] Jiangsu Prov Hosp Tradit Chinese Med, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Durham, NC 27709 USA; [Birnbaumer, Lutz] BOMED Catholic Univ Argentina, Biomed Res Inst, C1107AAZ, Buenos Aires, DF, Argentina	China Pharmaceutical University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National University of Singapore; Nanjing University of Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yang, Y (corresponding author), China Pharmaceut Univ, Ctr New Drug Safety Evaluat & Res, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing 211198, Jiangsu, Peoples R China.; Birnbaumer, L (corresponding author), NIEHS, Neurobiol Lab, Durham, NC 27709 USA.; Birnbaumer, L (corresponding author), BOMED Catholic Univ Argentina, Biomed Res Inst, C1107AAZ, Buenos Aires, DF, Argentina.	birnbau1@gmail.com; yy@cpu.edu.cn		Bian, Jinsong/0000-0002-7741-598X	Intramural Research Program of the NIH [Z01-ES101684]; 111 Project [111-2-07]; National Science Foundation of China [91529304, 81673468, 81603132, 81403020]; Natural Science Foundation of Jiangsu Province [BK20160753]; China Postdoctoral Science Foundation [2016M591965]	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Mrs. Ning Su for IHC studies, Mrs. Jian-hua Ding for HPLC studies, and Dr. Wen-tao Liu for gelatin zymography experiments and helpful suggestions. This study was supported by grants from Intramural Research Program of the NIH (Z01-ES101684 to LB), The 111 Project (No. 111-2-07), National Science Foundation of China (91529304, 81673468 to YY, 81603132 to XG and 81403020 to LY), Natural Science Foundation of Jiangsu Province (No. BK20160753 to XG), and China Postdoctoral Science Foundation (No. 2016M591965 to XG).	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Barbieri A, 2015, INT J ONCOL, V47, P527, DOI 10.3892/ijo.2015.3038; BATKIN S, 1970, P NATL ACAD SCI USA, V67, P1521, DOI 10.1073/pnas.67.3.1521; Batty GD, 2017, BMJ-BRIT MED J, V356, P108; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; de la Taille A, 2000, EUR UROL, V38, P79, DOI 10.1159/000020256; Dimitrov S, 2010, J IMMUNOL, V184, P503, DOI 10.4049/jimmunol.0902189; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Feng Y, 2016, PSYCHIAT RES, V243, P92, DOI 10.1016/j.psychres.2016.06.021; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; Gaston SM, 2005, NAT MED, V11, P95, DOI 10.1038/nm1169; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Harryman WL, 2016, BBA-REV CANCER, V1866, P221, DOI 10.1016/j.bbcan.2016.09.005; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Incio J, 2016, CANCER DISCOV, V6, P852, DOI 10.1158/2159-8290.CD-15-1177; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Ko CJ, 2015, CANCER RES, V75, P2949, DOI 10.1158/0008-5472.CAN-14-3297; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Law NC, 2017, ENDOCRINOLOGY, V158, P2043, DOI 10.1210/en.2017-00163; Le CP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10634; Li XJ, 2015, P NATL ACAD SCI USA, V112, P4731, DOI 10.1073/pnas.1503779112; Lopez-Calderero I, 2017, ACTAS UROL ESP, V41, P368, DOI 10.1016/j.acuro.2016.12.006; Lu DH, 2016, CLIN CANCER RES, V22, P765, DOI 10.1158/1078-0432.CCR-15-0101; Ma XJ, 2012, J BIOL CHEM, V287, P18925, DOI 10.1074/jbc.M112.352260; Madden KS, 2017, DEV COMP IMMUNOL, V66, P92, DOI 10.1016/j.dci.2016.04.015; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Mao J, 2016, CANCER LETT, V380, P134, DOI 10.1016/j.canlet.2016.06.020; Lopez-Colome AM, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0418-y; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Mehta RD, 2015, CA-CANCER J CLIN, V65, P299, DOI 10.3322/caac.21285; Mo F, 2017, EUR UROL; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Piiper A, 2003, BIOCHEM BIOPH RES CO, V301, P848, DOI 10.1016/S0006-291X(03)00055-X; Prasad SM, 2014, J CLIN ONCOL, V32, P2471, DOI 10.1200/JCO.2013.51.1048; Qin JF, 2015, BMB REP, V48, P295, DOI 10.5483/BMBRep.2015.48.5.008; Slack-Davis JK, 2009, MOL CANCER THER, V8, P2470, DOI 10.1158/1535-7163.MCT-09-0262; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Sullivan DR, 2016, J CLIN ONCOL, V34, P3984, DOI 10.1200/JCO.2016.66.8459; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Uehara A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34012; Venkatesh H, 2017, TRENDS CANCER, V3, P89, DOI 10.1016/j.trecan.2016.12.008; Venkitaraman R, 2015, EUR UROL, V67, P673, DOI 10.1016/j.eururo.2014.10.004; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	55	33	36	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	22					2953	2966		10.1038/s41388-018-0177-4	http://dx.doi.org/10.1038/s41388-018-0177-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GH8RM	29515233	Green Accepted			2022-12-26	WOS:000433936300004
J	Lawrence, DW; Kombluth, J				Lawrence, Donald W.; Kornbluth, Jacki			Reduced inflammation and cytokine production in NKLAM deficient mice during Streptococcus pneumoniae infection	PLOS ONE			English	Article							UBIQUITIN LIGASE NKLAM; LYTIC-ASSOCIATED MOLECULE; ALPHA GENE-EXPRESSION; STAT1 DEFICIENCY; IFN-GAMMA; RESISTANCE; PROTEIN-1; DISEASE; PARKIN; INTERLEUKIN-12	Streptococcus pneumoniae is a leading cause of pneumonia and a significant economic burden. Antibiotic-resistant S. pneumoniae has become more prevalent in recent years and many pneumonia cases are caused by S. pneumoniae that is resistant to at least one antibiotic. The ubiquitin ligase natural killer lytic-associated molecule (NKLAM/RNF19b) plays a role in innate immunity and studies using NKLAM-knockout (NKLAM-KO) macrophages have demonstrated that NKLAM positively affects the transcriptional activity of STAT1. Using an inhalation infection model, we found that NKLAM-KO mice had a significantly higher lung bacterial load than WT mice but had less lung inflammation. Coincidently, NKLAM-KO mice had fewer neutrophils and NK cells in their lungs. NKLAM-KO mice also expressed less iNOS in their lungs as well as less MCP-1, MIP1 alpha, TNF alpha, IL-12, and IFN gamma. Both neutrophils and macrophages from NKLAM-KO mice were defective in killing S. pneumoniae as compared to wild type cells (WT). The phosphorylation of STAT1 and STAT3 in NKLAM-KO lungs was lower than in WT lungs at 24 hours post-infection. NKLAM-KO mice were afforded some protection against a lethal dose of S. pneumoniae compared to WT mice. In summary, our novel data demonstrate a role for E3 ubiquitin ligase NKLAM in modulating innate immunity via the positive regulation of inflammatory cytokine expression and bactericidal activity.	[Lawrence, Donald W.; Kornbluth, Jacki] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Kornbluth, Jacki] VA St Louis Hlth Care Syst, St Louis, MO 63106 USA	Saint Louis University	Kombluth, J (corresponding author), St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.; Kombluth, J (corresponding author), VA St Louis Hlth Care Syst, St Louis, MO 63106 USA.	jacki.kornbluth@health.slu.edu		Lawrence, Donald/0000-0001-5912-6992	United States Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [101 BX0000705]; Veterans Affairs [I01BX000705] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Biomedical Laboratory Research and Development Service; Veterans Affairs(US Department of Veterans Affairs)	This research was funded by a Merit Award (101 BX0000705) provided to JK by the United States Department of Veterans Affairs, Biomedical Laboratory Research and Development Service (https://www.va.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory-Rivier CF, 2000, CRIT CARE MED, V28, P3249, DOI 10.1097/00003246-200009000-00021; Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Balamayooran G, 2011, INFECT IMMUN, V79, P2567, DOI 10.1128/IAI.00067-11; Center for Disease Control and Prevention, 2016, ANT ANT RES 2016; Center for Disease Control and Prevention, 2015, PNEUM DIS 2015; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chappell VL, 2000, SHOCK, V14, P400, DOI 10.1097/00024382-200014030-00027; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cooper JA, 2015, MOL CELL BIOL, V35, P1886, DOI 10.1128/MCB.00098-15; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Fardilha M, 2011, MOL HUM REPROD, V17, P466, DOI 10.1093/molehr/gar004; Hoover RG, 2009, J IMMUNOL, V183, P6913, DOI 10.4049/jimmunol.0901679; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Kozlowski M, 1999, J IMMUNOL, V163, P1775; Kurup PK, 2015, P NATL ACAD SCI USA, V112, P1202, DOI 10.1073/pnas.1417423112; Lawrence DW, 2016, CELL SIGNAL, V28, P1833, DOI 10.1016/j.cellsig.2016.08.014; Lawrence DW, 2015, IMMUNOBIOLOGY, V220, P83, DOI 10.1016/j.imbio.2014.08.016; Lawrence DW, 2012, CELL IMMUNOL, V279, P46, DOI 10.1016/j.cellimm.2012.09.004; Letsiou E, 2017, TRANSL RES, V181, P71, DOI 10.1016/j.trsl.2016.09.002; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moorthy AN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00056; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Takagi K, 2005, J IMMUNOL, V174, P1801, DOI 10.4049/jimmunol.174.4.1801; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461	38	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0194202	10.1371/journal.pone.0194202	http://dx.doi.org/10.1371/journal.pone.0194202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518136	Green Published, gold, Green Submitted			2022-12-26	WOS:000426902900074
J	Abdul-Cader, MS; Amarasinghe, A; Palomino-Tapia, V; Ahmed-Hassan, H; Bakhtawar, K; Nagy, E; Sharif, S; Gomis, S; Abdul-Careem, MF				Abdul-Cader, Mohamed Sarjoon; Amarasinghe, Aruna; Palomino-Tapia, Victor; Ahmed-Hassan, Hanaa; Bakhtawar, Khawaja; Nagy, Eva; Sharif, Shayan; Gomis, Susantha; Abdul-Careem, Mohamed Faizal			In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; BURSAL DISEASE VIRUS; RECEPTOR 2 LIGAND; LIPOTEICHOIC ACID; BACTERIAL-DNA; B-CELLS; CHICKENS; OLIGODEOXYNUCLEOTIDES; MOTIFS; ACTIVATION	Cytosine-guanosine deoxynucleotides (CpG) DNA can be delivered in ovo at embryo day (ED) 18 for the stimulation of toll-like receptor (TLR) 21 signaling pathway that ultimately protects chickens against a number of bacterial and viral infections. There is a dearth of information understanding the mechanisms of protection induced by in ovo delivered CpG DNA. The objective of this study was to determine the immune cell changes post-hatch following in ovo delivery of the TLR21 ligand, CpG DNA. In order to quantify changes of percentage of KUL01+, IgM+ B, cluster of differentiation (CD) 4+ and CD8a+ cells, trachea, lung, duodenum, large intestine, spleen and bursa of Fabricius were collected on day 1 post-hatch. We found increased recruitments of KUL01+ cells, in organs of these body systems post-hatch following in ovo delivery of CpG DNA. Although IgM+ B cells, CD4+ and CD8a+ cells were increased in lungs and immune system organs, these cells were not quantifiable from the trachea, duodenum and large intestine immediately following the hatch. Furthermore, when CpG DNA is delivered in ovo and subsequently infected with infectious laryngotracheitis virus (ILTV) post-hatch on day 1, CpG DNA reduces morbidity and mortality resulting from ILTV infection. This study provides insights into the mechanisms of host responses elicited following in ovo delivery of CpG DNA in avian species.	[Abdul-Cader, Mohamed Sarjoon; Amarasinghe, Aruna; Palomino-Tapia, Victor; Ahmed-Hassan, Hanaa; Bakhtawar, Khawaja; Abdul-Careem, Mohamed Faizal] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Hlth Res Innovat Ctr, Calgary, AB, Canada; [Ahmed-Hassan, Hanaa] Cairo Univ, Fac Vet Med, Zoonoses Dept, Giza, Egypt; [Nagy, Eva; Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Gomis, Susantha] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK, Canada	University of Calgary; Egyptian Knowledge Bank (EKB); Cairo University; University of Guelph; University of Saskatchewan	Abdul-Careem, MF (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Hlth Res Innovat Ctr, Calgary, AB, Canada.	faizal.abdulcareem@ucalgary.ca	Careem, Faizal/H-8005-2019; Palomino, Víctor/GYI-8959-2022	Careem, Faizal/0000-0002-9974-7600; 	Canadian Poultry Research Council [AMN088]; Alberta Agriculture and Forestry [2016R003R]; Natural Sciences and Engineering Research Council of Canada [CRDPJ/491522-2015]	Canadian Poultry Research Council; Alberta Agriculture and Forestry; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Poultry Research Council (http://cp-rc.ca), AMN088, received by MFA; the Alberta Agriculture and Forestry (http://www.agric.gov.ab.ca/app21/ministrypage), 2016R003R, received by MFA; and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), CRDPJ/491522-2015, received by MFA.	Abdul-Cader MS, 2017, J GEN VIROL, V98, P1209, DOI 10.1099/jgv.0.000787; Abdul-Cader MS, 2017, VIRAL IMMUNOL, P1; Abdul-Cader MS, 2016, CYTOSINE GUANOSINE D; Abdul-Careem MF, 2015, MAIN CHALLENGES POUL; Ashkar AA, 2003, J VIROL, V77, P8948, DOI 10.1128/JVI.77.16.8948-8956.2003; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; Bhat A, 2010, MOL IMMUNOL, V47, P1337, DOI 10.1016/j.molimm.2009.12.011; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Brisbin JT, 2012, BENEF MICROBES, V3, P205, DOI 10.3920/BM2012.0014; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Buchanan BM, 2011, CELL IMMUNOL, V271, P16, DOI 10.1016/j.cellimm.2011.05.016; Bui VN, 2011, J VET MED SCI, V73, P209, DOI 10.1292/jvms.10-0356; Chrzastek K, 2013, POL J VET SCI, V16, P551, DOI 10.2478/pjvs-2013-0076; Dalpke AH, 2004, INT J MED MICROBIOL, V294, P345, DOI 10.1016/j.ijmm.2004.07.005; Davila E, 2002, BLOOD, V100, P2537, DOI 10.1182/blood-2002-02-0401; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; Dunon D, 1998, DEV COMP IMMUNOL, V22, P279, DOI 10.1016/S0145-305X(98)00010-X; FAHEY KJ, 1990, J GEN VIROL, V71, P2401, DOI 10.1099/0022-1317-71-10-2401; Gomis S, 2004, AVIAN DIS, V48, P813, DOI 10.1637/7194-041204R; Haddadi S, 2015, DEV COMP IMMUNOL, V48, P22, DOI 10.1016/j.dci.2014.08.011; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HONDA T, 1994, J VET MED SCI, V56, P1051, DOI 10.1292/jvms.56.1051; Jiang T, 2011, ANTIVIR RES, V89, P124, DOI 10.1016/j.antiviral.2010.11.013; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg Arthur M, 2004, Curr Oncol Rep, V6, P88, DOI 10.1007/s11912-004-0019-0; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Loncoman CA, 2017, APPL ENV MICROBIOLOG; LOWENTHAL JW, 1994, IMMUNOL CELL BIOL, V72, P115, DOI 10.1038/icb.1994.18; Macfarlane DE, 1997, IMMUNOLOGY, V91, P586, DOI 10.1046/j.1365-2567.1997.00301.x; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V127, P371, DOI 10.1016/j.vetimm.2008.10.001; Mahmood MS, 2006, VACCINE, V24, P4838, DOI 10.1016/j.vaccine.2006.03.016; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Park Mi-Hee, 2012, Immune Netw, V12, P27, DOI 10.4110/in.2012.12.1.27; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pontarollo RA, 2002, VET IMMUNOL IMMUNOP, V84, P43, DOI 10.1016/S0165-2427(01)00379-8; Qureshi MA, 2000, DEV COMP IMMUNOL, V24, P103, DOI 10.1016/S0145-305X(99)00067-1; St Paul Michael, 2012, BMC Res Notes, V5, P616, DOI 10.1186/1756-0500-5-616; St Paul M, 2012, VET IMMUNOL IMMUNOP, V149, P237, DOI 10.1016/j.vetimm.2012.07.008; Taghavi A, 2008, AVIAN DIS, V52, P398, DOI 10.1637/8196-121907-Reg; Taghavi Azita, 2009, Current Drug Delivery, V6, P76; Thapa S, 2015, VET IMMUNOL IMMUNOP, V164, P170, DOI 10.1016/j.vetimm.2015.02.006; Thapa S, 2015, VIRUSES-BASEL, V7, P1832, DOI 10.3390/v7041832; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Wang C, 1999, AVIAN DIS, V43, P590, DOI 10.2307/1592661; Wang XQ, 2003, AVIAN DIS, V47, P1305, DOI 10.1637/6045; Wattrang E, 2009, VET IMMUNOL IMMUNOP, V131, P218, DOI 10.1016/j.vetimm.2009.04.013; WHO, 2007, REC LAB PROC DET AV, P7; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Xie H, 2003, DEV COMP IMMUNOL, V27, P823, DOI 10.1016/S0145-305X(03)00079-X; Yi AK, 1998, J IMMUNOL, V160, P5898	51	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193964	10.1371/journal.pone.0193964	http://dx.doi.org/10.1371/journal.pone.0193964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513732	gold, Green Published, Green Submitted			2022-12-26	WOS:000426896800093
J	Viana, JPG; Siqueira, MVBM; Araujo, FL; Grando, C; Sujii, PS; Silvestre, ED; Novello, M; Pinheiro, JB; Cavallari, MM; Brancalion, PHS; Rodrigues, RR; de Souza, AP; Catchen, J; Zucchi, MI				Gomes Viana, Joao Paulo; Bohrer Monteiro Siqueira, Marcos Vinicius; Araujo, Fabiano Lucas; Grando, Carolina; Sujii, Patricia Sanae; Silvestre, Ellida de Aguiar; Novello, Mariana; Pinheiro, Jose Baldin; Cavallari, Marcelo Mattos; Brancalion, Pedro H. S.; Rodrigues, Ricardo Ribeiro; de Souza, Anete Pereira; Catchen, Julian; Zucchi, Maria I.			Genomic diversity is similar between Atlantic Forest restorations and natural remnants for the native tree Casearia sylvestris Sw.	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; POPULATION-GENETICS; R-PACKAGE; CONSERVATION; DISPERSAL; FABACEAE; POLLEN; POWER; BASE	The primary focus of tropical forest restoration has been the recovery of forest structure and tree taxonomic diversity, with limited attention given to genetic conservation. Populations reintroduced through restoration plantings may have low genetic diversity and be genetically structured due to founder effects and genetic drift, which limit the potential of restoration to recover ecologically resilient plant communities. Here, we studied the genetic diversity, genetic structure and differentiation using single nucleotide polymorphisms (SNP) markers between restored and natural populations of the native tree Casearia sylvestris in the Atlantic Forest of Brazil. We sampled leaves from approximately 24 adult individuals in each of the study sites: two restoration plantations (27 and 62 years old) and two forest remnants. We prepared and sequenced a genotyping-by-sequencing library, SNP markers were identified de novo using Stacks pipeline, and genetic parameters and structure analyses were then estimated for populations. The sequencing step was successful for 80 sampled individuals. Neutral genetic diversity was similar among restored and natural populations (A(R) = 1.72 +/- 0.005; H-O = 0.135 +/- 0.005; H-E = 0.167 +/- 0.005; F-IS = 0.16 +/- 0.022), which were not genetically structured by population subdivision. In spite of this absence of genetic structure by population we found genetic structure within populations but even so there is not spatial genetic structure in any population studied. Less than 1% of the neutral alleles were exclusive to a population. In general, contrary to our expectations, restoration plantations were then effective for conserving tree genetic diversity in human-modified tropical landscapes. Furthermore, we demonstrate that genotyping-by-sequencing can be a useful tool in restoration genetics.	[Gomes Viana, Joao Paulo; Grando, Carolina; Sujii, Patricia Sanae; Silvestre, Ellida de Aguiar; Novello, Mariana] Univ Estadual Campinas, Grad Program Genet & Mol Biol, Campinas, SP, Brazil; [Bohrer Monteiro Siqueira, Marcos Vinicius] Univ Sagrado Coracao, Bauru, SP, Brazil; [Araujo, Fabiano Lucas] Agron Inst Campinas, Grad Program Trop & Subtrop Agr, Campinas, SP, Brazil; [Pinheiro, Jose Baldin] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Cavallari, Marcelo Mattos] EMBRAPA, Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Brancalion, Pedro H. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Forest Sci, Piracicaba, SP, Brazil; [Rodrigues, Ricardo Ribeiro] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Biol, Piracicaba, SP, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas, Dept Plant Biol, Campinas, SP, Brazil; [Catchen, Julian] Univ Illinois, Dept Anim Biol, Champaign, IL USA; [Zucchi, Maria I.] Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil	Universidade Estadual de Campinas; Universidade do Sagrado Coracao; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Illinois System; University of Illinois Urbana-Champaign	Zucchi, MI (corresponding author), Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil.	mizucchi@apta.sp.gov.br	Cavallari, Marcelo M/A-5304-2017; siqueira, marcos vinicius bohrer monteiro/ABG-2520-2020; Rodrigues, Ricardo Ribeiro/D-5557-2012; Pinheiro, Jose Baldin B/D-2818-2012; DE SOUZA, ANETE PEREIRA/B-8663-2012; Viana, João Paulo JPGV Gomes/K-1178-2012; Brancalion, Pedro/D-6995-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Grando, Carolina/I-2594-2013; Zucchi, Maria Imaculada/D-2637-2012	siqueira, marcos vinicius bohrer monteiro/0000-0002-6541-0903; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Pinheiro, Jose Baldin B/0000-0003-1294-2081; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604; Brancalion, Pedro/0000-0001-8245-4062; Zucchi, Maria Imaculada/0000-0002-4863-1843; Grando, Carolina/0000-0002-0944-1633; Zucchi, Maria Imaculada/0000-0002-4863-1843	Sao Paulo Research Foundation (FAPESP) [2011/50296-8, 2013/05762-6, 2016/05765-3]; National Council for Scientific and Technological Development of Brazil (CNPq) [304817/2015-5, 310446/2015-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Sao Paulo Research Foundation (FAPESP) for the financial support (#2011/50296-8). PHSB and MIZ thank the National Council for Scientific and Technological Development of Brazil (CNPq) for a productivity grant (#304817/2015-5 and #310446/2015-5). JPGV thanks the Sao Paulo Research Foundation (FAPESP) for the research grants provided (#2013/05762-6 and #2016/05765-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Andrianoelina O, 2006, BIODIVERS CONSERV, V15, P1109, DOI 10.1007/s10531-004-2178-6; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2016, INT STANDARDS PRACTI, DOI DOI 10.1111/rec.12261; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araujo FL, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019105; Arroyo-Rodriguez V, 2017, BIOL REV, V92, P326, DOI 10.1111/brv.12231; Barbosa A.A.A., 1997, THESIS; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Brancalion PHS, 2012, RESTOR ECOL, V20, P704, DOI 10.1111/j.1526-100X.2011.00839.x; Burgarella C, 2007, ANN FOREST SCI, V64, P757, DOI 10.1051/forest:2007055; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Cavallari MM, 2010, ANN BOT-LONDON, V106, P627, DOI 10.1093/aob/mcq151; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chen H., 2016, VENNDIAGRAM GENERATE; de Rezende CL, 2015, BIODIVERS CONSERV, V24, P2255, DOI 10.1007/s10531-015-0980-y; Dias Marilda Carvalho, 1998, Revista Brasileira de Botanica, V21, P183, DOI 10.1590/S0100-84041998000200011; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter Paul D, 2012, Methods Mol Biol, V888, P135, DOI 10.1007/978-1-61779-870-2_9; Marmontel CVF, 2013, BIOSCI J, V29, P2042; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Ganzhorn SM, 2015, ENDANGER SPECIES RES, V26, P189, DOI 10.3354/esr00645; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Hamrick James L., 1996, P203; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2017, SCIENCE, V355, P455, DOI 10.1126/science.aam5432; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kahilainen A, 2014, GLOB ECOL CONSERV, V2, P315, DOI 10.1016/j.gecco.2014.10.013; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kettenring KM, 2014, J APPL ECOL, V51, P339, DOI 10.1111/1365-2664.12202; Kettle CJ, 2008, BIOL CONSERV, V141, P1953, DOI 10.1016/j.biocon.2008.05.008; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; Leidner AK, 2011, CONSERV BIOL, V25, P1022, DOI 10.1111/j.1523-1739.2011.01720.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lloyd H, 2011, RESTOR ECOL, V19, P74, DOI 10.1111/j.1526-100X.2009.00542.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Martins K, 2016, CONSERV GENET, V17, P509, DOI 10.1007/s10592-015-0800-7; Mijangos JL, 2015, MOL ECOL, V24, P22, DOI 10.1111/mec.12995; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Otalora MG, 2011, BIODIVERS CONSERV, V20, P1239, DOI 10.1007/s10531-011-0025-0; Paquette SR., 2012, R PACKAGE, V1; Ramalho Mauro, 2004, Acta Bot. Bras., V18, P37, DOI 10.1590/S0102-33062004000100005; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ritchie AL, 2012, RESTOR ECOL, V20, P441, DOI 10.1111/j.1526-100X.2011.00791.x; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Sato T, 2006, HEREDITY, V96, P79, DOI 10.1038/sj.hdy.6800748; Schaberg PG, 2008, FOREST ECOL MANAG, V256, P855, DOI 10.1016/j.foreco.2008.06.038; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Silva A. F. da, 2003, Revista Arvore, V27, P311, DOI 10.1590/S0100-67622003000300006; Silva T.R.S., 2002, FLORA FANEROGAMICA E, V2, P101; SOS Mata Atlantica INPE, 2015, ATL REM FLOR MAT ATL; TABARELLI M, 1993, REV I FLORESTAL SAO, V0005, P00095; Thomas E, 2014, FOREST ECOL MANAG, V333, P66, DOI 10.1016/j.foreco.2014.07.015; Toro MA, 2005, PHILOS T R SOC B, V360, P1367, DOI 10.1098/rstb.2005.1680; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; [No title captured]	68	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192165	10.1371/journal.pone.0192165	http://dx.doi.org/10.1371/journal.pone.0192165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513673	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800010
J	Solocinski, J; Osgood, QA; Rosiek, E; Underwood, L; Zikanov, O; Chakraborty, N				Solocinski, Jason; Osgood, Quinn A.; Rosiek, Eric; Underwood, Lukas; Zikanov, Oleg; Chakraborty, Nilay			Development of a surface tension mediated technique for dry stabilization of mammalian cells	PLOS ONE			English	Article							DESICCATION TOLERANCE; ANHYDROBIOSIS; VITRIFICATION; PRESERVATION; EVOLUTION	Dry state preservation at ambient temperatures (lyopreservation) is a biomimetic alternative to low temperature stabilization (cryopreservation) of biological materials. Lyopreservation is hypothesized to rely upon the creation of a glassy environment, which is commonly observed in desiccation-tolerant organisms. Non-uniformities in dried samples have been indicated as one of the reasons for instability in storage outcome. The current study presents a simple, fast, and uniform surface tension based technique that can be implemented for lyopreservation of mammalian cells. The technique involves withdrawing cells attached to rigid substrates to be submerged in a solution of lyoprotectant and then withdrawing the samples at a specific rate to an inert environment. This creates a uniform thin film of desiccated lyoprotectant due to sudden change of surface tension. The residual moisture contents at different locations in the desiccated film was quantified using a spatially resolved Raman microspectroscopy technique. Post-desiccation cellular viability and growth are quantified using fluorescent microscopy and dye exclusion assays. Cellular injury following desiccation is evaluated by bioenergetic quantification of metabolic functions using extracellular flux analysis and by a Raman microspectroscopic analysis of change in membrane structure. The technique developed here addresses an important bottleneck of lyoprocessing which requires the fast and uniform desiccation of cellular samples.	[Solocinski, Jason; Osgood, Quinn A.; Rosiek, Eric; Underwood, Lukas; Zikanov, Oleg; Chakraborty, Nilay] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA; [Osgood, Quinn A.] OtziBio LLC, Livonia, MI USA	University of Michigan System; University of Michigan	Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.	nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Osgood, Quinn/0000-0002-8233-5634	NSF [SusChEM 1510072, CHE 1609440]; University of Michigan [U038726, U051381]	NSF(National Science Foundation (NSF)); University of Michigan(University of Michigan System)	This research was supported by the NSF (www.nsf.gov) grant numbers SusChEM 1510072 and CHE 1609440. Authors would also like to acknowledge University of Michigan (www.umich.edu) grant numbers U038726 (NC) and U051381 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2004, ENG DESICCATION TOLE, P563; Aksan A, 2004, LANGMUIR, V20, P5521, DOI 10.1021/la0355186; Bonifacio A, 2015, ANAL BIOANAL CHEM, V407, P1089, DOI 10.1007/s00216-014-8321-7; Chakraborty N, 2008, BIOTECHNOL BIOENG, V100, P782, DOI 10.1002/bit.21801; Chakraborty N, 2012, CRYOBIOLOGY, V64, P91, DOI 10.1016/j.cryobiol.2011.11.007; Chakraborty N, 2011, ANN BIOMED ENG, V39, P1582, DOI 10.1007/s10439-011-0253-1; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; CROWE JH, 1982, CRYOBIOLOGY, V19, P317, DOI 10.1016/0011-2240(82)90160-2; Crowe JH, 2013, CRYOBIOLOGY, V66, P348; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Edwards C, 2015, LANGMUIR, V31, P11020, DOI 10.1021/acs.langmuir.5b02148; Elliott GD, 2008, BIOPRESERV BIOBANK, V6, DOI 10.1089/bio.2008.0011; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006; He XM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336304; Johnson PE, 2015, ACS NANO, V9, P6961, DOI 10.1021/acsnano.5b01139; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LEENAARS AFM, 1990, LANGMUIR, V6, P1701, DOI 10.1021/la00101a014; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; Liu TT, 2014, PHYS LETT A, V378, P1191, DOI 10.1016/j.physleta.2014.02.024; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Nuzzo M, 2015, LANGMUIR, V31, P10946, DOI 10.1021/acs.langmuir.5b02023; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Ragoonanan V, 2008, BIOPHYS J, V94, P2212, DOI 10.1529/biophysj.107.110684; Vogl CJ, 2012, P ROY SOC A-MATH PHY, V468, P3348, DOI 10.1098/rspa.2012.0170; Wolke K, 1996, SOLID STATE TECHNOL, V39, P87; Wolkers WF, 2010, SPECTROSC-INT J, V24, P525, DOI 10.1155/2010/576151; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zikanov O, 2001, J ENG MATH, V40, P249, DOI 10.1023/A:1017596621570	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193160	10.1371/journal.pone.0193160	http://dx.doi.org/10.1371/journal.pone.0193160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505556	Green Published, gold, Green Submitted			2022-12-26	WOS:000426548200005
J	Kumlert, R; Chaisiri, K; Anantatat, T; Stekolnikov, AA; Morand, S; Prasartvit, A; Makepeace, BL; Sungvornyothin, S; Paris, DH				Kumlert, Rawadee; Chaisiri, Kittipong; Anantatat, Tippawan; Stekolnikov, Alexandr A.; Morand, Serge; Prasartvit, Anchana; Makepeace, Benjamin L.; Sungvornyothin, Sungsit; Paris, Daniel H.			Autofluorescence microscopy for paired-matched morphological and molecular identification of individual chigger mites (Acari: Trombiculidae), the vectors of scrub typhus	PLOS ONE			English	Article							MITOCHONDRIAL PSEUDOGENES; ORIENTIA-TSUTSUGAMUSHI; LEPTOTROMBIDIUM ACARI; GENE	4 Background Conventional gold standard characterization of chigger mites involves chemical preparation procedures (i.e. specimen clearing) for visualization of morphological features, which however contributes to destruction of the arthropod host DNA and any endosymbiont or pathogen DNA harbored within the specimen. Methodology/Principal findings In this study, a novel work flow based on autofluorescence microscopy was developed to enable identification of trombiculid mites to the species level on the basis of morphological traits without any special preparation, while preserving the mite DNA for subsequent geno-typing. A panel of 16 specifically selected fluorescence microscopy images of mite features from available identification keys served for complete chigger morphological identification to the species level, and was paired with corresponding genotype data. We evaluated and validated this method for paired chigger morphological and genotypic ID using the mitochondrial cytochrome c oxidase subunit I gene (coi) in 113 chigger specimens representing 12 species and 7 genera (Leptotrombidium, Ascoschoengastia, Gahrliepia, Walchia, Blankaartia, Schoengastia and Schoutedenichia) from the Lao People's Democratic Republic (Lao PDR) to the species level (complete characterization), and 153 chiggers from 5 genera (Leptotrombidium, Ascoschoengastia, Helenicula, Schoengastiella and Walchia) from Thailand, Cambodia and Lao PDR to the genus level. A phylogenetic tree constructed from 77 coi gene sequences (approximately 640 bp length, n = 52 new coi sequences and n = 25 downloaded from GenBank), demonstrated clear grouping of assigned morphotypes at the genus levels, although evidence of both genetic polymorphism and morphological plasticity was found. Conclusions/Significance With this new methodology, we provided the largest collection of characterized coi gene sequences for trombiculid mites to date, and almost doubled the number of available characterized coi gene sequences with a single study. The ability to provide paired phenotypic-genotypic data is of central importance for future characterization of mites and dissecting the molecular epidemiology of mites transmitting diseases like scrub typhus.	[Kumlert, Rawadee; Chaisiri, Kittipong; Sungvornyothin, Sungsit] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Kumlert, Rawadee; Prasartvit, Anchana] Minist Publ Hlth, Dept Dis Control, Bangkok, Thailand; [Chaisiri, Kittipong] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool Sci Pk IC2, Liverpool, Merseyside, England; [Anantatat, Tippawan; Paris, Daniel H.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Stekolnikov, Alexandr A.] Russian Acad Sci, Zool Inst, Univ Skaya Embankment 1, St Petersburg, Russia; [Morand, Serge] Kasetsart Univ, Fac Vet Technol, CNRS, ISEM,CIRAD ASTRE, Bangkok, Thailand; [Paris, Daniel H.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Paris, Daniel H.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Paris, Daniel H.] Univ Basel, Fac Med, Basel, Switzerland	Mahidol University; Ministry of Public Health - Thailand; University of Liverpool; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Kasetsart University; University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Geneva	Paris, DH (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Paris, DH (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Paris, DH (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Paris, DH (corresponding author), Univ Basel, Fac Med, Basel, Switzerland.	daniel.paris@swisstph.ch	Paris, Daniel/AFV-4762-2022; Morand, Serge/M-5433-2018; Paris, Daniel/GLN-7566-2022; Stekolnikov, Alexandr A/G-7966-2011; Chaisiri, Kittipong/S-8166-2016	Morand, Serge/0000-0003-3986-7659; Stekolnikov, Alexandr A/0000-0001-7548-2671; Chaisiri, Kittipong/0000-0001-6795-3541	National Research Council of Thailand; LKS Strategic Award [LG34]; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); LKS Strategic Award; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand	This study was supported in part by a scholarship granted to Rawadee Kumlert for FY2017, as a thesis grant for doctoral degree students from the National Research Council of Thailand, the LKS Strategic Award (LG34) "The Natural Immune Response in Pediatric Scrub Typhus in Chiang Rai" (DHP was the PI), and a supportive research grant for the PhD thesis of Rawadee Kumlert from the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. We would also like to thank Dr. Aulia Rahmi Pawestri for interesting and productive scientific discussions.; This study was supported in part by a scholarship for doctoral degree students from the National Research Council of Thailand granted to Rawadee Kumlert for the FY2017; the LKS Strategic Award (LG34) "The Natural Immune Response in Pediatric Scrub Typhus in Chiang Rai" (DHP is PI); and a supportive research grant from the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand to Rawadee Kumlert for writing her PhD thesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; Beland F A, 1999, Toxic Rep Ser, P1; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Chaisiri K., 2016, MOL ECOLOGY CHIGGER; Chaisiri K, 2016, J MED ENTOMOL, V53, P321, DOI 10.1093/jme/tjv244; DOHANY AL, 1978, AM J TROP MED HYG, V27, P1261, DOI 10.4269/ajtmh.1978.27.1261; Ewing H. E., 1944, JOUR PARASITOL, V30, P339, DOI 10.2307/3272686; Fernandes S. J. S., 2003, STUDIES TROMBICULID; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GOFF ML, 1982, J MED ENTOMOL, V19, P221, DOI 10.1093/jmedent/19.3.221; Henderson Rosa C., 2001, Systematic and Applied Acarology Special Publications, V7, P1; Herbreteau V., 2011, FIELD LAB PROTOCOLS; James SL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004723; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Krantz G. W., 2008, MANUAL ACAROLOGY, V3rd; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; Liviac D, 2010, WATER RES, V44, P2638, DOI 10.1016/j.watres.2010.01.026; Moniuszko H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1339-2; Moniuszko H, 2015, EXP APPL ACAROL, V67, P123, DOI 10.1007/s10493-015-9925-0; Nadchatram M, 1974, PICTORIAL KEY SUBFAM; Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064; Park SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003814; Peng P- Y, 2016, PARASITOL RES; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Phommasone K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002163; Pogacnik M, 1998, ACTA DERM-VENEREOL, V7, P173; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Santibanez P, 2015, ROLE CHIGGERS HUMAN; SASA M, 1961, ANNU REV ENTOMOL, V6, P221, DOI 10.1146/annurev.en.06.010161.001253; Schaudien D, 2007, DIAGN MOL PATHOL, V16, P153, DOI 10.1097/PDM.0b013e31803c558a; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shatrov AB, 2008, ANN ZOOLOGICI; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stekolnikov AA, 2013, ZOOTAXA, V3728, P1; Takhampunya R, 2014, AM J TROP MED HYG, V90, P139, DOI 10.4269/ajtmh.13-0393; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; TRAUB R., 1957, STUD INST MED RES MALAYA, V28, P297; Traub R, 1956, SMITHSONIAN MISCELLA, V128, P1; UPTON MS, 1993, B ENTOMOL RES, V83, P267, DOI 10.1017/S0007485300034763; Vercammen-Grandjean P. H., 1975, CHIGGER MITES WORLD; Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657; Womersley H., 1952, Records of the South Australian Museum, V10, P1; Zander RH, 1997, BRYOLOGIST, V100, P380; Zhang L, 2012, MUTAT RES-GEN TOX EN, V741, P89, DOI 10.1016/j.mrgentox.2011.11.004	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193163	10.1371/journal.pone.0193163	http://dx.doi.org/10.1371/journal.pone.0193163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494599	Green Published, Green Accepted, gold			2022-12-26	WOS:000426363200026
J	Yang, YQ; Yin, HX; Yuan, HB; Jiang, YW; Dong, CW; Deng, YL				Yang, Yan-Qin; Yin, Hong-Xu; Yuan, Hai-Bo; Jiang, Yong-Wen; Dong, Chun-Wang; Deng, Yu-Liang			Characterization of the volatile components in green tea by IRAE-HS-SPME/GC-MS combined with multivariate analysis	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CHROMATOGRAPHY-MASS SPECTROMETRY; SIMULTANEOUS DISTILLATION-EXTRACTION; 2-DIMENSIONAL GAS-CHROMATOGRAPHY; PU-ERH TEA; ASSISTED EXTRACTION; GC-MS; CAPILLARY-ELECTROPHORESIS; BIOACTIVE CONSTITUENTS; AROMA COMPONENTS	In the present work, a novel infrared-assisted extraction coupled to headspace solid-phase microextraction ( IRAE-HS-SPME) followed by gas chromatography-mass spectrometry ( GC-MS) was developed for rapid determination of the volatile components in green tea. The extraction parameters such as fiber type, sample amount, infrared power, extraction time, and infrared lamp distance were optimized by orthogonal experimental design. Under optimum conditions, a total of 82 volatile compounds in 21 green tea samples from different geographical origins were identified. Compared with classical water-bath heating, the proposed technique has remarkable advantages of considerably reducing the analytical time and high efficiency. In addition, an effective classification of green teas based on their volatile profiles was achieved by partial least square-discriminant analysis ( PLS-DA) and hierarchical clustering analysis ( HCA). Furthermore, the application of a dual criterion based on the variable importance in the projection ( VIP) values of the PLS-DA models and on the category from one-way univariate analysis ( ANOVA) allowed the identification of 12 potential volatile markers, which were considered to make the most important contribution to the discrimination of the samples. The results suggest that IRAE-HS-SPME/GC-MS technique combined with multivariate analysis offers a valuable tool to assess geographical traceability of different tea varieties.	[Yang, Yan-Qin; Yin, Hong-Xu; Yuan, Hai-Bo; Jiang, Yong-Wen; Dong, Chun-Wang; Deng, Yu-Liang] Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, HB; Jiang, YW (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.	192168092@tricaas.com; jiangyw@tricaas.com		Yang, Yanqin/0000-0001-8793-9157	Natural Science Foundation of Zhejiang Province [LQ18C160006]; National Natural Science Foundation of China [31471651]; Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2014-TRICAAS]; Three Rural Six Project Foundation of Zhejiang Province [SN2014017]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences; Three Rural Six Project Foundation of Zhejiang Province	This work was supported by the Natural Science Foundation of Zhejiang Province (LQ18C160006), the National Natural Science Foundation of China (31471651), the Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2014-TRICAAS) and the Three Rural Six Project Foundation of Zhejiang Province (SN2014017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasalvar C, 2012, J AGR FOOD CHEM, V60, P6323, DOI 10.1021/jf301498p; Baba R, 2014, J AGR FOOD CHEM, V62, P8308, DOI 10.1021/jf502308a; Bhuyan DJ, 2015, IND CROP PROD, V69, P290, DOI 10.1016/j.indcrop.2015.02.044; Cai Y, 2011, FOOD CHEM, V127, P1872, DOI 10.1016/j.foodchem.2011.02.026; Chan CH, 2011, J CHROMATOGR A, V1218, P6213, DOI 10.1016/j.chroma.2011.07.040; Chen YL, 2010, J SEP SCI, V33, P2888, DOI 10.1002/jssc.201000234; Cuevas FJ, 2016, FOOD CHEM, V199, P479, DOI 10.1016/j.foodchem.2015.12.049; Du LP, 2014, FOOD RES INT, V57, P61, DOI 10.1016/j.foodres.2014.01.008; Duan HT, 2010, J CHROMATOGR A, V1217, P4511, DOI 10.1016/j.chroma.2010.04.069; Fu YJ, 2012, J SEP SCI, V35, P468, DOI 10.1002/jssc.201100816; Fu YJ, 2011, J SEP SCI, V34, P3272, DOI 10.1002/jssc.201100649; Gan ZB, 2012, FOOD CHEM, V130, P1122, DOI 10.1016/j.foodchem.2011.08.018; Giannetti V, 2017, FOOD CONTROL, V78, P215, DOI 10.1016/j.foodcont.2017.02.036; Guo S, 2017, FUEL, V208, P499, DOI 10.1016/j.fuel.2017.07.032; He CJ, 2016, ANAL METHODS-UK, V8, P4727, DOI 10.1039/c6ay00700g; Hou WQ, 2016, MICROCHEM J, V128, P75, DOI 10.1016/j.microc.2016.04.011; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Cuevas FJ, 2017, FOOD CHEM, V221, P1930, DOI 10.1016/j.foodchem.2016.11.156; Kumazawa K, 2002, J AGR FOOD CHEM, V50, P5660, DOI 10.1021/jf020498j; Kwon TY, 2013, J AGR FOOD CHEM, V61, P8514, DOI 10.1021/jf402487a; Lv S., 2014, PLOS ONE, V9; Magagna F, 2017, FOOD CHEM, V225, P276, DOI 10.1016/j.foodchem.2017.01.003; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Rega B, 2009, FOOD CHEM, V112, P9, DOI 10.1016/j.foodchem.2008.05.028; San AT, 2017, FOOD CHEM, V221, P613, DOI 10.1016/j.foodchem.2016.11.130; Sheibani E, 2016, J FOOD SCI, V81, pC348, DOI 10.1111/1750-3841.13203; Tang JC, 2016, APPL ENERG, V169, P696, DOI 10.1016/j.apenergy.2016.02.042; Tang ZT, 2016, J CHROMATOGR A, V1461, P18, DOI 10.1016/j.chroma.2016.07.047; Wu Y, 2016, CHEM CENTRAL J, P10; Wu YS, 2016, CYTA-J FOOD, V14, P423, DOI 10.1080/19476337.2015.1123298; Xu YQ, 2016, FOOD ANAL METHOD, V9, P1188, DOI 10.1007/s12161-015-0303-7; Yang CQ, 2017, ANAL METHODS-UK, V9, P2144, DOI [10.1039/C7AY00011A, 10.1039/c7ay00011a]; Yang YQ, 2016, J SEP SCI, V39, P4192, DOI 10.1002/jssc.201600503; Yang YQ, 2016, J SEP SCI, V39, P1173, DOI 10.1002/jssc.201501185; Yang YQ, 2011, TALANTA, V86, P356, DOI 10.1016/j.talanta.2011.09.028; Ye J, 2016, ANAL METHODS-UK, V8, P593, DOI 10.1039/c5ay02652k; Yener S, 2016, TALANTA, V152, P45, DOI 10.1016/j.talanta.2016.01.050; Zheng J, 2014, FOOD RES INT, V56, P77, DOI 10.1016/j.foodres.2013.12.011; Zhu Y, 2016, SEP PURIF TECHNOL, V164, P146, DOI 10.1016/j.seppur.2016.03.028	39	26	34	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193393	10.1371/journal.pone.0193393	http://dx.doi.org/10.1371/journal.pone.0193393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494626	gold, Green Published, Green Submitted			2022-12-26	WOS:000426363200043
J	Grames, MS; Dayton, RD; Jackson, KL; Richard, AD; Lu, XH; Klein, RL				Grames, Mychal S.; Dayton, Robert D.; Jackson, Kasey L.; Richard, Adam D.; Lu, Xiaohong; Klein, Ronald L.			Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra	FASEB JOURNAL			English	Article						adeno-associated virus; alpha-synuclein; tau; TDP-43; pathological protein spreading	AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-SYNUCLEIN; GENE-TRANSFER; TAU; DEGENERATION; MUTATION; TDP-43; PATHOLOGY; PROMOTER	Recombinant adeno-associated virus (AAV) vectors are a popular genetic approach in neuroscience because they confer such efficient transgene expression in the brain and spinal cord. A number of studies have used AAV to express pathological disease-related proteins in the dopaminergic neurons of the substantia nigra in situ (e.g., -synuclein to model aspects of Parkinson's disease). The neuropathology and neurodegeneration of Parkinson's disease occur in a circumscribed pattern in the brain, and one of the most important goals of any gene transfer study is accurate, pinpoint targeting. By combining Cre recombinase-dependent AAVs in Cre-driver rats in which Cre is expressed only in the tyrosine hydroxylase neurons, we have achieved more highly targeted expression of several disease-relevant neuropathological proteins in the substantia nigra pars compacta than using constitutive expression AAV vectors. Alpha-synuclein, tau, transactive response DNA-binding protein of 43 kDa, or the control fluorescent protein yellow fluorescent protein was individually expressed to induce highly targeted, dopaminergic neuron-specific neurodegeneration models. The refined targeting foreshadows a next-generation disease modeling system for expressing neurodegenerative disease-related proteins in a disease-relevant manner. We foresee specific utilities of this in vivo AAV vector targeting of pathological proteins to a well-defined and well-demarcated cell population.Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., Klein, R. L. Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra.	[Grames, Mychal S.; Dayton, Robert D.; Jackson, Kasey L.; Richard, Adam D.; Lu, Xiaohong; Klein, Ronald L.] Louisiana State Univ LSU Hlth Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Klein, RL (corresponding author), LSU Hlth Shreveport, Dept Pharmacol Toxicol & Neurosci, 1501 Kings Highway, Shreveport, LA 71130 USA.	klein@lsuhsc.edu			Amyotrophic Lateral Sclerosis (ALS) Association [15-TALS-296]; Meira GTx	Amyotrophic Lateral Sclerosis (ALS) Association; Meira GTx	The authors thank Thomas Lawson for his charitable donation for neurodegenerative disease research, and Jean-Charles Paterna (Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland) for critiquing the manuscript. This work was supported by the Amyotrophic Lateral Sclerosis (ALS) Association (Grant 15-TALS-296) and Meira GTx. Meira GTx had no involvement in the design or execution of the experiments, or in the decision to publish this research. The authors are collaborating with Meira GTx on a preclinical gene therapy project for ALS involving TDP-43. The authors declare no conflicts of interest.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Jackson KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169291; Kim C, 2016, EXP NEUROBIOL, V25, P113, DOI 10.5607/en.2016.25.3.113; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2005, NEUROBIOL DIS, V20, P64, DOI 10.1016/j.nbd.2005.02.001; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Leverenz JB, 2007, BRAIN, V130, P1360, DOI 10.1093/brain/awm069; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miki Y, 2010, NEUROPATHOLOGY, V30, P149, DOI 10.1111/j.1440-1789.2009.01046.x; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Mishima T, 2017, J NEUROPATH EXP NEUR, V76, P676, DOI 10.1093/jnen/nlx049; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Peel AL, 2000, J NEUROSCI METH, V98, P95, DOI 10.1016/S0165-0270(00)00183-7; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Rolland AS, 2017, NEUROSCIENCE, V346, P126, DOI 10.1016/j.neuroscience.2017.01.014; Schneider JA, 2002, J HISTOCHEM CYTOCHEM, V50, P99, DOI 10.1177/002215540205000111; Smedemark-Margulies N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00018; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; WAKABAYASHI K, 1994, ACTA NEUROPATHOL, V87, P545; Wider C, 2009, PARKINSONISM RELAT D, V15, P281, DOI 10.1016/j.parkreldis.2008.07.005; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang H, 2008, ACTA NEUROPATHOL, V115, P115, DOI 10.1007/s00401-007-0285-7; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	43	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4420	4427		10.1096/fj.201701529RR	http://dx.doi.org/10.1096/fj.201701529RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29513569				2022-12-26	WOS:000439325400030
J	Lv, ZP; Fan, H; Zhang, BB; Ning, C; Xing, K; Guo, YM				Lv, Zengpeng; Fan, Hao; Zhang, Beibei; Ning, Chao; Xing, Kun; Guo, Yuming			Dietary genistein supplementation in laying broiler breeder hens alters the development and metabolism of offspring embryos as revealed by hepatic transcriptome analysis	FASEB JOURNAL			English	Article						genistein; embryo; transcriptome; metabolism; development	CHICKEN GALLUS-DOMESTICUS; LIPID-METABOLISM; SKELETAL-MUSCLE; POSTMENOPAUSAL WOMEN; SOY ISOFLAVONE; EGG-YOLK; LIVER; ACTIVATION; QUALITY; GROWTH	Genistein (GEN) is a type of isoflavone mainly derived from soy products. In this experiment, we added 40 and 400 mg/kg GEN to the diet of laying broiler breeder hens to clarify the maternal effects of GEN on the development and metabolism of chick embryos. GEN treatment at 40 mg/kg increased embryonic length, weight, and liver index, as well as the width of the proliferative zone in the tibial growth plate of chick embryos. Gene ontology (GO) cluster analysis of the hepatic transcriptome showed that GEN treatment promoted embryonic development and cell proliferation. Low-dose GEN treatment increased insulin growth factor-binding protein (IGFBP)3 mRNA expression in the embryonic liver, whereas high-dose GEN treatment increased IGFBP5 expression and activated the apoptosis and protein tyrosine kinase signaling pathways. Furthermore, adding supplemental GEN to the diet of hens promoted the glycolysis process in the embryonic liver through the insulin-signaling pathway, upregulated target genes (phosphoglucomutase-2, hexokinase 1, dihydroxyacetone phosphate by aldolase, phosphofructokinase, platelet, and enolase 2), and enhanced the transport of carboxylic acids and cholesterol and the synthesis of unsaturated fatty acid (arachidonic acid) in the embryonic liver through upregulation of liver X receptor, sterol regulatory element-binding protein 1, and patatin-like phospholipase A. Additionally, GEN treatment increased fatty acid -oxidation and Na+/K+-ATPase activity in the embryonic liver through activation of peroxisome proliferator-activated receptors (PPARs; PPAR and PPAR) and the AMPK signaling pathway, which could provide energy for embryonic development. In addition, GEN treatment in hens increased superoxide dismutase activity and metallothionein expression in the chick embryonic liver and promoted lymphocyte proliferation through upregulation of mRNA expression of CDKN1A, IL12RB1, Sox11, PRKAR1A, PRKCQ, and TCF3. The improved immunity and antioxidant capacity, as a result of maternal GEN effects, was conducive to embryonic development. In summary, the addition of GEN to the diet of laying broiler breeder hens significantly promoted the development and metabolism of chick embryos.Lv, Z., Fan, H., Zhang, B., Ning, C., Xing, K., Guo, Y. Dietary genistein supplementation in laying broiler breeder hens alters the development and metabolism of offspring embryos as revealed by hepatic transcriptome analysis.	[Lv, Zengpeng; Fan, Hao; Zhang, Beibei; Ning, Chao; Xing, Kun; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Guo, YM (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	guoyum@cau.edu.cn	Fan, Hao/AAY-7810-2020	Fan, Hao/0000-0001-5245-9698; Ning, Chao/0000-0001-8247-1700	China Agricultural Research System program [CARS-41]; Chinese Universities Scientific Fund	China Agricultural Research System program; Chinese Universities Scientific Fund	The authors thank the Animal Quantitative Inheritance Lab (College of Animal Science and Technology, China Agricultural University, Beijing, China) for providing the server for RNA-Seq analysis. This work was financially supported by the China Agricultural Research System program (CARS-41) and the Chinese Universities Scientific Fund. The authors declare no conflicts of interest.	Akdemir F, 2009, POULTRY SCI, V88, P2125, DOI 10.3382/ps.2009-00004; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloedon LT, 2002, AM J CLIN NUTR, V76, P1126, DOI 10.1093/ajcn/76.5.1126; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; BURKE WH, 1989, POULTRY SCI, V68, P805, DOI 10.3382/ps.0680805; Clapper J., 2015, Open Journal of Animal Sciences, V5, P163, DOI 10.4236/ojas.2015.52019; Cooke P. S., 2003, PROG OBES RES, V9, P98; DANESCH U, 1994, J BIOL CHEM, V269, P27258; Das B, 2004, PARASITOL INT, V53, P345, DOI 10.1016/j.parint.2004.06.002; Doerge DR, 2001, REPROD TOXICOL, V15, P105, DOI 10.1016/S0890-6238(01)00108-3; Feast M, 1998, J ANAT, V193, P383, DOI 10.1046/j.1469-7580.1998.19330383.x; Flynn KM, 2000, TOXICOL SCI, V55, P311, DOI 10.1093/toxsci/55.2.311; Fu Z, 2012, APPL PHYSIOL NUTR ME, V37, P480, DOI [10.1139/H2012-005, 10.1139/h2012-005]; 박옥진, 2007, Preventive Nutrition and Food Science, V12, P197; Jiang SQ, 2007, FOOD CHEM, V105, P1086, DOI 10.1016/j.foodchem.2007.05.010; Jones S, 2016, TOXICOLOGY, V355, P21, DOI 10.1016/j.tox.2016.05.008; Jungbauer A, 2014, J STEROID BIOCHEM, V139, P277, DOI 10.1016/j.jsbmb.2012.12.009; Kamboh AA, 2013, POULTRY SCI, V92, P2411, DOI 10.3382/ps.2012-02960; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; KOUBA M, 1995, COMP BIOCHEM PHYS B, V110, P47, DOI 10.1016/0305-0491(94)00147-M; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; Ley D, 2013, PEDIATR RES, V73, P68, DOI 10.1038/pr.2012.146; [马海田 Ma Haitian], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P297; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Minutoli L, 2009, J UROLOGY, V181, P1913, DOI 10.1016/j.juro.2008.11.095; Morabito N, 2002, OSTEOPOROSIS INT, V13, pS22; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; NOBLE RC, 1985, LIPIDS, V20, P278, DOI 10.1007/BF02534260; NOBLE RC, 1990, PROG LIPID RES, V29, P107, DOI 10.1016/0163-7827(90)90014-C; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Palanisamy N, 2008, RENAL FAILURE, V30, P645, DOI 10.1080/08860220802134532; Paulson C. N, 2010, THESIS; Pitt BR, 1997, AM J PHYSIOL-LUNG C, V273, pL856, DOI 10.1152/ajplung.1997.273.4.L856; Rasouli E, 2015, ANIMAL, V9, P1473, DOI 10.1017/S1751731115000853; Rehfeldt C, 2007, MEAT SCI, V75, P103, DOI 10.1016/j.meatsci.2006.06.028; Retana-Marquez S, 2016, PHYSIOL BEHAV, V164, P1, DOI 10.1016/j.physbeh.2016.05.004; Saitoh S, 2001, BIOSCI BIOTECH BIOCH, V65, P2220, DOI 10.1271/bbb.65.2220; Sakai J, 2004, SEIKAGAKU, V76, P517; Sassi-Messai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004935; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Shin JH, 2012, KOREAN J FOOD SCI AN, V32, P404, DOI 10.5851/kosfa.2012.32.4.404; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Steinshamn H, 2010, ANIM SCI PAP REP, V28, P195; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Kaay DCM, 2009, GROWTH HORM IGF RES, V19, P198, DOI 10.1016/j.ghir.2008.08.010; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wu Q, 2017, CELL SIGNAL, V37, P62, DOI 10.1016/j.cellsig.2017.06.001; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199; Yon JM, 2012, J EMB T, V27, P101; Yoo NY, 2015, J AGR FOOD CHEM, V63, P4305, DOI 10.1021/acs.jafc.5b00398; Zanella I, 2015, EUR J NUTR, V54, P1095, DOI 10.1007/s00394-014-0786-9; Zhao L, 2016, J AGR FOOD CHEM, V64, P7291, DOI 10.1021/acs.jafc.6b02907; Zhi-Ping H. U., 2011, CHINESE J EXP TRADIT, V41, P121	57	11	12	1	56	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4214	4228		10.1096/fj.201701457R	http://dx.doi.org/10.1096/fj.201701457R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29518347				2022-12-26	WOS:000439325400013
J	Esquirol, L; Peat, TS; Wilding, M; Liu, JW; French, NG; Hartley, CJ; Onagi, H; Nebl, T; Easton, CJ; Newman, J; Scott, C				Esquirol, Lygie; Peat, Thomas S.; Wilding, Matthew; Liu, Jian-Wei; French, Nigel G.; Hartley, Carol J.; Onagi, Hideki; Nebl, Thomas; Easton, Christopher J.; Newman, Janet; Scott, Colin			An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein evolution; xenobiotic; enzyme catalysis; bacterial metabolism; Pseudomonas; enzyme; enzyme structure; bacteria; complex; protein complex; amidase; biuret; cyanuric acid; small protein; triazine; transamidosome; low-molecular-weight protein	ALLOPHANATE HYDROLASE; PSEUDOMONAS SP; AMIDASE DOMAIN; AMIDOHYDROLASE; SUPERFAMILY; REFINEMENT; SEQUENCE; PLASMID; CLONING; GENES	Cyanuric acid is a metabolic intermediate of s-triazines, such as atrazine (a common herbicide) and melamine (used in resins and plastics). Cyanuric acid is mineralized to ammonia and carbon dioxide by the soil bacterium Pseudomonas sp. strain ADP via three hydrolytic enzymes (AtzD, AtzE, and AtzF). Here, we report the purification and biochemical and structural characterization of AtzE. Contrary to previous reports, we found that AtzE is not a biuret amidohydrolase, but instead it catalyzes the hydrolytic deamination of 1-carboxybiuret. X-ray crystal structures of apo AtzE and AtzE bound with the suicide inhibitor phenyl phosphorodiamidate revealed that the AtzE enzyme complex consists of two independent molecules in the asymmetric unit. We also show that AtzE forms an 22 heterotetramer with a previously unidentified 68-amino acid-long protein (AtzG) encoded in the cyanuric acid mineralization operon from Pseudomonas sp. strain ADP. Moreover, we observed that AtzG is essential for the production of soluble, active AtzE and that this obligate interaction is a vestige of their shared evolutionary origin. We propose that AtzEG was likely recruited into the cyanuric acid-mineralizing pathway from an ancestral glutamine transamidosome that required protein-protein interactions to enforce the exclusion of solvent from the transamidation reaction.	[Esquirol, Lygie; Liu, Jian-Wei; French, Nigel G.; Hartley, Carol J.; Scott, Colin] CSIRO Land & Water, Biocatalysis & Synthet Biol Team, Canberra, ACT 2601, Australia; [Scott, Colin] CSIRO Land & Water, Synthet Biol Future Sci Platform, Canberra, ACT 2601, Australia; [Esquirol, Lygie; Wilding, Matthew; Onagi, Hideki; Easton, Christopher J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Peat, Thomas S.; Wilding, Matthew; Nebl, Thomas; Newman, Janet] CSIRO Biomed Mfg, Melbourne, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scott, C (corresponding author), CSIRO Land & Water, Fdn Bldg,Black Mt Sci & Innovat Pk, Canberra, ACT 2601, Australia.	colin.scott@csiro.au	Scott, Colin/A-4682-2009; Peat, Thomas S/F-9817-2010; Liu, Jian-Wei/C-3313-2009; Hartley, Carol J/C-2255-2008; Easton, Chris J/K-3531-2014; Newman, Janet M/D-1857-2011; Wilding, Matthew A/D-4173-2012; Onagi, Hideki/O-6978-2019; Nebl, Thomas/N-1620-2017	Scott, Colin/0000-0001-6110-6982; Peat, Thomas S/0000-0002-6488-0831; Hartley, Carol J/0000-0002-1927-8040; Easton, Chris J/0000-0002-2263-1204; Newman, Janet M/0000-0003-2666-3219; Wilding, Matthew A/0000-0002-3921-7771; Onagi, Hideki/0000-0003-0085-7349; Esquirol, Lygie/0000-0002-4887-3260; Nebl, Thomas/0000-0003-4003-9340				Baek J, 2017, G3-GENES GENOM GENET, V7, P983, DOI 10.1534/g3.116.036939; Balotra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137700; Balotra S, 2015, APPL ENVIRON MICROB, V81, P470, DOI 10.1128/AEM.02783-14; Balotra S, 2014, ACTA CRYSTALLOGR F, V70, P310, DOI 10.1107/S2053230X13034705; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cameron SM, 2011, ACS CATAL, V1, P1075, DOI 10.1021/cs200295n; Case D.A., 2017, AMBER16; Cheng G, 2005, APPL ENVIRON MICROB, V71, P4437, DOI 10.1128/AEM.71.8.4437-4445.2005; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; DESOUZA ML, 1995, APPL ENVIRON MICROB, V61, P3373, DOI 10.1128/AEM.61.9.3373-3378.1995; EATON RW, 1991, J BACTERIOL, V173, P1363, DOI 10.1128/jb.173.3.1363-1366.1991; Esquirol L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192736; Hucker SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184119; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUTZI K, 1982, BIOCHEM J, V208, P679, DOI 10.1042/bj2080679; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Parkhurst JM, 2016, J APPL CRYSTALLOGR, V49, P1912, DOI 10.1107/S1600576716013595; Pavelka A, 2016, IEEE ACM T COMPUT BI, V13, P505, DOI 10.1109/TCBB.2015.2459680; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Peat TS, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03365-16; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Rosa N, 2015, J BIOMOL SCREEN, V20, P898, DOI 10.1177/1087057115584059; Sadowsky MJ, 1998, J BACTERIOL, V180, P152, DOI 10.1128/JB.180.1.152-158.1998; Seffernick JL, 2007, J BACTERIOL, V189, P6989, DOI 10.1128/JB.00630-07; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; Suzuki T, 2015, P NATL ACAD SCI USA, V112, P382, DOI 10.1073/pnas.1423314112; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	45	12	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7880	7891		10.1074/jbc.RA118.001996	http://dx.doi.org/10.1074/jbc.RA118.001996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29523689	Green Published, hybrid			2022-12-26	WOS:000437256500034
J	Halaby, SL; Fromme, JC				Halaby, Steve L.; Fromme, J. Christopher			The HUS box is required for allosteric regulation of the Sec7 Arf-GEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Golgi; guanine nucleotide exchange factor (GEF); intracellular trafficking; ADP ribosylation factor (ARF); allosteric regulation	GUANINE-NUCLEOTIDE-EXCHANGE; ADP-RIBOSYLATION FACTOR; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; BREFELDIN-A; FACTOR GBF1; PROTEIN; ACTIVATION; DOMAIN	The Golgi complex is the central membrane and protein-sorting station in eukaryotic cells. Activation of Arf (ADP-ribosylation factor) GTPases is essential for vesicle formation via recruitment of cargo adaptors and coat proteins necessary for Golgi trafficking. Arf activation is spatially and temporally regulated by distinct guanine nucleotide exchange factors (GEFs) at different Golgi compartments. The yeast Arf-GEF Sec7 is a conserved and essential activator of Arf1 at the trans-Golgi network. Sec7 contains a highly conserved regulatory region, the homology upstream of Sec7 (HUS) box, with an unknown mechanistic role. In this study we explore how the HUS box, which is N-terminal to the catalytic domain, acts together with C-terminal regulatory domains in the allosteric activation of Sec7. We report that mutation of the HUS box disrupts positive feedback and allosteric activation of Sec7 by the GTPase Ypt31, a yeast Rab11 homolog. Taken together, our results support a model in which the inter- and intramolecular interactions of the HUS box and the C terminus are necessary for the allosteric activation of Sec7.	[Halaby, Steve L.; Fromme, J. Christopher] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Fromme, JC (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jcf14@cornell.edu		Fromme, J. Christopher/0000-0002-8837-0473; Halaby, Steve/0000-0001-7724-8176	NIGMS, National Institutes of Health [R01GM09861, T32GM007273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, R01GM098621] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM09861 (to J.C.F.) and NIGMS, National Institutes of Health Training Grant T32GM007273 (to S.L.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bhatt JM, 2016, AM J PHYSIOL-CELL PH, V310, pC456, DOI 10.1152/ajpcell.00185.2015; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Dehring DAK, 2008, J BIOL CHEM, V283, P34188, DOI 10.1074/jbc.M806023200; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Galindo A, 2016, CELL REP, V16, P839, DOI 10.1016/j.celrep.2016.06.022; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grebe M, 2000, PLANT CELL, V12, P343, DOI 10.1105/tpc.12.3.343; Gustafson MA, 2017, MOL BIOL CELL, V28, P3660, DOI 10.1091/mbc.E17-06-0370; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lowery J, 2013, J BIOL CHEM, V288, P11532, DOI 10.1074/jbc.M112.438481; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Marino-Ramirez L, 2002, YEAST, V19, P641, DOI 10.1002/yea.867; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McDonold CM, 2014, DEV CELL, V30, P759, DOI 10.1016/j.devcel.2014.07.016; Meissner JM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210245; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Paczkowski JE, 2016, METHODS MOL BIOL, V1496, P41, DOI 10.1007/978-1-4939-6463-5_4; Park SK, 2005, MOL BIOL CELL, V16, P3786, DOI 10.1091/mbc.E05-04-0289; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Qiu BA, 2014, BIOCHEM BIOPH RES CO, V446, P380, DOI 10.1016/j.bbrc.2014.02.125; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Richardson BC, 2016, ELIFE, V5, DOI [10.7554/eLife.12411, 10.7554/eLife.18204]; Richardson BC, 2015, METHOD CELL BIOL, V130, P101, DOI 10.1016/bs.mcb.2015.03.020; Richardson BC, 2012, DEV CELL, V22, P799, DOI 10.1016/j.devcel.2012.02.006; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Wang R, 2016, J MOL CELL BIOL, V8, P459, DOI 10.1093/jmcb/mjw033; WEISS O, 1989, J BIOL CHEM, V264, P21066; Wessels E, 2007, J VIROL, V81, P5238, DOI 10.1128/JVI.02680-06	46	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6682	6691		10.1074/jbc.RA117.001318	http://dx.doi.org/10.1074/jbc.RA117.001318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29514977	Green Published, hybrid			2022-12-26	WOS:000431487300005
J	Song, JL; Huang, B; Li, RR				Song, Jinglu; Huang, Bo; Li, Rongrong			Assessing local resilience to typhoon disasters: A case study in Nansha, Guangzhou	PLOS ONE			English	Article							COMMUNITY RESILIENCE; ECOLOGICAL RESILIENCE; SOCIAL VULNERABILITY; CLIMATE-CHANGE; RECOVERY; HAZARDS; INDICATORS; FRAMEWORK	Building communities' resilience to natural weather hazards requires the appropriate assessment of such capabilities. The resilience of a community is affected not only by social, economic, and infrastructural factors but also by natural factors (including both site characteristics and the intensity and frequency of events). To date, studies of natural factors have tended to draw on annual censuses and to use aggregated data, thus allowing only a limited understanding of site-specific hot or cold spots of resilience. To improve this situation, we carried out a comprehensive assessment of resilience to typhoon disasters in Nansha district, Guangzhou, China. We measured disaster resilience on 1x1-km grid units with respect to socioeconomic and infrastructural dimensions using a set of variables and also estimated natural factors in a detailed manner with a meteorological modeling tool, the Weather Research and Forecast model. We selected typhoon samples over the past 10 years, simulated the maximum typhoon-borne strong winds and precipitation of each sample, and predicted the wind speed and precipitation volume at the 100-year return-level on the basis of extreme value analysis. As a result, a composite resilience index was devised by combining factors in different domains using factor analysis coupled with the analytic hierarchy process. Resilience mapping using this composite resilience index allows local governments and planners to identify potential hot or cold spots of resilience and the dominant factors in particular locations, thereby assisting them in making more rational site-specific measures to improve local resilience to future typhoon disasters.	[Song, Jinglu; Huang, Bo] Chinese Univ Hong Kong, Dept Geog & Resource Management, Shatin, Hong Kong, Peoples R China; [Huang, Bo; Li, Rongrong] Chinese Univ Hong Kong, Inst Space & Earth Informat Sci, Shatin, Hong Kong, Peoples R China; [Huang, Bo] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Huang, B (corresponding author), Chinese Univ Hong Kong, Dept Geog & Resource Management, Shatin, Hong Kong, Peoples R China.; Huang, B (corresponding author), Chinese Univ Hong Kong, Inst Space & Earth Informat Sci, Shatin, Hong Kong, Peoples R China.; Huang, B (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	bohuang@cuhk.edu.hk	Song, Diva/AGZ-8138-2022; Huang, Bo/H-9874-2014	Song, Diva/0000-0002-5220-6364; Huang, Bo/0000-0002-5063-3522				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Babbie E.R., 2013, BASICS SOCIAL RES; Berke PR, 2006, ANN AM ACAD POLIT SS, V604, P192, DOI 10.1177/0002716205285533; Blaikie P., 2014, RISK NATURAL HAZARDS, DOI DOI 10.4324/9780203714775; Boon HJ, 2014, NAT HAZARDS, V71, P683, DOI 10.1007/s11069-013-0935-0; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; Bruneau M, 2003, EARTHQ SPECTRA, V19, P733, DOI 10.1193/1.1623497; Burton CG, 2015, ANN ASSOC AM GEOGR, V105, P67, DOI 10.1080/00045608.2014.960039; Council N. R, 2006, FAC HAZ DIS UND HUM; Cumming GS, 2005, ECOSYSTEMS, V8, P975, DOI 10.1007/s10021-005-0129-z; Cutter S., 2008, FRAMEWORK MEASURING; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2016, NAT HAZARDS, V80, P741, DOI 10.1007/s11069-015-1993-2; Cutter SL, 2014, GLOBAL ENVIRON CHANG, V29, P65, DOI 10.1016/j.gloenvcha.2014.08.005; Cutter SL, 2010, J HOMEL SECUR EMERG, V7; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; DAVISON AC, 1990, J ROY STAT SOC B MET, V52, P393; DOVERS SR, 1992, GLOBAL ENVIRON CHANG, V2, P262, DOI 10.1016/0959-3780(92)90044-8; Ernstson H, 2010, AMBIO, V39, P531, DOI 10.1007/s13280-010-0081-9; Fu J., 2014, 1 KM GRID POPULATION; Gilleland E., 2011, EOS T AM GEOPHYS UN, V92, P1314, DOI [10.1029/2011EO020001, DOI 10.1029/2011EO020001, https://doi.org/10.1029/2011EO020001]; Gilleland E., 2014, EXTREMES 2 0 EXTREME; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; HOSKING JRM, 1987, TECHNOMETRICS, V29, P339, DOI 10.2307/1269343; Joerin J, 2011, COMM ENV DISAST RISK, V6, P47, DOI 10.1108/S2040-7262(2011)0000006009; Jones B, 2007, INT J EMERG MANAG, V4, P269, DOI 10.1504/IJEM.2007.013994; Jordan E, 2013, NAT HAZARDS REV, V14, P21, DOI 10.1061/(ASCE)NH.1527-6996.0000087; Klein RJT, 1999, AMBIO, V28, P182; Lam NSN, 2014, J COASTAL RES, P473, DOI 10.2112/SI70-080.1; Li X., 2015, NAT HAZARD EARTH SYS, V7, P81, DOI [10.5194/nhessd-3-81-2015, DOI 10.5194/NHESSD-3-81-2015, 10.1007/s13753-016-0109-2]; Mayunga J.S., 2009, MEASURING MEASURE MU; Meerow S, 2016, LANDSCAPE URBAN PLAN, V147, P38, DOI 10.1016/j.landurbplan.2015.11.011; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Palutikof JP, 1999, METEOROL APPL, V6, P119, DOI 10.1017/S1350482799001103; Paton D., 2006, DISASTER RESILIENCE, DOI [10.1007/s10464-007-9156-6, DOI 10.1007/S10464-007-9156-6]; Prasad N, 2009, CLIMATE RESILIENT CITIES: A PRIMER ON REDUCING VULNERABILITIES TO DISASTERS, P1, DOI 10.1596/978-0-8213-7766-6; Reams Margaret A, 2012, Am J Clim Change, V1, P194; Richard B., 2014, RESILIENCE CITIES GR; Rose A., 2004, DISASTER PREV MANAG, V13, P307, DOI [10.1108/09653560410556528, DOI 10.1108/09653560410556528]; SAATY RW, 1987, MATH MODELLING, V9, P161, DOI 10.1016/0270-0255(87)90473-8; Schneiderbauer Stefan., 2006, MEASURING VULNERABIL, P78; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Shahid S, 2008, NAT HAZARDS, V46, P391, DOI 10.1007/s11069-007-9191-5; Song JL, 2017, WATER-SUI, V9, DOI 10.3390/w9080619; Stevens MR, 2010, LANDSCAPE URBAN PLAN, V94, P105, DOI 10.1016/j.landurbplan.2009.08.004; The Planning Research Center of Nansha District, 2012, COMPR PLANN NANSH NE; Timmerman P., 1981, REVIEWOFMODELS POSSI; U. S. Indian Ocean Tsunami Warning System Program, 2007, RES IS YOUR COAST CO; UNISDR, 2012, HDB LOC GOV LEAD; United Nations Office for Disaster Risk Reduction (UNISDR), 2005, 18060066 UNISDR NAT; Wang SH, 2012, LANDSCAPE URBAN PLAN, V106, P303, DOI 10.1016/j.landurbplan.2012.04.002; Wilks D. S, 2011, STAT METHODS ATMOSPH, V100; Wood NJ, 2010, NAT HAZARDS, V52, P369, DOI 10.1007/s11069-009-9376-1; Yu S, 2015, RELIAB ENG SYST SAFE, V137, P6, DOI 10.1016/j.ress.2014.12.007	55	12	14	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2018	13	3							e0190701	10.1371/journal.pone.0190701	http://dx.doi.org/10.1371/journal.pone.0190701			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY7GW	29522526	Green Submitted, Green Published, gold			2022-12-26	WOS:000427030800003
J	O'Boyle, N; Sutherland, E; Berry, CC; Davies, RL				O'Boyle, Nicky; Sutherland, Erin; Berry, Catherine C.; Davies, Robert L.			Optimisation of growth conditions for ovine airway epithelial cell differentiation at an air-liquid interface	PLOS ONE			English	Article							MUCOCILIARY DIFFERENTIATION; RETINOIC ACID; BASAL-CELLS; CULTURES; TRIIODOTHYRONINE; TRACHEA; MUCIN; SHEEP; FLUID; LUNG	Respiratory tract infections are of significant concern in the agriculture industry. There is a requirement for the development of well-characterised in vitro epithelial cell culture models in order to dissect the diverse molecular interactions occurring at the host-pathogen interface in airway epithelia. We have analysed key factors that influence growth and differentiation of ovine tracheal epithelial cells in an air-liquid interface (ALI) culture system. Cellular differentiation was assessed at 21 days post-ALI, a time-point which we have previously shown to be sufficient for differentiation in standard growth conditions. We identified a dose dependent response to epidermal growth factor (EGF) in terms of both epithelial thickening and ciliation levels. Maximal ciliation levels were observed with 25 ng m(-1) EGF. We identified a strict requirement for retinoic acid (RA) in epithelial differentiation as RA exclusion resulted in the formation of a stratified squamous epithelium, devoid of cilia. The pore-density of the growth substrate also had an influence on differentiation as high pore-density inserts yielded higher levels of ciliation and more uniform cell layers than low pore-density inserts. Differentiation was also improved by culturing the cells in an atmosphere of sub ambient oxygen concentration. We compared two submerged growth media and observed differences in the rate of proliferation/expansion, barrier formation and also in terminal differentiation. Taken together, these results indicate important differences between the response of ovine tracheal epithelial cells and other previously described airway epithelial models, to a variety of environmental conditions. These data also indicate that the phenotype of ovine tracheal epithelial cells can be tailored in vitro by precise modulation of growth conditions, thereby yielding a customisable, potential infection model.	[O'Boyle, Nicky; Sutherland, Erin; Davies, Robert L.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Berry, Catherine C.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Davies, RL (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	robert.davies@glasgow.ac.uk	O'Boyle, Nicky/GLU-1241-2022; Berry, Catherine/AAE-4493-2021	O'Boyle, Nicky/0000-0002-8669-7237; 	BBSRC [BB/L010534/1]; Biotechnology and Biological Sciences Research Council [BB/L010534/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by BBSRC (BB/L010534/1). The project was also part-funded by MSD animal health (http://www.msd-animal-health.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-26; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bateman AC, 2013, INFLUENZA OTHER RESP, V7, P139, DOI 10.1111/j.1750-2659.2012.00371.x; Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418; Berge ACB, 2006, JAVMA-J AM VET MED A, V229, P1279, DOI 10.2460/javma.229.8.1279; Chen LC, 1997, TOXICOL APPL PHARM, V143, P96, DOI 10.1006/taap.1996.8073; CLARK AB, 1995, AM J RESP CELL MOL, V12, P329, DOI 10.1165/ajrcmb.12.3.7873199; Cozens D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19079-y; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Davenport EA, 1996, AM J RESP CELL MOL, V14, P19, DOI 10.1165/ajrcmb.14.1.8534482; Delgado-Ortega M, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-14; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Gerovac BJ, 2014, AM J RESP CELL MOL, V51, P516, DOI 10.1165/rcmb.2013-0237OC; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Harkema J.R., 2000, PULMONARY IMMUNOTOXI, P1, DOI [10.1007/978-1-4615-4535-4_1, DOI 10.1007/978-1-4615-4535-4_1]; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Jud C, 2015, BIORESEARCH OPEN ACC, V4, P457, DOI 10.1089/biores.2015.0037; KAARTINEN L, 1993, IN VITRO CELL DEV-AN, V29A, P481, DOI 10.1007/BF02639383; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim SW, 2007, CANCER RES, V67, P6565, DOI 10.1158/0008-5472.CAN-06-2783; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Lama E, 2011, J VIROL METHODS, V178, P117, DOI 10.1016/j.jviromet.2011.08.025; Lee MK, 2005, DRUG DELIV, V12, P305, DOI 10.1080/10717540500177009; Li YN, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0842-0; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; Mao H, 2009, CRYOBIOLOGY, V59, P250, DOI 10.1016/j.cryobiol.2009.07.012; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Mondragon-Teran P, 2011, BIOTECHNOL PROGR, V27, P1700, DOI 10.1002/btpr.675; Moon SK, 2000, ACTA OTO-LARYNGOL, V120, P944, DOI 10.1080/00016480050218672; O'Boyle N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181583; OSTROWSKI LE, 1995, EXP LUNG RES, V21, P957, DOI 10.3109/01902149509031773; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Prytherch Z, 2011, MACROMOL BIOSCI, V11, P1467, DOI 10.1002/mabi.201100181; Radi ZA, 2004, J VET MED A, V51, P167, DOI 10.1111/j.1439-0442.2004.00620.x; ROBINSON CB, 1991, J TISSUE CULTURE MET, V13, P95; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rogers DF, 2003, INT J BIOCHEM CELL B, V35, P1, DOI 10.1016/S1357-2725(02)00083-3; Sachs LA, 2003, IN VITRO CELL DEV-AN, V39, P56; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Sellgren KL, 2014, LAB CHIP, V14, P3349, DOI 10.1039/c4lc00552j; SERGENT-ENGELEN T, 1990, Biotechnology Techniques, V4, P89, DOI 10.1007/BF00163279; Singh K, 2011, VET PATHOL, V48, P338, DOI 10.1177/0300985810377182; SUNDELL HW, 1980, AM J PATHOL, V100, P707; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Wang X., 2012, J BIOMED BIOTECHNOL, V1, P1; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Ward ACS, 2006, CAN J VET RES, V70, P34; WHITCUTT MJ, 1988, IN VITRO CELL DEV B, V24, P420; Widdicombe JH, 2003, IN VITRO CELL DEV-AN, V39, P51; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; Xue D, 2015, VET IMMUNOL IMMUNOP, P163; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	64	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2018	13	3							e0193998	10.1371/journal.pone.0193998	http://dx.doi.org/10.1371/journal.pone.0193998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5UV	29518140	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000426902900058
J	Han, J; Li, Y; Liu, XL; Zhou, TR; Sun, HJ; Edwards, P; Gao, H; Yu, FS; Qiao, XX				Han, Jing; Li, Yue; Liu, Xiuli; Zhou, Tongrong; Sun, Haijing; Edwards, Paul; Gao, Hua; Yu, Fu-Shin; Qiao, Xiaoxi			Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-KAPPA-B; ENDOTHELIAL-CELLS; SUBRETINAL NEOVASCULARIZATION; DIABETIC-RETINOPATHY; ADHESION MOLECULE-1; CANCER PREVENTION; EXPRESSION; PROLIFERATION; PATHOGENESIS	The oral anti-diabetic drug metformin has been found to reduce cardiovascular complications independent of glycemic control in diabetic patients. However, its role in diabetic retinal microvascular complications is not clear. This study is to investigate the effects of metformin on retinal vascular endothelium and its possible mechanisms, regarding two major pathogenic features of diabetic retinopathy: angiogenesis and inflammation. In human retinal vascular endothelial cell culture, metformin inhibited various steps of angiogenesis including endothelial cell proliferation, migration, and tube formation in a dose-dependent manner. Its anti-angiogenic activity was confirmed in vivo that metformin significantly reduced spontaneous intraretinal neovascularization in a very-low-density lipoprotein receptor knockout mutant mouse (p<0.05). Several inflammatory molecules upregulated by tumor necrosis factor-alpha in human retinal vascular endothelial cells were markedly reduced by metformin, including nuclear factor kappa B p65 (NF kappa B p65), intercellular adhesion molecule-1 (ICAM-1), monocyte chemotactic protein-1 (MCP-1), and interleukin-8 (IL-8). Further, metformin significantly decreased retinal leukocyte adhesion (p<0.05) in streptozotocin-induced diabetic mice. Activation of AMP-activated protein kinase was found to play a partial role in the suppression of ICAM-1 and MCP-1 by metformin, but not in those of NF kappa B p65 and IL-8. Our findings support the notion that metformin has considerable anti-angiogenic and anti-inflammatory effects on retinal vasculature. Metformin could be potentially used for the purpose of treating diabetic retinopathy in addition to blood glucose control in diabetic patients.	[Han, Jing; Li, Yue; Liu, Xiuli; Zhou, Tongrong; Edwards, Paul; Gao, Hua; Qiao, Xiaoxi] Henry Ford Hlth Syst, Dept Ophthalmol, Detroit, MI 48202 USA; [Han, Jing] Fourth Mil Med Univ, Tangdu Hosp, Dept Ophthalmol, Xian, Shaanxi, Peoples R China; [Sun, Haijing; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Sun, Haijing; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Henry Ford Health System; Henry Ford Hospital; Air Force Military Medical University; Wayne State University; Wayne State University	Qiao, XX (corresponding author), Henry Ford Hlth Syst, Dept Ophthalmol, Detroit, MI 48202 USA.	xgiao1@hfhs.org			Henry Ford Health System [A10248]; Alliance for Vision Research [F60553]; NIH/NEI [R01EY10869]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY004068, R01EY010869, R01EY017960] Funding Source: NIH RePORTER	Henry Ford Health System; Alliance for Vision Research; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Henry Ford Health System (A10248) and Alliance for Vision Research (F60553) to XQ, and by NIH/NEI (R01EY10869) to FSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2003, ARCH OPHTHALMOL-CHIC, V121, P740, DOI 10.1001/archopht.121.5.740; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; [Anonymous], 2012, DIABETIC RETINOPATHY; [Anonymous], 2014, SCREENING DIABETIC R; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Chahed S, 2010, DIABETES, V59, P694, DOI 10.2337/db08-1524; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dallaglio K, 2014, CARCINOGENESIS, V35, P1055, DOI 10.1093/carcin/bgu001; de Jager J, 2014, J INTERN MED, V275, P59, DOI 10.1111/joim.12128; Di Pietro M, 2015, ENDOCRINOLOGY, V156, P1453, DOI 10.1210/en.2014-1765; Doganay S, 2002, EYE, V16, P163, DOI 10.1038/sj.eye.6700095; Eisenreich A, 2017, CURR MED CHEM, V24, P3397, DOI 10.2174/0929867324666170404143102; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Holman R, 2007, Journ Annu Diabetol Hotel Dieu, P13; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Jiang AH, 2011, VISION RES, V51, P93, DOI 10.1016/j.visres.2010.10.008; Jiang AH, 2009, INVEST OPHTH VIS SCI, V50, P844, DOI 10.1167/iovs.08-2447; Joe SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119708; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x; Kannarkatt J, 2016, ONCOLOGY-BASEL, V91, P179, DOI 10.1159/000448175; Kastelan S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/213130; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kim AJ, 2017, INVEST OPHTH VIS SCI, V58, P106, DOI 10.1167/iovs.16-20691; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Lee PP, 2003, OPHTHALMOLOGY, V110, P1952, DOI 10.1016/S0161-6420(03)00817-0; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Munie M, 2014, INVEST OPHTH VIS SCI, V55; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Patel Nishal, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P222; Paz SH, 2006, OPHTHALMOLOGY, V113, P1372, DOI 10.1016/j.ophtha.2006.04.018; Phoenix KN, 2009, BREAST CANCER RES TR, V113, P101, DOI 10.1007/s10549-008-9916-5; Roy S, 2017, AM J PATHOL, V187, P9, DOI 10.1016/j.ajpath.2016.08.022; SCHRODER S, 1991, AM J PATHOL, V139, P81; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Tang S, 1994, Ger J Ophthalmol, V3, P131; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Venna VR, 2014, EUR J NEUROSCI, V39, P2129, DOI 10.1111/ejn.12556; Werner EA, 1922, J CHEM SOC, V121, P1790, DOI 10.1039/ct9222101790; Wurm R, 2016, HEART, V102, P1544, DOI 10.1136/heartjnl-2015-308711; Xavier DO, 2010, BIOMED PHARMACOTHER, V64, P220, DOI 10.1016/j.biopha.2009.08.004; Yue W, 2014, CANCER PREV RES, V7, P388, DOI 10.1158/1940-6207.CAPR-13-0337; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	59	57	59	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193031	10.1371/journal.pone.0193031	http://dx.doi.org/10.1371/journal.pone.0193031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513760	gold, Green Published			2022-12-26	WOS:000426896800031
J	Mapoure, NY; Budzi, MN; Eloumou, SAFB; Malongue, A; Okalla, C; Luma, HN				Mapoure, N. Y.; Budzi, M. N.; Eloumou, S. A. F. B.; Malongue, A.; Okalla, C.; Luma, H. N.			Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PERIPHERAL NEUROPATHY; EXTRAHEPATIC MANIFESTATIONS; VIRUS; PREVALENCE; INFECTION; DYSFUNCTION; IMPAIRMENT; DISORDERS; RNA	Background Chronic hepatitis C infection is a major public health concern, with a high burden in SubSaharan Africa. There is growing evidence that chronic hepatitis C virus (HCV) infection causes neurological complications. This study aimed at assessing the prevalence and factors associated with neurological manifestations in chronic hepatitis C patients. Methods Through a cross-sectional design, a semi-structured questionnaire was used to collect data from consecutive chronic HCV infected patients attending the outpatient gastroenterology unit of the Douala General Hospital (DGH). Data collection was by interview, patient record review (including HCV RNA quantification, HCV genotyping and the assessment of liver fibrosis and necroinflammatory activity), clinical examination complemented by 3 tools; Neuropathic pain diagnostic questionnaire, Brief peripheral neuropathy screen and mini mental state examination score. Data were analysed using Statistical package for social sciences version 20 for windows. Results Of the 121 chronic hepatitis C patients (51.2% males) recruited, 54.5% (95% Confidence interval: 46.3%, 62.8%) had at least one neurological manifestation, with peripheral nervous system manifestations being more common (50.4%). Age >= 55 years (Adjusted Odds Ratio: 4.82, 95% CI: 1.02 +/- 18.81, p = 0.02), longer duration of illness (AOR: 1.012, 95% CI: 1.00 +/- 1.02, p = 0.01) and high viral load (AOR: 3.40, 95% CI: 1.20 +/- 9.64, p = 0.02) were significantly associated with neurological manifestations. Peripheral neuropathy was the most common neurological manifestation (49.6%), presenting mainly as sensory neuropathy (47.9%). Age >= 55 years (AOR: 6.25, 95% CI: 1.33 +/- 29.08, p = 0.02) and longer duration of illness (AOR: 1.01, 1.00 +/- 1.02, p = 0.01) were significantly associated with peripheral neuropathy. Conclusion Over half of the patients with chronic hepatitis C attending the DGH have a neurological manifestation, mainly presenting as sensory peripheral neuropathy. Routine screening of chronic hepatitis C patients for peripheral neuropathy is therefore necessary, with prime focus on those with older age and longer duration of illness.	[Mapoure, N. Y.; Eloumou, S. A. F. B.] Univ Douala, Fac Med & Pharmaceut Sci, Dept Clin Sci, Douala, Cameroon; [Mapoure, N. Y.; Eloumou, S. A. F. B.; Malongue, A.; Okalla, C.; Luma, H. N.] Douala Gen Hosp, Dept Internal Med, Douala, Cameroon; [Budzi, M. N.] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Okalla, C.] Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon; [Luma, H. N.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med, Yaounde, Cameroon	University of Yaounde I	Mapoure, NY (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Dept Clin Sci, Douala, Cameroon.; Mapoure, NY (corresponding author), Douala Gen Hosp, Dept Internal Med, Douala, Cameroon.	mapoureypcouba@gmail.com		MAPOURE, Yacouba Njankouo/0000-0003-3304-6171				Abulhassan M, 2008, J TAIBAH UNIV MED SC, V3, P25, DOI 10.1016/S1658-3612(08)70041-6; Adinolfi LE, 2015, WORLD J GASTROENTERO, V21, P2269, DOI 10.3748/wjg.v21.i8.2269; Al-Soud A. A., 2011, The Journal of American Science, V7, P282; Authier FJ, 2003, NEUROLOGY, V60, P808, DOI 10.1212/01.WNL.0000044399.71601.EA; Biasiotta A, 2014, J NEUROL, V261, P725, DOI 10.1007/s00415-014-7261-7; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2014, DIGEST LIVER DIS, V46, pS165, DOI 10.1016/j.dld.2014.10.005; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; El lehleh Ayman M, 2010, ALEXIANDRIA J, V8, P35; Fontana RJ, 2005, J HEPATOL, V43, P614, DOI 10.1016/j.jhep.2005.04.006; Forton DM, 2006, EUR J GASTROEN HEPAT, V18, P333, DOI 10.1097/00042737-200604000-00005; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Ghoneimy ATE, 2009, ARAB J GASTROENTEROL, V10, P82; Gomes I, 2006, ARQ NEURO-PSIQUIAT, V64, P600, DOI 10.1590/S0004-282X2006000400014; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hilsabeck RC, 2003, J INT NEUROPSYCHOL S, V9; Jember G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0295-5; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Khalek MAA, 2012, EGYPT RHEUMATOL, V34, P91, DOI 10.1016/j.ejr.2012.04.001; Kramer L, 2002, J HEPATOL, V37, P349, DOI 10.1016/S0168-8278(02)00172-1; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Luma HN, 2016, INT J INFECT DIS, V45, P53, DOI 10.1016/j.ijid.2016.02.013; Mathew S, 2016, WORLD J HEPATOL, V8, P545, DOI 10.4254/wjh.v8.i12.545; McAndrews MP, 2005, HEPATOLOGY, V41, P801, DOI 10.1002/hep.20635; Mohamed AA, 2015, WORLD J HEPATOL, V7, P2676, DOI 10.4254/wjh.v7.i26.2676; Monaco S, 2015, WORLD J GASTROENTERO, V21, P11974, DOI 10.3748/wjg.v21.i42.11974; Mora N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1584-1; Nabil Abd El Fatah Al kafrawy, 2014, WOLTERS KLUWER HLTH, V27, P458; Perry W, 2008, DIGEST DIS SCI, V53, P307, DOI 10.1007/s10620-007-9896-z; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Santoro L, 2006, J NEUROL NEUROSUR PS, V77, P626, DOI 10.1136/jnnp.2005.081570; Sterling Richard K, 2006, Curr Gastroenterol Rep, V8, P53, DOI 10.1007/s11894-006-0064-y; Szymanowicz A, 2007, SPECTRA BIOL, V26, P47; Tellez-Zenteno Jose Francisco, 2003, J Clin Neuromuscul Dis, V4, P109; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; World Health Organisation, 2016, WHO HEP C FACTSH; Yoon MS, 2011, J NEUROL, V258, P80, DOI 10.1007/s00415-010-5686-1; Zaltron S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-S2-S2; Zaltron S, 1998, ITAL J GASTROENTEROL, V30, P391; Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192406	10.1371/journal.pone.0192406	http://dx.doi.org/10.1371/journal.pone.0192406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513678	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800014
J	Nilsson, B; Hansen, BW				Nilsson, Birgitte; Hansen, Benni Winding			Timing of embryonic quiescence determines viability of embryos from the calanoid copepod, Acartia tonsa (Dana)	PLOS ONE			English	Article							ZOOPLANKTON EGG BANKS; SILKWORM BOMBYX-MORI; NEWLY-LAID EGGS; SCHISTOCERCA-GREGARIA; ECDYSTEROID LEVELS; COLD-STORAGE; RESTING EGGS; PLANKTONIC COPEPODS; MARINE COPEPODS; EMBRYOGENESIS	Like 41 other calanoid copepods, Acartia tonsa, are capable of inducing embryonic quiescence when experiencing unfavorable environmental conditions. The ecdysone-signaling cascade is known to have a key function in developmental processes like embryogenesis and molting of arthropods, including copepods. We examined the role of ecdysteroid-phosphate phosphatase (EPPase), ecdysone receptor (EcR), 8 fushi tarazu transcription factor 1 (BFTZ-F1), and the ecdysteroid-regulated early gene E74 (E74), which represent different levels of the ecdysone-signaling cascade in our calanoid model organism. Progression of embryogenesis was monitored and hatching success determined to evaluate viability. Embryos that were induced quiescence before the gastrulation stage would stay in gastrulation during the rest of quiescence and exhibited a slower pace of hatching as compared to subitaneous embryos. In contrast, embryos developed further than gastrulation would stay in gastrulation or later stages during quiescence and showed a rapid pace in hatching after quiescence termination. Expression patterns suggested two peaks of the biological active ecdysteroids, 20-hydroxyecdysone (20E). The first peak of 20E was expressed in concert with the beginning of embryogenesis originating from yolk-conjugated ecdysteroids, based on EPPase expression. The second peak is suggested to originate from de novo synthesized 20E around the limb bud stage. During quiescence, the expression patterns of EPPase, EcR, 8FTZ-F1, and E74 were either decreasing or not changing over time. This suggests that the ecdysone-signaling pathway play a key role in the subitaneous development of A. tonsa embryogenesis, but not during quiescence. The observation is of profound ecological and practical relevance for the dynamics of egg banks.	[Nilsson, Birgitte; Hansen, Benni Winding] Roskilde Univ, Dept Sci & Environm, Univ Vej 1, Roskilde, Denmark	Roskilde University	Hansen, BW (corresponding author), Roskilde Univ, Dept Sci & Environm, Univ Vej 1, Roskilde, Denmark.	bhansen@ruc.dk	Hansen, Benni W/K-3299-2015	Hansen, Benni W/0000-0003-1145-561X; Nilsson, Birgitte/0000-0002-6143-8394	Villum Foundation [Project AMPHICOP] [8960]	Villum Foundation [Project AMPHICOP]	This work was supported by the Villum Foundation [Project AMPHICOP no. 8960, to B.W.H.].	Asada M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu043; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; BORDESALLEAUME N, 1987, INT J INVER REP DEV, V11, P109, DOI 10.1080/01688170.1987.10510270; BOWNES M, 1988, P NATL ACAD SCI USA, V85, P1554, DOI 10.1073/pnas.85.5.1554; Chen F, 1997, MAR BIOL, V127, P587, DOI 10.1007/s002270050049; DINAN LN, 1981, J INSECT PHYSIOL, V27, P51, DOI 10.1016/0022-1910(81)90032-9; Drillet G, 2006, AQUACULTURE, V254, P714, DOI 10.1016/j.aquaculture.2005.11.018; Drillet G, 2006, AQUAC RES, V37, P756, DOI 10.1111/j.1365-2109.2006.01489.x; GANDE AR, 1979, J INSECT PHYSIOL, V25, P669, DOI 10.1016/0022-1910(79)90117-3; GHARIB B, 1981, EXPERIENTIA, V37, P1107, DOI 10.1007/BF02085039; GLASS H, 1978, CELL TISSUE RES, V194, P237; GOLTZENE F, 1978, H-S Z PHYSIOL CHEM, V359, P1427, DOI 10.1515/bchm2.1978.359.2.1427; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hairston NG, 2002, INTEGR COMP BIOL, V42, P481, DOI 10.1093/icb/42.3.481; Hansen BW, 2010, J PLANKTON RES, V32, P305, DOI 10.1093/plankt/fbp122; Hansen BW, 2016, AQUACULT INT, V24, P949, DOI 10.1007/s10499-015-9963-y; Hansen BW, 2016, AQUACULTURE, V457, P131, DOI 10.1016/j.aquaculture.2016.02.024; Hansen BW, 2012, J COMP PHYSIOL B, V182, P613, DOI 10.1007/s00360-012-0646-y; Holm MW, 2018, J PLANKTON RES, V40, P2, DOI 10.1093/plankt/fbx062; Holmstrup M, 2006, AQUAC RES, V37, P625, DOI 10.1111/j.1365-2109.2006.01472.x; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; LAGUEUX M, 1981, MOL CELL ENDOCRINOL, V24, P325, DOI 10.1016/0303-7207(81)90007-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makka T, 2002, ARCH INSECT BIOCHEM, V51, P111, DOI 10.1002/arch.10055; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Martini A, 2011, B INSECTOL, V64, P253; Nilsson B, 2014, J PLANKTON RES, V36, P513, DOI 10.1093/plankt/fbt099; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; PAFFENHOFER GA, 1988, MAR ECOL PROG SER, V42, P33, DOI 10.3354/meps042033; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; R T. R Core Team, 2017, R LANG ENV STAT COMP; SABATINI ME, 1990, CRUSTACEANA, V59, P53, DOI 10.1163/156854090X00282; Shahin R, 2016, INSECT MOL BIOL, V25, P138, DOI 10.1111/imb.12207; Sichlau MH, 2011, MAR BIOL, V158, P665, DOI 10.1007/s00227-010-1590-6; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; STOTTRUP JG, 1986, AQUACULTURE, V52, P87, DOI 10.1016/0044-8486(86)90028-1; STOTTRUP JG, 1990, J EXP MAR BIOL ECOL, V141, P87, DOI 10.1016/0022-0981(90)90216-Y; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Thompson PA, 2012, AUSTRAL ECOLOGY; Turner JT, 2004, ZOOL STUD, V43, P255; Vitiello V, 2016, ECOTOXICOLOGY, V25, P1033, DOI 10.1007/s10646-016-1660-8; Yamada M, 2000, DEVELOPMENT, V127, P5083; YANG CM, 1977, CRUSTACEANA, V33, P33, DOI 10.1163/156854077X00205; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	47	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193727	10.1371/journal.pone.0193727	http://dx.doi.org/10.1371/journal.pone.0193727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513715	Green Published, gold, Green Submitted			2022-12-26	WOS:000426896800073
J	Zhu, WH; Yao, TJ; Ni, JY; Wei, BG; Lu, ZG				Zhu, Wenhao; Yao, Tengjun; Ni, Jianyue; Wei, Baogang; Lu, Zhiguo			Dependency-based Siamese long short-term memory network for learning sentence representations	PLOS ONE			English	Article								Textual representations play an important role in the field of natural language processing (NLP). The efficiency of NLP tasks, such as text comprehension and information extraction, can be significantly improved with proper textual representations. As neural networks are gradually applied to learn the representation of words and phrases, fairly efficient models of learning short text representations have been developed, such as the continuous bag of words (CBOW) and skip-gram models, and they have been extensively employed in a variety of NLP tasks. Because of the complex structure generated by the longer text lengths, such as sentences, algorithms appropriate for learning short textual representations are not applicable for learning long textual representations. One method of learning long textual representations is the Long Short-Term Memory (LSTM) network, which is suitable for processing sequences. However, the standard LSTM does not adequately address the primary sentence structure (subject, predicate and object), which is an important factor for producing appropriate sentence representations. To resolve this issue, this paper proposes the dependency-based LSTM model (D-LSTM). The D-LSTM divides a sentence representation into two parts: a basic component and a supporting component. The D-LSTM uses a pre-trained dependency parser to obtain the primary sentence information and generate supporting components, and it also uses a standard LSTM model to generate the basic sentence components. A weight factor that can adjust the ratio of the basic and supporting components in a sentence is introduced to generate the sentence representation. Compared with the representation learned by the standard LSTM, the sentence representation learned by the DLSTM contains a greater amount of useful information. The experimental results show that the D-LSTM is superior to the standard LSTM for sentences involving compositional knowledge (SICK) data.	[Zhu, Wenhao; Yao, Tengjun; Ni, Jianyue] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Wei, Baogang] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Lu, Zhiguo] Shanghai Univ, Lib Shanghai Univ, Shanghai, Peoples R China	Shanghai University; Zhejiang University; Shanghai University	Lu, ZG (corresponding author), Shanghai Univ, Lib Shanghai Univ, Shanghai, Peoples R China.	luzg@staff.shu.edu.cn			National Natural Science Foundation of China [61572434, 61303097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work of this paper is supported by National Natural Science Foundation of China (No. 61572434 and No. 61303097) to WZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzianidze Lasha, 2015, P 2015 C EMPIRICAL M, P2492; Agirre Eneko, 2013, SEM 2013; [Anonymous], 2017, MEAN SQUAR ERR; [Anonymous], 2017, PEARS CORR COEFF; [Anonymous], 2017, SPEARM RANK CORR COE; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bowman Samuel R., 2015, P 2015 C EMP METH NA, P632, DOI DOI 10.18653/V1/D15-1075; Chen Danqi, P EMNLP 2014; Cho K., 2014, EMNLP 2014 2014 C EM, DOI DOI 10.3115/V1/D14-1179; Chopra S, 2005, PROC CVPR IEEE, P539, DOI 10.1109/cvpr.2005.202; Gers FA, 2000, IEEE IJCNN, P189, DOI 10.1109/IJCNN.2000.861302; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2012, STUD COMPUT INTELL, V385, P37; Greff K., 2016, ARXIV150304069, P2222, DOI [10.1109/TNNLS.2016.2582924, DOI 10.1109/TNNLS.2016.2582924]; Iyyer M, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P1681; Kenter T, 2016, ARXIV160604640V1; Kiros R., 2015, ADV NEURAL INFORM PR, P3294; Lien E., 2015, P 14 INT C PARS TECH, P40, DOI DOI 10.18653/V1/W15-2205; Marelli M, 2014, SOLID WASTE MANAGEME, P1; Mikolov T., 2013, 1 INT C LEARN REPR I; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mueller J, 2016, AAAI CONF ARTIF INTE, P2786; Norouzi M., 2012, ADV NEURAL INFORM PR, P1070, DOI DOI 10.5555/2999134.2999253; Pascanu R., 2013, INT C MACH LEARN, P1310; Le Q, 2014, PR MACH LEARN RES, V32, P1188; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Tai K. S., 2015, ARXIV150300075V3; Yih Wt, 2011, P 15 C COMP NAT LANG, P247; Zeiler Matthew D, 2012, ARXIV12125701	30	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193919	10.1371/journal.pone.0193919	http://dx.doi.org/10.1371/journal.pone.0193919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513748	Green Published, Green Submitted, gold			2022-12-26	WOS:000426896800088
J	van Westen, E; Poelen, MCM; van den Dobbelsteen, GPJM; Oloo, EO; Ochs, MM; Rots, NY; van Els, CACM				van Westen, Els; Poelen, Martien C. M.; van den Dobbelsteen, Germie P. J. M.; Oloo, Eliud O.; Ochs, Martina M.; Rots, Nynke Y.; van Els, Cecile A. C. M.			Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1	PLOS ONE			English	Article							PNEUMOCOCCAL PROTEIN VACCINE; INFANT MURINE MODEL; TRIVALENT RECOMBINANT PCPA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL COLONIZATION; CRYSTAL-STRUCTURE; PROTECTION; IMMUNIZATION; MICE; INFECTION	Detoxified pneumolysin, PlyD1, is a protein vaccine candidate that induces protection against infections with Streptococcus pneumoniae in mouse models. Despite extensive knowledge on antibody responses against PlyD1, limited information is available about PlyD1 induced T cell recognition. Here we interrogated epitope breadth and functional characteristics of the T cell response to PlyD1 in two mouse strains. BALB/c (H-2(d)) and C57BL/6 (H-2(b)) mice were vaccinated with Al(OH)(3)-adjuvanted or non-adjuvanted PlyD1, or placebo, on day 0, 21 and 42 and were sacrificed at day 56 for collection of sera and spleens. Vaccination with adjuvanted and non-adjuvanted PlyD1 induced anti-pneumolysin IgG antibodies with neutralizing capacity in both mouse strains. Adjuvantation of PlyD1 enhanced the serological responses in both strains. In vitro restimulation of splenocytes with PlyD1 and 18-mer synthetic peptides derived from pneumolysin revealed specific proliferative and cytokine responses. For both mouse strains, one immunodominant and three subdominant natural epitopes were identified. Overlap between H-2(d) and H-2(b) restricted T cell epitopes was limited, yet similarities were found between epitopes processed in mice and predicted to be immunogenic in humans. H-2(d) restricted T cell epitopes were localized in pneumolysin domains 2 and 3, whereas H-2(b) epitopes were scattered over the protein. Cytokine responses show mostly a Th2 profile, with low levels of Th1 cytokines, in both mouse strains. In conclusion, PlyD1 evokes T cell responses in mice directed against multiple epitope regions, that is dependent on Major Histocompatibility Complex (MHC) background. These results are important to understand human PlyD1 T cell immunogenicity, to guide cell mediated immunity studies in the context of vaccine development.	[van Westen, Els; Poelen, Martien C. M.; van den Dobbelsteen, Germie P. J. M.; Rots, Nynke Y.; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Oloo, Eliud O.] Sanofi Pasteur, Cambridge, MA USA; [Ochs, Martina M.] Sanofi Pasteur, Marcy Letoile, France; [van den Dobbelsteen, Germie P. J. M.] Janssen, Bacterial Vaccines, Leiden, Netherlands; [Oloo, Eliud O.] Schrodinger Inc, Cambridge, MA USA	Netherlands National Institute for Public Health & the Environment; Sanofi-Aventis; Johnson & Johnson; Janssen Pharmaceuticals	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl						ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchard-Rohner G, 2011, EXPERT REV VACCINES, V10, P673, DOI 10.1586/erv.11.14; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Brooks WA, 2015, VACCINE, V33, P4610, DOI 10.1016/j.vaccine.2015.06.078; Converso TR, 2017, VACCINE, V35, P149, DOI 10.1016/j.vaccine.2016.11.027; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Gray C, 2014, MUCOSAL IMMUNOL, V7, P705, DOI 10.1038/mi.2013.89; Jefferies JMC, 2010, J MED MICROBIOL, V59, P808, DOI 10.1099/jmm.0.018663-0; Kamtchoua T, 2013, VACCINE, V31, P327, DOI 10.1016/j.vaccine.2012.11.005; KANCLERSKI K, 1987, J CLIN MICROBIOL, V25, P222, DOI 10.1128/JCM.25.2.222-225.1987; Kaur R, 2014, INFECT IMMUN, V82, P5069, DOI 10.1128/IAI.02124-14; Khan MN, 2014, J INFECT DIS, V210, P1658, DOI 10.1093/infdis/jiu321; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Korchev YE, 1998, BIOCHEM J, V329, P571; Lawrence SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14352; Ljutic B, 2012, VACCINE, V30, P2981, DOI 10.1016/j.vaccine.2012.02.038; Lock RA, 1996, MICROB PATHOGENESIS, V21, P71, DOI 10.1006/mpat.1996.0044; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Mann B, 2014, J INFECT DIS, V209, P1116, DOI 10.1093/infdis/jit502; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Marshall JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13293; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moffitt KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043445; Moffitt KL, 2012, VACCINE, V30, P4316, DOI 10.1016/j.vaccine.2012.01.034; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P1577, DOI 10.4161/hv.24615; Oloo EO, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191148; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11; Southwood S, 1998, J IMMUNOL, V160, P3363; Suarez-Alvarez B, 2003, IMMUNOL LETT, V88, P227, DOI 10.1016/S0165-2478(03)00081-6; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Verhoeven D, 2014, CLIN VACCINE IMMUNOL, V21, P1037, DOI 10.1128/CVI.00052-14; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; Wall EC, 2012, CLIN INFECT DIS, V54, P701, DOI 10.1093/cid/cir926; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wilson R, 2015, MUCOSAL IMMUNOL, V8, P627, DOI 10.1038/mi.2014.95; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Xu Q, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.01.011; Xu QF, 2017, VACCINE, V35, P337, DOI 10.1016/j.vaccine.2016.11.046; Zafar MA, 2017, CELL HOST MICROBE, V21, P73, DOI 10.1016/j.chom.2016.12.005	51	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193650	10.1371/journal.pone.0193650	http://dx.doi.org/10.1371/journal.pone.0193650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509778	Green Submitted, Green Published, gold			2022-12-26	WOS:000426813200019
J	Yanagisawa, S; Baker, JR; Vuppusetty, C; Koga, T; Colley, T; Fenwick, P; Donnelly, LE; Barnes, PJ; Ito, K				Yanagisawa, Satoru; Baker, Jonathan R.; Vuppusetty, Chaitanya; Koga, Takeshi; Colley, Thomas; Fenwick, Peter; Donnelly, Louise E.; Barnes, Peter J.; Ito, Kazuhiro			The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DEPENDENT HISTONE DEACETYLASE; OXIDATIVE STRESS; INFLAMMATION; GLUTATHIONE; INHIBITION; PROTEIN; METABOLISM; CANCER; MICE	SIRT1 (silent information regulator 2 homolog 1) is a crucial cellular survival protein especially in oxidative stress environments, and has been thought to locate within the nuclei, but also known to shuttle between cytoplasm and nuclei in some cell types. Here, we show for the first time the dynamics of SIRT1 in the presence of single or concurrent cigarette smoke extract (CSE) exposure in human bronchial epithelial cells (HBEC). In BEAS-2B HBEC or primary HBEC, SIRT1 was localized predominantly in cytoplasm, and the CSE (3%) induced nuclear translocation of SIRT1 from cytoplasm in the presence of L-buthionine sulfoximine (an irreversible inhibitor of Y-glutamylcystein synthetase), mainly through the activation of phosphatidylinositol 3-kinase (PI3K) alpha subunit. This SIRT1 nuclear shuttling was associated with FOXO3a nuclear translocation and the strong induction of several anti-oxidant genes including superoxide dismutase (SOD) 2 and 3; therefore seemed to be an adaptive response. When BEAS-2B cells were pretreated with repeated exposure to a lower concentration of CSE (0.3%), the CSE-induced SIRT1 shuttling and resultant SOD2/3 mRNA induction were significantly impaired. Thus, this result offers a useful cell model to mimic the impaired anti-oxidant capacity in cigarette smoking-associated lung disease such as chronic obstructive pulmonary disease.	[Yanagisawa, Satoru; Baker, Jonathan R.; Vuppusetty, Chaitanya; Koga, Takeshi; Colley, Thomas; Fenwick, Peter; Donnelly, Louise E.; Barnes, Peter J.; Ito, Kazuhiro] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England	Imperial College London	Ito, K (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England.	k.ito@imperial.ac.uk	Yanagisawa, Satoru/D-8292-2018; Ito, Kazuhiro/AAF-5994-2019	Yanagisawa, Satoru/0000-0003-3895-5518; Barnes, Peter/0000-0002-5122-4018; Donnelly, Louise/0000-0002-0753-5425	Wellcome Trust Programme Grant [093080/Z/10/Z]; Banyu Life Science Foundation International fellowship; Wellcome Trust; Pulmocide Ltd	Wellcome Trust Programme Grant(Wellcome Trust); Banyu Life Science Foundation International fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Pulmocide Ltd	This study was supported by the Wellcome Trust Programme Grant (093080/Z/10/Z). S.Y is a recipient of a Banyu Life Science Foundation International fellowship. CV and JB are recipients of a Wellcome Trust grant shown above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pulmocide Ltd also provided support in the form of salaries for authors [KI, TC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Wellcome Trust Programme Grant (093080/Z/10/Z). S.Y is a recipient of a Banyu Life Science Foundation International fellowship. CV and JB are recipients of a Wellcome Trust grant shown above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pulmocide Ltd provided support in the form of salaries for authors [KI, TC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Byles V, 2010, INT J BIOL SCI, V6, P599; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chen Z, 2013, ANTIOXID REDOX SIGN, V19, P1522, DOI 10.1089/ars.2012.4803; Dong X Charlie, 2012, Diabetes Manag (Lond), V2, P243; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Engelen MPKJ, 2000, AM J RESP CRIT CARE, V161, P98, DOI 10.1164/ajrccm.161.1.9901031; Faes S, 2015, INT J MOL SCI, V16, P21138, DOI 10.3390/ijms160921138; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Ghigo A, 2010, BIOESSAYS, V32, P185, DOI 10.1002/bies.200900150; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Martinez-Redondo Paloma, 2013, Genes Cancer, V4, P148, DOI 10.1177/1947601913483767; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Meng CB, 2011, J INNOV OPT HEAL SCI, V4, P133, DOI 10.1142/S1793545811001356; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mitani A, 2016, AM J RESP CRIT CARE, V193, P143, DOI 10.1164/rccm.201503-0593OC; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Turgut T, 2014, J THORAC DIS, V6, P765, DOI 10.3978/j.issn.2072-1439.2014.04.24; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Yao HW, 2014, AM J PHYSIOL-LUNG C, V306, pL816, DOI 10.1152/ajplung.00323.2013; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zheng ZH, 2011, MOL PHARMACOL, V80, P657, DOI 10.1124/mol.111.072546	48	36	37	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193921	10.1371/journal.pone.0193921	http://dx.doi.org/10.1371/journal.pone.0193921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509781	gold, Green Published, Green Submitted			2022-12-26	WOS:000426813200043
J	Ndlovu, Z; Fajardo, E; Mbofana, E; Maparo, T; Garone, D; Metcalf, C; Bygrave, H; Kao, K; Zinyowera, S				Ndlovu, Zibusiso; Fajardo, Emmanuel; Mbofana, Elton; Maparo, Tatenda; Garone, Daniela; Metcalf, Carol; Bygrave, Helen; Kao, Kekeletso; Zinyowera, Sekesai			Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SCALE-UP; CARE; MORTALITY	Background HIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. GeneXpert (Cepheid, CA, USA) is a polyvalent near point-of-care platform and is widely implemented for Xpert MTB/RIF diagnosis. This study sought to evaluate the operational feasibility of integrated HIV VL, EID and MTB/RIF testing in new GeneXpert platforms. Methods Whole blood samples were collected from consenting patients due for routine HIV VL testing and DBS samples from infants due for EID testing, at three rural health facilities in Zimbabwe. Sputum samples were collected from all individuals suspected of TB. GeneXpert testing was reserved for all EID, all TB suspects and priority HIV VL at each site. Blood samples were further sent to centralized laboratories for confirmatory testing. GeneXpert polyvalent testing results and patient outcomes, including infrastructural and logistical requirements are reported. The study was conducted over a 10-month period. Results The fully automated GeneXpert testing device, required minimal training and biosafety considerations. A total of 1,302 HIV VL, 277 EID and 1,581 MTB/RIF samples were tested on a four module GeneXpert platform in each study site. Xpert HIV-1 VL testing was prioritized for patients who presented with advanced HIV disease, pregnant women, adolescents and suspected ART failures patients. On average, the study sites had a GeneXpert utilization rate of 50.4% (Gutu Mission Hospital), 63.5% (Murambinda Mission Hospital) and 17.5% (Chimombe Rural Health Centre) per month. GeneXpert polyvalent testing error rates remained lower than 4% in all sites. Decentralized EID and VL testing on Xpert had shorter overall median TAT (1 day [IQR: 0-4] and 1 day [IQR: 0-1] respectively) compared to centralized testing (17 days [IQR: 13-21] and 26 days [IQR: 23-32] respectively). Among patients with VL >1000 copies/ml (73/640; 11.4%) at GMH health facility, median time to enhanced adherence counselling was 8 days and majority of those with documented outcomes had re-suppressed VL (20/32; 62.5%). Median time to ART initiation among Xpert EID positive infants at GMH was 1 day [IQR: 0-1]. Conclusion Implementation of near point-of-care GeneXpert platform for integrated multi-disease testing within district and sub-district healthcare settings is feasible and will increase access to VL, and EID testing to priority populations. Quality management systems including monitoring of performance indicators, together with regular on-site supervision are crucial, and near-POC test results must be promptly actioned-on by clinicians for patient management.	[Ndlovu, Zibusiso; Metcalf, Carol; Bygrave, Helen] Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa; [Fajardo, Emmanuel] Access Campaign, Med Sans Frontieres, Geneva, Switzerland; [Mbofana, Elton; Maparo, Tatenda; Garone, Daniela] Med Sans Frontieres, Harare, Zimbabwe; [Kao, Kekeletso] Fdn Innovat New Diagnost, Geneva, Switzerland; [Zinyowera, Sekesai] Minist Hlth & Child Care, Natl Microbiol Reference Lab, Harare, Zimbabwe	Doctors Without Borders; Foundation For Innovative New Diagnostics	Ndlovu, Z (corresponding author), Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa.	ndlovinizee@gmail.com	Ndlovu, Zibusiso/AAC-5605-2021	Ndlovu, Zibusiso/0000-0003-0386-8641	FIND	FIND	Foundation for Innovative New Diagnostics (FIND=> https://www.finddx.org/) supported in the acquisition of GeneXpert reagents and Medecins Sans Frontieres (MSF) provided support for aqcusition of GeneXpert platforms. The financial support from FIND went straight to Cepheid (manufactuer of reagents for HIV and TB diagnosis). The opinions expressed herein are those of the authors and do not necessarily reflect the views of Medecins Sans Frontieres, National Microbiology Reference Laboratory or Foundation for Innovative New Diagnostics.	Abbott Molecular Inc. USA, ABB REAL TIM HIV 1; Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; [Anonymous], 2013, POLICY; [Anonymous], CEPH GENEXPERT OMN; BioMerieux Clinial Diagnostics, 2009, BIOMERIEUX CLINIAL D; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cepheid GeneXpert HIV-1 Quant HIV-1 Qual MTB/Rif, CEPH GENEXPERT HIV 1; Cepheid Inc, 2016, GENEXPERT SAF DAT SH; Clouse K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171384; Desai M, 2017, THE LANCET HIV; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Essajee S, 2017, JAIDS-J ACQ IMM DEF, V75, pS51, DOI [10.1097/qai.0000000000001319, 10.1097/QAI.0000000000001319]; Essajee S, 2015, J INT AIDS SOC, V18, P14, DOI 10.7448/IAS.18.7.20299; Fonjungo PN, 2016, AIDS, V30, P1317, DOI 10.1097/QAD.0000000000001031; Global Laboratory Initiative (GLI), ADV TB DIAGN; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani I, 2017, C RETR OPP INF CROI; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Joloba M, 2016, J INFECT DIS, V213, pS41, DOI 10.1093/infdis/jiw035; Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576; Kiyaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078609; Mashamba-Thompson T, 2017, DIAGNOSTICS, V7; Medecins Sans Frontieres, 2016, MAK VIR LOAD ROUT SU; Meyers A, 2016, AFRICAN J LAB MED, V2; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; Mor O, 2015, J CLIN MICROBIOL, V10, P1128; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Roche Molecular Diagnostics, ROCH CAB AMPLIPREP C; Schumacher S, 2015, INT J TUBERCULOSIS L, V19; Ssonko C, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21654; Stevens W, 2017, JAIDS; Stevens W, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0173-7; UNAIDS, 2016, GET FAST TRACK LIFE; Vojnov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155256; Waldrop G, TROPICAL MED INT HLT; WHO, 2016, PROGR REP 2016; World Health Organization, 2016, THE END TB STRAT; World Health Organization, 2014, UPD XPERT MTB RIF IM; World Health Organization, 2016, PQDX025907000 WHO; World Health Organization, 2017, CONS AD US MULT TEST	44	48	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193577	10.1371/journal.pone.0193577	http://dx.doi.org/10.1371/journal.pone.0193577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499042	Green Submitted, Green Published, gold			2022-12-26	WOS:000426472300015
J	Chae, S; Jung, SW; Park, HS				Chae, Sanghoon; Jung, Sung-Weon; Park, Hyung-Soon			In vivo biomechanical measurement and haptic simulation of portal placement procedure in shoulder arthroscopic surgery	PLOS ONE			English	Article							ROTATOR-CUFF REPAIR; SURGICAL SIMULATOR; KNEE ARTHROSCOPY; LEARNING-CURVE; SKILLS; ACQUISITION; FEEDBACK	A survey of 67 experienced orthopedic surgeons indicated that precise portal placement was the most important skill in arthroscopic surgery. However, none of the currently available virtual reality simulators include simulation / training in portal placement, including haptic feedback of the necessary puncture force. This study aimed to: (1) measure the in vivo force and stiffness during a portal placement procedure in an actual operating room and (2) implement active haptic simulation of a portal placement procedure using the measured in vivo data. We measured the force required for port placement and the stiffness of the joint capsule during portal placement procedures performed by an experienced arthroscopic surgeon. Based on the acquired mechanical property values, we developed a cable-driven active haptic simulator designed to train the portal placement skill and evaluated the validity of the simulated haptics. Ten patients diagnosed with rotator cuff tears were enrolled in this experiment. The maximum peak force and joint capsule stiffness during posterior portal placement procedures were 66.46 (+/- 10.76N) and 2560.82(+/- 252.92) N/m, respectively. We then designed an active haptic simulator using the acquired data. Our cable-driven mechanism structure had a friction force of 3.763 +/- 0.341 N, less than 6% of the mean puncture force. Simulator performance was evaluated by comparing the target stiffness and force with the stiffness and force reproduced by the device. R-squared values were 0.998 for puncture force replication and 0.902 for stiffness replication, indicating that the in vivo data can be used to implement a realistic haptic simulator.	[Chae, Sanghoon] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Jung, Sung-Weon] Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Dept Orthopaed Surg, Chang Won, South Korea; [Park, Hyung-Soon] Korea Adv Inst Sci & Technol KAIST, Dept Mech Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Advanced Institute of Science & Technology (KAIST)	Park, HS (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Mech Engn, Daejeon, South Korea.	hyungspark@kaist.ac.kr	Park, Hyung-Soon/B-3334-2010	Park, Hyung-Soon/0000-0003-4274-7420; Chae, Sang-Hoon/0000-0002-7143-5074	Korean National Research Foundation [NRF-2017R1A2B4011961]; Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health Welfare, Korea [NRCTR-EX16002]	Korean National Research Foundation(National Research Foundation of Korea); Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health Welfare, Korea	This work was supported by Korean National Research Foundation (Grant No.: NRF-2017R1A2B4011961, (https://www.nrf.re.kr/eng/main). This study was also supported by a grant (NRCTR-EX16002) of the Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health & Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, J SURG RES, V145, P80, DOI 10.1016/j.jss.2007.04.027; Aim F, 2016, ARTHROSCOPY, V32, P224, DOI 10.1016/j.arthro.2015.07.023; Allin S, 2002, HAPT INT VIRT ENV TE; Andersen C, 2011, ACTA ORTHOP, V82, P90, DOI 10.3109/17453674.2011.552776; Bey MJ, 2005, J SHOULDER ELB SURG, V14, P201, DOI 10.1016/j.jse.2004.06.016; Buess E, 2005, ARTHROSCOPY, V21, P597, DOI 10.1016/j.arthro.2005.01.002; Colaco HB, 2017, J SURG EDUC, V74, P47, DOI 10.1016/j.jsurg.2016.07.006; Dankelman J, 2008, WORLD J SURG, V32, P149, DOI 10.1007/s00268-007-9150-z; DEORIO JK, 1984, J BONE JOINT SURG AM, V66A, P563, DOI 10.2106/00004623-198466040-00011; Frank RM, 2014, ARTHROSCOPY, V30, P121, DOI 10.1016/j.arthro.2013.09.084; Fucentese SF, 2015, KNEE SURG SPORT TR A, V23, P1077, DOI 10.1007/s00167-014-2888-6; Gandhi MJ, 2015, ARTHROSCOPY, V31, P1671, DOI 10.1016/j.arthro.2015.03.019; Guttmann D, 2005, ARTHROSCOPY, V21, P394, DOI 10.1016/j.arthro.2004.12.006; Hui Y, 2013, INT J COMPUT ASS RAD, V8, P945, DOI 10.1007/s11548-013-0833-7; Kneebone R, 2009, BRIT MED J PUBLISHIN; Kohn, 2000, ERR IS HUMAN BUILDIN; Lim YJ, 2009, SURG ENDOSC, V23, P1298, DOI 10.1007/s00464-008-0154-z; Mabrey J. D., 2002, ARTHROSCOPY, V18, P1; Madan SS, 2014, SIMUL HEALTHC, V9, P127, DOI 10.1097/SIH.0b013e3182a86165; McCarthy AD, 2006, CLIN ORTHOP RELAT R, P13, DOI 10.1097/01.blo.0000194678.10130.ff; Meyer M, 2007, ARTHROSCOPY, V23, P529, DOI 10.1016/j.arthro.2006.12.022; Morris PJ, 2004, BMJ-BRIT MED J, V328, P1133, DOI 10.1136/bmj.328.7448.1133; Motola I, 2013, MED TEACH, V35, pE1511, DOI 10.3109/0142159X.2013.818632; Nho SJ, 2007, J BONE JOINT SURG AM, V89A, P127, DOI 10.2106/JBJS.G.00583; NOTTAGE WM, 1993, ORTHOP CLIN N AM, V24, P19; O'Neill PJ, 2002, ARTHROSCOPY, V18, P795, DOI 10.1053/jars.2002.31699; Oh JH, 2008, ARTHROSCOPY, V24, P983, DOI 10.1016/j.arthro.2008.06.007; Pedowitz R, 2002, ARTHROSCOPY, V18, P1; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Podder T, 2006, MED PHYS, V33, P2915, DOI 10.1118/1.2218061; Randelli P, 2015, EFFECTIVE TRAINING A; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; STANISH WD, 1995, ARTHROSCOPY, V11, P458, DOI 10.1016/0749-8063(95)90201-5; Tay BK, 2006, IEEE T BIO-MED ENG, V53, P2129, DOI 10.1109/TBME.2006.879474; Thomas Geb W, 2014, Iowa Orthop J, V34, P181; Ward JW, 1998, FUTURE GENER COMP SY, V14, P243, DOI 10.1016/S0167-739X(98)00028-4	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193736	10.1371/journal.pone.0193736	http://dx.doi.org/10.1371/journal.pone.0193736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494691	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200092
J	Cui, JT; Yan, WJ; Xu, SX; Wang, QF; Zhang, WH; Liu, WJ; Ni, AP				Cui, Jingtao; Yan, Wenjuan; Xu, Shaoxia; Wang, Qiaofeng; Zhang, Weihong; Liu, Wenjing; Ni, Anping			Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NONHUMAN PRIMATE MODEL; BABOON; IMMUNOGENICITY; EXPRESSION; INDUCTION; TRANSPLANTATION; GENERATION; ADVANTAGES; NEURONS	Background Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) which is prevalent in South China, and its association with systemic lupus erythematosus (SLE) or other autoimmune diseases has not been studied in the mainland of China. The EBV serological tests have been performed on patients with various diseases or manifestations for years at our institution and their values need to be evaluated. Methods For routine medical purposes, anti-EB viral capsid antigen (VCA) IgG, IgA and IgM antibodies, anti-EBV diffuse early antigen (EA-D) IgA antibodies, and anti- EBV nuclear antigen-1 (EBNA-1) IgG antibodies were tested with commercial enzyme-linked immunosorbent assay (ELISA) in patients visiting Peking Union Medical College Hospital between 2013 and 2017. The test results were analyzed in this retrospective study. Results There were a total of 11122 serum samples available to be tested in the study. As indicators of past EBV infection, the prevalence of VCA-IgG/EBNA1-IgG were 66.6%/58.5%, 84.3%/78.8%, 92.9%/87.0% and 98.5%/95.4% in patients aged under 5 years, 6-10 years, 11-20 years and 21-30 years old, respectively, and these values maintained at this highest rate as age increased further. The prevalence of VCA-IgM, as a parameter of acute EBV infection, was 14.6%, 10.2%, 10.4%, 6.3% and 3.1% in patients aged under 5 years, 6-10 years, 11-20 years, 21-30 years, 31-40 years old, respectively, and decreased to 2%similar to 3% in older patients. Patients with elevated serum liver enzymes were more likely to have a higher prevalence of EA/D IgA antibody (P < 0.01) and young patients (<= 30 years) with lymphadenopathy were more likely to have higher prevalence of VCA-IgM antibody (P < 0.01). The prevalence of VCA-IgA and EAD-IgA were 87.0% and 59.2% in NPC patients, respectively, and both were significantly higher (P < 0.001) than that in non-NPC patients. The prevalence of VCA-IgA was 45.4% and 25.6% in SLE patients and patients with other autoimmune diseases, respectively, which were significantly (P < 0.001) and mildly (P = 0.039) higher than their controls. In pediatric SLE patients between 6 and 10 years old, the prevalence of VCA-IgG, VCA-IgA and EBNA1-IgG was 100%, 59.5% and 100%, respectively, all being significantly higher than the age (6-10y) related controls (P<0.01). In the 705 cerebral spinal fluid (CSF) specimens, VCA-IgG, VCA-IgM, VCA-IgA and EAD-IgA were found to be positive in 12.1%, 0.15%, 0.25% and 0.25%, respectively. There were 157 paired specimens (CSF and serum were collected simultaneously) and VCA-IgG was identified as positive in 12.7% of the CSF and 100% of the serum specimens. Conclusions Around 98% of Chinese patients were infected with EBV before 30 years of age and the highest rate of acute EBV infection were observed in patients under 5 years old. EBV infection was found to be associated with elevated serum liver enzymes, NPC and SLE. Acute anti-EBV antibody was valued for young patients with lymphadenopathy but limited value for CNS neuropathy.	[Ni, Anping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ni, AP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China.	niap@pumch.cn			Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	This work is funded through a grant to J.M. from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; Chen IC, 2016, STEM CELLS DEV, V25, P1698, DOI 10.1089/scd.2016.0221; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Drukker M, 2008, STEMBOOK, DOI http://dx.doi.org/10.3824/stembook.1.14.1; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grow DA, 2016, STEM CELL RES, V17, P352, DOI 10.1016/j.scr.2016.08.013; Grow DA, 2016, STEM CELL TRANSL MED, V5, P1133, DOI 10.5966/sctm.2015-0073; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Ledford H, 2011, NATURE, V477, P526, DOI 10.1038/477526a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik Nasir, 2013, Methods Mol Biol, V997, P23, DOI 10.1007/978-1-62703-348-0_3; McFarlane D, 2011, J GERONTOL A-BIOL, V66, P1309, DOI 10.1093/gerona/glr146; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Mull AN, 2014, STEM CELL RES, V12, P539, DOI 10.1016/j.scr.2014.01.002; Murthy KK, 2006, VACCINE, V24, P4622, DOI 10.1016/j.vaccine.2005.08.047; Navara CS, 2007, STEM CELLS, V25, P2695, DOI 10.1634/stemcells.2007-0286; Navara CS, 2013, CELL REPROGRAM, V15, P495, DOI 10.1089/cell.2012.0093; NAVARA CS, 2007, CURR PROTOC STEM CEL, pCH1; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Perry DL, 2012, VIRUSES-BASEL, V4, P2400, DOI 10.3390/v4102400; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rogers J, 1997, AM J HUM GENET, V61, P489, DOI 10.1086/515527; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Simerly CR, 2009, STEM CELL RES, V2, P178, DOI 10.1016/j.scr.2009.02.004; Stacy S, 2008, J IMMUNOL, V181, P109, DOI 10.4049/jimmunol.181.1.109; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Todorova D, 2016, STEM CELLS, V34, P510, DOI 10.1002/stem.2227; VandeBerg J.L., 2009, BABOON BIOMEDICAL RE; VandeBerg JL, 1997, J MED PRIMATOL, V26, P113, DOI 10.1111/j.1600-0684.1997.tb00042.x; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wu YH, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/767195; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	47	19	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193171	10.1371/journal.pone.0193171	http://dx.doi.org/10.1371/journal.pone.0193171			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494658	Green Submitted, Green Published, gold			2022-12-26	WOS:000426363200028
J	Stone, MJ; Catterall, CP; Stork, NE				Stone, Marisa J.; Catterall, Carla P.; Stork, Nigel E.			Edge effects and beta diversity in ground and canopy beetle communities of fragmented subtropical forest	PLOS ONE			English	Article							SPECIES RESPONSES; VERTICAL STRATIFICATION; HABITAT EDGES; ASSEMBLAGES; CONSERVATION; MICROCLIMATE; METAANALYSIS	Clearing of dry forests globally creates edges between remnant forest and open anthropogenic habitats. We used flight intercept traps to evaluate how forest beetle communities are influenced by distance from such edges, together with vertical height, spatial location, and local vegetation structure, in an urbanising region ( Brisbane, Australia). Species composition ( but not total abundance or richness) differed greatly between ground and canopy. Species composition also varied strongly among sites at both ground and canopy levels, but almost all other significant effects occurred only at ground level, where: species richness declined from edge to interior; composition differed between positions near edges (<10 m) and interiors (>50 m); high local canopy cover was associated with greater total abundance and richness and differing composition; and greater distances to the city centre were associated with increased total abundances and altered composition. Analyses of individual indicator species associated with this variation enabled further biological interpretations. A global literature synthesis showed that most spatially well-replicated studies of edge effects on ground-level beetles within forest fragments have likewise found that positions within tens of metres from edges with open anthropogenic habitats had increased species richness and different compositions from forest interior sites, with fewer effects on abundance. Accordingly, negative edge effects will not prevent relatively small compact fragments ( if >10-20 ha) from supporting forest-like beetle communities, although indirect consequences of habitat degradation remain a threat. Retention of multiple spatially scattered forest areas will also be important in conserving forest-dependent beetles, given high levels of between-site diversity.	[Stone, Marisa J.; Catterall, Carla P.; Stork, Nigel E.] Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Nathan, Qld, Australia	Griffith University	Stone, MJ (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Nathan, Qld, Australia.	marisa.stone@griffithuni.edu.au		Stork, Nigel/0000-0001-7812-2452	Griffith University's School of Environment and Environmental Futures Research Institute	Griffith University's School of Environment and Environmental Futures Research Institute	This project was funded by Griffith University's School of Environment and Environmental Futures Research Institute.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2015, MAPS AV COND; Barnes AD, 2014, BIOL CONSERV, V170, P28, DOI 10.1016/j.biocon.2013.12.006; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P17; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Catterall C, 1997, CONSERVATION OUTSIDE, P367; Catterall CP, 2010, DIVERS DISTRIB, V16, P559, DOI 10.1111/j.1472-4642.2010.00665.x; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Guimaraes CDD, 2014, ENVIRON ENTOMOL, V43, P537, DOI 10.1603/EN13190; Didham RK, 2014, PAC SCI, V68, P493, DOI 10.2984/68.4.4; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Dodonov P, 2013, PLANT ECOL, V214, P1345, DOI 10.1007/s11258-013-0256-0; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FOA, 2015, FOR AUST 2013; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gaublomme E, 2014, INSECT CONSERV DIVER, V7, P82, DOI 10.1111/icad.12036; Grimbacher PS, 2006, AUSTRAL ECOL, V31, P458, DOI 10.1111/j.1442-9993.2006.01606.x; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hsieh TC, 2014, INEXT ONLINE INTERPO; Knapp M, 2013, BIOL CONSERV, V164, P22, DOI 10.1016/j.biocon.2013.04.012; Kotze DJ, 2001, BIODIVERS CONSERV, V10, P443, DOI 10.1023/A:1016606209906; Lacasella F, 2015, BIODIVERS CONSERV, V24, P447, DOI 10.1007/s10531-014-0825-0; MacGregor-Fors I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056794; Magura T, 2017, ECOL EVOL, V7, P1009, DOI 10.1002/ece3.2722; Major RE, 2003, BIOL CONSERV, V113, P35, DOI 10.1016/S0006-3207(02)00347-6; MEA (Millennium Ecosystem Assessment), 2005, MILL EC ASS EC HUM W; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Noreika N, 2012, J INSECT CONSERV, V16, P867, DOI 10.1007/s10841-012-9474-3; Normann C, 2016, FOREST ECOL MANAG, V361, P421, DOI 10.1016/j.foreco.2015.11.002; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peyras M, 2013, J INSECT CONSERV, V17, P807, DOI 10.1007/s10841-013-9563-y; R Core Team, 2015, R LANG ENV STAT COMP; Resasco J, 2017, ECOGRAPHY, V40, P109, DOI 10.1111/ecog.02546; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roberts D.W., 2016, LABDSV ORDINATION MU; Rosch V, 2015, OECOLOGIA, V179, P209, DOI 10.1007/s00442-015-3315-5; Sattler P., 1999, CONSERVATION STATUS; SOFR, 2015, AUSTR STAT FOR REP 2; Stork NE, 2016, AUSTRAL ECOL, V41, P168, DOI 10.1111/aec.12286; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Villada-Bedoya S, 2017, BIOTROPICA, V49, P195, DOI 10.1111/btp.12373	52	8	9	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193369	10.1371/journal.pone.0193369	http://dx.doi.org/10.1371/journal.pone.0193369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494680	Green Published, gold, Green Submitted			2022-12-26	WOS:000426363200041
